PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cretin, E; Pazart, L; Rousseau, MC; Noe, A; Decavel, P; Chassagne, A; Godard-Marceau, A; Trimaille, H; Mathieu-Nicot, F; Beaussant, Y; Gabriel, D; Daneault, S; Aubry, R				Cretin, Elodie; Pazart, Lionel; Rousseau, Marie-Christine; Noe, Alain; Decavel, Pierre; Chassagne, Aline; Godard-Marceau, Aurelie; Trimaille, Helene; Mathieu-Nicot, Florence; Beaussant, Yvan; Gabriel, Damien; Daneault, Serge; Aubry, Regis			Exploring the perceptions of physicians, caregivers and families towards artificial nutrition and hydration for people in permanent vegetative state: How can a photo-elicitation method help?	PLOS ONE			English	Article							HEALTH; DISORDERS; DISTRESS; GRIEF	The question of withdrawing artificial nutrition and hydration from people in a permanent vegetative state sparks considerable ethical and legal debate. Therefore, understanding the elements that influence such a decision is crucial. However, exploring perceptions of artificial nutrition and hydration is methodologically challenging for several reasons. First, because of the emotional state of the professionals and family members, who are facing an extremely distressing situation; second, because this question mirrors representations linked to a deep-rooted fear of dying of hunger and thirst; and third, because of taboos surrounding death. We sought to determine the best method to explore such complex situations in depth. This article aims to assess the relevance of the photo-elicitation interview method to analyze the perceptions and attitudes of health professionals and families of people in a permanent vegetative state regarding artificial nutrition and hydration. The photo-elicitation interview method consists in inserting one or more photographs into a research interview. An original set of 60 photos was built using Google Images and participants were asked to choose photos( 10 maximum) and talk about them. The situations of 32 patients were explored in 23 dedicated centers for people in permanent vegetative state across France. In total, 138 interviews were conducted with health professionals and family members. We found that the photo-elicitation interview method 1) was well accepted by the participants and allowed them to express their emotions constructively, 2) fostered narration, reflexivity and introspection, 3) offered a sufficient "unusual angle" to allow participants to go beyond stereotypes and habits of thinking, and 4) can be replicated in other research areas. The use of visual methods currently constitutes an expanding area of research and this study stressed that this is of special interest to enhance research among populations facing end-of-life and ethical issues.	[Cretin, Elodie; Pazart, Lionel; Chassagne, Aline; Godard-Marceau, Aurelie; Trimaille, Helene; Mathieu-Nicot, Florence; Beaussant, Yvan; Gabriel, Damien; Aubry, Regis] Univ Hosp Besancon, CIC Inserm 1431, Clin Invest Ctr, Besancon, France; [Cretin, Elodie; Chassagne, Aline; Godard-Marceau, Aurelie; Trimaille, Helene; Mathieu-Nicot, Florence; Beaussant, Yvan; Aubry, Regis] Univ Hosp Besancon, Palliat Care Unit, Besancon, France; [Cretin, Elodie] Univ Bourgogne Franche Comte, Dept Philosophy EA 2274, Besancon, France; [Cretin, Elodie; Pazart, Lionel; Decavel, Pierre; Godard-Marceau, Aurelie; Gabriel, Damien; Aubry, Regis] Univ Bourgogne Franche Comte, Dept Neurosci EA 481, Besancon, France; [Cretin, Elodie; Aubry, Regis] Reg Ctr Med Eth Bourgogne Franche Comte EREBFC, Besancon, France; [Rousseau, Marie-Christine] San Salvadour Hosp, AP HP, PVS MCS Unit, Hyeres, France; [Noe, Alain] Ctr Funct Reeduc & Rehabil Bretignier, PVS MCS Unit, Hericourt, France; [Decavel, Pierre] Ctr Funct Reeduc & Rehabil Les Salins de Bregille, PVS MCS Unit, Besancon, France; [Chassagne, Aline] Univ Bourgogne Franche Comte, Dept Socioanthropol EA 3189, Besancon, France; [Mathieu-Nicot, Florence] Univ Bourgogne Franche Comte, Dept Psychol EA 3188, Besancon, France; [Daneault, Serge] Univ Hosp Montreal, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire San Salvadour - APHP; Universite de Franche-Comte; Universite de Franche-Comte	Cretin, E (corresponding author), Univ Hosp Besancon, CIC Inserm 1431, Clin Invest Ctr, Besancon, France.; Cretin, E (corresponding author), Univ Hosp Besancon, Palliat Care Unit, Besancon, France.; Cretin, E (corresponding author), Univ Bourgogne Franche Comte, Dept Philosophy EA 2274, Besancon, France.; Cretin, E (corresponding author), Univ Bourgogne Franche Comte, Dept Neurosci EA 481, Besancon, France.; Cretin, E (corresponding author), Reg Ctr Med Eth Bourgogne Franche Comte EREBFC, Besancon, France.	ecretin@chu-besancon.fr	Pazart, Lionel/GYU-1917-2022; DECAVEL, Pierre/H-4032-2017	DECAVEL, Pierre/0000-0002-0567-7171; gabriel, damien/0000-0001-5413-3640; Aubry, Regis/0000-0001-7580-567X	National Clinical Research Grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC) [12-04]	National Clinical Research Grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC)	This study was supported by a National Clinical Research Grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC 2008 No12-04: http://social-sante.gouv.fr/IMG/pdf/resultats_PHRC_2008_hors_cancer.pdf to RA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbus D., 1972, ESTATE DIANE ARBUS D; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Banks Marcus., 2015, VISUAL METHODS SOCIA, V2nd ed; Bugos E, 2014, PREVENTING CHRONIC D, V11; Cappello M., 2005, FIELD METHODS, V17, P170, DOI DOI 10.1177/1525822X05274553; Catalani C, 2010, HEALTH EDUC BEHAV, V37, P424, DOI 10.1177/1090198109342084; COLLIER J, 1957, AM ANTHROPOL, V59, P843; Collier J., 1986, VISUAL ANTHR PHOTOGR; Copeland F, 2014, WOMEN BIRTH, V27, P126, DOI 10.1016/j.wombi.2013.11.004; Creighton G, 2013, SOC SCI MED, V84, P35, DOI 10.1016/j.socscimed.2013.02.022; Cretin E., 2013, INTER FACULTY, V4; Cruzado JA, 2013, BRAIN INJURY, V27, P793, DOI 10.3109/02699052.2013.793402; Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Desclaux A, 2008, Bull Soc Pathol Exot, V101, P77; Epstein I., 2006, INT J QUAL METH, V5, P1, DOI [DOI 10.1177/160940690600500301, 10.1177/160940690600500301]; Fraser K.D., 2011, ART HLTH, V3, P110, DOI [10.1080/17533015.2011, 10.1080/17533015.2011.561357, DOI 10.1080/17533015.2011.561357]; Gosseries O, 2012, BRAIN INJURY, V26, P1493, DOI 10.3109/02699052.2012.695426; Graham C, 2011, VISUAL STUD, V26, P87, DOI 10.1080/1472586X.2011.571883; Gubrium AC, 2014, AM J PUBLIC HEALTH, V104, P1606, DOI 10.2105/AJPH.2013.301310; Harper D., 2002, VISUAL STUD, V17, P13; Harper D., 1994, HDB QUALITATIVE RES; Harper Douglas, 1998, IMAGE BASED RES SOUR, P24; Harrison B, 2002, SOCIOL HEALTH ILL, V24, P856, DOI 10.1111/1467-9566.00322; Horstman Marie, 2002, Eur J Oncol Nurs, V6, P75, DOI 10.1054/ejon.2002.0185; Jennett B, 2005, PROG BRAIN RES, V150, P537, DOI 10.1016/S0079-6123(05)50037-2; Kitzinger C., 2014, SOCIAL CONSTRUCTION, P239; Kitzinger C, 2015, J MED ETHICS, V41, DOI 10.1136/medethics-2013-101799; Kitzinger C, 2014, CLIN REHABIL, V28, P627, DOI 10.1177/0269215514527844; Moretta P, 2014, CLIN REHABIL, V28, P717, DOI 10.1177/0269215514521826; Paille A P, 2012, ANAL QUALITATIVE SCI; Paille P., 1994, CAH RECH SOCIOL, V23, P147, DOI [10.7202/1002253ar, DOI 10.7202/1002253AR]; Shell L, 2014, INT J QUAL METH, V13, P170, DOI 10.1177/160940691401300106; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; Switzer S, 2015, SOC SCI MED, V133, P77, DOI 10.1016/j.socscimed.2015.03.040; Volpe T, 2012, FORUM QUALITATIVE SO, V13; Wiles, 2010, ARTS HEALTH, V2, DOI [DOI 10.1080/17533010903495298, 10.1080/17533010903495298]; Yi-Frazier JP, 2015, QUAL HEALTH RES, V25, P1372, DOI 10.1177/1049732315583282	37	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186776	10.1371/journal.pone.0186776	http://dx.doi.org/10.1371/journal.pone.0186776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073185	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400053
J	Fox, GE; Li, M; Zhao, F; Tsien, JZ				Fox, Grace E.; Li, Meng; Zhao, Fang; Tsien, Joe Z.			Distinct retrosplenial cortex cell populations and their spike dynamics during ketamine-induced unconscious state	PLOS ONE			English	Article							METHYL-D-ASPARTATE; ENTORHINAL CORTEX; FEAR MEMORY; PYRAMIDAL NEURONS; RAT-BRAIN; HIPPOCAMPAL-FORMATION; GAMMA OSCILLATIONS; HEALTHY-VOLUNTEERS; PHENCYCLIDINE; SCHIZOPHRENIA	Ketamine is known to induce psychotic-like symptoms, including delirium and visual hallucinations. It also causes neuronal damage and cell death in the retrosplenial cortex (RSC), an area that is thought to be a part of high visual cortical pathways and at least partially responsible for ketamine's psychotomimetic activities. However, the basic physiological properties of RSC cells as well as their response to ketamine in vivo remained largely unexplored. Here, we combine a computational method, the Inter-Spike Interval Classification Analysis (ISICA), and in vivo recordings to uncover and profile excitatory cell subtypes within layers 2&3 and 5&6 of the RSC in mice within both conscious, sleep, and ketamine-induced unconscious states. We demonstrate two distinct excitatory principal cell sub-populations, namely, high-bursting excitatory principal cells and low-bursting excitatory principal cells, within layers 2&3, and show that this classification is robust over the conscious states, namely quiet awake, and natural unconscious sleep periods. Similarly, we provide evidence of high-bursting and low-bursting excitatory principal cell sub-populations within layers 5&6 that remained distinct during quiet awake and sleep states. We further examined how these subtypes are dynamically altered by ketamine. During ketamine-induced unconscious state, these distinct excitatory principal cell subtypes in both layer 2&3 and layer 5&6 exhibited distinct dynamics. We also uncovered different dynamics of local field potential under various brain states in layer 2&3 and layer 5&6. Interestingly, ketamine administration induced high gamma oscillations in layer 2&3 of the RSC, but not layer 5&6. Our results show that excitatory principal cells within RSC layers 2&3 and 5&6 contain multiple physiologically distinct sub-populations, and they are differentially affected by ketamine.	[Fox, Grace E.; Li, Meng; Zhao, Fang; Tsien, Joe Z.] Augusta Univ, Brain & Behav Discovery Inst, Med Coll Georgia, Augusta, GA 30912 USA; [Fox, Grace E.; Li, Meng; Zhao, Fang; Tsien, Joe Z.] Augusta Univ, Dept Neurol, Med Coll Georgia, Augusta, GA 30912 USA; [Zhao, Fang] Banna Biomed Res Inst, Brain Decoding Ctr, Xi Shuang Ban Na Prefect, Yunnan, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Zhao, F; Tsien, JZ (corresponding author), Augusta Univ, Brain & Behav Discovery Inst, Med Coll Georgia, Augusta, GA 30912 USA.; Zhao, F; Tsien, JZ (corresponding author), Augusta Univ, Dept Neurol, Med Coll Georgia, Augusta, GA 30912 USA.; Zhao, F (corresponding author), Banna Biomed Res Inst, Brain Decoding Ctr, Xi Shuang Ban Na Prefect, Yunnan, Peoples R China.	zhao.fang@bbri.ac.cn; jtsien@augusta.edu			National Institutes of Health [NS079774]; Georgia Research Alliance [2012BA004, 2014DG002]; Yunnan Province Department of Science and Technology [2015DFA11470]; International Science and Technology Cooperation Program of China; NIH [NS079774]; Georgia Research Alliance (GRA) from Yunnan Province Department of Science and Technology [2012BA004, 2014DG002]; International S&T Cooperation Program of China [2015DFA11470]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; Yunnan Province Department of Science and Technology; International Science and Technology Cooperation Program of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance (GRA) from Yunnan Province Department of Science and Technology; International S&T Cooperation Program of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by (A) NS079774, National Institutes of Health, https://www.nih.gov/, JZT, (B) 2012BA004 and 2014DG002, Georgia Research Alliance, http://gra.org/, JZT (C) 2015DFA11470, Yunnan Province Department of Science and Technology and International Science and Technology Cooperation Program of China, http://www.most.gov.cn/eng/, JZT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All experiments were performed according to procedures approved by the Augusta University IACUC committees. This work was supported by funds from the NIH (NS079774), Georgia Research Alliance (GRA), grants (2012BA004, 2014DG002) from Yunnan Province Department of Science and Technology and International S&T Cooperation Program of China. No. 2015DFA11470.	Aalto S, 2005, PSYCHOPHARMACOLOGY, V182, P375, DOI 10.1007/s00213-005-0092-6; Adler CM, 1998, BIOL PSYCHIAT, V43, P811, DOI 10.1016/S0006-3223(97)00556-8; Aggleton JP, 2012, HIPPOCAMPUS, V22, P1883, DOI 10.1002/hipo.22024; Alexander AS, 2015, NAT NEUROSCI, V18, P1143, DOI 10.1038/nn.4058; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Bohm C, 2015, J NEUROSCI, V35, P13608, DOI 10.1523/JNEUROSCI.5034-14.2015; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Chan KWS, 2013, ADDICT BEHAV, V38, P2128, DOI 10.1016/j.addbeh.2013.01.014; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Corcoran KA, 2013, J NEUROSCI, V33, P19492, DOI 10.1523/JNEUROSCI.3338-13.2013; Corcoran KA, 2011, J NEUROSCI, V31, P11655, DOI 10.1523/JNEUROSCI.2107-11.2011; CORSSEN G, 1966, ANESTH ANAL CURR RES, V45, P29; Cowansage KK, 2014, NEURON, V84, P432, DOI 10.1016/j.neuron.2014.09.022; Czajkowski R, 2013, J NEUROSCI, V33, P15779, DOI 10.1523/JNEUROSCI.2646-13.2013; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; DOMINO EF, 1965, CLIN PHARMACOL THER, V6, P279; Duncan GE, 1998, BRAIN RES, V787, P181, DOI 10.1016/S0006-8993(97)01390-5; Fletcher PC, 2006, TRENDS COGN SCI, V10, P167, DOI 10.1016/j.tics.2006.02.008; Gass N, 2014, NEUROPSYCHOPHARMACOL, V39, P895, DOI 10.1038/npp.2013.290; GASS P, 1993, NEUROSCIENCE, V53, P749, DOI 10.1016/0306-4522(93)90621-L; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; Heinemann U, 2000, ANN NY ACAD SCI, V911, P112; Hervig ME, 2016, NEUROSCIENCE, V334, P13, DOI 10.1016/j.neuroscience.2016.07.028; Ichinohe N, 2002, NEUROREPORT, V13, P757, DOI 10.1097/00001756-200205070-00005; Ichinohe N, 2008, CEREB CORTEX, V18, P1125, DOI 10.1093/cercor/bhm148; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Katche C, 2013, LEARN MEMORY, V20, P170, DOI 10.1101/lm.030080.112; Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895; Keene CS, 2008, BEHAV NEUROSCI, V122, P89, DOI 10.1037/0735-7044.122.1.89; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Kocsis B, 2013, CNS NEUROSCI THER, V19, P437, DOI 10.1111/cns.12081; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kuang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015209; Kurotani T, 2013, BRAIN STRUCT FUNCT, V218, P239, DOI 10.1007/s00429-012-0398-1; Kwapis JL, 2015, NEUROBIOL LEARN MEM, V123, P110, DOI 10.1016/j.nlm.2015.06.007; Kwapis JL, 2014, NEUROBIOL LEARN MEM, V113, P41, DOI 10.1016/j.nlm.2013.09.007; Lasztoczi B, 2014, NEURON, V81, P1126, DOI 10.1016/j.neuron.2014.01.021; Li Ming, 2015, J GANSU TEACHERS COL, V10-11, p[2015, 20], DOI DOI 10.1089/DNA.2015.3171; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Lukoyanov NV, 2006, BEHAV BRAIN RES, V173, P229, DOI 10.1016/j.bbr.2006.06.026; Miller AMP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00586; Mistry R, 2011, HIPPOCAMPUS, V21, P1157, DOI 10.1002/hipo.20815; Miyashita T, 2007, EUR J NEUROSCI, V26, P1193, DOI 10.1111/j.1460-9568.2007.05745.x; Morgan CJA, 2004, PSYCHOPHARMACOLOGY, V172, P298, DOI 10.1007/s00213-003-1656-y; Murrough JW, 2012, CLIN PHARMACOL THER, V91, P303, DOI 10.1038/clpt.2011.244; Nakao S, 2003, ACTA ANAESTH SCAND, V47, P284, DOI 10.1034/j.1399-6576.2003.00040.x; NAKAO S, 1993, NEUROSCI LETT, V151, P33, DOI 10.1016/0304-3940(93)90038-M; Nelson AJD, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3339/fnbeh.2015.00126, 10.3389/fnbeh.2015.00126]; Niesters M, 2014, BRIT J CLIN PHARMACO, V77, P357, DOI 10.1111/bcp.12094; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Robinson S, 2012, J NEUROSCI, V32, P12076, DOI 10.1523/JNEUROSCI.2814-12.2012; Sabbagh JJ, 2012, PHYSIOL BEHAV, V107, P355, DOI 10.1016/j.physbeh.2012.08.007; Sachser RM, 2015, LEARN MEMORY, V22, P584, DOI 10.1101/lm.039891.115; Salaj M, 2015, BRAIN RES, V1627, P201, DOI 10.1016/j.brainres.2015.09.031; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; Schwindel CD, 2011, PROG BRAIN RES, V193, P163, DOI 10.1016/B978-0-444-53839-0.00011-9; SHARP FR, 1992, J NEUROSCI RES, V33, P605, DOI 10.1002/jnr.490330413; Sigwald EL, 2016, BRAIN STRUCT FUNCT, V221, P1861, DOI 10.1007/s00429-015-1008-9; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; SLOMIANKA L, 1991, J COMP NEUROL, V303, P339, DOI 10.1002/cne.903030302; Smith DM, 2012, HIPPOCAMPUS, V22, P1121, DOI 10.1002/hipo.20958; Sugar CA, 2003, J AM STAT ASSOC, V98, P750, DOI 10.1198/016214503000000666; Sugar Jorgen, 2011, Front Neuroinform, V5, P7, DOI 10.3389/fninf.2011.00007; Todd TP, 2017, BEHAV BRAIN RES, V320, P143, DOI 10.1016/j.bbr.2016.11.033; Todd TP, 2016, NEUROBIOL LEARN MEM, V133, P257, DOI 10.1016/j.nlm.2016.05.006; Todd TP, 2016, LEARN MEMORY, V23, P278, DOI 10.1101/lm.041822.116; Todd TP, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/414173; Todd TP, 2015, HIPPOCAMPUS, V25, P137, DOI 10.1002/hipo.22385; Tsien JZ, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00019; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Vedder LC, 2016, RETROSPLENIAL CORTIC; VOGT BA, 1976, J COMP NEUROL, V169, P63, DOI 10.1002/cne.901690105; Wang JH, 2006, NEUROSCIENCE, V140, P993, DOI 10.1016/j.neuroscience.2006.02.062; WYSS JM, 1990, J COMP NEUROL, V295, P33; Zgraggen E, 2012, CEREB CORTEX, V22, P144, DOI 10.1093/cercor/bhr097; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071466	80	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187198	10.1371/journal.pone.0187198	http://dx.doi.org/10.1371/journal.pone.0187198			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073221	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400131
J	Motwani, MP; Newson, J; Kwong, S; Richard-Loendt, A; Colas, R; Dalli, J; Gilroy, DW				Motwani, Madhur P.; Newson, Justine; Kwong, Simon; Richard-Loendt, Angela; Colas, Romain; Dalli, Jesmond; Gilroy, Derek W.			Prolonged immune alteration following resolution of acute inflammation in humans	PLOS ONE			English	Article							STIMULATED LYMPH-NODES; DENDRITIC CELLS; SUPPRESSOR-CELLS; IN-VIVO; PROSTAGLANDIN-E2; INFECTION; ANTIGEN; MACROPHAGES; INHIBITION; ACTIVATION	Acute inflammation is an immediate response to infection and injury characterised by the influx of granulocytes followed by phagocytosing mononuclear phagocytes. Provided the antigen is cleared and the immune system of the host is fully functional, the acute inflammatory response will resolve. Until now it is considered that resolution then leads back to homeostasis, the physiological state tissues experienced before inflammation occurred. Using a human model of acute inflammation driven by intradermal UV killed Escherichia coli, we found that bacteria and granulocyte clearance as well as pro-inflammatory cytokine catabolism occurred by 72h. However, following a lag phase of about 4 days there was an increase in numbers of memory T cells and CD163(+) macrophage at the post-resolution site up to day 17 as well as increased biosynthesis of cyclooxygenase-derived prostanoids and DHA-derived D series resolvins. Inhibiting post-resolution prostanoids using naproxen showed that numbers of tissue memory CD4 cells were under the endogenous control of PGE(2), which exerts its suppressive effects on T cell proliferation via the EP4 receptor. In addition, we re-challenged the post-resolution site with a second injection of E. coli, which when compared to saline controls resulted in primarily a macrophage-driven response with comparatively fewer PMNs; the macrophage-dominated response was reversed by cyclooxygenase inhibition. Re-challenge experiments were also carried out in mice where we obtained similar results as in humans. Therefore, we report that acute inflammatory responses in both humans and rodents do not revert back to homeostasis, but trigger a hitherto unappreciated sequence of immunological events that dictate subsequent immune response to infection.	[Motwani, Madhur P.; Newson, Justine; Kwong, Simon; Gilroy, Derek W.] UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London, England; [Richard-Loendt, Angela] UCL, Inst Neurol, Div Neuropathol, Queen Sq, London, England; [Richard-Loendt, Angela] UCL, Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Colas, Romain; Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Lipid Mediator Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; Queen Mary University London	Gilroy, DW (corresponding author), UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London, England.	d.gilroy@ucl.ac.uk	Gilroy, Derek/AAP-7227-2020; Gilroy, Derek W/C-2588-2009	Gilroy, Derek/0000-0003-3476-0844; Motwani, Madhur/0000-0001-6970-897X; Dalli, Jesmond/0000-0001-6328-3640	Wellcome Trust [WT087520]; Sir Henry Dale Fellowship; Royal Society [107613/Z/15/Z]; Barts Charity [MGU0343]	Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship; Royal Society(Royal Society of London); Barts Charity	This work was funded by the Wellcome Trust by a Senior Research Fellowship awarded to DWG (Grant number: WT087520). This work also was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant number: 107613/Z/15/Z) and the Barts Charity (Grant number: MGU0343) to JD.	BAKER PE, 1981, CELL IMMUNOL, V61, P52, DOI 10.1016/0008-8749(81)90353-1; BETZ M, 1991, J IMMUNOL, V146, P108; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; HOPKINS J, 1981, IMMUNOLOGY, V42, P225; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; JOHNSTON MG, 1979, AM J PATHOL, V95, P225; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kalinski P, 1997, J IMMUNOL, V159, P28; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Mao YM, 2014, CLIN CANCER RES, V20, P4096, DOI 10.1158/1078-0432.CCR-14-0635; MCCONNELL I, 1981, IMMUNOLOGY, V42, P217; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P9324, DOI 10.1073/pnas.87.23.9324; Motwani MP, 2016, J PATHOL CLIN RES, V2, P154, DOI 10.1002/cjp2.43; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Obermajer N, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-15; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SEGAL AW, 1976, LANCET, V1, P1363; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Tripp C S, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17B, P1085; TRIPP CS, 1987, J CLIN INVEST, V79, P399, DOI 10.1172/JCI112825; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186964	10.1371/journal.pone.0186964	http://dx.doi.org/10.1371/journal.pone.0186964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073216	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400082
J	Goff, J; Golitko, M; Cochrane, E; Curnoe, D; Williams, S; Terrell, J				Goff, James; Golitko, Mark; Cochrane, Ethan; Curnoe, Darren; Williams, Shaun; Terrell, John			Reassessing the environmental context of the Aitape Skull - The oldest tsunami victim in the world?	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; 17 JULY 1998; FLOW SPEED; DEPOSITS; SUBDUCTION; INDONESIA; SEDIMENTS; ISLANDS; EVENTS; RECORD	There is increasing recognition of the long-lasting effects of tsunamis on human populations. This is particularly notable along tectonically active coastlines with repeated inundations occurring over thousands of years. Given the often high death tolls reported from historical events though it is remarkable that so few human skeletal remains have been found in the numerous palaeotsunami deposits studied to date. The 1929 discovery of the Aitape Skull in northern Papua New Guinea and its inferred late Pleistocene age played an important role in discussions about the origins of humans in Australasia for over 25 years until it was more reliably radiocarbon dated to around 6000 years old. However, no similar attention has been given to reassessing the deposit in which it was found-a coastal mangrove swamp inundated by water from a shallow sea. With the benefit of knowledge gained from studies of the 1998 tsunami in the same area, we conclude that the skull was laid down in a tsunami deposit and as such may represent the oldest known tsunami victim in the world. These findings raise the question of whether other coastal archaeological sites with human skeletal remains would benefit from a re-assessment of their geological context.	[Goff, James] Univ New South Wales, Sch Biol Earth & Environm Sci, PANGEA Res Ctr, Sydney, NSW, Australia; [Goff, James] Univ Bourgogne Franche Comte, CNRS, Lab Chronoenvironm, Besancon, France; [Golitko, Mark] Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA; [Cochrane, Ethan] Univ Auckland, Sch Social Sci, Anthropol, Auckland, New Zealand; [Curnoe, Darren] Univ New South Wales, ARC Ctr Excellence Australian Biodivers & Heritag, Sydney, NSW, Australia; [Curnoe, Darren] Univ New South Wales, PANGEA Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Williams, Shaun] Natl Inst Water & Atmospher Res, Christchurch, New Zealand; [Terrell, John] Field Museum Nat Hist, Social Sci, Integrat Res Ctr, Chicago, IL 60605 USA	University of New South Wales Sydney; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; University of Notre Dame; University of Auckland; University of New South Wales Sydney; University of New South Wales Sydney; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Field Museum of Natural History (Chicago)	Goff, J (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, PANGEA Res Ctr, Sydney, NSW, Australia.; Goff, J (corresponding author), Univ Bourgogne Franche Comte, CNRS, Lab Chronoenvironm, Besancon, France.	j.goff@unsw.edu.au	CABAH, ARC/T-6419-2019; Williams, Shaun/AAH-2814-2020	Williams, Shaun/0000-0003-3986-612X; Goff, James/0000-0001-9265-8667; Curnoe, Darren/0000-0001-8622-4141	National Science Foundation [BCS-1155338]; Royal Academy of Engineering Distinguished Visiting Fellowship at School of Engineering, University of Plymouth	National Science Foundation(National Science Foundation (NSF)); Royal Academy of Engineering Distinguished Visiting Fellowship at School of Engineering, University of Plymouth	This work was supported by National Science Foundation award no. BCS-1155338 to MG. JG completed this paper while undertaking a Royal Academy of Engineering Distinguished Visiting Fellowship at the School of Engineering, University of Plymouth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by National Science Foundation award No. BCS-1155338. We would like to thank Jason Kariwiga, Thomas Winter, Esther M. Schechter, Elliott Wong, and Misty Mikuls-Alloy for their assistance in the fieldwork and analysis that contributed to this project. JG completed this paper while undertaking a Royal Academy of Engineering Distinguished Visiting Fellowship at the School of Engineering, University of Plymouth. We are extremely grateful to Dr Arthur Durband of Kansas State University for the use of his photo of the Aitape Skull in Figure 1.	Anderson A, 2006, HOLOCENE, V16, P1, DOI 10.1191/0959683606hl901ft; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Bulbeck D, 2011, HOMO, V62, P1, DOI 10.1016/j.jchb.2010.10.002; Cassie VA, 1989, BIBLIOTHECA PHYCOLOG, V17; Chague-Goff C, 2017, EARTH-SCI REV, V165, P203, DOI 10.1016/j.earscirev.2016.12.003; Chiles L, 1996, THESIS; Choowong M, 2008, MAR GEOL, V248, P179, DOI 10.1016/j.margeo.2007.10.011; Coon C.S., 1963, ORIGIN RACES; CSIRO, 1972, AUSTR COMM SCI IND R, V30; Davies HL, 2003, PURE APPL GEOPHYS, V160, P1895, DOI 10.1007/s00024-003-2413-1; Davies HL, 2016, AITAPE STORY GREAT N; Dawson S, 2007, SEDIMENT GEOL, V200, P328, DOI 10.1016/j.sedgeo.2007.01.011; de Lange WP, 2007, SEDIMENT GEOL, V200, P232, DOI 10.1016/j.sedgeo.2007.01.006; Dengler L, 2003, PURE APPL GEOPHYS, V160, P2001, DOI 10.1007/s00024-003-2417-x; Durband AC, 2011, ARCHAEOL OCEAN, V46, P1; Farrell E.J., 2015, COASTAL MARINE HAZAR, V1st, P93, DOI DOI 10.1016/B978-0-12-396483-0.00004-2; Fenner Frank J., 1941, REC SOUTH AUSTRALIAN MUS, V6, P335; Foged N., 1979, BIBLIOTHECA PHYCOLOG, V47; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; GDC, 2017, WORLD DAT SERV NGDC; Goff J, 2016, ISL ARC, V25, P305, DOI 10.1111/iar.12117; Goff J, 2012, SEDIMENT GEOL, V243, P70, DOI 10.1016/j.sedgeo.2011.11.002; Goff J, 2011, EARTH-SCI REV, V107, P141, DOI 10.1016/j.earscirev.2010.10.005; Golitko M, 2016, J PACIFIC ARCHAEOLOG, V7, P139; GOTO K, 2012, J GEOL SOC JPN, V118, P431, DOI DOI 10.5575/geosoc.2012.0042; Goto K, 2014, MAR GEOL, V358, P2, DOI 10.1016/j.margeo.2014.08.008; Haberle SG, 2001, PALAEOGEOGR PALAEOCL, V171, P259, DOI 10.1016/S0031-0182(01)00248-6; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Holm RJ, 2016, EARTH-SCI REV, V156, P66, DOI 10.1016/j.earscirev.2016.03.005; Hossfeld DS, 1965, P ROYAL SOC VICTORIA, VLXXVI, P161; HOSSFELD PAUL S., 1964, AUSTRALIAN J SCI, V27, P179; HOSSFELD PAUL S., 1949, TRANS ROY SOC S AUSTRALIA, V72, P201; Howells, 1973, PACIFIC ISLANDERS; Hugh D., 2002, NATURAL DISASTERS CU, P28; Huls H., 1957, DIATOMEENFLORA NEDER, V1; Huntington K., 2007, EOS T AM GEOPHYS UN, V88, P577, DOI DOI 10.1029/2007EO520001; Jaffe B, 2011, EARTH-SCI REV, V107, P23, DOI 10.1016/j.earscirev.2011.03.009; Jaffe BE, 2007, SEDIMENT GEOL, V200, P347, DOI 10.1016/j.sedgeo.2007.01.013; Jaffe BE, 2012, SEDIMENT GEOL, V282, P90, DOI 10.1016/j.sedgeo.2012.09.002; Joku GN, 2007, PURE APPL GEOPHYS, V164, P433, DOI 10.1007/s00024-006-0167-2; Keim M., 2006, OCEANOGRAPHY, V19, P40, DOI 10.5670/oceanog.2006.62; Kikuchi M, 1999, EARTH PLANETS SPACE, V51, P1319, DOI 10.1186/BF03351605; Macintosh N, 1965, ABORIGINAL MAN AUSTR; Matsumoto H, 2012, T JAPANESE GEOMORPHO, V33, P385; MCCARTHY FD, 1961, ASIAN PERSPECT, V5, P141; McFadgen BG, 2007, SEDIMENT GEOL, V200, P263, DOI 10.1016/j.sedgeo.2007.01.007; McFadgen BG., 2007, HOSTILE SHORES CATAS; McMillan AD, 2002, ETHNOHISTORY, V49, P41, DOI 10.1215/00141801-49-1-41; McSaveney MJ, 2000, MAR GEOL, V170, P81, DOI 10.1016/S0025-3227(00)00067-0; Mimura N, 2011, MITIG ADAPT STRAT GL, V16, P803, DOI 10.1007/s11027-011-9297-7; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Nason-Jones J, 1930, GEOLOGY FINSCH COAST; Nichol SL, 2010, SEDIMENT GEOL, V229, P41, DOI 10.1016/j.sedgeo.2010.06.001; O'Connell JF, 2012, AUST ARCHAEOL, P5; O'Connor S, 2011, J PAC ARCHAEOL, V2, P1; RENBERG I, 1990, Journal of Paleolimnology, V4, P87; Satake K, 2007, PURE APPL GEOPHYS, V164, P249, DOI 10.1007/s00024-006-0172-5; Seligman CG, 1907, PREHISTORIC OBJECTS; Spiske M, 2010, SEDIMENT GEOL, V224, P29, DOI 10.1016/j.sedgeo.2009.12.005; Stodder AL, 2011, FIELDIANA ANTHR, V42, P197, DOI DOI 10.3158/0071-4739-42.1.197; Summerhayes GR, 2016, QUATERNARY IN PRESS; SWADLING P, 1989, Archaeology in Oceania, V24, P106; Swadling P., 1991, B INDOPACIFIC PREHIS, V11, P92; Tappin DR, 2008, NAT HAZARD EARTH SYS, V8, P243, DOI 10.5194/nhess-8-243-2008; Terrell JE, 2002, JCAS S SERIES, V16; Terrell JE., 2011, FIELDIANA ANTHR, V42, P21; Torrence R, 2000, GEOL SOC SPEC PUBL, V171, P225, DOI 10.1144/GSL.SP.2000.171.01.18; Torrence R, 2008, ANTIQUITY, V82, P600, DOI 10.1017/S0003598X00097258; Tregoning P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020190; Weiss R, 2008, MAR GEOL, V250, P251, DOI 10.1016/j.margeo.2008.01.018; Wright D, 2013, J WORLD PREHIST, V26, P25, DOI 10.1007/s10963-013-9063-8	72	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185248	10.1371/journal.pone.0185248	http://dx.doi.org/10.1371/journal.pone.0185248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069104	Green Submitted, gold, Green Published			2022-12-26	WOS:000413663600003
J	Arnold, WD; Taylor, RS; Li, J; Nagy, JA; Sanchez, B; Rutkove, SB				Arnold, W. David; Taylor, Rebecca S.; Li, Jia; Nagy, Janice A.; Sanchez, Benjamin; Rutkove, Seward B.			Electrical impedance myography detects age-related muscle change in mice	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SKELETAL-MUSCLE; COMPUTED-TOMOGRAPHY; OLDER-ADULTS; HIND-LIMB; STRENGTH; SARCOPENIA; HEALTH; QUALITY; ATTENUATION	Loss of muscle mass and strength represents one of the most significant contributors to impaired function in older adults. Convenient and non-invasive biomarkers are needed that can readily identify and track age-related muscle change. Previous data has suggested electrical impedance myography (EIM) has the potential to serve in this capacity. In this study we investigated how changes in EIM compared with other standard measures of muscle structure and function in aged compared with young mice. A total of 19 male mice aged approximately 25 months and 19 male mice aged 3 months underwent surface multifrequency EIM of the right gastrocnemius muscle using standard methods. Fore and hind limb grip strength, sciatic compound muscle action potential amplitude, and in-situ force of the gastrocnemius were also measured; after sacrifice, gastrocnemius myofiber size was assessed using standard histology. Spearman correlation coefficients were calculated to investigate the association between EIM and muscle characteristics. EIM in aged animals demonstrated significantly lower 50 kHz impedance phase (p<0.001) and reactance (p<0.01) values as well as reduced multifrequency parameters. In contrast, absolute gastrocnemius muscle mass was no different between young and aged mice (p = 0.58) but was reduced in aged mice after normalization to body mass (p<0.001). Median myofiber size in the aged mice was not different from that of young mice (p = 0.72). Aged mice showed reduced muscle function on the basis of normalized fore limb (p<0.001) and normalized hind limb (p<0.001) grip strength, as well as normalized gastrocnemius twitch (p<0.001) and normalized maximal isometric force (p<0.001). Sciatic compound muscle action potential amplitude was reduced in aged mice (p<0.05). EIM parameters showed good correlation with reduced standard physiological and electrophysiological measures of muscle health. Our study suggests that EIM is sensitive to aged-related muscle change and may represent a convenient and valuable method of quantifying loss of muscle health.	[Arnold, W. David] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Taylor, Rebecca S.; Li, Jia; Nagy, Janice A.; Sanchez, Benjamin; Rutkove, Seward B.] Harvard Med Sch, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	University System of Ohio; Ohio State University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rutkove, SB (corresponding author), Harvard Med Sch, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	srutkove@bidmc.harvard.edu	Arnold, W. David/AAM-5649-2020	Rutkove, Seward/0000-0002-6375-3312; Arnold, W. David/0000-0001-9889-7036	National Institute of Health/National Institute of Neurological Disorders and Stroke [R01NS055099]; National Institute on Aging/National Institute of Health [R03AG050877]	National Institute of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute of Health/National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov/) grant R01NS055099 to SBR. WDA received funding from the National Institute on Aging/National Institute of Health (https://www.nia.nih.gov/) (Grant R03AG050877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron R, 2006, PHYSIOL MEAS, V27, P953, DOI 10.1088/0967-3334/27/10/002; Anderson DE, 2014, AM J PHYS MED REHAB, V93, P553, DOI 10.1097/PHM.0000000000000059; [Anonymous], PLOS ONE; Arnold WD, 2015, JOVE-J VIS EXP, DOI 10.3791/52899; Arnold WD, 2014, ANN CLIN TRANSL NEUR, V1, P34, DOI 10.1002/acn3.23; Arnold WD RS, 2016, JOURNAL OF CACHEXIA, V7, P626; Ballak SB, 2014, AGE, V36, DOI 10.1007/s11357-014-9726-0; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; Cawthon PM, 2009, J AM GERIATR SOC, V57, P1411, DOI 10.1111/j.1532-5415.2009.02366.x; Cesari M, 2012, J CACHEXIA SARCOPENI, V3, P181, DOI 10.1007/s13539-012-0078-2; Chai RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028090; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029; Fragala MS, 2015, SPORTS MED, V45, P641, DOI 10.1007/s40279-015-0305-z; Gilmore KJ, 2016, MUSCLE NERVE; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Graber TG, 2015, AGE, V37, DOI 10.1007/s11357-015-9773-1; Grimnes S, 2008, BIOIMPEDANCE AND BIO; Kaya RD, 2013, EXP GERONTOL, V48, P920, DOI 10.1016/j.exger.2013.06.008; Krishnan VS, 2016, J NEUROPATH EXP NEUR, V75, P464, DOI 10.1093/jnen/nlw019; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Li J, 2013, J MUSCULOSKEL NEURON, V13, P37; Li J, 2016, AMYOTROPH LAT SCL FR, V17, P397, DOI 10.3109/21678421.2016.1165258; Li J, 2014, MUSCLE NERVE, V49, P829, DOI 10.1002/mus.24086; Li JLL, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-678; Lynch NA, 1999, J APPL PHYSIOL, V86, P188, DOI 10.1152/jappl.1999.86.1.188; Marcus Robin L, 2012, J Aging Res, V2012, P629637, DOI 10.1155/2012/629637; McGregor Robin A, 2014, Longev Healthspan, V3, P9, DOI 10.1186/2046-2395-3-9; Narici MV, 2008, DISABIL REHABIL, V30, P1548, DOI 10.1080/09638280701831058; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Newman AB, 2003, J AM GERIATR SOC, V51, P323, DOI 10.1046/j.1532-5415.2003.51105.x; Payne AM, 2006, J PHYSIOL-LONDON, V570, P283, DOI 10.1113/jphysiol.2005.100032; Romanick M, 2013, BBA-MOL BASIS DIS, V1832, P1410, DOI 10.1016/j.bbadis.2013.03.011; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Rutkove SB, 2014, PEDIATR NEUROL, V51, P88, DOI 10.1016/j.pediatrneurol.2014.02.015; Rutkove SB, 2014, MUSCLE NERVE, V49, P441, DOI 10.1002/mus.24128; Rutkove SB, 2012, AMYOTROPH LATERAL SC, V13, P439, DOI 10.3109/17482968.2012.688837; Rutkove SB, 2012, MUSCLE NERVE, V45, P642, DOI 10.1002/mus.23233; Rutkove SB, 2010, MUSCLE NERVE, V42, P915, DOI 10.1002/mus.21784; Sanchez B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140521; Sanchez B, 2013, MED ENG PHYS, V35, P1349, DOI 10.1016/j.medengphy.2013.03.006; Sung M, 2013, J MUSCULOSKEL NEURON, V13, P405; Tarulli AW, 2009, ARCH PHYS MED REHAB, V90, P1806, DOI 10.1016/j.apmr.2009.04.007; Therkelsen KE, 2016, AGE, V38, DOI 10.1007/s11357-016-9893-2; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Walsh ME, 2015, J GERONTOL A-BIOL, V70, P1312, DOI 10.1093/gerona/glu208; Wang ZM, 2005, J PHYSIOL-LONDON, V565, P757, DOI 10.1113/jphysiol.2005.087601; Ward RE, 2015, J GERONTOL A-BIOL, V70, P464, DOI 10.1093/gerona/glu183; Zaidman CM, 2015, MUSCLE NERVE, V52, P592, DOI 10.1002/mus.24611	54	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185614	10.1371/journal.pone.0185614	http://dx.doi.org/10.1371/journal.pone.0185614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049394	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900014
J	Cannon, MV; Craine, J; Hester, J; Shalkhauser, A; Chan, ER; Logue, K; Small, S; Serre, D				Cannon, Matthew V.; Craine, Joseph; Hester, James; Shalkhauser, Amanda; Chan, Ernest R.; Logue, Kyle; Small, Scott; Serre, David			Dynamic microbial populations along the Cuyahoga River	PLOS ONE			English	Article							BACTERIAL COMMUNITY; DIVERSITY; WATER	The study of the microbial communities has gained traction in recent years with the advent of next-generation sequencing with, or without, PCR-based amplification of the 16S ribosomal RNA region. Such studies have been applied to topics as diverse as human health and environmental ecology. Fewer studies have investigated taxa outside of bacteria, however. We present here data demonstrating the utility of studying taxa outside of bacteria including algae, diatoms, archaea and fungi. Here, we show how location along the Cuya-hoga River as well as a transient rainfall event heavily influence the microbial composition. Our data reveal how individual OTUs vary between samples and how the patterns of OTU abundance can accurately predict sampling location. The clustering of samples reveals that these taxa are all sensitive to water conditions in unique ways and demonstrate that, for our dataset, algae was most distinctive between sample groups, surpassing bacteria. Diversity between sampling sites could allow studies investigating pollution or water quality to identify marker OTUs or patterns of OTU abundance as indicators to assess environmental conditions or the impact of human activity. We also directly compare data derived from primers amplifying distinct taxa and show that taxa besides bacteria are excellent indicators of water condition.	[Cannon, Matthew V.; Hester, James; Shalkhauser, Amanda; Chan, Ernest R.; Logue, Kyle; Serre, David] Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; [Craine, Joseph] Jonah Ventures, Manhattan, KS USA; [Small, Scott] Case Western Reserve Univ, Dept Global Hlth & Dis, Cleveland, OH 44106 USA; [Cannon, Matthew V.; Serre, David] Univ Maryland, Baltimore, MD 21201 USA; [Hester, James] RStudio, Boston, MA USA; [Shalkhauser, Amanda] NASA, Glenn Res Ctr, Cleveland, OH USA; [Chan, Ernest R.] Case Western Reserve Univ, Inst Computat Biol, Cleveland, OH 44106 USA; [Logue, Kyle] Univ Hosp Cleveland, Seidman Canc Ctr, Cleveland, OH 44106 USA; [Small, Scott] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Cleveland Clinic Foundation; Case Western Reserve University; University System of Maryland; University of Maryland Baltimore; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; Case Western Reserve University; University Hospitals of Cleveland; University of Notre Dame	Cannon, MV (corresponding author), Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA.; Cannon, MV (corresponding author), Univ Maryland, Baltimore, MD 21201 USA.	matthewvc1@gmail.com	Craine, Joseph/D-4569-2009	Craine, Joseph/0000-0001-6561-3244; Chan, Ernest/0000-0001-9277-5329; Hester, James/0000-0002-2739-7082; Cannon, Matthew/0000-0002-3035-9490	NCI NIH HHS [T32 CA094186] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alonso C, 2010, AQUAT MICROB ECOL, V61, P57, DOI 10.3354/ame01439; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Cannon MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep22908; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Egge ES, 2015, MOL ECOL, V24, P3026, DOI 10.1111/mec.13160; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Garcia Arniisen T, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE; Graczyk TK, 2008, PARASITE, V15, P458, DOI 10.1051/parasite/2008153458; Gutierrez MH, 2015, ENVIRON MICROBIOL, V17, P3882, DOI 10.1111/1462-2920.12872; Kermarrec L, 2013, MOL ECOL RESOUR, V13, P607, DOI 10.1111/1755-0998.12105; Kermarrec L, 2014, FRESHW SCI, V33, P349, DOI 10.1086/675079; Lu SD, 2016, ARCH ENVIRON CON TOX, V71, P122, DOI 10.1007/s00244-016-0277-5; Mclellan SL, 2015, INT MICROBIOL, V18, P141; Savio D, 2015, ENVIRON MICROBIOL, V17, P4994, DOI 10.1111/1462-2920.12886; Staley C, 2013, J APPL MICROBIOL, V115, P1147, DOI 10.1111/jam.12323; Staley C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00524; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Tang XY, 2012, J ENVIRON SCI-CHINA, V24, P351, DOI 10.1016/S1001-0742(11)60753-5; Torres MA, 2008, ECOTOX ENVIRON SAFE, V71, P1, DOI 10.1016/j.ecoenv.2008.05.009; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Zhang H, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0379-7; Zhang JX, 2015, APPL MICROBIOL BIOT, V99, P3291, DOI 10.1007/s00253-014-6262-x; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	26	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186290	10.1371/journal.pone.0186290	http://dx.doi.org/10.1371/journal.pone.0186290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049324	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900055
J	Hashimoto, N; Kiyono, T; Saitow, F; Asada, M; Yoshida, M				Hashimoto, Naohiro; Kiyono, Tohru; Saitow, Fumihito; Asada, Minoru; Yoshida, Masaki			Reversible differentiation of immortalized human bladder smooth muscle cells accompanied by actin bundle reorganization	PLOS ONE			English	Article							HUMAN MYOGENIC CELLS; URINARY-BLADDER; PHENOTYPIC MODULATION; IN-VITRO; MOLECULAR-MECHANISMS; STEM-CELLS; GENERATION; CONTRACTION; KINASE; EXPRESSION	Previous studies have shown that phenotypic modulation of smooth muscle cells (SMCs) plays a pivotal role in human diseases. However, the molecular mechanisms underlying the reversible differentiation of SMCs remain elusive particularly because cultured SMCs that reproducibly exhibit bidirectional phenotypic modulation have not been established. Here we established an immortalized human bladder SMC line designated as hBS11. Under differentiation-inducing conditions, hBS11 cells underwent smooth muscle differentiation accompanied by the robust expression of smooth muscle differentiation markers and isoform-dependent reorganization of actin bundles. The cholinergic receptor agonist carbachol increased intracellular calcium in differentiated hBS11 cells in an acetylcholine muscarinic receptor-dependent manner. Differentiated hBS11 cells displayed contractile properties depending on the elevation in the levels of intracellular calcium. Depolarization of membrane potential triggered inward sodium current in differentiated hBS11 cells. However, differentiated hBS11 cells lost the differentiated phenotype and resumed mitosis when re-fed with growth medium. Our study provides direct evidence pertaining to the human bladder SMCs being able to retain the capacity of reversible differentiation and that the reorganization of actin bundles is involved in the reinstatement of contractility. Moreover, we have established a human SMC line retaining high proliferating potential without compromising differentiation potential.	[Hashimoto, Naohiro] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Regenerat Med, Oobu, Aichi, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Carcinogenesis & Canc Prevent, Chuo Ku, Tokyo, Japan; [Saitow, Fumihito; Asada, Minoru] Nippon Med Sch, Dept Pharmacol, Bunkyo Ku, Tokyo, Japan; [Yoshida, Masaki] Natl Ctr Geriatr & Gerontol, Dept Urol, Oobu, Aichi, Japan	National Center for Geriatrics & Gerontology; National Cancer Center - Japan; Nippon Medical School; National Center for Geriatrics & Gerontology	Hashimoto, N (corresponding author), Natl Ctr Geriatr & Gerontol, Res Inst, Dept Regenerat Med, Oobu, Aichi, Japan.	nao@ncgg.go.jp	SAITOW, Fumihito/AAF-2281-2020	SAITOW, Fumihito/0000-0002-5625-8460; Hashimoto, Naohiro/0000-0002-9231-8053	KAKENHI, Japan [25462531]	KAKENHI, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI, 25462531), Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grants-in-Aid for Scientific Research (KAKENHI, 25462531), Japan. We thank H. Miyoshi and C. Chaponnier for providing reagents, Shiro Konishi and Si Yong Song for discussion and encouragement, Hidenori Suzuki for encouragement, and Ne Long and Saki Okubo for technical assistance.	Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Arnoldi R, 2013, EUR J CELL BIOL, V92, P187, DOI 10.1016/j.ejcb.2013.06.002; Bao JJ, 2002, P NATL ACAD SCI USA, V99, P9556, DOI 10.1073/pnas.142298599; Campbell JH, 2012, ARTERIOSCL THROM VAS, V32, P1784, DOI 10.1161/ATVBAHA.111.243212; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Gunning P, 1998, BIOESSAYS, V20, P892, DOI 10.1002/(SICI)1521-1878(199811)20:11<892::AID-BIES4>3.3.CO;2-4; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; HASHIMOTO N, 1994, FEBS LETT, V352, P236, DOI 10.1016/0014-5793(94)00964-3; HASHIMOTO N, 1995, EUR J BIOCHEM, V227, P379, DOI 10.1111/j.1432-1033.1995.tb20400.x; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Li SH, 1999, CIRC RES, V85, P338, DOI 10.1161/01.RES.85.4.338; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; Muller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070636; Mukai A, 2008, EXP CELL RES, V314, P387, DOI 10.1016/j.yexcr.2007.10.006; Mukai A, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-37; Mukai A, 2009, EXP CELL RES, V315, P3052, DOI 10.1016/j.yexcr.2009.07.010; Neuhaus J, 2002, WORLD J UROL, V20, P250, DOI 10.1007/s00345-002-0289-9; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Saitow F, 2005, J NEUROSCI, V25, P2108, DOI 10.1523/JNEUROSCI.4254-04.2005; Shiomi K, 2011, GENE THER, V18, P857, DOI 10.1038/gt.2011.44; Shiomi K, 2014, J PHARM PHARMACOL, V66, P418, DOI 10.1111/jphp.12171; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Sobue K, 1998, HORM RES, V50, P15, DOI 10.1159/000053119; Usukura E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27472; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wray S, 2010, PHYSIOL REV, V90, P113, DOI 10.1152/physrev.00018.2008; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Yanagisawa M, 2011, EXP CELL RES, V317, P221, DOI 10.1016/j.yexcr.2010.10.011; Zheng YM, 2002, AM J PHYSIOL-CELL PH, V283, pC373, DOI 10.1152/ajpcell.00002.2002; Zheng YM, 2012, IN VITRO CELL DEV-AN, V48, P84, DOI 10.1007/s11626-011-9473-9; Zimmerman RA, 2004, J UROLOGY, V172, P1667, DOI 10.1097/01.ju.0000139874.48574.1b	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186584	10.1371/journal.pone.0186584	http://dx.doi.org/10.1371/journal.pone.0186584			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049386	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900083
J	Lee, BR; Joo, KI; Choi, ES; Jahng, J; Kim, H; Kim, E				Lee, Bo-Ram; Joo, Kyung-Il; Choi, Eun Sook; Jahng, Junghoon; Kim, Hyunmin; Kim, Eunjoo			Evans blue dye-enhanced imaging of the brain microvessels using spectral focusing coherent anti-Stokes Raman scattering microscopy	PLOS ONE			English	Article							CARS-MICROSCOPY; LIPID DROPLETS; IN-VIVO; BARRIER; SPECTROSCOPY; PERMEABILITY; RESOLUTION; CELLS; LASER	We performed dye-enhanced imaging of mouse brain microvessels using spectral focusing coherent anti-Stokes Raman scattering (SF-CARS) microscopy. The resonant signals from C-H stretching in forward CARS usually show high background intensity in tissues, which makes CARS imaging of microvessels difficult. In this study, epi-detection of back-scattered SF-CARS signals showed a negligible background, but the overall intensity of resonant CARS signals was too low to observe the network of brain microvessels. Therefore, Evans blue (EB) dye was used as contrasting agent to enhance the back-scattered SF-CARS signals. Breakdown of brain microvessels by inducing hemorrhage in a mouse was clearly visualized using backward SF-CARS signals, following intravenous injection of EB. The improved visualization of brain microvessels with EB enhanced the sensitivity of SF-CARS, detecting not only the blood vessels themselves but their integrity as well in the brain vasculature.	[Lee, Bo-Ram; Choi, Eun Sook; Kim, Hyunmin; Kim, Eunjoo] DGIST, Compan Diagnost & Med Technol Res Grp, Daegu, South Korea; [Joo, Kyung-Il] Kyungpook Natl Univ, Sch Elect Engn, Daegu, South Korea; [Jahng, Junghoon] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA USA	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Kyungpook National University; University of California System; University of California Irvine	Kim, H; Kim, E (corresponding author), DGIST, Compan Diagnost & Med Technol Res Grp, Daegu, South Korea.	Hyunmin.kim@dgist.ac.kr; ejkim@dgist.ac.kr	Jahng, Junghoon/GXF-0922-2022	Jahng, Junghoon/0000-0002-5745-9686	DGIST - Ministry of Science, ICT, and Future Planning of Korea [17-BT-01, 17-BT-02, 17-BD-06, 17-01-HRMA-02]; Ministry of Science, ICT, and Future Planning of Korea [2016R1A2B4014728]	DGIST - Ministry of Science, ICT, and Future Planning of Korea; Ministry of Science, ICT, and Future Planning of Korea	This research was supported by the research programs of DGIST (17-BT-01, 17-BT-02, 17-BD-06, and 17-01-HRMA-02) funded by the Ministry of Science, ICT, and Future Planning of Korea. It was also supported by the research program 2016R1A2B4014728 funded by the Ministry of Science, ICT, and Future Planning of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camp CH, 2016, J RAMAN SPECTROSC, V47, P408, DOI 10.1002/jrs.4824; Camp CH, 2015, NAT PHOTONICS, V9, P295, DOI 10.1038/NPHOTON.2015.60; Camp CH, 2014, NAT PHOTONICS, V8, P627, DOI [10.1038/nphoton.2014.145, 10.1038/NPHOTON.2014.145]; Cheng JX, 2001, J PHYS CHEM B, V105, P1277, DOI 10.1021/jp003774a; Cummings RJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2966122; Dodia KJ, 2014, MOL CRYST LIQ CRYST, V592, P1, DOI 10.1080/15421406.2013.837995; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Galli R, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071402; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Heinrich C, 2008, OPT EXPRESS, V16, P2699, DOI 10.1364/OE.16.002699; Hellerer T, 2004, APPL PHYS LETT, V85, P25, DOI 10.1063/1.1768312; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Kim H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09571-w; Liu B, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4919104; Masia F, 2013, ANAL CHEM, V85, P10820, DOI 10.1021/ac402303g; Masters BR, 2008, HDB BIOMEDICAL NONLI; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Moger J, 2012, J RAMAN SPECTROSC, V43, P668, DOI 10.1002/jrs.3156; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; Peng JH, 2009, J MOD OPTIC, V56, P1964, DOI 10.1080/09500340903398432; Pilatou M. C., 2003, Archives of Physiology and Biochemistry, V111, P389; Potma EO, 2003, J RAMAN SPECTROSC, V34, P642, DOI 10.1002/jrs.1045; Rinia HA, 2008, BIOPHYS J, V95, P4908, DOI 10.1529/biophysj.108.137737; Rocha-Mendoza I, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3028346; Rodriguez LG, 2006, CYTOM PART A, V69A, P779, DOI 10.1002/cyto.a.20299; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Runnels JM, 2006, MOL IMAGING, V5, P31, DOI 10.2310/7290.2006.00004; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sharma HS, 2012, INT REV NEUROBIOL, V102, P47, DOI 10.1016/B978-0-12-386986-9.00003-X; Shi YZ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3641988; Venkata HNN, 2012, CHEM BIOL, V19, P1373, DOI 10.1016/j.chembiol.2012.08.020; Xie RX, 2014, BIOMED OPT EXPRESS, V5, P2390, DOI 10.1364/BOE.5.002390; Yao JJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251044	33	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0185519	10.1371/journal.pone.0185519	http://dx.doi.org/10.1371/journal.pone.0185519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049299	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900010
J	Murphy-Marshman, H; Quensel, K; Xu, SW; Barnfield, R; Kelly, J; Peidl, A; Stratton, RJ; Leask, A				Murphy-Marshman, Hannah; Quensel, Katherine; Xu Shi-Wen; Barnfield, Rebecca; Kelly, Jacalyn; Peidl, Alex; Stratton, Richard J.; Leask, Andrew			Antioxidants and NOX1/NOX4 inhibition blocks TGF beta 1-induced CCN2 and alpha-SMA expression in dermal and gingival fibroblasts	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; MYOFIBROBLAST DIFFERENTIATION; MOUSE FIBROBLASTS; SKIN FIBROBLASTS; N-ACETYLCYSTEINE; PTEN EXPRESSION; GENE-EXPRESSION; FIBROSIS; INDUCTION; ADHESION	TGFbeta induces fibrogenic responses in fibroblasts. Reactive oxygen species (ROS)/nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) may contribute to fibrogenic responses. Here, we examine if the antioxidant N-acetylcysteine (NAC), the NOX inhibitor diphenyleneiodonium (DPI) and the selective NOX1/NOX4 inhibitor GKT-137831 impairs the ability of TGFbeta to induce profibrotic gene expression in human gingival (HGF) and dermal (HDF) fibroblasts. We also assess if GKT-137831 can block the persistent fibrotic phenotype of lesional scleroderma (SSc) fibroblasts. We use real-time polymerase chain reaction and Western blot analysis to evaluate whether NAC and DPI impair the ability of TGFbeta1 to induce expression of fibrogenic genes in fibroblasts. The effects of GKT-137831 on TGFbeta-induced protein expression and the persistent fibrotic phenotype of lesional scleroderma (SSc) fibroblasts were tested using Western blot and collagen gel contraction analyses. In HDF and HGF, TGFbeta1 induces CCN2, CCN1, endothelin-1 and alpha-smooth muscle actin (SMA) in a fashion sensitive to NAC. Induction of COL1A1 mRNA was unaffected. Similar results were seen with DPI. NAC and DPI impaired the ability of TGFbeta1 to induce protein expression of CCN2 and alpha-SMA in HDF and HGF. GKT-137831 impaired TGFbeta-induced CCN2 and alpha-SMA protein expression in HGF and HDF. In lesional SSc dermal fibroblasts, GKT-137831 reduced alpha-SMA and CCN2 protein overexpression and collagen gel contraction. These results are consistent with the hypothesis that antioxidants or NOX1/4 inhibition may be useful in blocking profibrotic effects of TGFbeta on dermal and gingival fibroblasts and warrant consideration for further development as potential antifibrotic agents.	[Murphy-Marshman, Hannah; Quensel, Katherine; Leask, Andrew] Univ Western Ontario, Schulich Sch Med & Dent, Dept Dent, London, ON, Canada; [Xu Shi-Wen; Stratton, Richard J.] Royal Free & Univ Coll, Med Sch, Ctr Rheumatol, London, England; [Barnfield, Rebecca; Kelly, Jacalyn] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biol, London, ON, Canada; [Peidl, Alex; Leask, Andrew] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); University of London; University College London; Western University (University of Western Ontario); Western University (University of Western Ontario)	Leask, A (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Dent, London, ON, Canada.; Leask, A (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada.	Andrew.Leask@schulich.uwo.ca	Leask, Andrew/G-5217-2015; Leask, Andy/ABH-9433-2020		Canadian Institutes of Health Research [MOP 77603, 119410]; National Sciences and Engineering Research Council; Canadian Institutes of Health Research Summer Studentship; Joint Motion Program (JuMP)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research Summer Studentship(Canadian Institutes of Health Research (CIHR)); Joint Motion Program (JuMP)	Our work is supported by grants from the Canadian Institutes of Health Research (MOP 77603 and 119410) and the National Sciences and Engineering Research Council to AL. KQ was the recipient of a Canadian Institutes of Health Research Summer Studentship. HMM and KQ were recipients of summer studentships from the Joint Motion Program (JuMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our work is supported by grants from the Canadian Institutes of Health Research (MOP 77603 and 119410) and the National Sciences and Engineering Research Council to AL. KQ was the recipient of a Canadian Institutes of Health Research Summer Studentship. HMM and KQ were recipients of summer studentships from the Joint Motion Program (JuMP).	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Behr J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-101; Black SA, 2008, J BIOL CHEM, V283, P10835, DOI 10.1074/jbc.M710363200; Black SA, 2007, J BIOL CHEM, V282, P15416, DOI 10.1074/jbc.M610432200; Damasceno LS, 2012, BRAZ ORAL RES, V26, P373, DOI 10.1590/S1806-83242012005000012; Dendooven A, 2011, BIOMARKERS, V16, P289, DOI 10.3109/1354750X.2011.561366; Eckes B, 2014, J MOL MED, V92, P913, DOI 10.1007/s00109-014-1190-x; Fowdar K, 2017, HEART LUNG, V46, P120, DOI 10.1016/j.hrtlng.2016.12.004; Guo F, 2013, J INVEST DERMATOL, V133, P1646, DOI 10.1038/jid.2013.28; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027097; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Homma S, 2012, RESPIROLOGY, V17, P467, DOI 10.1111/j.1440-1843.2012.02132.x; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Kleinschmidt EG, 2017, CURR OPIN CELL BIOL, V45, P24, DOI 10.1016/j.ceb.2017.01.003; Kuk H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123689; Kurundkar AR, 2016, FASEB J, V30, P2135, DOI 10.1096/fj.201500173; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; Liu JQ, 2014, J CELL PHYSIOL, V229, P1121, DOI 10.1002/jcp.24630; Liu SX, 2014, WOUND REPAIR REGEN, V22, P119, DOI 10.1111/wrr.12131; Liu SX, 2013, ARTHRITIS RHEUM-US, V65, P2940, DOI 10.1002/art.38121; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Lota HK, 2013, EXPERT OPIN PHARMACO, V14, P79, DOI 10.1517/14656566.2013.758250; Mah W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090715; Meraw SY, 1998, MAYO CLIN PROC, V73, P1196, DOI 10.4065/73.12.1196; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Parapuram SK, 2015, MATRIX BIOL, V43, P35, DOI 10.1016/j.matbio.2015.01.017; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Sobral Lays Martin, 2010, Braz. oral res., V24, P182, DOI 10.1590/S1806-83242010000200010; Spadoni T, 2015, ARTHRITIS RHEUMATOL, V67, P1611, DOI 10.1002/art.39084; Tazzeo T, 2009, BRIT J PHARMACOL, V158, P790, DOI 10.1111/j.1476-5381.2009.00394.x; Teixeira G, 2017, BRIT J PHARMACOL, V174, P1647, DOI 10.1111/bph.13532; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Xu SW, 2012, RHEUMATOLOGY, V51, P2146, DOI 10.1093/rheumatology/kes234	41	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186740	10.1371/journal.pone.0186740	http://dx.doi.org/10.1371/journal.pone.0186740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049376	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900106
J	Orellana, R; Chaput, G; Markillie, LM; Mitchell, H; Gaffrey, M; Orr, G; DeAngelis, KM				Orellana, Roberto; Chaput, Gina; Markillie, Lye Meng; Mitchell, Hugh; Gaffrey, Matt; Orr, Galya; DeAngelis, Kristen M.			Multi-time series RNA-seq analysis of Enterobacter lignolyticus SCF1 during growth in lignin-amended medium	PLOS ONE			English	Article							FORMATE-HYDROGEN LYASE; ESCHERICHIA-COLI; AROMATIC-COMPOUNDS; CLOSTRIDIUM-ACETOBUTYLICUM; ENZYMATIC-HYDROLYSIS; GENOME SEQUENCE; MODEL COMPOUNDS; BOND-CLEAVAGE; FUEL ETHANOL; WHEAT-STRAW	The production of lignocellulosic-derived biofuels is a highly promising source of alternative energy, but it has been constrained by the lack of a microbial platform capable to efficiently degrade this recalcitrant material and cope with by-products that can be toxic to cells. Species that naturally grow in environments where carbon is mainly available as lignin are promising for finding new ways of removing the lignin that protects cellulose for improved conversion of lignin to fuel precursors. Enterobacter lignolyticus SCF1 is a facultative anaerobic Gammaproteobacteria isolated from tropical rain forest soil collected in El Yunque forest, Puerto Rico under anoxic growth conditions with lignin as sole carbon source. Whole transcriptome analysis of SCF1 during E. lignolyticus SCF1 lignin degradation was conducted on cells grown in the presence (0.1%, w/w) and the absence of lignin, where samples were taken at three different times during growth, beginning of exponential phase, mid-exponential phase and beginning of stationary phase. Lignin-amended cultures achieved twice the cell biomass as unamended cultures over three days, and in this time degraded 60% of lignin. Transcripts in early exponential phase reflected this accelerated growth. A complement of laccases, aryl-alcohol dehydrogenases, and peroxidases were most up-regulated in lignin amended conditions in mid-exponential and early stationary phases compared to unamended growth. The association of hydrogen production by way of the formate hydrogenlyase complex with lignin degradation suggests a possible value added to lignin degradation in the future.	[Orellana, Roberto] Univ Tecn Federico Santa Maria, Ctr Biotecnol Daniel Alkalay Lowitt, Valparaiso, Chile; [Chaput, Gina; DeAngelis, Kristen M.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Markillie, Lye Meng; Mitchell, Hugh; Gaffrey, Matt; Orr, Galya] Pacific Northwest Natl Lab, Richland, WA USA	Universidad Tecnica Federico Santa Maria; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Energy (DOE); Pacific Northwest National Laboratory	DeAngelis, KM (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	deangelis@microbio.umass.edu		Mitchell, Hugh/0000-0003-0143-8461; Chaput, Gina/0000-0001-5612-5687; orellana, roberto/0000-0003-0633-3458	University of Massachusetts Amherst; US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; DOE Office of Biological and Environmental Research; US DOE [AC06-76RLO1830]; Joint BioEnergy Institute	University of Massachusetts Amherst; US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); US DOE(United States Department of Energy (DOE)); Joint BioEnergy Institute	This work was supported by the University of Massachusetts Amherst and the Joint BioEnergy Institute (http://www.jbei.org) supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, under Contract No. DE-AC02-05CH11231. Some work was conducted at EMSL (Environmental Molecular Sciences Laboratory), a national scientific user facility sponsored by DOE Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. PNNL is operated by Battelle for the US DOE under contract AC06-76RLO1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Massachusetts Amherst and the Joint BioEnergy Institute (http://www.jbei.org) supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, under Contract No. DE-AC02-05CH11231. Some work was conducted at EMSL, a national scientific user facility sponsored by DOE Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. PNNL is operated by Battelle for the US DOE under contract AC06-76RLO1830. We also want to thank Begu E m Topcuoglu and Dr. Jim Holden for their assistance with the gas chromatography and hydrogen quantification.	Ahmad M, 2010, MOL BIOSYST, V6, P815, DOI 10.1039/b908966g; Akobi C, 2016, APPL ENERG, V184, P548, DOI 10.1016/j.apenergy.2016.10.039; AXLEY MJ, 1990, J BIOL CHEM, V265, P18213; Bagramyan K, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1159, DOI 10.1023/B:BIRY.0000009129.18714.a4; Berlemont R, 2015, APPL ENVIRON MICROB, V81, P1513, DOI 10.1128/AEM.03718-14; Billings AF, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0100-3; BLOM A, 1992, APPL ENVIRON MICROB, V58, P331, DOI 10.1128/AEM.58.1.331-334.1992; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Coppi MV, 2005, MICROBIOL-SGM, V151, P1239, DOI 10.1099/mic.0.27535-0; Davin-Regli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00392; De Souza WR, MICROBIAL DEGRADATIO; DeAngelis KM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00280; DeAngelis KM, 2011, STAND GENOMIC SCI, V5, P69, DOI 10.4056/sigs.2104875; DUTTON PL, 1969, BIOCHEM J, V113, P525, DOI 10.1042/bj1130525; Eudes A, 2014, CURR OPIN BIOTECH, V26, P189, DOI 10.1016/j.copbio.2014.01.002; Federle MJ, 2009, CONTRIB MICROBIOL, V16, P18, DOI 10.1159/000219371; Ferreira P, 2009, J BIOL CHEM, V284, P24840, DOI 10.1074/jbc.M109.011593; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; Galai S, RESPONSE SURFACE MET; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Grimmler C, 2010, J BIOTECHNOL, V150, P315, DOI 10.1016/j.jbiotec.2010.09.938; Gu F, 2014, J WOOD SCI, V60, P346, DOI 10.1007/s10086-014-1411-5; Hatakka A., 2005, BIODEGRADATION LIGNI; HEALY JB, 1980, APPL ENVIRON MICROB, V39, P436, DOI 10.1128/AEM.39.2.436-444.1980; Ho DP, 2014, BIORESOURCE TECHNOL, V169, P742, DOI 10.1016/j.biortech.2014.07.022; Ibraheem O, 2013, INT J BIOL SCI, V9, P598, DOI 10.7150/ijbs.6091; Ingram LO, 1999, BIOTECHNOL PROGR, V15, P855, DOI 10.1021/bp9901062; Jimenez DJ, 2016, APPL MICROBIOL BIOT, V100, P10463, DOI 10.1007/s00253-016-7713-3; Kaarik A, 1966, STUDIA FORESTALIA SU, P31; Kameshwar AKS, 2016, INT J BIOL SCI, V12, P156, DOI 10.7150/ijbs.13537; Kato S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14295; Khudyakov JI, 2012, P NATL ACAD SCI USA, V109, pE2173, DOI 10.1073/pnas.1112750109; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lim SH, 2013, J ORG CHEM, V78, P9431, DOI 10.1021/jo401680z; LINDEBERG G, 1948, PHYSIOL PLANTARUM, V1, P196, DOI 10.1111/j.1399-3054.1948.tb07124.x; Liptzin D, 2011, ECOSYSTEMS, V14, P171, DOI 10.1007/s10021-010-9402-x; Majumdar S, 2014, BIOCHEMISTRY-US, V53, P4047, DOI 10.1021/bi500285t; Makela MR, 2013, FUNGAL BIOL-UK, V117, P62, DOI 10.1016/j.funbio.2012.11.006; Manter DK, 2011, CURR MICROBIOL, V62, P1044, DOI 10.1007/s00284-010-9809-9; McDowall JS, 2014, P NATL ACAD SCI USA, V111, pE3948, DOI 10.1073/pnas.1407927111; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Oh S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00035; Parenti A, 2013, BIORESOURCE TECHNOL, V133, P142, DOI 10.1016/j.biortech.2013.01.072; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; Record E, 2002, EUR J BIOCHEM, V269, P602, DOI 10.1046/j.0014-2956.2001.02690.x; Reiter J, 2013, GREEN CHEM, V15, P1373, DOI 10.1039/c3gc40295a; Rico A, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-6; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosnow JJ, 2016, CRIT REV BIOTECHNOL, P1; Schuhle K, 2003, J BACTERIOL, V185, P4920, DOI 10.1128/JB.185.16.4920-4929.2003; Scully ED, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1096; Silver WL, 1999, BIOGEOCHEMISTRY, V44, P301, DOI 10.1007/BF00996995; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; Sjostrom E, 1993, WOOD CHEM FUNDAMENTA, P71, DOI [10.1016/B978-0-08-092589-9.50008-5, DOI 10.1016/B978-0-08-092589-9.50008-5]; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Taylor CR, 2012, J APPL MICROBIOL, V113, P521, DOI 10.1111/j.1365-2672.2012.05352.x; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Webber CA, 1997, MOL MICROBIOL, V24, P1039, DOI 10.1046/j.1365-2958.1997.4021765.x; Woo HL, 2014, STAND GENOMIC SCI, V9, DOI 10.1186/1944-3277-9-19; Yelle DJ, 2013, BIOENERG RES, V6, P211, DOI 10.1007/s12155-012-9247-6; YOUNG LY, 1987, GEOMICROBIOL J, V5, P261, DOI 10.1080/01490458709385973; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zbell AL, 2009, APPL ENVIRON MICROB, V75, P1456, DOI 10.1128/AEM.02064-08	72	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186440	10.1371/journal.pone.0186440	http://dx.doi.org/10.1371/journal.pone.0186440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049419	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900069
J	Gotschke, J; Mertsch, P; Bischof, M; Kneidinger, N; Matthes, S; Renner, ED; Schultz, K; Traidl-Hoffmann, C; Duchna, HW; Behr, J; Schmude, J; Huber, RM; Milger, K				Goetschke, Jeremias; Mertsch, Pontus; Bischof, Michael; Kneidinger, Nikolaus; Matthes, Sandhya; Renner, Ellen D.; Schultz, Konrad; Traidl-Hoffmann, Claudia; Duchna, Hans-Werner; Behr, Juergen; Schmude, Juergen; Huber, Rudolf M.; Milger, Katrin			Perception of climate change in patients with chronic lung disease	PLOS ONE			English	Article							AIR-POLLUTION; HEALTH-RISK; ASTHMA; ALLERGY; RAGWEED; SUMMER; POLLEN; STATES	Background Climate change affects human health. The respective consequences are predicted to increase in the future. Patients with chronic lung disease are particularly vulnerable to the involved environmental alterations. However, their subjective perception and reactions to these alterations remain unknown. Methods In this pilot study, we surveyed 172 adult patients who underwent pulmonary rehabilitation and 832 adult tourists without lung disease in the alpine region about their perception of being affected by climate change and their potential reaction to specific consequences. The patients' survey also contained the COPD Assessment Test (CAT) to rate the severity of symptoms. Results Most of the patients stated asthma (73.8%), COPD (9.3%) or both (11.0%) as underlying disease while 5.8% suffered from other chronic lung diseases. Patients and tourists feel equally affected by current climate change in general, while allergic subjects in both groups feel significantly more affected (p = 0.04). The severity of symptoms assessed by CAT correlates with the degree of feeling affected (p< 0.01). The main disturbing consequences for patients are decreased air quality, increasing numbers of ticks and mosquitos and a rising risk for allergy and extreme weather events such as thunderstroms, while tourists are less disturbed by these factors. Increasing number of heat-days is of little concern to both groups. Conclusion Overall patients are more sensitive to health-related consequences of climate change. Yet, the hazard of heat-days seems underestimated and awareness should be raised.	[Goetschke, Jeremias; Mertsch, Pontus; Kneidinger, Nikolaus; Matthes, Sandhya; Behr, Juergen; Huber, Rudolf M.; Milger, Katrin] Univ Munich, Dept Internal Med 5, Comprehens Pneumol Ctr CPC M, Munich, Germany; [Goetschke, Jeremias; Mertsch, Pontus; Kneidinger, Nikolaus; Matthes, Sandhya; Behr, Juergen; Huber, Rudolf M.; Milger, Katrin] German Ctr Lung Res DZL, Munich, Germany; [Bischof, Michael; Schmude, Juergen] Univ Munich, Dept Geog, Chair Econ Geog & Tourism Res, Munich, Germany; [Renner, Ellen D.; Traidl-Hoffmann, Claudia; Duchna, Hans-Werner] CK CARE, Davos, Switzerland; [Renner, Ellen D.; Traidl-Hoffmann, Claudia] Tech Univ Munich, UNIKA T, Chair & Inst Environm Med, Augsburg, Germany; [Renner, Ellen D.; Traidl-Hoffmann, Claudia] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Augsburg, Germany; [Renner, Ellen D.; Duchna, Hans-Werner] Hochgebirgsklin Davos, Davos, Switzerland; [Schultz, Konrad] Deutsch Rentenversicherung Bayern Sud, Klin Bad Reichenhall, Bad Reichenhall, Germany; [Behr, Juergen] Asklepios Fachkliniken Munchen Gauting, Gauting, Germany	University of Munich; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Milger, K (corresponding author), Univ Munich, Dept Internal Med 5, Comprehens Pneumol Ctr CPC M, Munich, Germany.; Milger, K (corresponding author), German Ctr Lung Res DZL, Munich, Germany.	Katrin.Milger@med.uni-muenchen.de	Schmude, Juergen/K-1692-2013; Huber, Rudolf M./L-2464-2019; Renner, Ellen/R-7168-2016; Milger, Katrin/AFI-3881-2022	Huber, Rudolf M./0000-0001-7041-6368; Renner, Ellen/0000-0001-9816-8538; Gotschke, Jeremias/0000-0002-3426-2194; Bischof, Michael/0000-0002-1378-2326; Milger, Katrin/0000-0003-2914-8773	Bavarian State Ministry of the Environment and Consumer Protection	Bavarian State Ministry of the Environment and Consumer Protection	This study was supported by a grant from the Bavarian State Ministry of the Environment and Consumer protection. This grant paid the salary of Jeremias Gotschke throughout the main study period from Jan 2016 to July 2016. All the other resources used for this study were from the University of Munich as part of regular department funding. There were no other external or internal funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the Bavarian State Ministry of the Environment and Consumer Protection.	Akerlof K, 2010, INT J ENV RES PUB HE, V7, P2559, DOI 10.3390/ijerph7062559; Akompab DA, 2013, INT J ENV RES PUB HE, V10, P2164, DOI 10.3390/ijerph10062164; Bonten TN, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02008-2016; Bortenschlager S, 2007, ALTERING AIRBORNE PO, P3134; D'Amato G, 2016, ALLERGY ASTHMA IMMUN, V8, P391, DOI 10.4168/aair.2016.8.5.391; D'Amato G, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0073-0; El Arfaui A, 2014, PNEUMOLOGIE, V68, pV580; Ferrari U, 2012, INT J BIOMETEOROL, V56, P137, DOI 10.1007/s00484-011-0405-x; Global Initiative for Asthma (GINA), 2015, GLOB STRAT ASTHM MAN, P1; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Hayes D, 2012, AM J RESP CRIT CARE, V185, P1190, DOI 10.1164/rccm.201201-0088OC; Hoflich C, 2016, INT J HYG ENVIR HEAL, V219, P252, DOI 10.1016/j.ijheh.2016.01.007; Holgate ST, 2017, CLIN MED, V17, P8, DOI 10.7861/clinmedicine.17-1-8; Jehn M, 2013, TELEMONITORING REDUC, P1; Kurashima K, 2016, INT J CHRONIC OBSTR, V11, P479, DOI 10.2147/COPD.S97343; Lee SD, 2014, RESP MED, V108, P600, DOI 10.1016/j.rmed.2013.12.014; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Maibach EW, 2015, ANN GLOB HEALTH, V81, P396, DOI 10.1016/j.aogh.2015.08.010; Mirsaeidi M, 2016, ANN AM THORAC SOC, V13, P1223, DOI 10.1513/AnnalsATS.201511-729PS; Osberghaus D, 2013, KLIMAWANDEL IN DEUTS; Pinto LM, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-68; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Schneiter D, 2002, Allerg Immunol (Paris), V34, P113; Shea KM, 2010, CLIMATE CHANGE ALLER, P443; Sin DD, 2016, EUR RESPIR J, V48, P664, DOI 10.1183/13993003.00436-2016; Stafoggia M, 2008, J EPIDEMIOL COMMUN H, V62, P209, DOI 10.1136/jech.2007.060715; Strachan DP, 2004, CLIMATE PREVALENCE S, P609; Vinnikov D, 2016, ERJ OPEN RES, V2; Wanka A, 2014, Z GERONTOL GERIATR, V47, P468, DOI 10.1007/s00391-014-0674-1; WHO, 2016, CLIM CHANG HLTH; Witt C, 2015, EFFECTS CLIMATE CHAN, P2050; World Health Organization, 2014, QUANT RISK ASS EFF C, P128; Zanobetti A, 2012, P NATL ACAD SCI USA, V109, P6608, DOI 10.1073/pnas.1113070109; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032; 2012, GLOBAL SURVEILLANCE, P1	36	3	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186632	10.1371/journal.pone.0186632	http://dx.doi.org/10.1371/journal.pone.0186632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045479	Green Published, gold			2022-12-26	WOS:000413168100082
J	Zhang, L; Gu, C; Yang, LJ; Tang, FC; Gao, YQ				Zhang, Ling; Gu, Chan; Yang, Lijiang; Tang, Fuchou; Gao, Yi Qin			The sequence preference of DNA methylation variation in mammalians	PLOS ONE			English	Article							GENE-EXPRESSION; PATTERNS; BASE; EPIGENOME; INSIGHT; MAPS	Methylation of cytosine at the 5 position of the pyrimidine ring is the most prevalent and significant epigenetic modifications in mammalian DNA. The CpG methylation level shows a bimodal distribution but the bimodality can be overestimated due to the heterogeneity of per-base depth. Here, we developed an algorithm to eliminate the effect of per-base depth inhomogeneity on the bimodality and obtained a random CpG methylation distribution. By quantifying the deviation of the observed methylation distribution and the random one using the information formula, we find that in tetranucleotides 5'-N(5)CGN(3)-3' (N-5, N-3 = A, C, G or T), GCGN(3) and CCGN(3) show less apparent deviation than ACGN(3) and TCGN(3), indicating that GCGN(3) and CCGN(3) are less variant in their level of methylation. The methylation variation of N(5)CGN(3) are conserved among different cells, tissues and species, implying common features in the mechanisms of methylation and demethylation, presumably mediated by DNMTs and TETs in mammalians, respectively. Sequence dependence of DNA methylation variation also relates to gene regulatory and promotes the reexamination of the role of DNA sequence in fundamental biological processes.	[Zhang, Ling; Yang, Lijiang; Tang, Fuchou; Gao, Yi Qin] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing, Peoples R China; [Zhang, Ling; Gu, Chan; Yang, Lijiang; Gao, Yi Qin] Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing, Peoples R China; [Gu, Chan] Sichuan Univ, West China Univ Hosp 2, Key Lab Obstet Gynecol & Pediat Dis & Birth Defe, Prenatal Diag Ctr,Dept Obstet & Gynecol,Minst Edu, Chengdu, Sichuan, Peoples R China	Peking University; Peking University; Sichuan University	Gao, YQ (corresponding author), Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing, Peoples R China.; Gao, YQ (corresponding author), Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing, Peoples R China.	gaoyq@pku.edu.cn	gao, yi/HCI-8298-2022; Yang, Lijiang/AAS-2662-2020	Gu, Chan/0000-0002-4212-2394	National Natural Science Foundation of China [21573006, 21233002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under 21573006, 21233002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Falckenhayn C, 2013, J EXP BIOL, V216, P1423, DOI 10.1242/jeb.080754; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jin L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/304563; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kullback S., 1968, INFORMATION THEORY A; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Matje DM, 2011, BIOCHEMISTRY-US, V50, P1465, DOI 10.1021/bi101446g; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Sur I, 2016, NAT REV CANCER, V16, P483, DOI 10.1038/nrc.2016.62; Wang YP, 2013, NEW PHYTOL, V198, P274, DOI 10.1111/nph.12137; Young MA, 1997, BIOPHYS J, V73, P2313, DOI 10.1016/S0006-3495(97)78263-8; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	37	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186559	10.1371/journal.pone.0186559	http://dx.doi.org/10.1371/journal.pone.0186559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045493	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100073
J	Qu, RZ; Chen, XM; Wang, WH; Qiu, C; Ban, MM; Guo, LL; Vasilev, K; Chen, JY; Li, WW; Zhao, YP				Qu, Ruize; Chen, Xiaomin; Wang, Wenhan; Qiu, Cheng; Ban, Miaomiao; Guo, Linlin; Vasilev, Krasimir; Chen, Jianying; Li, Weiwei; Zhao, Yunpeng			Ghrelin protects against osteoarthritis through interplay with Akt and NF-kappa B signaling pathways	FASEB JOURNAL			English	Article						inflammatory cytokines; IL-1 beta; TNF-alpha; cartilage; chondrocyte	VITREOUS CYTOKINE LEVELS; TNF-ALPHA; CARTILAGE DEGRADATION; ARTICULAR-CARTILAGE; CATABOLIC EVENTS; GENE-EXPRESSION; INFLAMMATION; INHIBITION; APOPTOSIS; OVEREXPRESSION	Osteoarthritis (OA) is a common chronic degenerative disease characterized by degeneration in the joints and subsequent destruction of cartilage and bone, yet much remains to be elucidated regarding its molecular mechanism. Ghrelin is a recently discovered neuropeptide with anti-inflammatory actions, but it is unknown whether ghrelin is involved in OA. Human primary chondrocyte and cartilage samples were collected from patients with OA, and the expression pattern of ghrelin was assessed. Human chondrocyte and cartilage samples were stimulated with IL-1 beta and TNF-alpha, and exogenous ghrelin-alleviated disorganization of catabolism and anabolism were mediated by IL-1 beta and TNF-alpha. Destabilization of the medial meniscus and anterior cruciate ligament transection models were established in wild-type mice that were administered ghrelin or PBS. Severity of inflammation and degeneration in the joints were determined by measuring the levels of various inflammatory cytokines and degeneration-associated molecules. Ghrelin down-regulated the production of various inflammatory cytokines, inhibited apoptosis of chondrocytes, decreased the levels of metalloproteinases (including matrix metalloproteinase-13 and a disintegrin and metalloproteinase with thrombospondin motif-5), and maintained the expression of critical matrix components, such as aggrecan and collagen 2. Moreover, suppression of the Akt signaling pathway and activation of NF-kappa B signaling in chondrocytes during OA development was antagonized by ghrelin administration. This supports the assessment of ghrelin as a potential therapeutic approach to treat degenerative cartilage diseases, including OA.	[Qu, Ruize; Chen, Xiaomin; Li, Weiwei] Shandong Univ, Dept Pathol, Qilu Hosp, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Wang, Wenhan; Zhao, Yunpeng] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan, Shandong, Peoples R China; [Qu, Ruize; Chen, Xiaomin; Wang, Wenhan; Qiu, Cheng; Ban, Miaomiao; Guo, Linlin] Shandong Univ, Med Sch, Jinan, Shandong, Peoples R China; [Vasilev, Krasimir] Univ South Australia, Sch Engn, Mawson Lakes, SA, Australia; [Chen, Jianying] Inst Biopharmaceut Shandong Prov, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; University of South Australia	Li, WW (corresponding author), Shandong Univ, Dept Pathol, Qilu Hosp, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.; Zhao, YP (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthopaed Surg, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.	miraculously2008@163.com; liweiweizhao@163.com	Vasilev, Krasimir/C-5248-2008; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022	Qu, Ruize/0000-0002-6280-3322; Vasilev, Krasimir/0000-0003-3534-4754	Key Research and Development Projects of Shandong Province [2015GSF118115]; Natural Science Foundation of Shandong Province [BS2014YY048, BS2015SW028]; National Natural Science Foundation of China [81501880, 26010105131643]	Key Research and Development Projects of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Research and Development Projects of Shandong Province (Grant 2015GSF118115), the Natural Science Foundation of Shandong Province (Grants BS2014YY048 and BS2015SW028), and the National Natural Science Foundation of China (Grants 81501880 and 26010105131643). The authors declare no conflicts of interest.	Akamizu T, 2008, J AM GERIATR SOC, V56, P2363, DOI 10.1111/j.1532-5415.2008.02031.x; Ansari M. Y., 2017, OSTEOARTHRITIS CARTI; Barboza E, 2017, ARTHRITIS RHEUMATOL, V69, P1221, DOI 10.1002/art.40056; Bayliss JA, 2016, NEURAL REGEN RES, V11, P1228, DOI 10.4103/1673-5374.189171; Bianchi E, 2016, J SURG RES, V201, P226, DOI 10.1016/j.jss.2015.10.044; Bonior J., 2017, INT J MOL SCI, V18; Bouaziz W, 2016, P NATL ACAD SCI USA, V113, P5453, DOI 10.1073/pnas.1514854113; Caminos JE, 2005, ENDOCRINOLOGY, V146, P1285, DOI 10.1210/en.2004-1379; Campbell KA, 2013, ARTHRITIS RHEUM-US, V65, P3120, DOI 10.1002/art.38182; Chen WH, 2014, BIOMATERIALS, V35, P9599, DOI 10.1016/j.biomaterials.2014.07.058; Chen YX, 2017, ONCOTARGET, V8, P31065, DOI 10.18632/oncotarget.16075; Chung H, 2016, J ENDOCRINOL, V230, P239, DOI 10.1530/JOE-16-0126; Conaghan PG, 2014, ANN RHEUM DIS, V73, P1442, DOI 10.1136/annrheumdis-2013-204660; Cui X, 2016, SCI REP-UK, V6, DOI 10.1038/srep23117; Cui Z, 2016, ANN RHEUM DIS, V75, P1714, DOI 10.1136/annrheumdis-2015-207923; da Costa BR, 2016, LANCET, V387, P2093, DOI 10.1016/S0140-6736(16)30002-2; Feng ZY, 2015, CELL TISSUE RES, V362, P187, DOI 10.1007/s00441-015-2194-8; Fortier LA, 2014, AM J SPORT MED, V42, pNP31, DOI 10.1177/0363546514537991; Genre F, 2014, CLIN EXP RHEUMATOL, V32, P218; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Gul FC, 2013, GRAEF ARCH CLIN EXP, V251, P1235, DOI 10.1007/s00417-013-2259-x; Heard BJ, 2013, OSTEOARTHR CARTILAGE, V21, P1942, DOI 10.1016/j.joca.2013.08.019; Hou CH, 2015, CELL PHYSIOL BIOCHEM, V36, P1753, DOI 10.1159/000430148; Hu JQ, 2017, AM J TRANSL RES, V9, P79; Iezaki T, 2016, J PATHOL, V239, P426, DOI 10.1002/path.4739; Ismail HM, 2015, ARTHRITIS RHEUMATOL, V67, P1826, DOI 10.1002/art.39099; Jia HR, 2016, P NATL ACAD SCI USA, V113, P14360, DOI 10.1073/pnas.1608938113; Kalunian KC, 2016, CURR OPIN RHEUMATOL, V28, P246, DOI 10.1097/BOR.0000000000000273; Karagiozoglou-Lampoudi T, 2011, METABOLISM, V60, P1359, DOI 10.1016/j.metabol.2011.03.006; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Katsara O., 2016, ARTHRITIS RHEUMATOL; Klooster AR, 2005, ARTHRITIS RES THER, V7, pR127, DOI 10.1186/ar1464; Kuroda K, 2015, ENDOCRINOLOGY, V156, P4437, DOI 10.1210/en.2015-1561; Lai YJ, 2014, ANN RHEUM DIS, V73, P1575, DOI 10.1136/annrheumdis-2013-203561; Legrand R, 2016, EUR NEUROPSYCHOPHARM, V26, P948, DOI 10.1016/j.euroneuro.2016.03.010; Li W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.223; Li WW, 2015, FEBS J, V282, P2317, DOI 10.1111/febs.13278; Li X, 2009, ARTHRITIS RHEUM-US, V60, P513, DOI 10.1002/art.24258; Lin YG, 2017, EUR J PHARMACOL, V811, P260, DOI 10.1016/j.ejphar.2017.06.032; Liu CC, 2016, 2016 6TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY FOR MANUFACTURING SYSTEMS (ITMS 2016), P6; Lorenz J, 2014, METHODS MOL BIOL, V1194, P401, DOI 10.1007/978-1-4939-1215-5_23; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Manfredi AA, 2016, ANN RHEUM DIS, V75, P1511, DOI 10.1136/annrheumdis-2015-208442; Mao YQ, 2015, INT J MOL SCI, V16, P21911, DOI 10.3390/ijms160921911; Matuszyk A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/718314; Mevel E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33527; Minashima T, 2014, OSTEOARTHR CARTILAGE, V22, P852, DOI 10.1016/j.joca.2014.04.008; Minashima T, 2014, ARTHRITIS RHEUMATOL, V66, P1228, DOI 10.1002/art.38373; Mobasheri A, 2017, OSTEOARTHR CARTILAGE, V25, P199, DOI 10.1016/j.joca.2016.12.016; Pearson MJ, 2016, ARTHRITIS RHEUMATOL, V68, P845, DOI 10.1002/art.39520; Raghu H., 2016, ANN RHEUM DIS, V76; Ratneswaran A, 2017, J MOL MED, V95, P431, DOI 10.1007/s00109-016-1501-5; Ruozi G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8388; Sasazawa F, 2014, OSTEOARTHR CARTILAGE, V22, P313, DOI 10.1016/j.joca.2013.11.015; Sherwood J, 2015, ANN RHEUM DIS, V74, P2207, DOI 10.1136/annrheumdis-2014-205546; Stock M, 2017, ARTHRITIS RHEUMATOL, V69, P1233, DOI 10.1002/art.40042; Tian X., 2017, LIFE SCI; Toegel S, 2016, J IMMUNOL, V196, P1910, DOI 10.4049/jimmunol.1501165; Turgut B, 2013, DRUG DES DEV THER, V7, P19, DOI 10.2147/DDDT.S39453; Wang H, 2017, MOL THER, V25, P715, DOI 10.1016/j.ymthe.2016.12.020; Wang LF, 2017, MOL BIOL REP, V44, P219, DOI 10.1007/s11033-017-4098-z; Whirledge SD, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123570; Wu YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17602; Yamamoto K, 2016, MATRIX BIOL, V56, P57, DOI 10.1016/j.matbio.2016.03.007; Yan DY, 2013, J BIOL CHEM, V288, P31655, DOI 10.1074/jbc.M112.440420; Yan DY, 2013, GENE, V517, P12, DOI 10.1016/j.gene.2013.01.001; Yuan MJ, 2009, EUR J PHARMACOL, V618, P52, DOI 10.1016/j.ejphar.2009.07.015; Zhang HW, 2013, INT J MOL MED, V32, P851, DOI 10.3892/ijmm.2013.1452; Zhao Y, 2014, JOVE-J VIS EXP, V84, DOI DOI 10.3791/50924; Zhao YP, 2015, ANN RHEUM DIS, V74, P2244, DOI 10.1136/annrheumdis-2014-205779; Zhao YP, 2016, INFLAMMATION, V39, P385, DOI 10.1007/s10753-015-0260-8; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zhou S, 2016, OSTEOARTHR CARTILAGE, V24, P2181, DOI 10.1016/j.joca.2016.07.005	74	33	34	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1044	1058		10.1096/fj.201700265R	http://dx.doi.org/10.1096/fj.201700265R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29070587	Bronze			2022-12-26	WOS:000425146900043
J	Zhao, WK; Huang, YK; Zhang, JZ; Liu, MJ; Ji, HJ; Wang, CC; Cao, N; Li, CJ; Xia, Y; Jiang, Q; Qin, JZ				Zhao, Wukui; Huang, Yikai; Zhang, Jingzi; Liu, Mengjie; Ji, Haijing; Wang, Congcong; Cao, Ning; Li, Chaojun; Xia, Yin; Jiang, Qing; Qin, Jinzhong			Polycomb group RING finger proteins 3/5 activate transcription via an interaction with the pluripotency factor Tex10 in embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; embryonic stem cell; pluripotency; polycomb; transcriptional coactivator; Pcgf3; Pcgf5; Tex10; transcriptional activation	GENE-EXPRESSION; COMPLEX; PRC1; DIFFERENTIATION; HEMATOPOIESIS; METHYLATION; RECRUITMENT; MECHANISMS; REPRESSION; ENHANCER	Polycomb group (PcG) proteins are epigenetic transcriptional repressors that orchestrate numerous developmental processes and have been implicated in the maintenance of embryonic stem (ES) cell state. More recent evidence suggests that a subset of PcG proteins engages in transcriptional activation in some cellular contexts, but how this property is exerted remains largely unknown. Here, we generated ES cells with single or combined disruption of polycomb group RING finger protein 3 (Pcgf3) and Pcgf5 with the CRISPR-Cas9 technique. We report that although these mutant cells maintained their self-renewal and colony-forming capacity, they displayed severe defects in mesoderm differentiation in vitro and in vivo. Using RNA-seq to analyze transcriptional profiles of ES cells with single or combined Pcgf3/5 deficiencies, we found that in contrast to the canonical role of the related polycomb repressive complex 1 (PRC1) in gene repression, Pcgf3/5 mainly function as transcriptional activators driving expression of many genes involved in mesoderm differentiation. Proteomic approaches and promoter occupancy analyses helped to establish an extended Pcgf3/5 interactome and identified several novel Pcgf3/5 interactors. These included testis-expressed 10 (Tex10), which may directly contribute to transcriptional activation via the transcriptional co-activator p300. Furthermore, Pcgf3/5 deletion in ES cells substantially reduced the occupancy of Tex10 and p300 at target genes. Finally, we demonstrated that Pcgf3/5 are essential for regulating global levels of the histone modifier H2AK119ub1 in ES cells. Our findings establish Pcgf3/5 as transcriptional activators that interact with Tex10 and p300 in ES cells and point to redundant activity of Pcgf3/5 in pluripotency maintenance.	[Zhao, Wukui; Huang, Yikai; Zhang, Jingzi; Liu, Mengjie; Wang, Congcong; Cao, Ning; Li, Chaojun; Qin, Jinzhong] Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China; [Ji, Haijing] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210014, Jiangsu, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Qing] Med Sch Nanjing Univ, Nanjing Drum Tower Hosp, Dept Sports Med & Adult Reconstruct Surg, Nanjing 21008, Jiangsu, Peoples R China	Nanjing University; Nanjing Agricultural University; Chinese University of Hong Kong	Qin, JZ (corresponding author), Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	qinjz@nicemice.cn	zhao, wukui/AAI-9846-2020; Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532; Li, Chaojun/0000-0001-9474-7321	National Natural Science Foundation of China [31471387, 31671532]; Shuangchuang Program of Jiangsu Province; Nanjing University Innovation and Creative Program for Ph.D. Candidates [2016027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shuangchuang Program of Jiangsu Province; Nanjing University Innovation and Creative Program for Ph.D. Candidates	This work was supported by National Natural Science Foundation of China Grants 31471387 and 31671532 and the 2015 Shuangchuang Program of Jiangsu Province (to J. Q.). This project was supported by Nanjing University Innovation and Creative Program for Ph.D. Candidates Grant 2016027 (to W. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Almeida M, 2017, SCIENCE, V356, P1081, DOI 10.1126/science.aal2512; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Creppe C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004851; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, COLD SH Q B, V75, P71, DOI 10.1101/sqb.2010.75.053; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Frangini A, 2013, MOL CELL, V51, P647, DOI 10.1016/j.molcel.2013.08.022; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Gunning PW, 2001, J CELL SCI, V114, P513; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondo T, 2016, TRENDS BIOCHEM SCI, V41, P9, DOI 10.1016/j.tibs.2015.11.005; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Lee HG, 2015, GENOME RES, V25, P1170, DOI 10.1101/gr.188920.114; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu H, 2013, MOL CELLS, V36, P112, DOI 10.1007/s10059-013-0012-2; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Luis NM, 2012, CELL STEM CELL, V11, P16, DOI 10.1016/j.stem.2012.06.005; Morey L, 2015, CELL STEM CELL, V17, P300, DOI 10.1016/j.stem.2015.08.009; Morey L, 2015, MOL CELL BIOL, V35, P2716, DOI 10.1128/MCB.00266-15; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Si S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154561; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smagulova FO, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-67; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yan Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46276; Yang YS, 2015, GENE EXPR PATTERNS, V19, P45, DOI 10.1016/j.gep.2015.07.002; Zhao WK, 2017, J BIOL CHEM, V292, P2773, DOI 10.1074/jbc.M116.763961	50	30	30	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21527	21537		10.1074/jbc.M117.804054	http://dx.doi.org/10.1074/jbc.M117.804054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29054931	Green Published, hybrid			2022-12-26	WOS:000419013000027
J	Al-Hashimi, AA; Lebeau, P; Majeed, F; Polena, E; Lhotak, S; Collins, CAF; Pinthus, JH; Gonzalez-Gronow, M; Hoogenes, J; Pizzo, SV; Crowther, M; Kapoor, A; Rak, J; Gyulay, G; D'Angelo, S; Marchio, S; Pasqualini, R; Arap, W; Shayegan, B; Austin, RC				Al-Hashimi, Ali A.; Lebeau, Paul; Majeed, Fadwa; Polena, Enio; Lhotak, Sarka; Collins, Celeste A. F.; Pinthus, Jehonathan H.; Gonzalez-Gronow, Mario; Hoogenes, Jen; Pizzo, Salvatore V.; Crowther, Mark; Kapoor, Anil; Rak, Janusz; Gyulay, Gabriel; D'Angelo, Sara; Marchio, Serena; Pasqualini, Renata; Arap, Wadih; Shayegan, Bobby; Austin, Richard C.			Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED PROTEIN 78; FACTOR PROCOAGULANT ACTIVITY; PROSTATE-CANCER; ENDOPLASMIC-RETICULUM; EXPRESSION; STRESS; CARCINOMA; RECEPTOR; BINDING; ANGIOGENESIS	Tumor cells display on their surface several molecular chaperones that normally reside in the endoplasmic reticulum. Because this display is unique to cancer cells, these chaperones are attractive targets for drug development. Previous epitope-mapping of autoantibodies (AutoAbs) from prostate cancer patients identified the 78-kDa glucose-regulated protein (GRP78) as one such target. Although we previously showed that anti-GRP78 AutoAbs increase tissue factor (TF) procoagulant activity on the surface of tumor cells, the direct effect of TF activation on tumor growth was not examined. In this study, we explore the interplay between the AutoAbs against cell surface-associated GRP78, TF expression/activity, and prostate cancer progression. First, we show that tumor GRP78 expression correlates with disease stage and that anti-GRP78 AutoAb levels parallel prostate-specific antigen concentrations in patient-derived serum samples. Second, we demonstrate that these anti-GRP78 AutoAbs target cell-surface GRP78, activating the unfolded protein response and inducing tumor cell proliferation through a TF-dependent mechanism, a specific effect reversed by neutralization or immunodepletion of the AutoAb pool. Finally, these AutoAbs enhance tumor growth in mice bearing human prostate cancer xenografts, and heparin derivatives specifically abrogate this effect by blocking AutoAb binding to cell-surface GRP78 and decreasing TF expression/activity. Together, these results establish a molecular mechanism in which AutoAbs against cell-surface GRP78 drive TF-mediated tumor progression in an experimental model of prostate cancer. Heparin derivatives counteract this mechanism and, as such, represent potentially appealing compounds to be evaluated in well-designed translational clinical trials.	[Al-Hashimi, Ali A.; Lebeau, Paul; Majeed, Fadwa; Polena, Enio; Lhotak, Sarka; Collins, Celeste A. F.; Pinthus, Jehonathan H.; Hoogenes, Jen; Crowther, Mark; Kapoor, Anil; Gyulay, Gabriel; Shayegan, Bobby; Austin, Richard C.] McMaster Univ, Dept Med, Hamilton, ON L8N 4A6, Canada; [Al-Hashimi, Ali A.; Lebeau, Paul; Majeed, Fadwa; Polena, Enio; Lhotak, Sarka; Collins, Celeste A. F.; Pinthus, Jehonathan H.; Hoogenes, Jen; Crowther, Mark; Kapoor, Anil; Gyulay, Gabriel; Shayegan, Bobby; Austin, Richard C.] St Josephs Healthcare Hamilton, Hamilton, ON L8N 4A6, Canada; [Al-Hashimi, Ali A.; Pinthus, Jehonathan H.; Hoogenes, Jen; Kapoor, Anil; Shayegan, Bobby] McMaster Univ, Dept Surg, Hamilton, ON L8N 4A6, Canada; [Gonzalez-Gronow, Mario; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Rak, Janusz] McGill Univ, Fac Med, Div Expt Med, Dept Pediat, Montreal, PQ H3A 0G4, Canada; [D'Angelo, Sara; Marchio, Serena; Pasqualini, Renata; Arap, Wadih] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87106 USA; [D'Angelo, Sara; Marchio, Serena; Pasqualini, Renata] Univ New Mexico, Sch Med, Div Mol Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Arap, Wadih] Univ New Mexico, Sch Med, Div Hematol Oncol, Dept Internal Med, Albuquerque, NM 87131 USA; [Marchio, Serena] Univ Turin, Dept Oncol, I-10124 Turin, Italy; [Marchio, Serena] IRCCS, FPO, Candiolo Canc Inst, I-10060 Candiolo, Italy	McMaster University; McMaster University; McMaster University; Duke University; McGill University; University of New Mexico; University of New Mexico; University of New Mexico; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia	Austin, RC (corresponding author), 50 Charlton Ave E,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Hoogenes, Jen/M-9034-2017; Pinthus, Jehonathan/AAQ-1667-2021; Kapoor, Anil/AAQ-7184-2021; MARCHIO', Serena/G-9054-2017	Hoogenes, Jen/0000-0002-4905-7986; Kapoor, Anil/0000-0001-9180-8029; MARCHIO', Serena/0000-0001-8214-0776	Ontario Institute for Cancer Research	Ontario Institute for Cancer Research	Biological Materials were provided by the Ontario Tumor Bank, which is funded by the Ontario Institute for Cancer Research. We thank Life Science Editors for editing assistance.	Abdulkadir SA, 2000, HUM PATHOL, V31, P443, DOI 10.1053/hp.2000.6547; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Caldwell JA, 2010, LAB INVEST, V90, P953, DOI 10.1038/labinvest.2010.59; Chinni SR, 1997, CLIN CANCER RES, V3, P1557; Cohen M, 2011, CANCER LETT, V309, P104, DOI 10.1016/j.canlet.2011.05.022; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; de Ridder GG, 2011, MELANOMA RES, V21, P35, DOI 10.1097/CMR.0b013e3283426805; Delie F, 2012, J ONCOL, V2012, DOI 10.1155/2012/468615; Delpino A, 1998, MOL MEMBR BIOL, V15, P21, DOI 10.3109/09687689809027514; Dobroff AS, 2016, P NATL ACAD SCI USA, V113, P12780, DOI 10.1073/pnas.1615288113; Epstein JI, 2017, AM J SURG PATHOL, V41, pE1, DOI 10.1097/PAS.0000000000000820; Fang CH, 1996, THROMB HAEMOSTASIS, V76, P361; Ferrara F., 2016, P NATL ACAD SCI USA, DOI [10.1073/pnas.16154001135, DOI 10.1073/PNAS.16154001135]; Gifford JB, 2016, MOL CANCER THER, V15, P1043, DOI 10.1158/1535-7163.MCT-15-0774; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gopal U, 2016, J BIOL CHEM, V291, P10904, DOI 10.1074/jbc.M115.708131; HANSEN LK, 1995, BBA-PROTEIN STRUCT M, V1252, P135, DOI 10.1016/0167-4838(95)00113-9; Hoffman RM, 1995, CANCER EPIDEM BIOMAR, V25, P259; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Khorana AA, 2009, ANN ONCOL, V20, P1619, DOI 10.1093/annonc/mdp068; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Miao YR, 2013, CLIN CANCER RES, V19, P2107, DOI 10.1158/1078-0432.CCR-12-2991; Milsom C, 2007, PATHOPHYSIOL HAEMO T, V36, P160, DOI 10.1159/000175154; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2015, J BIOL CHEM, V290, P9571, DOI 10.1074/jbc.M114.617837; Mousa SA, 2006, THROMB HAEMOSTASIS, V96, P816, DOI 10.1160/TH06-05-0289; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Papalas JA, 2010, MODERN PATHOL, V23, P134, DOI 10.1038/modpathol.2009.152; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Raiter A, 2014, INT J BIOL MARKER, V29, pE431, DOI 10.5301/jbm.5000086; Rak J, 2006, SEMIN THROMB HEMOST, V32, P54, DOI 10.1055/s-2006-933341; Rasche L, 2015, HAEMATOLOGICA, V100, P377, DOI 10.3324/haematol.2014.117945; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao Q, 2012, INT J ONCOL, V41, P1061, DOI 10.3892/ijo.2012.1515; Staquicini DI, 2018, PHARMACOGENOMICS J, V18, P436, DOI 10.1038/tpj.2017.46; Teeter AE, 2013, UROLOGY, V82, P53, DOI 10.1016/j.urology.2012.10.090; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Hemelrijck M, 2010, LANCET ONCOL, V11, P450, DOI 10.1016/S1470-2045(10)70038-3; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060	49	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21180	21192		10.1074/jbc.M117.799908	http://dx.doi.org/10.1074/jbc.M117.799908			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29066620	Green Published, hybrid			2022-12-26	WOS:000418453400032
J	Covarrubias, S; Robinson, EK; Shapleigh, B; Vollmers, A; Katzman, S; Hanley, N; Fong, N; McManus, MT; Carpenter, S				Covarrubias, Sergio; Robinson, Elektra K.; Shapleigh, Barbara; Vollmers, Apple; Katzman, Sol; Hanley, Nicole; Fong, Nicholas; McManus, Michael T.; Carpenter, Susan			CRISPR/Cas-based screening of long non-coding RNAs (lncRNAs) in macrophages with an NF-kappa B reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; GENE-EXPRESSION; ACTIVATION; TRANSCRIPTION; INFLAMMATION; REPRESSION; CANCER; ASSAY	The innate immune system protects against infections by initiating an inducible inflammatory response. NF-kappa B is one of the critical transcription factors controlling this complex response, but some aspects of its regulation remain unclear. For example, although long non-coding RNAs (lncRNAs) have been shown to critically regulate gene expression, only a fraction of these have been functionally characterized, and the extent to which lncRNAs control NF-kappa B expression is unknown. Here, we describe the generation of a GFP-based NF-kappa B reporter system in immortalized murine bone marrow-derived macrophages (iBMDM). Activation of this reporter, using Toll-like receptor ligands, resulted in GFP expression, which could be monitored by flow cytometry. We also established a CRISPR/Cas9 gene deletion system in this NF-kappa B reporter line, enabling us to screen for genes that regulate NF-kappa B signaling. Our deletion-based approach identified two long intergenic non-coding (linc) RNAs, lincRNA-Cox2 and lincRNA-AK170409, that control NF-kappa B signaling. We demonstrate a potential novel role for lincRNA-Cox2 in promoting I kappa B alpha degradation in the cytoplasm. For lincRNA-AK170409, we provide evidence that this nuclearly-localized lincRNA regulates a number of inflammation-related genes. In conclusion, we have established an NF-kappa B-GFP iBMDM reporter cell line and a line that stably expresses Cas9. Our approach enabled the identification of lincRNA-Cox2 and lincRNA-AK170409 as NF-kappa B regulators, and this tool will be useful for identifying additional genes involved in regulating this transcription factor critical for immune function.	[Covarrubias, Sergio; Robinson, Elektra K.; Shapleigh, Barbara; Vollmers, Apple; Hanley, Nicole; Fong, Nicholas; Carpenter, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Katzman, Sol] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [McManus, Michael T.] Univ Calif Santa Cruz, Diabet Ctr, Dept Microbiol & Immunol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Carpenter, S (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	sucarpen@ucsc.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Vollmers, Apple/0000-0003-2787-0797; Covarrubias, Sergio/0000-0002-7197-9952	National Institutes of Health [R03AI131019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI131019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R03AI131019 (to S. Carpenter).	Beamer CA, 2013, SEMIN IMMUNOPATHOL, V35, P693, DOI 10.1007/s00281-013-0391-7; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Burger-Kentischer A, 2010, J IMMUNOL METHODS, V358, P93, DOI 10.1016/j.jim.2010.03.020; Carpenter S, 2016, VIRUS RES, V212, P137, DOI 10.1016/j.virusres.2015.08.019; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chen PH, 2012, ONCOGENE, V31, P2555, DOI 10.1038/onc.2011.438; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Hellweg CE, 2003, J BIOMOL SCREEN, V8, P511, DOI 10.1177/1087057103257204; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hu GK, 2016, J IMMUNOL, V196, P2799, DOI 10.4049/jimmunol.1502146; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; Sakai J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01600-y; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	29	43	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20911	20920		10.1074/jbc.M117.799155	http://dx.doi.org/10.1074/jbc.M117.799155			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29051223	Green Published, hybrid			2022-12-26	WOS:000418453400009
J	Alves-Cabratosa, L; Garcia-Gil, M; Comas-Cufi, M; Ponjoan, A; Marti-Lluch, R; Parramon, D; Blanch, J; Elosua-Bayes, M; Ramos, R				Alves-Cabratosa, Lia; Garcia-Gil, Maria; Comas-Cufi, Marc; Ponjoan, Anna; Marti-Lluch, Ruth; Parramon, Didac; Blanch, Jordi; Elosua-Bayes, Marc; Ramos, Rafel			Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006-2015	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; HEART-DISEASE; PRIMARY-CARE; RISK SCORE; MANAGEMENT; PREVENTION; CHOLESTEROL; THERAPY; STROKE; INFORMATION	Hypertension is the most prevalent risk factor for new-onset atrial fibrillation (AF). But few studies have addressed the effect of statins on the incidence of this arrhythmia in patients with hypertension. This study aimed to evaluate the effect of statins on new-onset of this arrhythmia in a hypertensive population, accounting for AF risk. Data from the Information System for the Development of Research in Primary Care was used to recruit a retrospective cohort of >= 55-year-old hypertensive individuals with no ischemic vascular disease, in 2006-2007, followed up through 2015. The effect of initiating statin treatment on new-onset atrial fibrillation was assessed with Cox proportional hazards models adjusted by the propensity score of receiving statin treatment, in the overall study population and stratified by AF risk. Of 100 276 included participants, 9814 initiated statin treatment. The AF incidence per 1000 person-years (95% confidence interval) was 12.5 (12.3-12.8). Statin use associated with a significant (9%) reduction in AF incidence. Differences in absolute AF incidence were higher in the highest AF risk subgroup, and the estimated number needed to treat to avoid one case was 720. The relative effect was poor, similar across groups, and non-significant, as was the association of statins with adverse effects. We found a limited protective effect of statins over new-onset AF in this hypertensive population with no ischemic vascular disease. If there is no further indication, hypertensive patients would not benefit from statin use solely for AF primary prevention.	[Alves-Cabratosa, Lia; Garcia-Gil, Maria; Comas-Cufi, Marc; Ponjoan, Anna; Marti-Lluch, Ruth; Parramon, Didac; Blanch, Jordi; Elosua-Bayes, Marc; Ramos, Rafel] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Vasc Hlth Res Grp Girona ISV Girona, Girona, Catalonia, Spain; [Ponjoan, Anna; Ramos, Rafel] Dr Josep Trueta Univ Hosp, Inst Invest Biomed Girona IDIBGI, Girona, Catalonia, Spain; [Marti-Lluch, Ruth] Univ Girona, Sch Med, Translab Res Grp, Dept Med Sci, Girona, Catalonia, Spain; [Parramon, Didac; Ramos, Rafel] Girona Catalan Inst Hlth ICS, Primary Care Serv, Girona, Catalonia, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona	Ramos, R (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Vasc Hlth Res Grp Girona ISV Girona, Girona, Catalonia, Spain.; Ramos, R (corresponding author), Dr Josep Trueta Univ Hosp, Inst Invest Biomed Girona IDIBGI, Girona, Catalonia, Spain.; Ramos, R (corresponding author), Girona Catalan Inst Hlth ICS, Primary Care Serv, Girona, Catalonia, Spain.	rramos.girona.ics@gencat.cat	García-Gil, M/E-5093-2016; Alves, Lia/U-1469-2019; Martí, Ruth/H-8198-2014; Blanch, Jordi/U-1407-2019; Ramos, Rafel/P-2083-2019; Ramos, Rafel/D-9627-2016; Ponjoan, Anna/ABA-3221-2020; Comas-Cufí, Marc/V-5842-2019; Comas-Cufí, Marc/A-4935-2015	García-Gil, M/0000-0001-8146-5288; Alves, Lia/0000-0002-5006-952X; Martí, Ruth/0000-0002-7320-9521; Blanch, Jordi/0000-0001-8211-3292; Ramos, Rafel/0000-0001-7970-5537; Ramos, Rafel/0000-0001-7970-5537; Comas-Cufí, Marc/0000-0001-9759-0622; Comas-Cufí, Marc/0000-0001-9759-0622; Parramon, Didac/0000-0001-6833-7345; Elosua-Bayes, Marc/0000-0001-5315-815X	Institut d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol); Primary Care Services [4R14/026]; Carlos Ill Health Institute, within the Net for Research in Preventive Activities and Health Enhancement (RedIAPP) [RD16/0007/0004]; Spanish Ministry of Health [EC10-84]; Agency for Management of University and Research Grants [SGR 902]	Institut d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol); Primary Care Services; Carlos Ill Health Institute, within the Net for Research in Preventive Activities and Health Enhancement (RedIAPP); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Agency for Management of University and Research Grants	Lia Alves-Cabratosa was supported by a Ph.D. grant from Institut d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol) and Primary Care Services (4R14/026). This project was also supported by clinical research grants from Carlos Ill Health Institute, within the Net for Research in Preventive Activities and Health Enhancement (RedIAPP RD16/0007/0004) framework; the Spanish Ministry of Health(EC10-84); and the Agency for Management of University and Research Grants (2014 SGR 902).	Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Bolibar B, 2012, MED CLIN-BARCELONA, V138, P617, DOI 10.1016/j.medcli.2012.01.020; Califf RM, 2012, JAMA-J AM MED ASSOC, V308, P1747, DOI 10.1001/jama.2012.28745; Camm AJ, 2012, AM HEART J, V164, P292, DOI 10.1016/j.ahj.2012.05.017; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Dominguez-Berjon MF, 2008, GAC SANIT, V22, P179, DOI 10.1157/13123961; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Fabritz L, 2016, NAT REV CARDIOL, V13, P230, DOI 10.1038/nrcardio.2015.194; Garcia-Gil M, 2015, J CLIN LIPIDOL; Garcia-Gil M Del Mar, 2011, Inform Prim Care, V19, P135; Gillis AM, 2013, CAN J CARDIOL, V29, P1141, DOI 10.1016/j.cjca.2013.07.006; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goren A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071264; Gotto AM, 2003, CLIN CARDIOL, V26, P3, DOI 10.1002/clc.4960261503; Hung CY, 2013, AM J MED, V126, P133, DOI 10.1016/j.amjmed.2012.06.027; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Marrugat J, 2007, J EPIDEMIOL COMMUN H, V61, P40, DOI 10.1136/jech.2005.038505; McGrath LJ, 2015, AM J EPIDEMIOL, V182, P17, DOI 10.1093/aje/kwu485; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Perk J, 2012, EUROPEAN HEART J; Ponjoan A, 2014, ENVIRON RES, V132, P190, DOI 10.1016/j.envres.2014.03.039; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; R Core Team, 2021, R LANGUAGE ENV STAT; Rahimi K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1250; Ramos R, 2016, J AM COLL CARDIOL, V67, P630, DOI 10.1016/j.jacc.2015.11.052; Ramos R, 2012, REV ESP CARDIOL, V65, P29, DOI [10.1016/j.rec.2011.07.016, 10.1016/j.recesp.2011.07.017]; Ray KK, 2014, EUR HEART J, V35, P960, DOI 10.1093/eurheartj/ehu107; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rose G., 2008, ROSES STRATEGY PREVE; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Savelieva I, 2010, N-S ARCH PHARMACOL, V381, P207, DOI 10.1007/s00210-009-0468-y; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Schotten U, 2016, J INTERN MED, V279, P428, DOI 10.1111/joim.12492; SIDIAP (ES), 2017, ARTICLES; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Tannen RL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b81; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; van Buuren S, 2011, J STAT SOFTW, V45, P1; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186972	10.1371/journal.pone.0186972	http://dx.doi.org/10.1371/journal.pone.0186972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073212	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400084
J	He, GJ; Liu, CX; Liu, XB; Wang, QZ; Fan, AY; Wang, SJ; Qian, XL				He, Guangjie; Liu, Chenxi; Liu, Xiaobo; Wang, Qingzhi; Fan, Aiying; Wang, Songjun; Qian, Xinlai			Design and synthesis of a fluorescent probe based on naphthalene anhydride and its detection of copper ions	PLOS ONE			English	Article							SELECTIVE DETECTION; CELLS; COMPLEX	Copper, as the third most abundant transition metal ions of human, plays an essential role in the redox reaction, signal transduction, hematopoiesis, and other physiological processes. Abnormal content of copper ions in the body will cause some diseases such as anemia, coronary heart disease, Menkes' syndrome. In this article, a new fluorescence probe L for Cu2+ was designed and synthetized by using 4-bromo-1,8 naphthalene anhydride and 2-thiophene formaldehyde as raw materials. Fluorescent probe L itself exhibited strong fluorescence, upon the addition of Cu2+ ions, the fluorescence was quenched. The fluorescent detection limit for Cu2+ ions was determined to be 1.8 mu M based on a 3 delta/S method. UV-vis absorption and fluorescence spectra indicated that probe L showed good selectivity and sensitivity for Cu2+, and this selectivity was not interfered by other metal ions and anions. Further cell fluorescence imaging experiments indicated that the probe L had potential to be used to examine copper ions in vivo.	[He, Guangjie; Liu, Chenxi; Liu, Xiaobo; Wang, Qingzhi; Fan, Aiying] Xinxiang Med Univ, Dept Forens Med, Xinxiang, Henan, Peoples R China; [Wang, Songjun] Hebei Med Univ, Hebei Key Lab Forens Med, Shijiazhuang, Hebei, Peoples R China; [Qian, Xinlai] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Henan, Peoples R China	Xinxiang Medical University; Hebei Medical University; Xinxiang Medical University	He, GJ (corresponding author), Xinxiang Med Univ, Dept Forens Med, Xinxiang, Henan, Peoples R China.; Qian, XL (corresponding author), Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Henan, Peoples R China.	guangjiehe@163.com; qxlfssws@163.com		He, Guangjie/0000-0002-4658-5214	National Natural Science Foundation of China [21371148]; Hebei Key Laboratory of Forensic Medicine [KF201601]; Disciplinary group of Psychology and Neuroscience, Xinxiang Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Key Laboratory of Forensic Medicine; Disciplinary group of Psychology and Neuroscience, Xinxiang Medical University	We gratefully acknowledge financial support from the National Natural Science Foundation of China (no. 21371148) to Guangjie He, the Hebei Key Laboratory of Forensic Medicine (no. KF201601) to Guangjie He, and the Disciplinary group of Psychology and Neuroscience, Xinxiang Medical University to Guangjie He. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge financial support from the National Natural Science Foundation of China (No. 21371148), the Hebei Key Laboratory of Forensic Medicine (No. KF201601), and the Disciplinary group of Psychology and Neuroscience, Xinxiang Medical University.	Bekhradnia A, 2016, SPECTROCHIM ACTA A, V152, P18, DOI 10.1016/j.saa.2015.07.029; Bhattacharjee S, 2014, CHEM COMMUN, V50, P11690, DOI 10.1039/c4cc04712e; Brider T, 2016, RES CHEM INTERMEDIAT, V42, P1741, DOI 10.1007/s11164-015-2115-1; Das K, 2017, J BIOL INORG CHEM, V22, P481, DOI 10.1007/s00775-016-1428-x; He GJ, 2017, TETRAHEDRON, V73, P272, DOI 10.1016/j.tet.2016.12.012; He GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148026; Huck CW, 2016, CURR MED CHEM, V23, P3052, DOI 10.2174/0929867323666160607110507; Jung HS, 2009, J AM CHEM SOC, V131, P2008, DOI 10.1021/ja808611d; Kang YJ, 2011, PHARMACOL THERAPEUT, V129, P321, DOI 10.1016/j.pharmthera.2010.11.004; Kanthlal S.K., 2016, ASIAN PAC J TROP DIS, V6, P668, DOI DOI 10.1016/S2222-1808(16)61107-6; Li JF, 2016, DYES PIGMENTS, V130, P209, DOI 10.1016/j.dyepig.2016.02.024; Li P, 2011, CHEM COMMUN, V47, P7755, DOI 10.1039/c1cc11885d; Li ZP, 2016, CHEM COMMUN, V52, P6613, DOI 10.1039/c6cc01476c; Liu JJ, 2013, CURR ORG CHEM, V17, P564; Lu HR, 2016, TALANTA, V146, P477, DOI 10.1016/j.talanta.2015.09.014; Merza H, 2015, CLIN CASE REP, V3, P819, DOI 10.1002/ccr3.344; Naskar B, 2017, DALTON T, V46, P9498, DOI 10.1039/c7dt01932g; Paes G, 2014, MOLECULES, V19, P9380, DOI 10.3390/molecules19079380; Pessoa KD, 2017, SPECTROCHIM ACTA A, V185, P310, DOI 10.1016/j.saa.2017.05.072; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; Shen RH, 2017, TETRAHEDRON, V73, P373, DOI 10.1016/j.tet.2016.12.016; Squitti R, 2016, METALLOMICS, V8, P863, DOI [10.1039/C6MT00101G, 10.1039/c6mt00101g]; TIAN H, 1994, DYES PIGMENTS, V26, P159, DOI 10.1016/0143-7208(94)80032-4; Torrado A, 1998, J AM CHEM SOC, V120, P609, DOI 10.1021/ja973357k; Waggoner DJ, 1999, NEUROBIOL DIS, V6, P221, DOI 10.1006/nbdi.1999.0250; Wang J, 2017, BIOSENS BIOELECTRON, V97, P157, DOI 10.1016/j.bios.2017.05.035; Wang YL, 2017, ANAL CHEM, V89, P6392, DOI 10.1021/acs.analchem.6b05106; You QH, 2014, CHEM COMMUN, V50, P6207, DOI 10.1039/c4cc00521j; Zhang CH, 2016, TALANTA, V154, P278, DOI 10.1016/j.talanta.2016.03.067; Zhang HT, 2016, ACS APPL MATER INTER, V8, P16227, DOI 10.1021/acsami.6b03254; Zhang HT, 2017, BIOSENS BIOELECTRON, V94, P24, DOI 10.1016/j.bios.2017.02.037; Zhang XL, 2013, CURR ORG CHEM, V17, P580, DOI 10.2174/1385272811317060004; Zhu XY, 2016, PHOTOCH PHOTOBIO SCI, V15, P412, DOI 10.1039/c5pp00468c	33	27	27	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186994	10.1371/journal.pone.0186994	http://dx.doi.org/10.1371/journal.pone.0186994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073217	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400091
J	Wu, C; Chen, HC; Chen, ST; Chiang, SY; Wu, KY				Wu, Charlene; Chen, Hsin-Chang; Chen, Shu-Ting; Chiang, Su-Yin; Wu, Kuen-Yuh			Elevation in and persistence of multiple urinary biomarkers indicative of oxidative DNA stress and inflammation: Toxicological implications of maleic acid consumption using a rat model	PLOS ONE			English	Article							GLUTATHIONE DEPLETION; SEX-DIFFERENCES; IN-VITRO; MALEATE; DAMAGE; 8-ISOPROSTANE; MECHANISMS; MARKER; INJURY; NEPHROTOXICITY	Maleic acid (MA), an intermediate reagent used in many industrial products, instigated public health concerns in Taiwan when it was used to adulterate an array of starch-based delicacies to improve texture and storage time. Established studies reported that exposure to high concentrations of MA induce renal injury; little is known whether oxidative stress is induced at a relative low dose. This study aims to investigate the effect of oral single dose exposure of MA on the status of oxidative stress and inflammation. Single dose of MA at 0, 6 and 60 mg/kg (control, low-and high-dose groups, respectively) were orally administered to adult male and female rats. Urine samples were collected and analyzed to measure 8-hydroxy-2 '-deoxyguanosine (8-OHdG), 8-iso-prostaglandin F-2 alpha (8-IsoPGF(2 alpha)), 8-nitroguanine (8-NO(2)Gua) and N-acetyl-S-(tetrahydro-5-hydroxy-2-pentyl-3-furanyl)-L-cysteine (HNE-MA) using LC-MS/MS. Results revealed that oral consumption of MA induced oxidative DNA damage and lipid peroxidation, as demonstrated by the statistically significant increases in urinary levels of 8-NO(2)Gua, 8-OHdG, and 8-isoPGF(2 alpha), in high-dosed male rats within 12 h of oral gavage (p < 0.05). Additionally, increases in concentration of these biomarkers persist for days after consumption; male rats appear to be more sensitive to oxidative burden compared to their counterparts. The aforementioned findings could help elucidate the mechanisms through which nephrotoxicity occur.	[Wu, Charlene; Chen, Hsin-Chang; Wu, Kuen-Yuh] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Chen, Shu-Ting] Natl Hlth Res Inst, Natl Environm Hlth Res Ctr, Miaoli, Taiwan; [Chiang, Su-Yin] China Med Univ, Sch Chinese Med, Taichung, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; China Medical University Taiwan	Wu, KY (corresponding author), Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan.; Chiang, SY (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	sychiang@mail.cmu.edu.tw; kuenyuhwu@ntu.edu.tw		Chen, Hsin-Chang/0000-0003-4879-3639; Wu, Charlene/0000-0002-1407-7397	Ministry of Science and Technology of Taiwan; National Taiwan University	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was supported by the Ministry of Science and Technology of Taiwan and National Taiwan University. We also thank China Medical University for instrumental support and animal care.	Alary J, 2003, CHEM RES TOXICOL, V16, P320, DOI 10.1021/tx025671k; Alexeeff G, 2000, DETERMINATION NONCAN; Andreoli R, 2011, FREE RADICAL BIO MED, V50, P254, DOI 10.1016/j.freeradbiomed.2010.11.009; [Anonymous], 1997, RENAL FAILURE, V19, P373; [Anonymous], 2000, ULLMANNS ENCY IND CH; Badr KF, 2005, ANTIOXIDANTS REDOX S, V7; Ballal NV, 2013, CLIN ORAL INVEST, P1; Balog B., 2010, MED SCI, V35, P16; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brunelli E, 2014, CURR DRUG TARGETS, V15, P811, DOI 10.2174/1389450115666140624112317; Burnett CL, 2011, INT J TOXICOL, V30, p5S, DOI [10.1177/1091581811400636, 10.1177/1091581811407934]; Cassis P, 2011, TRANSPLANTATION, V92, P271, DOI 10.1097/TP.0b013e3182241106; Chen H. L., 2014, COMP MATH MATH PHYS, V2014, P14, DOI DOI 10.1016/J.TALANTA.2014.11.021; Cooke MS, 2001, BIOCHEM BIOPH RES CO, V284, P232, DOI 10.1006/bbrc.2001.4954; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Di Minno A, 2016, ANTIOXID REDOX SIGN, V24, P548, DOI 10.1089/ars.2015.6508; Djamali A, 2007, AM J PHYSIOL-RENAL, V293, pF445, DOI 10.1152/ajprenal.00037.2007; Esposito E, 2011, N-S ARCH PHARMACOL, V383, P493, DOI 10.1007/s00210-011-0610-5; FSANZ (Food Standards Australia New Zealand), 2003, MON GLUT SAF ASS; Fu HY, 2017, FOOD CHEM, V227, P322, DOI 10.1016/j.foodchem.2017.01.061; GSTRAUNTHALER G, 1983, BIOCHEM PHARMACOL, V32, P2969, DOI 10.1016/0006-2952(83)90404-5; Hakim IA, 2012, CANCER EPIDEM BIOMAR, V21, P2193, DOI 10.1158/1055-9965.EPI-12-0820; Helmersson J, 2002, CLIN SCI, V102, P39, DOI 10.1042/CS20010179; HIGINBOTHAM KG, 1992, CANCER RES, V52, P4747; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hou ML, 2016, MOLECULES, V21, DOI 10.3390/molecules21030367; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Janssen LJ, 2001, BRIT J PHARMACOL, V132, P127, DOI 10.1038/sj.bjp.0703784; Johns NP, 2012, ASIAN PAC J CANCER P, V13, P775, DOI 10.7314/APJCP.2012.13.3.775; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; KAWAMURA K, 1987, ENVIRON SCI TECHNOL, V21, P105, DOI 10.1021/es00155a014; KELLERMAN PS, 1993, J CLIN INVEST, V92, P1940, DOI 10.1172/JCI116787; Kinnula VL, 2007, EUR RESPIR J, V29, P51, DOI 10.1183/09031936.00023606; Kitanovski Z, 2011, J CHROMATOGR A, V1218, P4417, DOI 10.1016/j.chroma.2011.05.020; Kuiper HC, 2011, FREE RADICAL BIO MED, V50, P848, DOI 10.1016/j.freeradbiomed.2011.01.004; Lai CQ, 2008, DIABETES, V57, P809, DOI 10.2337/db07-1238; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Loft S, 1998, ESTIMATION OXIDATIVE; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Montuschi P, 1998, AM J RESP CRIT CARE, V158, P1524, DOI 10.1164/ajrccm.158.5.9803102; NATH KA, 1995, AM J PHYSIOL-CELL PH, V268, pC227, DOI 10.1152/ajpcell.1995.268.1.C227; Nissim I, 1996, KIDNEY INT, V49, P684, DOI 10.1038/ki.1996.97; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; Ohshima H, 2006, ANTIOXID REDOX SIGN, V8, P1033, DOI 10.1089/ars.2006.8.1033; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; Pavlovic V, 2007, MOL CELL BIOCHEM, V303, P161, DOI 10.1007/s11010-007-9469-7; Pedraza-Chaverri J, 2006, AM J PHYSIOL-RENAL, V290, pF196, DOI 10.1152/ajprenal.00230.2005; Reusch C, 1991, ENZYME ACTIVITIES UR; Sartori-Valinotti JC, 2007, CLIN EXP PHARMACOL P, V34, P938, DOI 10.1111/j.1440-1681.2007.04643.x; Sharma A, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0192-5; Tapia E, 2014, FREE RADICAL RES, V48, P1342, DOI 10.3109/10715762.2014.954109; Tirmenstein MA, 2000, CHEM-BIOL INTERACT, V127, P201, DOI 10.1016/S0009-2797(00)00180-0; Topic A, 2013, CLIN BIOCHEM, V46, P321, DOI 10.1016/j.clinbiochem.2012.12.008; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; van Kesteren PJM, 1998, THROMB HAEMOSTASIS, V79, P1029; Wan GH, 2013, PEDIATR RES, V74, P8; Wu C, J APPL TOXICOLOGY; Wu C, 2016, DRUG METAB PHARMACOK, V31, P451, DOI 10.1016/j.dmpk.2016.09.005; Wu C, 2016, ANAL BIOCHEM, V512, P26, DOI 10.1016/j.ab.2016.07.030; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Zager RA, 2008, AM J PHYSIOL-RENAL, V294, pF187, DOI 10.1152/ajprenal.00434.2007	63	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0183675	10.1371/journal.pone.0183675	http://dx.doi.org/10.1371/journal.pone.0183675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073142	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400001
J	Kessel, ST; Elamin, NA; Yurkowski, DJ; Chekchak, T; Walter, RP; Klaus, R; Hill, G; Hussey, NE				Kessel, Steven Thomas; Elamin, Nasreldin Alhasan; Yurkowski, David James; Chekchak, Tarik; Walter, Ryan Patrick; Klaus, Rebecca; Hill, Graham; Hussey, Nigel Edward			Conservation of reef manta rays (Manta alfredi) in a UNESCO World Heritage Site: Large-scale island development or sustainable tourism?	PLOS ONE			English	Article							RED-SEA; IMPACT; PHYTOPLANKTON; MANAGEMENT; MOVEMENTS; BIROSTRIS; FUTURE; ISSUES; SPACE; WATER	A large reef manta ray (Manta alfredi) aggregation has been observed off the north Sudanese Red Sea coast since the 1950s. Sightings have been predominantly within the boundaries of a marine protected area (MPA), which was designated a UNESCO World Heritage Site in July 2016. Contrasting economic development trajectories have been proposed for the area (small-scale ecotourism and large-scale island development). To examine space-use, Wildlife Computers (R) SPOT 5 tags were secured to three manta rays. A two-state switching Bayesian state space model (BSSM), that allowed movement parameters to switch between resident and travelling, was fit to the recorded locations, and 50% and 95% kernel utilization distributions (KUD) home ranges calculated. A total of 682 BSSM locations were recorded between 30 October 2012 and 6 November 2013. Of these, 98.5% fell within the MPA boundaries; 99.5% for manta 1, 91.5% for manta 2, and 100% for manta 3. The BSSM identified that all three mantas were resident during 99% of transmissions, with 50% and 95% KUD home ranges falling mainly within the MPA boundaries. For all three mantas combined (88.4%), and all individuals (manta 1-92.4%, manta 2-64.9%, manta 3-91.9%), the majority of locations occurred within 15 km of the proposed large-scale island development. Results indicated that the MPA boundaries are spatially appropriate for manta rays in the region, however, a close association to the proposed large-scale development highlights the potential threat of disruption. Conversely, the focused nature of spatial use highlights the potential for reliable ecotourism opportunities.	[Kessel, Steven Thomas] John G Shedd Aquarium, Daniel P Haerther Ctr Conservat & Res, Chicago, IL 60605 USA; [Kessel, Steven Thomas; Chekchak, Tarik; Klaus, Rebecca; Hussey, Nigel Edward] Equipe Cousteau, Paris, France; [Elamin, Nasreldin Alhasan] Wildlife Conservat Gen Adm, Port Sudan, Sudan; [Yurkowski, David James; Walter, Ryan Patrick] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON, Canada; [Klaus, Rebecca] Senckenberg Res Inst, Senckenberganlage 25, Frankfurt, Germany; [Klaus, Rebecca] Museum Nat Frankfurt Marine Zool Ichthyol, Senckenberganlage 25, Frankfurt, Germany; [Hill, Graham] Deep Aquarium, Kingston Upon Hull, N Humberside, England; [Hussey, Nigel Edward] Univ Windsor, Biol Sci, Windsor, ON, Canada	University of Windsor; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Windsor	Kessel, ST (corresponding author), John G Shedd Aquarium, Daniel P Haerther Ctr Conservat & Res, Chicago, IL 60605 USA.; Kessel, ST (corresponding author), Equipe Cousteau, Paris, France.	skessel80@gmail.com		Yurkowski, David/0000-0003-2264-167X; Kessel, Steven/0000-0001-7729-7701	Deep Aquarium [00176]; Darwin Initiative [21-019]	Deep Aquarium; Darwin Initiative	This study was funded by The Deep Aquarium (grant # 00176; www.thedeep.co.uk) and The Darwin Initiative (grant # 21-019; www. gov.uk/government/groups/the-darwin-initiative). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APF, 2006, SURV REP SUD MAR PAR; Armstrong AO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153393; Aspinall R, 2017, GUARDIAN; BAK RPM, 1978, MAR POLLUT BULL, V9, P14, DOI 10.1016/0025-326X(78)90275-8; Bartholomew A, 2008, LANDSCAPE ECOL, V23, P55, DOI 10.1007/s10980-007-9136-0; Braun CD, 2015, MAR BIOL, V162, P2351, DOI 10.1007/s00227-015-2760-3; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005; Cousteau, 2013, SUST FUT RED SEA C 1; Couturier LIE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077152; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Croll DA, 2016, AQUAT CONSERV, V26, P562, DOI 10.1002/aqc.2591; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DELESALLE B, 1992, CONT SHELF RES, V12, P939, DOI 10.1016/0278-4343(92)90053-M; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Dulvy NK, 2014, PEERJ, V2, DOI 10.7717/peerj.400; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Gadig OBF, 2014, ACTA ETHOL, V17, P119, DOI 10.1007/s10211-013-0165-1; Germanov ES, 2014, PLOS ONE, V9; Girondot M, 2015, J MAR BIOL ASSOC UK, V95, P153, DOI 10.1017/S0025315414001398; Gladstone W, 2003, OCEAN COAST MANAGE, V46, P741, DOI 10.1016/S0964-5691(03)00065-6; Gladstone W, 1999, OCEAN COAST MANAGE, V42, P671, DOI 10.1016/S0964-5691(99)00040-X; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harwood J, 2016, ADV EXP MED BIOL, V875, P417, DOI 10.1007/978-1-4939-2981-8_49; Hass H, 1952, UNDER THE RED SEA; Hass H., 1956, UNDER THE RED SEA; Homma K, 1999, THE INDO PACIFIC, P209; Hussey N, 2014, NATURE, V514, P305, DOI 10.1038/514305d; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Iannuzzi TJ, 1996, ESTUARIES, V19, P257, DOI 10.2307/1352231; Jaine FRA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Jennings DE, 2008, ENVIRON BIOL FISH, V83, P369, DOI 10.1007/s10641-008-9357-3; Jing LD, 2013, ECOL ENG, V52, P167, DOI 10.1016/j.ecoleng.2012.12.109; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kemp J., 2002, PERSGA SAP COMPONENT, V5, P164; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2010, AFR J MAR SCI, V32, P573, DOI 10.2989/1814232X.2010.538152; McCauley DJ, 2014, MAR BIOL, V161, P1987, DOI 10.1007/s00227-014-2478-7; McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1117; Nayar S, 2004, ECOTOX ENVIRON SAFE, V59, P349, DOI 10.1016/j.ecoenv.2003.08.015; O'Malley MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065051; Papastamatiou YP, 2012, MAR ECOL PROG SER, V456, P233, DOI 10.3354/meps09721; Sale PF, 2011, AMBIO, V40, P4, DOI 10.1007/s13280-010-0092-6; Shaalan IM, 2005, J CLEAN PROD, V13, P83, DOI 10.1016/j.jclepro.2003.12.012; Walter RP, 2014, MAR BIODIVERS, V44, P1, DOI 10.1007/s12526-013-0183-2; Ward-Paige CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074835; White WT, 2006, FISH RES, V82, P65, DOI 10.1016/j.fishres.2006.08.008	53	19	21	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185419	10.1371/journal.pone.0185419	http://dx.doi.org/10.1371/journal.pone.0185419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069079	Green Submitted, Green Published, gold			2022-12-26	WOS:000413663600006
J	Hu, LF; Li, HZ; Cai, ZN; Lin, FY; Hong, GL; Chen, HL; Lu, ZQ				Hu, Lufeng; Li, Huaizhong; Cai, Zhennao; Lin, Feiyan; Hong, Guangliang; Chen, Huiling; Lu, Zhongqiu			A new machine-learning method to prognosticate paraquat poisoned patients by combining coagulation, liver, and kidney indices	PLOS ONE			English	Article							GREY WOLF OPTIMIZER; FACE RECOGNITION; CLASSIFICATION; PREDICTION	The prognosis of paraquat (PQ) poisoning is highly correlated to plasma PQ concentration, which has been identified as the most important index in PQ poisoning. This study investigated the predictive value of coagulation, liver, and kidney indices in prognosticating PQ-poisoning patients, when aligned with plasma PQ concentrations. Coagulation, liver, and kidney indices were first analyzed by variance analysis, receiver operating characteristic curves, and Fisher discriminant analysis. Then, a new, intelligent, machine learning-based system was established to effectively provide prognostic analysis of PQ-poisoning patients based on a combination of the aforementioned indices. In the proposed system, an enhanced extreme learning machine wrapped with a grey wolf-optimization strategy was developed to predict the risk status from a pool of 103 patients (56 males and 47 females); of these, 52 subjects were deceased and 51 alive. The proposed method was rigorously evaluated against this real-life dataset, in terms of accuracy, Matthews correlation coefficients, sensitivity, and specificity. Additionally, the feature selection was investigated to identify correlating factors for risk status. The results demonstrated that there were significant differences in the coagulation, liver, and kidney indices between deceased and surviving subjects (p<0.05). Aspartate aminotransferase, prothrombin time, prothrombin activity, total bilirubin, direct bilirubin, indirect bilirubin, alanine aminotransferase, urea nitrogen, and creatinine were the most highly correlated indices in PQ poisoning and showed statistical significance (p<0.05) in predicting PQ-poisoning prognoses. According to the feature selection, the most important correlated indices were found to be associated with aspartate aminotransferase, the aspartate aminotransferase to alanine ratio, creatinine, prothrombin time, and prothrombin activity. The method proposed here showed excellent results that were better than that produced based on blood-PQ concentration alone. These promising results indicated that the combination of these indices can provide a new avenue for prognosticating the outcome of PQ poisoning.	[Hu, Lufeng; Lin, Feiyan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pharm, Wenzhou, Peoples R China; [Li, Huaizhong] Lishui Univ, Dept Comp, Lishui, Zhejiang, Peoples R China; [Cai, Zhennao; Chen, Huiling] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China; [Hong, Guangliang; Lu, Zhongqiu] Wenzhou Med Univ, Dept Emergency, Affiliated Hosp 1, Wenzhou, Peoples R China	Wenzhou Medical University; Lishui University; Wenzhou University; Wenzhou Medical University	Chen, HL (corresponding author), Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China.; Lu, ZQ (corresponding author), Wenzhou Med Univ, Dept Emergency, Affiliated Hosp 1, Wenzhou, Peoples R China.	chenhuiling.jlu@gmail.com; wzlu2014@126.com	chen, huiling/J-2477-2013; Chen, Huiling/N-8510-2019	Chen, Huiling/0000-0002-7714-9693	National Natural Science Foundation of China [6137316661772248, 81571937pro]; Zhejiang Provincial Natural Science Foundation of China [LY17F020012, LY16H300005]; Traditional Chinese Medicine Project of Zhejiang Province [2015ZZ015]; Science and Technology Plan Project of Wenzhou [ZG2017019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Traditional Chinese Medicine Project of Zhejiang Province; Science and Technology Plan Project of Wenzhou	Funded by National Natural Science Foundation of China 6137316661772248 Huaizhong Li. National Natural Science Foundation of China 81571937pro Zhonqiu Lu. Zhejiang Provincial Natural Science Foundation of China LY17F020012 Huiling Chen. Zhejiang Provincial Natural Science Foundation of China LY16H300005 Lufeng Hu. The Traditional Chinese Medicine Project of Zhejiang Province 2015ZZ015 pro Zhonqiu Lu. The Science and Technology Plan Project of Wenzhou ZG2017019 Lufeng Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2016, BASIC CLIN PHARM TOX; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Daniel E, 2017, BIOMED SIGNAL PROCES, V34, P36, DOI 10.1016/j.bspc.2017.01.003; Emary E, 2016, NEUROCOMPUTING, V172, P371, DOI 10.1016/j.neucom.2015.06.083; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Hong GL, 2016, J PHARMACOL TOX MET, V80, P75, DOI 10.1016/j.vascn.2016.05.010; HOUZE P, 1990, HUM EXP TOXICOL, V9, P5, DOI 10.1177/096032719000900103; Hu L, 2016, J PHARM TOXICOLOGICA, V84, P78; Hu LF, 2015, COMPUT BIOL MED, V59, P116, DOI 10.1016/j.compbiomed.2015.02.003; Huang CJ, 2005, AM J MED SCI, V330, P254, DOI 10.1097/00000441-200511000-00011; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Jayabarathi T, 2016, ENERGY, V111, P630, DOI 10.1016/j.energy.2016.05.105; Kamboj VK, 2016, NEURAL COMPUT APPL, V27, P1643, DOI 10.1007/s00521-015-1962-4; Komaki GM, 2015, J COMPUT SCI-NETH, V8, P109, DOI 10.1016/j.jocs.2015.03.011; Li L-N., 2012, J MED SYST, P1; Lu C, 2017, ENG APPL ARTIF INTEL, V57, P61, DOI 10.1016/j.engappai.2016.10.013; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Mohammed AA, 2011, PATTERN RECOGN, V44, P2588, DOI 10.1016/j.patcog.2011.03.013; Moreno R, 2014, NEUROCOMPUTING, V128, P207, DOI 10.1016/j.neucom.2013.03.057; Pal M, 2009, INT J REMOTE SENS, V30, P3835, DOI 10.1080/01431160902788636; Peng Y, 2015, NEUROCOMPUTING, V149, P340, DOI 10.1016/j.neucom.2013.12.065; Precup RE, 2017, IEEE T IND ELECTRON, V64, P527, DOI 10.1109/TIE.2016.2607698; Salzberg SL, 1997, DATA MIN KNOWL DISC, V1, P317, DOI 10.1023/A:1009752403260; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Shi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040911; Suresh S, 2009, APPL SOFT COMPUT, V9, P541, DOI 10.1016/j.asoc.2008.07.005; Tan J. T., 2008, MED J MALAYSIA, V68, P384; Wang SJ, 2014, NEURAL PROCESS LETT, V39, P25, DOI 10.1007/s11063-013-9288-7; Wang XQ, 2015, BIOL PHARM BULL, V38, P470, DOI 10.1248/bpb.b14-00781; Wang YB, 2015, NEUROCOMPUTING, V149, P415, DOI 10.1016/j.neucom.2014.04.073; Wong KI, 2015, NEUROCOMPUTING, V149, P397, DOI 10.1016/j.neucom.2013.09.074; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012; Zhang S, 2017, OPTIK, V130, P1229, DOI 10.1016/j.ijleo.2016.11.173	34	42	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186427	10.1371/journal.pone.0186427	http://dx.doi.org/10.1371/journal.pone.0186427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049326	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900068
J	Jiang, XW; Feyertag, F; Robertson, DL				Jiang, Xiaowei; Feyertag, Felix; Robertson, David L.			Protein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism	PLOS ONE			English	Article							N-LINKED GLYCOSYLATION; CORECEPTOR USAGE; HIV-1; GLYCOPROTEIN; CXCR4; CCR5; EVOLUTIONARY; RECEPTOR; PREDICTION; IDENTIFICATION	Human immunodeficiency virus type 1 (HIV-1) envelope gp120 is partly an intrinsically disordered (unstructured/disordered) protein as it contains regions that do not fold into well-defined protein structures. These disordered regions play important roles in HIV's life cycle, particularly, V3 loop-dependent cell entry, which determines how the virus uses two coreceptors on immune cells, the chemokine receptors CCR5 (R5), CXCR4 (X4) or both (R5X4 virus). Most infecting HIV-1 variants utilise CCR5, while a switch to CXCR4-use occurs in the majority of infections. Why does this 'rewiring' event occur in HIV-1 infected patients? As changes in the charge of the V3 loop are associated with this receptor switch and it has been suggested that charged residues promote structure disorder, we hypothesise that the intrinsic disorder of the V3 loop is permissive to sequence variation thus contributing to the switch in cell tropism. To test this we use three independent data sets of gp120 to analyse V3 loop disorder. We find that the V3 loop of X4 virus has significantly higher intrinsic disorder tendency than R5 and R5X4 virus, while R5X4 virus has the lowest. These results indicate that structural disorder plays an important role in HIV-1 cell tropism and CXCR4 binding. We discuss the potential evolutionary mechanisms leading to the fixation of disorder promoting mutations and the adaptive potential of protein structural disorder in viral host adaptation.	[Jiang, Xiaowei; Feyertag, Felix; Robertson, David L.] Univ Manchester, Sch Biol Sci, Evolut & Genom Sci, Fac Life Sci, Manchester, Lancs, England; [Jiang, Xiaowei] Univ Cambridge, Dept Genet, Cambridge, England; [Jiang, Xiaowei] Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford, England; [Feyertag, Felix] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Robertson, David L.] Univ Glasgow, Ctr Virus Res, MRC, Garscube Campus, Glasgow, Lanark, Scotland	University of Manchester; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Glasgow	Jiang, XW; Robertson, DL (corresponding author), Univ Manchester, Sch Biol Sci, Evolut & Genom Sci, Fac Life Sci, Manchester, Lancs, England.; Jiang, XW (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.; Jiang, XW (corresponding author), Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford, England.; Robertson, DL (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Garscube Campus, Glasgow, Lanark, Scotland.	xj234@well.ox.ac.uk; david.l.robertson@glasgow.ac.uk	Jiang, Xiaowei/D-1079-2010	Jiang, Xiaowei/0000-0002-6030-1249	BBSRC; MRC [G1001806/1]; WT [097820/Z/11/A]; Issac Newton Trust; Medical Research Council [G1001806/1]; Wellcome Trust [097820/Z/11/A]; MRC [G1001806, MC_UU_12014/12] Funding Source: UKRI; Medical Research Council [G1001806, MC_UU_12014/12] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WT; Issac Newton Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank Simon Lovell for helpful discussion, and Frank Konietschke and Marius Placzek for providing an updated version of the R Nparcomp package. FF was supported by a BBSRC studentship and XJ by the MRC (G1001806/1) and WT (097820/Z/11/A) grants to DLR, and by the Issac Newton Trust and WT funding to John Welch, University of Cambridge.; This work was supported by Medical Research Council (G1001806/1, http://gtr.rcuk.ac.uk/project/B49A67AE-9D16-4EB6-9024-6499FF854BAC) and Wellcome Trust (097820/Z/11/A) to DLR and by the Issac Newton Trust and Wellcome Trust funding to John Welch, University of Cambridge. FF was supported by a BBSRC studentship and XJ by the MRC (G1001806/1) and WT (097820/Z/11/A) grants to DLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001022; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Bartlett AD, 2014, AIDS, V28, P1611, DOI 10.1097/QAD.0000000000000288; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Chandramouli B, 2014, J STRUCT BIOL, V186, P132, DOI 10.1016/j.jsb.2014.02.014; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edo-Matas D, 2012, VIROLOGY, V422, P70, DOI 10.1016/j.virol.2011.10.005; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Jiang XW, 2015, J VIROL, V89, P11457, DOI 10.1128/JVI.01384-15; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kalinina OV, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-130; Kimura M., 1983, THE NEUTRAL THEORY O; Konietschke F, 2012, ELECTRON J STAT, V6, P1358, DOI 10.1214/12-EJS714; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Land A, 2001, BIOCHIMIE, V83, P783, DOI 10.1016/S0300-9084(01)01314-1; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Levy ED, 2012, P NATL ACAD SCI USA, V109, P20461, DOI 10.1073/pnas.1209312109; Li Y, 2001, AIDS RES HUM RETROV, V17, P1473, DOI 10.1089/08892220152644179; Meehan CJ, 2010, J MED VIROL, V82, P2004, DOI 10.1002/jmv.21922; Mild M, 2013, INFECT GENET EVOL, V19, P369, DOI 10.1016/j.meegid.2013.05.004; Mild M, 2010, INFECT GENET EVOL, V10, P356, DOI 10.1016/j.meegid.2009.05.003; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mosca R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014969; Moscoso CG, 2014, SCI REP-UK, V4, DOI 10.1038/srep07025; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Ortiz JF, 2013, GENOME BIOL EVOL, V5, P504, DOI 10.1093/gbe/evt026; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Polzer S, 2002, VIROLOGY, V304, P70, DOI 10.1006/viro.2002.1760; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Tamamis P, 2013, BIOPHYS J, V105, P1502, DOI 10.1016/j.bpj.2013.07.049; Tasca S, 2008, J VIROL, V82, P7089, DOI 10.1128/JVI.00570-08; Tompa P, 2015, CURR OPIN STRUC BIOL, V35, P49, DOI 10.1016/j.sbi.2015.08.009; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; TSUCHIYA K, 2013, SCI REP UK, V3; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN., 2013, PROTEIN SCIENCE A PU; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wood NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080301; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xue B, 2012, CELL MOL LIFE SCI, V69, P1211, DOI 10.1007/s00018-011-0859-3	61	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185790	10.1371/journal.pone.0185790	http://dx.doi.org/10.1371/journal.pone.0185790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049306	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000413195900020
J	Minaeva, E; Zalutskaya, Z; Filina, V; Ermilova, E				Minaeva, Ekaterina; Zalutskaya, Zhanneta; Filina, Valentina; Ermilova, Elena			Truncated hemoglobin 1 is a new player in Chlamydomonas reinhardtii acclimation to sulfur deprivatione	PLOS ONE			English	Article							ACETYL-L-SERINE; NITRIC-OXIDE; NITRATE REDUCTASE; SULFATE ASSIMILATION; GENE-EXPRESSION; NITROGEN-METABOLISM; PLANT HEMOGLOBINS; UNICELLULAR EUKARYOTES; LEMNA-MINOR; TRANSPORT	Truncated hemoglobins constitute a large family, present in bacteria, in archaea and in eukaryotes. However, a majority of physiological functions of these proteins remains to be elucidated. Identification and characterization of a novel role of truncated hemoglobins in the model alga provides a framework for a more complete understanding of their biological functions. Here, we use quantitative RT-PCR to show that three truncated hemoglobins of Chlamydomonas reinhardtii, THB1, THB2 and THB12, are induced under conditions of depleted sulfur (S) supply. THB1 underexpression results in the decrease in cell size, as well in levels of proteins, chlorophylls and mRNA of several S-responsive genes under S starvation. We provide evidence that knock-down of THB1 enhances NO production under S deprivation. In S-deprived cells, a subset of S limitation-responsive genes is controlled by NO in THB1-dependent pathway. Moreover, we demonstrate that deficiency for S represses the nitrate reduction and that THB1 is involved in this control. Thus, our data support the idea that in S-deprived cells THB1 plays a dual role in NO detoxification and in coordinating sulfate limitation with nitrate assimilation. This study uncovers a new function for the Chlamydomonas reinhardtii THB1 in the control of proper response to S deprivation.	[Minaeva, Ekaterina; Zalutskaya, Zhanneta; Filina, Valentina; Ermilova, Elena] St Petersburg State Univ, Biol Fac, St Petersburg, Russia	Saint Petersburg State University	Ermilova, E (corresponding author), St Petersburg State Univ, Biol Fac, St Petersburg, Russia.	e.ermilova@spbu.ru	Zalutskaya, Zhanneta/AAJ-8812-2021; Zalutskaya, Zhanneta/H-7716-2013; /H-1738-2013	Zalutskaya, Zhanneta/0000-0001-6067-1488; /0000-0003-0800-5933	Russian Science Foundation [16-14-10004]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation (research grant No. 16-14-10004 to Elena Ermilova). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; Aksoy M, 2013, PLANT PHYSIOL, V162, P195, DOI 10.1104/pp.113.214593; BRUNOLD C, 1993, SULFUR NUTRITION AND ASSIMILATION IN HIGHER PLANTS, P61; Chamizo-Ampudia A, 2017, TRENDS PLANT SCI, V22, P163, DOI 10.1016/j.tplants.2016.12.001; Chellamuthu VR, 2014, CELL, V159, P1188, DOI 10.1016/j.cell.2014.10.015; DAVIES JP, 1994, PLANT CELL, V6, P53, DOI 10.2307/3869674; Davies JP, 1996, EMBO J, V15, P2150, DOI 10.1002/j.1460-2075.1996.tb00568.x; de Montaigu A, 2010, PLANT CELL, V22, P1532, DOI 10.1105/tpc.108.062380; Droux M, 2004, PHOTOSYNTH RES, V79, P331, DOI 10.1023/B:PRES.0000017196.95499.11; Ermilova EV, 2010, PLANT CELL ENVIRON, V33, P1049, DOI 10.1111/j.1365-3040.2010.02126.x; Floryszak-Wieczorek J, 2006, PLANTA, V224, P1363, DOI 10.1007/s00425-006-0321-1; Frey AD, 2003, FEMS MICROBIOL REV, V27, P525, DOI 10.1016/S0168-6445(03)00056-1; Garrocho-Villegas V, 2007, GENE, V398, P78, DOI 10.1016/j.gene.2007.01.035; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Harris EH, 1989, THE CHLAMYDOMONAS SO; Hemschemeier A, 2013, P NATL ACAD SCI USA, V110, P10854, DOI 10.1073/pnas.1302592110; Hoy JA, 2008, PLANT PHYSIOL BIOCH, V46, P371, DOI 10.1016/j.plaphy.2007.12.016; Hunt PW, 2002, P NATL ACAD SCI USA, V99, P17197, DOI 10.1073/pnas.212648799; Hunt PW, 2001, PLANT MOL BIOL, V47, P677, DOI 10.1023/A:1012440926982; Huwald D, 2015, PLANTA, V242, P167, DOI 10.1007/s00425-015-2294-4; Irihimovitch V, 2008, FEMS MICROBIOL LETT, V283, P1, DOI 10.1111/j.1574-6968.2008.01154.x; Johnson EA, 2014, BIOCHEMISTRY-US, V53, P4573, DOI 10.1021/bi5005206; Kim H, 1999, PLANTA, V209, P282, DOI 10.1007/s004250050634; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kopriva S, 2002, PLANT PHYSIOL, V130, P1406, DOI 10.1104/pp.007773; Koprivova A, 2000, PLANT PHYSIOL, V122, P737, DOI 10.1104/pp.122.3.737; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Migge A, 2000, PLANTA, V211, P587, DOI 10.1007/s004250000322; Milani M, 2003, IUBMB LIFE, V55, P623, DOI 10.1080/15216540310001628708; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Nardini M, 2007, GENE, V398, P2, DOI 10.1016/j.gene.2007.02.045; NEUENSCHWANDER U, 1991, PLANT PHYSIOL, V97, P253, DOI 10.1104/pp.97.1.253; Planchet E, 2006, J EXP BOT, V57, P3043, DOI 10.1093/jxb/erl070; Pootakham W, 2010, PLANT PHYSIOL, V153, P1653, DOI 10.1104/pp.110.157875; POPOV N, 1975, ACTA BIOL MED GER, V34, P1441; Prosser IM, 2001, J EXP BOT, V52, P113, DOI 10.1093/jexbot/52.354.113; REUVENY Z, 1980, P NATL ACAD SCI-BIOL, V77, P6670, DOI 10.1073/pnas.77.11.6670; Sakihama Y, 2002, PLANT CELL PHYSIOL, V43, P290, DOI 10.1093/pcp/pcf034; Sanz-Luque E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155128; Sanz-Luque E, 2015, PLANT J, V81, P467, DOI 10.1111/tpj.12744; Sarma HK, 2005, SYMBIOSIS, V39, P151; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takahashi H, 1996, PLANT PHYSIOL, V112, P273, DOI 10.1104/pp.112.1.273; Takahashi H, 2001, PLANT PHYSIOL, V127, P665, DOI 10.1104/pp.127.2.665; Vazquez-Limon C, 2012, PLANT SCI, V191, P71, DOI 10.1016/j.plantsci.2012.04.013; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4; Wei LL, 2014, PLANT CELL, V26, P353, DOI 10.1105/tpc.113.120121; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Wu GH, 2003, ADV MICROB PHYSIOL, V47, P255, DOI 10.1016/S0065-2911(03)47005-7; Yordanova ZP, 2010, CELL BIOL INT, V34, P301, DOI 10.1042/CBI20090138; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	53	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186851	10.1371/journal.pone.0186851	http://dx.doi.org/10.1371/journal.pone.0186851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049377	Green Submitted, Green Published, gold			2022-12-26	WOS:000413195900119
J	Hwang, IH; Oh, SY; Jang, HJ; Jo, E; Joo, JC; Lee, KB; Yoo, HS; Lee, MY; Park, SJ; Jang, IS				Hwang, In-Hu; Oh, Seung Yoon; Jang, Hyun-Jin; Jo, Eunbi; Joo, Jong Cheon; Lee, Kyung-Bok; Yoo, Hwa-Seung; Lee, Mi Young; Park, Soo Jung; Jang, Ik-Soon			Cordycepin promotes apoptosis in renal carcinoma cells by activating the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE PRODUCTION; IN-VIVO; JNK; CANCER; INFLAMMATION; KINASE; PHOSPHORYLATION; SUPPRESSION; ANTICANCER	Cellular FLICE inhibitory protein (c-FLIP) is a key anti-apoptotic regulator that associates with the signaling complex downstream of NF-kappa B, negatively interfering with apoptotic signaling. The role of c-FLIP downregulation by negative regulation of NF-kappa B signaling during apoptosis is poorly understood. Here, we demonstrate that NF-kappa B-mediated c-FLIPL negatively regulates the JNK signaling pathway, and that cordycepin treatment of human renal cancer cells leads to apoptosis induction through c-FLIPL inhibition. TNF-alpha-induced inflammatory microenvironments stimulated NF-kappa B signaling and the c-FLIP long form (c-FLIPL) in TK-10 cells. Specifically, cordycepin inhibited TNF-alpha-mediated NF-kappa B activation, which induced renal cancer cell apoptosis. Cordycepin downregulated GADD45B and c-FLIPL, but upregulated MKK7 and phospho-JNK, by preventing nuclear mobilization of NF-kappa B. Furthermore, siRNA-mediated knockdown of GADD45B in cordycepin-treated TK-10 cells considerably increased MKK7 compared to cordycepin alone. siRNA-mediated knockdown of cFLIP(L) prevented TNF-a-induced JNK inactivation, whereas c-FLIPL overexpression inhibited cordycepin-mediated JNK activation. The JNK inhibitor SP600125 strongly inhibited Bax expression. In nude mice, cordycepin significantly decreased tumor volume. Taken together, the results indicate that cordycepin inhibits TNF-a-mediated NF-kappa B/GADD45B signaling, which activates the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression, thus inducing TK-10 cell apoptosis.	[Hwang, In-Hu] Korea Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Hwang, In-Hu] Korea Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea; [Oh, Seung Yoon; Joo, Jong Cheon] Wonkwang Univ, Dept Sasang Constitut Med, Iksan, South Korea; [Jang, Hyun-Jin; Jo, Eunbi; Lee, Kyung-Bok; Jang, Ik-Soon] Korea Basic Sci Inst, Div Bioconvergence Anal, Daejeon, South Korea; [Yoo, Hwa-Seung] Daejeon Univ, East West Canc Ctr, Daejeon, South Korea; [Lee, Mi Young] Korea Inst Oriental Med, KM Convergence Res Div, Daejeon, South Korea; [Park, Soo Jung] Woosuk Univ, Dept Sasang Constitut Med, Wonju, Jeonbuk, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Wonkwang University; Korea Basic Science Institute (KBSI); Daejeon University; Korea Institute of Oriental Medicine (KIOM); Woosuk University	Jang, IS (corresponding author), Korea Basic Sci Inst, Div Bioconvergence Anal, Daejeon, South Korea.	jangiksn@kbsi.re.kr		Lee, Kyung-Bok/0000-0003-1495-3462; Jang, Ik Soon/0000-0003-2092-6372	National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058744, 2016R1A2B4009614]; Korea Institute of Oriental Medicine [K17060]	National Research Foundation of Korea (NRF) - Ministry of Education; Korea Institute of Oriental Medicine	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01058744, 2016R1A2B4009614) and the Korea Institute of Oriental Medicine (K17060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; Bagnoli M, 2010, INT J BIOCHEM CELL B, V42, P210, DOI 10.1016/j.biocel.2009.11.015; Baselga J, 1998, CANCER RES, V58, P2825; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang R, 2002, J ALTERN COMPLEM MED, V8, P559, DOI 10.1089/107555302320825066; Chang W, 2008, EUR J PHARMACOL, V597, P64, DOI 10.1016/j.ejphar.2008.08.030; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Groppe M, 2003, ANAL BIOANAL CHEM, V376, P797, DOI 10.1007/s00216-003-1979-x; Hwang IH, 2016, FASEB J, V30, P3107, DOI 10.1096/fj.201600240RR; Imamura K, 2015, BIOSCI BIOTECH BIOCH, V79, P1021, DOI 10.1080/09168451.2015.1008977; Jeong JW, 2011, TOXICOL IN VITRO, V25, P817, DOI 10.1016/j.tiv.2011.02.001; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Kim KM, 2003, TOXICOL APPL PHARM, V190, P1, DOI 10.1016/S0041-008X(03)00152-2; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Nakajima A, 2008, ONCOGENE, V27, P76, DOI 10.1038/sj.onc.1210624; Nakamura K, 2015, J PHARMACOL SCI, V127, P53, DOI 10.1016/j.jphs.2014.09.001; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ren ZH, 2012, INT IMMUNOPHARMACOL, V14, P698, DOI 10.1016/j.intimp.2012.10.008; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Rogers JA, 2007, NITRIC OXIDE-BIOL CH, V16, P379, DOI 10.1016/j.niox.2007.02.001; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Safa AR, 2013, J CARCINOG MUTAGEN S; Stockert JC, 2012, ACTA HISTOCHEM, V114, P785, DOI 10.1016/j.acthis.2012.01.006; Tian XW, 2015, ONCOL LETT, V10, P595, DOI 10.3892/ol.2015.3273; Tornatore L, 2014, CANCER CELL, V26, P495, DOI 10.1016/j.ccr.2014.07.027; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yao WL, 2014, ANTI-CANCER AGENT ME, V14, P29, DOI 10.2174/18715206113139990305; Yin JQ, 2007, ACTA PHARMACOL SIN, V28, P712, DOI 10.1111/j.1745-7254.2007.00559.x	36	13	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186489	10.1371/journal.pone.0186489	http://dx.doi.org/10.1371/journal.pone.0186489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045468	gold, Green Published			2022-12-26	WOS:000413168100064
J	Krzyzanowska, W; Pomierny, B; Bystrowska, B; Pomierny-Chamiolo, L; Filip, M; Budziszewska, B; Pera, J				Krzyzanowska, Weronika; Pomierny, Bartosz; Bystrowska, Beata; Pomierny-Chamiolo, Lucyna; Filip, Malgorzata; Budziszewska, Boguslawa; Pera, Joanna			Ceftriaxone- and N-acetylcysteine-induced brain tolerance to ischemia: Influence on glutamate levels in focal cerebral ischemia	PLOS ONE			English	Article							HYPOXIC NEURONAL INJURY; SYSTEM X(C)(-) ACTIVITY; UP-REGULATION; COCAINE SEEKING; EXPRESSION; RATS; TRANSPORTER; ASTROCYTES; INDUCTION; GLT-1	One of the major players in the pathophysiology of cerebral ischemia is disrupted homeostasis of glutamatergic neurotransmission, resulting in elevated extracellular glutamate (Glu) concentrations and excitotoxicity-related cell death. In the brain, Glu concentrations are regulated by Glu transporters, including Glu transporter-1 (GLT-1) and cystine/Glu antiporter (system x(c)(-)). Modulation of these transporters by administration of ceftriaxone (CEF, 200 mg/kg, i. p.) or N-acetylcysteine (NAC, 150 mg/kg, i. p.) for 5 days before focal cerebral ischemia may induce brain tolerance to ischemia by significantly limiting stroke-related damage and normalizing Glu concentrations. In the present study, focal cerebral ischemia was induced by 90-minute middle cerebral artery occlusion (MCAO). We compared the effects of CEF and NAC pretreatment on Glu concentrations in extracellular fluid and cellular- specific expression of GLT-1 and xCT with the effects of two reference preconditioning methods, namely, ischemic preconditioning and chemical preconditioning in rats. Both CEF and NAC significantly reduced Glu levels in the frontal cortex and hippocampus during focal cerebral ischemia, and this decrease was comparable with the Glu level achieved with the reference preconditioning strategies. The results of immunofluorescence staining of GLT-1 and xCT on astrocytes, neurons and microglia accounted for the observed changes in extracellular Glu levels to a certain extent. Briefly, after MCAO, the expression of GLT-1 on astrocytes decreased, but pretreatment with CEF seemed to prevent this downregulation. In addition, every intervention used in this study seemed to reduce xCT expression on astrocytes and neurons. The results of this study indicate that modulation of Glu transporter expression may restore Glu homeostasis. Moreover, our results suggest that CEF and NAC may induce brain tolerance to ischemia by influencing GLT-1 and system x(c)(-) expression levels. These transporters are presumably good targets for the development of novel therapies for brain ischemia.	[Krzyzanowska, Weronika; Pomierny, Bartosz; Budziszewska, Boguslawa] Jagiellonian Univ, Med Coll, Fac Pharm, Dept Biochem Toxicol, Krakow, Poland; [Bystrowska, Beata; Pomierny-Chamiolo, Lucyna] Jagiellonian Univ, Med Coll, Fac Pharm, Dept Toxicol, Krakow, Poland; [Filip, Malgorzata] Polish Acad Sci, Inst Pharmacol, Lab Drug Addict Pharmacol, Krakow, Poland; [Pera, Joanna] Jagiellonian Univ, Med Coll, Fac Med, Dept Neurol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University	Pomierny, B (corresponding author), Jagiellonian Univ, Med Coll, Fac Pharm, Dept Biochem Toxicol, Krakow, Poland.	bartosz.pomierny@uj.edu.pl	Bystrowska, Beata/ABI-6649-2020; Pomierny, Bartosz/U-5303-2018; Bystrowska, Beata/AAB-7392-2019; Pera, Joanna/U-5552-2018	Pomierny, Bartosz/0000-0002-5352-5324; Bystrowska, Beata/0000-0001-6501-8656; Pera, Joanna/0000-0001-6142-2969; Krzyzanowska, Weronika/0000-0003-1166-6126; Pomierny-Chamiolo, Lucyna/0000-0002-8308-8030; Budziszewska, Boguslawa/0000-0001-9685-5158; Filip, Malgorzata/0000-0002-4321-7942	National Science Centre [2011/01/B/NZ4/00783]	National Science Centre(National Science Centre, Poland)	This study was supported by National Science Centre grant No. 2011/01/B/NZ4/00783. JP acquired the funding. http://www.ncn.gov.pl.	Baker DA, 2002, J NEUROSCI, V22, P9134; Bond A, 1999, EUR J PHARMACOL, V380, P91, DOI 10.1016/S0014-2999(99)00523-3; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dar N.J., 2017, MOL NEUROBIOL, V55, P1; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; Fink SL, 1996, EXP NEUROL, V138, P298, DOI 10.1006/exnr.1996.0068; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; Gong JX, 2014, AMINO ACIDS, V46, P1537, DOI 10.1007/s00726-014-1723-1; Harvey BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022135; Hu YY, 2015, J NEUROCHEM, V132, P194, DOI 10.1111/jnc.12958; Inui T, 2013, NEUROSCIENCE, V242, P1, DOI 10.1016/j.neuroscience.2013.03.018; Jackman NA, 2010, GLIA, V58, P1806, DOI 10.1002/glia.21050; Jastrzebska J, 2015, BEHAV BRAIN RES, V293, P62, DOI 10.1016/j.bbr.2015.06.040; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Knackstedt LA, 2010, BIOL PSYCHIAT, V67, P81, DOI 10.1016/j.biopsych.2009.07.018; Krzyzanowska W, 2016, NEUROTOX RES, V29, P539, DOI 10.1007/s12640-016-9602-z; Krzyzanowska W, 2014, ACTA PHARMACOL SIN, V35, P444, DOI 10.1038/aps.2014.1; LaCrosse AL, 2017, J NEUROSCI, V37, P5809, DOI 10.1523/JNEUROSCI.3717-16.2017; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Liu AJ, 2011, J NEUROCHEM, V119, P202, DOI 10.1111/j.1471-4159.2011.07396.x; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Moran MM, 2005, J NEUROSCI, V25, P6389, DOI 10.1523/JNEUROSCI.1007-05.2005; Napolitano M, 2008, NEUROSCI LETT, V434, P241, DOI 10.1016/j.neulet.2007.09.056; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Pera J, 2004, J NEUROSCI RES, V78, P132, DOI 10.1002/jnr.20232; Rao VLR, 2000, NEUROCHEM INT, V36, P531, DOI 10.1016/S0197-0186(99)00153-9; Roberts-Wolfe DJ, 2015, CNS NEUROL DISORD-DR, V14, P745, DOI 10.2174/1871527314666150529144655; Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Thone-Reineke C, 2008, J HYPERTENS, V26, P2426, DOI 10.1097/HJH.0b013e328313e403; Verma R, 2010, EUR J PHARMACOL, V638, P65, DOI 10.1016/j.ejphar.2010.04.021; Zhang FJ, 2011, TOXICOL SCI, V120, P87, DOI 10.1093/toxsci/kfq364; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1352, DOI 10.1038/sj.jcbfm.9600441	39	38	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186243	10.1371/journal.pone.0186243	http://dx.doi.org/10.1371/journal.pone.0186243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045497	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100045
J	Qiao, Y; Zhang, C; Li, A; Wang, D; Luo, Z; Ping, Y; Zhou, B; Liu, S; Li, H; Yue, D; Zhang, Z; Chen, X; Shen, Z; Lian, J; Li, Y; Wang, S; Li, F; Huang, L; Wang, L; Zhang, B; Yu, J; Qin, Z; Zhang, Y				Qiao, Y.; Zhang, C.; Li, A.; Wang, D.; Luo, Z.; Ping, Y.; Zhou, B.; Liu, S.; Li, H.; Yue, D.; Zhang, Z.; Chen, X.; Shen, Z.; Lian, J.; Li, Y.; Wang, S.; Li, F.; Huang, L.; Wang, L.; Zhang, B.; Yu, J.; Qin, Z.; Zhang, Y.			IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma	ONCOGENE			English	Article							BREAST-CANCER; CHEMOKINE RECEPTOR; DRUG-RESISTANCE; MYELOMA CELLS; TUMOR-GROWTH; IN-VIVO; MICROENVIRONMENT; METASTASIS; EXPRESSION; SURVIVAL	Various factors and cellular components in the tumor microenvironment are key drivers associated with drug resistance in many cancers. Here, we analyzed the factors and molecular mechanisms involved in chemoresistance in patients with esophageal squamous cell carcinoma (ESCC). We found that interleukin 6 (IL6) derived mainly from cancer-associated fibroblasts played the most important role in chemoresistance by upregulating C-X-C motif chemokine receptor 7 (CXCR7) expression through signal transducer and activator of transcription 3/nuclear factor-kappa B pathway. CXCR7 knockdown resulted in the inhibition of IL6-induced proliferation and chemoresistance. In addition, CXCR7 silencing significantly decreased gene expression associated with stemness, chemoresistance and epithelial-mesenchymal transition and suppressed the proliferation ability of ESCC cells in three-dimensional culture systems and angiogenesis assay. In clinical samples, ESCC patients with high expression of CXCR7 and IL6 presented a significantly worse overall survival and progression-free survival upon receiving cisplatin after operation. These results suggest that the IL6-CXCR7 axis may provide a promising target for the treatment of ESCC.	[Qiao, Y.; Zhang, C.; Li, A.; Wang, D.; Luo, Z.; Ping, Y.; Zhou, B.; Liu, S.; Li, H.; Yue, D.; Zhang, Z.; Chen, X.; Shen, Z.; Lian, J.; Li, Y.; Wang, S.; Li, F.; Huang, L.; Zhang, Y.] Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr, Zhengzhou 450052, Henan, Peoples R China; [Qiao, Y.; Zhang, C.; Li, A.; Wang, D.; Luo, Z.; Yue, D.; Chen, X.; Shen, Z.; Wang, S.; Wang, L.; Zhang, Y.] Zhengzhou Univ, Affiliated Hosp 1, Canc Ctr, Zhengzhou, Henan, Peoples R China; [Zhou, B.; Liu, S.; Lian, J.; Li, Y.; Zhang, Y.] Zhengzhou Univ, Sch Life Sci, Zhengzhou, Henan, Peoples R China; [Zhang, B.] Northwestern Univ, Sch Med, Dept Hematol Oncol, Chicago, IL USA; [Yu, J.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA; [Qin, Z.] Zhengzhou Univ, Affiliated Hosp 1, Med Res Ctr, Zhengzhou, Henan, Peoples R China; [Zhang, Y.] Key Lab Tumor Immunol & Biotherapy Henan Prov, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Northwestern University; University System of Ohio; University of Cincinnati; Zhengzhou University	Zhang, Y (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr, Zhengzhou 450052, Henan, Peoples R China.	yizhang@zzu.edu.cn		Zhang, Yi/0000-0001-9861-4681	National Natural Science Foundation of China [81171986]; Research Grant from the Ministry of Public Health [201501004]; Basic and Advanced Technology Research Foundation from Science and Technology Department of Henan Province [112300410153, 122300410155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grant from the Ministry of Public Health; Basic and Advanced Technology Research Foundation from Science and Technology Department of Henan Province	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81171986), Research Grant from the Ministry of Public Health (Grant No. 201501004) and the Basic and Advanced Technology Research Foundation from Science and Technology Department of Henan Province (Grant Nos. 112300410153 and 122300410155).	Alas S, 2001, CLIN CANCER RES, V7, P709; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Bid HK, 2013, CLIN CANCER RES, V19, P6716, DOI 10.1158/1078-0432.CCR-13-0842; Calinescu AA, 2017, CLIN CANCER RES, V23, P1250, DOI 10.1158/1078-0432.CCR-15-2888; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Demeester SR, 2005, GUT, V54, P440; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Gil M, 2013, P NATL ACAD SCI USA, V110, pE1291, DOI 10.1073/pnas.1220580110; Goto M, 2017, ANN SURG ONCOL, V24, P832, DOI 10.1245/s10434-015-4974-5; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Heinecke JL, 2014, P NATL ACAD SCI USA, V111, P6323, DOI 10.1073/pnas.1401799111; Hinton CV, 2010, CLIN EXP METASTAS, V27, P97, DOI 10.1007/s10585-008-9210-2; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jin Z, 2009, INT J CANCER, V125, P2229, DOI 10.1002/ijc.24612; Kerdivel G, 2013, BIOCHEM BIOPH RES CO, V431, P729, DOI 10.1016/j.bbrc.2013.01.050; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Lin L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.392; Lippitz BE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1093722; Liu FY, 2011, ONCOL REP, V25, P383, DOI 10.3892/or.2010.1090; Liu JQ, 2011, CLIN CANCER RES, V17, P3638, DOI 10.1158/1078-0432.CCR-10-2456; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Park YH, 2009, CLIN CANCER RES, V15, P2107, DOI 10.1158/1078-0432.CCR-08-1588; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Schweigert M, 2013, NAT REV GASTRO HEPAT, V10, P230, DOI 10.1038/nrgastro.2012.236; Shi WJ, 2016, WORLD J GASTRO ONCOL, V8, P673, DOI 10.4251/wjgo.v8.i9.673; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smith MR, 1998, BRIT J HAEMATOL, V102, P1090, DOI 10.1046/j.1365-2141.1998.00850.x; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tachezy M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-238; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Velaei K, 2016, BREAST, V30, P92, DOI 10.1016/j.breast.2016.09.002; Villanueva M Teresa, 2012, Nat Rev Clin Oncol, V9, P490, DOI 10.1038/nrclinonc.2012.129; Wang LH, 2004, IMMUNITY, V20, P205, DOI 10.1016/S1074-7613(04)00030-5; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Wu K, 2016, AM J TRANSL RES, V8, P3398; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; ZHANG L, 2013, J TRANSL MED, V11; Zhao S, 2014, TRANSL ONCOL, V7, P429, DOI 10.1016/j.tranon.2014.04.001	48	95	96	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					873	883		10.1038/onc.2017.387	http://dx.doi.org/10.1038/onc.2017.387			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059160				2022-12-26	WOS:000425281800005
J	Gao, LL; Zhu, XC; Li, C; Cheng, LZ				Gao, Lulu; Zhu, Xicun; Li, Cheng; Cheng, Lizhen			Evaluation of the nitrogen content during the new-shoot-growing stage in apple leaves using two-dimensional correlation spectroscopy	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY; MINERAL PROSPECTIVITY; FEATURE-SELECTION; DILUTION CURVE; INFORMATION; ALGORITHM; INDICATOR; MOISTURE; MACHINE	The new-shoot-growing stage is an important period of apple tree nutrition distribution. The objective of this study is to provide technical support for apple tree nutrition diagnosis by constructing quantitative evaluation models between the apple leaf nitrogen content during the new-shoot-growing stage and characteristic spectral parameters. The correlation coefficients between the original spectral data and the nitrogen content were calculated. Then, the sensitive bands of the nitrogen content were selected using the theory of two-dimensional (2D) correlation spectroscopy. Finally, partial least squares regression (PLSR) and support vector machine (SVM) evaluation models were established using 2 parameters: Rx (maximum spectral reflectivity in the waveband) and Sx (total spectral reflectivity in the waveband). The results showed that the sensitive bands in the 2D correlation synchronous and asynchronous spectrograms were 537-560 nm and 708-719 nm. The PLSR model can be used to estimate the nitrogen content. Compared with PLSR, SVM provided better modeling and testing results, with a larger coefficient of determination (R-2) and a smaller root-mean-square error (RMSE). The SVM model based on Sx was a good backup method. The calibration R-2 of the model was 0.821, its RMSE was 0.710 g.kg(-1), the validation R-2 was 0.768, and its RMSE was 1.019 g.kg(-1). The SVM model based on 2D correlation spectroscopy can be used to quantitatively estimate the nitrogen content in apple leaves.	[Gao, Lulu; Zhu, Xicun; Li, Cheng; Cheng, Lizhen] Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China; [Zhu, Xicun] Shandong Agr Univ, Key Lab Agr Ecol & Environm, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Zhu, XC (corresponding author), Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China.; Zhu, XC (corresponding author), Shandong Agr Univ, Key Lab Agr Ecol & Environm, Tai An, Shandong, Peoples R China.	zxc@sdau.edu.cn		Li, Cheng/0000-0002-1758-6031	National Natural Science Foundation of China (NSFC) [41671346, 41271369]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This paper was supported by the National Natural Science Foundation of China (NSFC), the fund ID was 41671346 & 41271369.; The authors thank the anonymous reviewers for their constructive comments. What's more, the study was supported by the National Natural Science Foundation of China (NSFC), the fund ID was 41671346 & 41271369.	Abedi M, 2012, COMPUT GEOSCI-UK, V46, P272, DOI 10.1016/j.cageo.2011.12.014; Alchanatis V., 2005, Precision Agriculture, V6, P25, DOI 10.1007/s11119-005-0682-7; Ata-Ul-Karim ST, 2014, FIELD CROP RES, V167, P76, DOI 10.1016/j.fcr.2014.07.010; Bajcsy P, 2004, PHOTOGRAMM ENG REM S, V70, P793, DOI 10.14358/PERS.70.7.793; Chen PF, 2010, REMOTE SENS ENVIRON, V114, P1987, DOI 10.1016/j.rse.2010.04.006; [陈伟 Chen Wei], 2011, [生态学报, Acta Ecologica Sinica], V31, P6877; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; He L, 2016, REMOTE SENS ENVIRON, V174, P122, DOI 10.1016/j.rse.2015.12.007; Hyde JR, 2004, ANAL CHEM, V76, P6197, DOI 10.1021/ac049360l; Ji RongHua, 2014, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V45, P269; Kawamura K, 2010, GRASSL SCI, V56, P205, DOI 10.1111/j.1744-697X.2010.00196.x; KIRK PL, 1950, ANAL CHEM, V22, P354, DOI 10.1021/ac60038a038; Kooistra L, 2003, ANAL CHIM ACTA, V484, P189, DOI 10.1016/S0003-2670(03)00331-3; Lepine LC, 2016, REMOTE SENS ENVIRON, V173, P174, DOI 10.1016/j.rse.2015.11.028; Li MZ., 2006, SPECTRAL ANAL TECHNO; McCarty GW, 2002, SOIL SCI SOC AM J, V66, P640, DOI 10.2136/sssaj2002.0640; Menesatti P, 2010, BIOSYST ENG, V105, P448, DOI 10.1016/j.biosystemseng.2010.01.003; Noda I, 2000, APPL SPECTROSC, V54, P994, DOI 10.1366/0003702001950472; Noda I, 2004, VIB SPECTROSC, V36, P143, DOI 10.1016/j.vibspec.2003.12.016; NODA I, 1993, APPL SPECTROSC, V47, P1329, DOI 10.1366/0003702934067694; Noda I, 2000, APPL SPECTROSC, V54, p236A, DOI 10.1366/0003702001950454; Noda I, 2014, J MOL STRUCT, V1069, P3, DOI 10.1016/j.molstruc.2014.01.025; Noh H, 2012, COMPUT ELECTRON AGR, V83, P52, DOI 10.1016/j.compag.2012.01.014; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qin J, 2011, T ASABE, V54, P2331, DOI 10.13031/2013.40643; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Rodriguez-Galiano V, 2015, ORE GEOL REV, V71, P804, DOI 10.1016/j.oregeorev.2015.01.001; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Ryu C, 2009, BIOSYST ENG, V104, P465, DOI 10.1016/j.biosystemseng.2009.09.002; Serpico SB, 2001, IEEE T GEOSCI REMOTE, V39, P1360, DOI 10.1109/36.934069; Shinzawa H, 2014, J MOL STRUCT, V1069, P176, DOI 10.1016/j.molstruc.2014.02.013; Song HY, 2014, SPECTROSC SPECT ANAL, V34, P1240, DOI 10.3964/j.issn.1000-0593(2014)05-1240-04; Summers D, 2011, ECOL INDIC, V11, P123, DOI 10.1016/j.ecolind.2009.05.001; Sun Xiao-Ling, 2010, Chinese Journal of Plant Ecology, V34, P989, DOI 10.3773/j.issn.1005-264x.2010.08.012; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xing J, 2005, BIOSYST ENG, V90, P27, DOI 10.1016/j.biosystemseng.2004.08.002; Yang D, 2017, INFRARED PHYS TECHN, V83, P206, DOI 10.1016/j.infrared.2017.05.005; Yao X, 2014, INT J APPL EARTH OBS, V32, P114, DOI 10.1016/j.jag.2014.03.014; Yao X, 2014, EUR J AGRON, V55, P20, DOI 10.1016/j.eja.2013.12.004; Zhang Y, 2015, COMPUT ELECTRON AGR, V112, P20, DOI 10.1016/j.compag.2015.01.006	40	5	5	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186751	10.1371/journal.pone.0186751	http://dx.doi.org/10.1371/journal.pone.0186751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073247	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400047
J	Hall, JA; Brockman, JA; Davidson, SJ; MacLeay, JM; Jewell, DE				Hall, Jean A.; Brockman, Jeff A.; Davidson, Stephen J.; MacLeay, Jen M.; Jewell, Dennis E.			Increased dietary long-chain polyunsaturated fatty acids alter serum fatty acid concentrations and lower risk of urine stone formation in cats	PLOS ONE			English	Article							KIDNEY-FUNCTION BIOMARKERS; CALCIUM-OXALATE; EICOSAPENTAENOIC ACID; SYMMETRIC DIMETHYLARGININE; COMPUTER-PROGRAM; ARACHIDONIC-ACID; FORMERS; UROLITHIASIS; NEPHROLITHIASIS; SATURATION	The lifespan of cats with non-obstructive kidney stones is shortened compared with healthy cats indicating a need to reduce stone formation and minimize chronic kidney disease. The purpose of this study was to investigate the effects of increasing dietary polyunsaturated fatty acids (PUFA) on urine characteristics. Domestic-short-hair cats (n = 12; mean age 5.6 years) were randomized into two groups and fed one of two dry-cat foods in a cross-over study design. For one week before study initiation, all cats consumed control food that contained 0.07% arachidonic acid (AA), but no eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). Group 1 continued eating control food for 56 days. Group 2 was fed test food for 56 days, which was control food plus fish oil and high-AA oil. Test food contained 0.17% AA, 0.09% EPA and 0.18% DHA. After 56 days, cats were fed the opposite food for another 56 days. At baseline and after each feeding period, serum was analyzed for fatty acid concentrations, and urine for specific gravity, calcium concentration, relative-super-saturation for struvite crystals, and a calcium-oxalate-titrimetric test was performed. After consuming test food, cats had increased (all P<0.001) serum concentrations of EPA (173%), DHA (61%), and AA (35%); decreased urine specific gravity (P = 0.02); decreased urine calcium concentration (P = 0.06); decreased relative-super-saturation for struvite crystals (P = 0.03); and increased resistance to oxalate crystal formation (P = 0.06) compared with cats consuming control food. Oxalate crystal formation was correlated with serum calcium concentration (r = 0.41; P<0.01). These data show benefits for reducing urine stone formation in cats by increasing dietary PUFA.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Brockman, Jeff A.; Davidson, Stephen J.; MacLeay, Jen M.; Jewell, Dennis E.] Hills Pet Nutr, Pet Nutr Ctr, Topeka, KS USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Hall, Jean/0000-0002-7758-6703; Jewell, Dennis/0000-0003-2305-1014	Pet Nutrition Center, Hill's Pet Nutrition, Topeka, KS	Pet Nutrition Center, Hill's Pet Nutrition, Topeka, KS	The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Topeka, KS (http://www.hilispet.com/our-company.html). The funder provided support in the form of salaries for authors [JAB, SJD, JMM, DEJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams LG, 2013, NEW ZEAL VET J, V61, P212, DOI 10.1080/00480169.2013.775691; Baggio B, 1999, J AM SOC NEPHROL, V10, pS381; Baggio B, 1999, NEPHROL DIAL TRANSPL, V14, P553, DOI 10.1093/ndt/14.3.553; Bartges JW, 1999, VET CLIN N AM-SMALL, V29, P45, DOI 10.1016/S0195-5616(99)50004-1; BUCK AC, 1991, J UROLOGY, V146, P188, DOI 10.1016/S0022-5347(17)37750-9; BUCK AC, 1983, J UROLOGY, V129, P421, DOI 10.1016/S0022-5347(17)52130-8; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cannon AB, 2007, JAVMA-J AM VET MED A, V231, P570, DOI 10.2460/javma.231.4.570; CLAASSEN N, 1995, PROSTAG LEUKOTR ESS, V53, P13, DOI 10.1016/0952-3278(95)90078-0; Ferraro PM, 2017, J UROL; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gupta M., 2011, INT J RES PHARM CHEM, V1, P793; Hall JA, 2014, VET J, V202, P588, DOI 10.1016/j.tvjl.2014.10.021; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2013, PLOS ONE, V8; Hall JA, 2006, J NUTR, V136, P2338, DOI 10.1093/jn/136.9.2338; Hall JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174854; Hall JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153654; HOUSER M, 1984, KIDNEY INT, V26, P176, DOI 10.1038/ki.1984.152; Jung H, 2017, WORLD J UROL, V35, P1331, DOI 10.1007/s00345-017-2000-1; Kavanagh JP, 2006, J UROLOGY, V175, P766, DOI 10.1016/S0022-5347(05)00145-X; Kirk CA, 2006, VET THER, V7, P333; Laube N, 2002, J CHEM INF COMP SCI, V42, P633, DOI 10.1021/ci0102620; Laube N, 2000, UROL RES, V28, P274, DOI 10.1007/s002400000124; Lekcharoensuk C, 2001, J AM VET MED ASSOC, V219, P1228, DOI 10.2460/javma.2001.219.1228; Lulich JP, 2013, JAVMA-J AM VET MED A, V243, P1147, DOI 10.2460/javma.243.8.1147; Milosevic D, 1998, J CHEM INF COMP SCI, V38, P646, DOI 10.1021/ci9701087; Moor MB, 2016, AM J PHYSIOL-RENAL, V310, pF1337, DOI 10.1152/ajprenal.00273.2015; Naya Y, 2002, BJU INT, V89, P842, DOI 10.1046/j.1464-410X.2002.02740.x; Ortiz-Alvarado O, 2012, UROLOGY, V79, P282, DOI 10.1016/j.urology.2011.08.022; Osborne CA, 1996, VET CLIN N AM-SMALL, V26, P589, DOI 10.1016/S0195-5616(96)50087-2; OSBORNE CA, 1990, J AM VET MED ASSOC, V196, P1053; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P183, DOI 10.1016/j.cvsm.2008.09.011; Prezioso D, 2015, ARCH ITAL UROL ANDRO, V87, P105, DOI 10.4081/aiua.2015.2.105; ROBERT M, 1994, BRIT J UROL, V73, P358, DOI 10.1111/j.1464-410X.1994.tb07596.x; Roush JK, 2010, JAVMA-J AM VET MED A, V236, P59, DOI 10.2460/javma.236.1.59; Siener R, 2011, J UROLOGY, V185, P719, DOI 10.1016/j.juro.2010.09.074; SINCLAIR AJ, 1979, LIPIDS, V14, P932, DOI 10.1007/BF02533508; WERNESS PG, 1985, J UROLOGY, V134, P1242, DOI 10.1016/S0022-5347(17)47703-2; Yasui T, 2001, EUR UROL, V39, P580, DOI 10.1159/000052507	41	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187133	10.1371/journal.pone.0187133	http://dx.doi.org/10.1371/journal.pone.0187133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073223	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400119
J	Yang, N; Qiao, JZ; Liu, SY; Zou, ZM; Zhu, LL; Liu, XY; Zhou, SH; Li, HR				Yang, Ning; Qiao, Jinzeng; Liu, Shiyu; Zou, Zhanming; Zhu, Linlin; Liu, Xinyu; Zhou, Shuanghai; Li, Huanrong			Change in the immune function of porcine iliac artery endothelial cells infected with porcine circovirus type 2 and its inhibition on monocyte derived dendritic cells maturation	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; IN-VITRO; T-CELLS; RIG-I; PIGS; PCV2; EXPRESSION; ADHESION; PROTEIN; DIFFERENTIATION	Porcine circovirus-associated disease is caused by porcine circovirus type 2 PCV2) infection, which targets iliac artery endothelial cells PIECs); it leads to severe immunopathologies and is associated with major economic losses in the porcine industry. Here, we report that in vitro PCV2 infection of PIECs causes cell injury, which affects DC function as well as adaptive immunity. Specifically, PCV2 infection downregulated PIEC antigen-presenting molecule expression, upregulated cytokines involved in the immune and inflammatory response causing cell damage and repair, and altered the migratory capacity of PIECs. In addition, PCV2-infected PIECs inhibited DC maturation, enhanced the endocytic ability of DCs, and weakened the stimulatory effect of DCs on T lymphocytes. Together, these findings indicate that profound functional impairment of DCs in the presence of PCV2-infected PIECs may be a potential pathogenic mechanism associated with PCV2-induced porcine disease.	[Yang, Ning; Qiao, Jinzeng; Liu, Shiyu; Zou, Zhanming; Zhu, Linlin; Liu, Xinyu; Zhou, Shuanghai; Li, Huanrong] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing Key Lab Tradit Chinese Vet Med, Beijing, Peoples R China	Beijing University of Agriculture	Zhou, SH; Li, HR (corresponding author), Beijing Agr Univ, Coll Anim Sci & Technol, Beijing Key Lab Tradit Chinese Vet Med, Beijing, Peoples R China.	shhaizhou@sina.com; lihuarong1@126.com			National Natural Science Foundation of China [31472174, 31272571]; Beijing Natural Science Foundation [KZ201510020022]; Key Project of Science and Technology Plan of Beijing Education Commission [KZ201510020022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Key Project of Science and Technology Plan of Beijing Education Commission	This work was supported by the National Natural Science Foundation of China [grant numbers 31472174, 31272571] and Beijing Natural Science Foundation & Key Project of Science and Technology Plan of Beijing Education Commission [grant number KZ201510020022]. The funding agency had no involvement in the study design; in the collection, analysis, and interpretation of the data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Allan G, 2012, VIRUS RES, V164, P4, DOI 10.1016/j.virusres.2011.09.013; Arens R, 2004, J EXP MED, V199, P1595, DOI 10.1084/jem.20031111; Balmelli C, 2011, IMMUNOLOGY, V132, P57, DOI 10.1111/j.1365-2567.2010.03339.x; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Christiansen AJ, 2016, ONCOTARGET, V7, P39421, DOI 10.18632/oncotarget.9820; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Franca TD, 2005, PESQUI VET BRASIL, V25, P39, DOI 10.1590/S0100-736X2005000100009; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492; Hu YY, 2016, J IMMUNOTOXICOL, V13, P141, DOI 10.3109/1547691X.2015.1017624; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; HUNNINGHAKE GW, 1980, J CLIN INVEST, V66, P473, DOI 10.1172/JCI109878; Jang YS, 2013, CLIN IMMUNOL, V149, P379, DOI 10.1016/j.clim.2013.09.007; Jiang YH, 2005, CLIN HEMORHEOL MICRO, V32, P261; Kaczmarek J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099574; Kim N, 2016, J MICROBIOL, V54, P583, DOI 10.1007/s12275-016-6322-2; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Li JD, 2012, VET J, V193, P199, DOI 10.1016/j.tvjl.2011.10.016; Liu YL, 2016, J VIROL, V90, P9406, DOI 10.1128/JVI.00748-16; Liu Yuan-Lin, 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V19, P480; Lu XX, 2015, VIRUS RES, V195, P162, DOI 10.1016/j.virusres.2014.10.011; Lu Y, 2001, CHINESE J IMMUNOLOGY, V17, P3; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Marks FS, 2016, BRAZ J MICROBIOL, V47, P870, DOI 10.1016/j.bjm.2016.07.001; Marks FS, 2010, VET MICROBIOL, V141, P22, DOI 10.1016/j.vetmic.2009.08.004; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Meng XJ, 2013, ANNU REV ANIM BIOSCI, V1, P43, DOI 10.1146/annurev-animal-031412-103720; Meng XJ, 2012, VIRUS RES, V164, P1, DOI 10.1016/j.virusres.2011.12.005; Moret I, 2011, EUR RESPIR J, V38, P1158, DOI 10.1183/09031936.00190410; Nadiv O, 2007, MOL IMMUNOL, V44, P3147, DOI 10.1016/j.molimm.2007.02.001; Nissen MH, 1998, INT IMMUNOL, V10, P167, DOI 10.1093/intimm/10.2.167; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Opriessnig T, 2006, J COMP PATHOL, V134, P105, DOI 10.1016/j.jcpa.2005.06.007; Park S, 2007, CELL MOL IMMUNOL, V4, P329; Resendes AR, 2015, VET PATHOL, V52, P497, DOI 10.1177/0300985814540542; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Segales J, 2004, VET MICROBIOL, V98, P151, DOI 10.1016/j.vetmic.2003.10.007; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Srinivasan S, 2003, CIRC RES, V92, P371, DOI 10.1161/01.RES.0000061714.74668.5C; Tasaki K, 2000, CANCER GENE THER, V7, P247, DOI 10.1038/sj.cgt.7700094; Thomas R, 1996, STEM CELLS, V14, P196, DOI 10.1002/stem.140196; Tian F, 2007, J IMMUNOL, V179, P3742, DOI 10.4049/jimmunol.179.6.3742; TISCHER I, 1987, ARCH VIROL, V96, P39, DOI 10.1007/BF01310989; Ucci JW, 2007, BIOCHEMISTRY-US, V46, P55, DOI 10.1021/bi061531o; Vasselon T, 2002, INFECT IMMUN, V70, P1033, DOI 10.1128/IAI.70.3.1033-1041.2002; Wethmar K, 2006, EUR J IMMUNOL, V36, P2781, DOI 10.1002/eji.200526311; Yu S, 2007, VET IMMUNOL IMMUNOP, V115, P261, DOI 10.1016/j.vetimm.2006.11.006; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zhang KX, 2017, HEMATOL REP, V9, P62, DOI 10.4081/hr.2017.7053	53	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186775	10.1371/journal.pone.0186775	http://dx.doi.org/10.1371/journal.pone.0186775			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073194	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400052
J	Charifi, M; Sow, M; Ciret, P; Benomar, S; Massabuau, JC				Charifi, Mohcine; Sow, Mohamedou; Ciret, Pierre; Benomar, Soumaya; Massabuau, Jean-Charles			The sense of hearing in the Pacific oyster, Magallana gigas	PLOS ONE			English	Article							SOUND DETECTION; ACOUSTIC DETECTION; CRASSOSTREA-GIGAS; PARTICLE MOTION; SENSITIVITY; BEHAVIOR; STATOCYST; FIELD; VIBRATION; BIVALVE	There is an increasing concern that anthropogenic noise could have a significant impact on the marine environment, but there is still insufficient data for most invertebrates. What do they perceive? We investigated this question in oysters Magallana gigas (Crassostrea gigas) using pure tone exposures, accelerometer fixed on the oyster shell and hydrophone in the water column. Groups of 16 oysters were exposed to quantifiable waterborne sinusoidal sounds in the range of 10 Hz to 20 kHz at various acoustic energies. The experiment was conducted in running seawater using an experimental flume equipped with suspended loudspeakers. The sensitivity of the oysters was measured by recording their valve movements by high-frequency noninvasive valvometry. The tests were 3 min tone exposures including a 70 sec fade-in period. Three endpoints were analysed: the ratio of responding individuals in the group, the resulting changes of valve opening amplitude and the response latency. At high enough acoustic energy, oysters transiently closed their valves in response to frequencies in the range of 10 to < 1000 Hz, with maximum sensitivity from 10 to 200 Hz. The minimum acoustic energy required to elicit a response was 0.02 m.s(-2) at 122 dBrms re 1 mu Pa for frequencies ranging from 10 to 80 Hz. As a partial valve closure cannot be differentiated from a nociceptive response, it is very likely that oysters detect sounds at lower acoustic energy. The mechanism involved in sound detection and the ecological consequences are discussed.	[Charifi, Mohcine; Sow, Mohamedou; Ciret, Pierre; Massabuau, Jean-Charles] Univ Bordeaux, EPOC, UMR 5805, Arcachon, France; [Charifi, Mohcine; Sow, Mohamedou; Ciret, Pierre; Massabuau, Jean-Charles] CNRS, EPOC, UMR 5805, Talence, France; [Charifi, Mohcine; Benomar, Soumaya] Mohammed V Agdal Univ, Fac Sci, Unit Res Biol Rhythms Neurosci & Environm, Rabat, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Mohammed V University in Rabat	Massabuau, JC (corresponding author), Univ Bordeaux, EPOC, UMR 5805, Arcachon, France.; Massabuau, JC (corresponding author), CNRS, EPOC, UMR 5805, Talence, France.	jean-charles.massabuau@u-bordeaux.fr		Massabuau, Jean-Charles/0000-0003-1302-1719	Campus France; MoIIuSCAN eye Project	Campus France; MoIIuSCAN eye Project	M. Charifi was supported by scholarships provided by Campus France within the framework 603 of the Cooperation between MESRSFC (Morocco) and the Embassy of France / Institut 604 Francais in Morocco, NEUROMED (7th Programme Framework on Capacity Building In 605 Mediterranean Area) and GDRI de Neurosciences, no 198, CNRS, INSERM (France) and 606 CNRST (Morocco). This work was funded the MoIIuSCAN eye Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Soto NA, 2016, ADV EXP MED BIOL, V875, P17, DOI 10.1007/978-1-4939-2981-8_3; Andrade H, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00187; Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Auguie B, 2017, GRIDEXTRA MISCELLANE; BARBER VC, 1969, Z ZELLFORSCH MIK ANA, V94, P462, DOI 10.1007/BF00936053; BREITHAUPT T, 1990, ADV LIF SCI, P114; Budelmann B.-U., 1989, P607; BUDELMANN BU, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P141; CRAGG SM, 1977, J EXP MAR BIOL ECOL, V27, P23, DOI 10.1016/0022-0981(77)90051-X; Tran D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32435; Deane GB, 1997, J ACOUST SOC AM, V102, P2671, DOI 10.1121/1.420321; Dolmer P, 2000, J SEA RES, V44, P221, DOI 10.1016/S1385-1101(00)00052-6; Dubrovsky NA, 1996, SEA SURFACE SOUND 94, P112; ELLERS O, 1995, BIOL BULL-US, V189, P128, DOI 10.2307/1542463; Erdmann W., 1934, WISS MEERESUNTERS NF, V19, P24; Fine ML, 1981, HEARING SOUND COMMUN, P257; Gaylord B, 1999, J EXP MAR BIOL ECOL, V239, P85, DOI 10.1016/S0022-0981(99)00031-3; GOODALL C, 1990, ADV LIF SCI, P106; Gotz T., 2009, BIODIVERSITY SERIES; Haxel JH, 2013, J ACOUST SOC AM, V133, P2586, DOI 10.1121/1.4796132; Henninger HP, 2005, J EXP BIOL, V208, P3421, DOI 10.1242/jeb.01771; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kaifu K., 2007, J MARINE ACOUSTICS S, V34, P266, DOI DOI 10.3135/JMASJ.34.266; Kaifu K, 2008, FISHERIES SCI, V74, P781, DOI 10.1111/j.1444-2906.2008.01589.x; KARLSEN HE, 1992, J EXP BIOL, V171, P173; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Massabuau JC, 1996, CAN J ZOOL, V74, P423, DOI 10.1139/z96-049; Mat AM, 2014, MAR BIOL, V161, P89, DOI 10.1007/s00227-013-2317-2; Mooney TA, 2010, J EXP BIOL, V213, P3748, DOI 10.1242/jeb.048348; MORTON B, 1985, J ZOOL, V206, P23; MOSHER J I, 1972, Proceedings of the Malacological Society of London, V40, P125; Nedwell J., 2004, 534R0109 SUB LTD; PACKARD A, 1990, J COMP PHYSIOL A, V166, P501; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Patek SN, 2006, MAR FRESHW BEHAV PHY, V39, P99, DOI 10.1080/10236240600563289; Peng C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24266; Peng C, 2015, INT J ENV RES PUB HE, V12, P12304, DOI 10.3390/ijerph121012304; Popper AN, 2001, J COMP PHYSIOL A, V187, P83, DOI 10.1007/s003590100184; POPPER AN, 2009, ENCY OCEAN SCI, P476; Popper AN, 2011, HEARING RES, V273, P25, DOI 10.1016/j.heares.2009.12.023; PUMPHREY RJ, 1950, SYM SOC EXP BIOL, V4, P3; Roberts L, 2016, J EXP MAR BIOL ECOL, V474, P185, DOI 10.1016/j.jembe.2015.09.014; Roberts L, 2015, MAR ECOL PROG SER, V538, P185, DOI 10.3354/meps11468; Rogers P.H., 1988, P131; Salmon M., 1972, P60; SALMON M, 1971, PHYSIOL ZOOL, V44, P210, DOI 10.1086/physzool.44.4.30152493; Samson JE, 2014, J EXP BIOL, V217, P4347, DOI 10.1242/jeb.113365; Schwartzmann C, 2011, LIMNOL OCEANOGR, V56, P1940, DOI 10.4319/lo.2011.56.5.1940; Sigray P, 2011, J ACOUST SOC AM, V130, P200, DOI 10.1121/1.3596464; Sow M, 2011, ENVIRON MONIT ASSESS, V182, P155, DOI 10.1007/s10661-010-1866-9; Tonolla D, 2009, AQUAT SCI, V71, P449, DOI 10.1007/s00027-009-0111-5; Tran D, 2011, CHRONOBIOL INT, V28, P307, DOI 10.3109/07420528.2011.565897; Tsirulis TP., 1981, CELL TISSUE BIOL, V23, P631; Ubertini M, 2017, AQUACULTURE, V473, P51, DOI 10.1016/j.aquaculture.2017.01.025; Vazzana M, 2016, COMP BIOCHEM PHYS A, V201, P61, DOI 10.1016/j.cbpa.2016.06.029; WILLIAMSON R, 1988, J EXP BIOL, V134, P451; Zhadan P.M., 2005, RUSSIAN J MARINE BIO, V31, P28, DOI DOI 10.1007/S11179-005-0040-7	59	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185353	10.1371/journal.pone.0185353	http://dx.doi.org/10.1371/journal.pone.0185353			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069092	Green Published, gold, Green Submitted			2022-12-26	WOS:000413663600005
J	Mahendrasingam, S; Fettiplace, R; Alagramam, KN; Cross, E; Furness, DN				Mahendrasingam, Shanthini; Fettiplace, Robert; Alagramam, Kumar N.; Cross, Ellen; Furness, David N.			Spatiotemporal changes in the distribution of LHFPL5 in mice cochlear hair bundles during development and in the absence of PCDH15	PLOS ONE			English	Article							CELL MECHANOTRANSDUCER CHANNELS; GUINEA-PIG ORGAN; CROSS-LINKS; PROTEIN ABUNDANCE; MOUSE COCHLEA; TRANSDUCTION; LOCALIZATION; STEREOCILIA; PROTOCADHERIN-15; CONDUCTANCE	Mechanosensory transduction by vertebrate hair cells depends on a protein complex at the tips of shorter stereocilia associated with mechanoelectrical transduction channels activated by tip links in the hair bundle. In mammalian hair cells, this complex includes transmembrane channel-like protein subunit 1 (TMC1), lipoma HMGIC fusion partner-like 5 protein (LHFPL5) and protocadherin 15 (PCDH15), a lower-end component of the tip link. TMC1 interacts with LHFPL5 and PCDH15 but how the complex develops to maturity, and the relationships between these proteins, remains uncertain. Here we evaluate the spatiotemporal development of LHFPL5 distributions in mouse cochlear hair bundles by immunofluorescence and immunogold transmission electron microscopy, from postnatal day 0 (P0) through P21 in wild type and PCDH15-deficient mice. At P0, hair bundles contain many short microvilli-like processes which we term unranked stereocilia, and a subset of lengthening rows, adjacent to a kinocilium. LHFPL5 is distributed throughout the bundle, including on stereocilia tips and the kinocilium. At P3, 4-to-6 rows of ranked stereocilia are evident, total LHFPL5 expression peaks, and LHFPL5 is localised to ranked stereocilia tips of all rows and to lower shaft/ankle links. By P12, the bundle has a mature pattern with 3 ranked rows but virtually no unranked stereocilia or kinocilium; LHFPL5 expression has declined and become restricted to the tips of shorter stereocilia. Throughout development from P0, expression of LHFPL5 is greater overall on apical than basal bundles, but there is, on average, an equal amount of labelling per labelled tip. In P3 mice lacking PCDH15, LHFPL5 labelling is not at the tips but is primarily on unranked stereocilia and lower lateral links. These data show that LHFPL5 is already present in the MET apparatus at P0 but requires PCDH15 at P3 to remain there. Shaft/ankle link localisation suggests it interacts with link proteins other than PCDH15.	[Mahendrasingam, Shanthini; Cross, Ellen; Furness, David N.] Keele Univ, Sch Life Sci, Keele, Staffs, England; [Fettiplace, Robert] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA; [Alagramam, Kumar N.] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Cross, Ellen] Cardiff Univ, Sch Biosci, Cardiff, Wales	Keele University; University of Wisconsin System; University of Wisconsin Madison; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Cardiff University	Furness, DN (corresponding author), Keele Univ, Sch Life Sci, Keele, Staffs, England.	d.n.furness@keele.ac.uk			Biotechnology and Biologcial Sciences Research Council [BB/M010074/1]; National Insitutes of Health, US [R01 DC05385]; Maniglia Endowed Chair, University Hospitals Cleveland Medical Center; BBSRC [BB/M010074/1] Funding Source: UKRI; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M010074/1] Funding Source: researchfish	Biotechnology and Biologcial Sciences Research Council; National Insitutes of Health, US; Maniglia Endowed Chair, University Hospitals Cleveland Medical Center; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biologcial Sciences Research Council (GB). Main funders of the project, grant awarded to DNF number BB/M010074/1 and supports SM. http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Insitutes of Health, US. Grant awarded to RF number R01 DC015439. https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Insitutes of Health, US. Grant awarded to KNA number R01 DC05385. https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maniglia Endowed Chair, University Hospitals Cleveland Medical Center (award to KNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2016, P NATL ACAD SCI USA, V113, P6767, DOI 10.1073/pnas.1601067113; Beurg M, 2015, P NATL ACAD SCI USA, V112, P1589, DOI 10.1073/pnas.1420906112; Beurg M, 2014, J GEN PHYSIOL, V144, P53, DOI 10.1085/jgp.201411173; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; Furness DN, 2006, SPR HDB AUD, V27, P95; FURNESS DN, 1986, HEARING RES, V21, P243, DOI 10.1016/0378-5955(86)90222-4; FURNESS DN, 1989, HEARING RES, V38, P95, DOI 10.1016/0378-5955(89)90131-7; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hackney CM, 2013, J CELL SCI, V126, P1721, DOI 10.1242/jcs.106120; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kim KX, 2013, J GEN PHYSIOL, V142, P493, DOI 10.1085/jgp.201311068; Mahendrasingam S, 1997, HEARING RES, V111, P85, DOI 10.1016/S0378-5955(97)00091-9; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wu ZZ, 2017, NAT NEUROSCI, V20, P24, DOI 10.1038/nn.4449; Xiong W, 2012, CELL, V151, P1283, DOI 10.1016/j.cell.2012.10.041; Zhao B, 2014, NEURON, V84, P954, DOI 10.1016/j.neuron.2014.10.041	25	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185285	10.1371/journal.pone.0185285	http://dx.doi.org/10.1371/journal.pone.0185285			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069081	Green Published, gold, Green Submitted			2022-12-26	WOS:000413663600004
J	Picillo, M; Pivonello, R; Santangelo, G; Pivonello, C; Savastano, R; Auriemma, R; Amboni, M; Scannapieco, S; Pierro, A; Colao, A; Barone, P; Pellecchia, MT				Picillo, Marina; Pivonello, Rosario; Santangelo, Gabriella; Pivonello, Claudia; Savastano, Riccardo; Auriemma, Renata; Amboni, Marianna; Scannapieco, Sara; Pierro, Angela; Colao, Annamaria; Barone, Paolo; Pellecchia, Maria Teresa			Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease	PLOS ONE			English	Article							GROWTH-FACTOR-I; OLDER MEN; INSULIN; IMPAIRMENT; BRAIN; RISK; SYMPTOMS; DEMENTIA; WOMEN	Objective Cognitive deficits are common in Parkinson's disease (PD) since the early stages and many patients eventually develop dementia. Yet, occurrence of dementia in PD is unpredictable. Evidence supports the hypothesis that insulin-like growth factor-1 (IGF-1) is involved in cognitive deficits. Our aim was to evaluate the relationship between serum IGF-1 levels and neuropsychological scores in a large cohort of drug-naive PD patients during the earliest stages of the disease. Methods Serum IGF-1 levels were determined in 405 early, drug-naive PD patients and 191 healthy controls (HC) enrolled in the Parkinson's Progression Markers Initiative (PPMI). The association between serum IGF-1 levels and neuropsychological scores was evaluated with linear regression analysis. Results IGF-1 levels were similar in PD and HC. In PD patients the lowest IGF-1 quartile was a predictor of lower performances at the Semantic Fluency task (beta = -3.46, 95% CI: -5.87 to -1.01, p = 0.005), the Symbol Digit Modalities Score (beta = -2.09, 95% CI: -4.02 to -0.15, p = 0.034), and Hopkins Verbal Learning Test Retention (beta = -0.05, 95% CI: -0.09 to -0.009, p = 0.019). Conclusions Lower serum IGF-1 levels are associated to poor performances in cognitive tasks assessing executive function, attention and verbal memory in a large cohort of early PD patients. Follow-up studies are warranted to assess if IGF-1 is related to the development of dementia in PD.	[Picillo, Marina; Savastano, Riccardo; Amboni, Marianna; Scannapieco, Sara; Pierro, Angela; Barone, Paolo; Pellecchia, Maria Teresa] Univ Salerno, Ctr Neurodegenerat Dis CEMAND, Dept Med & Surg, Neurosci Sect, Salerno, Italy; [Pivonello, Rosario; Pivonello, Claudia; Colao, Annamaria] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Santangelo, Gabriella] Univ Naples 2, Dept Psychol, Neuropsychol Lab, Caserta, Italy; [Auriemma, Renata] IOS & Coleman Medicina Futura Med Ctr, Naples, Italy; [Amboni, Marianna] IDC Hermitage Capodimonte, Naples, Italy	University of Salerno; University of Naples Federico II; Universita della Campania Vanvitelli	Pellecchia, MT (corresponding author), Univ Salerno, Ctr Neurodegenerat Dis CEMAND, Dept Med & Surg, Neurosci Sect, Salerno, Italy.	mpellecchia@unisa.it	Amboni, Marianna/ABD-1421-2021; Amboni, Marianna/AGK-4180-2022; Barone, Paolo/AAC-4886-2022; Picillo, Marina/AAF-4297-2020; picillo, marina/AAC-2210-2019; Pellecchia, Maria Teresa/AHH-4069-2022; Pivonello, Claudia/A-3676-2016	picillo, marina/0000-0001-9025-137X; Pivonello, Claudia/0000-0003-4276-8600; PELLECCHIA, MARIA TERESA/0000-0002-6217-313X	Michael J. Fox Foundation	Michael J. Fox Foundation	Maria Teresa Pellecchia received a grant from the Michael J. Fox Foundation (Cognition biomarkers, 2013) to perform this study. Drs Picillo, Pivonello R, Pivonello C, Santangelo, Savastano, Scannapieco, Pierro Auriemma, Amboni, Colao, and Barone report no disclosures.	Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; Al-Delaimy WK, 2009, J AM GERIATR SOC, V57, P1441, DOI 10.1111/j.1532-5415.2009.02343.x; Aleman A, 1999, J CLIN ENDOCR METAB, V84, P471, DOI 10.1210/jc.84.2.471; Barone P, 2011, MOVEMENT DISORD, V26, P2483, DOI 10.1002/mds.23919; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Bellar D, 2011, NEUROSCIENCE, V178, P133, DOI 10.1016/j.neuroscience.2010.12.023; BENTON A L, 1978, Archives of Neurology, V35, P364; Bernhard FP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150552; Brandt J, 2001, HOPKINS VERBAL LEARN; Burman P, 1998, PSYCHOTHER PSYCHOSOM, V67, P154, DOI 10.1159/000012276; Carro E, 2004, EUR J PHARMACOL, V490, P127, DOI 10.1016/j.ejphar.2004.02.050; DEKEYSER J, 1994, SYNAPSE, V17, P196, DOI 10.1002/syn.890170309; Dik MG, 2003, NEUROBIOL AGING, V24, P573, DOI 10.1016/S0197-4580(02)00136-7; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Godau J, 2011, ARCH NEUROL-CHICAGO, V68, P925, DOI 10.1001/archneurol.2011.129; Godau J, 2010, J NEUROL NEUROSUR PS, V81, P536, DOI 10.1136/jnnp.2009.175752; Kalmijn S, 2000, J CLIN ENDOCR METAB, V85, P4551, DOI 10.1210/jc.85.12.4551; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Kao SY, 2009, BIOCHEM BIOPH RES CO, V385, P434, DOI 10.1016/j.bbrc.2009.05.089; Li DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144755; Liu R, 2015, NEUROLOGY, V84, P2107, DOI 10.1212/WNL.0000000000001609; Ma JH, 2015, ENVIRON TOXICOL PHAR, V39, P1, DOI 10.1016/j.etap.2014.11.004; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Numao A, 2014, PARKINSONISM RELAT D, V20, P212, DOI 10.1016/j.parkreldis.2013.11.005; Okereke O, 2007, NEUROBIOL AGING, V28, P135, DOI 10.1016/j.neurobiolaging.2005.10.012; Okereke OI, 2006, J CLIN ENDOCR METAB, V91, P4306, DOI 10.1210/jc.2006-1325; Pappata S, 2011, NEUROLOGY, V77, P1357, DOI 10.1212/WNL.0b013e3182315259; Pellecchia MT, 2014, EUR J NEUROL, V21, P802, DOI 10.1111/ene.12137; Perani D, 2003, BRAIN LANG, V85, P357, DOI 10.1016/S0093-934X(02)00561-8; Picillo M, 2013, J NEUROL, V260, P2849, DOI [10.1007/s00415-013-7085-x, 10.1007/s00415-013-6851-0]; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; Sathiavageeswaran M, 2007, EUR J ENDOCRINOL, V156, P439, DOI 10.1530/eje.1.02346; Smith A., 1982, SYMBOL DIGIT MODALIT; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; van Dam PS, 2004, EUR J PHARMACOL, V490, P87, DOI 10.1016/j.ejphar.2004.02.047; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wechsler D., 2012, WAIS 4 KASIKIRJA; Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111	41	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186508	10.1371/journal.pone.0186508	http://dx.doi.org/10.1371/journal.pone.0186508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK5VD	29065116	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900016
J	Wu, MH; Shih, MH; Hsu, WB; Dubey, NK; Lee, WF; Lin, TY; Hsieh, MY; Chen, CF; Peng, KT; Huang, TJ; Shi, CS; Guo, RS; Cai, CJ; Chung, CY; Wong, CH				Wu, Meng-Huang; Shih, Ming-Hung; Hsu, Wei-Bin; Dubey, Navneet Kumar; Lee, Wen-Fu; Lin, Tsai-Yu; Hsieh, Meng-Yow; Chen, Chin-Fu; Peng, Kuo-Ti; Huang, Tsung-Jen; Shi, Chung-Sheng; Guo, Ren-Shyang; Cai, Chang-Jhih; Chung, Chiu-Yen; Wong, Chung-Hang			Evaluation of a novel biodegradable thermosensitive keto-hydrogel for improving postoperative pain in a rat model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CESAREAN DELIVERY; DRUG-DELIVERY; DOUBLE-BLIND; SUBCUTANEOUS INSTILLATION; WOUND INFILTRATION; ANALGESIC EFFICACY; LOCAL-ANESTHETICS; CONTROLLED-TRIAL; DENTAL PAIN	This study evaluates the sustained analgesic effect of ketorolac-eluting thermosensitive biodegradable hydrogel in the plantar incisional pain model of the rat hind-paw. A ketorolac-embedded 2, 2'-Bis (2-oxazolin) (BOX) linking methoxy-poly(ethylene glycol) and poly(lactide-co-glycolide) (mPEG-PLGA) diblock copolymer (BOX copolymer) was synthesized as keto-hydrogel based on optimal sol-gel phase transition and in vitro drug release profile. The effect of keto-hydrogel on postoperative pain (POP) was assessed using the established plantar incisional pain model in hind-paw of rats and compared to that of ketorolac solution. Pain and sensory threshold, as well as pain scoring, were evaluated with behavioral tests by means of anesthesiometer and incapacitance apparatus, respectively. Pro-inflammatory cytokine levels (TNF-alpha, IL-6, VEGF, and IL-1 beta) around incisional wounds were measured by ELISA. Tissue histology was assessed using hematoxylin and eosin and Masson's trichrome staining. Ten mg/mL (25 wt%) keto-hydrogel showed a sol-gel transition at 26.4 degrees C with a 10-day sustained drug release profile in vitro. Compared to ketorolac solution group, the concentration of ketorolac in tissue fluid was higher in the keto-hydrogel group during the first 18 h of application. Keto-hydrogel elevated pain and sensory threshold, increased weight-bearing capacity, and significantly reduced the levels of TNF-alpha, IL-6, and IL-1 beta while enhanced VEGF in tissue fluid. Histologic analysis reveals greater epithelialization and collagen deposition around wound treated with keto-hydrogel. In conclusion, our study suggests that keto-hydrogel is an ideal compound to treat POP with a secondary gain of improved incisional wound healing.	[Wu, Meng-Huang; Huang, Tsung-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Orthopaed, Taipei, Taiwan; [Shih, Ming-Hung; Huang, Tsung-Jen] Taipei Med Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Wu, Meng-Huang; Shi, Chung-Sheng] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Shih, Ming-Hung; Wong, Chung-Hang] Chang Gung Mem Hosp, Dept Anaesthesiol, Chiayi, Taiwan; [Hsu, Wei-Bin] Chang Gung Mem Hosp, Sports Med Ctr, Chiayi, Taiwan; [Dubey, Navneet Kumar] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan; [Lee, Wen-Fu] Tatung Univ, Dept Chem Engn, Taipei, Taiwan; [Lin, Tsai-Yu; Hsieh, Meng-Yow; Chen, Chin-Fu] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Hsieh, Meng-Yow] Natl Taiwan Univ, Inst Biomed Engn, Coll Engn, Coll Med, Taipei, Taiwan; [Peng, Kuo-Ti; Guo, Ren-Shyang] Chang Gung Mem Hosp, Dept Orthopaed Surg, Chiayi, Taiwan; [Cai, Chang-Jhih; Chung, Chiu-Yen] Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; [Chung, Chiu-Yen] Chang Gung Mem Hosp, Dept Med Res, Chiayi, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Taipei Medical University; Tatung University; Industrial Technology Research Institute - Taiwan; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wong, CH (corresponding author), Chang Gung Mem Hosp, Dept Anaesthesiol, Chiayi, Taiwan.	wong@cgmh.org.tw	Wu, Meng-huang/AAH-2195-2020; Dubey, Navneet Kumar/H-3870-2019	Wu, Meng-huang/0000-0003-1606-2444; Dubey, Navneet Kumar/0000-0002-3540-5281; Huang, Tsung-Jen/0000-0002-3640-3018; Shi, Chung-Sheng/0000-0002-5548-7675; Hsu, Wei-Bin/0000-0003-1917-4804; wong, Chung-Hang/0000-0002-5073-4833	Chang Gung Memorial Hospital at Chiayi; Chang Gung Medical Foundation [CMRPG690291, CMRPG6A0021, BMRP288A]	Chang Gung Memorial Hospital at Chiayi; Chang Gung Medical Foundation	This work was supported by research grant from Chang Gung Memorial Hospital at Chiayi, Chang Gung Medical Foundation. [#CMRPG690291(Wu) to Meng-Huang Wu, #CMRPG6A0021 to Chung-Hang Wong and #BMRP288A (Wong) to Chung-Hang Wong]. (https://www.cgmh.org.tw/eng2002/index.asp) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Benoit MA, 1997, INT ORTHOP, V21, P403; Bikhazi GB, 2004, AM J OBSTET GYNECOL, V191, P1183, DOI 10.1016/j.ajog.2004.05.006; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Carvalho B, 2013, J PAIN, V14, P48, DOI 10.1016/j.jpain.2012.10.002; Carvalho B, 2010, ANESTH ANALG, V111, P1452, DOI 10.1213/ANE.0b013e3181f579de; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen C, 2014, RSC ADV, V4, P8789, DOI 10.1039/c3ra47494a; Chou LB, 2008, FOOT ANKLE INT, V29, P1063, DOI 10.3113/FAI.2008.1063; de Paula Eneida, 2010, Recent Pat Drug Deliv Formul, V4, P23; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gollwitzer H, 2005, J ORTHOP RES, V23, P802, DOI 10.1016/j.orthres.2005.02.003; Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hu CC, 2015, J COMPUT THEOR NANOS, V12, P762, DOI 10.1166/jctn.2015.3799; Hu CC, 2014, BIO-MED MATER ENG, V24, P1941, DOI 10.3233/BME-141003; Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999; Kjaergaard M, 2012, ACTA ANAESTH SCAND, V56, P282, DOI 10.1111/j.1399-6576.2011.02629.x; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; LASCELLES BDX, 1995, PAIN, V62, P201, DOI 10.1016/0304-3959(94)00266-H; Lavand'homme PM, 2007, ANESTHESIOLOGY, V106, P1220, DOI 10.1097/01.anes.0000267606.17387.1d; Liu CM, 2010, J APPL TOXICOL, V30, P680, DOI 10.1002/jat.1541; Magari K, 2004, INFLAMM RES, V53, P469, DOI 10.1007/s00011-004-1284-y; McCarthy D, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/709531; Mehlisch DR, 2010, CLIN THER, V32, P882, DOI 10.1016/j.clinthera.2010.04.022; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Moiniche S, 1998, BRIT J ANAESTH, V81, P377, DOI 10.1093/bja/81.3.377; Mony D, 2016, J CLIN DIAGN RES, V10, pZC102, DOI 10.7860/JCDR/2016/17696.8045; Olmedo MV, 2001, PAIN, V90, P135, DOI 10.1016/S0304-3959(00)00396-1; Peng KT, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1131-7; Peng KT, 2010, BIOMATERIALS, V31, P5227, DOI 10.1016/j.biomaterials.2010.03.027; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Romsing J, 2000, ACTA ANAESTH SCAND, V44, P672, DOI 10.1034/j.1399-6576.2000.440607.x; Sawynok J, 2003, PHARMACOL REV, V55, P1, DOI 10.1124/pr.55.1.1; Shen H. H., 2012, Taiwan patent, Patent No. [US 8211959B2, 8211959]; SHRESTHA M, 1995, ANN EMERG MED, V26, P682, DOI 10.1016/S0196-0644(95)70037-4; Siribumrungwong K, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0522-5; Spofford CM, 2009, ANESTH ANALG, V109, P1992, DOI 10.1213/ANE.0b013e3181bbd9a3; Stuhldreher JM, 2012, SURG ENDOSC, V26, P1617, DOI 10.1007/s00464-011-2079-1; Veiranto M, 2002, J MATER SCI-MATER M, V13, P1259, DOI 10.1023/A:1021187331458; Viscusi ER, 2008, REGION ANESTH PAIN M, V33, P146, DOI 10.1016/j.rapm.2007.11.005; Wharton M, 2011, INT J COSMETIC SCI, V33, P164, DOI 10.1111/j.1468-2494.2010.00607.x; Yu L, FRONTIERS IN BIOENGI	47	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186784	10.1371/journal.pone.0186784	http://dx.doi.org/10.1371/journal.pone.0186784			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059223	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000041
J	Sarabia, JM; Moya-Ramon, M; Hernandez-Davo, JL; Fernandez-Fernandez, J; Sabido, R				Sarabia, J. M.; Moya-Ramon, M.; Hernandez-Davo, J. L.; Fernandez-Fernandez, J.; Sabido, R.			The effects of training with loads that maximise power output and individualised repetitions vs. traditional power training	PLOS ONE			English	Article							BENCH PRESS STRENGTH; RESISTANCE EXERCISE; HORMONAL RESPONSES; BALLISTIC-POWER; PERFORMANCE; ADAPTATIONS; INTENSITY; VELOCITY; FAILURE; GAINS	Background It has been suggested that strength training effects (i.e. neural or structural) vary, depending on the total repetitions performed and velocity loss in each training set. Purpose The aim of this study is to compare the effects of two training programmes (i.e. one with loads that maximise power output and individualised repetitions, and the other following traditional power training). Methods Twenty-five males were divided into three groups (optimum power [OP = 10], traditional training [TT = 9] and control group [CG = 6]). The training load used for OP was individualised using loads that maximised power output (41.7%-5.8 of one repetition maximum [1RM]) and repetitions at maximum power (4 to 9 repetitions, or 'reps'). Volume (sets x repetitions) was the same for both experimental groups, while intensity for TT was that needed to perform only 50% of the maximum number of possible repetitions (i.e. 61.1%-66.6% of 1RM). The training programme ran over 11 weeks (2 sessions per week; 4-5 sets per session; 3-minute rests between sets), with pre-, intermediate and post-tests which included: anthropometry, 1RM, peak power output (PPO) with 30%, 40% and 50% of 1RM in the bench press throw, and salivary testosterone (ST) and cortisol (SC) concentrations. Rate of perceived exertion (RPE) and power output were recorded in all sessions. Results Following the intermediate test, PPO was increased in the OP group for each load (10.9%- 13.2%). Following the post-test, both experimental groups had increased 1RM (11.8%-13.8%) and PPO for each load (14.1%-19.6%). Significant decreases in PPO were found for the TT group during all sets (4.9%-15.4%), along with significantly higher RPE (37%). Conclusion OP appears to be a more efficient method of training, with less neuromuscular fatigue and lower RPE.	[Sarabia, J. M.; Moya-Ramon, M.; Hernandez-Davo, J. L.; Fernandez-Fernandez, J.; Sabido, R.] Univ Miguel Hernandez Elche, Sports Res Ctr, Elche, Spain; [Fernandez-Fernandez, J.] Univ Leon, Fac Phys Act & Sports Sci, Leon, Spain	Universidad Miguel Hernandez de Elche; Universidad de Leon	Sarabia, JM (corresponding author), Univ Miguel Hernandez Elche, Sports Res Ctr, Elche, Spain.	jsarabia@goumh.es	Sabido, Rafael/AAO-5763-2021; Hernandez, Jose/AAS-6643-2021; Fernandez-Fernandez, Jaime/AAO-9270-2020; Sarabia, Jose M/F-4014-2016; MOYA, MANUEL/F-7172-2016	Sabido, Rafael/0000-0003-0158-9075; Sarabia, Jose M/0000-0002-1917-6634; MOYA, MANUEL/0000-0002-2291-5899; Fernandez-Fernandez, Jaime/0000-0002-5284-303X; Hernandez-Davo, Jose Luis/0000-0001-5785-4697				Ahtlainen JP, 2003, INT J SPORTS MED, V24, P410; Argus CK, 2014, J STRENGTH COND RES, V28, P240, DOI 10.1519/JSC.0b013e318295d1c9; Bautista IJ, 2014, J HUM KINET, V44, P161, DOI 10.2478/hukin-2014-0122; Casey A, 1996, AM J PHYSIOL-ENDOC M, V271, pE38, DOI 10.1152/ajpendo.1996.271.1.E38; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cormie P, 2011, SPORTS MED, V41, P17, DOI 10.2165/11537690-000000000-00000; Cormie P, 2010, MED SCI SPORT EXER, V42, P1582, DOI 10.1249/MSS.0b013e3181d2013a; Cormie P, 2010, MED SCI SPORT EXER, V42, P1566, DOI 10.1249/MSS.0b013e3181cf818d; Crewther B, 2006, SPORTS MED, V36, P215, DOI 10.2165/00007256-200636030-00004; Drinkwater EJ, 2005, J STRENGTH COND RES, V19, P382; Filaire E, 2009, PSYCHONEUROENDOCRINO, V34, P150, DOI 10.1016/j.psyneuen.2008.08.022; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Folland JP, 2002, BRIT J SPORT MED, V36, P370, DOI 10.1136/bjsm.36.5.370; Fry AC, 2004, SPORTS MED, V34, P663, DOI 10.2165/00007256-200434100-00004; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Gonzalez-Badillo JJ, 2006, J STRENGTH COND RES, V20, P73; Gorostiaga EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040621; HAKKINEN K, 1991, EUR J APPL PHYSIOL O, V63, P194, DOI 10.1007/BF00233847; HAKKINEN K, 1988, J APPL PHYSIOL, V65, P2406, DOI 10.1152/jappl.1988.65.6.2406; Harris NK, 2008, J STRENGTH COND RES, V22, P1742, DOI 10.1519/JSC.0b013e318187458a; Davo JLH, 2016, J STRENGTH COND RES, V30, P1265, DOI 10.1519/JSC.0000000000001214; HICKSON RC, 1994, J APPL PHYSIOL, V76, P663, DOI 10.1152/jappl.1994.76.2.663; Izquierdo M, 2006, J APPL PHYSIOL, V100, P1647, DOI 10.1152/japplphysiol.01400.2005; Izquierdo M, 2002, EUR J APPL PHYSIOL, V87, P264, DOI 10.1007/s00421-002-0628-y; Izquierdo-Gabarren M, 2010, MED SCI SPORT EXER, V42, P1191, DOI 10.1249/MSS.0b013e3181c67eec; Gonzalez-Badillo JJ, 2010, J STRENGTH COND RES, V24, P3443, DOI 10.1519/JSC.0b013e3181bac37d; Kaneko M, 1983, SCAND J SPORTS SCI, V5, P50; Kawamori N, 2004, J STRENGTH COND RES, V18, P675; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Legaz-Arrese A, 2007, J SPORT MED PHYS FIT, V47, P427; Loturco I, 2013, J SPORT SCI MED, V12, P109; Marques MC, 2014, J STRENGTH COND RES, V28, P2366, DOI 10.1519/JSC.0000000000000390; Marx JO, 2001, MED SCI SPORT EXER, V33, P635, DOI 10.1097/00005768-200104000-00019; MAYHEW JL, 1995, J SPORT MED PHYS FIT, V35, P108; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; McGuigan MR, 2012, INT J SPORT PHYSIOL, V7, P2, DOI 10.1123/ijspp.7.1.2; McKinnon NB, 2017, AGEING RES REV, V35, P147, DOI 10.1016/j.arr.2016.09.003; Picerno P, 2016, EUR J APPL PHYSIOL, V116, P2035, DOI 10.1007/s00421-016-3457-0; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Robertson RJ, 2003, MED SCI SPORT EXER, V35, P333, DOI 10.1249/01.MSS.0000048831.15016.2A; Romero-Arenas S, 2017, J STRENGTH CONDITION; Sanborn K, 2000, J STRENGTH COND RES, V14, P328; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Spassov A, 1988, STRENGTH CON J, V10, P58; Stone MH, 2003, J STRENGTH COND RES, V17, P140; Verkhoshansky Y, 1989, NSCA J, V11, P58; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILSON GJ, 1993, MED SCI SPORT EXER, V25, P1279; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Zaras N, 2013, J SPORT SCI MED, V12, P130	50	18	18	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186601	10.1371/journal.pone.0186601	http://dx.doi.org/10.1371/journal.pone.0186601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053725	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100026
J	Mulu, A; Maier, M; Liebert, UG				Mulu, Andargachew; Maier, Melanie; Liebert, Uwe Gerd			Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: A decade longitudinal study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TREATMENT-NAIVE INDIVIDUALS; ANTIRETROVIRAL TREATMENT; THERAPY; ROLLOUT; UPDATE; ADULTS	Background The emergence, accumulation and spread of HIV-1 drug resistance strains in Africa could compromise the effectiveness of HIV treatment programs. This study was aimed at determining the incidence of virological failure and acquired drug resistance mutations overtime and identifying the most common mutational pathways of resistance in a well characterized HIV-1C infected Ethiopian cohort. Methods A total of 320 patients (220 ART naive and 100 on first lines ART) were included and followed. ART initiation and patients' monitoring was based on the WHO clinical and immunological parameters. HIV viral load measurement and genotypic drug resistance testing were done at baseline (T0-2008) and after on average at a median time of 30 months on ART at three time points (T1-2011, T2-2013, T3-2015). Findings The incidence of virological failure has increased overtime from 11 at T1 to 17 at T2 and then to 30% at T3. At all time point's almost all of the patients with virological failure and accumulated drug resistance mutations had not met the WHO clinical and immunologic failure criteria and continued the failing regimen. A steep increase in the incidence and accumulation of major acquired NRTI and NNRTI drug resistance mutations have been observed (from 40% at T1 to 64% at T2 and then to 66% at T3). The most frequent NRTIs drug resistance associated mutations are mainly the lamivudine-induced mutation M184V which was detected in 4 patients at T1 and showed a 2 fold increase in the following time points (T2: n = 8) and at (T3: n = 12) and the thymidine analogue mutations (such as D67N, K70R and K219E) which were not-detected at baseline T0 and T1 but were increased progressively to 10 at T2 and to 17 at T3. The most frequent NNRTIs associated mutations were K103N, V106M and Y188C. Conclusions An upward trend in the incidence of virological failure and accumulation of NRTI and NNRTI associated acquired antiretroviral drug resistance mutations are observed. The data suggest the need for virological monitoring, resistance testing for early detection of failure and access for TDF and PI containing drugs. Population-level and patient targeted interventions to prevent the spread of mutant variants is warranted.	[Mulu, Andargachew] Armauer Hanssen Res Inst, Addis Ababa, Ethiopia; [Maier, Melanie; Liebert, Uwe Gerd] Univ Leipzig, Med Fac, Inst Virol, Leipzig, Germany	Leipzig University	Mulu, A (corresponding author), Armauer Hanssen Res Inst, Addis Ababa, Ethiopia.	andargachewmulu@yahoo.com	Mulu, Andargachew/GMW-4823-2022	Mulu, Andargachew/0000-0003-2862-0175				Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; [Anonymous], 2016, LANCET INFECT DIS, V16, P565, DOI [10.1016/S1473-3099(15)00536-8, DOI 10.1016/S1473-3099(15)00536-8]; Assefa Y, 2015, J ACQ IMMUN DEF SYND, V70, P414, DOI [10.1097/QAI.0000000000000753, DOI 10.1097/QAI.0000000000000753]; Assefa Y, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-43; Assefa Y, 2010, LANCET, V376, P1053, DOI 10.1016/S0140-6736(10)61487-0; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Baxter JD, 2015, HIV MED, V16, P77, DOI 10.1111/hiv.12236; Boender TS, 2015, CLIN INFECT DIS; Clutter DS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020048; Demissie K, 2015, HIV AIDS-RES PALLIAT, V7, P183, DOI 10.2147/HIV.S78300; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2013, CURR OPIN HIV AIDS, V8, P19, DOI 10.1097/COH.0b013e32835b7f94; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Hawkins C, 2016, J ANTIMICROB CHEMOTH, V71, P1966, DOI 10.1093/jac/dkw051; Hofstra LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110749; Huruy K, 2015, J MED VIROL, V87, P978, DOI 10.1002/jmv.24110; Iyidogan P, 2014, VIRUSES-BASEL, V6, P4095, DOI 10.3390/v6104095; Jordan MR, 2012, CLIN INFECT DIS, V54, pS245, DOI 10.1093/cid/cis206; Kenyon CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140835; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Mulu A., 2014, BMC INFECT DIS, V14; Mulu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141318; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-28; Rhee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145772; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Shewamene Z, 2015, HIV AIDS-RES PALLIAT, V7, P119, DOI 10.2147/HIV.S79122; Ssemwanga D, 2015, AIDS REV, V17, P3; Wensing AM, 2017, TOP ANTIVIR MED, V24, P132	30	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186619	10.1371/journal.pone.0186619	http://dx.doi.org/10.1371/journal.pone.0186619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049402	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900090
J	Wen, SM; Meng, QK; Feng, C; Tang, CJ				Wen, Shameng; Meng, Qingkun; Feng, Chao; Tang, Chaojing			Protocol vulnerability detection based on network traffic analysis and binary reverse engineering	PLOS ONE			English	Article								Network protocol vulnerability detection plays an important role in many domains, including protocol security analysis, application security, and network intrusion detection. In this study, by analyzing the general fuzzing method of network protocols, we propose a novel approach that combines network traffic analysis with the binary reverse engineering method. For network traffic analysis, the block-based protocol description language is introduced to construct test scripts, while the binary reverse engineering method employs the genetic algorithm with a fitness function designed to focus on code coverage. This combination leads to a substantial improvement in fuzz testing for network protocols. We build a prototype system and use it to test several real-world network protocol implementations. The experimental results show that the proposed approach detects vulnerabilities more efficiently and effectively than general fuzzing methods such as SPIKE.	[Wen, Shameng; Meng, Qingkun; Feng, Chao; Tang, Chaojing] Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Wen, SM; Feng, C (corresponding author), Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China.	wenshameng@126.com; chaofeng@nudt.edu.cn	Meng, Q./GSI-6185-2022					Aitel D., 2002, ADVANTAGES BLOCK BAS, P106; Banerjee U., 2010, INT J COMPUT APPL, V6, P1; Brumley D., 2007, USENIX SEC S 2007, P15; Caballero J, 2007, CCS'07: PROCEEDINGS OF THE 14TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P317; Chen K, 2014, CHINESE J ELECTRON, V23, P18; Cui W., 2006, NDSS; DUNLAP GW, 2002, ACM SIGOPS OPERATING, P211; Eronen J, 2005, CRIT INFR PROT 1 IEE, P9; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Kaksonen R, 2001, INT FED INFO PROC, V64, P174; Leita C., 2005, COMP SEC APPL C 21 A; Newsome James, 2005, NETWORK DISTRIBUTED, V5, P3; Pencheva T., 2009, INT J BIOAUTOMATION, V13, P257; Portokalidis G., 2006, ACM SIGOPS OPERATING, V40, P15; Wondracek G., 2008, NDSS, V8, P1	15	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186188	10.1371/journal.pone.0186188	http://dx.doi.org/10.1371/journal.pone.0186188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049409	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900048
J	Litaker, RW; Holland, WC; Hardison, DR; Pisapia, F; Hess, P; Kibler, SR; Tester, PA				Litaker, R. Wayne; Holland, William C.; Hardison, D. Ransom; Pisapia, Francesco; Hess, Philipp; Kibler, Steven R.; Tester, Patricia A.			Ciguatoxicity of Gambierdiscus and Fukuyoa species from the Caribbean and Gulf of Mexico	PLOS ONE			English	Article							DINOFLAGELLATE GAMBIERDISCUS; TOXIC DINOFLAGELLATE; GENETIC DIVERSITY; TEMPERATE WATERS; KARENIA BREVIS; COASTAL AREAS; 1ST REPORT; CIGUATERA; DINOPHYCEAE; FISH	Dinoflagellate species belonging to the genera Gambierdiscus and Fukuyoa produce ciguatoxins (CTXs), potent neurotoxins that concentrate in fish causing ciguatera fish poisoning (CFP) in humans. While the structures and toxicities of ciguatoxins isolated from fish in the Pacific and Caribbean are known, there are few data on the variation in toxicity between and among species of Gambierdiscus and Fukuyoa. Quantifying the differences in species-specific toxicity is especially important to developing an effective cell-based risk assessment strategy for CFP. This study analyzed the ciguatoxicity of 33 strains representing seven Gambierdiscus and one Fukuyoa species using a cell based Neuro-2a cytotoxicity assay. All strains were isolated from either the Caribbean or Gulf of Mexico. The average toxicity of each species was inversely proportional to growth rate, suggesting an evolutionary trade-off between an investment in growth versus the production of defensive compounds. While there is 2- to 27-fold variation in toxicity within species, there was a 1740-fold difference between the least and most toxic species. Consequently, production of CTX or CTX-like compounds is more dependent on the species present than on the random occurrence of high or low toxicity strains. Seven of the eight species tested (G. belizeanus, G. caribaeus, G. carolinianus, G. carpenteri, Gambierdiscus ribotype 2, G. silvae and F. ruetzleri) exhibited low toxicities, ranging from 0 to 24.5 fg CTX3C equivalents cell(-1), relative to G. excentricus, which had a toxicity of 469 fg CTX3C eq. cell(-1). Isolates of G. excentricus from other regions have shown similarly high toxicities. If the hypothesis that G. excentricus is the primary source of ciguatoxins in the Atlantic is confirmed, it should be possible to identify areas where CFP risk is greatest by monitoring only G. excentricus abundance using species-specific molecular assays.	[Litaker, R. Wayne; Holland, William C.; Hardison, D. Ransom; Kibler, Steven R.] Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC 28516 USA; [Pisapia, Francesco; Hess, Philipp] Ifremer, Lab Phycotoxines, F-44311 Nantes 3, France; [Tester, Patricia A.] Ocean Tester LLC, Beaufort, NC USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Ifremer	Litaker, RW (corresponding author), Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC 28516 USA.	wayne.litaker@noaa.gov	Hess, Philipp/G-1761-2010; Litaker, Richard Wayne/AAH-2036-2021	Hess, Philipp/0000-0002-9047-1345; Litaker, Richard Wayne/0000-0001-6293-8000	NOAA Ecology and Oceanography of Harmful Algal Blooms Program [900]; Regional Council of the Pays de la Loire [COSELMAR 2012-09684, 2014-08222]; L'Institut Francais de Recherche pour l'Exploitation de la Mer (DRH/AA/JC) [2014-C258]; Francesco Pisapia's PhD research	NOAA Ecology and Oceanography of Harmful Algal Blooms Program; Regional Council of the Pays de la Loire(Region Pays de la Loire); L'Institut Francais de Recherche pour l'Exploitation de la Mer (DRH/AA/JC); Francesco Pisapia's PhD research	This work was supported by the NOAA Ecology and Oceanography of Harmful Algal Blooms Program, ECOHAB contribution no. 900 and by grants from the Regional Council of the Pays de la Loire (Conventions COSELMAR 2012-09684 and Francesco Pisapia PhD contract 2014-08222) and L'Institut Francais de Recherche pour l'Exploitation de la Mer (DRH/AA/JC no 2014-C258) which partly funded Francesco Pisapia's PhD research.	Aligizaki K, 2008, TOXICON, V51, P418, DOI 10.1016/j.toxicon.2007.10.016; Alpermann TJ, 2009, MOL ECOL, V18, P2122, DOI 10.1111/j.1365-294X.2009.04165.x; Antonella P, 2013, ENVIRON SCI POLLUT R, V20, P6851, DOI 10.1007/s11356-012-1377-z; Asaeda G, 2001, J EMERG MED, V20, P263, DOI 10.1016/S0736-4679(00)00319-X; BENOIT E, 1986, TOXICON, V24, P357, DOI 10.1016/0041-0101(86)90195-9; BIDARD JN, 1984, J BIOL CHEM, V259, P8353; Botana L.M., 2014, SEAFOOD FRESHWATER T; Caillaud A, 2011, HARMFUL ALGAE, V10, P433, DOI 10.1016/j.hal.2011.02.004; Caillaud A, 2010, MAR DRUGS, V8, P1838, DOI 10.3390/md8061838; Carlson RD, 1984, DISTRIBUTION PERIODI; Chan TYK, 2016, AM J TROP MED HYG, V94, P704, DOI 10.4269/ajtmh.15-0686; Chan TYK, 2014, TOXINS, V6, P2989, DOI 10.3390/toxins6102989; Chateau-Degat ML, 2005, HARMFUL ALGAE, V4, P1053, DOI 10.1016/j.hal.2005.03.003; Chinain M, 1999, MAR BIOL, V135, P259, DOI 10.1007/s002270050623; Chinain M, 2010, TOXICON, V56, P739, DOI 10.1016/j.toxicon.2009.06.013; Dai XF, 2017, HARMFUL ALGAE, V67, P107, DOI 10.1016/j.hal.2017.07.002; Dechraoui MYB, 2005, TOXICON, V46, P261, DOI 10.1016/j.toxicon.2005.04.006; Dickey RW, 2010, TOXICON, V56, P123, DOI 10.1016/j.toxicon.2009.09.008; Dyhrman ST, 2006, HARMFUL ALGAE, V5, P242, DOI 10.1016/j.hal.2005.07.005; Ennaffah Btissam, 2015, Harmful Algae News, V50, P20; Epelboin L, 2014, J TRAVEL MED, V21, P397, DOI 10.1111/jtm.12161; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; Fraga S, 2014, PROTIST, V165, P839, DOI 10.1016/j.protis.2014.09.003; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; Gomez F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119676; Hardison DR, 2014, LIMNOL OCEANOGR, V59, P560, DOI 10.4319/lo.2014.59.2.0560; Hardison DR, 2012, J PHYCOL, V48, P844, DOI 10.1111/j.1529-8817.2012.01186.x; Hardison DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058545; HAYHOME BA, 1987, J PHYCOL, V23, P573; Holland WC, 2013, TOXICON, V65, P15, DOI 10.1016/j.toxicon.2012.12.016; Jeong HJ, 2012, J EUKARYOT MICROBIOL, V59, P637, DOI 10.1111/j.1550-7408.2012.00645.x; John U, 2004, PROTIST, V155, P169, DOI 10.1078/143446104774199574; Kaly Ursula L., 1994, Memoirs of the Queensland Museum, V34, P523; Keller M.D., 1985, P113; KELLER MD, 1988, J EXP MAR BIOL ECOL, V117, P279, DOI 10.1016/0022-0981(88)90063-9; Kibler SR, 2017, ECOL MODEL, V360, P204, DOI 10.1016/j.ecolmodel.2017.07.007; Kibler SR, 2015, ECOL MODEL, V316, P194, DOI 10.1016/j.ecolmodel.2015.08.020; Kibler SR, 2012, HARMFUL ALGAE, V19, P1, DOI 10.1016/j.hal.2012.04.007; Kohli GS, 2014, HARMFUL ALGAE, V39, P134, DOI 10.1016/j.hal.2014.07.007; Kohli GS, 2014, HARMFUL ALGAE, V37, P125, DOI 10.1016/j.hal.2014.05.018; Lartigue J, 2009, HARMFUL ALGAE, V8, P781, DOI 10.1016/j.hal.2008.05.006; Lebret K, 2012, ENVIRON MICROBIOL, V14, P2395, DOI 10.1111/j.1462-2920.2012.02769.x; Lehane L, 2000, INT J FOOD MICROBIOL, V61, P91, DOI 10.1016/S0168-1605(00)00382-2; Lehane L, 2000, MED J AUSTRALIA, V172, P176, DOI 10.5694/j.1326-5377.2000.tb125546.x; Lewis RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160006; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Litaker RW, 2010, TOXICON, V56, P711, DOI 10.1016/j.toxicon.2010.05.017; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; Llewellyn LE, 2010, TOXICON, V56, P691, DOI 10.1016/j.toxicon.2009.08.011; Medlin LK, 2000, ANTARCT SCI, V12, P325, DOI 10.1017/S0954102000000389; MOLGO J, 1990, BRIT J PHARMACOL, V99, P695, DOI 10.1111/j.1476-5381.1990.tb12991.x; Nascimento SM, 2015, PHYCOLOGIA, V54, P628, DOI 10.2216/15-61.1; Nishimura T, 2016, HARMFUL ALGAE, V52, P11, DOI 10.1016/j.hal.2015.11.018; Nishimura T, 2014, J PHYCOL, V50, P506, DOI 10.1111/jpy.12175; OHIZUMI Y, 1981, J PHARMACOL EXP THER, V217, P475; Parsons ML, 2007, HARMFUL ALGAE, V6, P658, DOI 10.1016/j.hal.2007.01.001; Pawlowiez R, 2013, FOOD ADDIT CONTAM A, V30, P567, DOI 10.1080/19440049.2012.755644; Pisapia F, 2017, MAR DRUGS, V15, DOI 10.3390/md15070220; Pisapia F, 2017, HARMFUL ALGAE, V63, P173, DOI 10.1016/j.hal.2017.02.005; Reverte L, 2014, MAR DRUGS, V12, P5719, DOI 10.3390/md12125719; Rhodes L, 2014, HARMFUL ALGAE, V39, P185, DOI 10.1016/j.hal.2014.07.018; Roeder K, 2010, TOXICON, V56, P731, DOI 10.1016/j.toxicon.2009.07.039; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; SEINO A, 1988, BRIT J PHARMACOL, V95, P876, DOI 10.1111/j.1476-5381.1988.tb11717.x; Smith KF, 2017, MAR DRUGS, V15, DOI 10.3390/md15080243; Solino L, 2015, TOXICON, V102, P62, DOI 10.1016/j.toxicon.2015.05.015; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Sunda WG, 2006, J PHYCOL, V42, P963, DOI 10.1111/j.1529-8817.2006.00261.x; Tan T.-H., 2013, MAR RES INDONESIA, V38, P11; Tawong W, 2016, PHYCOLOGIA, V55, P274, DOI 10.2216/15-111.1; Tester PA, 2014, HARMFUL ALGAE, V39, P8, DOI 10.1016/j.hal.2014.06.009; Tester PA, 2010, TOXICON, V56, P698, DOI 10.1016/j.toxicon.2010.02.026; Vandersea MW, 2012, J PHYCOL, V48, P902, DOI 10.1111/j.1529-8817.2012.01146.x; Wood SA, 2013, NEW ZEAL J MAR FRESH, V47, P90, DOI 10.1080/00288330.2012.745885; Xu YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153197; Xu YX, 2014, HARMFUL ALGAE, V34, P56, DOI 10.1016/j.hal.2014.02.007; YASUMOTO T, 1976, B JPN SOC SCI FISH, V42, P359; Yogi K, 2014, J AOAC INT, V97, P398, DOI 10.5740/jaoacint.SGEYogi; Yogi K, 2013, FOOD HYG SAFE SCI, V54, P385, DOI 10.3358/shokueishi.54.385; Yogi K, 2011, ANAL CHEM, V83, P8886, DOI 10.1021/ac200799j; Yoshimatsu T, 2016, HARMFUL ALGAE, V60, P107, DOI 10.1016/j.hal.2016.10.009; Yoshimatsu T, 2014, HARMFUL ALGAE, V35, P29, DOI 10.1016/j.hal.2014.03.007; Zar JH., 2010, BIOSTAT ANAL, V5th	83	83	85	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185776	10.1371/journal.pone.0185776	http://dx.doi.org/10.1371/journal.pone.0185776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045489	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100027
J	Wotanis, CK; Brennan, WP; Angotti, AD; Villa, EA; Zayner, JP; Mozina, AN; Rutkovsky, AC; Sobe, RC; Bond, WG; Karatan, E				Wotanis, Caitlin K.; Brennan, William P., III; Angotti, Anthony D.; Villa, Elizabeth A.; Zayner, Josiah P.; Mozina, Alexandra N.; Rutkovsky, Alexandria C.; Sobe, Richard C.; Bond, Whitney G.; Karatan, Ece			Relative contributions of norspermidine synthesis and signaling pathways to the regulation of Vibrio cholerae biofilm formation	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; VIRULENCE DETERMINANTS; POLYAMINE DISTRIBUTION; BACTERIA; GENE; IRON; THERMOSPERMINE; EUKARYOTES; WIDESPREAD	The polyamine norspermidine is one of the major polyamines synthesized by Vibrionales and has also been found in various aquatic organisms. Norspermidine is among the environmental signals that positively regulate Vibrio cholerae biofilm formation. The NspS/MbaA signaling complex detects extracellular norspermidine and mediates the response to this polyamine. Norspermidine binding to the NspS periplasmic binding protein is thought to inhibit the phosphodiesterase activity of MbaA, increasing levels of the biofilm-promoting second messenger cyclic diguanylate monophosphate, thus enhancing biofilm formation. V. cholerae can also synthesize norspermidine using the enzyme NspC as well as import it from the environment. Deletion of the nspC gene was shown to reduce accumulation of bacteria in biofilms, leading to the conclusion that intracellular norspermidine is also a positive regulator of biofilm formation. Because V. cholerae uses norspermidine to synthesize the siderophore vibriobactin it is possible that intracellular norspermidine is required to obtain sufficient amounts of iron, which is also necessary for robust biofilm formation. The objective of this study was to assess the relative contributions of intracellular and extracellular norspermidine to the regulation of biofilm formation in V. cholerae. We show the biofilm defect of norspermidine synthesis mutants does not result from an inability to produce vibriobactin as vibriobactin synthesis mutants do not have diminished biofilm forming abilities. Furthermore, our work shows that extracellular, but not intracellular norspermidine, is mainly responsible for promoting biofilm formation. We establish that the NspS/MbaA signaling complex is the dominant mediator of biofilm formation in response to extracellular norspermidine, rather than norspermidine synthesized by NspC or imported into the cell.	[Wotanis, Caitlin K.; Brennan, William P., III; Angotti, Anthony D.; Villa, Elizabeth A.; Zayner, Josiah P.; Mozina, Alexandra N.; Rutkovsky, Alexandria C.; Sobe, Richard C.; Bond, Whitney G.; Karatan, Ece] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA	University of North Carolina; Appalachian State University	Karatan, E (corresponding author), Appalachian State Univ, Dept Biol, Boone, NC 28608 USA.	karatane@appstate.edu		Rutkovsky, Alex C/0000-0001-8480-1128; Bond, Whitney/0000-0001-9529-4360	Appalachian State University Department of Biology; Office of Student Research grant; NIH-NIAID [AI096358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI096358] Funding Source: NIH RePORTER	Appalachian State University Department of Biology; Office of Student Research grant; NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the following sources: Appalachian State University Department of Biology, the Office of Student Research grants to CKW, WPB, ADA, EAV, JPZ, ANM (https://osr.appstate.edu/) and by NIH-NIAID (https://www.niaid.nih.gov/) (Grant number AI096358 to E.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bomchil N, 2003, J BACTERIOL, V185, P1384, DOI 10.1128/JB.185.4.1384-1390.2003; Butterton JR, 2000, J BACTERIOL, V182, P1731, DOI 10.1128/JB.182.6.1731-1738.2000; BUTTERTON JR, 1992, J BACTERIOL, V174, P3729, DOI 10.1128/JB.174.11.3729-3738.1992; Cockerell SR, 2014, MICROBIOL-SGM, V160, P832, DOI 10.1099/mic.0.075903-0; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; HAMANA K, 1982, J BIOCHEM-TOKYO, V91, P1321, DOI 10.1093/oxfordjournals.jbchem.a133818; Hamana K, 2004, J GEN APPL MICROBIOL, V50, P289, DOI 10.2323/jgam.50.289; Hamana K, 1997, J GEN APPL MICROBIOL, V43, P49, DOI 10.2323/jgam.43.49; Hamana K, 1998, CAN J BOT, V76, P130, DOI 10.1139/cjb-76-1-130; Hamana K, 2016, J GEN APPL MICROBIOL, V2016; Hamana K, 2003, MICROBIOL CULT COLLE, V19, P3; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Haugo AJ, 2002, MOL MICROBIOL, V45, P471, DOI 10.1046/j.1365-2958.2002.03023.x; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; KIRCHMAN D, 1982, APPL ENVIRON MICROB, V43, P200, DOI 10.1128/AEM.43.1.200-209.1982; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; McNeill K, 2003, FEMS MICROBIOL LETT, V221, P25, DOI 10.1016/S0378-1097(03)00164-2; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Michael AJ, 2016, J BIOL CHEM, V291, P14896, DOI 10.1074/jbc.R116.734780; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Parker ZM, 2012, FEMS MICROBIOL LETT, V329, P18, DOI 10.1111/j.1574-6968.2012.02498.x; PEDROSALIO C, 1983, ARCH HYDROBIOL, V98, P354; Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993, DOI 10.1128/JB.181.19.5993-6002.1999; ROGERS HJ, 1973, INFECT IMMUN, V7, P445, DOI 10.1128/IAI.7.3.445-456.1973; Sagor GHM, 2015, FEBS LETT, V589, P3071, DOI 10.1016/j.febslet.2015.08.045; Sobe RC, 2017, J BIOL CHEM JBC, VM117; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Sugiyama Y, 2016, J BIOL CHEM, V291, P26343, DOI 10.1074/jbc.M116.762450; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Tashima KT, 1996, INFECT IMMUN, V64, P1756, DOI 10.1128/IAI.64.5.1756-1761.1996; WALDOR MK, 1994, J INFECT DIS, V170, P278, DOI 10.1093/infdis/170.2.278; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; ZAPPIA V, 1978, FEBS LETT, V94, P161, DOI 10.1016/0014-5793(78)80928-4	44	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186291	10.1371/journal.pone.0186291	http://dx.doi.org/10.1371/journal.pone.0186291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045455	gold, Green Published			2022-12-26	WOS:000413168100051
J	Sodi, VL; Bacigalupa, ZA; Ferrer, CM; Lee, JV; Gocal, WA; Mukhopadhyay, D; Wellen, KE; Ivan, M; Reginato, MJ				Sodi, V. L.; Bacigalupa, Z. A.; Ferrer, C. M.; Lee, J. V.; Gocal, W. A.; Mukhopadhyay, D.; Wellen, K. E.; Ivan, M.; Reginato, M. J.			Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation	ONCOGENE			English	Article							BETA-N-ACETYLGLUCOSAMINE; C-MYC; PROSTATE-CANCER; BREAST-CANCER; TRANSCRIPTION FACTORS; GLCNACYLATION; CELLS; AMPK; LIPOGENESIS; METASTASIS	Elevated O-GlcNAcylation is associated with disease states such as diabetes and cancer. O-GlcNAc transferase (OGT) is elevated in multiple cancers and inhibition of this enzyme genetically or pharmacologically inhibits oncogenesis. Here we show that O-GlcNAcylation modulates lipid metabolism in cancer cells. OGT regulates expression of the master lipid regulator the transcription factor sterol regulatory element binding protein 1 (SREBP-1) and its transcriptional targets both in cancer and lipogenic tissue. OGT regulates SREBP-1 protein expression via AMP-activated protein kinase (AMPK). SREBP-1 is critical for OGT-mediated regulation of cell survival and of lipid synthesis, as overexpression of SREBP-1 rescues lipogenic defects associated with OGT suppression, and tumor growth in vitro and in vivo. These results unravel a previously unidentified link between O-GlcNAcylation, lipid metabolism and the regulation of SREBP-1 in cancer and suggests a crucial role for O-GlcNAc signaling in transducing nutritional state to regulate lipid metabolism.	[Sodi, V. L.; Bacigalupa, Z. A.; Ferrer, C. M.; Gocal, W. A.; Mukhopadhyay, D.; Reginato, M. J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th Street, Philadelphia, PA 19102 USA; [Lee, J. V.] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ivan, M.] Indiana Univ, Dept Med, Indianapolis, IN USA	Drexel University; University of Pennsylvania; Pennsylvania Medicine; Indiana University System; Indiana University-Purdue University Indianapolis	Reginato, MJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th Street, Philadelphia, PA 19102 USA.	Mauricio.Reginato@drexelmed.edu		Gocal, Wiktoria/0000-0001-8894-8047	NCI [CA192868, CA183574, CA155413]; NATIONAL CANCER INSTITUTE [F31CA192868, F31CA183574, R01CA155413] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Nicholas Xerri for technical support and Mignon Keaton for help in analyzing LC-MS metabolite data. This work was supported by NCI grants CA192868 (to VLS), CA183574 (to CMF) and CA155413 (to MJR).	Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Beckner ME, 2010, INT J CANCER, V126, P2282, DOI 10.1002/ijc.24918; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Ferrer CM, 2017, ONCOGENE, V36, P559, DOI 10.1038/onc.2016.228; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Jones SF, 2015, CLIN CANCER RES, V21, P5434, DOI 10.1158/1078-0432.CCR-15-0126; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li WH, 2012, CELL CYCLE, V11, P2348, DOI 10.4161/cc.20811; Li XY, 2016, ONCOTARGET, V7, P12869, DOI 10.18632/oncotarget.7331; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lopez-Ibanez J, 2016, NUCLEIC ACIDS RES, V44, pW201, DOI 10.1093/nar/gkw253; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Shaw Reuben J, 2012, F1000 Biol Rep, V4, P2, DOI 10.3410/B4-2; Sodi VL, 2015, MOL CANCER RES, V13, P923, DOI 10.1158/1541-7786.MCR-14-0536; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Varki A., 1999, ESSENTIALS GLYCOBIOL; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Zadra G, 2015, MOL CANCER RES, V13, P1059, DOI 10.1158/1541-7786.MCR-15-0068	41	37	42	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					924	934		10.1038/onc.2017.395	http://dx.doi.org/10.1038/onc.2017.395			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059153	Green Submitted, Green Accepted			2022-12-26	WOS:000425281800009
J	Stark, RJ; Koch, SR; Choi, H; Mace, EH; Dikalov, SI; Sherwood, ER; Lamb, FS				Stark, Ryan J.; Koch, Stephen R.; Choi, Hyehun; Mace, Eric H.; Dikalov, Sergey I.; Sherwood, Edward R.; Lamb, Fred S.			Endothelial nitric oxide synthase modulates Toll-like receptor 4-mediated IL-6 production and permeability via nitric oxide-independent signaling	FASEB JOURNAL			English	Article						inflammation; eNOS; endothelial cells; TLR-4; p38	MICROVASCULAR PERMEABILITY; GENE-EXPRESSION; SEVERE SEPSIS; IN-VITRO; CYTOKINE; DYSFUNCTION; CELLS; ACTIVATION; GENERATION; ENDOTOXIN	Endothelial dysfunction, characterized by changes in eNOS, is a common finding in chronic inflammatory vascular diseases. These states are associated with increased infectious complications. We hypothesized that alterations in eNOS would enhance the response to LPS-mediated TLR4 inflammation. Human microvascular endothelial cells were treated with sepiapterin or N-nitro-L-arginine methylester (L-NAME) to alter endogenous NO production, and small interfering RNA to knockdown eNOS. Alterations of endogenous NO by sepiapterin, and L-NAME provided no significant changes to LPS inflammation. In contrast, eNOS knockdown greatly enhanced endothelial IL-6 production and permeability in response to LPS. Knockdown of eNOS enhanced LPS-induced p38. Inhibition of p38 with SB203580 prevented IL-6 production, without altering permeability. Knockdown of p38 impaired NF-kappa B activation. Physical interaction between p38 and eNOS was demonstrated by immunoprecipitation, suggesting a novel, NO-independent mechanism for eNOS regulation of TLR4. In correlation, biopsy samples in patients with systemic lupus erythematous showed reduced eNOS expression with associated elevations in TLR4 and p38, suggesting an in vivo link. Thus, reduced expression of eNOS, as seen in chronic inflammatory disease, was associated with enhanced TLR4 signaling through p38. This may enhance the response to infection in patients with chronic inflammatory conditions.	[Stark, Ryan J.; Koch, Stephen R.; Choi, Hyehun; Mace, Eric H.; Lamb, Fred S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Dikalov, Sergey I.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Sherwood, Edward R.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Stark, RJ (corresponding author), Vanderbilt Univ, Sch Med, 2200 Childrens Way,5121 Doctors Off Tower, Nashville, TN 37232 USA.	ryan.stark@vanderbilt.edu	Stark, Ryan/O-1862-2019; Stark, Ryan/GZL-7445-2022	Stark, Ryan/0000-0001-6142-5502; Stark, Ryan/0000-0001-6142-5502; Dikalov, Sergey/0000-0003-2976-6184; Lamb, Fred/0000-0003-2955-5133	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [K08-GM117367, R01-GM104306]; NIH National Heart, Lung, and Blood Institute [R01-HL128386]; American Heart Association [16SDG30610002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124116, R01HL128386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM117367, R01GM119197, R01GM104306] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021630] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants K08-GM117367 (to R.J.S.) and R01-GM104306 (to E.R.S.) and NIH National Heart, Lung, and Blood Institute Grant R01-HL128386 (to F.S.L.), and by American Heart Association Grant 16SDG30610002 (to H.C.). The authors declare no conflicts of interest.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; AlFadhli S, 2013, DIS MARKERS, V34, P349, DOI [10.3233/DMA-130983, 10.1155/2013/613978]; Balk RA, 2014, VIRULENCE, V5, P20, DOI 10.4161/viru.27135; Brandes RP, 2014, HYPERTENSION, V64, P924, DOI 10.1161/HYPERTENSIONAHA.114.03575; Cardaropoli S, 2003, J HYPERTENS, V21, P2103, DOI 10.1097/00004872-200311000-00020; Castellon X, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0803; Chrestensen CA, 2012, FEBS OPEN BIO, V2, P51, DOI 10.1016/j.fob.2012.02.002; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; De Cruz Sharon J, 2009, Expert Rev Respir Med, V3, P511, DOI 10.1586/ers.09.39; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; DeVries HE, 1996, J PHARMACOL EXP THER, V277, P1418; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Dreger H, 2016, GENOMICS, V107, P145, DOI 10.1016/j.ygeno.2016.02.002; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Flaherty MP, 2007, CARDIOVASC TOXICOL, V7, P165, DOI 10.1007/s12012-007-0028-y; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; GROSS SS, 1992, J BIOL CHEM, V267, P25722; Hauser B, 2005, ANESTH ANALG, V101, P488, DOI 10.1213/01.ANE.0000177117.80058.4D; Kirkeboen KA, 1999, ACTA ANAESTH SCAND, V43, P275; Kobayashi Y, 2010, J LEUKOCYTE BIOL, V88, P1157, DOI 10.1189/jlb.0310149; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; KUBES P, 1992, AM J PHYSIOL, V262, pH611, DOI 10.1152/ajpheart.1992.262.2.H611; Li LZ, 2015, PROCEEDINGS 2015 SIXTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND ENGINEERING APPLICATIONS ISDEA 2015, P5, DOI 10.1109/ISDEA.2015.12; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu Q, 2016, IMMUNOL CELL BIOL, V94, P538, DOI 10.1038/icb.2016.18; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; RAMIREZ MM, 1995, MICROVASC RES, V50, P223, DOI 10.1006/mvre.1995.1055; Santos MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044668; Shi LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093846; Stark R, 2015, INNATE IMMUN-LONDON, V21, P565, DOI 10.1177/1753425914564172; Steyers CM, 2014, INT J MOL SCI, V15, P11324, DOI 10.3390/ijms150711324; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]; Varma S, 2002, MICROVASC RES, V63, P172, DOI 10.1006/mvre.2001.2381; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Woods ME, 2005, ANN NY ACAD SCI, V1063, P239, DOI 10.1196/annals.1355.037; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127931; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110	40	13	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					945	956		10.1096/fj.201700410R	http://dx.doi.org/10.1096/fj.201700410R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29061842	Green Published, Bronze			2022-12-26	WOS:000425146900035
J	Tanaka, SE; Aikawa, T; Takeuchi-Kaneko, Y; Fukuda, K; Kanzaki, N				Tanaka, Suguru E.; Aikawa, Takuya; Takeuchi-Kaneko, Yuko; Fukuda, Kenji; Kanzaki, Natsumi			Artificial induction of third-stage dispersal juveniles of Bursaphelenchusxylophilus using newly established inbred lines	PLOS ONE			English	Article							PINE WOOD NEMATODE; MONOCHAMUS-ALTERNATUS COLEOPTERA; PLANT-PARASITIC NEMATODES; CONTROLLING DAUER FORMATION; N-SP NEMATODA; XYLOPHILUS APHELENCHIDA; ECOLOGICAL SIGNIFICANCE; LARVAL DEVELOPMENT; INTERACTING GENES; NATURAL VARIATION	The pine wood nematode, Bursaphelenchus xylophilus, is the causal agent of pine wilt disease. This nematode has two developmental forms in its life cycle; i.e., the propagative and dispersal forms. The former is the form that builds up its population inside the host pine. The latter is specialized for transport by the vector. This form is separated into two dispersal stages (third and fourth); the third-stage dispersal juvenile (J(III)) is specialized for survival under unfavorable conditions, whereas the fourth-stage juvenile (J(IV)), which is induced by a chemical signal from the carrier Monochamus beetle, is transported to new host pines and invades them. Because of its importance in the disease cycle, molecular and chemical aspects of the J(IV) have been investigated, while the mechanism of J(III) induction has not been sufficiently investigated. In an effort to clarify the J(III) induction process, we established inbred lines of B. xylophilus and compared their biological features. We found that the total number of nematodes (propagation proportion) was negatively correlated with the J(III) emergence proportion, likely because nematode development was arrested at J(III); i.e., they could not develop to adults via the reproductive stage. In addition, J(III) induction seemed to be regulated by a small number of genes because the J(III) induction proportion varied among inbred lines despite the high homozygosity of the parental line. We also demonstrated that J(III) can be artificially induced by the nematode's secreted substances. This is the first report of artificial induction of J(III) in B. xylophilus. The dauer (dispersal) juvenile of the model organism Caenorhabditis elegans corresponds functionally to J(III) of B. xylophilus, and this stage is known to be induced by a chemical signal referred to as daumone, derived from the nematodes' secretion. The artificial induction of JIII suggests the presence of daumone-like material in B. xylophilus.	[Tanaka, Suguru E.; Fukuda, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Forest Bot, Bunkyo Ku, Tokyo, Japan; [Aikawa, Takuya] FFPRI, Tohoku Res Ctr, Morioka, Iwate, Japan; [Takeuchi-Kaneko, Yuko] Kyoto Univ, Grad Sch Agr, Lab Terr Microbial Ecol, Sakyo Ku, Kyoto, Japan; [Kanzaki, Natsumi] FFPRI, Kansai Res Ctr, Fushimi Ku, Kyoto, Japan	University of Tokyo; Forestry & Forest Products Research Institute - Japan; Kyoto University; Forestry & Forest Products Research Institute - Japan	Kanzaki, N (corresponding author), FFPRI, Kansai Res Ctr, Fushimi Ku, Kyoto, Japan.	nkanzaki@affrc.go.jp	Fukuda, Kenji/F-9355-2017	Fukuda, Kenji/0000-0002-9980-3107	Japan Society for the Promotion of Science and Environment Research [15H04514, 17H03831, 15J03034]	Japan Society for the Promotion of Science and Environment Research	This study was supported in part by the Grants-in-Aid for Scientific Research (B), Nos. 15H04514 and 17H03831 and Grant-in-Aid for JSPS Research Fellow, No. 15J03034 from the Japan Society for the Promotion of Science and Environment Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 1998, APPL ENTOMOL ZOOL, V33, P231, DOI 10.1303/aez.33.231; Aikawa T, 1998, P 24 INT NEM S DUND, V44, P451; Arakawa Y, 2002, J NEMATOL, V34, P396; Bose N, 2014, CURR BIOL, V24, P1536, DOI 10.1016/j.cub.2014.05.045; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, ORG LETT, V11, P3100, DOI 10.1021/ol901011c; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Felix MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094723; Forge TA, 1996, FUND APPL NEMATOL, V19, P349; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Giblin-Davis Robin M., 1993, P302; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOTTLIEB S, 1994, GENETICS, V137, P107; Hooper D. J., 1986, LAB METHODS WORK PLA, P59; Ishibashi N., 1974, Japanese Journal of Nematology, V4, P1; ISHIBASHI N, 1977, APPL ENTOMOL ZOOL, V12, P293, DOI 10.1303/aez.12.293; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Jia KL, 2002, DEVELOPMENT, V129, P221; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kanzaki N, 2016, NEMATOLOGY, V18, P209, DOI 10.1163/15685411-00002954; Kanzaki N, 2015, NEMATOLOGY, V17, P831, DOI 10.1163/15685411-00002908; Kanzaki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099241; Kanzaki N, 2013, J PARASITOL, V99, P803, DOI 10.1645/GE-3253.1; Kikuchi T, 2007, MOL BIOCHEM PARASIT, V155, P9, DOI 10.1016/j.molbiopara.2007.05.002; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; KIYOHARA T, 1990, FOREST SCI, V36, P1061; Kiyohara T., 1976, Japanese Journal of Nematology, V6, P56; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Kiyohara T., 1975, T JPN FOR SOC, V86, P296; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; KONDO E, 1978, APPL ENTOMOL ZOOL, V13, P1; Kosaka H, 2001, EUR J PLANT PATHOL, V107, P667, DOI 10.1023/A:1011954828685; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Maehara N, 2001, NEMATOLOGY, V3, P455, DOI 10.1163/156854101753250782; Maehara N, 1997, FUND APPL NEMATOL, V20, P611; Maehara N, 2016, NEMATOLOGY, V18, P679, DOI 10.1163/15685411-00002983; Mamiya Y, 2004, NEMATOL MONOGR PERSP, V1, P9; Mamiya Y., 1975, Japanese Journal of Nematology., V5, P16; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; MAMIYA Y, 1972, Review of Plant Protection Research, V5, P46; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; MAMIYA Y, 1979, NEMATOLOGICA, V25, P353, DOI 10.1163/187529279X00091; Mayer MG, 2011, P ROY SOC B-BIOL SCI, V278, P2784, DOI 10.1098/rspb.2010.2760; Morimoto K., 1972, Journal of the Japanese Forestry Society, V54, P177; Mota M.M., 2008, PINE WILT DIS, P33, DOI [10.1371/journal.pone.0067377, DOI 10.1371/JOURNAL.PONE.0067377]; NICKLE WR, 1981, J NEMATOL, V13, P385; Noguez JH, 2012, ACS CHEM BIOL, V7, P961, DOI 10.1021/cb300056q; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; Ogura Nobuo, 2002, Japanese Journal of Nematology, V32, P53, DOI 10.3725/jjn1993.32.2_53; Palomares-Rius JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2085-0; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Ryss A, 2005, NEMATOLOGY, V7, P393, DOI 10.1163/156854105774355581; Sone K, 2011, J FOREST RES-JPN, V16, P82, DOI 10.1007/s10310-010-0212-y; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Stamps WT, 2001, NEMATOLOGY, V3, P295, DOI 10.1163/156854101317020213; Stasiuk SJ, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-1; Steiner G, 1934, J AGRIC RES, V48, P0949; Takemoto S, 2007, APPL ENTOMOL ZOOL, V42, P247, DOI 10.1303/aez.2007.247; THOMAS JH, 1993, GENETICS, V134, P1105; Tokushige Y., 1969, Journal of the Japanese Forestry Society, V51, P193; Tomalak M, 2011, NEMATOLOGY, V13, P619, DOI 10.1163/138855410X532168; Viney ME, 2003, DEV GROWTH DIFFER, V45, P389, DOI 10.1046/j.1440-169X.2003.00703.x; VOWELS JJ, 1992, GENETICS, V130, P105; Wang DD, 2013, FOREST PATHOL, V43, P144, DOI 10.1111/efp.12011; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020; Zhao B.G., 2008, PINE WILT DISEASE, P18; Zhao LL, 2014, TRENDS PARASITOL, V30, P299, DOI 10.1016/j.pt.2014.04.007; Zhao LJ, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-56	75	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187127	10.1371/journal.pone.0187127	http://dx.doi.org/10.1371/journal.pone.0187127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073232	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400117
J	Prasad, GVR; Pandey, DK; Alberti, M; Fursich, FT; Thakkar, MG; Chauhan, GD				Prasad, Guntupalli V. R.; Pandey, Dhirendra K.; Alberti, Matthias; Fuersich, Franz T.; Thakkar, Mahesh G.; Chauhan, Gaurav D.			Discovery of the first ichthyosaur from the Jurassic of India: Implications for Gondwanan palaeobiogeography	PLOS ONE			English	Article							KACHCHH WESTERN INDIA; REPTILIA ICHTHYOSAURIA; NEUQUEN BASIN; AALENIAN-BAJOCIAN; ATLANTIC SEAWAY; ARGENTINA; GENUS; RECORD; KUTCH; PLATYPTERYGIUS	An articulated and partially preserved skeleton of an ichthyosaur was found in the Upper Jurassic (Upper Kimmeridgian) Katrol Formation exposed at a site south of the village Lodai in Kachchh district, Gujarat (western India). Here we present a detailed description and inferred taxonomic relationship of the specimen. The present study revealed that the articulated skeleton belongs to the family Ophthalmosauridae. The new discovery from India further improves the depauperate fossil record of ichthyosaurs from the former Gondwanan continents. Based on the preserved length of the axial skeleton and anterior part of the snout and taking into account the missing parts of the skull and postflexural region, it is suggested that the specimen may represent an adult possibly reaching a length of 5.0-5.5 m. The widespread occurrence of ophthalmosaurids in the Upper Jurassic deposits of western Tethys, Madagascar, South America and India points to possible faunal exchanges between the western Tethys and Gondwanan continents through a southern seaway.	[Prasad, Guntupalli V. R.] Univ Delhi, Ctr Adv Studies, Dept Geol, Delhi, India; [Pandey, Dhirendra K.] Manipal Univ, Manipal Ctr Nat Sci, Earth & Planetary Sci Grp, Manipal, Karnataka, India; [Alberti, Matthias] Christian Albrechts Univ Kiel, Inst Geowissensch, Kiel, Germany; [Fuersich, Franz T.] Friedrich Alexander Univ Erlangen Nurnberg, GeoZentrum Nordbayern, Erlangen, Germany; [Thakkar, Mahesh G.; Chauhan, Gaurav D.] KSKV Kachchh Univ, Dept Earth & Environm Sci, Bhuj, India	University of Delhi; Manipal Academy of Higher Education (MAHE); University of Kiel; University of Erlangen Nuremberg	Prasad, GVR (corresponding author), Univ Delhi, Ctr Adv Studies, Dept Geol, Delhi, India.	guntupalli.vrprasad@gmail.com	Pandey, Dhirendra Kumar/AAH-5372-2021; Alberti, Matthias/G-5600-2011	Alberti, Matthias/0000-0003-1094-8885	Science and Engineering Research (SERB), New Delhi [SR/S2/JCB-14/2010]; Alexander von Humboldt Foundation	Science and Engineering Research (SERB), New Delhi; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	GVRP acknowledges research grant from J.C.Bose National Fellowship (Grant No.SR/S2/JCB-14/2010) of the Science and Engineering Research (SERB), New Delhi for this work. MA greatly acknowledges financial support by the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M, 2001, PALAEOGEOGR PALAEOCL, V165, P375, DOI 10.1016/S0031-0182(00)00172-3; Alberti M, 2012, PALAEOGEOGR PALAEOCL, V344, P49, DOI 10.1016/j.palaeo.2012.05.018; Arkell W.J., 1956, MONOGTAPHS PALAEONTO; Arkhangelsky M. S., 2014, Trudy Zoologicheskogo Instituta, V318, P187; Arratia Gloria, 1996, P243; Ayyasami K, 2016, J GEOL SOC INDIA, V87, P706, DOI 10.1007/s12594-016-0442-5; Ballent SC, 2000, ALCHERINGA, V24, P229, DOI 10.1080/03115510008619209; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; BARDET N, 1990, GEOBIOS-LYON, V23, P169, DOI 10.1016/S0016-6995(06)80049-5; BARDET N, 1991, CR ACAD SCI II, V313, P1343; Bardhan S, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P375, DOI 10.1007/978-1-4020-6806-5_17; Biswas S. K., 1991, STRATIGRAPHY SEDIMEN, V1, P74; Boulenger, 1904, P ZOOL SOC LOND, V1, P424; Buchy MC, 2010, J PALEONTOL, V84, P149; Cariou E., 1988, PALAEONTOGR ABT A, P149; Carlon E., 1973, P287; Carmignani L, 2002, J AFR EARTH SCI, V34, P3; Cecca F, 1999, PALAEOGEOGR PALAEOCL, V147, P1, DOI 10.1016/S0031-0182(98)00149-7; Damborenea S.E., 2000, Georesearch Forum, V6, P369; Delsett LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169971; Druckenmiller PS, 2012, NORW J GEOL, V92, P311; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Efimov, 1999, PALEONTOL J, V33, P174; Enay R., 1972, Geobios, V5, P355, DOI 10.1016/S0016-6995(72)80013-5; Fernandez M, 2000, J VERTEBR PALEONTOL, V20, P191, DOI 10.1671/0272-4634(2000)020[0191:AOIRFV]2.0.CO;2; Fernandez Marta, 1994, Ameghiniana, V31, P291; Fernandez Marta S., 2015, Asociacion Paleontologica Argentina Publicacion Electronica, V15, P20; Fernandez MS, 2014, GEOL MAG, V151, P49, DOI 10.1017/S0016756813000058; Fernandez MS, 2012, GEOBIOS-LYON, V45, P535, DOI 10.1016/j.geobios.2012.02.001; Fernandez Marta S., 2000, Historical Biology, V14, P133; Fernandez MS, 1997, J PALEONTOL, V71, P479, DOI 10.1017/S0022336000039494; Fernandez MS, 1999, J PALEONTOL, V73, P677, DOI 10.1017/S0022336000032492; Fernandez MS, 2003, J VERTEBR PALEONTOL, V23, P691, DOI 10.1671/1864; Fernandez MS, 1997, J VERTEBR PALEONTOL, V17, P752, DOI 10.1080/02724634.1997.10011023; Fernandez MS, 2007, J PALEONTOL, V81, P677; Fischer V, 2011, CRETACEOUS RES, V32, P155, DOI 10.1016/j.cretres.2010.11.005; Fischer V, 2016, PEERJ, V4, DOI 10.7717/peerj.2604; Fischer V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10825; Fischer V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084709; Fischer V, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0021; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; FORSTER R, 1975, PALAEOGEOGR PALAEOCL, V17, P267, DOI 10.1016/0031-0182(75)90002-4; FURSICH F. T., 2013, BERINGERIA, V7, P1; Fursich FT, 2005, PALAEOGEOGR PALAEOCL, V217, P289, DOI 10.1016/j.palaeo.2004.11.026; Fursich FT, 1998, FACIES, V39, P243, DOI 10.1007/BF02537019; Gasparini Z., 1992, World and Regional Geology, V3, P361; Gasparini Zulma, 2007, Asociacion Paleontologica Argentina Publicacion Especial, V11, P125; Gasparini Z, 2009, PALAEONTOLOGY, V52, P661, DOI 10.1111/j.1475-4983.2009.00871.x; Geiger M, 2004, J AFR EARTH SCI, V38, P363, DOI 10.1016/j.jafrearsci.2004.02.003; Halder K, 2000, J AFR EARTH SCI, V31, P175, DOI 10.1016/S0899-5362(00)00082-8; HALLAM A, 1983, PALAEOGEOGR PALAEOCL, V43, P181, DOI 10.1016/0031-0182(83)90010-X; Hikuroa DCH, 2009, ANTARCT SCI, V21, P169, DOI 10.1017/S0954102008001715; Hulke, 1871, Q J GEOL SOC LOND, V27, P440, DOI DOI 10.1144/GSL.JGS.1871.027.01-02.52; Ji C, 2015, J VERTEBRATE PALEONT; Khosla SC, 1997, MICROPALEONTOLOGY, V43, P1, DOI 10.2307/1485920; Kirton AM, 1983, THESIS; Krishna J., 1987, Journal of the Palaeontological Society of India, V32, P136; Krishna J, 1996, GEORES FORUM, V1&2, P195; Krishna J, 1995, CR ACAD SCI II A, V321, P1187; Krishna J, 2009, GEOBIOS-LYON, V42, P197, DOI 10.1016/j.geobios.2008.03.005; Krishna Jai, 1993, Geobios Memoire Special (Villeurbanne), V15, P227; Leanza HA, 1996, GEORES FORUM, V1&2, P451; Lomax DR, 2016, J SYSTEMATIC PALAEON; Lydekker R., 1888, GEOLOGICAL MAGAZINE, V5, P309, DOI DOI 10.1017/S0016756800181968; Lydekker R., 1877, RECORDS GEOLOGICAL S, V10, P41; Lydekker R., 1879, PALEONT INDICA, V1, P1; Maisch Michael W., 2010, Palaeodiversity, P151; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; MARSH OC, 1879, AM J SCI, V3, P85; Martill David M., 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V2, P77; Martin AK, 2007, TECTONOPHYSICS, V445, P245, DOI 10.1016/j.tecto.2007.08.011; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Maxwell EE, 2006, CAN J EARTH SCI, V43, P1291, DOI 10.1139/E06-029; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; MCGOWAN C, 1978, J PALEONTOL, V52, P1155; MCGOWAN C., 2003, HDB PALEOHERPETOLOGY, V8, P1; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; PANDEY DK, 1994, NEWSL STRATIGR, V30, P75; Pardo-Perez Judith, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P287, DOI 10.1007/s12549-012-0074-8; PHANSALKAR VG, 1994, CURR SCI INDIA, V67, P460; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; RICCARDI AC, 1991, PALAEOGEOGR PALAEOCL, V87, P155, DOI 10.1016/0031-0182(91)90134-D; Roberts AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103152; Russell D.A., 1993, GEOLOGICAL SURVEY CA, P195; SALAZAR SOTO C.A, 2012, THESIS RUPECHT KARLS; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Schubert BW, 2005, ACTA PALAEONTOL POL, V50, P93; Seeley H. G., 1874, Q J GEOL SOC LOND, V30, P699; Shome S, 2005, J PALEONTOL, V79, P619, DOI 10.1666/0022-3360(2005)079<0619:ROTAAF>2.0.CO;2; Shome S, 2004, CURR SCI INDIA, V86, P197; Shome Sabyasachi, 2009, Journal of the Palaeontological Society of India, V54, P1; Shultz MR, 2003, PALAIOS, V18, P69, DOI 10.1669/0883-1351(2003)018<0069:OOTSSA>2.0.CO;2; Singh C.S.P., 1982, Newsletters on Stratigraphy, V11, P37; Sollas W.J., 1916, PHILOS T ROYAL SOC B, V208, P62; Thorne PM, 2011, P NATL ACAD SCI USA, V108, P8339, DOI 10.1073/pnas.1018959108; Tyborowski D, 2016, ACTA PALAEONTOL POL, V61, P791, DOI 10.4202/app.00252.2016; Underwood CJ, 2011, J VERTEBR PALEONTOL, V31, P539, DOI 10.1080/02724634.2011.574518; Veevers JJ, 2004, EARTH-SCI REV, V68, P1, DOI 10.1016/j.earscirev.2004.05.002; Verma KK, 1979, 4 INT GONDW S IND 19, P217; WAAGEN W.H., 1873, PALAEONTOL INDICA, V9, P1; Wagner A., 1853, ABHANDLUNGEN KONI MP, V7, P239; WHITHAM A.G., 1989, J S AM EARTH SCI, V2, P371, DOI DOI 10.1016/0895-9811(89)90015-1; Wynne AB., 1872, MEMOIRS GEOL SURVEY, V9; Young MT, 2012, ANAT REC, V295, P1147, DOI 10.1002/ar.22491; Zammit M, 2012, GEOSCIENCES, V2, P11, DOI 10.3390/geosciences2020011; Zammit M, 2011, ALCHERINGA, V35, P341, DOI 10.1080/03115518.2010.497056; Zverkov N.G., 2015, [Труды Зоологического института РАН, Trudy Zoologicheskogo instituta RAN], V319, P558	109	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185851	10.1371/journal.pone.0185851	http://dx.doi.org/10.1371/journal.pone.0185851			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069082	Green Published, Green Submitted, gold			2022-12-26	WOS:000413663600009
J	Cheng, AC; Yang, KY; Chen, NJ; Hsu, TL; Jou, R; Hsieh, SL; Tseng, PH				Cheng, An-Chieh; Yang, Kuang-Yao; Chen, Nien-Jung; Hsu, Tsui-Ling; Jou, Ruwen; Hsieh, Shie-Liang; Tseng, Ping-Hui			CLEC9A modulates macrophage-mediated neutrophil recruitment in response to heat-killed Mycobacterium tuberculosis H37Ra	PLOS ONE			English	Article							DC-SIGN; DENDRITIC CELLS; IMMUNE-RESPONSE; LEUKEMIA-CELLS; F-ACTIN; RECEPTOR; RECOGNITION; ACTIVATION; INDUCTION; INNATE	Tuberculosis is a fatal human infectious disease caused by Mycobacterium tuberculosis (M. tuberculosis) that is prevalent worldwide. Mycobacteria differ from other bacteria in that they have a cell wall composed of specific surface glycans that are the major determinant of these organisms' pathogenicity. The interaction of M. tuberculosis with pattern recognition receptors (PRRs), in particular C-type lectin receptors (CLRs), on the surface of macrophages plays a central role in initiating innate and adaptive immunity, but the picture as a whole remains a puzzle. Defining novel mechanisms by which host receptors interact with pathogens in order to modulate a specific immune response is an area of intense research. In this study, based on an in vitro lectin binding assay, CLEC9A (DNGR-1) is identified as a novel CLR that binds with mycobacteria. Our results with CLEC9A-knocked down cells and a CLEC9A-Fc fusion protein as blocking agents show that CLEC9A is involved in the activation of SYK and MAPK signaling in response to heat-killed M. tuberculosis H37Ra treatment, and it then promotes the production of CXCL8 and IL-1 beta in macrophages. The CXCL8 and IL-1 beta secreted by the activated macrophages are critical to neutrophil recruitment and activation. In a in vivo mouse model, when the interaction between CLEC9A and H37Ra is interfered with by treatment with CLEC9A-Fc fusion protein, this reduces lung inflammation and cell infiltration. These findings demonstrate that CLEC9A is a specialized receptor that modulates the innate immune response when there is a mycobacterial infection.	[Cheng, An-Chieh; Tseng, Ping-Hui] Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei, Taiwan; [Yang, Kuang-Yao] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei, Taiwan; [Yang, Kuang-Yao] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Yang, Kuang-Yao; Chen, Nien-Jung; Tseng, Ping-Hui] Natl Yang Ming Univ, Infect & Immun Res Ctr, Taipei, Taiwan; [Chen, Nien-Jung; Jou, Ruwen] Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei, Taiwan; [Hsu, Tsui-Ling; Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Jou, Ruwen] Taiwan Ctr Dis Control, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Tseng, PH (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei, Taiwan.; Tseng, PH (corresponding author), Natl Yang Ming Univ, Infect & Immun Res Ctr, Taipei, Taiwan.	phtseng@ym.edu.tw	Hsieh, Shie-Liang Edmond/ABA-9184-2021; Hsu, Tsui-Ling/H-6704-2015; Hsu, Tsui-Ling/AAE-8821-2019	Hsu, Tsui-Ling/0000-0002-2912-3261	Taiwan Ministry of Science and Technology [MOST105-2321-B-010-005]; "Aim for the Top University Plan" project of the Taiwan Ministry of Education	Taiwan Ministry of Science and Technology; "Aim for the Top University Plan" project of the Taiwan Ministry of Education	This work was supported by grants to P.-H.T. from the Taiwan Ministry of Science and Technology (MOST105-2321-B-010-005), and a grant from the "Aim for the Top University Plan" project of the Taiwan Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; [Anonymous], [No title captured]; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; Chen C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002400; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Ishikawa E, 2017, TRENDS IMMUNOL, V38, P66, DOI 10.1016/j.it.2016.10.009; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kato M, 2007, J IMMUNOL, V179, P6052, DOI 10.4049/jimmunol.179.9.6052; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Mortaz E, 2015, J CLIN IMMUNOL, V35, P1, DOI 10.1007/s10875-014-0103-7; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Torrado E, 2013, ADV EXP MED BIOL, V783, P121, DOI 10.1007/978-1-4614-6111-1_7; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Wilson GJ, 2015, CELL HOST MICROBE, V17, P252, DOI 10.1016/j.chom.2015.01.004; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yang KY, 2011, CHEST, V140, P1243, DOI 10.1378/chest.11-0539; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	45	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186780	10.1371/journal.pone.0186780	http://dx.doi.org/10.1371/journal.pone.0186780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065139	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900037
J	Fang, X; Liang, PD; Raba, DA; Rosas-Lemus, M; Chakravarthy, S; Tuz, K; Juarez, O				Fang, Xuan; Liang, Pingdong; Raba, Daniel Alexander; Rosas-Lemus, Monica; Chakravarthy, Srinivas; Tuz, Karina; Juarez, Oscar			Kinetic characterization of Vibrio cholerae ApbE: Substrate specificity and regulatory mechanisms	PLOS ONE			English	Article							PUMPING NADHQUINONE OXIDOREDUCTASE; NADH-QUINONE REDUCTASE; DESULFOVIBRIO-VULGARIS FLAVODOXIN; VIRULENCE GENE-EXPRESSION; COVALENTLY BOUND FLAVIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; SHEWANELLA-ONEIDENSIS; THIAMINE SYNTHESIS	ApbE is a member of a novel family of flavin transferases that incorporates flavin mononucleotide (FMN) to subunits of diverse respiratory complexes, which fulfill important homeostatic functions. In this work a detailed characterization of Vibrio cholerae ApbE physiologic activity, substrate specificity and pH dependency was carried out. The data obtained show novel characteristics of the regulation and function of this family. For instance, our experiments indicate that divalent cations are essential for ApbE function, and that the selectivity depends largely on size and the coordination sphere of the cation. Our data also show that ApbE regulation by pH, ADP and potassium is an important mechanism that enhances the adaptation, survival and colonization of V. cholerae in the small intestine. Moreover, studies of the pH-dependency of the activity show that the reaction is favored under alkaline conditions, with a pKa of 8.4. These studies, together with sequence and structure analysis allowed us to identify His257, which is absolutely conserved in the family, as a candidate for the residue whose deprotonation controls the activity. Remarkably, the mutant H257G abolished the flavin transfer activity, strongly indicating that this residue plays an important role in the catalytic mechanism of ApbE.	[Fang, Xuan; Liang, Pingdong; Raba, Daniel Alexander; Rosas-Lemus, Monica; Chakravarthy, Srinivas; Tuz, Karina; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Chakravarthy, Srinivas] Argonne Natl Lab, Biophys Collaborat Access Team, Adv Photon Source, Lemont, IL USA	Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory	Juarez, O (corresponding author), IIT, Dept Biol Sci, Chicago, IL 60616 USA.	ojuarez@iit.edu	Fang, Xuan/CAG-5381-2022; Rosas-Lemus, Monica/U-4691-2019	Fang, Xuan/0000-0001-6394-4015; Liang, Pingdong/0000-0002-8950-5755; Juarez, Oscar/0000-0002-2915-8413; Tuz, Karina/0000-0002-1669-4612	Illinois Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	Illinois Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by startup funds provided by Illinois Institute of Technology to OJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Illinois institute of Technology startup funds to OJ. Authors would like to thank SSGT Devin Nissen, Celio Cabral and Marciele Andrade for their contributions during various phases of this study.	Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Beck BJ, 1999, J BACTERIOL, V181, P7285, DOI 10.1128/JB.181.23.7285-7290.1999; Beck BJ, 1998, J BACTERIOL, V180, P885, DOI 10.1128/JB.180.4.885-891.1998; Bertsova YV, 2013, J BIOL CHEM, V288, P14276, DOI 10.1074/jbc.M113.455402; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Bogachev AV, 2012, MOL MICROBIOL, V86, P1452, DOI 10.1111/mmi.12067; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; Covington ED, 2010, MOL MICROBIOL, V78, P519, DOI 10.1111/j.1365-2958.2010.07353.x; Cowan JA, 2002, BIOMETALS, V15, P225, DOI 10.1023/A:1016022730880; COWAN JA, 1991, INORG CHEM, V30, P2740, DOI 10.1021/ic00013a008; Deka RK, 2016, MICROBIOLOGYOPEN, V5, P21, DOI 10.1002/mbo3.306; Deka RK, 2015, MBIO, V6, DOI 10.1128/mBio.00519-15; Deka RK, 2013, J BIOL CHEM, V288, P11106, DOI 10.1074/jbc.M113.449975; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Gennari FJ, 2008, CLIN J AM SOC NEPHRO, V3, P1861, DOI 10.2215/CJN.02450508; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gupta VK, 2001, INT J PHARM, V213, P83, DOI 10.1016/S0378-5173(00)00649-9; Han GW, 2006, PROTEINS, V64, P1083, DOI 10.1002/prot.20950; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 2010, FEMS MICROBIOL LETT, V304, P12, DOI 10.1111/j.1574-6968.2009.01879.x; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; KOBAYASHI H, 1972, J BIOCHEM, V71, P387; Koetter JWA, 2005, J MOL BIOL, V352, P418, DOI 10.1016/j.jmb.2005.07.041; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Lacomba-Perales R, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/37002; Lostao A, 2000, J BIOL CHEM, V275, P9518, DOI 10.1074/jbc.275.13.9518; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; MATHEWS FS, 1991, BIOCHEMISTRY-US, V30, P238, DOI 10.1021/bi00215a034; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Murray TA, 2003, BIOCHEMISTRY-US, V42, P2307, DOI 10.1021/bi026967s; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Oliver D.B, 1987, CELLULAR MOL BIOL, P56; Osei FB, 2012, CHOLERA; Patel K, 2007, BBA-PROTEINS PROTEOM, V1774, P1247, DOI 10.1016/j.bbapap.2007.07.010; PEELEN S, 1994, ARCH BIOCHEM BIOPHYS, V314, P291, DOI 10.1006/abbi.1994.1445; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rashid MH, 2004, FEMS MICROBIOL LETT, V230, P105, DOI 10.1016/S0378-1097(03)00879-6; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Segel IH., 1975, ENZYME KINETICS, P1, DOI 10.1016/0014-5793(75)80457-1; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2818; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Wagner MA, 1999, BIOCHEMISTRY-US, V38, P5588, DOI 10.1021/bi982955o; WALKER WH, 1972, EUR J BIOCHEM, V26, P279, DOI 10.1111/j.1432-1033.1972.tb01766.x; WATENPAUGH KD, 1973, P NATL ACAD SCI USA, V70, P3857, DOI 10.1073/pnas.70.12.3857; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Zhang L, 2017, BBA-BIOENERGETICS, V1858, P95, DOI 10.1016/j.bbabio.2016.11.008; ZITZER AO, 1993, ZBL BAKT-INT J MED M, V279, P494, DOI 10.1016/S0934-8840(11)80421-4	72	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186805	10.1371/journal.pone.0186805	http://dx.doi.org/10.1371/journal.pone.0186805			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065131	gold, Green Published, Green Submitted			2022-12-26	WOS:000413568900043
J	Littman, R; Takacs, A				Littman, Ran; Takacs, Adam			Do all inhibitions act alike? A study of go/nogo and stop-signal paradigms	PLOS ONE			English	Article							TRAINING RESPONSE-INHIBITION; GO TASK; ELECTROPHYSIOLOGICAL EVIDENCE; SELECTIVE ATTENTION; EMOTIONAL PICTURES; MOTOR INHIBITION; NEGATIVE STIMULI; NEURAL BASIS; IMPULSIVITY; DISORDER	Response inhibition is frequently measured by the Go/no-go and Stop-signal tasks. These two are often used indiscriminately under the assumption that both measure similar inhibitory control abilities. However, accumulating evidence show differences in both tasks' modulations, raising the question of whether they tap into equivalent cognitive mechanisms. In the current study, a comparison of the performance in both tasks took place under the influence of negative stimuli, following the assumption that ''controlled inhibition'', as measured by Stop-signal, but not ''automatic inhibition'', as measured by Go/no-go, will be affected. 54 young adults performed a task in which negative pictures, neutral pictures or no-pictures preceded go trials, no-go trials, and stop-trials. While the exposure to negative pictures impaired performance on go trials and improved the inhibitory capacity in Stop-signal task, the inhibitory performance in Go/no-go task was generally unaffected. The results support the conceptualization of different mechanisms operated by both tasks, thus emphasizing the necessity to thoroughly fathom both inhibitory processes and identify their corresponding cognitive measures. Implications regarding the usage of cognitive tasks for strengthening inhibitory capacity among individuals struggling with inhibitory impairments are discussed.	[Littman, Ran] Eotvos Lorand Univ, Inst Psychol, Dept Clin Psychol & Addictol, Izabella Utca 46, Budapest, Hungary; [Takacs, Adam] Eotvos Lorand Univ, Dept Cognit Psychol, Inst Psychol, Izabella Utca 46, Budapest, Hungary; [Littman, Ran] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Takacs, Adam] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Eotvos Lorand University; Eotvos Lorand University; Hebrew University of Jerusalem; University of Glasgow	Littman, R (corresponding author), Eotvos Lorand Univ, Inst Psychol, Dept Clin Psychol & Addictol, Izabella Utca 46, Budapest, Hungary.; Littman, R (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel.	ran.littman@mail.huji.ac.il		Littman, Ran/0000-0001-5624-6198				Adams RC, 2017, APPETITE, V109, P11, DOI 10.1016/j.appet.2016.11.014; Aichert DS, 2012, J CLIN EXP NEUROPSYC, V34, P1016, DOI 10.1080/13803395.2012.706261; Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Allom V, 2016, HEALTH PSYCHOL REV, V10, P168, DOI 10.1080/17437199.2015.1051078; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Badcock JC, 2002, PSYCHOL MED, V32, P287, DOI 10.1017/S0033291701005128; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; Chajut E, 2010, EMOTION, V10, P944, DOI 10.1037/a0020172; Chajut E, 2010, J EXP PSYCHOL LEARN, V36, P1567, DOI 10.1037/a0020710; Chamberlain SR, 2007, NEUROPSYCHOLOGIA, V45, P654, DOI 10.1016/j.neuropsychologia.2006.07.016; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Codispoti M, 2003, PSYCHOPHYSIOLOGY, V40, P863, DOI 10.1111/1469-8986.00104; Cohen N, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00033; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Congdon E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00037; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dan-Glauser ES, 2011, BEHAV RES METHODS, V43, P468, DOI 10.3758/s13428-011-0064-1; De Houwer J, 2010, PSYCHON B REV, V17, P699, DOI 10.3758/PBR.17.5.699; Dennis Tracy A, 2008, Depress Anxiety, V25, pE1, DOI 10.1002/da.20308; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Eagle DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1311, DOI 10.1038/npp.2008.202; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Enticott PG, 2008, PSYCHIAT RES, V157, P251, DOI 10.1016/j.psychres.2007.04.007; Estes Z, 2008, AUTOMATIC VIGILANCE; Estes Z, 2008, COGNITION, V108, P557, DOI 10.1016/j.cognition.2008.03.003; Ferrey AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00575; Fleck DE, 2011, J AFFECT DISORDERS, V133, P333, DOI 10.1016/j.jad.2011.03.053; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; Goldstein M, 2007, NEUROIMAGE, V36, P1026, DOI 10.1016/j.neuroimage.2007.01.056; Gole M, 2012, J BEHAV THER EXP PSY, V43, P532, DOI 10.1016/j.jbtep.2011.07.002; Hahn S, 2007, PSYCHON B REV, V14, P159, DOI 10.3758/BF03194044; Hamilton KR, 2015, PERSONAL DISORD, V6, P168, DOI 10.1037/per0000100; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Houben K, 2015, APPETITE, V87, P318, DOI 10.1016/j.appet.2015.01.005; Houben K, 2011, DRUG ALCOHOL DEPEN, V116, P132, DOI 10.1016/j.drugalcdep.2010.12.011; Houben K, 2011, APPETITE, V56, P345, DOI 10.1016/j.appet.2010.12.017; Kalanthroff E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00078; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Lang P.J., 2008, INT AFFECTIVE PICTUR; Lawrence NS, 2015, APPETITE, V95, P17, DOI 10.1016/j.appet.2015.06.009; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Lopez-Caneda E, 2014, ALCOHOL ALCOHOLISM, V49, P173, DOI 10.1093/alcalc/agt168; McGaugh JL, 2006, TRENDS COGN SCI, V10, P345, DOI 10.1016/j.tics.2006.06.001; Meng XX, 2009, NEUROSCI LETT, V464, P228, DOI 10.1016/j.neulet.2009.08.064; Mohanty A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00102; Mohanty A, 2009, J NEUROSCI, V29, P10563, DOI 10.1523/JNEUROSCI.1170-09.2009; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P1129, DOI 10.1017/S0954579405050534; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Okon-Singer H, 2013, BIOL PSYCHOL, V92, P480, DOI 10.1016/j.biopsycho.2012.05.010; Pace-Schott EF, 2011, NEUROBIOL LEARN MEM, V95, P24, DOI 10.1016/j.nlm.2010.10.006; Padmala S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00192; Passarotti AM, 2010, PSYCHIAT RES-NEUROIM, V181, P36, DOI 10.1016/j.pscychresns.2009.07.002; Pawliczek CM, 2013, NEUROIMAGE, V79, P264, DOI 10.1016/j.neuroimage.2013.04.104; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pessoa L, 2012, EMOTION, V12, P192, DOI 10.1037/a0024109; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rubia K, 2007, CHILD NEUROPSYCHOL, V13, P276, DOI 10.1080/09297040600770761; Ruchsow M, 2008, J NEURAL TRANSM, V115, P127, DOI 10.1007/s00702-007-0819-0; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Schimmack U, 2005, EMOTION, V5, P55, DOI 10.1037/1528-3542.5.1.55; Schulz KP, 2007, ARCH CLIN NEUROPSYCH, V22, P151, DOI 10.1016/j.acn.2006.12.001; Senderecka M, 2016, BIOL PSYCHOL, V113, P24, DOI 10.1016/j.biopsycho.2015.11.003; Shafritz KM, 2006, NEUROIMAGE, V31, P468, DOI 10.1016/j.neuroimage.2005.11.053; Silbersweig D, 2007, AM J PSYCHIAT, V164, P1832, DOI 10.1176/appi.ajp.2007.06010126; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Singh MK, 2010, J CHILD ADOL PSYCHOP, V20, P15, DOI 10.1089/cap.2009.0004; Spierer L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00427; Stice E, 2016, CLIN PSYCHOL REV, V49, P16, DOI 10.1016/j.cpr.2016.06.005; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Turton R, 2016, NEUROSCI BIOBEHAV R, V61, P132, DOI 10.1016/j.neubiorev.2015.12.008; van Koningsbruggen GM, 2014, BRIT J HEALTH PSYCH, V19, P767, DOI 10.1111/bjhp.12075; Veling H, 2013, BRIT J HEALTH PSYCH, V18, P354, DOI 10.1111/j.2044-8287.2012.02092.x; Veling H, 2011, BEHAV RES THER, V49, P771, DOI 10.1016/j.brat.2011.08.005; Verbruggen F, 2007, COGNITION EMOTION; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; Verbruggen F, 2008, BEHAV RES METHODS, V40, P479, DOI 10.3758/BRM.40.2.479; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wang Y, 2011, NEUROSCI LETT, V502, P112, DOI 10.1016/j.neulet.2011.07.039; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Wright L, 2014, J ABNORM PSYCHOL, V123, P429, DOI 10.1037/a0036295; Yin JS, 2016, BRAIN IMAGING BEHAV, V10, P497, DOI 10.1007/s11682-015-9418-0; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan JJ, 2012, BIOL PSYCHOL, V89, P240, DOI 10.1016/j.biopsycho.2011.10.015	105	52	54	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186774	10.1371/journal.pone.0186774	http://dx.doi.org/10.1371/journal.pone.0186774			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK5VD	29065184	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000413568900035
J	Oud, L				Oud, Lavi			Critical illness among adults with cystic fibrosis in Texas, 2004-2013: Patterns of ICU utilization, characteristics, and outcomes	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; LONG-TERM OUTCOMES; ASSISTED VENTILATION; PALLIATIVE CARE; MORTALITY; SURVIVORS; IMPACT; STATES; EPIDEMIOLOGY; PREVALENCE	Objective Available reports on critically ill adults with cystic fibrosis (CF) suggest improving short-term outcomes. However, there is marked heterogeneity in reported findings, with studies mostly based on single-centered data, limiting generalizability. We sought to examine population-level patterns of demand for critical care resources, and the characteristics, resource utilization, and outcomes of ICU-managed adults with CF. Methods We used the Texas Inpatient Public Use Data File to identify ICU admissions with CF aged >= 18 years in Texas between 2004-2013. We examined ICU utilization at population level (using CF Foundation annual reports) and, among ICU admissions, socio-demographic characteristics, burden of comorbidities, organ failure, life-support utilization and hospital disposition. Linear regression and multilevel logistic regression were used to examine temporal trends and predictors of short-term mortality (hospital death and discharge to hospice), respectively. Results Of 9,579 hospitalizations of adults with CF, 1,249 (13%) were admitted to ICU. The incidence of ICU admission among adults with CF in Texas increased between 2004-2005 and 2012-2013 from 16.7 to 19.2 per 100 person-years (p = 0.0181), with ICU admissions aged >= 30 years accounting for 80.3% of the change. Among ICU admissions the following changes were noted between 2004-2005 and 2012-2013: any organ failure 30.2% vs. 56.3% (p = 0.0004), mechanical ventilation 11.5% vs. 19.2% (p = 0.0216), and hemodialysis 1.0% vs. 8.1% (p = 0.0007). Short-term mortality for the whole cohort and for those with mechanical ventilation was 11.4% and 41.8%, respectively, with corresponding home discharge among survivors 84% and 62.1%, respectively. Key predictors (adjusted odds ratios [aOR (95% CI)]) of short-term mortality included age >= 45 years (2.051 [1.231-3.415]), female gender (1.907 [1.237-2.941]), and mechanical ventilation (7.982 [5.001-12.739]). Conclusions Adults with CF had high and rising population-level burden of critical illness. Although ICU admissions were increasingly older and sicker, the majority survived hospitalization, with most discharged home, supporting short-term benefits of critical care in the present cohort.	[Oud, Lavi] Texas Tech Univ, Div Pulm & Crit Care Med, Hlth Sci Ctr Permian Basin, Dept Internal Med, Odessa, TX 79763 USA	Texas Tech University System; Texas Tech University	Oud, L (corresponding author), Texas Tech Univ, Div Pulm & Crit Care Med, Hlth Sci Ctr Permian Basin, Dept Internal Med, Odessa, TX 79763 USA.	lavi.oud@ttuhsc.edu		Oud, Lavi/0000-0002-9003-6845				Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; [Anonymous], CF PAT REG REP; [Anonymous], 2015, PAT REG ANN DAT REP; Barrett M., 2011, HCUP STAT BRIEF, V185, P2014; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; DAVIS PB, 1978, JAMA-J AM MED ASSOC, V239, P1851, DOI 10.1001/jama.239.18.1851; Ellaffi M, 2005, AM J RESP CRIT CARE, V171, P158, DOI 10.1164/rccm.200405-667OC; Estrada-Veras J, 2013, J PALLIAT MED, V16, P446, DOI 10.1089/jpm.2013.9515; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; Hayes D, 2011, LUNG, V189, P409, DOI 10.1007/s00408-011-9311-6; HCUPnet, HEALTHC COST UT PROJ; Heltshe SL, 2017, AM J RESP CRIT CARE, V195, P979, DOI 10.1164/rccm.201606-1250PP; Hill AD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1248-y; Iwashyna TJ, 2010, ANN INTERN MED, V153, P204, DOI 10.7326/0003-4819-153-3-201008030-00013; Kahn JM, 2008, CRIT CARE MED, V36, P3085, DOI 10.1097/CCM.0b013e31818c37b2; Ketchell I, 2010, J ROY SOC MED, V103, pS20, DOI 10.1258/jrsm.2010.s11005; Kopp BT, 2012, PEDIATR PULM, V47, P245, DOI 10.1002/ppul.21535; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; MacKenzie T, 2014, ANN INTERN MED, V161, P233, DOI 10.7326/M13-0636; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mogayzel PJ, 2014, BMJ QUAL SAF, V23, P3, DOI 10.1136/bmjqs-2013-002363; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nick JA, 2010, AM J RESP CRIT CARE, V182, P614, DOI 10.1164/rccm.201001-0092OC; Okumura MJ, 2006, ARCH PEDIAT ADOL MED, V160, P1054, DOI 10.1001/archpedi.160.10.1054; Oud L, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/618067; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Ranzani OT, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0986-6; Rosenthal M, 2010, J ROY SOC MED, V103, pS25, DOI 10.1258/jrsm.2010.s11006; Sakr Y, 2015, CRIT CARE MED, V43, P519, DOI 10.1097/CCM.0000000000000754; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Slieker MG, 2006, INTENS CARE MED, V32, P754, DOI 10.1007/s00134-006-0085-x; Sood N, 2001, AM J RESP CRIT CARE, V163, P335, DOI 10.1164/ajrccm.163.2.2003076; Stephenson A, 2011, J CYST FIBROS, V10, P93, DOI 10.1016/j.jcf.2010.10.005; Texas Department of State Health Services, TEX INP PUBL US DAT; Texereau J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-14; Thomas SR, 2003, THORAX, V58, P357, DOI 10.1136/thorax.58.4.357; Thomas SR, 2000, PEDIATR PULM, V20, P292; Vedam Hima, 2004, J Cyst Fibros, V3, P8, DOI 10.1016/j.jcf.2003.12.003; Wallick K, 2001, AM J RESP CRIT CARE, V163, P310, DOI 10.1164/ajrccm.163.2.ed2000d; Wang CY, 2014, INTENS CARE MED, V40, P388, DOI 10.1007/s00134-013-3186-3; Watts KD, 2009, PEDIATR PULM, V44, P594, DOI 10.1002/ppul.21037; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186770	10.1371/journal.pone.0186770	http://dx.doi.org/10.1371/journal.pone.0186770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065161	gold, Green Submitted, Green Published			2022-12-26	WOS:000413568900034
J	Reimer, LC; Will, SE; Schomburg, D				Reimer, Lorenz C.; Will, Sabine E.; Schomburg, Dietmar			The fate of lysine: Non-targeted stable isotope analysis reveals parallel ways for lysine catabolization in Phaeobacter inhibens	PLOS ONE			English	Article							MASS-SPECTROMETRY DATA; DSM 17395; ROSEOBACTER CLADE; GEN. NOV.; GROWTH; IDENTIFICATION; PATHWAYS; MEMBER; TOOL; COA	For a detailed investigation of the degradation of lysine in Phaeobacter inhibens DSM 17395, stable isotope experiments with uniformly C-13 labeled L-lysine were carried out with lysine adapted cells and the metabolites were analyzed using GC/MS and HPLC/MS. A non-targeted stable isotope analysis was used which compares labeled and not labeled samples to determine the Mass Isotopomer Distribution not only for known metabolites but for all labeled compounds in our GC/MS analysis. We show that P. inhibens uses at least two parallel pathways for the first degradation steps of lysine. Further investigations identified L-pipecolate as an L-lysine degradation intermediate in P. inhibens. The analysis of HPLC/MS data as well as the labeling data of tricarboxylic acid (TCA) cycle intermediates show that L-lysine is not only catabolized directly to acetyl-CoA but also via the ethylmalonyl-CoA-pathway, leading to entry points into the TCA cycle via acetyl-CoA, succinyl-CoA, and malate. Altogether the presented data give a detailed insight into the catabolization of L-lysine following the fate of C-13 labeled carbon via several ways into the TCA cycle.	[Reimer, Lorenz C.; Will, Sabine E.; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany; [Reimer, Lorenz C.] Leibniz Inst DSMZ Deutsche Sammlung Mikroorganism, Braunschweig, Germany	Braunschweig University of Technology; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Reimer, LC (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig, Germany.; Reimer, LC (corresponding author), Leibniz Inst DSMZ Deutsche Sammlung Mikroorganism, Braunschweig, Germany.	lorenz.reimer@dsmz.de			Deutsche Forschungsgemeinschaft [SFB TRR 51]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft, SFB TRR 51 (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sabine Kaltenhauser for technical assistance and Meina Neumann-Schaal for assistance in the <SUP>13</SUP>C analysis. This study was supported by the Deutsche Forschungsgemeinschaft (SFB TRR 51).	Abu Dawud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039896; Benton HP, 2008, ANAL CHEM, V80, P6382, DOI 10.1021/ac800795f; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; CALVIN M, 1948, SCIENCE, V107, P476, DOI 10.1126/science.107.2784.476; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chokkathukalam A, 2013, BIOINFORMATICS, V29, P281, DOI 10.1093/bioinformatics/bts674; Druppel K, 2014, ENVIRON MICROBIOL, V16, P218, DOI 10.1111/1462-2920.12276; ENTNER N, 1952, J BIOL CHEM, V196, P853; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; FOTHERGILL JC, 1977, J GEN MICROBIOL, V99, P139, DOI 10.1099/00221287-99-1-139; Geng HF, 2010, CURR OPIN BIOTECH, V21, P332, DOI 10.1016/j.copbio.2010.03.013; Gram L, 2015, SYST APPL MICROBIOL, V38, P483, DOI 10.1016/j.syapm.2015.07.006; HIGASHINO K, 1965, BIOCHEM BIOPH RES CO, V20, P285, DOI 10.1016/0006-291X(65)90361-X; Hiller K, 2013, BIOINFORMATICS, V11, P11; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Huang XJ, 2014, ANAL CHEM, V86, P1632, DOI 10.1021/ac403384n; Kind S, 2013, METAB ENG, V15, P184, DOI 10.1016/j.ymben.2012.07.005; Martens T, 2006, INT J SYST EVOL MICR, V56, P1293, DOI 10.1099/ijs.0.63724-0; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Reimer LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086799; Revelles O, 2005, J BACTERIOL, V187, P7500, DOI 10.1128/JB.187.21.7500-7510.2005; Revelles O, 2007, J BACTERIOL, V189, P2787, DOI 10.1128/JB.01538-06; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Trautwein K, 2016, ENVIRON MICROBIOL, V18, P4817, DOI 10.1111/1462-2920.13381; Wiegmann K, 2014, APPL ENVIRON MICROB, V80, P4725, DOI 10.1128/AEM.00719-14; WilliamsElegbe S, 2017, PUBLIC PROCUREMENT AND MULTILATERAL DEVELOPMENT BANKS: LAW, PRACTICE AND PROBLEMS, P1; Wolf J, 2016, MOL MICROBIOL; Zech H, 2013, PROTEOMICS, V13, P2869, DOI 10.1002/pmic.201200560; Zech H, 2013, PROTEOMICS, V13, P2851, DOI 10.1002/pmic.201200513; Zech H, 2009, PROTEOMICS, V9, P3677, DOI 10.1002/pmic.200900120	34	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186395	10.1371/journal.pone.0186395	http://dx.doi.org/10.1371/journal.pone.0186395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059219	gold, Green Published, Green Submitted			2022-12-26	WOS:000413403000021
J	Bandaru, S; Alvala, M; Nayarisseri, A; Sharda, S; Goud, H; Mundluru, HP; Singh, SK				Bandaru, Srinivas; Alvala, Mallika; Nayarisseri, Anuraj; Sharda, Saphy; Goud, Himshikha; Mundluru, Hema Prasad; Singh, Sanjeev Kumar			Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of beta 2 adrenergic receptor	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; PARTICLE MESH EWALD; BETA(2)-ADRENERGIC RECEPTOR; ASTHMA EXACERBATIONS; AGONISTS; MANAGEMENT; POLYMORPHISMS; SALMETEROL; PREVENTION; PREDICTION	The natural variant C491T (rs1800088) in ADRB2 gene substitutes Threonine to Isoleucine at 164th position in beta 2AR and results in receptor sequestration and altered binding of agonists. Present investigation pursues to identify the effect of T164I variation on function and structure of beta 2AR through systematic computational approaches. The study, in addition, addresses altered binding of salbutamol in T164I variant through molecular dynamic simulations. Methods involving changes in free energy, solvent accessibility surface area, root mean square deviations and analysis of binding cavity revealed structural perturbations in receptor to incur upon T164I substitution. For comprehensive understanding of receptor upon substitution, OPLS force field aided molecular dynamic simulations were performed for 10 ns. Simulations revealed massive structural departure for T164I beta 2AR variant from the native state along with considerably higher root mean square fluctuations of residues near the cavity. Affinity prediction by molecular docking showed two folds reduced affinity of salbutamol in T164I variant. To validate the credibility docking results, simulations for ligand-receptor complex were performed which demonstrated unstable salbutamol-T164I beta 2AR complex formation. Further, analysis of interactions in course of simulations revealed reduced ligand-receptor interactions of salbutamol in T164I variant. Taken together, studies herein provide structural rationales for suboptimal binding of salbutamol in T164I variant through integrated molecular modeling approaches.	[Bandaru, Srinivas; Mundluru, Hema Prasad] Osmania Univ, Inst Genet & Hosp Genet Dis, Hyderabad, Andhra Prades, India; [Bandaru, Srinivas; Alvala, Mallika] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Mol Modeling Lab, Hyderabad, Andhra Prades, India; [Nayarisseri, Anuraj; Sharda, Saphy; Goud, Himshikha] Eminent Biosci, In Silico Res Lab, Indore, Madhya Pradesh, India; [Nayarisseri, Anuraj] LeGene Biosci Private Ltd, Bioinformat Res Lab, Indore, Madhya Pradesh, India; [Nayarisseri, Anuraj; Singh, Sanjeev Kumar] Alagappa Univ, Dept Bioinformat, Comp Aided Drug Designing & Mol Modeling Lab, Karaikkudi, Tamil Nadu, India	Osmania University; National Institute of Pharmaceutical Education & Research, Hyderabad; National Institute of Pharmaceutical Education & Research (NIPER); Alagappa University	Singh, SK (corresponding author), Alagappa Univ, Dept Bioinformat, Comp Aided Drug Designing & Mol Modeling Lab, Karaikkudi, Tamil Nadu, India.	skysanjeev@gmail.com	Singh, Sanjeev Kumar/GZG-9941-2022; Singh, Kumar/AAP-1954-2020; , Saphy/H-5635-2017; Nayarisseri, Anuraj/A-4190-2016; bandaru, srinivas/GMW-4690-2022; Bandaru, Srinivas/AAS-5865-2021; Alvala, Mallika/F-2123-2018	Singh, Kumar/0000-0003-4153-6437; , Saphy/0000-0002-5115-2245; Nayarisseri, Anuraj/0000-0003-2567-9630; bandaru, srinivas/0000-0002-1289-0042; Alvala, Mallika/0000-0003-3770-4725; HYDERABAD, NIPER/0000-0001-7521-1150				Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Bandaru S, 2016, CURR PHARM DESIGN, V22, P5221, DOI 10.2174/1381612822666160513145721; Bandaru S, 2016, GENE, V592, P15, DOI 10.1016/j.gene.2016.07.043; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; BEASLEY R, 1991, AUST NZ J MED, V21, P753, DOI 10.1111/j.1445-5994.1991.tb01385.x; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Bermingham M, 2011, EUR J HEART FAIL, V13, P885, DOI 10.1093/eurjhf/hfr063; Camargo CA., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001115, DOI 10.1002/14651858.CD001115]; Camargo Carlos A Jr, 2009, Proc Am Thorac Soc, V6, P357, DOI 10.1513/pats.P09ST2; Chai, 2008, J APPL CLIN PEDIAT, V23, P272; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Donohue James F, 2004, Chest, V126, p125S, DOI 10.1378/chest.126.2_suppl_1.125S; DONOHUE JF, 2004, CHEST, V126, pS159, DOI DOI 10.1378/CHEST.126.2_SUPPL_1.125S; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Feng D., 2003, J MOD CLIN MED BIOEN, V10, P5; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gedeborg R, 2000, CRIT CARE MED, V28, P1423, DOI 10.1097/00003246-200005000-00028; GIEMBYCZ MA, 1991, J AUTON PHARMACOL, V11, P365, DOI 10.1111/j.1474-8673.1991.tb00260.x; Green SA, 2001, EUR J PHARMACOL, V421, P141, DOI 10.1016/S0014-2999(01)01049-4; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Gromiha MM, 2000, NUCLEIC ACIDS RES, V28, P283, DOI 10.1093/nar/28.1.283; HEAD JD, 1985, CHEM PHYS LETT, V122, P264, DOI 10.1016/0009-2614(85)80574-1; Hon K-LE, 2017, RECENT PAT INFLAMM A; Huffel H, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052115; JACK D, 1991, BRIT J CLIN PHARMACO, V31, P501, DOI 10.1111/j.1365-2125.1991.tb05571.x; Johnson M, 2001, Paediatr Respir Rev, V2, P57, DOI 10.1053/prrv.2000.0102; JONES TR, 1990, J PHARMACOL EXP THER, V255, P697; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kim Daehwan, ANTIMICROB AGENTS CH, V14, pR36, DOI [10.1186/gb-2013-14-4-r36, DOI 10.1128/AAC.04231-14]; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Liang SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104488; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Migita O, 2004, INT ARCH ALLERGY IMM, V134, P150, DOI 10.1159/000078648; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Pagaria M, 2007, THORAX, V62, P28; Palamar J, 2011, HEALTH POLICY, V99, P1, DOI 10.1016/j.healthpol.2010.07.007; Papiris S., 2001, J CRITICAL CARE, V6, P1; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Quan LJ, 2016, BIOINFORMATICS, V32, P2936, DOI 10.1093/bioinformatics/btw361; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sears Malcolm R., 2002, Journal of Allergy and Clinical Immunology, V110, pS322, DOI 10.1067/mai.2002.129966; Sears MR, 2005, RESP MED, V99, P152, DOI 10.1016/j.rmed.2004.07.003; Silverman R, 2000, CLIN CHEST MED, V21, P361, DOI 10.1016/S0272-5231(05)70272-0; Sin DD, 2004, JAMA-J AM MED ASSOC, V292, P367, DOI 10.1001/jama.292.3.367; Sirin S, 2014, PROTEINS, V82, P3397, DOI 10.1002/prot.24694; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Sprang SR, 2011, NATURE, V469, P172, DOI 10.1038/469172a; STRADER CD, 1989, J BIOL CHEM, V264, P16470; Thomsen M, 2012, EUR RESPIR J, V39, P558, DOI 10.1183/09031936.00023511; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; VANMETRE TE, 1969, J ALLERGY, V43, P101, DOI 10.1016/0021-8707(69)90130-0; Wachter SB, 2012, CARDIOLOGY, V122, P104, DOI 10.1159/000339271; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Waldeck B, 2002, EUR J PHARMACOL, V445, P1, DOI 10.1016/S0014-2999(02)01728-4; Woods BD, 2009, BR J ANAESTH S1, V103, pi57	66	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186666	10.1371/journal.pone.0186666	http://dx.doi.org/10.1371/journal.pone.0186666			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053759	Green Submitted, Green Published, gold			2022-12-26	WOS:000413315100032
J	Khan, AL; Asaf, S; Al-Rawahi, A; Lee, IJ; Al-Harrasi, A				Khan, Abdul Latif; Asaf, Sajjad; Al-Rawahi, Ahmed; Lee, In-Jung; Al-Harrasi, Ahmed			Rhizospheric microbial communities associated with wild and cultivated frankincense producing Boswellia sacra tree	PLOS ONE			English	Article							PARTICLE-SIZE FRACTIONS; FUNGAL COMMUNITIES; BACTERIAL; SOIL; DIVERSITY; MINERALIZATION; MICROORGANISMS; METAGENOMICS; BIOGEOGRAPHY; ENDOPHYTES	Boswellia sacra, a frankincense producing endemic tree, has been well known for its cultural, religious and economic values. However, the tree has been least explored for the associated microsymbiota in the rhizosphere. The current study elucidates the fungal and bacterial communities of the rhizospheric regions of the wild and cultivated B. sacra tree populations through next generation sequencing. The sequence analysis showed the existence of 1006 +/- 8.9 and 60.6 +/- 3.1 operational taxonomic unit (OTUs) for bacterial and fungal communities respectively. In fungal communities, five major phyla were found with significantly higher abundance of Ascomycota (60.3%) in wild population and Basidiomycota (52%) in cultivated tree rhizospheres. Among bacterial communities, 31 major phyla were found, with significant distribution of Actinobacteria in wild tree rhizospheres, whereas Proteobacteria and Acidobacteria were highly abundant in cultivated trees. The diversity and abundance of microbiome varied significantly depending upon soil characteristics of the three different populations. In addition, significantly higher glucosidases, cellulases and indole-3-acetic acid were found in cultivated tree's rhizospheres as compared to wild tree populations. for these plants to survive the harsh arid-land environmental conditions. The current study is a first comprehensive work and advances our knowledge about the core fungal and bacterial microbial microbiome associated with this economically important tree.	[Khan, Abdul Latif; Al-Rawahi, Ahmed; Al-Harrasi, Ahmed] Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman; [Asaf, Sajjad; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea	University of Nizwa; Kyungpook National University	Al-Harrasi, A (corresponding author), Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman.	aharrasi@unizwa.edu.om	Lee, In-Jung/GLS-0432-2022; Asaf, Sajjad/ABA-3647-2021	Lee, In-Jung/0000-0001-7154-4820; Khan, Abdul Latif/0000-0001-9700-8903	Oman Research Council (TRC) [0RG/EBR/15/007]	Oman Research Council (TRC)	This study was funded by The Oman Research Council (TRC) through 0RG/EBR/15/007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P, 2011, APPL ENV SOIL SCI, P2011; Adriaenssens EM, 2015, ENVIRON MICROBIOL, V17, P480, DOI 10.1111/1462-2920.12528; Akinsanya MA, 2015, GENOM DATA, V6, P159, DOI 10.1016/j.gdata.2015.09.004; Al-Harrasi A, 2008, MOLECULES, V13, P2181, DOI 10.3390/molecules13092181; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Alzubaidy H, 2016, GENE, V576, P626, DOI 10.1016/j.gene.2015.10.032; Andrew DR, 2012, APPL ENVIRON MICROB, V78, P7527, DOI 10.1128/AEM.01459-12; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Burke DJ, 2009, APPL ENVIRON MICROB, V75, P7639, DOI 10.1128/AEM.01648-09; Buyer JS, 1999, CAN J MICROBIOL, V45, P138, DOI 10.1139/cjm-45-2-138; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Cheng Da, 2016, SCI REP-UK, P6; Cipriano MAP, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw197; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Debnath R, 2016, FRONT PLANT SCI, P7; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Nagerabi SA, 2013, BIODIVERSITAS J BIOL, V15; Eshete A, 2012, FOREST ECOL MANAG, V274, P136, DOI 10.1016/j.foreco.2012.02.024; Fang M, 2007, APPL SOIL ECOL, V37, P150, DOI 10.1016/j.apsoil.2007.06.001; Farah M., 2008, NONTIMBER FOREST PRO; Fonseca-Garcia C, 2016, FRONT MICROBIOL, P7; Garcia A, 2016, GENETICS MOL RES GMR, V15; Gebrehiwot K, 2003, INT FOREST REV, V5, P348, DOI 10.1505/IFOR.5.4.348.22661; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; Griffiths RI, 2003, FEMS MICROBIOL ECOL, V43, P35, DOI 10.1111/j.1574-6941.2003.tb01043.x; Guo MX, 2017, ECOL ENG, V99, P22, DOI 10.1016/j.ecoleng.2016.11.018; Hacquard S, 2015, NEW PHYTOL, V205, P1424, DOI 10.1111/nph.13133; Hamarashid NH., 2010, EGYPTIAN J EXPT BIOL, V6, P59; Hao DC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22006; Jain S.M., 2015, DATE PALM GENETIC RE; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; KANAZAWA S, 1986, MICROBIAL ECOL, V12, P205, DOI 10.1007/BF02011205; Kaplan D, 2013, AM J BOT, V100, P1713, DOI 10.3732/ajb.1200615; Khan AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158207; Khan AL, 2015, CRIT REV BIOTECHNOL, V35, P62, DOI 10.3109/07388551.2013.800018; Khan AL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-3; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Lagaert S, 2009, SEMIN CELL DEV BIOL; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Li Z., 2016, SCI REP UK, V6; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Mondejar R, 2016, SCI REP-UK, P6; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Marx MC, 2001, SOIL BIOL BIOCHEM, V33, P1633, DOI 10.1016/S0038-0717(01)00079-7; Meaden S, 2016, ENV MICROBIOL REP, V8, P649, DOI 10.1111/1758-2229.12418; Miao CP, 2016, J GINSENG RES, V40, P127, DOI 10.1016/j.jgr.2015.06.004; Ofek-Lalzar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5950; Pascual J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146558; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pfeiffer S, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw242; POSTMA J, 1990, MICROB ECOL, V19, P149, DOI 10.1007/BF02012096; Qi XJ, 2012, WORLD J MICROB BIOT, V28, P2257, DOI 10.1007/s11274-012-1033-2; Raffaelli M., 2003, Webbia, V58, P133; Reinhold-Hurek B, 2006, MOL PLANT MICROBE IN, V19, P181, DOI 10.1094/MPMI-19-0181; Ritpitakphong U, 2016, NEW PHYTOL, V210, P1033, DOI 10.1111/nph.13808; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Shakya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076382; Solomon EB, 2005, J FOOD PROTECT, V68, P870, DOI 10.4315/0362-028X-68.4.870; Takahashi M, 2012, CARCINOGENESIS, V33, P2441, DOI 10.1093/carcin/bgs286; Taketani RG, 2017, MICROB ECOL, V73, P153, DOI 10.1007/s00248-016-0835-4; Tan Y, 2017, J BASIC MICROB, V57, P337, DOI 10.1002/jobm.201600464; Tian BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17087; Tolera M, 2013, FOREST ECOL MANAG, V304, P65, DOI 10.1016/j.foreco.2013.04.036; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020611; Wu P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164082; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Xiong W, 2016, FRONT MICROBIOL, P7; Zhang PJ, 2007, COLLOID SURFACE B, V58, P264, DOI 10.1016/j.colsurfb.2007.03.018	83	3	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186939	10.1371/journal.pone.0186939	http://dx.doi.org/10.1371/journal.pone.0186939			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053752	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100051
J	Liu, SY; Chrystal, PV; Cowieson, AJ; Truong, HH; Moss, AF; Selle, PH				Liu, Sonia Y.; Chrystal, Peter V.; Cowieson, Aaron J.; Truong, Ha H.; Moss, Amy F.; Selle, Peter H.			The influence of the selection of macronutrients coupled with dietary energy density on the performance of broiler chickens	PLOS ONE			English	Article							NUTRIENT UTILIZATION; GEOMETRIC ANALYSIS; PARTICLE-SIZE; PROTEIN; GROWTH	A total of 360 male Ross 308 broiler chickens were used in a feeding study to assess the influence of macronutrients and energy density on feed intakes from 10 to 31 days post-hatch. The study comprised ten dietary treatments from five dietary combinations and two feeding approaches: sequential and choice feeding. The study included eight experimental diets and each dietary combination was made from three experimental diets. Choice fed birds selected between three diets in separate feed trays at the same time; whereas the three diets were offered to sequentially fed birds on an alternate basis during the experimental period. There were no differences between starch and protein intakes between choice and sequentially fed birds (P > 0.05) when broiler chickens selected between diets with different starch, protein and lipid concentrations. When broiler chickens selected between diets with different starch and protein but similar lipid concentrations, both sequentially and choice fed birds selected similar ratios of starch and protein intake (P > 0.05). However, when broiler chickens selected from diets with different protein and lipid but similar starch concentrations, choice fed birds had higher lipid intake (129 versus 118 g/bird, P = 0.027) and selected diets with lower protein concentrations (258 versus 281 g/kg, P = 0.042) than birds offered sequential diet options. Choice fed birds had greater intakes of the high energy diet (1471 g/bird, P < 0.0001) than low energy (197 g/bird) or medium energy diets (663 g/bird) whilst broiler chickens were offered diets with different energy densities but high crude protein (300 g/kg) or digestible lysine (17.5 g/kg) concentrations. Choice fed birds had lower FCR (1.217 versus 1.327 g/g, P < 0.0001) and higher carcass yield (88.1 versus 87.3%, P = 0.012) than sequentially fed birds. This suggests that the dietary balance between protein and energy is essential for optimal feed conversion efficiency. The intake path of macronutrients from 10-31 days in choice and sequential feeding groups were plotted and compared with the null path if broiler chickens selected equal amounts of the three diets in the combination. Regardless of feeding regimen, the intake paths of starch and protein are very close to the null path; however, lipid and protein intake paths in choice fed birds are father from the null path than sequentially fed birds.	[Liu, Sonia Y.; Cowieson, Aaron J.; Truong, Ha H.; Moss, Amy F.; Selle, Peter H.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Poultry Res Fdn, Camden, NSW, Australia; [Liu, Sonia Y.] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [Chrystal, Peter V.] Baiada Poultry Pty Ltd, Pendle Hill, Australia; [Cowieson, Aaron J.] DSM Nutr Prod, Kaiseraugst, Switzerland; [Truong, Ha H.] Univ New England, Poultry Cooperat Res Ctr, Armidale, NSW, Australia	University of Sydney; University of Sydney; DSM NV; University of New England	Liu, SY (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Poultry Res Fdn, Camden, NSW, Australia.; Liu, SY (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.	sonia.liu@sydney.edu.au	Truong, Ha/AAX-6874-2020	Truong, Ha/0000-0002-2322-378X; Moss, Amy/0000-0002-8647-8448; Chrystal, Peter/0000-0001-7421-5109	Celestino Baiada Research Fellowship in Poultry Science	Celestino Baiada Research Fellowship in Poultry Science	The present study was funded by the Celestino Baiada Research Fellowship in Poultry Science, a generous donation to The University of Sydney by Baiada Poultry Pty Limited, Sydney, Australia. It provided financial support in the form of Dr Sonia Liu's salary. As a gift to The University of Sydney, the donor generously agreed to share research outcomes with the public. The funder provided support in the form of salaries for S.Y.L., and Mr Peter Chrystal contributed to the study design and preparation of the manuscript.	Amerah AM, 2007, POULTRY SCI, V86, P2615, DOI 10.3382/ps.2007-00212; Collin A, 2003, BRIT J NUTR, V90, P261, DOI 10.1079/BJN2003910; EMMANS GC, 1987, WORLD POULTRY SCI J, V43, P208, DOI 10.1079/WPS19870014; Gous RM, 2000, BRIT POULTRY SCI, V41, P136, DOI 10.1080/713654920; Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429; HILL FW, 1958, J NUTR, V64, P587, DOI 10.1093/jn/64.4.587; JACKSON S, 1982, POULTRY SCI, V61, P2232, DOI 10.3382/ps.0612232; JACKSON S, 1982, POULTRY SCI, V61, P2224, DOI 10.3382/ps.0612224; Klasing K.C., 1998, COMP AVIAN NUTR, P171; Liu SY, 2016, ANIM FEED SCI TECH, V218, P70, DOI 10.1016/j.anifeedsci.2016.05.008; Liu SY, 2015, WORLD POULTRY SCI J, V71, P297, DOI 10.1017/S0043933915000306; Liu SY, 2016, BRIT J NUTR, V116, P2129, DOI 10.1017/S0007114516004190; Liu SY, 2017, BR J NUTR UNPUB; de Castro MDL, 2010, J CHROMATOGR A, V1217, P2383, DOI 10.1016/j.chroma.2009.11.027; Mabayo RT, 1996, APPL ANIM BEHAV SCI, V49, P213, DOI 10.1016/0168-1591(96)01047-7; Mahasukhonthachat K, 2010, J CEREAL SCI, V51, P392, DOI 10.1016/j.jcs.2010.02.008; NIR I, 1994, POULTRY SCI, V73, P781, DOI 10.3382/ps.0730781; Noblet J, 2010, P 21 ANN AUSTR POULT; Ravindran V, 2016, ANIM FEED SCI TECH, V213, P1, DOI 10.1016/j.anifeedsci.2016.01.012; Roura E, 2013, ANIM FEED SCI TECH, V180, P1, DOI 10.1016/j.anifeedsci.2012.11.001; SIMPSON SJ, 1995, J INSECT PHYSIOL, V41, P545, DOI 10.1016/0022-1910(95)00006-G; SIMPSON SJ, 1993, PHILOS T R SOC B, V342, P381, DOI 10.1098/rstb.1993.0166; SIRIWAN P, 1993, BRIT POULTRY SCI, V34, P939, DOI 10.1080/00071669308417654	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0185480	10.1371/journal.pone.0185480	http://dx.doi.org/10.1371/journal.pone.0185480			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053729	gold, Green Published, Green Submitted			2022-12-26	WOS:000413315100003
J	Sjoberg, F; Barkman, C; Nookaew, I; Ostman, S; Adlerberth, I; Saalman, R; Wold, AE				Sjoberg, Fei; Barkman, Cecilia; Nookaew, Intawat; Ostman, Sofia; Adlerberth, Ingegerd; Saalman, Robert; Wold, Agnes E.			Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FECAL MICROBIOTA; INTESTINAL MICROBIOTA; CROHNS-DISEASE; ORAL TOLERANCE; CHILDHOOD; BACTERIAL; ONSET; DIVERSITY; MICROFLORA	Background Inflammatory bowel disease (IBD) is characterized by gut dysbiosis. To date, the large bowel microbiota has been in focus. However, the microbiota of the small intestine may also be of importance, as the small bowel is a site for the induction and control of mucosal immune responses, which can be modulated by constituents of the local microbiota. Methods Duodenal fluids were collected during diagnostic work-up of treatment-naive children who were suspected of having IBD. The duodenal fluids were analyzed by pyrosequencing (average of 32,000 reads/sample, read length of 500 nucleotides). After diagnosis, the duodenal microbiota of subjects with ulcerative colitis (N = 8) or Crohn's disease (N = 5), and non-IBD controls (N = 8) were compared. Results Pyrosequencing revealed that the duodenal microbiota of children with ulcerative colitis contained fewer Operational Taxonomic Units (OTUs) per individual than the duodenal microbiota of the controls (P = 0.005). This reduction in richness of the duodenal microbiota was seen for three major phyla: Firmicutes, Actinobacteria, and Bacteroidetes. Several bacterial genera were detected less frequently in the children with ulcerative colitis than in the non-IBD controls, including Collinsella (P = 0.001), Lactobacillus (P = 0.007), and Bacillus (P = 0.007), as well as a non-identified member of the order Sphingobacteriales (P = 0.007). Conclusions In this pilot study, we show that the duodenal microbiota of children with ulcerative colitis exhibits reduced overall richness, despite the fact that the inflammation is primarily localized to the colon. These results should be corroborated in a larger study.	[Sjoberg, Fei; Barkman, Cecilia; Ostman, Sofia; Adlerberth, Ingegerd; Wold, Agnes E.] Univ Gothenburg, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Nookaew, Intawat] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Nookaew, Intawat] Univ Arkansas Med Sci, Coll Med, Dept Biomed Informat, Little Rock, AR 72205 USA; [Saalman, Robert] Univ Gothenburg, Inst Clin Sci, Dept Paediat, Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology; University of Arkansas System; University of Arkansas Medical Sciences; University of Gothenburg	Sjoberg, F (corresponding author), Univ Gothenburg, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.	fei.sjoberg@microbio.gu.se		Sjoberg, Fei/0000-0002-8305-7648	Swedish Research Council; Mayflower Foundation; Torsten and Ragnar Soderberg's Foundation; Wilhelm and Martina Lundgren's Foundation; ALF/LUA	Swedish Research Council(Swedish Research CouncilEuropean Commission); Mayflower Foundation; Torsten and Ragnar Soderberg's Foundation; Wilhelm and Martina Lundgren's Foundation; ALF/LUA	This work was supported by grants from the Swedish Research Council, grants for clinical research under the ALF/LUA agreement, and funding from the Mayflower Foundation, the Torsten and Ragnar Soderberg's Foundation, and the Wilhelm and Martina Lundgren's Foundation.	Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Ahrne S, 2011, NUTRIENTS, V3, P104, DOI 10.3390/nu3010104; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Angelakis E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137784; Assa A, 2016, INFLAMM BOWEL DIS, V22, P1533, DOI 10.1097/MIB.0000000000000776; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; BENNO Y, 1986, MICROBIOL IMMUNOL, V30, P521, DOI 10.1111/j.1348-0421.1986.tb02978.x; Braegger CP, 2011, J PEDIATR GASTR NUTR, V53, P141, DOI 10.1097/MPG.0b013e318218be35; Bryan PF, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9890141; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CARTER PB, 1971, J RETICULOENDOTH SOC, V9, P580; Cheng J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-113; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Cucchiara S, 2012, J CLIN GASTROENTEROL, V46, pS64, DOI 10.1097/MCG.0b013e31826a857f; Dlugosz A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08508; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Felliet H, 2004, CURR OPIN GASTROEN, V20, P560; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hansen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058825; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Li GP, 2015, J MICROBIOL BIOTECHN, V25, P1136, DOI 10.4014/jmb.1412.12047; Lim LG, 2014, INFLAMM BOWEL DIS, V20, P892, DOI 10.1097/MIB.0000000000000027; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Malmborg P, 2015, INFLAMM BOWEL DIS, V21, P1098, DOI 10.1097/MIB.0000000000000356; Malmborg P, 2013, J PEDIATR GASTR NUTR, V57, P29, DOI 10.1097/MPG.0b013e31828f21b4; Maukonen J, 2015, J CROHNS COLITIS, V9, P1088, DOI 10.1093/ecco-jcc/jjv147; Mearin F, 2016, GASTROENTEROLOGY; Michail S, 2012, INFLAMM BOWEL DIS, V18, P1799, DOI 10.1002/ibd.22860; Mobini R, 2017, DIABETES OBES METAB, V19, P579, DOI 10.1111/dom.12861; MOORE WEC, 1978, AM J CLIN NUTR, V31, pS33, DOI 10.1093/ajcn/31.10.S33; MOREAU MC, 1988, INFECT IMMUN, V56, P2766, DOI 10.1128/IAI.56.10.2766-2768.1988; Nagalingam NA, 2012, INFLAMM BOWEL DIS, V18, P968, DOI 10.1002/ibd.21866; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Radon K, 2007, PEDIATRICS, V120, P354, DOI 10.1542/peds.2006-3624; Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Springmann V, 2014, INFLAMM BOWEL DIS, V20, P1346, DOI 10.1097/MIB.0000000000000098; Stenlund H, 2009, ANAL CHEM, V81, P203, DOI 10.1021/ac801803e; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Thorkildsen LT, 2013, GASTROENT RES PRACT, V2013, DOI DOI 10.1155/2013/636785; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Wegner K, 2017, ANAL BIOANAL CHEM, V409, P1231, DOI 10.1007/s00216-016-0048-1; Wold S, 1993, PLS 3D QSAR DRUG DES; Wu L, 2009, TISSUE ANTIGENS, V73, P535, DOI 10.1111/j.1399-0039.2009.01256.x; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Yu H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-182; Zaidi D, 2016, J PEDIAT GASTROENTER; Zaidi D, 2016, J PEDIATR GASTR NUTR, V63, P644, DOI 10.1097/MPG.0000000000001182	60	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186178	10.1371/journal.pone.0186178	http://dx.doi.org/10.1371/journal.pone.0186178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049404	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900046
J	Kim, PK; Keum, SJ; Osinubi, MOV; Franka, R; Shin, JY; Park, ST; Kim, MS; Park, MJ; Lee, SY; Carson, W; Greenberg, L; Yu, PC; Tao, XY; Wang, LH; Tang, Q; Liang, GD; Shampur, M; Rupprecht, CE; Chang, SJ				Kim, Pan Kyeom; Keum, Sun Ju; Osinubi, Modupe O. V.; Franka, Richard; Shin, Ji Young; Park, Sang Tae; Kim, Man Su; Park, Mi Jung; Lee, Soo Young; Carson, William; Greenberg, Lauren; Yu, Pengcheng; Tao, Xiaoyan; Wang Lihua; Tang, Qing; Liang, Guodong; Shampur, Madhusdana; Rupprecht, Charles E.; Chang, Shin Jae			Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus	PLOS ONE			English	Article							IMMUNE GLOBULIN; GLYCOPROTEIN; PROPHYLAXIS; PATHOGENICITY; LYSSAVIRUSES; DETERMINANT; COMBINATION; COCKTAIL; EPITOPE	Current post-exposure prophylaxis for rabies virus infection has several limitations in terms of supply, cost, safety, and efficacy. Attempts to replace human or equine rabies immune globulins (HRIG or ERIG) have been made by several companies and institutes. We developed potent monoclonal antibodies to neutralize a broad spectrum of rabies viruses by screening hybridomas received from the U.S. Centers for Disease Control and Prevention (CDC). Two kinds of chimeric human antibodies (chimeric #7 and #17) were constructed by cloning the variable regions from selected hybridomas and the constant region of a human antibody. Two antibodies were bound to antigenic site III and I/IV, respectively, and were able to neutralize 51 field isolates of rabies virus that were isolated at different times and places such as Asia, Africa, North America, South America, and Australia. These two antibodies neutralize rabies viruses with high efficacy in an in vivo test using Syrian hamster and mouse models and show low risk for adverse immunogenicity.	[Kim, Pan Kyeom; Keum, Sun Ju; Shin, Ji Young; Park, Sang Tae; Kim, Man Su; Park, Mi Jung; Lee, Soo Young; Chang, Shin Jae] Celltrion Inc, Dept Res & Dev, Incheon, South Korea; [Osinubi, Modupe O. V.; Franka, Richard; Carson, William; Greenberg, Lauren] Ctr Dis Control & Prevent, Atlanta, GA USA; [Yu, Pengcheng; Tao, Xiaoyan; Wang Lihua; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Shampur, Madhusdana] Natl Inst Mental Hlth & Neurosci, Bangalore, Karnataka, India; [Rupprecht, Charles E.] LYSSA LLC, Cummings, GA USA	Celltrion; Centers for Disease Control & Prevention - USA; Chinese Center for Disease Control & Prevention; National Institute of Mental Health & Neurosciences - India	Chang, SJ (corresponding author), Celltrion Inc, Dept Res & Dev, Incheon, South Korea.	shinjae.chang@celltrion.com	Rupprecht, Charles/AAI-1544-2020					Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; BENMANSOUR A, 1991, J VIROL, V65, P4198, DOI 10.1128/JVI.65.8.4198-4203.1991; Both L, 2013, FASEB J, V27, P2055, DOI 10.1096/fj.12-219964; Botvinkin AD, 2003, EMERG INFECT DIS, V9, P1623, DOI 10.3201/eid0912.030374; BUNSCHOTEN H, 1989, J GEN VIROL, V70, P291, DOI 10.1099/0022-1317-70-2-291; Champion JM, 2000, J IMMUNOL METHODS, V235, P81, DOI 10.1016/S0022-1759(99)00223-9; Cliquet F, 1998, J IMMUNOL METHODS, V212, P79, DOI 10.1016/S0022-1759(97)00212-3; Consales CA, 2007, J VENOM ANIM TOXINS, V13, P5, DOI 10.1590/S1678-91992007000100002; De Benedictis P, 2016, EMBO MOL MED, V8, P407, DOI 10.15252/emmm.201505986; de Kruif J, 2007, ANNU REV MED, V58, P359, DOI 10.1146/annurev.med.58.061705.145053; DIETZSCHOLD B, 1983, P NATL ACAD SCI-BIOL, V80, P70, DOI 10.1073/pnas.80.1.70; DIETZSCHOLD B, 1990, J VIROL, V64, P3087, DOI 10.1128/JVI.64.6.3087-3090.1990; Fooks AR, 2003, EPIDEMIOL INFECT, V131, P1029, DOI 10.1017/S0950268803001481; Goudsmit J, 2006, J INFECT DIS, V193, P796, DOI 10.1086/500470; HAMPSON K, 2015, PLOS NEGLECT TROP D, V9; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kuzmin IV, 2003, VIRUS RES, V97, P65, DOI 10.1016/S0168-1702(03)00217-X; Kuzmina N.A., 2013, J ANTIVIRALS ANTIRET, V5, P37, DOI DOI 10.4172/JAA.1000061; LAFON M, 1983, J GEN VIROL, V64, P843, DOI 10.1099/0022-1317-64-4-843; Marissen WE, 2005, J VIROL, V79, P4672, DOI 10.1128/JVI.79.8.4672-4678.2005; Meslin FX, 1996, LAB TECHNIQUES RABIE; Muller T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000542; PREHAUD C, 1988, J VIROL, V62, P1; Prosniak M, 2003, J INFECT DIS, V188, P53, DOI 10.1086/375247; Rupprecht C., 2017, F1000 RES, V6, P184, DOI [DOI 10.12688/F1000RESEARCH.10416.1, 10.12688/f1000research.10416.1]; Rupprecht CE, 2004, NEW ENGL J MED, V351, P2626, DOI 10.1056/NEJMcp042140; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; SEIF I, 1985, J VIROL, V53, P926, DOI 10.1128/JVI.53.3.926-934.1985; Sloan SE, 2007, VACCINE, V25, P2800, DOI 10.1016/j.vaccine.2006.12.031; SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535; Suwansrinon K, 2007, T ROY SOC TROP MED H, V101, P206, DOI 10.1016/j.trstmh.2006.04.009; Tang XC, 2005, EMERG INFECT DIS, V11, P1970, DOI 10.3201/eid1112.050271; Wang Y, 2011, ANTIVIR RES, V91, P187, DOI 10.1016/j.antiviral.2011.06.002; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9; WHO, 2013, WHO TECH REP SER, V982, P1; WHO, 2002, WHO CONS RAB MON ANT; WHO, GUID POST PROPH; WILDE H, 1989, VACCINE, V7, P10, DOI 10.1016/0264-410X(89)90003-0; WILDE H, 1989, B WORLD HEALTH ORGAN, V67, P731; World Health Organization, 1997, WHO RECOMMENDATIONS	41	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186380	10.1371/journal.pone.0186380	http://dx.doi.org/10.1371/journal.pone.0186380			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045436	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100056
J	Young, HA; Williams, C; Pink, AE; Freegard, G; Owens, A; Benton, D				Young, Hayley A.; Williams, Claire; Pink, Aimee E.; Freegard, Gary; Owens, Amy; Benton, David			Getting to the heart of the matter: Does aberrant interoceptive processing contribute towards emotional eating?	PLOS ONE			English	Article							ANOREXIA-NERVOSA; SENSITIVITY; WOMEN; AWARENESS; BEHAVIOR; QUESTIONNAIRE; OVERWEIGHT; INFERENCE; ACCURACY; DISORDER	According to estimates from Public Health England, by 2034 70% of adults are expected to be overweight or obese, therefore understanding the underpinning aetiology is a priority. Eating in response to negative affect contributes towards obesity, however, little is known about the underlying mechanisms. Evidence that visceral afferent signals contribute towards the experience of emotion is accumulating rapidly, with the emergence of new influential models of 'active inference'. No longer viewed as a 'bottom up' process, new interoceptive facets based on 'top down' predictions have been proposed, although at present it is unclear which aspects of interoception contribute to aberrant eating behaviour and obesity. Study one examined the link between eating behaviour, body mass index and the novel interoceptive indices; interoceptive metacognitive awareness (IAw) and interoceptive prediction error (IPE), as well as the traditional measures; interoceptive accuracy (IAc) and interoceptive sensibility (IS). The dissociation between these interoceptive indices was confirmed. Emotional eaters were characterised by a heightened interoceptive signal but reduced meta-cognitive awareness of their interoceptive abilities. In addition, emotional eating correlated with IPE; effects that could not be accounted for by differences in anxiety and depression. Study two confirmed the positive association between interoceptive accuracy and emotional eating using a novel unbiased heartbeat discrimination task based on the method of constant stimuli. Results reveal new and important mechanistic insights into the processes that may underlie problematic affect regulation in overweight populations.	[Young, Hayley A.; Williams, Claire; Pink, Aimee E.; Freegard, Gary; Owens, Amy; Benton, David] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales	Swansea University	Young, HA (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	h.a.young@swansea.ac.uk	Young, Hayley/HGD-6766-2022; Pink, Aimee/AAK-3476-2021	Pink, Aimee/0000-0003-1516-7922; Williams, Claire/0000-0002-0791-744X; Young, Hayley/0000-0002-6954-3519	Swansea University	Swansea University	We would like to thank Swansea University for supporting this research.	Ambrosecchia M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00219; Andreescu AC, 2015, EMOTION PROCESSING D; Barrett LF, 2015, NAT REV NEUROSCI, V16, P419, DOI 10.1038/nrn3950; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berner LA, 2018, PSYCHOL MED, V48, P142, DOI 10.1017/S0033291717001635; Berner L, 2017, BIOL PSYCHIAT, V81, pS376, DOI 10.1016/j.biopsych.2017.02.656; Blinder BJ, 2006, PSYCHOSOM MED, V68, P454, DOI 10.1097/01.psy.0000221254.77675.f5; Bluemel S, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-016-0560-y; Bohon C, 2014, OBESITY, V22, P1814, DOI 10.1002/oby.20759; Bohon C, 2009, INT J EAT DISORDER, V42, P210, DOI 10.1002/eat.20615; Brener J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0015; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; de Sampaio FTP, 2013, PSYCHIAT RES, V210, P1116, DOI 10.1016/j.psychres.2013.08.051; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; Dunn B. D., 2010, PSYCHOL SCI, DOI 10.11.77/0956797610389191; Eccles JA, 2015, NEUROPSYCHOLOGIA, V77, P90, DOI 10.1016/j.neuropsychologia.2015.08.006; ELMORE DK, 1990, INT J EAT DISORDER, V9, P179, DOI 10.1002/1098-108X(199003)9:2&lt;179::AID-EAT2260090207&gt;3.0.CO;2-O; Eshkevari E, 2014, EUR EAT DISORD REV, V22, P383, DOI 10.1002/erv.2305; Fassino S, 2004, PSYCHOPATHOLOGY, V37, P168, DOI 10.1159/000079420; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fischer D, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00199; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Forkmann T, 2016, INT J PSYCHOPHYSIOL, V109, P71, DOI 10.1016/j.ijpsycho.2016.09.019; Friston KJ, 2013, TRENDS COGN SCI, V17, P1, DOI 10.1016/j.tics.2012.11.003; Garfinkel SN, 2016, BIOL PSYCHOL, V114, P117, DOI 10.1016/j.biopsycho.2015.12.003; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Gibson EL, 2012, BEHAV PHARMACOL, V23, P442, DOI 10.1097/FBP.0b013e328357bd4e; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2014, EAT BEHAV, V15, P445, DOI 10.1016/j.eatbeh.2014.06.002; Herbert BM, 2013, APPETITE, V70, P22, DOI 10.1016/j.appet.2013.06.082; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; Jewell T, 2015, INT J EATING DISORDE; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; Klabunde M, 2017, J PSYCHIAT RES; Klabunde M, 2013, EAT BEHAV, V14, P488, DOI 10.1016/j.eatbeh.2013.08.002; Koch A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01003; LORR M, 1982, J PERS ASSESS, V46, P432, DOI 10.1207/s15327752jpa4604_16; Mata F, 2015, APPETITE, V93, P24, DOI 10.1016/j.appet.2015.03.024; Mehling WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048230; Nowakowski ME, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-21; Ouwens MA, 2009, APPETITE, V53, P245, DOI 10.1016/j.appet.2009.06.001; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Pezzulo G, 2015, PROG NEUROBIOL, V134, P17, DOI 10.1016/j.pneurobio.2015.09.001; Pinaquy S, 2003, OBES RES, V11, P195, DOI 10.1038/oby.2003.31; Pollatos O, 2005, HUM BRAIN MAPP, V26, P54, DOI 10.1002/hbm.20121; Pollatos O, 2016, PSYCHIAT RES, V240, P328, DOI 10.1016/j.psychres.2016.04.072; Quintana DS, 2012, EUR J APPL PHYSL, P1; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Stein RI, 2007, INT J EAT DISORDER, V40, P195, DOI 10.1002/eat.20352; Stern RA, 1997, APHASIOLOGY, V11, P59, DOI 10.1080/02687039708248455; Terasawa Y., 2012, SOC COGN AFFECT NEUR; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tylka TL, 2006, J COUNS PSYCHOL, V53, P226, DOI 10.1037/0022-0167.53.2.226; Vainik U, 2013, NEUROSCI BIOBEHAV R, V37, P279, DOI 10.1016/j.neubiorev.2012.11.008; van Dyck Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163574; van Strien Tatjana, 2007, Eat Behav, V8, P251, DOI 10.1016/j.eatbeh.2006.06.004; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; WARDLE J, 1987, J PSYCHOSOM RES, V31, P161, DOI 10.1016/0022-3999(87)90072-9; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9	62	30	30	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186312	10.1371/journal.pone.0186312	http://dx.doi.org/10.1371/journal.pone.0186312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045451	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100053
J	Chen, SH; Gong, X; Zhang, Y; Van Horn, RD; Yin, T; Huber, L; Burke, TF; Manro, J; Iversen, PW; Wu, W; Bhagwat, SV; Beckmann, RP; Tiu, RV; Buchanan, SG; Peng, SB				Chen, S-H; Gong, X.; Zhang, Y.; Van Horn, R. D.; Yin, T.; Huber, L.; Burke, T. F.; Manro, J.; Iversen, P. W.; Wu, W.; Bhagwat, S. V.; Beckmann, R. P.; Tiu, R. V.; Buchanan, S. G.; Peng, S-B			RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1	ONCOGENE			English	Article							CELL-CYCLE; ANTITUMOR ACTIVITIES; METASTATIC MELANOMA; ONCOGENIC MUTATIONS; MAPK PATHWAY; B-RAF; VEMURAFENIB; RESISTANCE; REACTIVATION; BRAF(V600E)	KRAS, NRAS and BRAF mutations are among the most important oncogenic drivers in many major cancer types, such as melanoma, lung, colorectal and pancreatic cancer. There is currently no effective therapy for the treatment of RAS mutant cancers. LY3009120, a pan-RAF and RAF dimer inhibitor advanced to clinical study has been shown to inhibit both RAS and BRAF mutant cell proliferation in vitro and xenograft tumor growth in vivo. Abemaciclib, a CDK4/6-selective inhibitor, is currently in phase III studies for ER-positive breast cancer and KRAS mutant lung cancer. In this study, we found that combinatory treatment with LY3009120 and abemaciclib synergistically inhibited proliferation of tumor cells in vitro and led to tumor growth regression in xenograft models with a KRAS, NRAS or BRAF mutation at the doses of two drugs that were well tolerated in combination. Further in vitro screen in 328 tumor cell lines revealed that tumor cells with KRAS, NRAS or BRAF mutation, or cyclin D activation are more sensitive, whereas tumor cells with PTEN, PIK3CA, PIK3R1 or retinoblastoma (Rb) mutation are more resistant to this combination treatment. Molecular analysis revealed that abemaciclib alone inhibited Rb phosphorylation partially and caused an increase of cyclin D1. The combinatory treatment cooperatively demonstrated more complete inhibition of Rb phosphorylation, and LY3009120 suppressed the cyclin D1 upregulation mediated by abemaciclib. These results were further verified by CDK4/6 siRNA knockdown. Importantly, the more complete phospho-Rb inhibition and cyclin D1 suppression by LY3009120 and abemaciclib combination led to more significant cell cycle G(0)/G(1) arrest of tumor cells. These preclinical findings suggest that combined inhibition of RAF and D-cyclin-dependent kinases might provide an effective approach to treat patients with tumors harboring mutations in RAS or RAF genes.	[Chen, S-H; Gong, X.; Zhang, Y.; Van Horn, R. D.; Yin, T.; Huber, L.; Burke, T. F.; Wu, W.; Bhagwat, S. V.; Beckmann, R. P.; Buchanan, S. G.; Peng, S-B] Eli Lilly & Co, Oncol Res, Indianapolis, IN 46285 USA; [Manro, J.; Iversen, P. W.] Eli Lilly & Co, Stat, Indianapolis, IN 46285 USA; [Tiu, R. V.] Eli Lilly & Co, Early Phase Oncol & Oncol Business Unit, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Peng, SB (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	peng_sheng-bin@lilly.com			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	All authors are employees of Eli Lilly and Company at the time that the work was done. All research described herein was funded by Eli Lilly and Company.	Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dong JL, 2003, CANCER RES, V63, P3883; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gelbert LM, 2014, INVEST NEW DRUG, V32, P825, DOI 10.1007/s10637-014-0120-7; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Henry JR, 2015, J MED CHEM, V58, P4165, DOI 10.1021/acs.jmedchem.5b00067; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Johnpulle RAN, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-015-0485-6; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067583; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Monahan KB, 2010, ONCOGENE, V29, P5809, DOI 10.1038/onc.2010.314; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Patnaik A, 2016, CANCER DISCOV, V6, P740, DOI 10.1158/2159-8290.CD-16-0095; Peng SB, 2015, CANCER CELL, V28, P384, DOI 10.1016/j.ccell.2015.08.002; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Sanchez-Laorden B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004815; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Yadav V, 2015, PHARMACOL THERAPEUT, V149, P139, DOI 10.1016/j.pharmthera.2014.12.003; Yadav V, 2014, MOL CANCER THER, V13, P2253, DOI 10.1158/1535-7163.MCT-14-0257; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	48	40	43	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					821	832		10.1038/onc.2017.384	http://dx.doi.org/10.1038/onc.2017.384			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059158				2022-12-26	WOS:000424628100013
J	Chen, XY; Zhou, L; Peng, NF; Yu, HS; Li, MQ; Cao, ZY; Lin, Y; Wang, XY; Li, Q; Wang, J; She, YL; Zhu, CL; Lu, MJ; Zhu, Y; Liu, S				Chen, Xueyuan; Zhou, Li; Peng, Nanfang; Yu, Haisheng; Li, Mengqi; Cao, Zhongying; Lin, Yong; Wang, Xueyu; Li, Qian; Wang, Jun; She, Yinglong; Zhu, Chengliang; Lu, Mengji; Zhu, Ying; Liu, Shi			MicroRNA-302a suppresses influenza A virus-stimulated interferon regulatory factor-5 expression and cytokine storm induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine induction; cytokine storm; influenza virus; interferon regulatory factor (IRF); microRNA (miRNA); signaling	TRANSCRIPTION FACTOR; SIGNALING PATHWAY; GENE INDUCTION; I INTERFERON; CELLS; REPLICATION; IRF5; INFLAMMATION; INFECTION; RESPONSES	During influenza A virus (IAV) infection, cytokine storms play a vital and critical role in clinical outcomes. We have previously reported that microRNA (miR)-302c regulates IAV-induced IFN expression by targeting the 3-UTR of nuclear factor B (NF-B)-inducing kinase. In the current study, we found that miR-302a, another member of the miR-302 cluster, controls the IAV-induced cytokine storm. According to results from cell-based and knockout mouse models, IAV induces a cytokine storm via interferon regulatory factor-5 (IRF-5). We also found that IAV infection up-regulates IRF-5 expression and that IRF-5 in turn promotes IAV replication. Furthermore, we observed that IRF-5 is a direct target of miR-302a, which down-regulated IRF-5 expression by binding its 3-UTR. Moreover, IAV increased IRF-5 expression by down-regulating miR-302a expression. Interestingly, miR-302a inhibited IAV replication. In IAV-infected patients, miR-302a expression was down-regulated, whereas IRF-5 expression was up-regulated. Taken together, our work uncovers and defines a signaling pathway implicated in an IAV-induced cytokine storm.	[Chen, Xueyuan; Peng, Nanfang; Yu, Haisheng; Li, Mengqi; Cao, Zhongying; She, Yinglong; Zhu, Ying; Liu, Shi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Zhou, Li] Wuhan Univ, Sch Med, Ctr Expt Anim, Anim Biosafety Level Lab 3, Wuhan 430072, Hubei, Peoples R China; [Lin, Yong; Wang, Xueyu; Li, Qian; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45122 Essen, Germany; [Zhu, Chengliang] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan 430060, Hubei, Peoples R China; [Wang, Jun] Jiangnan Univ, Peoples Hosp Wuxi 5, Ctr Clin Lab, Wuxi 214005, Jiangsu, Peoples R China	Wuhan University; Wuhan University; University of Duisburg Essen; Wuhan University; Jiangnan University	Liu, S (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liushi_liushi@whu.edu.cn	Lu, Mengji/ABF-9410-2020; Li, Hongpu/B-7707-2014	Li, Hongpu/0000-0003-2323-6107	National Natural Science Foundation of China [31500149, 31570870, 81301428]; Fundamental Research Funds for the Central Universities [2042017kf0221, 2042015kf0188]; National Basic Research Program of China (973 Program) [2014CB542603]; Deutsche Forschungsgemeinschaft [TRR60, RTG1949]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Natural Science Foundation of China Grants 31500149 (to S. L.), 31570870 (to Y. Z.), and 81301428 (to L. Z.); Fundamental Research Funds for the Central Universities Grants 2042017kf0221 (to S. L.) and 2042015kf0188 (to L. Z.); National Basic Research Program of China (973 Program) Grant 2014CB542603 (to S. L.); and Deutsche Forschungsgemeinschaft Grants TRR60 and RTG1949 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bi XH, 2011, J INTERF CYTOK RES, V31, P373, DOI 10.1089/jir.2010.0084; Cai N, 2013, RNA, V19, P85, DOI 10.1261/rna.035295.112; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen L, 2015, CANCER RES, V75, P3832, DOI 10.1158/0008-5472.CAN-14-3690; Clark IA, 2007, IMMUNOL CELL BIOL, V85, P271, DOI 10.1038/sj.icb.7100062; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Gao M, 2015, J IMMUNOL, V195, P672, DOI 10.4049/jimmunol.1403155; Gui SL, 2015, FEBS LETT, V589, P4112, DOI 10.1016/j.febslet.2015.11.011; Harrison C, 2010, NAT REV DRUG DISCOV, V9, P360, DOI 10.1038/nrd3162; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Iwasaki A, 2011, CELL, V146, P861, DOI 10.1016/j.cell.2011.08.027; Jing MZ, 2016, VACCINE, V34, P516, DOI 10.1016/j.vaccine.2015.11.069; Kedzierski L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004134; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Liu S, 2015, J HEPATOL, V62, P1015, DOI 10.1016/j.jhep.2014.11.035; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Morens DM, 2012, NATURE, V486, P335, DOI 10.1038/nature11170; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Peng L, 2016, EBIOMEDICINE, V14, P83, DOI 10.1016/j.ebiom.2016.10.041; Peng NF, 2016, J IMMUNOL, V196, P2753, DOI 10.4049/jimmunol.1501481; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Schmolke M, 2009, J IMMUNOL, V183, P5180, DOI 10.4049/jimmunol.0804198; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Si LL, 2016, SCIENCE, V354, P1170, DOI 10.1126/science.aah5869; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Teijaro JR, 2014, P NATL ACAD SCI USA, V111, P3799, DOI 10.1073/pnas.1400593111; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Xie JJ, 2014, BBA-MOL BASIS DIS, V1842, P2479, DOI 10.1016/j.bbadis.2014.04.017; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhang HP, 2017, INFLAMMATION, V40, P1450, DOI 10.1007/s10753-017-0588-3; Zhu SL, 2016, BIOCHEM BIOPH RES CO, V471, P95, DOI 10.1016/j.bbrc.2016.01.173	41	40	42	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21291	21303		10.1074/jbc.M117.805937	http://dx.doi.org/10.1074/jbc.M117.805937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29046356	Green Published, hybrid			2022-12-26	WOS:000419013000007
J	Bae, N; Gao, M; Li, X; Premkumar, T; Sbardella, G; Chen, JJ; Bedford, MT				Bae, Narkhyun; Gao, Min; Li, Xu; Premkumar, Tolkappiyan; Sbardella, Gianluca; Chen, Junjie; Bedford, Mark T.			A transcriptional coregulator, SPIN.DOC, attenuates the coactivator activity of Spindlin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUDOR-LIKE DOMAINS; HISTONE MODIFICATIONS; CELL-CYCLE; METHYLATION; PROTEIN; OVEREXPRESSION; RECOGNITION; LANGUAGE; NETWORK; COMPLEX	Spindlin1 (SPIN1) is a transcriptional coactivator with critical functions in embryonic development and emerging roles in cancer. SPIN1 harbors three Tudor domains, two of which engage the tail of histone H3 by reading the H3-Lys-4 trimethylation and H3-Arg-8 asymmetric dimethylation marks. To gain mechanistic insight into how SPIN1 functions as a transcriptional coactivator, here we purified its interacting proteins. We identified an uncharacterized protein (C11orf84), which we renamed SPIN1 docking protein (SPIN.DOC), that directly binds SPIN1 and strongly disrupts its histone methylation reading ability, causing it to disassociate from chromatin. The Spindlin family of coactivators has five related members (SPIN1, 2A, 2B, 3, and 4), and we found that all of them bind SPIN.DOC. It has been reported previously that SPIN1 regulates gene expression in the Wnt signaling pathway by directly interacting with transcription factor 4 (TCF4). Weobserved here that SPIN.DOC associates with TCF4 in a SPIN1-dependent manner and dampens SPIN1 coactivator activity in TOPflash reporter assays. Furthermore, knockdown and overexpression experiments indicated that SPIN.DOC represses the expression of a number of SPIN1-regulated genes, including those encoding ribosomal RNA and the cytokine IL1B. In conclusion, we have identified SPIN.DOC as a transcriptional repressor that binds SPIN1 and masks its ability to engage the H3-Lys-4 trimethylation activation mark.	[Bae, Narkhyun; Premkumar, Tolkappiyan; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Gao, Min; Li, Xu; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Sbardella, Gianluca] Univ Salerno, Epigenet Med Chem Lab, Dipartimento Farm, Via Giovanni Paolo 2 132, I-84084 Fisciano, SA, Italy	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Salerno	Bedford, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	Sbardella, Gianluca/E-2823-2010	Sbardella, Gianluca/0000-0003-0748-1145; Premkumar, Tolkappiyan/0000-0003-2540-5533; bedford, mark/0000-0002-8899-1050; /0000-0002-5592-9349	Odyssey Fellowship Program at The University of Texas MD Anderson Cancer Center; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Progetti di Ricerca di Interesse Nazionale [PRIN 20152TE5PK]; Universita di Salerno (Italy); European Cooperation in Science and Technology (COST Action) [CM1406]; National Institutes of Health [CA216911, DK062248]; CPRIT [RP130432]	Odyssey Fellowship Program at The University of Texas MD Anderson Cancer Center; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Progetti di Ricerca di Interesse Nazionale; Universita di Salerno (Italy); European Cooperation in Science and Technology (COST Action)(European Cooperation in Science and Technology (COST)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT	Supported by the Odyssey Fellowship Program at The University of Texas MD Anderson Cancer Center.; Supported by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Progetti di Ricerca di Interesse Nazionale (PRIN 20152TE5PK), Universita di Salerno (Italy), and European Cooperation in Science and Technology (COST Action CM1406).; Supported by National Institutes of Health Grant CA216911.; Supported by National Institutes of Health Grant DK062248 and CPRIT Grant RP130432 for the protein array analysis.	Bae N, 2017, NAT CHEM BIOL, V13, P750, DOI 10.1038/nchembio.2377; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Chen SD, 2015, MOL CELL, V60, P319, DOI 10.1016/j.molcel.2015.08.019; Chew TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069764; Drane P, 2017, NATURE, V543, P211, DOI 10.1038/nature21358; Franz H, 2015, ONCOTARGET, V6, P4773, DOI 10.18632/oncotarget.3000; Gao YH, 2005, BIOCHEM BIOPH RES CO, V335, P343, DOI 10.1016/j.bbrc.2005.07.087; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; Li X, 2017, CELL REP, V20, P737, DOI 10.1016/j.celrep.2017.06.077; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Oh B, 1997, DEVELOPMENT, V124, P493; Shanle EK, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0117-5; Staub E, 2002, GENOME BIOL, V3; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su XN, 2014, GENE DEV, V28, P622, DOI 10.1101/gad.233239.113; Su ZL, 2016, ACS CHEM BIOL, V11, P564, DOI 10.1021/acschembio.5b00864; Wagner T, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw089; Wang JX, 2012, MOL CANCER RES, V10, P326, DOI 10.1158/1541-7786.MCR-11-0440; Wang WX, 2011, EMBO REP, V12, P1160, DOI 10.1038/embor.2011.184; Wang Y, 2010, J BIOL CHEM, V285, P10890, DOI 10.1074/jbc.M109.058347; Yang N, 2012, P NATL ACAD SCI USA, V109, P17954, DOI 10.1073/pnas.1208517109; Yuan HF, 2008, GENE, V410, P67, DOI 10.1016/j.gene.2007.11.019; Yue Wen, 2004, Ai Zheng, V23, P141; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhan YN, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0026-4; Zhang AL, 2017, J BIOL CHEM, V292, P6461, DOI 10.1074/jbc.M117.777474; Zhang P, 2008, J CELL PHYSIOL, V217, P400, DOI 10.1002/jcp.21515; Zhao Q, 2007, J BIOL CHEM, V282, P647, DOI 10.1074/jbc.M604029200	30	17	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20808	20817		10.1074/jbc.M117.814913	http://dx.doi.org/10.1074/jbc.M117.814913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29061846	Green Published, hybrid			2022-12-26	WOS:000418453400001
J	Mast, N; Lin, JB; Anderson, KW; Bjorkhem, I; Pikuleva, IA				Mast, Natalia; Lin, Joseph B.; Anderson, Kyle W.; Bjorkhem, Ingemar; Pikuleva, Irina A.			Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)	PLOS ONE			English	Article							ACYL-COENZYME; IN-VITRO; PROTEIN-PHOSPHORYLATION; TAU PHOSPHORYLATION; EXCHANGE FACTOR; RAB GTPASES; METABOLISM; 24-HYDROXYLASE; NEURONS; HOMEOSTASIS	Cytochrome P450 46A1 (CYP46A1) converts cholesterol to 24-hydroxycholesterol and thereby controls the major pathways of cholesterol removal from the brain. Cyp46a1(-/-) mice have a reduction in the rate of cholesterol biosynthesis in the brain and significant impairments to memory and learning. To gain insights into the mechanisms underlying Cyp46a1(-/-) phenotype, we used Cyp46a1(-/-) mice and quantified their brain sterol levels and the expression of the genes pertinent to cholesterol homeostasis. We also compared the Cyp46a1(-/-) and wild type brains for protein phosphorylation and ubiquitination. The data obtained enable the following inferences. First, there seems to be a compensatory upregulation in the Cyp46a1(-/-) brain of the pathways of cholesterol storage and CYP46A1-independent removal. Second, transcriptional regulation of the brain cholesterol biosynthesis via sterol regulatory element binding transcription factors is not significantly activated in the Cyp46a1(-/-) brain to explain a compensatory decrease in cholesterol biosynthesis. Third, some of the liver X receptor target genes (Abca1) are paradoxically upregulated in the Cyp46a1(-/-) brain, possibly due to a reduced activation of the small GTPases RAB8, CDC42, and RAC as a result of a reduced phosphorylation of RAB3IP and PAK1. Fourth, the phosphorylation of many other proteins (a total of 146) is altered in the Cyp46a1(-/-) brain, including microtubule associated and neurofilament proteins (the MAP and NEF families) along with proteins related to synaptic vesicles and synaptic neurotransmission (e.g., SLCs, SHANKs, and BSN). Fifth, the extent of protein ubiquitination is increased in the Cyp46a1(-/-) brain, and the affected proteins pertain to ubiquitination (UBE2N), cognition (STX1B and ATP1A2), cytoskeleton function (TUBA1A and YWHAZ), and energy production (ATP1A2 and ALDOA). The present study demonstrates the diverse potential effects of CYP46A1 deficiency on brain functions and identifies important proteins that could be affected by this deficiency.	[Mast, Natalia; Lin, Joseph B.; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Anderson, Kyle W.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Anderson, Kyle W.] Inst Biosci & Biotechnol Res, Rockville, MD USA; [Bjorkhem, Ingemar] Karolinska Inst, Div Clin Chem, Dept Lab Med, Huddinge, Sweden	Case Western Reserve University; National Institute of Standards & Technology (NIST) - USA; Karolinska Institutet	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	iap8@case.edu		Bjorkhem, Ingemar/0000-0002-0575-9425; Lin, Joseph/0000-0001-6667-9018; Anderson, Kyle/0000-0002-2808-3026; Pikuleva, Irina/0000-0001-9742-6232	National Institute of General Medical Sciences [GM062882]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant GM062882 (IAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 2013, J LIPID RES, V54, P1033, DOI 10.1194/jlr.M034124; Anderson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118839; Anderson KW, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9098-1; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Brachet A, 2015, J CELL BIOL, V208, P791, DOI 10.1083/jcb.201407122; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Diaz-Garcia CM, 2017, CELL METAB, V26, P361, DOI 10.1016/j.cmet.2017.06.021; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Giese KP, 2013, LEARN MEMORY, V20, P540, DOI 10.1101/lm.028449.112; Habegger KM, 2012, ENDOCRINOLOGY, V153, P2130, DOI 10.1210/en.2011-2099; Han J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00005; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hoang JJ, 2013, BIOCHEM PHARMACOL, V86, P168, DOI 10.1016/j.bcp.2013.04.005; Hodge CD, 2015, ACS CHEM BIOL, V10, P1718, DOI 10.1021/acschembio.5b00222; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jiang W, 2014, DIABETES METAB J, V38, P171, DOI 10.4093/dmj.2014.38.3.171; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Joo Y, 2015, FASEB J, V29, P4133, DOI 10.1096/fj.14-265009; Kinoshita PF, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00195; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Kotti T, 2008, P NATL ACAD SCI USA, V105, P11394, DOI 10.1073/pnas.0805556105; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kumar P, 2015, J ALZHEIMERS DIS, V43, P341, DOI 10.3233/JAD-140933; Kumar R, 2017, GENE, V605, P20, DOI 10.1016/j.gene.2016.12.014; Leal G, 2017, VITAM HORM, V104, P153, DOI 10.1016/bs.vh.2016.10.004; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liao WL, 2008, ANAL BIOCHEM, V377, P55, DOI 10.1016/j.ab.2008.03.016; Lin JB, 2016, J LIPID RES, V57, P258, DOI 10.1194/jlr.M064469; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Luu W, 2013, IUBMB LIFE, V65, P675, DOI 10.1002/iub.1182; Maiga SF, 2014, BIOCHIMIE, V96, P56, DOI 10.1016/j.biochi.2013.08.027; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; Mast N, 2017, J BIOL CHEM, V292, P12934, DOI 10.1074/jbc.M117.794909; Mast N, 2017, NEUROPHARMACOLOGY, V123, P465, DOI 10.1016/j.neuropharm.2017.06.026; Mast N, 2017, J BIOL CHEM, V292, P4913, DOI 10.1074/jbc.M116.774760; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Monteiro P, 2017, NAT REV NEUROSCI, V18, P147, DOI 10.1038/nrn.2016.183; Moutinho M, 2014, MOL NEUROBIOL; Moutinho M, 2016, BBA-MOL CELL BIOL L, V1861, P1911, DOI 10.1016/j.bbalip.2016.09.011; Moutinho M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30928; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Ng EL, 2008, BRAIN RES REV, V58, P236, DOI 10.1016/j.brainresrev.2008.04.006; Nunes MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053394; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Qureshi HY, 2013, BIOCHEMISTRY-US, V52, P6445, DOI 10.1021/bi400442d; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Ren Y, 2003, J NEUROSCI, V23, P3316; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rudrabhatla P, 2014, J ALZHEIMERS DIS, V41, P671, DOI 10.3233/JAD-130794; Saeed AA, 2014, J BIOL CHEM, V289, P23712, DOI 10.1074/jbc.M114.556159; Schroder MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058814; Schuetz G, 2004, J CELL BIOL, V167, P945, DOI 10.1083/jcb.200404108; Semenova G, 2017, BIOCHEM SOC T, V45, P79, DOI 10.1042/BST20160134; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Shafaati M, 2009, BIOCHEM BIOPH RES CO, V378, P689, DOI 10.1016/j.bbrc.2008.11.103; Sodero AO, 2012, EMBO J, V31, P1764, DOI 10.1038/emboj.2012.31; Sodero AO, 2011, J NEUROCHEM, V116, P747, DOI 10.1111/j.1471-4159.2010.07079.x; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Teng FYH, 2001, GENOME BIOL, V2; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; TURLEY SD, 1981, J LIPID RES, V22, P551; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Wang JF, 2015, P NATL ACAD SCI USA, V112, P148, DOI 10.1073/pnas.1412089112; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Waterham HR, 2006, FEBS LETT, V580, P5442, DOI 10.1016/j.febslet.2006.07.027; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	97	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187168	10.1371/journal.pone.0187168	http://dx.doi.org/10.1371/journal.pone.0187168			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073233	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400129
J	Yang, L; Ji, Y; Chen, L; Li, M; Wu, F; Hu, JM; Jiang, JF; Cui, XB; Chen, YZ; Pang, LJ; Wei, YT; Li, F				Yang, Lan; Ji, Yu; Chen, Ling; Li, Mei; Wu, Fei; Hu, Jianming; Jiang, Jinfang; Cui, Xiaobin; Chen, Yunzhao; Pang, Lijuan; Wei, Yutao; Li, Feng			Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; LUNG-CANCER; POLYMORPHISMS; SUSCEPTIBILITY; METAANALYSIS; EXPRESSION; VIRUS; AREA; TAP1	The Kazakh population in Xinjiang Province in northwestern China exhibits a high incidence of esophageal squamous cell carcinoma (ESCC). Although the etiology of esophageal carcinoma (EC) has not been elucidated, there are reports of the involvement of an immunologic mechanism. In the current study, 268 Kazakh ESCC patients and 500 age-and sexmatched control subjects were recruited. DNA was extracted from paraffin-embedded tumor specimens from the patients and peripheral blood lymphocytes from the controls and used for LMP2/LMP7 genotyping. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis was performed to detect LMP2/LMP7 gene singlenucleotide polymorphisms (SNPs). We found a clear increased risk of ESCC in the Kazakh population for the heterozygous LMP2 R/C genotype and the homozygous C/C genotype (OR = 1.470, 95% CI = 1.076-2.008, p = 0.015 for LMP2R/C; OR = 2.048, 95% CI = 1.168-3.591, p = 0.011 for LMP2 C/C). Conversely, the heterozygous LMP7 Q/K polymorphism was found to decrease the risk of ESCC in this population (OR = 0.421, 95% CI = 0.286-0.621, p = 8.83x10(-6)). Moreover, LMP2 R/C+C/C genotype was associated with increased tumor invasion depth (p = 0.041). Haplotype analysis showed that haplotype A, which includes wild-type homozygous LMP2/TAP1 and mutant LMP7, decreases susceptibility to ESCC in the Kazakh population; in contrast, haplotype E, which includes wild-type homozygous LMP2/LMP7/TAP1, acts as a risk factor for increased susceptibility to ESCC. This is the first study to report that the heterozygous LMP2 R/C and homozygous C/C genotypes increase susceptibility to ESCC in the Kazakh population and that the heterozygous LMP7 Q/K genotype decreases susceptibility to ESCC in this population. Nevertheless, neither LMP2 nor LMP7 was associated with human papillomavirus (HPV) infection. Understanding LMP2/LMP7 genetic variability will provide a new therapeutic perspective for Kazakh patients with ESCC.	[Yang, Lan; Ji, Yu; Chen, Ling; Li, Mei; Wu, Fei; Hu, Jianming; Jiang, Jinfang; Cui, Xiaobin; Chen, Yunzhao; Pang, Lijuan; Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Yang, Lan; Ji, Yu; Chen, Ling; Li, Mei; Wu, Fei; Hu, Jianming; Jiang, Jinfang; Cui, Xiaobin; Chen, Yunzhao; Pang, Lijuan; Li, Feng] Shihezi Univ, Sch Med, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Wei, Yutao] Shihezi Univ, Affiliated Hosp 1, Sch Med, Shihezi, Xinjiang, Peoples R China; [Li, Feng] Capital Med Univ, Beijing ChaoYang Hosp, Dept Pathol, Beijing, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Capital Medical University	Li, F (corresponding author), Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China.; Li, F (corresponding author), Shihezi Univ, Sch Med, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.; Li, F (corresponding author), Capital Med Univ, Beijing ChaoYang Hosp, Dept Pathol, Beijing, Peoples R China.	lifeng7855@126.com	zhang, xu/GYE-3558-2022; Sui, Yanwei/AAH-9928-2021; zhang, xu/GRX-9733-2022		National Natural Science Foundation of China [81260301, 81560399, 81160301, 81360358, 81460362]; Xinjiang Production and Construction Corps [20141313019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang Production and Construction Corps	This research has been supported in part by the National Natural Science Foundation of China (Grant Nos. 81260301, 81560399, 81160301, 81360358, and 81460362), and the doctoral grant from the Xinjiang Production and Construction Corps (Grant No. 20141313019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camarena A, 2010, RESP MED, V104, P889, DOI 10.1016/j.rmed.2010.01.014; Cao BW, 2012, HUM IMMUNOL, V73, P580, DOI 10.1016/j.humimm.2011.12.005; Cao BW, 2005, CARCINOGENESIS, V26, P1280, DOI 10.1093/carcin/bgi071; Casp CB, 2003, GENES IMMUN, V4, P492, DOI 10.1038/sj.gene.6364016; CEPPELLINI R, 1989, NATURE, V339, P392, DOI 10.1038/339392a0; CHANG FJ, 1992, GASTROENTEROLOGY, V103, P1336, DOI 10.1016/0016-5085(92)91526-A; Cui XB, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0791-5; Cui XB, 2013, GENE, V530, P315, DOI 10.1016/j.gene.2013.08.057; de Villiers EM, 1999, INT J CANCER, V81, P225, DOI 10.1002/(SICI)1097-0215(19990412)81:2&lt;225::AID-IJC10&gt;3.0.CO;2-0; Deshpande A, 2008, J INFECT DIS, V197, P371, DOI 10.1086/524300; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Gostout BS, 2003, GYNECOL ONCOL, V88, P326, DOI 10.1016/S0090-8258(02)00074-4; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kraemer U, 2007, GENES IMMUN, V8, P513, DOI 10.1038/sj.gene.6364404; Lambert R, 2007, BEST PRACT RES CL GA, V21, P921, DOI 10.1016/j.bpg.2007.10.001; Li T, 2001, CARCINOGENESIS, V22, P929, DOI 10.1093/carcin/22.6.929; Ma X, 2015, ONCOL LETT, V10, P509, DOI 10.3892/ol.2015.3154; Messmann H, 2001, BEST PRACT RES CL GA, V15, P249, DOI 10.1053/bega.2000.0172; Milne ANA, 2006, MODERN PATHOL, V19, P564, DOI 10.1038/modpathol.3800563; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Ozbas-Gerceker F, 2013, ASIAN PAC J CANCER P, V14, P6399, DOI 10.7314/APJCP.2013.14.11.6399; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qin JM, 2008, WORLD J GASTROENTERO, V14, P6986, DOI 10.3748/wjg.14.6986; Rafiei Alireza, 2007, Iran Biomed J, V11, P23; Schutt P, 2010, HUM IMMUNOL, V71, P489, DOI 10.1016/j.humimm.2010.02.015; Song L, 2014, HUM IMMUNOL, V75, P239, DOI 10.1016/j.humimm.2013.12.006; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sur M, 1998, PATHOLOGY, V30, P348, DOI 10.1080/00313029800169616; Vargas-Alarcon G, 2004, HUM IMMUNOL, V65, P1437, DOI 10.1016/j.humimm.2004.09.007; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449; Xu CQ, 2007, J CLIN IMMUNOL, V27, P534, DOI 10.1007/s10875-007-9095-x; Yu ZB, 2013, OMICS, V17, P200, DOI 10.1089/omi.2012.0089; Zhang YM, 2012, GENET MOL RES, V11, P3389, DOI 10.4238/2012.September.25.7; Zheng ST, 2010, EUR J GASTROEN HEPAT, V22, P917, DOI 10.1097/MEG.0b013e3283313d8b; Zou NJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0185-y	38	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186319	10.1371/journal.pone.0186319	http://dx.doi.org/10.1371/journal.pone.0186319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073155	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400022
J	Krishtal, J; Bragina, O; Metsla, K; Palumaa, P; Tougu, V				Krishtal, Jekaterina; Bragina, Olga; Metsla, Kristel; Palumaa, Peep; Tougu, Vello			In situ fibrillizing amyloid- beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells	PLOS ONE			English	Article							HUMAN NEUROBLASTOMA; A-BETA; ALZHEIMERS-DISEASE; RETINOIC ACID; PEPTIDE NEUROTOXICITY; MECHANISM; VITRO; MTT; OLIGOMERS; SECONDARY	The progression of Alzheimer's disease is causatively linked to the accumulation of amy-loid-beta aggregates in the brain, however, it is not clear how the amyloid aggregates initiate the death of neuronal cells. The in vitro toxic effects of amyloid peptides are most commonly examined using the human neuroblastoma derived SH-SY5Y cell line and here we show that differentiated neuron-like SH-SY5Y cells are more sensitive to amyloid peptides than non-differentiated cells, because the latter lack long neurites. Exogenous soluble amyloid-beta 1-42 covered cell bodies and whole neurites in differentiated cells with dense fibrils, causing neurite beading and fragmentation, whereas preformed amyloid-beta 1-42 fibrils had no toxic effects. Importantly, spontaneously fibrillizing amyloid-beta 1-42 peptide exhibited substantially higher cellular toxicity than amyloid-beta 1-40, which did not form fibrils under the experimental conditions. These results support the hypothesis that peptide toxicity is related to the active fibrillization process in the incubation mixture.	[Krishtal, Jekaterina; Bragina, Olga; Metsla, Kristel; Palumaa, Peep; Tougu, Vello] Tallinn Univ Technol, Dept Chem & Biotechnol, Tallinn, Estonia	Tallinn University of Technology	Krishtal, J (corresponding author), Tallinn Univ Technol, Dept Chem & Biotechnol, Tallinn, Estonia.	katerina.kristall@gmail.com	Bragina, Olga/K-9159-2019; Krishtal, Jekaterina/P-4195-2019; Palumaa, Peep/B-4668-2019; Tõugu, Vello/B-4462-2019; Krishtal, Jekaterina/B-4613-2019; Bragina, Olga/B-5112-2019; Palumaa, Peep/AAF-7617-2020; Metsla, Kristel/B-5135-2019	Bragina, Olga/0000-0001-5281-7758; Krishtal, Jekaterina/0000-0001-9279-1839; Palumaa, Peep/0000-0002-3505-3466; Krishtal, Jekaterina/0000-0001-9279-1839; Palumaa, Peep/0000-0002-3505-3466; Tougu, Vello/0000-0002-6271-7993; Metsla, Kristel/0000-0002-7274-1233	Estonian Research Council [IUT 19-8]; Estonian Science Foundation [9318]	Estonian Research Council; Estonian Science Foundation	This work was supported by the Estonian Research Council (grant IUT 19-8) to PP and Estonian Science Foundation grant 9318 to VT.; This work was supported by the Estonian Research Council (grant IUT 19-8) to PP and Estonian Science Foundation grant 9318 to VT. Authors thank Dr. Urmas Arumae for his valuable comments on the manuscript, Dr. Juri Jarvet and Dr. Jasper Adamson for taking and interpreting the <SUP>1</SUP>HNMR spectra of peptides and Ms. Merlin Friedemann for the quality checks of the peptides by using MALDI-MS and SDS-PAGE techniques. The authors thank Lewis Taylor for academic writing support.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Amijee H, 2012, BIOCHEMISTRY-US, V51, P8338, DOI 10.1021/bi300415v; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Chen YS, 2014, EXP NEUROL, V253, P63, DOI 10.1016/j.expneurol.2013.12.009; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; Datki Z, 2003, BRAIN RES BULL, V62, P223, DOI 10.1016/j.brainresbull.2003.09.011; Di Scala C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28781; Dorostkar MM, 2015, ACTA NEUROPATHOL, V130, P1, DOI 10.1007/s00401-015-1449-5; Edsjo A, 2003, LAB INVEST, V83, P813, DOI 10.1097/01.LAB.0000074895.48776.D8; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Endres Kristina, 2013, Am J Neurodegener Dis, V2, P247; Ferrone FA, 2015, NAT STRUCT MOL BIOL, V22, P180, DOI 10.1038/nsmb.2980; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Forster JI, 2016, J BIOMOL SCREEN; Funderburk SF, 2010, MT SINAI J MED, V77, P59, DOI 10.1002/msj.20161; Gurry T, 2014, BIOCHEMISTRY-US, V53, P6981, DOI 10.1021/bi500695g; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Isobe I, 1999, NEUROSCI LETT, V266, P129, DOI 10.1016/S0304-3940(99)00282-7; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Jankowska A, 2017, CURR MED CHEM; Julien C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040020; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kawataki T, 2008, BRAIN RES, V1230, P37, DOI 10.1016/j.brainres.2008.06.075; LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320; LAMBERT MP, 1994, J NEUROSCI RES, V39, P377, DOI 10.1002/jnr.490390404; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Liu YB, 1999, PROG NEURO-PSYCHOPH, V23, P377, DOI 10.1016/S0278-5846(99)00003-2; Lu LH, 2012, TOXICOL IN VITRO, V26, P636, DOI 10.1016/j.tiv.2012.02.006; Marshall KE, 2014, PRION, V8, P192, DOI 10.4161/pri.28860; Matsuzaki K., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/956104; Milton NGN, 2012, ACS CHEM NEUROSCI, V3, P706, DOI 10.1021/cn300045d; Morris GP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0135-5; Munter LM, 2016, J NEUROCHEM, V136, P437, DOI 10.1111/jnc.13502; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Olah J, 2011, J BIOL CHEM, V286, P34088, DOI 10.1074/jbc.M111.243907; Picone P, 2009, BIOPHYS J, V96, P4200, DOI 10.1016/j.bpj.2008.11.056; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Ramsey A, 2016, J BEHAV HEALTH SER R, V43, P54, DOI 10.1007/s11414-014-9436-5; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Silva-Alvarez C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00097; Song MS, 2006, NEUROBIOL AGING, V27, P1224, DOI 10.1016/j.neurobiolaging.2005.06.007; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tiiman A, 2015, BIOCHEMISTRY-US, V54, P7203, DOI 10.1021/acs.biochem.5b00976; Tiiman A, 2013, J PEPT SCI, V19, P386, DOI 10.1002/psc.2513; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Wakabayashi M, 2007, J MOL BIOL, V371, P924, DOI 10.1016/j.jmb.2007.06.008; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Xiao ZM, 2013, EUR J PHARMACOL, V721, P286, DOI 10.1016/j.ejphar.2013.09.023; Xicoy H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0149-0; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447; Zovo K, 2010, ANAL CHEM, V82, P8558, DOI 10.1021/ac101583q	58	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186636	10.1371/journal.pone.0186636	http://dx.doi.org/10.1371/journal.pone.0186636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065138	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900023
J	Lei, S; Ding, Y; Fu, Y; Wu, S; Xie, X; Wang, CC; Liang, HJ				Lei, Shun; Ding, Yao; Fu, Yun; Wu, Shuang; Xie, Xiong; Wang, Cancan; Liang, Houjie			The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; AUTOPHAGY; BCL-2; COMBINATIONS; APOPTOSIS; PATHWAYS; TARGET; DEATH	TW-37 is a novel, potent and non-peptide Bcl-2 small-molecule inhibitor. Its activity in colorectal cancer (CRC) cells is studied. In both HCT-116 cells and primary human colon cancer cells, treatment with TW-37 at only nM concentration efficiently inhibited cell survival and proliferation. TW-37 also induced caspase-3/9 and apoptosis activation in CRC cells. Feedback autophagy activation was observed in TW-37-treated CRC cells. Reversely pharmacological autophagy inhibition or Beclin-1 knockdown by targeted-shRNA potentiated TW-37-induced apoptosis and killing of CRC cells. In vivo, intravenous injection of TW-37 inhibited HCT-116 tumor growth in mice. TW-37's anti-tumor activity was further potentiated against Beclin-1-silenced HCT-116 tumors. Together, targeting Bcl-2 family protein by TW-37 efficiently inhibits CRC cell growth in vitro and in vivo. Inhibition of feedback autophagy activation could further sensitize TW-37.	[Lei, Shun; Ding, Yao; Wu, Shuang; Xie, Xiong; Wang, Cancan; Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Lei, Shun; Ding, Yao; Wu, Shuang; Xie, Xiong; Wang, Cancan; Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Fu, Yun] Gao Xin Dist Peoples Hosp Chong Qing, Dept Gen Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.; Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China.	lianghoujie@sina.com			National Nature Science Foundation of China [81702443, 81702929]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National Nature Science Foundation of China (Grant No. 81702443 and 81702929). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Katib AM, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-8; Ashimori N, 2009, MOL CANCER THER, V8, P893, DOI 10.1158/1535-7163.MCT-08-1078; Bravo-San Pedro JM, 2015, AUTOPHAGY, V11, P452, DOI 10.1080/15548627.2015.1017191; Brouquet A, 2013, NAT REV GASTRO HEPAT, V10, P266, DOI 10.1038/nrgastro.2013.53; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chen MB, 2016, ONCOTARGET, V7, P17047, DOI 10.18632/oncotarget.7742; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Frankfurt OS, 2001, J IMMUNOL METHODS, V253, P133, DOI 10.1016/S0022-1759(01)00387-8; Fu LL, 2013, INT J BIOCHEM CELL B, V45, P921, DOI 10.1016/j.biocel.2013.02.007; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hubbard JM, 2015, NAT REV CLIN ONCOL, V12, P73, DOI 10.1038/nrclinonc.2014.233; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuipers EJ, 2013, NAT REV CLIN ONCOL, V10, P130, DOI 10.1038/nrclinonc.2013.12; Leake Isobel, 2014, Nat Rev Gastroenterol Hepatol, V11, P270, DOI 10.1038/nrgastro.2014.60; Li C, 2015, CANCER BIOL THER, V16, P34, DOI 10.4161/15384047.2014.972274; Li JP, 2016, ONCOTARGET, V7, P77815, DOI 10.18632/oncotarget.12802; Lu PH, 2016, ONCOTARGET, V7, P45889, DOI 10.18632/oncotarget.9969; Manne U, 1997, INT J CANCER, V74, P346, DOI 10.1002/(SICI)1097-0215(19970620)74:3<346::AID-IJC19>3.0.CO;2-9; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Reyjal J, 2014, ADV EXP MED BIOL, V772, P167, DOI 10.1007/978-1-4614-5915-6_8; Schmoll HJ, 2014, NAT REV CLIN ONCOL, V11, P79, DOI 10.1038/nrclinonc.2013.254; Schonewolf CA, 2014, WORLD J GASTRO ONCOL, V6, P74, DOI 10.4251/wjgo.v6.i3.74; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Wang ZW, 2008, INT J CANCER, V123, P958, DOI 10.1002/ijc.23610; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Yang LF, 2016, AM J CANCER RES, V6, P1345; Yao X, 2017, TUMOR BIOL, V39, P1, DOI DOI 10.1177/1010428317695965; Zhen YF, 2016, ONCOTARGET, V7, P79403, DOI 10.18632/oncotarget.12712	34	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0184501	10.1371/journal.pone.0184501	http://dx.doi.org/10.1371/journal.pone.0184501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065135	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900002
J	Piazzolla, G; Castrovilli, A; Liotino, V; Vulpi, MR; Fanelli, M; Mazzocca, A; Candigliota, M; Berardi, E; Resta, O; Sabba, C; Tortorella, C				Piazzolla, Giuseppina; Castrovilli, Anna; Liotino, Vito; Vulpi, Maria Rosaria; Fanelli, Margherita; Mazzocca, Antonio; Candigliota, Mafalda; Berardi, Elsa; Resta, Onofrio; Sabba, Carlo; Tortorella, Cosimo			Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D	PLOS ONE			English	Article							PLASMA 25-HYDROXYVITAMIN D; D DEFICIENCY; CARDIOVASCULAR-DISEASE; LUNG-FUNCTION; RISK; SUPPLEMENTATION; MITOCHONDRIA; ASSOCIATION; POPULATION; PREVALENCE	Background A close relationship between Metabolic Syndrome (MetS) and Chronic Obstructive Pulmonary Disease (COPD) has been described, but the exact nature of this link remains unclear. Current epidemiological data refer exclusively to the MetS prevalence among patients with COPD and data about the prevalence of COPD in MetS patients are still unavailable. Aim of the study To analyse and compare risk factors, clinical and metabolic characteristics, as well as the main respiratory function parameters, among patients affected by MetS, COPD or both diseases. Patients We recruited 59 outpatients with MetS and 76 outpatients with COPD. After medical history collection, physical examination, blood sampling for routine analysis, spirometric evaluation, they were subdivided into MetS (n = 46), MetS+COPD (n = 60), COPD (n = 29). Results A MetS diagnosis was assigned to 62% of COPD patients recruited in the COPD Outpatients Clinic of the Pneumology Department, while the COPD prevalence in MetS patients enrolled in the Internal Medicine Metabolic Disorders Outpatients Clinic was 22%. More than 60% of subjects enrolled in each Department were unaware that they suffered from an additional disease. MetS+ COPD patients exhibited significantly higher C-peptide levels. We also found a positive relation between C-peptide and pack-years in all subjects and a negative correlation between C-peptide and vitamin D only in current smokers. Finally, a negative association emerged between smoking and vitamin D. Conclusions We have estimated, for the first time, the COPD prevalence in MetS and suggest a potential role of smoking in inducing insulin resistance. Moreover, a direct effect of smoking on vitamin D levels is proposed as a novel mechanism, which may account for both insulin resistance and COPD development.	[Piazzolla, Giuseppina; Castrovilli, Anna; Fanelli, Margherita; Mazzocca, Antonio; Candigliota, Mafalda; Berardi, Elsa; Sabba, Carlo; Tortorella, Cosimo] Univ Bari, Sch Med, Interdisciplinary Dept Med, Bari, Italy; [Liotino, Vito; Vulpi, Maria Rosaria; Resta, Onofrio] Univ Bari, Sch Med, Dept Cardiac Thorac & Vasc Sci, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Piazzolla, G (corresponding author), Univ Bari, Sch Med, Interdisciplinary Dept Med, Bari, Italy.	giuseppina.piazzolla@uniba.it	Fanelli, Margherita/AAC-9761-2022	Piazzolla, Giuseppina/0000-0003-3221-6562; Castrovilli, Anna/0000-0003-2694-2533; MAZZOCCA, Antonio/0000-0003-0940-7352; Fanelli, Margherita/0000-0002-0128-9745	Universita degli Studi di Bari	Universita degli Studi di Bari	This work was supported by Universita degli Studi di Bari (C.T.; G.P.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2014, THORAX, V69, P24, DOI 10.1136/thoraxjnl-2013-203682; Agrawal A, 2016, AM J PHYSIOL-LUNG C, V310, pL103, DOI 10.1152/ajplung.00320.2015; ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baffi CW, 2016, CHEST, V149, P1525, DOI 10.1016/j.chest.2015.12.034; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Breyer MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098013; Cazzola M, 2011, RESP MED, V105, P386, DOI 10.1016/j.rmed.2010.09.022; Cena H, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-28; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204; Diez-Manglano J, 2014, INTERN EMERG MED, V9, P419, DOI 10.1007/s11739-013-0945-7; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Heulens N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160482; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kastorini CM, 2016, NUTR METAB CARDIOVAS, V26, P223, DOI 10.1016/j.numecd.2015.12.010; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Lange NE, 2012, AM J RESP CRIT CARE, V186, P616, DOI 10.1164/rccm.201110-1868OC; Lipovec NC, 2016, COPD, V13, P399, DOI 10.3109/15412555.2016.1140732; Lonardo A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00546-2017; Longoni A, 2017, NUTR RES, V38, P52, DOI 10.1016/j.nutres.2017.01.007; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; Minas M, 2011, COPD, V8, P414, DOI 10.3109/15412555.2011.619600; Mirrakhimov AE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-132; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Muscogiuri G, 2012, NUTR METAB CARDIOVAS, V22, P81, DOI 10.1016/j.numecd.2011.11.001; Onat A, 2007, ATHEROSCLEROSIS, V193, P380, DOI 10.1016/j.atherosclerosis.2006.07.002; Patel ARC, 2011, EXPERT REV RESP MED, V5, P647, DOI [10.1586/ERS.11.62, 10.1586/ers.11.62]; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Silvagno F, 2017, MOL CELL ENDOCRINOL, V450, P24, DOI 10.1016/j.mce.2017.04.013; Singh S, 2016, AM J PHYSIOL-LUNG C, V310, pL837, DOI 10.1152/ajplung.00091.2015; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Viglino D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01923-2016; Vogelmeier C. F, 2017, EUR RESP J, V49, P1700214; Wada T, 2007, INTERNAL MED, V46, P1079, DOI 10.2169/internalmedicine.46.0026; Watz H, 2009, CHEST, V136, P1039, DOI 10.1378/chest.09-0393; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	43	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186708	10.1371/journal.pone.0186708	http://dx.doi.org/10.1371/journal.pone.0186708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065130	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900026
J	Tomas, C; Brown, A; Strassheim, V; Elson, J; Newton, J; Manning, P				Tomas, Cara; Brown, Audrey; Strassheim, Victoria; Elson, Joanna; Newton, Julia; Manning, Philip			Cellular bioenergetics is impaired in patients with chronic fatigue syndrome	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; RESPONSES; EXERCISE; REVEALS	Chronic fatigue syndrome (CFS) is a highly debilitating disease of unknown aetiology. Abnormalities in bioenergetic function have been cited as one possible cause for CFS. Preliminary studies were performed to investigate cellular bioenergetic abnormalities in CFS patients. A series of assays were conducted using peripheral blood mononuclear cells (PBMCs) from CFS patients and healthy controls. These experiments investigated cellular patterns in oxidative phosphorylation (OXPHOS) and glycolysis. Results showed consistently lower measures of OXPHOS parameters in PBMCs taken from CFS patients compared with healthy controls. Seven key parameters of OXPHOS were calculated: basal respiration, ATP production, proton leak, maximal respiration, reserve capacity, non-mitochondrial respiration, and coupling efficiency. While many of the parameters differed between the CFS and control cohorts, maximal respiration was determined to be the key parameter in mitochondrial function to differ between CFS and control PBMCs due to the consistency of its impairment in CFS patients found throughout the study (p <= 0.003). The lower maximal respiration in CFS PBMCs suggests that when the cells experience physiological stress they are less able to elevate their respiration rate to compensate for the increase in stress and are unable to fulfil cellular energy demands. The metabolic differences discovered highlight the inability of CFS patient PBMCs to fulfil cellular energetic demands both under basal conditions and when mitochondria are stressed during periods of high metabolic demand.	[Tomas, Cara; Brown, Audrey; Newton, Julia; Manning, Philip] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Strassheim, Victoria] Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Strassheim, Victoria; Newton, Julia] NHS Fdn Trust, Newcastle Upon Tyne Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Elson, Joanna] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [Elson, Joanna] North West Univ, Ctr Human Metabol, Potchefstroom, South Africa	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; North West University - South Africa	Tomas, C (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	c.j.tomas@ncl.ac.uk		/0000-0002-3551-5624; Newton, Julia/0000-0002-1249-5253; Tomas, Cara/0000-0002-6471-6281	Medical Research Council, Action for ME, ME Research UK; ME association; Newcastle Molecular Pathology Node (Medical Research Council); Newcastle Molecular Pathology Node (Engineering and Physical Sciences Research Council); MRC [MR/N005872/1, MR/J002712/1] Funding Source: UKRI; Medical Research Council [MR/N005872/1, 1512767, MR/J002712/1] Funding Source: researchfish	Medical Research Council, Action for ME, ME Research UK; ME association; Newcastle Molecular Pathology Node (Medical Research Council); Newcastle Molecular Pathology Node (Engineering and Physical Sciences Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank the following funders for their financial support for this study: The Medical Research Council, Action for ME, ME Research UK, the ME association and the Newcastle Molecular Pathology Node (which is jointly sponsored by the Medical Research Council and the Engineering and Physical Sciences Research Council).	Agilent Technologies 4, REP GEN US GUID XF C; Anderson JS, 1997, J NERV MENT DIS, V185, P359, DOI 10.1097/00005053-199706000-00001; [Anonymous], 2015, MYALG ENC CHRON FAT; Billing-Ross P, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0771-6; Biniecka MC M., 2016, ANNULS RHEUMATIC DIS, V75; Bishop R., 2010, ME CHRONIC FATIGUE S; Blackwood SK, 1998, J NEUROL NEUROSUR PS, V65, P541, DOI 10.1136/jnnp.65.4.541; Booth NE, 2012, INT J CLIN EXP MED, V5, P208; Brown AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122982; Calton EK, 2016, REDOX BIOL, V10, P243, DOI 10.1016/j.redox.2016.10.007; Castro-Marrero J, 2013, ANTIOXID REDOX SIGN, V19, P1855, DOI 10.1089/ars.2013.5346; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; Craig T, 2002, AM FAM PHYSICIAN, V65, P1083; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Filler K, 2014, BBA CLIN, V1, P12, DOI 10.1016/j.bbacli.2014.04.001; Fluge O, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89376; Fritschi CF, 2012, EUROPEAN ENDOCRINOLO, V8, P80; Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Germain A, 2017, MOL BIOSYST, V13, P371, DOI 10.1039/c6mb00600k; Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001; Hartman ML, 2014, VASC MED, V19, P67, DOI 10.1177/1358863X14521315; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; Jones N, 2015, CLIN EXP IMMUNOL, V182, P69, DOI 10.1111/cei.12662; Kennedy G, 2005, FREE RADICAL BIO MED, V39, P584, DOI 10.1016/j.freeradbiomed.2005.04.020; Lawson N., 2016, J NATURE SCI, V2; Lindal E, 2006, NORD J PSYCHIAT, V60, P183; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Myhill S, 2013, INT J CLIN EXP MED, V6, P1; Myhill S, 2009, INT J CLIN EXP MED, V2, P1; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; National Institute for Health and Care Excellence, 2007, CHRONIC FATIGUE SYND; Naviaux RN J., 2016, PNAS, V113; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Omodei D, 2015, METABOLISM, V64, P396, DOI 10.1016/j.metabol.2014.10.025; Ottenweller JE, 2001, NEUROPSYCHOBIOLOGY, V43, P34, DOI 10.1159/000054863; Picard M, 2015, P NATL ACAD SCI USA, V112, pE6614, DOI 10.1073/pnas.1515733112; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Schoeman EM, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0387-6; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Smits B, 2011, MITOCHONDRION, V11, P735, DOI 10.1016/j.mito.2011.05.005; Tyrrell DJ, 2015, EXP GERONTOL, V70, P84, DOI 10.1016/j.exger.2015.07.015; VanNess JM, 2008, J CHRONIC FATIGUE SY, V14, P77; Vermeulen RCW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-93; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08; Wessely S, 1997, AM J PUBLIC HEALTH, V87, P1449, DOI 10.2105/AJPH.87.9.1449; WONG R, 1992, CHEST, V102, P1716, DOI 10.1378/chest.102.6.1716; Yamano E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34990	49	69	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186802	10.1371/journal.pone.0186802	http://dx.doi.org/10.1371/journal.pone.0186802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK5VD	29065167	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900042
J	Honsdorf, N; March, TJ; Pillen, K				Honsdorf, Nora; March, Timothy J.; Pillen, Klaus			QTL controlling grain filling under terminal drought stress in a set of wild barley introgression lines	PLOS ONE			English	Article							VULGARE SSP SPONTANEUM; AGRONOMIC TRAITS; SPRING BARLEY; MALTING QUALITY; POWDERY MILDEW; EXOTIC ALLELES; IDENTIFICATION; RESISTANCE; YIELD; VERIFICATION	Drought is a major abiotic stress impeding the yield of cereal crops globally. Particularly in Mediterranean environments, water becomes a limiting factor during the reproductive developmental stage, causing yield losses. The wild progenitor of cultivated barley Hordeum vulgare ssp spontaneum (Hsp) is a potentially useful source of drought tolerance alleles. Wild barley introgression lines like the S42IL library may facilitate the introduction of favorable exotic alleles into breeding material. The complete set of 83 S42ILs was genotyped with the barley 9k iSelect platform in order to complete genetic information obtained in previous studies. The new map comprises 2,487 SNPs, spanning 989.8 cM and covering 94.5% of the Hsp genome. Extent and positions of introgressions were confirmed and new information for ten additional S42ILs was collected. A subset of 49 S42ILs was evaluated for drought response in four greenhouse experiments. Plants were grown under well-watered conditions until ten days post anthesis. Subsequently drought treatment was applied by reducing the available water. Several morphological and harvest parameters were evaluated. Under drought treatment, trait performance was reduced. However, there was no interaction effect between genotype and treatment, indicating that genotypes, which performed best under control treatment, also performed best under drought treatment. In total, 40 QTL for seven traits were detected in this study. For instance, favorable Hsp effects were found for thousand grain weight (TGW) and number of grains per ear under drought stress. In particular, line S42IL-121 is a promising candidate for breeding improved malting cultivars, displaying a TGW, which was increased by 17% under terminal drought stress due to the presence of an unknown wild barley QTL allele on chromosome 4H. The introgression line showed a similar advantage in previous field experiments and in greenhouse experiments under early drought stress. We, thus, recommend using S42IL-121 in barley breeding programs to enhance terminal drought tolerance.	[Honsdorf, Nora; March, Timothy J.; Pillen, Klaus] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Plant Breeding, Halle, Germany; [Honsdorf, Nora] Int Maize & Wheat Improvement Ctr CIMMYT, Sustainable Intensificat Program, Texcoco, Mexico; [March, Timothy J.] Univ Adelaide, Sch Agr Food & Wine, Waite Campus, Adelaide, SA, Australia	Martin Luther University Halle Wittenberg; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Adelaide	Pillen, K (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, Plant Breeding, Halle, Germany.	klaus.pillen@landw.uni-halle.de	Pillen, Klaus/I-6511-2012	Pillen, Klaus/0000-0003-4646-6351	German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF) [0315041B]; Interdisciplinary Centre for Crop Plant Research (IZN), Halle; Joint Research Cooperation Scheme of the German Academic Exchange Service (DAAD) [54391967]; Group of Eight, Australia [G08]	German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Centre for Crop Plant Research (IZN), Halle; Joint Research Cooperation Scheme of the German Academic Exchange Service (DAAD); Group of Eight, Australia	This work was supported by the German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF, project 0315041B to KP, https://www.bmbf.de/en), the Interdisciplinary Centre for Crop Plant Research (IZN), Halle, (http://www.uni-halle.de/izn to KP), the Joint Research Cooperation Scheme of the German Academic Exchange Service (DAAD, ID 54391967 to KP, https://www.daad.de/en/) and the Group of Eight, Australia, to TJM, (G08, https://g08.edu.au). We are grateful to TraitGenetics GmbH, Gatersleben, Germany, for genotyping S42ILs with the Infinium iSelect 9k SNP chip. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elwafa SF, 2016, CR BIOL, V339, P153, DOI 10.1016/j.crvi.2016.03.001; Arriagada O, 2017, ACTA SCI-AGRON, V39, P321, DOI 10.4025/actasciagron.v39i3.32612; Baum M, 2003, THEOR APPL GENET, V107, P1215, DOI 10.1007/s00122-003-1357-2; Blum A, 1998, EUPHYTICA, V100, P77, DOI 10.1023/A:1018303922482; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Butler D., 2007, TECHNICAL REPORT; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Dawson IK, 2015, NEW PHYTOL, V206, P913, DOI 10.1111/nph.13266; Dolferus R, 2011, PLANT SCI, V181, P331, DOI 10.1016/j.plantsci.2011.05.015; El Soda M, 2010, MOL BREEDING, V26, P583, DOI 10.1007/s11032-010-9393-5; Gruszka D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01824; Hoffmann A, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-88; Honsdorf N, 2014, MOL BREEDING, V34, P1475, DOI 10.1007/s11032-014-0131-2; Honsdorf N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097047; Ivandic V, 2000, J EXP BOT, V51, P2021, DOI 10.1093/jexbot/51.353.2021; Kapusi E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00540; Lakew B, 2011, FIELD CROP RES, V120, P161, DOI 10.1016/j.fcr.2010.09.011; Lakew B, 2013, EUPHYTICA, V189, P9, DOI 10.1007/s10681-012-0674-4; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li J, 2005, THEOR APPL GENET, V110, P356, DOI 10.1007/s00122-004-1847-x; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Maurer A, 2016, J EXP BOT, V67, P2507, DOI 10.1093/jxb/erw070; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Mikolajczak K, 2017, J APPL GENET, V58, P23, DOI 10.1007/s13353-016-0358-1; Mora F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00909; Moragues M, 2010, THEOR APPL GENET, V120, P1525, DOI 10.1007/s00122-010-1273-1; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Naz AA, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0107-6; Nice LM, 2016, GENETICS, V203, P1453, DOI 10.1534/genetics.116.190736; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; R Core Team, 2020, R LANG ENV STAT COMP; Radchuk VV, 2009, PLANT PHYSIOL, V150, P190, DOI 10.1104/pp.108.133520; Ren XiFeng, 2013, Australian Journal of Crop Science, V7, P878; Reuscher S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153392; Saal B, 2011, EUPHYTICA, V177, P223, DOI 10.1007/s10681-010-0252-6; Sayed MA, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-61; Schmalenbach I, 2009, THEOR APPL GENET, V118, P483, DOI 10.1007/s00122-008-0915-z; Schmalenbach I, 2008, THEOR APPL GENET, V117, P1093, DOI 10.1007/s00122-008-0847-7; Schmalenbach I, 2011, G3-GENES GENOM GENET, V1, P187, DOI 10.1534/g3.111.000182; Schmalenbach I, 2009, THEOR APPL GENET, V118, P1411, DOI 10.1007/s00122-009-0991-8; Schnaithmann F, 2013, EUPHYTICA, V189, P67, DOI 10.1007/s10681-012-0711-3; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; von Korff M, 2005, THEOR APPL GENET, V111, P583, DOI 10.1007/s00122-005-2049-x; von Korff M, 2004, THEOR APPL GENET, V109, P1736, DOI 10.1007/s00122-004-1818-2; von Korff M, 2008, MOL BREEDING, V21, P81, DOI 10.1007/s11032-007-9110-1; Wallwork MAB, 1998, ANN BOT-LONDON, V82, P587, DOI 10.1006/anbo.1998.0721; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	50	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0185983	10.1371/journal.pone.0185983	http://dx.doi.org/10.1371/journal.pone.0185983			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053716	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100007
J	DeVivo, MT; Edmunds, DR; Kauffman, MJ; Schumaker, BA; Binfet, J; Kreeger, TJ; Richards, BJ; Schatzl, HM; Cornish, TE				DeVivo, Melia T.; Edmunds, David R.; Kauffman, Matthew J.; Schumaker, Brant A.; Binfet, Justin; Kreeger, Terry J.; Richards, Bryan J.; Schatzl, Hermann M.; Cornish, Todd E.			Endemic chronic wasting disease causes mule deer population decline in Wyoming	PLOS ONE			English	Article							WHITE-TAILED DEER; ODOCOILEUS-HEMIONUS; SURVIVAL; VULNERABILITY; EPIDEMIOLOGY; VIRGINIANUS; PREDATION; GROWTH	Chronic wasting disease (CWD) is a fatal transmissible spongiform encephalopathy affecting white-tailed deer (Odocoileus virginianus), mule deer (Odocoileus hemionus), Rocky Mountain elk (Cervus elaphus nelsoni), and moose (Alces alces shirasi) in North America. In southeastern Wyoming average annual CWD prevalence in mule deer exceeds 20% and appears to contribute to regional population declines. We determined the effect of CWD on mule deer demography using age-specific, female-only, CWD transition matrix models to estimate the population growth rate (lambda). Mule deer were captured from 2010-2014 in southern Converse County Wyoming, USA. Captured adult (>= 1.5 years old) deer were tested ante-mortem for CWD using tonsil biopsies and monitored using radio telemetry. Mean annual survival rates of CWD-negative and CWD-positive deer were 0.76 and 0.32, respectively. Pregnancy and fawn recruitment were not observed to be influenced by CWD. We estimated lambda = 0.79, indicating an annual population decline of 21% under current CWD prevalence levels. A model derived from the demography of only CWD-negative individuals yielded; lambda = 1.00, indicating a stable population if CWD were absent. These findings support CWD as a significant contributor to mule deer population decline. Chronic wasting disease is difficult or impossible to eradicate with current tools, given significant environmental contamination, and at present our best recommendation for control of this disease is to minimize spread to new areas and naive cervid populations.	[DeVivo, Melia T.; Schumaker, Brant A.; Cornish, Todd E.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Edmunds, David R.] Colorado State Univ, Nat Resource Ecol Lab, US Geol Survey, Ft Collins, CO 80523 USA; [Kauffman, Matthew J.] Univ Wyoming, US Geol Survey, Wyoming Cooperat Fish & Wildlife Res Unit, Dept Zool & Physiol, Laramie, WY 82071 USA; [Binfet, Justin] Wyoming Game & Fish Dept, Casper, WY USA; [Kreeger, Terry J.] Wyoming Game & Fish Dept, Wheatland, WY USA; [Richards, Bryan J.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Schatzl, Hermann M.] Univ Calgary, Dept Comparat Biol Expt Med, Calgary, AB, Canada	University of Wyoming; Colorado State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Wyoming; United States Department of the Interior; United States Geological Survey; University of Calgary	DeVivo, MT (corresponding author), Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA.	meliadevivo@gmail.com		Schatzl, Hermann/0000-0003-4972-8740	US Geological Survey National Wildlife Health Center [RWO 184, 194]; Mule Deer Foundation; Wyoming Game and Fish Department, Wyoming State Veterinary Laboratory	US Geological Survey National Wildlife Health Center(United States Geological Survey); Mule Deer Foundation; Wyoming Game and Fish Department, Wyoming State Veterinary Laboratory	This research was funded by the US Geological Survey National Wildlife Health Center (RWO 184 and 194), Wyoming Game and Fish Department, Wyoming State Veterinary Laboratory, and the Mule Deer Foundation. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; [Anonymous], 2007, HDB WILDLIFE CHEM IM; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caswell, 2000, MATRIX POPULATION MO; Chronic Wasting Disease Alliance, CHRON SIGN EV HIST C; COX DR, 1972, J R STAT SOC B, V34, P187; Deer Mule, 2014, CWD MODEL GENETIC SE; DeVivo MT, 2015, THESIS; Dulberger J, 2010, J WILDLIFE DIS, V46, P1086, DOI 10.7589/0090-3558-46.4.1086; Edmunds DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161127; Edmunds DR, 2013, THESIS; Evans TS, 2014, J FISH WILDL MANAG, V5, P387, DOI 10.3996/032014-JFWM-021; Forrester TD, 2013, MAMMAL REV, V43, P292, DOI 10.1111/mam.12002; Game Wyoming, 2013, MULE DEER JOB COMPLE; Geremia C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140687; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Hibler CP, 2003, J VET DIAGN INVEST, V15, P311, DOI 10.1177/104063870301500402; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Johnstone-Yellin TL, 2009, J MAMMAL, V90, P453, DOI 10.1644/08-MAMM-A-030.1; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Krumm CE, 2005, J WILDLIFE DIS, V41, P503, DOI 10.7589/0090-3558-41.3.503; Krumm CE, 2009, BIOL LETT; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Low W. A., 1963, Journal of Wildlife Management, V27, P466, DOI 10.2307/3798521; Lukacs PM, 2009, J WILDLIFE MANAGE, V73, P817, DOI 10.2193/2008-480; Mich PM, 2008, J ZOO WILDLIFE MED, V39, P480, DOI 10.1638/2007-0150.1; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2004, J WILDLIFE DIS, V40, P320, DOI 10.7589/0090-3558-40.2.320; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2002, VET REC, V151, P610, DOI 10.1136/vr.151.20.610; Monello RJ, 2014, J WILDLIFE MANAGE, V78, P214, DOI 10.1002/jwmg.665; Morris W. F., 2002, QUANTITATIVE CONSERV; Nichols TA, 2015, PRION, V9, P367, DOI 10.1080/19336896.2015.1086061; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; POLLOCK KH, 1989, BIOMETRICS, V45, P99, DOI 10.2307/2532037; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; R Core Team, 2021, R LANGUAGE ENV STAT; ROBINETTE W. LESLIE, 1957, JOUR WILDLIFE MANAGEMENT, V21, P134, DOI 10.2307/3797579; Robinson HS, 2002, CAN J ZOOL, V80, P556, DOI 10.1139/Z02-025; Robinson SJ, 2012, ECOL APPL, V22, P1050, DOI 10.1890/11-0907.1; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Therneau T, 2014, PACKAGE SURVIVAL ANA; Venables WN., 2002, MODERN APPL STAT S, V4; Wasley T., 2004, MULE DEER POPULATION; Webb SL, 2008, J WILDLIFE MANAGE, V72, P310, DOI 10.2193/2007-101; Wild MA, 2002, J GEN VIROL, V83, P2629, DOI 10.1099/0022-1317-83-10-2629; Wild MA, 2011, J WILDLIFE DIS, V47, P78, DOI 10.7589/0090-3558-47.1.78; Williams AL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00013.1; WILLIAMS ES, 1993, VET PATHOL, V30, P36, DOI 10.1177/030098589303000105; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wolfe L, 2014, J WILDL DIS, V50; Wyoming Game and Fish Department, 2010, MUL DEER JOB COMPL R; Wyoming Game and Fish Department, 2014, MUL DEER JOB COMPL R	60	54	54	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186512	10.1371/journal.pone.0186512	http://dx.doi.org/10.1371/journal.pone.0186512			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049389	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900076
J	Manabe, K; Osaka, R; Nakano, Y; Takasago, Y; Fujita, T; Shiragami, C; Hirooka, K; Muraoka, Y; Tsujikawa, A				Manabe, Koichiro; Osaka, Rie; Nakano, Yuki; Takasago, Yukari; Fujita, Tomoyoshi; Shiragami, Chieko; Hirooka, Kazuyuki; Muraoka, Yuki; Tsujikawa, Akitaka			Metamorphopsia associated with central retinal vein occlusion	PLOS ONE			English	Article							EPIRETINAL MEMBRANE; MACULAR EDEMA; FOVEAL MICROSTRUCTURE; M-CHARTS; QUANTIFICATION	This prospective study aimed to investigate metamorphopsia in eyes with central retinal vein occlusion (CRVO) and included 28 eyes (28 patients) with unilateral CRVO that had macular edema (ME) in the acute phase. The ME was treated with anti-vascular endothelial growth factor agents. At baseline and at 1 and 6 months after initiation of treatment, quantitative measurements of metamorphopsia were performed using M-CHARTS and the retinal morphologic changes were examined by optical coherence tomography. At baseline, metamorphopsia was detected on M-CHARTS in 14 (50.0%) eyes. The mean M-CHARTS score was 0.37 +/- 0.53. At 1 month and 6 months after initiation of treatment, there was substantial resolution of ME and significant recovery of visual acuity. In contrast, metamorphopsia was still detected in 16 eyes at 6 months; the mean M-CHARTS scores were 0.29 +/- 0.37 at 1 month and 0.32 +/- 0.38 at 6 months, and had not significantly improved from baseline (p = 0.580, and p = 0.604, respectively). Although the M-CHARTS score at 6 months was associated with the baseline M-CHARTS score (p = 0.004), it did not have any associations with morphologic parameters at baseline. However, the M-CHARTS score at 6 months was significantly associated with foveal photoreceptor status, height of serous detachment, and parafoveal thickening at 1 month. Metamorphopsia associated with CRVO could be quantified using M-CHARTS, and often persisted in contrast with the recovery of visual acuity and resolution of ME after treatment with anti-vascular endothelial growth factor agents.	[Manabe, Koichiro; Osaka, Rie; Nakano, Yuki; Takasago, Yukari; Fujita, Tomoyoshi; Shiragami, Chieko; Hirooka, Kazuyuki; Tsujikawa, Akitaka] Kagawa Univ, Fac Med, Dept Ophthalmol, Miki, Kagawa, Japan; [Muraoka, Yuki; Tsujikawa, Akitaka] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kagawa University; Kyoto University	Manabe, K (corresponding author), Kagawa Univ, Fac Med, Dept Ophthalmol, Miki, Kagawa, Japan.	kmanabe@med.kagawa-u.ac.jp		Tsujikawa, Akitaka/0000-0003-0779-7799				Achiron A, 2015, ACTA OPHTHALMOL, V93, pE649, DOI 10.1111/aos.12735; Akagi-Kurashige Y, 2014, AM J OPHTHALMOL, V157, P1239, DOI 10.1016/j.ajo.2014.02.026; Arimura E, 2011, INVEST OPHTH VIS SCI, V52, P128, DOI 10.1167/iovs.09-3535; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486; Faes L, 2014, EYE, V28, P788, DOI 10.1038/eye.2014.104; Hayreh SS, 2014, PROG RETIN EYE RES, V41, P1, DOI 10.1016/j.preteyeres.2014.04.001; Jonas J, 2010, DEV OPHTHALMOL, V47, P111, DOI 10.1159/000320076; Kim JW, 2016, ACTA OPHTHALMOL, V94, pE54, DOI 10.1111/aos.12795; Manabe K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153817; Matsumoto C, 2003, INVEST OPHTH VIS SCI, V44, P4012, DOI 10.1167/iovs.03-0117; McGowan G, 2016, RETINA-J RET VIT DIS, V36, P703, DOI 10.1097/IAE.0000000000000778; Midena E, 2016, OPHTHALMIC RES, V55, P26, DOI 10.1159/000441033; Murakami T, 2016, GRAEF ARCH CLIN EXP, V254, P2191, DOI 10.1007/s00417-016-3382-2; Nakagawa Tomoya, 2007, Nippon Ganka Gakkai Zasshi, V111, P331; Nitta E, 2013, AM J OPHTHALMOL, V155, P1014, DOI 10.1016/j.ajo.2013.01.021; Okamoto F, 2015, RETINA-J RET VIT DIS, V35, P2107, DOI 10.1097/IAE.0000000000000602; Okamoto F, 2012, INVEST OPHTH VIS SCI, V53, P6770, DOI 10.1167/iovs.12-9683; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Ota M, 2010, JPN J OPHTHALMOL, V54, P555, DOI 10.1007/s10384-010-0878-x; Simunovic MP, 2015, RETINA-J RET VIT DIS, V35, P1285, DOI 10.1097/IAE.0000000000000581; Stanga P. E., 2001, International Ophthalmology, V23, P191, DOI 10.1023/A:1014476430078; Tsujikawa A, 2010, AM J OPHTHALMOL, V149, P291, DOI 10.1016/j.ajo.2009.09.007; Watanabe A, 2009, OPHTHALMOLOGY, V116, P1788, DOI 10.1016/j.ophtha.2009.04.046	25	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186737	10.1371/journal.pone.0186737	http://dx.doi.org/10.1371/journal.pone.0186737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049410	gold, Green Submitted, Green Published			2022-12-26	WOS:000413195900105
J	Nakamura, S; Hayashi, K; Imaoka, Y; Kitamura, Y; Akazawa, Y; Tabata, K; Groen, R; Tsuchiya, T; Yamasaki, N; Nagayasu, T; Fukuoka, J				Nakamura, Sayuri; Hayashi, Kentaro; Imaoka, Yuki; Kitamura, Yuka; Akazawa, Yuko; Tabata, Kazuhiro; Groen, Ruben; Tsuchiya, Tomoshi; Yamasaki, Naoya; Nagayasu, Takeshi; Fukuoka, Junya			Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer	PLOS ONE			English	Article							PD-L1 EXPRESSION; TISSUE MICROARRAYS; PROTEIN EXPRESSION; CLINICAL-PRACTICE; IHC ASSAY; NIVOLUMAB; IMMUNOTHERAPY; STATISTICS; DOCETAXEL; CARCINOMA	Programmed cell death ligand-1 (PD-L1) expression may predict the response to both programmed cell death-1 and PD-L1 inhibitors in lung cancer. However, the extent of intratumoral heterogeneity of PD-L1 expression, which may cause false negative results, is largely unexplored. We aimed to assess the intratumoral heterogeneity of PD-L1 expression in surgically resected lung cancer specimens by applying a novel method of tissue microarray, namely Spiral Arrays, which enables us to observe the heterogeneity in spiral-shaped tissue cores. Adenocarcinoma and squamous cell carcinoma specimens were obtained from consecutive patients with lung cancer who had undergone surgical resection at Nagasaki University Hospital (Nagasaki, Japan) since 2009. Small cell lung cancer and large cell carcinoma specimens were selected from patients in the same archive who had undergone resection since 1998. Spiral Arrays were constructed of spiral-shaped cores, prepared from representative blocks of each case, which were subjected to immunohistochemistry using an anti-PD-L1 antibody. Each core was divided into 8 segments and each segment was classified as either PD-L1-positive or PD-L1-negative using thresholds of 1.0%, 5.0%, 10.0%, and 50.0%, respectively. In total, 138 specimens were selected, including 60 adenocarcinomas, 59 squamous cell carcinomas, 12 small cell lung cancers, and 7 large cell carcinomas. The majority of specimens with PD-L1-positive segments exhibited heterogeneous expression (i.e., had a mixture of PD-L1-positive and PD-L1-negative segments within a core) irrespective of the threshold (1.0%, 66.7%; 5.0%, 74.4%; 10.0%, 75.8%; and 50.0%, 85.7%]. Large variations in the ratios of PD-L1-positive segments were observed. At least 50.0% of the segments within a core were negative in no fewer than 50.0% (range, 50.0-76.0%) of cases with heterogeneous PD-L1 expression. In conclusion, intratumoral heterogeneity of PD-L1 expression was frequently observed in cases of lung cancer. Thus, multiple tumor biopsy specimens may be needed to accurately determine the PD-L1 expression status.	[Nakamura, Sayuri; Hayashi, Kentaro; Imaoka, Yuki; Kitamura, Yuka; Akazawa, Yuko; Tabata, Kazuhiro; Groen, Ruben; Fukuoka, Junya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki, Japan; [Tsuchiya, Tomoshi; Yamasaki, Naoya; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki, Japan; [Hayashi, Kentaro] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan; [Tabata, Kazuhiro] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA	Nagasaki University; Nagasaki University; Nagasaki University; Memorial Sloan Kettering Cancer Center	Fukuoka, J (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki, Japan.	fukuokaj@nagasaki-u.ac.jp	Fukuoka, Junya/AAT-2924-2021	Fukuoka, Junya/0000-0002-2496-3050; Tsuchiya, Tomoshi/0000-0002-8419-1478	Pathology Institute Corp	Pathology Institute Corp	JF received support in the form of salary from Pathology Institute Corp. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTMAN DG, 1991, STAT MED, V10, P1897, DOI 10.1002/sim.4780101206; Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Callea M, 2015, CANCER IMMUNOL RES, V3, P1158, DOI 10.1158/2326-6066.CIR-15-0043; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Dill EA, 2017, AM J SURG PATHOL, V41, P334, DOI 10.1097/PAS.0000000000000780; Foundation for Promotion of Cancer Research (JP), 2016, CANC STAT JAP 15; Fukuoka J, 2012, ARCH PATHOL LAB MED, V136, P1377, DOI 10.5858/arpa.2011-0393-OA; Hamanishi J, 2016, INT J CLIN ONCOL, V21, P462, DOI 10.1007/s10147-016-0959-z; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Ilie M, 2016, ANN ONCOL, V27, P147, DOI 10.1093/annonc/mdv489; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Katayama R, 2015, CLIN CANCER RES, V21, P2227, DOI 10.1158/1078-0432.CCR-14-2791; Kim MY, 2015, LUNG CANCER, V88, P24, DOI 10.1016/j.lungcan.2015.01.016; Kitazono S, 2015, CLIN LUNG CANCER, V16, P385, DOI 10.1016/j.cllc.2015.03.008; Komiya A, 2014, INT J ONCOL, V44, P195, DOI 10.3892/ijo.2013.2173; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Madore J, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12340; Mansfield AS, 2016, CLIN PHARMACOL THER, V100, P220, DOI 10.1002/cpt.360; Mino-Kenudson M, 2016, CANCER BIOL MED, V13, P157, DOI 10.20892/j.issn.2095-3941.2016.0009; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Phillips T, 2015, APPL IMMUNOHISTO M M, V23, P541, DOI 10.1097/PAI.0000000000000256; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Soria JC, 2015, CLIN CANCER RES, V21, P2256, DOI 10.1158/1078-0432.CCR-14-2959; Stewart BW, WORLD CANC REPORT 20; Suda K, 2017, J THORAC ONCOL, V12, P1015, DOI 10.1016/j.jtho.2017.02.002; Tabata K, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-23; Takada K, 2016, ANTICANCER RES, V36, P3409; Taplin SH, 2000, AM J ROENTGENOL, V174, P1257, DOI 10.2214/ajr.174.5.1741257; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Villaruz LC, 2016, CLIN PHARMACOL THER, V100, P212, DOI 10.1002/cpt.385; Yu H, 2016, J THORAC ONCOL, V11, P964, DOI 10.1016/j.jtho.2016.04.014	36	37	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186192	10.1371/journal.pone.0186192	http://dx.doi.org/10.1371/journal.pone.0186192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049375	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900050
J	Van den Bossche, L; Schoonenberg, VAC; Burgener, IA; Penning, LC; Schrall, IM; Kruitwagen, HS; van Wolferen, ME; Grinwis, GCM; Kummeling, A; Rothuizen, J; van Velzen, JF; Stathonikos, N; Molenaar, MR; Helms, BJ; Brouwers, JFHM; Spee, B; van Steenbeek, FG				Van den Bossche, Lindsay; Schoonenberg, Vivien A. C.; Burgener, Iwan A.; Penning, Louis C.; Schrall, Ingrid M.; Kruitwagen, Hedwig S.; van Wolferen, Monique E.; Grinwis, Guy C. M.; Kummeling, Anne; Rothuizen, Jan; van Velzen, Jeroen F.; Stathonikos, Nikolas; Molenaar, Martijn R.; Helms, Bernd J.; Brouwers, Jos F. H. M.; Spee, Bart; van Steenbeek, Frank G.			Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MULTISYSTEM DISEASE; OXIDATIVE STRESS; DOGS; ATTENUATION; STEATOSIS; PROTEINS; MODEL; CATS; GENE	Non-alcoholic fatty liver disease (NAFLD) is a poorly understood multifactorial pandemic disorder. One of the hallmarks of NAFLD, hepatic steatosis, is a common feature in canine congenital portosystemic shunts. The aim of this study was to gain detailed insight into the pathogenesis of steatosis in this large animal model. Hepatic lipid accumulation, gene-expression analysis and HPLC-MS of neutral lipids and phospholipids in extrahepatic (EHPSS) and intrahepatic portosystemic shunts (IHPSS) was compared to healthy control dogs. Liver organoids of diseased dogs and healthy control dogs were incubated with palmitic- and oleic-acid, and lipid accumulation was quantified using LD540. In histological slides of shunt livers, a 12-fold increase of lipid content was detected compared to the control dogs (EHPSS P<0.01; IHPSS P = 0.042). Involvement of lipid-related genes to steatosis in portosystemic shunting was corroborated using gene-expression profiling. Lipid analysis demonstrated different triglyceride composition and a shift towards short chain and omega-3 fatty acids in shunt versus healthy dogs, with no difference in lipid species composition between shunt types. All organoids showed a similar increase in triacylglycerols after free fatty acids enrichment. This study demonstrates that steatosis is probably secondary to canine portosystemic shunts. Unravelling the pathogenesis of this hepatic steatosis might contribute to a better understanding of steatosis in NAFLD.	[Van den Bossche, Lindsay; Schoonenberg, Vivien A. C.; Burgener, Iwan A.; Penning, Louis C.; Schrall, Ingrid M.; Kruitwagen, Hedwig S.; van Wolferen, Monique E.; Kummeling, Anne; Rothuizen, Jan; Spee, Bart; van Steenbeek, Frank G.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [van Velzen, Jeroen F.] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Stathonikos, Nikolas] Univ Med Ctr, Dept Pathol, Utrecht, Netherlands; [Molenaar, Martijn R.; Helms, Bernd J.; Brouwers, Jos F. H. M.] Fac Vet Med Utrecht, Dept Biochem & Cell Biol, Utrecht, Netherlands; [Molenaar, Martijn R.; Helms, Bernd J.; Brouwers, Jos F. H. M.] Inst Biomembranes, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	van Steenbeek, FG (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	f.g.vansteenbeek@uu.nl	Kummeling, Anne/GNW-3198-2022; Penning, Louis/AAC-7524-2019; van Steenbeek, F.G./AFL-0046-2022; Brouwers, Jos F/AAH-1444-2019	van Steenbeek, F.G./0000-0001-5460-6540; Brouwers, Jos F/0000-0003-2924-3279; Molenaar, Martijn/0000-0001-5221-608X; Schoonenberg, Vivien A. C./0000-0002-7865-7120; Grinwis, Guy/0000-0002-1583-9648	Dutch Research Council NWO ZonMw [116004121]	Dutch Research Council NWO ZonMw	The study was partially funded by the Dutch Research Council NWO ZonMw (116004121). There was no additional external funding received for this study.	Aller MA, 2012, ACTA HISTOCHEM, V114, P301, DOI 10.1016/j.acthis.2011.06.011; [Anonymous], 2021, LANG ENV STAT COMP; Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x; Baade S, 2006, J COMP PATHOL, V134, P80, DOI 10.1016/j.jcpa.2005.07.003; Bhanumathy CD, 2002, DEV DYNAM, V223, P59, DOI 10.1002/dvdy.1235; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Carr RM, 2016, GASTROENTEROL CLIN N, V45, P639, DOI 10.1016/j.gtc.2016.07.003; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Collings AJ, 2012, J SMALL ANIM PRACT, V53, P228, DOI 10.1111/j.1748-5827.2011.01192.x; Cullen JM, 2006, WSAVA STANDARDS CLIN, P41; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Dienel GA, 2014, METAB BRAIN DIS, V29, P1041, DOI 10.1007/s11011-013-9442-y; Fujita Y, 2004, J HUM GENET, V49, P24, DOI 10.1007/s10038-003-0101-8; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Huisman A, 2010, HUM PATHOL, V41, P751, DOI 10.1016/j.humpath.2009.08.026; Hunt GB, 2013, VET PATHOL, V50, P1109, DOI 10.1177/0300985813481609; Hunt GB, 2014, VET SURG, V43, P920, DOI 10.1111/j.1532-950X.2014.12197.x; Isobe K, 2008, J VET MED SCI, V70, P133, DOI 10.1292/jvms.70.133; Jeucken A, ENCY LIPIDO IN PRESS; Kerr MG, 1999, VET REC, V144, P693, DOI 10.1136/vr.144.25.693; Koteish A, 2002, BEST PRACT RES CL GA, V16, P679, DOI 10.1053/bega.2002.0332; Lee KCL, 2011, JAVMA-J AM VET MED A, V239, P638, DOI 10.2460/javma.239.5.638; Lisovsky M, 2011, AM J SURG PATHOL, V35, P1381, DOI 10.1097/PAS.0b013e3182230ce4; Lullmann-Rauch R, 1979, Front Biol, V48, P49; Mann JP, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00145; McIntosh AL, 2012, AM J PHYSIOL-CELL PH, V303, pC728, DOI 10.1152/ajpcell.00448.2011; Mikolasevic I, 2016, WORLD J GASTROENTERO, V22, P9488, DOI 10.3748/wjg.v22.i43.9488; Nantasanti S, 2015, STEM CELL REP, V5, P895, DOI 10.1016/j.stemcr.2015.09.002; Ostrander EA, 2000, GENOME RES, V10, P1271, DOI 10.1101/gr.155900; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Parker JS, 2008, JAVMA-J AM VET MED A, V232, P1511, DOI 10.2460/javma.232.10.1511; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Retra K, 2008, RAPID COMMUN MASS SP, V22, P1853, DOI 10.1002/rcm.3562; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sokollik C, 2013, J PEDIATR GASTR NUTR, V56, P675, DOI 10.1097/MPG.0b013e31828b3750; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STALKER MJ, 2007, JUBB KENNEDY PALMERS, P297; Staziaki PV, 2013, CNS NEUROL DISORD-DR, V12, P84; Stringer MD, 2008, CLIN ANAT, V21, P147, DOI 10.1002/ca.20574; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Valenti L, 2016, LIVER INT, V36, P1563, DOI 10.1111/liv.13185; Van den Bossche L, 2016, VET J, V211, P14, DOI 10.1016/j.tvjl.2015.09.025; van Steenbeek FG, 2016, ANIM GENET, V47, P519, DOI 10.1111/age.12460; van Steenbeek FG, 2009, J VET INTERN MED, V23, P950, DOI 10.1111/j.1939-1676.2009.0319.x; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; van Steenbeek FG, 2012, MAMM GENOME, V23, P76, DOI 10.1007/s00335-011-9364-0; van Straten G, 2015, VET J, V204, P282, DOI 10.1016/j.tvjl.2015.04.020; van Straten G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100077; VANDENINGH TSGAM, 1995, VET QUART, V17, P70, DOI 10.1080/01652176.1995.9694536; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Winkler JT, 2003, J AM ANIM HOSP ASSOC, V39, P169, DOI 10.5326/0390169; Wolschrijn CF, 2000, VET QUART, V22, P94, DOI 10.1080/01652176.2000.9695032; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yenuganti VR, 2016, GEN COMP ENDOCR, V232, P134, DOI 10.1016/j.ygcen.2016.04.020	63	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186491	10.1371/journal.pone.0186491	http://dx.doi.org/10.1371/journal.pone.0186491			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049355	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900072
J	Wang, JS; Fogerty, RL; Horwitz, LI				Wang, Jessica S.; Fogerty, Robert L.; Horwitz, Leora I.			Effect of therapeutic interchange on medication reconciliation during hospitalization and upon discharge in a geriatric population	PLOS ONE			English	Article							ADMISSION; SUBSTITUTION; ERRORS; CARE; DISCREPANCIES; PROGRAM; TRANSITIONS; INHIBITORS; HISTORIES; ORDERS	Background Therapeutic interchange of a same class medication for an outpatient medication is a widespread practice during hospitalization in response to limited hospital formularies. However, therapeutic interchange may increase risk of medication errors. The objective was to characterize the prevalence and safety of therapeutic interchange. Methods and findings Secondary analysis of a transitions of care study. We included patients over age 64 admitted to a tertiary care hospital between 2009-2010 with heart failure, pneumonia, or acute coronary syndrome who were taking a medication in any of six commonly-interchanged classes on admission: proton pump inhibitors (PPIs), histamine H-2-receptor antagonists (H2 blockers), hydroxymethylglutaryl CoA reductase inhibitors (statins), angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and inhaled corticosteroids (ICS). There was limited electronic medication reconciliation support available. Main measures were presence and accuracy of therapeutic interchange during hospitalization, and rate of medication reconciliation errors on discharge. We examined charts of 303 patients taking 555 medications at time of admission in the six medication classes of interest. A total of 244 (44.0%) of medications were therapeutically interchanged to an approved formulary drug at admission, affecting 64% of the study patients. Among the therapeutically interchanged drugs, we identified 78 (32.0%) suspected medication conversion errors. The discharge medication reconciliation error rate was 11.5% among the 244 therapeutically interchanged medications, compared with 4.2% among the 311 unchanged medications (relative risk [RR] 2.75, 95% confidence interval [CI] 1.45-5.19). Conclusions Therapeutic interchange was prevalent among hospitalized patients in this study and elevates the risk for potential medication errors during and after hospitalization. Improved electronic systems for managing therapeutic interchange and medication reconciliation may be valuable.	[Wang, Jessica S.] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Fogerty, Robert L.] Yale Sch Med, Dept Internal Med, Sect Gen Internal Med, New Haven, CT USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, New York, NY 10003 USA; [Horwitz, Leora I.] NYU Langone Hlth, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10016 USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Med, Div Gen Internal Med & Clin Innovat, New York, NY 10003 USA	University of California System; University of California San Francisco; Yale University; New York University; NYU Langone Medical Center; New York University	Horwitz, LI (corresponding author), NYU, Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, New York, NY 10003 USA.; Horwitz, LI (corresponding author), NYU Langone Hlth, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10016 USA.; Horwitz, LI (corresponding author), NYU, Sch Med, Dept Med, Div Gen Internal Med & Clin Innovat, New York, NY 10003 USA.	Leora.Horwitz@nyumc.org	Horwitz, Leora/ABD-1292-2020	Fogerty, Robert/0000-0001-9119-7707	CTSA from National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 RR024139]; NIH road map for Medical Research; Claude D. Pepper Older Americans Independence Center at Yale University School of Medicine [P30AG021342 NIH/NIA]; John A. Hartford Foundation; American Federation for Aging Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER	CTSA from National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH road map for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claude D. Pepper Older Americans Independence Center at Yale University School of Medicine; John A. Hartford Foundation; American Federation for Aging Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was made possible by CTSA Grant Number UL1 RR024139 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH road map for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCATS or NIH. This work was also supported by the Claude D. Pepper Older Americans Independence Center at Yale University School of Medicine (#P30AG021342 NIH/NIA) and The John A. Hartford Foundation and the American Federation for Aging Research. No funding source had any role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the John A. Hartford Foundation, or the American Federation for Aging Research.	Amidon PB, 2000, AM J MANAG CARE, V6, P593; Chong PH, 2002, ANN PHARMACOTHER, V36, P1907, DOI 10.1345/aph.1C116; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; DOERING PL, 1982, AM J HOSP PHARM, V39, P1028, DOI 10.1093/ajhp/39.6.1028; Galt KA, 2001, P T J, V26, P151; Glaholt Sarah, 2014, P T, V39, P267; Gleason KM, 2004, AM J HEALTH-SYST PH, V61, P1689, DOI 10.1093/ajhp/61.16.1689; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Grimes TC, 2011, BRIT J CLIN PHARMACO, V71, P449, DOI 10.1111/j.1365-2125.2010.03834.x; Grossman JM, HOSP EXPERIENCES USI; Himmel W, 1996, EUR J CLIN PHARMACOL, V50, P253, DOI 10.1007/s002280050103; Holmes DR, 2011, J AM COLL CARDIOL, V58, P1287, DOI 10.1016/j.jacc.2011.06.001; Institute for Safe Medication Practices Canada, MED REC 2016; KORMAN L, 1995, AM J HEALTH-SYST PH, V52, P1078, DOI 10.1093/ajhp/52.10.1078; Kramer JS, 2007, AM J HEALTH-SYST PH, V64, P404, DOI 10.2146/ajhp060506; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Office of the National Coordinator for Health Information Technology, HOSP AD MEAN US STAG; Pedersen CA, 2011, AM J HEALTH-SYST PH, V68, P669, DOI [10.2146/ajhp100711, 10.2146/ajhp090596]; Pippins JR, 2008, J GEN INTERN MED, V23, P1414, DOI 10.1007/s11606-008-0687-9; Reeder TA, 2008, AM J HEALTH-SYST PH, V65, P857, DOI 10.2146/ajhp070292; Schachtner JM, 2002, AM J HEALTH-SYST PH, V59, P529, DOI 10.1093/ajhp/59.6.529; Schneeweiss S, 2006, CLIN PHARMACOL THER, V79, P379, DOI 10.1016/j.clpt.2005.12.304; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Sodorff MM, 2002, PHARMACOTHERAPY, V22, P500, DOI 10.1592/phco.22.7.500.33677; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Taylor AJ, 2001, PHARMACOTHERAPY, V21, P1130, DOI 10.1592/phco.21.13.1130.34616; Usher-Smith J, 2008, INT J CLIN PRACT, V62, P480, DOI 10.1111/j.1742-1241.2007.01690.x; Vira T, 2006, QUAL SAF HEALTH CARE, V15, P122, DOI 10.1136/qshc.2005.015347; Wohlauer MV, 2012, ACAD MED, V87, P411, DOI 10.1097/ACM.0b013e318248e766; Wong JD, 2008, ANN PHARMACOTHER, V42, P1373, DOI 10.1345/aph.1L190; Ziaeian B, 2012, J GEN INTERN MED, V27, P1513, DOI 10.1007/s11606-012-2168-4	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186075	10.1371/journal.pone.0186075	http://dx.doi.org/10.1371/journal.pone.0186075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049325	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900039
J	Gabel, M; Regoes, RR; Graw, F				Gabel, Michael; Regoes, Roland R.; Graw, Frederik			More or less-On the influence of labelling strategies to infer cell population dynamics	PLOS ONE			English	Article							T-LYMPHOCYTES; IN-VIVO; HIV-1 INFECTION; MEMORY; DIFFERENTIATION; TURNOVER; PROLIFERATION; REPERTOIRE; RESPONSES; KINETICS	The adoptive transfer of labelled cell populations has been an essential tool to determine and quantify cellular dynamics. The experimental methods to label and track cells over time range from fluorescent dyes over congenic markers towards single-cell labelling techniques, such as genetic barcodes. While these methods have been widely used to quantify cell differentiation and division dynamics, the extent to which the applied labelling strategy actually affects the quantification of the dynamics has not been determined so far. This is especially important in situations where measurements can only be obtained at a single time point, as e. g. due to organ harvest. To this end, we studied the appropriateness of various labelling strategies as characterised by the number of different labels and the initial number of cells per label to quantify cellular dynamics. We simulated adoptive transfer experiments in systems of various complexity that assumed either homoeostatic cellular turnover or cell expansion dynamics involving various steps of cell differentiation and proliferation. Re-sampling cells at a single time point, we determined the ability of different labelling strategies to recover the underlying kinetics. Our results indicate that cell transition and expansion rates are differently affected by experimental shortcomings, such as loss of cells during transfer or sampling, dependent on the labelling strategy used. Furthermore, uniformly distributed labels in the transferred population generally lead to more robust and less biased results than non-equal label sizes. In addition, our analysis indicates that certain labelling approaches incorporate a systematic bias for the identification of complex cell expansion dynamics.	[Gabel, Michael; Graw, Frederik] Heidelberg Univ, Ctr Modelling & Simulat Biosci, BioQuant Ctr, D-69120 Heidelberg, Germany; [Regoes, Roland R.] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gabel, M; Graw, F (corresponding author), Heidelberg Univ, Ctr Modelling & Simulat Biosci, BioQuant Ctr, D-69120 Heidelberg, Germany.	michael.gabel@bioquant.uni-heidelberg.de; frederik.graw@bioquant.uni-heidelberg.de			Center for Modeling and Simulation in the Biosciences (BIOMS)	Center for Modeling and Simulation in the Biosciences (BIOMS)	FG and MG are supported by the Center for Modeling and Simulation in the Biosciences (BIOMS, http://www.bioms.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattman JN, 2000, J IMMUNOL, V165, P6081, DOI 10.4049/jimmunol.165.11.6081; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; Chervin AS, 2013, GENE THER, V20, P634, DOI 10.1038/gt.2012.80; Cvejic A, 2016, IMMUNOL CELL BIOL, V94, P230, DOI 10.1038/icb.2015.96; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001; De Boer RJ, 2013, J THEOR BIOL, V327, P45, DOI 10.1016/j.jtbi.2012.12.025; Ganusov VV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003586; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gillespie D, 2006, JOURNAL OF CHEMICAL, V124; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Hofer T, 2016, ANNU REV IMMUNOL, V34, P449, DOI 10.1146/annurev-immunol-032414-112019; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; Kaiser P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003532; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Naik SH, 2014, EXP HEMATOL, V42, P598, DOI 10.1016/j.exphem.2014.05.003; Nguyen LV, 2014, CELL STEM CELL, V14, P253, DOI 10.1016/j.stem.2013.12.011; PENIT C, 1995, J IMMUNOL, V154, P5103; Perie L, 2014, CELL REP, V6, P617, DOI 10.1016/j.celrep.2014.01.016; Proserpio V, 2016, IMMUNOL CELL BIOL, V94, P225, DOI 10.1038/icb.2015.106; R Development Core Team, 2006, R LANG ENV STAT COMP; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Rohr JC, 2014, TRENDS IMMUNOL, V35, P170, DOI 10.1016/j.it.2014.02.006; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Turner SJ, 2003, IMMUNITY, V18, P549, DOI 10.1016/S1074-7613(03)00087-6; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Yates A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-196; Zarnitsyna VI, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00485	44	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185523	10.1371/journal.pone.0185523	http://dx.doi.org/10.1371/journal.pone.0185523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045427	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100019
J	Hanigan, TW; Taha, TY; Aboukhatwa, SM; Frasor, J; Petukhov, PA				Hanigan, Thomas W.; Taha, Taha Y.; Aboukhatwa, Shaimaa M.; Frasor, Jonna; Petukhov, Pavel A.			Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; BREAST-CANCER CELLS; HEMATOLOGIC MALIGNANCIES; SOLID TUMORS; PHASE-I; EXPRESSION; PANOBINOSTAT; ACETYLATION; CARCINOMA; CHROMATIN	The mechanism of action of histone deacetylase inhibitors (HDACi) is mainly attributed to the inhibition of the deacetylase catalytic activity for their histone substrates. In this study, we analyzed the abundance of class I HDACs in the cytosolic, nuclear soluble and chromatin bound cellular fractions in breast cancer cells after HDACi treatment. We found that potent N-hydroxy propenamide-based HDACi induced a concentration dependent decrease in the HDAC1 associated with chromatin and a lasting concomitant increase in cytoplasmic HDAC1 while maintaining total protein expression. No such change occurred with HDAC2 or 8, however, an increase in cytoplasmic non-phosphorylated HDAC3 was also observed. The subcellular re-equilibration of HDAC1 was subsequent to the accumulation of acetylated histones and might be cell cycle dependent. This study suggests that the biological activity of a subset of N-hydroxy propenamide-based HDACi may stem from direct competition with histone substrates of HDACs as well as from spatial separation from their substrates in the nucleus and/or change in post-translational modification status of HDACs.	[Hanigan, Thomas W.; Taha, Taha Y.; Aboukhatwa, Shaimaa M.; Petukhov, Pavel A.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA; [Aboukhatwa, Shaimaa M.] Tanta Univ, Fac Pharm, Dept Pharmaceut Chem, Tanta, Egypt; [Frasor, Jonna] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Egyptian Knowledge Bank (EKB); Tanta University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Petukhov, PA (corresponding author), Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.	pap4@uic.edu		Aboukhatwa, Shaimaa/0000-0002-5013-7158; Taha, Taha/0000-0002-7344-7490; Hangian, Thomas/0000-0003-0752-4707	National Cancer Institute/NIH [R21 CM 83627, R01 CA131970, R01 HL130760]; Alzheimer's Drug Discovery Foundation [20101103]	National Cancer Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alzheimer's Drug Discovery Foundation	This study was funded by the National Cancer Institute/NIH grants R21 CM 83627, R01 CA131970, R01 HL130760, and the Alzheimer's Drug Discovery Foundation grant ADDF #20101103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrin C, 2004, J BIOL CHEM, V279, P25017, DOI 10.1074/jbc.M401805200; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fortunati N, 2014, INT J ONCOL, V44, P700, DOI 10.3892/ijo.2013.2218; Galasinski SC, 2002, J BIOL CHEM, V277, P19618, DOI 10.1074/jbc.M201174200; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Glaser KB, 2003, MOL CANCER THER, V2, P151; Gray SG, 1998, BIOCHEM BIOPH RES CO, V245, P423, DOI 10.1006/bbrc.1998.8449; Hanigan TW, 2017, CELL CHEM B IN PRESS; He SH, 2013, J CELL PHYSIOL, V228, P1525, DOI 10.1002/jcp.24311; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Min A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0534-y; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Rosato RR, 2003, CANCER RES, V63, P3637; Sanderson L, 2004, DRUG METAB DISPOS, V32, P1132, DOI 10.1124/dmd.104.000638; Savelieva M, 2015, EUR J CLIN PHARMACOL, V71, P663, DOI 10.1007/s00228-015-1846-7; SEE YP, 1985, ELECTROPHORESIS, V6, P382, DOI 10.1002/elps.1150060806; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; SUTHERLAND RL, 1983, CANCER RES, V43, P3998; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tavakoli-Yaraki M, 2013, TUMOR BIOL, V34, P241, DOI 10.1007/s13277-012-0544-7; Van den Wyngaert I, 2000, FEBS LETT, V478, P77, DOI 10.1016/S0014-5793(00)01813-5; Ververis K, 2012, AM J TRANSL RES, V4, P24; Vijayaraghavalu S, 2013, MOL PHARMACEUT, V10, P337, DOI 10.1021/mp3004622; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186620	10.1371/journal.pone.0186620	http://dx.doi.org/10.1371/journal.pone.0186620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045501	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100079
J	Liu, Y; Zhou, H; Zhu, R; Ding, F; Li, Y; Cao, X; Liu, Z				Liu, Y.; Zhou, H.; Zhu, R.; Ding, F.; Li, Y.; Cao, X.; Liu, Z.			SPSB3 targets SNAIL for degradation in GSK-3 beta phosphorylation-dependent manner and regulates metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; OVARIAN-CANCER CELLS; C-MYC; PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTORS; UBIQUITIN LIGASE; TUMOR RECURRENCE; PROGRESSION; STABILITY; LINES	Epithelial-mesenchymal transition (EMT) is a process during which normal epithelial cells acquire mesenchymal characteristics. EMT has a critical role in various human diseases especially in cancer. EMT facilitates tumor initiation and progression by mediating cancer cell stemness and motility. Zinc finger transcription factor SNAIL is one of the most important initiators of EMT. Therefore, it is of great significance to understand the regulating mechanism of SNAIL. In this study, we carried out a luciferase-based genome-wide screening using small interfering RNA library against similar to 200 of E3 ligases and ubiquitin-related genes and identified SOCS box protein SPSB3 as a novel E3 ligase component that targets SNAIL into polyubiquitination and degradation in response to GSK-3 beta phosphorylation of SNAIL. Functionally, we observed that SPSB3 overexpression greatly inhibits tumor metastasis by regulating SNAIL degradation both in vitro and in vivo. The expression of SPSB3 and SNAIL are negatively correlated in human esophageal squamous cell carcinoma tissues, and low SPSB3 expression indicates lymph node metastasis. Moreover, high SPSB3 expression indicates good survivals in various kinds of cancer. Collectively, these findings suggest that SPSB3-mediated SNAIL degradation has a vital role in regulating EMT and cancer progression.	[Liu, Y.; Zhou, H.; Zhu, R.; Ding, F.; Li, Y.; Liu, Z.] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Liu, Y.; Zhou, H.; Zhu, R.; Ding, F.; Li, Y.; Liu, Z.] Peking Union Med Coll, Beijing 100021, Peoples R China; [Cao, X.] Nanjing Med Univ, Nanjing Hosp 1, Dept Surg Oncol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing Medical University	Liu, Z (corresponding author), Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.; Liu, Z (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn	Liu, Yongshuo/AGZ-8274-2022; Liu, Yongshuo/GRX-6416-2022	Liu, Yongshuo/0000-0001-8190-0139; Liu, Yongshuo/0000-0001-8190-0139	National Key R&D program of China [2016YFC1302100, 2013CB911004]; National Science Foundation of China [81420108025]; CAMS Initiative for Innovative Medicine [2016-I2M-1-001]	National Key R&D program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine	We thank Professor Binhua P Zhou (University of Kentucky College of Medicine, Lexington, KY, USA) for kindly providing the plasmids of WT-GSK-3 beta and KD-GSK-3 beta. This work was supported by grants from the National Key R&D program of China (2016YFC1302100, 2013CB911004), the National Science Foundation of China (81420108025) and CAMS Initiative for Innovative Medicine (2016-I2M-1-001).	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bastea LI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030459; Bruyere F, 2010, UROL ONCOL-SEMIN ORI, V28, P591, DOI 10.1016/j.urolonc.2008.11.005; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Diaz VM, 2014, CELL ADHES MIGR, V8, P418, DOI 10.4161/19336918.2014.969998; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Felipe Lima J, 2016, J CLIN MED, V5; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Jin Y, 2015, CANCER LETT, V362, P70, DOI 10.1016/j.canlet.2015.03.037; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marino N, 2012, CANCER METAST REV, V31, P593, DOI 10.1007/s10555-012-9374-8; Mei ZC, 2015, J BIOL CHEM, V290, P16202, DOI 10.1074/jbc.M115.645978; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Okumura F, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0016-3; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Paul I, 2013, ONCOGENE, V32, P1284, DOI 10.1038/onc.2012.144; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Tang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163324; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Vinas-Castells R, 2014, NUCLEIC ACIDS RES, V42, P1079, DOI 10.1093/nar/gkt935; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou H, 2017, ONCOGENE, V36, P3312, DOI 10.1038/onc.2016.479	40	30	31	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					768	776		10.1038/onc.2017.370	http://dx.doi.org/10.1038/onc.2017.370			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059170				2022-12-26	WOS:000424628100008
J	Kalogeraki, E; Pielecka-Fortuna, J; Lowel, S				Kalogeraki, Evgenia; Pielecka-Fortuna, Justyna; Loewel, Siegrid			Environmental enrichment accelerates ocular dominance plasticity in mouse visual cortex whereas transfer to standard cages resulted in a rapid loss of increased plasticity	PLOS ONE			English	Article							RECEPTIVE-FIELD PROPERTIES; CRITICAL-PERIOD PLASTICITY; MONOCULAR DEPRIVATION; CORTICAL PLASTICITY; INTRINSIC SIGNAL; ADULT; EXPERIENCE; VISION; MICE; ORGANIZATION	In standard cage (SC) raised mice, experience-dependent ocular dominance (OD) plasticity in the primary visual cortex (V1) rapidly declines with age: in postnatal day 25-35 (critical period) mice, 4 days of monocular deprivation (MD) are sufficient to induce OD-shifts towards the open eye; thereafter, 7 days of MD are needed. Beyond postnatal day 110, even 14 days of MD failed to induce OD-plasticity in mouse V1. In contrast, mice raised in a so-called "enriched environment" (EE), exhibit lifelong OD-plasticity. EE-mice have more voluntary physical exercise (running wheels), and experience more social interactions (bigger housing groups) and more cognitive stimulation (regularly changed labyrinths or toys). Whether experience-dependent shifts of V1-activation happen faster in EE-mice and how long the plasticity promoting effect would persist after transferring EE-mice back to SCs has not yet been investigated. To this end, we used intrinsic signal optical imaging to visualize V1-activation i) before and after MD in EE-mice of different age groups (from 1-9 months), and ii) after transferring mice back to SCs after postnatal day 130. Already after 2 days of MD, and thus much faster than in SC-mice, EE-mice of all tested age groups displayed a significant OD-shift towards the open eye. Transfer of EE-mice to SCs immediately abolished OD-plasticity: already after 1 week of SC-housing and MD, OD-shifts could no longer be visualized. In an attempt to rescue abolished OD-plasticity of these mice, we either administered the anti-depressant fluoxetine (in drinking water) or supplied a running wheel in the SCs. OD-plasticity was only rescued for the running wheel-mice. Altogether our results show that raising mice in less deprived environments like large EE-cages strongly accelerates experience-dependent changes in V1-activation compared to the impoverished SC-raising. Furthermore, preventing voluntary physical exercise of EE-mice in adulthood immediately precludes OD-shifts in V1.	[Kalogeraki, Evgenia; Pielecka-Fortuna, Justyna; Loewel, Siegrid] Univ Gottingen, JFB Inst Zool & Anthropol, Dept Syst Neurosci, Gottingen, Germany; [Kalogeraki, Evgenia] Gottingen Grad Sch Neurosci Biophys & Mol Biosci, Gottingen, Germany	University of Gottingen	Kalogeraki, E; Lowel, S (corresponding author), Univ Gottingen, JFB Inst Zool & Anthropol, Dept Syst Neurosci, Gottingen, Germany.; Kalogeraki, E (corresponding author), Gottingen Grad Sch Neurosci Biophys & Mol Biosci, Gottingen, Germany.	ekaloge@gwdg.de; sloewei@gwdg.de	889, CRC/L-1607-2018	889, CRC/0000-0002-6678-3138	Federal Ministry of Education and Research, Germany [01GQ0921, 01GQ0810]; Deutsche Forschungsgemeinschaft through the Collaborative Research Center 889 "Cellular Mechanisms of Sensory Processing"; Goettingen University	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft through the Collaborative Research Center 889 "Cellular Mechanisms of Sensory Processing"; Goettingen University	This work was supported by the Federal Ministry of Education and Research, Germany, Grants 01GQ0921 (to E.K, J.P-F) and 01GQ0810 (to S.L) and by grants of the Deutsche Forschungsgemeinschaft through the Collaborative Research Center 889 "Cellular Mechanisms of Sensory Processing" (Project B5 to S.L.). We acknowledge support by the Open Access Publication Funds of the Goettingen University.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Baroncelli L, 2012, NEUROPHARMACOLOGY, V62, P2388, DOI 10.1016/j.neuropharm.2012.02.010; Baroncelli L, 2010, EXP NEUROL, V226, P100, DOI 10.1016/j.expneurol.2010.08.009; Branchi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062226; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Greifzu F, 2016, NEUROBIOL AGING, V41, P130, DOI 10.1016/j.neurobiolaging.2016.02.014; Greifzu F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149771; Greifzu F, 2014, P NATL ACAD SCI USA, V111, P1150, DOI 10.1073/pnas.1313385111; Greifzu F, 2011, P NATL ACAD SCI USA, V108, P15450, DOI 10.1073/pnas.1016458108; Hengen KB, 2013, NEURON, V80, P335, DOI 10.1016/j.neuron.2013.08.038; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kalogeraki E, 2014, J NEUROSCI, V34, P15476, DOI 10.1523/JNEUROSCI.2678-14.2014; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Lehmann K, 2012, RESTOR NEUROL NEUROS, V30, P161, DOI 10.3233/RNN-2012-110192; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Marlatt MW, 2010, BRAIN RES, V1341, P93, DOI 10.1016/j.brainres.2010.03.086; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; METIN C, 1988, EXP BRAIN RES, V69, P594; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P429, DOI 10.1037/h0041137; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Scali M, 2012, EXP GERONTOL, V47, P337, DOI 10.1016/j.exger.2012.01.007; Trachtenberg JT, 2015, CURR OPIN NEUROBIOL, V35, P44, DOI 10.1016/j.conb.2015.06.006; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	41	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186999	10.1371/journal.pone.0186999	http://dx.doi.org/10.1371/journal.pone.0186999			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073219	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400093
J	Maier, MB; Lenz, CA; Vogel, RF				Maier, Maximilian B.; Lenz, Christian A.; Vogel, Rudi F.			Non-linear pressure/temperaturedependence of high pressure thermal inactivation of proteolytic Clostridium botulinum type B in foods	PLOS ONE			English	Article							HEAT-RESISTANCE; SPORES; ENDOSPORES; SURVIVAL	The effect of high pressure thermal (HPT) processing on the inactivation of spores of proteolytic type B Clostridium botulinum TMW 2.357 in four differently composed low-acid foods (green peas with ham, steamed sole, vegetable soup, braised veal) was studied in an industrially feasible pressure range and temperatures between 100 and 120 degrees C. Inactivation curves exhibited rapid inactivation during compression and decompression followed by strong tailing effects. The highest inactivation (approx. 6-log cycle reduction) was obtained in braised veal at 600 MPa and 110 degrees C after 300 s pressure-holding time. In general, inactivation curves exhibited similar negative exponential shapes, but maximum achievable inactivation levels were lower in foods with higher fat contents. At high treatment temperatures, spore inactivation was more effective at lower pressure levels (300 vs. 600 MPa), which indicates a non-linear pressure/temperature-dependence of the HPT spore inactivation efficiency. A comparison of spore inactivation levels achievable using HPT treatments versus a conventional heat sterilization treatment (121.1 degrees C, 3 min) illustrates the potential of combining high pressures and temperatures to replace conventional retorting with the possibility to reduce the process temperature or shorten the processing time. Finally, experiments using varying spore inoculation levels suggested the presence of a resistant fraction comprising approximately 0.01% of a spore population as reason for the pronounced tailing effects in survivor curves. The loss of the high resistance properties upon cultivation indicates that those differences develop during sporulation and are not linked to permanent modifications at the genetic level.	[Maier, Maximilian B.; Lenz, Christian A.; Vogel, Rudi F.] Tech Univ Munich, Lehrstuhl Tech Mikrobiol, Freising Weihenstephan, Germany	Technical University of Munich	Vogel, RF (corresponding author), Tech Univ Munich, Lehrstuhl Tech Mikrobiol, Freising Weihenstephan, Germany.	rudi@vogel@wzw.tum.de		Lenz, Christian/0000-0001-6700-5955	European Union's Horizon research and innovation program [635643]; German Research Foundation (DFG); Technical University of Munich (TUM)	European Union's Horizon research and innovation program; German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 635643 and was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program.	Ahn J, 2007, INT J FOOD MICROBIOL, V113, P321, DOI 10.1016/j.ijfoodmicro.2006.08.012; [Anonymous], THESIS; Artin I, 2008, APPL ENVIRON MICROB, V74, P2391, DOI 10.1128/AEM.02587-07; Ball C.O., 1957, STERILIZATION FOOD T; Bull MK, 2009, APPL ENVIRON MICROB, V75, P434, DOI 10.1128/AEM.01426-08; Casolari A., 1994, FOOD MICROBIOL; CERF O, 1977, J APPL BACTERIOL, V42, P1, DOI 10.1111/j.1365-2672.1977.tb00665.x; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; Hauschild A.H.W., 1993, CLOSTRIDIUM BOTULINU; Lenz CA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00652; Lenz CA, 2014, FOOD MICROBIOL, V44, P156, DOI 10.1016/j.fm.2014.05.010; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Margosch D, 2004, J FOOD PROTECT, V67, P2530, DOI 10.4315/0362-028X-67.11.2530; Margosch D, 2006, APPL ENVIRON MICROB, V72, P3476, DOI 10.1128/AEM.72.5.3476-3481.2006; MOLIN N, 1967, APPL MICROBIOL, V15, P1422, DOI 10.1128/AEM.15.6.1422-1426.1967; Morgan MT, 2010, PRINCIPLES OF ASEPTIC PROCESSING AND PACKAGING, 3RD EDITION, P3; Norton T, 2008, FOOD BIOPROCESS TECH, V1, P2, DOI 10.1007/s11947-007-0007-0; Peck MW, 2006, J APPL MICROBIOL, V101, P556, DOI 10.1111/j.1365-2672.2006.02987.x; Pflug I, 1978, REV F VALUES USED EN; PFLUG IJ, 1987, J FOOD PROTECT, V50, P608, DOI 10.4315/0362-028X-50.7.608; Reddy NR, 2006, INNOV FOOD SCI EMERG, V7, P169, DOI 10.1016/j.ifset.2006.03.002; Reddy NR, 1999, J FOOD SAFETY, V19, P277, DOI 10.1111/j.1745-4565.1999.tb00252.x; Reddy NR, 2003, J FOOD PROTECT, V66, P1402, DOI 10.4315/0362-028X-66.8.1402; Schnabel J, 2015, HIGH PRESSURE RES, V35, P78, DOI 10.1080/08957959.2014.999057; Sevenich R, 2016, INNOV FOOD SCI EMERG, V38, P65, DOI 10.1016/j.ifset.2016.09.013; Stumbo C.R., 1973, THERMOBACTERIOLOGY F; Wilson DR, 2008, TRENDS FOOD SCI TECH, V19, P289, DOI 10.1016/j.tifs.2008.01.005	27	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187023	10.1371/journal.pone.0187023	http://dx.doi.org/10.1371/journal.pone.0187023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073204	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400097
J	Sung, MS; Lee, TH; Heo, H; Park, SW				Sung, Mi Sun; Lee, Tae Hee; Heo, Hwan; Park, Sang Woo			Clinical features of superficial and deep peripapillary microvascular density in healthy myopic eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VISUAL-FIELD PROGRESSION; DISC ROTATION; BLOOD-FLOW; ANGIOGRAPHY; ANGLE; TILT; MICROCIRCULATION; ATROPHY; RETINA	Purpose To evaluate the clinical features of peripapillary microvasculature in myopic eyes and investigate the association between the superficial and deep peripapillary microvascular density and the myopic optic disc characteristics. Materials and methods This cross-sectional study included one hundred and fifty healthy myopic eyes with beta-peripapillary atrophy (beta-PPA). Ovality index, degree of optic disc rotation, and the area of beta-PPA were measured. Superficial and deep peripapillary microvascular density was measured using optical coherence tomography angiography. Logistic regression analysis was performed to look for the factors associated with peripapillary microvascular reduction. Results The mean superficial peripapillary microvascular density was 62.14 +/- 5.47%; 33 (22.0%) participants were found to have decreased microvascular density. Increased axial length (p < 0.001) and decreased average peripapillary retinal nerve fiber layer thickness (p = 0.027) were associated with the superficial peripapillary microvascular reduction. The mean deep peripapillary microvascular density was 73.76 +/- 4.02%; 26 (17.33%) participants were found to have decreased microvascular density. Larger ovality index (p = 0.028) and more inferiorly rotated optic disc (p = 0.021) were associated with the deep peripapillary microvascular reduction. Conclusions Axial elongation was significantly associated with microvascular reduction in the superficial peripapillary retina, whereas it was not associated with deep peripapillary microvascular reduction. The deep peripapillary microvascular density was independently associated with myopic optic disc characteristics such as ovality index and optic disc rotation.	[Sung, Mi Sun; Lee, Tae Hee; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea; [Sung, Mi Sun; Lee, Tae Hee; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Res Inst Med Sci, Gwangju, South Korea; [Park, Sang Woo] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Res Inst Med Sci, Gwangju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea.	exo70@naver.com			National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A01059630]; National Research Foundation of Korea - Korean government [MSIP-2017M3A9E8023019]	National Research Foundation of Korea - Ministry of Education; National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This research was supported by the Basic Science Research program through the National Research Foundation of Korea (http://www.nrf.re.kr) funded by the Ministry of Education (NRF-2015R1D1A1A01059630 / Sang Woo Park) and Bio & Medical Technology Development Program of the National Research Foundation of Korea funded by the Korean government (MSIP-2017M3A9E8023019 / Mi Sun Sung). The funding organizations had no role in the design or conduct of this research.	Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; AVETISOV ES, 1977, ANN OPHTHALMOL, V9, P1261; Azemin MZ, 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/783525; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cheung SW, 2000, OPHTHAL PHYSL OPT, V20, P119, DOI 10.1016/S0275-5408(99)00045-9; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P4991, DOI 10.1167/iovs.14-14663; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P595, DOI 10.1016/S1350-9462(01)00005-2; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Lee EJ, 2016, INVEST OPHTH VIS SCI, V57, P6265, DOI 10.1167/iovs.16-20287; Li M, 2017, AM J OPHTHALMOL, V174, P56, DOI 10.1016/j.ajo.2016.10.018; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Liu WF, 2017, CURR EYE RES, V42, P1308, DOI 10.1080/02713683.2017.1307992; Park HYL, 2015, INVEST OPHTH VIS SCI, V56, P156, DOI 10.1167/iovs.13-12327; Shimada N, 2004, GRAEF ARCH CLIN EXP, V242, P284, DOI 10.1007/s00417-003-0836-0; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Sung MS, 2016, OPHTHALMOLOGY, V123, P1484, DOI 10.1016/j.ophtha.2016.03.040; Sung MS, 2016, OPHTHALMOLOGY, V123, P400, DOI 10.1016/j.ophtha.2015.10.018; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Xu H, 2016, INVEST OPHTH VIS SCI, V57, P4464, DOI 10.1167/iovs.16-19603; Yamada H, 2016, OPHTHALMOLOGY, V123, P542, DOI 10.1016/j.ophtha.2015.10.061; Yang Y, 2016, INVEST OPHTH VIS SCI, V57, P6020, DOI 10.1167/iovs.16-19542; Yarmohammadi A, 2016, OPHTHALMOLOGY, V123, P2498, DOI 10.1016/j.ophtha.2016.08.041	30	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187160	10.1371/journal.pone.0187160	http://dx.doi.org/10.1371/journal.pone.0187160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073242	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400127
J	Williams, VL; Loveridge, AJ; Newton, DJ; Macdonald, DW				Williams, Vivienne L.; Loveridge, Andrew J.; Newton, David J.; Macdonald, David W.			Questionnaire survey of the pan-African trade in lion body parts	PLOS ONE			English	Article							WILDLIFE CONSERVATION; TRADITIONAL MEDICINE; HUNTING INDUSTRY; NATIONAL-PARK; LAND USES; POPULATIONS; MANAGEMENT; PROVINCE; ANIMALS; IMPACTS	The African lion is in decline across its range, and consumptive utilisation and trade of their body parts and skins has been postulated as a cause for concern. We undertook a pan-African questionnaire and literature survey to document informed opinion and evidence for the occurrence of domestic and international trade and consumption in African lion body parts across current and former range states. Sixty-five people from 18 countries participated in the online questionnaire survey (run from July 2014 to May 2015), with information provided for 28 countries (including 20 out of 24 countries believed to have extant populations). Respondents were experts within their professional spheres, and 77% had >= 6 years relevant experience within lion conservation or allied wildlife matters. Their opinions revealed wide sub-regional differences in consumptive use, drivers of trade, and access to lions that impact wild lion populations in different ways. Traditional medicine practices (African and Asian) were perceived to be the main uses to which lion body parts and bones are put domestically and traded internationally, and there is reason for concern about persistent imports from former lion range states (mainly in West Africa) for parts for this purpose. The domestic, rather than international, trade in lion body parts was perceived to be a bigger threat to wild lion populations. Parts such as skin, claws, teeth and bones are thought to be in most demand across the continent. The impact of international trade on wild populations was acknowledged to be largely unknown, but occasionally was judged to be 'high', and therefore vigilance is needed to monitor emerging detrimental impacts. Seventeen countries were nominated as priorities for immediate monitoring, including: South Africa, Tanzania, Zimbabwe, Mozambique, Zambia, Botswana, Kenya, Nigeria, and Cameroon. Reasons for their selection include: prevalence of trophy hunting, 'hot spots' for poaching, active domestic trade in lion body parts, trade in curios for the tourist market, and histories of legal-illegal wildlife trade. This survey, and increased incident reports since mid-2015 of lion poisoning and poaching in Mozambique, Zimbabwe and South Africa, and sporadic poaching events in Uganda and Tanzania, are signalling an escalating trend in the trade of lion products that is an increasing threat to some national populations. The evidence is sufficient to make more detailed investigation of this trade a conservation priority.	[Williams, Vivienne L.; Newton, David J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Loveridge, Andrew J.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recananti Kaplan Ctr, Tubney House, Tubney, Oxon, England; [Newton, David J.] IUCN ESARO, TRAFFIC East Southern Africa, Pretoria, South Africa	University of Witwatersrand; University of Oxford	Williams, VL (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	vivienna.pub1@wildsaence.co.za	Williams, Vivienne Linda/M-1453-2019	Williams, Vivienne Linda/0000-0003-0698-6512	Robertson Foundation; Recanati-Kaplan Foundation; Mackenzie Foundation; National Research Foundation	Robertson Foundation; Recanati-Kaplan Foundation; Mackenzie Foundation; National Research Foundation	This work received support from the Robertson Foundation, Recanati-Kaplan Foundation, Mackenzie Foundation, and the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEOLA MO, 1992, ENVIRON CONSERV, V19, P125, DOI 10.1017/S0376892900030605; AFOLAYAN TA, 1980, ENVIRON CONSERV, V7, P207, DOI 10.1017/S0376892900007591; Aid Lion, 2011, SUMM REP TROPH HUNT; Al Safi A., 2007, TRADITIONAL SUDANESE; ALERT, ALERT; Alves R.R., 2013, ANIM TRADIT FOLK MED, V9, P171, DOI [10.1007/978-3-642-29026-8_9, DOI 10.1007/978-3-642-29026-8_9]; Amir O. G., 2006, WILDLIFE TRADE SOMAL; [Anonymous], 2014, ABC NEWS; [Anonymous], 2012, NEWS24; [Anonymous], 2013, LAST GREAT APE ORG; [Anonymous], 2011, TIMESLIVE       0920; [Anonymous], 2012, GLOBALPOST      0412; [Anonymous], 2013, LEGALBRIEF DAIL 1001; [Anonymous], STATUT CONSERVATION; [Anonymous], COMP MACR CONT REG G; [Anonymous], [No title captured]; [Anonymous], 2014, LEGALBRIEF TODA 0805; [Anonymous], 2014, SHANGHAIDAILY   0320; [Anonymous], 2015, ANGOLA PRESS    0916; ANYINAM C, 1995, SOC SCI MED, V40, P321, DOI 10.1016/0277-9536(94)E0098-D; Ashforth A, 2005, SOC DYNAMICS, V31, P211, DOI 10.1080/02533950508628714; Atta Elmanan A.M., 2007, CROP NEWSL, V10; BALAKRISHNAN M, 1992, ENVIRON CONSERV, V19, P135, DOI 10.1017/S0376892900030617; Bauer H, 2015, IUCN RED LIST THREAT; Bauer H., 2016, PANTHERA LEO ERRATA, DOI [10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.EN, 10.2305/IUCN.UK.2016-3.RLTS.T20522A71739753.en]; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Becker MS, 2013, J WILDLIFE MANAGE, V77, P128, DOI 10.1002/jwmg.446; Beninguisse Gervais, 2004, Afr J Reprod Health, V8, P152, DOI 10.2307/3583401; Born Free Foundation, 2008, TOO MUCH PRESS HANDL; Bouche P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155763; Bryant A.T., 1966, ZULU MED MED MEN; Burton AC, 2011, AFR J ECOL, V49, P122, DOI 10.1111/j.1365-2028.2010.01234.x; Butynski T.M., 1974, UNASYLVA, V26, P24; Chardonnet P., 2002, CONSERVATION AFRICAN; Chardonnet P, 2005, WORKSH LION W AFR CE; Chardonnet P., 2010, 13 FAO; Chardonnet P, 2009, CONSERVATION STATUS; Chauqu M., 2010, ANALISE COMERCIALIZA; Chavunduka G. L., 1980, ZAMBEZIA, V8, P129; Cheikh Oumar BA, 2006, EC VALUE WILD RESOUR; CITES, 2016, DEC AFR LIO IN PRESS; CITES, 2014, 2433 CITES AC2T; CITES Scientific Authority (South Africa), 2013, UNPUB; Cocker Mark, 2000, Bulletin of the African Bird Club, V7, P60; Cocks M, 2000, SOC SCI MED, V51, P1505, DOI 10.1016/S0277-9536(00)00050-2; Cocks M, 2002, SOC SCI MED, V54, P387, DOI 10.1016/S0277-9536(01)00037-5; Cory H, 1949, AFRICA, V19, P13, DOI 10.2307/1156261; Cruise A., 2015, EYEWITNESS NEWS 0826; Cunningham AB, 1991, UNPUB; Cunningham T., 1989, INDICATOR SA, V6, P51; DEDEKE G. A., 2006, AFR J INDIG KNOWL SY, V5, P87; Dedeke GA, 2005, INDILINGA AFRICA J I, V5, P175; DILLONMALONE C, 1988, SOC SCI MED, V26, P1159, DOI 10.1016/0277-9536(88)90191-8; Djagoun CAMS., 2013, ANIMALS TRADITIONAL, P367, DOI DOI 10.1007/978-3-642-29026-8_17; Douglas LR, 2014, BIOL CONSERV, V171, P270, DOI 10.1016/j.biocon.2014.01.031; Edwards IB, THESIS; El-Kamali HH, 2000, J ETHNOPHARMACOL, V72, P279, DOI 10.1016/S0378-8741(00)00209-9; Ethiopian Wildlife Conservation Authority (EWCA), 2012, NATL ACTION PLAN CON, P40; Everatt KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099389; Farrand D., 1980, THESIS; Fish US and Service Wildlife, 2012, FED REGISTER, V77, P70727; Fusari A., 2010, CONSERVATION STRATEG; Game ET, 2014, CONSERV LETT, V7, P271, DOI 10.1111/conl.12050; Gandiwa E, 2013, J NAT CONSERV, V21, P133, DOI 10.1016/j.jnc.2012.11.009; Garba H., GCPINT679 EC; Gebresenbet F, 2009, P NAT LION CONS WORK; GELFAND M, 1955, Cent Afr J Med, V1, P304; Gelfand M., 1985, TRADITIONAL MED PRAC; Habati MA., 2011, INDEPENDENT; Haule KS, 2002, J ENVIRON MANAGE, V66, P31, DOI 10.1006/jema.2002.0572; Henschel Philipp, 2010, Cat News, V52, P34; Heuler H., 2013, VOA NEWS        0212; Houpline C., 2010, CEPA MAGAZINE, V22, P5; Ikanda DK, 2008, NDF WORKSH CAS STUD, V1; IUCN SSC Cat Specialist Group, 2006, CONS STRAT LION PANT; IUCN SSC Cat Specialist Group, 2006, CONS STRAT LION W CE; Junod H.A, 1962, LIFE S AFRICAN TRIBE, VII; Kamatenesi-Mugisha M, 2007, J ETHNOPHARMACOL, V109, P1, DOI 10.1016/j.jep.2006.06.011; Kapama F., 2015, TANZANIA DAILY N OCT; Karugaba M., 2010, NEW VISION; LAGA. The Last Great Ape Organization, WILDL LAW ENF VAR DO; Lewis DM, 1997, CONSERV BIOL, V11, P59, DOI 10.1046/j.1523-1739.1997.94389.x; Lindsey P, 2012, S AFR J WILDL RES, V42, P11, DOI 10.3957/056.042.0103; Lindsey P, 2011, ILLEGAL HUNTING BUSH; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey PA, 2013, ORYX, V47, P41, DOI 10.1017/S0030605311001049; Lindsey PA, 2011, ORYX, V45, P96, DOI 10.1017/S0030605310000153; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; LOEB EM, 1956, J AM FOLKLORE, V69, P147, DOI 10.2307/537275; LONGMORE L, 1958, Cent Afr J Med, V4, P242; Macdonald David W., 2016, REPORT LION CONSERVA; Macleod F, 2013, MAIL GUARDIAN; Mail&Guardian, 2003, MAIL GUARDIAN; Majaliwa C., 2014, TANZANIA NEWS D 0801; Marshall NT, 1998, SEARCHING CURE CONSE; Mauck Gareth, 2013, WILDLIFE LEGISLATION; McConnell T., 2011, GLOBALPOST      0921; McCord JB, 1918, S AFRICAN MED RECORD, V16; Mcleod F., 2012, MAIL GUARDIAN; Mesochina P, 2010, CONSERVATION STATUS; Moghari NM, THESIS; Morris B, 1998, Anthropol Med, V5, P81, DOI 10.1080/13648470.1998.9964550; N'Diaye C., 2014, UTILISATION COMMERCE; Nadembega P, 2011, J ETHNOPHARMACOL, V133, P378, DOI 10.1016/j.jep.2010.10.010; Ngwenya MP, 2001, NA12404 KZN WILDL; Ntiamoa-Baidu Y., 1987, Unasylva, V39, P27; Nyanganji G, 2011, SURVEY LION PANTHERA; Olupot W., 2009, 38 WILDL CONS SOC; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Panthera WILDAID, 2016, CEC AFR LIONS CRIS; Pellerin M., 2009, STATUT CONSERVATION; Pettifer HL, 1978, FAUNA FLORA, V32, P14; Place J, 2010, PETITION LIST AFRICA; Reuters, 2015, LION SPOTT GAB 1 TIM; Samuelsson E, 2007, S AFR J WILDL RES, V37, P41, DOI 10.3957/0379-4369-37.1.41; Schumann M, 2008, S AFR J WILDL RES, V38, P123, DOI 10.3957/0379-4369-38.2.123; Sifuna N., 2012, ADV ANTHR, V2, P31, DOI DOI 10.4236/AA.2012.21004; Simelane TS, 1998, S AFR J WILDL RES, V28, P121; Simelane TS, 1996, THESIS; Smith MJ, 2011, BIOL CONSERV, V144, P82, DOI 10.1016/j.biocon.2010.10.018; Sodeinde O.A., 1999, Traffic Bulletin, V18, P35; Soewu DA, 2013, ANIMALS TRADITIONAL, P347, DOI DOI 10.1007/978-3-642-29026-8_16; Soewu DA, 2012, GLOBAL J MED RES, V12; Soewu DA, 2008, AFR J AGRIC RES, V3, P421; Sogbohossou E., 2011, THESIS; Sogbohossou E. A, 2006, CONSERVATION GRANDS; Sogbohossou EA, 2007, CONTRIBUTION WILD DO; Taylor M.E., 1992, Nigerian Field, V57, P119; Tehou CA, 2013, PLAN ACTIONS CONSERV; TRAFFIC, 1997, TRAFFIC B SEIZ PROS; TRAFFIC, 2015, TRAFFIC B, V27, P67; TRAFFIC, 2016, TRAFFIC B, V28, P33; Tumenta PN, 2010, AFR J ECOL, V48, P888, DOI 10.1111/j.1365-2028.2009.01181.x; Ujorha T., 2014, DAILY TRUST     0315; UNEP, 2012, UNEPCBDCOPDEC1125; US Fish and Service Wildlife, 2015, FED REGISTER, V80, P79999; Vats R, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0001-y; Warchol GL, 2004, CRIM JUSTICE STUD CR, V1, P57, DOI DOI 10.1080/08884310420001679334; WHITE RM, 2004, INDIGENOUS FORESTS W, P474; Whiting MJ, 2011, J ZOOL, V284, P84, DOI 10.1111/j.1469-7998.2010.00784.x; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Williams VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135144; Williams VL, 2015, NATURE, V523, P290, DOI 10.1038/523290a; Williams VL, 2016, J ETHNOPHARMACOL, V179, P265, DOI 10.1016/j.jep.2015.12.024; Williams VL., 2015, BONES CONTENTION ASS; Williams VL, PLOS ONE; Woodford DJ, 2016, NEOBIOTA, P63, DOI 10.3897/neobiota.31.10038; Zambia Wildlife Authority, 2009, ZAMB CONS STRAT ACT	150	22	22	8	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187060	10.1371/journal.pone.0187060	http://dx.doi.org/10.1371/journal.pone.0187060			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073202	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400104
J	Ojeda-Perez, ZZ; Jimenez-Bremont, JF; Delgado-Sanchez, P				Zarely Ojeda-Perez, Zaida; Francisco Jimenez-Bremont, Juan; Delgado-Sanchez, Pablo			Continuous high and low temperature induced a decrease of photosynthetic activity and changes in the diurnal fluctuations of organic acids in Opuntia streptacantha	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; COLD-ACCLIMATION; WATER RELATIONS; QUANTUM YIELD; HEAT-STRESS; CO2 UPTAKE; CAM PLANT; METABOLISM; CACTUS; GROWTH	Opuntia plants grow naturally in areas where temperatures are extreme and highly variable in the day during the entire year. These plants survive through different adaptations to respond to adverse environmental conditions. Despite this capability, it is unknown how CAM photosynthetic activity and growth in Opuntia plantlets is affected by constant heat or cold. Therefore, the main objective of this research was to evaluate the short-term effect of high (40 degrees C) and low (4 degrees C) continuous temperatures on the photosynthetic efficiency, the organic acid content (malic acid) and the relative growth rate (RGR) in seven-month-old Opuntia streptacantha plantlets during 5, 10, and 15 days. Chlorophyll fluorescence analysis allowed us to determine that high temperatures negatively impact the photosynthetic efficiency of O. streptacantha plantlets, which exhibited the lowest values of maximum quantum efficiency of the photosystem II (F-v/F-m = 52%, F-v/F-0 = 85%), operational quantum yield of PS (phi(PSII) = 65%) and relative electron transport rate (rETR = 65%), as well as highest values of basal fluorescence (F-0 = 226%) during 15 days of treatment. Similarly, low temperatures decreased Fv/Fm (16%), F-v/F-0 (50%), phi(PSII) and rETR (16%). High temperatures also decreased nocturnal acidification in approximately 34-50%, whereas low temperatures increased it by 30-36%. Additionally, both continuous temperatures affected drastically diurnal consumption of malic acid, which was related to a significant RGR inhibition, where the specific photosynthetic structure area component was the most affected. Our results allowed determining that, despite the high tolerance to extreme temperatures described for Opuntia plants, young individuals of O. streptacantha suffered photosynthetic impairment that led to the inhibition of their growth. Thus, the main findings reported in this study can help to predict the potential impact of climatic change on the establishment and survival of succulent species of arid and semiarid regions of Mexico.	[Zarely Ojeda-Perez, Zaida; Delgado-Sanchez, Pablo] Univ Autonoma San Luis Potosi, Lab Biotecnol, Fac Agron & Vet, Soledad De Graciano Sanc, Slp, Mexico; [Zarely Ojeda-Perez, Zaida] Univ Pedag Tecnol & Colombia, Sede Cent, Lab Cultivo Tejidos Vegetales Bioplasma, Escuela Ciencias Biol,Fac Ciencias Basicas, Tunja, Boyaca, Colombia; [Francisco Jimenez-Bremont, Juan] Inst Potosino Invest Cient & Tecnol AC, Lab Biol Mol Hongos & Plantas, Div Biol Mol, San Luis Potosi, Slp, Mexico	Universidad Autonoma de San Luis Potosi; Universidad Pedagogica y Tecnologica de Colombia (UPTC); Instituto Potosino Investigacion Cientifica y Tecnologica	Delgado-Sanchez, P (corresponding author), Univ Autonoma San Luis Potosi, Lab Biotecnol, Fac Agron & Vet, Soledad De Graciano Sanc, Slp, Mexico.	pablo.delgado@uaslp.mx	Jiménez Bremont, Juan Francisco/CAF-4866-2022; Jiménez Bremont, Juan Francisco/C-9256-2011; Jiménez Bremont, Juan Francisco/CAI-1278-2022; Delgado-Sánchez, Pablo/AAV-3840-2021; Ojeda Perez, Zaida Zarely/B-1003-2015	Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Ojeda Perez, Zaida Zarely/0000-0003-1630-6699; Delgado-Sanchez, Pablo/0000-0003-2560-871X	Consejo Nacional de Ciencia y Tecnologia-Fondo Ciencia Basica [179982, 382480]	Consejo Nacional de Ciencia y Tecnologia-Fondo Ciencia Basica	This study was supported by the Consejo Nacional de Ciencia y Tecnologia-Fondo Ciencia Basica (No. 179982 to Pablo Delgado Sanchez) and PhD student grant (No. 382480 to Zaida Zarely Ojeda Perez).	Al-Turki TA, 2014, J PLANT INTERACT, V9, P107, DOI 10.1080/17429145.2013.774442; Angert AL, 2006, OECOLOGIA, V148, P183, DOI 10.1007/s00442-006-0361-z; [Anonymous], J BOT LE; Babani F, 1996, J PLANT PHYSIOL, V148, P555, DOI 10.1016/S0176-1617(96)80075-7; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Barker DH, 1997, OECOLOGIA, V109, P353, DOI 10.1007/s004420050093; Bascunan-Godoy L, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-114; Brestic M, 2012, ABSTR INT SCI C ESNA, P62; Chen WH, 2008, PLANT CELL REP, V27, P1667, DOI 10.1007/s00299-008-0591-0; Cony MA, 2008, J PROF ASSOC CACTUS, V10, P36; Neto ADD, 2011, REV CIENC AGRON, V42, P893, DOI 10.1590/S1806-66902011000400010; de Mattos EA, 1999, J EXP BOT, V50, P253, DOI 10.1093/jexbot/50.331.253; Delgado-Sanchez P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081513; Dessena L, 2016, INT J BIOMETEOROL, V60, P677, DOI 10.1007/s00484-015-1062-2; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GOLDSTEIN G, 1994, PLANT PHYSIOL, V104, P675, DOI 10.1104/pp.104.2.675; Granados-Sanchez D, 1991, NOPAL HIST FISIOLOGI; HARTSOCK TL, 1976, NATURE, V262, P574, DOI 10.1038/262574b0; Hasanuzzaman M, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P169, DOI 10.5772/54833; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Hernandez-Gonzalez O, 2007, AM J BOT, V94, P1344, DOI 10.3732/ajb.94.8.1344; Holtum JAM, 2014, FUNCT PLANT BIOL, V41, P843, DOI 10.1071/FP13284; Huerta C, 2013, PLANT CELL REP, V32, P293, DOI 10.1007/s00299-012-1363-4; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; Kana R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01849; Kennedy J, 2016, GLOBAL REGIONAL CLIM, V71, P185; KENYON WH, 1981, PLANT PHYSIOL, V68, P1002, DOI 10.1104/pp.68.5.1002; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; KOCH KE, 1980, OECOLOGIA, V45, P390, DOI 10.1007/BF00540212; LAKSO AN, 1975, PLANT PHYSIOL, V56, P370, DOI 10.1104/pp.56.3.370; Lichtenthaler HK, 2005, PHOTOSYNTHETICA, V43, P379, DOI 10.1007/s11099-005-0062-6; LOIK ME, 1993, PLANT PHYSIOL, V103, P871, DOI 10.1104/pp.103.3.871; Andrade JL, 2007, B SOC BOT MEX, V81, P37; Aragon-Gastelum JL, 2014, FLORA, V209, P499, DOI 10.1016/j.flora.2014.06.002; Lujan R, 2009, WEBER PLANT CELL ENV, V32, P1791; Martinazzo Emanuela Garbin, 2012, Braz. J. Plant Physiol., V24, P237, DOI 10.1590/S1677-04202013005000001; MEDINA E, 1976, PHOTOSYNTHETICA, V10, P155; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Musil CF, 2009, ENVIRON EXP BOT, V66, P79, DOI 10.1016/j.envexpbot.2008.11.008; Musil CF, 2005, NEW PHYTOL, V165, P539, DOI 10.1111/j.1469-8137.2004.01243.x; Nobel P, 2003, NOPAL COMO FORRAJE, P17; Nobel PS, 2008, J ARID ENVIRON, V72, P633, DOI 10.1016/j.jaridenv.2007.08.005; Nobel P. S., 1988, Environmental biology of agaves and cacti.; Nobel PS, 2003, NEW PHYTOL, V157, P271, DOI 10.1046/j.1469-8137.2003.00675.x; Nobel PS, 2002, BIOTROPICA, V34, P225, DOI 10.1111/j.1744-7429.2002.tb00533.x; NOBEL PS, 1983, PLANT PHYSIOL, V71, P71, DOI 10.1104/pp.71.1.71; Nobel PS, 1983, ADV AGR BIOTECHNOLOG, V3, P165, DOI [10.1007/978-94-009-6813-4, DOI 10.1007/978-94-009-6813-4]; Ortiz C, 2001, J EXP BOT, V52, P1711, DOI 10.1093/jexbot/52.361.1711; Osmond CB, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P1; Preston JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00167; Rasband W, 1997, IMAGEJ 1 47V, P2016; Romo-Campos R, 2013, BOT SCI, V91, P319; Shipley B, 2002, FUNCT ECOL, V16, P682, DOI 10.1046/j.1365-2435.2002.00672.x; Song YP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-111; STATSOFT INC, 2004, STAT DAT AN SOFTW SY; SZAREK SR, 1974, PLANT PHYSIOL, V54, P829, DOI 10.1104/pp.54.6.829; Twardosz R, 2016, ACTA GEOPHYS; Valdez-Cepeda RD, 2001, J PROF ASSOC CACTUS, V4, P105; Walz H., 2014, MINI PAM 2 MANUAL TO; Wang XN, 1997, J PROF ASSOC CACTUS, V2, P48; Zotz G, 1998, J PLANT PHYSIOL, V152, P545, DOI 10.1016/S0176-1617(98)80276-9	61	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186540	10.1371/journal.pone.0186540	http://dx.doi.org/10.1371/journal.pone.0186540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059203	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000030
J	Chen, SY; Liu, LH; Fu, MZ; Zhang, GW; Yi, J; Lai, SJ; Wang, W				Chen, Shi-Yi; Liu, Linhai; Fu, Maozhong; Zhang, Gong-Wei; Yi, Jun; Lai, Song-Jia; Wang, Wei			Simultaneous introgression of three POLLED mutations into a synthetic breed of Chinese cattle	PLOS ONE			English	Article							BOS-TAURUS; ASSOCIATION; LOCUS; GENE; YAKS	The polled phenotype of cattle is increasingly becoming favourable mainly because of the enhanced emphasis on animal welfare, for which the causative mutations have been reported during the past years. The Shuxuan cattle are a new synthetic breed by crossing the indigenous cattle with both Simmental and Holstein semen in Sichuan of Southwest China, in which about 15% of polled individuals have newly emerged. Because official record about POLLED genotypes for the historically imported sires is unavailable, we therefore genotyped the proposed POLLED variants of P-202ID, P-80kbID and P-219ID among 48 polled and 16 horned Shuxuan cattle. It was first revealed that all three candidate mutations have been simultaneously introgressed into Shuxuan cattle, whereas the P-202ID mutation is dominant. Furthermore, one polled animal still remains to carry none of the three candidate mutations, which suggests that further mutation(s) would also exist. Additionally, we sequenced mitochondrial DNA and found that Shuxuan cattle are composed of two matrilineal origins of Bos taurus (65.6%) and B. indicus (34.4%); and there is no origin-biased distribution of polled phenotype. In conclusion, our study first supports the recently reported novel candidate mutation of P-219ID and detects simultaneous presences of all three known POLLED mutations within a cattle breed.	[Chen, Shi-Yi; Liu, Linhai; Lai, Song-Jia] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China; [Fu, Maozhong; Yi, Jun; Wang, Wei] Sichuan Anim Sci Acad, Chengdu, Sichuan, Peoples R China; [Zhang, Gong-Wei] Southwest Univ, Coll Anim Sci, Chongqing, Peoples R China	Sichuan Agricultural University; Southwest University - China	Chen, SY (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.; Wang, W (corresponding author), Sichuan Anim Sci Acad, Chengdu, Sichuan, Peoples R China.	sychensau@gmail.com; wws20062127@163.com	Chen, Shi-Yi/GWU-5321-2022	Zhang, Gong-Wei/0000-0002-9043-6945	Agricultural Department ("Sichuan Agriculture Research System"); Science & Technology Department of Sichuan Province	Agricultural Department ("Sichuan Agriculture Research System"); Science & Technology Department of Sichuan Province	This work was financially supported by Agricultural Department ("Sichuan Agriculture Research System") and Science & Technology Department of Sichuan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; CHEN SY, 2008, SPRINGER OPTIM APPL, V46, P206, DOI DOI 10.1007/S10528-008-9144-Z; Cozzi G, 2015, LIVEST SCI, V179, P4, DOI 10.1016/j.livsci.2015.05.011; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Gaspa G, 2015, LIVEST SCI, V179, P86, DOI 10.1016/j.livsci.2015.05.020; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Glatzer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067992; Lai SJ, 2006, MOL PHYLOGENET EVOL, V38, P146, DOI 10.1016/j.ympev.2005.06.013; Liang CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158642; Liu WB, 2014, ANIM GENET, V45, P138, DOI 10.1111/age.12081; Lundrigan B, 1996, J MAMMAL, V77, P462, DOI 10.2307/1382822; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; Medugorac I, 2017, NAT GENET, V49, P470, DOI 10.1038/ng.3775; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; ROTHAMMER S, 2014, GENET SEL EVOL, V46; Schafberg R, 2015, LIVEST SCI, V179, P54, DOI 10.1016/j.livsci.2015.05.017; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435; Wiener DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127691; Windig JJ, 2015, LIVEST SCI, V179, P96, DOI 10.1016/j.livsci.2015.05.021	26	6	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186862	10.1371/journal.pone.0186862	http://dx.doi.org/10.1371/journal.pone.0186862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053739	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100042
J	Prabhu, SA; Ndlovu, B; Engelbrecht, J; van den Berg, N				Prabhu, S. Ashok; Ndlovu, Buyani; Engelbrecht, Juanita; van den Berg, Noelani			Generation of composite Persea americana (Mill.) (avocado) plants: A proof-of-concept-study	PLOS ONE			English	Article							RHIZOGENES-TRANSFORMED ROOTS; STUDYING GENE-EXPRESSION; AGROBACTERIUM-RHIZOGENES; MEDIATED TRANSFORMATION; PHYTOPHTHORA-CINNAMOMI; HAIRY ROOTS; TRANSGENIC ROOTS; SYSTEM; REGENERATION; CULTURES	Avocado (Persea americana (Mill.)), an important commercial fruit, is severely affected by Phytophthora Root Rot in areas where the pathogen is prevalent. However, advances in molecular research are hindered by the lack of a high-throughput transient transformation system in this non-model plant. In this study, a proof-of-concept is demonstrated by the successful application of Agrobacterium rhizogenes-mediated plant transformation to produce composite avocado plants. Two ex vitro strategies were assessed on two avocado genotypes (Itzamna and A0.74): In the first approach, 8-week-old etiolated seedlings were scarred with a sterile hacksaw blade at the base of the shoot, and in the second, inch-long incisions were made at the base of the shoot (20-week-old non-etiolated plants) with a sterile blade to remove the cortical tissue. The scarred/wounded shoot surfaces were treated with A. rhizogenes strains (K599 or ARqua1) transformed with or without binary plant transformation vectors pRedRootII (DsRed1 marker), pBYR2e1-GFP (GFP-green fluorescence protein marker) or pBINUbiGUSint (GUS-beta-glucuronidase marker) with and without rooting hormone (Dip 'N' Grow) application. The treated shoot regions were air-layered with sterile moist cocopeat to induce root formation. Results showed that hormone application significantly increased root induction, while Agrobacterium-only treatments resulted in very few roots. Combination treatments of hormone+Agrobacterium (-/+ plasmids) showed no significant difference. Only the ARqua1(+plasmid): A0.74 combination resulted in root transformants, with hormone+ARqua1(+pBINUbiGUSint) being the most effective treatment with similar to 17 and 25% composite plants resulting from strategy-1 and strategy-2, respectively. GUS- and GFP-expressing roots accounted for less than 4 and similar to 11%, respectively, of the total roots/treatment/avocado genotype. The average number of transgenic roots on the composite plants was less than one per plant in all treatments. PCR and Southern analysis further confirmed the transgenic nature of the roots expressing the screenable marker genes. Transgenic roots showed hyper-branching compared to the wild-type roots but this had no impact on Phytophthora cinnamomi infection. There was no difference in pathogen load 7-days-post inoculation between transformed and control roots. Strategy-2 involving A0.74: ARqua1 combination was the best ex vitro approach in producing composite avocado plants. The approach followed in this proof-of-concept study needs further optimisation involving multiple avocado genotypes and A. rhizogenes strains to achieve enhanced root transformation efficiencies, which would then serve as an effective high-throughput tool in the functional screening of host and pathogen genes to improve our understanding of the avocado-P. cinnamomi interaction.	[Prabhu, S. Ashok; Ndlovu, Buyani; Engelbrecht, Juanita; van den Berg, Noelani] Univ Pretoria, FABI, Pretoria, South Africa; [Prabhu, S. Ashok; Ndlovu, Buyani; van den Berg, Noelani] Univ Pretoria, Dept Microbiol & Plant Pathol, Pretoria, South Africa	University of Pretoria; University of Pretoria	van den Berg, N (corresponding author), Univ Pretoria, FABI, Pretoria, South Africa.; van den Berg, N (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, Pretoria, South Africa.	noelani.vdberg@fabi.up.ac.za	Engelbrecht, Juanita/ABE-2891-2021	Engelbrecht, Juanita/0000-0002-4439-1205	Hans Merenshy Foundation (HMF), South Africa; University of Pretoria post-doctoral fellowship programme; HMF; National Research Foundation (NRF), South Africa	Hans Merenshy Foundation (HMF), South Africa; University of Pretoria post-doctoral fellowship programme; HMF; National Research Foundation (NRF), South Africa(National Research Foundation - South Africa)	The research was carried out with a grant from the Hans Merenshy Foundation (HMF), South Africa. SAP was supported financially by University of Pretoria post-doctoral fellowship programme and HMF. BN received student bursaries from National Research Foundation (NRF), South Africa and HMF. JE was fully supported by HMF.	Acosta-Muniz CH, 2012, PHYSIOL PLANTARUM, V144, P59, DOI 10.1111/j.1399-3054.2011.01522.x; Ahmed M. F., 2012, American Journal of Plant Sciences, V3, P1225; Alpizar E, 2006, PLANT CELL REP, V25, P959, DOI 10.1007/s00299-006-0159-9; [Anonymous], [No title captured]; [Anonymous], 2014, FAOSTAT; Armengaud J, 2014, J PROTEOMICS, V105, P5, DOI 10.1016/j.jprot.2014.01.007; Balasubramanian A., 2011, BMC P, V5, pO45, DOI DOI 10.1186/1753-6561-5-S7-045; Brunner I., 2001, MOL IDENTIFICATION F, P2079; Chaparro-Pulido CA, 2014, IN VITRO CELL DEV-PL, V50, P292, DOI 10.1007/s11627-013-9564-2; Christey MC, 2001, IN VITRO CELL DEV-PL, V37, P687; Coffey M. D., 1992, Plant diseases of international importance. Volume III. Diseases of fruit crops., P423; Collier R, 2005, PLANT J, V43, P449, DOI 10.1111/j.1365-313X.2005.02454.x; Cruz-Hernandez A, 1998, PLANT CELL REP, V17, P497, DOI 10.1007/s002990050431; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Darvas J. M., 1987, Yearbook, South African Avocado Growers' Association, V10, P91; DIOUF D, 1995, MOL PLANT MICROBE IN, V8, P532, DOI 10.1094/MPMI-8-0532; Falasca G, 2000, NEW PHYTOL, V145, P77, DOI 10.1046/j.1469-8137.2000.00558.x; Frolich E. F., 1971, CALIF AVOCADO SOC, V55, P97; Gherbi H, 2008, MOL PLANT MICROBE IN, V21, P518, DOI 10.1094/MPMI-21-5-0518; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; GUELLEC V, 1990, PLANT CELL TISS ORG, V20, P211; Haggman HM, 2000, FOR SCI, V66, P47; Han KH, 1997, CAN J FOREST RES, V27, P464, DOI 10.1139/cjfr-27-4-464; HAN KH, 1993, PLANT SCI, V88, P149, DOI 10.1016/0168-9452(93)90086-F; HANSEN J, 1989, PLANT CELL REP, V8, P12, DOI 10.1007/BF00735768; Hardy GES, 2001, AUSTRALAS PLANT PATH, V30, P133, DOI 10.1071/AP01012; Horn P, 2014, PLANT CELL REP, V33, P1977, DOI 10.1007/s00299-014-1672-x; Huberli D, 2000, AUSTRALAS PLANT PATH, V29, P164, DOI 10.1071/AP00029; Ilina EL, 2012, ANN BOT-LONDON, V110, P479, DOI 10.1093/aob/mcs086; Ishida JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025802; Kereszt A, 2007, NAT PROTOC, V2, P948, DOI 10.1038/nprot.2007.141; Kifle S, 1999, PLANT CELL REP, V18, P514, DOI 10.1007/s002990050614; Kong P, 2003, PLANT PATHOL, V52, P681, DOI 10.1111/j.1365-3059.2003.00935.x; Limpens E, 2004, J EXP BOT, V55, P983, DOI 10.1093/jxb/erh122; Mellor KE, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-22; Mogala M., 2015, PROFILE S AFRICAN AV, P1; Molinier J, 2000, PLANT CELL REP, V19, P219, DOI 10.1007/s002990050002; Mrosk C, 2009, J EXP BOT, V60, P3797, DOI 10.1093/jxb/erp220; Narayanan RA, 1999, CROP SCI, V39, P1680, DOI 10.2135/cropsci1999.3961680x; Nilsson O, 1997, PHYSIOL PLANTARUM, V100, P463, DOI [10.1111/j.1399-3054.1997.tb03050.x, 10.1034/j.1399-3054.1997.1000307.x]; Noorda-nguyen K., 2010, TRANSGENIC PLANT J, V4, P94; Otani M, 1996, PLANT SCI, V116, P169, DOI 10.1016/0168-9452(96)04394-4; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Pacholczak AZJ, 2005, ACTA PHYSIOL PLANT, V27, P417, DOI 10.1007/s11738-005-0046-y; Palomo-Rios E, 2017, PLANT CELL TISS ORG, V128, P447, DOI 10.1007/s11240-016-1122-2; Pegg KG, 2002, AVOCADO BOT PRODUCTI, P432; Purez-Jimunez RM., 2008, EUROPEAN J PLANT SCI, V2, P1; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; Raharjo SHT, 2008, IN VITRO CELL DEV-PL, V44, P254, DOI 10.1007/s11627-008-9117-2; Riker AJ, 1930, J AGRIC RES, V41, P0507; Rinallo C, 1999, J HORTIC SCI BIOTECH, V74, P502, DOI 10.1080/14620316.1999.11511143; SAUERWEIN M, 1992, J PLANT PHYSIOL, V140, P147, DOI 10.1016/S0176-1617(11)80925-9; Schaarschmidt S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r62; SHIN DI, 1994, CAN J FOREST RES, V24, P2059, DOI 10.1139/x94-264; Taylor NJ, 2002, DNA CELL BIOL, V21, P963, DOI 10.1089/104454902762053891; Veena V, 2007, IN VITRO CELL DEV-PL, V43, P383, DOI 10.1007/s11627-007-9096-8; Vitha S, 1995, Methods Mol Biol, V44, P185; Wagenknecht M, 2011, MICROBIOL RES, V166, P14, DOI 10.1016/j.micres.2009.12.005; Xiang TH, 2016, BANGL J BOT, V45, P935; Zentmyer G., 1980, AM PHYTOPATHOL SOC M; Zhang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173006	61	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0185896	10.1371/journal.pone.0185896	http://dx.doi.org/10.1371/journal.pone.0185896			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053757	Green Submitted, Green Published, gold			2022-12-26	WOS:000413315100006
J	Weber, TM; Lackner, HK; Roessler, A; Papousek, I; Kolovetsiou-Kreiner, V; Lucovnik, M; Schmid-Zalaudek, K; Lang, U; Moertl, MG				Weber, Thomas Michael; Lackner, Helmut Karl; Roessler, Andreas; Papousek, Ilona; Kolovetsiou-Kreiner, Vassiliki; Lucovnik, Miha; Schmid-Zalaudek, Karin; Lang, Uwe; Moertl, Manfred Georg			Heart rate variability and baroreceptor reflex sensitivity in early-versus late-onset preeclampsia	PLOS ONE			English	Article							BLOOD-PRESSURE VARIABILITY; BAROREFLEX SENSITIVITY; NORMAL-PREGNANCY; EPIDEMIOLOGY; INTERVAL; RISK	Objective To determine whether there are differences in autonomic nervous system function in early-versus late-onset preeclampsia. Methods Matched case-control study. Cases were defined as singleton pregnancies with preeclampsia at < 34(+0) weeks of gestation (early-onset preeclampsia) and >= 34(+0) weeks of gestation (late-onset preeclampsia). For each case in each of the preeclampsia subgroups, three "control" uncomplicated singleton pregnancies were matched by maternal age, height, and week of gestation. Blood pressure and heart rate were measured continuously for 30 minutes in each participant. Baroreceptor reflex sensitivity (assessed using sequence technique), time and frequency domain heart rate variability measures, as SDNN, RMSSD, LFRRI, HFRRI and LF/HFRRI of R-R intervals, were compared between groups (p<0.05 significant). Results 24 women with preeclampsia (10 with early-onset and 14 with late-onset preeclampsia) and 72 controls were included in the study. SDNN, RMSSD and HFRRI were significantly higher in the late-onset preeclampsia group compared to gestational age matched controls (p = 0.033, p = 0.002 and p = 0.018, respectively). No significant differences in SDNN RMSSD and HFRRI between early-onset preeclampsia group and gestational age matched controls were observed (p = 0.304, p = 0.325 and p = 0.824, respectively). Similarly, baroreceptor reflex sensitivity was higher in late-onset preeclampsia compared to controls at >= 34 weeks (p = 0.037), but not different between early- onset preeclampsia compared to controls at < 34 weeks (p = 0.50). Conclusions Heart rate variability and baroreceptor reflex sensitivity are increased in late-but not earlyonset preeclampsia compared to healthy pregnancies. This indicates a better autonomic nervous system mediated adaptation to preeclampsia related cardiovascular changes in late-onset disease.	[Weber, Thomas Michael; Lackner, Helmut Karl; Roessler, Andreas; Schmid-Zalaudek, Karin] Med Univ Graz, Dept Physiol, Graz, Austria; [Lackner, Helmut Karl] Graz Univ Technol, Dept Med Engn, Graz, Austria; [Papousek, Ilona] Karl Franzens Univ Graz, Dept Psychol, Biol Psychol Unit, Graz, Austria; [Kolovetsiou-Kreiner, Vassiliki; Lang, Uwe] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Lucovnik, Miha] Univ Med Ctr Ljubljana, Div Obstet & Gynecol, Dept Perinatol, Ljubljana, Slovenia; [Moertl, Manfred Georg] Clin Ctr, Dept Obstet & Gynecol, Klagenfurt, Austria	Medical University of Graz; Graz University of Technology; University of Graz; Medical University of Graz; University Medical Centre Ljubljana	Lackner, HK (corresponding author), Med Univ Graz, Dept Physiol, Graz, Austria.; Lackner, HK (corresponding author), Graz Univ Technol, Dept Med Engn, Graz, Austria.	helmut.lackner@medunigraz.at	Schmid-Zalaudek, Karin/AAJ-2417-2021; Roessler, Andreas/A-5751-2008; Papousek, Ilona/H-3043-2019	Schmid-Zalaudek, Karin/0000-0002-3422-0031; Roessler, Andreas/0000-0001-9543-8870; Papousek, Ilona/0000-0002-6620-0318; Lackner, Helmut/0000-0002-0159-3720	OeNB Anniversary Fund [1642]	OeNB Anniversary Fund	This study was supported by the OeNB Anniversary Fund, project no. 1642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2013, TASK FORC HYP PREGN; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; BERTINIERI G, 1988, AM J PHYSIOL, V254, pH377, DOI 10.1152/ajpheart.1988.254.2.H377; Camm AJ, 1996, EUR HEART J, V17, P354; DI RIENZO M, 1991, AM J PHYSIOL, V261, pH1811, DOI 10.1152/ajpheart.1991.261.6.H1811; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Ekholm EMK, 1996, EUR J OBSTET GYN R B, V64, P29, DOI 10.1016/0301-2115(95)02255-4; Faber R, 2004, J HUM HYPERTENS, V18, P707, DOI 10.1038/sj.jhh.1001730; Fortin J, 2006, COMPUT BIOL MED, V36, P1185, DOI 10.1016/j.compbiomed.2005.06.001; Fu Q, 2009, SEMIN REPROD MED, V27, P330, DOI 10.1055/s-0029-1225261; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HERNANDEZDIAZ S, 2009, BMJ, V338; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Kuo CD, 2000, BRIT J ANAESTH, V84, P323, DOI 10.1093/oxfordjournals.bja.a013433; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Li XL, 2016, PREGNANCY HYPERTENS, V6, P47, DOI 10.1016/j.preghy.2015.12.003; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Lucovnik M, 2017, HYPERTENS PREGNANCY, V36, P276, DOI 10.1080/10641955.2017.1364381; Lucovnik M, 2016, J PERINAT MED, V44, P505, DOI 10.1515/jpm-2015-0271; Lucovnik M, 2012, J PERINAT MED, V40, P379, DOI 10.1515/jpm-2011-0252; Moertl MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060675; Ouzounian JG, 2012, CARDIOL CLIN, V30, P317, DOI 10.1016/j.ccl.2012.05.004; PAGANI M, 1988, HYPERTENSION, V12, P600, DOI 10.1161/01.HYP.12.6.600; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; PARMER RJ, 1992, CIRCULATION, V85, P497, DOI 10.1161/01.CIR.85.2.497; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; ROBBE HWJ, 1987, HYPERTENSION, V10, P538, DOI 10.1161/01.HYP.10.5.538; Schobel HP, 1996, NEW ENGL J MED, V335, P1480, DOI 10.1056/NEJM199611143352002; Shi Junmei, 2014, Zhonghua Yi Xue Za Zhi, V94, P1342; Silver HM, 2001, AM J OBSTET GYNECOL, V184, P1189, DOI 10.1067/mob.2001.112871; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Voss A, 2000, AM J HYPERTENS, V13, P1218, DOI 10.1016/S0895-7061(00)01199-7; World Health Organization, WORLD HLTH REP 2005; Yang CCH, 2000, AM J PHYSIOL-HEART C, V278, pH1269, DOI 10.1152/ajpheart.2000.278.4.H1269; Yokusoglu M, 2009, TURK KLIN TIP BILIM, V29, P605; [No title captured], DOI DOI 10.1097/HJH.0B013E3283588189	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186521	10.1371/journal.pone.0186521	http://dx.doi.org/10.1371/journal.pone.0186521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053723	Green Submitted, Green Published, gold			2022-12-26	WOS:000413315100022
J	Garcia-Hermoso, A; Hackney, AC; Ramirez-Velez, R				Garcia-Hermoso, Antonio; Hackney, Anthony C.; Ramirez-Velez, Robinson			Ideal cardiovascular health predicts lower risk of abnormal liver enzymes levels in the Chilean National Health Survey (2009-2010)	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; FATTY LIVER; ALANINE AMINOTRANSFERASE; PHYSICAL-ACTIVITY; LIFE-STYLE; EUROPEAN ADOLESCENTS; INSULIN-RESISTANCE; METABOLIC SYNDROME; CAROTID PLAQUES; DISEASE	High levels of gamma glutamyltransferase (gamma-GT) and alanine aminotransferase (ALT), as well as fatty liver index (FLI) has been associated with higher cardiovascular disease risk factors in adults. The aim of this study was to examine the relationship between gamma-GT, ALT, and fatty liver index FLI levels across a gradient number of ideal cardiovascular health metrics in a representative sample of adults from the Chilean National Health Survey 2009-2010. Data from 1,023 men and 1,449 women (>= 15 years) from the Chilean Health Survey 2009-2010 were analyzed. Ideal cardiovascular health was defined as meeting ideal levels of the following components: four behaviours (smoking, body mass index, physical activity and diet adherence) and three factors (total cholesterol, blood pressure and fasting glucose). Adults were grouped into three categories according to their number of ideal cardiovascular health metrics: ideal (5-7 metrics), intermediate (3-4 metrics), and poor (0-2 metrics). Blood levels of gamma-GT and ALT were measured and the FLI was calculated. A higher number of ideal cardiovascular health index metric was associated with lower gamma-GT, ALT and FLI (p from trend analysis < 0.001). Also, adults meeting at least 3-4 metrics were predicted less likely to have prevalence of abnormal levels of gamma-GT and FLI (p<0.001) compared to adults who met only 0-2 metrics. These findings reinforce the usefulness of the ideal cardiovascular health metrics proposed by the American Heart Association as a tool to identify target subjects and promote cardiovascular health in South-American adults.	[Garcia-Hermoso, Antonio] Univ Santiago Chile, Lab Ciencias Actividad Fis Deporte & Salud, Fac Ciencias Med, USACH, Santiago, Chile; [Hackney, Anthony C.] Univ North Carolina Chapel Hill, Endocrine Sect, Appl Physiol Lab, Chapel Hill, NC USA; [Ramirez-Velez, Robinson] Univ Rosario, Ctr Estudios Med Actividad Fis CEMA, Escuela Med & Ciencias Salud, Bogota, DC, Colombia	Universidad de Santiago de Chile; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Universidad del Rosario	Ramirez-Velez, R (corresponding author), Univ Rosario, Ctr Estudios Med Actividad Fis CEMA, Escuela Med & Ciencias Salud, Bogota, DC, Colombia.	robin640@hotmail.com	García-Hermoso, Antonio/ADU-2591-2022; García-Hermoso, Antonio/P-1857-2017; Ramírez-Vélez, Robinson/D-5311-2016; Garcia-Hermoso, Antonio/AGK-7815-2022	García-Hermoso, Antonio/0000-0002-1397-7182; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Garcia-Hermoso, Antonio/0000-0002-1397-7182	Proyectos Basales (Proyectos Basal USA) y Vicerrectoria de Investigacion, Desarrollo e Innovacion (Universidad de Santiago de Chile, USACH) [1555-Vridei 021787GH_MOV]	Proyectos Basales (Proyectos Basal USA) y Vicerrectoria de Investigacion, Desarrollo e Innovacion (Universidad de Santiago de Chile, USACH)	AGH was funded by Proyectos Basales (Proyectos Basal USA 1555-Vridei 021787GH_MOV) y Vicerrectoria de Investigacion, Desarrollo e Innovacion (Universidad de Santiago de Chile, USACH).	Alkerwi A, 2015, BRIT J NUTR, V113, P259, DOI 10.1017/S0007114514003456; [Anonymous], 2000, WHO TECHN REP SER; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Carvalhana S, 2014, LIVER INT, V34, pE111, DOI 10.1111/liv.12305; Celis-Morales C, 2016, J PUBLIC HEALTH-UK, V38, pE98, DOI 10.1093/pubmed/fdv079; Choi JW, 2003, ANN CLIN LAB SCI, V33, P257; Colak Y, 2013, ENDOCRINE, V43, P100, DOI 10.1007/s12020-012-9712-1; El Golli N, 2016, TOXICOL MECH METHOD, P1; Alvarado ME, 2009, REV MED CHILE, V137, P1463, DOI /S0034-98872009001100008; Eshraghian A, 2017, HEPATOLOGY, V65, P1077, DOI 10.1002/hep.28937; Fraser A, 2007, HEPATOLOGY, V46, P158, DOI 10.1002/hep.21667; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Higashikawa A, 2005, ARCH MED RES, V36, P567, DOI 10.1016/j.arcmed.2005.03.027; Houghton D, 2017, CLIN GASTROENTEROL H, V15, P96, DOI 10.1016/j.cgh.2016.07.031; Jager S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124749; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Kim HK, 2009, AM J MED SCI, V337, P98, DOI 10.1097/MAJ.0b013e3181812879; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Kistler KD, 2011, AM J GASTROENTEROL, V106, P460, DOI 10.1038/ajg.2010.488; Kontogianni MD, 2014, CLIN NUTR, V33, P678, DOI 10.1016/j.clnu.2013.08.014; Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210; Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555; Labayen I, 2015, PEDIATR OBES, V10, P361, DOI 10.1111/ijpo.273; Labayen I, 2017, J PHYSL BIOCH, V34, P1; Lanas F, 2017, J CLIN EPIDEMIOL, V86, P111, DOI 10.1016/j.jclinepi.2016.04.018; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Loprinzi PD, 2016, INT J CARDIOL, V223, P284, DOI 10.1016/j.ijcard.2016.08.194; Meffert PJ, 2014, AM J GASTROENTEROL, V109, P1404, DOI 10.1038/ajg.2014.155; Mouzaki M, 2012, J CLIN GASTROENTEROL, V46, P457, DOI 10.1097/MCG.0b013e31824cf51e; Nelson RK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-10; Oliveira AC, 2008, J PEDIATR-US, V152, P337, DOI 10.1016/j.jpeds.2007.07.013; Pattyn N, 2013, SPORTS MED, V43, P121, DOI 10.1007/s40279-012-0003-z; Perry IJ, 1998, DIABETES CARE, V21, P732, DOI 10.2337/diacare.21.5.732; Ramirez-Velez R, 2016, J PEDIATR-US, V179, P82, DOI 10.1016/j.jpeds.2016.08.099; Redgrave JNE, 2010, STROKE, V41, P2288, DOI 10.1161/STROKEAHA.110.587006; Rom O, 2012, J MUSCLE RES CELL M, V33, P199, DOI 10.1007/s10974-012-9299-4; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; Ruiz JR, 2015, HEART, V101, P766, DOI 10.1136/heartjnl-2014-306750; Schindhelm RK, 2005, EUR J CLIN INVEST, V35, P369, DOI 10.1111/j.1365-2362.2005.01502.x; Sun Y, 2013, CHIN MED J, V127, P1858; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Terry PE, 2016, AM J HEALTH PROMOT, V30, P394, DOI 10.1177/0890117116647702; Tsunoda K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005824; Wruck W, 2017, STEM CELLS, V35, P89, DOI 10.1002/stem.2454; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Xanthakis V, 2014, CIRCULATION, V130, P1676, DOI 10.1161/CIRCULATIONAHA.114.009273	50	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185908	10.1371/journal.pone.0185908	http://dx.doi.org/10.1371/journal.pone.0185908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049384	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900029
J	Gurkov, A; Sadovoy, A; Shchapova, E; Teh, C; Meglinski, I; Timofeyev, M				Gurkov, Anton; Sadovoy, Anton; Shchapova, Ekaterina; Teh, Cathleen; Meglinski, Igor; Timofeyev, Maxim			Microencapsulated fluorescent pH probe as implantable sensor for monitoring the physiological state of fish embryos	PLOS ONE			English	Article							IN-VIVO; DANIO-RERIO; POLYELECTROLYTE MICROCAPSULES; CARBONATE MICROPARTICLES; ZEBRAFISH EMBRYOS; TOXICITY; ECOTOXICOLOGY; NANOSENSORS; POLLUTANTS; MANAGEMENT	In vivo physiological measurement is a major challenge in modern science and technology, as is environment conservation at the global scale. Proper toxicological testing of widely produced mixtures of chemicals is a necessary step in the development of new products, allowing us to minimize the human impact on aquatic ecosystems. However, currently available bioassay-based techniques utilizing small aquatic organisms such as fish embryos for toxicity testing do not allow assessing in time the changes in physiological parameters in the same individual. In this study, we introduce microencapsulated fluorescent probes as a promising tool for in vivo monitoring of internal pH variation in zebrafish embryos. The pH alteration identified under stress conditions demonstrates the applicability of the microencapsulated fluorescent probes for the repeated analysis of the embryo's physiological state. The proposed approach has strong potential to simultaneously measure a range of physiological characteristics using a set of specific fluorescent probes and to finally bring toxicological bioassays and related research fields to a new level of effectiveness and sensitivity.	[Gurkov, Anton; Shchapova, Ekaterina; Meglinski, Igor; Timofeyev, Maxim] Irkutsk State Univ, Inst Biol, Irkutsk, Russia; [Gurkov, Anton] Baikal Res Ctr, Irkutsk, Russia; [Sadovoy, Anton] Agcy Sci Technol & Res, Inst Mat Res & Engn, Singapore, Singapore; [Teh, Cathleen] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Meglinski, Igor] Univ Oulu, Optoelect & Measurement Tech Lab, Oulu, Finland	Irkutsk State University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Oulu	Meglinski, I; Timofeyev, M (corresponding author), Irkutsk State Univ, Inst Biol, Irkutsk, Russia.; Sadovoy, A (corresponding author), Agcy Sci Technol & Res, Inst Mat Res & Engn, Singapore, Singapore.; Meglinski, I (corresponding author), Univ Oulu, Optoelect & Measurement Tech Lab, Oulu, Finland.	sadovoyav@imre.a-star.edu.sg; igor.meglinski@oulu.fi; m.a.timofeyev@gmail.com	Meglinski, Igor/N-3552-2019; Timofeyev, Maxim/F-2071-2010; Gurkov, Anton/M-8708-2014	Meglinski, Igor/0000-0002-7613-8191; Timofeyev, Maxim/0000-0002-5250-6818; Gurkov, Anton/0000-0002-8390-1570; Shchapova, Ekaterina/0000-0001-9084-7675	Agency for Science, Technology and Research of Singapore (A*STAR); Russian Science Foundation [15-14-10008]; Singapore International Pre-Graduate Award	Agency for Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); Russian Science Foundation(Russian Science Foundation (RSF)); Singapore International Pre-Graduate Award	This work was supported by the Agency for Science, Technology and Research of Singapore (A*STAR); the Russian Science Foundation (grant #15-14-10008); "Contact Singapore" 's program "Experience@Singapore: Summer Research Internship 2013" and by Singapore International Pre-Graduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Altenburger R, 2015, SCI TOTAL ENVIRON, V512, P540, DOI 10.1016/j.scitotenv.2014.12.057; [Anonymous], 2010, MOL PROBES HDB A GUI, P664; Axenov-Gribanov D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164226; Balaconis MK, 2015, ANALYST, V140, P716, DOI 10.1039/c4an01775g; Beyer J, 2014, MAR ENVIRON RES, V96, P81, DOI 10.1016/j.marenvres.2013.10.008; Billingsley K, 2010, ANAL CHEM, V82, P3707, DOI 10.1021/ac100042e; Borvinskaya E, 2017, BIOL OPEN, V6, P673, DOI 10.1242/bio.024380; Bownik A, 2015, COMP BIOCHEM PHYS C, V168, P2, DOI 10.1016/j.cbpc.2014.11.001; Bugel Sean M, 2014, Curr Environ Health Rep, V1, P341; Cash KJ, 2015, ACS NANO, V9, P1692, DOI 10.1021/nn5064858; Cash KJ, 2013, ANAL CHEM, V85, P6312, DOI 10.1021/ac400575u; Chawla K, 2009, J BIOMED MATER RES A, V90A, P742, DOI 10.1002/jbm.a.32141; Choy CA, 2013, MAR ECOL PROG SER, V485, P155, DOI 10.3354/meps10342; Cocchiaro JL, 2013, JOVE-J VIS EXP, DOI 10.3791/4434; del Mercato LL, 2015, SMALL, V11, P6417, DOI 10.1002/smll.201502171; Du WB, 2010, HEPATOB PANCREAT DIS, V9, P122; Dubach JM, 2011, INTEGR BIOL-UK, V3, P142, DOI 10.1039/c0ib00020e; Evans DH, 1997, PHYSL FISHES; Fowles J, 2013, CRIT REV TOXICOL, V43, P811, DOI 10.3109/10408444.2013.836155; Ghannoum M, 2010, CLIN TOXICOL, V48, P34, DOI 10.3109/15563650903344785; Gurkov A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36427; Haldi M, 2012, ZEBRAFISH: METHODS FOR ASSESSING DRUG SAFETY AND TOXICITY, P15; Halsey TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r104; Hampel M, 2015, ENVIRON SCI POLLUT R, V22, P17261, DOI 10.1007/s11356-015-5565-5; Heo YJ, 2011, P NATL ACAD SCI USA, V108, P13399, DOI 10.1073/pnas.1104954108; Hothorn T, 2008, J STAT SOFTW, V28, P1; JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846; Jamieson AJ, 2017, NAT ECOL EVOL, V1, DOI [10.1038/s41559-016-00511, 10.1038/s41559-016-0051]; Janeesh PA, 2014, RSC ADV, V4, P24484, DOI 10.1039/c4ra02418d; Kamstra JH, 2015, ENVIRON SCI POLLUT R, V22, P16262, DOI 10.1007/s11356-014-3466-7; Kandel E., 2000, PRINCIPLES NEURAL SC; Kazakova LI, 2011, PHYS CHEM CHEM PHYS, V13, P11110, DOI 10.1039/c1cp20354a; KING K A, 1977, Southwestern Naturalist, V21, P417; Kirchner C, 2005, TALANTA, V67, P486, DOI 10.1016/j.talanta.2005.06.042; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Kokkali V, 2014, TRAC-TREND ANAL CHEM, V61, P133, DOI 10.1016/j.trac.2014.08.001; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Kreft O, 2007, J MATER CHEM, V17, P4471, DOI 10.1039/b705419j; Li XD, 2006, CHEM-EUR J, V12, P5770, DOI 10.1002/chem.200600349; LoPachin RM, 2004, NEUROTOXICOLOGY, V25, P617, DOI 10.1016/j.neuro.2004.01.004; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; McGrath P, 2012, ZEBRAFISH: METHODS FOR ASSESSING DRUG SAFETY AND TOXICITY, P27; Molich A, 2005, J EXP BIOL, V208, P4137, DOI 10.1242/jeb.01878; Nery LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105862; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Ozaydin-Ince G, 2011, P NATL ACAD SCI USA, V108, P2656, DOI 10.1073/pnas.1015544108; Pane EF, 2003, AQUAT TOXICOL, V63, P65, DOI 10.1016/S0166-445X(02)00131-5; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Redelstein R, 2015, ENVIRON SCI POLLUT R, V22, P16290, DOI 10.1007/s11356-015-5328-3; Sadovoy A, 2012, LASER PHYS LETT, V9, P542, DOI 10.7452/lapl.201210020; Schmidt S, 2016, CHEMOSPHERE, V152, P503, DOI 10.1016/j.chemosphere.2016.03.006; Shibata H, 2010, P NATL ACAD SCI USA, V107, P17894, DOI 10.1073/pnas.1006911107; Song XX, 2014, J COLLOID INTERF SCI, V416, P252, DOI 10.1016/j.jcis.2013.11.008; Tong WJ, 2008, J MATER CHEM, V18, P3799, DOI 10.1039/b805717f; van Dongen SFM, 2012, CHEM SCI, V3, P3000, DOI 10.1039/c2sc20652h; Wattendorf U, 2008, BIOMACROMOLECULES, V9, P100, DOI 10.1021/bm700857s; Webster L, 2014, MAR POLLUT BULL, V88, P14, DOI 10.1016/j.marpolbul.2014.09.034; Wen QX, 2010, J HAZARD MATER, V175, P955, DOI 10.1016/j.jhazmat.2009.10.102; Zhang Q, 2015, ECOTOXICOLOGY, V24, P707, DOI 10.1007/s10646-015-1417-9; Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004; Zhu HG, 2005, CHEM MATER, V17, P2323, DOI 10.1021/cm048229r	62	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186548	10.1371/journal.pone.0186548	http://dx.doi.org/10.1371/journal.pone.0186548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045437	Green Published, Green Accepted, gold			2022-12-26	WOS:000413168100071
J	Umeh, NI; Ajegba, B; Buscetta, AJ; Abdallah, KE; Minniti, CP; Bonham, VL				Umeh, Nkeiruka I.; Ajegba, Brittany; Buscetta, Ashley J.; Abdallah, Khadijah E.; Minniti, Caterina P.; Bonham, Vence L.			The psychosocial impact of leg ulcers in patients with sickle cell disease: I don't want them to know my little secret	PLOS ONE			English	Article							QUALITY-OF-LIFE; PAIN; ULCERATION; ATTITUDES	Background Sickle cell disease (SCD) impacts millions of individuals worldwide and more than 100,000 people in the United States. Leg ulcers are the most common cutaneous manifestation of SCD. The health status of individuals living with chronic leg ulcers is not only influenced by clinical manifestations such as pain duration and intensity, but also by psychosocial factors. Garnering insights into the psychosocial impact can provide a more holistic view of their influence on quality of life. Methods Semi-structured interviews were conducted with participants living with active SCD-associated leg ulcers or with a history of ulcers. Subjects were recruited from an ongoing study (INSIGHTS, Clin Trial.Gov NCT02156102) and consented to this qualitative phase of the study. Five areas were explored: leg ulcer pain, physical function, social-isolation, social relationships and religious support. Data was collected from 20 individuals during these interviews and a thematic analysis was performed and reported. Results Twenty participants with a mean age of 42.4 (SD +/- 11.1years) were included in the study. Major themes identified included: 1) pain (acute and chronic); 2) compromised physical function as demonstrated by decreased ability to walk, run, and play sports; 3) social isolation from activities either by others or self-induced as a means of avoiding certain emotions, such as embarrassment; 4) social relationships (family support and social network); 5) support and comfort through their religion or spirituality. Conclusions SCD patients with leg ulcers expressed that they experience social isolation, intense and frequent ulcer pain, and difficulty in physical function. SCD-associated leg ulcers have been studied from a clinical approach, but the psychosocial factors investigated in this study informs how quality of life is impacted by the leg ulcers.	[Umeh, Nkeiruka I.; Ajegba, Brittany; Buscetta, Ashley J.; Abdallah, Khadijah E.; Bonham, Vence L.] NHGRI, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA; [Umeh, Nkeiruka I.] Albany Med Coll, Albany, NY 12208 USA; [Ajegba, Brittany] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA; [Minniti, Caterina P.] Montefiore Med Ctr, Sickle Cell Ctr, Div Hematol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Albany Medical College; Michigan State University; Michigan State University College of Human Medicine; Montefiore Medical Center	Bonham, VL (corresponding author), NHGRI, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA.	bonhamv@mail.nih.gov	Minniti, Caterina/AAX-3187-2021		National Human Genome Research Institute, National Institutes of Health [ZIAHG200394-03]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200394] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported solely by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (Project Number: ZIAHG200394-03). The content is the responsibility of the authors and does not represent any position or policy of the National Human Genome Research Institute, National Institutes of Health, or the U.S. Department of Health and Human Services.	Asnani MR, 2016, COCHRANE DB SYST REV, V10; Briggs M, 2007, J ADV NURS, V59, P319, DOI 10.1111/j.1365-2648.2007.04348.x; Caird H, 2011, BRIT J HEALTH PSYCH, V16, P542, DOI 10.1348/135910710X529278; Charles H, 1995, Prof Nurse, V10, P571; Coleman B, 2016, BRIT J HEALTH PSYCH, V21, P190, DOI 10.1111/bjhp.12157; Cumming V, 2008, BRIT J HAEMATOL, V142, P119, DOI 10.1111/j.1365-2141.2008.07115.x; Darlow B, 2012, EUR J PAIN, V16, P3, DOI 10.1016/j.ejpain.2011.06.006; Fuggle P, 1996, ARCH DIS CHILD, V75, P199, DOI 10.1136/adc.75.3.199; GIL KM, 1993, J PEDIATR PSYCHOL, V18, P621, DOI 10.1093/jpepsy/18.5.621; Halabi-Tawil M, 2008, BRIT J DERMATOL, V158, P339, DOI 10.1111/j.1365-2133.2007.08323.x; Harmer C, 1994, J WOUND CARE, V3, P99; Herber OR, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-44; Hyland M E, 1994, J Wound Care, V3, P294; Joachim G, 2000, J ADV NURS, V32, P243, DOI 10.1046/j.1365-2648.2000.01466.x; Keller SD, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0125-0; Ladizinski B, 2012, ADV SKIN WOUND CARE, V25, P420, DOI 10.1097/01.ASW.0000419408.37323.0c; Marti-Carvajal AJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008394.pub3; Minniti CP, 2016, AM J HEMATOL, V91, P22, DOI 10.1002/ajh.24134; Minniti Caterina P, 2010, Am J Hematol, V85, P831, DOI 10.1002/ajh.21838; PHILLIPS T, 1994, J AM ACAD DERMATOL, V31, P49, DOI 10.1016/S0190-9622(94)70134-2; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Rodrigues-de-Souza DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159554; Serjeant GR, 2005, HEMATOL ONCOL CLIN N, V19, P943, DOI 10.1016/j.hoc.2005.08.005; Singh AP, 2016, J PAIN SYMPTOM MANAG, V51, P628, DOI 10.1016/j.jpainsymman.2015.11.004; Steinberg MH, 2014, LANCET HAEMATOL, V1, pE86, DOI 10.1016/S2352-3026(14)00020-9; Thomas VJ, 2002, BRIT J HEALTH PSYCH, V7, P345, DOI 10.1348/135910702760213724; Urquhart DM, 2008, BMC MUSCULOSKEL DIS, V9, P1; WALSHE C, 1995, J ADV NURS, V22, P1092; Werner EM, 2006, BLOOD, V108, p953A, DOI 10.1182/blood.V108.11.3339.3339	29	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186270	10.1371/journal.pone.0186270	http://dx.doi.org/10.1371/journal.pone.0186270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045487	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100047
J	Zhou, H; Qin, Y; Ji, S; Ling, J; Fu, J; Zhuang, Z; Fan, X; Song, L; Yu, X; Chiao, PJ				Zhou, H.; Qin, Y.; Ji, S.; Ling, J.; Fu, J.; Zhuang, Z.; Fan, X.; Song, L.; Yu, X.; Chiao, P. J.			SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer	ONCOGENE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; UP-REGULATION; DNA-DAMAGE; INHIBITION; ACTIVATION; CARCINOMA	SRY (sex determining region Y)-box 9 (SOX9) is required for oncogenic Kras-mediated acinar-to-ductal metaplasia (ADM), pancreatic intraepithelial neoplasias (PanINs) and ultimately pancreatic ductal adenocarcinoma (PDAC). However, how oncogenic Kras affects SOX9 activity is not yet understood, and SOX9-associated genes in PDAC are also unknown at all. Here, we investigated the mechanistic link between SOX9 and oncogenic Kras, studied biological function of SOX9, and identified SOX9-related genes and their clinical significance in patients with PDAC. Our studies reveal that oncogenic Kras induces SOX9 mRNA and protein expression as well as phosphorylated SOX9 expression in human pancreatic ductal progenitor cells (HPNE) and pancreatic ductal cells (HPDE). Moreover, oncogenic Kras promoted nuclear translocation and transcriptional activity of SOX9 in these cells. TAK1/I kappa Ba/NF-kappa B pathway contributed to induction of SOX9 by oncogenic Kras, and SOX9 in turn enhanced NF-kappa B activation. SOX9 promoted the proliferation of HPNE and PDAC cells, and correlated with minichromosome maintenance complex components (MCMs) and mediator of DNA damage checkpoint 1 (MDC1) expression. The overexpressive MDC1 was associated with less perineural and lymph node invasion of tumors and early TNM-stage of patients. Our results indicate that oncogenic Kras induces constitutive activation of SOX9 in HPNE and HPDE cells, and Kras/TAK1/I kappa Ba/NF-kappa B pathway and a positive feedback between SOX9 and NF-kappa B are involved in this inducing process. SOX9 accelerates proliferation of cells and affects MCMs and MDC1 expression. MDC1 is associated negatively with invasion and metastasis of PDAC.	[Zhou, H.; Ling, J.; Fu, J.; Zhuang, Z.; Chiao, P. J.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Unit 107,1515 Holcombe Blvd, Houston, TX 77030 USA; [Zhou, H.; Ling, J.; Fu, J.; Zhuang, Z.; Fan, X.; Chiao, P. J.] Fudan Univ, Liver Canc Inst, Shanghai, Peoples R China; [Zhou, H.; Ling, J.; Fu, J.; Zhuang, Z.; Fan, X.; Chiao, P. J.] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China; [Qin, Y.; Ji, S.; Yu, X.] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200032, Peoples R China; [Qin, Y.; Ji, S.; Yu, X.] Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China; [Zhuang, Z.] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Dept Gen Surg, Beijing, Peoples R China; [Song, L.] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan, Peoples R China; [Chiao, P. J.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Fudan University; Fudan University; Fudan University; Fudan University; Tsinghua University; Zhengzhou University; University of Texas System; University of Texas Health Science Center Houston	Chiao, PJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Unit 107,1515 Holcombe Blvd, Houston, TX 77030 USA.; Yu, X (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200032, Peoples R China.	yuxianjun@fudan.edu.cn; pjchiao@mdanderson.org			Skip Viragh foundation; National Cancer Institute [CA109405, CA142674]; Cancer Center Core Supporting grant [CA16672]; China National Natural Science Foundation [81272733]; NATIONAL CANCER INSTITUTE [R01CA207031, P30CA016672] Funding Source: NIH RePORTER	Skip Viragh foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Core Supporting grant; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Jun Yao in the Department of Biostatistics, MD Anderson Cancer Center, for statistical analysis of data from RNA-seq. This work was supported in part by grants from Skip Viragh foundation (to PJC), the National Cancer Institute (CA109405 and CA142674 to PJC), a Cancer Center Core Supporting grant (CA16672) and China National Natural Science Foundation (81272733).	Belo J, 2013, STEM CELLS DEV, V22, P2935, DOI 10.1089/scd.2013.0106; Chang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101452; Chang Z, 2013, CLIN CANCER RES, V19, P549, DOI 10.1158/1078-0432.CCR-12-0032; Chen LM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1234570; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Espersen MLM, 2016, HUM PATHOL, V52, P38, DOI 10.1016/j.humpath.2015.12.026; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fujioka S, 2003, ONCOGENE, V22, P1365, DOI 10.1038/sj.onc.1206323; Grimont A, 2015, GUT, V64, P1790, DOI 10.1136/gutjnl-2014-307075; Guo D, 2012, MOL CELL BIOCHEM, V363, P179, DOI 10.1007/s11010-011-1170-1; Hong YC, 2015, ONCOTARGET, V6, P31241, DOI 10.18632/oncotarget.5160; Kawaguchi Y, 2013, J CLIN INVEST, V123, P1881, DOI 10.1172/JCI66022; Kim JE, 2006, MOL CARCINOGEN, V45, P403, DOI 10.1002/mc.20221; Kist R., MUS MUSCULUS SRY BOX; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Lei M, 2001, J CELL SCI, V114, P1447; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Luanpitpong S, 2016, ONCOGENE, V35, P2824, DOI 10.1038/onc.2015.351; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Melisi D, 2011, JNCI-J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Melisi D, 2009, MOL CANCER RES, V7, P624, DOI 10.1158/1541-7786.MCR-08-0201; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Piper K, 2002, MECH DEVELOP, V116, P223, DOI 10.1016/S0925-4773(02)00145-4; Saegusa M, 2012, AM J PATHOL, V181, P684, DOI 10.1016/j.ajpath.2012.05.008; Simon NE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/549719; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sun L, 2013, STEM CELLS, V31, P1454, DOI 10.1002/stem.1394; Wang CY, 2015, NUCLEIC ACIDS RES, V43, P4893, DOI 10.1093/nar/gkv394; Wang HY, 2015, ONCOTARGET, V6, P20711, DOI 10.18632/oncotarget.4133; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Xia SH, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0358-0; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhou HJ, 2010, GUT, V59, P1699, DOI 10.1136/gut.2010.218404; Zou RL, 2015, INT J BIOL SCI, V11, P992, DOI 10.7150/ijbs.10918	40	33	35	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					912	923		10.1038/onc.2017.393	http://dx.doi.org/10.1038/onc.2017.393			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059173	Green Accepted			2022-12-26	WOS:000425281800008
J	Holmes, B; Benavides-Serrato, A; Freeman, RS; Landon, KA; Bashir, T; Nishimura, RN; Gera, J				Holmes, B.; Benavides-Serrato, A.; Freeman, R. S.; Landon, K. A.; Bashir, T.; Nishimura, R. N.; Gera, J.			mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma	ONCOGENE			English	Article							MTOR COMPLEX 2; HEAT-SHOCK; RICH ELEMENTS; CYCLIN D1; PTEN LOSS; AKT; CANCER; HSF1; TRANSLATION; PATHWAY	Overexpression of Rictor has been demonstrated to result in increased mechanistic target of rapamycin C2 (mTORC2) nucleation and activity leading to tumor growth and increased invasive characteristics in glioblastoma multiforme (GBM). However, the mechanisms regulating Rictor expression in these tumors is not clearly understood. In this report, we demonstrate that Rictor is regulated at the level of mRNA translation via heat-shock transcription factor 1 (HSF1)-induced HuR activity. HuR is shown to directly bind the 3' untranslated region of the Rictor transcript and enhance translational efficiency. Moreover, we demonstrate that mTORC2/AKT signaling activates HSF1 resulting in a feed-forward cascade in which continued mTORC2 activity is able to drive Rictor expression. RNAi-mediated blockade of AKT, HSF1 or HuR is sufficient to downregulate Rictor and inhibit GBM growth and invasive characteristics in vitro and suppress xenograft growth in mice. Modulation of AKT or HSF1 activity via the ectopic expression of mutant alleles support the ability of AKT to activate HSF1 and demonstrate continued HSF1/HuR/Rictor signaling in the context of AKT knockdown. We further show that constitutive overexpression of HuR is able to maintain Rictor expression under conditions of AKT or HSF1 loss. The expression of these components is also examined in patient GBM samples and correlative associations between the relative expression of these factors support the presence of these signaling relationships in GBM. These data support a role for a feed-forward loop mechanism by which mTORC2 activity stimulates Rictor translational efficiency via an AKT/HSF1/HuR signaling cascade resulting in enhanced mTORC2 activity in these tumors.	[Holmes, B.; Benavides-Serrato, A.; Gera, J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Holmes, B.; Benavides-Serrato, A.; Freeman, R. S.; Landon, K. A.; Bashir, T.; Nishimura, R. N.; Gera, J.] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA USA; [Nishimura, R. N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Gera, J.] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Gera, J.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gera, J (corresponding author), Greater Los Angeles VA Healthcare Syst, Dept Hematol Oncol, 16111 Plummer St 151,Bldg 1,Room C111A, Los Angeles, CA 91343 USA.	gera@ucla.edu		Holmes, Brent/0000-0002-2768-2991; Gera, Joseph/0000-0002-2908-6894	VA MERIT grant [I01BX002665]; NIH grant [R01CA109312]; NATIONAL CANCER INSTITUTE [R01CA109312] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002665] Funding Source: NIH RePORTER	VA MERIT grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr Eugene Kandel, Dr Jacob Fleischmann, Dr Norimoto Yanagawa, Dr Sanjai Sharma and Dr Paul Mischel for cell lines and reagents. We also thank Dr Alan Lichtenstein for comments on the manuscript and Jheralyn Martin and Janine Masri for technical assistance. This work was supported, in whole or in part, by VA MERIT I01BX002665 and NIH R01CA109312 grants.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bashir T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047741; Bhattacharya K, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.34; Carpenter RL, 2015, ONCOGENE, V34, P546, DOI 10.1038/onc.2013.582; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cheng HY, 2015, CANCER DISCOV, V5, P1262, DOI 10.1158/2159-8290.CD-14-0971; Chou SD, 2015, ONCOGENE, V34, P2178, DOI 10.1038/onc.2014.177; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Dai CK, 2012, J CLIN INVEST, V122, P3742, DOI 10.1172/JCI62727; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Driscoll DR, 2016, CANCER RES, V76, P6911, DOI 10.1158/0008-5472.CAN-16-0810; Gabai VL, 2012, MOL CELL BIOL, V32, P929, DOI 10.1128/MCB.05921-11; Gibault L, 2012, MODERN PATHOL, V25, P197, DOI 10.1038/modpathol.2011.163; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Holmes B, 2016, J BIOL CHEM, V291, P14146, DOI 10.1074/jbc.M116.726927; Hsu JH, 2002, ONCOGENE, V21, P1391, DOI 10.1038/sj/onc/1205194; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Koo J, 2015, J BIOL CHEM, V290, P14120, DOI 10.1074/jbc.M114.633057; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leach MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11704; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Masui K, 2016, BIOESSAYS, V38, P839, DOI 10.1002/bies.201600026; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Nabors LB, 2001, CANCER RES, V61, P2154; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Read RD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003253; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Tandon M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3611; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Vartanian R, 2011, MOL CANCER RES, V9, P115, DOI 10.1158/1541-7786.MCR-10-0105; Wang B, 2017, NATURE, V545, P365, DOI 10.1038/nature22344; Wu Si-Han, 2014, Cancer Biology Medicine, V11, P255, DOI 10.7497/j.issn.2095-3941.2014.04.004; Yasuda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142943; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	42	32	35	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					732	743		10.1038/onc.2017.360	http://dx.doi.org/10.1038/onc.2017.360			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059166	Green Accepted, Green Submitted			2022-12-26	WOS:000424628100005
J	Fink, A; Buchmann, N; Tegeler, C; Steinhagen-Thiessen, E; Demuth, I; Doblhammer, G				Fink, Anne; Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja; Doblhammer, Gabriele			Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community dwelling elderly population in Germany	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEUROPSYCHOLOGICAL ASSESSMENT; UNITED-STATES; LIFE-STYLE; DEMENTIA; PREVALENCE; RISK; IMPAIRMENT; TRENDS; METAANALYSIS	Aims/Hypothesis The increasing number of people with dementia and cognitive impairments makes it essential to detect and prevent modifiable risk factors of dementia. This study focuses on type 2 diabetes mellitus, especially on undiagnosed cases and their increased risk of cognitive impairment. Furthermore, the potential of physical activity and social integration to moderate the relation between diabetes and cognitive impairment is assessed. Methods We used cross-sectional data from 1299 participants of the Berlin Aging Study II (BASE-II) aged between 60 to 84 years and performed logistic regression models to analyze the association of diabetes status, physical activity, and cohabitation status with poor cognitive performance. Cognitive performance was measured with the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)-Plus test battery. Results Undiagnosed diabetes (odds ratio (OR) = 2.12, p = 0.031), physical inactivity (OR = 1.43, p = 0.008) and non-cohabiting (OR = 1.58, p = 0.002) were associated with an increased likelihood of poor cognitive performance. The highest odds were observed in participants who suffered from undiagnosed or insulin-dependent diabetes and, in addition, were inactive (undiagnosed diabetes: OR = 3.44, p = 0.003; insulin-dependent diabetes: OR = 6.19, p = 0.019) or lived alone (undiagnosed diabetes: OR = 4.46, p = 0.006; insulin-dependent diabetes: OR = 6.46 p = 0.052). Physical activity and cohabiting appeared to be beneficial. Conclusions/Interpretation Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance. Special attention should be paid to undiagnosed and insulin-dependent diabetes cases, which have a particularly high risk of poor cognitive performance.	[Fink, Anne; Doblhammer, Gabriele] German Ctr Neurodegenerat Dis, Bonn, Germany; [Fink, Anne; Doblhammer, Gabriele] Rostock Ctr Study Demog Change, Rostock, Germany; [Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Charite Univ Med Berlin, Interdisciplinary Metab Ctr, Lipid Clin, Berlin, Germany; [Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Free Univ Berlin, Berlin, Germany; [Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Humboldt Univ, Berlin, Germany; [Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Berlin Inst Hlth, Berlin, Germany; [Buchmann, Nikolaus] Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Innere Med B, Greifswald, Germany; [Steinhagen-Thiessen, Elisabeth] Ernst Moritz Arndt Univ Greifswald, Bereich Geriatrie Univ Med Greifswald, Greifswald, Germany; [Doblhammer, Gabriele] Univ Rostock, Inst Sociol & Demog, Rostock, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Rostock	Fink, A (corresponding author), German Ctr Neurodegenerat Dis, Bonn, Germany.; Fink, A (corresponding author), Rostock Ctr Study Demog Change, Rostock, Germany.; Demuth, I (corresponding author), Charite Univ Med Berlin, Interdisciplinary Metab Ctr, Lipid Clin, Berlin, Germany.; Demuth, I (corresponding author), Free Univ Berlin, Berlin, Germany.; Demuth, I (corresponding author), Humboldt Univ, Berlin, Germany.; Demuth, I (corresponding author), Berlin Inst Hlth, Berlin, Germany.	anne.fink@dzne.de; iljademuth@charite.de	Demuth, Ilja/ABD-5352-2021; Buchmann, Nina/E-6095-2011	Demuth, Ilja/0000-0002-4340-2523; Buchmann, Nina/0000-0003-0826-2980; Buchmann, Nikolaus/0000-0002-4345-3515; Tegeler-Nonnen, Christina/0000-0002-8642-1142	German Federal Ministry of education and Research [BMBF] [16SV5536K]; German Center of Neurodegenerative Diseases (DZNE)	German Federal Ministry of education and Research [BMBF](Federal Ministry of Education & Research (BMBF)); German Center of Neurodegenerative Diseases (DZNE)(Helmholtz Association)	This study was funded by the German Federal Ministry of education and Research [BMBF (grant number #16SV5536K)] and the German Center of Neurodegenerative Diseases (DZNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452; Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P90, DOI 10.1097/WAD.0b013e31819fe7d1; Baker LD, 2015, 8 CLIN TRIALS ALZHEI; Barberger-Gateau P, 2004, DEMENT GERIATR COGN, V18, P330, DOI 10.1159/000080127; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Bertram L, 2014, INT J EPIDEMIOL, V43, P703, DOI 10.1093/ije/dyt018; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bowling A, 2000, REV CLIN GERONTOL, V10, P407, DOI DOI 10.1017/S0959259800104101; Chandler MJ, 2005, NEUROLOGY, V65, P102, DOI 10.1212/01.wnl.0000167607.63000.38; Chen L, 2015, METABOLISM, V64, P338, DOI 10.1016/j.metabol.2014.10.018; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Doblhammer G, 2013, GERIATRIC MENTAL HLT, V1, P29, DOI DOI 10.1016/J.GMHC.2013.04.002; Doblhammer G, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0146-x; Doblhammer G, 2015, ALZHEIMERS DEMENT, V11, P291, DOI 10.1016/j.jalz.2014.02.006; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Geda YE, 2010, ARCH NEUROL-CHICAGO, V67, P80, DOI 10.1001/archneurol.2009.297; Gerstorf D, 2016, GERONTOLOGY IN PRESS; Grodstein F, 2001, DIABETES CARE, V24, P1060, DOI 10.2337/diacare.24.6.1060; Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087; Hakansson K, 2009, BMJ, V339; Helmer C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b1690; Heneka MT, 2015, ANN NEUROL, V78, P284, DOI 10.1002/ana.24439; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lytle ME, 2004, ALZ DIS ASSOC DIS, V18, P57, DOI 10.1097/01.wad.0000126614.87955.79; Manton K C, 2005, Adv Gerontol, V16, P30; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Memory Clinic Basel, 2005, CERAD PLUS 2005; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Palta P, 2014, J INT NEUROPSYCH SOC, V20, P278, DOI 10.1017/S1355617713001483; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Seo EH, 2010, AM J GERIAT PSYCHIAT, V18, P801, DOI 10.1097/JGP.0b013e3181cab764; Topolski T. D., 2006, CTR DIS CONTROL PREV, V3, P1; University of Washington Health Promotion Research Center, 2015, PHYS ACT AR YOU ASS; van den Berg E, 2010, DIABETOLOGIA, V53, P58, DOI 10.1007/s00125-009-1571-9; van Gelder BM, 2006, J GERONTOL B-PSYCHOL, V61, pP213, DOI 10.1093/geronb/61.4.P213; World Health Organization, 2017, BOD MASS IND BMI 201; Xu WL, 2009, DIABETOLOGIA, V52, P1031, DOI 10.1007/s00125-009-1323-x	53	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187119	10.1371/journal.pone.0187119	http://dx.doi.org/10.1371/journal.pone.0187119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073237	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400115
J	Weirathmueller, MJ; Stafford, KM; Wilcock, WSD; Hilmo, RS; Dziak, RP; Trehu, AM				Weirathmueller, Michelle J.; Stafford, Kathleen M.; Wilcock, William S. D.; Hilmo, Rose S.; Dziak, Robert P.; Trehu, Anne M.			Spatial and temporal trends in fin whale vocalizations recorded in the NE Pacific Ocean between 2003-2013	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; LOW-FREQUENCY WHALE; MID-ATLANTIC OCEAN; BALAENOPTERA-PHYSALUS; CULTURAL TRANSMISSION; NORTHEAST PACIFIC; BLUE WHALE; MEGAPTERA-NOVAEANGLIAE; HUMPBACK WHALES; ACOUSTIC LINK	In order to study the long-term stability of fin whale (Balaenoptera physalus) singing behavior, the frequency and inter-pulse interval of fin whale 20 Hz vocalizations were observed over 10 years from 2003-2013 from bottom mounted hydrophones and seismometers in the northeast Pacific Ocean. The instrument locations extended from 40 degrees N to 48 degrees N and 130 degrees W to 125 degrees W with water depths ranging from 1500-4000 m. The inter-pulse interval (IPI) of fin whale song sequences was observed to increase at a rate of 0.54 seconds/year over the decade of observation. During the same time period, peak frequency decreased at a rate of 0.17 Hz/year. Two primary call patterns were observed. During the earlier years, the more commonly observed pattern had a single frequency and single IPI. In later years, a doublet pattern emerged, with two dominant frequencies and IPIs. Many call sequences in the intervening years appeared to represent a transitional state between the two patterns. The overall trend was consistent across the entire geographical span, although some regional differences exist. Understanding changes in acoustic behavior over long time periods is needed to help establish whether acoustic characteristics can be used to help determine population identity in a widely distributed, difficult to study species such as the fin whale.	[Weirathmueller, Michelle J.; Wilcock, William S. D.; Hilmo, Rose S.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Stafford, Kathleen M.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Dziak, Robert P.] NOAA, Pacific Marine Environm Lab, Newport, OR USA; [Trehu, Anne M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Weirathmueller, MJ (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	michellejw@gmail.com	Dziak, Robert/AAC-6107-2020	Wilcock, William/0000-0001-7224-7246	U.S. Office of Naval Research [N00014-14-1-0423]; Office of Naval Research [N00014-14-1-0423]	U.S. Office of Naval Research(Office of Naval Research); Office of Naval Research(Office of Naval Research)	This work was supported by Grant Number N00014-14-1-0423 from the U.S. Office of Naval Research (http://www.onr.navy.mil/) (WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The analysis presented in this manuscript was supported by the Office of Naval Research under Award Number N00014-14-1-0423. This is PMEL contribution number 4595. Additional advice and insights were provided by Trevor Branch and Julie Keister via helpful discussions during the analysis and manuscript preparation.	Andrew RK, 2011, J ACOUST SOC AM, V129, P642, DOI 10.1121/1.3518770; Barnes C.R., 2015, SEAFLOOR OBSERVATORI, P415, DOI [10.1007/978-3-642-11374-1_16, DOI 10.1007/978-3-642-11374-1_16]; Berube A M, 2002, FISHERIES SCI, V3, P183; Bracewell RN., 1986, FOURIER TRANSFORM IT; Broughton W. B., 1963, ACOUSTIC BEHAVIOUR A, P3; Buchan SJ, 2014, ENDANGER SPECIES RES, V23, P241, DOI 10.3354/esr00566; Carretta JV, 2015, US PACIFIC MARINE MA, P2014; Castellote M, 2012, MAR MAMMAL SCI, V28, P325, DOI 10.1111/j.1748-7692.2011.00491.x; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Cox C., 1984, Journal of Atmospheric and Oceanic Technology, V1, P237, DOI 10.1175/1520-0426(1984)001<0237:ADSDPG>2.0.CO;2; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Delaney J. R., 2015, SEAFLOOR OBSERVATORI, P465, DOI [DOI 10.1007/978-3-642-11374-1, 10.1007/978-3-642-11374-1]; Delarue J, 2013, ARCTIC, V66, P159; Delarue J, 2009, J ACOUST SOC AM, V125, P1774, DOI 10.1121/1.3068454; Ding T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066751; Foote AD, 2004, NATURE, V428, P910, DOI 10.1038/428910a; Fujino K., 1960, SCI REP WHALES RES I, V15, P84; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Gedamke J, 2010, DEEP-SEA RES PT II, V57, P968, DOI 10.1016/j.dsr2.2008.10.042; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Hatch LT, 2004, THESIS, P160; JENKINS PF, 1978, ANIM BEHAV, V26, P50, DOI 10.1016/0003-3472(78)90007-6; Jones E., SCIPY OPEN SOURCE SC; Koot B., 2015, WINTER BEHAV POPULAT; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; McDonald Mark A., 2009, Endangered Species Research, V9, P13, DOI 10.3354/esr00217; McGill PR, 2003, AM GEOPH UN FALL M 2; McKenna MF, 2012, J ACOUST SOC AM, V132, pEL169, DOI 10.1121/1.4740225; Mellinger DK, 2003, J ACOUST SOC AM, V114, P1108, DOI 10.1121/1.1593066; Mizroch SA, 2009, MAMMAL REV, V39, P193, DOI 10.1111/j.1365-2907.2009.00147.x; Moore SE, 1998, MAR MAMMAL SCI, V14, P617, DOI 10.1111/j.1748-7692.1998.tb00749.x; Morano JL, 2012, J ACOUST SOC AM, V132, P1207, DOI 10.1121/1.4730890; Nieukirk SL, 2012, J ACOUST SOC AM, V131, P1102, DOI 10.1121/1.3672648; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; NORTHROP J, 1968, J ACOUST SOC AM, V43, P383, DOI 10.1121/1.1910799; Oleson EM, 2003, MAR MAMMAL SCI, V19, P407; Oleson EM, 2014, PLOS ONE, V9, P1; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Parks SE, 2009, J ACOUST SOC AM, V125, P1230, DOI 10.1121/1.3050282; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; Rankin S, 2005, J ACOUST SOC AM, V118, P3346, DOI 10.1121/1.2046747; Reilly SB, 2013, BALAENOPTERA PHYSALU, V2013; Rendell L, 2007, MAR ECOL PROG SER, V52, P175; Richerson P.J, 1988, CULTURE EVOLUTIONARY; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2013, MAR BIOL, V160, P47, DOI 10.1007/s00227-012-2061-z; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; SLATER PJB, 1986, TRENDS ECOL EVOL, V1, P94, DOI 10.1016/0169-5347(86)90032-7; Soule D. C., 2011, J ACOUST SOC AM, V129, P2638; Soule DC, 2013, J ACOUST SOC AM, V133, P1751, DOI 10.1121/1.4774275; Stafford KM, 2011, MAR MAMMAL SCI, V27, P828, DOI 10.1111/j.1748-7692.2010.00437.x; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafford KM, 2003, MAR MAMMAL SCI, V19, P682, DOI 10.1111/j.1748-7692.2003.tb01124.x; Stafford KM, 2005, J ACOUST SOC AM, V117, P2724, DOI 10.1121/1.1887005; Stafford KM, 1998, J ACOUST SOC AM, V104, P3616, DOI 10.1121/1.423944; Stafford KM, 1999, MAR MAMMAL SCI, V15, P1258, DOI 10.1111/j.1748-7692.1999.tb00889.x; Stafford KM, 1999, J ACOUST SOC AM, V106, P3687, DOI 10.1121/1.428220; THOMPSON PO, 1992, J ACOUST SOC AM, V92, P3051, DOI 10.1121/1.404201; Toomey DR, 2014, OCEANOGRAPHY, V27, P138, DOI 10.5670/oceanog.2014.49; WATKINS W A, 1981, Scientific Reports of the Whales Research Institute Tokyo, P83; WATKINS W A, 1984, Rit Fiskideildar, V8, P1; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; WATKINS WA, 1981, DEEP-SEA RES, V28, P577, DOI 10.1016/0198-0149(81)90118-7; Watkins William A., 2000, Oceanography, V13, P62; WEST MJ, 1983, J COMP PSYCHOL, V97, P327, DOI 10.1037/0735-7036.97.4.327; Williams MC, 2011, B SEISMOL SOC AM, V101, P940, DOI 10.1785/0120100198	75	25	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186127	10.1371/journal.pone.0186127	http://dx.doi.org/10.1371/journal.pone.0186127			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073230	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400014
J	Xu, SS; Sun, F; Ren, LP; Yang, H; Tian, N; Peng, S				Xu, Shuanshuan; Sun, Fen; Ren, Lipeng; Yang, Hong; Tian, Na; Peng, Sha			Resveratrol controlled the fate of porcine pancreatic stem cells through the Wnt/beta-catenin signaling pathway mediated by Sirt1	PLOS ONE			English	Article							GENE-EXPRESSION; BETA-CATENIN; C-MYC; CANCER; P53; IDENTIFICATION; INVOLVEMENT; ACTIVATION; MOLECULE; PROTEIN	Porcine pancreatic stem cells (PSCs) are considered promising transplant materials that may be used to treat diabetes, but some problems, such as insufficient cell number and low differentiation efficiency, should be solved before its clinical application. Resveratrol is a natural polyphenolic compound that can alleviate the complications of diabetes. In this study, we aimed to explore the specific effect of resveratrol on porcine PSCs. We treated porcine PSCs with 10 mu M, 25 mu M resveratrol to explore the effect of resveratrol on porcine PSCs. We found that 10 mu M resveratrol improved the proliferation of porcine PSCs, increased the expression of A-beta-catenin (active beta-catenin), Pcna, C-Myc, Bcl-2 and sirtuin-1 (Sirt1), and decreased the expression of P53, Caspase3. While 25 mu M resveratrol had almost opposite effect compared with 10 mu M resveratrol group. The utilization of Dickkopf-related protein 1 (DKK1, Wnt signaling pathway inhibitor) and nicotinamide (Sirt1 inhibitor) suggested that resveratrol regulated cell proliferation by controlling Wnt signaling pathway and this effect was mediated by Sirt1. Our results further revealed that 10 mu M resveratrol promoted the formation of beta-like cells regulated by Wnt/beta-catenin signal pathway. Relatively low-dose resveratrol could improve porcine PSCs fate. It lays theoretical foundation for diabetes treatment with cell transplantation in future.	[Xu, Shuanshuan; Sun, Fen; Ren, Lipeng; Yang, Hong; Tian, Na; Peng, Sha] Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Peng, S (corresponding author), Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Yangling, Shaanxi, Peoples R China.	pengshacxh@163.com	tian, na/GVR-9226-2022		Northwest AF University [2452015034]; Agricultural Science and Technology Innovation and Key Project of Shaanxi Province [2016NY094]	Northwest AF University; Agricultural Science and Technology Innovation and Key Project of Shaanxi Province	This work was supported by Basal Research Fund of Northwest A&F University, grant number [2452015034], URL http://en.nwsuaf.edu.cn/, and Agricultural Science and Technology Innovation and Key Project of Shaanxi Province [2016NY094], URL http://www.sninfo.gov.cn. The funders were used for study design, data collection and analysis, decision to publish.	Abdelgany Amr, 2005, J RNAi Gene Silencing, V1, P88; Bonora M, 2015, ONCOGENE, V34, P1608, DOI [10.1038/onc.2014.462, 10.1038/onc.2014.96]; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Bruin JE, 2015, STEM CELL REP, V4, P605, DOI 10.1016/j.stemcr.2015.02.011; Cao H, 2011, CELL PROLIFERAT, V44, P19, DOI 10.1111/j.1365-2184.2010.00714.x; Cao H., 2012, SPACECR RECOVER REMO, V3, P7, DOI DOI 10.1371/J0URNAL.P0NE.0031502; Chu Yuankui, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P448; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Ding H, 2016, CARDIOVASC THER, V34, P283, DOI 10.1111/1755-5922.12200; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Fritz RD, 2011, BBA-MOL CELL RES, V1813, P1971, DOI 10.1016/j.bbamcr.2011.02.008; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoffman B, 1998, ONCOGENE, V17, P3351, DOI 10.1038/sj.onc.1202592; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu SX, 2016, CELL PROLIFERAT, V49, P395, DOI 10.1111/cpr.12263; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jarskog LF, 2004, AM J PSYCHIAT, V161, P109, DOI 10.1176/appi.ajp.161.1.109; Kim YD, 2015, YONSEI MED J, V56, P410, DOI 10.3349/ymj.2015.56.2.410; Kupisiewicz K, 2010, CALCIFIED TISSUE INT, V87, P437, DOI 10.1007/s00223-010-9399-3; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Malik MZ, 2015, COMPUT BIOL CHEM, V59, P55, DOI 10.1016/j.compbiolchem.2015.07.014; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rogers SA, 2007, XENOTRANSPLANTATION, V14, P591, DOI 10.1111/j.1399-3089.2007.00429.x; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Rubinfeld B, 1997, LOSS TUMOR SUPPRESSO, V57, P4624; Sanders TH, 2000, J AGR FOOD CHEM, V48, P1243, DOI 10.1021/jf990737b; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Wang B, 2014, J CELL MOL MED, V18, P1599, DOI 10.1111/jcmm.12312; Wang XF, 2016, CELL BIOL INT, V40, P716, DOI 10.1002/cbin.10610; Xiao M, 2008, SCI CHINA SER C, V51, P779, DOI 10.1007/s11427-008-0109-6; Zhang Ya-hong, 2011, Yaoxue Xuebao, V46, P1332; Zhou Y., 2015, CYBERNETICS IEEE T, VPP, P1; Zhou Y, 2016, ONCOTARGET, V7; Zhou Y, 2015, INT J AEROSPACE ENG, V2015, DOI 10.1155/2015/381478	44	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187159	10.1371/journal.pone.0187159	http://dx.doi.org/10.1371/journal.pone.0187159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073244	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400126
J	Graham, DF; Carty, CP; Lloyd, DG; Barrett, RS				Graham, David F.; Carty, Christopher P.; Lloyd, David G.; Barrett, Rod S.			Muscle contributions to the acceleration of the whole body centre of mass during recovery from forward loss of balance by stepping in young and older adults	PLOS ONE			English	Article							DYNAMIC STABILITY CONTROL; TRUNK KINEMATICS; FUTURE FALLS; SINGLE; SUPPORT; WALKING; PROGRESSION; PREDICTION; RESPONSES; SPEEDS	The purpose of this study was to determine the muscular contributions to the acceleration of the whole body centre of mass (COM) of older compared to younger adults that were able to recover from forward loss of balance with a single step. Forward loss of balance was achieved by releasing participants (14 older adults and 6 younger adults) from a static whole-body forward lean angle of approximately 18 degrees. 10 older adults and 6 younger adults were able to recover with a single step and included in subsequent analysis. A scalable anatomical model consisting of 36 degrees-of-freedom was used to compute kinematics and joint moments from motion capture and force plate data. Forces for 92 muscle actuators were computed using Static Optimisation and Induced Acceleration Analysis was used to compute individual muscle contributions to the three-dimensional acceleration of the whole body COM. There were no significant differences between older and younger adults in step length, step time, 3D COM accelerations or muscle contributions to 3D COM accelerations. The stance and stepping leg Gastrocnemius and Soleus muscles were primarily responsible for the vertical acceleration experienced by the COM. The Gastrocnemius and Soleus from the stance side leg together with bilateral Hamstrings accelerated the COM forwards throughout balance recovery while the Vasti and Soleus of the stepping side leg provided the majority of braking accelerations following foot contact. The Hip Abductor muscles provided the greatest contribution to medial-lateral accelerations of the COM. Deficits in the neuromuscular control of the Gastrocnemius, Soleus, Vasti and Hip Abductors in particular could adversely influence balance recovery and may be important targets in interventions to improve balance recovery performance.	[Graham, David F.; Carty, Christopher P.; Lloyd, David G.; Barrett, Rod S.] Griffith Univ, Sch Allied Hlth Sci, Nathan, Qld, Australia; [Graham, David F.; Carty, Christopher P.; Lloyd, David G.; Barrett, Rod S.] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia	Griffith University; Griffith University	Barrett, RS (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Nathan, Qld, Australia.; Barrett, RS (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia.	r.barrett@griffith.edu.au	Lloyd, David Gavin/AAH-6066-2020	Lloyd, David Gavin/0000-0002-0824-9682; Barrett, Rod/0000-0002-1784-1629; Carty, Christopher/0000-0002-8969-5181; Graham, David/0000-0001-7338-3995	National Health and Medical Research Council [536508]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (536508) to Rod S. Barrett. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arampatzis A, 2008, J BIOMECH, V41, P1754, DOI 10.1016/j.jbiomech.2008.02.022; Barrett RS, 2012, J BIOMECH, V45, P183, DOI 10.1016/j.jbiomech.2011.10.005; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Carty CP, 2015, AGE AGEING, V44, P109, DOI 10.1093/ageing/afu054; Carty CP, 2012, CLIN BIOMECH, V27, P1031, DOI 10.1016/j.clinbiomech.2012.07.009; Carty CP, 2012, J GERONTOL A-BIOL, V67, P1246, DOI 10.1093/gerona/gls149; Carty CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033591; Carty CP, 2011, GAIT POSTURE, V33, P261, DOI 10.1016/j.gaitpost.2010.11.017; Crenshaw JR, 2012, J BIOMECH, V45, P129, DOI 10.1016/j.jbiomech.2011.09.022; Cronin NJ, 2013, J ELECTROMYOGR KINES, V23, P1139, DOI 10.1016/j.jelekin.2013.05.012; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; Daggfeldt K, 2003, J BIOMECH, V36, P815, DOI 10.1016/S0021-9290(03)00015-0; De Witt JK, 2010, J BIOMECH, V43, P3067, DOI 10.1016/j.jbiomech.2010.07.009; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Giarmatzis G, 2015, J BONE MINER RES, V30, P1431, DOI 10.1002/jbmr.2483; Grabiner MD, 2008, J ELECTROMYOGR KINES, V18, P197, DOI 10.1016/j.jelekin.2007.06.009; Grabiner MD, 2012, MED SCI SPORT EXER, V44, P2410, DOI 10.1249/MSS.0b013e318268c89f; Graham DF, 2016, J BIOMECH, V49, P2619, DOI 10.1016/j.jbiomech.2016.05.033; Graham DF, 2015, EXP GERONTOL, V66, P39, DOI 10.1016/j.exger.2015.04.006; Graham DF, 2014, J BIOMECH, V47, P667, DOI 10.1016/j.jbiomech.2013.11.047; Hamner SR, 2013, J BIOMECH, V46, P780, DOI 10.1016/j.jbiomech.2012.11.024; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Marjorie JH, 2008, ARCH PHYS MED REHAB, V89, P1708, DOI 10.1016/j.apmr.2008.01.023; John CT, 2012, J BIOMECH, V45, P2438, DOI 10.1016/j.jbiomech.2012.06.037; Kainz H, 2015, CLIN BIOMECH, V30, P319, DOI 10.1016/j.clinbiomech.2015.02.005; Karamanidis K, 2008, J ELECTROMYOGR KINES, V18, P980, DOI 10.1016/j.jelekin.2007.04.003; Lin YC, 2015, J BIOMECH, V48, P340, DOI 10.1016/j.jbiomech.2014.11.019; Liu MQ, 2006, J BIOMECH, V39, P2623, DOI 10.1016/j.jbiomech.2005.08.017; Lord SR, 2007, FALLS IN OLDER PEOPLE: RISK FACTORS AND STRATEGIES FOR PREVENTION, 2ND EDITION, P1, DOI 10.1017/CBO9780511722233; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Madigan ML, 2006, J APPL BIOMECH, V22, P186, DOI 10.1123/jab.22.3.186; Mille ML, 2013, J GERONTOL A-BIOL, V68, P1540, DOI 10.1093/gerona/glt062; Modenese L, 2012, MULTIBODY SYST DYN, V28, P157, DOI 10.1007/s11044-011-9274-7; Nagano H, 2015, GAIT POSTURE, V42, P257, DOI 10.1016/j.gaitpost.2015.05.014; Owings TM, 2001, CLIN BIOMECH, V16, P813, DOI 10.1016/S0268-0033(01)00077-8; Pijnappels M, 2008, EUR J APPL PHYSIOL, V102, P585, DOI 10.1007/s00421-007-0613-6; Pizzolato C, 2015, J BIOMECH, V48, P3929, DOI 10.1016/j.jbiomech.2015.09.021; Rogers MW, 2001, J GERONTOL A-BIOL, V56, pM589, DOI 10.1093/gerona/56.9.M589; Schillings AM, 2005, J NEUROPHYSIOL, V94, P1158, DOI 10.1152/jn.00396.2004; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; Thelen DG, 1997, J GERONTOL A-BIOL, V52, pM8, DOI 10.1093/gerona/52A.1.M8; Wezenberg D, 2011, GAIT POSTURE, V33, P544, DOI 10.1016/j.gaitpost.2011.01.007; Zajac FE, 2002, GAIT POSTURE, V16, P215, DOI 10.1016/S0966-6362(02)00068-1	45	9	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185564	10.1371/journal.pone.0185564	http://dx.doi.org/10.1371/journal.pone.0185564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK7DC	29069097	Green Published, Green Submitted, gold			2022-12-26	WOS:000413663600007
J	Madhu, B; Jauhiainen, A; McGuire, S; Griffiths, JR				Madhu, Basetti; Jauhiainen, Alexandra; McGuire, Sean; Griffiths, John R.			Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS H-1 NMR spectra	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; VIVO H-1 MRS; HIGH-GRADE GLIOMAS; IN-VIVO; EX-VIVO; ENERGY-METABOLISM; MOBILE LIPIDS; CLASSIFICATION; METABOLOMICS; METASTASES	Methods We quantified 378 HRMAS H-1 NMR spectra of human brain tumours (132 glioblastomas, 101 astrocytomas, 75 meningiomas, 37 oligodendrogliomas and 33 metastases) from the eTumour database and looked for metabolic interactions by metabolite-metabolite correlation analysis (MMCA). Results All tumour types showed remarkably similar metabolic correlations. Lactate correlated positively with alanine, glutamate with glutamine; creatine + phosphocreatine (tCr) correlated positively with lactate, alanine and choline + phosphocholine + glycerophosphocholine (tCho), and tCho correlated positively with lactate; fatty acids correlated negatively with lactate, glutamate + glutamine (tGlut), tCr and tCho. Oligodendrogliomas had fewer correlations but they still fitted that pattern. Conclusions Possible explanations include (i) glycolytic tumour cells (the Warburg effect) generating pyruvate which is converted to lactate, alanine, glutamate and then glutamine; (ii) an association between elevated glycolysis and increased choline turnover in membranes; (iii) an increase in the tCr pool to facilitate phosphocreatine-driven glutamate uptake; (iv) lipid signals come from cytosolic lipid droplets in necrotic or pre-necrotic tumour tissue that has lower concentrations of anabolic and catabolic metabolites. Additional metabolite exchanges with host cells may also be involved. If tumours co-opt a standard set of biochemical mechanisms to grow in the brain, then drugs might be developed to disrupt those mechanisms.	[Madhu, Basetti; McGuire, Sean; Griffiths, John R.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England; [Jauhiainen, Alexandra] AstraZeneca AB R&D, Early Clin Biometr, Gothenburg, Sweden	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Madhu, B (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England.	Madhu.Basetti@cruk.cam.ac.uk	Madhu, Basetti/AAW-9665-2020	Madhu, Basetti/0000-0001-5844-856X	University of Cambridge; Cancer Research UK [C14303/A17197]; AstraZeneca AB RD; VI National RD Plan; Instituto de Salud Carlos III; Iniciativa Ingenio; Consolider Program; CIBER Actions; Cancer Research UK [11562] Funding Source: researchfish	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); AstraZeneca AB RD(AstraZeneca); VI National RD Plan; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Iniciativa Ingenio(Spanish Government); Consolider Program(Spanish Government); CIBER Actions; Cancer Research UK(Cancer Research UK)	We acknowledge the support of The University of Cambridge, Cancer Research UK (C14303/A17197). AstraZeneca AB R&D provided support in the form of a salary for author AJ. The specific role of this author is articulated in the "author contributions" section. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of The University of Cambridge, Cancer Research UK (C14303/A17197).; We acknowledge our gratitude to all the groups and members of the eTumour project and we give special thanks to Dr Margarida Julia-Sape, Institut de Biotecnologia i Biomedicina (IBB), Universitat Autanoma de Barcelona, Spain for her help with accessing the database. Since September 2009, maintenance of the eTumour database has been performed by the joint CIBER-BBN platform of the Universitat Autanoma de Barcelona and Centro de Investigacion Biomedica en Red - Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN) (Cerdanyola del Valles, Spain), Unit 25 of NANBIOSIS. CIBER-BBN is an initiative funded by the VI National R&D Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund	Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Andronesi OC, 2008, INT J ONCOL, V33, P1017, DOI 10.3892/ijo_00000090; Andronesi OC, 2008, J MAGN RESON, V193, P251, DOI 10.1016/j.jmr.2008.05.017; Armitage EG, 2014, SPRINGERBRIEFS SYSTE, P21; Barton SJ, 1999, MAGN RESON MATER PHY, V8, P121; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Bolliger CS, 2013, NEUROIMAGE, V83, P1031, DOI 10.1016/j.neuroimage.2013.07.062; Cheng LL, 2000, NEURO-ONCOLOGY, V2, P87, DOI 10.1093/neuonc/2.2.87; Cuellar-Baena S, 2010, INT J MOL MED, V26, P941, DOI 10.3892/ijmm_00000546; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Erb G, 2008, MAGN RESON MED, V59, P959, DOI 10.1002/mrm.21486; Gabr RE, 2011, AM J PHYSIOL-CELL PH, V301, pC234, DOI 10.1152/ajpcell.00500.2010; Garcia-Gomez JM, 2009, MAGN RESON MATER PHY, V22, P5, DOI 10.1007/s10334-008-0146-y; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Griffin JL, 2002, NMR BIOMED, V15, P375, DOI 10.1002/nbm.792; Griffin JL, 2007, FEBS J, V274, P1132, DOI 10.1111/j.1742-4658.2007.05676.x; Jauhiainen A, 2014, BIOINFORMATICS, V30, P2155, DOI 10.1093/bioinformatics/btu175; Julia-Sape A M, 2015, CLIN TRIALS MRS METH; Julia-Sape M, 2015, NMR BIOMED, V28, P1772, DOI 10.1002/nbm.3439; Julia-Sape M, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas035; Li XJ, 2005, AM J NEURORADIOL, V26, P760; Liimatainen T, 2009, NMR BIOMED, V22, P272, DOI 10.1002/nbm.1320; Madhu B, 2015, METABOLOMICS, V11, P1848, DOI 10.1007/s11306-015-0838-z; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Martinez-Bisbal MC, 2004, NMR BIOMED, V17, P191, DOI 10.1002/nbm.888; Opstad KS, 2008, NMR BIOMED, V21, P677, DOI 10.1002/nbm.1239; Opstad KS, 2010, J MAGN RESON IMAGING, V31, P289, DOI 10.1002/jmri.22039; Opstad KS, 2004, J MAGN RESON IMAGING, V20, P187, DOI 10.1002/jmri.20093; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Petersen AK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-120; Piccirillo SGM, 2012, BRIT J CANCER, V107, P462, DOI 10.1038/bjc.2012.271; Sijens PE, 1996, NMR BIOMED, V9, P65, DOI 10.1002/(SICI)1099-1492(199604)9:2<65::AID-NBM397>3.0.CO;2-N; Sjobakk TE, 2008, NMR BIOMED, V21, P175, DOI 10.1002/nbm.1180; Sjobakk TE, 2013, INT J MOL SCI, V14, P2104, DOI 10.3390/ijms14012104; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Tisell A, 2013, MAGN RESON MED, V70, P905, DOI 10.1002/mrm.24554; Wilson M, 2009, NMR BIOMED, V22, P213, DOI 10.1002/nbm.1306; Wilson M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-6; Wright AJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-66; Xu CJ, 1996, J BIOL CHEM, V271, P13435, DOI 10.1074/jbc.271.23.13435; Zong H., 2015, COLD SPRING HARB PER, V7	42	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185980	10.1371/journal.pone.0185980	http://dx.doi.org/10.1371/journal.pone.0185980			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069098	Green Published, Green Submitted, gold			2022-12-26	WOS:000413663600011
J	Black, E; Owens, K; Staub, R; Li, JZ; Mills, K; Valenstein, J; Hilgren, J				Black, Elaine; Owens, Krista; Staub, Richard; Li, Junzhong; Mills, Kristen; Valenstein, Justin; Hilgren, John			Evaluation of AISI Type 304 stainless steel as a suitable surface material for evaluating the efficacy of peracetic acid-based disinfectants against Clostridium difficile spores	PLOS ONE			English	Article							STERILANTS; CARRIER	Disinfectants play an important role in controlling microbial contamination on hard surfaces in hospitals. The effectiveness of disinfectants in real life can be predicted by laboratory tests that measure killing of microbes on carriers. The modified Quantitative Disk Carrier Test (QCT-2) is a standard laboratory method that employs American Iron and Steel Institute (AISI) Type 430 stainless steel carriers to measure hospital disinfectant efficacy against Clostridium difficile spores. The formation of a rust-colored precipitate was observed on Type 430 carriers when testing a peracetic acid (PAA)-based disinfectant with the QCT-2 method. It was hypothesized that the precipitate was indicative of corrosion of the Type 430 carrier, and that corrosion could impact efficacy results. The objective of this study was to compare the suitability of AISI Type 430 to Type 304 stainless steel carriers for evaluating PAA-based disinfectants using the QCT-2 method. Type 304 is more corrosion-resistant than Type 430, is ubiquitous in healthcare environments, and is used in other standard methods. Suitability of the carriers was evaluated by comparing their impacts on efficacy results and PAA degradation rates. In efficacy tests with 1376 ppm PAA, reductions of C. difficile spores after 5, 7 and 10 minutes on Type 430 carriers were at least about 1.5 log10 lower than reductions on Type 304 carriers. In conditions simulating a QCT-2 test, PAA concentration with Type 430 carriers was reduced by approximately 80% in 10 minutes, whereas PAA concentration in the presence of Type 304 carriers remained stable. Elemental analyses of residues on each carrier type after efficacy testing were indicative of corrosion on the Type 430 carrier. Use of Type 430 stainless steel carriers for measuring the efficacy of PAA-based disinfectants should be avoided as it can lead to an underestimation of real life sporicidal efficacy. Type 304 stainless steel carriers are recommended as a suitable alternative.	[Black, Elaine; Owens, Krista; Staub, Richard; Li, Junzhong; Mills, Kristen; Valenstein, Justin; Hilgren, John] Ecolab Res, Dev & Engn Ctr, Eagan, MN 55121 USA	Ecolab Inc.	Black, E (corresponding author), Ecolab Res, Dev & Engn Ctr, Eagan, MN 55121 USA.	elaine.black@ecolab.com						American Iron and Steel Institute, STEEL GLOSS FERR; AOAC official method 955. 15 testing disinfectants against Staphylococcus aureus, 2016, OFFICIAL METHODS ANA; Block S.S., 2001, DISINFECTION STERILI, Vfifth, P185; British Stainless Steel Association, CHEM HANDL CONT SEL; Cambridge Biomedical, POT SOD CHLORD FEC; Centers for Disease Control and Prevention, 2017, IS CLOSTR DIFF TRANS; European Chemicals Agency, 2017, GUID BIOC PROD REG, VII; Heubner U., STAINLESS STEEL HLTH, V2; Jeffery GH., 1989, VOGELS TXB QUANTITAT, V5, P980; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lewus M, 2002, P 4 EUR STAINL STEEL; McDonnell G, 2000, J AOAC INT, V83, P269; McDonnell G, 2003, J AOAC INT, V86, P407; Newson T., 2003, P BRIT STAINL STEEL; Nickel Development Institute, DES GUID SEL US STAI, V9014; OECD, 2013, SER TEST ASS; Russell A., 2001, DISINFECTION STERILI, P31; Uhlig S, 2009, VALIDATION EFFICACY; United States Environmental Protection Agency, 2000, 712C07005 US EPA; United States Environmental Protection Agency, 2014, PROD SPOR CLOSTR DIF; United States Environmental Protection Agency, 1998, 712C98001 US EPA; United States Environmental Protection Agency, 2014, 43598 US EPA ATCC	22	0	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0187074	10.1371/journal.pone.0187074	http://dx.doi.org/10.1371/journal.pone.0187074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065168	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900068
J	Forfert, N; Troxler, A; Retschnig, G; Gauthier, L; Straub, L; Moritz, RFA; Neumann, P; Williams, GR				Forfert, Nadege; Troxler, Aline; Retschnig, Gina; Gauthier, Laurent; Straub, Lars; Moritz, Robin F. A.; Neumann, Peter; Williams, Geoffrey R.			Neonicotinoid pesticides can reduce honeybee colony genetic diversity	PLOS ONE			English	Article							APIS-MELLIFERA; EXTREME POLYANDRY; LEARNING PERFORMANCES; INSECTICIDES; EVOLUTION; FREQUENCY; EXPOSURE; THIAMETHOXAM; INSECTS; SUCCESS	Neonicotinoid insecticides can cause a variety of adverse sub-lethal effects in bees. In social species such as the honeybee, Apis mellifera, queens are essential for reproduction and colony functioning. Therefore, any negative effect of these agricultural chemicals on the mating success of queens may have serious consequences for the fitness of the entire colony. Queens were exposed to the common neonicotinoid pesticides thiamethoxam and clothianidin during their developmental stage. After mating, their spermathecae were dissected to count the number of stored spermatozoa. Furthermore, their worker offspring were genotyped with DNA microsatellites to determine the number of matings and the genotypic composition of the colony. Colonies providing the male mating partners were also inferred. Both neonicotinoid and control queens mated with drones originating from the same drone source colonies, and stored similar number of spermatozoa. However, queens reared in colonies exposed to both neonicotinoids experienced fewer matings. This resulted in a reduction of the genetic diversity in their colonies (i.e. higher intracolonial relatedness). As decreased genetic diversity among worker bees is known to negatively affect colony vitality, neonicotinoids may have a cryptic effect on colony health by reducing the mating frequency of queens.	[Forfert, Nadege; Moritz, Robin F. A.] Martin Luther Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany; [Troxler, Aline; Retschnig, Gina; Straub, Lars; Neumann, Peter; Williams, Geoffrey R.] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Gauthier, Laurent; Neumann, Peter; Williams, Geoffrey R.] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Moritz, Robin F. A.] Univ Pretoria, Social Insect Res Grp, Dept Zool & Entomol, Pretoria, South Africa; [Williams, Geoffrey R.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Martin Luther University Halle Wittenberg; University of Bern; Swiss Federal Research Station Agroscope; University of Pretoria; Auburn University System; Auburn University	Forfert, N (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany.	nadege.forfert@zoologie.uni-halle.de	Neumann, Peter/C-9964-2015; Moritz, Robin FA/K-6053-2012; Straub, Lars/AAP-2820-2020; Williams, Geoffrey/C-9637-2015	Neumann, Peter/0000-0001-5163-5215; Moritz, Robin FA/0000-0003-0791-887X; Straub, Lars/0000-0002-2091-1499; Retschnig, Gina/0000-0001-6249-9853; Williams, Geoffrey/0000-0002-0093-1126	Vinetum foundation; Ricola foundation; Swiss National Science foundation; Swiss Federal Office for the Environment, Agroscope; FIT BEE project (Bundesministerium fur Ernahrung und Landwirtschaft)	Vinetum foundation; Ricola foundation; Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Office for the Environment, Agroscope; FIT BEE project (Bundesministerium fur Ernahrung und Landwirtschaft)	Financial support was provided by the Vinetum, Ricola, and Swiss National Science foundations, the Swiss Federal Office for the Environment, Agroscope, and the FIT BEE project (Bundesministerium fur Ernahrung und Landwirtschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; [Anonymous], 1971, INSECT SOC; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Bresslau E., 1905, ZOOL ANZ, V29, P299; Brodschneider Robert, 2012, Insects, V3, P857, DOI 10.3390/insects3030857; Buchler R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.07; Dade HA, 1977, ANATOMY DISSECTION H, P158; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Forfert N, 2016, INFECT GENET EVOL, V44, P549, DOI 10.1016/j.meegid.2016.07.017; Fuchs S, 1999, BEHAV ECOL SOCIOBIOL, V45, P269, DOI 10.1007/s002650050561; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gross M, 2008, CURR BIOL, V18, pR684, DOI 10.1016/j.cub.2008.08.004; HARBO JR, 1979, J APICULT RES, V18, P204, DOI 10.1080/00218839.1979.11099969; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Jaffe R, 2014, SOCIOBIOLOGY, V61, P1; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Koeniger G., 2015, MATING BIOL HONEY BE; Koeniger N, 2005, INSECT SOC, V52, P31, DOI 10.1007/s00040-004-0763-z; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Lundin O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136928; Maienfisch P, 2001, PEST MANAG SCI, V57, P906, DOI 10.1002/ps.365; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Medrzycki Piotr, 2003, Bulletin of Insectology, V56, P59; MORITZ RFA, 1984, J APICULT RES, V23, P164, DOI 10.1080/00218839.1984.11100626; Moritz RFA, 2008, J INSECT CONSERV, V12, P455, DOI 10.1007/s10841-007-9078-5; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Neumann P, 1999, J APICULT RES, V38, P11, DOI 10.1080/00218839.1999.11100990; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Page Jr RE, 1990, SELF ORG ADAPTATION, P289; PAGE RE, 1986, ANNU REV ENTOMOL, V31, P297, DOI 10.1146/annurev.en.31.010186.001501; Pamilo P, 1996, OIKOS, V75, P533, DOI 10.2307/3545895; Pettis JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147220; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Retschnig G, 2015, ENVIRON MICROBIOL, V17, P4322, DOI 10.1111/1462-2920.12825; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ruttner F., 1966, Z BIENENFORSCH, V8, P332; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Schluns H, 2005, ANIM BEHAV, V70, P125, DOI 10.1016/j.anbehav.2004.11.005; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Starr C.K., 1984, P427; StataCorp, 2015, STAT STAT SOFTW REL; Straub L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0506; Straub L, 2015, CURR OPIN INSECT SCI, V12, P109, DOI 10.1016/j.cois.2015.10.010; TABER S, 1954, J ECON ENTOMOL, V47, P995, DOI 10.1093/jee/47.6.995; Tarpy DR, 2013, NATURWISSENSCHAFTEN, V100, P723, DOI 10.1007/s00114-013-1065-y; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Taylor OR, 1987, AFRICANIZED BEES BEE, P173; Thompson HM, 2007, PEST MANAG SCI, V63, P1058, DOI 10.1002/ps.1458; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Williams GR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14621; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Williams GR, 2009, J INVERTEBR PATHOL, V101, P77, DOI 10.1016/j.jip.2009.01.004; Williams GR, 2013, J APICULT RES, V2013, P52; Winston M., 1987, The biology of the honey bee.; Zmarlicki C., 1963, J apid Res London, V2, P64	75	27	28	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186109	10.1371/journal.pone.0186109	http://dx.doi.org/10.1371/journal.pone.0186109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059234	Green Published, Green Submitted, gold			2022-12-26	WOS:000413403000014
J	Rasoahanitralisoa, R; Rakotosamimanana, N; Stucki, D; Sola, C; Gagneux, S; Razanamparany, VR				Rasoahanitralisoa, Rondroarivelo; Rakotosamimanana, Niaina; Stucki, David; Sola, Christophe; Gagneux, Sebastien; Razanamparany, Voahangy Rasolofo			Evaluation of spoligotyping, SNPs and customised MIRU-VNTR combination for genotyping Mycobacterium tuberculosis clinical isolates in Madagascar	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DIVERSITY; COMPLEX; STRAINS	Background Combining different molecular typing methods for Mycobacterium tuberculosis complex (MTBC) can be a powerful tool for molecular epidemiology-based investigation of TB. However, the current standard method that provides high discriminatory power for such a combination, mycobacterial interspersed repetitive units-variable numbers of tandem repeats typing (MIRU-VNTR), is laborious, time-consuming and often too costly for many resource-limited laboratories. We aimed to evaluate a reduced set of loci for MIRU-VNTR typing in combination with spoligotyping and SNP-typing for routine molecular epidemiology of TB. Method Spoligotyping and SNP-typing, in combination with the 15 loci MIRU-VNTR typing, were first used to type clinical MTBC isolates (n = 158) from Madagascar. A step by step reduction of MIRU-VNTR loci number was then performed according to the Hunter and Gaston Discriminatory Index (HGDI) and to the Principal component analysis (PCA) correlation with the spoligotype profiles to evaluate the discrimination power inside the generated spoligotype clusters. The 15 MIRU-VNTR was used as reference and SNP-typing was used to determine the main MTBC lineages. Results Of the 158 clinical isolates studied, the SNP-typing classified 23 into Lineage 1 (14.6%), 31 into Lineage 2 (19.6%), 23 into Lineage 3 (14.6%) and 81 into Lineage 4 strains (51.3%). 37 different spoligotypes profiles were obtained, 15 of which were unique and 20 in clusters. 15-loci MIRU-VNTR typing revealed 144 different genotypes: 132 isolates had a unique MIRU-VNTR profile and 27 isolates were grouped into 12 clusters. After a stepwise reduction of the MIRU-VNTR loci number within each main spoligotype families, three different sets composed of 5 customised MIRU-VNTR loci had a similar discrimination level to the reference 15 loci MIRU-VNTR in lineage 1, lineage 2 and lineage 3. For lineage 4, a set of 4 and 3 MIRU-VNTR loci were proposed to subtype the Harleem and LAM spoligotype families, respectively. For the T spoligotype family, a set of 5 MIRU-VNTR loci was proposed. Conclusion According to the lineages and the spoligotype families, the number of MIRU-VNTR loci can be reduced to get an optimal classification of MTBC. These customized sets of MIRU-VNTR loci reduce workload and save resources while maintaining optimal discriminatory power.	[Rasoahanitralisoa, Rondroarivelo; Rakotosamimanana, Niaina; Razanamparany, Voahangy Rasolofo] Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo, Madagascar; [Rasoahanitralisoa, Rondroarivelo] Univ Antananarivo, Fac Sci, Ecole Doctorale Sci Vie & Environm, Antananarivo, Madagascar; [Stucki, David; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Stucki, David; Sola, Christophe] Univ Basel, Basel, Switzerland; [Gagneux, Sebastien] CEA CNRS UP Saclay, UMR9198, I2BC, Inst Integrat Cell Biol, Orsay, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University Antananarivo; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Rakotosamimanana, N (corresponding author), Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo, Madagascar.	niaina@pasteur.mg	Gagneux, Sebastien/ABE-7909-2020; Sola, Christophe/A-7992-2016	Sola, Christophe/0000-0003-4672-2140; Rakotosamimanana, Niaina/0000-0002-2352-9797; Gagneux, Sebastien/0000-0001-7783-9048; Stucki, David/0000-0003-0131-9980	Institut Pasteur de Madagascar	Institut Pasteur de Madagascar	This work was supported by Institut Pasteur de Madagascar to Rondroarivelo Rasoahanitralisoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Asante-Poku A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092675; Aze J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130912; Chaoui I, 2014, INFECT GENET EVOL, V21, P463, DOI 10.1016/j.meegid.2013.05.023; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Lu W, 2014, SCAND J INFECT DIS, V46, P98, DOI 10.3109/00365548.2013.858182; Luo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089726; Maes M, 2008, TUBERCULOSIS, V88, P490, DOI 10.1016/j.tube.2008.04.003; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; Rasolofo-Razanamparany V, 2000, RES MICROBIOL, V151, P785, DOI 10.1016/S0923-2508(00)01144-X; Saavedra-Campos M, 2010, THORAX; Silva C, 2014, INT J ANTIMICROB AG, V44, P546, DOI 10.1016/j.ijantimicag.2014.06.021; Sola C, 2015, TUBERCULOSIS, V95, pS159, DOI 10.1016/j.tube.2015.02.029; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Streit E, 2015, INFECT GENET EVOL, V30, P114, DOI 10.1016/j.meegid.2014.12.015; Stucki D, 2012, PLOS ONE, V7; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; World Health Organization, 2015, WHOHTMTB2015; Zhang J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-42	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186088	10.1371/journal.pone.0186088	http://dx.doi.org/10.1371/journal.pone.0186088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053711	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100012
J	Heckenhauer, J; Abu Salim, K; Chase, MW; Dexter, KG; Pennington, RT; Tan, S; Kaye, ME; Samuel, R				Heckenhauer, Jacqueline; Abu Salim, Kamariah; Chase, Mark W.; Dexter, Kyle G.; Pennington, R. Toby; Tan, Sylvester; Kaye, Maria Ellen; Samuel, Rosabelle			Plant DNA barcodes and assessment of phylogenetic community structure of a tropical mixed dipterocarp forest in Brunei Darussalam (Borneo)	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; SPATIAL SCALES; COMPETITION; DIVERSITY; PATTERNS; TRAIT; RELATEDNESS; EVOLUTION; ECOLOGY; OVERDISPERSION	DNA barcoding is a fast and reliable tool to assess and monitor biodiversity and, via community phylogenetics, to investigate ecological and evolutionary processes that may be responsible for the community structure of forests. In this study, DNA barcodes for the two widely used plastid coding regions rbcL and matK are used to contribute to identification of morphologically undetermined individuals, as well as to investigate phylogenetic structure of tree communities in 70 subplots (10 x 10m) of a 25-ha forest-dynamics plot in Brunei (Borneo, Southeast Asia). The combined matrix (rbcL + matK) comprised 555 haplotypes (from >= 154 genera, 68 families and 25 orders sensu APG, Angiosperm Phylogeny Group, 2016), making a substantial contribution to tree barcode sequences from Southeast Asia. Barcode sequences were used to reconstruct phylogenetic relationships using maximum likelihood, both with and without constraining the topology of taxonomic orders to match that proposed by the Angiosperm Phylogeny Group. A third phylogenetic tree was reconstructed using the program Phylomatic to investigate the influence of phylogenetic resolution on results. Detection of non-random patterns of community assembly was determined by net relatedness index (NRI) and nearest taxon index (NTI). In most cases, community assembly was either random or phylogenetically clustered, which likely indicates the importance to community structure of habitat filtering based on phylogenetically correlated traits in determining community structure. Different phylogenetic trees gave similar overall results, but the Phylomatic tree produced greater variation across plots for NRI and NTI values, presumably due to noise introduced by using an unresolved phylogenetic tree. Our results suggest that using a DNA barcode tree has benefits over the traditionally used Phylomatic approach by increasing precision and accuracy and allowing the incorporation of taxonomically unidentified individuals into analyses.	[Heckenhauer, Jacqueline; Samuel, Rosabelle] Univ Vienna, Dept Bot & Biodivers Res, Fac Life Sci, Vienna, Austria; [Abu Salim, Kamariah] Univ Brunei Darussalam, Environm & Life Sci, Fac Sci, Gadong, Brunei; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Chase, Mark W.] Univ Western Australia, Sch Biol Sci, Crawley, WA, Australia; [Dexter, Kyle G.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Dexter, Kyle G.; Pennington, R. Toby] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Pennington, R. Toby] Univ Exeter, Geog, Exeter, Devon, England; [Tan, Sylvester] Sarawak Forest Dept, Kuching, Sarawak, Malaysia; [Kaye, Maria Ellen] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of Vienna; University Brunei Darussalam; Royal Botanic Gardens, Kew; University of Western Australia; University of Edinburgh; University of Exeter; Jabatan Hutan Sarawak; University of Aberdeen	Heckenhauer, J (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Fac Life Sci, Vienna, Austria.	jacqueline.heckenhauer@univie.ac.at	Dexter, Kyle G/D-5589-2018; Heckenhauer, Jacqueline/S-2206-2019	Dexter, Kyle G/0000-0001-9232-5221; Chase, Mark/0000-0002-9927-4938; Pennington, Toby/0000-0002-8196-288X; Samuel, Mary Rosabelle/0000-0003-0197-4854	Austrian Science Fund FWF; Kuala Belalong Field Studies Center of the University of Brunei Darussalam;  [P26548-B22]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Kuala Belalong Field Studies Center of the University of Brunei Darussalam; 	This work was funded by the Austrian Science Fund FWF (https://www.fwf.ac.at). The grant (P26548-B22) was given to R. Samuel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fieldwork was done in Kuala Belalong Field Study Center with collaboration of the University of Brunei Darussalam (UBD). The 25-ha long-term Forest Dynamics Research Project is a collaborative project of the University of Brunei Darussalam, Brunei Darussalam, the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute, USA, and The Hong Kong Shanghai Bank Corp. Ltd., Brunei Darussalam. The Kuala Belalong plot is part of the Center for Tropical Forest Science, a global network of large-scale demographic tree plots. We acknowledge the Kuala Belalong Field Studies Center of the University of Brunei Darussalam for supporting and maintaining the project in the Temburong National Park of the Batu Apoi Forest Reserve. Mr. Khoo Min Sheng and Mrs. Rafizah Mat Serudin are acknowledged as they led most of the fieldwork for the establishment of the plot. Field assistants Fiona Willinathy, Anak Amdani, Sawai Anak Amba and Teddy Chua of the KBFSC, Brunei Darussalam, are acknowledged for their support during our fieldwork. UBD-CTFS are acknowledged for all information on the plots. We thank both Brunei Heart of Borneo Secretariat for granting permission to export material for research purposes. Michael Barfuss and Ovidiu Paun are acknowledged for help in sampling of material. Verena Klejna and Elfriede Grasserbauer have been a great help in the laboratory for DNA extraction and sequencing. David Burslem is acknowledged for helping with initial discussions and preliminary analysis. We acknowledge Stuart Davies, Director of the CTFS, for his initiation and interest in the progress of the work in these plots and for a helpful review of the manuscript. We also thank an additional anonymous reviewer for useful comments and suggestions.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; ASHTON PS, 1992, J ECOL, V80, P459, DOI 10.2307/2260691; Ashton PS, 1964, OXFORD FORESTRY MEMO, V25; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Bawa K.S., 1998, REV DIPTEROCARPS TAX; Beaulieu JM, 2012, ECOLOGY, V93, pS4, DOI 10.1890/11-0638.1; Becerra JX, 2007, P NATL ACAD SCI USA, V104, P7483, DOI 10.1073/pnas.0608253104; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bennett JA, 2013, ECOL LETT, V16, P1168, DOI 10.1111/ele.12153; Britton T, 2002, MOL PHYLOGENET EVOL, V24, P58, DOI 10.1016/S1055-7903(02)00268-3; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dick Christopher W, 2012, Methods Mol Biol, V858, P379, DOI 10.1007/978-1-61779-591-6_18; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Erickson DL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00358; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harms KE, 2014, P BIOL SCI, V281; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heckenhauer J, 2017, BOT J LINN SOC, V185, P1, DOI 10.1093/botlinnean/box044; Heckenhauer J, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500137; Herbert PND, 2004, P NATL ACAD SCI USA, V101, P14812, DOI DOI 10.1073/PNAS.0406166101; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Jeanson ML, 2011, ANN BOT-LONDON, V108, P1445, DOI 10.1093/aob/mcr158; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; Losos JB, 1996, ECOLOGY, V77, P1344, DOI 10.2307/2265532; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Malecot V, 1990, J MOL EVOL, V31, P294; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Muscarella R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112843; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Pei NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021273; Poe S, 1999, NATURE, V398, P299, DOI 10.1038/18592; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 1993, SPECIES DIVERSITY IN; ROUGHGARDEN J, 1983, AM NAT, V122, P583, DOI 10.1086/284160; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Slik JWF, 2003, J BIOGEOGR, V30, P1517, DOI 10.1046/j.1365-2699.2003.00967.x; Slingsby JA, 2006, AM NAT, V168, P14, DOI 10.1086/505158; Smithsonian Tropical Research Institute, ABOUT CTFS; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukri RS, 2012, BIOTROPICA, V44, P595, DOI 10.1111/j.1744-7429.2011.00837.x; Sun H, 2001, TAXON, V50, P1001, DOI 10.2307/1224717; Sun YX, 2016, MOL PHYLOGENET EVOL, V96, P93, DOI 10.1016/j.ympev.2015.12.006; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson Nathan G, 2012, Methods Mol Biol, V858, P409, DOI 10.1007/978-1-61779-591-6_20; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Whitfeld TJS, 2012, ECOGRAPHY, V35, P821, DOI 10.1111/j.1600-0587.2011.07181.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Yamakura T., 1995, TROPICS, V5, P41, DOI [10.3759/tropics.5.41, DOI 10.3759/tropics.5.41, DOI 10.3759/TROPICS.5.41]; Yang J, 2014, FUNCT ECOL, V28, P520, DOI 10.1111/1365-2435.12176; Yessoufou K, 2013, J ECOL, V101, P614, DOI 10.1111/1365-2745.12059	100	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185861	10.1371/journal.pone.0185861	http://dx.doi.org/10.1371/journal.pone.0185861			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049301	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900026
J	Lavinia, PD; Bustos, EON; Kopuchian, C; Lijtmaer, DA; Garcia, NC; Hebert, PDN; Tubaro, PL				Lavinia, Pablo D.; Nunez Bustos, Ezequiel O.; Kopuchian, Cecilia; Lijtmaer, Dario A.; Garcia, Natalia C.; Hebert, Paul D. N.; Tubaro, Pablo L.			Barcoding the butterflies of southern South America: Species delimitation efficacy, cryptic diversity and geographic patterns of divergence	PLOS ONE			English	Article							LEPIDOPTERA NYMPHALIDAE; PHYLOGENETIC ANALYSIS; ATLANTIC FOREST; DNA BARCODES; IDENTIFICATION; BIODIVERSITY; INTEGRATION; MORPHOLOGY; INDICATORS; TAXONOMY	Because the tropical regions of America harbor the highest concentration of butterfly species, its fauna has attracted considerable attention. Much less is known about the butterflies of southern South America, particularly Argentina, where over 1,200 species occur. To advance understanding of this fauna, we assembled a DNA barcode reference library for 417 butterfly species of Argentina, focusing on the Atlantic Forest, a biodiversity hotspot. We tested the efficacy of this library for specimen identification, used it to assess the frequency of cryptic species, and examined geographic patterns of genetic variation, making this study the first large-scale genetic assessment of the butterflies of southern South America. The average sequence divergence to the nearest neighbor (i.e. minimum interspecific distance) was 6.91%, ten times larger than the mean distance to the furthest conspecific (0.69%), with a clear barcode gap present in all but four of the species represented by two or more specimens. As a consequence, the DNA barcode library was extremely effective in the discrimination of these species, allowing a correct identification in more than 95% of the cases. Singletons (i.e. species represented by a single sequence) were also distinguishable in the gene trees since they all had unique DNA barcodes, divergent from those of the closest non-conspecific. The clustering algorithms implemented recognized from 416 to 444 barcode clusters, suggesting that the actual diversity of butterflies in Argentina is 3%-9% higher than currently recognized. Furthermore, our survey added three new records of butterflies for the country (Eurema agave, Mithras hannelore, Melanis hillapana). In summary, this study not only supported the utility of DNA barcoding for the identification of the butterfly species of Argentina, but also highlighted several cases of both deep intraspecific and shallow interspecific divergence that should be studied in more detail.	[Lavinia, Pablo D.; Nunez Bustos, Ezequiel O.; Lijtmaer, Dario A.; Garcia, Natalia C.; Tubaro, Pablo L.] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Kopuchian, Cecilia] Consejo Nacl Invest Cient & Tecn, Ctr Ecol Aplicada Litoral CECOAL, Lab Biol Conservac, Corrientes, Argentina; [Hebert, Paul D. N.] Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Guelph	Lavinia, PD (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina.	pablodlo23@gmail.com			Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Fondo iBOL Argentina (CONICET); Fundacion Williams from Argentina; International Developmental Research Centre (IDRC) of Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo iBOL Argentina (CONICET); Fundacion Williams from Argentina; International Developmental Research Centre (IDRC) of Canada	This study was funded by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Fondo iBOL Argentina (CONICET), and Fundacion Williams from Argentina, and the International Developmental Research Centre (IDRC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzamendia V, 2009, J BIOGEOGR, V36, P1739, DOI 10.1111/j.1365-2699.2009.02116.x; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Barbosa EP, 2015, ORG DIVERS EVOL, V15, P577, DOI 10.1007/s13127-015-0221-y; Barco A, 2016, MOL ECOL RESOUR, V16, P288, DOI 10.1111/1755-0998.12440; Blagoev GA, 2016, MOL ECOL RESOUR, V16, P325, DOI 10.1111/1755-0998.12444; Bonebrake TC, 2010, BIOL CONSERV, V143, P1831, DOI 10.1016/j.biocon.2010.04.044; Breinholt JW, 2017, SYST BIOL, V7; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Brower AVZ, 2010, SYST BIODIVERS, V8, P485, DOI 10.1080/14772000.2010.534512; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Brown KS, 2000, BIOTROPICA, V32, P934, DOI 10.1646/0006-3606(2000)032[0934:AFBIFL]2.0.CO;2; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Canals G., 2003, BUTTERFLIES MISIONES; Carnaval AC, 2014, P R SOC LONDON B, V281; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Chazot N, 2016, MOL ECOL, V25, P5765, DOI 10.1111/mec.13773; Chifflet L, 2016, J EVOLUTION BIOL, V29, P790, DOI 10.1111/jeb.12827; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cong Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24863; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; Dinca V, 2010, P R SOC LONDON B, V278; Dinca V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12395; Duarte M, 2010, REV BRAS ENTOMOL, V54, P45, DOI 10.1590/S0085-56262010000100006; Duarte Marcelo, 2009, Zootaxa, V2325, P39; Elias M, 2009, MOL ECOL, V18, P1716, DOI 10.1111/j.1365-294X.2009.04149.x; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Freitas AVL, 2015, ZOOTAXA, V3981, P521, DOI 10.11646/zootaxa.3981.4.4; Galindo-Leal C, 2003, STATE HOTS, P3; Garzon-Orduna IJ, 2014, J BIOGEOGR, V41, P1631, DOI 10.1111/jbi.12330; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hausmann A, 2011, SPIXIANA, V34, P47; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hebert PDN, 2003, P R SOC LONDON B, V270; Hebert PDN, 2010, BIOL LETT, V6; Heikkila M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0520-0; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P1; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Lamas G, 2004, CHECKLIST 4, DOI DOI 10.1093/sysbio/syw044; Lijtmaer DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020744; Marin MA, 2017, NEOTROP ENTOMOL, V46, P514, DOI 10.1007/s13744-016-0481-z; Beccacece HM, 2014, ZOOTAXA, V3847, P595, DOI 10.11646/zootaxa.3847.4.10; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Mutanen M, 2016, SYST BIOL, V65, P1024, DOI 10.1093/sysbio/syw044; Mutanen M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02901; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nunez Bustos Ezequiel, 2017, Historia Natural (Corrientes), V7, P111; Oliveira U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03098-w; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Penz C, 2015, ECOGRAPHY, V38, P410, DOI 10.1111/ecog.01172; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roe Amanda D., 2010, P1; Rosser N, 2012, BIOL J LINN SOC, V105, P479, DOI 10.1111/j.1095-8312.2011.01814.x; Sheth BP, 2017, GENOME, V60, P618, DOI 10.1139/gen-2015-0167; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Warren A. D., 2016, ILLUSTRATED LISTS AM; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3; Wilson JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061610; Yang MS, 2016, MITOCHONDRIAL DNA A, V27, P2523, DOI 10.3109/19401736.2015.1038788; Zacca T, 2017, AUSTRAL ENTOMOL, V56, P169, DOI 10.1111/aen.12223; Zenker MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148423; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	83	30	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186845	10.1371/journal.pone.0186845	http://dx.doi.org/10.1371/journal.pone.0186845			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049373	Green Submitted, gold, Green Published			2022-12-26	WOS:000413195900118
J	Raimondo, MG; Pericleous, C; Radziszewska, A; Borghi, MO; Pierangeli, S; Meroni, PL; Giles, I; Rahman, A; Ioannou, Y				Raimondo, Maria Gabriella; Pericleous, Charis; Radziszewska, Anna; Borghi, Maria Orietta; Pierangeli, Silvia; Meroni, Pier Luigi; Giles, Ian; Rahman, Anisur; Ioannou, Yiannis			Oxidation of beta 2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome	PLOS ONE			English	Article							BETA(2)-GLYCOPROTEIN I; CLASSIFICATION; PATHOGENICITY; PATHOGENESIS; CRITERIA; BINDING	Domain I (DI) of beta-2-glycoprotein I (beta(2)GPI) contains the immunodominant epitope for pathogenic antiphospholipid antibodies (aPL). DI is exposed in the linear form of the molecule but not in the circular form that comprises 90% of serum beta(2)GPI. The majority of circulating beta(2)GPI is biochemically reduced with two free thiols in Domain V. However, increased levels of oxidised beta(2)GPI are found in patients with antiphospholipid syndrome (APS). It is not known whether oxidation of beta(2)GPI favours the linear form of the molecule and thus promotes development of anti-DI antibodies. We investigated whether the proportion of oxidised beta(2)GPI associates with the presence of anti-DI in APS patients. Serum samples from 44 APS patients were screened for IgG, IgM and IgA anti-DI, anti-beta(2)GPI, anti-cardiolipin (anti-CL) and biochemically reduced beta(2)GPI. A negative correlation was found between the proportion of beta(2)GPI in the biochemically reduced form and IgG anti-DI levels (r = -0.54, p = 0.0002), but not with IgM or IgA anti-DI. Moreover, the proportion of beta(2)GPI in the reduced form was lower in IgG anti-DI positive than anti-DI negative APS patients (p = 0.02). The relative amount of reduced beta(2)GPI was no different between patients who were positive or negative for IgG, IgM and IgA anti-beta(2)GPI or anti-CL. This study demonstrates that oxidised beta(2)GPI lacking free cysteine-thiol groups most closely associates with IgG anti-DI positivity compared to IgG anti-CL and anti-beta(2)GPI. Future studies are required to ascertain the directionality of this association to define causation.	[Raimondo, Maria Gabriella; Pericleous, Charis; Radziszewska, Anna; Giles, Ian; Rahman, Anisur; Ioannou, Yiannis] UCL, Div Med, Ctr Rheumatol Res, London, England; [Raimondo, Maria Gabriella; Borghi, Maria Orietta; Meroni, Pier Luigi] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Radziszewska, Anna; Ioannou, Yiannis] UCL, Div Med, Arthrit Res UK Ctr Adolescent Rheumatol, London, England; [Borghi, Maria Orietta; Meroni, Pier Luigi] IRCCS, Ist Auxol Italiano, Milan, Italy; [Pierangeli, Silvia] Univ Texas Med Branch, Dept Med, Div Rheumatol, Galveston, TX 77555 USA	University of London; University College London; University of Milan; University of London; University College London; IRCCS Istituto Auxologico Italiano; University of Texas System; University of Texas Medical Branch Galveston	Raimondo, MG (corresponding author), UCL, Div Med, Ctr Rheumatol Res, London, England.; Raimondo, MG (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.	mg.raimondo@gmail.com	Borghi, Maria Orietta/K-8768-2016; meroni, pier luigi/K-8473-2016; Giles, Ian/G-7471-2015	Borghi, Maria Orietta/0000-0001-8967-9678; meroni, pier luigi/0000-0002-3394-1451; Giles, Ian/0000-0001-8913-3894; Radziszewska, Ania/0000-0002-3885-3477; Pericleous, Charis/0000-0001-8804-0493	Arthritis Research UK [20164]; Arthritis Research UK Programme [19423]; Lupus UK; Rosetrees Trust [M281] Funding Source: researchfish; Versus Arthritis [19423] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Arthritis Research UK Programme(Versus Arthritis); Lupus UK; Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	The work of YI is supported by Arthritis Research UK Grant 20164. CP, YI, IG and AR are supported by Arthritis Research UK Programme Grant 19423. This work was also supported by Lupus UK.	Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Agostinis C, 2014, BLOOD, V123, P3478, DOI 10.1182/blood-2013-11-537704; Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001; Chighizola CB, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0402-7; Cousins L, 2015, ANN RHEUM DIS, V74, P317, DOI 10.1136/annrheumdis-2014-206483; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Ioannou Y, 2007, ARTHRITIS RHEUM-US, V56, P280, DOI 10.1002/art.22306; Ioannou Y, 2011, ARTHRITIS RHEUM-US, V63, P2774, DOI 10.1002/art.30383; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Passam FH, 2010, BLOOD, V116, P1995, DOI 10.1182/blood-2010-02-271494; Pericleous C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156407; Pericleous C, 2015, RHEUMATOLOGY, V54, P722, DOI 10.1093/rheumatology/keu360; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Svard A, 2015, ARTHRITIS RHEUMATOL, V67, P2032, DOI 10.1002/art.39170; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101	17	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186513	10.1371/journal.pone.0186513	http://dx.doi.org/10.1371/journal.pone.0186513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049363	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900077
J	Jonker, I; Schoevers, R; Klein, H; Rosmalen, J				Jonker, Iris; Schoevers, Robert; Klein, Hans; Rosmalen, Judith			The association between herpes virus infections and functional somatic symptoms in a general population of adolescents. The TRAILS study	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; C-REACTIVE PROTEIN; IRRITABLE-BOWEL-SYNDROME; VIRAL-INFECTION; UNITED-STATES; LIFE EVENTS; DEPRESSION; STRESS; SENSITIVITY; ANXIETY	Background FSS have been suggested to follow activation of the immune system, triggered by herpes virus infections. The aim of this study was to find out whether herpes virus infections were associated with the experience of FSS in adolescents, and whether this association was mediated by hsCRP, as a general marker of immune activation. Methods This study was performed in TRAILS, a large prospective population cohort of 2230 adolescents (mean age: 16.1 years, SD =.66, 53.4% girls). FSS were assessed using the somatic complaints subscale of the Youth Self- Report. FSS were analyzed as total scores and divided in two group clusters based on previous studies in this cohort. Levels of hsCRP and antibody levels to the herpes viruses HSV1, HSV2, CMV, EBV and HHV6 were assessed in blood samples at age 16. Also a value for pathogen burden was created adding the number of viruses the adolescents were seropositive for. Multiple regression analysis with bootstrapping was used to analyze the association between viral antibodies and pathogen burden, hsCRP and FSS scores. Results Antibody levels and pathogen burden were not associated with FSS total scores or FSS scores in both symptom groups. hsCRP was associated with the total FSS score (B =.02, 95% CI:.004 to.028, p =.01) and FSS score in the symptom group of headache and gastrointestinal complaints (B =.02, 95% CI:.001 to.039, p =.04). Conclusion Our study showed no association between herpes virus infections and FSS in general or specific FSS symptom clusters. A role for inflammatory processes in FSS development was supported by the significant association we found between hsCRP levels and FSS, especially in the symptom group of headache and gastrointestinal complaints.	[Jonker, Iris; Schoevers, Robert; Klein, Hans; Rosmalen, Judith] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Rosmalen, Judith] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands	University of Groningen; University of Groningen	Jonker, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	i.jonker01@umcg.nl	Rosmalen, Judith G.M./F-5375-2011	Rosmalen, Judith G.M./0000-0002-6393-0032; Jonker, Iris/0000-0003-2186-6834; Schoevers, Robert A/0000-0003-0760-9866; Klein, Hans/0000-0001-9429-828X	Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW) [100-001-004, 60-60600-97-118, 261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council) [GB-MaGW 480-01-006, GB-MaGW 480-07-001, GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO [175.010.2003.005, 481-08-013, 481-11-001]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; SMRI Grant [07R-178]	Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research NWO (Social Sciences Council)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS)(European Science Foundation (ESF)); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; SMRI Grant	TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013 and 481-11-001), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), and the participating universities. The antibody tests were done at the Stanley Neurovirology Laboratory in Baltimore, US, Robert Yolken. SMRI Grant ID# 07R-178. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi DV, 2000, J CLIN VIROL, V16, P179, DOI 10.1016/S1386-6532(99)00079-7; Acabchuk RL, 2017, SOC SCI MED, V185, P166, DOI 10.1016/j.socscimed.2017.04.039; Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; [Anonymous], 2015, MOL PSYCHIAT; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Bansal AS, 2012, BRAIN BEHAV IMMUN, V26, P24, DOI 10.1016/j.bbi.2011.06.016; Bergstrom T, 1996, INTERVIROLOGY, V39, P176, DOI 10.1159/000150493; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Bonvanie IJ, 2017, BRIT J PSYCHOL, V108, P318, DOI 10.1111/bjop.12198; Bonvanie IJ, 2015, CHILD ABUSE NEGLECT, V46, P1, DOI 10.1016/j.chiabu.2015.06.001; Buchwald D, 1996, J MED VIROL, V50, P25, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;25::AID-JMV6&gt;3.0.CO;2-V; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Cameron B, 2010, J MED VIROL, V82, P1684, DOI 10.1002/jmv.21873; Campo JV, 2012, J CHILD PSYCHOL PSYC, V53, P575, DOI 10.1111/j.1469-7610.2012.02535.x; Cao YP, 2009, PSYCHOSOMATICS, V50, P24, DOI 10.1176/appi.psy.50.1.24; Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; deGroot A, 1996, J ABNORM CHILD PSYCH, V24, P651, DOI 10.1007/BF01670105; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Dickerson FB, 2003, ARCH GEN PSYCHIAT, V60, P466, DOI 10.1001/archpsyc.60.5.466; Edwards RR, 2008, PAIN, V140, P135, DOI 10.1016/j.pain.2008.07.024; Enders G, 2012, MED MICROBIOL IMMUN, V201, P303, DOI 10.1007/s00430-012-0232-7; Euteneuer F, 2012, PSYCHIAT RES, V195, P60, DOI 10.1016/j.psychres.2011.07.032; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Fouad YM, 2010, J GASTROEN HEPATOL, V25, P1285, DOI 10.1111/j.1440-1746.2010.06311.x; Halvorson HA, 2006, AM J GASTROENTEROL, V101, P1894, DOI 10.1111/j.1572-0241.2006.00654.x; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Janssens KA, 2011, PSYCHONEUROENDOCRINO; Janssens KAM, 2010, J CHILD PSYCHOL PSYC, V51, P304, DOI 10.1111/j.1469-7610.2009.02174.x; Jonker I, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.62; Jonker I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101549; Karatzias T, 2017, CHILD ABUSE NEGLECT, V63, P1, DOI 10.1016/j.chiabu.2016.11.011; Karlovic D, 2012, PSYCHIAT RES, V198, P74, DOI 10.1016/j.psychres.2011.12.007; Kato K, 2010, J PSYCHOSOM RES, V68, P447, DOI 10.1016/j.jpsychores.2010.01.010; Klimas Nancy G, 2007, Curr Rheumatol Rep, V9, P482, DOI 10.1007/s11926-007-0078-y; Koelle DM, 2002, CLIN INFECT DIS, V35, P518, DOI 10.1086/341774; Lacourt TE, 2013, PSYCHOSOM MED, V75, P759, DOI 10.1097/PSY.0b013e3182a3d91f; Lerner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047891; Moss-Morris R, 2006, PSYCHOSOM MED, V68, P463, DOI 10.1097/01.psy.0000221384.07521.05; Paulis WD, 2014, OBES REV, V15, P52, DOI 10.1111/obr.12067; Ramchandani PG, 2005, PEDIATRICS, V116, P46, DOI 10.1542/peds.2004-1854; Rask CU, 2013, J PEDIATR-US, V162, P335, DOI 10.1016/j.jpeds.2012.08.001; Reeves WC, 2000, CLIN INFECT DIS, V31, P48, DOI 10.1086/313908; Ribes JA, 2002, J CLIN MICROBIOL, V40, P1071, DOI 10.1128/JCM.40.3.1071-1072.2002; Rifai N, 2001, CLIN CHEM, V47, P403; Roelofs K, 2007, CLIN PSYCHOL REV, V27, P798, DOI 10.1016/j.cpr.2007.07.004; Rohleder N, 2003, STRESS, V6, P207, DOI 10.1080/1025389031000153658; Rohleder N, 2012, PSYCHONEUROENDOCRINO, V37, P307, DOI 10.1016/j.psyneuen.2011.12.015; Sainz B, 2001, MED HYPOTHESES, V56, P348, DOI 10.1054/mehy.2000.1219; Sbarouni E, 2011, BIOMARKERS, V16, P457, DOI 10.3109/1354750X.2011.576431; Spiller R, 2009, DIGEST LIVER DIS, V41, P844, DOI 10.1016/j.dld.2009.07.007; Tak LM, 2009, BRAIN BEHAV IMMUN, V23, P1014, DOI 10.1016/j.bbi.2009.05.059; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; Wang GY, 2011, J CLIN ENDOCR METAB, V96, P3226, DOI 10.1210/jc.2011-0590; Wright D.B., 2011, J EXPER PSYCHOPATHOL, V2, P252, DOI [10.5127/jep.013611, DOI 10.5127/JEP.013611]; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	58	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185608	10.1371/journal.pone.0185608	http://dx.doi.org/10.1371/journal.pone.0185608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045430	gold, Green Published, Green Submitted			2022-12-26	WOS:000413168100021
J	Liu, W; Karemera, NJU; Wu, T; Yang, YF; Zhang, XZ; Xu, XF; Wang, Y; Han, ZH				Liu, Wei; Karemera, N. J. Umuhoza; Wu, Ting; Yang, Yafei; Zhang, Xinzhong; Xu, Xuefeng; Wang, Yi; Han, Zhenhai			The ethylene response factor AtERF4 negatively regulates the iron deficiency response in Arabidopsis thaliana	PLOS ONE			English	Article							CLUSTER ROOT-FORMATION; STRATEGY-I PLANTS; TRANSCRIPTION FACTOR; STRESS RESPONSES; GENE-EXPRESSION; ABSCISIC-ACID; MALUS-XIAOJINENSIS; SIGNALING PATHWAYS; REDUCTASE-ACTIVITY; FERRIC REDUCTASE	Iron (Fe) deficiency is one of many conditions that can seriously damage crops. Low levels of photosynthesis can lead to the degradation of chlorophyll content and impaired respiration in affected plants, which together cause poor growth and reduce quality. Although ethylene plays an important role in responses to Fe deficiency, a limited number of studies have been carried out on ethylene response factor (ERFs) as components of plant regulation mechanisms. Thus, this study aimed to investigate the role of AtERF4 in plant responses to Fe deficiency. Results collected when Arabidopsis thaliana was grown under Fe deficient conditions as well as in the presence of 1-aminocyclopropane-1-carboxylic acid (ACC) revealed that leaf chlorosis did not occur over short timescales and that chloroplast structural integrity was retained. At the same time, expression of the chlorophyll degradation-related genes AtPAO and AtCLH1 was inhibited and net H+ root flux was amplified. Our results show that chlorophyll content was enhanced in the mutant erf4, while expression of the chlorophyll degradation gene AtCLH1 was reduced. Ferric reductase activity in roots was also significantly higher in the mutant than in wild type plants, while erf4 caused high levels of expression of the genes AtIRT1 and AtHA2 under Fe deficient conditions. We also utilized yeast one-hybrid technology in this study to determine that AtERF4 binds directly to the AtCLH1 and AtITR1 promoter. Observations show that transient over-expression of AtERF4 resulted in rapid chlorophyll degradation in the leaves of Nicotiana tabacum and the up-regulation of gene AtCLH1 expression. In summary, AtERF4 plays an important role as a negative regulator of Fe deficiency responses, we hypothesize that AtERF4 may exert a balancing effect on plants subject to nutrition stress.	[Liu, Wei; Karemera, N. J. Umuhoza; Wu, Ting; Yang, Yafei; Zhang, Xinzhong; Xu, Xuefeng; Wang, Yi; Han, Zhenhai] China Agr Univ, Coll Hort, Inst Hort Plants, Beijing, Peoples R China; [Liu, Wei; Karemera, N. J. Umuhoza; Wu, Ting; Yang, Yafei; Zhang, Xinzhong; Xu, Xuefeng; Wang, Yi; Han, Zhenhai] Key Lab Beijing Municipal Stress Physiol & Mol Bi, Beijing, Peoples R China	China Agricultural University	Wang, Y; Han, ZH (corresponding author), China Agr Univ, Coll Hort, Inst Hort Plants, Beijing, Peoples R China.; Wang, Y; Han, ZH (corresponding author), Key Lab Beijing Municipal Stress Physiol & Mol Bi, Beijing, Peoples R China.	wangyi@cau.edu.cn; rschan@cau.edu.cn		Wang, Yi/0000-0002-6303-385X	earmarked fund for China Agriculture Research System [CARS-27]; National Key Technology RD Program [2013BAD02B01-4, 2014BAD16603]; Beijing Municipal Education Commission [CEFF-PXM2017_014207_000043]	earmarked fund for China Agriculture Research System; National Key Technology RD Program(National Key Technology R&D Program); Beijing Municipal Education Commission(Beijing Municipal Commission of Education)	Financial support for this research was provided by the earmarked fund for China Agriculture Research System (CARS-27), National Key Technology R&D Program (2013BAD02B01-4, 2014BAD16603) and grants from the Beijing Municipal Education Commission (CEFF-PXM2017_014207_000043).	AONO M, 1993, PLANT CELL PHYSIOL, V34, P129; BIENFAIT HF, 1985, J BIOENERG BIOMEMBR, V17, P73, DOI 10.1007/BF00744199; Briat JF, 1995, BIOL CELL, V84, P69, DOI 10.1016/0248-4900(96)81320-7; Brumbarova T, 2005, PLANT PHYSIOL, V137, P1018, DOI 10.1104/pp.104.054270; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Dong W, 2012, GENE, V511, P38, DOI 10.1016/j.gene.2012.09.039; Du J, 2015, ANN BOT-LONDON, V116, P23, DOI 10.1093/aob/mcv058; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Garcia MJ, 2011, PLANT PHYSIOL BIOCH, V49, P537, DOI 10.1016/j.plaphy.2011.01.019; Garcia MJ, 2010, J EXP BOT, V61, P3885, DOI 10.1093/jxb/erq203; Graziano M, 2007, PLANT J, V52, P949, DOI 10.1111/j.1365-313X.2007.03283.x; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; KAO CH, 1983, PLANT PHYSIOL, V73, P881, DOI 10.1104/pp.73.4.881; Khan MIR, 2014, PROTOPLASMA, V251, P1007, DOI 10.1007/s00709-014-0610-7; Kobayashi T, 2016, PLANT MOL BIOL, V91, P533, DOI 10.1007/s11103-016-0486-3; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lei GJ, 2014, PLANT CELL ENVIRON, V37, P852, DOI 10.1111/pce.12203; Li GJ, 2015, J EXP BOT, V66, P2041, DOI 10.1093/jxb/erv005; Li H, 2015, GENE, V554, P16, DOI 10.1016/j.gene.2014.10.004; Li XL, 2016, PLANT PHYSIOL, V170, P2478, DOI 10.1104/pp.15.01827; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Lingam S, 2011, PLANT CELL, V23, P1815, DOI 10.1105/tpc.111.084715; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Lucena C, 2006, J EXP BOT, V57, P4145, DOI 10.1093/jxb/erl189; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Movahedi S, 2012, BIOL PLANTARUM, V56, P37, DOI 10.1007/s10535-012-0013-6; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Qiu C, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022603, 10.1371/journal.pone.0025216]; Rehman S, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1929-1; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Romera FJ, 1999, ANN BOT-LONDON, V83, P51, DOI 10.1006/anbo.1998.0793; Romera FJ, 2004, FUNCT PLANT BIOL, V31, P315, DOI 10.1071/FP03165; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sauter M, 2013, BIOCHEM J, V451, P145, DOI 10.1042/BJ20121744; Schmidt W, 2003, TRENDS PLANT SCI, V8, P188, DOI 10.1016/S1360-1385(03)00048-7; Seguela M, 2008, PLANT J, V55, P289, DOI 10.1111/j.1365-313X.2008.03502.x; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; Walker EL, 2008, CURR OPIN PLANT BIOL, V11, P530, DOI 10.1016/j.pbi.2008.06.013; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Wang HY, 2007, PLANTA, V226, P897, DOI 10.1007/s00425-007-0535-x; Wang SJ, 2014, TREE GENET GENOMES, V10, P573, DOI 10.1007/s11295-014-0705-5; Wang SC, 2009, J MOL RECOGNIT, V22, P474, DOI 10.1002/jmr.965; Waters BM, 2000, PLANT SOIL, V225, P21, DOI 10.1023/A:1026513022280; Waters BM, 2007, PLANT PHYSIOL BIOCH, V45, P293, DOI 10.1016/j.plaphy.2007.03.011; Wu JJ, 2011, J EXP BOT, V62, P667, DOI 10.1093/jxb/erq301; Wu T, 2012, J EXP BOT, V63, P859, DOI 10.1093/jxb/err314; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Ye LX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00953; Yin XR, 2016, PLANT J, V86, P403, DOI 10.1111/tpj.13178; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Zaid H, 2003, ANN BOT-LONDON, V92, P673, DOI 10.1093/aob/mcg186; Zhai Y, 2013, GENE, V513, P174, DOI 10.1016/j.gene.2012.10.018; Zhang HW, 2010, TRANSGENIC RES, V19, P809, DOI 10.1007/s11248-009-9357-x; Zhang J, 2015, PLANT CELL, V27, P787, DOI 10.1105/tpc.114.132704; Zhang M, 2012, J VET SCI, V13, P253, DOI 10.4142/jvs.2012.13.3.253; Zhang ZJ, 2010, PLANT MOL BIOL, V73, P241, DOI 10.1007/s11103-010-9609-4; Zhao Q, 2016, PLANT BIOTECHNOL J, V14, P1633, DOI 10.1111/pbi.12526; Zhong SW, 2014, P NATL ACAD SCI USA, V111, P3913, DOI 10.1073/pnas.1402491111; Zhong SW, 2009, P NATL ACAD SCI USA, V106, P21431, DOI 10.1073/pnas.0907670106; Zhou X, 2016, PLANT PHYSIOL, V171, P2760, DOI 10.1104/pp.16.00154	69	33	39	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186580	10.1371/journal.pone.0186580	http://dx.doi.org/10.1371/journal.pone.0186580			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045490	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100075
J	Ly, V; Roijendijk, L; Hazebroek, H; Tonnaer, C; Hagenaars, MA				Ly, Verena; Roijendijk, Linsey; Hazebroek, Hans; Tonnaer, Clemon; Hagenaars, Muriel A.			Incident experience predicts freezing-like responses in firefighters	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; TONIC IMMOBILITY; FEAR BRADYCARDIA; PICTURES; THREAT; AVOIDANCE; DISORDER; BEHAVIOR; OPTIMISM; ANXIETY	Freezing is a defensive response to acute stress that is associated with coping and alterations in attentional processing. However, it remains unclear whether individuals in high risk professions, who are skilled at making rapid decisions in emergency situations, show altered threat-induced freezing. Here we investigated the effect of incident experience in a high risk profession on freezing. Additionally, we explored whether any effect of incident experience on freezing would be different for profession-related and -unrelated threat. Forty experienced and inexperienced firefighters were presented neutral, pleasant, relatedunpleasant, and unrelated-unpleasant pictures in a passive viewing task. Postural sway and heart rate were assessed to determine freezing. Both postural and heart rate data evidenced reduced freezing upon unpleasant pictures in the experienced versus the inexperienced group. Relatedness of the unpleasant pictures did not modulate these effects. These findings indicate that higher incident experience relates to decreased threat-induced freezing, at least in a passive task context. This might suggest that primary defense responses are malleable through experience. Finally, these findings demonstrate the potential of using animal to human translational approaches to investigate defensive behaviors in relation to incident experience in high risk professions and stimulate future research on the role of freezing in resilience and coping.	[Ly, Verena] Leiden Univ, Dept Clin Psychol, Leiden, Netherlands; [Ly, Verena] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Roijendijk, Linsey; Hagenaars, Muriel A.] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Roijendijk, Linsey] TNO Human Factors, Soesterberg, Netherlands; [Hazebroek, Hans; Tonnaer, Clemon] Fire Serv Acad, Inst Fysieke Veiligheid, Inst Safety, Arnhem, Netherlands; [Hagenaars, Muriel A.] Univ Utrecht, Dept Clin Psychol, Expt Psychopathol Grp, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Netherlands Organization Applied Science Research; Utrecht University	Ly, V (corresponding author), Leiden Univ, Dept Clin Psychol, Leiden, Netherlands.; Ly, V (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	v.ly@fsw.leidenuniv.nl		Ly, Verena/0000-0001-8932-3065	VENI Grant from the Netherlands Organization for Scientific Research (NWO) [451-09-018]; NWO (Dutch Scientific Organization) VENI-grant [451-09-018]	VENI Grant from the Netherlands Organization for Scientific Research (NWO); NWO (Dutch Scientific Organization) VENI-grant	M. A. Hagenaars was supported by VENI Grant (#451-09-018) from the Netherlands Organization for Scientific Research (NWO). This project was further financed with an NWO (Dutch Scientific Organization) VENI-grant awarded to Muriel Hagenaars (#451-09-018). The funder provided support in the form of salaries for authors M. A. H. and L. R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. L. R. is currently employed at TNO, an independent non-profit organisation. The study was conducted while she was working at her previous employer, the Radboud University. TNO has no financial or any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenauer H, 2010, PSYCHOPHYSIOLOGY, V47, P315, DOI 10.1111/j.1469-8986.2009.00940.x; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Arnaudova I, 2017, BEHAV RES THERAPY LI, P93; Azevedo TM, 2005, PSYCHOPHYSIOLOGY, V42, P255, DOI 10.1111/j.1469-8986.2005.00287.x; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Blechert J, 2007, PSYCHOSOM MED, V69, P935, DOI 10.1097/PSY.0b013e31815a8f6b; Chida Y, 2009, CHRONIC PSYCHOSOCIAL, V134, P829; Collins KA, 2014, J NEUROSCI, V34, P14733, DOI 10.1523/JNEUROSCI.2152-14.2014; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; Forsyth JP, 2000, TONIC IMMOBILITY SCA; Fragkaki I, 2017, REDUCED FREEZING POS, V8, P1; Fuse T, 2007, J ANXIETY DISORD, V21, P265, DOI 10.1016/j.janxdis.2006.05.004; Gladwin TE, 2016, NEUROSCI LETT, V619, P182, DOI 10.1016/j.neulet.2016.03.027; Hagenaars MA, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00073; Hagenaars MA, 2014, NEUROSCI BIOBEHAV R, V47, P165, DOI 10.1016/j.neubiorev.2014.07.021; Hagenaars MA, 2014, ANXIETY STRESS COPIN, V27, P27, DOI 10.1080/10615806.2013.809420; Hagenaars MA, 2012, J EXP PSYCHOL GEN, V141, P98, DOI 10.1037/a0024211; Hagenaars MA, 2011, J BEHAV THER EXP PSY, V42, P379, DOI 10.1016/j.jbtep.2011.02.013; Hermans EJ, 2013, NEUROIMAGE, V66, P278, DOI 10.1016/j.neuroimage.2012.10.063; Kerr DL, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00557; Lang P. J., 1997, ATTENTION ORIENTING, V97, P135; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Lojowska M, 2015, J EXP PSYCHOL GEN, V144, P1080, DOI 10.1037/xge0000117; Lopes FL, 2009, ASS ANTICIPATORY ANX, V921, P917; Ly V, 2016, J ABNORM PSYCHOL, V125, P657, DOI 10.1037/abn0000166; Ly V, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00237; Maier SF, 2016, PSYCHOL REV, V123, P349, DOI 10.1037/rev0000033; Maier SF, 2015, NEUROBIOL STRESS, V1, P12, DOI 10.1016/j.ynstr.2014.09.003; Maier SF, 2010, BRAIN RES, V1355, P52, DOI 10.1016/j.brainres.2010.08.039; Marx BP, 2008, CLIN PSYCHOL-SCI PR, V15, P74, DOI 10.1111/j.1468-2850.2008.00112.x; Mazzietti A, 2017, COGNITION EMOTION, V28, P1483; Mobbs D, 2009, J NEUROSCI, V29, P12236, DOI 10.1523/JNEUROSCI.2378-09.2009; Moscarello JM, 2013, J NEUROSCI, V33, P3815, DOI 10.1523/JNEUROSCI.2596-12.2013; Niermann HCM, 2015, FRONT BEHAV NEUROSCI, V9; Puig-Perez S, 2015, INT J PSYCHOPHYSIOL, V98, P213, DOI 10.1016/j.ijpsycho.2015.09.002; Roelofs K, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0206; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stanton NA, 2001, SAFETY SCI, V39, P189, DOI 10.1016/S0925-7535(01)00010-8; Stins JF, 2007, EFFECTS AFFECTIVE PI, V7, P2; Stoffels M, 2017, J BEHAV THER EXP PSY, V57, P6, DOI 10.1016/j.jbtep.2017.02.001; Volchan E, 2017, NEUROSCI BIOBEHAV R, V76, P29, DOI 10.1016/j.neubiorev.2017.01.025; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	45	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186648	10.1371/journal.pone.0186648	http://dx.doi.org/10.1371/journal.pone.0186648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045469	Green Published, gold			2022-12-26	WOS:000413168100084
J	Serrano, BP; Szydlo, HS; Alfandari, D; Hardy, JA				Serrano, Banyuhay P.; Szydlo, Hannah S.; Alfandari, Dominique; Hardy, Jeanne A.			Active site-adjacent phosphorylation at Tyr-397 by c-Abl kinase inactivates caspase-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABL tyrosine kinase; apoptosis; caspase; protease; protein phosphorylation; phosphocapture; phosphoenrichment; substrate-binding groove	DEATH PROTEASE CASPASE-9; TYROSINE KINASE; BCR-ABL; FAMILY KINASES; CYTOCHROME-C; CANCER-CELLS; ACTIVATION; APOPTOSIS; CLEAVAGE; STRESS	Caspase-9 (casp-9) is an initiator caspase and plays a central role in activating apoptotic cell death. Control of all caspases is tightly regulated by a series of phosphorylation events enacted by several different kinases. Caspase-9 is the most heavily phosphorylated of all caspases, with phosphorylation of at least 11 distinct residues in all three caspase-9 domains by nine kinases. Caspase-9 phosphorylation by the non-receptor tyrosine kinase c-Abl at Tyr-153 reportedly leads to caspase-9 activation. All other phosphorylation events on caspases have been shown to block proteolytic function by a number of mechanisms, so we sought to unravel the molecular mechanism of the putative caspase-9 activation by phosphorylation. Surprisingly, we observed no evidence for Tyr-153 phosphorylation of caspase-9 in vitro or in cells, suggesting that Tyr-153 is not phosphorylated by c-Abl. Instead, we identified a new site for c-Abl-mediated phosphorylation, Tyr-397. This residue is adjacent to the caspase-9 active site but, as a member of the second shell, not a residue that directly contacts substrate. Our results further indicate that Tyr-397 is the dominant site of c-Abl phosphorylation both in vitro and upon c-Abl activation in cells. Of note, phosphorylation at this site inhibits caspase-9 activity, and the bulk of the added phosphate moiety appeared to directly block substrate binding. c-Abl plays both proapoptotic and prosurvival roles, and our findings suggest that c-Abl's effects on caspase-9 activity promote the prosurvival mode.	[Serrano, Banyuhay P.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, 104 LGRT,710 North Pleasant St, Amherst, MA 01003 USA; [Szydlo, Hannah S.; Alfandari, Dominique] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 104 LGRT,710 North Pleasant St, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Hardy, Jeanne/0000-0002-3406-7997	National Institutes of Health [GM080532, RO1DE016289]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080532, T32GM008515] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD021485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant GM080532 (to J. A. H.) and RO1DE016289 and R24OD021485 (to D. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Checinska A, 2009, J PROTEOMICS, V72, P575, DOI 10.1016/j.jprot.2008.11.016; CHENG HC, 1993, MOL CELL BIOCHEM, V128, P103, DOI 10.1007/BF01076761; Cheng TC, 2016, ELIFE, V5, DOI 10.7554/eLife.17755; Dagbay K, 2014, METHOD ENZYMOL, V544, P215, DOI 10.1016/B978-0-12-417158-9.00009-1; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Eron SJ, 2017, STRUCTURE, V25, P27, DOI 10.1016/j.str.2016.11.001; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Franklin RA, 2000, LEUKEMIA, V14, P2019, DOI 10.1038/sj.leu.2401967; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang WJ, 2013, GENE DEV, V27, P2039, DOI 10.1101/gad.224428.113; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Machuy N, 2004, CELL DEATH DIFFER, V11, P290, DOI 10.1038/sj.cdd.4401336; Manning Brendan D, 2002, Sci STKE, V2002, ppe49, DOI 10.1126/stke.2002.162.pe49; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; McDonnell MA, 2008, J BIOL CHEM, V283, P20149, DOI 10.1074/jbc.M802846200; Mylona A, 2016, SCIENCE, V354, P233, DOI 10.1126/science.aad1872; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Powley IR, 2016, ONCOGENE, V35, P5629, DOI 10.1038/onc.2016.99; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Seaman JE, 2016, CELL DEATH DIFFER, V23, P1717, DOI 10.1038/cdd.2016.62; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Serrano B. P., 2017, CELL DEATH IN PRESS; Shaul Y, 2000, CELL DEATH DIFFER, V7, P10, DOI 10.1038/sj.cdd.4400626; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Skotte NH, 2017, CELL DEATH DIFFER, V24, P433, DOI 10.1038/cdd.2016.139; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tsang JLY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153946; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Velazquez-Delgado EM, 2012, STRUCTURE, V20, P742, DOI 10.1016/j.str.2012.02.003; Voss J, 2000, ONCOGENE, V19, P1684, DOI 10.1038/sj.onc.1203467; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Witkowski WA, 2009, PROTEIN SCI, V18, P1459, DOI 10.1002/pro.151; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wu CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13565; Wu JZJ, 1998, BIOORG MED CHEM LETT, V8, P2279, DOI 10.1016/S0960-894X(98)00413-2; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Zamaraev AV, 2017, TRENDS CELL BIOL, V27, P322, DOI 10.1016/j.tcb.2017.01.003; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	60	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21352	21365		10.1074/jbc.M117.811976	http://dx.doi.org/10.1074/jbc.M117.811976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29066624	Green Published, hybrid			2022-12-26	WOS:000419013000012
J	Carlsen, JF; Ewertsen, C; Sletting, S; Talman, ML; Vejborg, I; Nielsen, MB				Carlsen, Jonathan Frederik; Ewertsen, Caroline; Sletting, Susanne; Talman, Maj-Lis; Vejborg, Ilse; Nielsen, Michael Bachmann			Strain histograms are equal to strain ratios in predicting malignancy in breast tumours	PLOS ONE			English	Article							SHEAR-WAVE ELASTOGRAPHY; 1 BASIC PRINCIPLES; ULTRASOUND ELASTOGRAPHY; CLINICAL-USE; EFSUMB GUIDELINES; WFUMB GUIDELINES; BENIGN; MASSES; LESIONS; DIFFERENTIATION	Objectives To assess whether strain histograms are equal to strain ratios in predicting breast tumour malignancy and to see if either could be used to upgrade Breast Imaging Reporting and Data System (BI-RADS) 3 tumours for immediate biopsy. Methods Ninety-nine breast tumours were examined using B-mode BI-RADS scorings and strain elastography. Strain histograms and ratios were assessed, and areas-under-the-receiveroperating- characteristic-curve (AUROC) for each method calculated. In BI-RADS 3 tumours cut-offs for strain histogram and ratio values were calculated to see if some tumours could be upgraded for immediate biopsy. Linear regression was performed to evaluate the effect of tumour depth and size, and breast density on strain elastography. Results Forty-four of 99 (44.4%) tumours were malignant. AUROC of BI-RADS, strain histograms and strain ratios were 0.949, 0.830 and 0.794 respectively. There was no significant difference between AUROCs of strain histograms and strain ratios (P = 0.405), while they were both inferior to BI-RADS scoring (P< 0.001, P = 0.008). Four out of 26 BI-RADS 3 tumours were malignant. When cut-offs of 189 for strain histograms and 1.44 for strain ratios were used to upgrade BI-RADS 3 tumours, AUROCS were 0.961 (Strain histograms and BIRADS) and 0.941 (Strain ratios and BI-RADS). None of them was significantly different from BI-RADS scoring alone (P = 0.249 and P = 0.414). Tumour size and depth, and breast density influenced neither strain histograms (P = 0.196, P = 0.115 and P = 0.321) nor strain ratios (P = 0.411, P = 0.596 and P = 0.321) Conclusion Strain histogram analyses are reliable and easy to do in breast cancer diagnosis and perform comparably to strain ratio analyses. No significant difference in AUROCs between BI-RADS scoring and elastography combined with BI- RADS scoring was found in this study.	[Carlsen, Jonathan Frederik; Ewertsen, Caroline; Sletting, Susanne; Vejborg, Ilse; Nielsen, Michael Bachmann] Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Blegdamsvej 9, Copenhagen, Denmark; [Ewertsen, Caroline] Tech Univ Denmark, Dept Elect Engn, CFU, Lyngby, Denmark; [Talman, Maj-Lis] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Blegdamsvej 9, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Technical University of Denmark; Rigshospitalet; University of Copenhagen	Carlsen, JF (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Blegdamsvej 9, Copenhagen, Denmark.	jonathan.carlsen@gmail.com	Nielsen, Michael Bachmann/U-2749-2018	Nielsen, Michael Bachmann/0000-0002-9380-1688				Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Barr RG, 2015, ULTRASOUND MED BIOL, V41, P1148, DOI 10.1016/j.ultrasmedbio.2015.03.008; Barr RG, 2012, J ULTRAS MED, V31, P895, DOI 10.7863/jum.2012.31.6.895; Berg WA, 2012, AM J ROENTGENOL, V199, P224, DOI 10.2214/AJR.11.7324; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Carlsen J, 2015, ULTRASCHALL MED, V36, P550, DOI 10.1055/s-0035-1553293; Carlsen JF, 2015, AM J ROENTGENOL, V204, pW236, DOI 10.2214/AJR.14.13076; Carlsen JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088699; Chen LM, 2014, JPN J RADIOL, V32, P592, DOI 10.1007/s11604-014-0349-2; Christiansen P, DANISH BREAST CANC C; Chung SY, 2010, ACTA RADIOL, V51, P9, DOI 10.3109/02841850903273966; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Fischer T, 2012, ULTRASCHALL MED, V33, P372, DOI 10.1055/s-0031-1273222; Hatzung G, 2010, ULTRASCHALL MED, V31, P596, DOI 10.1055/s-0029-1245526; Havre RF, 2012, ULTRASCHALL MED, V33, P559, DOI 10.1055/s-0031-1273247; HERMANSEN C, 1987, CANCER, V60, P1866, DOI 10.1002/1097-0142(19871015)60:8<1866::AID-CNCR2820600832>3.0.CO;2-Z; Houelleu Demay M-L, 2012, Diagn Interv Imaging, V93, P757, DOI 10.1016/j.diii.2012.03.015; Kim MY, 2013, KOREAN J RADIOL, V14, P559, DOI 10.3348/kjr.2013.14.4.559; Lee SH, 2014, RADIOLOGY, V273, P61, DOI 10.1148/radiol.14132443; Lee SH, 2014, ULTRASONOGRAPHY, V33, P3, DOI 10.14366/usg.13012; Mendelson EB, 2003, BREAST IMAGING REPOR, V1; Moon WK, 2010, AM J ROENTGENOL, V195, P1460, DOI 10.2214/AJR.09.3140; Moon WK, 2009, ULTRASOUND MED BIOL, V35, P1794, DOI 10.1016/j.ultrasmedbio.2009.06.1094; Rasband WS, 2012, RECORD ASCL, V1206; Sadigh G, 2012, BREAST CANCER RES TR, V134, P923, DOI 10.1007/s10549-012-2020-x; Sadigh G, 2012, BREAST CANCER RES TR, V133, P23, DOI 10.1007/s10549-011-1857-8; Shiina T, 2015, ULTRASOUND MED BIOL, V41, P1126, DOI 10.1016/j.ultrasmedbio.2015.03.009; Stachs A, 2013, ULTRASCHALL MED, V34, P131, DOI 10.1055/s-0032-1313168; Tozaki M, 2012, JPN J RADIOL, V30, P659, DOI 10.1007/s11604-012-0106-3; Yoon JH, 2011, AM J ROENTGENOL, V196, P730, DOI 10.2214/AJR.10.4654; Youk JH, 2013, EUR RADIOL, V23, P2695, DOI 10.1007/s00330-013-2873-3; Zhi H, 2008, ACAD RADIOL, V15, P1347, DOI 10.1016/j.acra.2008.08.003	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186230	10.1371/journal.pone.0186230	http://dx.doi.org/10.1371/journal.pone.0186230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073170	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400017
J	Liu, HW; Chen, YJ; Lai, YC; Huang, CY; Huang, YL; Lin, MT; Han, SY; Chen, CL; Yu, CJ; Lee, PL				Liu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; Chen, Chi-Ling; Yu, Chong-Jen; Lee, Pei-Lin			Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; ORAL APPLIANCE TREATMENT; MANDIBULAR ADVANCEMENT; CONTROLLED TRIAL; BLOOD-PRESSURE; THERAPY; UPDATE; ADHERENCE; OUTCOMES; DISEASE	Introduction This study aimed to determine the effect of combining positive airway pressure (PAP) therapy and mandibular advancement device (MAD) in patients with severe obstructive sleep apnea (OSA) who were pressure intolerant for PAP and were unresponsive to MAD. Methods This retrospective study reviewed the medical records of severe OSA patients with apneahypopnea index (AHI) >= 30/hr who were diagnosed between October 1, 2008 and June 30, 2014. Patients were initially treated with 2 weeks of PAP, and those who were intolerant to high-pressure PAP (>= 15 cm H2O) were switched to 12 weeks of MAD, which is a monobloc designed at 75% of maximum protrusion. Patients who had high residual AHI (>= 15/hr) on MAD underwent 12 weeks of combination therapy (CT) with MAD and CPAP and were enrolled in the present study. Enrolled subjects who completed the 12-week CT were followed-up until June 30, 2016. Results A total of 14 male patients were included. All three treatments effectively reduced AHI, oxygen desaturation index (ODI), and total sleep time with SpO(2) <90% (% TST-SpO(2)<90%) compared to pretreatment values. The residual AHI and ODI on CT was lower than that on MAD or PAP. The residual % TST-SpO(2)<90% was lower than that on MAD and similar to that on PAP. The therapeutic pressure on CT was on average 9.2 cm H2O lower than that on PAP. For the 11 patients who completed CT, only CT reduced ESS compared to pretreatment value. No treatment had significant impact on% slow wave sleep or overnight change of blood pressure. For patients who completed CT, the average usage was 5.9 +/- 1.7 hr/night at 12th week and 6.4 +/- 1.5 hr/night at a median follow-up of 36.5-months. Conclusions Combining MAD and CPAP showed additive effects on reducing AHI and ODI, and lowered the therapeutic pressures.	[Liu, Hsiang-Wen] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin, Taiwan; [Liu, Hsiang-Wen; Lin, Ming-Tzer] Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chen, Yunn-Jy; Huang, Ching-Yi] Grad Inst Clin Dent, Sch Dent, Dept Dent, Taipei, Taiwan; [Lai, Yi-Chun] Natl Yang Ming Univ Hosp, Dept Internal Med, Ilan, Taiwan; [Huang, Ya-Ling; Yu, Chong-Jen; Lee, Pei-Lin] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lin, Ming-Tzer] Hsiao Chung Cheng Hosp, Dept Internal Med, New Taipei, Taiwan; [Han, Sung-Ying] Mackay Mem Hosp, Dept Dent, Taipei, Taiwan; [Chen, Chi-Ling] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Lee, Pei-Lin] Natl Taiwan Univ Hosp, Ctr Sleep Disorder, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Mackay Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, PL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Lee, PL (corresponding author), Natl Taiwan Univ Hosp, Ctr Sleep Disorder, Taipei, Taiwan.	leepeilin@ntu.edu.tw	Lee, Pei-Lin/L-5564-2019	Lee, Pei-Lin/0000-0002-6883-9502; Yu, Chong-Jen/0000-0001-5664-9392	Ministry of Science and Technology [MOST 103-2314-B-002-139-MY3, NSC 102-2314-B-002-099]; National Taiwan University [NTU-ERP-104R8951-1, 105R8951-1, 106R880301]; National Taiwan University Hospital [NTUH 105-S2998]; NTU-NTUH-MediaTek Innovative Medical Electronics Research Center	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University(National Taiwan University); National Taiwan University Hospital(National Taiwan University); NTU-NTUH-MediaTek Innovative Medical Electronics Research Center	The study was supported by grants to Prof. Pei-Lin Lee from the Ministry of Science and Technology (project number MOST 103-2314-B-002-139-MY3, NSC 102-2314-B-002-099); National Taiwan University (project number NTU-ERP-104R8951-1, 105R8951-1, 106R880301); National Taiwan University Hospital (NTUH 105-S2998); and NTU-NTUH-MediaTek Innovative Medical Electronics Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarab G, 2010, CLIN ORAL INVEST, V14, P339, DOI 10.1007/s00784-009-0298-9; [Anonymous], 2007, AASM MANUAL SCORING; Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007; Bloch KE, 2000, AM J RESP CRIT CARE, V162, P246, DOI 10.1164/ajrccm.162.1.9908112; Budhiraja R, 2007, SLEEP, V30, P320; Chai-Coetzer CL, 2013, SLEEP, V36, P1929, DOI 10.5665/sleep.3232; de Vries GE DM, 2016, J DENT SLEEP MED, V3, P6; El-Solh AA, 2002, CHEST, V121, P1541, DOI 10.1378/chest.121.5.1541; El-Solh AA, 2011, SLEEP BREATH, V15, P203, DOI 10.1007/s11325-010-0437-1; Fava C, 2014, CHEST, V145, P762, DOI 10.1378/chest.13-1115; Gotsopoulos H, 2002, AM J RESP CRIT CARE, V166, P743, DOI 10.1164/rccm.200203-208OC; Gozal D, 2008, AM J RESP CRIT CARE, V177, P369, DOI 10.1164/rccm.200608-1190PP; Kaminska M, 2014, CAN RESPIR J, V21, P234, DOI 10.1155/2014/408073; Kato J, 2000, CHEST, V117, P1065, DOI 10.1378/chest.117.4.1065; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Kuo YL, 2015, OTOLARYNG HEAD NECK, V152, P931, DOI 10.1177/0194599815573927; Kushida CA, 2008, J CLIN SLEEP MED, V4, P157; Kushida CA, 2006, SLEEP, V29, P240, DOI 10.1093/sleep/29.2.240; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marklund M, 1998, CHEST, V113, P707, DOI 10.1378/chest.113.3.707; Pelletier-Fleury N, 2001, SLEEP MED, V2, P225, DOI 10.1016/S1389-9457(00)00063-0; Phillips CL, 2013, AM J RESP CRIT CARE, V187, P879, DOI 10.1164/rccm.201212-2223OC; Ramar K, 2015, J CLIN SLEEP MED, V11, P773, DOI 10.5664/jcsm.4858; Sugiura T, 2007, RESPIRATION, V74, P56, DOI 10.1159/000089836; Sutherland K, 2014, J CLIN SLEEP MED, V10, P215, DOI 10.5664/jcsm.3460; Vroegop AVMT, 2012, SLEEP MED, V13, P314, DOI 10.1016/j.sleep.2011.08.005; Walker-Engstrom Marie-Louise, 2003, Sleep Breath, V7, P119, DOI 10.1007/s11325-003-0119-3; Weaver TE, 1997, SLEEP, V20, P278, DOI 10.1093/sleep/20.4.278; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711; Wu C. Y., 2008, THESIS	30	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187032	10.1371/journal.pone.0187032	http://dx.doi.org/10.1371/journal.pone.0187032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073254	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400098
J	Shirakawa, K; Endo, J; Katsumata, Y; Yamamoto, T; Kataoka, M; Isobe, S; Yoshida, N; Fukuda, K; Sano, M				Shirakawa, Kohsuke; Endo, Jin; Katsumata, Yoshinori; Yamamoto, Tsunehisa; Kataoka, Masaharu; Isobe, Sarasa; Yoshida, Naohiro; Fukuda, Keiichi; Sano, Motoaki			Negative legacy of obesity	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; WEIGHT-LOSS; CELL-SENESCENCE; LIVER-DISEASE; CRUCIAL ROLE; OSTEOPONTIN; INFLAMMATION; MEMORY; HEART	Obesity promotes excessive inflammation, which is associated with senescence-like changes in visceral adipose tissue (VAT) and the development of type 2 diabetes (T2DM) and cardiovascular diseases. We have reported that a unique population of CD44(hi) CD62L(lo) CD4(+) T cells that constitutively express PD-1 and CD153 exhibit cellular senescence and cause VAT inflammation by producing large amounts of osteopontin. Weight loss improves glycemic control and reduces cardiovascular disease risk factors, but its long-term effects on cardiovascular events and longevity in obese individuals with T2DM are somewhat disappointing and not well understood. High-fat diet (HFD)-fed obese mice were subjected to weight reduction through a switch to a control diet. They lost body weight and visceral fat mass, reaching the same levels as lean mice fed a control diet. However, the VAT of weight reduction mice exhibited denser infiltration of macrophages, which formed more crown-like structures compared to the VAT of obese mice kept on the HFD. Mechanistically, CD153(+) PD-1(+) CD4(+) T cells are long-lived and not easily eliminated, even after weight reduction. Their continued presence maintains a self-sustaining chronic inflammatory loop via production of large amounts of osteopontin. Thus, we concluded that T-cell senescence is essentially a negative legacy effect of obesity.	[Shirakawa, Kohsuke; Endo, Jin; Katsumata, Yoshinori; Yamamoto, Tsunehisa; Kataoka, Masaharu; Isobe, Sarasa; Yoshida, Naohiro; Fukuda, Keiichi; Sano, Motoaki] Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Yoshida, Naohiro] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan	Keio University; Tokyo Women's Medical University	Sano, M (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan.	msano@a8.keio.jp	Sano, Motoaki/L-3405-2013; Isobe, Sarasa/F-8480-2014; Katsumata, Yoshinori/AAC-4159-2021	Katsumata, Yoshinori/0000-0001-5576-5789; Sano, Motoaki/0000-0003-1771-8310; Yamamoto, Tsunehisa/0000-0002-5241-9482	Japan Science and Technology Agency PRESTO to Motoaki Sano; Japan Society for the Promotion of Science [15H04825, 15H01160]	Japan Science and Technology Agency PRESTO to Motoaki Sano; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Science and Technology Agency PRESTO to Motoaki Sano, Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (Grant Number 15H04825) to Motoaki Sano and Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research on Innovative Areas (Grant Number 15H01160) to Motoaki Sano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalrhim AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156965; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Georgiadou P, 2010, EUR J CLIN INVEST, V40, P288, DOI 10.1111/j.1365-2362.2010.02257.x; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Romeo S, 2012, DIABETES CARE, V35, P2613, DOI 10.2337/dc12-0193; Sanchis-Gomar F, 2016, CLIN CHEM LAB MED, V54, P873, DOI 10.1515/cclm-2015-0821; Schmitz J, 2016, MOL METAB, V5, P328, DOI 10.1016/j.molmet.2015.12.001; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319; Tamura A, 2003, CIRC J, V67, P742; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	18	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186303	10.1371/journal.pone.0186303	http://dx.doi.org/10.1371/journal.pone.0186303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073165	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400021
J	Beblo-Vranesevic, K; Bohmeier, M; Perras, AK; Schwendner, P; Rabbow, E; Moissl-Eichinger, C; Cockell, CS; Pukall, R; Vannier, P; Marteinsson, VT; Monaghan, EP; Ehrenfreund, P; Garcia-Descalzo, L; Gomez, F; Malki, M; Amils, R; Gaboyer, F; Westall, F; Cabezas, P; Walter, N; Rettberg, P				Beblo-Vranesevic, Kristina; Bohmeier, Maria; Perras, Alexandra K.; Schwendner, Petra; Rabbow, Elke; Moissl-Eichinger, Christine; Cockell, Charles S.; Pukall, Rudiger; Vannier, Pauline; Marteinsson, Viggo T.; Monaghan, Euan P.; Ehrenfreund, Pascale; Garcia-Descalzo, Laura; Gomez, Felipe; Malki, Moustafa; Amils, Ricardo; Gaboyer, Frederic; Westall, Frances; Cabezas, Patricia; Walter, Nicolas; Rettberg, Petra			The responses of an anaerobic microorganism, Yersinia intermedia MASE-LG-1 to individual and combined simulated Martian stresses	PLOS ONE			English	Article							RADIATION-RESISTANCE; IONIZING-RADIATION; DEINOCOCCUS-RADIODURANS; OXIDATIVE STRESS; WATER-ACTIVITY; MARS; SURVIVAL; UV; BACTERIA; DNA	The limits of life of aerobic microorganisms are well understood, but the responses of anaerobic microorganisms to individual and combined extreme stressors are less well known. Motivated by an interest in understanding the survivability of anaerobic microorganisms under Martian conditions, we investigated the responses of a new isolate, Yersinia intermedia MASE-LG-1 to individual and combined stresses associated with the Martian surface. This organism belongs to an adaptable and persistent genus of anaerobic microorganisms found in many environments worldwide. The effects of desiccation, low pressure, ionizing radiation, varying temperature, osmotic pressure, and oxidizing chemical compounds were investigated. The strain showed a high tolerance to desiccation, with a decline of survivability by four orders of magnitude during a storage time of 85 days. Exposure to X-rays resulted in dose-dependent inactivation for exposure up to 600 Gy while applied doses above 750 Gy led to complete inactivation. The effects of the combination of desiccation and irradiation were additive and the survivability was influenced by the order in which they were imposed. Ionizing irradiation and subsequent desiccation was more deleterious than vice versa. By contrast, the presence of perchlorates was not found to significantly affect the survival of the Yersinia strain after ionizing radiation. These data show that the organism has the capacity to survive and grow in physical and chemical stresses, imposed individually or in combination that are associated with Martian environment. Eventually it lost its viability showing that many of the most adaptable anaerobic organisms on Earth would be killed on Mars today.	[Beblo-Vranesevic, Kristina; Bohmeier, Maria; Rabbow, Elke; Rettberg, Petra] German Aerosp Ctr DLR, Inst Aerosp Med, Radiat Biol Dept, Cologne, Germany; [Perras, Alexandra K.; Moissl-Eichinger, Christine] Med Univ Graz, Dept Internal Med, Graz, Austria; [Perras, Alexandra K.] Univ Regensburg, Dept Microbiol & Archaea, Regensburg, Germany; [Schwendner, Petra; Cockell, Charles S.] Univ Edinburgh, UK Ctr Astrobiol, Sch Phys & Astron, Edinburgh, Midlothian, Scotland; [Moissl-Eichinger, Christine] BioTechMed Graz, Graz, Austria; [Pukall, Rudiger] Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany; [Vannier, Pauline; Marteinsson, Viggo T.] MATIS Prokaria, Reykjavik, Iceland; [Marteinsson, Viggo T.] Univ Iceland, Fac Food Sci & Nutr, Reykjavik, Iceland; [Monaghan, Euan P.; Ehrenfreund, Pascale] Leiden Univ, Leiden Observ, Leiden, Netherlands; [Ehrenfreund, Pascale] George Washington Univ, Inst Space Policy, Washington, DC 20052 USA; [Garcia-Descalzo, Laura; Gomez, Felipe] Ctr Astrobiol CAB, INTA, Madrid, Spain; [Malki, Moustafa; Amils, Ricardo] UAM, Madrid, Spain; [Gaboyer, Frederic; Westall, Frances] CNRS, Ctr Biophys Mol, Orleans, France; [Cabezas, Patricia; Walter, Nicolas] ESF, Strasbourg, France	Helmholtz Association; German Aerospace Centre (DLR); Medical University of Graz; University of Regensburg; University of Edinburgh; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Iceland; Leiden University; Leiden University - Excl LUMC; George Washington University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Autonomous University of Madrid; Centre National de la Recherche Scientifique (CNRS)	Beblo-Vranesevic, K (corresponding author), German Aerosp Ctr DLR, Inst Aerosp Med, Radiat Biol Dept, Cologne, Germany.	kristina.beblo@dlr.de	Gómez, Felipe/L-7315-2014; Rettberg, Petra/AAI-4493-2021; García-Descalzo, Laura/S-2777-2018; Moissl-Eichinger, Christine/A-6682-2015; Vannier, Pauline/GZZ-4844-2022; Amils, Ricardo/X-2706-2019	Gómez, Felipe/0000-0001-9977-7060; Rettberg, Petra/0000-0003-4439-2395; García-Descalzo, Laura/0000-0002-0083-6786; Moissl-Eichinger, Christine/0000-0001-6755-6263; Vannier, Pauline/0000-0002-7747-8534; Marteinsson, Viggo/0000-0001-8340-821X; Cabezas, Patricia/0000-0002-6336-4093	European Community's Seventh Framework Program [607297]	European Community's Seventh Framework Program(European Commission)	MASE is supported by European Community's Seventh Framework Program (FP7/2007-2013) under Grant Agreement no 607297.	AGBALIKA F, 1985, WATER RES, V19, P1255, DOI 10.1016/0043-1354(85)90179-4; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Babujee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076567; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Beblo K, 2011, ARCH MICROBIOL, V193, P797, DOI 10.1007/s00203-011-0718-5; Beblo K, 2009, EXTREMOPHILES, V13, P521, DOI 10.1007/s00792-009-0239-1; Beblo-Vranesevic K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01369; BERCOVIER H, 1984, INT J SYST BACTERIOL, V34, P166, DOI 10.1099/00207713-34-2-166; Billi D, 2000, APPL ENVIRON MICROB, V66, P1489, DOI 10.1128/AEM.66.4.1489-1492.2000; BRENNER DJ, 1980, CURR MICROBIOL, V4, P207, DOI 10.1007/BF02605858; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; CLAVERO MRS, 1994, APPL ENVIRON MICROB, V60, P2069, DOI 10.1128/AEM.60.6.2069-2075.1994; Cockell CS, 2016, ASTROBIOLOGY, V16, P89, DOI 10.1089/ast.2015.1295; Cockell CS, 2005, ASTROBIOLOGY, V5, P127, DOI 10.1089/ast.2005.5.127; Cockell CS, 2017, INT J ASTRO IN PRESS, P1, DOI DOI 10.1017/S1473550417000246; Crawford RL, 2005, APPL ENVIRON MICROB, V71, P4163, DOI 10.1128/AEM.71.8.4163-4168.2005; Dartnell LR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027494; de Groot A, 2005, INT J SYST EVOL MICR, V55, P2441, DOI 10.1099/ijs.0.63717-0; de La Vega UP, 2007, ADV SPACE RES, V40, P1672, DOI 10.1016/j.asr.2007.05.022; Derecho I, 2014, ASTROBIOLOGY, V14, P837, DOI 10.1089/ast.2014.1193; DeVincenzi DL, 1998, J GEOPHYS RES-PLANET, V103, P28577, DOI 10.1029/98JE01600; ELZAWAHRY YA, 1979, APPL ENVIRON MICROB, V37, P50, DOI 10.1128/AEM.37.1.50-54.1979; Fendrihan S, 2009, ASTROBIOLOGY, V9, P104, DOI 10.1089/ast.2007.0234; Ferreira AC, 1997, INT J SYST BACTERIOL, V47, P939, DOI 10.1099/00207713-47-4-939; Fisk MR, 1999, J GEOPHYS RES-PLANET, V104, P11805, DOI 10.1029/1999JE900010; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Franson M. A. H., 1985, STANDARD METHODS EXA; Gomez F, 2010, ICARUS, V209, P482, DOI 10.1016/j.icarus.2010.05.027; Gut IM, 2016, APPL ENVIRON MICROB, V82, P2809, DOI 10.1128/AEM.03989-15; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harm W, 1980, BIOLOGICAL EFFECTS U; Hassler DM, 2014, SCIENCE, V343, DOI 10.1126/science.1244797; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Horneck G, 2000, PLANET SPACE SCI, V48, P1053, DOI 10.1016/S0032-0633(00)00079-9; HOWARDFLANDERS P, 1957, RADIAT RES, V7, P518, DOI 10.2307/3570400; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; Jolivet-Gougeon A, 2000, APPL ENVIRON MICROB, V66, P5484, DOI 10.1128/AEM.66.12.5484-5487.2000; KERR RA, 2013, SCIENCE, V340, P138; Keto-Timonen R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01151; Kounaves SP, 2014, ICARUS, V232, P226, DOI 10.1016/j.icarus.2014.01.016; Kral TA, 2016, PLANET SPACE SCI, V120, P87, DOI 10.1016/j.pss.2015.11.014; La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Leuko S, 2015, ASTROBIOLOGY, V15, P987, DOI 10.1089/ast.2015.1310; Liebensteiner MG, 2014, INT BIODETER BIODEGR, V96, P216, DOI 10.1016/j.ibiod.2014.07.019; Martin-Torres FJ, 2015, NAT GEOSCI, V8, P357, DOI [10.1038/ngeo2412, 10.1038/NGEO2412]; Matthia D, 2016, J SPACE WEATHER SPAC, V6, DOI 10.1051/swsc/2016008; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; McEwen AS, 2011, SCIENCE, V333, P740, DOI 10.1126/science.1204816; McNally A, 2016, NAT REV MICROBIOL, V14, P177, DOI 10.1038/nrmicro.2015.29; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Moissl-Eichinger C, 2016, FEMS MICROBIOL REV; Musilova M, 2015, ASTROBIOLOGY, V15, P1076, DOI 10.1089/ast.2014.1278; Newcombe DA, 2005, APPL ENVIRON MICROB, V71, P8147, DOI 10.1128/AEM.71.12.8147-8156.2005; Oren A, 2014, EXTREMOPHILES, V18, P75, DOI 10.1007/s00792-013-0594-9; Osborne DJ, 1994, SEED SCI RES, V4, P175, DOI 10.1017/S0960258500002166; PARISI A, 1974, APPL MICROBIOL, V28, P41, DOI 10.1128/AEM.28.1.41-46.1974; PARK S, 1995, APPL ENVIRON MICROB, V61, P4378, DOI 10.1128/AEM.61.12.4378-4381.1995; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Probst A, 2010, APPL ENVIRON MICROB, V76, P2837, DOI 10.1128/AEM.02167-09; Rettberg P, 2004, ESA SP PUBL, V545, P59; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rocha ER, 1996, J BACTERIOL, V178, P6895, DOI 10.1128/jb.178.23.6895-6903.1996; Rose LJ, 2003, APPL ENVIRON MICROB, V69, P2166, DOI 10.1128/AEM.69.4.2166-2171.2003; Saffary R, 2002, FEMS MICROBIOL LETT, V215, P163, DOI 10.1016/S0378-1097(02)00953-9; SCHULTEFROHLINDE D, 1994, ADV SPACE RES, V14, P277, DOI 10.1016/0273-1177(94)90478-2; Schumann P, 2014, METHOD MICROBIOL, V41, P275, DOI 10.1016/bs.mim.2014.06.002; Sommers CH, 2002, MEAT SCI, V61, P323, DOI 10.1016/S0309-1740(01)00200-5; Stevenson A, 2015, ISME J, V9, P1333, DOI 10.1038/ismej.2014.219; Stieglmeier M, 2009, APPL ENVIRON MICROB, V75, P3484, DOI 10.1128/AEM.02565-08; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorarinsson S, 1953, GEOGR TIDSSKR-DEN, P52; Tillett D, 2000, J PHYCOL, V36, P251, DOI 10.1046/j.1529-8817.2000.99079.x; Wadsworth J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04910-3; Wassmann M, 2012, ASTROBIOLOGY, V12, P498, DOI 10.1089/ast.2011.0772; Westall F, 2013, ASTROBIOLOGY, V13, P887, DOI 10.1089/ast.2013.1000	77	12	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185178	10.1371/journal.pone.0185178	http://dx.doi.org/10.1371/journal.pone.0185178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069099	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000413663600002
J	Drew, JA; Amatangelo, KL				Drew, Joshua A.; Amatangelo, Kathryn L.			Community assembly of coral reef fishes along the Melanesian biodiversity gradient	PLOS ONE			English	Article							PELAGIC LARVAL DURATION; NULL MODEL ANALYSIS; INDO-PACIFIC; EVOLUTIONARY ORIGINS; MARINE BIODIVERSITY; RANGE SIZE; R PACKAGE; POMACENTRIDAE; DISPERSAL; DIVERSITY	The Indo-Pacific is home to Earth's most biodiverse coral reefs. Diversity on these reefs decreases from the Coral Triangle east through the islands of Melanesia. Despite this pattern having been identified during the early 20 th century, our knowledge about the interaction between pattern and process remains incomplete. To evaluate the structure of coral reef fish communities across Melanesia, we obtained distributional records for 396 reef fish species in five taxa across seven countries. We used hierarchical clustering, nestedness, and multiple linear regression analyses to evaluate the community structure. We also compiled data on life history traits (pelagic larval duration, body size and schooling behavior) to help elucidate the ecological mechanisms behind community structure. Species richness for these taxa along the gradient was significantly related to longitude but not habitat area. Communities are significantly nested, indicating that species-poor communities are largely composed of subsets of the species found on species rich reefs. These trends are robust across taxonomic groups except for the Pomacentridae, which exhibit an anti-nested pattern, perhaps due to a large number of endemic species. Correlations between life history traits and the number of reefs on which species occurred indicate that dispersal and survival ability contribute to determining community structure. We conclude that distance from the Coral Triangle dominates community structure in reef fish; however, conservation of the most species-rich areas will not be sufficient alone to conserve the vivid splendor of this region.	[Drew, Joshua A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Drew, Joshua A.] Amer Museum Nat Hist, Div Vertebrate Zool, New York, NY 10024 USA; [Amatangelo, Kathryn L.] SUNY Coll Brockport, Dept Environm Sci & Biol, Brockport, NY 14420 USA	Columbia University; American Museum of Natural History (AMNH); State University of New York (SUNY) System	Drew, JA (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA.; Drew, JA (corresponding author), Amer Museum Nat Hist, Div Vertebrate Zool, New York, NY 10024 USA.	j.drew@columbia.edu		Drew, Joshua/0000-0001-9072-0885				Allen G. R., 2012, REEF FISHES E INDIES, VI-III; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Allen Gerald R., 2012, Aqua, V18, P171; Allen Gerald R., 2010, Aqua, V16, P129; Allen Gerald R., 2008, Aqua (Miradolo Terme), V14, P105; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Alonso D, 2015, ECOL LETT, V18, P451, DOI 10.1111/ele.12426; [Anonymous], 2010, CLUSTSIG SIGNIFICANT; [Anonymous], 1989, JMP 12 1; Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Barber PH, 2015, ECOLOGY FISHES CORAL, V258; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bender MG, 2016, ECOGRAPHY IN PRESS; Bonhomme F, 2000, ENVIRON BIOL FISH, V59, P365, DOI 10.1023/A:1026508715631; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Cardoso P, 2014, J BIOGEOGR, V41, P749, DOI 10.1111/jbi.12239; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; CHASE CG, 1971, GEOL SOC AM BULL, V82, P3087, DOI 10.1130/0016-7606(1971)82[3087:THOTFP]2.0.CO;2; Collins MD, 2011, J BIOGEOGR, V38, P2373, DOI 10.1111/j.1365-2699.2011.02506.x; Cowman PF, 2009, MOL PHYLOGENET EVOL, V52, P621, DOI 10.1016/j.ympev.2009.05.015; DeBoer TS, 2014, B MAR SCI, V90, P277, DOI 10.5343/bms.2013.1003; Donahue MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130694; Drew JA, 2010, CORAL REEFS, V29, P439, DOI 10.1007/s00338-010-0586-5; Drew J, 2009, MOL PHYLOGENET EVOL, V53, P335, DOI 10.1016/j.ympev.2009.04.014; Drew JA, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-15; Drew JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047710; Faurby S, 2012, MOL ECOL, V21, P3419, DOI 10.1111/j.1365-294X.2012.05609.x; Fessler JL, 2007, MOL PHYLOGENET EVOL, V45, P50, DOI 10.1016/j.ympev.2007.05.018; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Frederich B, 2013, AM NAT, V181, P94, DOI 10.1086/668599; Fricke R, 2014, ZOOTAXA, V3832, P1, DOI 10.11646/zootaxa.3832.1.1; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Herrera M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0309; Hobbs JPA, 2009, BIOL LETTERS, V5, P258, DOI 10.1098/rsbl.2008.0561; Hoeksema BW, 2015, ESTUAR COAST SHELF S, V165, P190, DOI 10.1016/j.ecss.2015.05.015; Hubert N, 2011, ECOL EVOL, V1, P229, DOI 10.1002/ece3.19; JOKIEL P, 1992, J BIOGEOGR, V19, P449, DOI 10.2307/2845572; Jonsson KA, 2010, J BIOGEOGR, V37, P245, DOI 10.1111/j.1365-2699.2009.02220.x; Jordan D. S., 1908, Proceedings of the United States National Museum Smithsonian Institution Washington, V34; Jordan DS, 1906, FISHES SAMOA DESCRIP; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kulbicki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081847; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Luiz OJ, 2015, J BIOGEOGR, V42, P2323, DOI 10.1111/jbi.12574; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; MAC ARTHUR ROBERT H., 1967; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCord CL, 2016, MOL PHYLOGENET EVOL, V94, P397, DOI 10.1016/j.ympev.2015.09.014; Mouillot D, 2013, J BIOGEOGR, V40, P2228, DOI 10.1111/jbi.12194; Neall VE, 2008, PHILOS T R SOC B, V363, P3293, DOI 10.1098/rstb.2008.0119; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nickols KJ, 2015, AM NAT, V185, P196, DOI 10.1086/679503; Oksanen J., 2019, VEGAN COMMUNITY ECOL; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Parravicini V, 2013, ECOGRAPHY, V36, P1254, DOI 10.1111/j.1600-0587.2013.00291.x; Pellissier L, 2014, SCIENCE, V344, P1016, DOI 10.1126/science.1249853; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rieucau G, 2016, ANIM BEHAV, V117, P69, DOI 10.1016/j.anbehav.2016.05.002; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson DR, 2008, DIVERS DISTRIB, V14, P891, DOI 10.1111/j.1472-4642.2008.00519.x; RODDA P, 1967, NEW ZEAL J GEOL GEOP, V10, P1248, DOI 10.1080/00288306.1967.10420216; Sarnat EM, 2011, MOL ECOL, V20, P114, DOI 10.1111/j.1365-294X.2010.04916.x; SCHOFIELD JC, 1967, NEW ZEAL J GEOL GEOP, V10, P1424, DOI 10.1080/00288306.1967.10423226; SHELDON AL, 1968, ECOLOGY, V49, P193, DOI 10.2307/1934447; Sims CA, 2014, CORAL REEFS, P1; SPRINGER VG, 1982, SMITHSONIAN CONTR ZO, V367, P1, DOI DOI 10.5479/SI.00810282.367; Team RC, 2014, LANG ENV STAT COMP; THRESHER RE, 1989, COPEIA, P420; Tornabene L, 2015, MOL PHYLOGENET EVOL, V82, P200, DOI 10.1016/j.ympev.2014.09.012; Traveset A, 2014, J BIOGEOGR, V41, P823, DOI 10.1111/jbi.12243; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174	85	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0186123	10.1371/journal.pone.0186123	http://dx.doi.org/10.1371/journal.pone.0186123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069096	Green Published, Green Submitted, gold			2022-12-26	WOS:000413663600015
J	Gao, H; He, F; Lin, XH; Wu, YH				Gao, Han; He, Fang; Lin, Xinhua; Wu, Yihui			Drosophila VAMP7 regulates Wingless intracellular trafficking	PLOS ONE			English	Article							MORPHOGEN GRADIENT; DALLY-LIKE; TRANSMEMBRANE PROTEIN; RETROMER COMPLEX; WNT SECRETION; WG SECRETION; WNTLESS; PATHWAY; TRANSCYTOSIS; ENDOCYTOSIS	Drosophila Wingless (Wg) is a morphogen that determines cell fate during development. Previous studies have shown that endocytic pathways regulate Wg trafficking and signaling. Here, we showed that loss of vamp7, a gene required for vesicle fusion, dramatically increased Wg levels and decreased Wg signaling. Interestingly, we found that levels of Dally-like (Dlp), a glypican that can interact with Wg to suppress Wg signaling at the dorsoventral boundary of the Drosophila wing, were also increased in vamp7 mutant cells. Moreover, Wg puncta in Rab4-dependent recycling endosomes were Dlp positive. We hypothesize that VAMP7 is required for Wg intracellular trafficking and the accumulation of Wg in Rab4-dependent recycling endosomes might affect Wg signaling.	[Gao, Han] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Gao, Han; He, Fang] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China; [He, Fang; Wu, Yihui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lin, Xinhua] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Inst Genet,State Key Lab Genet Engn, Shanghai, Peoples R China; [Lin, Xinhua] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Wu, Yihui] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Cincinnati Children's Hospital Medical Center; Chinese Academy of Sciences; Institute of Zoology, CAS	Wu, YH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Lin, XH (corresponding author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Inst Genet,State Key Lab Genet Engn, Shanghai, Peoples R China.; Lin, XH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.; Wu, YH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China.	xlin@fudan.edu.cn; yihuiwu@ioz.ac.cn		Wu, Yihui/0000-0002-0723-4657	National Natural Science Foundation of China [31371464, 31571507, 81361120382]; National Institutes of Health [1R01GM115995]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115995] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/)) (31371464 for YW, 31571507 for XL, and 81361120382 for XL), and National Institutes of Health Grants (https://www.nih.gov/grants-funding) (1R01GM115995 for XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Daste F, 2015, J CELL SCI, V128, P4263, DOI 10.1242/jcs.178574; Dunst S, 2015, DEV CELL, V33, P351, DOI 10.1016/j.devcel.2015.03.022; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Gagliardi M, 2014, J CELL SCI, V127, P4918, DOI 10.1242/jcs.155424; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Hemalatha A, 2016, P NATL ACAD SCI USA, V113, pE6993, DOI 10.1073/pnas.1610565113; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; Jean S, 2015, EMBO REP, V16, P297, DOI 10.15252/embr.201439464; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Langton PF, 2016, TRENDS CELL BIOL, V26, P756, DOI 10.1016/j.tcb.2016.05.011; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Purvanov V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000877; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Takats S, 2014, MOL BIOL CELL, V25, P1338, DOI 10.1091/mbc.E13-08-0449; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; XU T, 1993, DEVELOPMENT, V117, P1223; Yamazaki Y, 2016, NAT CELL BIOL, V18, P451, DOI 10.1038/ncb3325; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; You J, 2011, DEV DYNAM, V240, P640, DOI 10.1002/dvdy.22562; Zhang P, 2011, CELL RES, V21, P1677, DOI 10.1038/cr.2011.167	54	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186938	10.1371/journal.pone.0186938	http://dx.doi.org/10.1371/journal.pone.0186938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065163	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900055
J	Yang, RF; Fang, SY; Wang, J; Zhang, CY; Zhang, R; Liu, D; Zhao, YQ; Hu, XX; Li, N				Yang, Ruifei; Fang, Suyun; Wang, Jing; Zhang, Chunyuan; Zhang, Ran; Liu, Di; Zhao, Yiqiang; Hu, Xiaoxiang; Li, Ning			Genome-wide analysis of structural variants reveals genetic differences in Chinese pigs	PLOS ONE			English	Article							COPY NUMBER VARIATION; HUMAN PHYSIOLOGICAL-RESPONSES; SINGLE-NUCLEOTIDE RESOLUTION; P2Y(4) RECEPTOR; COLD-EXPOSURE; DOMESTIC PIG; PAIRED-END; EXPRESSION; SELECTION; WILD	Pigs have experienced long-term selections, resulting in dramatic phenotypic changes. Structural variants (SVs) are reported to exert extensive impacts on phenotypic changes. We built a high resolution and informative SV map based on high-depth sequencing data from 66 Chinese domestic and wild pigs. We inferred the SV formation mechanisms in the pig genome and used SVs as materials to perform a population-level analysis. We detected the selection signals on chromosome X for northern Chinese domestic pigs, as well as the differentiated loci across the whole genome. Analysis showed that these loci differ between southern and northern Chinese domestic pigs. Our results based on SVs provide new insights into genetic differences in Chinese pigs.	[Yang, Ruifei; Wang, Jing; Zhang, Chunyuan; Zhao, Yiqiang] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Yang, Ruifei; Fang, Suyun; Wang, Jing; Zhang, Chunyuan; Zhang, Ran; Zhao, Yiqiang; Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Liu, Di] Heilongjiang Acad Agr Sci, Inst Anim Ind, Harbin, Heilongjiang, Peoples R China; [Hu, Xiaoxiang] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Heilongjiang Academy of Agricultural Sciences; China Agricultural University	Zhao, YQ (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.; Zhao, YQ; Hu, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Hu, XX (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Beijing, Peoples R China.	yiqiangz@cau.edu.cn; huxx@cau.edu.cn	padilha, hugo cp cezarotti/R-9840-2017	wang, jing/0000-0002-7120-0857	National Special Foundation for Transgenic Species of China [2014ZX0800950B-003]; Whole Genome Analysis and Introduction of Important Functional Genes in Animals (948 Program) [2012-G1 (4)]; National Program on the Key Basic Research Project (973 Program) [2014CB138501]	National Special Foundation for Transgenic Species of China; Whole Genome Analysis and Introduction of Important Functional Genes in Animals (948 Program); National Program on the Key Basic Research Project (973 Program)(National Basic Research Program of China)	This work was supported by the National Special Foundation for Transgenic Species of China (2014ZX08009506-003) to Yiqiang Zhao, Whole Genome Analysis and Introduction of Important Functional Genes in Animals (948 Program) (2012-G1 (4)) to Xiaoxiang Hu, and the National Program on the Key Basic Research Project (973 Program) (2014CB138501) to Ran Zhang.; We thank Zhaoliang Liu for reading the early version of this manuscript and providing comments. This work was supported by the National Special Foundation for Transgenic Species of China (2014ZX0800950B-003), Whole Genome Analysis and Introduction of Important Functional Genes in Animals (948 Program) (2012-G1 (4)), and the National Program on the Key Basic Research Project (973 Program) (2014CB138501). The authors declare no competing financial interests.	Abyzov A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8256; Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Ai HS, 2015, NAT GENET, V47, P217, DOI 10.1038/ng.3199; Ai HS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-834; Ai HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056001, 10.1371/journal.pone.0069836, 10.1371/journal.pone.0063641]; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; BOULANT JA, 1986, ANNU REV PHYSIOL, V48, P639, DOI 10.1146/annurev.ph.48.030186.003231; Castellani JW, 2016, AUTON NEUROSCI-BASIC, V196, P63, DOI 10.1016/j.autneu.2016.02.009; Cavaliere F, 2005, NEUROBIOL DIS, V18, P100, DOI 10.1016/j.nbd.2004.09.001; CHAFFEE RRJ, 1969, FED PROC, V28, P1029; Chen K, 2014, GENOME RES, V24, P310, DOI 10.1101/gr.162883.113; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen L, 2014, J GENET GENOMICS, V41, P653, DOI 10.1016/j.jgg.2014.10.001; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Currall Benjamin B, 2013, Curr Genet Med Rep, V1, P81; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Frantz LAF, 2015, NAT GENET, V47, P1141, DOI 10.1038/ng.3394; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groenen MAM, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0204-2; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hutter S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-409; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; Jenkins Dagan, 2007, J Pediatr Urol, V3, P2, DOI 10.1016/j.jpurol.2006.03.002; Kawelke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145797; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuo IY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153632; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Li Y, 2015, NATURE, V521, P520, DOI 10.1038/nature14269; Li ZC, 2016, ANIM GENET, V47, P672, DOI 10.1111/age.12475; Lieber MR, 2010, SUBCELL BIOCHEM, V50, P279, DOI 10.1007/978-90-481-3471-7_14; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; Mouillesseaux KP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13247; Panteleyev AA, 2003, J INVEST DERMATOL, V121, P13, DOI 10.1046/j.1523-1747.2003.12319.x; Paudel Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1449-9; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Pielberg G, 2003, GENOME RES, V13, P2171, DOI 10.1101/gr.1188203; Pielberg G, 2002, GENETICS, V160, P305; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Reed B, 2008, AM J KIDNEY DIS, V52, P1042, DOI 10.1053/j.ajkd.2008.05.015; Sprissler RS, 2017, EXP NEUROL, V288, P134, DOI 10.1016/j.expneurol.2016.11.002; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stocks JM, 2004, AVIAT SPACE ENVIR MD, V75, P444; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; TAJIMA F, 1989, GENETICS, V123, P585; Wang L., 2011, ANIMAL GENETIC RESOU, P2; Warnefors M, 2010, MOL BIOL EVOL, V27, P1955, DOI 10.1093/molbev/msq084; Warr A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00338; Weckselblatt B, 2015, TRENDS GENET, V31, P587, DOI 10.1016/j.tig.2015.05.010; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wengert M, 2013, ARCH BIOCHEM BIOPHYS, V535, P136, DOI 10.1016/j.abb.2013.03.013; Xia WL, 2015, STEM CELL REP, V4, P795, DOI 10.1016/j.stemcr.2015.03.004; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zhao PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18501	70	6	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186721	10.1371/journal.pone.0186721	http://dx.doi.org/10.1371/journal.pone.0186721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065176	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900028
J	Fragala, MS; Bi, CX; Chaump, M; Kaufman, HW; Kroll, MH				Fragala, Maren S.; Bi, Caixia; Chaump, Michael; Kaufman, Harvey W.; Kroll, Martin H.			Associations of aerobic and strength exercise with clinical laboratory test values	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GLOMERULAR-FILTRATION-RATE; SERUM URIC-ACID; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; IRON STATUS; PARAMETERS; ENDURANCE; ALBUMIN	Objectives Physical exercise may affect levels of blood-based biomarkers. However, exercise status is seldom considered in the interpretation of laboratory results. This study reports the associations between habitual exercise participation and clinical laboratory test results. Methods The effects of days per week of aerobic and strength exercise participation on laboratory test results for 26 biomarkers in young adults aged 18 to 34 years (n = 80,111) were evaluated using percentile distribution analyses and multivariate regression. Results In both men and women, more days per week of either aerobic or strength exercise were significantly associated with lower levels of glucose, hemoglobin A1c, LDL cholesterol, total cholesterol, triglycerides, estimated glomerular filtration rate, globulin, and C-reactive protein, and significantly higher levels of HDL cholesterol, creatinine, iron, and percent saturation (all p <.05). Type of exercise or gender influenced the observed relationships with exercise frequency for total cholesterol, aspartate aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, uric acid, bilirubin, and iron binding capacity. Conclusions Physical exercise shifted the distribution of results into the direction suggestive of better health. Reported relationships may help clinicians and patients to better understand and interpret laboratory results in athletic populations and possibly re-evaluate interpretation of reference intervals for physically active populations.	[Fragala, Maren S.; Bi, Caixia; Chaump, Michael; Kaufman, Harvey W.; Kroll, Martin H.] Quest Diagnost, 3 Giralda Farms, Madison, NJ 07940 USA		Fragala, MS (corresponding author), Quest Diagnost, 3 Giralda Farms, Madison, NJ 07940 USA.	Maren.S.Fragala@questdiagnostics.com			Quest Diagnostics	Quest Diagnostics	Quest Diagnostics provided support in the form of salaries for MSF, CB, MC, HWK, and MHK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfi G, 2008, J SPORT MED PHYS FIT, V48, P479; Banfi G, 2012, ADV CLIN CHEM, V56, P1, DOI 10.1016/B978-0-12-394317-0.00015-7; Banfi G, 2009, SPORTS MED, V39, P331, DOI 10.2165/00007256-200939040-00005; Bruinvels G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149881; Busher J. T. Serum, 1990, CLIN METHODS HIST PH; Ceriotti Ferruccio, 2007, Clin Biochem Rev, V28, P115; Colombini A, 2014, J SPORT MED PHYS FIT, V54, P658; Constantini N, 2006, MIL MED, V171, P866, DOI 10.7205/MILMED.171.9.866; de Ferranti S, 2002, CLIN CHIM ACTA, V317, P1, DOI 10.1016/S0009-8981(01)00797-5; DODDS WN, 1984, INJURY, V16, P94, DOI 10.1016/S0020-1383(84)80006-6; Du Toit C, 2007, J SCI MED SPORT, V10, P351, DOI 10.1016/j.jsams.2007.01.001; Dubnov G, 2004, INT J SPORT NUTR EXE, V14, P30, DOI 10.1123/ijsnem.14.1.30; EDWARDS JG, 1994, BIOCHEM BIOPH RES CO, V199, P1482, DOI 10.1006/bbrc.1994.1398; EHN L, 1980, MED SCI SPORT EXER, V12, P61; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Fallon KE, 1999, BRIT J SPORT MED, V33, P264, DOI 10.1136/bjsm.33.4.264; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; FRIDAY KE, 1993, J CLIN ENDOCR METAB, V77, P1605, DOI 10.1210/jc.77.6.1605; Froiland K, 2004, INT J SPORT NUTR EXE, V14, P104, DOI 10.1123/ijsnem.14.1.104; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GREEN HJ, 1988, MED SCI SPORT EXER, V20, P55, DOI 10.1249/00005768-198802000-00008; GRIMSTON SK, 1993, J CLIN ENDOCR METAB, V76, P867, DOI 10.1210/jc.76.4.867; Gullu S, 2004, EUR J ENDOCRINOL, V150, P655, DOI 10.1530/eje.0.1500655; Hampl, 1996, Endocr Regul, V30, P57; Haskell W L, 1984, Exerc Sport Sci Rev, V12, P205; Hawkins MS, 2011, MED SCI SPORT EXER, V43, P1457, DOI 10.1249/MSS.0b013e31820c0130; Hinton PS, 2000, J APPL PHYSIOL, V88, P1103, DOI 10.1152/jappl.2000.88.3.1103; Huang C, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-258; JAMES WPT, 1968, J CLIN INVEST, V47, P1958, DOI 10.1172/JCI105885; Karamizrak SO, 1996, BRIT J SPORT MED, V30, P15, DOI 10.1136/bjsm.30.1.15; KRAMER BK, 1988, CLIN CHEM, V34, P2516; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Lidegaard LP, 2015, DIABETOLOGIA, V58, P2709, DOI 10.1007/s00125-015-3738-x; Lippi G, 2004, CLIN CHEM LAB MED, V42, P644, DOI 10.1515/CCLM.2004.110; Lippi G, 2008, INT J SPORTS MED, V29, P948, DOI 10.1055/s-2008-1038745; Lippi G, 2011, EUR J INTERN MED, V22, pE36, DOI 10.1016/j.ejim.2011.02.007; LJUNGHALL S, 1984, EUR J CLIN INVEST, V14, P469, DOI 10.1111/j.1365-2362.1984.tb01215.x; MCLAREN DS, 1965, AM J CLIN NUTR, V17, P152, DOI 10.1093/ajcn/17.3.152; Meyer T, 2011, INT J SPORTS MED, V32, P875, DOI 10.1055/s-0031-1280776; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; NIEMAN DC, 1989, INT J SPORTS MED, V10, P124, DOI 10.1055/s-2007-1024887; NILSSEN O, 1990, AM J EPIDEMIOL, V132, P318, DOI 10.1093/oxfordjournals.aje.a115661; NYMAN MT, 1991, ANN CHIR GYNAECOL, V80, P289; Perseghin G, 2009, EUR J ENDOCRINOL, V161, P871, DOI 10.1530/EJE-09-0569; Pettersson J, 2008, BRIT J CLIN PHARMACO, V65, P253, DOI 10.1111/j.1365-2125.2007.03001.x; Plaisance EP, 2006, SPORTS MED, V36, P443, DOI 10.2165/00007256-200636050-00006; Puglisi MJ, 2008, J NUTR, V138, P2293, DOI 10.3945/jn.108.097188; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; ROCKER L, 1976, EUR J APPL PHYSIOL O, V36, P57, DOI 10.1007/BF00421634; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435, DOI 10.1152/ajpendo.00266.2001; Rudberg A, 2000, CALCIFIED TISSUE INT, V66, P342, DOI 10.1007/s002230010071; SCHOBERSBERGER W, 1990, EUR J APPL PHYSIOL O, V60, P163, DOI 10.1007/BF00839152; Schumacher YO, 2002, MED SCI SPORT EXER, V34, P869; Tice JA, 2003, AM J MED, V114, P199, DOI 10.1016/S0002-9343(02)01497-3; Waring WS, 2003, CLIN SCI, V105, P425, DOI 10.1042/CS20030149; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; WILLIS WT, 1987, J APPL PHYSIOL, V62, P2442, DOI 10.1152/jappl.1987.62.6.2442; Witard OC, 2011, MED SCI SPORT EXER, V43, P598, DOI 10.1249/MSS.0b013e3181f684c9; Zarzeczny R, 1996, J PHYSIOL PHARMACOL, V47, P503	59	22	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0180840	10.1371/journal.pone.0180840	http://dx.doi.org/10.1371/journal.pone.0180840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059178	Green Published, Green Submitted, gold			2022-12-26	WOS:000413403000001
J	Glen, K; Eston, R; Loetscher, T; Partitt, G				Glen, Kate; Eston, Roger; Loetscher, Tobias; Partitt, Gaynor			Exergaming: Feels good despite working harder	PLOS ONE			English	Article							GRADED-EXERCISE TEST; PEAK OXYGEN-UPTAKE; AFFECTIVE RESPONSES; PHYSICAL-ACTIVITY; PHYSIOLOGICAL-RESPONSES; INTENSITY EXERCISE; ENJOYMENT; DISSOCIATION; RELIABILITY; VALIDITY	Strategies to encourage exercise have led to research on cycle ergometer 'exergaming', as a means of enhancing exercise enjoyment. This research has typically prescribed the exercise intensity and used one exercise mode. The aim of this study was to compare self-selected exercise intensity on a cycle ergometer with and without exergaming modes activated. A total of 20 participants aged between 18-40 years (M = 24.2 +/- 5.9) completed a sub-maximal exercise test. Participants returned two days later to complete one 45 minute session of self-selected exercise with 15 minutes in each of 'control' (standard ergometer), 'track', and 'game' modes, with order randomized. Heart rate, work rate, perceived exertion, and affective valence were recorded during exercise. Dissociation and enjoyment were recorded in the rest interval between each mode. Participants exercised above ventilatory threshold (VT) in all three modes (track, M = 9.5 +/- 12%; game, M = 6.2 +/- 12%; and control, M = 4.4 +/- 14% above VT) and at higher work rates (P < 0.05) exergaming (track, M = 94.5 +/- 27.9; game, M = 96.2 +/- 32.8 watts) than control (M = 86.6 +/- 26.5 watts). Despite exercising at a higher intensity, participants perceived exercise during the exergaming modes to be most pleasant (P < 0.01), with greater enjoyment (P < 0.01) and dissociation (P < 0.01) in the game than track mode, and both modes higher on these variables than the control mode. Findings support the use of exergaming as a strategy to encourage individuals to exercise, with participants choosing to work harder physiologically, but reporting more positive psychological responses during and following the exercise.	[Glen, Kate; Loetscher, Tobias] Univ South Australia, Sch Psychol, Adelaide, SA, Australia; [Eston, Roger; Partitt, Gaynor] Univ South Australia, ARENA, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA, Australia	Flinders University South Australia; University of South Australia; University of South Australia	Partitt, G (corresponding author), Univ South Australia, ARENA, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA, Australia.	gaynor.parfitt@unisa.edu.au	Eston, Roger G/C-7666-2011; Loetscher, Tobias/I-1865-2019; Parfitt, Gaynor/G-7640-2012	Eston, Roger G/0000-0002-2680-7473; Loetscher, Tobias/0000-0003-1967-2926; Parfitt, Gaynor/0000-0002-5547-5797				American College of Sports Medicine, 2014, ACSMS GUIDELINES EXE; Benjamin CC, 2012, PEDIATR EXERC SCI, V24, P275, DOI 10.1123/pes.24.2.275; Borg G, 1998, BORGS PERCEIVED EXER; Connolly CT, 2010, J APPL SOC PSYCHOL, V40, P1123, DOI 10.1111/j.1559-1816.2010.00613.x; Coquart J, 2016, SPORTS MED, V46, P885, DOI 10.1007/s40279-015-0465-x; Coquart JB, 2014, SPORTS MED, V44, P563, DOI 10.1007/s40279-013-0139-5; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Ekkekakis P, 2009, SPORTS MED, V39, P857, DOI 10.2165/11315210-000000000-00000; Eston R, 2012, EUR J APPL PHYSIOL, V112, P3459, DOI 10.1007/s00421-012-2326-8; Evans H, 2014, EUR J SPORT SCI, V14, P452, DOI 10.1080/17461391.2013.832804; Exercise and Sport Science Australia, 2011, AD PRE EX SCREEN TOO; Focht BC, 2015, J STRENGTH COND RES, V29, P3067, DOI 10.1519/JSC.0000000000000985; Lamboglia CMGF, 2013, J OBES, V2013, DOI 10.1155/2013/438364; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; Greene DR, 2015, SPORT EXERC PERFORM, V4, P75, DOI 10.1037/spy0000030; Hall EE, 2002, BRIT J HEALTH PSYCH, V7, P47, DOI 10.1348/135910702169358; Hamlyn-Williams CC, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-35; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hutchinson JC, 2007, PSYCHOL SPORT EXERC, V8, P233, DOI 10.1016/j.psychsport.2006.03.006; Hutchinson JC, 2015, ANN BEHAV MED, V49, P199, DOI 10.1007/s12160-014-9647-2; Jekauc D, 2013, J PEDIATR PSYCHOL, V38, P104, DOI 10.1093/jpepsy/jss088; Jones L, 2014, J SPORT EXERCISE PSY, V36, P528, DOI [10.1123/jsep.2013-0251, 10.1123/jsep.2014-0251]; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; LeBlanc AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065351; Legrand FD, 2011, J APPL SPORT PSYCHOL, V23, P65, DOI 10.1080/10413200.2010.523754; Leventhal H., 1979, EMOTIONS PERSONALITY, P261, DOI [DOI 10.1007/978-1-4613-2892-6_10, 10.1007/978-1-4613-2892-6_10]; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Lewis BA, 2016, PSYCHOL HEALTH, V31, P456, DOI 10.1080/08870446.2015.1111372; Lind E, 2009, SPORTS MED, V39, P743, DOI 10.2165/11315120-000000000-00000; Monedero J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118470; Parfitt G, 2006, BRIT J HEALTH PSYCH, V11, P39, DOI 10.1348/135910705X43606; Oliveira BRR, 2015, J SPORT SCI, V33, P777, DOI 10.1080/02640414.2014.968191; Reed J, 2006, PSYCHOL SPORT EXERC, V7, P477, DOI 10.1016/j.psychsport.2005.11.003; Rose EA, 2007, J SPORT EXERCISE PSY, V29, P281, DOI 10.1123/jsep.29.3.281; Russell WD, 2008, EDUC TECHNOL SOC, V11, P294; Sheppard KE, 2008, PEDIATR EXERC SCI, V20, P129, DOI 10.1123/pes.20.2.129; Smith AE, 2015, EUR J APPL PHYSIOL, V115, P1855, DOI 10.1007/s00421-015-3167-z; Tammen VV, 1996, J APPL SPORT PSYCHOL, V8, P1, DOI 10.1080/10413209608406304; Tenenbaum G., 2007, HDB SPORT PSYCHOL; Van Landuyt LM, 2000, J SPORT EXERCISE PSY, V22, P208, DOI 10.1123/jsep.22.3.208; Warburton DER, 2007, APPL PHYSIOL NUTR ME, V32, P655, DOI 10.1139/H07-038; Welch AS, 2007, PSYCHOL SPORT EXERC, V8, P401, DOI 10.1016/j.psychsport.2006.09.002; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; Williams DM, 2013, PSYCHOL SPORT EXERC, V14, P767, DOI 10.1016/j.psychsport.2013.04.001; Williams DM, 2012, ANN BEHAV MED, V44, P43, DOI 10.1007/s12160-012-9362-9; Wolpern AE, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0011-z	51	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186526	10.1371/journal.pone.0186526	http://dx.doi.org/10.1371/journal.pone.0186526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK3RE	29059227	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000413403000029
J	Lee, DH; Kim, MJ; Song, EJ; Kim, JH; Ahn, J; Nam, YD; Jang, YJ; Ha, TY; Jung, CH				Lee, Da-Hye; Kim, Min Jung; Song, Eun-Ji; Kim, Jin Hee; Ahn, Jiyun; Nam, Young-Do; Jang, Young-Jin; Ha, Tae-Youl; Jung, Chang Hwa			Nutrikinetic study of genistein metabolites in ovariectomized mice	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; ANTIOXIDANT ACTIVITY; SOY ISOFLAVONES; RATS; BIOAVAILABILITY; PHARMACOKINETICS; ABSORPTION; DAIDZEIN; CELLS; EQUOL	This study was designed to evaluate the effect of ovariectomy on nutrikinetics of genistein metabolites. To characterize the time-dependent changes in genistein metabolite concentrations, we identified 13 genistein metabolites using ultra-performance liquid chromatographyquadrupole time-of-flight mass spectrometry. The nutrikinetics of the individual metabolites at different time points were analyzed. Nutrikinetic analysis showed that genistein, genistein 4 '-glucuronide, genistein 7-glucuronide, 3-hydroxygenistein, and hippuric acid showed relatively high bioavailability in the sham group compared to that in the ovariectomy group, suggesting that ovariectomy likely results in lower genistein bioavailability. These results may be related to alteration of gut microbiota by ovariectomy. The relative abundance of species of the Parabacteroides, Dorea, and Butyricimonas genera, and Desulfovibrionaceae_unclassified, Lachnospiraceae_unclassified, and Rikenellaceae_unclassified families increased in the ovariectomy group while the relative abundance of 523_7_unclassified and Y52_unclassified_ unclassified increased in the sham group. These results suggest that gut microbiota alteration by ovariectomy may affect genistein bioavailability.	[Lee, Da-Hye; Kim, Min Jung; Kim, Jin Hee; Ahn, Jiyun; Jang, Young-Jin; Ha, Tae-Youl; Jung, Chang Hwa] Korea Food Res Inst, Res Grp Metab Mech, Seongnam, South Korea; [Lee, Da-Hye; Song, Eun-Ji; Ahn, Jiyun; Nam, Young-Do; Ha, Tae-Youl; Jung, Chang Hwa] Korea Univ Sci & Technol, Dept Food Biotechnol, Seongnam, South Korea; [Song, Eun-Ji; Nam, Young-Do] Korea Food Res Inst, Res Grp Gut Microbiome, Seongnam, South Korea	Korea Food Research Institute (KFRI); Korea Food Research Institute (KFRI)	Jung, CH (corresponding author), Korea Food Res Inst, Res Grp Metab Mech, Seongnam, South Korea.; Jung, CH (corresponding author), Korea Univ Sci & Technol, Dept Food Biotechnol, Seongnam, South Korea.	chjung@kfri.re.kr	Jang, Young Jin/AAT-1192-2020; Jang, Young Jin/GLU-3087-2022; Song, Eun-Ji/HDO-8376-2022	Jung, Chang Hwa/0000-0002-1076-750X; Nam, Young-Do/0000-0002-2660-3569	Korea Food Research Institute of South Korea [E0150101-03]	Korea Food Research Institute of South Korea	This study was supported by a grant (E0150101-03) from the Korea Food Research Institute of South Korea (www.kfri.re.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekel DL, 2010, AM J CLIN NUTR, V91, P218, DOI 10.3945/ajcn.2009.28306; Bolca S, 2013, CURR OPIN BIOTECH, V24, P220, DOI 10.1016/j.copbio.2012.09.009; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bursztyka J, 2008, FOOD CHEM TOXICOL, V46, P939, DOI 10.1016/j.fct.2007.10.023; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen KL, 2016, TRENDS ENDOCRIN MET, V27, P752, DOI 10.1016/j.tem.2016.08.001; Choi EJ, 2014, MOL MED REP, V9, P328, DOI 10.3892/mmr.2013.1752; Cox-York KA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12488; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erfanian A, 2015, J AGR FOOD CHEM, V63, P5795, DOI 10.1021/acs.jafc.5b01468; Goto H, 2009, CHEM PHARM BULL, V57, P346, DOI 10.1248/cpb.57.346; Greenblatt HK, 2015, CLIN PHARMACOKINET, V54, P573, DOI 10.1007/s40262-015-0259-1; Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003; Hu M, 2003, DRUG METAB DISPOS, V31, P924, DOI 10.1124/dmd.31.7.924; Jourova L, 2016, BIOMED PAP, V160, P317, DOI 10.5507/bp.2016.039; King RA, 1996, J NUTR, V126, P176, DOI 10.1093/jn/126.1.176; Kwon SH, 2007, INT J PHARMACEUT, V337, P148, DOI 10.1016/j.ijpharm.2006.12.046; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee DE, 2010, J BIOL CHEM, V285, P21458, DOI 10.1074/jbc.M109.094797; Legette LL, 2014, J AGR FOOD CHEM, V62, P1294, DOI 10.1021/jf400097m; Li J, 2016, P NATL ACAD SCI USA, V113, pE1306, DOI 10.1073/pnas.1518189113; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; Marin L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/905215; Nielsen ILF, 2007, NUTR CANCER, V57, P1, DOI 10.1080/01635580701267677; Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009; Pugazhendhi D, 2008, J ENDOCRINOL, V197, P503, DOI 10.1677/JOE-07-0384; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2015, AM J GASTROENTEROL, V110, P278, DOI 10.1038/ajg.2014.427; Russo M, 2016, FOOD CHEM, V196, P589, DOI 10.1016/j.foodchem.2015.09.085; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Sirichakwal PP, 2015, J NUTR, V145, P990, DOI 10.3945/jn.114.207290; Smit S, 2014, MOL NUTR FOOD RES, V58, P2111, DOI 10.1002/mnfr.201400325; Soukup ST, 2016, ARCH TOXICOL, V90, P1335, DOI 10.1007/s00204-016-1663-5; Spagnuolo C, 2015, ADV NUTR, V6, P408, DOI 10.3945/an.114.008052; Usui T, 2013, CLIN ENDOCRINOL, V78, P365, DOI 10.1111/j.1365-2265.2012.04400.x; van Acker FAA, 2000, J MED CHEM, V43, P3752, DOI 10.1021/jm000951n; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wong VWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062885; Yang Z, 2012, ANTI-CANCER AGENT ME, V12, P1264, DOI 10.2174/187152012803833107; Yuan B, 2012, J AGR FOOD CHEM, V60, P1428, DOI 10.1021/jf204421c; Zhang Y, 1999, J NUTR, V129, P399, DOI 10.1093/jn/129.2.399	45	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186320	10.1371/journal.pone.0186320	http://dx.doi.org/10.1371/journal.pone.0186320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059247	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000018
J	Smit, M; Cassidy, R; Cozzi-Lepri, A; Quiros-Roldan, E; Girardi, E; Mammone, A; Antinori, A; Saracino, A; Bai, F; Rusconi, S; Magnani, G; Castelli, F; Hsue, P; Monforte, AD; Hallett, TB				Smit, Mikaela; Cassidy, Rachel; Cozzi-Lepri, Alessandro; Quiros-Roldan, Eugenia; Girardi, Enrico; Mammone, Alessia; Antinori, Andrea; Saracino, Annalisa; Bai, Francesca; Rusconi, Stefano; Magnani, Giacomo; Castelli, Francesco; Hsue, Priscilla; Monforte, Antonella d'Arminio; Hallett, Timothy B.			Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the USA: A modelling study	PLOS ONE			English	Article							POPULATION; INFECTION; CASCADE	Background Country-specific forecasts of the growing non-communicable disease (NCD) burden in ageing HIV-positive patients will be key to guide future HIV policies. We provided the first national forecasts for Italy and the Unites States of America (USA) and quantified direct cost of caring for these increasingly complex patients. Methods and Setting We adapted an individual-based model of ageing HIV-positive patients to Italy and the USA, which followed patients on HIV-treatment as they aged and developed NCDs (chronic kidney disease, diabetes, dyslipidaemia, hypertension, non-AIDS malignancies, myocardial infarctions and strokes). The models were parameterised using data on 7,469 HIV-positive patients from the Italian Cohort Naive to Antiretrovirals Foundation Study and 3,748 commercially-insured patients in the USA and extrapolated to national level using national surveillance data. Results The model predicted that mean age of HIV-positive patients will increase from 46 to 59 in Italy and from 49 to 58 in the USA in 2015-2035. The proportion of patients in Italy and the USA diagnosed with >= 1 NCD is estimated to increase from 64% and 71% in 2015 to 89% and 89% by 2035, respectively, driven by moderate cardiovascular disease (CVD) (hypertension and dyslipidaemia), diabetes and malignancies in both countries. NCD treatment costs as a proportion of total direct HIV costs will increase from 11% to 23% in Italy and from 40% to 56% in the USA in 2015-2035. Conclusions HIV patient profile in Italy and the USA is shifting to older patients diagnosed with multiple co-morbidity. This will increase NCD treatment costs and require multi-disciplinary patient management.	[Smit, Mikaela; Cassidy, Rachel; Hallett, Timothy B.] Imperial Coll, Dept Infect Dis Epidemiol, London, England; [Cozzi-Lepri, Alessandro] UCL, Dept Infect & Populat Hlth, London, England; [Quiros-Roldan, Eugenia; Castelli, Francesco] Univ Brescia, Univ Dept Infect & Trop Dis, Brescia, Italy; [Quiros-Roldan, Eugenia; Castelli, Francesco] Brescia Spedali Civili Gen Hosp, Brescia, Italy; [Girardi, Enrico; Mammone, Alessia] Natl Inst Infect Dis Lazzaro Spallanzani, Clin Epidemiol Unit, Rome, Italy; [Antinori, Andrea] Natl Inst Infect Dis Lazzaro Spallanzani, Clin Dept, Rome, Italy; [Saracino, Annalisa] Univ Bari, Clin Infect Dis, Bari, Italy; [Bai, Francesca; Monforte, Antonella d'Arminio] Univ Milan, ASST Santi Paolo & Carlo, Clin Infect & Trop Dis, Dept Hlth Sci, Milan, Italy; [Rusconi, Stefano] Univ Milan, DIBIC Luigi Sacco, Infect Dis Unit, Milan, Italy; [Magnani, Giacomo] S Maria Nuova IRCCS Hosp, Dept Infect Dis, Reggio Emilia, Italy; [Hsue, Priscilla] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	Imperial College London; University of London; University College London; University of Brescia; Hospital Spedali Civili Brescia; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; Universita degli Studi di Bari Aldo Moro; University of Milan; University of Milan; Luigi Sacco Hospital; University of California System; University of California San Francisco	Smit, M (corresponding author), Imperial Coll, Dept Infect Dis Epidemiol, London, England.	mikaela.smit@imperial.ac.uk	ROLDAN, Maria Eugenia QUIROS/K-7586-2015; Bai, Francesca/K-4823-2018; Rusconi, Stefano/H-9263-2012; Antinori, Andrea/K-7125-2016; Mammone, Alessia/K-9217-2016	ROLDAN, Maria Eugenia QUIROS/0000-0003-1452-9100; Rusconi, Stefano/0000-0002-0375-9990; Antinori, Andrea/0000-0003-2121-4684; Smit, Mikaela/0000-0001-8530-748X; Castelli, Francesco/0000-0001-9161-7804; Cassidy, Rachel/0000-0002-4824-0260; Mammone, Alessia/0000-0003-2250-1247; Hallett, Timothy/0000-0002-9681-0424	Gilead Sciences; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Gilead Sciences(Gilead Sciences); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Gilead Sciences. The funder had no role in the analysis or the decision to publish.	AIDSinfo, 2016, GUIDELINES USE ANTIR; Althoff KN, 2016, CURR OPIN HIV AIDS; Andreoni M., 2016, CURE; CDC, 2015, EFFECTS GALECTINS AN; CDC, 2019, HIV SURVEILLANCE REP; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dunn A., 2014, DEVELOPING FRAMEWORK, P545; European AIDS Clinical Society, 2013, GUID 2013; European AIDS Clinical Society, 2016, GUIDELINES; Gebo KA, 2006, DRUG AGING, V23, P897, DOI 10.2165/00002512-200623110-00005; Gebo Kelly A, 2009, Curr Infect Dis Rep, V11, P246, DOI 10.1007/s11908-009-0036-0; High K, 2005, J AM GERIATR SOC, V53, P528, DOI 10.1111/j.1532-5415.2005.53240.x; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, 2014 GAP; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Landovitz RJ, 2016, CURR OPIN HIV AIDS, V11, P122, DOI 10.1097/COH.0000000000000219; Magoni M, 2011, HIV MED, V12, P129, DOI 10.1111/j.1468-1293.2010.00861.x; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Onen NF, 2010, HIV CLIN TRIALS, V11, P100, DOI 10.1310/hct1102-100; Pellowski JA, 2013, AM PSYCHOL, V68, P197, DOI 10.1037/a0032694; Quiros-Roldan E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3804-4; Schouten J, 2014, CLIN INFECT DIS OFF; Shirley DK, 2013, AIDS PATIENT CARE ST, V27, P604, DOI 10.1089/apc.2013.0128; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Tanser F, 2015, CURR OPIN HIV AIDS, V10, P430, DOI 10.1097/COH.0000000000000192; UNAIDS, 2015, NUMB PEOPL LIV HIV; Vourli G, 2017, ASSESSING REPRESENTA	27	42	42	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186638	10.1371/journal.pone.0186638	http://dx.doi.org/10.1371/journal.pone.0186638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK3RE	29059202	Green Published, gold, Green Accepted			2022-12-26	WOS:000413403000031
J	Hastings, MH; Gong, K; Freibauer, A; Courchesne, C; Fan, XT; Sossin, WS				Hastings, Margaret H.; Gong, Katrina; Freibauer, Alexander; Courchesne, Caitlin; Fan, Xiaotang; Sossin, Wayne S.			Novel calpain families and novel mechanisms for calpain regulation in Aplysia	PLOS ONE			English	Article							PROTEIN-KINASE-C; LONG-TERM FACILITATION; PHYLOGENETIC ANALYSIS; SYNAPTIC PLASTICITY; MAMMALIAN-TISSUES; DIFFERENT FORMS; OPERANT MEMORY; EF-HAND; CALCIUM; BRAIN	Calpains are a family of intracellular proteases defined by a conserved protease domain. In the marine mollusk Aplysia californica, calpains are important for the induction of long-term synaptic plasticity and memory, at least in part by cleaving protein kinase Cs (PKCs) into constitutively active kinases, termed protein kinase Ms (PKMs). We identify 14 genes encoding calpains in Aplysia using bioinformatics, including at least one member of each of the four major calpain families into which metazoan calpains are generally classified, as well as additional truncated and atypical calpains. Six classical calpains containing a penta-EF-hand (PEF) domain are present in Aplysia. Phylogenetic analysis determined that these six calpains come from three separate classical calpain families. One of the classical calpains in Aplysia, AplCCal1, has been implicated in plasticity. We identify three splice cassettes and an alternative transcriptional start site in AplCCal1. We characterize several of the possible isoforms of AplCCal1 in vitro, and demonstrate that AplCCal1 can cleave PKCs into PKMs in a calcium-dependent manner in vitro. We also find that AplCCal1 has a novel mechanism of auto-inactivation through N-terminal cleavage that is modulated through its alternative transcriptional start site.	[Hastings, Margaret H.; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Psychol, Montreal, PQ, Canada; [Gong, Katrina; Freibauer, Alexander; Courchesne, Caitlin; Fan, Xiaotang; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University; McGill University	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Psychol, Montreal, PQ, Canada.; Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	wayne.sossin@mcgill.ca		Sossin, Wayne/0000-0003-1927-9315	Canadian Institute of Health Research (CIHR) [MOP 12046, 340328]; Fonds de recherche du Quebec - Sante (FRSQ)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante (FRSQ)	This work was supported by Canadian Institute of Health Research (CIHR) grant MOP 12046 and 340328 to W.S.S. W.S.S. is a James McGill Professor. M.H.H. was supported by a Fonds de recherche du Quebec - Sante (FRSQ) studentship.	Amini M, 2013, J NEUROSCI, V33, P5773, DOI 10.1523/JNEUROSCI.4247-12.2013; Bertipaglia I., 2007, V45, P29; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Bougie JK, 2012, J NEUROSCI, V32, P14630, DOI 10.1523/JNEUROSCI.3026-11.2012; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Briz V, 2016, NEUROSCIENTIST; Cai DC, 2011, J NEUROSCI, V31, P6421, DOI 10.1523/JNEUROSCI.4744-10.2011; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; CONG JY, 1989, J BIOL CHEM, V264, P10096; Elce JS, 1997, J BIOL CHEM, V272, P11268; Farah CA, 2017, LEARN MEMORY, V24, P1, DOI 10.1101/lm.043745.116; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; Gallardo Eduard, 2011, Handb Clin Neurol, V101, P97, DOI 10.1016/B978-0-08-045031-5.00006-2; Gan-Or Z, 2016, AM J HUM GENET, V98, P1038, DOI 10.1016/j.ajhg.2016.04.002; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Hajimohammadreza I, 1997, J NEUROCHEM, V69, P1006; Hata S, 2016, J BIOL CHEM, V291, P27313, DOI 10.1074/jbc.M116.763912; Hata S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001040; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hu JY, 2017, CURR BIOL, V27, P1888, DOI 10.1016/j.cub.2017.05.081; Hu JY, 2017, J NEUROSCI, V37, P2746, DOI 10.1523/JNEUROSCI.2805-16.2017; Hu JY, 2015, J NEUROSCI, V35, P16159, DOI 10.1523/JNEUROSCI.2034-15.2015; INOMATA M, 1985, J BIOCHEM-TOKYO, V98, P407, DOI 10.1093/oxfordjournals.jbchem.a135295; INOUE M, 1977, J BIOL CHEM, V252, P7610; Jekely G, 1999, J BIOL CHEM, V274, P23893, DOI 10.1074/jbc.274.34.23893; Jekely G, 1999, J MOL EVOL, V49, P272, DOI 10.1007/PL00006549; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Khoutorsky A, 2013, NEURON, V78, P298, DOI 10.1016/j.neuron.2013.02.025; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; Kovacs L, 2009, FEBS J, V276, P4959, DOI 10.1111/j.1742-4658.2009.07198.x; KRUGER KE, 1991, J NEUROSCI, V11, P2303; Liu Y. Q., 2016, CHINESE J INTEGRATIV, V2016, P1, DOI DOI 10.1177/0894845316661831; Liu Y, 2016, NEUROPHARMACOLOGY, V105, P471, DOI 10.1016/j.neuropharm.2016.02.022; Low KE, 2014, BBA-GEN SUBJECTS, V1840, P3367, DOI 10.1016/j.bbagen.2014.08.014; Lu XY, 2001, J NEUROCHEM, V77, P1553, DOI 10.1046/j.1471-4159.2001.00359.x; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Lyons LC, 2017, NEUROBIOL LEARN MEM, V137, P134, DOI 10.1016/j.nlm.2016.11.018; Macqueen DJ, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130219; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Michel M, 2012, J NEUROSCI, V32, P4581, DOI 10.1523/JNEUROSCI.6264-11.2012; OLIVER MW, 1989, BRAIN RES, V505, P233, DOI 10.1016/0006-8993(89)91448-0; Ono Y, 2016, BIOCHIMIE, V122, P169, DOI 10.1016/j.biochi.2015.09.010; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Park MW, 2008, J BIOCHEM, V143, P217, DOI 10.1093/jb/mvm211; Potz BA, 2016, J NAT SCI, V2; Ravulapalli R, 2009, FEBS J, V276, P973, DOI 10.1111/j.1742-4658.2008.06833.x; Rawlings ND, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0095-0; Retief J D, 2000, Methods Mol Biol, V132, P243; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Santella L, 1998, CELL CALCIUM, V23, P123, DOI 10.1016/S0143-4160(98)90110-5; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Sossin WS, 2006, BRAIN BEHAV EVOLUT, V68, P145, DOI 10.1159/000094084; Sossin WS, 2009, BRAIN BEHAV EVOLUT, V74, P191, DOI 10.1159/000258666; Sossin WS, 1996, J NEUROSCI, V16, P10; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sutton MA, 2004, J NEUROSCI, V24, P3600, DOI 10.1523/JNEUROSCI.1134-03.2004; SUZUKI K, 1981, J BIOCHEM-TOKYO, V90, P275, DOI 10.1093/oxfordjournals.jbchem.a133463; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; Villareal G, 2009, J NEUROSCI, V29, P5100, DOI 10.1523/JNEUROSCI.4149-08.2009; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wang YZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4470; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Zadran S, 2013, NEUROMOL MED, V15, P74, DOI 10.1007/s12017-012-8196-8; Zadran S, 2010, MOL NEUROBIOL, V42, P143, DOI 10.1007/s12035-010-8145-1; Zhang WL, 1996, BIOCHEM BIOPH RES CO, V227, P890, DOI 10.1006/bbrc.1996.1601; Zhao S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-193; Zhu GQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42788	75	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186646	10.1371/journal.pone.0186646	http://dx.doi.org/10.1371/journal.pone.0186646			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053733	Green Submitted, gold, Green Published			2022-12-26	WOS:000413315100031
J	Maclachlan, L; Watson, S; Gallagher, P; Finkelmeyer, A; Jason, LA; Sunnquist, M; Newton, JL				Maclachlan, Laura; Watson, Stuart; Gallagher, Peter; Finkelmeyer, Andreas; Jason, Leonard A.; Sunnquist, Madison; Newton, Julia L.			Are current chronic fatigue syndrome criteria diagnosing different disease phenotypes?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; MYALGIC ENCEPHALOMYELITIS; CASE DEFINITIONS; VARIABILITY; RELIABILITY; VALIDATION; CONSENSUS; SYMPTOMS	Importance Chronic fatigue syndrome (CFS) is characterised by a constellation of symptoms diagnosed with a number of different polythetic criteria. Heterogeneity across these diagnostic criteria is likely to be confounding research into the as-yet-unknown pathophysiology underlying this stigmatised and debilitating condition and may diagnose a disease spectrum with significant implications for clinical management. No studies to date have objectively investigated this possibility using a validated measure of CFS symptoms-the DePaul Symptom Questionnaire (DSQ). Objective To examine whether current CFS diagnostic criteria are identifying different disease phenotypes using the DSQ. Design Case control study. Setting Clinical Research Facility of the Royal Victoria Infirmary, Newcastle upon Tyne, UK. Participants 49 CFS subjects and ten matched, sedentary community controls, excluded for co-morbid depression. Main outcomes and measures Self-reported autonomic and cognitive features were assessed with the Composite Autonomic Symptom Score (COMPASS) and Cognitive Failures Questionnaire (COGFAIL) respectively. Objective autonomic cardiovascular parameters were examined using the Task Force (R) Monitor and a battery of neuropsychological tests administered for objective cognitive assessment. Results Self-reported autonomic and cognitive symptoms were significantly greater in CFS subjects compared to controls. There were no statistically significant differences in objective autonomic measures between CFS and controls. There were clinically significant differences between DSQ subgroups on objective autonomic testing. Visuospatial memory, verbal memory and psychomotor speed were significantly different between DSQ subgroups. Conclusions and relevance The finding of no significant differences in objective autonomic testing between CFS and control subjects may reflect the inclusion of sedentary controls or exclusion for co-morbid depression. Consistent exclusion criteria would enable better delineation of these two conditions and their presenting symptoms. Findings across CFS subgroups suggest subjects have a different disease burden on subjective and objective measures of function, autonomic parameters and cognitive impairment when categorised using the DSQ. Different CFS criteria may at best be diagnosing a spectrum of disease severities and at worst different CFS phenotypes or even different diseases. This complicates research and disease management and may contribute to the significant stigma associated with the condition.	[Maclachlan, Laura; Newton, Julia L.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Watson, Stuart; Gallagher, Peter; Finkelmeyer, Andreas] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Watson, Stuart] Northumberland Tyne & Wear NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Jason, Leonard A.; Sunnquist, Madison] Depaul Univ, Chicago, IL 60604 USA; [Newton, Julia L.] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Maclachlan, Laura] Univ Gothenburg, Dept Publ Hlth & Community Med, Gothenburg, Sweden	Newcastle University - UK; Newcastle University - UK; DePaul University; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Gothenburg	Newton, JL (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.; Newton, JL (corresponding author), Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.	julia.newton@ncl.ac.uk	watson, stuart/B-8728-2009	watson, stuart/0000-0002-2558-3367; Gallagher, Peter/0000-0002-9808-7460; Maclachlan, Laura/0000-0002-8867-2201; Sunnquist, Madison/0000-0002-8164-3790; Newton, Julia/0000-0002-1249-5253	Medical Research Council [MR/J002712/1]; MRC [MR/J002712/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Medical Research Council grant number MR/J002712/1 to Julia Newton.	BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brown AA, 2014, FATIGUE, V2, DOI 10.1080/21641846.2014.928014; Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Clayton EW, 2015, JAMA-J AM MED ASSOC, V313, P1101, DOI 10.1001/jama.2015.1346; Cockshell SJ, 2010, PSYCHOL MED, V40, P1253, DOI 10.1017/S0033291709992054; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Della Sala S., 1997, VISUAL PATTERNS TEST; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fortin J, 1998, P ANN INT IEEE EMBS, V20, P360, DOI 10.1109/IEMBS.1998.745917; Fortin J, EXTERNAL PAPER RESUL; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gallagher P, 2014, PSYCHOL MED, V44, P961, DOI 10.1017/S0033291713001487; Gallagher P, 2014, PSYCHOL MED, V45, P1; Gambridge Brain Sciences, SPAT SPAN; Gandhi RA, 2010, DIABETES CARE, V33, P1585, DOI 10.2337/dc09-2314; Hawk C, 2007, J CHRONIC FATIGUE SY, V13, P41, DOI DOI 10.1300/J092V13N04_; He JB, 2013, NEUROIMAGE-CLIN, V2, P168, DOI 10.1016/j.nicl.2012.12.006; Jason L, 2010, AM J BIOCH BIOTECHNO, V6, P120, DOI [DOI 10.3844/AJBBSP.2010.120, DOI 10.3844/AJBBSP.2010.120.135]; Jason LA, 2003, EVAL HEALTH PROF, V26, P3, DOI 10.1177/0163278702250071; Jason LA, DEPAUL UNIVERSITY FA; Jason LA, 1997, J CHRONIC FATIGUE SY, V3, P39, DOI DOI 10.1300/J092V03N01_04; Jason LA SM, 2015, J NEUROLOGY, V1; Jason LA, 2015, FATIGUE, V3, P16, DOI 10.1080/21641846.2014.978110; Jason LA, 2012, EVAL HEALTH PROF, V35, P280, DOI 10.1177/0163278711424281; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; King C, 2005, BIOL PSYCHOL, V68, P87, DOI 10.1016/j.biopsycho.2004.03.015; KURTZE N, 2008, BMC MED RES METHODOL, V8; Mathias CJ, 2003, J NEUROL NEUROSUR PS, V74, pIII31, DOI 10.1136/jnnp.74.suppl_3.iii31; Meeus M, 2013, SEMIN ARTHRITIS RHEU, V43, P279, DOI 10.1016/j.semarthrit.2013.03.004; Michiels V, 2001, ACTA PSYCHIAT SCAND, V103, P84, DOI 10.1034/j.1600-0447.2001.00017.x; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Morris G, 2013, NEUROENDOCRINOL LETT, V34, P185; National Institute of Health and Care Excellence, CHRON FAT SYNDR MYAL; NHS Choices, CHRON FAT SYNDR DIAG; Reeves William C, 2007, Popul Health Metr, V5, P5; Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013; Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523; Van Cauwenbergh D, 2014, EUR J CLIN INVEST, V44, P516, DOI 10.1111/eci.12256; Wolin KY, 2008, J PHYS ACT HEALTH, V5, P746, DOI 10.1123/jpah.5.5.746	41	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186885	10.1371/journal.pone.0186885	http://dx.doi.org/10.1371/journal.pone.0186885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK2MA	29053742	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100047
J	Xie, DF; Li, MJ; Tan, JB; Price, M; Xiao, QY; Zhou, SD; Yu, Y; He, XJ				Xie, Deng-Feng; Li, Min-Jie; Tan, Jin-Bo; Price, Megan; Xiao, Qun-Ying; Zhou, Song-Dong; Yu, Yan; He, Xing-Jin			Phylogeography and genetic effects of habitat fragmentation on endemic Urophysa (Ranunculaceae) in Yungui Plateau and adjacent regions	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; CHLOROPLAST PHYLOGEOGRAPHY; POPULATION-STRUCTURE; PLANT; CONSEQUENCES; EVOLUTION; DIVERSITY; HISTORY; UPLIFT; DNA	Urophysa is a Chinese endemic genus with only two species (U. rockii and U. henryi) distributed in Yungui Plateau (Guizhou Province) and adjacent regions (i.e., Provinces of Hunan, Hubei, Chongqing and Sichuan). The aim of this study was to determine the genetic diversity and population differentiation within Urophysa and investigate the effect of the Yungui Plateau uplift and climate oscillations on evolution of Urophysa. In this study, micro-morphological characteristics, nine microsatellite loci (SSR), two nuclear loci (ITS and ETS) and two chloroplast fragments (psbA-trnH and trnL-trnF) were used to analyze the phylogenetic relationships and assess genetic and phylogeographical structure of Urophysa. Isolation by distance (IBD) was performed to research the effects of geographical isolation. We detected high genetic diversity at the species level but low genetic diversity within populations. Striking genetic differentiation (AMOVA) among populations and a significant phylogeographical structure (N-ST > G(ST), p < 0.01) were detected among U. henryi populations, along with significant effects of isolation by distance (IBD). Molecular clock estimation using calibration strategy and cpDNA substitution rate indicated that the divergence of U. henryi occurred during late Miocene to early Quaternary, when the orogeny of Yungui Plateau was violent. U. rockii originated at the early Quaternary and further differentiated at early Pleistocene. Our results suggested that habitat fragmentation played an important role in the genetic diversity and population differentiation of U. rockii and U. henryi. Heterogenous geomorphological configuration and complicated environment resulted from rapid uplift of the Yungui Plateau were inferred as important incentives for the modern phylogeograhpical pattern and species divergence of Urophysa. The geographical isolation, limited gene flow, specialized morphologies and the Pleistocene climatic oscillation greatly contributed to the allopatric divergence of U. rockii. Significant genetic drift and inbreeding were detected in these two species, in situ measures should be implemented to protect them.	[Xie, Deng-Feng; Li, Min-Jie; Tan, Jin-Bo; Xiao, Qun-Ying; Zhou, Song-Dong; Yu, Yan; He, Xing-Jin] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Sichuan, Peoples R China; [Price, Megan] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Yu, Y; He, XJ (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Sichuan, Peoples R China.	yyu@scu.edu.cn; xjhe@scu.edu.cn	He, Xingjin/Y-4126-2018; Yu, Yan/HCG-9743-2022; Yu, Yan/T-3280-2019	He, Xingjin/0000-0003-2064-0112; , Deng-Feng/0000-0002-9244-456X; Yu, Yan/0000-0001-7177-7552	National Natural Science Foundation of China [31270241, 31470009, 31570198, 31500188]; Specimen Platform of China, Teaching Specimen's sub-platform; Science and Technology Basic Work [2013FY112100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specimen Platform of China, Teaching Specimen's sub-platform; Science and Technology Basic Work	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31270241, 31470009, 31570198, 31500188), and the Specimen Platform of China, Teaching Specimen's sub-platform (Available website: http://mnh.scu.edu.cn/), the Science and Technology Basic Work (Grant No. 2013FY112100).; We are grateful to De-Qing Huang, Yun-Dong Gao and Xiang-Guang Ma for their guidance in paper revision and to Mr. Zheng-Yu Liu from the Chongqing Institute Of Medicinal Plant Cultivation for providing the materials information of the CQ population. This work was supported by the National Natural Science Foundation of China (Grant Nos. 31270241, 31470009, 31570198, 31500188), and the Specimen Platform of China, Teaching Specimen's sub-platform (Available website: http://mnh.scu.edu.cn), the Science and Technology Basic Work (Grant No. 2013FY112100).	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; Bastida JM, 2010, PLANT SYST EVOL, V284, P171, DOI 10.1007/s00606-009-0243-z; Burland T G, 2000, Methods Mol Biol, V132, P71; CARSON HL, 1990, TRENDS ECOL EVOL, V5, P228, DOI 10.1016/0169-5347(90)90137-3; Chen DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047268; CHENG J, 2001, GEOSCIENCE, V15, P290; Dai PF., 2012, THESIS; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Du BC, 2010, JIANGSHU AGR SCI, V1, P324; Dubreuil M, 2010, AM J BOT, V97, P303, DOI 10.3732/ajb.0900148; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Fu YX, 1997, GENETICS, V147, P915; Grivet D, 2002, MOL ECOL, V11, P1351, DOI 10.1046/j.1365-294X.2002.01522.x; Hamilton MB, 1999, MOL ECOL, V8, P521; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Heinken T, 2013, PERSPECT PLANT ECOL, V15, P205, DOI 10.1016/j.ppees.2013.05.003; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jaquiery J, 2009, CONSERV BIOL, V23, P207, DOI 10.1111/j.1523-1739.2008.01052.x; Kang M, 2014, NEW PHYTOL, V202, P1371, DOI 10.1111/nph.12726; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knobloch E, 1986, ROZPRAVY STRED HO ST, V47, P1; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Li C.Y., 2006, CLASSIFICATION SYSTE, V7, P3; Li LF, 2011, AM J BOT, V98, pE213, DOI 10.3732/ajb.1100057; Li Xi-Wen, 1993, Acta Botanica Yunnanica, V15, P217; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034013; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lienert Judit, 2004, Journal for Nature Conservation (Jena), V12, P53, DOI 10.1016/j.jnc.2003.07.002; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Lu GJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-241; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander J.A.A, 2004, MRMODELTEST V2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 1997, P NATL ACAD SCI USA, V94, P9996, DOI 10.1073/pnas.94.18.9996; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Qi XS, 2012, NEW PHYTOL, V196, P617, DOI 10.1111/j.1469-8137.2012.04242.x; Qing GF., 2002, J FORESTRY RES, V15, P406; Qiu YX, 2006, BIOCHEM SYST ECOL, V34, P745, DOI 10.1016/j.bse.2006.06.001; Rambaut A., 2009, FIGTREE1 3 1; Ro KE, 1997, MOL PHYLOGENET EVOL, V8, P117, DOI 10.1006/mpev.1997.0413; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 1997, GENETICS, V145, P1219; Shimono Y, 2009, AM J BOT, V96, P728, DOI 10.3732/ajb.0800242; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; [孙航 Sun Hang], 2003, [地球科学进展, Advance in Earth Sciences], V18, P852; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; Wang CB, 2014, MOL PHYLOGENET EVOL, V80, P205, DOI 10.1016/j.ympev.2014.08.015; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; [王静峰 WANG Jingfeng], 2011, [建筑结构学报, Journal of Building Structures], V32, P69; Wang JX, 2011, J SICHUAN FORESTRY S, V32, P28; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; Wang YH, 2015, NEW PHYTOL, V206, P852, DOI 10.1111/nph.13261; Wang Z.H., 2011, STUDY TYPICAL CONTIN; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright SD, 2001, J BIOGEOGR, V28, P769, DOI 10.1046/j.1365-2699.2001.00605.x; Wu FY, 2008, ACTA PETROL SIN, V24, P1; Xie DF, 2016, BIOCHEM SYST ECOL, V69, P76, DOI 10.1016/j.bse.2016.07.021; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang AH, 2016, SCI REPORTS, V6; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Yuan QJ, 2008, MOL ECOL, V17, P1054, DOI 10.1111/j.1365-294X.2007.03628.x; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061954, 10.1371/journal.pone.0069046]; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112923; Zhang JJ, 2015, ANN BOT; Zhang Yun-Xiang, 2013, Plant Diversity and Resources, V35, P303, DOI 10.7677/ynzwyj201313036; Zhang Yunxiang, 2013, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V33, P1098; Zhou TH, 2010, MOL PHYLOGENET EVOL, V57, P176, DOI 10.1016/j.ympev.2010.07.001	99	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186378	10.1371/journal.pone.0186378	http://dx.doi.org/10.1371/journal.pone.0186378			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053749	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100019
J	Ivanova, J; Zhang, SJ; Wang, RL; Schoenfuss, HL				Ivanova, Jelena; Zhang, Shiju; Wang, Rong-Lin; Schoenfuss, Heiko L.			Social hierarchy modulates responses of fish exposed to contaminants of emerging concern	PLOS ONE			English	Article							MINNOWS PIMEPHALES-PROMELAS; MALE FATHEAD MINNOWS; ENDOCRINE-DISRUPTING CHEMICALS; TELEOST FISH; ESTROGEN-RECEPTOR; RAINBOW-TROUT; SEROTONIN; EXPRESSION; DOMINANCE; BEHAVIOR	Many organisms, including the fathead minnow (Pimephales promelas), a toxicological model organism, establish social hierarchies. The social rank of each male in a population is under the control of the hypothalamic-pituitary-gonadal (HPG) axis mainly through regulation of circulating androgen concentrations, which in turn drive the expression of secondary sex characteristics (SSCs). As dominant and subordinate males in an exposure study are initially under different physiological conditions (i.e., differing plasma androgen concentrations), we proposed that they belong to different subpopulations in the context of exposure to compounds that may interact with the HPG axis. Using a meta-analysis of our data from several previously published studies, we corroborated the hypothesis that social status, as indicated by SSCs, results in distinct clusters (eigenvalues >0.8 explaining >80% of variability) with differential expression of plasma vitellogenin, a commonly used biomarker of exposure to contaminants of emerging concern (CEC). Furthermore, we confirmed our predictions that exposure to estrogenic CECs would homogenize plasma vitellogenin response (E1: cluster mean SSC values decreased to 4.33 and 4.86 relative to those of control; E2: decreased to 4.8 and 5.37) across the social hierarchy. In contrast, serotonin-specific reuptake inhibitors expand this response range (cluster mean SSC increased to 5.21 and 6.5 relative to those of control). Our results demonstrated that social hierarchies in male fathead minnows result in heterogeneous responses to chemical exposure. These results represent a cautionary note for the experimental design of single-sex exposure studies. We anticipate our study to be a starting point for the re-evaluation of toxicological data analyses in single sex exposure experiments.	[Ivanova, Jelena; Schoenfuss, Heiko L.] St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA; [Zhang, Shiju] St Cloud State Univ, Dept Math & Stat, St Cloud, MN 56301 USA; [Wang, Rong-Lin] US EPA, Exposure Methods & Measurements Div, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	Minnesota State Colleges & Universities; Saint Cloud State University; Minnesota State Colleges & Universities; Saint Cloud State University; United States Environmental Protection Agency	Schoenfuss, HL (corresponding author), St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA.	hschoenfuss@stcloudstate.edu		Schoenfuss, Heiko/0000-0001-5464-992X	US Fish & Wildlife Service [628737]; National Science Foundation [CBET 1336062]; SETAC	US Fish & Wildlife Service(US Fish & Wildlife Service); National Science Foundation(National Science Foundation (NSF)); SETAC	HLS (St Cloud State University) received funding from the US Fish & Wildlife Service for this project (628737). Additional support was provided to HLS by a National Science Foundation grant (CBET 1336062). Travel grants and award funds by SETAC (to JL) are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SM, 1994, ENVIRON TOXICOL CHEM, V13, P1673, DOI [10.1897/1552-8618(1994)13[1673:AOCVAI]2.0.CO;2, 10.1002/etc.5620131018]; Ankley GT, 2004, ILAR J, V45, P469, DOI 10.1093/ilar.45.4.469; BILLARD R, 1982, CAN J FISH AQUAT SCI, V39, P65, DOI 10.1139/f82-009; Bjerselius R, 2001, AQUAT TOXICOL, V53, P139, DOI 10.1016/S0166-445X(00)00160-0; Brian JV, 2011, J FISH BIOL, V79, P80, DOI 10.1111/j.1095-8649.2011.02993.x; Brian JV, 2008, SCI TOTAL ENVIRON, V397, P72, DOI 10.1016/j.scitotenv.2008.02.036; Cubitt KF, 2008, PHYSIOL BEHAV, V94, P529, DOI 10.1016/j.physbeh.2008.03.009; Dammann AA, 2011, AQUAT TOXICOL, V105, P559, DOI 10.1016/j.aquatox.2011.08.011; Danylchuk AJ, 2001, BEHAV ECOL, V12, P482, DOI 10.1093/beheco/12.4.482; Deckel AW, 1996, BEHAV BRAIN RES, V78, P175; DENNY JS, 1987, GUIDELINES CULTURE F; Desban L, 2016, SCI, P352; Feifarek D, 2015, THESIS; FERNANDEZDUQUE E, 1994, CONSERV BIOL, V8, P555, DOI 10.1046/j.1523-1739.1994.08020555.x; Filby AL, 2012, ENVIRON SCI TECHNOL, V46, P3472, DOI 10.1021/es204023d; Fox HE, 1997, J NEUROSCI, V17, P6463; Gavrilescu M, 2015, NEW BIOTECHNOL, V32, P147, DOI 10.1016/j.nbt.2014.01.001; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; Harries JE, 2000, ENVIRON SCI TECHNOL, V34, P3003, DOI 10.1021/es991292a; Hyndman KM, 2010, AQUAT TOXICOL, V96, P264, DOI 10.1016/j.aquatox.2009.11.004; Ikeuchi T, 2001, COMP BIOCHEM PHYS B, V129, P449, DOI 10.1016/S1096-4959(01)00375-X; Jacob A, 2009, ANIM BEHAV, V77, P823, DOI 10.1016/j.anbehav.2008.12.006; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Jolliffe I.T., 1986, PRINCIPLE COMPONENT; KAH O, 1993, FISH PHYSIOL BIOCHEM, V11, P85, DOI 10.1007/BF00004554; KAH O, 1992, NEUROENDOCRINOLOGY, V55, P396, DOI 10.1159/000126150; Kah O, 2011, HORMONES AND REPRODU, V1; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kolok AS, 2012, J ENVIRON MONITOR, V14, P202, DOI 10.1039/c1em10703h; Larson ET, 2001, BEHAV BRAIN RES, V121, P95, DOI 10.1016/S0166-4328(00)00393-4; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Martinez-Martin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030204; Martinovic D, 2007, ENVIRON TOXICOL CHEM, V26, P271, DOI 10.1897/06-065R.1; Martinovic-Weigelt D, 2003, P 3 INT C PHARM END, P125; Miracle A, 2006, ECOTOX ENVIRON SAFE, V63, P337, DOI 10.1016/j.ecoenv.2005.12.002; Munakata A, 2010, GEN COMP ENDOCR, V165, P456, DOI 10.1016/j.ygcen.2009.04.011; Nagler JJ, 2007, GENE, V392, P164, DOI 10.1016/j.gene.2006.12.030; Overli O, 2007, COMP BIOCH PHYSL, V146, pS75; Panter GH, 1998, AQUAT TOXICOL, V42, P243, DOI 10.1016/S0166-445X(98)00038-1; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; Proust M, 2013, JMP DOCUMENTATION LI; Rantala MJ, 2004, BEHAV ECOL, V15, P187, DOI 10.1093/beheco/arg103; Rearick DC, 2014, ENVIRON TOXICOL CHEM, V33, P553, DOI 10.1002/etc.2461; Schoenfuss HL, 2008, AQUAT TOXICOL, V86, P91, DOI 10.1016/j.aquatox.2007.10.004; Schultz MM, 2012, ARCH ENVIRON CON TOX, V63, P114, DOI 10.1007/s00244-011-9748-x; Schultz MM, 2011, AQUAT TOXICOL, V104, P38, DOI 10.1016/j.aquatox.2011.03.011; SCHULZ RW, 1993, FISH PHYSIOL BIOCHEM, V11, P107, DOI 10.1007/BF00004556; Shappell NW, 2010, AQUAT TOXICOL, V100, P1, DOI 10.1016/j.aquatox.2010.07.005; SMITH RJF, 1978, CAN J ZOOL, V56, P2103, DOI 10.1139/z78-285; SMITH RJF, 1974, T AM FISH SOC, V103, P65, DOI 10.1577/1548-8659(1974)103<65:FMOTDP>2.0.CO;2; SOMOZA GM, 1991, GEN COMP ENDOCR, V82, P103, DOI 10.1016/0016-6480(91)90301-L; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Thorpe KL, 2009, ENVIRON SCI TECHNOL, V43, P2976, DOI 10.1021/es803103c; Thorpe KL, 2003, FISH PHYSIOL BIOCHEM, V28, P451, DOI 10.1023/B:FISH.0000030627.76841.ed; Trudeau V L, 1997, Rev Reprod, V2, P55, DOI 10.1530/ror.0.0020055; Watanabe KH, 2007, COMP BIOCHEM PHYS C, V146, P348, DOI 10.1016/j.cbpc.2007.04.015; Winberg S, 1998, AM J PHYSIOL-REG I, V274, pR645, DOI 10.1152/ajpregu.1998.274.3.R645; Winberg S, 1997, NEUROSCI LETT, V230, P113, DOI 10.1016/S0304-3940(97)00488-6; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	61	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186807	10.1371/journal.pone.0186807	http://dx.doi.org/10.1371/journal.pone.0186807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049393	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900115
J	Yoo, YJ; Hwang, JM; Yang, HK				Yoo, Yung Ju; Hwang, Jeong-Min; Yang, Hee Kyung			Differences in pupillary light reflex between optic neuritis and ischemic optic neuropathy	PLOS ONE			English	Article							NERVE-FIBER LAYER; MULTIPLE-SCLEROSIS; INFRARED PUPILLOMETER; DIAMETER; DEFECT; TRIAL; PERIMETRY; DISEASE; LATENCY; SIZE	Objectives To determine the differences in pupillary light reflex (PLR) between the acute and chronic phases of optic neuritis (ON) and nonarteritic anterior ischemic optic neuropathy (NAION). Methods The study included 30 patients with ON and 22 patients with NAION whose PLR were measured by a dynamic pupillometer (PLR-200; NeurOptics Inc., Irvine, USA). Age-matched controls included 58 healthy individuals with normal vision and optic nerve function. Pupil diameters, latency, constriction ratio, constriction velocity and dilation velocity were noted. The differences in PLR measurements were compared among the acute and chronic phases of ON and NAION, and in age-matched controls. Regression analysis determined factors associated with PLR measurements, including visual acuity, color vision defect, visual field defects and retinal nerve fiber layer thickness measurements on optical coherence tomography. Results Pupillary constriction velocity, constriction ratio and latency were all significantly decreased in the acute phase of ON and NAION. ON showed significantly delayed constriction latency compared to NAION (P = 0.047). Pupillary constriction velocity, constriction ratio and latency were recovered in the chronic phase of ON (P = 0.038, 0.018, and 0.045), however, these parameters were not recovered in NAION (P = 0.693, 0.173 and 0.994). Conclusions Pupillary constriction velocity, constriction ratio, and latency were significantly decreased in the acute phase of ON and NAION compared to normal controls. ON showed delayed constriction latency compared to NAION. Decreased PLR were recovered in the chronic phase of ON, but not in NAION.	[Yoo, Yung Ju] Kangwon Natl Univ, Grad Sch Med, Kangwon Natl Univ Hosp, Dept Ophthalmol, Chunchon, South Korea; [Hwang, Jeong-Min; Yang, Hee Kyung] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU)	Yang, HK (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	nan282@snu.ac.kr						Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; BARBUR JL, 1994, OPHTHAL PHYSL OPT, V14, P139, DOI 10.1111/j.1475-1313.1994.tb00102.x; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; BECK RW, 1993, ARCH OPHTHALMOL-CHIC, V111, P773, DOI 10.1001/archopht.1993.01090060061023; Behbehani R, 2007, CLIN OPHTHALMOL, V1, P233; Bellusci C, 2008, GRAEF ARCH CLIN EXP, V246, P641, DOI 10.1007/s00417-008-0767-x; Bergamin O, 2003, INVEST OPHTH VIS SCI, V44, P1546, DOI 10.1167/iovs.02-0468; Bernstein SL, 2011, PROG RETIN EYE RES, V30, P167, DOI 10.1016/j.preteyeres.2011.02.003; Bradley JC, 2010, J CATARACT REFR SURG, V36, P277, DOI 10.1016/j.jcrs.2009.09.025; Burton Erik V, 2011, Pathophysiology, V18, P81, DOI 10.1016/j.pathophys.2010.04.009; Capo-Aponte JE, 2013, JOURNAL OF SPINE, V2013; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Cohen LM, 2015, CURR EYE RES, V40, P1120, DOI 10.3109/02713683.2014.980007; Du R, 2005, NEUROSURGERY, V57, P198, DOI 10.1227/01.NEU.0000163425.79170.CB; Foroozan Rod, 2002, Curr Opin Ophthalmol, V13, P375, DOI 10.1097/00055735-200212000-00006; Fotiou D F, 2007, Electromyogr Clin Neurophysiol, V47, P11; Hults Kathryn N, 2006, J Neurosci Nurs, V38, P447; JOHNSON LN, 1988, OPHTHALMOLOGY, V95, P1649; KARDON RH, 1993, AM J OPHTHALMOL, V115, P351, DOI 10.1016/S0002-9394(14)73587-1; Kupersmith MJ, 2011, J NEUROL SCI, V308, P117, DOI 10.1016/j.jns.2011.05.039; LEVATIN P, 1959, ARCH OPHTHALMOL-CHIC, V62, P768; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Ludtke H, 1999, GRAEF ARCH CLIN EXP, V237, P207, DOI 10.1007/s004170050220; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Nagia L, 2016, INVEST OPHTH VIS SCI, V57, P4679, DOI 10.1167/iovs.16-19315; Newman NJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1366; Peeler C, 2016, SEMIN OPHTHALMOL, V31, P99, DOI 10.3109/08820538.2015.1115248; Pro MJ, 2006, J NEUROL SCI, V250, P114, DOI 10.1016/j.jns.2006.08.012; RADZIUS A, 1989, BEHAV RES METH INSTR, V21, P611, DOI 10.3758/BF03210585; RASMINSKY M, 1984, ANN NY ACAD SCI, V436, P68, DOI 10.1111/j.1749-6632.1984.tb14776.x; RIZZO JF, 1991, ARCH OPHTHALMOL-CHIC, V109, P1668, DOI 10.1001/archopht.1991.01080120052024; Schallenberg M, 2010, J REFRACT SURG, V26, P134, DOI 10.3928/1081597X-20100121-09; Schmitz S, 2003, GRAEF ARCH CLIN EXP, V241, P472, DOI 10.1007/s00417-003-0669-x; Sharma S, 2016, GRAEFES ARCH CLIN EX; Shwe-Tin A, 2012, J NEURO-OPHTHALMOL, V32, P111, DOI 10.1097/WNO.0b013e31823f45e5; Smith KJ, 1999, PHILOS T R SOC B, V354, P1649, DOI 10.1098/rstb.1999.0510; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; VANDIEMEN HAM, 1992, ELECTROEN CLIN NEURO, V82, P213, DOI 10.1016/0013-4694(92)90170-M; Warner JEA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1408, DOI 10.1001/archopht.1997.01100160578009; Wickremasinghe SS, 2005, J CATARACT REFR SURG, V31, P1171, DOI 10.1016/j.jcrs.2004.10.049; Wilhelm H, 2007, J NEURO-OPHTHALMOL, V27, P263, DOI 10.1097/WNO.0b013e31815bf865; WILSON WB, 1978, AM J OPHTHALMOL, V86, P530, DOI 10.1016/0002-9394(78)90302-1	43	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186741	10.1371/journal.pone.0186741	http://dx.doi.org/10.1371/journal.pone.0186741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049405	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900107
J	Lee, C; Lee, S; Lee, SJ; Song, H; Kim, DH; Cho, S; Jo, K; Han, Y; Chung, YH; Kim, JS				Lee, Chaeyeong; Lee, Sangmin; Lee, Seung-Jae; Song, Hankyeol; Kim, Dae-Hyun; Cho, Sungkoo; Jo, Kwanghyun; Han, Youngyih; Chung, Yong Hyun; Kim, Jin Sung			Monte Carlo simulation of secondary neutron dose for scanning proton therapy using FLUKA	PLOS ONE			English	Article							CANCER	Proton therapy is a rapidly progressing field for cancer treatment. Globally, many proton therapy facilities are being commissioned or under construction. Secondary neutrons are an important issue during the commissioning process of a proton therapy facility. The purpose of this study is to model and validate scanning nozzles of proton therapy at Samsung Medical Center (SMC) by Monte Carlo simulation for beam commissioning. After the commissioning, a secondary neutron ambient dose from proton scanning nozzle (Gantry 1) was simulated and measured. This simulation was performed to evaluate beam properties such as percent depth dose curve, Bragg peak, and distal fall-off, so that they could be verified with measured data. Using the validated beam nozzle, the secondary neutron ambient dose was simulated and then compared with the measured ambient dose from Gantry 1. We calculated secondary neutron dose at several different points. We demonstrated the validity modeling a proton scanning nozzle system to evaluate various parameters using FLUKA. The measured secondary neutron ambient dose showed a similar tendency with the simulation result. This work will increase the knowledge necessary for the development of radiation safety technology in medical particle accelerators.	[Lee, Chaeyeong; Lee, Seung-Jae; Song, Hankyeol; Chung, Yong Hyun] Yonsei Univ, Dept Radiol Sci, Wonju, South Korea; [Lee, Sangmin] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Program Biomed Radiat Sci, Seoul, South Korea; [Kim, Dae-Hyun; Cho, Sungkoo; Jo, Kwanghyun; Han, Youngyih; Kim, Jin Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Jin Sung] Yonsei Univ, Coll Med Seoul, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea	Yonsei University; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Kim, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea.; Kim, JS (corresponding author), Yonsei Univ, Coll Med Seoul, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea.	jinsung@yuhs.ac		Lee, Seungjae/0000-0003-3377-1066; Lee, Sangmin/0000-0003-1241-2857; Kim, Jin Sung/0000-0003-1415-6471; Lee, Seungjae/0000-0001-9081-2835	Ministry of Science, ICT and Future Planning, Korea [NRF-2015M3A9E2067001]	Ministry of Science, ICT and Future Planning, Korea	This work was supported by Ministry of Science, ICT and Future Planning, Korea through the R&D program of NRF-2015M3A9E2067001.	Chung K, 2015, RADIAT ONCOL J, V33, P337, DOI 10.3857/roj.2015.33.4.337; Farah J, 2015, MED PHYS, V42, P2572, DOI 10.1118/1.4916667; Ferrari A., P MC93 INT C MONT CA, P277; Hall E.J., 2006, INT J RAD OONOCOL BI, V65; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; Jarlskog CZ, 2008, INT J RADIAT ONCOL, V72, P228, DOI 10.1016/j.ijrobp.2008.04.069; Kim JS, 2015, J KOREAN PHYS SOC, V67, P142, DOI 10.3938/jkps.67.142; Lawrence TD, 2014, MED PHYS, DOI [10.1118/1.4869175, DOI 10.1118/1.4869175]; Miller DW, 1995, MED PHYS, P22; Newhauser WD, 2015, PHYS MED BIOL; Ning MS, 2015, J NEURO-ONCOL, V122, P321, DOI 10.1007/s11060-014-1712-y; Olsen DR, 2007, RADIOTHER ONCOL, V83, P123, DOI 10.1016/j.radonc.2007.03.001; Paganetti H, 2002, PHYS MED BIOL, V47, P747, DOI 10.1088/0031-9155/47/5/305; Schneider U, 2000, RADIAT RES, V154, P382, DOI 10.1667/0033-7587(2000)154[0382:CRAOSC]2.0.CO;2; Shin JS, 2011, RADIAT ONCOL J, V29, P206, DOI 10.3857/roj.2011.29.3.206; Yonai S, 2008, MED PHYS, V35, P4782, DOI 10.1118/1.2989019	16	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186544	10.1371/journal.pone.0186544	http://dx.doi.org/10.1371/journal.pone.0186544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045491	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100069
J	Robiou-du-Pont, S; Anand, SS; Morrison, KM; McDonald, SD; Atkinson, SA; Teo, KK; Meyre, D				Robiou-du-Pont, Sebastien; Anand, Sonia S.; Morrison, Katherine M.; McDonald, Sarah D.; Atkinson, Stephanie A.; Teo, Koon K.; Meyre, David			Parental and offspring contribution of genetic markers of adult blood pressure in early life: The FAMILY study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CYTOSKELETAL REORGANIZATION; CARDIOVASCULAR RISK; HYPERTENSION; CHILDREN; HERITABILITY; CHILDHOOD; VARIANTS; LOCI; AMERICAN	Previous genome wide association studies (GWAS) identified associations of multiple common variants with diastolic and systolic blood pressure traits in adults. However, the contribution of these loci to variations of blood pressure in early life is unclear. We assessed the child and parental contributions of 33 GWAS single-nucleotide polymorphisms (SNPs) for blood pressure in 1,525 participants (515 children, 406 mothers and 237 fathers) of the Family Atherosclerosis Monitoring In early life (FAMILY) study followed-up for 5 years. Two genotype scores for systolic (29 SNPs) and diastolic (24 SNPs) blood pressure were built. Linear mixedeffect regressions showed significant association between rs1378942 in CSK and systolic blood pressure (beta = 0.98 +/- 0.46, P = 3.4x10(-2)). The child genotype scores for diastolic and systolic blood pressure were not associated in children. Nominally significant parental genetic effects were found between the SNPs rs11191548 (CYP17A1) (paternal, beta = 2.78 +/- 1.49, P = 6.1x10(-2) for SBP and beta = 3.60 +/- 1.24, P = 3.7x10(-3) for DBP), rs17367504 (MTHFR) (paternal, beta = 2.42 +/- 0.93, P = 9.3x10(-3) for SBP and beta = 1.89 +/- 0.80, P = 1.8x10(-2) for DBP and maternal, beta = -1.32 +/- 0.60, P = 2.9x10(-2) and beta = -1.97 +/- 0.77, P = 1.0x10(-2), for SBP and DBP respectively) and child blood pressure. Our study supports the view that adult GWAS loci have a limited impact on blood pressure during the five first years of life. The parental genetic effects observed on blood pressure in children may suggest epigenetic mechanisms in the transmission of the risk of hypertension. Further replication is needed to confirm our results.	[Robiou-du-Pont, Sebastien; Anand, Sonia S.; McDonald, Sarah D.; Teo, Koon K.; Meyre, David] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Anand, Sonia S.; Teo, Koon K.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Morrison, Katherine M.; Atkinson, Stephanie A.] Hamilton Hlth Sci, Dept Pediat, Hamilton, ON, Canada; [Morrison, Katherine M.; Atkinson, Stephanie A.] McMaster Univ, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Meyre, David] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Meyre, D (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Meyre, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	meyred@mcmaster.ca	Atkinson, Stephanie/AAS-4146-2021; Morrison, Katherine/AAO-8046-2021	Atkinson, Stephanie/0000-0002-5680-7546; Morrison, Katherine/0000-0002-1737-256X; Teo, Koon/0000-0002-3731-0956	Heart and Stroke Foundation of Ontario [NA 7293]; Hamilton Health Science Foundation; Canadian Institutes of Health Research; Heart & Stroke Foundation of Ontario; PHRI internal funds; Canada Research Chair in Genetics of Obesity; Canadian Institutes of Health Research New Investigator Salary Award; Heart & Stroke Foundation Career Fellowship in preventive cardiology	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Hamilton Health Science Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart & Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); PHRI internal funds; Canada Research Chair in Genetics of Obesity; Canadian Institutes of Health Research New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); Heart & Stroke Foundation Career Fellowship in preventive cardiology	The present study has been funded by the Heart and Stroke Foundation of Ontario (grant # NA 7293 "Early genetic origins of cardiovascular risk factors"). The FAMILY study was funded by the Hamilton Health Science Foundation, the Canadian Institutes of Health Research and by Heart & Stroke Foundation of Ontario as well as additional grants from the PHRI internal funds. D. M. is supported by a Canada Research Chair in Genetics of Obesity. S.R.P is supported by the Heart and Stroke Foundation of Ontario (grant # NA 7293). S.S.A. holds the Heart and Stroke Foundation of Ontario, Michael G. DeGroote endowed Chair in Population Health and a Canada Research Chair in Ethnicity and Cardiovascular Disease. S.D.M is supported by a Canadian Institutes of Health Research New Investigator Salary Award. K.M.M. was supported by the Heart & Stroke Foundation Career Fellowship in preventive cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR, V1; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danese E, 2013, CLIN CHEM LAB MED, V51, P2253, DOI 10.1515/cclm-2013-0405; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Flavahan S, 2014, AM J PHYSIOL-HEART C, V307, pH628, DOI 10.1152/ajpheart.00327.2014; Fowler SP, 2013, HUM GENET, V132, P1059, DOI 10.1007/s00439-013-1315-2; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Howe LD, 2013, CIRC-CARDIOVASC GENE, V6, P608, DOI 10.1161/CIRCGENETICS.113.000197; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Kaplan NM, 2006, LANCET, V367, P168, DOI 10.1016/S0140-6736(06)67965-8; Knuiman MW, 1996, ANN EPIDEMIOL, V6, P188, DOI 10.1016/1047-2797(96)00004-X; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Leon DA, 2005, CIRCULATION, V112, P3478, DOI 10.1161/CIRCULATIONAHA.104.497610; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li A, 2013, INT J OBESITY, V37, P559, DOI 10.1038/ijo.2012.82; Li A., 2016, PEDIAT OBES; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Mathias RA, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S36; Mitsumata K, 2012, HYPERTENSION, V60, P1124, DOI 10.1161/HYPERTENSIONAHA.112.201129; Moreno-Dominguez A, 2014, J BIOL CHEM, V289, P20939, DOI 10.1074/jbc.M114.553743; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oikonen M, 2011, HYPERTENSION, V58, P1079, DOI 10.1161/HYPERTENSIONAHA.111.179291; Parmar PG, 2016, CIRC CARDIOVASC GENE; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; Sitlani CM, 2015, STAT MED, V34, P118, DOI 10.1002/sim.6323; Slama M, 2002, CURR OPIN CARDIOL, V17, P531, DOI 10.1097/00001573-200209000-00014; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; Sohani ZN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152107; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Taal HR, 2012, HYPERTENSION, V59, P241, DOI 10.1161/HYPERTENSIONAHA.111.179481; Tragante V, 2014, AM J HUM GENET, V94, P349, DOI 10.1016/j.ajhg.2013.12.016; Vinck WJ, 2001, J HYPERTENS, V19, P1007, DOI 10.1097/00004872-200106000-00003; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; WHINCUP PH, 1992, ARCH DIS CHILD, V67, P1423, DOI 10.1136/adc.67.12.1423; Xi B, 2013, AM J HYPERTENS, V26, P990, DOI 10.1093/ajh/hpt046	41	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186218	10.1371/journal.pone.0186218	http://dx.doi.org/10.1371/journal.pone.0186218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045471	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100043
J	Saoura, M; Pinnock, K; Pujantell-Graell, M; Levinger, L				Saoura, Makenzie; Pinnock, Kyla; Pujantell-Graell, Maria; Levinger, Louis			Substitutions in conserved regions preceding and within the linker affect activity and flexibility of tRNase Z(L), the long form of tRNase Z	PLOS ONE			English	Article							RNASE-Z; SUBSTRATE RECOGNITION; MITOCHONDRIAL; CATALYSIS; RESIDUES; ENZYMES; BINDING; YEAST; SIDE	The enzyme tRNase Z, a member of the metallo-beta-lactamase family, endonucleolytically removes 3' trailers from precursor tRNAs, preparing them for CCA addition and aminoacylation. The short form of tRNase Z, tRNase Z(S), functions as a homodimer and is found in all prokaryotes and some eukaryotes. The long form, tRNase Z(L), related to tRNase Z(S) through tandem duplication and found only in eukaryotes, possesses similar to 2,000-fold greater catalytic efficiency than tRNase Z(S). tRNase Z(L) consists of related but diverged amino and carboxy domains connected by a flexible linker (also referred to as a flexible tether) and functions as a monomer. The amino domain retains the flexible arm responsible for substrate recognition and binding while the carboxy domain retains the active site. The linker region was explored by Ala-scanning through two conserved regions of D. melanogaster tRNase Z: NdomTprox, located at the carboxy end of the amino domain proximal to the linker, and T-flex, a flexible site in the linker. Periodic substitutions in a hydrophobic patch (F-329 and L-332) at the carboxy end of N(dom)T(pro)x show 2,700 and 670-fold impairment relative to wild type, respectively, accompanied by reduced linker flexibility at N-T inside the N-dom-linker boundary. The Ala substitution for N-378 in the T-flex region has 10-fold higher catalytic efficiency than wild type and locally decreased flexibility, while the Ala substitution at R-382 reduces catalytic efficiency similar to 50-fold. These changes in pre-tRNA processing kinetics and protein flexibility are interpreted in light of a recent crystal structure for S. cerevisiae tRNase Z, suggesting transmission of local changes in hydrophobicity into the skeleton of the amino domain.	[Saoura, Makenzie; Pinnock, Kyla; Pujantell-Graell, Maria; Levinger, Louis] CUNY York Coll, Jamaica, NY 11451 USA; [Saoura, Makenzie; Pinnock, Kyla; Pujantell-Graell, Maria; Levinger, Louis] CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA; [Pinnock, Kyla] SUNY Hlth Sci Ctr, Coll Med, Brooklyn, NY USA; [Pujantell-Graell, Maria] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Inst Germans Trias & Pujol, AIDS Res Inst IrsiCaixa & Hlth Res, Badalona, Spain; [Levinger, Louis] CUNY, PhD Programs Biochem & Mol Cellular & Dev Biol, Jamaica, NY 11451 USA	City University of New York (CUNY) System; York College NY (CUNY); City University of New York (CUNY) System; York College NY (CUNY); State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; City University of New York (CUNY) System	Levinger, L (corresponding author), CUNY York Coll, Jamaica, NY 11451 USA.; Levinger, L (corresponding author), CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA.; Levinger, L (corresponding author), CUNY, PhD Programs Biochem & Mol Cellular & Dev Biol, Jamaica, NY 11451 USA.	llevinger@york.cuny.edu			National Institutes of Health [R15GM101620]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by grant R15GM101620 from the National Institutes of Health.	Aravind L, 1999, In Silico Biol, V1, P69; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Karkashon S, 2007, BIOCHEMISTRY-US, V46, P9380, DOI 10.1021/bi700578v; Levinger L, 2009, J BIOL CHEM, V284, P15685, DOI 10.1074/jbc.M900745200; Ma M, 2017, NUCLEIC ACIDS RES, V45, P6209, DOI 10.1093/nar/gkx216; Moore PB, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003780; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Skowronek E, 2014, RNA, V20, P115, DOI 10.1261/rna.041467.113; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Wilson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066942; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Zareen N, 2005, J MOL BIOL, V350, P189, DOI 10.1016/j.jmb.2005.04.073; Zhao W, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-272	19	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186277	10.1371/journal.pone.0186277	http://dx.doi.org/10.1371/journal.pone.0186277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045449	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100049
J	van Samkar, G; Hermanns, H; Lirk, P; Hollmann, MW; Stevens, MF				van Samkar, Ganapathy; Hermanns, Henning; Lirk, Philipp; Hollmann, Markus W.; Stevens, Markus F.			Influence on number of top-ups after implementing patient controlled epidural analgesia: A cohort study	PLOS ONE			English	Article							POSTOPERATIVE PAIN MANAGEMENT; LABOR ANALGESIA; SURGICAL-PATIENTS; MAJOR SURGERY; METAANALYSIS; INFUSION; EXPERIENCE	Postoperative epidural analgesia often needs rate readjustment using top-ups. Patient-controlled epidural analgesia (PCEA) is said to reduce the requirement of epidural top-ups when compared to continuous epidural analgesia (CEA). We compared CEA and PCEA in major thoracic and abdominal surgery, in a cohort study. The primary endpoint was the required number of epidural top-ups. Secondary endpoints were pain scores, side effects and workload differences. We analysed 199 patients with CEA and 187 with PCEA. Both groups had similar pain scores. The total number of top-ups was 75 in 57 patients (CEA) versus 20 top-ups in 18 patients (PCEA). (p = 0.0001) Sedation tended to occur more frequently in patients with CEA versus PCEA, 5.5% vs 1.6% (p = 0.05). Implementation of PCEA led to a decreased number of top-ups, fewer side-effects and decreased use of the postoperative care unit.	[van Samkar, Ganapathy; Hermanns, Henning; Lirk, Philipp; Hollmann, Markus W.; Stevens, Markus F.] Acad Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands; [Lirk, Philipp] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hollmann, MW (corresponding author), Acad Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands.	m.w.hollmann@amc.uva.nl		Stevens, Markus Florian/0000-0002-0032-860X; Hermanns, Henning/0000-0002-4297-495X; Hollmann, Markus/0000-0001-8248-0244	Academic Medical Center, Amsterdam, The Netherlands [SH102002, 201015b]; B. Braun Medical B.V. (Oss, The Netherlands)	Academic Medical Center, Amsterdam, The Netherlands(Netherlands Government); B. Braun Medical B.V. (Oss, The Netherlands)	The study was funded by an internal developmental grant (project code SH102002; grant number 201015b) of the Academic Medical Center, Amsterdam, The Netherlands to MS. We would like to acknowledge B. Braun Medical B.V. (Oss, The Netherlands) for giving financial support of 750 Euros as a contribution to the costs of publication. B. Braun Medical was not involved in any part of the research, including design, analysis, or writing of the manuscript.	Block BM, 2003, JAMA-J AM MED ASSOC, V290, P2455, DOI 10.1001/jama.290.18.2455; Brodner G, 2000, EUR J ANAESTH, V17, P566, DOI 10.1046/j.1365-2346.2000.00738.x; Capogna G, 2013, CURR OPIN ANESTHESIO, V26, P261, DOI 10.1097/ACO.0b013e328360b069; George RB, 2013, ANESTH ANALG, V116, P133, DOI 10.1213/ANE.0b013e3182713b26; Golster M, 2014, EUROPEAN J ANAESTHES; Hermanides J, 2012, BRIT J ANAESTH, V109, P144, DOI 10.1093/bja/aes214; Kainzwaldner V, 2013, ANAESTHESIST, V62, P453, DOI 10.1007/s00101-013-2177-7; Kim SH, 2013, KOREAN J PAIN, V26, P39, DOI 10.3344/kjp.2013.26.1.39; Lim Y, 2006, ANAESTHESIA, V61, P339, DOI 10.1111/j.1365-2044.2006.04535.x; Lopard E, 2006, ANN FR ANESTH, V25, P593, DOI 10.1016/j.annfar.2006.02.012; Loubert C, 2011, ANAESTHESIA, V66, P191, DOI 10.1111/j.1365-2044.2010.06616.x; Nightingale JJ, 2007, BRIT J ANAESTH, V98, P380, DOI 10.1093/bja/ael367; Popping DM, 2008, BRIT J ANAESTH, V101, P832, DOI 10.1093/bja/aen300; Ready LB, 1999, REGION ANESTH PAIN M, V24, P499, DOI 10.1016/S1098-7339(99)90038-X; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Schuster M, 2004, ANESTH ANALG, V98, P708; Sia AT, 2013, ANAESTHESIA, V68, P267, DOI 10.1111/anae.12093; Stienstra R, 2000, Curr Opin Anaesthesiol, V13, P253, DOI 10.1097/00001503-200006000-00002; van der Vyver M, 2002, BRIT J ANAESTH, V89, P459, DOI 10.1093/bja/aef217; Wigfull J, 2001, ANAESTHESIA, V56, P70, DOI 10.1046/j.1365-2044.2001.01763-6.x	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186225	10.1371/journal.pone.0186225	http://dx.doi.org/10.1371/journal.pone.0186225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045482	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100044
J	Walker, WA				Walker, Wade A.			A Lagrangian meshfree method applied to linear and nonlinear elasticity	PLOS ONE			English	Article							FINITE MASS METHOD; SMOOTHED PARTICLE HYDRODYNAMICS; GEOMETRIC CONSERVATION LAW; FLOW COMPUTATIONS; STRONG SHOCKS; GAS-DYNAMICS; SIMULATION; SCHEME	The repeated replacement method (RRM) is a Lagrangian meshfree method which we have previously applied to the Euler equations for compressible fluid flow. In this paper we present new enhancements to RRM, and we apply the enhanced method to both linear and nonlinear elasticity. We compare the results of ten test problems to those of analytic solvers, to demonstrate that RRM can successfully simulate these elastic systems without many of the requirements of traditional numerical methods such as numerical derivatives, equation system solvers, or Riemann solvers. We also show the relationship between error and computational effort for RRM on these systems, and compare RRM to other methods to highlight its strengths and weaknesses. And to further explain the two elastic equations used in the paper, we demonstrate the mathematical procedure used to create Riemann and Sedov-Taylor solvers for them, and detail the numerical techniques needed to embody those solvers in code.				wwalker3@austin.rr.com		Walker, Wade/0000-0003-2453-8043				ALSMEYER H, 1976, J FLUID MECH, V74, P497, DOI 10.1017/S0022112076001912; Barlow AJ, 2016, J COMPUT PHYS, V322, P603, DOI 10.1016/j.jcp.2016.07.001; Barnes P. D., 2013, P 2013 ACM SIGSIM C, P327, DOI DOI 10.1145/2486092.2486134; Barton PT, 2009, J COMPUT PHYS, V228, P7046, DOI 10.1016/j.jcp.2009.06.014; BERGER MJ, 1989, J COMPUT PHYS, V82, P64, DOI 10.1016/0021-9991(89)90035-1; Burton DE, 2015, J COMPUT PHYS, V299, P229, DOI 10.1016/j.jcp.2015.06.041; Burton DE, 2013, COMPUT FLUIDS, V83, P33, DOI 10.1016/j.compfluid.2012.09.008; Carre G, 2009, J COMPUT PHYS, V228, P5160, DOI 10.1016/j.jcp.2009.04.015; CATMULL E, 1974, SUBDIVISION ALGORITH; Chaikin G, 1974, COMPUT VISION GRAPH, V3, P346, DOI DOI 10.1016/0146-664X(74)90028-8; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Despres B, 2005, ARCH RATION MECH AN, V178, P327, DOI 10.1007/s00205-005-0375-4; Duffell PC, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/15; Frontiere N, 2017, J COMPUT PHYS, V332, P160, DOI 10.1016/j.jcp.2016.12.004; FUJIMOTO RM, 1990, COMMUN ACM, V33, P30, DOI 10.1145/84537.84545; Gaburov E, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/103; Gaburov E, 2011, MON NOT R ASTRON SOC, V414, P129, DOI 10.1111/j.1365-2966.2011.18313.x; Gauger C, 2000, SIAM J NUMER ANAL, V37, P1768, DOI 10.1137/S0036142999352564; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Godunov S, 1959, MAT SBORNIK, V47, P271; Godunov SK, 1999, J COMPUT PHYS, V153, P6, DOI 10.1006/jcph.1999.6271; Guillard H, 2000, COMPUT METHOD APPL M, V190, P1467, DOI 10.1016/S0045-7825(00)00173-0; Hess S, 2010, MON NOT R ASTRON SOC, V406, P2289, DOI 10.1111/j.1365-2966.2010.16892.x; HIRT CW, 1974, J COMPUT PHYS, V14, P227, DOI 10.1006/jcph.1997.5702; JEFFERSON DR, 1985, ACM T PROGR LANG SYS, V7, P404, DOI 10.1145/3916.3988; Klingler M, 2005, SIAM J SCI COMPUT, V26, P1744, DOI 10.1137/S1064827502420483; Klingler M, 2007, SIAM J SCI COMPUT, V30, P117, DOI 10.1137/050641235; Kluth G, 2010, J COMPUT PHYS, V229, P9092, DOI 10.1016/j.jcp.2010.08.024; Laney, 1998, COMPUTATIONAL GASDYN; Lanson N, 2008, SIAM J NUMER ANAL, V46, P1912, DOI 10.1137/S0036142903427718; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Maire PH, 2007, SIAM J SCI COMPUT, V29, P1781, DOI 10.1137/050633019; Maire PH, 2009, J COMPUT PHYS, V228, P2391, DOI 10.1016/j.jcp.2008.12.007; Message Passing Interface Forum, 2012, MPI MESSAGE PASSING; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; PERAIRE J, 1987, J COMPUT PHYS, V72, P449, DOI 10.1016/0021-9991(87)90093-3; Radovitzky R, 1998, INT J NUMER METH ENG, V43, P607, DOI 10.1002/(SICI)1097-0207(19981030)43:4<607::AID-NME399>3.0.CO;2-N; Reed WH, 1973, LOS ALAMOS REPORT LA; Sedov L., 1959, SIMILARITY DIMENSION, DOI [10.1016/B978-1-4832-0088-0.50005-0, DOI 10.1016/B978-1-4832-0088-0.50005-0]; TAYLOR G, 1950, PROC R SOC LON SER-A, V201, P175, DOI 10.1098/rspa.1950.0050; TAYLOR G, 1950, PROC R SOC LON SER-A, V201, P159, DOI 10.1098/rspa.1950.0049; THOMAS PD, 1979, AIAA J, V17, P1030, DOI 10.2514/3.61273; Titarev V, 2006, NI06018NPA I NEWT I; Toro EF, 1999, RIEMANN SOLVERS AND; Vilar F, 2016, J COMPUT PHYS, V312, P385, DOI 10.1016/j.jcp.2016.02.027; Wadsley JW, 2008, MON NOT R ASTRON SOC, V387, P427, DOI 10.1111/j.1365-2966.2008.13260.x; Walker WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039999; WHITEHURST R, 1995, MON NOT R ASTRON SOC, V277, P655, DOI 10.1093/mnras/277.2.655; WOODWARD P, 1984, J COMPUT PHYS, V54, P115, DOI 10.1016/0021-9991(84)90142-6	51	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186345	10.1371/journal.pone.0186345	http://dx.doi.org/10.1371/journal.pone.0186345			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045443	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100054
J	Han, W; Gao, S; Barrett, D; Ahmed, M; Han, D; Macoska, JA; He, HH; Cai, C				Han, W.; Gao, S.; Barrett, D.; Ahmed, M.; Han, D.; Macoska, J. A.; He, H. H.; Cai, C.			Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer	ONCOGENE			English	Article							SPLICE VARIANTS; INCREASED SURVIVAL; GENE-EXPRESSION; TUMORIGENESIS; ENZALUTAMIDE; ABIRATERONE; CELLS; DEPRIVATION; METABOLISM; ACTIVATION	Androgen receptor (AR) is a transcriptional activator that, in prostate cells, stimulates gene expression required for various cellular functions, including metabolisms and proliferation. AR signaling is also essential for the development of hormone-dependent prostate cancer (PCa) and its activity can be blocked by androgen-deprivation therapies (ADTs). Although PCa patients initially respond well to ADTs, the cancer inevitably relapses and progresses to lethal castration-resistant prostate cancer (CRPC). Although AR activity is generally restored in CRPC despite the castrate level of androgens, it is unclear whether AR signaling is significantly reprogrammed. In this study, we examined the AR cistrome in a PCa cell line-derived CRPC model using integrated bioinformatical analyses. Significantly, we found that the AR cistrome is largely retained in the CRPC stage. In particular, AR-mediated lipid biosynthesis is highly conserved and reactivated during the progression to CRPC, and increased level of lipid synthesis is associated with poor prognosis. The restoration of lipid biosynthetic pathways is partially due to the increased expression of AR splice variants. Blocking lipid/cholesterol synthesis in AR variants-expressing CRPC cell line and xenograft models markedly reduces tumor growth through inhibition of mTOR pathway. Silencing the expression of a fatty acid elongase, ELOVL7, also leads to the regression of CRPC xenograft tumors. These results demonstrate the importance of reactivation of AR-regulated lipid biosynthetic pathways in driving CRPC progression, and suggest that ADTs may be therapeutically enhanced by blocking lipid biosynthetic pathways.	[Han, W.; Gao, S.; Barrett, D.; Han, D.; Macoska, J. A.; Cai, C.] Univ Massachusetts, Ctr Personalized Canc Therapy, 100 Morrissey Blvd,ISC 4-4720, Boston, MA 02125 USA; [Ahmed, M.; He, H. H.] Univ Hlth Network, Princess Margaret Canc Ctr, 101 Coll St, Toronto, ON M5G 1L7, Canada; [He, H. H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Massachusetts System; University of Massachusetts Boston; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Cai, C (corresponding author), Univ Massachusetts, Ctr Personalized Canc Therapy, 100 Morrissey Blvd,ISC 4-4720, Boston, MA 02125 USA.; He, HH (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, 101 Coll St, Toronto, ON M5G 1L7, Canada.	hansenhe@uhnresearch.ca; changmeng.cai@umb.edu	Han, Wanting/AEX-5349-2022; Cai, Changmeng/AAE-6835-2020; He, Hansen/ABD-8439-2020; Han, Wanting/GQA-5728-2022	Han, Wanting/0000-0002-2173-3647; He, Hansen/0000-0003-2898-3363; Cai, Changmeng/0000-0002-8701-2586; Gao, Shuai/0000-0002-7304-8801	NIH [R00 CA166507]; NIH (SPORE in Prostate Cancer) [P50 CA090381-13]; DOD [W81XWH-15-1-0554, W81XWH-15-1-0519, W81XWH-16-1-0445]; CIHR [142246]; Prostate Cancer Canada [RS2016-1022]; NSERC [498706]; CCSRI [703800]; Princess Margaret Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA090381, R00CA166507] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (SPORE in Prostate Cancer)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); CIHR(Canadian Institutes of Health Research (CIHR)); Prostate Cancer Canada; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CCSRI; Princess Margaret Cancer Foundation(University of Toronto); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from NIH (R00 CA166507 to CC, and SPORE in Prostate Cancer P50 CA090381-13), DOD (W81XWH-15-1-0554 to SG, and W81XWH-15-1-0519 and W81XWH-16-1-0445 to CC), CIHR (142246 to HHH), Prostate Cancer Canada (RS2016-1022 to HHH), NSERC (498706 to HHH), CCSRI (703800 to HHH) and Princess Margaret Cancer Foundation (to HHH). We thank Dr Steven P Balk (Beth Israel Deaconess Medical Center) for the advice of experiment design and Drs Myles Brown and X Shirley Liu (Dana-Farber Cancer Institute) for the support of bioinformatical analyses.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Ananthanarayanan V, 2005, PROSTATE, V63, P341, DOI 10.1002/pros.20196; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Chan SC, 2015, NUCLEIC ACIDS RES, V43, P5880, DOI 10.1093/nar/gkv262; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Evans AJ, 2003, J CLIN PATHOL, V56, P892, DOI 10.1136/jcp.56.12.892; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Green SM, 2012, MOL CELL ENDOCRINOL, V360, P3, DOI 10.1016/j.mce.2011.09.046; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Harshman LC, 2015, JAMA ONCOL, V1, P495, DOI 10.1001/jamaoncol.2015.0829; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Kichenadasse G, 2013, NEW ENGL J MED, V368, P1457, DOI 10.1056/NEJMc1301594; Kochuparambil ST, 2011, J PHARMACOL EXP THER, V336, P496, DOI 10.1124/jpet.110.174870; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Lu CX, 2013, TRANSL ANDROL UROL, V2, P178, DOI 10.3978/j.issn.2223-4683.2013.09.08; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Mills IG, 2014, NAT REV CANCER, V14, P187, DOI 10.1038/nrc3678; Padanad MS, 2016, CELL REP, V16, P1614, DOI 10.1016/j.celrep.2016.07.009; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Pon D, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0474-5; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Sivaprasad U, 2006, MOL CANCER THER, V5, P2310, DOI 10.1158/1535-7163.MCT-06-0175; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Tamura K, 2009, CANCER RES, V69, P8133, DOI 10.1158/0008-5472.CAN-09-0775; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu ZY, 2014, CLIN CANCER RES, V20, P1590, DOI 10.1158/1078-0432.CCR-13-1863; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zhuang LY, 2005, J CLIN INVEST, V115, P959	47	48	48	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					710	721		10.1038/onc.2017.385	http://dx.doi.org/10.1038/onc.2017.385			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059155	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000424628100003
J	Viborg, AH; Katayama, T; Arakawa, T; Abou Hachem, M; Lo Leggio, L; Kitaoka, M; Svensson, B; Fushinobu, S				Viborg, Alexander Holm; Katayama, Takane; Arakawa, Takatoshi; Abou Hachem, Maher; Lo Leggio, Leila; Kitaoka, Motomitsu; Svensson, Birte; Fushinobu, Shinya			Discovery of alpha-L-arabinopyranosidases from human gut microbiome expands the diversity within glycoside hydrolase family 42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MILK OLIGOSACCHARIDES; BIFIDOBACTERIUM-BREVE UCC2003; BETA-GALACTOSIDASE; L-ARABINOFURANOSIDASE; CRYSTAL-STRUCTURE; METABOLISM; SPECIFICITIES; SEQUENCE; REVEALS; BIOSYNTHESIS	Enzymes of the glycoside hydrolase family 42 (GH42) are widespread in bacteria of the human gut microbiome and play fundamental roles in the decomposition of both milk and plant oligosaccharides. All GH42 enzymes characterized so far have beta-galactosidase activity. Here, we report the existence of a GH42 subfamily that is exclusively specific for beta-L-arabinopyranoside and describe the first representative of this subfamily. We found that this enzyme (BlArap42B) from a probiotic Bifidobacterium species cannot hydrolyze beta-galactosides. However, BlArap42B effectively hydrolyzed paeonolide and ginsenoside Rb2, plant glycosides containing an aromatic aglycone conjugated to beta-L-arabinopyranosyl-(1,6)-beta-D-glucopyranoside. Paeonolide, a natural glycoside from the roots of the plant genus Paeonia, is not hydrolyzed by classicalGH42 beta-galactosidases. X-ray crystallography revealed a unique Trp345-X12-Trp358 sequence motif at the BlArap42B active site, as compared with a Phe-X12-His motif in classicalGH42 beta-galactosidases. This analysis also indicated that the C6 position of galactose is blocked by the aromatic side chains, hence allowing accommodation only of Arap lacking this carbon. Automated docking of paeonolide revealed that it can fit into the BlArap42B active site. The Glcp moiety of paeonolide stacks onto the aromatic ring of the Trp252 at subsite beta 1 and C4-OH is hydrogen bonded with Asp249. Moreover, the aglycone stacks against Phe421 from the neighboring monomer in the BlArap42B trimer, forming a proposed subsite beta 2. These results further support the notion that evolution of metabolic specialization can be tracked at the structural level in key enzymes facilitating degradation of specific glycans in an ecological niche.	[Viborg, Alexander Holm; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Tokyo 1138657, Japan; [Katayama, Takane] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Katayama, Takane] Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Nonoichi, Ishikawa 9218836, Japan; [Viborg, Alexander Holm; Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Biotechnol & Biomed, DK-2400 Lyngby, Denmark; [Lo Leggio, Leila] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Viborg, Alexander Holm] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 124, Canada	University of Tokyo; Kyoto University; Ishikawa Prefecture University; Technical University of Denmark; University of Copenhagen; National Agriculture & Food Research Organization - Japan; University of British Columbia	Fushinobu, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Lab Enzymol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Arakawa, Takatoshi/K-9739-2013; Kitaoka, Motomitsu/R-1536-2019; Abou Hachem, Maher/M-4772-2019; Viborg, Alexander/AAI-4943-2021; Fushinobu, Shinya/E-4987-2011	Arakawa, Takatoshi/0000-0001-6496-5440; Kitaoka, Motomitsu/0000-0002-0083-1838; Abou Hachem, Maher/0000-0001-8250-1842; Fushinobu, Shinya/0000-0003-1346-6435; Katayama, Takane/0000-0003-4009-7874; Svensson, Birte/0000-0002-2993-8196	Japan Society for the Promotion of Science (JSPS); JSPS [15H02443, 26660083]; Platform for Drug Discovery, Informatics, and Structural Life Science - MEXT; Technical University of Denmark	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Platform for Drug Discovery, Informatics, and Structural Life Science - MEXT; Technical University of Denmark	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Research Fellowship (to A. H. V.), and JSPS KAKENHI Grant Numbers 15H02443 and 26660083 (to S. F.), the Platform for Drug Discovery, Informatics, and Structural Life Science funded by MEXT, and a Technical University of Denmark Ph.D. fellowship (to A. H. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ding LQ, 2017, NAT PROD RES, V31, P253, DOI 10.1080/14786419.2016.1230114; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P1615, DOI [10.1099/ijs.0.02143-0, 10.1099/00207713-52-5-1615]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraisse D, 2000, FITOTERAPIA, V71, P463, DOI 10.1016/S0367-326X(00)00145-3; Godoy AS, 2016, FEBS J, V283, P4097, DOI 10.1111/febs.13908; Han NS, 2012, BIOTECHNOL ADV, V30, P1268, DOI 10.1016/j.biotechadv.2011.11.003; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; James K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38560; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kosugi A, 2002, J BACTERIOL, V184, P6859, DOI 10.1128/JB.184.24.6859-6865.2002; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lee DY, 2015, J MICROBIOL BIOTECHN, V25, P2011, DOI 10.4014/jmb.1505.05069; Lee JH, 2011, J APPL MICROBIOL, V111, P1097, DOI 10.1111/j.1365-2672.2011.05128.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maksimainen M, 2012, FEBS J, V279, P1788, DOI 10.1111/j.1742-4658.2012.08555.x; Metwally AM, 2010, PHARMACOGN MAG, V6, P212, DOI 10.4103/0973-1296.66939; Motherway MO, 2011, MICROB BIOTECHNOL, V4, P403, DOI 10.1111/j.1751-7915.2010.00218.x; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OURA H, 1975, J BIOCHEM-TOKYO, V77, P1057, DOI 10.1093/oxfordjournals.jbchem.a130806; Peacock KS, 2013, J AGR FOOD CHEM, V61, P12612, DOI 10.1021/jf403789r; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shin HY, 2003, APPL ENVIRON MICROB, V69, P7116, DOI 10.1128/AEM.69.12.7116-7123.2003; Solomon HV, 2015, ACTA CRYSTALLOGR D, V71, P2433, DOI 10.1107/S1399004715018672; Tabachnikov O, 2013, FEBS J, V280, P950, DOI 10.1111/febs.12089; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Van Laere KMJ, 2000, APPL ENVIRON MICROB, V66, P1379, DOI 10.1128/AEM.66.4.1379-1384.2000; Viborg AH, 2014, GLYCOBIOLOGY, V24, P208, DOI 10.1093/glycob/cwt104; Viborg AH, 2015, TRENDS GLYCOSCI GLYC, V27, pE9, DOI 10.4052/tigg.1436.4E; Viborg AH, 2014, MOL MICROBIOL, V94, P1024, DOI 10.1111/mmi.12815; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116	48	5	5	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21092	21101		10.1074/jbc.M117.792598	http://dx.doi.org/10.1074/jbc.M117.792598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29061847	Green Published, hybrid			2022-12-26	WOS:000418453400024
J	Debelyy, MO; Waridel, P; Quadroni, M; Schneiter, R; Conzelmann, A				Debelyy, Mykhaylo O.; Waridel, Patrice; Quadroni, Manfredo; Schneiter, Roger; Conzelmann, Andreas			Chemical crosslinking and mass spectrometry to elucidate the topology of integral membrane proteins	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IDENTIFICATION; YEAST; TOPOGENESIS; MECHANISM; COMPLEX; CELLS	Here we made an attempt to obtain partial structural information on the topology of multi-span integral membrane proteins of yeast by isolating organellar membranes, removing peripheral membrane proteins at pH 11.5 and introducing chemical crosslinks between vicinal amino acids either using homo- or hetero-bifunctional crosslinkers. Proteins were digested with specific proteases and the products analysed by mass spectrometry. Dedicated software tools were used together with filtering steps optimized to remove false positive crosslinks. In proteins of known structure, crosslinks were found only between loops residing on the same side of the membrane. As may be expected, crosslinks were mainly found in very abundant proteins. Our approach seems to hold to promise to yield low resolution topological information for naturally very abundant or strongly overexpressed proteins with relatively little effort. Here, we report novel XL-MS-based topology data for 17 integral membrane proteins (Akr1p, Fks1p, Gas1p, Ggc1p, Gpt2p, Ifa38p, Ist2p, Lag1p, Pet9p, Pma1p, Por1p, Sct1p, Sec61p, Slc1p, Spf1p, Vph1p, Ybt1p).	[Debelyy, Mykhaylo O.; Schneiter, Roger; Conzelmann, Andreas] Univ Fribourg, Div Biochem, Dept Biol, Fribourg, Switzerland; [Waridel, Patrice; Quadroni, Manfredo] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Prot Anal Facil, Lausanne, Switzerland	University of Fribourg; University of Lausanne	Debelyy, MO; Conzelmann, A (corresponding author), Univ Fribourg, Div Biochem, Dept Biol, Fribourg, Switzerland.	mykhaylo.debelyy@unifr.ch; andreas.conzelmann@unifr.ch		Quadroni, Manfredo/0000-0002-2720-4084; Debelyy, Mykhaylo/0000-0001-9746-5055; Schneiter, Roger/0000-0002-9102-8396	Swiss National Science Foundation [CRSI33_125232, 31003AB_131078, 31003A_153416]; Novartis Foundation for medical biological research [14C155]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for medical biological research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Swiss National Science Foundation (http://www.snf.ch) grant numbers CRSI33_125232 and 31003AB_131078 (to AC), and 31003A_153416 (to RS), and the Novartis Foundation for medical biological research (http://www.stiftungmedbiol.novartis.com) grant 14C155 (to AC).	Bochud A, 2013, BIOCHEM SOC T, V41, P35, DOI 10.1042/BST20120212; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Choudhary OP, 2014, NAT STRUCT MOL BIOL, V21, P626, DOI 10.1038/nsmb.2841; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Dormeyer W, 2008, PROTEOMICS, V8, P4036, DOI 10.1002/pmic.200800143; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Kim H, 2003, P NATL ACAD SCI USA, V100, P7460, DOI 10.1073/pnas.1332735100; Koch B, 2014, J BIOL CHEM, V289, P19306, DOI 10.1074/jbc.M114.556944; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Leitner A, 2016, TRENDS BIOCHEM SCI, V41, P20, DOI 10.1016/j.tibs.2015.10.008; Liu F, 2015, CURR OPIN STRUC BIOL, V35, P100, DOI 10.1016/j.sbi.2015.10.006; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Rivera-Santiago RF, 2015, METHODS, V89, P99, DOI 10.1016/j.ymeth.2015.04.031; Sagane K, 2011, J BIOL CHEM, V286, P14649, DOI 10.1074/jbc.M110.193490; Sriswasdi S, 2014, J PROTEOME RES, V13, P898, DOI 10.1021/pr400953w; VIDUGIRIENE J, 1993, J CELL BIOL, V121, P987, DOI 10.1083/jcb.121.5.987; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099	26	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186840	10.1371/journal.pone.0186840	http://dx.doi.org/10.1371/journal.pone.0186840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073188	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400058
J	Seckler, JM; Meyer, NM; Burton, ST; Bates, JN; Gaston, B; Lewis, SJ				Seckler, James M.; Meyer, Nikki M.; Burton, Spencer T.; Bates, James N.; Gaston, Benjamin; Lewis, Stephen J.			Detection of trace concentrations of S-nitrosothiols by means of a capacitive sensor	PLOS ONE			English	Article							NITRIC-OXIDE; BIOLOGICAL-SYSTEMS; CYSTIC-FIBROSIS; NITROSYLATION; PROTEIN; BIOSENSORS; CYSTEINE; NITROSOGLUTATHIONE; PERSPECTIVES; DOPAMINE	Small molecule S-nitrosothiols are a class of endogenous chemicals in the body, which have been implicated in a variety of biological functions. However, the labile nature of NO and the limits of current detection assays have made studying these molecules difficult. Here we present a method for detecting trace concentrations of S-nitrosothiols in biological fluids. Capacitive sensors when coupled to a semiconducting material represent a method for detecting trace quantities of a chemical in complex solutions. We have taken advantage of the semiconducting and chemical properties of polydopamine to construct a capacitive sensor and associated method of use, which specifically senses S-nitrosothiols in complex biological solutions.	[Seckler, James M.; Meyer, Nikki M.; Burton, Spencer T.; Gaston, Benjamin; Lewis, Stephen J.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Bates, James N.] Univ Iowa, Dept Anesthesia, Iowa City, IA 52242 USA; [Gaston, Benjamin] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA	Case Western Reserve University; University of Iowa; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Lewis, SJ (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	sjl78@case.edu		lewis, stephen/0000-0001-7050-0666; Bates, James/0000-0002-6898-9527	National Institutes of Health (NIH) [1 P01 HL128192, 1P01HL101871, 1T32HL125245]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health (NIH) Grants: 1 P01 HL128192, 1P01HL101871, 1T32HL125245.	Ambrico M, 2013, J MATER CHEM C, V1, P1018, DOI 10.1039/c2tc00480a; Anand P, 2014, P NATL ACAD SCI USA, V111, P18572, DOI 10.1073/pnas.1417816112; Bazin I, 2017, BIOSENS BIOELECTRON, V87, P285, DOI 10.1016/j.bios.2016.06.083; Berggren C, 1997, ANAL CHEM, V69, P3651, DOI 10.1021/ac970203e; Carver J, 2005, METHOD ENZYMOL, V396, P95, DOI 10.1016/S0076-6879(05)96010-2; Cha WS, 2009, BIOSENS BIOELECTRON, V24, P2441, DOI 10.1016/j.bios.2008.12.022; Chen JY, 2018, BIOSENS BIOELECTRON, V99, P593, DOI 10.1016/j.bios.2017.08.032; Clarke H.T., 1933, J AM CHEM SOC, V55, P4571, DOI [10.1021/ja01338a041, DOI 10.1021/JA01338A041]; Diers AR, 2014, BBA-GEN SUBJECTS, V1840, P892, DOI 10.1016/j.bbagen.2013.07.026; Doctor A, 2005, P NATL ACAD SCI USA, V102, P5709, DOI 10.1073/pnas.0407490102; Elphinstone RE, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00371-17; Erturk G, 2017, CAPACITIVE BIOSENSOR, V17; Estrela P, 2005, ELECTROCHIM ACTA, V50, P4995, DOI 10.1016/j.electacta.2005.02.075; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; Gaudin V, 2017, BIOSENS BIOELECTRON, V90, P363, DOI 10.1016/j.bios.2016.12.005; GESQUIERE JC, 1990, J CHEM SOC CHEM COMM, P1402, DOI 10.1039/c39900001402; Giuffrida MC, 2017, BIOSENS BIOELECTRON, V90, P174, DOI 10.1016/j.bios.2016.11.045; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; Gradinaru I, 2007, MAGNESIUM RES, V20, P254; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JASTRZEBSKA MM, 1990, GEN PHYSIOL BIOPHYS, V9, P373; Koch S, 1999, BIOSENS BIOELECTRON, V14, P413, DOI 10.1016/S0956-5663(99)00008-1; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; Marozkina NV, 2015, ANNU REV PHYSIOL, V77, P431, DOI 10.1146/annurev-physiol-021113-170352; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McKinnon WR, 2008, J APPL PHYS, V104, DOI 10.1063/1.3050329; Moya MP, 2002, LANCET, V360, P141, DOI 10.1016/S0140-6736(02)09385-6; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Peng B, 2013, ELECTROANAL, V25, P914, DOI 10.1002/elan.201200445; Pfeiffer F, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00025; Prodromidis MI, 2010, ELECTROCHIM ACTA, V55, P4227, DOI 10.1016/j.electacta.2009.01.081; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Raffay TM, 2016, MOL PHARMACOL, V90, P418, DOI 10.1124/mol.116.104125; Ratner S, 1937, J AM CHEM SOC, V59, P200, DOI 10.1021/ja01280a050; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Schoning MJ, 2002, ANALYST, V127, P1137, DOI 10.1039/b204444g; Sharma S, 2016, ESSAYS BIOCHEM, V60, P9, DOI 10.1042/EBC20150002; Sharma SK, 2017, ANAL BIOCHEM, V535, P1, DOI 10.1016/j.ab.2017.07.019; Shen XM, 1997, CHEM RES TOXICOL, V10, P147, DOI 10.1021/tx960145c; Shinwari MW, 2007, MICROELECTRON RELIAB, V47, P2025, DOI 10.1016/j.microrel.2006.10.003; Singel DJ, 2004, NATURE, V430, P297, DOI 10.1038/430297a; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Stsiapura VI, 2015, ANAL CHEM, V87, P3345, DOI 10.1021/ac5045143; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Swift HR, 1997, J CHEM SOC PERK T 2, P1933, DOI 10.1039/a702937c; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Thavarajah Rooban, 2012, J Oral Maxillofac Pathol, V16, P400, DOI 10.4103/0973-029X.102496; Tripathi KM, 2016, RSC ADV, V6, P37319, DOI 10.1039/c6ra04030f; Tripathi KM, 2016, NEW J CHEM, V40, P1571, DOI 10.1039/c5nj02037a; Veigas B, 2015, SENSORS-BASEL, V15, P10380, DOI 10.3390/s150510380; Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; Zaman K, 2014, BIOCHEM BIOPH RES CO, V443, P1257, DOI 10.1016/j.bbrc.2013.12.130	59	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187149	10.1371/journal.pone.0187149	http://dx.doi.org/10.1371/journal.pone.0187149			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073241	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400122
J	Billen, A; Madrigal, JA; Scior, K; Shaw, BE; Strydom, A				Billen, Annelies; Madrigal, J. Alejandro; Scior, Katrina; Shaw, Bronwen E.; Strydom, Andre			Donation of peripheral blood stem cells to unrelated strangers: A thematic analysis	PLOS ONE			English	Article							BONE-MARROW DONATION; COLONY-STIMULATING FACTOR; QUALITY-OF-LIFE; PROSPECTIVE TRIAL; DONORS; EXPERIENCE; MOTIVATIONS; RECOVERY; SAFETY	Background Donation of haematopoietic stem cells, either through bone marrow ( BM) or peripheral blood stem cell (PBSC) collection, is a generally safe procedure for healthy donors, although side effects are a known risk. Previous research, including our recent quantitative study, has shown that the psychosocial response to donating is usually a positive one and most donors would be willing to donate again in the future. This is often despite experiencing significant side effects during the donation process. Due to the relative recent introduction of PBSC, a comprehensive understanding of the range of physical and emotional issues donors may experience is lacking, as well as an understanding of specific donor characteristics Qualitative research can provide rich narrative data into these areas. This study was set up in order to identify specific donor characteristics and to further explore the relationship between pre-donation physical health and the donation experience, as previously identified in our quantitative study. Methods It involved in-depth telephone interviews with 14 PBSC donors who participated in our original quantitative study. Thematic analysis was used to analyse the findings and the results provide a summary of participants' characteristics using themes and constituent codes. Results We identified several donor characteristics, including strong intrinsic motivation, altruism, sense of duty, determination, low levels of ambivalence and the ability to develop a strong emotional relationship with an (unknown/anonymous) recipient whilst being able to manage strong feelings and emotions. Conclusions These personality traits may explain the resilience that has been observed previously in haematopoietic stem cells donors. Significant feelings of grief were reported after a recipient's death. Possibilities to alleviate these symptoms may include raising awareness of potential poor outcomes in the recipient and offering improved counselling services if the recipient dies. We acknowledge several limitations including the sampling frame.	[Billen, Annelies; Madrigal, J. Alejandro; Shaw, Bronwen E.] Anthony Nolan, London, England; [Billen, Annelies; Madrigal, J. Alejandro] UCL, Canc Inst, London, England; [Scior, Katrina] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Shaw, Bronwen E.] Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA; [Strydom, Andre] UCL, Mental Hlth Sci Unit, London, England	University of London; University College London; University of London; University College London; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; University of London; University College London	Strydom, A (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	a.strydom@ucl.ac.uk		Scior, Katrina/0000-0002-4679-0090; Strydom, Andre/0000-0002-2502-6704; Madrigal, Alejandro/0000-0001-8359-9917				Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Atkinson Miriam, 2005, Nurs Stand, V19, P41; Billen A, 2015, BIOL BLOOD MARROW TR, V21, P350, DOI 10.1016/j.bbmt.2014.10.028; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bredeson C, 2004, BIOL BLOOD MARROW TR, V10, P405, DOI 10.1016/j.bbmt.2004.02.003; Bryman A., 2008, SOCIAL RES METHODS; Butterworth V A, 1992, Omega (Westport), V26, P161; BUTTERWORTH VA, 1993, BLOOD, V81, P1947; Christopher K A, 2000, Oncol Nurs Forum, V27, P693; de la Rubia J, 2008, HAEMATOLOGICA, V93, P735, DOI 10.3324/haematol.12285; Garcia MC, 2013, BIOL BLOOD MARROW TR, V19, P1046, DOI 10.1016/j.bbmt.2013.04.012; GOLDMAN JM, 1994, BLOOD, V84, P2833; Hatzimichael E, 2010, STEM CELLS CLONING, V3, P105, DOI 10.2147/SCCAA.S6815; Heldal D, 2002, BONE MARROW TRANSPL, V29, P479, DOI 10.1038/sj.bmt.1703418; Holig K, 2009, BLOOD, V114, P3757, DOI 10.1182/blood-2009-04-218651; Holroyd E, 2000, SOC SCI MED, V51, P29, DOI 10.1016/S0277-9536(99)00427-X; Jackle A, 200641 ISER U ESS; Miller JP, 2008, BIOL BLOOD MARROW TR, V14, P29, DOI 10.1016/j.bbmt.2008.05.018; Pamphilon D, 2008, TRANSFUSION, V48, P1495, DOI 10.1111/j.1537-2995.2008.01694.x; Pillay B, 2012, BONE MARROW TRANSPL, V47, P1361, DOI 10.1038/bmt.2012.22; Pulsipher MA, 2013, BLOOD, V121, P197, DOI 10.1182/blood-2012-03-417667; Pulsipher MA, 2009, BLOOD, V113, P3604, DOI 10.1182/blood-2008-08-175323; Siddiq S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006406.pub2; SIMMONS RG, 1993, J HEALTH SOC BEHAV, V34, P285, DOI 10.2307/2137368; STRONCEK DF, 1993, BLOOD, V81, P1940; Switzer GE, 2014, BIOL BLOOD MARROW TR, V20, P118, DOI 10.1016/j.bbmt.2013.10.024; Switzer GE, 2013, BLOOD, V121, P1469, DOI 10.1182/blood-2012-06-437343; Switzer GE, 2005, TRANSPLANTATION, V80, P890, DOI 10.1097/01.TP.0000173648.60978.30; Switzer GE, 1996, J APPL SOC PSYCHOL, V26, P469, DOI 10.1111/j.1559-1816.1996.tb02726.x; Switzer GE, 1997, SOC SCI MED, V45, P137, DOI 10.1016/S0277-9536(96)00327-9; Switzer GE, 2003, TRANSPLANTATION, V75, P1517, DOI 10.1097/01.TP.0000060251.40758.98; Switzer GE, 2001, BONE MARROW TRANSPL, V27, P917, DOI 10.1038/sj.bmt.1703011; Wanner Martina, 2009, BMC Health Serv Res, V9, P2, DOI 10.1186/1472-6963-9-2; Ware J.E., 2008, SF 36V2 HLTH SURVEY	34	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0186438	10.1371/journal.pone.0186438	http://dx.doi.org/10.1371/journal.pone.0186438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK7DC	29069088	Green Published, gold, Green Submitted			2022-12-26	WOS:000413663600019
J	Roncalli, V; Christie, AE; Sommer, SA; Cieslak, MC; Hartline, DK; Lenz, PH				Roncalli, Vittoria; Christie, Andrew E.; Sommer, Stephanie A.; Cieslak, Matthew C.; Hartline, Daniel K.; Lenz, Petra H.			A deep transcriptomic resource for the copepod crustacean Labidocera madurae: A potential indicator species for assessing near shore ecosystem health	PLOS ONE			English	Article							CALANUS-FINMARCHICUS CRUSTACEA; KANEOHE BAY; CORAL-REEF; MARINE COPEPODS; IDENTIFICATION; DATABASE; FISH; ZOOPLANKTON; GENERATION; COMPONENTS	Coral reef ecosystems of many sub-tropical and tropical marine coastal environments have suffered significant degradation from anthropogenic sources. Research to inform management strategies that mitigate stressors and promote a healthy ecosystem has focused on the ecology and physiology of coral reefs and associated organisms. Few studies focus on the surrounding pelagic communities, which are equally important to ecosystem function. Zooplankton, often dominated by small crustaceans such as copepods, is an important food source for invertebrates and fishes, especially larval fishes. The reef-associated zooplankton includes a sub-neustonic copepod family that could serve as an indicator species for the community. Here, we describe the generation of a de novo transcriptome for one such copepod, Labidocera madurae, a pontellid from an intensively-studied coral reef ecosystem, Kane' ohe Bay, Oahu, Hawaii. The transcriptome was assembled using high-throughput sequence data obtained from whole organisms. It comprised 211,002 unique transcripts, including 72,391 with coding regions. It was assessed for quality and completeness using multiple workflows. Bench-marking-universal-single-copy-orthologs (BUSCO) analysis identified transcripts for 88% of expected eukaryotic core proteins. Targeted gene-discovery analyses included searches for transcripts coding full-length "giant" proteins (> 4,000 amino acids), proteins and splice variants of voltage-gated sodium channels, and proteins involved in the circadian signaling pathway. Four different reference transcriptomes were generated and compared for the detection of differential gene expression between copepodites and adult females; 6,229 genes were consistently identified as differentially expressed between the two regardless of reference. Automated bioinformatics analyses and targeted manual gene curation suggest that the de novo assembled L. madurae transcriptome is of high quality and completeness. This transcriptome provides a new resource for assessing the global physiological status of a planktonic species inhabiting a coral reef ecosystem that is subjected to multiple anthropogenic stressors. The workflows provide a template for generating and assessing transcriptomes in other non-model species.	[Roncalli, Vittoria; Christie, Andrew E.; Sommer, Stephanie A.; Cieslak, Matthew C.; Hartline, Daniel K.; Lenz, Petra H.] Univ Hawaii Manoa, Bekesy Lab Neurobiol, Honolulu, HI 96822 USA; [Sommer, Stephanie A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Hawaii System; University of Hawaii Manoa; University of California System; University of California San Diego; Scripps Institution of Oceanography	Roncalli, V (corresponding author), Univ Hawaii Manoa, Bekesy Lab Neurobiol, Honolulu, HI 96822 USA.	roncalli@hawaii.edu	Lenz, Petra H/ABE-4940-2021	Roncalli, Vittoria/0000-0003-3024-7568; Matthews, Stephanie/0000-0001-9331-3521	National Science Foundation [OCE-1459235]; Bekesy Laboratory of Neurobiology Research fund; National Science Foundation NCGAS [DBI-1458641, ABI-1062432]; Directorate For Geosciences [1459235] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1458641] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Bekesy Laboratory of Neurobiology Research fund; National Science Foundation NCGAS; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation Grant OCE-1459235 to P.H. Lenz and A.E. Christie and by the Bekesy Laboratory of Neurobiology Research fund. Additional support was provided by the National Science Foundation NCGAS under Grants DBI-1458641 and ABI-1062432 to Indiana University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank T. Weatherby and L. Hata from the University of Hawaii at Mama, M. Belanger and R. Nilsen from the Georgia Genomics Facility at the University of Georgia. This research was supported by the National Science Foundation Grant OCE-1459235 to P.H. Lenz and A.E. Christie and by the Bekesy Laboratory of Neurobiology Research fund. Additional support was provided by the National Science Foundation NCGAS under Grants DBI-1458641 and ABI-1062432 to Indiana University. The views expressed herein are those of the authors and do not reflect the views of the funding agencies. This is the University of Hawai'i at Manoa School of Ocean and Earth Science and Technology contribution Number 10256.	Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Almada AA, 2016, FEMS MICROBIOL ECOL, V1, P92; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahr KD, 2015, PEERJ, V3, DOI 10.7717/peerj.1136; Bahr KD, 2015, PEERJ, V3, DOI 10.7717/peerj.950; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Brown JB, 2014, NATURE; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Christie AE, 2015, GEN COMP ENDOCR, V211, P92, DOI 10.1016/j.ygcen.2014.11.002; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P165, DOI 10.1016/j.cbd.2013.04.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Cohen JH, 2005, J COMP PHYSIOL A, V191, P291, DOI 10.1007/s00359-004-0594-4; Cohen JH, 2007, J COMP PHYSIOL A, V1, P573; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Fields DM, 1997, J PLANKTON RES, V19, P1289, DOI 10.1093/plankt/19.9.1289; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Francis WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-167; Goldin AL, 2002, J EXP BIOL, V205, P575; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamner WM, 2007, MAR ECOL PROG SER, V334, P83, DOI 10.3354/meps334083; HAMNER WM, 1988, B MAR SCI, V42, P459; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Hartline DK, 1996, MAR FRESHW BEHAV PHY, V27, P199, DOI 10.1080/10236249609378965; Hassett RP, 1999, MAR BIOL, V134, P571, DOI 10.1007/s002270050572; Havird JC, 2016, INTEGR COMP BIOL, V56, P1055, DOI 10.1093/icb/icw061; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; HUNTER CL, 1995, B MAR SCI, V57, P501; Huys R, 2009, ZOOTAXA, P1; JOKIEL PL, 1993, CORAL REEFS, V12, P177, DOI 10.1007/BF00334477; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jungbluth MJ, 2013, J PLANKTON RES, V35, P630, DOI 10.1093/plankt/fbt015; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim HS, 2016, MAR GENOM, V28, P37, DOI 10.1016/j.margen.2016.04.009; Kim HS, 2015, MAR GENOM, V24, P207, DOI 10.1016/j.margen.2015.05.011; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BY, 2015, COMP BIOCHEM PHYS D, V15, P12, DOI 10.1016/j.cbd.2015.04.002; LEIS JM, 1982, MAR BIOL, V72, P89, DOI 10.1007/BF00393952; Lenz PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088589; Lenz PH, 2000, J COMP PHYSIOL A, V186, P337, DOI 10.1007/s003590050434; Mauchline J, 1998, BIOL CALANOID COPEPO; Milligan MJ, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00476; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Nesbit KT, 2014, COMP BIOCHEM PHYS D, V12, P16, DOI 10.1016/j.cbd.2014.09.002; Ning J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063741; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Porter M, 2017, BIOL B IN PRESS; Reppert SM, 2007, COLD SPRING HARB SYM, V72, P113, DOI 10.1101/sqb.2007.72.056; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roncalli V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25708; Sanu VF, 2016, MAR BIODIVERS, V46, P95, DOI 10.1007/s12526-015-0326-8; Sbragaglia V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141893; Schaeffer L, 2015, ARXIV151007371; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; SMITH SV, 1981, PAC SCI, V35, P279; Stahl AL, 2017, DEV GENES EVOL, P1; Tarrant AM, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0091-8; Tassone EE, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw007; Tassone EE, 2016, GIGASCIENCE, V5, DOI [10.1186/s13742-016-0109-6, 10.1186/s13742-016-0130-9]; Tilden AR, 2011, COMP BIOCHEM PHYS D, V6, P282, DOI 10.1016/j.cbd.2011.06.002; Venny Oliveros J, 2015, INTERACTIVE TOOL COM; Weatherby TM, 2000, J COMP PHYSIOL A, V186, P347, DOI 10.1007/s003590050435; Yang Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/493825; YEN J, 1992, J PLANKTON RES, V14, P495, DOI 10.1093/plankt/14.4.495; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	69	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186794	10.1371/journal.pone.0186794	http://dx.doi.org/10.1371/journal.pone.0186794			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065152	Green Submitted, gold, Green Published			2022-12-26	WOS:000413568900041
J	Rood, EJJ; Goris, MGA; Pijnacker, R; Bakker, MI; Hartskeerl, RA				Rood, Ente J. J.; Goris, Marga G. A.; Pijnacker, Roan; Bakker, Mirjam I.; Hartskeerl, Rudy A.			Environmental risk of leptospirosis infections in the Netherlands: Spatial modelling of environmental risk factors of leptospirosis in the Netherlands	PLOS ONE			English	Article							EMERGENCE; ECOLOGY; WATER	Leptospirosis is a globally emerging zoonotic disease, associated with various climatic, biotic and abiotic factors. Mapping and quantifying geographical variations in the occurrence of leptospirosis and the surrounding environment offer innovative methods to study disease transmission and to identify associations between the disease and the environment. This study aims to investigate geographic variations in leptospirosis incidence in the Netherlands and to identify associations with environmental factors driving the emergence of the disease. Individual case data derived over the period 1995-2012 in the Netherlands were geo-coded and aggregated by municipality. Environmental covariate data were extracted for each municipality and stored in a spatial database. Spatial clusters were identified using kernel density estimations and quantified using local autocorrelation statistics. Associations between the incidence of leptospirosis and the local environment were determined using Simultaneous Autoregressive Models (SAR) explicitly modelling spatial dependence of the model residuals. Leptospirosis incidence rates were found to be spatially clustered, showing a marked spatial pattern. Fitting a spatial autoregressive model significantly improved model fit and revealed significant association between leptospirosis and the coverage of arable land, built up area, grassland and sabulous clay soils. The incidence of leptospirosis in the Netherlands could effectively be modelled using a combination of soil and land-use variables accounting for spatial dependence of incidence rates per municipality. The resulting spatially explicit risk predictions provide an important source of information which will benefit clinical awareness on potential leptospirosis infections in endemic areas.	[Rood, Ente J. J.; Pijnacker, Roan; Bakker, Mirjam I.] KIT Royal Trop Inst, Hlth Dept, Amsterdam, Netherlands; [Goris, Marga G. A.; Hartskeerl, Rudy A.] WHO FAO OIE, Amsterdam, Netherlands; [Goris, Marga G. A.; Hartskeerl, Rudy A.] Natl Collaborating Ctr Reference & Res Leptospiro, Amsterdam, Netherlands	Food & Agriculture Organization of the United Nations (FAO)	Rood, EJJ (corresponding author), KIT Royal Trop Inst, Hlth Dept, Amsterdam, Netherlands.	e.rood@kit.nl						Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Andre-Fontaine G, 2015, CURR MICROBIOL, V71, P136, DOI 10.1007/s00284-015-0836-4; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Bandara M, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0061-0; Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Bourhy P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002114; CBS, 2003, WIJK BUURTK; CRAN R, 2015, R R PROJ STAT COMP; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dupouey J, 2014, COMP IMMUNOL MICROB, V37, P77, DOI 10.1016/j.cimid.2013.12.002; Goris MGA, 2013, EMERG INFECT DIS, V19, P371, DOI 10.3201/eid1903.111260; Grondsoortenkaart, 2006, GRONDSOORTENKAART 20; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x; HENRY RA, 1978, APPL ENVIRON MICROB, V35, P492, DOI 10.1128/AEM.35.3.492-499.1978; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kadaster, 2008, TOPO50NL; Kuhlman T, 2006, AGRARWIRTSCHAFT; Lau CL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001669; Lau CL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0982-0; Lau CL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-19; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Schneider MC, 2013, INT J ENV RES PUB HE, V10, P7229, DOI 10.3390/ijerph10127229; Schneider MC, 2012, INT J ENV RES PUB HE, V9, P3883, DOI 10.3390/ijerph9113883; Vijayachari P, 2008, J BIOSCIENCES, V33, P557, DOI 10.1007/s12038-008-0074-z	28	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186987	10.1371/journal.pone.0186987	http://dx.doi.org/10.1371/journal.pone.0186987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065186	gold, Green Submitted, Green Published			2022-12-26	WOS:000413568900059
J	Sims, CA; Guan, YX; Singh, K; Werlin, EC; Reilly, PM; Baur, JA				Sims, Carrie A.; Guan Yuxia; Singh, Khushboo; Werlin, Evan C.; Reilly, Patrick M.; Baur, Joseph A.			Supplemental arginine vasopressin during the resuscitation of severe hemorrhagic shock preserves renal mitochondrial function	PLOS ONE			English	Article							PERMEABILITY TRANSITION; CARDIOVASCULAR-SYSTEM; HORMONAL-STIMULATION; CARDIAC-ARREST; CALCIUM-UPTAKE; LIVER TRAUMA; SEPTIC SHOCK; DYSFUNCTION; PHYSIOLOGY; CELLS	Arginine vasopressin (AVP), a hormone secreted by the posterior pituitary, plays a vital role in maintaining vasomotor tone during acute blood loss. We hypothesized that decompensated hemorrhagic shock is associated with decreased AVP stores and supplementation during resuscitation would improve both blood pressure and renal function. Using a decompensated hemorrhagic shock model, male Long-Evans rats were bled to mean arterial blood pressure (MAP) of 40mmHg and maintained until the MAP could not be sustained without fluid. Once 40% of the shed volume was returned in lactated Ringer's (Severe Shock), animals were resuscitated over 60 minutes with 4x the shed volume in lactated Ringer's (LR) or the same fluids with AVP (0.5 units/kg+ 0.03 units/kg/min). Animals (n = 6-9/group) were sacrificed before hemorrhage (Sham), at Severe Shock, following resuscitation (60R, 60R with AVP) or 18 hours post-resuscitation (18hr, 18hr with AVP). Blood samples were taken to measure AVP levels and renal function. Pituitaries were harvested and assayed for AVP. Kidney samples were taken to assess mitochondrial function, histology, and oxidative damage. Baseline pituitary AVP stores (30,364 +/- 5311 pg/mg) decreased with severe shock and were significantly depressed post-resuscitation (13,910 +/- 3016 pg/ml. p<0.05) and at 18hr (15,592 +/- 1169 pg/ml, p<0.05). Resuscitation with LR+AVP led to higher serum AVP levels at 60R (31 +/- 8 vs 79 +/- 12; p<0.01) with an improved MAP both at 60R (125 +/- 3 vs 77 +/- 7mmHg; p<0.01) and 18hr (82 +/- 6 vs 69 +/- 5mmHg; p<0.05). AVP supplementation preserved complex I respiratory capacity at 60R and both complex I and II function at 18hr (p<0.05). AVP was also associated with decreased reactive oxygen species at 60R (856 +/- 67 vs 622 +/- 48F RFU) and significantly decreased oxidative damage as measured by mitochondrial lipid peroxidation (0.9 +/- 0.1 vs 1.7 +/- 0.1 fold change, p<0.01) and nitrosylation (0.9 +/- 0.1 vs 1.4 +/- 0.2 fold change, p<0.05). With AVP, renal damage was mitigated at 60R and histologic architecture was conserved at 18 hours. In conclusion, pituitary and serum AVP levels decrease during severe hemorrhage and may contribute to the development of decompensated hemorrhagic shock. Supplementing exogenous AVP during resuscitation improves blood pressure, preserves renal mitochondrial function, and mitigates acute kidney injury.	[Sims, Carrie A.; Guan Yuxia; Singh, Khushboo; Reilly, Patrick M.] Univ Penn, Dept Surg, Trauma Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sims, Carrie A.; Baur, Joseph A.] Univ Penn, PARC, Philadelphia, PA 19104 USA; [Werlin, Evan C.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Baur, Joseph A.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine	Sims, CA (corresponding author), Univ Penn, Dept Surg, Trauma Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.; Sims, CA (corresponding author), Univ Penn, PARC, Philadelphia, PA 19104 USA.	Carrie.sims@uphs.upenn.edu		Baur, Joseph/0000-0001-8262-6549	NIH K08 Award through NIGMS [1 K08GM097614-01]	NIH K08 Award through NIGMS	This work was supported by NIH K08 Award through NIGMS, 1 K08GM097614-01, to Carrie Sims. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTURA BM, 1980, EXPERIENTIA, V36, P1080, DOI 10.1007/BF01965981; [Anonymous], 2016, NATL VITAL STAT REPO; Ayala A., 2001, SURG RES, P325; Benns M, 2013, J TRAUMA ACUTE CARE, V75, P426, DOI 10.1097/TA.0b013e31829cfa19; BROWN GC, 1990, EUR J BIOCHEM, V192, P355, DOI 10.1111/j.1432-1033.1990.tb19234.x; Cohn SM, 2013, J TRAUMA ACUTE CARE, V75, P620, DOI 10.1097/TA.0b013e31829eff31; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Cohn SM, 2010, RESUSCITATION, V81, P1473, DOI 10.1016/j.resuscitation.2010.06.005; Cruz DN, 2010, INTENS CARE MED, V36, P444, DOI 10.1007/s00134-009-1711-1; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; ERRINGTON ML, 1972, J PHYSIOL-LONDON, V227, P395, DOI 10.1113/jphysiol.1972.sp010039; Gazmuri RJ, 2015, PLOSONE; Haas T, 2004, J TRAUMA, V57, P177, DOI 10.1097/01.TA.0000044357.25191.1B; Han F, 2008, CRIT CARE MED, V36, pS447, DOI 10.1097/CCM.0b013e31818a8a51; Hauser CJ, 2005, SHOCK, V24, P24, DOI 10.1097/01.shk.0000191387.18818.43; Hjortrup PB, 2013, CRIT CARE, V17, DOI 10.1186/cc11855; HOEK JB, 1995, BBA-MOL BASIS DIS, V1271, P93, DOI 10.1016/0925-4439(95)00015-V; Hoek JB, 1997, MOL CELL BIOCHEM, V174, P173, DOI 10.1023/A:1006831703155; Holmes CL, 2001, CHEST, V120, P989, DOI 10.1378/chest.120.3.989; Holmes CL, 2004, CRIT CARE, V8, P15, DOI 10.1186/cc2338; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lax A, 2005, J BIOENERG BIOMEMBR, V37, P249, DOI 10.1007/s10863-005-6635-z; Lu SM, 2016, CYTOKINE, V81, P35, DOI 10.1016/j.cyto.2016.01.022; MACHUGANSKA A, 1985, Acta Physiologica et Pharmacologica Bulgarica, V11, P26; MACHUGANSKA A, 1986, Acta Physiologica et Pharmacologica Bulgarica, V12, P62; Meybohm P, 2007, J TRAUMA, V62, P640, DOI 10.1097/01.ta.0000240962.62319.c8; Moochhala S, 2009, FRONT BIOSCI-LANDMRK, V14, P4631, DOI 10.2741/3555; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Oliver H., 1895, J PHYSL, V18, P277, DOI [DOI 10.1113/JPHYSIOL.1895.SP000565, 10.1113/jphysiol.1895.sp000565]; Oliver JA, 2007, CURR OPIN CRIT CARE, V13, P376, DOI 10.1097/MCC.0b013e3282435e16; Rajani RR, 2009, AM SURGEON, V75, P1207; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Rush B F Jr, 1971, Adv Exp Med Biol, V23, P215; Sharshar T, 2002, CRIT CARE MED, V30, P497, DOI 10.1097/00003246-200203000-00001; Sims CA, 2017, AM J SURG; Spat A, 2004, MOL CELL ENDOCRINOL, V215, P115, DOI 10.1016/j.mce.2003.11.004; Stadlbauer KH, 2003, ANESTHESIOLOGY, V98, P699, DOI 10.1097/00000542-200303000-00018; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Wang H, 2015, SHOCK, V44, P173, DOI 10.1097/SHK.0000000000000390; Wang H, 2014, J TRAUMA ACUTE CARE, V77, P926, DOI 10.1097/TA.0000000000000358	45	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186339	10.1371/journal.pone.0186339	http://dx.doi.org/10.1371/journal.pone.0186339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065123	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900012
J	Harle, KM; Guo, DL; Zhang, SA; Paulus, MP; Yu, AJ				Harle, Katia M.; Guo, Dalin; Zhang, Shunan; Paulus, Martin P.; Yu, Angela J.			Anhedonia and anxiety underlying depressive symptomatology have distinct effects on reward-based decision-making	PLOS ONE			English	Article							TASK; ACTIVATION; PREDICTION; DEPENDENCE; DOPAMINE; CAPACITY; EMOTION; HUMANS; IMPACT	Depressive pathology, which includes both heightened negative affect (e.g., anxiety) and reduced positive affect (e.g., anhedonia), is known to be associated with sub-optimal decision-making, particularly in uncertain environments. Here, we use a computational approach to quantify and disambiguate how individual differences in these affective measures specifically relate to different aspects of learning and decision-making in reward-based choice behavior. Fifty-three individuals with a range of depressed mood completed a two-armed bandit task, in which they choose between two arms with fixed but unknown reward rates. The decision-making component, which chooses among options based on current expectations about reward rates, is modeled by two different decision policies: a learning-independent Win-stay/Lose-shift (WSLS) policy that ignores all previous experiences except the last trial, and Softmax, which prefers the arm with the higher expected reward. To model the learning component for the Softmax choice policy, we use a Bayesian inference model, which updates estimated reward rates based on the observed history of trial outcomes. Softmax with Bayesian learning better fits the behavior of 55% of the participants, while the others are better fit by a learning-independent WSLS strategy. Among Softmax "users", those with higher anhedonia are less likely to choose the option estimated to be most rewarding. Moreover, the Softmax parameter mediates the inverse relationship between anhedonia and overall monetary gains. On the other hand, among WSLS "users", higher state anxiety correlates with increasingly better ability of WSLS, relative to Softmax, to explain subjects' trial-by-trial choices. In summary, there is significant variability among individuals in their reward-based, exploratory decision-making, and this variability is at least partly mediated in a very specific manner by affective attributes, such as hedonic tone and state anxiety.	[Harle, Katia M.; Paulus, Martin P.] UCSD, Dept Psychiat, La Jolla, CA 92093 USA; [Guo, Dalin] UCSD, Dept Elect & Comp Engn, La Jolla, CA USA; [Zhang, Shunan; Yu, Angela J.] UCSD, Dept Cognit Sci, La Jolla, CA USA; [Paulus, Martin P.] Laureate Inst Brain Res, Tulsa, OK USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Laureate Institute for Brain Research, Inc.	Harle, KM (corresponding author), UCSD, Dept Psychiat, La Jolla, CA 92093 USA.	kharle@ucsd.edu	Guo, Dalin/ABD-2161-2020	Paulus, Martin/0000-0002-0825-3606	Veterans Affairs [IK2CX001584] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs)		BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Blanco NJ, 2013, COGNITION, V129, P563, DOI 10.1016/j.cognition.2013.08.018; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Dunn BD, 2004, J ABNORM PSYCHOL, V113, P654, DOI 10.1037/0021-843X.113.4.654; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Franken IHA, 2007, J AFFECT DISORDERS, V99, P83, DOI 10.1016/j.jad.2006.08.020; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Harle KM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01910; Harle KM, 2014, J NEUROSCI, V34, P4567, DOI 10.1523/JNEUROSCI.2297-13.2014; Harle KM, 2010, J ABNORM PSYCHOL, V119, P440, DOI 10.1037/a0018612; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Henriques JB, 2000, COGNITION EMOTION, V14, P711, DOI 10.1080/02699930050117684; Herrnstein R. J., 2000, MATCHING LAW PAPERS; Holmes Pizzagalli AJ, 2009, AM J PSYCHIAT, V43, P76; Ide JS, 2013, J NEUROSCI, V33, P2039, DOI 10.1523/JNEUROSCI.2201-12.2013; Luce R, 1959, INDIVIDUAL CHOICE BE; Ma N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01046; Matlab V, 2014, MATL V 8 3 0 532 R20; Nawijn L, 2015, NEUROSCI BIOBEHAV R, V51, P189, DOI 10.1016/j.neubiorev.2015.01.019; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Rutledge RB, 2017, JAMA PSYCHIAT; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Spielberger CD, 1994, STATE TRAIT ANXIETY; Team RC, 2014, R LANG ENV STAT COMP; Wang LH, 2006, BIOL PSYCHIAT, V60, P1139, DOI 10.1016/j.biopsych.2006.01.021; Worthy DA, 2013, PSYCHON B REV, V20, P364, DOI 10.3758/s13423-012-0324-9; Yu A J., 2014, DECISION, V1, P275, DOI [10.1037/dec0000013, DOI 10.1037/DEC0000013]; Yu AJ, 2009, ADV NEURAL INF PROCE, V21, P1873, DOI DOI 10.1371/JOURNAL.PONE.0099909; Zhang S, 2013, ADV NEURAL INFORM PR; Zhang S., 2013, RATIO; Zhang S., 2014, SEQUENTIAL EFFECTS B, V36	42	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186473	10.1371/journal.pone.0186473	http://dx.doi.org/10.1371/journal.pone.0186473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK3RE	29059254	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000025
J	Lee, JY; Han, GG; Lee, HB; Lee, SM; Kang, SK; Jin, GD; Park, J; Chae, BJ; Choi, YH; Kim, EB; Choi, YJ				Lee, Jun-Yeong; Han, Geon Goo; Lee, Ho-Bin; Lee, Sang-Mok; Kang, Sang-Kee; Jin, Gwi-Deuk; Park, Jongbin; Chae, Byung Jo; Choi, Yo Han; Kim, Eun Bae; Choi, Yun-Jaie			Prohibition of antibiotic growth promoters has affected the genomic profiles of Lactobacillus salivarius inhabiting the swine intestine	PLOS ONE			English	Article							RESISTANCE; BACTERIOCIN; GENES; TOLERANCE; COMMENSAL; ALIGNMENT; STRAINS; DIVERSE; CATTLE	After the introduction of a ban on the use of antibiotic growth promoters (AGPs) for livestock, the feeding environment, including the composition of animal intestinal microbiota, has changed rapidly. We hypothesized that the microbial genomes have also been affected by this legal prohibition, and investigated an important member of the swine gut microbiota, Lactobacillus salivarius, with a pan-genomic approach. Here, we isolated 21 L. salivarius strains composed of 6 strains isolated before the AGP prohibition (SBPs) and 15 strains isolated after the AGP prohibition (SAPs) at an interval of a decade, and the draft genomes were generated de novo. Several genomic differences between SBPs and SAPs were identified, although the number and function of antibiotic resistance genes were not different. SBPs showed larger genome size and a higher number of orthologs, as well as lower genetic diversity, than SAPs. SBPs had genes associated with the utilization of L-rhamnose and D-tagatose for energy production. Because these sugars are also used in exopolysaccharide (EPS) synthesis, we tried to identify differences in biofilm formation-associated genes. The genes for the production of EPSs and extracellular proteins were different in terms of amino acid sequences. Indeed, SAPs formed dense biofilm and survived better than SBPs in the swine intestinal environment. These results suggest that SAPs have evolved and adapted to protect themselves from new selection pressure of the swine intestinal microenvironment by forming dense biofilms, adopting a distinct antibiotic resistance strategy. This finding is particularly important to understand the evolutionary changes in host-microbe interaction and provide detailed insight for the development of effective probiotics for livestock.	[Lee, Jun-Yeong; Han, Geon Goo; Lee, Ho-Bin; Lee, Sang-Mok; Choi, Yun-Jaie] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kang, Sang-Kee] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea; [Jin, Gwi-Deuk; Park, Jongbin; Chae, Byung Jo; Choi, Yo Han; Kim, Eun Bae] Kangwon Natl Univ, Dept Anim Life Sci, Chunchon, South Korea; [Choi, Yun-Jaie] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Seoul National University (SNU)	Choi, YJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Kim, EB (corresponding author), Kangwon Natl Univ, Dept Anim Life Sci, Chunchon, South Korea.; Choi, YJ (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	itanimal@kangwon.ac.kr; cyjcow@snu.ac.kr		Lee, Jun-Yeong/0000-0002-4342-1863; Han, Geongoo/0000-0003-4866-1185	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [115084-2]; Kangwon National University; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [914005-04]; Brain Korea 21 Plus program	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Kangwon National University; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Brain Korea 21 Plus program	This work was supported by the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [grant number 914005-04], Agri-Bio Industry Technology Development Program, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [grant number 115084-2]. This study was also supported by 2017 Research Grant from Kangwon National University. Jun-Yeong Lee, Geon Goo Han, Ho-Bin Lee, Sang-Mok Lee, Gwi-Deuk Jin and Jongbin Park were supported by Brain Korea 21 Plus program.	Aarestrup M., 2003, DOCUMENT WHO CDS CPE, P6; Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Ambalam P, 2012, FEMS MICROBIOL LETT, V333, P10, DOI 10.1111/j.1574-6968.2012.02590.x; [Anonymous], 2013, PRACT ASSESS RES EVA; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Boerlin P, 2001, J CLIN MICROBIOL, V39, P4193, DOI 10.1128/JCM.39.11.4193-4195.2001; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dixon B, 2000, ASM NEWS, V66, P264; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang F, 2009, J BACTERIOL, V191, P5743, DOI 10.1128/JB.00506-09; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flynn S, 2002, MICROBIOL-SGM, V148, P973, DOI 10.1099/00221287-148-4-973; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Greenwood C, 2014, J PEDIATR-US, V165, P23, DOI 10.1016/j.jpeds.2014.01.010; Harrow SA, 2007, APPL ENVIRON MICROB, V73, P7123, DOI 10.1128/AEM.01289-07; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kim EB, 2014, APPL ENVIRON MICROB, V80, P154, DOI 10.1128/AEM.03108-13; KOJIC M, 1992, APPL ENVIRON MICROB, V58, P4086, DOI 10.1128/AEM.58.12.4086-4088.1992; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lazar V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.57; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee J-Y, 2017, MICROBIOLOGICAL RES; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Lim SK, 2007, INT J FOOD MICROBIOL, V116, P283, DOI 10.1016/j.ijfoodmicro.2006.12.014; Maldonado J, 2010, NUTRITION, V26, P1082, DOI 10.1016/j.nut.2009.08.023; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Messaoudi S, 2013, FOOD MICROBIOL, V36, P296, DOI 10.1016/j.fm.2013.05.010; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; O'Mahony L, 2006, AM J PHYSIOL-GASTR L, V290, pG839, DOI 10.1152/ajpgi.00112.2005; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Raftis EJ, 2011, APPL ENVIRON MICROB, V77, P954, DOI 10.1128/AEM.01687-10; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RCore Team, 2020, R LANG ENV STAT COMP; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rizk G, 2010, BIOINFORMATICS, V26, P2534, DOI 10.1093/bioinformatics/btq485; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tallon R, 2003, RES MICROBIOL, V154, P705, DOI 10.1016/j.resmic.2003.09.006; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Velez MP, 2007, FEMS MICROBIOL LETT, V276, P140, DOI 10.1111/j.1574-6968.2007.00908.x; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Zhou LJ, 2013, SCI TOTAL ENVIRON, V444, P183, DOI 10.1016/j.scitotenv.2012.11.087; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	60	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186671	10.1371/journal.pone.0186671	http://dx.doi.org/10.1371/journal.pone.0186671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059217	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000032
J	Harter, P; Hauke, J; Heitz, F; Reuss, A; Kommoss, S; Marme, F; Heimbach, A; Prieske, K; Richters, L; Burges, A; Neidhardt, G; de Gregorio, N; El-Balat, A; Hilpert, F; Meier, W; Kimmig, R; Kast, K; Sehouli, J; Baumann, K; Jackisch, C; Park-Simon, TW; Hanker, L; Krober, S; Pfisterer, J; Gevensleben, H; Schnelzer, A; Dietrich, D; Neunhoffer, T; Krockenberger, M; Brucker, SY; Nurnberg, P; Thiele, H; Altmuller, J; Lamla, J; Elser, G; du Bois, A; Hahnen, E; Schmutzler, R				Harter, Philipp; Hauke, Jan; Heitz, Florian; Reuss, Alexander; Kommoss, Stefan; Marme, Frederik; Heimbach, Andre; Prieske, Katharina; Richters, Lisa; Burges, Alexander; Neidhardt, Guido; de Gregorio, Nikolaus; El-Balat, Ahmed; Hilpert, Felix; Meier, Werner; Kimmig, Rainer; Kast, Karin; Sehouli, Jalid; Baumann, Klaus; Jackisch, Christian; Park-Simon, Tjoung-Won; Hanker, Lars; Kroeber, Sandra; Pfisterer, Jacobus; Gevensleben, Heidrun; Schnelzer, Andreas; Dietrich, Dimo; Neunhoeffer, Tanja; Krockenberger, Mathias; Brucker, Sara Y.; Nuernberg, Peter; Thiele, Holger; Altmueller, Janine; Lamla, Josefin; Elser, Gabriele; du Bois, Andreas; Hahnen, Eric; Schmutzler, Rita			Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)	PLOS ONE			English	Article							INHERITED MUTATIONS; FALLOPIAN-TUBE; BREAST; SUSCEPTIBILITY; SERIES; WOMEN; SURVIVAL; IMPACT; MODEL	Background Identification of families at risk for ovarian cancer offers the opportunity to consider prophylactic surgery thus reducing ovarian cancer mortality. So far, identification of potentially affected families in Germany was solely performed via family history and numbers of affected family members with breast or ovarian cancer. However, neither the prevalence of deleterious variants in BRCA1/2 in ovarian cancer in Germany nor the reliability of family history as trigger for genetic counselling has ever been evaluated. Methods Prospective counseling and germline testing of consecutive patients with primary diagnosis or with platinum-sensitive relapse of an invasive epithelial ovarian cancer. Testing included 25 candidate and established risk genes. Among these 25 genes, 16 genes (ATM, BRCA1, BRCA2, CDH1, CHEK2, MLH1, MSH2, MSH6, NBN, PMS2, PTEN, PALB2, RAD51C, RAD51D, STK11, TP53) were defined as established cancer risk genes. A positive family history was defined as at least one relative with breast cancer or ovarian cancer or breast cancer in personal history. Results In total, we analyzed 523 patients: 281 patients with primary diagnosis of ovarian cancer and 242 patients with relapsed disease. Median age at primary diagnosis was 58 years (range 16-93) and 406 patients (77.6%) had a high-grade serous ovarian cancer. In total, 27.9% of the patients showed at least one deleterious variant in all 25 investigated genes and 26.4% in the defined 16 risk genes. Deleterious variants were most prevalent in the BRCA1 (15.5%), BRCA2 (5.5%), RAD51C (2.5%) and PALB2 (1.1%) genes. The prevalence of deleterious variants did not differ significantly between patients at primary diagnosis and relapse. The prevalence of deleterious variants in BRCA1/2 (and in all 16 risk genes) in patients <60 years was 30.2% (33.2%) versus 10.6% (18.9%) in patients >= 60 years. Family history was positive in 43% of all patients. Patients with a positive family history had a prevalence of deleterious variants of 31.6% (36.0%) versus 11.4% (17.6%) and histologic subtype of high grade serous ovarian cancer versus other showed a prevalence of deleterious variants of 23.2% (29.1%) and 10.2% (14.8%), respectively. Testing only for BRCA1/2 would miss in our series more than 5% of the patients with a deleterious variant in established risk genes. Conclusions 26.4% of all patients harbor at least one deleterious variant in established risk genes. The threshold of 10% mutation rate which is accepted for reimbursement by health care providers in Germany was observed in all subgroups analyzed and neither age at primary diagnosis nor histo-type or family history sufficiently enough could identify a subgroup not eligible for genetic counselling and testing. Genetic testing should therefore be offered to every patient with invasive epithelial ovarian cancer and limiting testing to BRCA1/2 seems to be not sufficient.	[Harter, Philipp; Heitz, Florian; du Bois, Andreas] Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Hauke, Jan; Richters, Lisa; Neidhardt, Guido; Kroeber, Sandra; Hahnen, Eric; Schmutzler, Rita] Univ Hosp Cologne, Med Fac, Ctr Hereditary Breast & Ovarian Canc, Cologne, Germany; [Hauke, Jan; Richters, Lisa; Neidhardt, Guido; Kroeber, Sandra; Hahnen, Eric; Schmutzler, Rita] Univ Hosp Cologne, Med Fac, CIO, Cologne, Germany; [Reuss, Alexander] Philipps Univ Marburg, Coordinating Ctr Clin Trials, Marburg, Germany; [Kommoss, Stefan; Brucker, Sara Y.] Tubingen Univ Hosp, Dept Womens Hlth, Tubingen, Germany; [Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, Dept Gynecol, Heidelberg, Germany; [Heimbach, Andre] Univ Bonn, Inst Human Genet, Bonn, Germany; [Prieske, Katharina] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol & Gynecol Oncol, Hamburg, Germany; [Burges, Alexander] Univ Hosp MunichGrosshadern, Dept Gynecol, Munich, Germany; [de Gregorio, Nikolaus] Univ Ulm, Dept Gynecol, Ulm, Germany; [El-Balat, Ahmed] Goethe Univ Frankfurt, Dept Gynecol, Frankfurt, Germany; [Hilpert, Felix] Krankenhaus Jerusalem, Onkol Therapiezentrum, Hamburg, Germany; [Hilpert, Felix] Univ Kiel, Dept Gynecol, Kiel, Germany; [Meier, Werner] Evangel Krankenhaus, Dept Gynecol, Dusseldorf, Germany; [Kimmig, Rainer] Univ Essen Gesamthsch, Dept Gynecol, Essen, Germany; [Kast, Karin] Tech Univ Dresden, Dept Gynecol & Obstet, Med Fac, Dresden, Germany; [Kast, Karin] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Kast, Karin] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany; [Kast, Karin] German Canc Consortium DKTK, Dresden, Germany; [Kast, Karin] German Canc Res Ctr, Heidelberg, Germany; [Sehouli, Jalid] Campus Virchow, Charite, Dept Gynecol & Gynecol Oncol, Berlin, Germany; [Baumann, Klaus] Klinikum Ludwigshafen, Dept Gynecol & Obstet, Ludwigshafen, Germany; [Baumann, Klaus] Philipps Univers Marburg, Dept Gynecol Gynecol Endocrinol & Oncol, Marburg, Germany; [Jackisch, Christian] Sana Klinikum, Dept Gynecol & Obstet, Offenbach, Germany; [Park-Simon, Tjoung-Won] Hannover Med Sch, Dept Gynecol, Hannover, Germany; [Hanker, Lars] Univ Hosp Schleswig Holstein, Dept Gynecol & Obstet, Campus Lubeck, Lubeck, Germany; [Pfisterer, Jacobus] Ctr Gynecol Oncol, Kiel, Germany; [Gevensleben, Heidrun] Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [Schnelzer, Andreas] Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol, Munich, Germany; [Dietrich, Dimo] Univ Hosp Bonn, Dept Otolaryngol Head & Neck Surg, Bonn, Germany; [Neunhoeffer, Tanja] Dr Horst Schmidt Kliniken, Dept Gynecol, Wiesbaden, Germany; [Krockenberger, Mathias] Univ Wurzburg, Dept Gynecol, Wurzburg, Germany; [Nuernberg, Peter; Altmueller, Janine] Univ Cologne, CMMC, Cologne, Germany; [Nuernberg, Peter; Thiele, Holger; Altmueller, Janine] Univ Cologne, CCG, Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Lamla, Josefin] AGO Study Grp, Wiesbaden, Germany	Kliniken Essen-Mitte; University of Cologne; University of Cologne; Philipps University Marburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Goethe University Frankfurt; University of Kiel; University of Duisburg Essen; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ludwigshafen Hospital; Sana Klinikum Offenbach; Hannover Medical School; University of Kiel; Schleswig Holstein University Hospital; University of Bonn; Technical University of Munich; University of Bonn; University of Wurzburg; University of Cologne; University of Cologne; University of Cologne	Harter, P (corresponding author), Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany.	p.harter@gmx.de	de+Gregorio, Nikolaus/AAL-4158-2020; Thiele, Holger/ABE-6792-2020	de+Gregorio, Nikolaus/0000-0002-0037-127X; Thiele, Holger/0000-0002-0169-998X; Heitz, Florian/0000-0002-2412-0352; Schnelzer, Andreas/0000-0002-5410-3561; Altmuller, Janine/0000-0003-4372-1521; Hauke, Jan/0000-0001-8236-4075	Astra Zeneca Germany	Astra Zeneca Germany(AstraZeneca)	The study was funded by Astra Zeneca Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Eccles DM, 2016, ADV THER, V33, P129, DOI 10.1007/s12325-016-0281-1; Hanker LC, 2012, ANN ONCOL, V23, P2605, DOI 10.1093/annonc/mds203; Harter P, 2016, GYNECOL ONCOL, V140, P443, DOI 10.1016/j.ygyno.2015.12.027; Harter P, 2011, GYNECOL ONCOL, V121, P615, DOI 10.1016/j.ygyno.2011.02.014; Harter P, 2006, ANN SURG ONCOL, V13, P1702, DOI 10.1245/s10434-006-9058-0; Heitz F, 2012, ADV THER, V29, P723, DOI 10.1007/s12325-012-0041-9; Kiiski JI, 2014, P NATL ACAD SCI USA, V111, P15172, DOI 10.1073/pnas.1407909111; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kommoss S, 2016, BRIT J CANCER, V115, P993, DOI 10.1038/bjc.2016.273; Konstantinopoulos PA, 2015, CANCER DISCOV, V5, P1137, DOI 10.1158/2159-8290.CD-15-0714; Maistro S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2966-x; Malander S, 2004, EUR J CANCER, V40, P422, DOI 10.1016/j.ejca.2003.09.016; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Muller D, 2017, EUR J HLTH EC; Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Ramus SJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv214; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Sant M, 2015, EUR J CANC; Scambia G, 2016, ANN M EUR SOC MED ON; Schneider S, 2017, INT J GYNECOL CANCER, V27, P444, DOI 10.1097/IGC.0000000000000920; Scottish Intercollegiate Guidelines Network (SIGN), 2013, SIGN PUBL, V135; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Soegaard M, 2008, CLIN CANCER RES, V14, P3761, DOI 10.1158/1078-0432.CCR-07-4806; Walsh CS, 2015, GYNECOL ONCOL, V137, P343, DOI 10.1016/j.ygyno.2015.02.017; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108	35	69	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186043	10.1371/journal.pone.0186043	http://dx.doi.org/10.1371/journal.pone.0186043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053726	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100009
J	Moriguchi, Y; Mojica-Santiago, J; Grunert, P; Pennicooke, B; Berlin, C; Khair, T; Navarro-Ramirez, R; Arbona, RJR; Nguyen, J; Hartl, R; Bonassar, LJ				Moriguchi, Yu; Mojica-Santiago, Jorge; Grunert, Peter; Pennicooke, Brenton; Berlin, Connor; Khair, Thamina; Navarro-Ramirez, Rodrigo; Arbona, Rodolfo J. Ricart; Nguyen, Joseph; Hartl, Roger; Bonassar, Lawrence J.			Total disc replacement using tissue-engineered intervertebral discs in the canine cervical spine	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DENSITY COLLAGEN GEL; NUCLEUS PULPOSUS; IN-VIVO; ANIMAL-MODEL; RODENT SPINE; BACK-PAIN; DEGENERATION; REPAIR; TRANSPLANTATION	The most common reason that adults in the United States see their physician is lower back or neck pain secondary to degenerative disc disease. To date, approaches to treat degenerative disc disease are confined to purely mechanical devices designed to either eliminate or enable flexibility of the diseased motion segment. Tissue engineered intervertebral discs (TE-IVDs) have been proposed as an alternative approach and have shown promise in replacing native IVD in the rodent tail spine. Here we demonstrate the efficacy of our TE-IVDs in the canine cervical spine. TE-IVD components were constructed using adult canine annulus fibrosis and nucleus pulposus cells seeded into collagen and alginate hydrogels, respectively. Seeded gels were formed into a single disc unit using molds designed from the geometry of the canine spine. Skeletally mature beagles underwent discectomy with whole IVD resection at levels between C3/4 and C6/7, and were then divided into two groups that received only discectomy or discectomy followed by implantation of TE-IVD. Stably implanted TE-IVDs demonstrated significant retention of disc height and physiological hydration compared to discectomy control. Both 4-week and 16-week histological assessments demonstrated chondrocytic cells surrounded by proteoglycan-rich matrices in the NP and by fibrocartilaginous matrices in the AF portions of implanted TE-IVDs. Integration into host tissue was confirmed over 16 weeks without any signs of immune reaction. Despite the significant biomechanical demands of the beagle cervical spine, our stably implanted TE-IVDs maintained their position, structure and hydration as well as disc height over 16 weeks in vivo.	[Moriguchi, Yu; Grunert, Peter; Pennicooke, Brenton; Berlin, Connor; Khair, Thamina; Navarro-Ramirez, Rodrigo; Hartl, Roger] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA; [Mojica-Santiago, Jorge; Bonassar, Lawrence J.] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA; [Arbona, Rodolfo J. Ricart] Mem Sloan Kettering Canc Ctr, Ctr Comparat Med & Pathol, 1275 York Ave, New York, NY 10021 USA; [Arbona, Rodolfo J. Ricart] Weill Cornell Med, New York, NY USA; [Nguyen, Joseph] Hosp Special Surg, Inst Healthcare Res, 535 E 70th St, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Bonassar, LJ (corresponding author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.	lb244@cornell.edu	Nguyen, Joseph/ABC-1527-2021; Pennicooke, Brenton/AAK-4239-2020; Berlin, Connor/A-8993-2019	Nguyen, Joseph/0000-0003-1686-3911; Pennicooke, Brenton/0000-0002-4304-9141; Berlin, Connor/0000-0001-5090-1753; Ricart Arbona, Rodolfo/0000-0002-8917-4810; Mojica Santiago, Jorge/0000-0001-6350-1759	Clinical Translational Science Center (CTSC) at Weill Cornell Medical through NIH [UL1 TR000457-06]; Center for Advanced Technology (CAT) at Cornell University through the Empire State Development's Division of Science, Technology and Innovation (NYSTAR); NSF [DGE-1650441]; AO Foundation; Colin MacDonald Fund	Clinical Translational Science Center (CTSC) at Weill Cornell Medical through NIH; Center for Advanced Technology (CAT) at Cornell University through the Empire State Development's Division of Science, Technology and Innovation (NYSTAR); NSF(National Science Foundation (NSF)); AO Foundation; Colin MacDonald Fund	This work was supported by a seed grant from the Clinical Translational Science Center (CTSC) at Weill Cornell Medical through NIH UL1 TR000457-06 to RH; Center for Advanced Technology (CAT) at Cornell University through the Empire State Development's Division of Science, Technology and Innovation (NYSTAR) to LJB; NSF DGE-1650441 to JMS; the AO Foundation and the Colin MacDonald Fund.	Abbushi A, 2008, SPINE, V33, P1527, DOI 10.1097/BRS.0b013e3181788760; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Avila MJ, 2015, J CLIN NEUROSCI, V22, P1088, DOI 10.1016/j.jocn.2015.01.021; Bendtsen M, 2011, SPINE, V36, pE373, DOI 10.1097/BRS.0b013e3181dce34c; Benz K, 2012, EUR SPINE J, V21, P1758, DOI 10.1007/s00586-012-2443-4; Bergknut N, 2012, SPINE, V37, P351, DOI 10.1097/BRS.0b013e31821e5665; Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI [10.1089/ten.tea.2009.0442, 10.1089/ten.TEA.2009.0442]; Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108; Bowles RD, 2012, NMR BIOMED, V25, P443, DOI 10.1002/nbm.1651; Brodke Darrel S, 2005, Instr Course Lect, V54, P279; COLE TC, 1985, J ORTHOP RES, V3, P277, DOI 10.1002/jor.1100030304; Cunha C, 2016, STEM CELLS TRANSL ME; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Forterre F, 2011, VET SURG, V40, P34, DOI 10.1111/j.1532-950X.2010.00780.x; Frith JE, 2014, BIOMATERIALS, V35, P1150, DOI 10.1016/j.biomaterials.2013.10.056; Ganey T, 2009, SPINE, V34, P2297, DOI 10.1097/BRS.0b013e3181a54157; Gebhard Harry, 2011, Evid Based Spine Care J, V2, P29, DOI 10.1055/s-0030-1267084; Gebhard Harry, 2010, Evid Based Spine Care J, V1, P62, DOI 10.1055/s-0028-1100918; Ghosh P, 2012, J NEUROSURG-SPINE, V16, P479, DOI 10.3171/2012.1.SPINE11852; Goldschlager T, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1050; Grunert P, 2014, J NEUROSURG-SPINE, V20, P443, DOI 10.3171/2013.12.SPINE13112; Grunert P, 2015, ACTA BIOMATER, V26, P215, DOI 10.1016/j.actbio.2015.06.006; Grunert P, 2014, SPINE, V39, pE369, DOI 10.1097/BRS.0000000000000194; Grunert P, 2014, SPINE, V39, P198, DOI 10.1097/BRS.0000000000000103; Guehring T, 2006, SPINE, V31, P1658, DOI 10.1097/01.brs.0000224558.81765.56; Hamilton DJ, 2006, BIOMATERIALS, V27, P397, DOI 10.1016/j.biomaterials.2005.07.007; Hee HT, 2010, J BONE JOINT SURG BR, V92B, P726, DOI 10.1302/0301-620X.92B5.23015; Huang B, 2011, SPINE, V36, P2252, DOI 10.1097/BRS.0b013e318209fd85; Huang YC, 2014, NAT REV RHEUMATOL, V10, P561, DOI 10.1038/nrrheum.2014.91; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Itoho H, 2008, J VET MED SCI, V70, P37, DOI 10.1292/jvms.70.37; Iwashina T, 2006, SPINE, V31, P1177, DOI 10.1097/01.brs.0000217687.36874.c4; James Andrew R, 2011, Evid Based Spine Care J, V2, P55, DOI 10.1055/s-0031-1274758; Kelly MP, 2011, SPINE, V36, P1171, DOI 10.1097/BRS.0b013e3181ec5c7d; Kuo YW, 2014, SPINE, V39, pE550, DOI 10.1097/BRS.0000000000000269; Lam SKL, 2012, SPINE, V37, pE357, DOI 10.1097/BRS.0b013e318232909d; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Leung VYL, 2014, STEM CELLS, V32, P2164, DOI 10.1002/stem.1717; Li CQ, 2010, J MATER SCI-MATER M, V21, P741, DOI 10.1007/s10856-009-3871-5; LIM TH, 1994, J BIOMECH, V27, P1259, DOI 10.1016/0021-9290(94)90279-8; Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9; Lu DS, 1997, SPINE, V22, P1828, DOI 10.1097/00007632-199708150-00006; Martin JT, 2014, ACTA BIOMATER, V10, P2473, DOI 10.1016/j.actbio.2014.02.024; Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042; Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27; Nerurkar NL, 2010, SPINE, V35, P867, DOI 10.1097/BRS.0b013e3181d74414; Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215; O'Connell GD, 2007, SPINE, V32, P328, DOI 10.1097/01.brs.0000253961.40910.c1; Omlor GW, 2014, EUR SPINE J, V23, P1837, DOI 10.1007/s00586-014-3314-y; Panjabi MM, 2001, SPINE, V26, P2692, DOI 10.1097/00007632-200112150-00012; Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb; Revell PA, 2007, J MATER SCI-MATER M, V18, P303, DOI 10.1007/s10856-006-0693-6; Ross R, 2007, J BONE JOINT SURG BR, V89B, P785, DOI 10.1302/0301-620X.89B6.18806; Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI [10.1089/ten.tea.2009.0770, 10.1089/ten.TEA.2009.0770]; Ruan DK, 2007, LANCET, V369, P993, DOI 10.1016/S0140-6736(07)60496-6; Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c; Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346; Sugawara T, 2009, ACTA NEUROCHIR, V151, P303, DOI 10.1007/s00701-009-0217-5; Maldonado CV, 2011, EUR SPINE J, V20, P403, DOI 10.1007/s00586-011-1916-1; Xin HK, 2013, TISSUE ENG PT A, V19, P143, DOI [10.1089/ten.tea.2012.0255, 10.1089/ten.TEA.2012.0255]; Yang HL, 2010, SPINE J, V10, P802, DOI 10.1016/j.spinee.2010.06.019; Zhang YJ, 2015, AM J PHYS MED REHAB, V94, P530, DOI 10.1097/PHM.0000000000000194; Zhuang Y, 2011, BIOCHEM BIOPH RES CO, V407, P327, DOI 10.1016/j.bbrc.2011.03.015	63	31	31	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0185716	10.1371/journal.pone.0185716	http://dx.doi.org/10.1371/journal.pone.0185716			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053719	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100005
J	Winton, RS; Flanagan, N; Richardson, CJ				Winton, R. Scott; Flanagan, Neal; Richardson, Curtis J.			Neotropical peatland methane emissions along a vegetation and biogeochemical gradient	PLOS ONE			English	Article							AMAZON FLOODPLAIN; NATURAL WETLANDS; CH4 FLUXES; CARBON; VARIABILITY; OXYGEN; WATER; CO2	Tropical wetlands are thought to be the most important source of interannual variability in atmospheric methane (CH4) concentrations, yet sparse data prevents them from being incorporated into Earth system models. This problem is particularly pronounced in the neotropics where bottom-up models based on water table depth are incongruent with top-down inversion models suggesting unaccounted sinks or sources of CH4. The newly documented vast areas of peatlands in the Amazon basin may account for an important unrecognized CH4 source, but the hydrologic and biogeochemical controls of CH4 dynamics from these systems remain poorly understood. We studied three zones of a peatland in Madre de Dios, Peru, to test whether CH4 emissions and pore water concentrations varied with vegetation community, soil chemistry and proximity to groundwater sources. We found that the opencanopy herbaceous zone emitted roughly one-third as much CH4 as the Mauritia flexuosa palm-dominated areas (4.7 +/- 0.9 and 14.0 +/- 2.4 mg CH4 m(-)2 h(-)1, respectively). Emissions decreased with distance from groundwater discharge across the three sampling sites, and tracked changes in soil carbon chemistry, especially increased soil phenolics. Based on all available data, we calculate that neotropical peatlands contribute emissions of 43 +/- 11.9 Tg CH4 y -1, however this estimate is subject to geographic bias and will need revision once additional studies are published.	[Winton, R. Scott; Flanagan, Neal; Richardson, Curtis J.] Duke Univ, Nicholas Sch Environm, Wetland Ctr, Durham, NC 27708 USA; [Winton, R. Scott] Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Biogeochem & Pollutant Dynam IBP, Aquat Chem, Univ Str 16, Zurich, Switzerland	Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Winton, RS (corresponding author), Duke Univ, Nicholas Sch Environm, Wetland Ctr, Durham, NC 27708 USA.; Winton, RS (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Biogeochem & Pollutant Dynam IBP, Aquat Chem, Univ Str 16, Zurich, Switzerland.	scott.winton@gmail.com	Flanagan, Neal/AAJ-2678-2021; Richardson, Curtis J/A-8202-2009; Richardson, Curt/P-5905-2019	Flanagan, Neal/0000-0003-4184-1706; Winton, Robert/0000-0002-9048-9342	US Department of Energy Office of Science, Terrestrial Ecosystem Sciences [DE-SC0012272]; Duke University Wetland Center Endowment	US Department of Energy Office of Science, Terrestrial Ecosystem Sciences(United States Department of Energy (DOE)); Duke University Wetland Center Endowment	This work was funded by a grant from the US Department of Energy Office of Science, Terrestrial Ecosystem Sciences, under grant award DE-SC0012272. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Duke University Wetland Center Endowment also provided funding and the director of the Duke University Wetland Center is one of this study's co-authors.	[Anonymous], 2021, LANG ENV STAT COMP; BARTLETT KB, 1988, J GEOPHYS RES-ATMOS, V93, P1571, DOI 10.1029/JD093iD02p01571; Belger L, 2011, BIOGEOCHEMISTRY, V105, P171, DOI 10.1007/s10533-010-9536-0; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Carmichael MJ, 2014, BIOGEOCHEMISTRY, V119, P1, DOI 10.1007/s10533-014-9974-1; DEVOL AH, 1988, J GEOPHYS RES-ATMOS, V93, P1583, DOI 10.1029/JD093iD02p01583; Devol AH, 1990, SEASONAL DYNAMICS ME, P95; Draper FC, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/12/124017; Flores BM, 2017, P NATL ACAD SCI USA; Forge T.A., 2007, NEMATODES, P415; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; Gumbricht T, 2017, GLOB CHANG BIOL; Householder JE, 2012, WETLANDS, V32, P359, DOI 10.1007/s13157-012-0271-2; KAMPBELL DH, 1989, INT J ENVIRON AN CH, V36, P249, DOI 10.1080/03067318908026878; Kayranli B, 2010, WETLANDS, V30, P111, DOI 10.1007/s13157-009-0003-4; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/ngeo1955, 10.1038/NGEO1955]; Laanbroek HJ, 2010, ANN BOT-LONDON, V105, P141, DOI 10.1093/aob/mcp201; Lahteenoja O, 2009, CATENA, V79, P140, DOI 10.1016/j.catena.2009.06.006; Lahteenoja O, 2009, GLOBAL CHANGE BIOL, V15, P2311, DOI 10.1111/j.1365-2486.2009.01920.x; Lawson IT, 2015, WETL ECOL MANAG, V23, P327, DOI 10.1007/s11273-014-9402-2; Livingston G., 1995, BIOGENIC TRACE GASES, P14; Lowe L.E, 1993, SOIL SAMPLING METHOD; Marani L, 2007, ATMOS ENVIRON, V41, P1627, DOI 10.1016/j.atmosenv.2006.10.046; Martinson GO, 2010, NAT GEOSCI, V3, P766, DOI 10.1038/NGEO980; Murphy W, 2016, EGU GEN ASSEMBLY, P16391; Neu V, 2011, BIOGEOCHEMISTRY, V105, P133, DOI 10.1007/s10533-011-9581-3; Nisbet EG, 2016, GLOBAL BIOGEOCHEM CY, V30, P1356, DOI 10.1002/2016GB005406; Pangala SR, 2015, GLOBAL CHANGE BIOL, V21, P2642, DOI 10.1111/gcb.12891; Pangala SR, 2013, NEW PHYTOL, V197, P524, DOI 10.1111/nph.12031; Roucoux KH, 2017, CONSERV BIOL; Sjogersten S, 2014, GLOBAL BIOGEOCHEM CY, V28, P1371, DOI 10.1002/2014GB004844; Van Haren JLM, 2015, METHANE FLUX AMAZONI; Wang HJ, 2015, NAT CLIM CHANGE, V5, P584, DOI 10.1038/nclimate2643; Wassmann R, 1992, GLOBAL BIOGEOCHEM CY, V6, P3, DOI 10.1029/91GB01767; Weishampel Peter, 2008, P163, DOI 10.1007/978-1-4020-8506-2_12; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Winton RS, 2017, ECOLOGY, V98, P265, DOI 10.1002/ecy.1640; Winton RS, 2015, WETL ECOL MANAG; Wright EL, 2013, GLOBAL CHANGE BIOL, V19, P3775, DOI 10.1111/gcb.12330; Wright EL, 2011, GLOBAL CHANGE BIOL, V17, P2867, DOI 10.1111/j.1365-2486.2011.02448.x; Ye RZ, 2012, SOIL BIOL BIOCHEM, V54, P36, DOI 10.1016/j.soilbio.2012.05.015	44	17	18	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0187019	10.1371/journal.pone.0187019	http://dx.doi.org/10.1371/journal.pone.0187019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053738	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100054
J	Freundt, M; Lunz, D; Philipp, A; Panholzer, B; Lubnow, M; Friedrich, C; Rupprecht, L; Hirt, S; Haneya, A				Freundt, Miriam; Lunz, Dirk; Philipp, Alois; Panholzer, Bernd; Lubnow, Matthias; Friedrich, Christine; Rupprecht, Leopold; Hirt, Stephan; Haneya, Assad			Impact of dynamic changes of elevated bilirubin on survival in patients on veno-arterial extracorporeal life support for acute circulatory failure	PLOS ONE			English	Article							MEMBRANE-OXYGENATION SUPPORT; REFRACTORY CARDIOGENIC-SHOCK; CARDIAC-ARREST; HEPATIC-FAILURE; EXPERIENCE; DYSFUNCTION; MORTALITY; DISEASE; SYSTEM; STAGE	Aims Veno-arterial extracorporeal life support (ECLS) is an established method to stabilize acute circulatory failure. Parameters and data on when to ideally wean circulatory support are limited. Bilirubin is a marker of end-organ damage. Therefore, the purpose of this large study was to evaluate the impact of dynamic changes of elevated bilirubin levels on survival in patients on ECLS. Methods and results We reviewed 502 consecutive cases of ECLS from 2007 to 2015. Bilirubin levels were recorded before implantation and until six days after explantation. Dynamic bilirubin changes, and hemodynamic and laboratory outcome parameters were compared in survivors and nonsurvivors. Reason for ECLS implantation was cardiac arrest with ongoing resuscitation in 230 (45.8%), low cardiac output in 174 (34.7%) and inability to wean off cardiopulmonary bypass in 98 (19.5%) patients. 307 (61.2%) patients were weaned off ECLS, however, 206 (41.0%) survived. Mean duration of ECLS was 3 (2-6) days, and survivors received significantly longer ECLS (5 vs 3 days, p < 0.001). Survivors had significantly lower baseline bilirubin levels (p = 0.003). Bilirubin started to rise from day 2 in all patients. In survivors, bilirubin levels had trended down on the day of ECLS explantation and stayed at an acceptable level. However, in weaned patients who did not survive and patients who died on ECLS bilirubin levels continued to rise during the recorded period. Conclusion ECLS support improves survival in patients with acute circulatory failure. Down trending bilirubin levels on veno-arterial ECLS indicate improved chances of successful weaning and survival in hemodynamically stable patients.	[Freundt, Miriam; Philipp, Alois; Rupprecht, Leopold; Hirt, Stephan; Haneya, Assad] Univ Med Ctr Regensburg, Dept Cardiothorac Surg, Regensburg, Germany; [Lunz, Dirk] Univ Med Ctr Regensburg, Dept Anesthesiol & Crit Care, Regensburg, Germany; [Panholzer, Bernd; Friedrich, Christine; Haneya, Assad] Univ Schleswig Holstein, Dept Cardiovasc Surg, Campus Kiel, Kiel, Germany; [Lubnow, Matthias] Univ Med Ctr Regensburg, Dept Internal Med 2, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Kiel; Schleswig Holstein University Hospital; University of Regensburg	Haneya, A (corresponding author), Univ Med Ctr Regensburg, Dept Cardiothorac Surg, Regensburg, Germany.; Haneya, A (corresponding author), Univ Schleswig Holstein, Dept Cardiovasc Surg, Campus Kiel, Kiel, Germany.	assad.haneya@uksh.de	Haneya, Assad/ABE-6281-2020; Haneya, Assad/Q-7748-2017; Freundt, Miriam/ABB-5994-2020					Anselmi A, 2015, J THORAC CARDIOV SUR, V150, P947, DOI 10.1016/j.jtcvs.2015.05.070; Aso S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1261-1; Burrell AJC, 2015, J CRIT CARE; Distelmaier K, 2014, CRIT CARE, V18, DOI 10.1186/cc13711; Fuhrmann V, 2011, INTENS CARE MED, V37, P1302, DOI 10.1007/s00134-011-2248-7; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Girotra S, 2016, CIRCULATION; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Haneya A, 2012, PERFUSION-UK, V27, P150, DOI 10.1177/0267659111432330; Haneya A, 2012, RESUSCITATION, V83, P1331, DOI 10.1016/j.resuscitation.2012.07.009; Haneya A, 2009, ANN SAUDI MED, V29, P110, DOI 10.4103/0256-4947.51792; Heilmann C, 2012, EUR J CARDIO-THORAC, V42, P135, DOI 10.1093/ejcts/ezr249; Henrion J, 2003, MEDICINE, V82, P392, DOI 10.1097/01.md.0000101573.54295.bd; Lim H Sern, 2015, EUR HEAR J ACUTE CAR; Loforte A, 2014, G ITAL CARDIOL, V15, P577, DOI 10.1714/1672.18312; Loforte A, 2014, ARTIF ORGANS, V38, pE129, DOI 10.1111/aor.12317; Lubnow M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112316; Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009; NOUEL O, 1980, DIGEST DIS SCI, V25, P49, DOI 10.1007/BF01312732; Roth C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1242-4; Rousse N, 2015, ARTIF ORGANS; Schmidt M, 2015, EUR HEART J, V36, P2246, DOI 10.1093/eurheartj/ehv194; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wu MY, 2008, RESUSCITATION, V79, P54, DOI 10.1016/j.resuscitation.2008.05.002; Yang JA, 2012, J HEART LUNG TRANSPL, V31, P601, DOI 10.1016/j.healun.2012.02.027	25	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0184995	10.1371/journal.pone.0184995	http://dx.doi.org/10.1371/journal.pone.0184995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049294	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900006
J	Dou, XM; Gao, JJ; Gao, P; Tang, DD; Peng, DW; Mao, J; Huang, ZY; Chen, P; Chen, H; Ke, SW; Liang, CZ; Zhang, XS				Dou, Xianming; Gao, Jingjing; Gao, Pan; Tang, Dongdong; Peng, Dangwei; Mao, Jun; Huang, Zhenyu; Chen, Peng; Chen, He; Ke, Shengwei; Liang, Chaozhao; Zhang, Xiansheng			Association between RNA-binding protein Ptbp2 and germ cell injury in an experimentally-induced unilateral cryptorchidism murine model	PLOS ONE			English	Article							PHOSPHOGLYCERATE KINASE 2; MESSENGER-RNA; RAT MODELS; SPERMATOGENESIS; EXPRESSION; FERTILITY; TESTIS; INFERTILITY; MOUSE	RNA binding protein polypyrimidine tract binding protein 2 (Ptbp2) as a key alternative splicing regulator for male germ cell development is well established. However, its expression levels and role in cryptorchidism testes tissues has not been explored. Additionally, the molecular mechanism of heat stress impacts the correct proliferation and differentiation of germ cells is unclear. To investigate whether changes in Ptbp2 expression are correlated with heat stress-induced germ cell injury in testicular tissue, we used a murine model of intraperitoneal cryptorchidism with surgical operation. Here we present compelling evidence that germ cells are severely damaged in mice with unilateral cryptorchidism, with non-obstructive azoospermia. And the Ptbp2 and Pgk2 mRNA levels were significantly decreased in parallel, leading us to conclude that the negative correlation between Ptbp2 levels and germ cell injury in unilateral cryptorchidism murine model. We hypothesize that Ptbp2 is susceptible to heat stress and its disruption has resulted in stability decline of germ cell transcripts Pgk2 mRNA, which consequently lead to germ cell injury in cryptorchidism testes. Thus, we confirm that Ptbp2 is an essential factor in heat stress-induced sperm cell injury and non-obstructive azoospermia.	[Dou, Xianming; Gao, Jingjing; Tang, Dongdong; Peng, Dangwei; Mao, Jun; Huang, Zhenyu; Chen, Peng; Liang, Chaozhao; Zhang, Xiansheng] Anhui Med Univ, Dept Urol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Gao, Pan] Wannan Med Coll, Dept Urol, Affiliated Hosp 2, Wuhu, Anhui, Peoples R China; [Chen, He] Anhui Med Univ, Dept Lab, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Ke, Shengwei] Univ Sci & Technol China, Sch Life Sci, Dept Cell & Dev Biol, Hefei, Anhui, Peoples R China	Anhui Medical University; Wannan Medical College; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, XS (corresponding author), Anhui Med Univ, Dept Urol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China.	xiansheng-zhang@163.com	zhang, xian/GYA-0290-2022		National Natural Science Foundation of China [81370749]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (grant no. 81370749 to XZ).	Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; Bae WJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-367; Cheng Y, 2017, ONCOTARGETS THER, V10, P47, DOI 10.2147/OTT.S126401; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; Davis MB, 2002, MECH DEVELOP, V111, P143, DOI 10.1016/S0925-4773(01)00595-0; Docampo MJ, 2015, SEX DEV, V9, P269, DOI 10.1159/000442059; Dou Xian-Ming, 2016, Zhonghua Nan Ke Xue, V22, P856; Duan ZZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32265; Fawzy F, 2015, CLIN MED INSIGHTS-RE, V9, P39, DOI 10.4137/CMRH.S25056; Ferguson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077351; Gomez-Alcala A V, 1993, J Pediatr Surg, V28, P1521, DOI 10.1016/0022-3468(93)90488-7; Hu YA, 2013, ANDROLOGIA, V45, P315, DOI 10.1111/and.12010; Idler RK, 2012, J ANDROL, V33, P309, DOI 10.2164/jandrol.111.014167; Kim WC, 2016, FRANK J FABOZZI SER, P6; Kocak I, 2001, ASIAN J ANDROL, V3, P277; Liu XX, 2016, HUM REPROD, V31, P273, DOI 10.1093/humrep/dev301; Liu YX, 2010, SCI CHINA LIFE SCI, V53, P1274, DOI 10.1007/s11427-010-4072-7; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; Mizuno K, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.06.035; NISHIMUNE Y, 1978, FERTIL STERIL, V29, P95; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Robida MD, 2003, EMBO J, V22, P2924, DOI 10.1093/emboj/cdg301; Schneuer FJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2768; Sutherland JM, 2015, ASIAN J ANDROL, V17, P529, DOI 10.4103/1008-682X.151397; TAKANO H, 1990, ARCH HISTOL CYTOL, V53, P179, DOI 10.1679/aohc.53.179; Taran I, 2006, WORLD J UROL, V24, P231, DOI 10.1007/s00345-006-0056-4; Wang C, 1997, FERTIL STERIL, V68, P334, DOI 10.1016/S0015-0282(97)81525-7; Wang GS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12126; Xu MG, 2008, INT J ANDROL, V31, P457, DOI 10.1111/j.1365-2605.2008.00885.x; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079; Xu MG, 2008, NUCLEIC ACIDS RES, V36, P7157, DOI 10.1093/nar/gkn800; Zagore LL, 2015, MOL CELL BIOL, V35, P4030, DOI 10.1128/MCB.00676-15; Zakaria O, 1998, BRIT J UROL, V82, P574; Zvizdic Zlatan, 2014, Med Arch, V68, P79	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186654	10.1371/journal.pone.0186654	http://dx.doi.org/10.1371/journal.pone.0186654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045475	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100085
J	Shave, ME; Lindell, CA				Shave, Megan E.; Lindell, Catherine A.			Occupancy modeling reveals territory-level effects of nest boxes on the presence, colonization, and persistence of a declining raptor in a fruit-growing region	PLOS ONE			English	Article							FALCO-SPARVERIUS; AVIAN PREDATORS; INCREASE; HABITAT; SITES; BIRDS; POPULATIONS; CAVITIES	Nest boxes for predators in agricultural regions are an easily implemented tool to improve local habitat quality with potential benefits for both conservation and agriculture. The potential for nest boxes to increase raptor populations in agricultural regions is of particular interest given their positions as top predators. This study examined the effects of cherry orchard nest boxes on the local breeding population of a declining species, the American Kestrel (Falco sparverius), in a fruit-growing region of Michigan. During the 2013-2016 study, we added a total of 23 new nest boxes in addition to 24 intact boxes installed previously; kestrels used up to 100% of our new boxes each season. We conducted temporally-replicated surveys along four roadside transects divided into 1.6 km x 500 m sites. We developed a multi-season occupancy model under a Bayesian framework and found that nest boxes had strong positive effects on first-year site occupancy, site colonization, and site persistence probabilities. The estimated number of occupied sites increased between 2013 and 2016, which correlated with the increase in number of sites with boxes. Kestrel detections decreased with survey date but were not affected by time of day or activity at the boxes themselves. These results indicate that nest boxes determined the presence of kestrels at our study sites and support the conclusion that the local kestrel population is likely limited by nest site availability. Furthermore, our results are highly relevant to the farmers on whose properties the boxes were installed, for we can conclude that installing a nest box in an orchard resulted in a high probability of kestrels occupying that orchard or the areas adjacent to it.	[Shave, Megan E.; Lindell, Catherine A.] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Shave, Megan E.; Lindell, Catherine A.] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Lindell, Catherine A.] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Shave, ME (corresponding author), Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA.; Shave, ME (corresponding author), Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	megan.shave@gmail.com			National Institute of Food and Agriculture Specialty Crop Research Initiative Grant [MICL05052]; National Science Foundation Dynamics of Coupled Natural and Human Systems Grant [1518366]; North Central Region Sustainable Agriculture and Education Graduate Student Grant [GNC15-211]; North American Bluebird Society Research Grant	National Institute of Food and Agriculture Specialty Crop Research Initiative Grant; National Science Foundation Dynamics of Coupled Natural and Human Systems Grant; North Central Region Sustainable Agriculture and Education Graduate Student Grant; North American Bluebird Society Research Grant	This work was funded by a National Institute of Food and Agriculture Specialty Crop Research Initiative Grant (https://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) to CAL (Project Number MICL05052), a National Science Foundation Dynamics of Coupled Natural and Human Systems Grant (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id:=13681) to CAL (Award Number 1518366), a North Central Region Sustainable Agriculture and Education Graduate Student Grant (http://www.northcentralsare.org/Grants/Our-Grant-Programs/Graduate-Student-Grant-Program) to MES (Project Number GNC15-211), and a North American Bluebird Society Research Grant (http://nabluebirdsociety.org/Main/grants.htm) to MES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Askham L.R., 1990, Proceedings of the Vertebrate Pest Conference, V14, P144; BALGOOYEN T G, 1976, University of California Publications in Zoology, V103, P1; Brewer T, 1991, ATLAS BREEDING BIRDS; Brown JL, 2014, BIRD CONSERV INT, V24, P364, DOI 10.1017/S0959270913000415; Bruggeman JE, 2016, IBIS, V158, P61, DOI 10.1111/ibi.12313; Carlson JE, 2015, J RAPTOR RES, V49, P450, DOI 10.3356/rapt-49-04-450-457.1; Farmer CJ, 2009, J RAPTOR RES, V43, P263, DOI 10.3356/JRR-08-14.1; Gelman A., 2003, BAYESIAN DATA ANAL; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Heneberg P, 2013, RESOUR POLICY, V38, P542, DOI 10.1016/j.resourpol.2013.09.001; Jedlicka JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027347; Jimenez-Franco MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093628; KAY BJ, 1994, WILDLIFE RES, V21, P95, DOI 10.1071/WR9940095; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kiss O, 2014, BIRD STUDY, V61, P496, DOI 10.1080/00063657.2014.969191; Kross SM, 2012, CONSERV BIOL, V26, P142, DOI 10.1111/j.1523-1739.2011.01756.x; Labuschagne L, 2016, BIOL CONTROL, V101, P94, DOI 10.1016/j.biocontrol.2016.07.003; Leon-Ortega M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175597; Maas B, 2016, BIOL REV, V91, P1081, DOI 10.1111/brv.12211; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; McClure CJW, 2017, ECOL APPL, V27, P1155, DOI 10.1002/eap.1509; Mols CMM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000202; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Olea PP, 2001, BIRD STUDY, V48, P110, DOI 10.1080/00063650109461208; PALMER RS, 1988, HDB N AM BIRDS, V5; Paz A, 2013, PEST MANAG SCI, V69, P444, DOI 10.1002/ps.3289; Robles H, 2012, FOREST ECOL MANAG, V277, P46, DOI 10.1016/j.foreco.2012.04.017; Robles H, 2012, CONSERV BIOL, V26, P284, DOI 10.1111/j.1523-1739.2011.01816.x; Rohrbaugh RW, 1997, WILSON BULL, V109, P410; Saracco JF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00132.1; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Schmidt JH, 2013, BIOL CONSERV, V160, P130, DOI 10.1016/j.biocon.2013.01.007; Shave M. E., 2017, THESIS; Shave ME, 2017, J RAPTOR RES, V51, P50, DOI 10.3356/jrr-16-43.1; SMALLWOOD JA, 2002, BIRDS N AM, V602; Smallwood JA, 2009, J RAPTOR RES, V43, P308, DOI 10.3356/JRR-08-67.1; Smallwood JA, 2009, J RAPTOR RES, V43, P274, DOI 10.3356/JRR-08-83.1; Smallwood JA, 2009, J RAPTOR RES, V43, P291, DOI 10.3356/JRR-08-81.1; Su Y-S, 2015, R2JAGS USING R RUN; USDA 2012 Census of Agriculture, 2014, USDA 2012 CENS AGR C; VARLAND D E, 1991, Journal of Raptor Research, V25, P9; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Wiebe KL, 2011, J FIELD ORNITHOL, V82, P239, DOI 10.1111/j.1557-9263.2011.00327.x	45	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185701	10.1371/journal.pone.0185701	http://dx.doi.org/10.1371/journal.pone.0185701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045445	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100025
J	Signori, A; Sormani, MP; Schiavetti, I; Bisio, A; Bove, M; Bonzano, L				Signori, Alessio; Sormani, Maria Pia; Schiavetti, Irene; Bisio, Ambra; Bove, Marco; Bonzano, Laura			Quantitative assessment of finger motor performance: Normative data	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CALLOSAL CONTRIBUTIONS; BIMANUAL COORDINATION; WHITE-MATTER; FETAL SIZE; HUMAN HAND; MOVEMENTS; TASK; INHIBITION; INTEGRITY	Background Finger opposition movements are the basis of many daily living activities and are essential in general for manipulating objects; an engineered glove quantitatively assessing motor performance during sequences of finger opposition movements has been shown to be useful to provide reliable measures of finger motor impairment, even subtle, in subjects affected by neurological diseases. However, the obtained behavioral parameters lack published reference values. Objective To determine mean values for different motor behavioral parameters describing the strategy adopted by healthy people in performing repeated sequences of finger opposition movements, examining associations with gender and age. Methods Normative values for finger motor performance parameters were obtained on a sample of 255 healthy volunteers executing sequences of finger-to-thumb opposition movements, stratified by gender and over a wide range of ages. Touch duration, inter-tapping interval, movement rate, correct sequences (%), movements in advance compared with a metronome (%) and inter-hand interval were assessed. Results Increasing age resulted in decreased movement speed, advance movements with respect to a cue, correctness of sequences, and bimanual coordination. No significant performance differences were found between male and female subjects except for the duration of the finger touch, the interval between two successive touches and their ratio. Conclusions We report age-and gender-specific normal mean values and ranges for different parameters objectively describing the performance of finger opposition movement sequences, which may serve as useful references for clinicians to identify possible deficits in subjects affected by diseases altering fine hand motor skills	[Signori, Alessio; Sormani, Maria Pia; Schiavetti, Irene] Univ Genoa, Biostat Unit, Dept Hlth Sci, Via Pastore 1, Genoa, Italy; [Bisio, Ambra; Bove, Marco] Univ Genoa, Sect Human Physiol, Dept Expt Med, Viale Benedetto 15, Genoa, Italy; [Bonzano, Laura] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Largo Daneo 3, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa	Signori, A (corresponding author), Univ Genoa, Biostat Unit, Dept Hlth Sci, Via Pastore 1, Genoa, Italy.; Bonzano, L (corresponding author), Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Largo Daneo 3, Genoa, Italy.	alessio.signori@medicina.unige.it; laura.bonzano@unige.it	Signori, Alessio/L-3081-2016; Bisio, Ambra/N-4309-2013; Sormani, Maria Pia/ABH-8756-2020; Bisio, Ambra/AAM-4979-2020	Signori, Alessio/0000-0001-6289-9144; Bisio, Ambra/0000-0002-9385-1714; Schiavetti, Irene/0000-0002-5460-2977; SORMANI, MARIA PIA/0000-0001-6892-104X	European Union; Liguria region (PO CRO Fondo Sociale Europeo Regione Liguria Asse IV "Capitale Umano" ob.specifico I/6) [DPU12UNIGE83/4000]; project "ACIRAS: Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti Regione Liguria PARFAS - Progetto 4 Programma triennale per la ricerca e l'innovazione:	European Union(European Commission); Liguria region (PO CRO Fondo Sociale Europeo Regione Liguria Asse IV "Capitale Umano" ob.specifico I/6); project "ACIRAS: Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti Regione Liguria PARFAS - Progetto 4 Programma triennale per la ricerca e l'innovazione:	The present work was supported (post-doc fellowship to AS) by European Union and Liguria region (Project: DPU12UNIGE83/4000- PO CRO Fondo Sociale Europeo Regione Liguria 2007-2013 Asse IV "Capitale Umano" ob.specifico I/6) and by the project "ACIRAS: Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti Regione Liguria PARFAS 20072013 - Progetto 4 Programma triennale per la ricerca e l'innovazione: progetti integrati ad alta tecnologia". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti MA, 2015, J PERIPHER NERV SYST, V20, P410, DOI 10.1111/jns.12150; ALTMAN DG, 1993, ULTRASOUND OBST GYN, V3, P378, DOI 10.1046/j.1469-0705.1993.03060378.x; ALTMAN DG, 1994, BRIT J OBSTET GYNAEC, V101, P29, DOI 10.1111/j.1471-0528.1994.tb13006.x; ALTMAN DG, 1993, STAT MED, V12, P917, DOI 10.1002/sim.4780121003; Avanzino L, 2011, MOVEMENT DISORD, V26, P2114, DOI 10.1002/mds.23839; Avanzino L, 2009, EUR J NEUROSCI, V30, P1971, DOI 10.1111/j.1460-9568.2009.06984.x; BIRREN JE, 1995, ANNU REV PSYCHOL, V46, P329, DOI 10.1146/annurev.ps.46.020195.001553; Bonzano L, 2011, NEUROIMAGE, V57, P495, DOI 10.1016/j.neuroimage.2011.04.037; Bonzano L, 2008, J NEUROSCI, V28, P3227, DOI 10.1523/JNEUROSCI.4076-07.2008; Bonzano L, 2017, BEHAV BRAIN RES, V325, P63, DOI 10.1016/j.bbr.2017.02.008; Bonzano Laura, 2015, Front Hum Neurosci, V9, P503, DOI 10.3389/fnhum.2015.00503; Bonzano L, 2014, NEUROIMAGE, V90, P107, DOI 10.1016/j.neuroimage.2013.12.025; Bonzano L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065225; Bonzano L, 2013, NEUROIMAGE, V65, P257, DOI 10.1016/j.neuroimage.2012.10.012; Bonzano L, 2011, HUM BRAIN MAPP, V32, P218, DOI 10.1002/hbm.21011; Bove M, 2007, BRAIN RES, V1153, P84, DOI 10.1016/j.brainres.2007.03.063; Christou EA, 2011, EXERC SPORT SCI REV, V39, P77, DOI 10.1097/JES.0b013e31820b85ab; de Oliveira SC, 2002, ACTA PSYCHOL, V110, P139, DOI 10.1016/S0001-6918(02)00031-8; Eliassen JC, 2000, BRAIN, V123, P2501, DOI 10.1093/brain/123.12.2501; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; Fling BW, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00038; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Martino D, 2016, PARKINSONISM RELAT D, V32, P80, DOI 10.1016/j.parkreldis.2016.08.021; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Netz J, 1999, EEG CL N SU, P137; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pardini M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02001; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Seidler RD, 2002, MOTOR CONTROL, V6, P19, DOI 10.1123/mcj.6.1.19; Solesio-Jofre E, 2014, HUM BRAIN MAPP, V35, P3945, DOI 10.1002/hbm.22450; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Vanneste S, 2001, EXP AGING RES, V27, P83, DOI 10.1080/03610730125798; Vercauteren K, 2008, NEUROSCI LETT, V445, P209, DOI 10.1016/j.neulet.2008.09.013; Young RW, 2003, J ANAT, V202, P165, DOI 10.1046/j.1469-7580.2003.00144.x	36	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186524	10.1371/journal.pone.0186524	http://dx.doi.org/10.1371/journal.pone.0186524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045480	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100068
J	Luo, W; Xu, C; Ayello, J; Dela Cruz, F; Rosenblum, JM; Lessnick, SL; Cairo, MS				Luo, W.; Xu, C.; Ayello, J.; Dela Cruz, F.; Rosenblum, J. M.; Lessnick, S. L.; Cairo, M. S.			Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis	ONCOGENE			English	Article							THERAPEUTIC TARGET; CELL-MIGRATION; GENE; EXPRESSION; CANCER; TUMOR; PHOSPHORYLATION; INHIBITOR-1; DEGRADATION; MECHANISMS	Protein phosphatase inhibitors are often considered as tumor promoters. Protein phosphatase 1 regulatory subunit 1A (PPP1R1A) is a potent protein phosphatase 1 (PP1) inhibitor; however, its role in tumor development is largely undefined. Here we characterize, for the first time, the functions of PPP1R1A in Ewing sarcoma (ES) pathogenesis. We found that PPP1R1A is one of the top ranked target genes of EWS/FLI, the master regulator of ES, and is upregulated by EWS/FLI via a GGAA microsatellite enhancer element. Depletion of PPP1R1A resulted in a significant decrease in oncogenic transformation and cell migration in vitro as well as xenograft tumor growth and metastasis in an orthotopic mouse model. RNA-sequencing and functional annotation analyses revealed that PPP1R1A regulates genes associated with various cellular functions including cell junction, adhesion and neurogenesis. Interestingly, we found a significant overlap of PPP1R1A-regulated gene set with that of ZEB2 and EWS, which regulates metastasis and neuronal differentiation in ES, respectively. Further studies for characterization of the molecular mechanisms revealed that activation of PPP1R1A by PKA phosphorylation at Thr35, and subsequent PP1 binding and inhibition, was required for PPP1R1A-mediated tumorigenesis and metastasis, likely by increasing the phosphorylation levels of various PP1 substrates. Furthermore, we found that a PKA inhibitor impaired ES cell proliferation, tumor growth and metastasis, which was rescued by the constitutively active PPP1R1A. Together, these results offered new insights into the role and mechanism of PPP1R1A in tumor development and identified an important kinase and phosphatase pathway, PKA/PPP1R1A/PP1, in ES pathogenesis. Our findings strongly suggest a potential therapeutic value of inhibition of the PKA/PPP1R1A/PP1 pathway in the treatment of primary and metastatic ES.	[Luo, W.; Ayello, J.; Rosenblum, J. M.; Cairo, M. S.] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA; [Luo, W.; Cairo, M. S.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Xu, C.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Dela Cruz, F.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Lessnick, S. L.] Nationwide Childrens Hosp, Columbus, OH USA; [Cairo, M. S.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Cairo, M. S.] New York Med Coll, Dept Immunol & Microbiol, Valhalla, NY 10595 USA; [Cairo, M. S.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	New York Medical College; New York Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Memorial Sloan Kettering Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; New York Medical College; New York Medical College; New York Medical College	Luo, W (corresponding author), New York Med Coll Grasslands Reservat, Dept Pediat, Vosburgh Room 101, Valhalla, NY 10595 USA.; Luo, W (corresponding author), New York Med Coll Grasslands Reservat, Dept Pathol, Vosburgh Room 101, Valhalla, NY 10595 USA.; Cairo, MS (corresponding author), New York Med Coll, Skyline Off 1N D12, Pediat Med Pathol Microbiol & Immunol & Cell Biol, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA.	Wen_Luo@nymc.edu; mitchell_cairo@nymc.edu			Pediatric Cancer Research Foundation; Association for Research of Childhood Cancer	Pediatric Cancer Research Foundation; Association for Research of Childhood Cancer	We thank Drs David Virshup, Shirish Shenolikar, Angus Nairn and James Bibb for helpful discussion. We would also like to thank the members of the Cairo and Lessnick laboratories for technical assistance and helpful discussion, and Erin Morris RN for her administrative assistance in the preparation of this manuscript. This work is supported by funds from Pediatric Cancer Research Foundation (MSC) and Association for Research of Childhood Cancer (WL).	Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Chaturvedi Aashi, 2012, Genes Cancer, V3, P102, DOI 10.1177/1947601912457024; Chi LM, 2016, ACTA NEUROL BELG, V116, P543, DOI 10.1007/s13760-016-0613-6; Chu YY, 2015, CANCER IMMUNOL RES, V3, P333, DOI 10.1158/2326-6066.CIR-14-0114; Cohen PTW, 2002, J CELL SCI, V115, P241; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Croft DR, 2006, METHOD ENZYMOL, V406, P541, DOI 10.1016/S0076-6879(06)06042-3; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; Dela Cruz F, 2012, DIFFERENTIATION, V83, P220, DOI 10.1016/j.diff.2012.01.001; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; El-Rifai W, 2002, CANCER RES, V62, P4061; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Finger EC, 2015, P NATL ACAD SCI USA, V112, P4441, DOI 10.1073/pnas.1418164112; Fleuren EDG, 2016, NAT REV CANCER, V16, P83, DOI 10.1038/nrc.2015.18; Franzetti GA, 2017, ONCOGENE, V36, P3505, DOI 10.1038/onc.2016.498; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Huang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133152; HURTA RAR, 1992, BIOCHEM CELL BIOL, V70, P1081, DOI 10.1139/o92-153; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Li FR, 2012, J NEUROSCI RES, V90, P2237, DOI 10.1002/jnr.23121; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Luo W, 2009, ONCOGENE, V28, P4126, DOI 10.1038/onc.2009.262; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Ma DD, 2003, J BIOL CHEM, V278, P19358, DOI 10.1074/jbc.M301761200; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Mouravlev A, 2007, BRAIN RES, V1130, P31, DOI 10.1016/j.brainres.2006.10.076; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Niedan S, 2014, ONCOGENE, V33, P3927, DOI 10.1038/onc.2013.361; Ohali A, 2004, ONCOGENE, V23, P8997, DOI 10.1038/sj.onc.1208060; Patel M, 2012, GENOME RES, V22, P259, DOI 10.1101/gr.125666.111; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Potratz J, 2016, MOL ONCOL, V10, P677, DOI 10.1016/j.molonc.2015.12.009; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sainz-Jaspeado M, 2010, MOL CANCER RES, V8, P1489, DOI 10.1158/1541-7786.MCR-10-0060; Sand LGL, 2015, EUR J CANCER, V51, P2624, DOI 10.1016/j.ejca.2015.08.020; Sankar S, 2013, MOL CELL BIOL, V33, P4448, DOI 10.1128/MCB.00241-13; Sankar Savita, 2013, Genes Cancer, V4, P213, DOI 10.1177/1947601913489569; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Scotlandi K, 1996, CANCER RES, V56, P4570; Sechler M, 2017, ONCOGENE, V36, P4150, DOI 10.1038/onc.2017.44; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Volchenboum SL, 2015, J PATHOL CLIN RES, V1, P83, DOI 10.1002/cjp2.9; von Heyking K, 2017, MOL ONCOL, V11, P1288, DOI 10.1002/1878-0261.12057; Waisberg J, 2014, ANTICANCER RES, V34, P5599; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Wiles Elizabeth T, 2013, Genes Cancer, V4, P486, DOI 10.1177/1947601913506115	53	22	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					798	809		10.1038/onc.2017.378	http://dx.doi.org/10.1038/onc.2017.378			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059150				2022-12-26	WOS:000424628100011
J	Joshi, N; Werner, S				Joshi, Natasha; Werner, Sabine			Nrf2 is highly expressed in neutrophils, but myeloid cell-derived Nrf2 is dispensable for wound healing in mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; KEAP1; INFLAMMATION; REPAIR; MACROPHAGES; ACTIVATION	Immune cells of the myeloid lineage are key players in skin wound healing, since they secrete various cytokines and growth factors that orchestrate the repair process. In addition, they are crucial for the defense against invading pathogens through their capacity to produce high levels of reactive oxygen species (ROS). To limit the toxicity of ROS, cells have developed antioxidant defense strategies, including expression of the cytoprotective NRF2 transcription factor. Here we show that murine neutrophils and to a lesser extent macrophages strongly express Nrf2 already when present in the circulation and in particular at the wound site. To determine the role of Nrf2 in neutrophils and macrophages for wound repair, we generated mice with a gain-or loss-of-function of this transcription factor in the myeloid cell lineage. Expression of a constitutively active Nrf2 mutant in myeloid cells did not further enhance the overall Nrf2 activity in these cells due to the already high steady-state activity of endogenous Nrf2. Surprisingly, deletion of Nrf2 in myeloid cells only mildly affected the levels of ROS and the expression of pro-inflammatory cytokines by these cells. In particular, various parameters of wound healing, including wound closure, reepithelialization, wound contraction and the presence of myeloid cells at the wound site were not affected. These results reveal that Nrf2 in myeloid cells is dispensable for wound healing and suggest the presence of additional antioxidant defense strategies of these cells that compensate for the loss of Nrf2, even in the harsh environment of skin wounds.	[Joshi, Natasha; Werner, Sabine] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Otto Stern Weg 7, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Werner, S (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Otto Stern Weg 7, Zurich, Switzerland.	sabine.werner@biol.ethz.ch		Werner, Sabine/0000-0001-7397-8710	Swiss National Science Foundation [PDFMP3_137197/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by Swiss National Science Foundation Grant PDFMP3_137197/1 to SW; http://www.snf.ch.	Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dhall S, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/562625; Dias IHK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066407; Dinkova-Kostova AT, 2017, ARCH BIOCHEM BIOPHYS, V617, P84, DOI 10.1016/j.abb.2016.08.005; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Gerstgrasser A, 2017, J CROHNS COLITIS, V11, P485, DOI 10.1093/ecco-jcc/jjw172; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HEROVICI C, 1963, REV FR ETUD CLIN BIO, V8, P88; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kobayashi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/529219; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Lee LY, 2016, LIVER TRANSPLANT, V22, P1115, DOI 10.1002/lt.24473; Li B, 2014, BIOCHEM BIOPH RES CO, V444, P555, DOI 10.1016/j.bbrc.2014.01.101; Long M, 2016, DIABETES, V65, P780, DOI 10.2337/db15-0564; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Meher AK, 2012, FREE RADICAL BIO MED, V52, P1708, DOI 10.1016/j.freeradbiomed.2012.02.022; Rabbani PS, 2017, BIOMATERIALS, V132, P1, DOI 10.1016/j.biomaterials.2017.04.001; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schafer M, 2015, FREE RADICAL BIO MED, V88, P243, DOI 10.1016/j.freeradbiomed.2015.04.018; Schafer M, 2014, EMBO MOL MED, V6, P442, DOI 10.1002/emmm.201303281; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Soares MA, 2016, DIABETES, V65, P633, DOI 10.2337/db15-0453; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187162	10.1371/journal.pone.0187162	http://dx.doi.org/10.1371/journal.pone.0187162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073253	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400128
J	Okino-Delgado, CH; do Prado, DZ; Facanali, R; Marques, MMO; Nascimento, AS; Fernandes, CJD; Zambuzzi, WF; Fleuri, LF				Okino-Delgado, Clarissa Hamaio; do Prado, Debora Zanoni; Facanali, Roselaine; Ortiz Marques, Marcia Mayo; Nascimento, Augusto Santana; da Costa Fernandes, Celio Junior; Zambuzzi, William Fernando; Fleuri, Luciana Francisco			Bioremediation of cooking oil waste using lipases from wastes	PLOS ONE			English	Article							SKIN IRRITATION; BIODIESEL; CLONING	Cooking oil waste leads to well-known environmental impacts and its bioremediation by lipase-based enzymatic activity can minimize the high cytotoxic potential. In addition, they are among the biocatalysts most commercialized worldwide due to the versatility of reactions and substrates. However, although lipases are able to process cooking oil wastes, the products generated from this process do not necessarily become less toxic. Thus, the aim of the current study is to analyze the bioremediation of lipase-catalyzed cooking oil wastes, as well as their effect on the cytotoxicity of both the oil and its waste before and after enzymatic treatment. Thus, assessed the post-frying modification in soybean oil and in its waste, which was caused by hydrolysis reaction catalyzed by commercial and home-made lipases. The presence of lipases in the extracts obtained from orange wastes was identified by zymography. The profile of the fatty acid esters formed after these reactions was detected and quantified through gas chromatography and fatty acids profile compared through multivariate statistical analyses. Finally, the soybean oil and its waste, with and without enzymatic treatment, were assessed for toxicity in cytotoxicity assays conducted in vitro using fibroblast cell culture. The soybean oil wastes treated with core and frit lipases through transesterification reaction were less toxic than the untreated oils, thus confirming that cooking oil wastes can be bioremediated using orange lipases.	[Okino-Delgado, Clarissa Hamaio; do Prado, Debora Zanoni; Nascimento, Augusto Santana; da Costa Fernandes, Celio Junior; Zambuzzi, William Fernando; Fleuri, Luciana Francisco] Sao Paulo State Univ UNESP, Inst Biosci, Chem & Biochem Dept, Botucatu, SP, Brazil; [Facanali, Roselaine; Ortiz Marques, Marcia Mayo] CEP, Agron Inst IAC, Campinas, SP, Brazil	Universidade Estadual Paulista; Instituto Agronomico de Campinas (IAC)	Okino-Delgado, CH (corresponding author), Sao Paulo State Univ UNESP, Inst Biosci, Chem & Biochem Dept, Botucatu, SP, Brazil.	clarissaokino@gmail.com	Fernandes, Célio/L-3873-2018; Fernandes, Célio/AAD-1278-2019; Delgado, Clarissa H Okino/A-3524-2017; Delgado, Clarissa Okino/W-6075-2019; Prado, Débora/O-5611-2019; Prado, Débora Z/N-7141-2014; Fleuri, Luciana/H-5816-2012; Zambuzzi, Willian Fernando/F-9519-2012; Marques, Marcia O.M./E-1283-2019; Zambuzzi, Willian/ABD-8339-2020	Fernandes, Célio/0000-0003-1009-3127; Fernandes, Célio/0000-0003-1009-3127; Delgado, Clarissa H Okino/0000-0002-8750-7298; Delgado, Clarissa Okino/0000-0002-8750-7298; Prado, Débora/0000-0001-9731-103X; Prado, Débora Z/0000-0001-9731-103X; Zambuzzi, Willian Fernando/0000-0002-4149-5965; Marques, Marcia O.M./0000-0001-8270-4308; 	Research Support Foundation (FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2014/10962-7, 2015/01753-8, 2014/22689-3]; Coordination for the Improvement of Higher Education Personnel (CAPES - Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior); National Research Council (CNPq - Conselho Nacional de Pesquisa)	Research Support Foundation (FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); Coordination for the Improvement of Higher Education Personnel (CAPES - Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior); National Research Council (CNPq - Conselho Nacional de Pesquisa)	This study was supported by the Research Support Foundation (FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo / Processes 2014/10962-7; 2015/01753-8; 2014/22689-3), the Coordination for the Improvement of Higher Education Personnel (CAPES - Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior) and the National Research Council (CNPq - Conselho Nacional de Pesquisa).; The authors are grateful to Paulista State University Julio de Mesquita Filho (UNESP-Universidade Estadual Paulista Julio de Mesquita Filho), to the Agronomic Institute (IAC-Instituto Agronomico), to Sao Paulo State Research Support Foundation (FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo / Processes 2014/10962-7; 2015/01753-8; 2014/22689-3), to the Coordination for the Improvement of Higher Education Personnel (CAPESCoordenacao de Aperfeicoamento de Pessoal do Nivel Superior) and to the National Research Council (CNPq-Conselho Nacional de Pesquisa).	BASON MM, 1991, INT J DERMATOL, V30, P623, DOI 10.1111/j.1365-4362.1991.tb03485.x; Basso RC, 2012, FLUID PHASE EQUILIBR, V333, P55, DOI 10.1016/j.fluid.2012.07.018; Brown LD, 2017, OIL SPILL SCIENCE AND TECHNOLOGY, 2ND EDITION, P699, DOI 10.1016/B978-0-12-809413-6.00012-6; Duarte JG, 2016, FUEL, V177, P123, DOI 10.1016/j.fuel.2016.02.079; Eastmond PJ, 2004, J BIOL CHEM, V279, P45540, DOI 10.1074/jbc.M408686200; Fleuri L. F., 2014, INT J FOOD SCI TECH, V1, P1, DOI DOI 10.1111/IJFS.12589; Fleuri LF, 2014, FOOD SCI BIOTECHNOL, V23, P1199, DOI 10.1007/s10068-014-0164-7; Gioda A, 2016, TOXICOL IN VITRO, V34, P283, DOI 10.1016/j.tiv.2016.05.004; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Guillen MD, 2012, FOOD CHEM, V131, P915, DOI 10.1016/j.foodchem.2011.09.079; Lerma-Garcia MJ, 2016, FOOD CHEM, V196, P739, DOI 10.1016/j.foodchem.2015.10.009; Karim EK, 2005, FEBS LETT, V579, P6067, DOI 10.1016/j.febslet.2005.09.072; Kumar A, 2016, BIOL PROCED ONLINE, V18, DOI 10.1186/s12575-016-0033-2; Kumar S, 2012, BIORESOURCE TECHNOL, V120, P300, DOI 10.1016/j.biortech.2012.06.018; Lee JK, 2000, TOXICOL IN VITRO, V14, P345, DOI 10.1016/S0887-2333(00)00028-X; Macedo GA, 1997, REV MICROBIOL, V28, P90; Mita L, 2010, J MOL CATAL B-ENZYM, V62, P133, DOI 10.1016/j.molcatb.2009.09.016; Murugesan A, 2009, RENEW SUST ENERG REV, V13, P653, DOI 10.1016/j.rser.2007.10.007; Nwobi B. E., 2006, African Journal of Food, Agriculture, Nutrition and Development, V6, P1; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Okino-Delgado C. H., 2017, PROTOCOLS IO; Okino-Delgado C. H., 2015, FOOD REV INT, V1, P15; Okino-Delgado CH, 2014, FOOD CHEM, V163, P103, DOI 10.1016/j.foodchem.2014.04.090; Paques FW, 2006, QUIM NOVA, V29, P93, DOI 10.1590/S0100-40422006000100018; Rigo E, 2008, ENVIRON ENG SCI, V25, P1243, DOI 10.1089/ees.2007.0197; Salgado JM, 2014, APPL BIOCHEM BIOTECH, V172, P1832, DOI 10.1007/s12010-013-0613-4; Seth S, 2014, PROTEIN EXPRES PURIF, V95, P13, DOI 10.1016/j.pep.2013.11.006; Sivaperumal P, 2017, ADV FOOD NUTR RES, V80, P165, DOI 10.1016/bs.afnr.2016.10.006; Stacke J., 2009, REV DESTAQUE ACAD, V1, P71; Talukder MMR, 2007, BIOCHEM ENG J, V33, P60, DOI 10.1016/j.bej.2006.10.004; Teo JWP, 2003, GENE, V312, P181, DOI 10.1016/S0378-1119(03)00615-2; [王小行 Xiaoxing Wang], 2006, [植物学通报, Chinese Bulletin of Botany], V23, P634	32	34	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186246	10.1371/journal.pone.0186246	http://dx.doi.org/10.1371/journal.pone.0186246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073166	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400018
J	Wu, QQ; Xu, GH; Chen, LT; Luo, AL; Zhang, SC				Wu, Qingqiang; Xu, Guanghua; Chen, Longting; Luo, Ailing; Zhang, Sicong			Human action recognition based on kinematic similarity in real time	PLOS ONE			English	Article								Human action recognition using 3D pose data has gained a growing interest in the field of computer robotic interfaces and pattern recognition since the availability of hardware to capture human pose. In this paper, we propose a fast, simple, and powerful method of human action recognition based on human kinematic similarity. The key to this method is that the action descriptor consists of joints position, angular velocity and angular acceleration, which can meet the different individual sizes and eliminate the complex normalization. The angular parameters of joints within a short sliding time window (approximately 5 frames) around the current frame are used to express each pose frame of human action sequence. Moreover, three modified KNN (k-nearest-neighbors algorithm) classifiers are employed in our method: one for achieving the confidence of every frame in the training step, one for estimating the frame label of each descriptor, and one for classifying actions. Additional estimating of the frame's time label makes it possible to address single input frames. This approach can be used on difficult, unsegmented sequences. The proposed method is efficient and can be run in real time. The research shows that many public datasets are irregularly segmented, and a simple method is provided to regularize the datasets. The approach is tested on some challenging datasets such as MSR-Action3D, MSRDailyActivity3D, and UTD-MHAD. The results indicate our method achieves a higher accuracy.	[Wu, Qingqiang; Xu, Guanghua; Chen, Longting; Luo, Ailing; Zhang, Sicong] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China; [Luo, Ailing] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Xu, GH (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China.	ghxu@mail.xjtu.edu.cn	Qingqiang, Wu/HDN-0973-2022		National Natural Science Foundation of China;  [91420301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work is supported by National Natural Science Foundation of China (http://www. nsfc.gov.cn/). The grant number is 91420301. GX received the funding. The funder had a role in study design.	Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; Borghi G, 2016, INT C PATT RECOG, P997, DOI 10.1109/ICPR.2016.7899766; Chen C, 2015, IEEE IMAGE PROC, P168, DOI 10.1109/ICIP.2015.7350781; Chen C, 2016, J REAL-TIME IMAGE PR, V12, P155, DOI 10.1007/s11554-013-0370-1; Chen WB, 2015, J VIS COMMUN IMAGE R, V26, P182, DOI 10.1016/j.jvcir.2014.11.008; Du Y, 2015, PATT REC ACPR 2015 3; Ellis C, 2013, INT J COMPUT VISION, V101, P420, DOI 10.1007/s11263-012-0550-7; Eweiwi A., 2014, P AS C COMP VIS; Ghorbel E, 2016, INT C PATT RECOG, P919, DOI 10.1109/ICPR.2016.7899753; Hoai M, 2014, COMPUTER VISION PATT; Jalal A, 2016, J COMPUT NETW COMMUN, V2016, DOI 10.1155/2016/8087545; Laptev I., 2008, COMP VIS PATT REC 20; Li Wanqing, 2010, COMP VIS PATT REC WO; Liu MY, 2017, PATTERN RECOGN, V68, P346, DOI 10.1016/j.patcog.2017.02.030; Mahasseni B, 2016, PROC CVPR IEEE, P3054, DOI 10.1109/CVPR.2016.333; Megavannan V, 2012, SIGN PROC COMM SPCOM; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Veeriah V, 2015, P IEEE INT C COMP VI; Vemulapalli R, 2014, PROC CVPR IEEE, P588, DOI 10.1109/CVPR.2014.82; Vieira Antonio W., 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P252, DOI 10.1007/978-3-642-33275-3_31; Wang Jiang, 2012, COMP VIS PATT REC CV; Wang PC, 2016, MM'16: PROCEEDINGS OF THE 2016 ACM MULTIMEDIA CONFERENCE, P97, DOI 10.1145/2964284.2967191; Xia L, 2013, PROC CVPR IEEE, P2834, DOI 10.1109/CVPR.2013.365; Yang X., 2012, P 20 ACM INT C MULT; Yang X., 2012, COMP VIS PATT REC WO; Yang Z., 2014, PLOS ONE, V9; Zanfir M, 2013, P IEEE INT C COMP VI; Zhang J, 2016, PATTERN RECOGN, V60, P86, DOI 10.1016/j.patcog.2016.05.019; Zhu YM, 2013, ADV MATER RES-SWITZ, V826, P3, DOI 10.4028/www.scientific.net/AMR.826.3	31	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0185719	10.1371/journal.pone.0185719	http://dx.doi.org/10.1371/journal.pone.0185719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073131	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400006
J	Xu, Y; Li, N; Lu, MS; Dixon, E; Myers, RP; Jelley, RJ; Quan, HD				Xu, Yuan; Li, Ning; Lu, Mingshan; Dixon, Elijah; Myers, Robert P.; Jelley, Rachel J.; Quan, Hude			The effects of patient cost sharing on inpatient utilization, cost, and outcome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ELECTRONIC HEALTH RECORDS; RURAL CHINA; PROVIDER PAYMENT; MEDICAL-RECORD; CARE; DEMAND; INSURANCE; VALIDATION; BURDEN	Background Health insurance and provider payment reforms all over the world beg a key empirical question: what are the potential impacts of patient cost-sharing on health care utilization, cost and outcomes? The unique health insurance system and rich electronic medical record (EMR) data in China provides us a unique opportunity to study this topic. Methods Four years (2010 to 2014) of EMR data from one medical center in China were utilized, including 10,858 adult patients with liver diseases. We measured patient cost-sharing using actual reimbursement ratio (RR) which is allowed us to better capture financial incentive than using type of health insurance. A rigorous risk adjustment method was employed with both comorbidities and disease severity measures acting as risk adjustors. Associations between RR and health use, costs and outcome were analyzed by multivariate analyses. Results After risk adjustment, patients with more generous health insurance coverage (higher RR) were found to have longer hospital stay, higher total cost, higher medication cost, and higher ratio of medication to total cost, as well as higher number and likelihood that specific procedures were performed. Conclusion Our study implied that patient cost-sharing affects health care services use and cost. This reflects how patients and physicians respond to financial incentives in the current healthcare system in China, and the responses could be a joint effect of both demand and supply side moral hazard. In order to contain cost and improve efficiency in the system, reforming provide payment and insurance scheme is urgently needed.	[Xu, Yuan; Li, Ning] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China; [Xu, Yuan; Lu, Mingshan; Dixon, Elijah; Myers, Robert P.; Jelley, Rachel J.; Quan, Hude] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Lu, Mingshan] Univ Calgary, Dept Econ, Calgary, AB, Canada; [Dixon, Elijah] Univ Calgary, Div Gen Surg, Dept Med, Calgary, AB, Canada; [Myers, Robert P.] Univ Calgary, Div Gastroenterol & Hepatol, Dept Med, Liver Unit, Calgary, AB, Canada	Capital Medical University; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Li, N (corresponding author), Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China.	lirungya@ccmu.edu.cn		Xu, Yuan/0000-0003-2100-9437; Quan, Hude/0000-0002-7848-7256	Alberta Health Service (AHS); Libin Cardiovascular Institute of Alberta	Alberta Health Service (AHS); Libin Cardiovascular Institute of Alberta	The authors thank Dr. Guanmin Chen from Alberta Health Service (AHS) and Libin Cardiovascular Institute of Alberta and Dr. Mingfu Liu from Alberta Health Service (AHS) for their supports on data mining and analysis.	Bao XY, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2015-000051; Borah BJ, 2011, HEALTH ECON, V20, P1025, DOI 10.1002/hec.1757; Chang GM, 2011, MED CARE, V49, P1054, DOI 10.1097/MLR.0b013e318235382b; Devlin SS, 2008, J HLTH EC, V27, P1168; Farinati F, 2012, J HEPATOL, V57, P221, DOI 10.1016/j.jhep.2011.12.022; Ginsburg PB, 2013, HEALTH AFFAIR, V32, P929, DOI 10.1377/hlthaff.2012.1007; Ginsburg PB, 2011, NEW ENGL J MED, V365, P1268, DOI 10.1056/NEJMp1107019; Group NJaTIE, 1993, FREE ALL LESSONS RAN; Huang H, 2015, J EPIDEMIOL, V25, P626, DOI 10.2188/jea.JE20140215; Lei JB, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-96; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu DH, 2010, INT J MED INFORM, V79, P450, DOI 10.1016/j.ijmedinf.2010.03.002; Liu XQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007362; Ma J, 2008, HEALTH AFFAIR, V27, P937, DOI 10.1377/hlthaff.27.4.937; MANNING WG, 1987, AM ECON REV, V77, P251; Mort EA, 1996, MED CARE, V34, P783, DOI 10.1097/00005650-199608000-00006; Newhouse J.P., 2000, HDB HLTH EC; Powell-Jackson T, 2015, HEALTH ECON, V24, P755, DOI 10.1002/hec.3060; Remler DK, 2003, HEALTH ECON, V12, P269, DOI 10.1002/hec.725; Roayaie S, 2014, J HEPATOL, V61, P3, DOI 10.1016/j.jhep.2014.04.005; Sada Y, 2016, MED CARE, V54, pE9, DOI 10.1097/MLR.0b013e3182a30373; Tian Z, 2015, AUTOMATED EXTRACTION; Van de Voorde C, 2001, HEALTH ECON, V10, P457, DOI 10.1002/hec.631; Wang H, 2011, HEALTH AFFAIR, V30, P2427, DOI 10.1377/hlthaff.2009.0022; Williamson T, 2014, ANN FAM MED, V12, P367, DOI 10.1370/afm.1644; Winkelmann R, 2004, HEALTH ECON, V13, P1081, DOI 10.1002/hec.868; Xu Y, 2014, J AM MED INFORM ASSN, V21, pE84, DOI 10.1136/amiajnl-2013-001806; Xu Y, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-016-0559-4; Xu Y, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0348-6; Yang G, 2013, LANCET, V381, P1987, DOI DOI 10.1016/S0140-6736(13)61097-1; Yip W, 2014, HEALTH AFFAIR, V33, P502, DOI 10.1377/hlthaff.2013.0702; Yip W, 2009, CHINA ECON REV, V20, P613, DOI 10.1016/j.chieco.2009.08.003; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yuan SW, 2014, PHARMACOECONOMICS, V32, P265, DOI 10.1007/s40273-013-0079-9; Zhao T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2995-z	35	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187096	10.1371/journal.pone.0187096	http://dx.doi.org/10.1371/journal.pone.0187096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073234	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400113
J	Lubyova, B; Hodek, J; Zabransky, A; Prouzova, H; Hubalek, M; Hirsch, I; Weber, J				Lubyova, Barbora; Hodek, Jan; Zabransky, Ales; Prouzova, Hana; Hubalek, Martin; Hirsch, Ivan; Weber, Jan			PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core	PLOS ONE			English	Article							WD REPEAT PROTEIN; UBIQUITIN LIGASE; SPLICE VARIANT; RICH DOMAIN; IN-VIVO; RNA; METHYLTRANSFERASE; PHOSPHORYLATION; TRANSCRIPTION; ANTIGEN	In mammals, protein arginine methyltransferase 5, PRMT5, is the main type II enzyme responsible for the majority of symmetric dimethylarginine formation in polypeptides. Recent study reported that PRMT5 restricts Hepatitis B virus (HBV) replication through epigenetic repression of HBV DNA transcription and interference with encapsidation of pregenomic RNA. Here we demonstrate that PRMT5 interacts with the HBV core (HBc) protein and dimethylates arginine residues within the arginine-rich domain (ARD) of the carboxyl-terminus. ARD consists of four arginine rich subdomains, ARDI, ARDII, ARDIII and ARDIV. Mutation analysis of ARDs revealed that arginine methylation of HBc required the wild-type status of both ARDI and ARDII. Mass spectrometry analysis of HBc identified multiple potential ubiquitination, methylation and phosphorylation sites, out of which lysine K7 and arginines R150 (within ARDI) and R156 (outside ARDs) were shown to be modified by ubiquitination and methylation, respectively. The HBc symmetric dimethylation appeared to be linked to serine phosphorylation and nuclear import of HBc protein. Conversely, the monomethylated HBc retained in the cytoplasm. Thus, overexpression of PRMT5 led to increased nuclear accumulation of HBc, and vice versa, down-regulation of PRMT5 resulted in reduced levels of HBc in nuclei of transfected cells. In summary, we identified PRMT5 as a potent controller of HBc cell trafficking and function and described two novel types of HBc post-translational modifications (PTMs), arginine methylation and ubiquitination.	[Lubyova, Barbora; Hodek, Jan; Zabransky, Ales; Prouzova, Hana; Hubalek, Martin; Hirsch, Ivan; Weber, Jan] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Lubyova, Barbora; Hodek, Jan; Zabransky, Ales; Prouzova, Hana; Hubalek, Martin; Hirsch, Ivan; Weber, Jan] Gilead Res Ctr, Prague, Czech Republic; [Hirsch, Ivan] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague	Lubyova, B; Weber, J (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.; Lubyova, B; Weber, J (corresponding author), Gilead Res Ctr, Prague, Czech Republic.	lubyova@uochb.cas.cz; weber@uochb.cas.cz	Weber, Jan/B-5405-2013; Hirsch, Ivan/J-7726-2015; Hubalek, Martin/H-1400-2014; Hodek, Jan/G-5331-2014; Lubyova, Barbora/G-5921-2014	Weber, Jan/0000-0002-2799-7352; Hirsch, Ivan/0000-0003-1701-1438; Hubalek, Martin/0000-0003-0247-7956; Hodek, Jan/0000-0001-7677-9354; Lubyova, Barbora/0000-0002-8714-0414	Ministry of Education, Youth and Sports of the Czech Republic [LK11207]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (LK11207 to JW) and by the Czech Academy of Sciences (RVO: 61388963, institutional support). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Benhenda S, 2013, J VIROL, V87, P4360, DOI 10.1128/JVI.02574-12; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Burgos ES, 2015, J BIOL CHEM, V290, P9674, DOI 10.1074/jbc.M115.636894; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen C.-F., 2011, COMPUT MATH METHOD M, V2011, P7, DOI DOI 10.1371/J0URNAL.PPAT.1002388; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Chua PK, 2010, J VIROL, V84, P2340, DOI 10.1128/JVI.01666-09; Di Pietro A, 2013, J VIROL, V87, P4523, DOI 10.1128/JVI.02548-12; Duncan KW, 2016, ACS MED CHEM LETT, V7, P162, DOI 10.1021/acsmedchemlett.5b00380; Enomoto M, 2006, FEBS LETT, V580, P894, DOI 10.1016/j.febslet.2006.01.011; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Fulcher AJ, 2016, BBA-MOL CELL RES, V1863, P254, DOI 10.1016/j.bbamcr.2015.11.019; Gallucci L, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010021; Garcia ML, 2009, J VIROL, V83, P4923, DOI 10.1128/JVI.02644-08; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Hsu CH, 2012, ONCOGENE, V31, P2335, DOI 10.1038/onc.2011.415; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; Lee HW, 2016, WORLD J GASTROENTERO, V22, P8314, DOI 10.3748/wjg.v22.i37.8314; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Liang TJ, 2015, HEPATOLOGY, V62, P1893, DOI 10.1002/hep.28025; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Liu CD, 2013, BIOCHEM BIOPH RES CO, V430, P1097, DOI 10.1016/j.bbrc.2012.12.032; LIU Q, 1995, MOL CELL BIOL, V15, P2800; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Park YN, 1999, LIVER, V19, P199, DOI 10.1111/j.1478-3231.1999.tb00036.x; Ponsel D, 2003, J VIROL, V77, P416, DOI 10.1128/JVI.77.1.416-422.2003; Qian GH, 2015, DNA CELL BIOL, V34, P327, DOI 10.1089/dna.2014.2714; Qian GH, 2012, BIOTECHNOL LETT, V34, P29, DOI 10.1007/s10529-011-0751-0; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Rost M, 2006, J BIOL CHEM, V281, P29297, DOI 10.1074/jbc.M603517200; Sohail M, 2015, BBA-MOL CELL RES, V1853, P2444, DOI 10.1016/j.bbamcr.2015.07.003; Sohail M, 2015, MOL CELL BIOL, V35, P2203, DOI 10.1128/MCB.00190-15; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Su PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38959; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang M, 2017, HEPATOL INT; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Xia YC, 2017, METHODS MOL BIOL, V1540, P59, DOI 10.1007/978-1-4939-6700-1_6; Yang C, 2014, IEEE COMPUT SOC CONF, P9, DOI 10.1109/CVPRW.2014.7; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; YEH CT, 1990, J VIROL, V64, P6141, DOI 10.1128/JVI.64.12.6141-6147.1990; YEH CT, 1991, J VIROL, V65, P2327, DOI 10.1128/JVI.65.5.2327-2331.1991; YOO JY, 1990, J GASTROEN HEPATOL, V5, P239, DOI 10.1111/j.1440-1746.1990.tb01623.x; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P322, DOI 10.1016/j.bbrc.2009.11.057; Yu Michael C, 2011, Mol Biol Int, V2011, P163827, DOI 10.4061/2011/163827; Zhang W, 2017, HEPATOLOGY, V66, P398, DOI 10.1002/hep.29133; Zlotnick A, 1997, P NATL ACAD SCI USA, V94, P9556, DOI 10.1073/pnas.94.18.9556; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	69	34	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186982	10.1371/journal.pone.0186982	http://dx.doi.org/10.1371/journal.pone.0186982			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065155	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900058
J	Wei, YL; Deng, PP; Mohsin, A; Yang, Y; Zhou, HY; Guo, MJ; Fang, HQ				Wei, Yanlong; Deng, Pingping; Mohsin, Ali; Yang, Yan; Zhou, Huayan; Guo, Meijin; Fang, Hongqing			An electroporation-free method based on Red recombineering for markerless deletion and genomic replacement in the Escherichia coli DH1 genome	PLOS ONE			English	Article								The lambda-Red recombination system is a popular method for gene editing. However, its applications are limited due to restricted electroporation of DNA fragments. Here, we present an electroporation-free lambda-Red recombination method in which target DNA fragments are excised by I-CreI endonuclease in vivo from the landing pad plasmid. Subsequently, the I-SceI endonuclease-cutting chromosome and DNA double-strand break repair were required. Markerless deletion and genomic replacement were successfully accomplished by this novel approach. Eight nonessential regions of 2.4-104.4 kb in the Escherichia coli DH1 genome were deleted separately with selection efficiencies of 5.3-100%. Additionally, the recombination efficiencies were 2.5-45%, representing an order of magnitude improvement over the electroporation method. For example, for genomic replacement, lycopene expression flux (3.5 kb) was efficiently and precisely integrated into the chromosome, accompanied by replacement of nonessential regions separately into four differently oriented loci. The lycopene production level varied approximately by 5- and 10-fold, corresponding to the integrated position and expression direction, respectively, in the E. coli chromosome.	[Wei, Yanlong; Mohsin, Ali; Guo, Meijin; Fang, Hongqing] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China; [Deng, Pingping; Fang, Hongqing] Anhui Univ, Econ & Technol Dev Zone, Inst Hlth Sci, Hefei, Anhui, Peoples R China; [Yang, Yan] Luoyang Vocat & Tech Coll, Luoyang, Henan, Peoples R China; [Yang, Yan; Zhou, Huayan; Fang, Hongqing] Acad Mil Med Sci, Inst Biotechnol, Beijing, Peoples R China	East China University of Science & Technology; Anhui University; Academy of Military Medical Sciences - China	Guo, MJ; Fang, HQ (corresponding author), East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.; Fang, HQ (corresponding author), Anhui Univ, Econ & Technol Dev Zone, Inst Hlth Sci, Hefei, Anhui, Peoples R China.; Fang, HQ (corresponding author), Acad Mil Med Sci, Inst Biotechnol, Beijing, Peoples R China.	guo_mj@ecust.edu.cn; fanghongqing@vip.sina.com		Fang, Hongqing/0000-0002-2482-6830	National Natural Science Foundation of China [81373286]; National Basic Research Program of China [2011CBA00800]; State Key Laboratory of Bioreactor Engineering	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Bioreactor Engineering	This research was supported by grants from the National Natural Science Foundation of China (81373286), National Basic Research Program of China (2011CBA00800), and Open Funding Project of the State Key Laboratory of Bioreactor Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant JA, 2014, NUCLEIC ACIDS RES, V42, P11383, DOI 10.1093/nar/gku828; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Lee D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-7; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mizoguchi H, 2008, DNA RES, V15, P277, DOI 10.1093/dnares/dsn019; Mizoguchi H, 2007, BIOTECHNOL APPL BIOC, V46, P157, DOI 10.1042/BA200650107; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Pines G, 2015, ACS SYNTH BIOL, V4, P1176, DOI 10.1021/acssynbio.5b00009; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Tas H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136963; Wang JF, 2014, BIOTECHNOL LETT, V36, P1021, DOI 10.1007/s10529-014-1460-2; Yin J, 2015, APPL MICROBIOL BIOT, V99, P5523, DOI 10.1007/s00253-015-6510-8; Ying BW, 2014, MOL BIOSYST, V10, P375, DOI 10.1039/c3mb70254e; Yoon SH, 2006, BIOTECHNOL BIOENG, V94, P1025, DOI 10.1002/bit.20912; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359; Zhang J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0439-1	22	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186891	10.1371/journal.pone.0186891	http://dx.doi.org/10.1371/journal.pone.0186891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065183	Green Submitted, gold, Green Published			2022-12-26	WOS:000413568900052
J	Potthast, AB; Heuer, T; Warneke, SJ; Das, AM				Potthast, Arne Bjoern; Heuer, Theresa; Warneke, Simone Johanna; Das, Anibh Martin			Alterations of sirtuins in mitochondrial cytochrome c-oxidase deficiency	PLOS ONE			English	Article							FATTY-ACID OXIDATION; CALORIE RESTRICTION; ATP-SYNTHASE; INHIBITOR PROTEIN; SKELETAL-MUSCLE; SIRT1; CELLS; PATHWAY; DEACETYLATION; STRESS	Background Sirtuins are NAD(+) dependent deacetylases, which regulate mitochondrial energy metabolism as well as cellular response to stress. The NAD/NADH-system plays a crucial role in oxidative phosphorylation linking sirtuins and the mitochondrial respiratory chain. Furthermore, sirtuins are able to directly deacetylate and activate different complexes of the respiratory chain. This prompted us to analyse sirtuin levels in skin fibroblasts from patients with cytochrome c-oxidase (COX) deficiency and to test the impact of different pharmaceutical activators of sirtuins (SRT1720, paeonol) to modulate sirtuins and possibly respiratory chain enzymes in patient cells in vitro. Methods We assayed intracellular levels of sirtuin 1 and the mitochondrial sirtuins SIRT3 and SIRT4 in human fibroblasts from patients with COX-deficiency. Furthermore, sirtuins were measured after inhibiting complex IV in healthy control fibroblasts by cyanide and after incubation with activators SRT1720 and paeonol. To determine the effect of sirtuin inhibition at the cellular level we measured total cellular acetylation (control and patient cells, with and without treatment) by Western blot. Results We observed a significant decrease in cellular levels of all three sirtuins at the activity, protein and transcriptional level (by 15% to 50%) in COX-deficient cells. Additionally, the intracellular concentration of NAD(+) was reduced in patient cells. We mimicked the biochemical phenotype of COX-deficiency by incubating healthy fibroblasts with cyanide and observed reduced sirtuin levels. A pharmacological activation of sirtuins resulted in normalized sirtuin levels in patient cells. Hyper acetylation was also reversible after treatment with sirtuin activators. Pharmacological modulation of sirtuins resulted in altered respiratory chain complex activities. Conclusions We found inhibition of situins 1, 3 and 4 at activity, protein and transcriptional levels in fibroblasts from patient with COX-deficiency. Pharmacological activators were able to restore reduced sirtuin levels and thereby modulate respiratory chain activities.	[Potthast, Arne Bjoern; Heuer, Theresa; Warneke, Simone Johanna; Das, Anibh Martin] Hannover Med Sch, Clin Paediat Kidney Liver & Metab Dis, Hannover, Germany	Hannover Medical School	Das, AM (corresponding author), Hannover Med Sch, Clin Paediat Kidney Liver & Metab Dis, Hannover, Germany.	das.anibh@mh-hannover.de			Vitaflo Ltd. (UK); Vitaflo Ltd. (Germany)	Vitaflo Ltd. (UK); Vitaflo Ltd. (Germany)	This project was funded by Vitaflo Ltd. (UK and Germany) (https //www.nestlehealthscience.co.uk/Vitaflo/Patients/home). Funding included a PhD-student position (AB Potthast), a technical assistant position and material costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We like to thank A. Fitter and J. Bednarzcyk for technical assistance. Finally, we are indebted to Vitaflo Ltd. (UK and Germany) for financial support.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; BERKA V, 1993, FEBS LETT, V315, P237, DOI 10.1016/0014-5793(93)81171-U; Boylston JA, 2015, J MOL CELL CARDIOL, V88, P73, DOI 10.1016/j.yjmcc.2015.09.005; Brandauer J, 2013, J PHYSIOL-LONDON, V591, P5207, DOI 10.1113/jphysiol.2013.259515; BROWN GC, 1995, FEBS LETT, V369, P136, DOI 10.1016/0014-5793(95)00763-Y; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Das AM, 1998, J INHERIT METAB DIS, V21, P220, DOI 10.1023/A:1005395417041; Das AM, 1998, CLIN SCI, V94, P499, DOI 10.1042/cs0940499; DAS AM, 1989, FEBS LETT, V256, P97, DOI 10.1016/0014-5793(89)81725-9; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Dutnall RN, 2001, CELL, V105, P161, DOI 10.1016/S0092-8674(01)00305-1; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Funk JA, 2010, PHARM EXP THER, V333, P393; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jamal J, 2014, J ETHNOPHARMACOL, V154, P428, DOI 10.1016/j.jep.2014.04.025; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim Jeong Seok, 2014, J Exerc Nutrition Biochem, V18, P259, DOI 10.5717/jenb.2014.18.3.259; Kim SH, 2011, PLOS ONE, V6; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616; LIPPE G, 1988, BIOCHIM BIOPHYS ACTA, V933, P1, DOI 10.1016/0005-2728(88)90050-3; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; MATTHEWS PM, 1982, BIOCHIM BIOPHYS ACTA, V720, P163, DOI 10.1016/0167-4889(82)90008-8; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; MITCHELL P, 1972, J BIOENERG, V3, P5, DOI 10.1007/BF01515993; Miyo M, 2015, BRIT J CANCER, V113, P492, DOI 10.1038/bjc.2015.226; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Schakel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tanner KG, 2000, P NATL SCI, P14178; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; TILL U, 1977, ACTA BIOL MED GER, V36, P597; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002; Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667; YAMADA EW, 1988, J BIOL CHEM, V263, P11498; Zhu AY, 2012, ACS CHEM BIOL, V7, P155, DOI 10.1021/cb200230x	61	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186517	10.1371/journal.pone.0186517	http://dx.doi.org/10.1371/journal.pone.0186517			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059204	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000028
J	Yang, S; Mei, SH; Jin, H; Zhu, B; Tian, Y; Huo, JP; Cui, X; Guo, AC; Zhao, ZG				Yang, Shu; Mei, Shenghui; Jin, Hong; Zhu, Bin; Tian, Yue; Huo, Jiping; Cui, Xu; Guo, Anchen; Zhao, Zhigang			Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier	PLOS ONE			English	Article							JUNCTION PROTEIN EXPRESSION; ENDOTHELIAL-CELLS; COCULTURE MODEL; DRUG DISCOVERY; CULTURE MODELS; TRANSPORT; PENETRATION; PAMPA	To identify suitable cell lines for a mimetic system of in vivo blood-brain barrier (BBB) for drug permeability assessment, we characterized two immortalized cell lines, ECV304 and bEnd3 in the respect of the tightness, tight junction proteins, P-glycoprotein (P-gp) function and discriminative brain penetration. The ECV304 monoculture achieved higher transendothelial electrical resistance (TEER) and lower permeability to Lucifer yellow than bEnd3. However, co-culture with rat glioma C6 cells impaired the integrity of ECV304 and bEnd3 cell layers perhaps due to the heterogeneity among C6 cells in inducing BBB characteristics. The immunostaining of ZO-1 delivered distinct bands along cell borders on both cell lines while those of occludin and claudin-5 were diffused and weak. P-gp functionality was only proved in bEnd3 by Rhodamine 123 (R123) uptake assay. A permeability test of reference compounds displayed a similar rank order (digoxin < R123 < quinidine, verapamil < propranolol) in ECV304 and bEnd3 cells. In comparison with bEnd3, ECV304 developed tighter barrier for the passage of reference compounds and higher discrimination between transcellular and paracellular transport. However, the monoculture models of ECV304 and bEnd3 fail to achieve the sufficient tightness of in vitro BBB permeability models with high TEER and evident immunostaining of tight junction proteins. Further strategies to enhance the paracellular tightness of both cell lines to mimic in vivo BBB tight barrier deserve to be conducted.	[Yang, Shu; Mei, Shenghui; Zhu, Bin; Tian, Yue; Huo, Jiping; Zhao, Zhigang] Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China; [Jin, Hong] Inst Dis Prevent & Control PLA, Beijing, Peoples R China; [Cui, Xu] Henry Ford Hosp, Neurol Res, Detroit, MI 48202 USA; [Guo, Anchen] Capital Med Univ, Beijing Tiantan Hosp, Lab Clin Med Res, Beijing, Peoples R China; [Guo, Anchen] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Guo, Anchen] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China	Capital Medical University; Henry Ford Health System; Henry Ford Hospital; Capital Medical University	Zhao, ZG (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China.; Guo, AC (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Lab Clin Med Res, Beijing, Peoples R China.; Guo, AC (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.; Guo, AC (corresponding author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.	guoanchen@hotmail.com; 1022zzg@sina.com	Mei, Shenghui/X-3037-2019	Cui, Xu/0000-0002-6937-6191; Mei, Shenghui/0000-0003-1385-4315	Youth Foundation of Beijing Natural Science Foundation [7164256]; Youth Foundation of Beijing Tiantan Hospital [2016-YQN-11]	Youth Foundation of Beijing Natural Science Foundation; Youth Foundation of Beijing Tiantan Hospital	This work was supported by Youth Foundation of Beijing Natural Science Foundation (7164256) and Youth Foundation of Beijing Tiantan Hospital (2016-YQN-11).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Appelt-Menzel A, 2017, STEM CELL REP, V8, P894, DOI 10.1016/j.stemcr.2017.02.021; Barar J, 2010, MED SCI MONITOR, V16, pBR52; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Brown RC, 2003, J CELL SCI, V116, P693, DOI 10.1242/jcs.00264; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Carrara S, 2007, INT J PHARMACEUT, V345, P125, DOI 10.1016/j.ijpharm.2007.05.057; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Hellinger E, 2012, EUR J PHARM BIOPHARM, V82, P340, DOI 10.1016/j.ejpb.2012.07.020; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Hurst RD, 1996, J CELL PHYSIOL, V167, P81, DOI 10.1002/(SICI)1097-4652(199604)167:1<81::AID-JCP9>3.3.CO;2-F; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Mensch J, 2010, INT J PHARMACEUT, V395, P182, DOI 10.1016/j.ijpharm.2010.05.037; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neuhaus W, 2008, J PHARM SCI-US, V97, P5158, DOI 10.1002/jps.21371; Nicolazzo JA, 2006, J PHARM PHARMACOL, V58, P281, DOI 10.1211/jpp.58.3.0001; Novakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086806; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Scism JL, 1999, IN VITRO CELL DEV-AN, V35, P580; Toyoda K, 2013, CELL MOL NEUROBIOL, V33, P489, DOI 10.1007/s10571-013-9913-z; Wang GY, 2015, CELL MOL NEUROBIOL, V35, P1105, DOI 10.1007/s10571-015-0204-8; Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007; Watanabe T, 2013, BIOL PHARM BULL, V36, P492, DOI 10.1248/bpb.b12-00915; Wilhelm I, 2014, MOL PHARMACEUT, V11, P1949, DOI 10.1021/mp500046f; Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x	29	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0187017	10.1371/journal.pone.0187017	http://dx.doi.org/10.1371/journal.pone.0187017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059256	gold, Green Published, Green Submitted			2022-12-26	WOS:000413403000058
J	Riesco, MF; Oliveira, C; Soares, F; Gavaia, PJ; Dinis, MT; Cabrita, E				Riesco, Marta F.; Oliveira, Catarina; Soares, Florbela; Gavaia, Paulo J.; Dinis, Maria T.; Cabrita, Elsa			Solea senegalensis sperm cryopreservation: New insights on sperm quality	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; DNA-DAMAGE; GENE-EXPRESSION; GLUTATHIONE PEROXIDASE-1; COMMON CARP; L. SPERM; EGG-YOLK; FERTILIZATION; SPERMATOZOA; QUANTIFICATION	Cryopreservation of Senegalese sole sperm can represent an alternative to overcome some reproductive problems of this species. However, it is important to guarantee the safe use of cryopreserved sperm by selecting an appropriate protocol according to a high demand quality need to be ensured. It has been demonstrated that traditional assays such as motility and viability do not provide enough information to identify specific damage caused by cryopreservation process (freezing and thawing). Specific tests, including lipid peroxidation and DNA damage, should be performed. In the present study, motility and lipid peroxidation were performed as specific tests allowing us to discard cryopreservation conditions such as methanol as internal cryoprotectant and bovine serum albumin as external cryoprotectant. In addition, a caspase 3/7 detection by flow cytometry was performed to analyze apoptosis activity in the best selected conditions. Moreover, new highly sensitive tests based on transcript number detection have recently been described in fish sperm cryopreservation. For this reason, a transcript level detection assay was performed on certain oxidative and chaperone genes related to fertilization ability and embryo development (hsp70, hsp90BB, hsp90AA, gpx) to select the best cryopreservation conditions. DMSO+ egg yolk proved to be the best cryoprotectant combination in terms of transcript level. This study describes an optimized cryopreservation protocol for Solea senegalensis sperm demonstrating for the first time that transcript degradation is the most sensitive predictor of cell status in this species after cryopreservation.	[Riesco, Marta F.; Oliveira, Catarina; Gavaia, Paulo J.; Dinis, Maria T.; Cabrita, Elsa] Univ Algarve, CCMAR, Campus Gambelas, Faro, Portugal; [Soares, Florbela] IP, IPMA, Olhao, Portugal; [Gavaia, Paulo J.] Univ Algarve, DCBM, Campus Gambelas, Faro, Portugal	Universidade do Algarve; Instituto Portugues do Mar e da Atmosfera; Universidade do Algarve	Cabrita, E (corresponding author), Univ Algarve, CCMAR, Campus Gambelas, Faro, Portugal.	ecabrita@ualg.pt	Soares, Florbela/K-1184-2012; Soares, Florbela/AAB-9082-2019; Gavaia, Paulo/A-6470-2011; Riesco, Marta/O-9766-2014	Soares, Florbela/0000-0001-6075-2472; Soares, Florbela/0000-0001-6075-2472; Gavaia, Paulo/0000-0002-9582-1957; Riesco, Marta/0000-0002-3655-6401; Oliveira, Catarina/0000-0002-6679-761X	PROMAR Program [REPLING 31-03-05-FEP-69, KLING 31-03-05-FEP-73]; COST action (Food and Agriculture) AQUAGAMETE [FA1205]; Fundagao para a Ciencia e Tecnologia (FCT, Portugal) [CCMAR/Multi/04326/2013]; REPLING project [CCMAR/SC/BPD/09/2016]; FCT postdoctoral fellowship [SFRH/BPD/63933/2009]	PROMAR Program; COST action (Food and Agriculture) AQUAGAMETE; Fundagao para a Ciencia e Tecnologia (FCT, Portugal); REPLING project; FCT postdoctoral fellowship(Portuguese Foundation for Science and Technology)	This work was supported by project REPLING 31-03-05-FEP-69 and KLING 31-03-05-FEP-73 financed by the PROMAR Program, by COST action (Food and Agriculture) AQUAGAMETE (FA1205) and through the Fundagao para a Ciencia e Tecnologia (FCT, Portugal) through project CCMAR/Multi/04326/2013. Marta F Riesco was supported by a postdoc contract (CCMAR/SC/BPD/09/2016) financed by REPLING project. C. Oliveira, was supported by FCT postdoctoral fellowship (SFRH/BPD/63933/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; ALDERSON R, 1984, AQUACULTURE, V43, P351, DOI 10.1016/0044-8486(84)90036-X; Babiak I, 1998, PROG FISH CULT, V60, P146, DOI 10.1577/1548-8640(1998)060&lt;0146:COSFAA&gt;2.0.CO;2; Babiak I, 1999, THERIOGENOLOGY, V52, P473, DOI 10.1016/S0093-691X(99)00144-2; Beirao J, 2008, J APPL ICHTHYOL, V24, P508, DOI 10.1111/j.1439-0426.2008.01144.x; Beirao J, 2011, ANIM REPROD SCI, V126, P122, DOI 10.1016/j.anireprosci.2011.04.009; Beirao J, 2009, THERIOGENOLOGY, V72, P1251, DOI 10.1016/j.theriogenology.2009.07.021; Betsy C. Judith, 2015, Journal of Applied Aquaculture, V27, P40, DOI 10.1080/10454438.2014.965398; Cabrita E, 2006, AQUACULTURE, V261, P967, DOI 10.1016/j.aquaculture.2006.08.020; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; Cabrita E, 2011, THERIOGENOLOGY, V75, P1, DOI 10.1016/j.theriogenology.2010.07.003; Cabrita E, 2010, J APPL ICHTHYOL, V26, P623, DOI 10.1111/j.1439-0426.2010.01556.x; Cabrita E, 2001, THERIOGENOLOGY, V56, P623, DOI 10.1016/S0093-691X(01)00594-5; Carton-Garcia F, 2013, AQUACULTURE, V402, P106, DOI 10.1016/j.aquaculture.2013.03.034; Chereguini O, 2003, AQUAC RES, V34, P739, DOI 10.1046/j.1365-2109.2003.00877.x; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Dietrich GJ, 2005, THERIOGENOLOGY, V64, P1809, DOI 10.1016/j.theriogenology.2005.04.010; Ferlin A, 2010, J UROLOGY, V183, P1248, DOI 10.1016/j.juro.2009.11.009; Fraser L, 2007, THERIOGENOLOGY, V68, P248, DOI 10.1016/j.theriogenology.2007.05.001; Gonzalez-Rojo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114161; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Guerra SM, 2013, AQUACULTURE, V406, P28, DOI 10.1016/j.aquaculture.2013.04.032; Hagedorn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039397; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Infante C, 2008, BMC MOL BIOL, V9, DOI [10.1186/1471-2199-9-19, 10.1186/1471-2199-9-28]; Jodar M, 2013, HUM REPROD UPDATE, V19, P604, DOI 10.1093/humupd/dmt031; Labbe C, 2001, MOL REPROD DEV, V60, P397, DOI 10.1002/mrd.1102; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115841; Li P, 2010, BIOL REPROD, V83, P852, DOI 10.1095/biolreprod.110.085852; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manchado M, 2008, GENE, V416, P77, DOI 10.1016/j.gene.2008.03.007; Martin G, 2004, BIOL REPROD, V71, P28, DOI 10.1095/biolreprod.103.024281; Martinez-Paramo S, 2012, THERIOGENOLOGY, V77, P1129, DOI 10.1016/j.theriogenology.2011.10.017; Martinez-Pastor F, 2008, REPRODUCTION, V135, P449, DOI 10.1530/REP-07-0376; Matwee C, 2001, MOL HUM REPROD, V7, P829, DOI 10.1093/molehr/7.9.829; Mehaisen GMK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139814; Meseguer M, 2004, J ANDROL, V25, P773; Meseguer M, 2006, FERTIL STERIL, V86, P1376, DOI 10.1016/j.fertnstert.2006.03.053; Morais S, 2016, REV AQUACULT, V8, P227, DOI 10.1111/raq.12091; Neuer A, 1999, Infect Dis Obstet Gynecol, V7, P10, DOI 10.1155/S1064744999000034; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Perez-Cerezales S, 2009, THERIOGENOLOGY, V71, P605, DOI 10.1016/j.theriogenology.2008.09.057; QUINN PJ, 1980, J REPROD FERTIL, V60, P403, DOI 10.1530/jrf.0.0600403; Rasines I, 2012, AQUACULTURE, V326, P129, DOI 10.1016/j.aquaculture.2011.11.021; Riesco MF, 2012, J APPL ICHTHYOL, V28, P925, DOI 10.1111/jai.12089; Riesco MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067614; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Robles V, 2016, GEN COMP ENDOCR; Said TM, 2008, J ANDROL, V29, P134, DOI 10.2164/jandrol.107.003632; SCOTT AP, 1980, J FISH BIOL, V17, P707, DOI 10.1111/j.1095-8649.1980.tb02804.x; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Tapia-Paniagua ST, 2015, FISH SHELLFISH IMMUN, V46, P449, DOI 10.1016/j.fsi.2015.07.007; Tekin N, 2003, ISR J AQUACULT-BAMID, V55, P208; Valcarce DG, 2016, THERIOGENOLOGY, V86, P1195, DOI 10.1016/j.theriogenology.2016.04.010; Valcarce DG, 2013, ANDROLOGY-US, V1, P723, DOI 10.1111/j.2047-2927.2013.00116.x; Valcarce DG, 2013, CRYOBIOLOGY, V67, P84, DOI 10.1016/j.cryobiol.2013.05.007; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Yavas I, 2014, AQUACULT INT, V22, P141, DOI 10.1007/s10499-013-9698-6; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zilli L, 2003, CRYOBIOLOGY, V47, P227, DOI 10.1016/j.cryobiol.2003.10.002	60	18	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186542	10.1371/journal.pone.0186542	http://dx.doi.org/10.1371/journal.pone.0186542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053706	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100023
J	Chen, L; Zhou, ZY; Yang, Y; Chen, N; Xiang, HY				Chen, Lu; Zhou, Zhongyin; Yang, Yan; Chen, Na; Xiang, Hongyu			Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; INTESTINAL HOMEOSTASIS; PATHOGENESIS; WARTS; MODEL	Background Imiquimod is a Toll-like receptor-7 agonist that regulates immunity and can be used as an immune adjuvant. Ulcerative colitis has a close correlation with immune disorder. Aim To investigate the therapeutic effect of imiquimod on dextran sulfate sodium (DSS)-induced colitis and explore the underlying mechanisms. Methods C57BL/6J C57 mice received 3% DSS for 7 days to induce ulcerative colitis. Groups of mice were intraperitoneally injected with dexamethasone (DXM, 1.5 mg/kg) or imiquimod (IMQ, 30 mg/kg) at the same time daily. During the experimental period, clinical signs, body weight, stool consistency and visible fecal blood were monitored and recorded daily; colitis was evaluated by disease activity index (DAI) score and by histological score. At the conclusion of the experiment, the level of colonic myeloperoxidase (MPO) activity and the serum levels of the cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6) and interleukin 10 (IL-10) were measured. Results Administration of 3% DSS for 7 days successfully induced acute colitis associated with diarrhea, bloody mucopurulent stool, body weight decreases, and other changes. Colitis severity was significantly ameliorated in the IMQ treatment groups, as determined by hematoxylin-eosin (HE) staining and histopathological scores. Moreover, IMQ significantly reduced the activity of MPO in colonic tissue and the serum levels of inflammatory cytokines, increased colon length and spleen weight, and effectively inhibited microscopic damage to the colon tissue. Conclusion IMQ had beneficial effects on DSS-induced ulcerative colitis, supporting its further development and clinical application in ulcerative colitis.	[Chen, Lu; Zhou, Zhongyin; Yang, Yan; Chen, Na; Xiang, Hongyu] Wuhan Univ, RenMin Hosp, Hubei Key Lab Digest Syst Dis, Dept Gastroenterol, Wuhan, Hubei, Peoples R China	Wuhan University	Zhou, ZY (corresponding author), Wuhan Univ, RenMin Hosp, Hubei Key Lab Digest Syst Dis, Dept Gastroenterol, Wuhan, Hubei, Peoples R China.	zhouhu025@163.com						Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Actis Giovanni C, 2015, World J Gastrointest Pharmacol Ther, V6, P10, DOI 10.4292/wjgpt.v6.i2.10; Adams SM, 2013, AM FAM PHYSICIAN, V87, P699; Akhavan S, 2014, J OBSTET GYNAECOL RE, V40, P2110, DOI 10.1111/jog.12457; Becker C, 2013, GASTROENTEROLOGY, V144, P283, DOI 10.1053/j.gastro.2012.11.035; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; COOPER HS, 1993, LAB INVEST, V69, P238; de Witte CJ, 2015, GYNECOL ONCOL, V139, P377, DOI 10.1016/j.ygyno.2015.08.018; Dhamanage A, 2017, VIRAL IMMUNOL, V30, P28, DOI 10.1089/vim.2016.0084; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hubert FX, 2004, J IMMUNOL, V172, P7485, DOI 10.4049/jimmunol.172.12.7485; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; MacDonald TT, 2012, INFLAMM BOWEL DIS, V18, P2180, DOI 10.1002/ibd.22967; Magyari L, 2014, WORLD J GASTROENTERO, V20, P3208, DOI 10.3748/wjg.v20.i12.3208; Martinez-Lopez A, 2017, DERMATOL THER, V30, DOI 10.1111/dth.12413; Morrison G, 2009, AUST FAM PHYSICIAN, V38, P956; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Rutella S, 2011, WORLD J GASTROENTERO, V17, P3761, DOI 10.3748/wjg.v17.i33.3761; Schofer H, 2007, BRIT J DERMATOL, V157, P52, DOI 10.1111/j.1365-2133.2007.08274.x; Shi X, 2011, INFECT IMMUN, V79, P2031, DOI 10.1128/IAI.01213-10; Shih David Q, 2008, Curr Gastroenterol Rep, V10, P568, DOI 10.1007/s11894-008-0104-x; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suzuki Ryoma, 2016, Fukushima J Med Sci, V62, P90; Takagi T, 2011, DIGEST DIS SCI, V56, P1663, DOI 10.1007/s10620-010-1484-y; Thomsen LL, 2004, VACCINE, V22, P1799, DOI 10.1016/j.vaccine.2003.09.052; Torres A, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-7; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yin Kai-sheng, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P509	33	19	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186138	10.1371/journal.pone.0186138	http://dx.doi.org/10.1371/journal.pone.0186138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049372	Green Submitted, Green Published, gold			2022-12-26	WOS:000413195900044
J	De Voeght, A; Martens, H; Renard, C; Vaira, D; Debruche, M; Simonet, J; Geenen, V; Moutschen, M; Darcis, G				De Voeght, Adrien; Martens, Henri; Renard, Chantal; Vaira, Dolores; Debruche, Mathieu; Simonet, Julie; Geenen, Vincent; Moutschen, Michel; Darcis, Gilles			Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium	PLOS ONE			English	Article							SOLUBLE CD14; MICROBIAL TRANSLOCATION; DISEASE PROGRESSION; LIPOPOLYSACCHARIDE RECEPTOR; GASTROINTESTINAL-TRACT; HUMAN MONOCYTES; CELL DEPLETION; INFECTION; MICE; SUPPRESSION	Microbial translocation is now viewed as a central event in the pathogenesis of chronic inflammation during HIV infection. Thymic function failure is another crucial factor involved in HIV disease progression. The goal of this study was to explore the hypothesis of potential links between microbial translocation and thymic function in HIV-1 patients living in Belgium. The extent of microbial translocation was assessed through the measurement of soluble CD14 (sCD14). T-cell receptor excision circles (sjTRECs and d beta TRECs) were used as a measure of thymic function. Data were collected from 75 HIV-infected patients. Simple and complex linear regressions were done to analyze the link between these two processes. We found a statistically relevant negative correlation between thymopoiesis (sjTREC) and sCD14 level (p = 0.004). These results suggest a link between thymic function failure, microbial translocation and innate immune activation.	[De Voeght, Adrien; Simonet, Julie; Moutschen, Michel; Darcis, Gilles] Univ Liege, Univ Hosp Ctr Liege, Infect Dis Dept, Liege, Belgium; [De Voeght, Adrien; Moutschen, Michel] Univ Liege, GIGA Res Inst, Lab Immunol & Infect Dis, GIGA Inflammat Infect & Immun, Liege, Belgium; [Martens, Henri; Renard, Chantal; Debruche, Mathieu; Geenen, Vincent] Univ Liege, Dept Biomed & Preclin Sci, GIGA I Ctr Immunoendocrinol 3, GIGA Res Inst, Liege, Belgium; [Vaira, Dolores; Moutschen, Michel] Univ Liege, AIDS Reference Ctr, Univ Hosp Ctr Liege, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Darcis, G (corresponding author), Univ Liege, Univ Hosp Ctr Liege, Infect Dis Dept, Liege, Belgium.	gdarcis@chu.ulg.ac.be		Darcis, Gilles/0000-0001-8192-1351; Geenen, Vincent/0000-0002-8733-7284; Martens, Henri/0000-0003-4713-8982; De Voeght, Adrien/0000-0003-3727-5190				Abad-Fernandez M, 2013, JAIDS-J ACQ IMM DEF, V64, P149, DOI 10.1097/QAI.0b013e31829a2f12; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; BAZIL V, 1991, J IMMUNOL, V147, P1567; BERG RD, 1979, INFECT IMMUN, V23, P403, DOI 10.1128/IAI.23.2.403-411.1979; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Cioe PA, 2015, J ACQ IMMUN DEF SYND, V70, P400; De Voeght A, 2016, AIDS, V30, P921, DOI 10.1097/QAD.0000000000000996; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; DURIEUX JJ, 1994, EUR J IMMUNOL, V24, P2006, DOI 10.1002/eji.1830240911; Ferrando-Martinez S, 2017, CLIN INFECT DIS, V64, P1191, DOI 10.1093/cid/cix095; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hick RW, 2006, J IMMUNOL, V177, P169, DOI 10.4049/jimmunol.177.1.169; Jacque B, 2006, EUR J IMMUNOL, V36, P3007, DOI 10.1002/eji.200636038; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kitchens RL, 1999, J BIOL CHEM, V274, P34116, DOI 10.1074/jbc.274.48.34116; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kuijpers TW, 2011, BLOOD, V117, P5892, DOI 10.1182/blood-2011-01-329052; Lee PI, 2009, J INFECT DIS, V199, P1664, DOI 10.1086/598953; Leon A, 2015, AIDS, V29, P675, DOI 10.1097/QAD.0000000000000596; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Longenecker CT, 2014, AIDS, V28, P969, DOI 10.1097/QAD.0000000000000158; LOPPNOW H, 1995, INFECT IMMUN, V63, P1020, DOI 10.1128/IAI.63.3.1020-1026.1995; Morrhaye G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005668; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Ndhlovu LC, 2008, AIDS, V22, P990, DOI 10.1097/QAD.0b013e3282ff884e; OESTERREICHER C, 1995, J HEPATOL, V23, P396, DOI 10.1016/0168-8278(95)80197-9; OWENS WE, 1980, INFECT IMMUN, V27, P461, DOI 10.1128/IAI.27.2.461-467.1980; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; R Core Team, 2013, R LANG ENV STAT COMP; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; SCHUETT C, 1991, Allergie und Immunologie (Leipzig), V37, P159; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Su GL, 1999, J HEPATOL, V31, P435, DOI 10.1016/S0168-8278(99)80034-8; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; TAKESHITA S, 1989, EMBO J, V8, P3261, DOI 10.1002/j.1460-2075.1989.tb08486.x; Thompson PA, 2003, J BIOL CHEM, V278, P28367, DOI 10.1074/jbc.M302921200; WANG SD, 1994, J IMMUNOL, V152, P5014; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437	47	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185761	10.1371/journal.pone.0185761	http://dx.doi.org/10.1371/journal.pone.0185761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049344	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900018
J	Lane-Cordova, AD; Puterman, E; Gunderson, EP; Chan, C; Hou, LF; Carnethon, M				Lane-Cordova, Abbi D.; Puterman, Eli; Gunderson, Erica P.; Chan, Cheeling; Hou, Lifang; Carnethon, Mercedes			Gravidity is not associated with telomere length in a biracial cohort of middle-aged women: The Coronary Artery Risk Development in Young Adults (CARDIA) study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE MORTALITY; ATHEROSCLEROSIS; PARITY; HEALTH; BLOOD; MEN	Objective Having experienced 2-3 births is associated with reduced mortality versus women with <2 or >= 4 births. The effect of 2-3 births on lifespan may be associated with delayed cellular aging. We hypothesized telomere length, a marker of cellular aging, would be longer in women who had 2-3 pregnancies. Methods Leukocyte telomere length was measured using quantitative real-time polymerase chain reaction in 620 women in CARDIA at the year 15 and 20 exams, expressed as the ratio of telomere repeat copy number to single-copy gene copy number (T/S). Number of pregnancies at the time of telomere length measurement was obtained (mean age = 41 +/- 0.1 years, average gravidity = 2.64 +/- 0.1 pregnancies). Participants were divided into 4 groups by number of pregnancies: 0, 1, 2-3, and >= 4, to test for differences in telomere length by gravidity group. Results The mean and SD for telomere length was 0.98 +/- 0.20 T/S in the whole cohort. There were no differences in mean telomere length between groups; 0.98 +/- 0.02 T/S in women with 0 pregnancies, 1.01 +/- 0.02 T/S in women with 1 pregnancy, 0.97 +/- 0.01 T/S in women with 2-3 pregnancies, and 0.99 +/- 0.02 T/S in women with >= 4 pregnancies (p = 0.51). We defined high-risk (shorter) telomere length as <= 25th percentile, and low-risk (longer) telomere length as >= 75 percentile. There were no differences in the prevalence of high-risk or low-risk telomere length between gravidity groups. Conclusions Gravidity was not associated with telomere length in early middle age; the protective association of 2-3 births may act through other mechanisms.	[Lane-Cordova, Abbi D.; Chan, Cheeling; Hou, Lifang; Carnethon, Mercedes] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Puterman, Eli] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Gunderson, Erica P.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA	Northwestern University; Feinberg School of Medicine; University of British Columbia; Kaiser Permanente	Lane-Cordova, AD (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.	lanecord@mailbox.sc.edu	Puterman, Eli/AAA-5237-2022	Puterman, Eli/0000-0002-5898-2348; Carnethon, Mercedes/0000-0001-7035-0848	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C]; National Institute on Aging (NIA); NIA; NHLBI [AG0005]; American Heart Association Strategically Focused Research Network (Greenland, PI) [14SFRN20480260];  [4R00HL109247-03]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK059944, R01DK090047] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Strategically Focused Research Network (Greenland, PI); ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CARDIA is supported by the National Heart, Lung, and Blood Institute (NHLBI) HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C, and partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intraagency agreement between NIA and NHLBI (AG0005). This manuscript was reviewed by CARDIA for scientific content. EP was funded by 4R00HL109247-03 and ALC is supported by an American Heart Association Strategically Focused Research Network (14SFRN20480260 Greenland, PI) Fellow Grant.	Barha CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146424; Burnett-Hartman AN, 2012, MECH AGEING DEV, V133, P275, DOI 10.1016/j.mad.2012.03.002; Buxton JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04954; Carty CL, 2015, ARTERIOSCLEROSIS THR; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chae DH, 2014, AM J PREV MED, V46, P103, DOI 10.1016/j.amepre.2013.10.020; Davy P, 2009, PLACENTA, V30, P539, DOI 10.1016/j.placenta.2009.03.005; Denil SLIJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115071; Fragkiadaki P, 2016, MOL MED REP, V14, P16, DOI 10.3892/mmr.2016.5231; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Krauss J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026983; Kroenke CH, 2012, ATHEROSCLEROSIS, V220, P506, DOI 10.1016/j.atherosclerosis.2011.10.041; Lv HC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13411; Masi S, 2014, EUR HEART J, V35, P3296, DOI 10.1093/eurheartj/ehu226; Morris EA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.005; Needham BL, 2015, MOL PSYCHIATR, V20, P520, DOI 10.1038/mp.2014.89; Needham BL, 2014, HEALTH PLACE, V28, P167, DOI 10.1016/j.healthplace.2014.04.009; Niemczyk NA, 2015, OBESITY, V23, P1085, DOI 10.1002/oby.21044; O'Donovan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019687; Park M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128460; Sanghavi M, 2015, EUROPEAN J PREVENTIV; Strazhesko I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136676; Vaidya D, 2014, HYPERTENSION, V64, P253, DOI 10.1161/HYPERTENSIONAHA.114.03285; Verhoeven JE, 2015, PSYCHOSOM MED, V77, P882, DOI 10.1097/PSY.0000000000000226; Willerson James T, 2004, Circulation, V109, pII2	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186495	10.1371/journal.pone.0186495	http://dx.doi.org/10.1371/journal.pone.0186495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049398	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900073
J	Zhang, ZF; Zheng, FF; Yu, ZL; Hao, JJ; Chen, M; Yu, WD; Guo, W; Chen, YM; Huang, WL; Duan, ZJ; Deng, WG				Zhang, Zhifeng; Zheng, Fufu; Yu, Zhenlong; Hao, Jiajiao; Chen, Miao; Yu, Wendan; Guo, Wei; Chen, Yiming; Huang, Wenlin; Duan, Zhijun; Deng, Wuguo			XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers	PLOS ONE			English	Article							PROSTAGLANDIN E-2 BIOSYNTHESIS; STRAND BREAK REPAIR; COLORECTAL-CANCER; TRANSCRIPTION FACTORS; BINDING-PROTEIN; DNA; CELLS; COX-2; ACTIVATION; APOPTOSIS	Cyclooxygenase (COX) is the rate-limiting enzyme in prostaglandins (PGs) biosynthesis. Previous studies indicate that COX-2, one of the isoforms of COX, is highly expressed in colon cancers and plays a key role in colon cancer carcinogenesis. Thus, searching for novel transcription factors regulating COX-2 expression will facilitate drug development for colon cancer. In this study, we identified XRCC5 as a binding protein of the COX-2 gene promoter in colon cancer cells with streptavidin-agarose pulldown assay and mass spectrometry analysis, and found that XRCC5 promoted colon cancer growth through modulation of COX-2 signaling. Knockdown of XRCC5 by siRNAs inhibited the growth of colon cancer cells in vitro and of tumor xenografts in a mouse model in vivo by suppressing COX-2 promoter activity and COX-2 protein expression. Conversely, overexpression of XRCC5 promoted the growth of colon cancer cells by activating COX-2 promoter and increasing COX-2 protein expression. Moreover, the role of p300 (a transcription co-activator) in acetylating XRCC5 to co-regulate COX-2 expression was also evaluated. Immunofluorescence assay and confocal microscopy showed that XRCC5 and p300 proteins were co-located in the nucleus of colon cancer cells. Co-immunoprecipitation assay also proved the interaction between XRCC5 and p300 in nuclear proteins of colon cancer cells. Cell viability assay indicated that the overexpression of wild-type p300, but not its histone acetyltransferase (HAT) domain deletion mutant, increased XRCC5 acetylation, thereby up-regulated COX-2 expression and promoted the growth of colon cancer cells. In contrast, suppression of p300 by a p300 HAT-specific inhibitor (C646) inhibited colon cancer cell growth by suppressing COX-2 expression. Taken together, our results demonstrated that XRCC5 promoted colon cancer growth by cooperating with p300 to regulate COX-2 expression, and suggested that the XRCC5/p300/COX-2 signaling pathway was a potential target in the treatment of colon cancers.	[Zhang, Zhifeng; Yu, Zhenlong; Hao, Jiajiao; Yu, Wendan; Guo, Wei; Chen, Yiming; Duan, Zhijun] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China; [Zhang, Zhifeng; Yu, Zhenlong; Hao, Jiajiao; Yu, Wendan; Guo, Wei; Chen, Yiming; Duan, Zhijun] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China; [Zheng, Fufu] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Chen, Miao; Huang, Wenlin; Deng, Wuguo] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Huang, Wenlin; Deng, Wuguo] Guangzhou Double Bioprod Inc, State Key Lab Targeted Drug Tumors Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Dalian Medical University; Dalian Medical University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Duan, ZJ (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China.; Duan, ZJ (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China.; Deng, WG (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Deng, WG (corresponding author), Guangzhou Double Bioprod Inc, State Key Lab Targeted Drug Tumors Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	cathydoctor@sina.com; dengwg@sysucc.org.cn			National Natural Science Foundation of China [81470337, 81572706, 81472178, 81272195]; Education Department of Liaoning Province, China; Education Department of Liaoning Province, China [L2015142]; Guangzhou Double Bioproduct Inc	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Liaoning Province, China; Education Department of Liaoning Province, China; Guangzhou Double Bioproduct Inc	This work was supported by the funds from the National Natural Science Foundation of China (81470337, 81572706, 81472178, 81272195), the Education Department of Liaoning Province, China ("the Program for Pan-Deng Scholars"), the scientific research project from the Education Department of Liaoning Province, China (L2015142). Guangzhou Double Bioproduct Inc provided some salaries for authors (WH, WD) but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbas T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012914; Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; Andersson R, 2015, BIOESSAYS, V37, P314, DOI 10.1002/bies.201400162; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Ciombor KK, 2015, ANNU REV MED, V66, P83, DOI 10.1146/annurev-med-051513-102539; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Della Bella S, 1997, PROSTAG LEUKOTR ESS, V56, P177; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grabsch H, 2006, CLIN CANCER RES, V12, P1494, DOI 10.1158/1078-0432.CCR-05-2105; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Kawamura M, 2014, PROSTAG OTH LIPID M, V109, P14, DOI 10.1016/j.prostaglandins.2014.03.002; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Li J, 2016, PATHOL RES PRACT, V212, P204, DOI 10.1016/j.prp.2015.12.010; Li PW, 2015, GUT, V64, P1419, DOI 10.1136/gutjnl-2014-308260; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Ma QS, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-99; Majumder M, 2016, STEM CELLS, V34, P2290, DOI 10.1002/stem.2426; Monferran S, 2004, J MOL BIOL, V337, P503, DOI 10.1016/j.jmb.2004.01.057; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; O'Sullivan D, 2014, TUMOR BIOL, V35, P6983, DOI 10.1007/s13277-014-1857-5; Parker D, 1996, MOL CELL BIOL, V16, P694; Prados J, 2013, ANTI-CANCER AGENT ME, V13, P1204, DOI 10.2174/18715206113139990325; RATHMELL WK, 1994, P NATL ACAD SCI USA, V91, P7623, DOI 10.1073/pnas.91.16.7623; Rouzer CA, 2005, BIOCHEM BIOPH RES CO, V338, P34, DOI 10.1016/j.bbrc.2005.07.198; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Su CW, 2016, CRIT REV ONCOL HEMAT, V107, P33, DOI 10.1016/j.critrevonc.2016.08.010; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Thompson P. A., 2016, J NATL CANC I, V108; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wang DZ, 2005, CANCER RES, V65, P1822, DOI 10.1158/0008-5472.CAN-04-3671; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Wang S, 2015, WORLD J SURG, V39, P1773, DOI 10.1007/s00268-015-3023-7; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Xiao Y, 2015, ONCOTARGET, V6, P8046, DOI 10.18632/oncotarget.3508	44	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186900	10.1371/journal.pone.0186900	http://dx.doi.org/10.1371/journal.pone.0186900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049411	Green Submitted, Green Published, gold			2022-12-26	WOS:000413195900122
J	Mishra, MK; Loro, E; Sengupta, K; Wilton, SD; Khurana, TS				Mishra, Manoj K.; Loro, Emanuele; Sengupta, Kasturi; Wilton, Steve D.; Khurana, Tejvir S.			Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MDX; EXPRESSION; THERAPY; GENE; EXON; PHENOTYPE; PRODUCT; MOUSE	Duchenne muscular dystrophy (DMD) is a fatal genetic disease caused by an absence of the 427kD muscle-specific dystrophin isoform. Utrophin is the autosomal homolog of dystrophin and when overexpressed, can compensate for the absence of dystrophin and rescue the dystrophic phenotype of the mdx mouse model of DMD. Utrophin is subject to miRNA mediated repression by several miRNAs including let-7c. Inhibition of utrophin: let-7c interaction is predicted to ' repress the repression' and increase utrophin expression. We developed and tested the ability of an oligonucleotide, composed of 2'-O-methyl modified bases on a phosphorothioate backbone, to anneal to the utrophin 3' UTR and prevent let-7c miRNA binding, thereby upregulating utrophin expression and improving the dystrophic phenotype in vivo. Suppression of utrophin: let-7c interaction using bi-weekly intraperitoneal injections of let7 site blocking oligonucleotides (SBOs) for 1 month in the mdx mouse model for DMD, led to increased utrophin expression along with improved muscle histology, decreased fibrosis and increased specific force. The functional improvement of dystrophic muscle achieved using let7-SBOs suggests a novel utrophin upregulation-based therapeutic strategy for DMD.	[Mishra, Manoj K.; Loro, Emanuele; Sengupta, Kasturi; Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Mishra, Manoj K.; Loro, Emanuele; Sengupta, Kasturi; Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Wilton, Steve D.] Univ Western Australia, Perron Inst Neurol & Translat Sci, Perth, WA, Australia; [Wilton, Steve D.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Western Australia; Murdoch University	Khurana, TS (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.; Khurana, TS (corresponding author), Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA.	tsk@mail.med.upenn.edu	Sengupta, Kasturi/AAJ-1416-2020; Mishra, Manoj K/Y-5638-2019; Loro, Emanuele/J-5212-2019	Sengupta, Kasturi/0000-0003-1809-0780; Loro, Emanuele/0000-0002-0822-4514; Wilton, Steve/0000-0002-9400-893X; Mishra, Manoj K/0000-0002-3402-388X	Muscular Dystrophy Association, USA; Shire plc	Muscular Dystrophy Association, USA(Muscular Dystrophy Association); Shire plc	The study was supported in part by grants received by TSK from Muscular Dystrophy Association (https://www.mda.org/), USA and Shire plc (https://www.shire.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Basu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029376; Belanto JJ, 2014, P NATL ACAD SCI USA, V111, P5723, DOI 10.1073/pnas.1323842111; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chancellor DR, 2011, J MED CHEM, V54, P3241, DOI 10.1021/jm200135z; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Ervasti JM, 2008, INT REV CYTOL, V265, P191, DOI 10.1016/S0074-7696(07)65005-0; Ervasti JM, 1993, CURR OPIN CELL BIOL, V5, P82, DOI 10.1016/S0955-0674(05)80012-2; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Fisher R, 2001, NEUROMUSCULAR DISORD, V11, P713, DOI 10.1016/S0960-8966(01)00220-6; Gaudet D, 2015, NEW ENGL J MED, V373, P438, DOI 10.1056/NEJMoa1400283; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Guiraud S, 2015, HUM MOL GENET, V24, P4212, DOI 10.1093/hmg/ddv154; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Heydemann A, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-26; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Li DJ, 2010, J CELL SCI, V123, P2007, DOI 10.1242/jcs.064808; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Moorwood C, 2013, J BIOMOL SCREEN, V18, P400, DOI 10.1177/1087057112465648; Moorwood C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026169; Ottosen S, 2015, ANTIMICROB AGENTS CH, V59, P599, DOI 10.1128/AAC.04220-14; Pistilli EE, 2010, AM J PHYSIOL-REG I, V298, pR96, DOI 10.1152/ajpregu.00138.2009; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034204; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Vila MC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0070-6; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5	49	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0182676	10.1371/journal.pone.0182676	http://dx.doi.org/10.1371/journal.pone.0182676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045431	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100004
J	Walker, JN; Ross, JV; Black, AJ				Walker, James N.; Ross, Joshua V.; Black, Andrew J.			Inference of epidemiological parameters from household stratified data	PLOS ONE			English	Article							BAYESIAN-INFERENCE; 2009 INFLUENZA; EPIDEMICS; 1ST; COMMUNITY; MODELS	We consider a continuous-time Markov chain model of SIR disease dynamics with two levels of mixing. For this so-called stochastic households model, we provide two methods for inferring the model parameters-governing within-household transmission, recovery, and between-household transmission-from data of the day upon which each individual became infectious and the household in which each infection occurred, as might be available from First Few Hundred studies. Each method is a form of Bayesian Markov Chain Monte Carlo that allows us to calculate a joint posterior distribution for all parameters and hence the household reproduction number and the early growth rate of the epidemic. The first method performs exact Bayesian inference using a standard data-augmentation approach; the second performs approximate Bayesian inference based on a likelihood approximation derived from branching processes. These methods are compared for computational efficiency and posteriors from each are compared. The branching process is shown to be a good approximation and remains computationally efficient as the amount of data is increased.	[Walker, James N.; Ross, Joshua V.; Black, Andrew J.] Univ Adelaide, Sch Math Sci, Stochast Modelling & Operat Res Grp, Adelaide, SA 5005, Australia; [Walker, James N.; Ross, Joshua V.; Black, Andrew J.] Univ Adelaide, Sch Math Sci, ACEMS, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide	Black, AJ (corresponding author), Univ Adelaide, Sch Math Sci, Stochast Modelling & Operat Res Grp, Adelaide, SA 5005, Australia.; Black, AJ (corresponding author), Univ Adelaide, Sch Math Sci, ACEMS, Adelaide, SA 5005, Australia.	andrew.black@adelaide.edu.au		Black, Andrew/0000-0003-3299-4866; Walker, Camelia Rose/0000-0003-1470-858X; Ross, Joshua/0000-0002-9918-8167	Dr Michael and Heather Dunne PhD Scholarship in Applied Mathematics; Australian Government Research Training Program Scholarship; Australian Research Council Future Fellowship [FT130100254]; Australian Research Council Discovery Early Career Researcher Award [DE160100690]; ARC Centre of Excellence for Mathematical and Statistical Frontiers (CoE ACEMS); Australian Government NHMRC Centre for Research Excellence in Policy Relevant Infectious diseases Simulation and Mathematical Modelling [CRE PRISM2]	Dr Michael and Heather Dunne PhD Scholarship in Applied Mathematics; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council Future Fellowship(Australian Research Council); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); ARC Centre of Excellence for Mathematical and Statistical Frontiers (CoE ACEMS); Australian Government NHMRC Centre for Research Excellence in Policy Relevant Infectious diseases Simulation and Mathematical Modelling	JNW acknowledges the support provided by the Dr Michael and Heather Dunne PhD Scholarship in Applied Mathematics and an Australian Government Research Training Program Scholarship. JVR acknowledges the support of an Australian Research Council Future Fellowship (FT130100254) (http://www.arc.gov.au). AJB was supported by an Australian Research Council Discovery Early Career Researcher Award (DE160100690) (http://www.arc.gov.au). All authors also acknowledge support from both the ARC Centre of Excellence for Mathematical and Statistical Frontiers (CoE ACEMS) (http://acems.org.au), and the Australian Government NHMRC Centre for Research Excellence in Policy Relevant Infectious diseases Simulation and Mathematical Modelling (CRE PRISM2) (http://prism.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported with supercomputing resources provided by the Phoenix HPC service at the University of Adelaide.	ABATE J, 1992, OPER RES LETT, V12, P245, DOI 10.1016/0167-6377(92)90050-D; Athreya KB, 1972, BRANCHING PROCESSES; Australian Bureau of Statistics, 2011, HOUSEHOLD AND FAMILY; Australian Department of Health and Ageing, 2014, AUSTRALIAN HEALTH MA; Ball F, 1999, MATH BIOSCI, V156, P41, DOI 10.1016/S0025-5564(98)10060-3; Ball F, 2015, J MATH BIOL, V71, P1705, DOI 10.1007/s00285-015-0872-5; Ball F, 1997, ANN APPL PROBAB, V7, P46; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Black AJ, 2017, EPIDEMICS-NETH, V19, P61, DOI 10.1016/j.epidem.2017.01.004; Black AJ, 2014, J THEOR BIOL, V359, P45, DOI 10.1016/j.jtbi.2014.05.042; Black AJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1019; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Cauchemez S, 2008, J R SOC INTERFACE, V5, P885, DOI 10.1098/rsif.2007.1292; Demiris N, 2005, SCAND J STAT, V32, P265, DOI 10.1111/j.1467-9469.2005.00420.x; Demiris N, 2013, J ROYAL STAT SOC A, V177, P697; Dorman KS, 2004, SIAM REV, V46, P202, DOI 10.1137/S0036144502417843; England HPA, 2009, 1 FEW HUNDRED; Fintzi J, SIMULATION BASED BAY; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Jewell CP, 2009, BAYESIAN ANAL, V4, P465, DOI 10.1214/09-BA417; Lyons RG, 2011, UNDERSTANDING DIGITA, Vthird; McCaw JM, 2014, J PUBLIC HEALTH-UK, V36, P5, DOI 10.1093/pubmed/fdt058; McKinley TJ, 2014, COMPUT STAT DATA AN, V71, P434, DOI 10.1016/j.csda.2012.12.012; McLean E, 2010, EPIDEMIOL INFECT, V138, P1531, DOI 10.1017/S0950268810001366; O'Neill PD, 1999, J ROY STAT SOC A STA, V162, P121, DOI 10.1111/1467-985X.00125; Pellis L, 2015, REPRODUCTION NUMBERS; Pellis L, 2012, MATH BIOSCI, V235, P85, DOI 10.1016/j.mbs.2011.10.009; Pollett PK, 2002, J APPL PROBAB, V39, P901, DOI 10.1017/S0021900200022142; Pooley CM, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0225; Reed C, 2013, EMERG INFECT DIS, V19, P85, DOI 10.3201/eid1901.120124; Ross JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009666; Sidje RB, 1998, ACM T MATH SOFTWARE, V24, P130, DOI 10.1145/285861.285868; van Gageldonk-Lafeber AB, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-30; Vats D, MULTIVARIATE OUTPUT; Yang Y, 2009, BIOSTATISTICS, V10, P390, DOI 10.1093/biostatistics/kxn045	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185910	10.1371/journal.pone.0185910	http://dx.doi.org/10.1371/journal.pone.0185910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045456	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100030
J	Zera, K; Zastre, J				Zera, Kristy; Zastre, Jason			Thiamine deficiency activates hypoxia inducible factor-1 alpha to facilitate pro-apoptotic responses in mouse primary astrocytes	PLOS ONE			English	Article							FACTOR-I; WERNICKES ENCEPHALOPATHY; GLUTAMATE TRANSPORTER; MOLECULAR-PARAMETERS; OXIDATIVE STRESS; GENE-EXPRESSION; BRAIN CYP2E1; RAT; HIF-1; HIF-1-ALPHA	Thiamine is an essential enzyme cofactor required for proper metabolic function and maintenance of metabolism and energy production in the brain. In developed countries, thiamine deficiency (TD) is most often manifested following chronic alcohol consumption leading to impaired mitochondrial function, oxidative stress, inflammation and excitotoxicity. These biochemical lesions result in apoptotic cell death in both neurons and astrocytes. Comparable histological injuries in patients with hypoxia/ischemia and TD have been described in the thalamus and mammillary bodies, suggesting a congruency between the cellular responses to these stresses. Consistent with hypoxia/ischemia, TD stabilizes and activates Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) under physiological oxygen levels. However, the role of TD-induced HIF-1 alpha in neurological injury is currently unknown. Using Western blot analysis and RT-PCR, we have demonstrated that TD induces HIF-1 alpha expression and activity in primary mouse astrocytes. We observed a time-dependent increase in mRNA and protein expression of the pro-apoptotic and pro-inflammatory HIF-1a alpha arget genes MCP1, BNIP3, Nix and Noxa during TD. We also observed apoptotic cell death in TD as demonstrated by PI/Annexin V staining, TUNEL assay, and Cell Death ELISA. Pharmacological inhibition of HIF-1 alpha activity using YC1 and thiamine repletion both reduced expression of pro-apoptotic HIF-1 alpha target genes and apoptotic cell death in TD. These results demonstrate that induction of HIF-1 alpha mediated transcriptional up-regulation of pro-apoptotic/inflammatory signaling contributes to astrocyte cell death during thiamine deficiency.	[Zera, Kristy; Zastre, Jason] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Zastre, J (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	jzastre@uga.edu		Zera, Kristy/0000-0001-9178-6907	National Institute on Alcohol Abuse and Alcoholism of National Institutes of Health [R21AA021948]	National Institute on Alcohol Abuse and Alcoholism of National Institutes of Health	Research reported in this publication was supported by the National Institute on Alcohol Abuse and Alcoholism (https://www.niaaa.nih.gov) of the National Institutes of Health under award number R21AA021948 to JZ.	AIKAWA H, 1984, J NEUROPATH EXP NEUR, V43, P276, DOI 10.1097/00005072-198405000-00006; Albert MC, 2014, MOL CELL ONCOL, V1, DOI 10.4161/mco.29906; Althaus J, 2006, NEUROCHEM INT, V48, P687, DOI 10.1016/j.neuint.2005.12.008; Beauchesne E, 2009, NEUROCHEM INT, V55, P275, DOI 10.1016/j.neuint.2009.03.014; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; BETTENDORFF L, 1995, J NEUROCHEM, V65, P2178; BRIN M, 1964, TOXICOL APPL PHARM, V6, P454, DOI 10.1016/S0041-008X(64)80012-0; BUTTERWORTH RF, 1985, NEUROCHEM RES, V10, P1417, DOI 10.1007/BF00964982; BUTTERWORTH RF, 1993, ALCOHOL CLIN EXP RES, V17, P1084, DOI 10.1111/j.1530-0277.1993.tb05668.x; Chan H, 2004, NEUROSCI LETT, V366, P231, DOI 10.1016/j.neulet.2004.04.095; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Chen W, 2009, EXP NEUROL, V216, P7, DOI 10.1016/j.expneurol.2008.10.016; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Clarkson AN, 2005, ARCH IMMUNOL THER EX, V53, P213; COLLINS GH, 1967, AM J PATHOL, V50, P791; Fernandes LMP, 2017, EUR J CLIN NUTR; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gibson GE, 2013, MOL CELL NEUROSCI, V55, P17, DOI 10.1016/j.mcn.2012.09.001; Gong Y, 2017, FREE RADIC BIOL MED; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Habib P, 2014, NEUROENDOCRINOLOGY, V99, P156, DOI 10.1159/000362279; HAKIM AM, 1986, J CEREBR BLOOD F MET, V6, P79, DOI 10.1038/jcbfm.1986.10; HAKIM AM, 1983, ANN NEUROL, V13, P365, DOI 10.1002/ana.410130403; Hamidian A, 2015, BIOCHEM BIOPH RES CO, V461, P560, DOI 10.1016/j.bbrc.2015.04.083; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Hazell AS, 2010, GLIA, V58, P148, DOI 10.1002/glia.20908; Hazell AS, 2009, NEUROCHEM INT, V55, P129, DOI 10.1016/j.neuint.2009.02.020; Hazell AS, 2009, ALCOHOL ALCOHOLISM, V44, P141, DOI 10.1093/alcalc/agn120; HAZELL AS, 1993, J NEUROCHEM, V61, P1155, DOI 10.1111/j.1471-4159.1993.tb03635.x; Hazell AS, 2003, GLIA, V43, P175, DOI 10.1002/glia.10241; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Howard LA, 2003, BRIT J PHARMACOL, V138, P1376, DOI 10.1038/sj.bjp.0705146; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; HOYUMPA AM, 1980, AM J CLIN NUTR, V33, P2750, DOI 10.1093/ajcn/33.12.2750; Hua X, 2016, HEPATOL RES; Hwang TL, 2003, MOL PHARMACOL, V64, P1419, DOI 10.1124/mol.64.6.1419; Imai N, 2012, INTERNAL MED, V51, P929, DOI 10.2169/internalmedicine.51.6528; Jhala SS, 2014, BIOCHEM BIOPH RES CO, V448, P335, DOI 10.1016/j.bbrc.2014.04.017; Ke ZJ, 2003, J NEUROPATH EXP NEUR, V62, P195, DOI 10.1093/jnen/62.2.195; Khanh VQL, 2012, J NEUROL SCI, V316, P1, DOI 10.1016/j.jns.2012.02.008; Kim HL, 2006, INT J ONCOL, V29, P255; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kril JJ, 1996, METAB BRAIN DIS, V11, P9, DOI 10.1007/BF02080928; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Lakhan SE, 2013, FRONT NEUROL, V4; Latt N, 2014, INTERN MED J, V44, P911, DOI 10.1111/imj.12522; Li Lin, 2006, Hepatobiliary Pancreat Dis Int, V5, P560; Liu JY, 2006, J BIOL CHEM, V281, P6601, DOI 10.1074/jbc.M510951200; Liu SQ, 2010, CANCER CHEMOTH PHARM, V66, P171, DOI 10.1007/s00280-009-1148-9; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Matsushima K, 1997, NEUROREPORT, V8, P867; Mellor HR, 2007, CANCER METAST REV, V26, P553, DOI 10.1007/s10555-007-9080-0; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; Morishima T, 2008, NEUROSCI RES, V61, P18, DOI 10.1016/j.neures.2008.01.005; Nakagawa Hiroto, 2004, Rinsho Shinkeigaku, V44, P91; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Navarro D, 2005, J NEUROSCI RES, V79, P33, DOI 10.1002/jnr.20290; Navarro D, 2008, METAB BRAIN DIS, V23, P115, DOI 10.1007/s11011-007-9076-z; Pan SL, 2004, CARDIOVASC RES, V61, P152, DOI 10.1016/j.cardiores.2003.09.013; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Reddy VD, 2013, MOL CELL BIOCHEM, V375, P39, DOI 10.1007/s11010-012-1526-1; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Sechi G, 2007, LANCET NEUROL, V6, P442, DOI 10.1016/S1474-4422(07)70104-7; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Serres S, 2008, J CEREBR BLOOD F MET, V28, P712, DOI 10.1038/sj.jcbfm.9600568; Sowter HM, 2001, CANCER RES, V61, P6669; Subramanian VS, 2010, AM J PHYSIOL-RENAL, V299, pF28, DOI 10.1152/ajprenal.00140.2010; Subramanya SB, 2010, AM J PHYSIOL-GASTR L, V299, pG23, DOI 10.1152/ajpgi.00132.2010; Sweet RL, 2013, INT J VITAM NUTR RES, V83, P188, DOI 10.1024/0300-9831/a000159; Thomson AD, 2006, ALCOHOL ALCOHOLISM, V41, P151, DOI 10.1093/alcalc/agh249; Upadhya SC, 2000, ARCH BIOCHEM BIOPHYS, V373, P23, DOI 10.1006/abbi.1999.1477; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; VORTMEYER AO, 1988, VIRCHOWS ARCH A, V414, P61, DOI 10.1007/BF00749739; VORTMEYER AO, 1993, CLIN NEUROPATHOL, V12, P184; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang XD, 2013, FREE RADICAL BIO MED, V63, P175, DOI 10.1016/j.freeradbiomed.2013.05.009; WATANABE I, 1978, EXP MOL PATHOL, V28, P381, DOI 10.1016/0014-4800(78)90012-6; Yang GA, 2011, BRAIN PATHOL, V21, P279, DOI 10.1111/j.1750-3639.2010.00445.x; Yun JW, 2014, FREE RADICAL BIO MED, V77, P183, DOI 10.1016/j.freeradbiomed.2014.08.030; Zera K, 2016, GENE, V595, P212, DOI 10.1016/j.gene.2016.10.013; Zhong YJ, 2012, TOXICOLOGY, V302, P275, DOI 10.1016/j.tox.2012.08.009; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51; Zubaran C, 1997, POSTGRAD MED J, V73, P27, DOI 10.1136/pgmj.73.855.27	92	10	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186707	10.1371/journal.pone.0186707	http://dx.doi.org/10.1371/journal.pone.0186707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045486	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100090
J	Angelova, DM; Jones, HBL; Brown, DR				Angelova, Dafina M.; Jones, Hannah B. L.; Brown, David R.			Levels of alpha- and beta-synuclein regulate cellular susceptibility to toxicity from alpha-synuclein oligomers	FASEB JOURNAL			English	Article						FoxO3a; iron; Parkinson disease	FOXO TRANSCRIPTION FACTORS; NIGRAL IRON CONTENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; IN-VIVO; PHOSPHATIDYLINOSITOL 3-KINASE; FERRIREDUCTASE ACTIVITY; DOPAMINERGIC-NEURONS; PRESYNAPTIC PROTEIN	alpha-Synuclein (alpha-syn) is associated with a range of diseases, including Parkinson disease. In disease, alpha-syn is known to aggregate and has the potential to be neurotoxic. The association between copper and alpha-syn results in the formation of stellate toxic oligomers that are highly toxic to cultured neurons. We further investigated the mechanism of toxicity of alpha-syn oligomers. Cells that overexpress alpha-syn showed increased susceptibility to the toxicity of the oligomers, while those that overexpressed beta-syn showed increased resistance to the toxic oligomers. Elevated alpha-syn expression caused an increase in expression of the transcription factor Forkhead box O3a (FoxO3a). Inhibition of FoxO3a activity by the overexpression of DNA binding domain of FoxO3a resulted in significant protection from a-syn oligomer toxicity. Increased FoxO3a expression in cells was shown to be caused by increased ferrireductase activity and Fe(II) levels. These results suggest that alpha-syn increases FoxO3a expression as a result of its intrinsic ferrireductase activity. The results also suggest that FoxO3a plays a pivotal role in the toxicity of both Fe(II) and toxic alpha-syn species to neuronal cells.	[Angelova, Dafina M.; Jones, Hannah B. L.; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Brown, DR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Jones, Hannah/0000-0002-7834-0625				Ackerman D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002498; Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Brown JWP, 2016, SCI REP-UK, V6, DOI 10.1038/srep36010; Carboni E, 2015, METALLOMICS, V7, P395, DOI 10.1039/c4mt00339j; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Davies P, 2011, BIOCHEMISTRY-US, V50, P37, DOI 10.1021/bi101582p; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Dexter DT, 2011, J NEURAL TRANSM, V118, P223, DOI 10.1007/s00702-010-0531-3; DEXTER DT, 1987, LANCET, V2, P1219; DEXTER DT, 1992, ANN NEUROL, V32, pS94, DOI 10.1002/ana.410320716; DEXTER DT, 1990, J NEUROCHEM, V55, P16, DOI 10.1111/j.1471-4159.1990.tb08814.x; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; DEXTER DT, 1993, ADV NEUROL, V60, P273; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; El-Agnaf OMA, 2000, J STRUCT BIOL, V130, P300, DOI 10.1006/jsbi.2000.4262; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Febbraro F, 2013, EXP NEUROL, V247, P45, DOI 10.1016/j.expneurol.2013.03.017; Forloni G, 2000, ANN NEUROL, V47, P632, DOI 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.3.CO;2-E; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Haigh CL, 2006, J NEUROCHEM, V98, P677, DOI 10.1111/j.1471-4159.2006.03906.x; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hayashita-Kinoh H, 2006, BIOCHEM BIOPH RES CO, V341, P1088, DOI 10.1016/j.bbrc.2006.01.057; He Q, 2011, J NEURAL TRANSM, V118, P397, DOI 10.1007/s00702-010-0453-0; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Janowska MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15164; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee EN, 2003, J NEUROCHEM, V84, P1128, DOI 10.1046/j.1471-4159.2003.01612.x; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maiese Kenneth, 2016, J Transl Sci, V2, P241; Uranga RM, 2013, J BIOL CHEM, V288, P19773, DOI 10.1074/jbc.M113.457622; Uranga RM, 2009, TOXICOL SCI, V111, P331, DOI 10.1093/toxsci/kfp152; Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427; Masliah E, 1996, AM J PATHOL, V148, P201; Mateos MV, 2008, NEUROCHEM INT, V53, P199, DOI 10.1016/j.neuint.2008.07.005; McDowall JS, 2017, MOL CELL NEUROSCI, V85, P1, DOI 10.1016/j.mcn.2017.08.001; McDowall JS, 2017, BIOCHEMISTRY-US, V56, P2497, DOI 10.1021/acs.biochem.7b00257; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; PALL HS, 1987, LANCET, V2, P238; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Pino E, 2014, HUM MOL GENET, V23, P1435, DOI 10.1093/hmg/ddt530; Puukila S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122852; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Roostaee A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-5; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Shaltiel-Karyo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013863; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2005, J BIOL CHEM, V280, P7562, DOI 10.1074/jbc.M412887200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Su B, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-32; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tsigelny IF, 2012, FEBS J, V279, P1000, DOI 10.1111/j.1742-4658.2012.08489.x; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wang XY, 2010, J NEUROCHEM, V113, P704, DOI 10.1111/j.1471-4159.2010.06638.x; Windisch M, 2004, J MOL NEUROSCI, V24, P155, DOI 10.1385/JMN:24:1:155; Wright JA, 2013, MOL CELL NEUROSCI, V57, P33, DOI 10.1016/j.mcn.2013.09.002; Wright JA, 2009, FASEB J, V23, P2384, DOI 10.1096/fj.09-130039; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	84	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					995	1006		10.1096/fj.201700675R	http://dx.doi.org/10.1096/fj.201700675R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29054856	Green Submitted, Bronze			2022-12-26	WOS:000425146900039
J	Miranda, BH; Charlesworth, MR; Tobin, DJ; Sharpe, DT; Randall, VA				Miranda, Benjamin H.; Charlesworth, Matthew R.; Tobin, Desmond J.; Sharpe, David T.; Randall, Valerie A.			Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life	FASEB JOURNAL			English	Article						alopecia; balding; hirsutism; model system; intermediate hair follicles	DERMAL PAPILLA CELLS; NON-GENOMIC ACTIONS; PUBERTAL CHANGES; STEM-CELLS; IN-VITRO; RECEPTORS; REGENERATION; CONTAIN; INDUCE; NICHE	Male sex hormones-androgens-regulate male physique development. Without androgen signaling, genetic males appear female. During puberty, increasing androgens harness the hair follicle's unique regenerative ability to replace many tiny vellus hairs with larger, darker terminal hairs (e.g., beard). Follicle response is epigenetically varied: some remain unaffected (e.g., eyelashes) or are inhibited, causing balding. How sex steroid hormones alter such developmental processes is unclear, despite high incidences of hormone-driven cancer, hirsutism, and alopecia. Unfortunately, existing development models are not androgen sensitive. Here, we use hair follicles to establish an androgen-responsive human organ culture model. We show that women's intermediate facial follicles respond to men's higher androgen levels by synthesizing more hair over several days, unlike donor-matched, androgen-insensitive, terminal follicles. We demonstrate that androgen receptors-androgen-activated gene transcription regulators-are required and are present in vivo within these follicles. This is the first human organ that involves multiple cell types that responds appropriately to hormones in prolonged culture, in a way which mirrors its natural behavior. Thus, intermediate hair follicles offer a hormone-switchable human model with exceptional, unique availability of genetically identical, but epigenetically hormone-insensitive, terminal follicles. This should enable advances in understanding sex steroid hormone signaling, gene regulation, and developmental and regenerative systems and facilitate better therapies for hormone-dependent disorders.	[Miranda, Benjamin H.; Charlesworth, Matthew R.; Tobin, Desmond J.; Sharpe, David T.; Randall, Valerie A.] Univ Bradford, Ctr Skin Sci, Bradford, W Yorkshire, England; [Miranda, Benjamin H.; Sharpe, David T.] Univ Bradford, Plast Surg & Burns Res Unit, Bradford, W Yorkshire, England	University of Bradford; University of Bradford	Randall, VA (corresponding author), Univ Bradford, Ctr Skin Sci, Fac Life Sci, Richmond Rd, Bradford BD7 1DP, W Yorkshire, England.	v.a.randall@bradford.ac.uk	Miranda, BEN/AAV-3434-2020; Tobin, Desmond/A-5228-2009	Miranda, BEN/0000-0002-6403-546X; Tobin, Desmond/0000-0003-4566-9392	Plastic Surgery and Burns Research Unit; Faculty of Life Sciences at the University of Bradford (Bradford, United Kingdom)	Plastic Surgery and Burns Research Unit; Faculty of Life Sciences at the University of Bradford (Bradford, United Kingdom)	The authors thank the Plastic Surgery and Burns Research Unit and the Faculty of Life Sciences at the University of Bradford (Bradford, United Kingdom) for financial support for B.H.M. and M.R.C., respectively. The authors declare no conflicts of interest.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Ando Y, 1999, BRIT J DERMATOL, V141, P840, DOI 10.1046/j.1365-2133.1999.03156.x; AUBER L., 1952, TRANS ROY SOC EDINBURGH, V62, P191; Bieche I, 2001, CARCINOGENESIS, V22, P1521, DOI 10.1093/carcin/22.9.1521; Bunagan MJK, 2013, DERMATOL CLIN, V31, P141, DOI 10.1016/j.det.2012.08.012; Cash TF, 2001, CLIN DERMATOL, V19, P161, DOI 10.1016/S0738-081X(00)00127-9; Castoria G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.497; Chen CC, 2016, J MOL BIOL, V428, P1423, DOI 10.1016/j.jmb.2015.07.009; Chi W, 2015, EXP DERMATOL, V24, P265, DOI 10.1111/exd.12608; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; CROFT NJ, 2003, HAIR SCI TECHNOLOGY, P69; Cunha GR, 2011, DIFFERENTIATION, V82, P168, DOI 10.1016/j.diff.2011.04.002; Driskell RR, 2012, J INVEST DERMATOL, V132, P1084, DOI 10.1038/jid.2011.428; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Girman CJ, 1998, DERMATOLOGY, V197, P223, DOI 10.1159/000018001; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; HAMILTON JB, 1958, BIOL HAIR GROWTH, P399, DOI DOI 10.1016/B978-1-4832-3287-4.50022-2; Handesman D., 2001, ENDOCRINOLOGY, P2232; Hibberts NA, 1998, J ENDOCRINOL, V156, P59, DOI 10.1677/joe.0.1560059; Higgins CA, 2013, P NATL ACAD SCI USA, V110, P19679, DOI 10.1073/pnas.1309970110; Higgins CA, 2009, J INVEST DERMATOL, V129, P2100, DOI 10.1038/jid.2009.66; Hughes IA, 2012, SEMIN REPROD MED, V30, P432, DOI [10.1055/s-0032-1324728, 10.1016/S0140-6736(12)60071-3]; ITAMI S, 1995, BRIT J DERMATOL, V132, P527; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Khidhir KG, 2013, FASEB J, V27, P557, DOI 10.1096/fj.12-218156; Lay K, 2016, P NATL ACAD SCI USA, V113, pE1506, DOI 10.1073/pnas.1601569113; Leach DA, 2015, ONCOTARGET, V6, P16135, DOI 10.18632/oncotarget.3873; Lee SH, 2015, STEM CELLS, V33, P3356, DOI 10.1002/stem.2096; Lei MX, 2016, SCIENCE, V351, P559, DOI 10.1126/science.aaf1635; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Lin SJ, 2013, SCIENCE, V340, P1442, DOI 10.1126/science.1230374; Linke T, 2011, METHODS MOL BIOL, V776, P225, DOI 10.1007/978-1-61779-243-4_14; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Martin KA, 2008, J CLIN ENDOCR METAB, V93, P1105, DOI 10.1210/jc.2007-2437; McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x; Miranda BH, 2010, BRIT J DERMATOL, V163, P287, DOI 10.1111/j.1365-2133.2010.09867.x; Morgan B. A., 2014, PERSPECT MED, V4; Randall V. A., 2012, TESTOSTERONE ACTION, P154; RANDALL VA, 1992, J ENDOCRINOL, V133, P141, DOI 10.1677/joe.0.1330141; Randall VA, 2005, ENDOCRINOLOGY, P3295; Randall VA, 2008, DERMATOL THER, V21, P314, DOI 10.1111/j.1529-8019.2008.00214.x; Randall VA, 2007, SEMIN CELL DEV BIOL, V18, P274, DOI 10.1016/j.semcdb.2007.02.004; Reynolds AJ, 1999, NATURE, V402, P33, DOI 10.1038/46938; Ricke EA, 2012, CARCINOGENESIS, V33, P1391, DOI 10.1093/carcin/bgs153; SAITOH M, 1970, J INVEST DERMATOL, V54, P65, DOI 10.1111/1523-1747.ep12551679; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Shorter K, 2008, FASEB J, V22, P1725, DOI 10.1096/fj.07-099424; Thornton MJ, 2001, J ENDOCRINOL, V168, P401, DOI 10.1677/joe.0.1680401; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Wang C, 2014, INT J MOL SCI, V15, P15412, DOI 10.3390/ijms150915412; Wang XJ, 2014, J INVEST DERMATOL, V134, P736, DOI 10.1038/jid.2013.368	52	12	12	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					795	806		10.1096/fj.201700260RR	http://dx.doi.org/10.1096/fj.201700260RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29046359	Green Published, hybrid			2022-12-26	WOS:000425146900022
J	Hahn, C; Tyka, K; Saba, JD; Lenzen, S; Gurgul-Convey, E				Hahn, Claudine; Tyka, Karolina; Saba, Julie D.; Lenzen, Sigurd; Gurgul-Convey, Ewa			Overexpression of sphingosine-1-phosphate lyase protects insulin-secreting cells against cytokine toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; diabetes; inflammation; insulin secretion; pancreatic islet; sphingosine-1-phosphate (S1P); S1P-lyase; insulin-secreting cells	ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; SPHINGOSINE 1-PHOSPHATE; LEW.1AR1-IDDM RAT; SPHINGOLIPID METABOLISM; ISLET INFLAMMATION; MEDIATED MECHANISM; DIABETES-MELLITUS; INS-1 CELLS; S1P LYASE	Increasing evidence suggests a crucial role of inflammation in cytokine-mediated -cell dysfunction and death in type 1 diabetes mellitus, although the mechanisms are incompletely understood. Sphingosine 1-phosphate (S1P) is a multifunctional bioactive sphingolipid involved in the development of many autoimmune and inflammatory diseases. Here, we investigated the role of intracellular S1P in insulin-secreting INS1E cells by genetically manipulating the S1P-metabolizing enzyme S1P lyase (SPL). The expression of spl was down-regulated by cytokines in INS1E cells and rat islets. Overexpression of SPL protected against cytokine toxicity. Interestingly, the SPL overexpression did not suppress the cytokine-induced NFB-iNOS-NO pathway but attenuated calcium leakage from endoplasmic reticulum (ER) stores as manifested by lower cytosolic calcium levels, higher expression of the ER protein Sec61a, decreased dephosphorylation of Bcl-2-associated death promoter (Bad) protein, and weaker caspase-3 activation in cytokine-treated (IL-1, TNF, and IFN) cells. This coincided with reduced cytokine-mediated ER stress, indicated by measurements of CCAAT/enhancer-binding protein homologous protein (chop) and immunoglobulin heavy chain binding protein (bip) levels. Moreover, cytokine-treated SPL-overexpressing cells exhibited increased expression of prohibitin 2 (Phb2), involved in the regulation of mitochondrial assembly and respiration. SPL-overexpressing cells were partially protected against cytokine-mediated ATP reduction and inhibition of glucose-induced insulin secretion. siRNA-mediated spl suppression resulted in effects opposite to those observed for SPL overexpression. Knockdown of phb2 partially reversed beneficial effects of SPL overexpression. In conclusion, the relatively low endogenous Spl expression level in insulin-secreting cells contributes to their extraordinary vulnerability to proinflammatory cytokine toxicity and may therefore represent a promising target for -cell protection in type 1 diabetes mellitus.	[Hahn, Claudine; Tyka, Karolina; Lenzen, Sigurd; Gurgul-Convey, Ewa] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany; [Saba, Julie D.] Univ Calif San Francisco, Childrens Hosp, Oakland Res Inst, San Francisco, CA 94609 USA	Hannover Medical School; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco	Gurgul-Convey, E (corresponding author), Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany.	Gurgul-Convey.Ewa@mh-hannover.de		Gurgul-Convey, Ewa/0000-0002-9269-266X; Tyka, Karolina/0000-0002-4169-1675	Innovative Medicines Initiative Joint Undertaking [155005]; European Union; EFPIA companies; NATIONAL CANCER INSTITUTE [R01CA129438] Funding Source: NIH RePORTER	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA companies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Innovative Medicines Initiative Joint Undertaking under grant agreement 155005 (IMIDIA), resources of which are composed of a financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Aoki M, 2016, MEDIAT INFLAMM, V2016, DOI [DOI 10.1155/2016/8606878, 10.1155/2016/8606878]; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Candido K, 2016, MINI-REV MED CHEM, V16, P547, DOI 10.2174/1389557515666150709122517; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Coppieters KT, 2014, DIABETES, V63, P3581, DOI 10.2337/db14-0824; Degagne E, 2014, CLIN EXP GASTROENTER, V7, P205, DOI 10.2147/CEG.S43453; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2001, DIABETES, V50, pS64, DOI 10.2337/diabetes.50.2007.S64; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Gurgul-Convey E, 2012, ENDOCRINOLOGY, V153, P2612, DOI 10.1210/en.2011-2027; Gurgul-Convey E, 2011, J MOL MED, V89, P785, DOI 10.1007/s00109-011-0747-1; Gurgul-Convey E, 2010, J BIOL CHEM, V285, P11121, DOI 10.1074/jbc.M109.054775; Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hanzelka K, 2012, BIOCHEM J, V445, P349, DOI 10.1042/BJ20111920; Harris CM, 2016, J PHARMACOL EXP THER, V359, P151, DOI 10.1124/jpet.116.235002; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huwiler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022436; Japtok L, 2015, FASEB J, V29, P3357, DOI 10.1096/fj.14-263194; Jessup Claire F., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P262; Jorns A, 2014, J MOL MED, V92, P743, DOI 10.1007/s00109-014-1137-2; Jorns A, 2014, DIABETOLOGIA, V57, P512, DOI 10.1007/s00125-013-3125-4; Jorns A, 2010, ENDOCRINOLOGY, V151, P3555, DOI 10.1210/en.2010-0202; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Laychock SG, 2006, ENDOCRINOLOGY, V147, P4705, DOI 10.1210/en.2006-0456; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Mastrandrea LD, 2010, J LIPID RES, V51, P2171, DOI 10.1194/jlr.M000802; Mastrandrea LD, 2005, DIABETES, V54, P1429, DOI 10.2337/diabetes.54.5.1429; Mitroi DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep37064; Morgan NG, 2014, IUBMB LIFE, V66, P723, DOI 10.1002/iub.1330; Nagao K, 2013, BBA-MOL CELL BIOL L, V1831, P398, DOI 10.1016/j.bbalip.2012.11.002; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Rabinovitch A, 2003, REV ENDOCR METAB DIS, V4, P291, DOI 10.1023/A:1025160614313; Ramadan JW, 2011, CELL CALCIUM, V50, P481, DOI 10.1016/j.ceca.2011.08.005; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Roep BO, 2011, CURR OPIN IMMUNOL, V23, P746, DOI 10.1016/j.coi.2011.10.001; Saba JD, 2013, BBA-MOL CELL BIOL L, V1831, P167, DOI 10.1016/j.bbalip.2012.06.009; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152; Taguchi Y, 2016, J BIOL CHEM, V291, P12029, DOI 10.1074/jbc.M116.728170; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; van Vliet AR, 2017, MOL CELL, V65, P885, DOI 10.1016/j.molcel.2017.01.020; Veltman M, 2016, AM J PHYSIOL-LUNG C, V311, pL1000, DOI 10.1152/ajplung.00298.2016; Veret J, 2014, J CLIN MED, V3, P646, DOI 10.3390/jcm3020646; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; Ximenes HM, 2007, LIFE SCI, V80, P2045, DOI 10.1016/j.lfs.2007.03.001; Zhu Q, 2009, FEBS LETT, V583, P2136, DOI 10.1016/j.febslet.2009.05.047; Zimmermann R, 2016, J CLIN IMMUNOL, V36, pS5, DOI 10.1007/s10875-016-0250-0	66	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20292	20304		10.1074/jbc.M117.814491	http://dx.doi.org/10.1074/jbc.M117.814491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29070677	Green Published, hybrid			2022-12-26	WOS:000417696400032
J	Qiu, ZH; Wu, XL; Zhang, JX; Huang, CY				Qiu, Zhiheng; Wu, Xiangli; Zhang, Jinxia; Huang, Chenyang			High temperature enhances the ability of Trichoderma asperellum to infect Pleurotus ostreatus mycelia	PLOS ONE			English	Article							GREEN MOLD DISEASES; BIOCONTROL MECHANISMS; RHIZOCTONIA-SOLANI; BIOLOGICAL-CONTROL; BOTRYTIS-CINEREA; CELL-WALL; HARZIANUM; PURIFICATION; STRAINS; FUNGI	Trichoderma asperellum is one of the species which can be isolated from contaminated Pleurotus ostreatus cultivation substrate with green mold disease. This study focused on the relationship between high temperature and infectivity of T. asperellum to P. ostreatus. Antagonism experiments between T. asperellum and P. ostreatus mycelia revealed that high temperature-treated P. ostreatus mycelia were more easily infected by T. asperellum and covered by conidia. Microscopic observation also showed that P. ostreatus mycelia treated with high temperature could adsorb more T. asperellum conidia. Furthermore, conidia obtained from T. asperellum mycelia grown at 36 degrees C featured higher germination rate compared with that incubated at 28 degrees C. High temperature-treated T. asperellum mycelia can produce conidia in shorter periods, and T. asperellum mycelia were less sensitive to high temperature than P. ostreatus. Deactivated P. ostreatus mycelia can induce T. asperellum cell wall-degrading enzymes (CWDEs) and P. ostreatus mycelia subjected to high temperature showed induced CWDEs more effective than those incubated at 28 degrees C. Moreover, T. asperellum showed higher CWDEs activity at high temperature. In dual cultures, hydrogen peroxide (H2O2) increased after 36 degrees C, and high concentration of H2O2 could significantly inhibit the growth of P. ostreatus mycelia. In summary, our findings indicated for the first time that high temperature can induce a series of mechanisms to enhance infection abilities of T. asperellum to P. ostreatus mycelia and to cause Pleurotus green mold disease.	[Qiu, Zhiheng; Wu, Xiangli; Zhang, Jinxia; Huang, Chenyang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Qiu, Zhiheng; Wu, Xiangli; Zhang, Jinxia; Huang, Chenyang] Minist Agr, Key Lab Microbial Resources, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Huang, CY (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.; Huang, CY (corresponding author), Minist Agr, Key Lab Microbial Resources, Beijing, Peoples R China.	huangchenyang@caas.cn	Huang, Chenyang/A-4189-2013	Huang, Chenyang/0000-0002-1956-6229	National Basic Research Program of China [2014CB138303]; China Agriculture Research System [CARS20]	National Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System	This research was financially supported by the National Basic Research Program of China (2014CB138303) and China Agriculture Research System (CARS20).	Ait-Lahsen H, 2001, APPL ENVIRON MICROB, V67, P5833, DOI 10.1128/AEM.67.12.5833-5839.2001; Alan C, 1998, APPL ENVIRON MICROB, V64, P13; BARAK R, 1986, ARCH MICROBIOL, V144, P346, DOI 10.1007/BF00409883; Benitez T, 2004, INT MICROBIOL, V7, P249; Blaszczyk L, 2013, FOLIA MICROBIOL, V58, P325, DOI 10.1007/s12223-012-0214-6; Bonaterra A, 2005, FEMS MICROBIOL LETT, V250, P1, DOI 10.1016/j.femsle.2005.06.028; Lopes FAC, 2012, FUNGAL BIOL-UK, V116, P815, DOI 10.1016/j.funbio.2012.04.015; Carrillo L., 1998, Revista Argentina de Microbiologia, V30, P73; Daryaei A, 2016, BIOCONTROL SCI TECHN, V26, P189, DOI 10.1080/09583157.2015.1086312; Daryaei A, 2016, BIOCONTROL SCI TECHN, V26, P86, DOI 10.1080/09583157.2015.1077929; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Dubey SC, 2011, PEST MANAG SCI, V67, P1163, DOI 10.1002/ps.2168; Elad Y, 1996, EUR J PLANT PATHOL, V102, P719, DOI 10.1007/BF01877146; ELAD Y, 1983, J BACTERIOL, V154, P1431, DOI 10.1128/JB.154.3.1431-1435.1983; Geraldine AM, 2013, BIOL CONTROL, V67, P308, DOI 10.1016/j.biocontrol.2013.09.013; Gomes RC, 2001, J APPL MICROBIOL, V90, P653, DOI 10.1046/j.1365-2672.2001.01294.x; Guan GP, 2011, J BIOSCI BIOENG, V111, P641, DOI 10.1016/j.jbiosc.2011.02.009; Guigon-Lopez C, 2014, FUNGAL BIOL-UK, V118, P211, DOI 10.1016/j.funbio.2013.11.012; HALLSWORTH JE, 1995, MICROBIOL-SGM, V141, P1109, DOI 10.1099/13500872-141-5-1109; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hatvani L, 2007, PHYTOPATHOLOGY, V97, P532, DOI 10.1094/PHYTO-97-4-0532; Hatvani N, 2002, J APPL MICROBIOL, V92, P415, DOI 10.1046/j.1365-2672.2002.01542.x; Hoa HT, 2015, MYCOBIOLOGY, V43, P14, DOI 10.5941/MYCO.2015.43.1.14; Huang XQ, 2011, APPL MICROBIOL BIOT, V91, P741, DOI 10.1007/s00253-011-3259-6; In-YoungChoi, 2003, Mycobiology, V31, P139; In-YoungChoi, 2003, Mycobiology, V31, P74; INBAR J, 1994, MICROBIOL-SGM, V140, P651, DOI 10.1099/00221287-140-3-651; Kong WS., 2004, MUSHROOM GROWERS HDB; Kredics L, 2009, FEMS MICROBIOL LETT, V300, P58, DOI 10.1111/j.1574-6968.2009.01765.x; Lee YG, 2009, PROTEIN EXPRES PURIF, V65, P244, DOI 10.1016/j.pep.2008.12.004; Limon MC, 2004, APPL MICROBIOL BIOT, V64, P675, DOI 10.1007/s00253-003-1538-6; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montero-Barrientos M, 2011, APPL ENVIRON MICROB, V77, P3009, DOI 10.1128/AEM.02486-10; Oei P., 1991, CULTIVATION FERMENTE; Park Myung Soo, 2004, [华中农业大学学报, Journal of Huazhong Agricultural University], V23, P157; Samuels GJ, 1996, MYCOL RES, V100, P923, DOI 10.1016/S0953-7562(96)80043-8; SATAKE M, 1963, J BIOCHEM-TOKYO, V54, P8, DOI 10.1093/oxfordjournals.jbchem.a127750; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sobieralski K., 2012, Journal of Plant Protection Research, V52, P165, DOI 10.2478/v10045-012-0025-4; Ramada MHS, 2010, J MICROBIOL METH, V81, P6, DOI 10.1016/j.mimet.2010.01.010; Sterflinger K, 1998, ANTON LEEUW INT J G, V74, P271, DOI 10.1023/A:1001753131034; Tseng SC, 2008, J AGR FOOD CHEM, V56, P6914, DOI 10.1021/jf703626j; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; Woo S. L., 2004, ZHEJIANG DAXUE XUEBA, V30, P469; Yang HH, 2009, MYCOL RES, V113, P924, DOI 10.1016/j.mycres.2009.04.004; Zhang FG, 2014, FEMS MICROBIOL LETT, V359, P116, DOI 10.1111/1574-6968.12582; Zhang GQ, 2010, J BIOSCI BIOENG, V109, P20, DOI 10.1016/j.jbiosc.2009.06.022; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	48	19	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187055	10.1371/journal.pone.0187055	http://dx.doi.org/10.1371/journal.pone.0187055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073211	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400103
J	Liu, HF; Zong, QL; Lv, HX; Jin, J				Liu, Huanfang; Zong, Quanli; Lv, Hongxing; Jin, Jin			Analytical equation for outflow along the flow in a perforated fluid distribution pipe	PLOS ONE			English	Article							LATERAL DISCHARGE EQUATION; PLATE HEAT-EXCHANGERS; IRRIGATION LATERALS; PRESSURE-DROP; DESIGN; HYDRAULICS; ARRANGEMENT; MANIFOLDS; SYSTEMS	Perforated fluid distribution pipes have been widely used in agriculture, water supply and drainage, ventilation, the chemical industry, and other sectors. The momentum equation for variable mass flow with a variable exchange coefficient and variable friction coefficient was developed by using the momentum conservation method under the condition of a certain slope. The change laws of the variable momentum exchange coefficient and the variable resistance coefficient along the flow were analyzed, and the function of the momentum exchange coefficient was given. According to the velocity distribution of the power function, the momentum equation of variable mass flow was solved for different Reynolds numbers. The analytical solution contains components of pressure, gravity, friction and momentum and reflects the influence of various factors on the pressure distribution along the perforated pipe. The calculated results of the analytical solution were compared with the experimental values of the study by Jin et al. 1984 and Wang et al. 2001 with the mean errors 8.2%, 3.8% and 2.7%, and showed that the analytical solution of the variable mass momentum equation was qualitatively and quantitatively consistent with the experimental results.	[Liu, Huanfang; Zong, Quanli; Jin, Jin] Shihezi Univ, Coll Water Conservancy & Architectural Engn, Shihezi, Peoples R China; [Lv, Hongxing] Northwest Agr & Forestry Univ, Coll Water Resource & Architectural Engn, Yangling, Peoples R China	Shihezi University; Northwest A&F University - China	Zong, QL (corresponding author), Shihezi Univ, Coll Water Conservancy & Architectural Engn, Shihezi, Peoples R China.	quanli1871@126.com		Zong, Quanli/0000-0001-5525-3388	National Natural Science Foundation of China [11362019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 11362019).	ACRIVOS A, 1959, CHEM ENG SCI, V10, P112, DOI 10.1016/0009-2509(59)80030-0; Afrin T, 2016, J HYDRAUL ENG, V142, DOI 10.1061/(ASCE)HY.1943-7900.0001134; Afrin T, 2016, J HYDRAULIC ENG, V142; BASSIOUNY MK, 1984, CHEM ENG SCI, V39, P701, DOI 10.1016/0009-2509(84)80177-3; BASSIOUNY MK, 1984, CHEM ENG SCI, V39, P693, DOI 10.1016/0009-2509(84)80176-1; Clemo T, 2006, SPE PROD OPER, V21, P302, DOI 10.2118/89036-PA; HATHOOT HM, 1993, J IRRIG DRAIN ENG, V119, P756, DOI 10.1061/(ASCE)0733-9437(1993)119:5(756); HATHOOT HM, 1994, J IRRIG DRAIN ENG, V120, P534, DOI 10.1061/(ASCE)0733-9437(1994)120:3(534); Jain SK, 2002, J IRRIG DRAIN ENG, V128, P125, DOI 10.1061/(ASCE)0733-9437(2002)128:2(125); Jin Y, 1984, J CHEM IND ENG, V35, P203; KANG Y, 1995, T ASAE, V38, P1377, DOI 10.13031/2013.27961; Kang Y, 1996, T ASAE, V39, P921, DOI 10.13031/2013.27577; Liu H F, 2005, ADV FLUID MECH; [刘焕芳 Liu Huanfang], 2005, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V21, P46; Maynes D, 2013, CAVITATION INCEPTION, V135; Murphy P, 2014, J IRRIG DRAIN ENG, V140, DOI 10.1061/(ASCE)IR.1943-4774.0000740; Murphy P., 2013, THESIS; Myers L E, 1972, J IRRIGATION DRAINAG, V99, P403; Perold R. P., 1977, Journal of the Irrigation and Drainage Division, American Society of Civil Engineers, V103, P179; PEROLD RP, 1979, J IRR DRAIN DIV-ASCE, V105, P403; Ravikumar V, 2003, J IRRIG DRAIN ENG, V129, P295, DOI 10.1061/(ASCE)0733-9437(2003)129:4(295); SCALOPPI EJ, 1993, J IRRIG DRAIN ENG, V119, P91, DOI 10.1061/(ASCE)0733-9437(1993)119:1(91); SHEN PI, 1992, J FLUID ENG-T ASME, V114, P121, DOI 10.1115/1.2909987; Vallesquino P, 2001, J IRRIG DRAIN ENG, V127, P254, DOI 10.1061/(ASCE)0733-9437(2001)127:4(254); Wang J Y, 1999, J HYDRODYNAMICS, V14, P34; Wang JY, 2001, CHEM ENG J, V84, P1, DOI 10.1016/S1385-8947(00)00263-1; Wang JY, 1995, PROCEEDINGS OF CSPE-JSME-ASME INTERNATIONAL CONFERENCE ON POWER ENGINEERING-95 (ICOPE-95), VOLS 1 AND 2, P754; WARRICK AW, 1988, J IRRIG DRAIN ENG, V114, P281, DOI 10.1061/(ASCE)0733-9437(1988)114:2(281); Wu I. P., 1973, J IRRIGATION DRAINAG, V99, P157; Yildirim G, 2004, J IRRIG DRAIN ENG, V130, P201, DOI 10.1061/(ASCE)0733-9437(2004)130:3(201); YITAYEW M, 1988, J IRRIG DRAIN ENG, V114, P289, DOI 10.1061/(ASCE)0733-9437(1988)114:2(289)	31	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0185842	10.1371/journal.pone.0185842	http://dx.doi.org/10.1371/journal.pone.0185842			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065112	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900007
J	Royo-Cebrecos, C; Gudiol, C; Ardanuy, C; Pomares, H; Calvo, M; Carratala, J				Royo-Cebrecos, Cristina; Gudiol, Carlota; Ardanuy, Carmen; Pomares, Helena; Calvo, Mariona; Carratala, Jordi			A fresh look at polymicrobial bloodstream infection in cancer patients	PLOS ONE			English	Article							ESCHERICHIA-COLI; RISK-FACTORS; HEMATOLOGICAL MALIGNANCIES; VANCOMYCIN-RESISTANT; CLINICAL-FEATURES; SOLID TUMORS; BACTEREMIA; SPECTRUM; EPIDEMIOLOGY; OUTCOMES	Objectives To assess the current incidence, clinical features, risk factors, aetiology, antimicrobial resistance and outcomes of polymicrobial bloodstream infection (PBSI) in patients with cancer. Methods All prospectively collected episodes of PBSI in hospitalised patients were compared with episodes of monomicrobial bloodstream infection (MBSI) between 2006 and 2015. Results We identified 194 (10.2%) episodes of PBSI and 1702 MBSI (89.8%). The presence of cholangitis, biliary stenting, neutropenia, corticosteroids, neutropenic enterocolitis and other abdominal infections were identified as risk factors for PBSI. Overall, Gram-negative organisms were the most frequent aetiology, but Enterococcus spp. were especially frequent causes of Gram-positive PBSI (30.8%). Multidrug-resistant (MDR) organisms were more commonly found in PBSI than in MBSI (20.6% vs 12.9%; p = 0.003). Compared to patients with MBSI, those with PBSI presented with higher early (15% vs 1.4%; p = 0.04) and overall (32% vs 20.9%; p<0.001) case-fatality rates. Risk factors for overall case-fatality were a high-risk MASCC (Multinational Association of Supportive Care in Cancer) index score, corticosteroid use, persistent bacteraemia and septic shock. Conclusions PBSI is a frequent complication in patients with cancer and is responsible for high mortality rates. Physicians should identify patients at risk for PBSI and provide empiric antibiotic therapy that covers the most frequent pathogens involved in these infections, including MDR strains.	[Royo-Cebrecos, Cristina; Gudiol, Carlota; Carratala, Jordi] Univ Barcelona, Hosp Univ Bellvitge, IDIBELL Inst Invest Biomed Bellvitge, Dept Infect Dis, Barcelona, Spain; [Royo-Cebrecos, Cristina; Gudiol, Carlota; Carratala, Jordi] ISCIII, REIPI Spanish Network Res Infect Dis, Madrid, Spain; [Ardanuy, Carmen] Univ Barcelona, IDIBELL Inst Invest Biomed Bellvitge, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain; [Ardanuy, Carmen] ISCIII, CIBERes CIBER Enfermedades Resp, Madrid, Spain; [Pomares, Helena] Univ Barcelona, Inst Catala Oncol, Dept Hematol, Barcelona, Spain; [Calvo, Mariona] Univ Barcelona, Dept Oncol, Inst Catala Oncol, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Catalan Institute of Oncology; University of Barcelona; Catalan Institute of Oncology; University of Barcelona	Gudiol, C (corresponding author), Univ Barcelona, Hosp Univ Bellvitge, IDIBELL Inst Invest Biomed Bellvitge, Dept Infect Dis, Barcelona, Spain.; Gudiol, C (corresponding author), ISCIII, REIPI Spanish Network Res Infect Dis, Madrid, Spain.	cgudiol@iconcologia.net	Carratala, Jordi/AAC-2639-2020; Royo-Cebrecos, Cristina/GOV-2985-2022; Ardanuy, Carmen/C-4463-2015; Carratalà, Jordi/B-8410-2011	Carratala, Jordi/0000-0003-3209-2563; Royo-Cebrecos, Cristina/0000-0003-2554-4656; Carratalà, Jordi/0000-0003-3209-2563; Gudiol, Carlota/0000-0003-3095-4422	REIPI (Spanish Network for Research in Infectious Diseases); CIBERes (CIBER de Enfermedades Respiratorias), ISCIII, Madrid, Spain	REIPI (Spanish Network for Research in Infectious Diseases); CIBERes (CIBER de Enfermedades Respiratorias), ISCIII, Madrid, Spain	This study was supported by REIPI (Spanish Network for Research in Infectious Diseases) and CIBERes (CIBER de Enfermedades Respiratorias), ISCIII, Madrid, Spain.	[Anonymous], 2015, CLIN MICROBIOL INFEC, V21, P583; BODEY GP, 1965, ARCH INTERN MED, V116, P266, DOI 10.1001/archinte.1965.03870020106019; CLSI, 2019, PERFORMANCE STANDARD, V28th edn; Cooper GS, 1990, MEDICINE, V69, P23; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909; Elting LS, 1986, MEDICINE, V65, P25; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gomez L, 1998, CLIN INFECT DIS, V27, P695, DOI 10.1086/514946; Gudiol C, 2013, CLIN MICROBIOL INFEC, V19, P474, DOI 10.1111/j.1469-0691.2012.03879.x; Gudiol C, 2011, J ANTIMICROB CHEMOTH, V66, P657, DOI 10.1093/jac/dkq494; Gudiol C, 2016, VIRULENCE, V7, P298, DOI 10.1080/21505594.2016.1141161; Gudiol C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074734; Gudiol C, 2010, J ANTIMICROB CHEMOTH, V65, P333, DOI 10.1093/jac/dkp411; Ha YE, 2013, INT J ANTIMICROB AG, V42, P403, DOI 10.1016/j.ijantimicag.2013.07.018; HAUG JB, 1994, CLIN INFECT DIS, V19, P246, DOI 10.1093/clinids/19.2.246; HERMANS PE, 1970, ANN INTERN MED, V73, P387, DOI 10.7326/0003-4819-73-3-387; Horasan ES, 2011, MED SCI MONITOR, V17, pCR304, DOI 10.12659/MSM.881773; Kamboj M, 2010, BIOL BLOOD MARROW TR, V16, P1576, DOI 10.1016/j.bbmt.2010.05.008; KIANI D, 1979, JAMA-J AM MED ASSOC, V242, P1044, DOI 10.1001/jama.242.10.1044; Kim SH, 2013, ANN HEMATOL, V92, P533, DOI 10.1007/s00277-012-1631-y; Klastersky J, 2007, INT J ANTIMICROB AG, V30, pS51, DOI 10.1016/j.ijantimicag.2007.06.012; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mikulska M, 2014, J INFECTION, V68, P321, DOI 10.1016/j.jinf.2013.12.006; Montassier E, 2013, EUR J CLIN MICROBIOL, V32, P841, DOI 10.1007/s10096-013-1819-7; NOSKIN GA, 1995, CLIN INFECT DIS, V20, P296, DOI 10.1093/clinids/20.2.296; Reuben AG, 1989, REV INFECT DIS, V11, P83; Rolston KVI, 2007, CLIN INFECT DIS, V45, P228, DOI 10.1086/518873; ROSELLE GA, 1979, JAMA-J AM MED ASSOC, V242, P2411; Royo-Cebrecos C, 2017, J INFECTION, V74, P172, DOI 10.1016/j.jinf.2016.10.008; Satlin MJ, 2016, J INFECTION, V73, P336, DOI 10.1016/j.jinf.2016.07.002; Trecarichi EM, 2009, J INFECTION, V58, P299, DOI 10.1016/j.jinf.2009.02.002; Trifilio S, 2015, TRANSPL INFECT DIS, V17, P267, DOI 10.1111/tid.12363; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339	36	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0185768	10.1371/journal.pone.0185768	http://dx.doi.org/10.1371/journal.pone.0185768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065118	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900006
J	Abdel-Latif, MA; El-Far, AH; Elbestawy, AR; Ghanem, R; Mousa, SA; Abd El-Hamid, HS				Abdel-Latif, Mervat A.; El-Far, Ali H.; Elbestawy, Ahmed R.; Ghanem, Rania; Mousa, Shaker A.; Abd El-Hamid, Hatem S.			Exogenous dietary lysozyme improves the growth performance and gut microbiota in broiler chickens targeting the antioxidant and non-specific immunity mRNA expression	PLOS ONE			English	Article							INTESTINAL MORPHOLOGY; NECROTIC ENTERITIS; OXIDATIVE STATUS; ANTIBIOTICS; STABILITY; ENZYMES; HEALTH; MILK	Supplementation of exogenous enzymes in chickens has been widely practiced, yet mechanisms responsible are not fully delineated. To investigate the effects of the dietary lysozyme on the growth performance and immunity of broiler chickens, a total of 120 one-day-old Ross 308 chicks were randomly allocated into four groups, each having three replicates (30 birds/group). The chicks were fed the starter (1-21 d) and grower (22-35 d) diets supplemented with 0 (control), 70 (LYZ70), 90 (LYZ90) and 120 (LYZ120) g of lysozyme 10%(R) per ton of basal diet for five weeks. The results revealed significant improvement in the growth performance and gut environment. There were significant decreases (P < 0.05 or 0.01) in the harmful fecal Coliform and Clostridia and an increase (P < 0.05) in the beneficial Lactobacillus in the lysozyme-supplemented groups, especially in LYZ90. Moreover, the mRNA expressions of Cu, Zn-superoxide dismutase (SOD1), glutathione peroxidase (GSH-Px), interferon-gamma (IFN-gamma.), interleukin-10 (IL-10), and interleukin-18 (IL-18) were upregulated in response to lysozyme supplementation. In comparison to control, LYZ90 fed birds had a significant increase (P < 0.01) in the GSH-Px gene expression that enhances the antioxidant status of the gut. Expression of the biomarkers involved in the gut non-specific immunity indicated significant increases in the mRNA expression of INF-gamma. (P < 0.001), IL-10 (P < 0.001), and IL-18 (P < 0.05) in LYZ90 group. Also, serum globulin levels were significantly elevated (P < 0.05) in lysozyme-supplemented groups. Histologically, the intestinal villi length and crypts depth were also enhanced (P < 0.05) by dietary lysozyme supplementation. In conclusion, supplementation of broiler chickens with exogenous lysozyme, especially at 90 g of lysozyme per ton of basal diet dose rate, improved the growth performance, gut antioxidant status, and nonspecific immunity of broiler chickens.	[Abdel-Latif, Mervat A.] Damanhour Univ, Fac Vet Med, Dept Nutr & Vet Clin Nutr, Damanhour, Albeheira, Egypt; [El-Far, Ali H.] Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour, Albeheira, Egypt; [Elbestawy, Ahmed R.; Abd El-Hamid, Hatem S.] Damanhour Univ, Fac Vet Med, Dept Poultry Dis, Damanhour, Albeheira, Egypt; [Ghanem, Rania] Anim Hlth Res Inst, Mansoura Lab, Mansoura, Egypt; [Mousa, Shaker A.] Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, Albany, NY USA	Egyptian Knowledge Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB); Damanhour University; Animal Health Research Institute (AHRI); Albany College of Pharmacy & Health Sciences	El-Far, AH (corresponding author), Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour, Albeheira, Egypt.	ali.elfar@damanhour.edu.eg	Abdel-Latif, Mervat A./AAC-5685-2019; Elbestawy, Ahmed/J-3110-2018; El-Far, Prof Dr/Ali H./L-7946-2017; Abdel-Latif, Mervat/ABG-8943-2021; Mousa, Shaker A/A-7151-2017	Elbestawy, Ahmed/0000-0002-1272-153X; El-Far, Prof Dr/Ali H./0000-0001-9721-4360; Abdel-Latif, Mervat/0000-0002-7996-0121; Mousa, Shaker A/0000-0002-9294-015X				Akbarian A, 2014, POULTRY SCI, V93, P1930, DOI 10.3382/ps.2014-03896; AOAC, 1990, OFFICIAL METHODS ANA; Bai WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167339; Bancroft John D, 2013, THEORY PRACTICE HIST, P173, DOI 10.1016/ B978-0-7020-4226-3.00010-X; BRUGH M, 1978, AVIAN DIS, V22, P362, DOI 10.2307/1589552; Brundige DR, 2008, J NUTR, V138, P921, DOI 10.1093/jn/138.5.921; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Chen Y, 2014, AQUACULT NUTR, V20, P229, DOI 10.1111/anu.12069; Coles E.H., 1986, VET CLIN PATH; Cowieson AJ, 2005, POULTRY SCI, V84, P1860, DOI 10.1093/ps/84.12.1860; Edens F, 2003, FUNDAC APINCO CIENCI, V5, P75; FAD, 2011, BACT AN MAN EN ESCH; FDA, 2001, BACT AN MAN CLOSTR P; FRITZ JM, 2009, AM J RESP CRIT CARE, V179; Guo FC, 2004, BRIT POULTRY SCI, V45, P793, DOI 10.1080/00071660400012741; Hofacre CL, 2003, J APPL POULTRY RES, V12, P60, DOI 10.1093/japr/12.1.60; Humphrey BD, 2002, J NUTR, V132, P1214, DOI 10.1093/jn/132.6.1214; IBRAHIM HR, 1994, J BIOL CHEM, V269, P5059; Ivanovska N, 1996, INT J IMMUNOPHARMACO, V18, P515, DOI 10.1016/S0192-0561(96)00048-3; Jimenez-Saiz R, 2011, FOOD CHEM, V127, P1719, DOI 10.1016/j.foodchem.2011.02.047; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lalles JP, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0123-7; Liu D, 2010, AVIAN PATHOL, V39, P17, DOI 10.1080/03079450903447404; Long YR, 2016, ANIM SCI J, V87, P411, DOI 10.1111/asj.12444; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Maga EA, 2006, TRANSGENIC RES, V15, P515, DOI 10.1007/s11248-006-0014-3; Mine Y, 2004, J AGR FOOD CHEM, V52, P1088, DOI 10.1021/jf0345752; NRC, 1994, NUTR REQ POULTR; Oliveira L, 2014, LIVEST SCI, V167, P227, DOI 10.1016/j.livsci.2014.05.013; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Ravindran V, 2013, J APPL POULTRY RES, V22, P628, DOI 10.3382/japr.2013-00739; ROGOSA M, 1951, J BACTERIOL, V62, P132, DOI 10.1128/JB.62.1.132-133.1951; Sava G, 1996, EXS, V75, P433; Schiffrin EJ, 2002, EUR J CLIN NUTR, V56, pS60, DOI 10.1038/sj.ejcn.1601489; Siwicki AK, 1998, VET IMMUNOL IMMUNOP, V61, P369, DOI 10.1016/S0165-2427(97)00140-2; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; TAKATSY G, 1955, Acta Microbiol Acad Sci Hung, V3, P191; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; van de Crommenacker J, 2010, J EXP BIOL, V213, P3527, DOI 10.1242/jeb.045591; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang G, 2006, LETT APPL MICROBIOL, V42, P138, DOI 10.1111/j.1472-765X.2005.01812.x; Zhang GP, 2010, AVIAN DIS, V54, P1298, DOI 10.1637/9370-041410-ResNote.1	46	30	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0185153	10.1371/journal.pone.0185153	http://dx.doi.org/10.1371/journal.pone.0185153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059196	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000005
J	Krichene, H; Chakraborty, A; Inoue, H; Fujiwara, Y				Krichene, Hazem; Chakraborty, Abhijit; Inoue, Hiroyasu; Fujiwara, Yoshi			Business cycles' correlation and systemic risk of the Japanese supplier-customer network	PLOS ONE			English	Article							GROWTH DYNAMICS; SYNCHRONIZATION; ORIGINS	This work aims to study and explain the business cycle correlations of the Japanese production network. We consider the supplier-customer network, which is a directed network representing the trading links between Japanese firms (links from suppliers to customers). The community structure of this network is determined by applying the Infomap algorithm. Each community is defined by its GDP and its associated business cycle. Business cycle correlations between communities are estimated based on copula theory. Then, based on firms' attributes and network topology, these correlations are explained through linear econometric models. The results show strong evidence of business cycle correlations in the Japanese production network. A significant systemic risk is found for high negative or positive shocks. These correlations are explained mainly by the sector and by geographic similarities. Moreover, our results highlight the higher vulnerability of small communities and small firms, which is explained by the disassortative mixing of the production network.	[Krichene, Hazem; Chakraborty, Abhijit; Inoue, Hiroyasu; Fujiwara, Yoshi] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo, Japan	University of Hyogo	Krichene, H (corresponding author), Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo, Japan.	krichene.hazem@gmail.com	Chakraborty, Abhijit/GLN-5371-2022; Chakraborty, Abhijit/AAJ-4443-2021	Chakraborty, Abhijit/0000-0001-5866-1985; 	MEXT; Grants-in-Aid for Scientific Research [15K01217] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by MEXT as "Exploratory Challenges on Post-K computer (Studies of Multi-level Spatiotemporal Simulation of Socioeconomic Phenomena)."; This research was supported by MEXT as "Exploratory Challenges on Post-K Computer (Studies of Multi-level Spatiotemporal Simulation of Socioeconomic Phenomena)".	Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; Aguiar-Conraria L, 2017, BE J MACROECON, V17, P1935; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Artis M, 2009, TECHNICAL REPORT; Bosworth B., 2015, TECHNICAL REPORT; Brechmann EC, 2013, J STAT SOFTW, V52; Castaldi C, 2009, EMPIR ECON, V37, P475, DOI 10.1007/s00181-008-0242-x; Cerra V, 2008, AM ECON REV, V98, P439, DOI 10.1257/aer.98.1.439; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Dai Y., 2014, TECHNICAL REPORT; Duenas M, 2012, WORKING PAPER; Dufrenot G, 2014, ECON MODEL, V42, P186, DOI 10.1016/j.econmod.2014.07.001; Frankel JA, 1998, ECON J, V108, P1009, DOI 10.1111/1468-0297.00327; Gabaix X, 2011, ECONOMETRICA, V79, P733, DOI 10.3982/ECTA8769; Genest C, 2007, J HYDROL ENG, V12, P347, DOI 10.1061/(ASCE)1084-0699(2007)12:4(347); Gruben W, 2002, WORKING PAPER; Hodrick RJ, 1997, J MONEY CREDIT BANK, V29, P1, DOI 10.2307/2953682; Hummels D, 1995, Q J ECON, V110, P797; Ikeda Y, 2013, EVOL INST ECON REV, V10, P315, DOI 10.14441/eier.A2013016; Imbs J, 2004, REV ECON STAT, V86, P723, DOI 10.1162/0034653041811707; Joe H., 1996, TECHNICAL REPORT; Karadimitropoulou A, 2013, J ECON DYN CONTROL, V37, P2913, DOI 10.1016/j.jedc.2013.09.002; Lee YK, 1998, PHYS REV LETT, V81, P3275, DOI 10.1103/PhysRevLett.81.3275; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Magrini S, 2013, BE J MACROECON, V13, DOI 10.1515/bejm-2012-0018; Mizuno T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100712; Morrison AD, 2011, OXFORD REV ECON POL, V27, P498, DOI 10.1093/oxrep/grr020; Panzera F., 2011, INT J TRADE GLOBAL M, V4, P311, DOI DOI 10.1504/IJTGM.2011.041764; Papell DH, 2012, BE J MACROECON, V12, DOI 10.1515/1935-1690.101; Reinhart CM, 2009, THIS TIME IS DIFFERENT: EIGHT CENTURIES OF FINANCIAL FOLLY, P1; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Solow RM, 1996, Q J ECON, V70, P65	32	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186467	10.1371/journal.pone.0186467	http://dx.doi.org/10.1371/journal.pone.0186467			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK3RE	29059233	gold, Green Published, Green Submitted			2022-12-26	WOS:000413403000024
J	Pachanski, MJ; Kirkland, ME; Kosinski, DT; Mane, J; Cheewatrakoolpong, B; Xue, JY; Szeto, D; Forrest, G; Miller, C; Bunzel, M; Plummer, CW; Chobanian, HR; Miller, MW; Souza, S; Thomas-Fowlkes, BS; Ogawa, AM; Weinglass, AB; Di Salvo, J; Li, XY; Feng, Y; Tatosian, DA; Howard, AD; Colletti, SL; Trujillo, ME				Pachanski, Michele J.; Kirkland, Melissa E.; Kosinski, Daniel T.; Mane, Joel; Cheewatrakoolpong, Boonlert; Xue, Jiyan; Szeto, Daphne; Forrest, Gail; Miller, Corin; Bunzel, Michelle; Plummer, Christopher W.; Chobanian, Harry R.; Miller, Michael W.; Souza, Sarah; Thomas-Fowlkes, Brande S.; Ogawa, Aimie M.; Weinglass, Adam B.; Di Salvo, Jerry; Li, Xiaoyan; Feng, Yue; Tatosian, Daniel A.; Howard, Andrew D.; Colletti, Steven L.; Trujillo, Maria E.			GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodent	PLOS ONE			English	Article							FATTY-ACID RECEPTOR; INSULIN-SECRETION; RAT PANCREAS; GLUCAGON; ISLETS; IDENTIFICATION; ACTIVATION; REDUCTION; RELEASE; CELLS	GPR40 agonists are effective antidiabetic agents believed to lower glucose through direct effects on the beta cell to increase glucose stimulated insulin secretion. However, not all GPR40 agonists are the same. Partial agonists lower glucose through direct effects on the pancreas, whereas GPR40 AgoPAMs may incorporate additional therapeutic effects through increases in insulinotrophic incretins secreted by the gut. Here we describe how GPR40 AgoPAMs stimulate both insulin and incretin secretion in vivo over time in diabetic GK rats. We also describe effects of AgoPAMs in vivo to lower glucose and body weight beyond what is seen with partial GPR40 agonists in both the acute and chronic setting. Further comparisons of the glucose lowering profile of AgoPAMs suggest these compounds may possess greater glucose control even in the presence of elevated glucagon secretion, an unexpected feature observed with both acute and chronic treatment with AgoPAMs. Together these studies highlight the complexity of GPR40 pharmacology and the potential additional benefits AgoPAMs may possess above partial agonists for the diabetic patient.	[Pachanski, Michele J.; Kirkland, Melissa E.; Kosinski, Daniel T.; Mane, Joel; Cheewatrakoolpong, Boonlert; Xue, Jiyan; Szeto, Daphne; Forrest, Gail; Souza, Sarah; Thomas-Fowlkes, Brande S.; Ogawa, Aimie M.; Weinglass, Adam B.; Di Salvo, Jerry; Trujillo, Maria E.] Merck & Co Inc, Vivo Pharmacol, Kenilworth, NJ 07033 USA; [Miller, Corin; Bunzel, Michelle] Merck & Co Inc, Translat Imaging Biomarkers, Kenilworth, NJ USA; [Plummer, Christopher W.; Chobanian, Harry R.; Miller, Michael W.; Colletti, Steven L.] Merck & Co Inc, Dept Med Chem, Kenilworth, NJ USA; [Li, Xiaoyan; Feng, Yue; Howard, Andrew D.] Merck & Co Inc, Dept Cardio Metab Dis, Kenilworth, NJ USA; [Tatosian, Daniel A.] Merck & Co Inc, Pharmacokinet Pharmacodynam & Drug Metab, Kenilworth, NJ USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Trujillo, ME (corresponding author), Merck & Co Inc, Vivo Pharmacol, Kenilworth, NJ 07033 USA.	maria_trujillo@merck.com	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022		Merck and Co Inc.	Merck and Co Inc.(Merck & Company)	The funder Merck and Co Inc. provided support in the form of salaries for all authors, study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Brockunier L. L., 2014, [No title captured], Patent No. [WO 2014130608 A1, 2014130608, WO 2014130608]; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Day JW, 2012, BIOPOLYMERS, V98, P443, DOI 10.1002/bip.22072; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; GERICH JE, 1974, J CLIN INVEST, V54, P833, DOI 10.1172/JCI107823; Gorski JN, 2017, AM J PHYSL ENDOCRINO; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; Holst JJ, 2011, DIABETES OBES METAB, V13, P89, DOI 10.1111/j.1463-1326.2011.01452.x; Hyde AM, 2016, ORG LETT, V18, P5888, DOI 10.1021/acs.orglett.6b02910; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Lee AYH, 2016, CLIN CHEM, V62, P227, DOI 10.1373/clinchem.2015.244251; Li XY, 2013, J PHARMACOL EXP THER, V344, P407, DOI 10.1124/jpet.112.199083; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Luo J, 2013, METABOLISM, V62, P90, DOI 10.1016/j.metabol.2012.07.010; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046300; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Plummer CW, 2017, ACS MED CHEM LETT, V8, P221, DOI 10.1021/acsmedchemlett.6b00443; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Wang S-P, 2016, AM J PHYSL ENDOCRINO; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280	28	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186033	10.1371/journal.pone.0186033	http://dx.doi.org/10.1371/journal.pone.0186033			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053717	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100008
J	Dang, P; Yu, X; Le, H; Liu, JL; Shen, Z; Zhao, Z				Dang, Peng; Yu, Xuan; Le, Hien; Liu, Jinliang; Shen, Zhen; Zhao, Zhong			Effects of stand age and soil properties on soil bacterial and fungal community composition in Chinese pine plantations on the Loess Plateau	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ECTOMYCORRHIZAL FUNGI; SECONDARY SUCCESSION; SPECIES COMPOSITION; SEASONAL DYNAMICS; FOREST ECOSYSTEM; ORGANIC-CARBON; PONDEROSA PINE; NITROGEN; DIVERSITY	The effects of Chinese pine (Pinus tabuliformis) on soil variables after afforestation have been established, but microbial community changes still need to be explored. Using high-throughput sequencing technology, we analyzed bacterial and fungal community composition and diversity in soils from three stands of different-aged, designated 12-year-old (PF1), 29-year-old (PF2), and 53-year-old (PF3), on a Chinese pine plantation and from a natural secondary forest (NSF) stand that was almost 80 years old. Abandoned farmland (BL) was also analyzed. Shannon index values of both bacterial and fungal community in PF1 were greater than those in PF2, PF3 and NSF. Proteobacteria had the lowest abundance in BL, and the abundance increased with stand age. The abundance of Actinobacteria was greater in BL and PF1 soils than those in other sites. Among fungal communities, the dominant taxa were Ascomycota in BL and PF1 and Basidiomycota in PF2, PF3 and NSF, which reflected the successional patterns of fungal communities during the development of Chinese pine plantations. Therefore, the diversity and dominant taxa of soil microbial community in stands 12 and 29 years of age appear to have undergone significant changes; afterward, the soil microbial community achieved a relatively stable state. Furthermore, the abundances of the most dominant bacterial and fungal communities correlated significantly with organic C, total N, C:N, available N, and available P, indicating the dependence of these microbes on soil nutrients. Overall, our findings suggest that the large changes in the soil microbial community structure of Chinese pine plantation forests may be attributed to the phyla present (e.g., Proteobacteria, Actinobacteria, Ascomycota and Basidiomycota) which were affected by soil carbon and nutrients in the Loess Plateau.	[Dang, Peng; Yu, Xuan; Le, Hien; Liu, Jinliang; Shen, Zhen; Zhao, Zhong] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China; [Dang, Peng; Zhao, Zhong] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhao, Z (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.; Zhao, Z (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	zhaozhlunwen2010@126.com			Forestry Science and Technology Support Plan, Researches and Demonstration of the Key Technology for Plantation Sustainable Management in the Loess Plateau [2012BAD2260302]	Forestry Science and Technology Support Plan, Researches and Demonstration of the Key Technology for Plantation Sustainable Management in the Loess Plateau	This work was financially supported by the Research Special Topic under the auspices of the Forestry Science and Technology Support Plan, Researches and Demonstration of the Key Technology for Plantation Sustainable Management in the Loess Plateau (grant no. 2012BAD22B0302, http//www.most.gov.cn).	Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P1770, DOI 10.1016/j.soilbio.2007.02.006; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; Bastian F, 2009, SOIL BIOL BIOCHEM, V41, P262, DOI 10.1016/j.soilbio.2008.10.024; Bell TH, 2013, ISME J, V7, P1200, DOI 10.1038/ismej.2013.1; Bjork RG, 2008, SOIL BIOL BIOCHEM, V40, P266, DOI 10.1016/j.soilbio.2007.07.017; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Cao YS, 2010, EUR J SOIL BIOL, V46, P128, DOI 10.1016/j.ejsobi.2009.12.006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290; Chen TH, 2005, PEDOBIOLOGIA, V49, P645, DOI 10.1016/j.pedobi.2005.06.005; Cheng JM, 2016, ECOL ENG, V97, P170, DOI 10.1016/j.ecoleng.2016.09.003; Dennis KL, 2013, CANCER RES, V73, P5905, DOI 10.1158/0008-5472.CAN-13-1511; Devi NB, 2006, APPL SOIL ECOL, V31, P220, DOI 10.1016/j.apsoil.2005.05.005; Dini-Andreote F, 2014, ISME J, V8, P1989, DOI 10.1038/ismej.2014.54; Dove NC, 2015, FUNGAL ECOL, V13, P181, DOI 10.1016/j.funeco.2014.09.009; Durall DM, 2006, CAN J BOT, V84, P966, DOI 10.1139/B06-045; Durrer A, 2016, APPL SOIL ECOL; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elhottova D, 2002, FOLIA MICROBIOL, V47, P435, DOI 10.1007/BF02818704; Emteryd O., 1989, CHEM PHYS ANAL INORG; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Griffiths BS, 1999, SOIL BIOL BIOCHEM, V31, P145, DOI 10.1016/S0038-0717(98)00117-5; Hamamura N, 2006, APPL ENVIRON MICROB, V72, P6316, DOI 10.1128/AEM.01015-06; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Huttl RF, 2001, NATURWISSENSCHAFTEN, V88, P322, DOI 10.1007/s001140100241; Jia GM, 2010, PEDOSPHERE, V20, P352, DOI 10.1016/S1002-0160(10)60024-0; Jones MD, 2003, NEW PHYTOL, V157, P399, DOI 10.1046/j.1469-8137.2003.00698.x; Kasel S, 2008, SOIL BIOL BIOCHEM, V40, P1724, DOI 10.1016/j.soilbio.2008.02.011; Keith AM, 2009, SOIL BIOL BIOCHEM, V41, P1060, DOI 10.1016/j.soilbio.2009.02.009; KEIZER PJ, 1994, MYCORRHIZA, V4, P147, DOI 10.1007/BF00203533; Kuramae EE, 2010, ISME J, V4, P711, DOI 10.1038/ismej.2010.11; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Li H, 2013, ACTA PHYSIOL PLANT, V35, P2951, DOI 10.1007/s11738-013-1326-6; Macdonald CA, 2009, SOIL BIOL BIOCHEM, V41, P1642, DOI 10.1016/j.soilbio.2009.05.003; Malchair S, 2009, SOIL BIOL BIOCHEM, V41, P831, DOI 10.1016/j.soilbio.2009.02.004; Mitchell RJ, 2012, PLANT SOIL, V352, P65, DOI 10.1007/s11104-011-0980-y; Mummey DL, 2002, SOIL BIOL BIOCHEM, V34, P1717, DOI 10.1016/S0038-0717(02)00158-X; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Overby ST, 2015, APPL SOIL ECOL, V93, P1, DOI 10.1016/j.apsoil.2015.03.012; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Peralta RM, 2013, SCI TOTAL ENVIRON, V443, P725, DOI 10.1016/j.scitotenv.2012.11.052; Quatrini P, 2008, J APPL MICROBIOL, V104, P251; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ren CJ, 2016, FOREST ECOL MANAG, V376, P59, DOI 10.1016/j.foreco.2016.06.004; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rojas C, 2016, APPL SOIL ECOL, V105, P57, DOI 10.1016/j.apsoil.2016.03.012; Ros M, 2006, SOIL USE MANAGE, V22, P209, DOI 10.1111/j.1475-2743.2006.00027.x; Saetre P, 2000, SOIL BIOL BIOCHEM, V32, P909, DOI 10.1016/S0038-0717(99)00215-1; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Tian W, 2015, AGR ECOSYST ENVIRON, V213, P219, DOI 10.1016/j.agee.2015.08.009; Toljander JF, 2006, NEW PHYTOL, V170, P873, DOI 10.1111/j.1469-8137.2006.01718.x; Tonon G, 2005, BIOL FERT SOILS, V41, P101, DOI 10.1007/s00374-004-0813-8; VANBREEMEN N, 1988, ENVIRON POLLUT, V54, P249, DOI 10.1016/0269-7491(88)90115-7; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Weber CF, 2014, SOIL BIOL BIOCHEM, V69, P242, DOI 10.1016/j.soilbio.2013.11.010; Wen L, 2014, FOREST ECOL MANAG, V328, P150, DOI 10.1016/j.foreco.2014.05.037; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yao MJ, 2014, SOIL BIOL BIOCHEM, V79, P81, DOI 10.1016/j.soilbio.2014.09.009; Yelle DJ, 2008, ENVIRON MICROBIOL, V10, P1844, DOI 10.1111/j.1462-2920.2008.01605.x; Yin K, 2016, SCI REPORTS, P6; Yu HX, 2013, SCI WORLD J, DOI 10.1155/2013/606480; Yuan BC, 2012, PEDOSPHERE, V22, P1, DOI 10.1016/S1002-0160(11)60186-0; Yuan YL, 2014, FEMS MICROBIOL ECOL, V87, P121, DOI 10.1111/1574-6941.12197; Zhang C, 2016, SOIL BIOL BIOCHEM, V97, P40, DOI 10.1016/j.soilbio.2016.02.013; Zhang C, 2015, ECOL ENG, V75, P161, DOI 10.1016/j.ecoleng.2014.11.059; Zhang HQ, 2010, PLANT SOIL, V326, P415, DOI 10.1007/s11104-009-0022-1; Zhang JT, 2005, J ARID ENVIRON, V63, P458, DOI 10.1016/j.jaridenv.2005.03.027; Zhang YN, 2013, ECOL ENG, V52, P308, DOI 10.1016/j.ecoleng.2012.10.002; Zheng JF, 2017, APPL SOIL ECOL, V111, P94, DOI 10.1016/j.apsoil.2016.11.017; Zhu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054221, 10.1371/journal.pone.0071727]	79	40	42	19	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186501	10.1371/journal.pone.0186501	http://dx.doi.org/10.1371/journal.pone.0186501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049349	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900074
J	Wu, D				Wu, Di			Dynamic water patterns change the stability of the collapsed filter conformation of the KcsA K+ channel	PLOS ONE			English	Article							C-TYPE INACTIVATION; MOLECULAR-DYNAMICS; SELECTIVITY FILTER; STRUCTURAL BASIS; QUANTITATIVE DESCRIPTION; POTASSIUM CHANNELS; INTERNAL CAVITIES; ION SELECTIVITY; BURIED WATERS; SIMULATIONS	The selectivity filter of the KcsA K+ channel has two typical conformations-the conductive and the collapsed conformations, respectively. The transition from the conductive to the collapsed filter conformation can represent the process of inactivation that depends on many environmental factors. Water molecules permeating behind the filter can influence the collapsed filter stability. Here we perform the molecular dynamics simulations to study the stability of the collapsed filter of the KcsA K+ channel under the different water patterns. We find that the water patterns are dynamic behind the collapsed filter and the filter stability increases with the increasing number of water molecules. In addition, the stability increases significantly when water molecules distribute uniformly behind the four monomeric filter chains, and the stability is compromised if water molecules only cluster behind one or two adjacent filter chains. The altered filter stabilities thus suggest that the collapsed filter can inactivate gradually under the dynamic water patterns. We also demonstrate how the different water patterns affect the filter recovery from the collapsed conformation.	[Wu, Di] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai, Peoples R China	Fudan University	Wu, D (corresponding author), Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai, Peoples R China.	diwu@fudan.edu.cn			Natural Science Foundation of China [21003023]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (http://www.nsfc.gov.cn), Grant No. 21003023. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2002, BIOPHYS J, V82, P772, DOI 10.1016/S0006-3495(02)75439-8; Bhate MP, 2010, J MOL BIOL, V401, P155, DOI 10.1016/j.jmb.2010.06.031; Chakrapani S, 2007, J GEN PHYSIOL, V130, P479, DOI 10.1085/jgp.200709844; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Cheng WWL, 2011, P NATL ACAD SCI USA, V108, P5272, DOI 10.1073/pnas.1014186108; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Devaraneni PK, 2013, P NATL ACAD SCI USA, V110, P15698, DOI 10.1073/pnas.1308699110; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; LEVITT M, 1993, STRUCTURE, V1, P223, DOI 10.1016/0969-2126(93)90011-5; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mance D, 2015, ANGEW CHEM INT EDIT, V54, P15799, DOI 10.1002/anie.201509170; Medeiros-Silva J, 2016, ANGEW CHEM INT EDIT, V55, P13606, DOI 10.1002/anie.201606594; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Ostmeyer J, 2013, NATURE, V501, DOI 10.1038/nature12395; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RASHIN AA, 1986, BIOCHEMISTRY-US, V25, P3619, DOI 10.1021/bi00360a021; Roux B, 2002, BIOPHYS J, V82, P1681, DOI 10.1016/S0006-3495(02)75520-3; Takano K, 2003, PROTEIN ENG, V16, P5, DOI 10.1093/proeng/gzg001; Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415; Weingarth M, 2014, J AM CHEM SOC, V136, P2000, DOI 10.1021/ja411450y; WILLIAMS MA, 1994, PROTEIN SCI, V3, P1224, DOI 10.1002/pro.5560030808; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186789	10.1371/journal.pone.0186789	http://dx.doi.org/10.1371/journal.pone.0186789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049423	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900111
J	Revel, A; Jarzaguet, M; Peyron, MA; Papet, I; Hafnaoui, N; Migne, C; Mosoni, L; Polakof, S; Savary-Auzeloux, I; Remond, D; Dardevet, D				Revel, Aurelia; Jarzaguet, Marianne; Peyron, Marie-Agnes; Papet, Isabelle; Hafnaoui, Noureddine; Migne, Carole; Mosoni, Laurent; Polakof, Sergio; Savary-Auzeloux, Isabelle; Remond, Didier; Dardevet, Dominique			At same leucine intake, a whey/plant protein blend is not as effective as whey to initiate a transient post prandial muscle anabolic response during a catabolic state in mini pigs	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; AMINO-ACID-TRANSPORT; SKELETAL-MUSCLE; GLUCOCORTICOID EXCESS; GLUCOSE-TRANSPORT; WHOLE-BODY; OLD RATS; INGESTION; KINETICS; EXERCISE	Background Muscle atrophy has been explained by an anabolic resistance following food intake and an increase of dietary protein intake is recommended. To be optimal, a dietary protein has to be effective not only to initiate but also to prolong a muscle anabolic response in a catabolic state. To our knowledge, whether or not a dairy or a dairy/plant protein blend fulfills these criterions is unknown in a muscle wasting situation. Objective Our aim was, in a control and a catabolic state, to measure continuously muscle anabolism in term of intensity and duration in response to a meal containing casein (CAS), whey (WHEY) or a whey/plant protein blend (BLEND) and to evaluate the best protein source to elicit the best post prandial anabolism according to the physio-pathological state. Methods Adult male Yucatan mini pigs were infused with U-C-13-Phenylalanine and fed either CAS, WHEY or BLEND. A catabolic state was induced by a glucocorticoid treatment for 8 days (DEX). Muscle protein synthesis, proteolysis and balance were measured with the hind limb arterio-venous differences technique. Repeated time variance analysis were used to assess significant differences. Results In a catabolic situation, whey proteins were able to initiate muscle anabolism which remained transient in contrast to the stimulated muscle protein accretion with WHEY, CAS or BLEND in healthy conditions. Despite the same leucine intake compared to WHEY, BLEND did not restore a positive protein balance in DEX animals. Conclusions Even with WHEY, the duration of the anabolic response was not optimal and has to be improved in a catabolic state. The use of BLEND remained of lower efficiency even at same leucine intake than whey.	[Revel, Aurelia; Jarzaguet, Marianne; Peyron, Marie-Agnes; Papet, Isabelle; Hafnaoui, Noureddine; Migne, Carole; Mosoni, Laurent; Polakof, Sergio; Savary-Auzeloux, Isabelle; Remond, Didier; Dardevet, Dominique] Univ Clermont Auvergne, CRNH Auvergne, INRA, UNH,PFEM,MetaboHUB Clermont, Clermont Ferrand, France	INRAE; Universite Clermont Auvergne (UCA)	Dardevet, D (corresponding author), Univ Clermont Auvergne, CRNH Auvergne, INRA, UNH,PFEM,MetaboHUB Clermont, Clermont Ferrand, France.	dominique.dardevet@inra.fr	Polakof, Sergio/V-1132-2017	Polakof, Sergio/0000-0002-0976-8732; Remond, Didier/0000-0003-4430-0067; Mosoni, Laurent/0000-0002-5409-6760; Savary-Auzeloux, Isabelle/0000-0002-3298-9787; Dardevet, Dominique/0000-0001-7320-9970	Agence Nationale pour la Recherche (ANR) - Qualiment; Ministere de l'Agriculture, de la Recherche et de l'Enseignement Superieur	Agence Nationale pour la Recherche (ANR) - Qualiment(French National Research Agency (ANR)); Ministere de l'Agriculture, de la Recherche et de l'Enseignement Superieur	This study has been supported by the Agence Nationale pour la Recherche (ANR) - Qualiment to Dominique Dardevet and the Ministere de l'Agriculture, de la Recherche et de l'Enseignement Superieur to Dominique Dardevet.	AMATRUDA J M, 1985, Diabetes Metabolism Reviews, V1, P293; Atherton PJ, 2016, MOLEC NUTRITION, P109, DOI 10.1016/B978-0-12-802167-5.00009-8; Atherton PJ, 2012, J PHYSIOL-LONDON, V590, P1049, DOI 10.1113/jphysiol.2011.225003; Atherton PJ, 2010, AM J CLIN NUTR, V92, P1080, DOI 10.3945/ajcn.2010.29819; Balage M, J NUTR, V22, P219; Balage M, 2011, J NUTR BIOCHEM, V22, P219, DOI 10.1016/j.jnutbio.2010.02.001; Barbe F, 2014, FOOD CHEM, V143, P1, DOI 10.1016/j.foodchem.2013.07.100; Barbe F, 2013, FOOD CHEM, V136, P1203, DOI 10.1016/j.foodchem.2012.09.022; Beals JW, 2016, AM J CLIN NUTR, V104, P1014, DOI 10.3945/ajcn.116.130385; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; Biolo G, 2008, AM J CLIN NUTR, V88, P950, DOI 10.1093/ajcn/88.4.950; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Boirie Y, 1997, AM J CLIN NUTR, V65, P489; Boland MJ, 2013, TRENDS FOOD SCI TECH, V29, P62, DOI 10.1016/j.tifs.2012.07.002; Bruins MJ, 2002, AM J CLIN NUTR, V75, P1031, DOI 10.1093/ajcn/75.6.1031; Butteiger DN, 2013, CLIN NUTR, V32, P585, DOI 10.1016/j.clnu.2012.10.001; Cayol M, 1997, AM J PHYSIOL-ENDOC M, V272, pE584, DOI 10.1152/ajpendo.1997.272.4.E584; Choudry HA, 2006, J NUTR, V136, p314S, DOI 10.1093/jn/136.1.314S; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Dangin M, 2003, J PHYSIOL-LONDON, V549, P635, DOI 10.1113/jphysiol.2002.036897; Dardevet D, 1999, J ENDOCRINOL, V162, P77, DOI 10.1677/joe.0.1620077; DARDEVET D, 2012, THESCIENTIFICWORLDJO, P69531, DOI DOI 10.1100/2012/269531; Dideriksen K, 2013, NUTRIENTS, V5, P852, DOI 10.3390/nu5030852; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; Fouillet H, 2002, J NUTR, V132, P125, DOI 10.1093/jn/132.1.125; Fouillet H, 2009, AM J PHYSIOL-REG I, V297, pR1691, DOI 10.1152/ajpregu.00281.2009; Fujita S, 2006, AM J PHYSIOL-ENDOC M, V291, pE745, DOI 10.1152/ajpendo.00271.2005; Gorissen SHM, 2016, J NUTR, V146, P1651, DOI 10.3945/jn.116.231340; Guillet C, 2004, FASEB J, V18, P1586, DOI 10.1096/fj.03-1341fje; Guillet C, 2012, OBES REV, V13, P51, DOI 10.1111/j.1467-789X.2012.01037.x; Horstman AMH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080499; KONDO H, 1991, ACTA PHYSIOL SCAND, V142, P527, DOI 10.1111/j.1748-1716.1991.tb09191.x; LEIGHTON B, 1987, BIOCHEM J, V246, P551, DOI 10.1042/bj2460551; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Magne H, 2013, NUTR RES REV, V26, P149, DOI 10.1017/S0954422413000115; Magne H, 2012, J PHYSIOL-LONDON, V590, P2035, DOI 10.1113/jphysiol.2011.226266; Magne H, 2011, J PHYSIOL-LONDON, V589, P511, DOI 10.1113/jphysiol.2010.201707; Mitchell CJ, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0070-2; MOSONI L, 1995, AM J PHYSIOL-ENDOC M, V268, pE328, DOI 10.1152/ajpendo.1995.268.2.E328; Nicastro H, 2012, NUTRITION, V28, P465, DOI 10.1016/j.nut.2011.08.008; Nicastro H, 2011, AMINO ACIDS, V40, P287, DOI 10.1007/s00726-010-0636-x; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Paddon-Jones D, 2003, AM J PHYSIOL-ENDOC M, V284, pE946, DOI 10.1152/ajpendo.00397.2002; Phillips BE, 2012, CURR OPIN CLIN NUTR, V15, P58, DOI 10.1097/MCO.0b013e32834d19bc; Prod'homme M, 2004, CURR OPIN CLIN NUTR, V7, P71, DOI 10.1097/00075197-200401000-00012; Rand WM, 2003, AM J CLIN NUTR, V77, P109, DOI 10.1093/ajcn/77.1.109; Reidy PT, 2014, J APPL PHYSIOL, V116, P1353, DOI 10.1152/japplphysiol.01093.2013; Reidy PT, 2013, J NUTR, V143, P410, DOI 10.3945/jn.112.168021; Remond D, 2009, J NUTR, V139, P720, DOI 10.3945/jn.108.101675; Rieu I, 2004, EXP GERONTOL, V39, P1315, DOI 10.1016/j.exger.2004.06.005; Rieu I, 2009, J PHYSIOL-LONDON, V587, P5483, DOI 10.1113/jphysiol.2009.178319; Rudrappa SS, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00361; Savary I, 1998, BRIT J NUTR, V79, P297, DOI 10.1079/BJN19980047; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shah OJ, 2000, BIOCHEM J, V347, P389, DOI 10.1042/0264-6021:3470389; Tardif N, 2014, AGING CELL, V13, P1001, DOI 10.1111/acel.12263; TOURIAN A, 1969, J CELL PHYSIOL, V73, P159, DOI 10.1002/jcp.1040730210; van Vliet S, 2015, J NUTR, V145, P1981, DOI 10.3945/jn.114.204305; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; Wang XJ, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160096; WEINSTEIN SP, 1995, DIABETES, V44, P441, DOI 10.2337/diabetes.44.4.441; Zeanandin G, 2012, AGE, V34, P371, DOI 10.1007/s11357-011-9246-0	62	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186204	10.1371/journal.pone.0186204	http://dx.doi.org/10.1371/journal.pone.0186204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045496	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100042
J	Cho, HJ; Hwang, YS; Yoon, J; Lee, M; Lee, HG; Daar, IO				Cho, H. J.; Hwang, Y-S; Yoon, J.; Lee, M.; Lee, H. G.; Daar, I. O.			EphrinB1 promotes cancer cell migration and invasion through the interaction with RhoGDI1	ONCOGENE			English	Article							GDP-DISSOCIATION INHIBITOR; GTP-BINDING PROTEINS; EPH RECEPTORS; RHO-GTPASES; GASTRIC-CANCER; EXPRESSION; ACTIVATION; COMPLEX; PHOSPHORYLATION; REGULATORS	Eph receptors and their corresponding ephrin ligands have been associated with regulating cell-cell adhesion and motility, and thus have a critical role in various biological processes including tissue morphogenesis and homeostasis, as well as pathogenesis of several diseases. Aberrant regulation of Eph/ephrin signaling pathways is implicated in tumor progression of various human cancers. Here, we show that a Rho family GTPase regulator, Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1), can interact with ephrinB1, and this interaction is enhanced upon binding the extracellular domain of the cognate EphB2 receptor. Deletion mutagenesis revealed that amino acids 327-334 of the ephrinB1 intracellular domain are critical for the interaction with RhoGDI1. Stimulation with an EphB2 extracellular domain-Fc fusion protein (EphB2-Fc) induces RhoA activation and enhances the motility as well as invasiveness of wild-type ephrinB1-expressing cells. These Eph-Fc-induced effects were markedly diminished in cells expressing the mutant ephrinB1 construct (Delta 327-334) that is ineffective at interacting with RhoGDI1. Furthermore, ephrinB1 depletion by siRNA suppresses EphB2-Fc-induced RhoA activation, and reduces motility and invasiveness of the SW480 and Hs578T human cancer cell lines. Our study connects the interaction between RhoGDI1 and ephrinB1 to the promotion of cancer cell behavior associated with tumor progression. This interaction may represent a therapeutic target in cancers that express ephrinB1.	[Cho, H. J.; Lee, H. G.] Korea Res Inst Biosci & Biotechnol, Immunotherapy Convergence Res Ctr, Daejeon 34141, South Korea; [Cho, H. J.; Hwang, Y-S; Yoon, J.; Lee, M.; Daar, I. O.] NCI, Cancer & Dev Biol Lab, NIH, Frederick, MD 21702 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cho, HJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Immunotherapy Convergence Res Ctr, Daejeon 34141, South Korea.; Daar, IO (corresponding author), NCI, Canc & Dev Biol Lab, Bldg 560,Room 22-90D, Frederick, MD 21702 USA.	hjcho@kribb.re.kr; daari@mail.nih.gov	Lee, Moonsup/AAK-2333-2020	Daar, Ira/0000-0003-2657-526X; Yoon, Jaeho/0000-0003-2730-8606	Intramural Research Program of the NIH, National Cancer Institute; National Research Council of Science and Technology (NST) grant by the Korea government (MSIP) [CRC-15-02-KRIBB]; NATIONAL CANCER INSTITUTE [ZIABC010006, ZIABC010958] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Council of Science and Technology (NST) grant by the Korea government (MSIP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank our colleagues Dr Giovanna Tosato for critically reading of this manuscript, Dr Brad St Croix and Dr Deborah Morrison for cell lines. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, and the National Research Council of Science and Technology (NST) grant by the Korea government (MSIP) (CRC-15-02-KRIBB).	Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Brunet N, 2002, TRAFFIC, V3, P342, DOI 10.1034/j.1600-0854.2002.30504.x; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cho HJ, 2014, J BIOL CHEM, V289, P18556, DOI 10.1074/jbc.M114.558809; Cho HJ, 2010, EXPERT OPIN THER TAR, V14, P67, DOI 10.1517/14728220903449251; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Colbert PL, 2015, ONCOTARGET, V6, P953, DOI 10.18632/oncotarget.2823; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Daar IO, 2012, SEMIN CELL DEV BIOL, V23, P65, DOI 10.1016/j.semcdb.2011.10.012; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Donnelly SK, 2014, CELL ADHES MIGR, V8, P526, DOI 10.4161/cam.29712; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; Faure J, 1999, EUR J BIOCHEM, V262, P879, DOI 10.1046/j.1432-1327.1999.00458.x; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Kataoka H, 2002, J CANCER RES CLIN, V128, P343, DOI 10.1007/s00432-002-0355-0; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Lee HS, 2006, NAT CELL BIOL, V8, P55, DOI 10.1038/ncb1344; Lee HS, 2008, NAT CELL BIOL, V10, P979, DOI 10.1038/ncb1758; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Lu Y, 2013, J BIOL CHEM, V288, P34276, DOI 10.1074/jbc.M113.519744; Maeda M, 1999, ONCOGENE, V18, P4788, DOI 10.1038/sj.onc.1202871; McKinney N, 2015, J NEURO-ONCOL, V121, P109, DOI 10.1007/s11060-014-1618-8; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Pandya P, 2017, CURR OPIN CELL BIOL, V48, P87, DOI 10.1016/j.ceb.2017.06.006; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Porter Andrew P, 2016, Small GTPases, V7, P123, DOI 10.1080/21541248.2016.1173767; Sabbatini ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066029; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sawai Y, 2003, J HEPATOL, V39, P991, DOI 10.1016/S0168-8278(03)00498-7; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Tanaka M, 2010, CANCER SCI, V101, P87, DOI 10.1111/j.1349-7006.2009.01352.x; Varelias A, 2002, CANCER, V95, P862, DOI 10.1002/cncr.10749; Wu C, 2009, J NEUROSCI, V29, P7404, DOI 10.1523/JNEUROSCI.5841-08.2009; Xi HQ, 2012, J CELL MOL MED, V16, P2894, DOI 10.1111/j.1582-4934.2012.01612.x; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	53	22	22	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					861	872		10.1038/onc.2017.386	http://dx.doi.org/10.1038/onc.2017.386			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059157	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000425281800004
J	Zheng, J; Chen, YP; Li, ZR; Cao, SN; Zhang, ZX; Jia, HL				Zheng, Jun; Chen, Yaping; Li, Zhaoran; Cao, Shinuo; Zhang, Zhaoxia; Jia, Honglin			Translationally controlled tumor protein is required for the fast growth of Toxoplasma gondii and maintenance of its intracellular development	FASEB JOURNAL			English	Article						TCTP; knockout; invasion; replication; egress	HISTAMINE-RELEASING FACTOR; TRYPANOSOMA-BRUCEI; CALCIUM-BINDING; BRUGIA-MALAYI; IN-VITRO; TCTP; HOMOLOG; TARGET; OVEREXPRESSION; AMINOPEPTIDASE	Translationally controlled tumor protein (TCTP) is a highly conserved, multifunctional protein that has been implicated in a range of cell physiologic processes, especially cell growth and development. ATCTP-like gene has been identified in the Toxoplasma genome [Toxoplasma gondii TCTP (TgTCTP)], although its function remains unknown. The sequence analysis of TgTCTP indicated that it is a highly conserved protein in eukaryotes. We found that the expression level of TgTCTP in the virulent RH strain was significantly higher than that in the avirulent PLK strain. Indirect immunofluorescence showed that TgTCTP was expressed in the parasite cytoplasm. The localization of TgTCTP was unchanged during the replication of the parasite. We expressed a functional recombinant TgTCTP (rTgTCTP) protein in Escherichia coli and found that the recombinant protein could form a multimer. We then evaluated the function of TgTCTP using the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 knockout (KO) system. Phenotypic analysis of the KO strain (Delta TgTCTP) revealed that TgTCTP is required for the robust growth of the parasites. TgTCTP deficiency also led to early egress of the parasites and subsequent impairment in their invasion and attachment abilities. We subsequently found that the multimer formof TgTCTP might not be necessary for the growth and replication of the parasite. Then the expression profiling of genes in the Delta TgTCTP and complement strains were analyzed. The results revealed that 988 genes were regulated in Delta TgTCTP compared with the complement strain. Overall, although not essential, TgTCTP is required for the fast growth of Tg and maintenance of its intracellular development.	[Zheng, Jun; Chen, Yaping; Li, Zhaoran; Cao, Shinuo; Zhang, Zhaoxia; Jia, Honglin] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, 678 Haping St, Harbin 150069, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Jia, HL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, 678 Haping St, Harbin 150069, Heilongjiang, Peoples R China.	jiahonglin@caas.cn	洪林, 贾/AAN-3442-2020; Cao, Shinuo/ABH-3244-2021; Cao, Shinuo/AAD-1027-2020	洪林, 贾/0000-0001-7458-9565; 	National Natural Science Foundation of China [31402184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. K. A. Joiner (Yale University, New Haven, CT, USA) for providing the pHXNTPHA plasmids, generated by Dr. X. Xuan (Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan). This work was supported by a grant awarded to J.Z. by the National Natural Science Foundation of China (Grant 31402184). The authors have no conflicts of interest to declare.	Acunzo J, 2014, CANCER TREAT REV, V40, P760, DOI 10.1016/j.ctrv.2014.02.007; Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Amson R, 2013, TRENDS CELL BIOL, V23, P37, DOI 10.1016/j.tcb.2012.10.002; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Bae SY, 2017, AUTOPHAGY, V13, P820, DOI 10.1080/15548627.2017.1287650; Bhisutthibhan J, 1999, EUR J CELL BIOL, V78, P665, DOI 10.1016/S0171-9335(99)80052-1; Bhisutthibhan J, 2001, ANTIMICROB AGENTS CH, V45, P2397, DOI 10.1128/AAC.45.8.2397-2399.2001; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Caldas LA, 2007, VET PARASITOL, V147, P210, DOI 10.1016/j.vetpar.2007.05.012; Chen K, 2014, MOL BIOL EVOL, V31, P2194, DOI 10.1093/molbev/msu181; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Dong XC, 2009, J BIOL CHEM, V284, P23754, DOI 10.1074/jbc.M109.012823; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Gnanasekar M, 2007, PARASITOL RES, V101, P1533, DOI 10.1007/s00436-007-0671-z; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; Heaslip AT, 2016, MOL BIOL CELL, V27, P2080, DOI 10.1091/mbc.E15-12-0824; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Jia HL, 2010, MOL BIOCHEM PARASIT, V170, P1, DOI 10.1016/j.molbiopara.2009.11.005; Kim M, 2013, BIOCHIMIE, V95, P659, DOI 10.1016/j.biochi.2012.10.007; Kim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006464; Lun ZR, 2015, P NATL ACAD SCI USA, V112, P8835, DOI 10.1073/pnas.1502599112; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Miao X, 2013, TUMOR BIOL, V34, P3357, DOI 10.1007/s13277-013-0906-9; Morrissette N, 2015, EUKARYOT CELL, V14, P2, DOI 10.1128/EC.00225-14; Nagano-Ito M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/204960; Pszenny V, 2016, J BIOL CHEM, V291, P3725, DOI 10.1074/jbc.M115.671974; Qureshi BM, 2013, FASEB J, V27, P1034, DOI 10.1096/fj.11-180992; Reynolds MG, 2001, ANTIMICROB AGENTS CH, V45, P1271, DOI 10.1128/AAC.45.4.1271-1277.2001; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; Sibley LD, 2002, PHILOS T R SOC B, V357, P81, DOI 10.1098/rstb.2001.1017; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; THOMAS G, 1981, P NATL ACAD SCI-BIOL, V78, P5712, DOI 10.1073/pnas.78.9.5712; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108	44	8	9	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					906	919		10.1096/fj.201700994R	http://dx.doi.org/10.1096/fj.201700994R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29046358	Bronze			2022-12-26	WOS:000425146900032
J	Coignet, MV; Zirpoli, GR; Roberts, MR; Khoury, T; Bandera, EV; Zhu, QQ; Yao, S				Coignet, Marie V.; Zirpoli, Gary Robert; Roberts, Michelle R.; Khoury, Thaer; Bandera, Elisa V.; Zhu, Qianqian; Yao, Song			Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NATURAL MENOPAUSE; AGE; MENARCHE; VARIANTS; LOCI; HERITABILITY; METAANALYSIS; DETERMINANTS; REPLICATION	Reproductive aging phenotypes, including age at menarche (AM) and age at natural menopause (ANM), are well-established risk factors for breast cancer. In recent years, many genetic variants have been identified in association with AM and ANM in genome-wide association studies among European populations. Using data from the Women's Circle of Health Study (WCHS) of 1,307 European-American (EA) and 1,365 African-American (AA) breast cancer cases and controls, we aimed to replicate 53 earlier GWAS variants for AM and ANM in AA and EA groups and to perform analyses on total and net reproductive life-span (TRLS; NRLS). Breast cancer risk was also examined in relation to a polygenic risk score (PRS) for each of the reproductive aging phenotypes. We replicated a number of variants in EA women, including rs7759938 in LIN28B for AM and rs16991615 in MCM8 for ANM; whereas in the AA group, only one SNP (rs2947411 in TMEM18) for AM was directionally consistent and nominally significant. In analysis of TRLS and NRLS, several SNPs were significant, including rs466639 in RXRG that was associated with both phenotypes in both AA and EA groups. None of the PRS was associated with breast cancer risk. Given the paucity of data available among AA populations, our study contributes to the literature of genetics of reproductive aging in AA women and highlights the importance of cross population replication of GWAS variants.	[Coignet, Marie V.; Zirpoli, Gary Robert; Roberts, Michelle R.; Yao, Song] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Zirpoli, Gary Robert] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Roberts, Michelle R.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA; [Khoury, Thaer] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Bandera, Elisa V.] Rutgers Canc Inst New Jersey, Canc Prevent & Control Program, New Brunswick, NJ USA; [Zhu, Qianqian] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Roswell Park Cancer Institute	Yao, S (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA.	song.yao@roswellpark.org		Yao, Song/0000-0001-9442-1313	US National Institutes of Health [R01 CA100598, P01 CA151135, R03 CA192205, P30 CA016056]; US Army Medical Research and Material Command [DAMD-17-01-1-0334]; Roswell Park Cancer Institute Genomics Shared Resource, which is a National Cancer Institute Cancer Center Supported Grant (CCSG) shared resource [P30 CA016056]; National Program of Cancer Registries of the Centers for Disease Control and Prevention [1US58DP003931-01]; Surveillance, Epidemiology, and End Results program of the National Cancer Institute [N01-PC-2010-0027]; State of New Jersey; NATIONAL CANCER INSTITUTE [R03CA192205] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Roswell Park Cancer Institute Genomics Shared Resource, which is a National Cancer Institute Cancer Center Supported Grant (CCSG) shared resource; National Program of Cancer Registries of the Centers for Disease Control and Prevention; Surveillance, Epidemiology, and End Results program of the National Cancer Institute; State of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the US National Institutes of Health (R01 CA100598, P01 CA151135, and R03 CA192205 and P30 CA016056) and US Army Medical Research and Material Command (DAMD-17-01-1-0334). The genotyping work was performed by the Roswell Park Cancer Institute Genomics Shared Resource, which is a National Cancer Institute Cancer Center Supported Grant (CCSG) shared resource (P30 CA016056). The New Jersey State Cancer Registry is supported by the National Program of Cancer Registries of the Centers for Disease Control and Prevention under cooperative agreement 1US58DP003931-01 awarded to the New Jersey Department of Health. The collection of New Jersey cancer incidence data is also supported by the Surveillance, Epidemiology, and End Results program of the National Cancer Institute under contract N01-PC-2010-0027 and the State of New Jersey. The funding agents played no role in the design, collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Ambrosone CB, 2009, J ONCOL, V2009, DOI 10.1155/2009/871250; Bandera EV, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-71; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Bromberger JT, 1997, AM J EPIDEMIOL, V145, P124; Carty CL, 2013, HUM REPROD, V28, P1695, DOI 10.1093/humrep/det071; Chen CTL, 2014, HUM MOL GENET, V23, P3327, DOI 10.1093/hmg/ddu041; Chen CTL, 2012, HUM MOL GENET, V21, P1419, DOI 10.1093/hmg/ddr570; Cheng TYD, 2016, CANCER CAUSE CONTROL, V27, P965, DOI 10.1007/s10552-016-0774-x; CRAMER DW, 1995, FERTIL STERIL, V64, P740, DOI 10.1016/S0015-0282(16)57849-2; Day F, 2016, BIORXIV; Day FR, 2017, NAT GENET, V49, P834, DOI 10.1038/ng.3841; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Delahanty RJ, 2013, HUM REPROD, V28, P1135, DOI 10.1093/humrep/det011; Demerath EW, 2013, HUM MOL GENET, V22, P3329, DOI 10.1093/hmg/ddt181; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43; Giner XC, 2015, FASEB J, V29, P4256, DOI 10.1096/fj.14-259804; Gong ZH, 2015, INT J CANCER, V137, P666, DOI 10.1002/ijc.29434; He CY, 2014, MOL CELL ENDOCRINOL, V382, P767, DOI 10.1016/j.mce.2012.05.003; He CY, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3155; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Johnson N, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3662; Karapanou O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-115; Liu YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000420; MacMahon B, 1966, DATA NATL HLTH SURVE, V11, P1; Mbarek H, 2016, AM J HUM GENET, V98, P898, DOI 10.1016/j.ajhg.2016.03.008; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; Morris DH, 2010, BRIT J CANCER, V103, P1760, DOI 10.1038/sj.bjc.6605978; Murabito JM, 2005, J CLIN ENDOCR METAB, V90, P3427, DOI 10.1210/jc.2005-0181; Oh H, 2016, BREAST CANCER RES TR, V158, P341, DOI 10.1007/s10549-016-3859-z; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pritchard JK, 2000, GENETICS, V155, P945; Pyun JA, 2014, MENOPAUSE, V21, P522, DOI 10.1097/GME.0b013e3182a433f7; Quan L, 2014, ENDOCR-RELAT CANCER, V21, P853, DOI 10.1530/ERC-14-0250; Rahmani M, 2013, HUM REPROD, V28, P1987, DOI 10.1093/humrep/det106; Ruiz-Narvaez EA, 2011, AM J EPIDEMIOL, V173, P587, DOI 10.1093/aje/kwq401; Shen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058766; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; Spencer KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055258; Spratt DE, 2016, JAMA ONCOL, V2, P1070, DOI 10.1001/jamaoncol.2016.1854; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Treloar SA, 1998, LANCET, V352, P1084, DOI 10.1016/S0140-6736(05)79753-1; Tu WZ, 2015, J ADOLESCENT HEALTH, V56, P66, DOI 10.1016/j.jadohealth.2014.07.020; van Asselt KM, 2004, FERTIL STERIL, V82, P1348, DOI 10.1016/j.fertnstert.2004.04.047; Yao S, 2013, BREAST CANCER RES TR, V141, P447, DOI 10.1007/s10549-013-2698-4; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187205	10.1371/journal.pone.0187205	http://dx.doi.org/10.1371/journal.pone.0187205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073238	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400132
J	Wu, GC; Luo, JW; Li, HW; Huang, CH; Chang, CF				Wu, Guan-Chung; Luo, Jia-Wun; Li, Hau-Wen; Huang, Chen-Hsiu; Chang, Ching-Fong			Robust gdf9 and bmp15 expression in the oocytes of ovotestes through the Figla-independent pathway in the hermaphroditic black porgy, Acanthopagrus schlegelii	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-15; GERM-CELLS; SEX DETERMINATION; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; POTENTIAL ROLE; DIFFERENTIATION; FISH; FEMALE; OVARY	More than 1,500 fish species are hermaphroditic, but no hermaphroditic lineage appears to be evolutionarily ancient in fishes. Thus, whether more than one sex at a time was present during the evolutionary shift from gonochorism to hermaphroditism in fishes is an intriguing question. Ectopic oocytes were created in the ovotestes of protandrous black porgy via the withdrawal of estradiol (E2) administration. These ectopic oocytes reprogrammed the surrounding cells, which changed from Sertoli cells to follicle-like cells. We observed that gdf9 and bmp15 expression was localized in the primary oocytes and gradually decreased after oocytes entered a secondary oocyte stage. Robust expression of gdf9 and bmp15 in ectopic oocytes was associated with the surrounding Sertoli cells. However, blocking Cyp19a1a activity and increasing androgen levels did not stimulate the expression of gdf9 and bmp15. Thus, the robust gdf9 and bmp15 expression was not related to the inappropriate male microenvironment. Furthermore, in vitro data demonstrated that gdf9 and bmp15 were not downstream genes of Figla signaling. Therefore, our results suggest that there are two independent mechanisms, a Figla-dependent pathway and a Figla-independent pathway, by which oocyte-surrounding cells are altered from a male somatic fate to a female somatic fate. This functional switch might clarify how oocytes created an appropriate microenvironment during the transition from the ancient gonochorism to the present hermaphroditism.	[Wu, Guan-Chung; Luo, Jia-Wun; Li, Hau-Wen; Huang, Chen-Hsiu; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan; [Wu, Guan-Chung; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Ocean, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Wu, GC; Chang, CF (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan.; Wu, GC; Chang, CF (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Ocean, Keelung, Taiwan.	gcwu@mail.ntou.edu.tw; B0044@mail.ntou.edu.tw			Ministry of Science and Technology [MOST 102-2628-B-019-004-MY3, MOST 105-2313-B-019-012-MY3]; Ministry of Education, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the Ministry of Science and Technology (MOST 102-2628-B-019-004-MY3 and MOST 105-2313-B-019-012-MY3) and the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The English was corrected by the American Journal Experts. This work was supported by the Ministry of Science and Technology (MOST 102-2628-B-019-004-MY3 and MOST 105-2313-B-019-012-MY3) and the Ministry of Education, Taiwan.	Avise JC, 2009, SEX DEV, V3, P152, DOI 10.1159/000223079; CHANG CF, 1994, J EXP ZOOL, V268, P53, DOI 10.1002/jez.1402680107; Chen AQ, 2012, COMP BIOCHEM PHYS B, V163, P121, DOI 10.1016/j.cbpb.2012.05.009; Chen WT, 2017, BIOL REPROD, V96, P401, DOI 10.1095/biolreprod.116.144964; Clelland E, 2006, ENDOCRINOLOGY, V147, P201, DOI 10.1210/en.2005-1017; Clelland ES, 2007, ENDOCRINOLOGY, V148, P5451, DOI 10.1210/en.2007-0674; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Dranow DB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006323; Dranow DB, 2013, DEV BIOL, V376, P43, DOI 10.1016/j.ydbio.2013.01.016; Garcia-Lopez A, 2011, GEN COMP ENDOCR, V174, P326, DOI 10.1016/j.ygcen.2011.09.011; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Halm S, 2008, MOL CELL ENDOCRINOL, V291, P95, DOI 10.1016/j.mce.2008.03.002; He Z, 2012, GEN COMP ENDOCR, V178, P355, DOI 10.1016/j.ygcen.2012.06.016; Hecker M, 2006, REV ENVIRON CONTAM T, V187, P103, DOI 10.1007/0-387-32885-8_3; Hu W, 2010, MOL CELL BIOL, V30, P3661, DOI 10.1128/MCB.00201-10; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Juengel JL, 2004, ANIM REPROD SCI, V82-3, P447, DOI 10.1016/j.anireprosci.2004.04.021; Kanamori A, 2008, GENE, V423, P180, DOI 10.1016/j.gene.2008.07.007; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lee YH, 2002, BIOL REPROD, V66, P1749, DOI 10.1095/biolreprod66.6.1749; Liu L, 2007, BIOL REPROD, V76, P294, DOI 10.1095/biolreprod.106.054668; Liu ZW, 2012, MOL BIOL REP, V39, P3863, DOI 10.1007/s11033-011-1165-8; Mottershead DG, 2012, MOL HUM REPROD, V18, P121, DOI 10.1093/molehr/gar056; Nishimura T, 2015, SCIENCE, V349, P328, DOI 10.1126/science.aaa2657; Nishimura T, 2014, DEVELOPMENT, V141, P3363, DOI 10.1242/dev.106864; Nozu R, 2013, FISH PHYSIOL BIOCHEM, V39, P47, DOI 10.1007/s10695-012-9632-2; Paulini F, 2011, REPROD DOMEST ANIM, V46, P354, DOI 10.1111/j.1439-0531.2010.01739.x; Peng C, 2009, COMP BIOCHEM PHYS A, V153, P83, DOI 10.1016/j.cbpa.2008.09.034; Qiu YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123900; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Sun LN, 2014, ENDOCRINOLOGY, V155, P1476, DOI 10.1210/en.2013-1959; UPADHYAY S, 1982, P NATL ACAD SCI-BIOL, V79, P6584, DOI 10.1073/pnas.79.21.6584; Wu GC, 2008, BIOL REPROD, V78, P200, DOI 10.1095/biolreprod.107.062612; Wu GC, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137463; Wu GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145438; Wu GC, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126953; Wu GC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104398; Wu GC, 2013, FISH PHYSIOL BIOCHEM, V39, P33, DOI 10.1007/s10695-012-9618-0; Wu GC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095695; Wu GC, 2009, BIOL REPROD, V81, P1073, DOI 10.1095/biolreprod.109.077362; Wu GC, 2008, BIOL REPROD, V79, P1111, DOI 10.1095/biolreprod.108.069146; Zhang YY, 2014, GENE, V546, P214, DOI 10.1016/j.gene.2014.06.013	45	6	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186991	10.1371/journal.pone.0186991	http://dx.doi.org/10.1371/journal.pone.0186991			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073214	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400090
J	Che, ML; Kong, LL; Bell, RC; Yuan, Y				Che, Menglu; Kong, Linglong; Bell, Rhonda C.; Yuan, Yan			Trajectory modeling of gestational weight: A functional principal component analysis approach	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BIRTH-WEIGHT; PREGNANCY; GAIN; QUESTIONNAIRE; OBESITY; HEIGHT; WOMEN; RISK; FAT	Suboptimal gestational weight gain (GWG), which is linked to increased risk of adverse outcomes for a pregnant woman and her infant, is prevalent. In the study of a large cohort of Canadian pregnant women, our goals are to estimate the individual weight growth trajectory using sparsely collected bodyweight data, and to identify the factors affecting the weight change during pregnancy, such as prepregnancy body mass index (BMI), dietary intakes and physical activity. The first goal was achieved through functional principal component analysis (FPCA) by conditional expectation. For the second goal, we used linear regression with the total weight gain as the response variable. The trajectory modeling through FPCA had a significantly smaller root mean square error (RMSE) and improved adaptability than the classic nonlinear mixed-effect models, demonstrating a novel tool that can be used to facilitate real time monitoring and interventions of GWG. Our regression analysis showed that prepregnancy BMI had a high predictive value for the weight changes during pregnancy, which agrees with the published weight gain guideline.	[Che, Menglu] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada; [Kong, Linglong] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada; [Bell, Rhonda C.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Yuan, Yan] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Waterloo; University of Alberta; University of Alberta; University of Alberta	Yuan, Y (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	yyuan@ualberta.ca	padilha, hugo cp cezarotti/R-9840-2017; kong, Linglong/L-9551-2015	kong, Linglong/0000-0003-3011-9216; Che, Menglu/0000-0002-0594-5797; Yuan, Yan/0000-0002-2073-9924	Lois Hole Hospital for Women through the Women and Children's Health Research Institute; Women and Childrens Health Research Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Statistical Sciences Institute; Alberta Innovates Health Solutions	Lois Hole Hospital for Women through the Women and Children's Health Research Institute; Women and Childrens Health Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Statistical Sciences Institute; Alberta Innovates Health Solutions	This research project was made possible through grants from Women and Childrens Health Research Institute to YY (www.wchri.org), Natural Sciences and Engineering Research Council of Canada to LK (http://www.nserc-crsng.gc.ca/index_eng.asp), Canadian Statistical Sciences Institute to LK (http://www.canssi.ca), and Alberta Innovates Health Solutions to RB (http://www.aihealthsolutions.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the reviewers for their careful reviews and insightful comments, which helped us improve the clarity and presentation of this paper. We are grateful to APRON participants who contributed their time and information to research. This research is made possible because of the generous supporters of Lois Hole Hospital for Women through the Women and Children's Health Research Institute.	ABRAMS B, 1995, OBSTET GYNECOL, V86, P170, DOI 10.1016/0029-7844(95)00119-C; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bartholomew S., 2009, WHAT MOTH SAY CAN MA; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Brumback BA, 1998, J AM STAT ASSOC, V93, P961, DOI 10.2307/2669837; Che M., 2016, STAT MODELING DIETAR; Clarke PE, 2005, ANN HUM BIOL, V32, P247, DOI 10.1080/03014460500049915; Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Guo WS, 2002, BIOMETRICS, V58, P121, DOI 10.1111/j.0006-341X.2002.00121.x; Han Z, 2011, ACTA OBSTET GYN SCAN, V90, P935, DOI 10.1111/j.1600-0412.2011.01185.x; Hanning RM, 2009, CAN J DIET PRACT RES, V70, P172, DOI 10.3148/70.4.2009.172; HEDIGER ML, 1994, J NUTR, V124, P24, DOI 10.1093/jn/124.1.24; Ismail LC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i555; Jarman Megan, 2016, CMAJ Open, V4, pE338, DOI 10.9778/cmajo.20150132; Jianqing Fan, 1996, LOCAL POLYNOMIAL MOD, V66; Kaplan BJ, 2014, MATERN CHILD NUTR, V10, P44, DOI 10.1111/j.1740-8709.2012.00433.x; Lowell Helene, 2010, Health Rep, V21, P31; Mardia K. V., 1979, MULTIVARIATE STAT; Muller H. G., 2012, J AM STAT ASS; Nawaz H, 2001, AM J PREV MED, V20, P294, DOI 10.1016/S0749-3797(01)00293-8; Olson CM, 2008, ANNU REV NUTR, V28, P411, DOI 10.1146/annurev.nutr.28.061807.155322; RICE JA, 1991, J ROY STAT SOC B MET, V53, P233; Scholl TO, 1996, AM J HUM BIOL, V8, P735, DOI 10.1002/(SICI)1520-6300(1996)8:6<735::AID-AJHB5>3.0.CO;2-S; Sidebottom AC, 2001, EUR J OBSTET GYN R B, V94, P216, DOI 10.1016/S0301-2115(00)00329-8; Storey KE, 2009, PUBLIC HEALTH NUTR, V12, P2009, DOI 10.1017/S1368980009990292; Tanentsapf I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-81; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; Xu JJ, 2014, AM J CLIN NUTR, V99, P296, DOI 10.3945/ajcn.113.074120; Yaktine AL, 2009, WEIGHT GAIN PREGNANC; Yao F, 2005, J AM STAT ASSOC, V100, P577, DOI 10.1198/016214504000001745	31	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186761	10.1371/journal.pone.0186761	http://dx.doi.org/10.1371/journal.pone.0186761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065133	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900033
J	Matsuzaki, Y; Sakuma, T; Yamamoto, T; Saya, H				Matsuzaki, Yuriko; Sakuma, Tetsushi; Yamamoto, Takashi; Saya, Hideyuki			Establishment of pten knockout medaka with transcription activator-like effector nucleases (TALENs) as a model of PTEN deficiency disease	PLOS ONE			English	Article							ZEBRAFISH; CANCER	Phosphatase and tensin homolog (PTEN) is a lipid and protein phosphatase that antagonizes signaling by the phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway. The PTEN gene is a major tumor suppressor, with mutations of this gene occurring frequently in tumors of humans and mice. We have now developed mutant medaka deficient in PTEN with the use of transcription activator-like effector nuclease (TALEN) technology. Medaka possesses two pten genes, ptena and ptenb, similar to zebrafish. We established 16 ptena mutant lines and two ptenb mutant lines. Homozygous single pten mutants were found to be viable and fertile. In contrast, pten double-knockout (dko) embryos manifested severe abnormalities in vasculogenesis, eye size, and tail development at 72 hours post fertilization (hpf) and died before hatching. Immunoblot analysis revealed that the ratio of phosphorylated to total forms of AKT (pAKT/AKT) in pten dko embryos was four times that in wild-type embryos, indicative of up-regulation of signaling by the PI3K-AKT pathway. Treatment of pten dko embryos with the PI3K inhibitor LY294002 reduced the pAKT/AKT ratio by about one-half and partially rescued the defect in vasculogenesis. Additional inhibitors of the PI3K-AKT pathway, including rapamycin and N-alpha-tosyl-L-phenylalanyl chloromethyl ketone, also partially restored vasculogenesis in the dko embryos. Our model system thus allows pten dko embryos to be readily distinguished from wild-type embryos at an early stage of development and is suitable for the screening of drugs able to compensate for PTEN deficiency.	[Matsuzaki, Yuriko; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima, Japan	Keio University; Hiroshima University	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan.	hsaya@a5.keio.jp	Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takashi/U-4790-2017	Sakuma, Tetsushi/0000-0003-0396-1563; Yamamoto, Takashi/0000-0002-6516-2903; Saya, Hideyuki/0000-0001-6610-1902	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22130007]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Development of Novel Treatment Strategies Targeting Cancer Stem Cells" (22130007 to H.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Choorapoikayil S, 2013, DIS MODEL MECH, V6, P1159, DOI 10.1242/dmm.012377; Deveau AP, 2017, EXP HEMATOL, V45, P1, DOI 10.1016/j.exphem.2016.09.012; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Hansen-Kiss E, 2017, J MED GENET, V54, P471, DOI 10.1136/jmedgenet-2016-104484; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jelsig AM, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-101; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lin CY, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0236-5; Matsuzaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054424; Milella M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00024; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; SAKUMA T, 2013, SCI REP UK, V3; Schartl M, 2016, ADV EXP MED BIOL, V916, P531, DOI 10.1007/978-3-319-30654-4_23; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stumpf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154771; van Rooijen E, 2017, PIGM CELL MELANOMA R, V30, P402, DOI 10.1111/pcmr.12592; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186878	10.1371/journal.pone.0186878	http://dx.doi.org/10.1371/journal.pone.0186878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053747	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100044
J	Hijikata, M; Keicho, N; Duc, LV; Maeda, S; Hang, NTL; Matsushita, I; Kato, S				Hijikata, Minako; Keicho, Naoto; Le Van Duc; Maeda, Shinji; Nguyen Thi Le Hang; Matsushita, Ikumi; Kato, Seiya			Spoligotyping and whole-genome sequencing analysis of lineage 1 strains of Mycobacterium tuberculosis in Da Nang, Vietnam	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUG-RESISTANCE; BLOT HYBRIDIZATION; COMPLEX BACTERIA; EPIDEMIOLOGY; READS; ASSAY; DIFFERENTIATION; IDENTIFICATION; TOOL	Background Spacer oligonucleotide typing (spoligotyping), a widely used, classical genotyping method for Mycobacterium tuberculosis complex (MTBC), is a PCR-based dot-blot hybridization technique to detect the genetic diversity of the direct repeat (DR) region. Of the seven major MTBC lineages in the world, lineage 1 (Indo-Oceanic) mostly corresponds to the East African-Indian (EAI) spoligotype family in East Africa and Southeast Asia. Objectives We investigated the genomic features of Vietnamese lineage 1 strains, comparing spoligotype patterns using whole-genome sequencing (WGS) data. Methods M. tuberculosis strains isolated in Da Nang, Vietnam were subjected to conventional spoligotyping, followed by WGS analysis using a high-throughput sequencer. Vietnamese lineage 1 strains were further analyzed with other lineage 1 strains obtained from a public database. Results Indicating a major spoligotype in Da Nang, 86 (46.2%) of the 186 isolates belonged to the EAI family or lineage 1. Although typical EAI4-VNM strains are characterized by the deletion of spacers 26 and 27, 65 (75.6%) showed ambiguous signals on spacer 26. De novo assembly of the entire DR region and in silico spoligotyping analysis suggested the absence of spacer 26, and direct sequencing revealed that the 17th spacer sequence not used for conventional typing, was cross-hybridized to the spacer 26 probe. Vietnamese EAI4-VNM, other EAI-like strains, and those showing a non-EAI pattern lacking many spacers formed a monophyletic group separate from other EAI families in the world. Conclusion Information about the alignment of spacers in the entire DR region obtained from WGS data provides a clue for the determination of experimentally ambiguous spoligo patterns. WGS data also helped to analyze the hidden relationships between apparently distinct spoligo patterns.	[Hijikata, Minako; Matsushita, Ikumi] Japan AntiTB Assoc, Res Inst TB, Dept Pathophysiol & Host Def, Kiyose, Tokyo, Japan; [Keicho, Naoto; Kato, Seiya] Japan AntiTB Assoc, Res Inst TB, Kiyose, Tokyo, Japan; [Le Van Duc] Da Nang Lung Hosp, Da Nang, Vietnam; [Maeda, Shinji] Hokkaido Pharmaceut Univ, Sch Pharm, Sapporo, Hokkaido, Japan; [Nguyen Thi Le Hang] NCGM BMH Med Collaborat Ctr, Hanoi, Vietnam		Keicho, N (corresponding author), Japan AntiTB Assoc, Res Inst TB, Kiyose, Tokyo, Japan.	nkeicho-tky@umin.ac.jp	Keicho, Naoto/GQZ-0301-2022	Keicho, Naoto/0000-0001-8232-9448	Ministry of Science and Technology of Vietnam (MOST) [2372/QD-BKHCN]; International Collaborative Research Program The e-ASIA Joint Research Program (e-ASIA JRP) from Japan Agency for Medical Research and Development (AMED); Research Program on Emerging and Re-emerging Infectious Diseases from AMED	Ministry of Science and Technology of Vietnam (MOST); International Collaborative Research Program The e-ASIA Joint Research Program (e-ASIA JRP) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Research Program on Emerging and Re-emerging Infectious Diseases from AMED	This study was partially supported by the Ministry of Science and Technology of Vietnam (MOST) (grant number 2372/QD-BKHCN), https://www.most.gov.vn, (LVD); partially by the International Collaborative Research Program The e-ASIA Joint Research Program (e-ASIA JRP) from Japan Agency for Medical Research and Development (AMED), http://www.amed.go.jp/, (SK); and partially by the Research Program on Emerging and Re-emerging Infectious Diseases from AMED (SK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042323; Chuang PC, 2010, J CLIN MICROBIOL, V48, P4245, DOI 10.1128/JCM.00970-10; Coker OO, 2016, PEERJ, V4, DOI 10.7717/peerj.1905; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2011, TRENDS MICROBIOL, V19, P492, DOI 10.1016/j.tim.2011.07.002; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Faksri K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3213-1; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hawkey J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1860-2; Honisch C, 2010, J CLIN MICROBIOL, V48, P1520, DOI 10.1128/JCM.02299-09; Ismail F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114832; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Maeda S, 2014, TUBERCULOSIS, V94, P649, DOI 10.1016/j.tube.2014.09.005; Manson AL, 2017, NAT GENET, V49, P395, DOI 10.1038/ng.3767; Mbugi EV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154571; Molhuizen HOF, 1998, METH MOL B, V101, P381, DOI 10.1385/0-89603-471-2:381; Nakajima C, 2013, J CLIN MICROBIOL, V51, P2025, DOI 10.1128/JCM.03404-12; NGUYEN VAT, 2012, PLOS ONE, V0007; Pichat C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153580; Roychowdhury T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12567; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Nguyen VAT, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0784-6; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wada T., 2017, GENOME ANNOUNC, V5; Xia E, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0270-7; Zhang J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-42; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186800	10.1371/journal.pone.0186800	http://dx.doi.org/10.1371/journal.pone.0186800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049400	Green Submitted, gold, Green Published			2022-12-26	WOS:000413195900113
J	Lee, BJ; Kim, HY; Lim, SR; Huang, LF; Choi, HK				Lee, Byeong-Ju; Kim, Hye-Youn; Lim, Sa Rang; Huang, Linfang; Choi, Hyung-Kyoon			Discrimination and prediction of cultivation age and parts of Panax ginseng by Fourier-transform infrared spectroscopy combined with multivariate statistical analysis	PLOS ONE			English	Article							CORRELATION IR SPECTROSCOPY; AMERICAN GINSENG; FT-IR; BIOLOGICAL-MATERIALS; QUALITY-CONTROL; CA MEYER; IDENTIFICATION; METABOLOMICS; CANCER; SAPONINS	Panax ginseng C.A. Meyer is a herb used for medicinal purposes, and its discrimination according to cultivation age has been an important and practical issue. This study employed Fourier-transform infrared (FT-IR) spectroscopy with multivariate statistical analysis to obtain a prediction model for discriminating cultivation ages (5 and 6 years) and three different parts (rhizome, tap root, and lateral root) of P. ginseng. The optimal partial-least-squares regression (PLSR) models for discriminating ginseng samples were determined by selecting normalization methods, number of partial-least-squares (PLS) components, and variable influence on projection (VIP) cutoff values. The best prediction model for discriminating 5-and 6-year-old ginseng was developed using tap root, vector normalization applied after the second differentiation, one PLS component, and a VIP cutoff of 1.0 (based on the lowest root-mean-square error of prediction value). In addition, for discriminating among the three parts of P. ginseng, optimized PLSR models were established using data sets obtained from vector normalization, two PLS components, and VIP cutoff values of 1.5 (for 5-year-old ginseng) and 1.3 (for 6-year-old ginseng). To our knowledge, this is the first study to provide a novel strategy for rapidly discriminating the cultivation ages and parts of P. ginseng using FT-IR by selected normalization methods, number of PLS components, and VIP cutoff values.	[Lee, Byeong-Ju; Kim, Hye-Youn; Lim, Sa Rang; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Biointegrat Res Ctr Nutra Pharmaceut Epigenet, Seoul, South Korea; [Huang, Linfang] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China	Chung Ang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Biointegrat Res Ctr Nutra Pharmaceut Epigenet, Seoul, South Korea.	hykychoi@cau.ac.kr		Choi, Hyung-Kyoon/0000-0002-4523-0534	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2015R1A5A1008958]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [316081-04]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) - Ministry of Agriculture, Food and Rural Affairs (MAFRA)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2015R1A5A1008958) and by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Advanced Production Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (316081-04).	Akarachantachote N., 2014, INT J PURE APPL MATH, V94, P307, DOI [10.12732/ijpam.v94i3.2, DOI 10.12732/IJPAM.V94I3.2]; Aksoy C, 2012, SPECTROSC-INT J, V27, P167, DOI 10.1155/2012/513286; Baker MJ, 2008, BRIT J CANCER, V99, P1859, DOI 10.1038/sj.bjc.6604753; Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110; Beleites C, 2005, VIB SPECTROSC, V38, P143, DOI 10.1016/j.vibspec.2005.02.020; Bruun SW, 2006, APPL SPECTROSC, V60, P1029, DOI 10.1366/000370206778397371; Channa NA, 2007, J LIAQUAT UNIV MED H, V6, P66; Cho WCS, 2006, EUR J PHARMACOL, V550, P173, DOI 10.1016/j.ejphar.2006.08.056; Choi Jaeeul, 2010, [KOREAN JOURNAL OF MEDICINAL CROP SCIENCE, 한국약용작물학회지], V18, P118; Chung SH, 2001, ARCH PHARM RES, V24, P214, DOI 10.1007/BF02978260; Coon JT, 2002, DRUG SAFETY, V25, P323, DOI 10.2165/00002018-200225050-00003; Dey L, 2003, PHYTOMEDICINE, V10, P600, DOI 10.1078/094471103322331908; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Eriksson L., 2013, MULTI MEGAVARIATE DA; Feng L, 2016, J ETHNOPHARMACOL, V188, P39, DOI 10.1016/j.jep.2016.04.028; Filik J, 2012, ANALYST, V137, P853, DOI 10.1039/c2an15995c; Gault N, 2003, RADIAT RES, V160, P238, DOI 10.1667/RR3020.1; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Hu C, 2001, J AM OIL CHEM SOC, V78, P249, DOI 10.1007/s11746-001-0253-8; Kang SW, 2010, KOREAN GINSENG; Kareru PG, 2008, AFR J TRADIT COMPLEM, V5, P56; KIM JY, 1990, IMMUNOPHARM IMMUNOT, V12, P257, DOI 10.3109/08923979009019672; Kim N, 2011, J AGR FOOD CHEM, V59, P10435, DOI 10.1021/jf201718r; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kwon YK, 2014, J GINSENG RES, V38, P52, DOI 10.1016/j.jgr.2013.11.006; Lee DY, 2011, FOOD SCI BIOTECHNOL, V20, P1119, DOI 10.1007/s10068-011-0152-0; Lee SW, 2002, J GINSENG RES, V26, P213; Li C, 2012, INT J BIOL MACROMOL, V51, P968, DOI 10.1016/j.ijbiomac.2012.06.031; Li YM, 2004, VIB SPECTROSC, V36, P227, DOI 10.1016/j.vibspec.2003.12.009; Liu D, 2008, J MOL STRUCT, V883, P228, DOI 10.1016/j.molstruc.2008.02.025; Lum JHK, 2002, PROTEOMICS, V2, P1123, DOI 10.1002/1615-9861(200209)2:9<1123::AID-PROT1123>3.0.CO;2-S; Mao Q, 2014, J PHARMACEUT BIOMED, V97, P129, DOI 10.1016/j.jpba.2014.04.032; Matsuda Hideaki, 2010, Yakushigaku Zasshi, V45, P40; Meade AD, 2007, ANAL BIOANAL CHEM, V387, P1717, DOI 10.1007/s00216-006-0876-5; Meurens M, 1996, VIB SPECTROSC, V10, P341, DOI 10.1016/0924-2031(95)00030-5; Park EH, 2014, J GINSENG RES, V38, P22, DOI 10.1016/j.jgr.2013.11.007; PGaridel H.S., 2006, BIOPROCESS INT, P48; Rai D, 2003, J PHARMACOL SCI, V93, P458, DOI 10.1254/jphs.93.458; SCAGLIONE F, 1990, DRUG EXP CLIN RES, V16, P537; Shi W, 2007, FOOD CHEM, V102, P664, DOI 10.1016/j.foodchem.2006.05.053; Shibata S, 2001, J KOREAN MED SCI, V16, pS28, DOI 10.3346/jkms.2001.16.S.S28; Smidt E, 2007, WASTE MANAGE, V27, P268, DOI 10.1016/j.wasman.2006.01.016; Taylor J, 2002, BIOINFORMATICS, V18, pS241, DOI 10.1093/bioinformatics/18.suppl_2.S241; van der Kooy F, 2009, PLANTA MED, V75, P763, DOI 10.1055/s-0029-1185450; Xiang Z, 2011, PHYTOCHEM ANALYSIS, V22, P411, DOI 10.1002/pca.1296; Yang SO, 2013, J GINSENG RES, V37, P248, DOI 10.5142/jgr.2013.37.248; Yang SO, 2012, J PHARMACEUT BIOMED, V58, P19, DOI 10.1016/j.jpba.2011.09.016; Yap KYL, 2007, FOOD RES INT, V40, P643, DOI 10.1016/j.foodres.2006.11.009; Yun TK, 2001, J KOREAN MED SCI, V16, pS6, DOI 10.3346/jkms.2001.16.S.S6; Zhang YL, 2010, J MOL STRUCT, V974, P94, DOI 10.1016/j.molstruc.2009.12.027; Zhao XY, 2015, J FOOD PROCESS PRES, V39, P2017, DOI 10.1111/jfpp.12442	51	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186664	10.1371/journal.pone.0186664	http://dx.doi.org/10.1371/journal.pone.0186664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049369	gold, Green Submitted, Green Published			2022-12-26	WOS:000413195900095
J	Palacio, M; Robledo, GL; Reck, MA; Grassi, E; Goes-Neto, A; Drechsler-Santos, ER				Palacio, Melissa; Lucio Robledo, Gerardo; Reck, Mateus Arduvino; Grassi, Emanuel; Goes-Neto, Aristoteles; Drechsler-Santos, Elisandro Ricardo			Decrypting the Polyporus dictyopus complex: Recovery of Atroporus Ryvarden and segregation of Neodictyopus gen. nov (Polyporales, Basidiomyocta)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; DIVERSITY; MUSHROOMS; LENTINUS; RPB2	Polyporus dictyopus, with a large number of heterotypic synonyms, has been traditionally considered a species complex, characterized by wide morphological variation and geographic distribution. Thus, neotropical specimens previously identified as P. dictyopus from Amazonia, Cerrado and Atlantic Forest biomes were studied based on detailed macro-and micromorphological examination and phylogenetic analyses, using distinct ribosomal and protein-coding genomic regions: the nuclear ribosomal internal transcribed spacer (nrITS), nuclear ribosomal large subunit (nrLSU), and RNA polymerase II second subunit (RPB2). Two unrelated generic lineages, each one represented by different species, are reported: Atroporus is recovered and re-circumscribed to include A. diabolicus and A. rufoatratus comb. nov.; Neodictyopus gen. nov. is proposed to accommodate N. dictyopus comb. nov. and two new species, N. atlanticae and N. gugliottae. Our study showed that at least five distinct species were hidden under the name P. dictyopus. Detailed descriptions, pictures, illustrations, and a key are provided for Atroporus and Neodictyopus species.	[Palacio, Melissa; Reck, Mateus Arduvino; Drechsler-Santos, Elisandro Ricardo] Univ Fed Santa Catarina, Dept Botan, Programa Posgrad Biol Fungos Algas & Plantas, Florianopolis, SC, Brazil; [Lucio Robledo, Gerardo] Univ Nacl Cordoba, Inst Multidisciplinario Biol Vegetal, Cordoba, Spain; [Grassi, Emanuel] Inst Misionero Biodiversidad IMiBio, Puerto Iguazu Misiones, Argentina; [Goes-Neto, Aristoteles] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Mol & Computat Biol Fungi Lab, Belo Horizonte, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Minas Gerais	Palacio, M; Drechsler-Santos, ER (corresponding author), Univ Fed Santa Catarina, Dept Botan, Programa Posgrad Biol Fungos Algas & Plantas, Florianopolis, SC, Brazil.; Robledo, GL (corresponding author), Univ Nacl Cordoba, Inst Multidisciplinario Biol Vegetal, Cordoba, Spain.	melissapalacio@gmail.com; glrobledo@yahoo.com; e.ricardo@ufsc.br	Robledo, Gerardo/AAG-6715-2021; Goes-Neto, Aristoteles/A-6955-2013; Drechsler-Santos, Elisandro Ricardo/H-9743-2012	Robledo, Gerardo/0000-0002-3840-1104; Goes-Neto, Aristoteles/0000-0002-7692-6243; Drechsler-Santos, Elisandro Ricardo/0000-0002-3702-8715; Palacio, Melissa/0000-0003-2890-5189	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES (PNPD Institucional) [2011-23038.007790/2011-93]; PPGFAP/UFSC; BrBOL; FONCYT [PICT-2015-0830]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES (PNPD Institucional)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PPGFAP/UFSC; BrBOL; FONCYT(FONCyT)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided a master's scholarship for MP. CAPES (PNPD Institucional 2011-23038.007790/2011-93) provided support to MAR. Fiocruz performed the molecular sequencing. PPGFAP/UFSC and BrBOL provided partial financing of the research. FONCYT (PICT-2015-0830) provided financial support to G. Robledo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Berkeley MJ, 1856, HOOKERS LONDON J BOT, V8, P174; Da Silveira RMB, 2005, MYCOTAXON, V93, P1; Dai YC, 2014, FUNGAL DIVERS, V64, P133, DOI 10.1007/s13225-013-0248-3; Decock C, 2013, CRYPTOGAMIE MYCOL, V34, P15, DOI 10.7872/crym.v34.iss1.2013.15; Dentinger BTM, 2010, MOL ECOL RESOUR, V10, P628, DOI 10.1111/j.1755-0998.2009.02825.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Froslev TG, 2005, MOL PHYLOGENET EVOL, V37, P602, DOI 10.1016/j.ympev.2005.06.016; Gilbertson R. L., 1987, N AM POLYPORES, V2; Goes-Neto A, 1999, MYCOTAXON, V72, P43; Goes-Neto A., 2005, BIOTEMAS, V18, P19, DOI [10.5007/%25x, DOI 10.5007/%25X, DOI 10.5007/%25x]; Gomes-Silva AC, 2011, NOVA HEDWIGIA, V94, P227, DOI 10.1127/0029-5035/2012/0094-0227; Louza Gisele Siquelli Gouveia, 2007, Hoehnea, V34, P365; Gugliotta Adriana M., 1996, Revista Brasileira de Botanica, V19, P185; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HIBBETT DS, 1993, SYST BOT, V18, P409, DOI 10.2307/2419417; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kruger D, 2006, MYCOL PROG, V5, P185, DOI 10.1007/s11557-006-0512-y; Kruys N, 1999, CAN J FOREST RES, V29, P1295, DOI 10.1139/cjfr-29-8-1295; Li HJ, 2014, PERSOONIA, V32, P170, DOI 10.3767/003158514X681828; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; Miller M.A., 2010, P GAT COMP ENV WORKS; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Munsell, 1975, SOIL COLORS CHARTS; Nunez M, 1995, POLYPORUS BASIDIOMY; NUNEZ M., 2001, E ASIAN POLYPORES; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RYVARDEN L, 1976, Kew Bulletin, V31, P81, DOI 10.2307/4108997; RYVARDEN L, 1973, Norwegian Journal of Botany, V20, P1; RYVARDEN L., 1994, SYNOPSIS FUNGORUM, V7, P394; Ryvarden L, 1980, FUNGIFLORA, P1; Seelan JSS, 2015, MYCOLOGIA, V107, P460, DOI 10.3852/14-084; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Sotome K, 2008, MYCOLOGIA, V100, P603, DOI 10.3852/07-191R; Sotome K, 2013, FUNGAL DIVERS, V58, P245, DOI 10.1007/s13225-012-0213-6; Sotome K, 2011, MYCOSCIENCE, V52, P319, DOI 10.1007/s10267-011-0111-x; Sotome K, 2009, MYCOL PROG, V8, P123, DOI 10.1007/s11557-009-0584-6; Stalpers J. A., 1996, Studies in Mycology; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Zhou JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159495; Zmitrovich IV, 2016, INT J MED MUSHROOMS, V18, P23, DOI 10.1615/IntJMedMushrooms.v18.i1.40	46	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186183	10.1371/journal.pone.0186183	http://dx.doi.org/10.1371/journal.pone.0186183			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049417	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900047
J	Dixit, S; Alonso, A; Vittinghoff, E; Soliman, E; Chen, LY; Marcus, GM				Dixit, Shalini; Alonso, Alvaro; Vittinghoff, Eric; Soliman, Elsayed; Chen, Lin Y.; Marcus, Gregory M.			Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							AFRICAN-AMERICANS; WHITES	Background Although current alcohol consumption is a risk factor for incident atrial fibrillation (AF), the more clinically relevant question may be whether alcohol cessation is associated with a reduced risk. Methods and results We studied participants enrolled in the Atherosclerosis Risk in Communities Study (ARIC) between 1987 and 1989 without prevalent AF. Past and current alcohol consumption were ascertained at baseline and at 3 subsequent visits. Incident AF was ascertained via study ECGs, hospital discharge ICD-9 codes, and death certificates. Of 15,222 participants, 2,886 (19.0%) were former drinkers. During a median follow-up of 19.7 years, there were 1,631 cases of incident AF, 370 occurring in former consumers. Former drinkers had a higher rate of AF compared to lifetime abstainers and current drinkers. After adjustment for potential confounders, every decade abstinent from alcohol was associated with an approximate 20% (95% CI 11-28%) lower rate of incident AF; every additional decade of past alcohol consumption was associated with a 13% (95% CI 3-25%) higher rate of AF; and every additional drink per day during former drinking was associated with a 4% (95% CI 0-8%) higher rate of AF. Conclusions Among former drinkers, the number of years of drinking and the amount of alcohol consumed may each confer an increased risk of AF. Given that a longer duration of abstinence was associated with a decreased risk of AF, earlier modification of alcohol use may have a greater influence on AF prevention.	[Dixit, Shalini; Marcus, Gregory M.] Univ Calif San Francisco, Dept Med, Div Cardiol, Cardiac Electrophysiol Sect, San Francisco, CA 94143 USA; [Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Soliman, Elsayed] Wake Forest Univ, Dept Epidemiol, Div Publ Hlth Sci, Sch Med, Winston Salem, NC 27109 USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Cardiovasc Div, Minneapolis, MN 55455 USA	University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities	Marcus, GM (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, Cardiac Electrophysiol Sect, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021; Soliman, Elsayed Z/AAD-7135-2020; Alonso, Alvaro/A-4917-2010	Marcus, Gregory/0000-0001-5197-7696; Soliman, Elsayed Z/0000-0001-5632-8150; Alonso, Alvaro/0000-0002-2225-8323; Chen, Lin/0000-0002-0700-814X	National Center for Advancing Translational Sciences / National Institutes of Health (NIH) through UCSF-CTSI Grant [TL1 TR000144]; Doris Duke Charitable Foundation (DDCF); National Institute on Alcohol Abuse and Alcoholism (NIAAA)/NIH [R01AA022222]; American Heart Association [16EIA26410001]; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]	National Center for Advancing Translational Sciences / National Institutes of Health (NIH) through UCSF-CTSI Grant; Doris Duke Charitable Foundation (DDCF)(Doris Duke Charitable Foundation (DDCF)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.D. was supported by the National Center for Advancing Translational Sciences (https://ncats.nih.gov/) / National Institutes of Health (NIH, https://www.nih.gov/) through UCSF-CTSI Grant Number TL1 TR000144 and by the Doris Duke Charitable Foundation (DDCF, http://www.ddcf.org/). This study was also funded by grant R01AA022222 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA, https://www.niaaa.nih.gov/)/NIH (G.M.M.), grant 16EIA26410001 from the American Heart Association (A.A., http://www.heart.org/HEARTORG/), and by National Heart, Lung, and Blood Institute (NHLBI, https://www.nhlbi.nih.gov/) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, UCSF or the DDCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Chamberlain AM, 2011, HEART RHYTHM, V8, P1160, DOI 10.1016/j.hrthm.2011.03.038; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; Conen D, 2008, JAMA-J AM MED ASSOC, V300, P2489, DOI 10.1001/jama.2008.755; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004; Dukes JW, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2714; Eigenbrodt ML, 2001, AM J EPIDEMIOL, V153, P1102, DOI 10.1093/aje/153.11.1102; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Kodama S, 2011, J AM COLL CARDIOL, V57, P427, DOI 10.1016/j.jacc.2010.08.641; Mandyam MC, 2012, AM J CARDIOL, V110, P364, DOI 10.1016/j.amjcard.2012.03.033; Marcus GM, 2010, ARCH INTERN MED, V170, P1874, DOI 10.1001/archinternmed.2010.426; McManus DD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004060; Misialek JR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001159; Mukamal KJ, 2007, AM HEART J, V153, P260, DOI 10.1016/j.ahj.2006.10.039; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Shen JA, 2011, AM J CLIN NUTR, V93, P261, DOI 10.3945/ajcn.110.001305; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Volcik KA, 2008, ANN EPIDEMIOL, V18, P101, DOI 10.1016/j.annepidem.2007.07.103; Whitman IR, 2017, J AM COLL CARDIOL, V69, P13, DOI 10.1016/j.jacc.2016.10.048; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	22	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185228	10.1371/journal.pone.0185228	http://dx.doi.org/10.1371/journal.pone.0185228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045461	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100012
J	Marchbank, T; Playford, RJ				Marchbank, Tania; Playford, Raymond J.			Trefoil factor family peptides enhance cell migration by increasing cellular osmotic permeability and aquaporin 3 levels	FASEB JOURNAL			English	Article						repair; gastrointestinal; regulatory peptides; growth factors; pathophysiology	EPIDERMAL-GROWTH-FACTOR; SECRETORY TRYPSIN-INHIBITOR; INFLAMMATORY-BOWEL-DISEASE; WATER PERMEABILITY; EPITHELIAL BARRIER; IN-VITRO; MICE; PS2; ADENOCARCINOMA; PROLIFERATION	Trefoil factor family (TFF) peptides are produced rapidly at sites of injury, stimulating epithelial migration, a process involving rapid changes in cell shape and volume, requiring rapid flow of water into and out of the cell. We examined the effect of TFFs on fluidity of cells by measuring their sensitivity to osmotic challenges and cell migration, and determined whether those results were mediated through altering the levels of aquaporins (AQPs), a family of transmembrane water channels involved in cellular water homeostasis. Gastric (AGS) and colonic (Caco-2) cell lines had intrinsic TFF levels determined and the predominant TFF peptide knocked down (RNA interference). Knockdown caused lessened responsiveness to changes in external osmotic challenge (by 51 and 69% in AGS and Caco-2 cells, respectively) and reduced cell migration and transepithelial permeability but did not influence proliferation. Exogenous TFF increased several AQPs, particularly AQP3, and those were reciprocally reduced in knockdown cells. TFF-induced, but not fetal calf serum-induced, cell migration was inhibited by the presence of AQP3 blocker (CuSO4). We summarize that TFF peptides promptly produced at sites of injury increase AQP levels, most notably AQP3, thereby enhancing the cells' ability to rapidly change their shape as part of the restitutive process. TFF peptides also require functioning AQP3 channels to induce cell migration.	[Marchbank, Tania; Playford, Raymond J.] Plymouth Univ Peninsula Sch Med & Dent, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England		Playford, RJ (corresponding author), Plymouth Univ Peninsula Sch Med & Dent, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England.	raymond.playford@plymouth.ac.uk		Playford, Raymond/0000-0003-1235-8504				BARRANCO SC, 1983, CANCER RES, V43, P1703; CHINERY R, 1995, CLIN SCI, V88, P401, DOI 10.1042/cs0880401; Fenton RA, 2010, AM J PHYSIOL-RENAL, V298, pF224, DOI 10.1152/ajprenal.00463.2009; FitzGerald AJ, 2004, PEPTIDES, V25, P793, DOI 10.1016/j.peptides.2003.12.022; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Huang YM, 2010, CANCER BIOL THER, V9, P1000, DOI 10.4161/cbt.9.12.11705; Jaeger M, 1999, BIOPHYS J, V77, P1257, DOI 10.1016/S0006-3495(99)76977-8; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Lin N, 2013, BIOCHEM BIOPH RES CO, V440, P143, DOI 10.1016/j.bbrc.2013.09.049; Marchbank T, 1998, J PATHOL, V185, P153; Marchbank T, 2013, AM J PHYSIOL-RENAL, V305, pF382, DOI 10.1152/ajprenal.00357.2012; Marchbank T, 2009, AM J PHYSIOL-GASTR L, V296, pG697, DOI 10.1152/ajpgi.90565.2008; Martini E, 2017, CELL MOL GASTROENTER, V4, P33, DOI 10.1016/j.jcmgh.2017.03.007; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Matsuzaki Toshiyuki, 2004, Medical Electron Microscopy, V37, P71; Meir M, 2015, AM J PHYSIOL-GASTR L, V309, pG613, DOI 10.1152/ajpgi.00357.2014; Murphy MS, 1998, NUTRITION, V14, P771, DOI 10.1016/S0899-9007(98)00081-1; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; PLAYFORD RJ, 1995, GUT, V37, P595, DOI 10.1136/gut.37.5.595; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P108, DOI 10.1016/0016-5085(95)90014-4; Playford RJ, 1996, P NATL ACAD SCI USA, V93, P2137, DOI 10.1073/pnas.93.5.2137; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thiagarajah JR, 2017, P NATL ACAD SCI USA, V114, P568, DOI 10.1073/pnas.1612921114; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Wang JP, 2012, CANCER LETT, V319, P109, DOI 10.1016/j.canlet.2011.12.040; Yang PC, 2007, J GASTROEN HEPATOL, V22, P1823, DOI 10.1111/j.1440-1746.2006.04710.x; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zhu C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091399	35	7	7	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1017	1024		10.1096/fj.201700799R	http://dx.doi.org/10.1096/fj.201700799R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29046361	Green Submitted			2022-12-26	WOS:000425146900041
J	Ayed, SH; Cloutier, AD; McLeod, LJ; Foo, ACY; Damry, AM; Goto, NK				Ayed, Saud H.; Cloutier, Adam D.; McLeod, Laura J.; Foo, Alexander C. Y.; Damry, Adam M.; Goto, Natalie K.			Dissecting the role of conformational change and membrane binding by the bacterial cell division regulator MinE in the stimulation of MinD ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; cell division; circular dichroism (CD); conformational change; enzyme kinetics; nuclear magnetic resonance (NMR); protein structure; protein-lipid interaction	PROTEIN SECONDARY STRUCTURE; TO-POLE OSCILLATION; ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; IN-VITRO; TOPOLOGICAL SPECIFICITY; DYNAMIC LOCALIZATION; INHIBITOR MINC; CIRCULAR-DICHROISM; CORRECT PLACEMENT	The bacterial cell division regulators MinD and MinE together with the division inhibitor MinC localize to the membrane in concentrated zones undergoing coordinated pole-to-pole oscillation to help ensure that the cytokinetic division septum forms only at the mid-cell position. This dynamic localization is driven by MinD-catalyzed ATP hydrolysis, stimulated by interactions with MinE's anti-MinCD domain. This domain is buried in the 6--stranded MinE closed structure, but is liberated for interactions with MinD, giving rise to a 4--stranded open structure through an unknown mechanism. Here we show that MinE-membrane interactions induce a structural change into a state resembling the open conformation. However, MinE mutants lacking the MinE membrane-targeting sequence stimulated higher ATP hydrolysis rates than the full-length protein, indicating that binding to MinD is sufficient to trigger this conformational transition in MinE. In contrast, conformational change between the open and closed states did not affect stimulation of ATP hydrolysis rates in the absence of membrane binding, although the MinD-binding residue Ile-25 is critical for this conformational transition. We therefore propose an updated model where MinE is brought to the membrane through interactions with MinD. After stimulation of ATP hydrolysis, MinE remains bound to the membrane in a state that does not catalyze additional rounds of ATP hydrolysis. Although the molecular basis for this inhibited state is unknown, previous observations of higher-order MinE self-association may explain this inhibition. Overall, our findings have general implications for Min protein oscillation cycles, including those that regulate cell division in bacterial pathogens.	[Ayed, Saud H.; Cloutier, Adam D.; McLeod, Laura J.; Foo, Alexander C. Y.; Damry, Adam M.; Goto, Natalie K.] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Goto, NK (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada.	ngoto@uottawa.ca	Goto, Natalie/AAO-7979-2020	Goto, Natalie/0000-0003-4877-4884; Foo, Alexander/0000-0002-4331-2085	NSERC Discovery grant; Dr. Yu Scholarship; Ontario Graduate Scholarship; NSERC postgraduate scholarship	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dr. Yu Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC postgraduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by an NSERC Discovery grant (to N. K. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Dr. Yu Scholarship.; Supported by an Ontario Graduate Scholarship.; Supported by an NSERC postgraduate scholarship.	ADLER HI, 1967, P NATL ACAD SCI USA, V57, P321, DOI 10.1073/pnas.57.2.321; ANTHONY LSD, 1994, FEMS MICROBIOL LETT, V124, P157, DOI 10.1111/j.1574-6968.1994.tb07278.x; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eng NF, 2006, RES MICROBIOL, V157, P333, DOI 10.1016/j.resmic.2005.09.005; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani H, 2010, P NATL ACAD SCI USA, V107, P18416, DOI 10.1073/pnas.1007141107; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laughlin RB, 2015, P NATL ACAD SCI USA, V112, P10371, DOI 10.1073/pnas.1422855112; Leger MM, 2015, P NATL ACAD SCI USA, V112, P10239, DOI 10.1073/pnas.1421392112; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Park KT, 2017, P NATL ACAD SCI USA, V114, P7497, DOI 10.1073/pnas.1707385114; Park KT, 2012, MOL MICROBIOL, V85, P271, DOI 10.1111/j.1365-2958.2012.08110.x; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Parti RP, 2011, MICROB PATHOGENESIS, V51, P378, DOI 10.1016/j.micpath.2011.07.003; Parti RP, 2011, MICROBES INFECT, V13, P545, DOI 10.1016/j.micinf.2011.01.018; Ramirez-Arcos S, 2002, MOL MICROBIOL, V46, P493, DOI 10.1046/j.1365-2958.2002.03168.x; Ramirez-Arcos S, 2001, MICROBIOL-SGM, V147, P225, DOI 10.1099/00221287-147-1-225; Ramos D, 2006, BIOCHEMISTRY-US, V45, P4593, DOI 10.1021/bi060022j; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000; Sengupta S, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/056003; Shih YL, 2013, ENVIRON MICROBIOL, V15, P3229, DOI 10.1111/1462-2920.12119; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; SUD IJ, 1975, J BACTERIOL, V124, P713, DOI 10.1128/JB.124.2.713-717.1975; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szeto J, 2004, J BACTERIOL, V186, P7175, DOI 10.1128/JB.186.21.7175-7185.2004; Szeto J, 2001, J BACTERIOL, V183, P6253, DOI 10.1128/JB.183.21.6253-6264.2001; Taghbalout A, 2006, J BACTERIOL, V188, P2993, DOI 10.1128/JB.188.8.2993-3001.2006; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Vecchiarelli AG, 2016, P NATL ACAD SCI USA, V113, pE1479, DOI 10.1073/pnas.1600644113; Vecchiarelli AG, 2014, MOL MICROBIOL, V93, P453, DOI 10.1111/mmi.12669; Walsh JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128148; WESTLINGHAGGSTROM B, 1977, J BACTERIOL, V129, P333; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WOLDRINGH CL, 1990, RES MICROBIOL, V141, P39, DOI 10.1016/0923-2508(90)90096-9; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Zheng M, 2014, J BIOL CHEM, V289, P21252, DOI 10.1074/jbc.M114.571976; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003; Zieske K, 2014, ELIFE, V3, DOI 10.7554/eLife.03949; Zieske K, 2014, FEBS LETT, V588, P2545, DOI 10.1016/j.febslet.2014.06.026; Zieske K, 2013, ANGEW CHEM INT EDIT, V52, P459, DOI 10.1002/anie.201207078	69	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20732	20743		10.1074/jbc.M117.805945	http://dx.doi.org/10.1074/jbc.M117.805945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29066619	Green Published, hybrid			2022-12-26	WOS:000418267000033
J	Rossi, D; Palmio, J; Evila, A; Galli, L; Barone, V; Caldwell, TA; Policke, RA; Aldkheil, E; Berndsen, CE; Wright, NT; Malfatti, E; Brochier, G; Pierantozzi, E; Jordanova, A; Guergueltcheva, V; Romero, NB; Hackman, P; Eymard, B; Udd, B; Sorrentino, V				Rossi, Daniela; Palmio, Johanna; Evila, Anni; Galli, Lucia; Barone, Virginia; Caldwell, Tracy A.; Policke, Rachel A.; Aldkheil, Esraa; Berndsen, Christopher E.; Wright, Nathan T.; Malfatti, Edoardo; Brochier, Guy; Pierantozzi, Enrico; Jordanova, Albena; Guergueltcheva, Velina; Romero, Norma Beatriz; Hackman, Peter; Eymard, Bruno; Udd, Bjarne; Sorrentino, Vincenzo			A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy	PLOS ONE			English	Article							FILAMIN-C; MYOFIBRILLAR MYOPATHY; SARCOPLASMIC-RETICULUM; PROTEIN AGGREGATION; M-BAND; OBSCURIN; DOMAIN; MUTATIONS; INTEGRITY; DIAGNOSIS	A novel FLNC c.5161delG (p.Gly1722ValfsTer61) mutation was identified in two members of a French family affected by distal myopathy and in one healthy relative. This FLNC c.5161delG mutation is one nucleotide away from a previously reported FLNC mutation (c.5160delC) that was identified in patients and in asymptomatic carriers of three Bulgarian families with distal muscular dystrophy, indicating a low penetrance of the FLNC frameshift mutations. Given these similarities, we believe that the two FLNC mutations alone can be causative of distal myopathy without full penetrance. Moreover, comparative analysis of the clinical manifestations indicates that patients of the French family show an earlier onset and a complete segregation of the disease. As a possible explanation of this, the two French patients also carry a OBSCN c.13330C>T (p.Arg4444Trp) mutation. The p.Arg4444Trp variant is localized within the OBSCN Ig59 domain that, together with Ig58, binds to the ZIg9/ZIg10 domains of titin at Z-disks. Structural and functional studies indicate that this OBSCN p.Arg4444Trp mutation decreases titin binding by similar to 15-fold. On this line, we suggest that the combination of the OBSCN p.Arg4444Trp variant and of the FLNC c.5161delG mutation, can cooperatively affect myofibril stability and increase the penetrance of muscular dystrophy in the French family.	[Rossi, Daniela; Galli, Lucia; Barone, Virginia; Pierantozzi, Enrico; Sorrentino, Vincenzo] Univ Siena, Dept Mol & Dev Med, Mol Med Sect, Siena, Italy; [Rossi, Daniela; Galli, Lucia; Barone, Virginia; Pierantozzi, Enrico; Sorrentino, Vincenzo] Azienda Osped Univ Senese, Siena, Italy; [Palmio, Johanna; Udd, Bjarne] Tampere Univ, Neuromuscular Res Ctr, Tampere, Finland; [Palmio, Johanna; Udd, Bjarne] Univ Hosp, Tampere, Finland; [Evila, Anni; Hackman, Peter; Udd, Bjarne] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Evila, Anni; Hackman, Peter; Udd, Bjarne] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; [Caldwell, Tracy A.; Policke, Rachel A.; Aldkheil, Esraa; Berndsen, Christopher E.; Wright, Nathan T.] James Madison Univ, Dept Chem & Biochem, Harrisonburg, VA 22807 USA; [Malfatti, Edoardo; Brochier, Guy; Romero, Norma Beatriz; Eymard, Bruno] Grp Hosp La Pitie Salpetriere, Myol Inst, Neuromuscular Morphol Unit, Paris, France; [Malfatti, Edoardo; Brochier, Guy; Romero, Norma Beatriz; Eymard, Bruno] Grp Hosp La Pitie Salpetriere, Myol Inst, Reference Ctr Neuromuscular Dis, Paris, France; [Jordanova, Albena] Univ Antwerp, Mol Neurogen Grp, Antwerp, Belgium; [Jordanova, Albena] Med Univ Sofia, Dept Med Chem & Biochem, Mol Med Ctr, Sofia, Bulgaria; [Guergueltcheva, Velina] Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; [Udd, Bjarne] Vaasa Cent Hosp, Dept Neurol, Vaasa, Finland	University of Siena; University of Siena; University Hospital of Siena; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Helsinki; James Madison University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Antwerp; Medical University Sofia; Medical University Sofia; Vaasa Central Hospital	Sorrentino, V (corresponding author), Univ Siena, Dept Mol & Dev Med, Mol Med Sect, Siena, Italy.; Sorrentino, V (corresponding author), Azienda Osped Univ Senese, Siena, Italy.	vincenzo.sorrentino@unisi.it	Barone, Virginia/K-8782-2015; Rossi, Daniela/G-7764-2012; Sorrentino, Vincenzo/A-4793-2014; Jordanova, Albena/H-8323-2015	Barone, Virginia/0000-0001-8794-9291; Rossi, Daniela/0000-0003-0463-7327; Sorrentino, Vincenzo/0000-0002-8573-8631; Jordanova, Albena/0000-0002-3833-3754; Wright, Nathan/0000-0003-0177-6129; PIERANTOZZI, Enrico/0000-0003-2925-7339; Caldwell, Tracy/0000-0003-2914-7076; Berndsen, Christopher/0000-0002-4285-4341	U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Research Corporation Cottrell College Award [22450]; NSF RUI [MCB-1607024]; NSF REU [CHE-1062629]; 4-VA organization; AFM-Telethon [18822]; Regione Toscana; Ministry of Health [RF-2013-02356787]; Ministry of Research (MIUR), PRIN [2015ZZR4W3]	U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Research Corporation Cottrell College Award(Research Corporation for Science Advancement); NSF RUI(National Science Foundation (NSF)); NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); 4-VA organization; AFM-Telethon(Association Francaise contre les Myopathies); Regione Toscana(Regione Toscana); Ministry of Health; Ministry of Research (MIUR), PRIN(Ministry of Education, Universities and Research (MIUR))	We thank Changsoo Chang and the staff at the Structural Biology Center at APS for their help in this work. Results shown in this report are derived from work performed using Beamline 19-ID-D at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work was supported by Research Corporation Cottrell College Award 22450, NSF RUI (MCB-1607024) and NSF REU award (CHE-1062629) to Nathan Wright, a grant from the 4-VA organization to Christopher Berndsen, and by AFM-Telethon grant 18822; Regione Toscana, ToRSADE project (FAS-Salute 2014); Ministry of Health, grant RF-2013-02356787; Ministry of Research (MIUR), PRIN 2015 grant 2015ZZR4W3 to Vincenzo Sorrentino.; We would like to thank Dr P. Carlier, MRI and Spectroscopy Unit, Institute of Myology, Paris, and Professors S. de Seze and C. Tranchant, Neurology Department, University hospital, Strasbourg, France. We also thank the participating patients and their families. We thank Changsoo Chang and the staff at the Structural Biology Center at APS for their help in this work and Linda Columbus (at University of Virginia) for the use of SPR instrumentation. Results shown in this report are derived from work performed using Beamline 19-ID-D at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by University of Chicago, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work was supported by Research Corporation Cottrell College Award 22450, NSF REU award (CHE-1062629), and NSF RUI (MCB-1607024) (to N.T.W.).	Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Bertoldi L, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1654-4; Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06; Duff RM, 2011, AM J HUM GENET, V88, P729, DOI 10.1016/j.ajhg.2011.04.021; Evila A, 2016, NEUROMUSCULAR DISORD, V26, P7, DOI 10.1016/j.nmd.2015.10.003; Evila A, 2014, ANN NEUROL, V75, P230, DOI 10.1002/ana.24102; Furst DO, 2013, ACTA NEUROPATHOL, V125, P33, DOI 10.1007/s00401-012-1054-9; Fujita M, 2012, DEV BIOL, V361, P79, DOI 10.1016/j.ydbio.2011.10.008; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Gautel M, 2016, J EXP BIOL, V219, P135, DOI 10.1242/jeb.124941; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; Guergueltcheva V, 2011, NEUROLOGY, V77, P2105, DOI 10.1212/WNL.0b013e31823dc51e; Hu LYR, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603081; Kley RA, 2012, BRAIN, V135, P2642, DOI 10.1093/brain/aws200; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Leber Y, 2016, HUM MOL GENET, V25, P2776, DOI 10.1093/hmg/ddw135; Lowe T, 2007, HUM MOL GENET, V16, P1351, DOI 10.1093/hmg/ddm085; Luan XH, 2010, NEUROMUSCULAR DISORD, V20, P390, DOI 10.1016/j.nmd.2010.03.009; Malfatti E, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-44; Marston S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138568; Mastaglia FL, 1999, J NEUROL NEUROSUR PS, V67, P703, DOI 10.1136/jnnp.67.6.703; Meyer LC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00368; Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157; Ng R, 2012, PROG MOL BIOL TRANSL, V105, P83, DOI 10.1016/B978-0-12-394596-9.00004-4; Pernigo S, 2010, P NATL ACAD SCI USA, V107, P2908, DOI 10.1073/pnas.0913736107; Randazzo D, 2017, AM J PHYSIOL-CELL PH, V312, pC16, DOI 10.1152/ajpcell.00098.2016; Randazzo D, 2017, EXPERT OPIN THER TAR, V21, P897, DOI 10.1080/14728222.2017.1361931; Randazzo D, 2013, J CELL BIOL, V200, P523, DOI 10.1083/jcb.201205118; Razinia Z, 2012, ANNU REV BIOPHYS, V41, P227, DOI 10.1146/annurev-biophys-050511-102252; Rossi D, 2014, HUM MUTAT, V35, P1163, DOI 10.1002/humu.22631; Rossi D, 2014, BIOCHEM J, V458, P407, DOI 10.1042/BJ20130719; Rudloff MW, 2015, PROTEIN SCI, V24, P946, DOI 10.1002/pro.2670; Ruparelia AA, 2012, HUM MOL GENET, V21, P4073, DOI 10.1093/hmg/dds231; Sewry CA, 2010, ACTA NEUROPATHOL, V120, P343, DOI 10.1007/s00401-010-0727-5; Shatunov A, 2009, EUR J HUM GENET, V17, P656, DOI 10.1038/ejhg.2008.226; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Udd B, 2001, CURR OPIN NEUROL, V14, P561, DOI 10.1097/00019052-200110000-00003; Udd B, 2012, NEUROMUSCULAR DISORD, V22, P5, DOI 10.1016/j.nmd.2011.10.003; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110	41	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186642	10.1371/journal.pone.0186642	http://dx.doi.org/10.1371/journal.pone.0186642			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073160	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400036
J	Scott, I; Umair, S; Savoian, MS; Simpson, HV				Scott, Ian; Umair, Saleh; Savoian, Matthew S.; Simpson, Heather V.			Abomasal dysfunction and cellular and mucin changes during infection of sheep with larval or adult Teladorsagia circumcincta	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; HAEMONCHUS-CONTORTUS LARVAE; OSTERTAGIA-CIRCUMCINCTA; EXCRETORY/SECRETORY PRODUCTS; PARIETAL-CELLS; EPITHELIAL-CELLS; GASTRIC-MUCOSA; NIPPOSTRONGYLUS-BRASILIENSIS; IMMUNE EXCLUSION; PRIMARY CULTURES	This is the first integrated study of the effects on gastric secretion, inflammation and fundic mucins after infection with L3 T. circumcincta and in the very early period following transplantation of adult worms. At 3 months-of-age, 20 Coopworth lambs were infected intraruminally with 35,000 L3; infected animals were killed on Days 5, 10, 15, 20 and 30 postinfection and 6 controls on either Day 0 or 30 post-infection. Another 15 Romney cross lambs received 10,000 adult worms at 4-5 months-of-age though surgically-implanted abomasal cannulae and were killed after 6, 12, 24 and 72 hours; uninfected controls were also killed at 72 hours. Blood was collected at regular intervals from all animals for measurement of serum gastrin and pepsinogen and abomasal fluid for pH measurement from cannulated sheep. Tissues collected at necropsy were fixed in Bouin's fluid for light microscopy, immunocytochemistry and mucin staining and in Karnovsky's fluid for electron microscopy. Nodules around glands containing developing larvae were seen on Day 5 p.i., but generalised effects on secretion occurred only after parasite emergence and within hours after transplantation of adult worms. After L3 infection, there were maximum worm burdens on Days 10-15 post-infection, together with peak tissue eosinophilia, inhibition of gastric acid secretion, hypergastrinaemia,hyperpepsinogenaemia, loss of parietal cells, enlarged gastric pits containing less mucin and increased numbers of mucous neck cells. After adult transplantation, serum pepsinogen was significantly increased after 9 hours and serum gastrin after 18 hours. Parallel changes in host tissues and the numbers of parasites in the abomasal lumen suggest that luminal parasites, but not those in the tissues, are key drivers of the pathophysiology and inflammatory response in animals exposed to parasites for the first time. These results are consistent with initiation of the host response by parasite chemicals diffusing across the surface epithelium, possibly aided by components of ES products which increased permeability. Parietal cells appear to be a key target, resulting in secondary increases in serum gastrin, pit elongation, loss of surface mucins and inhibition of chief cell maturation. Inflammation occurs in parallel, and could either cause the pathology or exacerbate the direct effects of ES products.	[Scott, Ian; Simpson, Heather V.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Umair, Saleh] AgResearch Ltd, Hopkirk Res Inst, Palmerston North, New Zealand; [Savoian, Matthew S.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; AgResearch - New Zealand; Massey University	Simpson, HV (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	H.V.Simpson@massey.ac.nz			Meat and Wool New Zealand [96MU 25/1.1]; Massey University Research Fund; C. Alma Baker Trust; E. & C. Thoms Bequest	Meat and Wool New Zealand; Massey University Research Fund; C. Alma Baker Trust; E. & C. Thoms Bequest	This work received support from Meat and Wool New Zealand (96MU 25/1.1 Development of alternative methods of parasite control), Massey University Research Fund, C. Alma Baker Trust, E. & C. Thoms Bequest. These funders provided support for research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr S. Umair is employed by AgResearch Ltd., who provided his salary and some research materials for his contribution to mucin histology, but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; ANDERSON N, 1981, PARASITOLOGY, V82, P401, DOI 10.1017/S0031182000066932; ARMOUR J, 1966, AM J VET RES, V27, P1267; BADO A, 1994, YALE J BIOL MED, V67, P113; Balic A, 2000, VET IMMUNOL IMMUNOP, V75, P109, DOI 10.1016/S0165-2427(00)00189-6; Balic A, 2006, PARASITE IMMUNOL, V28, P107, DOI 10.1111/j.1365-3024.2006.00816.x; BEAUCHAMP RD, 1989, J CLIN INVEST, V84, P1017, DOI 10.1172/JCI114223; Behm CA, 2000, PARASITOL TODAY, V16, P202, DOI 10.1016/S0169-4758(99)01620-8; Bredemeyer AJ, 2009, DEV BIOL, V325, P211, DOI 10.1016/j.ydbio.2008.10.025; Canfield V, 1996, P NATL ACAD SCI USA, V93, P2431, DOI 10.1073/pnas.93.6.2431; CHEN MC, 1993, AM J PHYSIOL, V264, pG390, DOI 10.1152/ajpgi.1993.264.2.G390; CHRISTIE MG, 1970, J COMP PATHOL, V80, P89, DOI 10.1016/0021-9975(70)90035-6; COURTNEY CH, 1984, INT J PARASITOL, V14, P377, DOI 10.1016/0020-7519(84)90092-4; DEMPSEY PJ, 1992, GASTROENTEROLOGY, V103, P1950, DOI 10.1016/0016-5085(92)91455-D; Forstner G, 1982, MUCUS HLTH DISEASE, P199; Fox JG, 1996, GASTROENTEROLOGY, V110, P155, DOI 10.1053/gast.1996.v110.pm8536852; FOX MT, 1989, RES VET SCI, V46, P280, DOI 10.1016/S0034-5288(18)31160-3; FOX MT, 1988, VET REC, V122, P136, DOI 10.1136/vr.122.6.136; FOX MT, 1987, INT J PARASITOL, V17, P1181, DOI 10.1016/0020-7519(87)90170-6; FOX MT, 1993, RES VET SCI, V54, P384, DOI 10.1016/0034-5288(93)90140-B; FRYKLUND J, 1988, AM J PHYSIOL, V254, pG399, DOI 10.1152/ajpgi.1988.254.3.G399; Haag E, 2005, PARASITOL RES, V95, P155, DOI 10.1007/s00436-004-1274-6; Hagen SJ, 1997, AM J PHYSIOL-CELL PH, V272, pC48, DOI 10.1152/ajpcell.1997.272.1.C48; HANSKY J, 1969, LANCET, V2, P1388; Hashimoto K, 2009, PARASITE IMMUNOL, V31, P457, DOI 10.1111/j.1365-3024.2009.01123.x; Hasnain SZ, 2013, INT J BIOCHEM CELL B, V45, P364, DOI 10.1016/j.biocel.2012.10.011; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Hersey SJ, 1987, PHYSL GASTROINTESTIN, P947; Hertzberg H, 2000, VET J, V159, P238, DOI 10.1053/tvjl.1999.0475; Hertzberg H, 1999, P 17 INT C WAAVP COP, V199, P202; Hoang VC, 2010, VET PARASITOL, V171, P354, DOI 10.1016/j.vetpar.2010.04.007; Hoang VC, 2010, VET PARASITOL, V170, P253, DOI 10.1016/j.vetpar.2010.02.014; HOLMES PH, 1971, RES VET SCI, V12, P265; Huber A, 2005, PARASITOL RES, V96, P290, DOI 10.1007/s00436-005-1321-y; Ingham A, 2008, INT J PARASITOL, V38, P431, DOI 10.1016/j.ijpara.2007.07.012; ISHIKAWA N, 1994, IMMUNOLOGY, V81, P480; JENNINGS FW, 1966, AM J VET RES, V27, P1249; JOHNSON LR, 1976, GASTROENTEROLOGY, V71, P599; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; KARAM SM, 1994, AM J PHYSIOL, V266, pG745, DOI 10.1152/ajpgi.1994.266.4.G745; Karam SM, 2001, HISTOL HISTOPATHOL, V16, P469, DOI 10.14670/HH-16.469; KLESIUS PH, 1985, INT J PARASITOL, V15, P517, DOI 10.1016/0020-7519(85)90047-5; Lawton DEB, 1996, INT J PARASITOL, V26, P1063, DOI 10.1016/S0020-7519(96)00100-2; Lawton DEB, 2002, VET PARASITOL, V104, P243, DOI 10.1016/S0304-4017(01)00628-8; Lehmann FS, 1996, AM J PHYSIOL-GASTR L, V270, pG783, DOI 10.1152/ajpgi.1996.270.5.G783; LEHY T, 1972, AM J DIG DIS, V17, P887, DOI 10.1007/BF02239527; Li P, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-22; Li QT, 1996, J BIOL CHEM, V271, P3671, DOI 10.1074/jbc.271.7.3671; LI QT, 1995, J BIOL CHEM, V270, P15777, DOI 10.1074/jbc.270.26.15777; Li RW, 2009, VET PARASITOL, V165, P281, DOI 10.1016/j.vetpar.2009.07.008; MCKELLAR Q, 1986, RES VET SCI, V40, P367, DOI 10.1016/S0034-5288(18)30552-6; MCLEAY LM, 1973, PARASITOLOGY, V66, P241, DOI 10.1017/S0031182000045182; Meeusen ENT, 2000, PARASITOL TODAY, V16, P95, DOI 10.1016/S0169-4758(99)01607-5; Merkelbach P, 2002, VET PARASITOL, V104, P217, DOI 10.1016/S0304-4017(01)00635-5; Mihi B, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-121; MILLER HRP, 1983, RES VET SCI, V35, P357, DOI 10.1016/S0034-5288(18)32033-2; MILLER HRP, 1984, VET IMMUNOL IMMUNOP, V6, P167, DOI 10.1016/0165-2427(84)90051-5; Miyazaki Y, 1999, GASTROENTEROLOGY, V116, P78, DOI 10.1016/S0016-5085(99)70231-3; Moradpour N, 2013, PARASITOLOGY, V140, P1762, DOI 10.1017/S0031182013001042; MURAYAMA Y, 1995, GASTROENTEROLOGY, V109, P1051, DOI 10.1016/0016-5085(95)90562-6; MURRAY M, 1970, RES VET SCI, V11, P417; NEWLANDS GFJ, 1990, J COMP PATHOL, V102, P433, DOI 10.1016/S0021-9975(08)80164-8; NICHOLLS CD, 1988, RES VET SCI, V45, P124, DOI 10.1016/S0034-5288(18)30907-X; NICHOLLS CD, 1987, J COMP PATHOL, V97, P299, DOI 10.1016/0021-9975(87)90094-6; Ohning GV, 1996, AM J PHYSIOL-GASTR L, V271, pG470, DOI 10.1152/ajpgi.1996.271.3.G470; OTA H, 1992, HISTOCHEM J, V24, P86, DOI 10.1007/BF01082444; Prinz C, 1997, GASTROENTEROLOGY, V112, P364, DOI 10.1053/gast.1997.v112.pm9024290; Przemeck S, 2005, PARASITOL RES, V95, P213, DOI 10.1007/s00436-004-1280-8; Rehman ZU, 2016, VET PARASITOL, V221, P104, DOI 10.1016/j.vetpar.2016.03.017; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rinaldi M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-61; ROBERT A, 1991, LIFE SCI, V48, P123, DOI 10.1016/0024-3205(91)90405-Z; ROSS J G, 1971, Journal of Helminthology, V45, P1, DOI 10.1017/S0022149X00006878; Rowe A, 2009, VET PARASITOL, V161, P76, DOI 10.1016/j.vetpar.2008.12.023; RUTTEN MJ, 1993, AM J PHYSIOL, V265, pG361, DOI 10.1152/ajpgi.1993.265.2.G361; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Scott I, 1998, INT J PARASITOL, V28, P1383, DOI 10.1016/S0020-7519(98)00111-8; Scott I, 2000, VET PARASITOL, V89, P79, DOI 10.1016/S0304-4017(00)00188-6; SCOTT I, 1995, RES VET SCI, V59, P234, DOI 10.1016/0034-5288(95)90009-8; Serrano MT, 1997, GUT, V40, P42, DOI 10.1136/gut.40.1.42; SHARP R, 1995, DEVELOPMENT, V121, P149; Simcock DC, 1999, INT J PARASITOL, V29, P1053, DOI 10.1016/S0020-7519(99)00065-X; Simpson HV, 2009, VET PARASITOL, V165, P256, DOI 10.1016/j.vetpar.2009.07.030; Simpson HV, 2009, VET PARASITOL, V163, P73, DOI 10.1016/j.vetpar.2009.03.049; Simpson HV, 1999, NEW ZEAL VET J, V47, P20, DOI 10.1080/00480169.1999.36102; Simpson HV, 1997, INT J PARASITOL, V27, P825, DOI 10.1016/S0020-7519(97)00037-4; SIMPSON HV, 1993, COMP BIOCHEM PHYS A, V104, P461, DOI 10.1016/0300-9629(93)90447-C; Simpson HV, 2016, VET PARASITOL; SOMMERVILLE RI, 1953, NATURE, V171, P482, DOI 10.1038/171482a0; SOMMERVILLE RI, 1954, AUST J AGR RES, V5, P130, DOI 10.1071/AR9540130; SPICER SS, 1965, J HISTOCHEM CYTOCHEM, V13, P211, DOI 10.1177/13.3.211; STAFFORD KJ, 1994, NEW ZEAL VET J, V42, P30, DOI 10.1080/00480169.1994.35778; Sundler F, 1989, GASTROENTERLOLOGY, V96, P723; Taylor M. A., 2007, VET PARASITOL, V3rd; Tsubokawa D, 2009, EXP PARASITOL, V123, P319, DOI 10.1016/j.exppara.2009.08.008; Tsutsui S, 1997, BIOCHEM BIOPH RES CO, V235, P520, DOI 10.1006/bbrc.1997.6824; Turner DG, 2008, VET IMMUNOL IMMUNOP, V122, P138, DOI 10.1016/j.vetimm.2007.11.002; Van De Walle J, 2010, TOXICOL IN VITRO, V24, P1441, DOI 10.1016/j.tiv.2010.04.002; Weigert N, 1996, GASTROENTEROLOGY, V110, P147, DOI 10.1053/gast.1996.v110.pm8536851; Wildblood LA, 2005, VET IMMUNOL IMMUNOP, V107, P57, DOI 10.1016/j.vetimm.2005.03.010; Yamauchi J, 2006, APMIS, V114, P270, DOI 10.1111/j.1600-0463.2006.apm_353.x; Yanaoka K, 2008, CANCER EPIDEM BIOMAR, V17, P838, DOI 10.1158/1055-9965.EPI-07-2762	104	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186752	10.1371/journal.pone.0186752	http://dx.doi.org/10.1371/journal.pone.0186752			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073245	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400048
J	Illan, JG; Wang, GM; Cunningham, FL; King, DT				Illan, Javier Gutierrez; Wang, Guiming; Cunningham, Fred L.; King, D. Tommy			Seasonal effects of wind conditions on migration patterns of soaring American white pelican	PLOS ONE			English	Article							ATMOSPHERIC CONDITIONS; QUANTILE REGRESSION; MOVEMENT ECOLOGY; SPRING MIGRATION; BIRD MIGRATION; GOLDEN EAGLES; STEPPE EAGLES; HABITAT USE; FLIGHT; MIGRANTS	Energy and time expenditures are determinants of bird migration strategies. Soaring birds have developed migration strategies to minimize these costs, optimizing the use of all the available resources to facilitate their displacement. We analysed the effects of different wind factors (tailwind, turbulence, vertical updrafts) on the migratory flying strategies adopted by 24 satellite-tracked American white pelicans (Pelecanus erythrorhynchos) throughout spring and autumn in North America. We hypothesize that different wind conditions encountered along migration routes between spring and autumn induce pelicans to adopt different flying strategies and use of these wind resources. Using quantile regression and fine-scale atmospheric data, we found that the pelicans optimized the use of available wind resources, flying faster and more direct routes in spring than in autumn. They actively selected tailwinds in both spring and autumn displacements but relied on available updrafts predominantly in their spring migration, when they needed to arrive at the breeding regions. These effects varied depending on the flying speed of the pelicans. We found significant directional correlations between the pelican migration flights and wind direction. In light of our results, we suggest plasticity of migratory flight strategies by pelicans is likely to enhance their ability to cope with the effects of ongoing climate change and the alteration of wind regimes. Here, we also demonstrate the usefulness and applicability of quantile regression techniques to investigate complex ecological processes such as variable effects of atmospheric conditions on soaring migration.	[Illan, Javier Gutierrez; Wang, Guiming] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Starkville, MS 39759 USA; [Cunningham, Fred L.; King, D. Tommy] Mississippi State Univ, Wildlife Serv Natl Wildlife Res Ctr, Mississippi Field Stn, Starkville, MS USA	Mississippi State University; Mississippi State University	Illan, JG (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Starkville, MS 39759 USA.	jgi13@msstate.edu	Wang, Guiming/O-8925-2019; Gutierrez Illan, Javier/A-3756-2009	Wang, Guiming/0000-0001-5002-0120; Gutierrez Illan, Javier/0000-0002-3815-0536	Mississippi State University; USDA APHIS (Animal and Plant Health Inspection Service) Wildlife Services, National Wildlife Research Center [15-7428-1060-CA]	Mississippi State University; USDA APHIS (Animal and Plant Health Inspection Service) Wildlife Services, National Wildlife Research Center	This research was fully funded by Mississippi State University and the USDA APHIS (Animal and Plant Health Inspection Service) Wildlife Services, National Wildlife Research Center (Agreement No. 15-7428-1060-CA).; This research was fully funded by Mississippi State University and the USDA APHIS (Animal and Plant Health Inspection Service) Wildlife Services, National Wildlife Research Center (Agreement No. 15-7428-1060-CA). We also thank students, colleagues and technicians at Department of Wildlife, Fisheries & Aquaculture, MSU and APHIS for valuable help in the field.	Agostinelli C., 2011, R PACKAGE CIRCULAR C; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; ALERSTAM T, 1979, ORNIS SCAND, V10, P76, DOI 10.2307/3676347; Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Ambrosini R, 2016, J ANIM ECOL, V85, P749, DOI 10.1111/1365-2656.12497; Anderson JGT, 2005, WATERBIRDS, V28, P55, DOI 10.1675/1524-4695(2005)28[55:AAOBRO]2.0.CO;2; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bildstein KL, 2009, IBIS, V151, P382, DOI 10.1111/j.1474-919X.2009.00919.x; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Brennan A, 2015, J APPL ECOL, V52, P1656, DOI 10.1111/1365-2664.12514; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 1996, BIOMETRICS, V52, P886, DOI 10.2307/2533050; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; CANTOS FJ, 1994, J AVIAN BIOL, V25, P131, DOI 10.2307/3677031; Catry P, 2004, J AVIAN BIOL, V35, P170, DOI 10.1111/j.0908-8857.2004.03112.x; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Conklin JR, 2011, BEHAV ECOL, V22, P854, DOI 10.1093/beheco/arr054; Cornioley T, 2016, J ANIM ECOL, V85, P1318, DOI 10.1111/1365-2656.12552; Dodge S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0195; Duerr AE, 2015, FUNCT ECOL, V29, P779, DOI 10.1111/1365-2435.12381; Erni B, 2005, BEHAV ECOL, V16, P732, DOI 10.1093/beheco/ari046; Green M, 2004, J AVIAN BIOL, V35, P305, DOI 10.1111/j.0908-8857.2004.03181.x; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Horvitz N, 2014, ECOL LETT, V17, P670, DOI 10.1111/ele.12268; Houston C.S., 1972, Blue Jay, V30, P24; Katzner TE, 2012, J APPL ECOL, V49, P1178, DOI 10.1111/j.1365-2664.2012.02185.x; Kemp MU, 2012, METHODS ECOL EVOL, V3, P65, DOI 10.1111/j.2041-210X.2011.00138.x; Kerlinger P., 1989, FLIGHT STRATEGIES MI; King D. Tommy, 2001, North American Bird Bander, V26, P57; King DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40339; King DT, 2016, WATERBIRDS, V39, P287; King DT, 2005, WATERBIRDS, V28, P48, DOI 10.1675/1524-4695(2005)28[48:RPSOTA]2.0.CO;2; King DT, 2002, WATERBIRDS, V25, P410, DOI 10.1675/1524-4695(2002)025[0410:DAAHUO]2.0.CO;2; Klaassen RHG, 2012, BEHAV ECOL, V23, P58, DOI 10.1093/beheco/arr150; Klaassen RHG, 2011, P ROY SOC B-BIOL SCI, V278, P1339, DOI 10.1098/rspb.2010.2106; Klaassen RHG, 2010, J AVIAN BIOL, V41, P200, DOI 10.1111/j.1600-048X.2010.05058.x; Knopf FL, 2004, BIRDS N AM ONLINE; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R, 1996, 970100 U ILL; Leshem Y, 1996, IBIS, V138, P667, DOI 10.1111/j.1474-919X.1996.tb04768.x; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Liminana R, 2013, BEHAV ECOL SOCIOBIOL, V67, P823, DOI 10.1007/s00265-013-1506-9; Mallon JM, 2016, AUK, V133, P79, DOI 10.1642/AUK-15-114.1; Mandel JT, 2008, P NATL ACAD SCI USA, V105, P19102, DOI 10.1073/pnas.0801789105; McGrady MJ, 2002, CONDOR, V104, P39, DOI 10.1650/0010-5422(2002)104[0039:MAROPF]2.0.CO;2; McLaren JD, 2012, BEHAV ECOL, V23, P1089, DOI 10.1093/beheco/ars078; Meyburg BU, 2003, CONDOR, V105, P219, DOI 10.1650/0010-5422(2003)105[0219:MROSEB]2.0.CO;2; Miller RA, 2016, IBIS, V158, P106, DOI 10.1111/ibi.12326; Miller TA, 2016, IBIS, V158, P116, DOI 10.1111/ibi.12331; Moller AP, 2001, P ROY SOC B-BIOL SCI, V268, P203; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nourani E, 2016, IBIS, V158, P506, DOI 10.1111/ibi.12383; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pennycuick CJ, 1998, J AVIAN BIOL, V29, P449, DOI 10.2307/3677164; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pinheiro J., 2011, NLME LINEAR NONLINEA; Rayner J.M.V., 1988, Current Ornithology, V5, P1; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; RICHARDSON WJ, 1990, EXPERIENTIA, V46, P416, DOI 10.1007/BF01952175; ROGERS DT, 1966, WILSON BULL, V78, P415; Sapir N, 2011, P ROY SOC B-BIOL SCI, V278, P3380, DOI 10.1098/rspb.2011.0358; Shamoun-Baranes J, 2003, J AVIAN BIOL, V34, P97, DOI 10.1034/j.1600-048X.2003.03079.x; Shamoun-Baranes J, 2003, CONDOR, V105, P208, DOI 10.1650/0010-5422(2003)105[0208:DUOTCB]2.0.CO;2; Shamoun-Baranes J, 2017, J COMP PHYSIOL A, V203, P509, DOI 10.1007/s00359-017-1181-9; Shamoun-Baranes J, 2010, INTEGR COMP BIOL, V50, P280, DOI 10.1093/icb/icq011; Shannon HD, 2002, CONDOR, V104, P679, DOI 10.1650/0010-5422(2002)104[0679:AWPSFT]2.0.CO;2; Shepard ELC, 2013, AM NAT, V182, P298, DOI 10.1086/671257; Sinelschikova A, 2007, INT J BIOMETEOROL, V51, P431, DOI 10.1007/s00484-006-0077-0; Sovada MA, 2013, SCI INVESTIGATIONS R, P203; Sovada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083430; Spaar R, 1996, J AVIAN BIOL, V27, P289, DOI 10.2307/3677260; STRAIT LE, 1975, WILSON BULL, V87, P54; Thorup K, 2006, BEHAV ECOL, V17, P497, DOI 10.1093/beheco/arj054; van Loon EE, 2011, J THEOR BIOL, V270, P112, DOI 10.1016/j.jtbi.2010.10.038; Vansteelant WMG, 2015, J AVIAN BIOL, V46, P25, DOI 10.1111/jav.00457; Vansteelant WMG, 2017, J AVIAN BIOL, V48, P887, DOI 10.1111/jav.01298; Vansteelant WMG, 2017, J ANIM ECOL, V86, P179, DOI 10.1111/1365-2656.12593; Vidal-Mateo J, 2016, CURR ZOOL, V62, P89, DOI 10.1093/cz/zow008; Watanabe YY, 2016, ECOL LETT, V19, P907, DOI 10.1111/ele.12627; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054	86	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186948	10.1371/journal.pone.0186948	http://dx.doi.org/10.1371/journal.pone.0186948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065188	gold, Green Published, Green Submitted			2022-12-26	WOS:000413568900056
J	Singh, M; Ruhnke, I; de Koning, C; Drake, K; Skerman, AG; Hinch, GN; Glatz, PC				Singh, Mini; Ruhnke, Isabelle; de Koning, Carolyn; Drake, Kelly; Skerman, Alan G.; Hinch, Geoff N.; Glatz, Philip C.			Demographics and practices of semi-intensive free-range farming systems in Australia with an outdoor stocking density of <= 1500 hens/hectare	PLOS ONE			English	Article							ORGANIC POULTRY PRODUCTION; MANAGEMENT; CHICKENS; WELFARE	Baseline information on demographics and practices on semi-intensive free-range egg farms with an outdoor stocking density of <= 1500 hens/hectare in Australia is presented. Free-range egg production is changing the structure of the egg industry in Australia and a broad variety and tiers of free-range systems have emerged due to lack of concrete legislative standards on outdoor stocking densities in the past. Information was extracted from a pre-existing online free-range poultry survey dataset, consisting of a total of 79 questions related to nutrition, pasture management, welfare and health, animal housing, environmental impact and economics. Forty-one free-range egg farms, with an outdoor stocking density of <= 1500 hens/hectare, were identified in the dataset from all major Australian states. Two types of semi-intensive free-range housing systems were documented: mobile (modified caravan/trailer) housing (56%), and fixed sheds (44%). Seventy-two percent of respondents reported >75% of the hens in the flock used the outdoor range. All respondents reported ingestion of range components by hens in the form of vegetation, insects, stones and grit. Up to 10% mortality was reported by 40% respondents with predation (34%), cannibalism (29%), heat stress (24%) and grass impaction (19.5%) as major causes. Biosecurity on farms was sub-optimal with 8 of the 10 actions implemented by <50% respondents. Customer demand, consumer sentiment and welfare were the major factors for farmers moving into free-range egg production. This study resulted in identification of current practices and key challenges on semi-intensive free-range egg farms. Applied research and communication of results to farmers is highly recommended to ensure optimum health and welfare of free-range laying hens and sustained egg production.	[Singh, Mini] Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia; [Ruhnke, Isabelle; Hinch, Geoff N.] Univ New England, Sch Environm & Rural Sci, Anim Sci, Armidale, NSW, Australia; [de Koning, Carolyn; Drake, Kelly; Glatz, Philip C.] South Australian Res & Dev Inst, Roseworthy, Roseworthy, SA, Australia; [Skerman, Alan G.] Dept Agr & Fisheries, Toowoomba, Qld, Australia	University of Sydney; University of New England; South Australian Research & Development Institute (SARDI)	Singh, M (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia.	mini.singh@sydney.edu.au	Singh, Mini/AAE-5906-2019	Skerman, Alan/0000-0001-7684-4806; Ruhnke, Isabelle/0000-0001-5423-9306; Hinch, Geoffrey/0000-0003-4731-865X	Nutrition and Environment program; Poultry Cooperative Research Centre; Australian Government's Cooperative Research Centres Program	Nutrition and Environment program; Poultry Cooperative Research Centre; Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was funded under the Nutrition and Environment program (Sub-Project 2.9.2) by the Poultry Cooperative Research Centre, established and supported under the Australian Government's Cooperative Research Centres Program.; This research was conducted within the Poultry CRC, established and supported under the Australian Government's Cooperative Research Centers Program. The authors would like to thank the farmers who participated from all over Australia in the Free Range Poultry Survey.	Abbott R., 2010, Poultry International, V49, P32; Abdallah A. G., 2010, Egyptian Journal of Nutrition and Feeds, V13, P107; Abdallah A. G., 2011, Egyptian Poultry Science Journal, V31, P217; ACO, 2013, AUSTR CERT ORG STAND; AECL, 2012, PROD METH UND QA EV; AECL, 2016, AUSTR EGG CORP LTD A; [Anonymous], 2017, UK EGG STAT Q 1; [Anonymous], 2017, AUSTR CONSUMER LAW F; [Anonymous], 2002, MOD COD PRACT WELF A; Bejaei M, 2015, BRIT POULTRY SCI, V56, P425, DOI 10.1080/00071668.2015.1058917; Berg C, 2001, ACTA VET SCAND, P37; Bubier NE, 1998, BRIT POULTRY SCI, V39, pS5; Campbell DL, 2016, ANIMAL INT J ANIMAL, P1; DAFF (Department of Agriculture Fisheries and Forestry), 2009, NAT FARM BIOS MAN PO; Dal Bosco A, 2014, J APPL POULTRY RES, V23, P137, DOI 10.3382/japr.2013-00814; FREPA, 2015, FREE RANG EGG STAND; Hamilton SA, 2009, AUST VET J, V87, P165, DOI 10.1111/j.1751-0813.2009.00423.x; Hegelund L, 2005, BRIT POULTRY SCI, V46, P1, DOI 10.1080/00071660400023813; Jurjanz S, 2014, ANIM FEED SCI TECH, V188, P92, DOI 10.1016/j.anifeedsci.2013.11.004; KEELING LJ, 1988, FARM BUILD PROGR, P21; Maurer V, 2013, J APPL POULTRY RES, V22, P334, DOI 10.3382/japr.2012-00586; Miao ZH, 2005, ASIAN AUSTRAL J ANIM, V18, P113, DOI 10.5713/ajas.2005.113; Moberly R, 2004, VET RECORD J BRIT VE, V155; Nagle TAD, 2006, 18 AUSTR POULTR SCI; Pettersson IC, 2016, BRIT FOOD J, V118, P1979, DOI 10.1108/BFJ-02-2016-0065; Radu-Rusu C. G., 2012, Lucrari Stiintifice - Universitatea de Stiinte Agricole si Medicina Veterinara, Seria Zootehnie, V58, P188; RSPCA, 2015, LAYER HENS RSPCA APP; Ruhnke I, 2015, P 26 AUSTR POULTR SC; Scott P., 2009, STRUCTURE DYNAMICS A; Singh M, 2016, ANIM PROD SCI, V56, P1152, DOI 10.1071/AN14778; Singh M, 2013, ANIM PROD SCI, V53, P1202, DOI 10.1071/AN13199; Singh M, 2016, 27 ANN AUSTR POULTR; Sossidou EN, 2015, WORLD POULTRY SCI J, V71, P375, DOI 10.1017/S0043933915000379; Stadig LM, 2016, POULTRY SCI, V95, P715, DOI 10.3382/ps/pev334; USDA, 2017, USDA LIV POULTR GRAI; Wiedemann S., 2011, ENV ASSESSMENT EGG P	36	29	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0187057	10.1371/journal.pone.0187057	http://dx.doi.org/10.1371/journal.pone.0187057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065169	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900064
J	Patti, G; Cavallari, I; Antonucci, E; Calabro, P; Cirillo, P; Gresele, P; Palareti, G; Pengo, V; Pignatelli, P; Ricottini, E; Marcucci, R				Patti, Giuseppe; Cavallari, Ilaria; Antonucci, Emilia; Calabro, Paolo; Cirillo, Plinio; Gresele, Paolo; Palareti, Gualtiero; Pengo, Vittorio; Pignatelli, Pasquale; Ricottini, Elisabetta; Marcucci, Rossella			Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome	PLOS ONE			English	Article							PREVIOUS MYOCARDIAL-INFARCTION; PERIPHERAL ARTERIAL-DISEASE; ST-SEGMENT ELEVATION; SECONDARY PREVENTION; ATHEROTHROMBOTIC EVENTS; RISK; CLOPIDOGREL; DURATION; TRIAL; TICAGRELOR	There are limited real-world data on prevalence and predictors of dual antiplatelet therapy (DAPT) prolongation beyond one year after acute coronary syndrome (ACS). We have explored such issue in the START ANTIPLATELET Registry, which is a prospective, observational, multicenter, Italian registry performed in seven Italian cardiology institutions including patients admitted for ACS and followed up to one year. Out of a total population of 840 ACS patients, 596 patients had completed 12-month follow-up being on DAPT. Decision to prolong DAPT beyond one year was taken in 79 patients (13%), whereas in 517 patients DAPT was stopped. The strongest predictors of DAPT continuation were a new cardiovascular events after the index admission event (OR 3.3, 95% CI 1.4-7.7), no bleeding complications (OR 3.2, 95% CI 1.2-8.3) and no anemia during one-year follow-up (OR 2.6, 95% CI 1.1-5.9); other independent predictors were renal failure (OR 2.5, 95% CI 1.3-5.0) and peripheral artery disease (OR 1.8, 95% CI 1.1-3.0). The choice of DAPT prolongation was not correlated with younger ager, presence of diabetes mellitus, coronary angioplasty as initial treatment strategy or type of implanted stent (drug-eluting vs bare metal). In conclusion, this study provides a real-world snapshot on the factors influencing the option to continue DAPT beyond one year after ACS; a low bleeding risk seems to influence the choice to prolong DAPT more than a high ischemic risk.	[Patti, Giuseppe; Cavallari, Ilaria; Ricottini, Elisabetta] Univ Rome, Campus Biomed, Rome, Italy; [Antonucci, Emilia; Palareti, Gualtiero] Arianna Anticoagulaz Fdn, Bologna, Italy; [Calabro, Paolo] Monaldi Hosp, Div Cardiol, Naples, Italy; [Calabro, Paolo] Luigi Vanvitelli Univ Campania, Naples, Italy; [Cirillo, Plinio] Univ Naples Federico II, Sch Med, Dept Adv Biomed Sci, Naples, Italy; [Gresele, Paolo] Univ Perugia, Div Internal & Cardiovasc Med, Dept Med, Perugia, Italy; [Pengo, Vittorio] Univ Hosp Padua, Dept Cardiothorac & Vasc Sci, Padua, Italy; [Pignatelli, Pasquale] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rome, Italy; [Marcucci, Rossella] Univ Florence, Dept Expt & Clin Med, Ctr Atherothrombot Dis, Florence, Italy	Sapienza University Rome; University Campus Bio-Medico - Rome Italy; Universita della Campania Vanvitelli; University of Naples Federico II; University of Perugia; University of Padua; Azienda Ospedaliera - Universita di Padova; Sapienza University Rome; University of Florence	Patti, G (corresponding author), Univ Rome, Campus Biomed, Rome, Italy.	g.patti@unicampus.it	Marcucci, Rossella/K-8471-2016; Cavallari, Ilaria/AAC-3182-2022; gresele, paolo/AAG-8019-2019; Calabro, Paolo/AAC-2704-2022; pignatelli, pasquale/K-2116-2016	Cavallari, Ilaria/0000-0001-6735-9163; Ricottini, Elisabetta/0000-0002-0825-1942; Patti, Giuseppe/0000-0002-5404-3968; pignatelli, pasquale/0000-0002-2265-7455; Marcucci, Rossella/0000-0001-9549-7176	Bayer HealthCare; Daiichi Sankyo; BMS-Pfizer; Werfen Group; Bayer; Boehringer Ingelheim; Pfizer; Daichi-Sankyo; Astra Zeneca	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Daiichi Sankyo(Daiichi Sankyo Company Limited); BMS-Pfizer(Pfizer); Werfen Group; Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Daichi-Sankyo; Astra Zeneca(AstraZeneca)	The authors have the following interests: GiPa: speaker/consultant/advisory board for Bayer, Boehringer-Ingelheim, BMS-Pfizer, Daiichi Sankyo, Astra Zeneca, PIAM, Sanofi, AMGEN, Sigma-Tau, Malesci and MSD. VP: Advisory Board/Lecure fees for Bayer HealthCare, Daiichi Sankyo, BMS-Pfizer and Werfen Group; RM: Honoraria for lectures and consulting fees from: Bayer, Boehringer Ingelheim, Pfizer, Daichi-Sankyo, Astra Zeneca. IC, EA, PaCa, PICi, PG, GuPa, PP, ER: no disclosure. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Antonucci E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124719; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2016, J AM COLL CARDIOL, V67, P2732, DOI 10.1016/j.jacc.2016.03.529; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bohula EA, 2016, CIRCULATION, V134, P304, DOI 10.1161/CIRCULATIONAHA.115.019861; Bonaca MP, 2016, J AM COLL CARDIOL, V67, P2719, DOI 10.1016/j.jacc.2016.03.524; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Gresele P, 2013, BLOOD TRANSFUS-ITALY, V11, P349, DOI 10.2450/2013.0248-12; Jernberg T, 2015, EUR HEART J, V36, P1163, DOI 10.1093/eurheartj/ehu505; Kereiakes DJ, 2015, JACC-CARDIOVASC INTE, V8, P1552, DOI 10.1016/j.jcin.2015.05.026; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Lindholm D, 2014, EUR HEART J, V35, P2083, DOI 10.1093/eurheartj/ehu160; Magnani G, 2016, EUR HEART J, V37, P400, DOI 10.1093/eurheartj/ehv482; Mangiacapra F, 2014, PLATELETS, V25, P348, DOI 10.3109/09537104.2013.824562; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Meredith IT, 2016, CIRCULATION, V133, P1772, DOI 10.1161/CIRCULATIONAHA.115.016783; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Patti G, 2016, AM HEART J, V176, P36, DOI 10.1016/j.ahj.2016.03.005; Patti G, 2014, CIRC J, V78, P33, DOI 10.1253/circj.CJ-13-0742; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Schmidt ACS, 2017, CIRCULATION, V135, P1720, DOI 10.1161/CIRCULATIONAHA.116.024835; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Secemsky EA, 2017, JACC-CARDIOVASC INTE, V10, P942, DOI 10.1016/j.jcin.2017.02.013; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003; Yusuf S, 2001, NEW ENGL J MED, V345, P494	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186961	10.1371/journal.pone.0186961	http://dx.doi.org/10.1371/journal.pone.0186961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059255	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000055
J	Terrat, S; Horrigue, W; Dequietd, S; Saby, NPA; Lelievre, M; Nowak, V; Tripied, J; Regnier, T; Jolivet, C; Arrouays, D; Wincker, P; Cruaud, C; Karimi, B; Bispo, A; Maron, PA; Prevost-Boure, NC; Ranjard, L				Terrat, Sebastien; Horrigue, Walid; Dequietd, Samuel; Saby, Nicolas P. A.; Lelievre, Melanie; Nowak, Virginie; Tripied, Julie; Regnier, Tiffanie; Jolivet, Claudy; Arrouays, Dominique; Wincker, Patrick; Cruaud, Corinne; Karimi, Battle; Bispo, Antonio; Maron, Pierre Alain; Prevost-Boure, Nicolas Chemidlin; Ranjard, Lionel			Mapping and predictive variations of soil bacterial richness across France	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; BIOGEOGRAPHY; PATTERNS; MICROORGANISMS; VARIABILITY; TEXTURE; DRIVERS; IMPACT; CARBON	Although numerous studies have demonstrated the key role of bacterial diversity in soil functions and ecosystem services, little is known about the variations and determinants of such diversity on a nationwide scale. The overall objectives of this study were i) to describe the bacterial taxonomic richness variations across France, ii) to identify the ecological processes (i.e. selection by the environment and dispersal limitation) influencing this distribution, and iii) to develop a statistical predictive model of soil bacterial richness. We used the French Soil Quality Monitoring Network (RMQS), which covers all of France with 2,173 sites. The soil bacterial richness (i. e. OTU number) was determined by pyrosequencing 16S rRNA genes and related to the soil characteristics, climatic conditions, geomorphology, land use and space. Mapping of bacterial richness revealed a heterogeneous spatial distribution, structured into patches of about 111km, where the main drivers were the soil physico-chemical properties (18% of explained variance), the spatial descriptors (5.25%, 1.89% and 1.02% for the fine, medium and coarse scales, respectively), and the land use (1.4%). Based on these drivers, a predictive model was developed, which allows a good prediction of the bacterial richness (R-adj(2) of 0.56) and provides a reference value for a given pedoclimatic condition.	[Terrat, Sebastien; Horrigue, Walid; Dequietd, Samuel; Nowak, Virginie; Karimi, Battle; Maron, Pierre Alain; Prevost-Boure, Nicolas Chemidlin; Ranjard, Lionel] Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France; [Saby, Nicolas P. A.; Jolivet, Claudy; Arrouays, Dominique] INRA Orleans, US 1106, Unite INFOSOL, Orleans, France; [Lelievre, Melanie; Tripied, Julie; Regnier, Tiffanie] Agroecol Plateforme GenoSol, Dijon, France; [Wincker, Patrick; Cruaud, Corinne] CEA, Inst Genom Genoscope, Evry, France; [Bispo, Antonio] ADEME, Serv Agr & Foret, Angers, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CEA; UDICE-French Research Universities; Universite Paris Saclay	Ranjard, L (corresponding author), Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France.	lionel.ranjard@inra.fr	Terrat, Sebastien/T-3790-2017; Prévost-Bouré, Nicolas Chemidlin/U-7714-2017; BISPO, Antonio/AAQ-5782-2021; Karimi, Battle/Q-2877-2018	Terrat, Sebastien/0000-0001-5209-6196; Prévost-Bouré, Nicolas Chemidlin/0000-0002-8575-4295; BISPO, Antonio/0000-0002-6985-8385; Karimi, Battle/0000-0002-4523-974X; Cruaud, Corinne/0000-0002-4752-7278; Jolivet, Claudy/0000-0001-5871-6413; Horrigue, Walid/0000-0001-5834-9983	ADEME (French Environment and Energy Management Agency); France Genomique [ANR-10-INBS-09-08]; French state through the National Agency for Research [ANR-11-INBS-0001]	ADEME (French Environment and Energy Management Agency); France Genomique; French state through the National Agency for Research	This study was granted by ADEME (French Environment and Energy Management Agency) and by "France Genomique" through involvement of the technical facilities of Genoscope (project number ANR-10-INBS-09-08). In addition, due to the involvement of technical facilities at the GenoSol platform of the infrastructure ANAEE France, it also received a grant from the French state through the National Agency for Research under the program "Investments for the Future" (reference ANR-11-INBS-0001). RMQS soil sampling and physico-chemical analyses were supported by a French Scientific Group of Interest on soils: the "GIS Sol", involving the French Ministry of Ecology, Sustainable Development and Energy (MEEM), the French Ministry of Agriculture (MAP), the French Institute for Environment (IFEN), the Environment and Energy Management Agency (ADEME), the French Institute for Research and Development (IRD) and the National Institute for Agronomic Research (INRA).r This study was granted by ADEME (French Environment and Energy Management Agency) and by "France Genomique" through involvement of the technical facilities of Genoscope (project number ANR-10-INBS-09-08). In addition, due to the involvement of technical facilities at the GenoSol platform of the infrastructure ANAEE France, it also received a grant from the French state through the National Agency for Research under the program "Investments for the Future" (reference ANR-11-INBS-0001). RMQS soil sampling and physico-chemical analyses were supported by a French Scientific Group of Interest on soils: the "GIS Sol", involving the French Ministry of Ecology, Sustainable Development and Energy (MEEM), the French Ministry of Agriculture (MAP), the French Institute for Environment (IFEN), the Environment and Energy Management Agency (ADEME), the French Institute for Research and Development (IRD) and the National Institute for Agronomic Research (INRA). We thank all the soil surveyors and technical assistants involved in sampling the sites. Thanks are also extended to Jonathan Kreplak for the use to computation capacity and Diana Warwick for her comments on the manuscript.	Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Arrouays Dominique, 2002, Comptes Rendus de l'Academie d'Agriculture de France, V88, P93; Baumann K, 2013, BIOGEOCHEMISTRY, V114, P201, DOI 10.1007/s10533-012-9800-6; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Chau JF, 2011, ENVIRON FORENSICS, V12, P333, DOI 10.1080/15275922.2011.622348; Commission E, 2005, SOIL ATLAS OF EUROPE; Constancias F, 2015, MICROBIOLOGYOPEN, V4, P505, DOI 10.1002/mbo3.255; Cornillon P, 2011, REGRESSION AVEC R; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Delgado-Baquerizo M, 2016, ECOL MONOGR, V86, P373, DOI 10.1002/ecm.1216; Delgado-Baquerizo M, 2017, ENVIRON MICROBIOL, V19, P1176, DOI 10.1111/1462-2920.13642; Dequiedt S, 2011, GLOBAL ECOL BIOGEOGR, V20, P641, DOI 10.1111/j.1466-8238.2010.00628.x; Dequiedt S, 2009, ENV MICROBIOL REP, V1, P251, DOI 10.1111/j.1758-2229.2009.00040.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fox J., 2011, ZOMBIE IDEAS ECOLOGY; Fox J, 2008, APPL REGRESSION ANAL; Giller KE, 1998, SOIL BIOL BIOCHEM, V30, P1389, DOI 10.1016/S0038-0717(97)00270-8; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Griffiths RI, 2016, APPL SOIL ECOL, V97, P61, DOI 10.1016/j.apsoil.2015.06.018; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Horrigue W, 2016, ECOL INDIC, V64, P203, DOI 10.1016/j.ecolind.2015.12.004; Hubbell SP, 2001, MACARTHUR WILSONS RA; Jolivet C., 2006, ETUDE ET GESTION DES, V13, P149; Kuramae EE, 2012, FEMS MICROBIOL ECOL, V79, P12, DOI 10.1111/j.1574-6941.2011.01192.x; Lark RM, 2002, GEODERMA, V106, P173, DOI 10.1016/S0016-7061(01)00123-9; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lienhard P, 2014, AGRON SUSTAIN DEV, V34, P525, DOI 10.1007/s13593-013-0162-9; MAC ARTHUR ROBERT H., 1967; Maestre FT, 2015, P NATL ACAD SCI USA, V112, P15684, DOI 10.1073/pnas.1516684112; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Matheron G, 1965, VARIABLES REGIONALIS; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Minasny B, 2005, GEODERMA, V128, P192, DOI 10.1016/j.geoderma.2005.04.003; Moore DavidS., 2013, BASIC PRACTICE STAT, V6th; Naveed M, 2016, APPL SOIL ECOL, V103, P44, DOI 10.1016/j.apsoil.2016.03.004; O'Brien SL, 2016, ENVIRON MICROBIOL, V18, P2039, DOI 10.1111/1462-2920.13231; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Powell JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9444; Quintana-Segui P, 2008, J APPL METEOROL CLIM, V47, P92, DOI 10.1175/2007JAMC1636.1; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Ranjard L, 2010, AGRON SUSTAIN DEV, V30, P359, DOI 10.1051/agro/2009033; Saby NPA, 2009, SCI TOTAL ENVIRON, V407, P5644, DOI 10.1016/j.scitotenv.2009.07.002; Saltelli A, 2008, GLOBAL SENSITIVITY A, DOI 10.1002/9780470725184; Saltelli A, 2000, SENSITIVITY ANAL GAU; Schloss Patrick D, 2011, Appl Environ Microbiol, V77, P3219, DOI 10.1128/AEM.02810-10; Serna-Chavez HM, 2013, GLOBAL ECOL BIOGEOGR, V22, P1162, DOI 10.1111/geb.12070; Siles JA, 2016, MICROB ECOL, V72, P207, DOI 10.1007/s00248-016-0748-2; Storlie CB, 2008, RELIAB ENG SYST SAFE, V93, P28, DOI 10.1016/j.ress.2006.10.012; Tardy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130672; Tardy V, 2014, ENV MICROBIOL REP, V6, P173, DOI 10.1111/1758-2229.12126; Terrat S, 2014, HEREDITY, P1; Terrat S, 2015, MICROB BIOTECHNOL, V8, P131, DOI 10.1111/1751-7915.12162; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Trivedi P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00990; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vivant AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076991; Webster R., 2007, GEOSTATISTICS ENV SC; Zhou JZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12083	65	55	58	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186766	10.1371/journal.pone.0186766	http://dx.doi.org/10.1371/journal.pone.0186766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059218	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000040
J	van Oeveren, BT; de Ruiter, CJ; Beek, PJ; van Dieen, JH				van Oeveren, Ben T.; de Ruiter, Cornelis J.; Beek, Peter J.; van Dieen, Jaap H.			Optimal stride frequencies in running at different speeds	PLOS ONE			English	Article							STEP FREQUENCY; LENGTH; FORCES; KINEMATICS; STIFFNESS; INJURIES; DOWNHILL; BEHAVIOR; CONTACT; FATIGUE	During running at a constant speed, the optimal stride frequency (SF) can be derived from the u-shaped relationship between SF and heart rate (HR). Changing SF towards the optimum of this relationship is beneficial for energy expenditure and may positively change biomechanics of running. In the current study, the effects of speed on the optimal SF and the nature of the u-shaped relation were empirically tested using Generalized Estimating Equations. To this end, HR was recorded from twelve healthy (4 males, 8 females) inexperienced runners, who completed runs at three speeds. The three speeds were 90%, 100% and 110% of self-selected speed. A self-selected SF (SFself) was determined for each of the speeds prior to the speed series. The speed series started with a free-chosen SF condition, followed by five imposed SF conditions (SFself, 70, 80, 90, 100 strides.min(-1)) assigned in random order. The conditions lasted 3 minutes with 2.5 minutes of walking in between. SFself increased significantly (p<0.05) with speed with averages of 77, 79, 80 strides.min(-1) at 2.4, 2.6, 2.9 m.s(-1), respectively). As expected, the relation between SF and HR could be described by a parabolic curve for all speeds. Speed did not significantly affect the curvature, nor did it affect optimal SF. We conclude that over the speed range tested, inexperienced runners may not need to adapt their SF to running speed. However, since SFself were lower than the SFopt of 83 strides.min(-1), the runners could reduce HR by increasing their SFself.	[van Oeveren, Ben T.; de Ruiter, Cornelis J.; Beek, Peter J.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Amsterdam Movement Sci, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	de Ruiter, CJ (corresponding author), Vrije Univ Amsterdam, Amsterdam Movement Sci, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam, Netherlands.	c.j.de.ruiter@vu.nl	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; Beek, Peter/0000-0002-0917-8548; van Oeveren, Benjamin/0000-0001-5090-7637	COMMIT	COMMIT	This study was supported by COMMIT grant P3: "Sensor-based engagement for improved health". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T, 1996, SPORTS MED, V22, P76, DOI 10.2165/00007256-199622020-00003; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Buist I, 2008, AM J SPORT MED, V36, P35, DOI 10.1177/0363546507307505; Cavanagh P, 1977, BIOMECHANICAL COMPAR, P328; CAVANAGH PR, 1989, MED SCI SPORT EXER, V21, P467; CAVANAGH PR, 1982, MED SCI SPORT EXER, V14, P30, DOI 10.1249/00005768-198201000-00006; Chumanov ES, 2012, GAIT POSTURE, V36, P231, DOI 10.1016/j.gaitpost.2012.02.023; Connick MJ, 2014, GAIT POSTURE, V39, P634, DOI 10.1016/j.gaitpost.2013.07.112; Cuddy JS, 2014, J THERM BIOL, V43, P7, DOI 10.1016/j.jtherbio.2014.04.002; Daniels J., 2013, DANIELS RUNNING FORM; DAVIS JA, 1975, MED SCI SPORT EXER, V7, P295; de Ruiter CJ, 2014, EUR J SPORT SCI, V14, P251, DOI 10.1080/17461391.2013.783627; Derrick TR, 1998, MED SCI SPORT EXER, V30, P128, DOI 10.1097/00005768-199801000-00018; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; Gottschall JS, 2005, J BIOMECH, V38, P445, DOI 10.1016/j.jbiomech.2004.04.023; Heiderscheit BC, 2000, J ORTHOP SPORT PHYS, V30, P271, DOI 10.2519/jospt.2000.30.5.271; Heiderscheit BC, 2011, MED SCI SPORT EXER, V43, P296, DOI 10.1249/MSS.0b013e3181ebedf4; Hobara H, 2012, INT J SPORTS MED, V33, P310, DOI 10.1055/s-0031-1291232; Hofmijster MJ, 2007, J SPORT SCI, V25, P403, DOI 10.1080/02640410600718046; Hoyt DF, 2000, J EXP BIOL, V203, P221; Hunter I, 2007, EUR J APPL PHYSIOL, V100, P653, DOI 10.1007/s00421-007-0456-1; Kaur G, 2017, EUR J APPL PHYSIOL, V117, P225, DOI 10.1007/s00421-016-3522-8; Kyrolainen H, 2001, MED SCI SPORT EXER, V33, P1330; Le Meur Y, 2013, INT J SPORTS MED, V34, P748, DOI 10.1055/s-0032-1331205; Lenhart RL, 2014, MED SCI SPORT EXER, V46, P557, DOI 10.1249/MSS.0b013e3182a78c3a; Lieberman DE, 2015, J EXP BIOL, V218, P3406, DOI 10.1242/jeb.125500; MACERA CA, 1989, ARCH INTERN MED, V149, P2565, DOI 10.1001/archinte.149.11.2565; Mercer J., 2008, J EXERC PHYSL ONLINE, V11, P26; Mercer JA, 2002, EUR J APPL PHYSIOL, V87, P403, DOI 10.1007/s00421-002-0646-9; Mizrahi J, 2000, HUM MOVEMENT SCI, V19, P139, DOI 10.1016/S0167-9457(00)00013-0; Morin JB, 2007, J BIOMECH, V40, P3341, DOI 10.1016/j.jbiomech.2007.05.001; Nigg B, 1995, CLIN BIOMECH, V13, P434; Padulo JOP, 2011, KINEMATICS RUNNING D, V0, P1; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; SAIBENE F, 1990, EUR J CLIN NUTR, V44, P65; Saltin B, 1989, MED SCI SPORTS, V1, P50; Schubert AG, 2014, SPORTS HEALTH, V6, P210, DOI 10.1177/1941738113508544; Seay J, 2008, J SPORT SCI, V26, P1519, DOI 10.1080/02640410802298235; Sheehan RC, 2013, J ELECTROMYOGR KINES, V23, P826, DOI 10.1016/j.jelekin.2013.03.013; Snyder KL, 2011, J EXP BIOL, V214, P2089, DOI 10.1242/jeb.053157; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Wellenkotter J, 2014, INT J SPORTS MED, V35, P779, DOI 10.1055/s-0033-1363236; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991	43	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0184273	10.1371/journal.pone.0184273	http://dx.doi.org/10.1371/journal.pone.0184273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059198	Green Submitted, gold, Green Published			2022-12-26	WOS:000413403000002
J	Mehaisen, GMK; Ibrahim, RM; Desoky, AA; Safaa, HM; El-Sayed, OA; Abass, AO				Mehaisen, Gamal M. K.; Ibrahim, Rania M.; Desoky, Adel A.; Safaa, Hosam M.; El-Sayed, Osama A.; Abass, Ahmed O.			The importance of propolis in alleviating the negative physiological effects of heat stress in quail chicks	PLOS ONE			English	Article							DIETARY TURKISH PROPOLIS; EGG-PRODUCTION; LAYING HENS; CARCASS CHARACTERISTICS; GROWTH-PERFORMANCE; OXIDATIVE STRESS; BROILER-CHICKENS; VITAMIN-E; SALMONELLA-ENTERITIDIS; IMMUNE-RESPONSES	Heat stress is one of the most detrimental confrontations in tropical and subtropical regions of the world, causing considerable economic losses in poultry production. Propolis, a resinous product of worker honeybees, possesses several biological activities that could be used to alleviate the deleterious effects of high environmental temperature on poultry production. The current study was aimed at evaluating the effects of propolis supplementation to Japanese quail (Coturnix coturnix japonica) diets on the production performance, intestinal histomorphology, relative physiological and immunological parameters, and selected gene expression under heat stress conditions. Three hundred one-day-old Japanese quail chicks were randomly distributed into 20 wired-cages. At 28 d of age, the birds were divided into 2 temperature treatment groups; a normal at 24 degrees C (C group) and a heat stress at 35 degrees C (HS group). The birds in each group were further assigned to 2 subgroups; one of them was fed on a basal diet without propolis supplementation (-Pr subgroup) while the other was supplemented with propolis (+ Pr subgroup). Production performance including body weight gain, feed intake and feed conversion ratio were measured. The intestinal histomorphological measurements were also performed for all treatment groups. Relative physiological parameters including body temperature, corticosterone hormone level, malondialdehyde (MDA) and free triiodothyronine hormone (fT3), as well as the relative immunological parameters including the total white blood cells count (TWBC's), heterophil/ lymphocyte (H/L) ratio and lymphocyte proliferation index, were also measured. Furthermore, the mRNA expression for toll like receptor 5 (TLR5), cysteine-aspartic protease-6 (CASP6) and heat shock proteins 70 and 90 (Hsp70 and Hsp90) genes was quantified in this study. The quail production performance was significantly (P<0.05) impaired by HS treatment, while Pr treatment significantly improved the quail production performance. The villus width and area were significantly (P<0.05) lower in the HS compared to the C group, while Pr treatment significantly increased crypts depth of quail. A negative impact of HS treatment was observed on the physiological status of quail; however, propolis significantly alleviated this negative effect. Moreover, quail of the HS group expressed lower immunological parameters than C group, while propolis enhanced the immune status of the quail. The relative mRNA expression of TLR5 gene was down-regulated by HS treatment while it was up-regulated by the Pr treatment. Furthermore, the positive effects of propolis in HS-quail were evidenced by normalizing the high expressions of CASP6 and Hsp70 genes when compared to the C group. Based on these results, the addition of propolis to quail diets as a potential nutritional strategy in order to improve their performance, especially under heat stress conditions, is recommended.	[Mehaisen, Gamal M. K.; Ibrahim, Rania M.; Desoky, Adel A.; Safaa, Hosam M.; Abass, Ahmed O.] Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt; [Mehaisen, Gamal M. K.; Abass, Ahmed O.] Cairo Univ, Poultry Cellular & Mol Physiol Lab, Fac Agr, Giza, Egypt; [El-Sayed, Osama A.] Anim Prod Res Inst, Poultry Breeding Dept, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Mehaisen, GMK (corresponding author), Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt.; Mehaisen, GMK (corresponding author), Cairo Univ, Poultry Cellular & Mol Physiol Lab, Fac Agr, Giza, Egypt.	gamoka@cu.edu.eg	Mehaisen, Gamal/I-5277-2019; Safaa, Hosam/AAF-7797-2019	Mehaisen, Gamal/0000-0003-2006-4290; Safaa, Hosam/0000-0002-9192-6313; Nassar, Farid/0000-0003-0786-0612	project Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP); General Scientific Research Department at Cairo University (GSRD-CU)	project Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP); General Scientific Research Department at Cairo University (GSRD-CU)(Cairo University)	This work was supported by the project Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP). It was funded by the General Scientific Research Department at Cairo University (GSRD-CU); http://www.gsrd.cu.edu.eg/. Dr. Ahmed O. Abass was the principal investigator of the project and the fund was awarded to him during the implementation of the project. The funders approved the study design, data collection and analysis, the decision to publish, and preparation of the manuscript.; This study was funded by the General Scientific Research Department at Cairo University (GSRD-CU) under activities carried out by the Project of Rapid Climate Change in Poultry Cellular and Molecular Physiology (RCC-PCMP). Dr. Ahmed O. Abass was the principal investigator and research team leader of the project. The authors thank Prof. Dr. Farid Stino (Professor of Poultry Breeding, Cairo University), Prof. Dr. Magdi Mashaly (Professor of Poultry Immunology, Cairo University), and Prof. Dr. Abdel-Rahman M. M. Atta (Professor of Poultry Immunology, Cairo University), for their technical support during this study. We are very grateful to all the personnel from the Poultry Biotechnology Lab and members of Poultry Services Center at Faculty of Agriculture, Cairo University, for their assistance in sample preparation and monitoring of birds throughout the experimental period.	Agiang E. A., 2011, American Journal of Animal and Veterinary Sciences, V6, P130; Akdemir F, 2015, BRIT POULTRY SCI, V56, P247, DOI 10.1080/00071668.2015.1008992; Al-Aqil A, 2009, POULTRY SCI, V88, P1358, DOI 10.3382/ps.2008-00554; Bancroft JD, 2013, BANCROFTS THEORY PRA, V7; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; BOBEK S, 1980, GEN COMP ENDOCR, V40, P201, DOI 10.1016/0016-6480(80)90123-9; Bogin E, 1996, EUR J CLIN CHEM CLIN, V34, P463; Borrelli F, 2002, FITOTERAPIA, V73, pS53, DOI 10.1016/S0367-326X(02)00191-0; BOWEN SJ, 1984, POULTRY SCI, V63, P66, DOI 10.3382/ps.0630066; Burkholder KM, 2008, POULTRY SCI, V87, P1734, DOI 10.3382/ps.2008-00107; Cerci IH, 2003, INDIAN VET J, V80, P1153; Ciftci M, 2005, REV MED VET-TOULOUSE, V156, P107; Deng W, 2012, POULTRY SCI, V91, P575, DOI 10.3382/ps.2010-01293; Denli M, 2005, ASIAN AUSTRAL J ANIM, V18, P848, DOI 10.5713/ajas.2005.848; Ellestad LE, 2009, J MOL ENDOCRINOL, V42, P171, DOI 10.1677/JME-08-0066; Fan YP, 2013, CELL IMMUNOL, V281, P37, DOI 10.1016/j.cellimm.2013.01.008; Felver-Gant JN, 2012, POULTRY SCI, V91, P1542, DOI 10.3382/ps.2011-01988; Gehad A. E., 2008, International Journal of Poultry Science, V7, P193; Genchev A., 2008, Trakia Journal of Sciences, V6, P72; Habibian M, 2015, BIOL TRACE ELEM RES, V165, P183, DOI 10.1007/s12011-015-0275-x; Hai L, 2000, J ANIM PHYSIOL AN N, V83, P57, DOI 10.1046/j.1439-0396.2000.00223.x; Havlik P, 2014, P NATL ACAD SCI USA, V111, P3709, DOI 10.1073/pnas.1308044111; Hori Juliana I, 2013, Evid Based Complement Alternat Med, V2013, P418508, DOI 10.1155/2013/418508; Izuta H, 2008, J AGR FOOD CHEM, V56, P8944, DOI 10.1021/jf8014206; Kamel NN, 2017, INT J BIOMETEOROL, V61, P1637, DOI 10.1007/s00484-017-1342-0; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Kujala TS, 2000, J AGR FOOD CHEM, V48, P5338, DOI 10.1021/jf000523q; Kumar S, 1999, TRENDS BIOCHEM SCI, V24, P1, DOI 10.1016/S0968-0004(98)01332-2; LUEPRASITSAKUL W, 1990, ENDOCRINOLOGY, V126, P2890, DOI 10.1210/endo-126-6-2890; Mahmoud U. T., 2014, Journal of Advanced Veterinary Research, V4, P18; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; Mehaisen GMK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172684; Mehaisen GMK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158314; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; NAMGOONG SY, 1994, LIFE SCI, V54, P313, DOI 10.1016/0024-3205(94)00787-X; Niu ZY, 2009, POULTRY SCI, V88, P2101, DOI 10.3382/ps.2009-00220; Oktay M, 2003, LEBENSM-WISS TECHNOL, V36, P263, DOI 10.1016/S0023-6438(02)00226-8; Padmini E, 2011, CELL STRESS CHAPERON, V16, P411, DOI 10.1007/s12192-011-0255-9; Patra T., 2011, SAARC Journal of Agriculture, V9, P123; Prieto MT, 2010, POULTRY SCI, V89, P2071, DOI 10.3382/ps.2010-00716; Prytzyk E, 2003, J ETHNOPHARMACOL, V88, P189, DOI 10.1016/S0378-8741(03)00210-1; Quinteiro WM, 2012, AVIAN PATHOL, V41, P421, DOI 10.1080/03079457.2012.709315; Rolim A, 2005, J AOAC INT, V88, P1015; Runjaic-Antic D., 2010, Biotechnology in Animal Husbandry, V26, P203; Ruskin FR, 1991, MICROLIVESTOCK LITTL; Ryder AA, 2004, J APPL POULTRY RES, V13, P493, DOI 10.1093/japr/13.3.493; Sahin K, 2006, J THERM BIOL, V31, P307, DOI 10.1016/j.jtherbio.2005.12.006; Sahin K, 2002, RES VET SCI, V73, P307, DOI 10.1016/S0034-5288(02)00126-1; Sahin N, 2008, POULTRY SCI, V87, P276, DOI 10.3382/ps.2007-00207; Sandikci M, 2004, REV MED VET-TOULOUSE, V155, P552; Sayrafi R., 2011, Veterinary Research Forum, V2, P45; Seven I, 2010, ASIAN AUSTRAL J ANIM, V23, P1482, DOI 10.5713/ajas.2010.10009; Seven PT, 2008, ANIM FEED SCI TECH, V146, P137, DOI 10.1016/j.anifeedsci.2007.11.003; Seven PT, 2008, ASIAN AUSTRAL J ANIM, V21, P1164, DOI 10.5713/ajas.2008.70605; Seven PT, 2009, ACTA VET BRNO, V78, P75, DOI 10.2754/avb200978010075; Seven PT, 2008, J APPL ANIM RES, V34, P193, DOI 10.1080/09712119.2008.9706970; Sforcin JM, 2005, J ETHNOPHARMACOL, V98, P301, DOI 10.1016/j.jep.2005.01.042; Shalmany S. K., 2006, International Journal of Poultry Science, V5, P84; Shamoto K, 2000, POULTRY SCI, V79, P718, DOI 10.1093/ps/79.5.718; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; Sophia I, 2016, SMALL RUMINANT RES, V141, P11, DOI 10.1016/j.smallrumres.2016.06.005; Tayeb IT, 2014, IRAN J APPL ANIM SCI, V4, P621; Toman R., 2015, Pharmacognosy Communications, V5, P261, DOI 10.5530/pc.2015.4.8; VONA LC, 1984, J ANIM SCI, V59, P1582, DOI 10.2527/jas1984.5961582x; Wang BJ, 2004, FOOD CHEM, V86, P237, DOI 10.1016/j.foodchem.2003.09.031; Xie JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102204; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yu J, 2010, COMP BIOCHEM PHYS A, V156, P119, DOI 10.1016/j.cbpa.2010.01.008; Yuan J, 2012, INT J BIOL MACROMOL, V51, P400, DOI 10.1016/j.ijbiomac.2012.06.002; Zhang L, 2009, POULTRY SCI, V88, P2033, DOI 10.3382/ps.2009-00128	71	22	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186907	10.1371/journal.pone.0186907	http://dx.doi.org/10.1371/journal.pone.0186907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053741	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100049
J	Ma, Y; Wang, YJ; Chen, BR; Shi, HJ; Wang, H; Khurwolah, MR; Li, YF; Xie, ZY; Yang, Y; Wang, LS				Ma, Yao; Wang, Ying-Jun; Chen, Bing-Rui; Shi, Hao-Jie; Wang, Hao; Khurwolah, Mohammad Reeaze; Li, Ya-Fei; Xie, Zhi-Yong; Yang, Yang; Wang, Lian-Sheng			Study on association of working hours and occupational physical activity with the occurrence of coronary heart disease in a Chinese population	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; II PROSPECTIVE COHORT; RISK-FACTOR; CARDIOVASCULAR-DISEASE; SKELETAL-MUSCLE; JOB INSECURITY; HEALTH; METAANALYSIS; STRESS; ADULTS	Objective To explore the association of working hours and occupational physical activity (OPA) with the occurrence of coronary heart disease (CHD) in a Chinese population. Methods A total of 595 participants (354 and 241 patients with and without CHD, respectively) aged between 24 and 65 were enrolled in our study, which was conducted at the First Affiliated Hospital of Nanjing Medical University between December 2015 and October 2016. Participant characteristics were collected from face-to-face questionnaires, and logistic regression analysis was conducted to examine the association of working hours and OPA with the occurrence of CHD. Results Compared with non-employed people, long working hours (especially >= 55 hours/week) contributed to the occurrence of CHD (adjusted odds ratio[OR] = 2.213, 95% confidence interval [CI]: 1.125, 4.355, P = 0.021) after multivariate adjustment in the Chinese population. With the extension of worktime, the CHD risk increased (P for the dose-response trend = 0.022). Meanwhile, even after adjusting for engagement in physical activity during leisure time, sedentary behavior at work had an adverse effect on CHD risk (adjusted OR = 2.794, 95% CI: 1.526, 5.115, P = 0.001), and a linear relationship was also found between OPA and CHD (P for the trend = 0.005). Conclusions Long working hours and sedentary behavior at work are associated with a high risk of CHD. In addition, prolonged working hours in sedentary occupations increases the risk of CHD, independent of engagement in leisure time physical activity.	[Ma, Yao; Chen, Bing-Rui; Shi, Hao-Jie; Wang, Hao; Khurwolah, Mohammad Reeaze; Li, Ya-Fei; Xie, Zhi-Yong; Yang, Yang; Wang, Lian-Sheng] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Wang, Ying-Jun] Sheyang Cty Peoples Hosp, Div Cardiol, Yancheng, Peoples R China	Nanjing Medical University	Wang, LS (corresponding author), Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	drlswang@njmu.edu.cn			National Natural Science Foundation of China [81570363]; National Key Research and Development Program of China [2016YFA0201304]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [KYZZ15_0263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Natural Science Foundation of China (No. 81570363), the National Key Research and Development Program of China (No. 2016YFA0201304), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, No. KYZZ15_0263).	Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Bey L, 2003, PHYSIOL GENOMICS, V13, P157, DOI 10.1152/physiolgenomics.00001.2002; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; Chau JY, 2015, BRIT J SPORT MED, V49, P737, DOI 10.1136/bjsports-2012-091974; Cheng YW, 2014, INT J CARDIOL, V171, P419, DOI 10.1016/j.ijcard.2013.12.035; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Ferrie JE, 2013, ATHEROSCLEROSIS, V227, P178, DOI 10.1016/j.atherosclerosis.2012.12.027; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hayashi R, 2016, PREV MED, V89, P286, DOI 10.1016/j.ypmed.2016.06.008; Honkonen T, 2007, SCAND J WORK ENV HEA, V33, P29, DOI 10.5271/sjweh.1061; Kang MY, 2014, AM J IND MED, V57, P1227, DOI 10.1002/ajim.22367; Kawada T, 2016, AM J IND MED, V59, P336, DOI 10.1002/ajim.22524; Kivimaki M, 2006, PSYCHOSOM MED, V68, P402, DOI 10.1097/01.psy.0000221285.50314.d3; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Krause N, 2015, SCAND J WORK ENV HEA, V41, P124, DOI 10.5271/sjweh.3476; Krebs M, 2004, CURR MED CHEM, V11, P901, DOI 10.2174/0929867043455620; Kumar A, 2014, INT J NEUROSCI, V124, P748, DOI 10.3109/00207454.2013.879130; Lee DW, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0149-5; Lee S, 2004, ANN EPIDEMIOL, V14, P24, DOI 10.1016/S1047-2797(03)00074-7; Li J, 2004, IND HEALTH, V42, P260, DOI 10.2486/indhealth.42.260; Li J, 2015, INT J OCCUP MED ENV, V28, P8, DOI 10.2478/s13382-014-0303-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miller R, 2004, INT J BEHAV MED, V11, P219, DOI 10.1207/s15327558ijbm1104_5; Milner A, 2014, INT J EPIDEMIOL, V43, P1500, DOI 10.1093/ije/dyu148; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Picavet HSJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146639; Reis JP, 2005, MED SCI SPORT EXER, V37, P2075, DOI 10.1249/01.mss.0000179103.20821.00; Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775; Stamatakis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073753; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Tayama J, 2016, STRESS HEALTH, V32, P84, DOI 10.1002/smi.2580; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Virtanen M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4746; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901; Zhao S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146472	45	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185598	10.1371/journal.pone.0185598	http://dx.doi.org/10.1371/journal.pone.0185598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0UN	29049313	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900013
J	Stinemetz, EK; Gao, P; Pinkston, KL; Montealegre, MC; Murray, BE; Harvey, BR				Stinemetz, Emily K.; Gao, Peng; Pinkston, Kenneth L.; Montealegre, Maria Camila; Murray, Barbara E.; Harvey, Barrett R.			Processing of the major autolysin of E-faecalis, AtlA, by the zinc-metalloprotease, GelE, impacts AtlA septal localization and cell separation	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-FAECALIS; BIOFILM DEVELOPMENT; SERINE-PROTEASE; CHAIN-LENGTH; GELATINASE; FSR; ENDOCARDITIS; GENES; PHEROMONE	AtlA is the major peptidoglycan hydrolase of Enterococcus faecalis involved in cell division and cellular autolysis. The secreted zinc metalloprotease, gelatinase (GelE), has been identified as an important regulator of cellular function through post-translational modification of protein substrates. AtlA is a known target of GelE, and their interplay has been proposed to regulate AtlA function. To study the protease-mediated post-translational modification of AtlA, monoclonal antibodies were developed as research tools. Flow cytometry and Western blot analysis suggests that in the presence of GelE, surface-bound AtlA exists primarily as a N-terminally truncated form whereas in the absence of GelE, the N-terminal domain of AtlA is retained. We identified the primary GelE cleavage site occurring near the transition between the T/E rich Domain I and catalytic region, Domain II via N-terminal sequencing. Truncation of AtlA had no effect on the peptidoglycan hydrolysis activity of AtlA. However, we observed that N-terminal cleavage was required for efficient AtlA-mediated cell division while unprocessed AtlA was unable to resolve dividing cells into individual units. Furthermore, we observed that the processed AtlA has the propensity to localize to the cell septum on wild-type cells whereas unprocessed AtlA in the.gelE strain were dispersed over the cell surface. Combined, these results suggest that AtlA septum localization and subsequent cell separation can be modulated by a single GelE-mediated N-terminal cleavage event, providing new insights into the post-translation modification of AtlA and the mechanisms governing chaining and cell separation.	[Stinemetz, Emily K.; Gao, Peng; Pinkston, Kenneth L.; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Mol Imaging, Houston, TX 77030 USA; [Stinemetz, Emily K.; Montealegre, Maria Camila; Murray, Barbara E.; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Murray, Barbara E.; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Mol Imaging, Houston, TX 77030 USA.; Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.; Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA.	barrett.harvey@uth.tmc.edu		Montealegre, Maria Camila/0000-0001-9639-9690	Dunn Foundation; NIH grant from NIAID [R01 AI047923-14]	Dunn Foundation; NIH grant from NIAID	Support for this work was provided in part by the Dunn Foundation to BRH and NIH grant R01 AI047923-14 from NIAID to BEM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for this work was provided in part by the Dunn Foundation to BRH and NIH grant R01 AI047923-14 from NIAID to BEM. We thank the Protein Chemistry laboratory at Texas A&M for assistance with N-terminal sequencing.	Arias CA, 2007, J MED MICROBIOL, V56, P286, DOI 10.1099/jmm.0.46877-0; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Cabrera R, 2014, APPL MICROBIOL BIOT, V98, P9399, DOI 10.1007/s00253-014-6094-8; Canziani GA, 2004, ANAL BIOCHEM, V325, P301, DOI 10.1016/j.ab.2003.11.004; Chang Chungyu, 2013, Methods Mol Biol, V966, P77, DOI 10.1007/978-1-62703-245-2_5; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Engelbert M, 2004, INFECT IMMUN, V72, P3628, DOI 10.1128/IAI.72.6.3628-3633.2004; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; Joyanes P, 2000, EUR J CLIN MICROBIOL, V19, P124, DOI 10.1007/s100960050443; Joyanes Providencia, 1999, Clin Microbiol Infect, V5, P382, DOI 10.1111/j.1469-0691.1999.tb00160.x; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; LOMINSKI I, 1958, NATURE, V181, P1477, DOI 10.1038/1811477a0; MAKINEN PL, 1989, J BIOL CHEM, V264, P3325; Mesnage S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5269; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296; Palma L, 2014, TOXINS, V6, P1490, DOI 10.3390/toxins6051490; Panesso D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-20; Pinkston KL, 2011, J BACTERIOL, V193, P4317, DOI 10.1128/JB.05026-11; Prieto CI, 2003, VET MICROBIOL, V91, P157, DOI 10.1016/S0378-1135(02)00297-3; Qin X, 1998, ANTIMICROB AGENTS CH, V42, P2883, DOI 10.1128/AAC.42.11.2883; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Rodriguez JL, 2012, INFECT IMMUN, V80, P3454, DOI 10.1128/IAI.00587-12; Salamaga B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006526; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Singh KV, 2005, INFECT IMMUN, V73, P4888, DOI 10.1128/IAI.73.8.4888-4894.2005; Teixeira N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064740; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; Thurlow LR, 2010, INFECT IMMUN, V78, P4936, DOI 10.1128/IAI.01118-09; Waters CM, 2003, J BACTERIOL, V185, P3613, DOI 10.1128/JB.185.12.3613-3623.2003; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Zoll S, 2012, J BACTERIOL, V194, P3789, DOI 10.1128/JB.00331-12	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186706	10.1371/journal.pone.0186706	http://dx.doi.org/10.1371/journal.pone.0186706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049345	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900099
J	Barraza, CE; Solari, CA; Marcovich, I; Kershaw, C; Galello, F; Rossi, S; Ashe, MP; Portela, P				Barraza, Carla E.; Solari, Clara A.; Marcovich, Irina; Kershaw, Christopher; Galello, Fiorella; Rossi, Silvia; Ashe, Mark P.; Portela, Paula			The role of PKA in the translational response to heat stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							CATALYTIC ISOFORMS; MESSENGER-RNAS; BUDDING YEAST; KINASE; GRANULES; SUBUNITS; PHOSPHORYLATION; LOCALIZATION; INITIATION; SEQUESTRATION	Cellular responses to stress stem from a variety of different mechanisms, including translation arrest and relocation of the translationally repressed mRNAs to ribonucleoprotein particles like stress granules ( SGs) and processing bodies ( PBs). Here, we examine the role of PKA in the S. cerevisiae heat shock response. Under mild heat stress Tpk3 aggregates and promotes aggregation of eIF4G, Pab1 and eIF4E, whereas severe heat stress leads to the formation of PBs and SGs that contain both Tpk2 and Tpk3 and a larger 48S translation initiation complex. Deletion of TPK2 or TPK3 impacts upon the translational response to heat stress of several mRNAs including CYC1, HSP42, HSP30 and ENO2. TPK2 deletion leads to a robust translational arrest, an increase in SGs/PBs aggregation and translational hypersensitivity to heat stress, whereas TPK3 deletion represses SGs/PBs formation, translational arrest and response for the analyzed mRNAs. Therefore, this work provides evidence indicating that Tpk2 and Tpk3 have opposing roles in translational adaptation during heat stress, and highlight how the same signaling pathway can be regulated to generate strikingly distinct physiological outputs.	[Barraza, Carla E.; Solari, Clara A.; Galello, Fiorella; Rossi, Silvia; Portela, Paula] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Inst Quim Biol,Fac Ciencias Exactas & Nat,Consejo, Buenos Aires, DF, Argentina; [Marcovich, Irina] Inst Invest Ingn Genet & Biol Mol Dr Hector N Tor, Buenos Aires, DF, Argentina; [Kershaw, Christopher; Ashe, Mark P.] Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester, Lancs, England	University of Buenos Aires; University of Manchester	Portela, P (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Inst Quim Biol,Fac Ciencias Exactas & Nat,Consejo, Buenos Aires, DF, Argentina.	pportela@qb.fcen.uba.ar		Marcovich, Irina/0000-0002-2521-7340; Rossi, Silvia/0000-0001-6996-0622; Solari, Clara/0000-0001-9883-4182; Kershaw, Christopher/0000-0001-6625-7894; Portela, Paula/0000-0003-2906-4182	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2014-2937]; University of Buenos Aires [UBACYT2016, 20020150100035BA]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-20110100826]; Biotechnology and Biological Sciences Research Council [BB/N000757/1, BB/K005979/1]; BBSRC [BB/P018270/1, BB/N000757/1, BB/K005979/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P018270/1] Funding Source: researchfish	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Silvia Rossi was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2014-2937), from the University of Buenos Aires (UBACYT2016, 20020150100035BA) and from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 112-20110100826). Mark P. Ashe was supported by the Biotechnology and Biological Sciences Research Council (grant numbers BB/N000757/1 and BB/K005979/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Solari CA, 2014, BIOCHEM J, V462, P567, DOI 10.1042/BJ20140577; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baccarini L, 2015, BBA-GENE REGUL MECH, V1849, P1329, DOI 10.1016/j.bbagrm.2015.09.007; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BEULLENS M, 1988, EUR J BIOCHEM, V172, P227, DOI 10.1111/j.1432-1033.1988.tb13877.x; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Castelli LM, 2011, MOL BIOL CELL, V22, P3379, DOI 10.1091/mbc.E11-02-0153; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cherkasov V, 2015, FEBS LETT, V589, P3654, DOI 10.1016/j.febslet.2015.10.010; Cherkasov V, 2013, CURR BIOL, V23, P2452, DOI 10.1016/j.cub.2013.09.058; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chong PA, 2016, CURR OPIN STRUC BIOL, V41, P180, DOI 10.1016/j.sbi.2016.08.001; Cortes-Vieyra R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132867; Cowart LA, 2010, BIOCHEM J, V431, P31, DOI 10.1042/BJ20100307; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Galello F, 2010, J BIOL CHEM, V285, P29770, DOI 10.1074/jbc.M110.120378; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Giacometti R, 2009, YEAST, V26, P273, DOI 10.1002/yea.1665; Girardi C, 2014, BBA-MOL CELL RES, V1843, P1865, DOI 10.1016/j.bbamcr.2014.04.020; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449; Grousl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057083; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Haesendonckx S, 2012, BIOCHEM J, V448, P307, DOI 10.1042/BJ20121061; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jamison JT, 2008, NEUROSCIENCE, V154, P504, DOI 10.1016/j.neuroscience.2008.03.057; Kanshin E, 2015, MOL SYST BIOL, V11; Kato K, 2011, YEAST, V28, P339, DOI 10.1002/yea.1842; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Pautasso C, 2014, BBA-GENE REGUL MECH, V1839, P275, DOI 10.1016/j.bbagrm.2014.02.005; Portela P, 2002, J BIOL CHEM, V277, P30477, DOI 10.1074/jbc.M201094200; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Robertson LS, 2000, P NATL ACAD SCI USA, V97, P5984, DOI 10.1073/pnas.100113397; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; ROSKOSKI R, 1983, ADV EXP MED BIOL, V161, P159; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Tsai NP, 2010, CELL SIGNAL, V22, P668, DOI 10.1016/j.cellsig.2009.12.001; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; Tudisca V, 2012, J CELL SCI, V125, P5221, DOI 10.1242/jcs.111534; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Xie R, 2013, J CEREBR BLOOD F MET, V33, P1875, DOI 10.1038/jcbfm.2013.132; Zid BM, 2014, NATURE, V514, P117, DOI 10.1038/nature13578	54	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185416	10.1371/journal.pone.0185416	http://dx.doi.org/10.1371/journal.pone.0185416			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045428	gold, Green Published, Green Submitted			2022-12-26	WOS:000413168100018
J	Irwin, SV; Fisher, P; Graham, E; Malek, A; Robidoux, A				Irwin, Sally V.; Fisher, Peter; Graham, Emily; Malek, Ashley; Robidoux, Adriel			Sulfites inhibit the growth of four species of beneficial gut bacteria at concentrations regarded as safe for food	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; SODIUM-SULFITE; TRANSIT-TIME; MICROBIOME; FERMENTATION; DISEASE; OBESITY; HEALTH; IMPACT	Sulfites and other preservatives are considered food additives to limit bacterial contamination, and are generally regarded as safe for consumption by governmental regulatory agencies at concentrations up to 5000 parts per million (ppm). Consumption of bactericidal and bacteriostatic drugs have been shown to damage beneficial bacteria in the human gut and this damage has been associated with several diseases. In the present study, bactericidal and bacteriostatic effects of two common food preservatives, sodium bisulfite and sodium sulfite, were tested on four known beneficial bacterial species common as probiotics and members of the human gut microbiota. Lactobacillus species casei, plantarum and rhamnosus, and Streptococcus thermophilus were grown under optimal environmental conditions to achieve early log phase at start of experiments. Bacterial cultures were challenged with sulfite concentrations ranging between 10 and 3780 ppm for six hours. To establish a control, a culture of each species was inoculated into media containing no sulfite preservative. By two hours of exposure, a substantial decrease (or no increase) of cell numbers (based on OD600 readings) were observed for all bacteria types, in concentrations of sulfites between 250-500 ppm, compared to cells in sulfite free media. Further testing using serial dilution and drop plates identified bactericidal effects in concentrations ranging between 1000-3780 ppm on all the Lactobacillus species by 4 hours of exposure and bactericidal effects on S. thermophilus in 2000ppm NaHSO3 after 6 hours of exposure.	[Irwin, Sally V.; Fisher, Peter; Graham, Emily; Malek, Ashley; Robidoux, Adriel] Univ Hawaii, Maui Coll, Kahului, HI 96732 USA	University of Hawaii System	Irwin, SV (corresponding author), Univ Hawaii, Maui Coll, Kahului, HI 96732 USA.	sirwin@hawaii.edu	Fisher, Peter/T-4121-2019		Hawaii IDeA Network of Biomedical Research Excellence (INBRE-III) grant program [P20 GM103466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER	Hawaii IDeA Network of Biomedical Research Excellence (INBRE-III) grant program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funds from the Hawaii IDeA Network of Biomedical Research Excellence (INBRE-III) grant program (P20 GM103466, National Institute of General Medical Sciences at the National Institutes of Health). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Brewster JD, 2003, J MICROBIOL METH, V53, P77, DOI 10.1016/S0167-7012(02)00226-9; Champagne CP, 2010, FOOD MICROBIOL, V27, P968, DOI 10.1016/j.fm.2010.06.003; Chang IS, 1997, APPL ENVIRON MICROB, V63, P1; Chen CY, 2003, J MICROBIOL METH, V55, P475, DOI 10.1016/S0167-7012(03)00194-5; Ciardi C, 2012, BRIT J NUTR, V107, P826, DOI 10.1017/S0007114511003680; DANIEL JW, 1986, XENOBIOTICA, V16, P1073, DOI 10.3109/00498258609038984; Derrien M, 2015, TRENDS MICROBIOL, V23, P354, DOI 10.1016/j.tim.2015.03.002; Dinan TG, 2015, J PSYCHIATR RES, V63, P1, DOI 10.1016/j.jpsychires.2015.02.021; Enitan A, 2011, AFR J MICROBIOL RES, V5, P2059; Gardner PR, 2015, J BIOL CHEM, V290, P27204, DOI 10.1074/jbc.M115.679621; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Health Canada, LEG GUID FOOD NUTR; Kerns JC, 2015, ADV NUTR, V6, P147, DOI 10.3945/an.114.007526; Kolling GL, 2012, GUT MICROBES, V3, P523, DOI 10.4161/gmic.21757; Kouassi K. A., 2011, Journal of Applied Biosciences, V39, P2518; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Leclercq C., 2009, WHO FOOD ADDIT SER I, V60, P221; Leclerq C, 2000, FOOD ADDIT CONTAM A, V17, P979, DOI 10.1080/02652030010014402; Lee YY, 2014, J NEUROGASTROENTEROL, V20, P265, DOI [10.5056/jnm.2014.20.2.265, 10.5056/jnm.20.2.265]; Mangge H, 2013, CURR MED CHEM, V20, P2330, DOI 10.2174/0929867311320180004; Miller LE, 2013, WORLD J GASTROENTERO, V19, P4718, DOI 10.3748/wjg.v19.i29.4718; Moloney RD, 2014, MAMM GENOME, V25, P49, DOI 10.1007/s00335-013-9488-5; Montalto M., 2009, DIGEST LIVER DIS, V3, P30, DOI [10.1016/S1594-5804(09)60016-4, DOI 10.1016/S1594-5804(09)60016-4]; Nair B, 2003, INT J TOXICOL, V22, P63, DOI 10.1080/10915810390239478; NETA P, 1985, ENVIRON HEALTH PERSP, V64, P209, DOI 10.2307/3430011; Sanchez M, 2014, BR J NUTR, V2013, P1; Schulfer A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004903; Seetaramaiah K., 2011, International Journal of Pharmaceutical and Biological Archives, V2, P583; Vally Hassan, 2012, Gastroenterol Hepatol Bed Bench, V5, P16; WALKER R, 1985, Food Additives and Contaminants, V2, P5; Wang HY, 2016, J NEUROGASTROENTEROL, V22, P589, DOI 10.5056/jnm16018; [WHO FAO], INT FOOD STAND; YANG WH, 1985, CAN MED ASSOC J, V133, P865; Zalan Z, 2005, FOOD TECHNOL BIOTECH, V43, P219; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x	39	49	49	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186629	10.1371/journal.pone.0186629	http://dx.doi.org/10.1371/journal.pone.0186629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045472	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100081
J	Mo, YQ; Li, L; Li, JW; Rohwer, JG; Li, HW; Li, J				Mo, Yue-qing; Li, Lang; Li, Jian-wu; Rohwer, Jens G.; Li, Hsi-wen; Li, Jie			Alseodaphnopsis: A new genus of Lauraceae based on molecular and morphological evidence	PLOS ONE			English	Article							SEQUENCES; INFERENCE; MRBAYES; GENERA; MODEL	An investigation of a questionable species of the genus Alseodaphne led to the discovery of a new genus Alseodaphnopsis H.W.Li &J.Li,gen.nov., separated from Alseodaphne Nees, and a new species Alseodaphnopsis ximengensis H.W.Li & J.Li,sp.nov., endemic to Yunnan province, China. This new species is characterized by having big, axillary, paniculate inflorescences, as well as large, subglobose fruits. Based on DNA sequence data from two gene regions (nuclear ribosomal ITS and LEAFY intron II), we investigate its phylogenetic position within the Persea group. Phylogenies using maximum parsimony (MP) and Bayesian inference (BI) support the recognition of Alseodaphnopsis as a distinct genus but do not resolve well its relationship within the Persea group. The new genus is circumscribed, eight new combinations for its species are made, and a description and illustration of the new species are provided.	[Mo, Yue-qing; Li, Lang; Li, Jie] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Plant Phylogenet & Conservat Grp, Kunming, Yunnan, Peoples R China; [Mo, Yue-qing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Jian-wu] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Herbarium HITBC, Menglun, Yunnan, Peoples R China; [Rohwer, Jens G.] Univ Hamburg, Biozentrum Klein Flottbek, Hamburg, Germany; [Li, Hsi-wen] Chinese Acad Sci, Kunming Inst Bot, Herbarium KUN, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; University of Hamburg; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, J (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Plant Phylogenet & Conservat Grp, Kunming, Yunnan, Peoples R China.	jieli@xtbg.ac.cn		liLi, jieJie/0000-0001-8067-749X	Southeast Asia Biodiversity Research Institute, Chinese Academy of Science [Y4ZK111B01]	Southeast Asia Biodiversity Research Institute, Chinese Academy of Science	This work is funded by Southeast Asia Biodiversity Research Institute, Chinese Academy of Science(Y4ZK111B01).; The authors would like to thank the Center for Integrative Conservation. We are grateful to Zhi-fang Liu, Jian-hua Xiao for collection assistance and the Plant Phylogenetics & Conservation Group members for previous data accumulation. Special thanks go to Deby Arifiani, Henk van der Werff and Yu Song for their kindly help with leaf materials, and to Bing Liu, Yong Yang along with two anonymous reviewers for their valuable comments on the manuscript. This work is funded by Southeast Asia Biodiversity Research Institute, Chinese Academy of Science (Y4ZK111B01).	Bentham G., 1880, GENERA PLANTARUM, V3, P146; Boerlage J.G., 1900, HANDLEIDING FLORA NE, DOI DOI 10.5962/BHL.TITLE.289; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Esenbeck Nees CG, 1831, LAURACEAE PLANTAE AS; Gamble JS, 1912, J ASIATIC SOC BENGAL, V75, P35; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hooker J.D., 1886, FLORA BRIT INDIA, VV, P116, DOI [10.5962/bhl.title.678, DOI 10.5962/BHL.TITLE.678]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Julia S, 2009, BLUMEA, V54, P192, DOI 10.3767/000651909X476148; KOSTERMANS A J G H, 1973, Candollea, V28, P93; Kostermans A.J.G.H., 1957, REINWARDTIA, V4, P275; Lee S.K., 1979, ACTA PHYTOTAXON SIN, V17, P45; Li HW, 2004, ACTA PHYTOTAXON SIN, V42, P551; Li HW, 2008, FLORA CHINA, V7; Li HW, 1982, FLORA REIPUBLICAE PO, V31; Li JZ, 2009, SCI CHINA SER D, V52, P1537, DOI 10.1007/s11430-009-0120-1; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ridley H.N., 1925, FLORA MALAY PENINSUL, V5; Rohwer JG, 2009, TAXON, V58, P1153, DOI 10.1002/tax.584009; Rohwer JG, 2005, ANN MO BOT GARD, V92, P153; Rohwer JG, 2000, SYST BOT, V25, P60, DOI 10.2307/2666673; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van der Werff H, 2001, BLUMEA, V46, P125; Zhu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151941	27	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186545	10.1371/journal.pone.0186545	http://dx.doi.org/10.1371/journal.pone.0186545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045488	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100070
J	Chattaragada, MS; Riganti, C; Sassoe, M; Principe, M; Santamorena, MM; Roux, C; Curcio, C; Evangelista, A; Allavena, P; Salvia, R; Rusev, B; Scarpa, A; Cappello, P; Novelli, F				Chattaragada, M. S.; Riganti, C.; Sassoe, M.; Principe, M.; Santamorena, M. M.; Roux, C.; Curcio, C.; Evangelista, A.; Allavena, P.; Salvia, R.; Rusev, B.; Scarpa, A.; Cappello, P.; Novelli, F.			FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis	ONCOGENE			English	Article							OXYGEN SPECIES PRODUCTION; PANCREATIC-CANCER; MICROENVIRONMENTAL REGULATION; REDOX REGULATION; GENE-EXPRESSION; ALPHA-ENOLASE; IN-VITRO; CELLS; SURVIVAL; FISSION	Mitochondrial dysregulation plays a central role in cancers and drives reactive oxygen species (ROS)-dependent tumor progression. We investigated the pro-tumoral roles of mitochondrial dynamics and altered intracellular ROS levels in pancreatic ductal adenocarcinoma (PDAC). We identified 'family with sequence similarity 49 member B' (FAM49B) as a mitochondria-localized protein that regulates mitochondrial fission and cancer progression. Silencing FAM49B in PDAC cells resulted in increased fission and mitochondrial ROS generation, which enhanced PDAC cell proliferation and invasion. Notably, FAM49B expression levels in PDAC cells were downregulated by the tumor microenvironment. Overall, the results of this study show that FAM49B acts as a suppressor of cancer cell proliferation and invasion in PDAC by regulating tumor mitochondrial redox reactions and metabolism.	[Chattaragada, M. S.; Principe, M.; Santamorena, M. M.; Roux, C.; Curcio, C.; Cappello, P.; Novelli, F.] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Chattaragada, M. S.; Principe, M.; Santamorena, M. M.; Roux, C.; Curcio, C.; Cappello, P.; Novelli, F.] Azienda Univ Osped Citta Salute & Sci Torino, Ctr Expt Res & Med Studies, Turin, Italy; [Riganti, C.] Univ Turin, Dept Oncol, Turin, Italy; [Sassoe, M.] Univ Turin, Dept Neurosci Rita Levi Montalcini, Turin, Italy; [Evangelista, A.] Azienda Univ Osped Citta Salute & Sci, Dept Clin Epidemiol, Turin, Italy; [Evangelista, A.] CPO Piemonte, Turin, Italy; [Allavena, P.] Humanitas Clin & Res Ctr, Dept Gastroenterol, Lab Mol Gastroenterol, Milan, Italy; [Salvia, R.] Univ & Hosp Trust Verona, Pancreas Inst, Dept Surg, Verona, Italy; [Rusev, B.] Univ & Hosp Trust Verona, Dept Pathol & Publ Hlth, Verona, Italy; [Scarpa, A.] Univ & Hosp Trust Verona, ARC NET Res Ctr, Verona, Italy; [Cappello, P.; Novelli, F.] Univ Turin, Mol Biotechnol Ctr, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Turin	Novelli, F (corresponding author), Citta Salute & Sci Torino, Ctr Expt Res & Med Studies, Via Santena 5, I-10125 Turin, Italy.	franco.novelli@unito.it	Salvia, Roberto/J-1773-2018; Curcio, Claudia/AAB-3638-2019; Novelli, Francesco/Z-5990-2019; Allavena, Paola/HHM-5218-2022; Roux, Cecilia/AAB-9661-2019; Cappello, Paola/J-3127-2018; Scarpa, Aldo/K-6832-2016	Allavena, Paola/0000-0002-6697-6028; Roux, Cecilia/0000-0002-2883-167X; Cappello, Paola/0000-0002-5321-7794; Principe, Moitza/0000-0001-5013-7388; NOVELLI, FRANCESCO/0000-0002-6259-5666; Riganti, Chiara/0000-0001-9787-4836; evangelista, andrea/0000-0003-1901-2805; CURCIO, Claudia/0000-0001-5306-4399; Scarpa, Aldo/0000-0003-1678-739X	Associazione Italiana Ricerca sul Cancro (5 x mille) [12182, 15257, 15232]; University of Turin-Progetti Ateneo-Compagnia di San Paolo (PC-METAIMMUN-OTHER); University of Turin-Progetti Ateneo-Compagnia di San Paolo (PANTHER); Italian Ministry of Health-Progetti Ricerca Finalizzata [RF-2013-02354892]; Fondazione Ricerca Molinette Onlus; Fondazione Nadia Valsecchi; European Community FP7 Grant Cam-Pac [602783]; FIMP, Ministero Salute [CUP_J33G13000210001]; Fondazione Ursula e Giorgio Cytron, Torino	Associazione Italiana Ricerca sul Cancro (5 x mille)(Fondazione AIRC per la ricerca sul cancro); University of Turin-Progetti Ateneo-Compagnia di San Paolo (PC-METAIMMUN-OTHER); University of Turin-Progetti Ateneo-Compagnia di San Paolo (PANTHER); Italian Ministry of Health-Progetti Ricerca Finalizzata; Fondazione Ricerca Molinette Onlus; Fondazione Nadia Valsecchi; European Community FP7 Grant Cam-Pac; FIMP, Ministero Salute; Fondazione Ursula e Giorgio Cytron, Torino	We thank Roberta Curto for technical support in the in vivo experiments, Elena Frola for technical support in the electron microscopy and Dr Radhika Srinivasan for critically reading the manuscript. The nature research language editing service edited this work. This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (5 x mille no. 12182 to AS and FN, IG no. 15257 to FN, IG no. 15232 to AS); University of Turin-Progetti Ateneo 2014-Compagnia di San Paolo (PC-METAIMMUN-OTHER to FN and PANTHER to PC), Italian Ministry of Health-Progetti Ricerca Finalizzata (RF-2013-02354892 to FN), Fondazione Ricerca Molinette Onlus, Fondazione Nadia Valsecchi to FN, European Community FP7 Grant Cam-Pac (agreement no: 602783) to AS; FIMP, Ministero Salute (CUP_J33G13000210001) to AS. MSC was supported by Fondazione Ursula e Giorgio Cytron, Torino.	Al Saati T, 2013, AM J PATHOL, V182, P1996, DOI 10.1016/j.ajpath.2013.02.034; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Brahimi-Horn MC, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0133-5; Caino MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13730; Campia I, 2009, BRIT J PHARMACOL, V158, P1777, DOI 10.1111/j.1476-5381.2009.00465.x; Cappello P, 2013, GASTROENTEROLOGY, V144, P1098, DOI 10.1053/j.gastro.2013.01.020; Cappello P, 2009, INT J CANCER, V125, P639, DOI 10.1002/ijc.24355; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Ferreira-da-Silva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122308; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hancock JT, 2009, MOL BIOTECHNOL, V43, P162, DOI 10.1007/s12033-009-9189-1; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Kaistha BP, 2014, BRIT J CANCER, V111, P1780, DOI 10.1038/bjc.2014.460; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kodydkova J, 2013, PANCREAS, V42, P614, DOI 10.1097/MPA.0b013e318288360a; Konstantinidis IT, 2013, ANN SURG, V257, P731, DOI 10.1097/SLA.0b013e318263da2f; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Krska Zdenek, 2015, Prague Med Rep, V116, P253, DOI 10.14712/23362936.2015.65; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pinzon-Daza ML, 2012, BRIT J PHARMACOL, V167, P1431, DOI 10.1111/j.1476-5381.2012.02103.x; Principe M, 2015, ONCOTARGET, V6, P11098, DOI 10.18632/oncotarget.3572; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rambold Angelika S, 2011, Commun Integr Biol, V4, P752; Riganti C, 2008, TOXICOL APPL PHARM, V228, P277, DOI 10.1016/j.taap.2007.12.013; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Rishi A, 2015, SEMIN ONCOL, V42, P28, DOI 10.1053/j.seminoncol.2014.12.004; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Saborido A, 2005, FREE RADICAL RES, V39, P921, DOI 10.1080/10715760500188887; Sassoe-Pognetto M, 2000, J NEUROSCI, V20, P2192; Schwamb B, 2015, INT J CANCER, V137, P1318, DOI 10.1002/ijc.29498; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Storz P, 2017, NAT REV GASTRO HEPAT, V14, P296, DOI 10.1038/nrgastro.2017.12; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tomaino B, 2007, J PROTEOME RES, V6, P4025, DOI 10.1021/pr070281a; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Tung JC, 2015, FREE RADICAL BIO MED, V79, P269, DOI 10.1016/j.freeradbiomed.2014.11.020; Uzhachenko R, 2012, J PATHOL, V227, P456, DOI 10.1002/path.4039; Viltono L, 2008, J COMP NEUROL, V508, P579, DOI 10.1002/cne.21713; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wang ZW, 2010, CURR STEM CELL RES T, V5, P74, DOI 10.2174/157488810790442813; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang Q, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.215; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zhou LX, 2013, MOL CANCER RES, V11, P272, DOI 10.1158/1541-7786.MCR-12-0395	66	36	36	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					697	709		10.1038/onc.2017.358	http://dx.doi.org/10.1038/onc.2017.358			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059164	hybrid, Green Published			2022-12-26	WOS:000424628100002
J	Binnemars-Postma, K; Bansal, R; Storm, G; Prakash, J				Binnemars-Postma, Karin; Bansal, Ruchi; Storm, Gert; Prakash, Jai			Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer	FASEB JOURNAL			English	Article						TAMs; AS1517499; M2 macrophages; liver metastasis	STIMULATING FACTOR; POLARIZATION; MECHANISMS; RECRUITMENT; POPULATION; MIGRATION; RECEPTOR	Tumor-associated macrophages (TAMs) are the key effector cells in the tumor microenvironment and induce neoangiogenesis, matrix remodeling, and metastasis while suppressing the tumor immune system. These protumoral macrophages display an M2 phenotype induced by IL-4 and IL-13 cytokines. In this study, we hypothesized that the inhibition of the signal transducer and activator of transcription 6 (Stat6) pathway, a common downstream signaling pathway of IL-4 and IL-13, may be an interesting strategy by which to inhibit TAM differentiation and, thus, their protumorigenic activities. In vitro inhibition of the Stat6 pathway by using small interfering RNA or the pharmacologic inhibitor, AS1517499, inhibited the differentiation of mouse RAW264.7 macrophages into the M2 phenotype, as demonstrated by the reduction of Arg-1 (arginase-1) and Mrc-1 (mannose receptor 1) expression and arginase activity. In vivo, AS1517499 significantly attenuated tumor growth and early liver metastasis in an orthotopic 4T1 mammary carcinoma mouse model. Furthermore, in another experiment, we observed an increase in the intrahepatic mRNA expression of F4/80 (EGF-like module-containing mucin-like hormone receptor-like 1; total macrophages) and M2 macrophage markers [Ym-1 (chitinase 3-like protein 3) and Mrc-1] and metastatic niche markers [Mmp-2 (matrix metalloproteinase-2), Postn (periostin), and Cd34] in mice with increasing growth of primary tumors. Of interest, these markers were found to be reduced after treatment with AS1517499. In summary, inhibition of the Stat6 pathway in TAMs is a vital therapeutic approach to attenuate tumor growth and metastasis by inhibiting TAM-induced protumorigenic and prometastatic activities.	[Binnemars-Postma, Karin; Bansal, Ruchi; Storm, Gert; Prakash, Jai] Univ Twente, Inst Biomed Technol & Tech Med MIRA, Targeted Therapeut Biomat Sci & Technol, Enschede, Netherlands; [Storm, Gert] Univ Utrecht, Dept Pharmaceut, Utrecht, Netherlands	University of Twente; Utrecht University	Prakash, J (corresponding author), Univ Twente, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.	j.prakash@utwente.nl	Prakash, Jai/C-8015-2014; Bansal, Ruchi/D-4796-2016	Prakash, Jai/0000-0003-1050-650X; Bansal, Ruchi/0000-0003-2470-5876	Phospholipid Research Centre Heidelberg [30926319]; MIRA Institute, University of Twente	Phospholipid Research Centre Heidelberg; MIRA Institute, University of Twente	The authors thank Dr. Joop van Baarlen (LabPON, Hengelo, The Netherlands) for providing human breast tumor tissue. This study was supported by the Phospholipid Research Centre Heidelberg (Grant 30926319 to J.P.) and the MIRA Institute, University of Twente. The authors declare no conflicts of interest.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Brown HK, 2009, CURR CANCER DRUG TAR, V9, P807, DOI 10.2174/156800909789760339; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Guo QJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9720912; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; International Agency for Research on Cancer, BREAST CANC; Jia XM, 2014, BREAST CANCER RES TR, V148, P291, DOI 10.1007/s10549-014-3164-7; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Nagashima S, 2007, BIOORGAN MED CHEM, V15, P1044, DOI 10.1016/j.bmc.2006.10.015; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Ngambenjawong C, 2017, ADV DRUG DELIVER REV, V114, P206, DOI 10.1016/j.addr.2017.04.010; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Oishi K, 2015, SURG TODAY, V45, P715, DOI 10.1007/s00595-014-0989-y; Ostrand-Rosenberg S, 2000, J IMMUNOL, V165, P6015, DOI 10.4049/jimmunol.165.11.6015; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Sakurai M, 2003, J ANTIBIOT, V56, P513, DOI 10.7164/antibiotics.56.513; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	35	95	105	5	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					969	978		10.1096/fj.201700629R	http://dx.doi.org/10.1096/fj.201700629R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29066614	Green Submitted, Bronze			2022-12-26	WOS:000425146900037
J	Lloyd, KP; Ojelabi, OA; De Zutter, JK; Carruthers, A				Lloyd, Kenneth P.; Ojelabi, Ogooluwa A.; De Zutter, Julie K.; Carruthers, Anthony			Reconciling contradictory findings: Glucose transporter 1 (GLUT1) functions as an oligomer of allosteric, alternating access transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE GLUCOSE-TRANSPORTER; GLUT1-MEDIATED SUGAR-TRANSPORT; HOMOLOGY-SCANNING-MUTAGENESIS; CYTOCHALASIN-B; ESCHERICHIA-COLI; LIGAND-BINDING; SEQUENCE DETERMINANTS; FACILITATED DIFFUSION; CRYSTAL-STRUCTURE; ACCURATE DOCKING	Recent structural studies suggest that GLUT1 (glucose transporter 1)-mediated sugar transport is mediated by an alternating access transporter that successively presents exofacial (e2) and endofacial (e1) substrate-binding sites. Transport studies, however, indicate multiple, interacting (allosteric), and co-existent, exo-and endofacial GLUT1 ligand-binding sites. The present study asks whether these contradictory conclusions result from systematic analytical error or reveal a more fundamental relationship between transporter structure and function. Here, homology modeling supported the alternating access transporter model for sugar transport by confirming at least four GLUT1 conformations, the so-called outward, outward-occluded, inward-occluded, and inward GLUT1 conformations. Results from docking analysis suggested that outward and outward-occluded conformations present multiple beta-D-glucose and maltose interaction sites, whereas inward-occluded and inward conformations present only a single beta-D-glucose interaction site. Gln-282 contributed to sugar binding in all GLUT1 conformations via hydrogen bonding. Mutating Gln-282 to alanine (Q282A) doubled the Km(app) for 2-deoxy-D-glucose uptake and eliminated cis-allostery (stimulation of sugar uptake by sub-saturating extracellular maltose) but not trans-allostery (uptake stimulation by subsaturating cytochalasin B). cis-Allostery persisted, but trans-allostery was lost in an oligomerization-deficient GLUT1 variant in which we substituted membrane helix 9 with the equivalent GLUT3 sequence. Moreover, Q282A eliminated cis-allostery in the oligomerization variant. These findings reconcile contradictory conclusions from structural and transport studies by suggesting that GLUT1 is an oligomer of allosteric, alternating access transporters in which 1) cis-allostery is mediated by intrasubunit interactions and 2) trans-allostery requires intersubunit interactions.	[Lloyd, Kenneth P.; Ojelabi, Ogooluwa A.; De Zutter, Julie K.; Carruthers, Anthony] Univ Massachusetts, Med Sch, Grad Sch Biomed Sci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Rm 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK36081, DK44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK036081, R01DK044888, R01DK036081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK36081 and DK44888. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BAKER GF, 1973, J PHYSIOL-LONDON, V231, P143, DOI 10.1113/jphysiol.1973.sp010225; BAKER GF, 1979, BIOCHIM BIOPHYS ACTA, V550, P474, DOI 10.1016/0005-2736(79)90150-0; BAKER PF, 1981, J PHYSIOL-LONDON, V316, P481, DOI 10.1113/jphysiol.1981.sp013802; BALDWIN SA, 1979, BIOCHIM BIOPHYS ACTA, V552, P183, DOI 10.1016/0005-2736(79)90257-8; BARNETT JEG, 1973, BIOCHEM J, V131, P211, DOI 10.1042/bj1310211; BARNETT JEG, 1975, BIOCHEM J, V145, P417, DOI 10.1042/bj1450417a; BASKETTER DA, 1978, J PHYSIOL-LONDON, V278, P389, DOI 10.1113/jphysiol.1978.sp012311; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Blodgett DM, 2005, BIOCHEMISTRY-US, V44, P2650, DOI 10.1021/bi048247m; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3898, DOI 10.1021/bi00230a014; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; CODERRE PE, 1995, BIOCHEMISTRY-US, V34, P9762, DOI 10.1021/bi00030a014; Cunningham P, 2014, J MEMBRANE BIOL, V247, P1161, DOI 10.1007/s00232-014-9711-7; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cura AJ, 2010, J BIOL CHEM, V285, P15430, DOI 10.1074/jbc.M110.110593; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; HINKLE PC, 1979, FUNCTION MOL ASPECTS, P487; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JARVIS SM, 1986, BIOCHIM BIOPHYS ACTA, V855, P312, DOI 10.1016/0005-2736(86)90179-3; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P178, DOI 10.1016/0005-2736(74)90144-8; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NAFTALIN RJ, 1988, TRENDS BIOCHEM SCI, V13, P425; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; Ojelabi OA, 2016, J BIOL CHEM, V291, P26762, DOI 10.1074/jbc.M116.759175; PESSINO A, 1991, J BIOL CHEM, V266, P20213; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Reddy, 2013, FEBS J, V280, P3975, DOI 10.1111/febs.12405; Robichaud T, 2011, BIOCHEMISTRY-US, V50, P3137, DOI 10.1021/bi1020327; SOGIN DC, 1980, BIOCHEMISTRY-US, V19, P5417, DOI 10.1021/bi00564a041; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Yan N, 2017, J MOL BIOL, V429, P2710, DOI 10.1016/j.jmb.2017.07.009; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	52	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21035	21046		10.1074/jbc.M117.815589	http://dx.doi.org/10.1074/jbc.M117.815589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29066623	Green Published, hybrid			2022-12-26	WOS:000418453400019
J	Ma, YB; Min, HK; Oh, U; Hawkridge, AM; Wang, W; Mohsin, AA; Chen, Q; Sanyal, A; Lesnefsky, EJ; Fang, XJ				Ma, Yibao; Min, Hae-Ki; Oh, Unsong; Hawkridge, Adam M.; Wang, Wei; Mohsin, Ahmed A.; Chen, Qun; Sanyal, Arun; Lesnefsky, Edward J.; Fang, Xianjun			The lignan manassantin is a potent and specific inhibitor of mitochondrial complex I and bioenergetic activity in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSPORT CHAIN; SAURURUS-CHINENSIS; HEXOKINASE II; GLYCOLYSIS; PHOSPHORYLATION; DEFICIENCY; ACTIVATION; GENERATION; SAUCERNEOL; EXPRESSION	Dineolignans manassantinAandBfrom the plant Saururus cernuus are used in traditional medicine to manage a wide range of ailments such as edema, jaundice, and gonorrhea. Cell-based studies have identified several molecular target candidates of manassantin including NF-kappa B, MAPK, STAT3, and hypoxia-inducible factor 1 alpha (HIF-1 alpha). It is unclear whether or how these structurally diverse proteins or pathways mediate any of the medical benefits of manassantin in vivo. Moreover, it has recently been reported that manassantin causes developmental arrestin zebrafish by inhibiting the mitochondrial complex I, but it is unknown whether manassantin inhibits mitochondrial respiration in intact mammalian cells and live animals. Here, we present direct evidence that manas-santin potently and specifically inhibits the mitochondrial complex I and bioenergetic activity in mammalian systems. Manassantin had no effect on complex II- or complex IV-mediated respiration. Of note, it decreased NADH-ubiquinone reductase activity but not the activity of NADH-ferricyanide reductase. Treatment with manassantin reduced cellular ATP levels and concomitantly stimulated AMP-activated protein kinase in vitro and in vivo. As an adaptive response to manassantin-induced bioenergetic deficiency, mammalian cells up-regulated aerobic glycolysis, a process mediated by AMP-activated protein kinase (AMPK) independently of HIF-1 alpha. Together these results demonstrate a biologically important activity of manassantin in the control of complex I-mediated respiration and its profound effects on oxygen utilization, energy homeostasis, and glucose metabolism in mammalian cells.	[Ma, Yibao; Wang, Wei; Lesnefsky, Edward J.; Fang, Xianjun] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Min, Hae-Ki; Mohsin, Ahmed A.; Chen, Qun; Sanyal, Arun; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Oh, Unsong] Virginia Commonwealth Univ, Dept Neurol, Sch Med, Richmond, VA 23298 USA; [Hawkridge, Adam M.] Virginia Commonwealth Univ, Dept Pharmaceut, Sch Pharm, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Fang, XJ (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Sanger Hall 2-016,1101 East Marshall St, Richmond, VA 23298 USA.	xianjun.fang@vcuhealth.org	Ma, Yibao/H-3849-2016; Mohsin, Ahmed A/T-4012-2019; Chen, Qun/HGD-0868-2022; Mohsin, Ahmed A/AAC-7272-2021	Ma, Yibao/0000-0002-3270-8893; Mohsin, Ahmed A/0000-0001-7680-4636	Astar Biotech; Department of Veterans Affairs, Office of Research and Development, Medical Research Service [2IO1BX001355-01A2]; American Heart Association [15GRNT24480123]; NIA, National Institutes of Health [R21 AG054975]; Pauley Heart Center of Virginia Commonwealth University; National Institutes of Health [DK 105961, DK AA 20758, P30 CA16059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG054975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020758] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001355] Funding Source: NIH RePORTER	Astar Biotech; Department of Veterans Affairs, Office of Research and Development, Medical Research Service(US Department of Veterans Affairs); American Heart Association(American Heart Association); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pauley Heart Center of Virginia Commonwealth University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported in part by an Astar Biotech research award (to X. F.); Department of Veterans Affairs, Office of Research and Development, Medical Research Service Merit Review Award 2IO1BX001355-01A2 (to E. J. L.); American Heart Association Grant-in-aid 15GRNT24480123 (to Q. C.); NIA, National Institutes of Health Grant R21 AG054975 (to Q. C.); the Pauley Heart Center of Virginia Commonwealth University (to Q. C. and E. J. L.); National Institutes of Health Grants DK 105961 (to A. S.), DK AA 20758 (to A. S.), and Grant P30 CA16059 (to the Massey Cancer Center of Virginia Commonwealth University School of Medicine). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ball AL, 2016, TOXICOL SCI, V153, P341, DOI 10.1093/toxsci/kfw126; BEUTLER E, 1967, BLOOD-J HEMATOL, V30, P311, DOI 10.1182/blood.V30.3.311.311; BRASS EP, 1980, BIOCHEM J, V188, P451, DOI 10.1042/bj1880451; Chang JS, 2011, J PHARMACOL SCI, V115, P84, DOI 10.1254/jphs.10239SC; Chung BS, 1990, DICT KOREAN FOLK MED, P813; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Ferrick D., 2008, DRUG INDUCED MITOCHO, P373; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hargrave B, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12710; Hodges TW, 2004, J NAT PROD, V67, P767, DOI 10.1021/np030514m; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; Hossain CF, 2005, BIOCHEM BIOPH RES CO, V333, P1026, DOI 10.1016/j.bbrc.2005.05.191; Hwang BY, 2003, PHYTOCHEMISTRY, V64, P765, DOI 10.1016/S0031-9422(03)00391-1; Kim JY, 2009, J PHARMACOL SCI, V109, P583, DOI 10.1254/jphs.08299FP; Kim SJ, 2011, BIOL PHARM BULL, V34, P1769, DOI 10.1248/bpb.34.1769; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Komulainen T, 2015, TOXICOLOGY, V331, P47, DOI 10.1016/j.tox.2015.03.001; Kwon DY, 2015, J MED CHEM, V58, P7659, DOI 10.1021/acs.jmedchem.5b01220; Kwon OE, 2005, ARCH PHARM RES, V28, P55, DOI 10.1007/BF02975136; Lai K, 2013, ACS CHEM BIOL, V8, P257, DOI 10.1021/cb300495e; Lee JH, 2003, BIOCHEM PHARMACOL, V66, P1925, DOI 10.1016/S0006-2952(03)00553-7; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; Lee WS, 2004, BIOORG MED CHEM LETT, V14, P3109, DOI 10.1016/j.bmcl.2004.04.023; Lu Y, 2013, BIOL PHARM BULL, V36, P1370, DOI 10.1248/bpb.b13-00146; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma Y, 2016, ONCOGENE, V35, P6132, DOI 10.1038/onc.2016.150; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Mukherjee A, 2015, NEOPLASIA, V17, P723, DOI 10.1016/j.neo.2015.09.003; Murai M, 2016, BBA-BIOENERGETICS, V1857, P884, DOI 10.1016/j.bbabio.2015.11.009; Nicholls DG, 2010, J VIS EXP, P2511; Park HC, 2012, KOREAN J ANESTHESIOL, V62, P161, DOI 10.4097/kjae.2012.62.2.161; RAO KV, 1983, TETRAHEDRON LETT, V24, P4947, DOI 10.1016/S0040-4039(01)99818-1; Rho MC, 2003, PLANTA MED, V69, P1147, DOI 10.1055/s-2003-818007; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Seo CS, 2009, PHYTOTHER RES, V23, P1531, DOI 10.1002/ptr.2791; Shao HJ, 2016, ONCOTARGET, V7, P3832, DOI 10.18632/oncotarget.6757; Son KN, 2005, MOL CELLS, V20, P105; Song SY, 2005, INT J MOL MED, V16, P517; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Wallace MAG, 2016, J PROTEOME RES, V15, P2688, DOI 10.1021/acs.jproteome.6b00237; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	44	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20989	20997		10.1074/jbc.M117.812925	http://dx.doi.org/10.1074/jbc.M117.812925			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29046352	Green Published, hybrid			2022-12-26	WOS:000418453400015
J	Paungpin, W; Wiriyarat, W; Chaichoun, K; Tiyanun, E; Sangkachai, N; Changsom, D; Poltep, K; Ratanakorn, P; Puthavathana, P				Paungpin, Weena; Wiriyarat, Witthawat; Chaichoun, Kridsada; Tiyanun, Ekasit; Sangkachai, Nareerat; Changsom, Don; Poltep, Kanaporn; Ratanakorn, Parntep; Puthavathana, Pilaipan			Serosurveillance for pandemic influenza A (H1N1) 2009 virus infection in domestic elephants, Thailand	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PROTEIN A/G CONJUGATE; HEMAGGLUTINATION INHIBITION; NONSPECIFIC INHIBITORS; KAOLIN TREATMENT; IMMUNOGLOBULIN-G; WESTERN-BLOT; ANTIBODIES; SERUM; ANIMALS	The present study conducted serosurveillance for the presence of antibody to pandemic influenza A (H1N1) 2009 virus (H1N1pdm virus) in archival serum samples collected between 2009 and 2013 from 317 domestic elephants living in 19 provinces situated in various parts of Thailand. To obtain the most accurate data, hemagglutination-inhibition (HI) assay was employed as the screening test; and sera with HI antibody titers >= 20 were further confirmed by other methods, including cytopathic effect/hemagglutination based-microneutralization (microNT) and Western blot (WB) assays using H1N1pdm matrix 1 (M1) or hemagglutinin (HA) recombinant protein as the test antigen. Conclusively, the appropriate assays using HI in conjunction with WB assays for HA antibody revealed an overall seropositive rate of 8.5% (27 of 317). The prevalence of antibody to H1N1pdm virus was 2% (4/172) in 2009, 32% (17/53) in 2010, 9% (2/22) in 2011, 12% (1/8) in 2012, and 5% (3/62) in 2013. Notably, these positive serum samples were collected from elephants living in 7 tourist provinces of Thailand. The highest seropositive rate was obtained from elephants in Phuket, a popular tourist beach city. Young elephants had higher seropositive rate than older elephants. The source of H1N1pdm viral infection in these elephants was not explored, but most likely came from close contact with the infected mahouts or from the infected tourists who engaged in activities such as elephant riding and feeding. Nevertheless, it could not be excluded that elephant-to-elephant transmission did occur.	[Paungpin, Weena; Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand; [Paungpin, Weena; Wiriyarat, Witthawat; Chaichoun, Kridsada; Sangkachai, Nareerat; Poltep, Kanaporn; Ratanakorn, Parntep] Mahidol Univ, Fac Vet Sci, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Salaya, Nakhon Pathom, Thailand; [Tiyanun, Ekasit] Mahidol Univ, Hlth Anim Clin 1, Nakhon Sawan Campus, Nakhon Sawan, Thailand; [Changsom, Don; Puthavathana, Pilaipan] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Salaya, Nakhon Pathom, Thailand; [Puthavathana, Pilaipan] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya, Nakhon Pathom, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Puthavathana, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.; Puthavathana, P (corresponding author), Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Salaya, Nakhon Pathom, Thailand.; Puthavathana, P (corresponding author), Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya, Nakhon Pathom, Thailand.	pilaipan.put@mahidol.ac.th		Paungpin, Weena/0000-0002-3909-2884; POLTEP, KANAPORN/0000-0002-4160-3970; Puthavathana, Pilaipan/0000-0002-5481-9156	Mahidol University under the National Research Universities Initiative	Mahidol University under the National Research Universities Initiative	This work was supported by Mahidol University under the National Research Universities Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Mahidol University under the National Research Universities Initiative. We thank Dr. Sarin Suwanpakdee for a map on location of the study elephants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Adhami BH, 2014, VET PARASITOL, V200, P66, DOI 10.1016/j.vetpar.2013.11.004; ANANTHANARAYAN R, 1960, Bull World Health Organ, V22, P409; ANDERS EM, 1990, P NATL ACAD SCI USA, V87, P4485, DOI 10.1073/pnas.87.12.4485; ANDERSON SG, 1948, AUST J EXP BIOL MED, V26, P403, DOI 10.1038/icb.1948.41; Angkawanish T., 2009, Gajah, V31, P15; Berhane Y, 2010, AVIAN DIS, V54, P1275, DOI 10.1637/9422-061410-Reg.1; Bhide MR, 2004, COMP IMMUNOL MICROB, V27, P191, DOI 10.1016/j.cimid.2003.10.001; Boliar S, 2006, J VET DIAGN INVEST, V18, P264, DOI 10.1177/104063870601800305; Britton AP, 2010, EMERG INFECT DIS, V16, P1043, DOI 10.3201/eid1606.100352; COHEN A, 1959, VIROLOGY, V7, P59, DOI 10.1016/0042-6822(59)90177-1; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Crossley B, 2012, EMERG INFECT DIS, V18, P315, DOI 10.3201/eid1802.111245; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gocnik M, 2008, J GEN VIROL, V89, P958, DOI 10.1099/vir.0.83524-0; Goldstein T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062259; Gu Y, 2015, J VET DIAGN INVEST, V27, P616, DOI 10.1177/1040638715596033; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; HILLEMAN MR, 1953, J IMMUNOL, V71, P110; Howell E., 2013, WHAT ANIMALS CAN TEA; Humphreys AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116318; Iamsirithaworn S., 2011, Siriraj Medical Journal, V63, P64; Inoshima Y, 1999, CLIN DIAGN LAB IMMUN, V6, P388, DOI 10.1128/CDLI.6.3.388-391.1999; Jongcherdchootrakul Kanlaya, 2014, Journal of the Medical Association of Thailand, V97, pS145; Kelly PJ, 1998, COMP IMMUNOL MICROB, V21, P65, DOI 10.1016/S0147-9571(97)80053-7; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; KONNO JIRO, 1958, TOHOKU JOUR EXPTL MED, V67, P391; Krizanova O, 1969, Curr Top Microbiol Immunol, V47, P125; Lair R.C., 1997, GONE ASTRAY CARE MAN; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Leyva-Grado VH, 2012, EMERG INFECT DIS, V18, P1135, DOI 10.3201/eid1807.111930; Li DS, 2014, EMERG INFECT DIS, V20, P480, DOI 10.3201/eid2003.131531; Lin DG, 2012, J GEN VIROL, V93, P119, DOI 10.1099/vir.0.037358-0; Lin HT, 2014, JPN J VET RES, V62, P181; LOBMANN M, 1976, J HYG-CAMBRIDGE, V77, P181, DOI 10.1017/S0022172400024608; Louisirirotchanakul S, 2007, J CLIN MICROBIOL, V45, P2284, DOI 10.1128/JCM.00921-07; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nielsen K, 2004, VET MICROBIOL, V101, P123, DOI 10.1016/j.vetmic.2004.02.014; Nymo IH, 2013, J VET DIAGN INVEST, V25, P369, DOI 10.1177/1040638713485073; Panaampon J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036318; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Pereda A, 2010, EMERG INFECT DIS, V16, P304, DOI 10.3201/eid1602.091230; PRITCHETT TJ, 1989, J BIOL CHEM, V264, P9850; RYANPOIRIER KA, 1991, J VIROL, V65, P389, DOI 10.1128/JVI.65.1.389-395.1991; RYANPOIRIER KA, 1993, VIROLOGY, V193, P974, DOI 10.1006/viro.1993.1208; Schaefer JJ, 2012, J VET DIAGN INVEST, V24, P572, DOI 10.1177/1040638712442931; Schmeisser F, 2010, VACCINE, V28, P2442, DOI 10.1016/j.vaccine.2009.12.079; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Schrenzel MD, 2011, EMERG INFECT DIS, V17, P747, DOI [10.3201/eid1706.101355, 10.3201/eid1704.101355]; SPENCE L, 1960, P SOC EXP BIOL MED, V103, P425, DOI 10.3181/00379727-103-25545; Sponseller BA, 2010, EMERG INFECT DIS, V16, P534, DOI 10.3201/eid1603.091737; SUBBARAO EK, 1992, J CLIN MICROBIOL, V30, P996, DOI 10.1128/JCM.30.4.996-999.1992; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thai Elephant Conservation Center, THAIL EL; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Vongchan P, 2013, CHIANG MAI J SCI, V40, P376; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, WHOCDSCSRNCS20025; Zhang DL, 2010, CLIN VACCINE IMMUNOL, V17, P485, DOI 10.1128/CVI.00479-09	58	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186962	10.1371/journal.pone.0186962	http://dx.doi.org/10.1371/journal.pone.0186962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073255	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400080
J	Cao, L; Damborenea, C; Penchaszadeh, PE; Darrigran, G				Cao, Luciana; Damborenea, Cristina; Penchaszadeh, Pablo E.; Darrigran, Gustavo			Gonadal cycle of Corbicula fluminea (Bivalvia: Corbiculidae) in Pampean streams (Southern Neotropical Region)	PLOS ONE			English	Article							LIMNOPERNA-FORTUNEI BIVALVIA; INTRODUCED ASIATIC CLAM; FRESH-WATER CLAM; DE-LA-PLATA; POPULATION-DYNAMICS; NATURAL-POPULATION; HONG-KONG; MULLER; AMERICA; GAMETOGENESIS	Corbicula fluminea is an aggressive invasive species of bivalve that arrived into the Rio de la Plata River between the late 60's and early 70's, and dispersed widely throughout the Neotropical region, evidencing a great adaptive flexibility to different environmental conditions. This species is a functional hermaphrodite with larval incubation inside the inner demi-branch. Despite its widespread distribution, there are no previous studies of complete gonadal histology and reproductive cycle for this species in the Neotropical region. In this study, the reproductive dynamics of C. fluminea in a temperate region, the Santa Catalina Pampean stream, Argentina, is described. Samples of 20-30 individuals were collected monthly from April 2003-April 2005 and processed using traditional histological techniques. During the two years of this study, seven spawning events were recognized. Three major spawns occurred in spring and summer, and other four minor ones during summer and autumn. Events of oocyte recovery were observed after spawning. A high number of incubating individuals was detected. The results stressed the difficulty of identifying a particular pattern of gamete release and of spawning behaviour in this invasive species, especially when inhabiting an unstable environment.	[Cao, Luciana; Damborenea, Cristina; Darrigran, Gustavo] Museo La Plata FCNyM UNLP, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina; [Cao, Luciana; Damborenea, Cristina; Darrigran, Gustavo] Consejo Nacl Invest Cient & Tecn, La Plata, Buenos Aires, Argentina; [Penchaszadeh, Pablo E.] Museo Argentino Ciencias Nat Bernardino Rivadia, CONICET, Lab Ecosistemas Costeros Malacol, Buenos Aires, DF, Argentina	National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Darrigran, G (corresponding author), Museo La Plata FCNyM UNLP, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina.; Darrigran, G (corresponding author), Consejo Nacl Invest Cient & Tecn, La Plata, Buenos Aires, Argentina.	invasion@fcnym.unlp.edu.ar	Darrigran, Gustavo/AAE-5910-2021; Penchaszadeh, Pablo/ABB-8472-2021	Penchaszadeh, Pablo/0000-0002-2043-8814	Universidad de La Plata [11/N795]	Universidad de La Plata(National University of La Plata)	This work was supported by Universidad de La Plata (11/N795) to GD.	ALDRIDGE DW, 1978, J MOLLUS STUD, V44, P49; [Anonymous], 1774, COMUNICACIONES SOC M; Baba K, 1999, MAR ECOL PROG SER, V180, P213, DOI 10.3354/meps180213; Baudrimont M, 1997, COMP BIOCHEM PHYS C, V118, P361, DOI 10.1016/S0742-8413(97)00157-6; Beasley Colin Robert, 2003, Acta Amazonica, V33, P317; Belz CE, 2012, J SHELLFISH RES, V31, P777, DOI 10.2983/035.031.0322; BERRY A J, 1974, Malayan Nature Journal, V27, P99; BICKEL DAVID, 1966, STEKIANA, V23, P19; Boltovskoy D., 2015, SPRINGER SERIES INVA, V10; BRITTON J C, 1986, Malacological Review, V19, P1; Byrne M, 2000, HYDROBIOLOGIA, V418, P185, DOI 10.1023/A:1003986512832; Cataldo D, 1998, HYDROBIOLOGIA, V380, P153, DOI 10.1023/A:1003428728693; Cazzaniga NJ, 1997, J FRESHWATER ECOL, V12, P629, DOI 10.1080/02705060.1997.9663577; Corbicula Morton B., 1986, AM MALAC B, V2, P113; Crespo D, 2017, HYDROBIOLOGIA, V784, P337, DOI 10.1007/s10750-016-2887-3; Darrigran G, 2007, AMBIO, V36, P575, DOI 10.1579/0044-7447(2007)36[575:AEPFAP]2.0.CO;2; Darrigran Gustavo, 2002, Biological Invasions, V4, P145, DOI 10.1023/A:1020521811416; Dei Tos C, 2016, REV BIOL TROP, V64, P521, DOI 10.15517/rbt.v64i2.18837; Denton ME, 2012, J SHELLFISH RES, V31, P145, DOI 10.2983/035.031.0118; DOHERTY FG, 1987, AM MIDL NAT, V117, P71, DOI 10.2307/2425709; DREIER H, 1981, Illinois Natural History Survey Bulletin, V32, P378; Eng L. L., 1979, 1ST P INT CORB S, P39; Fernandez MLA, 2012, MOLUSCOS LIMNICOS IN, P129; Giglio ML, 2016, INVERTEBR REPROD DEV, V60, P175, DOI 10.1080/07924259.2016.1174159; Global Invasive Species Database, 2016, GLOBAL INVASIVE SPEC; HORNBACH DJ, 1992, AM MIDL NAT, V127, P248, DOI 10.2307/2426531; Houki S, 2011, ZOOL SCI, V28, P526, DOI 10.2108/zsj.28.526; Ilarri M, 2011, HDB GLOBAL FRESHWATE, P173; Ilarri MI, 2011, BIOL INVASIONS, V13, P277, DOI 10.1007/s10530-010-9833-5; Ishibashi R, 2003, ZOOL SCI, V20, P727, DOI 10.2108/zsj.20.727; Ituarte C.F., 1981, Neotropica (La Plata), V27, P79; ITUARTE CF, 1985, STUD NEOTROP FAUNA E, V20, P217, DOI 10.1080/01650528509360693; ITUARTE CF, 1994, NAUTILUS, V107, P129; Ituarte CF, 1844, REV MUSEO LA PLATA, V13, P231; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KENNEDY VS, 1985, BIOL BULL, V168, P50, DOI 10.2307/1541173; Komaru A, 1997, BIOL BULL, V193, P320, DOI 10.2307/1542934; Korniushin AV, 2003, ACTA ZOOL-STOCKHOLM, V84, P293, DOI 10.1046/j.1463-6395.2003.00150.x; Kraemer L.R, 1977, Bulletin Am malac Union, V1977, P48; Kraemer LR, 1986, AM MALACOLOGICAL B S, V2, P193; Lee T, 2005, AM MALACOL BULL, V20, P113; Leverger MT, 2016, BRASILIA MMA SERIE B, V39, P202; Linares MS, 2017, ECOL INDIC, V75, P279, DOI 10.1016/j.ecolind.2016.12.046; MARTINEZ R, 1987, ACTA CIENT VENEZ, V38, P384; Martins DS, 2006, BIOTA NEOTROP, P6; McMahon R.F., 1979, P227; McMahon R. F., 1986, AM MALACOL B, V2, P231; McMahon RF, 2000, NONINDIGENOUS FRESHWATER ORGANISMS, P315; MCMAHON RF, 1982, NAUTILUS, V96, P134; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Modesto V, 2013, J MOLLUS STUD, V79, P302, DOI 10.1093/mollus/eyt026; MORTON B, 1987, AM MALACOL BULL, V5, P91; MORTON B, 1977, J ZOOL, V181, P21; Mouthon J, 2004, ARCH HYDROBIOL, V161, P267, DOI 10.1127/0003-9136/2004/0161-0267; Mulisch M, 2010, ROMEIS MIKROSKOPISCH; Park GM, 2004, J SHELLFISH RES, V23, P179; Paschoal LRP, 2015, BRAZ J BIOL, V75, P135, DOI 10.1590/1519-6984.09113; Paschoal Lucas R.P., 2013, Pan-American Journal of Aquatic Sciences, V8, P369; Pechenik J. A., 2010, BIOL INVERTEBRATES; Pigneur LM, 2012, HEREDITY, V108, P581, DOI 10.1038/hdy.2012.3; Rajagopal S, 2000, ARCH HYDROBIOL, V149, P403; Rodrigues JCA, 2007, Braz. J. Biol., V67, P789, DOI 10.1590/S1519-69842007000400032; Russert Kraemer L., 1978, Bulletin of the American Malacological Union Incorporated, V1978, P40; Rybalkina SM, 2013, RUSS J MAR BIOL+, V39, P253, DOI 10.1134/S1063074013040093; Santos S, 2012, MOLUSCOS LIMNICOS IN, P25; Sickel JB, 1979, P 1 INT CORB S, P13; Sousa R, 2008, ANN LIMNOL-INT J LIM, V44, P85, DOI 10.1051/limn:2008017; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; Williams C.J., 1986, American Malacological Bulletin Special Edition, P99	69	12	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186850	10.1371/journal.pone.0186850	http://dx.doi.org/10.1371/journal.pone.0186850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065185	Green Published, gold			2022-12-26	WOS:000413568900050
J	Danis-Lozano, R; Diaz-Gonzalez, EE; Trujillo-Murillo, KDC; Caballero-Sosa, S; Sepulveda-Delgado, J; Malo-Garcia, IR; Canseco-Avila, LM; Salgado-Corsantes, LM; Dominguez-Arrevillaga, S; Torres-Zapata, R; Gomez-Cruz, O; Fernandez-Salas, I				Danis-Lozano, Rogelio; Eduardo Diaz-Gonzalez, Esteban; del Carmen Trujillo-Murillo, Karina; Caballero-Sosa, Sandra; Sepulveda-Delgado, Jesus; Rosalia Malo-Garcia, Iliana; Miguel Canseco-Avila, Luis; Manuel Salgado-Corsantes, Luis; Dominguez-Arrevillaga, Sergio; Torres-Zapata, Raul; Gomez-Cruz, Omar; Fernandez-Salas, Ildefonso			Clinical characterization of acute and convalescent illness of confirmed chikungunya cases from Chiapas, S. Mexico: A cross sectional study	PLOS ONE			English	Article							LABORATORY FEATURES; DENGUE VIRUS; INFECTION; OUTBREAK; DIAGNOSIS; FEVER	Background The emerging chikungunya virus (CHIKV), is an arbovirus causing intense outbreaks in North America. The situation in Mexico is alarming, and CHIKV threatens to spread further throughout North America. Clinical and biological features of CHIKF outbreaks in Mexico have not been well described; thus, we conducted a cross sectional study of a CHIKV outbreak in Chiapas, Southern Mexico to further characterize these features. Methodology/Principal findings We collected blood samples from patients suspected of having chikungunya fever (CHIKF) who presented to Clinical Hospital ISSSTE Dr. Roberto Nettel in Tapachula, Chiapas, Mexico. In addition to the clinical examination, real-time polymerase chain reaction (PCR) standardized for the Asian Chikungunya lineage and/or enzyme-linked immunosorbent assay for immunoglobulin M (IgM) were used to confirm CHIKV diagnosis. Of a total of 850 patients who presented with probably CHIKV at Hospital "Dr. Roberto Nettel", 112 probable CHIKF cases were enrolled in this study from November 2014-June 2015, of which 95 patients (84.8%) were CHIKV positive and 17 were negative (15.2%). Of these 95 CHIKV positive patients, 62 were positive by real-time reverse transcriptase PCR (+qRT-PCR); and 33 were seropositive to +IgM with a negative qRT-PCR. The most frequent symptoms reported were fever (100%), headache (82.3%), polyarthralgia (72.1%), and exanthem (82.3%). Biological abnormalities observed during CHIKV infection were lymphopenia (41.1%), leukopenia (51.6%), elevated transaminases (30.5%-46.3%) and high LDH (46.3%) and CRP (60.0%). Conclusion Clinical and biological data obtained from this study is providing more useful information for benchmarking purposes with outbreaks from different parts of the world and would be helpful for better patient care and treatment.	[Danis-Lozano, Rogelio; Rosalia Malo-Garcia, Iliana; Fernandez-Salas, Ildefonso] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Eduardo Diaz-Gonzalez, Esteban; Torres-Zapata, Raul; Fernandez-Salas, Ildefonso] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolaa De Los graza, Nuevo Leon, Mexico; [Eduardo Diaz-Gonzalez, Esteban; Fernandez-Salas, Ildefonso] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico; [del Carmen Trujillo-Murillo, Karina; Sepulveda-Delgado, Jesus; Miguel Canseco-Avila, Luis; Dominguez-Arrevillaga, Sergio] Hosp Reg Alta Especialidad Ciudad Salud, Secretaria Salud, Tapachula, Chiapas, Mexico; [del Carmen Trujillo-Murillo, Karina; Miguel Canseco-Avila, Luis; Dominguez-Arrevillaga, Sergio] Univ Autonoma Chiapas, Fac Ciencias Quim, Tapachula, Chiapas, Mexico; [Caballero-Sosa, Sandra; Manuel Salgado-Corsantes, Luis] Clin Hosp Dr Roberto Nettel, Inst Seguridad & Serv Sociale Trabajadores Estado, Tapachula, Chiapas, Mexico	Instituto Nacional de Salud Publica; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Chiapas	Fernandez-Salas, I (corresponding author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.; Fernandez-Salas, I (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolaa De Los graza, Nuevo Leon, Mexico.; Fernandez-Salas, I (corresponding author), Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico.	ildefonso.fernandez@insp.mx	Sepulveda D., Jesus/G-5450-2013	Sepulveda D., Jesus/0000-0003-1393-653X; Dominguez-Arrevillaga, Sergio/0000-0003-3471-2260; CANSECO AVILA, LUIS MIGUEL/0000-0002-5694-3118; Diaz Gonzalez, Esteban Eduardo/0000-0001-6124-3282	Mexican National Council of Science and Technology (Consejo Nacional de Ciencia y Tecnologia) [214952]	Mexican National Council of Science and Technology (Consejo Nacional de Ciencia y Tecnologia)	This work was supported by the Mexican National Council of Science and Technology (Consejo Nacional de Ciencia y Tecnologia) [CONACYT #214952] to IFS. URL: http//www.conacyt.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya-Larios IY, 2014, AM J TROP MED HYG, V91, P1057, DOI 10.4269/ajtmh.14-0145; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Centro Nacional de Programas Preventivos y Control de Enfermedades, 2014, DECL EM EP EE 2 2014; Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087; Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450; Direccion General de Epidemiologia, 2014, LIN EST VIG EP DIAGN, P39; Direccion General de Epidemiologoa, 2015, DIR GEN EP B EP SEM, V38, P32; Doaz-Quinonez JA, 2015, GENOME ANNOUNC AM SO, V3; Ede LC, 2013, PEDIATR RES, V73, P349, DOI 10.1038/pr.2012.179; Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158; Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274; Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013; Kautz TF, 2015, EMERG INFECT DIS, V21, P2070, DOI 10.3201/eid2111.150546; Keny Mukundraj S, 2014, Int J Appl Basic Med Res, V4, P47, DOI 10.4103/2229-516X.125695; Kiwanuka N, 1999, CLIN INFECT DIS, V29, P1243, DOI 10.1086/313462; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d; Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786; Macpherson C, 2016, AM J TROP MED HYG, V95, P890, DOI 10.4269/ajtmh.16-0122; Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; Norman FF, 2015, J TRAVEL MED, V22, P272, DOI 10.1111/jtm.12204; PAHO, 2017, CHIK STAT DAT; PAHO, 2011, PREP RESP ANT EV INT; Pan American Health Organization, 2015, NUM CAS REP FIEBR CH; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199; Secretaria de Hacienda del Estado de Chiapas, 2012, PROGR REG DES REG 10; Sissoko D, 2005, TROP MED INT HEALTH, V15, P600, DOI DOI 10.1111/J.1365-3156.2010.02485.X; Sistema Nacional de Informacion Municipal, 2010, BAS DAT; Staikowsky F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007603; Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704; Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15; Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Vijayakumar KP, 2011, J GLOB INFECT DIS, V3, P221, DOI 10.4103/0974-777X.83526; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004; World Health Organization, 2008, GUID CLIN MAN CHIK F	42	16	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186923	10.1371/journal.pone.0186923	http://dx.doi.org/10.1371/journal.pone.0186923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065182	Green Published, gold, Green Accepted			2022-12-26	WOS:000413568900054
J	Siwinska, N; Zak, A; Baron, M; Cylna, M; Borowicz, H				Siwinska, Natalia; Zak, Agnieszka; Baron, Monika; Cylna, Marta; Borowicz, Hieronim			Right dorsal colon ultrasonography in normal adult ponies and miniature horses	PLOS ONE			English	Article							EQUUS-FERUS-CABALLUS; INTESTINAL MOTILITY; WALL THICKNESS; MANAGEMENT; DIAGNOSIS; COLITIS; PASTURE; BREED; FOALS; AGE	The aim of this study was to determine the normal location, wall thickness and motility of the right dorsal colon in adult ponies and miniature horses. The abdominal ultrasonography examination was performed in a study group consisting of 23 ponies and miniature horses and in a control group comprising ten Thoroughbred horses. The procedure was performed in unsedated standing animals. The location and the thickness of the right dorsal colonic wall was examined on the right side of the abdomen between the 10 th and the 14 th intercostal space. The contractility was recorded in the 12 th intercostal space. A comparative analysis between the study group and control group was carried out using the Student's t-test. Pearson's linear correlation coefficient was used to calculate the correlation between the thickness of the colonic wall as well as the number of peristaltic movements and age, wither height and body mass of the animals. The right dorsal colon was identified in all the horses in the 12 th intercostal space. In all the intercostal spaces the mean +/- standard deviation (SD) wall thickness of the right dorsal colon was 0.27 +/- 0.03 cm in the horses from the study group and 0.37 +/- 0.03 cm in the control horses. The mean number of peristaltic contractions was 4.05 +/- 1.07 per minute in the animals from the study group and 1.7 +/- 0.46 contractions per minute in the control group. The values of the ultrasonographic wall thickness and peristaltic motility in small breed horses in the present study were different from the values obtained for large breed horses. The study also found that the right dorsal colon in small breed horses is physiologically located in the 12 th intercostal space. This suggests that different reference values should be used in small horse breeds when performing an ultrasound examination.	[Siwinska, Natalia; Zak, Agnieszka; Borowicz, Hieronim] Univ Environm & Life Sci, Dept Internal Med, Fac Vet Med, Wroclaw, Poland; [Siwinska, Natalia; Zak, Agnieszka; Borowicz, Hieronim] Univ Environm & Life Sci, Clin Dis Horses Dogs & Cats, Fac Vet Med, Wroclaw, Poland; [Baron, Monika; Cylna, Marta] Univ Environm & Life Sci, Fac Vet Med, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Siwinska, N (corresponding author), Univ Environm & Life Sci, Dept Internal Med, Fac Vet Med, Wroclaw, Poland.; Siwinska, N (corresponding author), Univ Environm & Life Sci, Clin Dis Horses Dogs & Cats, Fac Vet Med, Wroclaw, Poland.	natalia.siwinska@upwr.edu.pl	Żak, Agnieszka/V-5182-2018	Żak, Agnieszka/0000-0002-3532-6508				Abutarbush SM, 2006, JAVMA-J AM VET MED A, V228, P409, DOI 10.2460/javma.228.3.409; Aleman M, 2002, EQUINE VET J, V34, P649, DOI 10.2746/042516402776250414; Beccati F, 2011, EQUINE VET J, V43, P98, DOI 10.1111/j.2042-3306.2011.00428.x; BERNARD WV, 1989, J AM VET MED ASSOC, V194, P395; Bithell S, 2010, VET RADIOL ULTRASOUN, V51, P647, DOI 10.1111/j.1740-8261.2010.01715.x; Brinkmann L, 2016, J EXP BIOL, V219, P2559, DOI 10.1242/jeb.138784; Brinkmann L, 2012, J EXP BIOL, V215, P1061, DOI 10.1242/jeb.064832; Buchanan BR, 2006, JAVMA-J AM VET MED A, V228, P1339, DOI 10.2460/javma.228.9.1339; Busoni V, 2011, VET J, V188, P77, DOI 10.1016/j.tvjl.2010.02.017; Cohen HL, 1998, J ULTRAS MED, V17, P705; COHEN ND, 1995, J VET INTERN MED, V9, P272, DOI 10.1111/j.1939-1676.1995.tb01079.x; Curtis L, 2015, ACTA VET SCNAD, V6, P57; DABAREINER RM, 1995, J AM VET MED ASSOC, V206, P679; Delaney F, 2003, VET RADIOL ULTRASOUN, V44, P577, DOI 10.1111/j.1740-8261.2003.tb00510.x; Epstein K, 2008, VET RADIOL ULTRASOUN, V49, P282, DOI 10.1111/j.1740-8261.2008.00367.x; FLEISCHER AC, 1981, AM J ROENTGENOL, V136, P887, DOI 10.2214/ajr.136.5.887; Freeman S, 2002, IN PRACTICE, V24, P262; Freeman SL, 2001, EUR J ULTRASOUND, V13, P1; Freeman SL, 2002, PRACT; Galvin N, 2004, IRISH VET J, V57, P467, DOI 10.1186/2046-0481-57-8-467; Gomaa N, 2011, BERL MUNCH TIERARZTL, V124, P168, DOI 10.2376/0005-9366-124-168; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Jones SL, 2003, J AM VET MED ASSOC, V222, P1248, DOI 10.2460/javma.2003.222.1248; Klohnen A, 1996, J AM VET MED ASSOC, V209, P1597; Liu Y, 2017, NEUROGASTROENT MOTIL, V29, P1; Mezerova J, 2001, VET MED-CZECH, V46, P293, DOI 10.17221/7892-VETMED; Mitchell CF, 2005, CAN VET J, V46, P134; Mueller POE, 2000, COMP CONT EDUC PRACT, V22, P606; National Heart Blood and Lung Institute, 2007, NIH PUBLICATION, V08-5846, P43; Naylor JM, 2006, J VET INTERN MED, V20, P1408, DOI 10.1892/0891-6640(2006)20[1408:TEOFAF]2.0.CO;2; Norman T, 2010, VET RADIOL ULTRASOUN, V51, P642, DOI 10.1111/j.1740-8261.2010.01719.x; Pease AP, 2004, VET RADIOL ULTRASOUN, V45, P220, DOI 10.1111/j.1740-8261.2004.04038.x; PHILLIPS TJ, 1993, EQUINE VET J, V25, P427, DOI 10.1111/j.2042-3306.1993.tb02985.x; Proundman CJ, 1991, EQUINE VET J, V24, P90; Rabba S, 2009, IPPOLOGIA, V20, P5; Reef V. B., 2004, Clinical Techniques in Equine Practice, V3, P294, DOI 10.1053/j.ctep.2005.02.007; REEVES MJ, 1989, PREV VET MED, V7, P149, DOI 10.1016/0167-5877(89)90006-8; Sasaki N, 2008, RES VET SCI, V84, P305, DOI 10.1016/j.rvsc.2007.04.009; Scharner D., 2002, CLIN TECHNIQUES EQUI, V1, P118, DOI DOI 10.1053/ctep.2002.35579; Schumacher J, 2000, J VET INTERN MED, V14, P258, DOI 10.1892/0891-6640(2000)014&lt;0258:CIIBDO&gt;2.3.CO;2; Smith RS, 2004, SURG CLIN N AM, V84, P953, DOI 10.1016/j.suc.2004.04.002; Taintor J, 2004, JAVMA-J AM VET MED A, V225, P1829, DOI 10.2460/javma.2004.225.1829; Williams S, 2015, EQUINE VET J, V47, P96, DOI 10.1111/evj.12238; Williams S, 2011, EQUINE VET J, V43, P93, DOI 10.1111/j.2042-3306.2011.00399.x; Williams S, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-S1-S5	45	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186825	10.1371/journal.pone.0186825	http://dx.doi.org/10.1371/journal.pone.0186825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065146	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900046
J	Tanabe, Y; Ho, JS; Liu, JY; Liao, SY; Zhen, Z; Hsu, S; Shuto, C; Zhu, ZY; Ma, A; Vassos, C; Chen, P; Tse, HF; Poon, ASY				Tanabe, Yuji; Ho, John S.; Liu, Jiayin; Liao, Song-Yan; Zhen, Zhe; Hsu, Stephanie; Shuto, Chika; Zhu, Zi-Yi; Ma, Andrew; Vassos, Christopher; Chen, Peter; Tse, Hung Fat; Poon, Ada S. Y.			High-performance wireless powering for peripheral nerve neuromodulation systems	PLOS ONE			English	Article							SPINAL-CORD; STIMULATION; IMPLANTS; DELIVERY; DESIGN; TISSUE; BRAIN	Neuromodulation of peripheral nerves with bioelectronic devices is a promising approach for treating a wide range of disorders. Wireless powering could enable long-term operation of these devices, but achieving high performance for miniaturized and deeply placed devices remains a technological challenge. We report the miniaturized integration of a wireless powering system in soft neuromodulation device (15 mm length, 2.7 mm diameter) and demonstrate high performance (about 10%) during in vivo wireless stimulation of the vagus nerve in a porcine animal model. The increased performance is enabled by the generation of a focused and circularly polarized field that enhances efficiency and provides immunity to polarization misalignment. These performance characteristics establish the clinical potential of wireless powering for emerging therapies based on neuromodulation.	[Tanabe, Yuji; Hsu, Stephanie; Ma, Andrew; Vassos, Christopher; Poon, Ada S. Y.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Ho, John S.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117583, Singapore; [Liu, Jiayin; Shuto, Chika; Chen, Peter] St Jude Med Inc, Ctr Innovat & Strateg Collaborat, Orange, CA 92618 USA; [Liao, Song-Yan; Zhen, Zhe; Zhu, Zi-Yi; Tse, Hung Fat] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung Fat] Univ Hong Kong, Hong Kong Guangdong Joint Lab Stem Cell & Regener, Hong Kong, Hong Kong, Peoples R China	Stanford University; National University of Singapore; University of Hong Kong; University of Hong Kong	Poon, ASY (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	adapoon@stanford.edu	Tse, Hung-Fat/C-4426-2009	Tse, Hung-Fat/0000-0002-9578-7808; Tse, Hung Fat/0000-0003-4665-7887; ZHEN, ZHE/0000-0003-4125-3322; Ho, John/0000-0002-9458-9033	US National Science Foundation [ECCS-1351687]; US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) [21E6020894]; Hong Kong Innovation and Technology Fund [ITS/087/14]; National Defense Science and Engineering Graduate Fellowship; Reed-Hodgson Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB020894] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering); Hong Kong Innovation and Technology Fund; National Defense Science and Engineering Graduate Fellowship; Reed-Hodgson Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We acknowledge support from grants from the US National Science Foundation (ECCS-1351687), the US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering grant 21E6020894), and the Hong Kong Innovation and Technology Fund (ITS/087/14). J.S.H. was supported by a National Defense Science and Engineering Graduate Fellowship and S.H. was supported by a Reed-Hodgson Fellowship.; We acknowledge support from grants from the US National Science Foundation (ECCS-1351687), the US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering grant R2 1EB020894), and the Hong Kong Innovation and Technology Fund (ITS/087/14). J.S.H. was supported by a National Defense Science and Engineering Graduate Fellowship and S.H. was supported by a Reed-Hodgson Fellowship. We thank Alan De La Rama and Hieu Pham for their advice about the fabrication of the cuff electrodes and transmitter; and Rebecca Park, Xiaolin Hu, and Philip Wong for assisting in experiments that characterized the impedance of the cuff electrodes.	Abid A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46745; Agrawal DR, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0043; Ahn D, 2016, IEEE T BIOMED CIRC S, V10, P125, DOI 10.1109/TBCAS.2014.2370794; [Anonymous], 2005, C951 IEEE, V1; Ashkenazi A, 2008, J NEUROL NEUROSUR PS, V79, P415, DOI 10.1136/jnnp.2007.124420; Chew DJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007186; Cho SH, 2013, J MICROELECTROMECH S, V22, P170, DOI 10.1109/JMEMS.2012.2221155; Chow EY, 2011, IEEE T ANTENN PROPAG, V59, P2379, DOI 10.1109/TAP.2011.2144551; Dagdeviren C, 2014, P NATL ACAD SCI USA, V111, P1927, DOI 10.1073/pnas.1317233111; Das R, 2017, IEEE T MICROW THEORY, V65, P2485, DOI 10.1109/TMTT.2017.2647945; Deer T.R., 2012, TECHNIQUES REGIONAL, V16, P113, DOI [DOI 10.1053/J.TRAP.2013.02.007, 10.1053/j.trap.2013.02.007]; Deer TR, 2014, NEUROMODULATION, V17, P599, DOI 10.1111/ner.12204; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Gassler JP, 2014, J HUM HYPERTENS, V28, P469, DOI 10.1038/jhh.2013.139; Ho JS, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.125145; Ho JS, 2014, P NATL ACAD SCI USA, V111, P7974, DOI 10.1073/pnas.1403002111; Jegadeesan R, 2017, IEEE T MICROW THEORY, V65, P280, DOI 10.1109/TMTT.2016.2615623; Jow UM, 2007, IEEE T BIOMED CIRC S, V1, P193, DOI 10.1109/TBCAS.2007.913130; Kiani M, 2010, IEEE T CIRCUITS-II, V57, P260, DOI 10.1109/TCSII.2010.2043470; Kim S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203905; KO WH, 1977, MED BIOL ENG COMPUT, V15, P634, DOI 10.1007/BF02457921; Koo B, 2001, J CLIN NEUROPHYSIOL, V18, P429, DOI 10.1097/00004691-200109000-00007; Koopman FA, 2014, BEST PRACT RES CL RH, V28, P625, DOI 10.1016/j.berh.2014.10.015; Lee B, 2016, IEEE T BIOMED CIRC S, V10, P138, DOI 10.1109/TBCAS.2014.2376965; Lee D, 2016, SCI REP-UK, V6, DOI 10.1038/srep18935; Loeb GE, 2001, MED ENG PHYS, V23, P9, DOI 10.1016/S1350-4533(01)00011-X; Mercier PP, 2012, NAT BIOTECHNOL, V30, P1240, DOI 10.1038/nbt.2394; Montgomery KL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7577; Montgomery KL, 2015, NAT METHODS, V12, P969, DOI [10.1038/NMETH.3536, 10.1038/nmeth.3536]; Murakawa K, 1999, IEEE ENG MED BIOL, V18, P70, DOI 10.1109/51.805148; Ning X, 2012, J MICROMECHANICS MIC, V22; Rajasethupathy P, 2016, CELL, V165, P524, DOI 10.1016/j.cell.2016.03.047; RamRakhyani AK, 2011, IEEE T BIOMED CIRC S, V5, P48, DOI 10.1109/TBCAS.2010.2072782; Rao S, 2015, IEEE MICROW MAG, V16, P54, DOI 10.1109/MMM.2014.2377586; Rapoport BI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038436; Rush AJ, 2000, BIOL PSYCHIAT, V47, P276, DOI 10.1016/S0006-3223(99)00304-2; Schuder J.C., 1961, IRE INT CONV REC, V9, P119; Seo D, 2016, NEURON, V91, P529, DOI 10.1016/j.neuron.2016.06.034; Sokal P, 2017, J PAIN RES, V10, P613, DOI 10.2147/JPR.S128861; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Xu Q, 2015, IEEE T NEUR SYS REH, V23, P683, DOI 10.1109/TNSRE.2015.2396574; Yearwood TL, 2016, PROG NEUROL SURG, V29, P168, DOI 10.1159/000434670	42	23	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186698	10.1371/journal.pone.0186698	http://dx.doi.org/10.1371/journal.pone.0186698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065141	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900025
J	Murthy, S; Koval, OM; Diaz, JMR; Kumar, S; Nuno, D; Scott, JA; Allamargot, C; Zhu, LJ; Broadhurst, K; Santhana, V; Kutschke, WJ; Irani, K; Lamping, KG; Grumbach, IM				Murthy, Shubha; Koval, Olha M.; Diaz, Juan M. Ramiro; Kumar, Santosh; Nuno, Daniel; Scott, Jason A.; Allamargot, Chantal; Zhu, Linda J.; Broadhurst, Kim; Santhana, Velarchana; Kutschke, William J.; Irani, Kaikobad; Lamping, Kathryn G.; Grumbach, Isabella M.			Endothelial CaMKII as a regulator of eNOS activity and NO-mediated vasoreactivity	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-II; BLOOD-PRESSURE; CORONARY-CIRCULATION; VASCULAR REACTIVITY; BARRIER DYSFUNCTION; MICE LACKING; IN-VIVO; ACTIVATION; PHOSPHORYLATION	The multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a serine/ threonine kinase important in transducing intracellular Ca2+ signals. While in vitro data regarding the role of CaMKII in the regulation of endothelial nitric oxide synthase (eNOS) are contradictory, its role in endothelial function in vivo remains unknown. Using two novel transgenic models to express CaMKII inhibitor peptides selectively in endothelium, we examined the effect of CaMKII on eNOS activation, NO production, vasomotor tone and blood pressure. Under baseline conditions, CaMKII activation was low in the aortic wall. Consistently, systolic and diastolic blood pressure, heart rate and plasma NO levels were unaltered by endothelial CaMKII inhibition. Moreover, endothelial CaMKII inhibition had no significant effect on NO-dependent vasodilation. These results were confirmed in studies of aortic rings transduced with adenovirus expressing a CaMKII inhibitor peptide. In cultured endothelial cells, bradykinin treatment produced the anticipated rapid influx of Ca2+ and transient CaMKII and eNOS activation, whereas CaMKII inhibition blocked eNOS phosphorylation on Ser-1179 and dephosphorylation at Thr-497. Ca2+/CaM binding to eNOS and resultant NO production in vitro were decreased under CaMKII inhibition. Our results demonstrate that CaMKII plays an important role in transient bradykinin-driven eNOS activation in vitro, but does not regulate NO production, vasorelaxation or blood pressure in vivo under baseline conditions.	[Murthy, Shubha; Koval, Olha M.; Diaz, Juan M. Ramiro; Kumar, Santosh; Nuno, Daniel; Scott, Jason A.; Zhu, Linda J.; Broadhurst, Kim; Santhana, Velarchana; Kutschke, William J.; Irani, Kaikobad; Lamping, Kathryn G.; Grumbach, Isabella M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Murthy, Shubha; Koval, Olha M.; Irani, Kaikobad; Lamping, Kathryn G.; Grumbach, Isabella M.] Iowa City Vet Affairs Healthcare Syst, Iowa City, IA USA; [Allamargot, Chantal] Univ Iowa, Cent Microscopy Res Facil, Off Vice President Res & Econ Dev, Iowa City, IA USA; [Lamping, Kathryn G.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa	Grumbach, IM (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.; Grumbach, IM (corresponding author), Iowa City Vet Affairs Healthcare Syst, Iowa City, IA USA.	isabella.grumbach@uiowa.edu	Kumar, Santosh/N-9922-2014	Kumar, Santosh/0000-0003-1418-2020; Zhu, Linda/0000-0001-6246-4300; Koval, Olha/0000-0003-1644-0046; Grumbach, Isabella/0000-0002-2285-3157; Irani, Kaikobad/0000-0001-9194-7387	Merit Review Grants (Biomedical Laboratory Research and Development Service) from the United States Department of Veterans Affairs [I01 BX000163, 1I01BX002940, 1BX000543]; Pilot Grant (Rehabilitation Research and Development Service) from the United States Department of Veterans Affairs [I21 RX001561A]; NIH [R01 HL 108932]; American Heart Association [14POST20290006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108932] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000163] Funding Source: NIH RePORTER	Merit Review Grants (Biomedical Laboratory Research and Development Service) from the United States Department of Veterans Affairs; Pilot Grant (Rehabilitation Research and Development Service) from the United States Department of Veterans Affairs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Grants (Biomedical Laboratory Research and Development Service) I01 BX000163 (to IMG), 1I01BX002940 (to KI) and 1BX000543 (to KGL) and Pilot Grant (Rehabilitation Research and Development Service) I21 RX001561A (to IMG) from the United States Department of Veterans Affairs, by NIH R01 HL 108932 (to I MG) and American Heart Association 14POST20290006 (to JRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SW, 2003, BIOCHEM BIOPH RES CO, V306, P981, DOI 10.1016/S0006-291X(03)01086-6; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; Ching LC, 2011, CARDIOVASC RES, V91, P492, DOI 10.1093/cvr/cvr104; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Faraci FM, 2004, AM J PHYSIOL-HEART C, V287, pH2871, DOI 10.1152/ajpheart.00392.2004; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Ha JM, 2011, J MOL MED, V89, P1253, DOI 10.1007/s00109-011-0798-3; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Kobayashi T, 2012, CLIN SCI, V123, P375, DOI 10.1042/CS20110621; Kojima H, 2001, ANAL CHEM, V73, P1967, DOI 10.1021/ac001136i; Kumar S, 2017, P NATL ACAD SCI USA, V114, P1714, DOI 10.1073/pnas.1614112114; Lamping KG, 2004, ARTERIOSCL THROM VAS, V24, P1253, DOI 10.1161/01.ATV.0000130661.82773.ca; Lamping KG, 2000, AM J PHYSIOL-HEART C, V279, pH1906, DOI 10.1152/ajpheart.2000.279.4.H1906; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Mattiazzi A, 2004, MOL CELL BIOCHEM, V263, P131, DOI 10.1023/B:MCBI.0000041854.72511.14; Mollova MY, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00178; MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5; Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061; Pellicena P, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00021; Prasad AM, 2016, VASC PHARMACOL, V87, P172, DOI 10.1016/j.vph.2016.09.007; Prasad AM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001949; Prasad AM, 2013, HYPERTENSION, V62, P434, DOI 10.1161/HYPERTENSIONAHA.113.01508; Ridnour LA, 2000, ANAL BIOCHEM, V281, P223, DOI 10.1006/abio.2000.4583; Sanders PN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006135; Saura M, 2014, FASEB J, V28, P4719, DOI 10.1096/fj.14-252460; Schneider JC, 2003, AM J PHYSIOL-HEART C, V284, pH2311, DOI 10.1152/ajpheart.00932.2001; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; Scott JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071550; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Su KH, 2014, ACTA PHYSIOL, V212, P191, DOI 10.1111/apha.12378; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Toussaint F, 2015, CELL CALCIUM, V58, P275, DOI 10.1016/j.ceca.2015.06.005; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhu LJ, 2014, VASC PHARMACOL, V60, P75, DOI 10.1016/j.vph.2014.01.001	51	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186311	10.1371/journal.pone.0186311	http://dx.doi.org/10.1371/journal.pone.0186311			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059213	Green Submitted, gold, Green Published			2022-12-26	WOS:000413403000017
J	Toque, HA; Fernandez-Flores, A; Mohamed, R; Caldwell, RB; Ramesh, G; Caldwell, RW				Toque, Haroldo A.; Fernandez-Flores, Aracely; Mohamed, Riyaz; Caldwell, Ruth B.; Ramesh, Ganesan; Caldwell, R. William			Netrin-1 is a novel regulator of vascular endothelial function in diabetes	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; BLOOD-BRAIN-BARRIER; MYOCARDIAL-INFARCTION; FEEDFORWARD MECHANISM; THERAPEUTIC TARGET; APOPTOSIS; DYSFUNCTION; KIDNEY; DCC; OVEREXPRESSION	Background Netrin-1, a secreted laminin-like protein identified as an axon guidance molecule, has been shown to be of critical importance in the cardiovascular system. Recent studies have revealed pro-angiogenic, anti-apoptotic and anti-inflammatory properties of netrin-1 as well as cardioprotective actions against myocardial injury in diabetic mice. Aim To examine the role of netrin-1 in diabetes-and high glucose (HG)-induced vascular endothelial dysfunction (VED) using netrin-1 transgenic mice (Tg3) and cultured bovine aortic endothelial cells (BAEC). Main outcome Overexpression of netrin-1 prevented diabetes-induced VED in aorta from diabetic mice and netrin-1 treatment attenuated HG-induced impairment of nitric oxide synthase (NOS) function in BAECs. Methods and results Experiments were performed in Tg3 and littermate control (WT) mice rendered diabetic with streptozotocin (STZ) and in BAECs treated with HG (25 mmol/L). Levels of netrin-1 and its receptor DCC, markers of inflammation and apoptosis and vascular function were assessed in aortas from diabetic and non-diabetic Tg3 and WT mice. Vascular netrin-1 in WT mice was reduced under diabetic conditions. Aortas from non-diabetic Tg3 and WT mice showed similar maximum endothelium-dependent relaxation (MEDR) (83% and 87%, respectively). MEDR was markedly impaired in aorta from diabetic WT mice (51%). This effect was significantly blunted in Tg3 diabetic aortas (70%). Improved vascular relaxation in Tg3 diabetic mice was associated with increased levels of phospho-ERK1/2 and reduced levels of oxidant stress, NF kappa B, COX-2, p16(INK4A), cleaved caspase-3 and p16 and p53 mRNA. Netrin-1 treatment prevented the HG-induced decrease in NO production and elevation of oxidative stress and apoptosis in BAECs. Conclusions Diabetes decreases aortic levels of netrin-1. However, overexpression of netrin-1 attenuates diabetes-induced VED and limits the reduction of NO levels, while increasing expression of p-ERK1/2, and suppressing oxidative stress and inflammatory and apoptotic processes. Enhancement of netrin-1 function may be a useful therapeutic means for preventing vascular dysfunction in diabetes.	[Toque, Haroldo A.; Fernandez-Flores, Aracely; Caldwell, R. William] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA USA; [Mohamed, Riyaz; Caldwell, Ruth B.; Ramesh, Ganesan] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA; [Caldwell, Ruth B.] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Toque, HA (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA USA.	hflorestoque@augusta.edu		Mohamed, Riyaz/0000-0003-2398-3057; Caldwell, Ruth/0000-0003-0168-0354	American Heart Association SDG [13SDG17410007]; NIH [R01 HL070215, R01 EY011766]; NATIONAL EYE INSTITUTE [R01EY011766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK094765] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001233] Funding Source: NIH RePORTER	American Heart Association SDG(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported American Heart Association SDG 13SDG17410007 (HAT), NIH Grants R01 HL070215 (RWC) and R01 EY011766 (RWC and RBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Bernadskaya YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002863; Bernet A, 2008, EXPERT OPIN THER TAR, V12, P995, DOI [10.1517/14728222.12.8.995, 10.1517/14728222.12.8.995 ]; Bertoluci MC, 2015, WORLD J DIABETES, V6, P679, DOI 10.4239/wjd.v6.i5.679; Caldwell RB, 2015, TRENDS PHARMACOL SCI, V36, P395, DOI 10.1016/j.tips.2015.03.006; Caldwell RB, 2010, BRAIN RES BULL, V81, P303, DOI 10.1016/j.brainresbull.2009.08.025; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P1543, DOI 10.1038/jcbfm.2008.39; Finci L, 2015, PROG BIOPHYS MOL BIO, V118, P153, DOI 10.1016/j.pbiomolbio.2015.04.001; Gao S, 2016, CLIN SCI, V130, P1901, DOI 10.1042/CS20160133; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Graves DT, 2007, PERIODONTOL 2000, V45, P128, DOI 10.1111/j.1600-0757.2007.00219.x; Horani MH, 2003, CURR PHARM DESIGN, V9, P833, DOI 10.2174/1381612033455314; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kazuyama E, 2009, MOL CELL BIOCHEM, V332, P95, DOI 10.1007/s11010-009-0178-2; Ke TY, 2014, HUM GENE THER, V25, P787, DOI 10.1089/hum.2014.021; Kellogg AP, 2008, CURR DRUG TARGETS, V9, P68; Krimpenfort P, 2012, NATURE, V482, P538, DOI 10.1038/nature10790; Li QA, 2011, J SURG RES, V166, P162, DOI 10.1016/j.jss.2009.08.031; Li Q, 2015, P NATL ACAD SCI USA, V112, P899, DOI 10.1073/pnas.1420695112; Liu C, 2016, J NANOMATER, V2016, DOI 10.1155/2016/5208027; Lu Haiyan, 2011, Front Med, V5, P86, DOI 10.1007/s11684-011-0118-x; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mather KJ, 2013, REV ENDOCR METAB DIS, V14, P87, DOI 10.1007/s11154-013-9237-9; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Moali C, 1998, BIOCHEMISTRY-US, V37, P10453, DOI 10.1021/bi980742t; Mohamed R, 2012, AM J PATHOL, V181, P1991, DOI 10.1016/j.ajpath.2012.08.014; Nacci C, 2009, ENDOCRINOLOGY, V150, P849, DOI 10.1210/en.2008-1069; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Petit A, 2007, P NATL ACAD SCI USA, V104, P17837, DOI 10.1073/pnas.0703240104; Podjaski C, 2015, BRAIN, V138, P1598, DOI 10.1093/brain/awv092; Prasad Shikha, 2014, J Pharmacovigil, V2, P125; Ramesh Ganesan, 2012, Recent Pat Biomark, V2, P202; Ranganathan P, 2015, AM J NEPHROL, V41, P220, DOI 10.1159/000381428; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Rosales-Corral S, 2010, ANTIOXID REDOX SIGN, V13, P193, DOI 10.1089/ars.2009.2629; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Siu KL, 2015, J MOL CELL CARDIOL, V78, P174, DOI 10.1016/j.yjmcc.2014.07.005; Smith CJ, 2015, DIABETES METAB SYNDR, V8, P295, DOI 10.2147/DMSO.S61296; Son TW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.94; Toque HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072277; van Gils JM, 2013, ARTERIOSCL THROM VAS, V33, P911, DOI 10.1161/ATVBAHA.112.301155; Vincent AM, 2008, CURR DRUG TARGETS, V9, P94, DOI 10.2174/138945008783431754; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Wu TW, 2008, NEUROSCIENCE, V156, P475, DOI 10.1016/j.neuroscience.2008.08.015; Xian M, 2002, BIOORGAN MED CHEM, V10, P3049, DOI 10.1016/S0968-0896(02)00155-4; Xing Y, 2017, J MOL ENDOCRINOL; Xu B, 2010, NEUROSCIENCE, V169, P932, DOI 10.1016/j.neuroscience.2010.05.025; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Zhang HR, 2010, J MOL CELL CARDIOL, V48, P1033, DOI 10.1016/j.yjmcc.2009.12.008; Zhang J, 2010, J MOL CELL CARDIOL, V48, P1060, DOI 10.1016/j.yjmcc.2009.11.020	57	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186734	10.1371/journal.pone.0186734	http://dx.doi.org/10.1371/journal.pone.0186734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059224	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000039
J	van Loo, IHM; Dukers-Muijrers, NHTM; Heuts, R; van der Sande, MAB; Hoebe, CJPA				van Loo, Inge H. M.; Dukers-Muijrers, Nicole H. T. M.; Heuts, Rosalie; van der Sande, Marianne A. B.; Hoebe, Christian J. P. A.			Screening for HIV, hepatitis B and syphilis on dried blood spots: A promising method to better reach hidden high-risk populations with self-collected sampling	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEISSERIA-GONORRHOEAE; SURFACE-ANTIGEN; CHLAMYDIA-TRACHOMATIS; ACCEPTABILITY; CARE; SEX; MEN; INFECTIONS; WOMEN	Introduction Many people at high risk for sexually transmitted infections (STIs), e.g., men who have sex with men (MSM), are not optimally reached by current sexual health care systems with testing. To facilitate testing by home-based sampling or sampling in outreach setting we evaluated dried blood spots (DBS), a method for self-collected blood sampling for serological screening of HIV, hepatitis B (HBV) and syphilis. The aims of this study were to assess the acceptability and feasibility of self-collected DBS and to compare the test results for screening of HIV, HBV and syphilis from DBS with blood drawn by venous puncture. Methods DBS were collected from men who have sex with men (MSM), visiting the STI clinic of the public health service South Limburg (n = 183) and HIV positive and HBV positive patients (n = 34), visiting the outpatient clinics of the Maastricht University Medical Centre in the period January 2012-April 2015. The 93 first participating MSM visiting the STI clinic were asked to fill in a questionnaire about the feasibility and acceptability about self-collection of DBS in a setting without going to a health care facility and were asked to collect the DBS themselves. Serological screening tests for HIV (HIV combi PT, Roche), HBV (HBsAg, Roche) and syphilis (Treponema pallidum Ig, Biokit 3.0) were performed on DBS and on blood drawn by venous puncture, which was routinely taken for screening. Results In total 217 participants were included in the study with a median age of 40 years (range between 17-80). Of MSM 84% agreed that it was clear and easy to do the finger-prick, while 53% agreed that it was clear and easy to apply the blood onto the DBS card. Also, 80% of MSM would use the bloodspot test again. In 91% (198) of DBS, sufficient material was collected to perform the three tests. No difference was observed in DBS quality between self-collected DBS and health care worker collected DBS. For HIV (n = 195 DBS-serum pairs) sensitivity and specificity were 100%. For HBV the sensitivity for HBsAg (n = 202) was 90% and specificity was 99%. For syphilis (n = 191) the sensitivity of the DBS was 93% with a specificity of 99%. Analysis of the DBS of HIV positive participants (n = 38) did show similar test performance for HBV and syphilis as in HIV negatives. Conclusion DBS is an acceptable self-sampling method for MSM, as there was no difference in DBS quality in self-collected and health care worker collected DBS. Test performance, i.e., its high sensitivity (> 90%) and specificity (> 99%) measures show that DBS is a valid alternative for venous blood puncture. Especially when DBS is combined with home-collected sampling for Chlamydia trachomatis and Neisseria gonorrhoeae, complete STI screening can be done in outreach setting and/or home-collected sampling in MSM.	[van Loo, Inge H. M.; Heuts, Rosalie; Hoebe, Christian J. P. A.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [van Loo, Inge H. M.; Hoebe, Christian J. P. A.] Maastricht Univ, CAPHRI, Maastricht, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.] Publ Hlth Serv South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands; [van der Sande, Marianne A. B.] Inst Trop Med, Antwerp, Belgium	Maastricht University; Maastricht University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Institute of Tropical Medicine (ITM)	van Loo, IHM (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.; van Loo, IHM (corresponding author), Maastricht Univ, CAPHRI, Maastricht, Netherlands.	ihm.van.loo@mumc.nl	Dukers-Muijrers, Nicole/M-7178-2014; van der Sande, Marianne/AAQ-3573-2021	van Loo, Inge/0000-0002-5960-4357; van der Sande, Marianne AB/0000-0002-4778-6739	National Institute for Public Health and the Environment	National Institute for Public Health and the Environment	This study was funded by the National Institute for Public Health and the Environment to Christian J.P.A. Hoebe. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Castro AC, 2008, REV INST MED TROP SP, V50, P151, DOI 10.1590/S0036-46652008000300004; den Dees C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009480; den Heijer CDJ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2402-0; den Heijer CDJ, 2016, SEX TRANSM INFECT, V92, P211, DOI 10.1136/sextrans-2015-052065; Dukers-Muijrers NHTM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133575; Dukers-Muijrers NHTM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1118; Fajardo-Bernal L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011317.pub2; Halfon P, 2015, EUR J GASTROEN HEPAT, V27, P557, DOI 10.1097/MEG.0000000000000326; Hoebe CJPA, 2006, SEX TRANSM DIS, V33, P491, DOI 10.1097/01.olq.0000204619.87066.28; Kania D, 2013, CLIN MICROBIOL INFEC, V19, pE533, DOI 10.1111/1469-0691.12292; Lee CE, 2011, ANN ACAD MED SINGAP, V40, P448; McAllister G, 2015, J CLIN VIROL, V71, P10, DOI 10.1016/j.jcv.2015.07.303; Mendy M, 2005, J VIRAL HEPATITIS, V12, P642, DOI 10.1111/j.1365-2893.2005.00641.x; Odesanmi TY, 2013, SEX HEALTH, V10, P559, DOI 10.1071/SH13029; Paudyal P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124310; Ross RS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-72; Roth AM, 2013, INT J STD AIDS, V24, P323, DOI 10.1177/0956462412472791; Smit PW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-102; Spielberg F, 2000, AIDS, V14, P1819, DOI 10.1097/00002030-200008180-00018; Theunissen KATM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-996; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; Tuaillon E, 2012, J CLIN MICROBIOL, V50, P3096, DOI 10.1128/JCM.00971-12; Tuaillon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032143; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; van der Helm JJ, 2009, SEX TRANSM DIS, V36, P493, DOI 10.1097/OLQ.0b013e3181a44b8c; van Liere GAFS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0612-2; Verhaegh-Haasnoot A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1045-2; Verlee E Lisette, 2014, Ned Tijdschr Geneeskd, V158, pA7277; Villar LM, 2011, J MED VIROL, V83, P1522, DOI 10.1002/jmv.22138; Wayal S, 2011, CULT HEALTH SEX, V13, P343, DOI 10.1080/13691058.2010.535018	30	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186722	10.1371/journal.pone.0186722	http://dx.doi.org/10.1371/journal.pone.0186722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053737	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100035
J	Lucas-Roxburgh, R; Benschop, J; Lockett, B; van den Heever, U; Williams, R; Howe, L				Lucas-Roxburgh, Rebecca; Benschop, Jackie; Lockett, Bruce; van den Heever, Ursula; Williams, Ruth; Howe, Laryssa			The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NECK-CANCER; P16 IMMUNOHISTOCHEMISTRY; ORAL-CAVITY; HEAD; HPV; INFECTION; EPIDEMIOLOGY; EXPRESSION; TRENDS	Background The incidence of oropharyngeal cancer (OPC) in New Zealand (NZ) has more than doubled over the last 14 years with 126 cases in 2010. Overseas studies have shown that human papillomavirus (HPV) plays a significant role in the development of these cancers. However, the role of HPV in OPC and the burden on the NZ health system is unclear. Aim The aim of the study was to determine the prevalence and the genotypes of HPV associated with OPC in New Zealand. Methods In this study, 621 OPC were identified from cancer registry data from 1996-98, 2003-05, and 2010-12. Biopsies of 267 cases were then retrieved from laboratories throughout New Zealand. p16 immunohistochemistry and a human beta globin PCR were performed on all specimens. HPV genotyping was performed on all beta globin positive specimens using real-time PCR with melt analysis. Results Using a p16/ PCR algorithm, 77.9% (95% CI: 71.1-83.5%) of cases were attributable to HPV. Of these, 98.5% were HPV 16 positive. There was also one case each of HPV 33 and 35. The percentage of HPV positive cases increased from 61.9% (95% CI: 40.9%-79.2%) in 1996-98 to 87.5% (95% CI: 79.8%-92.5%) in 2010-12. Results from the multivariable model, adjusted for sex and ethnicity found statistically significant associations between HPV positivity and timeframe (OR: 5.65, 95% CI: 2.60-12.30, 2010-12 vs 1996-98), and between HPV positivity and patient age ( OR: 0.55, 95% CI: 0.33-0.99, >= 61 years vs <= 60 years). Conclusions This data is consistent with data from other developed countries showing an increase in cases of HPV positive OPC in New Zealand, and the majority of cases being attributable to HPV 16. These results support the recent inclusion of males into the nationally funded immunization schedule for Gardasil (R) 9.	[Lucas-Roxburgh, Rebecca; Howe, Laryssa] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Benschop, Jackie] Massey Univ, Hopkirk Res Inst, Mol Epidemiol & Publ Hlth Lab, Palmerston North, New Zealand; [Lockett, Bruce; van den Heever, Ursula; Williams, Ruth] MedLab Cent Ltd, Histopathol Dept, Palmerston North, New Zealand	Massey University; Massey University	Lucas-Roxburgh, R (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	R.Lucas-Roxburgh@massey.ac.nz		Benschop, Jackie/0000-0002-7814-4341	MedLab Central Ltd	MedLab Central Ltd	The funder (MedLab Central Ltd) provided support in the form of salaries for authors [BL, UV, RW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arthur AE, 2011, NUTR CANCER, V63, P734, DOI 10.1080/01635581.2011.570894; Chaturvedi AK, 2012, HEAD NECK PATHOL S1, V6, pS16, DOI [DOI 10.1007/s12105-012-0377-0, 10.1007/s12105-012-0377-0]; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chen ZW, 2012, HEAD NECK PATHOL, V6, P422, DOI 10.1007/s12105-012-0382-3; Chenevert J, 2012, HUM PATHOL, V43, P17, DOI 10.1016/j.humpath.2011.03.009; Deng ZY, 2013, HEAD NECK-J SCI SPEC, V35, P800, DOI 10.1002/hed.23034; Deschler DG, 2014, OTOLARYNGOL HEAD NEC; Dictor M, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-1; Doxtader EE, 2012, HUM PATHOL, V43, P327, DOI 10.1016/j.humpath.2011.05.010; Elwood JM, 2014, CANCER EPIDEMIOL, V38, P16, DOI 10.1016/j.canep.2013.12.004; Evans M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-220; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Junor E, 2012, BRIT J CANCER, V106, P358, DOI 10.1038/bjc.2011.542; Kreimer AR, HUMAN PAPILLOMAVIRUS; Kwon HJ, 2016, BRIT J ORAL MAX SURG, V54, P898, DOI 10.1016/j.bjoms.2016.05.033; Lewis JS, 2012, HEAD NECK PATHOL, V6, pS75, DOI 10.1007/s12105-012-0369-0; Lewis JS, 2012, MODERN PATHOL, V25, P1212, DOI 10.1038/modpathol.2012.79; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Rietbergen MM, 2013, INT J CANCER, V132, P1565, DOI 10.1002/ijc.27821; Saiki RK, 1988, PRIMER DIRECTED ENZY, P487; Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; Schlecht NF, 2011, MODERN PATHOL, V24, P1295, DOI 10.1038/modpathol.2011.91; Singhi AD, 2010, CANCER-AM CANCER SOC, V116, P2166, DOI 10.1002/cncr.25033; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Sturgis EM, 2007, TRENDS HEAD NECK CAN, P1429; Thavaraj S, 2011, J CLIN PATHOL, V64, P308, DOI 10.1136/jcp.2010.088450; Wang XHI, 2012, ANN DIAGN PATHOL, V16, P7, DOI 10.1016/j.anndiagpath.2011.07.003; Weinberger PM, 2006, J CLIN ONCOL, V24, P736, DOI 10.1200/JCO.2004.00.3335; Westra WH, 2014, ORAL ONCOLOGY; Westra WH, 2009, HEAD NECK PATHOL, V3, P78, DOI 10.1007/s12105-009-0100-y	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186424	10.1371/journal.pone.0186424	http://dx.doi.org/10.1371/journal.pone.0186424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049330	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900067
J	Toplak, T; Palmieri, B; Juanes-Garcia, A; Vicente-Manzanares, M; Grant, M; Wiseman, PW				Toplak, Tim; Palmieri, Benoit; Juanes-Garcia, Alba; Vicente-Manzanares, Miguel; Grant, Martin; Wiseman, Paul W.			Wavelet Imaging on Multiple Scales (WIMS) reveals focal adhesion distributions, dynamics and coupling between actomyosin bundle stability	PLOS ONE			English	Article							CORRELATION SPECTROSCOPY; MICROSCOPY; LOCALIZATION; CELLS; TIME; DECONVOLUTION; PAXILLIN	We introduce and use Wavelet Imaging on Multiple Scales (WIMS) as an improvement to fluorescence correlation spectroscopy to measure physical processes and features that occur across multiple length scales. In this study, wavelet transforms of cell images are used to characterize molecular dynamics at the cellular and subcellular levels (i.e. focal adhesions). We show the usefulness of the technique by applying WIMS to an image time series of a migrating osteosarcoma cell expressing fluorescently labelled adhesion proteins, which allows us to characterize different components of the cell ranging from optical resolution scale through to focal adhesion and whole cell size scales. Using WIMS we measured focal adhesion numbers, orientation and cell boundary velocities for retraction and protrusion. We also determine the internal dynamics of individual focal adhesions undergoing assembly, disassembly or elongation. Thus confirming as previously shown, WIMS reveals that the number of adhesions and the area of the protruding region of the cell are strongly correlated, establishing a correlation between protrusion size and adhesion dynamics. We also apply this technique to characterize the behavior of adhesions, actin and myosin in Chinese hamster ovary cells expressing a mutant form of myosin IIB (1935D) that displays decreased filament stability and impairs front-back cell polarity. We find separate populations of actin and myosin at each adhesion pole for both the mutant and wild type form. However, we find these populations move rapidly inwards toward one another in the mutant case in contrast to the cells that express wild type myosin IIB where those populations remain stationary. Results obtained with these two systems demonstrate how WIMS has the potential to reveal novel correlations between chosen parameters that belong to different scales.	[Toplak, Tim; Palmieri, Benoit; Grant, Martin; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Juanes-Garcia, Alba; Vicente-Manzanares, Miguel] Univ Autonoma Madrid, Sch Med, IIS Princesa Diego de Leon, Madrid, Spain; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada	McGill University; Autonomous University of Madrid; McGill University	Wiseman, PW (corresponding author), McGill Univ, Dept Phys, Montreal, PQ, Canada.; Wiseman, PW (corresponding author), McGill Univ, Dept Chem, Montreal, PQ, Canada.	paul.wiseman@mcgill.ca	Vicente-Manzanares, Miguel/H-1010-2018	Vicente-Manzanares, Miguel/0000-0001-5943-3220; Juanes Garcia, Alba/0000-0002-1009-9652	Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec - Nature et technologies	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec - Nature et technologies	This work was supported by Natural Sciences and Engineering Research Council of Canada (www.nserc.ca) and Fonds de recherche du Quebec - Nature et technologies (www.frqnt gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Prof. A.R. Horwitz (Department of Cell and Developmental Biology, The University of Virginia) for cell lines. We would also like to express gratitude to the Natural Sciences and Engineering Research Council of Canada, and Fonds de recherche du Quebec-Nature et technologies. Paul W. Wiseman acknowledges grant support from the Natural Sciences and Engineering Research Council of Canada.	ADDISON P. S., 2010, ILLUSTRATED WAVELET; Ashdown GW, 2014, BIOPHYS J, V107, pL21, DOI 10.1016/j.bpj.2014.09.018; Bekkers E, 2014, J MATH IMAGING VIS, V49, P583, DOI 10.1007/s10851-013-0488-6; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Broussard JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08124; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Chen LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040202; Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; de Monvel JB, 2001, BIOPHYS J, V80, P2455, DOI 10.1016/S0006-3495(01)76214-5; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hui KL, 2012, BIOPHYS J, V102, P1524, DOI 10.1016/j.bpj.2012.02.015; Izeddin I, 2012, OPT EXPRESS, V20, P2081, DOI 10.1364/OE.20.002081; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Juanes-Garcia A, 2015, J CELL BIOL, V209, P23, DOI 10.1083/jcb.201407059; Kobrinsky E, 2005, BIOPHYS J, V88, P3625, DOI 10.1529/biophysj.104.054056; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; Kolin DL, 2006, BIOPHYS J, V91, P3061, DOI 10.1529/biophysj.106.082768; Le Devedec SE, 2012, J CELL SCI, V125, P4498, DOI 10.1242/jcs.104273; Lewalle J., 2007, HDB EXPT FLUID MECH, P1378; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; Mount NJ, 2013, GEOMORPHOLOGY, V183, P82, DOI 10.1016/j.geomorph.2012.07.017; Parton RM, 2006, CELL BIOL, V3, P187; Paszek MJ, 2012, NAT METHODS, V9, DOI [10.1038/nmeth.2077, 10.1038/NMETH.2077]; PETERSEN NO, 1993, BIOPHYS J, V65, P1135, DOI 10.1016/S0006-3495(93)81173-1; RAILE K, 1994, J CELL PHYSIOL, V159, P531, DOI 10.1002/jcp.1041590317; Sarder P, 2006, IEEE SIGNAL PROC MAG, V23, P32, DOI 10.1109/MSP.2006.1628876; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Sethian JA, 1999, LEVEL SET METHODS AN; Singh AP, 2013, OPT EXPRESS, V21, P8652, DOI 10.1364/OE.21.008652; Toplak T, 2012, BIOPHYS J, V103, P1672, DOI 10.1016/j.bpj.2012.08.060; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; Wiseman PW, 1999, BIOPHYS J, V76, P963, DOI 10.1016/S0006-3495(99)77260-7; Wiseman PW, 2000, J MICROSC-OXFORD, V200, P14, DOI 10.1046/j.1365-2818.2000.00736.x; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Yang H, 2012, ADV CHEM PHYS, V146, P219	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186058	10.1371/journal.pone.0186058	http://dx.doi.org/10.1371/journal.pone.0186058			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049414	Green Published, gold			2022-12-26	WOS:000413195900037
J	Jeong, H; Baek, SY; Kim, SW; Eun, YH; Kim, IY; Lee, J; Jeon, CH; Koh, EM; Cha, HS				Jeong, Hyemin; Baek, Sun Young; Kim, Seon Woo; Eun, Yeong Hee; Kim, In Young; Lee, Jaejoon; Jeon, Chan Hong; Koh, Eun-Mi; Cha, Hoon-Suk			Comorbidities and health-related quality of life in Koreans with knee osteoarthritis: Data from the Korean National Health and Nutrition Examination Survey (KNHANES)	PLOS ONE			English	Article							POPULATION-BASED COHORT; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; DIABETES-MELLITUS; RISK-FACTORS	Objectives This study aimed to evaluate the association of knee osteoarthritis (OA) with comorbidities and health-related quality of life (HRQOL). Methods A total of 8,907 (weighted n = 13,687,058) participants aged >= 50 years who had undergone knee radiography were selected from the 2010-2012 Korea National Health and Nutrition Examination Survey. OA was classified into four subgroups based on the presence or absence of pain and radiographic OA (ROA): non-OA (Pain-/ROA-),pain only (Pain+/ROA-), ROA only (Pain-/ROA+), and painful ROA (Pain+/ROA+). ROA was defined as Kellgren-Lawrence grade >= 2. HRQOL measurements including EuroQOL visual analogue scale (EQ-VAS) scores and the five dimensions and summary index of the EuroQOL-5 dimension (EQ-5D index) were also analyzed. Multivariable logistic regression and linear regression analyses were performed. Results After adjustment for socioeconomic and lifestyle characteristics, cardiovascular disease, malignancy, and other comorbidities were not significantly associated with OA. Pain only and painful ROA were each significantly associated with limitations in physical activity (odds ratio (OR) 2.66, 95% CI 2.07-3.44, p < 0.001 and OR 2.83, 95% CI 2.25-3.58, p < 0.001, respectively), lower EQ-VAS (beta-coefficient = -10.95, p < 0.001 and beta-coefficient = -9.75, p < 0.001, respectively), and EQ-5D index (beta-coefficient = -0.10, p < 0.001 and beta-coefficient = -0.13, p < 0.001) compared with the non-OA group, whereas ROA only was not associated with limitations in physical activity or lower HRQOL score. Conclusions Comorbidities were not significantly associated with knee OA after adjustment. Knee OA was associated with physical activity and HRQOL. Painful knee OA, with or without ROA, was more strongly associated with decreased physical activity and lower quality of life than ROA without pain.	[Jeong, Hyemin; Jeon, Chan Hong] Soonchunhyang Univ Hosp, Dept Med, Div Rheumatol, Bucheon, South Korea; [Baek, Sun Young; Kim, Seon Woo] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Eun, Yeong Hee; Kim, In Young; Lee, Jaejoon; Koh, Eun-Mi; Cha, Hoon-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Rheumatol,Dept Med, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Cha, HS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Rheumatol,Dept Med, Seoul, South Korea.	hoonsuk.cha@samsung.com	Jeon, Chan Hong/AAK-2750-2021	Jeon, Chan Hong/0000-0002-2430-7264				Adams LM, 2015, CURR RHEUMATOL REV, V11, P96, DOI 10.2174/1573397111666150619095330; Araujo Ivan Luis Andrade, 2016, Knee Surg Relat Res, V28, P219, DOI 10.5792/ksrr.2016.28.3.219; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; DEXTER P, 1994, J RHEUMATOL, V21, P279; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Dimitroulas T, 2014, SEMIN ARTHRITIS RHEU, V44, P145, DOI 10.1016/j.semarthrit.2014.05.011; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Durante Alessandro, 2015, J Clin Med Res, V7, P379, DOI 10.14740/jocmr2122w; Edwards RR, 2011, NAT REV RHEUMATOL, V7, P216, DOI 10.1038/nrrheum.2011.2; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Elson DW, 2007, J BONE JOINT SURG BR, V89B, P1042, DOI 10.1302/0301-620X.89B8; Engstrom G, 2009, OSTEOARTHR CARTILAGE, V17, P168, DOI 10.1016/j.joca.2008.07.003; ETTINGER WH, 1994, J CLIN EPIDEMIOL, V47, P809, DOI 10.1016/0895-4356(94)90178-3; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Ferreira AH, 2015, REV BRAS REUMATOL, V55, P434, DOI 10.1016/j.rbr.2015.03.001; Goldring MB, 1999, CONNECT TISSUE RES, V40, P1, DOI 10.3109/03008209909005273; Gwilym SE, 2008, J BONE JOINT SURG BR, V90B, P280, DOI 10.1302/0301-620X.90B3.20167; Han CD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-603; Haugen IK, 2015, ANN RHEUM DIS, V74, P74, DOI 10.1136/annrheumdis-2013-203789; Hoeven TA, 2015, ANN RHEUM DIS, V74, P752, DOI 10.1136/annrheumdis-2013-204388; Hoogeboom TJ, 2013, RHEUMATOLOGY, V52, P543, DOI 10.1093/rheumatology/kes314; Hunter DJ, 2014, INT J RHEUM DIS, V17, P149, DOI 10.1111/1756-185X.12232; Il'yasova D, 2005, CANCER EPIDEM BIOMAR, V14, P2413, DOI 10.1158/1055-9965.EPI-05-0316; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jo Min Woo, 2007, Korean Journal of Health Promotion, V7, P96; Kadam UT, 2004, ANN RHEUM DIS, V63, P408, DOI 10.1136/ard.2003.007526; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Karvonen-Gutierrez CA, 2013, ARTHRIT CARE RES, V65, P936, DOI 10.1002/acr.21922; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kerola AM, 2012, ANN RHEUM DIS, V71, P1606, DOI 10.1136/annrheumdis-2012-201334; Kim MH, 2005, QUAL LIFE RES, V14, P1401, DOI 10.1007/s11136-004-5681-z; Kishimoto M, 2009, BULL HOSP JT DIS, V67, P230; Klein-Wieringa IR, 2011, ANN RHEUM DIS, V70, P851, DOI 10.1136/ard.2010.140046; Kluzek S, 2016, ANN RHEUM DIS, V75, P1749, DOI 10.1136/annrheumdis-2015-208056; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Leite AA, 2011, REV BRAS REUMATOL, V51, P113; Liaw FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22750; Lim Nan-Young, 2010, [The Journal of Muscle and Joint Health, 근관절건강학회지], V17, P203; Lindhardsen J, 2011, ANN RHEUM DIS, V70, P929, DOI 10.1136/ard.2010.143396; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; Manzi S, 2000, ANN RHEUM DIS, V59, P321, DOI 10.1136/ard.59.5.321; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; March L, 2014, BEST PRACT RES CL RH, V28, P353, DOI 10.1016/j.berh.2014.08.002; Mathiessen A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1229-9; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Neogi T, 2016, ARTHRITIS RHEUMATOL, V68, P654, DOI 10.1002/art.39488; Nielen MMJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-150; Niu JB, 2017, ARTHRITIS RHEUMATOL, V69, P1194, DOI 10.1002/art.40087; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Picavet HSJ, 2004, ANN RHEUM DIS, V63, P723, DOI 10.1136/ard.2003.010769; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rahman MM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002624; Rahman MM, 2013, ARTHRIT CARE RES, V65, P1951, DOI 10.1002/acr.22092; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Schiphof D, 2008, ANN RHEUM DIS, V67, P1034, DOI 10.1136/ard.2007.079020; Segal NA, 2009, AM J PHYS MED REHAB, V88, P180, DOI 10.1097/PHM.0b013e318198b51b; Singh G, 2002, AM J MANAG CARE, V8, pS383; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; Spector TD, 1997, ARTHRITIS RHEUM, V40, P723, DOI 10.1002/art.1780400419; Stannus OP, 2013, ANN RHEUM DIS, V72, P535, DOI 10.1136/annrheumdis-2011-201047; Stenholm S, 2010, CLIN ENDOCRINOL, V73, P55, DOI 10.1111/j.1365-2265.2009.03742.x; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; van Baar ME, 1998, J RHEUMATOL, V25, P125; van Dijk GM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-95; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep39672; Watanabe Hiroyuki, 2010, J Orthop Surg (Hong Kong), V18, P31; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569	74	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186141	10.1371/journal.pone.0186141	http://dx.doi.org/10.1371/journal.pone.0186141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045425	gold, Green Published, Green Submitted			2022-12-26	WOS:000413168100040
J	Mao, B; Moss, CF; Wilkinson, GS				Mao, Beatrice; Moss, Cynthia F.; Wilkinson, Gerald S.			Age-dependent gene expression in the inner ear of big brown bats (Eptesicus fuscus)	PLOS ONE			English	Article							SYNDROMIC HEARING-LOSS; HAIR-CELLS; TECTORIAL MEMBRANE; ECHOLOCATING BATS; MYOTIS-LUCIFUGUS; CONNEXIN 26; POSTNATAL-DEVELOPMENT; CHANNEL EXPRESSION; SYSTEM DEVELOPMENT; ALPHA-TECTORIN	For echolocating bats, hearing is essential for survival. Specializations for detecting and processing high frequency sounds are apparent throughout their auditory systems. Recent studies on echolocating mammals have reported evidence of parallel evolution in some hearing-related genes in which distantly related groups of echolocating animals (bats and toothed whales), cluster together in gene trees due to apparent amino acid convergence. However, molecular adaptations can occur not only in coding sequences, but also in the regulation of gene expression. The aim of this study was to examine the expression of hearing-related genes in the inner ear of developing big brown bats, Eptesicus fuscus, during the period in which echolocation vocalizations increase dramatically in frequency. We found that seven genes were significantly upregulated in juveniles relative to adults, and that the expression of four genes through development correlated with estimated age. Compared to available data for mice, it appears that expression of some hearing genes is extended in juvenile bats. These results are consistent with a prolonged growth period required to develop larger cochlea relative to body size, a later maturation of high frequency hearing, and a greater dependence on high frequency hearing in echolocating bats.	[Mao, Beatrice; Wilkinson, Gerald S.] Univ Maryland, Coll Comp Math & Nat Sci, Dept Biol, College Pk, MD 20742 USA; [Moss, Cynthia F.] Johns Hopkins Univ, Zanvyl Krieger Sch Arts & Sci, Dept Psychol & Brain Sci, Baltimore, MD USA; [Moss, Cynthia F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Mao, Beatrice] NIDCD, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Mao, B (corresponding author), Univ Maryland, Coll Comp Math & Nat Sci, Dept Biol, College Pk, MD 20742 USA.; Mao, B (corresponding author), NIDCD, NIH, Bethesda, MD 20892 USA.	beatrice.mao@nih.gov	Wilkinson, Gerald S./E-4424-2011	Wilkinson, Gerald S./0000-0001-7799-8444	National Institute of Deafness and Communicative Disorders of the National Institutes of Health [T32 DC000046]; UMD Libraries Open Access Publishing Fund	National Institute of Deafness and Communicative Disorders of the National Institutes of Health; UMD Libraries Open Access Publishing Fund	B.M. was supported on training grant No. T32 DC000046 from the National Institute of Deafness and Communicative Disorders of the National Institutes of Health (https://www.nidcd. nih.gov/), awarded to A. N. Popper. Partial funding for open access provided by the UMD Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Wei Xian provided logistical support in the procurement of samples, Josephine Reinhardt and Kimberly Paczolt offered advice on RNA extraction and qPCR, and the Moss and Wilkinson labs gave valuable feedback. Partial funding for open access provided by the UMD Libraries' Open Access Publishing Fund.	Bates ME, 2011, SCIENCE, V333, P627, DOI 10.1126/science.1202065; Booker BM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005738; Boulay AC, 2013, J NEUROSCI, V33, P430, DOI 10.1523/JNEUROSCI.4240-12.2013; BROWN PE, 1978, J COMP PHYSIOL, V126, P169, DOI 10.1007/BF00666371; BUCHLER ER, 1980, BEHAV ECOL SOCIOBIOL, V6, P211, DOI 10.1007/BF00569202; BURNETT CD, 1982, J MAMMAL, V63, P33, DOI 10.2307/1380668; Cheatham MA, 2014, J NEUROSCI, V34, P10325, DOI 10.1523/JNEUROSCI.1256-14.2014; Chen W, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032615; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Collins JG, 1997, PREVALENCE SELECTED; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davies KTJ, 2012, HEREDITY, V108, P480, DOI 10.1038/hdy.2011.119; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Dong D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-916; ECHTELER SM, 1989, NATURE, V341, P147, DOI 10.1038/341147a0; Egyhazi S, 2004, CLIN CHEM, V50, P975, DOI 10.1373/clinchem.2003.027102; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Falk B, 2011, J COMP PHYSIOL A, V197, P491, DOI 10.1007/s00359-010-0621-6; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Forge A, 2013, J CELL SCI, V126, P1703, DOI 10.1242/jcs.125476; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; HABERSETZER J, 1983, J COMP PHYSIOL, V152, P275, DOI 10.1007/BF00611192; HARRIS DM, 1984, SCIENCE, V225, P741, DOI 10.1126/science.6463651; HARTLEY DJ, 1989, J ACOUST SOC AM, V85, P1348, DOI 10.1121/1.397466; Heffner H. E., 2008, HDB SENSES AUDITION, P55, DOI DOI 10.1016/B978-012370880-9; Hom KN, 2016, J EXP BIOL, V219, P3253, DOI 10.1242/jeb.143578; Hsiao CJ, 2015, NEUROREPORT, V26, P478, DOI 10.1097/WNR.0000000000000375; Jagger DJ, 2015, CELL TISSUE RES, V360, P633, DOI 10.1007/s00441-014-2029-z; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Jones Gareth, 2000, P362, DOI 10.1017/CBO9780511541872.012; Kammerer R, 2012, J BIOL CHEM, V287, P21584, DOI 10.1074/jbc.M111.320481; Kammerer R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-12; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kidokoro Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108216; Kirwan JD, 2013, EVOL APPL, V6, P412, DOI 10.1111/eva.12047; KOSSL M, 1985, J COMP PHYSIOL A, V157, P687, DOI 10.1007/BF01351362; Kossl Manfred, 1995, Springer Handbook of Auditory Research, V5, P191; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Kurima K, 2015, CELL REP, V12, P1606, DOI 10.1016/j.celrep.2015.07.058; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2012, MOL BIOL EVOL, V29, P1441, DOI 10.1093/molbev/msr310; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026618; Lou XX, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-150; Mann ZF, 2014, NATURE COMM, V5; Martinez AD, 2009, ANTIOXID REDOX SIGN, V11, P309, DOI 10.1089/ars.2008.2138; Masaki K, 2009, BIOPHYS J, V96, P4717, DOI 10.1016/j.bpj.2009.02.056; Masuda M, 2008, NEUROSCI RES, V62, P15, DOI 10.1016/j.neures.2008.05.005; Mayberry HW, 2015, BIOL OPEN, V4, P22, DOI 10.1242/bio.201410181; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Mistrik P, 2010, JARO-J ASSOC RES OTO, V11, P559, DOI 10.1007/s10162-010-0226-3; Mistrik P, 2009, CONCEPTS AND CHALLENGES IN THE BIOPHYSICS OF HEARING, P377, DOI 10.1142/9789812833785_0060; Mistrik P, 2009, J R SOC INTERFACE, V6, P279, DOI 10.1098/rsif.2008.0201; Miwa T, 2013, MOL THER, V21, P1142, DOI 10.1038/mt.2013.62; Monroy JA, 2011, J COMP PHYSIOL A, V197, P459, DOI 10.1007/s00359-010-0614-5; Moss CF, 1997, ANIM BEHAV, V54, P131, DOI 10.1006/anbe.1996.0410; Moss CF, 2001, J ACOUST SOC AM, V110, P2207, DOI 10.1121/1.1398051; MOSS CF, 1988, ANIMAL SONAR PROCESS, P115; Moss CF, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00033; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; POWERS LV, 1991, J COMP PHYSIOL A, V168, P675; Qu Y, 2012, BIOCHEM BIOPH RES CO, V417, P245, DOI 10.1016/j.bbrc.2011.11.093; Rio C, 2002, J COMP NEUROL, V442, P156, DOI 10.1002/cne.10085; Rohmann KN, 2014, J EXP BIOL, V217, P2531, DOI 10.1242/jeb.103093; Rohmann KN, 2013, CURR BIOL, V23, P678, DOI 10.1016/j.cub.2013.03.014; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; RUBSAMEN R, 1987, J COMP PHYSIOL A, V161, P899, DOI 10.1007/BF00610231; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Shen YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002788; Simmons AM, 2016, J EXP BIOL, V219, P1031, DOI 10.1242/jeb.135319; Simmons AM, 2015, J ACOUST SOC AM, V138, P2430, DOI 10.1121/1.4931901; SIMMONS JA, 1973, J ACOUST SOC AM, V54, P157, DOI 10.1121/1.1913559; SIMMONS JA, 1971, J EXP ZOOL, V176, P315, DOI 10.1002/jez.1401760307; Smeti I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042987; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Steiner AB, 2014, P NATL ACAD SCI USA, V111, pE1393, DOI 10.1073/pnas.1318692111; Sterbing SJ, 2002, J MAMMAL, V83, P516, DOI 10.1644/1545-1542(2002)083<0516:PDOVAH>2.0.CO;2; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 2009, P ROY SOC B-BIOL SCI, V276, P853, DOI 10.1098/rspb.2008.1505; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Takada Y, 2014, HEARING RES, V309, P124, DOI 10.1016/j.heares.2013.11.009; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Tian C, 2010, BRAIN RES, V1328, P57, DOI 10.1016/j.brainres.2010.02.079; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; VATER M, 1992, J COMP NEUROL, V318, P367, DOI 10.1002/cne.903180403; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wang Z, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0021; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Wyatt AW, 2010, HUM MUTAT, V31, P781, DOI 10.1002/humu.21280; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Zheng J, 2011, P NATL ACAD SCI USA, V108, P4218, DOI 10.1073/pnas.1005842108; Zhou XX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030301; Zhu Y, 2015, NEUROSCIENCE, V284, P719, DOI 10.1016/j.neuroscience.2014.10.061	106	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186667	10.1371/journal.pone.0186667	http://dx.doi.org/10.1371/journal.pone.0186667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073148	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400038
J	Martin-Guerrero, SM; Munoz-Gamez, JA; Carrasco, MC; Salmeron, J; Martin-Estebane, M; Cuadros, MA; Navascues, J; Martin-Oliva, D				Martin-Guerrero, Sandra M.; Munoz-Gamez, Jose A.; Carrasco, Maria-Carmen; Salmeron, Javier; Martin-Estebane, Maria; Cuadros, Miguel A.; Navascues, Julio; Martin-Oliva, David			Poly(ADP-ribose) polymerases inhibitors prevent early mitochondrial fragmentation and hepatocyte cell death induced by H2O2	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; ADP-RIBOSE POLYMERASE-1; OXIDATIVE STRESS; RAT-LIVER; ANTIOXIDANT STATUS; RESPIRATORY-CHAIN; SOLID TUMORS; DNA-DAMAGE; PHASE-I; DISEASES	Poly(ADP-ribose) polymerases (PARPs) are a family of NAD(+) consuming enzymes that play a crucial role in many cellular processes, most clearly in maintaining genome integrity. Here, we present an extensive analysis of the alteration of mitochondrial morphology and the relationship to PARPs activity after oxidative stress using an in vitro model of human hepatic cells. The following outcomes were observed: reactive oxygen species (ROS) induced by oxidative treatment quickly stimulated PARPs activation, promoted changes in mitochondrial morphology associated with early mitochondrial fragmentation and energy dysfunction and finally triggered apoptotic cell death. Pharmacological treatment with specific PARP-1 (the major NAD(+) consuming poly(ADP-ribose) polymerases) and PARP-1/PARP-2 inhibitors after the oxidant insult recovered normal mitochondrial morphology and, hence, increased the viability of human hepatic cells. As the PARP-1 and PARP-1/PARP-2 inhibitors achieved similar outcomes, we conclude that most of the PARPs effects were due to PARP-1 activation. NAD(+) supplementation had similar effects to those of the PARPs inhibitors. Therefore, PARPs activation and the subsequent NAD+ depletion are crucial events in decreased cell survival (and increased apoptosis) in hepatic cells subjected to oxidative stress. These results suggest that the alterations in mitochondrial morphology and function seem to be related to NAD(+) depletion, and show for the first time that PARPs inhibition abrogates mitochondrial fragmentation. In conclusion, the inhibition of PARPs may be a valuable therapeutic approach for treating liver diseases, by reducing the cell death associated with oxidative stress.	[Martin-Guerrero, Sandra M.; Carrasco, Maria-Carmen; Martin-Estebane, Maria; Cuadros, Miguel A.; Navascues, Julio; Martin-Oliva, David] Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain; [Munoz-Gamez, Jose A.; Salmeron, Javier] Hosp Univ San Cecilio, Inst Invest Biomed IbsGranada, Granada, Spain	University of Granada; Hospital Universitario San Cecilio	Martin-Oliva, D (corresponding author), Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain.	dmoliva@ugr.es	ESTEBANÉ, MARÍA MARTÍN/AAR-5385-2020; Cuadros, Miguel A/L-3954-2014; Martín-Guerrero, Sandra María/P-9333-2018; Martín-Oliva, David/L-8472-2014	ESTEBANÉ, MARÍA MARTÍN/0000-0002-9680-581X; Cuadros, Miguel A/0000-0003-4259-1649; Martín-Guerrero, Sandra María/0000-0003-1489-4757; Martín-Oliva, David/0000-0002-8095-5442; Navascues, Julio/0000-0003-2958-2705	Ministerio de Economia y Competitividad, Spain [BFU2010-19981]; CEI BioTic Granada, Spain [BS9-2015]; Ministerio de Educacion, Cultura y Deporte, Spain [FPU14/02219]	Ministerio de Economia y Competitividad, Spain; CEI BioTic Granada, Spain; Ministerio de Educacion, Cultura y Deporte, Spain	This work was supported by grants from Ministerio de Economia y Competitividad, Spain (BFU2010-19981), CEI BioTic Granada, Spain (BS9-2015) and Ministerio de Educacion, Cultura y Deporte, Spain (FPU14/02219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Balmana J, 2014, ANN ONCOL, V25, P1656, DOI 10.1093/annonc/mdu187; Bando I, 2005, J BIOCHEM MOL TOXIC, V19, P154, DOI 10.1002/jbt.20067; Banerjee P, 2013, INDIAN J BIOCHEM BIO, V50, P377; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Berger N.A., 2017, BR J PHARM; Berridge M.V., 1996, BIOCHEMICA, V4, P14, DOI DOI 10.1155/2013/420601; Brunyanszki A, 2016, FREE RADICAL BIO MED, V100, P257, DOI 10.1016/j.freeradbiomed.2016.02.024; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Cortez-Pinto H, 1999, CLIN NUTR, V18, P353, DOI 10.1016/S0261-5614(99)80015-6; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Decker Patrice, 2002, Current Pharmaceutical Biotechnology, V3, P275, DOI 10.2174/1389201023378265; Del Conte G, 2014, BRIT J CANCER, V111, P651, DOI 10.1038/bjc.2014.345; Diani-Moore S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02332-9; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Feng GP, 2002, AM J PHYSIOL-GASTR L, V282, pG825, DOI 10.1152/ajpgi.00467.2001; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Galloway CA, 2012, J GEN PHYSIOL, V139, P455, DOI 10.1085/jgp.201210771; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; GUTIERREZRUIZ MC, 1994, IN VITRO CELL DEV-AN, V30A, P366, DOI 10.1007/BF02634356; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020; Hegedus C, 2014, REDOX BIOL, V2, P978, DOI 10.1016/j.redox.2014.08.003; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; Huang K, 2016, J HEPATOL, P30697; Huang Q, 2009, AUTOPHAGY, V5, P273, DOI 10.4161/auto.5.2.7640; Jang KH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.437; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kladna A, 2015, LUMINESCENCE, V30, P1153, DOI 10.1002/bio.2879; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Martin-Oliva D, 2011, INVEST OPHTH VIS SCI, V52, P7445, DOI 10.1167/iovs.11-7222; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ozgur E, 2010, INT J RADIAT BIOL, V86, P935, DOI 10.3109/09553002.2010.496029; Pellicciari R, 2008, CHEMMEDCHEM, V3, P914, DOI 10.1002/cmdc.200800010; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929; Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pieniazek A, 2013, ADV MED SCI-POLAND, V58, P104, DOI 10.2478/v10039-012-0063-1; Samarghandian S, 2014, INT J CLIN EXP MED, V7, P1449; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446; Sodhi RK, 2010, VASC PHARMACOL, V53, P77, DOI 10.1016/j.vph.2010.06.003; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Virag L, 1998, J IMMUNOL, V161, P3753; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Wlodkowic D, 2009, METHODS MOL BIOL, V559, P19, DOI 10.1007/978-1-60327-017-5_2; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Yelamos J, 2011, AM J CANCER RES, V1, P328; Yildirim NC, 2010, TURK J BIOCHEM, V35, P138; Yoon SP, 2016, ANAT CELL BIOL, V49, P165, DOI 10.5115/acb.2016.49.3.165; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284; Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352; Zhang LX, 2010, EXP CELL RES, V316, P716, DOI 10.1016/j.yexcr.2009.12.008; Zhu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26322	79	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187130	10.1371/journal.pone.0187130	http://dx.doi.org/10.1371/journal.pone.0187130			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073231	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400118
J	Sun, YW; Chen, KM; Kawasawa, YI; Salzberg, AC; Cooper, TK; Caruso, C; Aliga, C; Zhu, JJ; Gowda, K; Amin, S; EI-Bayoumy, K				Sun, Yuan-Wan; Chen, Kun-Ming; Kawasawa, Yuka Imamura; Salzberg, Anna C.; Cooper, Timothy K.; Caruso, Carla; Aliga, Cesar; Zhu, Junjia; Gowda, Krishne; Amin, Shantu; EI-Bayoumy, Karam			Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p] chrysene	PLOS ONE			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; DIOL EPOXIDE; OVEREXPRESSION; INHIBITION; MECHANISMS; DIAGNOSIS; ADDUCTS; PATHWAY; TISSUES	Genetic and epigenetic alterations observed at end stage OSCC formation could be considered as a consequence of cancer development and thus changes in normal or premalignant tissues which had been exposed to oral carcinogens such as Dibenzo[def,p]chrysene (DBP) may better serve as predictive biomarkers of disease development. Many types of DNA damage can induce epigenetic changes which can occur early and in the absence of evident morphological abnormalities. Therefore we used ERRBS to generate genome-scale, single-base resolution DNA methylomes from histologically normal oral tissues of mice treated with DBP under experimental conditions known to induce maximum DNA damage which is essential for the development of OSCC induced by DBP in mice. After genome-wide correction, 30 and 48 differentially methylated sites (DMS) were identified between vehicle control and DBP treated mice using 25% and 10% differences in methylation, respectively. RT-PCR was further performed to examine the expressions of nine selected genes. Among them, Fgf3, a gene frequently amplified in head and neck cancer, showed most prominent and significant gene expression change (2.4x increases), despite the hypomethylation of Fgf3 was identified at >10kb upstream of transcription start site. No difference was observed in protein expression between normal oral tissues treated with DBP or vehicle as examined by immunohistochemistry. Collectively, our results indicate that Fgf3 hypomethylation and gene overexpression, but not protein expression, occurred in the early stage of oral carcinogenesis induced by DBP. Thus, Fgf3 hypomethylation may serve as a potential biomarker for early detection of OSCC.	[Sun, Yuan-Wan; Chen, Kun-Ming; Kawasawa, Yuka Imamura; Aliga, Cesar; EI-Bayoumy, Karam] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 16801 USA; [Kawasawa, Yuka Imamura; Gowda, Krishne; Amin, Shantu] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; [Kawasawa, Yuka Imamura; Salzberg, Anna C.] Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA USA; [Cooper, Timothy K.] Penn State Univ, Coll Med, Dept Comparat Med, Hershey, PA USA; [Cooper, Timothy K.; Caruso, Carla] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Zhu, Junjia] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Cooper, Timothy K.] NIAID, Charles River Labs Contractor Supporting, Integrated Res Facil, Div Clin Res, Frederick, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sun, YW; EI-Bayoumy, K (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 16801 USA.	yxs12@psu.edu; kee2@psu.edu		GOWDA, KRISHNE/0000-0002-6042-0520	Department of Health and Human Services, National Institute of Health, National Cancer Institute [R01-CA173465]; NATIONAL CANCER INSTITUTE [R01CA173465] Funding Source: NIH RePORTER	Department of Health and Human Services, National Institute of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Health and Human Services, National Institute of Health, National Cancer Institute, R01-CA173465, https://www.cancer.gov/.Karam El-Bayoumy received funding to support study design, data collection and analysis.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Chen KM, 2013, INT J CANCER, V133, P1300, DOI 10.1002/ijc.28152; da Silva SD, 2015, CLIN EXP METASTAS, V32, P55, DOI 10.1007/s10585-014-9690-1; Demokan S, 2011, CLIN EPIGENETICS, V2, P123, DOI 10.1007/s13148-011-0045-3; Dionne KR, 2015, INT J CANCER, V136, P503, DOI 10.1002/ijc.28754; DKUEO, 2012, OVERVIEW ORAL CANC; El-Bayoumy K, 2017, CHEM RES TOXICOL, V30, P126, DOI 10.1021/acs.chemrestox.6b00306; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Foy JP, 2015, NEW DNA METHYLATION; Gromova ES, 2010, ACS SYM SER, V1041, P103; Guttenplan JB, 2012, INT J CANCER, V130, P2783, DOI 10.1002/ijc.26344; Jin HY, 2015, NUTR CANCER, V67, P167, DOI 10.1080/01635581.2015.976314; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leavitt SA, 2008, MUTAGENESIS, V23, P445, DOI 10.1093/mutage/gen033; Lese CM, 1995, GENES CHROMOSOMES CA, V12; Lewandowska J, 2011, MUTAGENESIS, V26, P475, DOI 10.1093/mutage/ger019; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Lindsey S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00358; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mizukami T, 2017, MOL CARCINOGEN, V56, P106, DOI 10.1002/mc.22476; Nagata S, 2012, CANCER-AM CANCER SOC, V118, P4298, DOI 10.1002/cncr.27417; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Parker BS, 2001, J BIOL CHEM, V276, P15953, DOI 10.1074/jbc.M009216200; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; Radoi L, 2013, COMMUNITY DENT ORAL, V41, DOI 10.1111/j.1600-0528.2012.00710.x; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider K, 2002, J APPL TOXICOL, V22, P73, DOI 10.1002/jat.828; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; SOMERS KD, 1990, ONCOGENE, V5, P915; Tanaka T, 2011, J ONCOL, V2011, DOI 10.1155/2011/603740; Tommasi S, 2014, CARCINOGENESIS, V35, P1726, DOI 10.1093/carcin/bgu026; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Towle R, 2012, J ONCOL, V2012, DOI 10.1155/2012/170172; Towle R, 2013, ORAL ONCOL, V49, P1033, DOI 10.1016/j.oraloncology.2013.08.005; von Zeidler SV, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-972; Wachsman JT, 1997, MUTAT RES-FUND MOL M, V375, P1, DOI 10.1016/S0027-5107(97)00003-1; Warnakulasuriya S, 2005, ORAL ONCOL, V41, P244, DOI 10.1016/j.oraloncology.2004.08.010; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weisenberger DJ, 1999, J BIOL CHEM, V274, P23948, DOI 10.1074/jbc.274.34.23948; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7; WOJCIECHOWSKI MF, 1984, J BIOL CHEM, V259, P9711; Worsham MJ, 2012, J ONCOL, V2012, DOI 10.1155/2012/752860; Zhang SM, 2014, CHEM RES TOXICOL, V27, P1199, DOI 10.1021/tx5001078; Zhang SY, 2012, ANAL CHEM, V84, P6421, DOI 10.1021/ac301464x	49	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186873	10.1371/journal.pone.0186873	http://dx.doi.org/10.1371/journal.pone.0186873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073177	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400067
J	Satoh, D; Iwado, S; Abe, S; Kazuki, K; Wakuri, S; Oshimura, M; Kazuki, Y				Satoh, Daisuke; Iwado, Satoru; Abe, Satoshi; Kazuki, Kanako; Wakuri, Shinobu; Oshimura, Mitsuo; Kazuki, Yasuhiro			Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; MECHANISM-BASED INHIBITOR; IN-VITRO; HEPG2 CELLS; INDUCED HEPATOTOXICITY; LIVER TOXICITY; METABOLISM; DISCOVERY; OXIDATION; ENZYMES	The utility of HepG2 cells to assess drug metabolism and toxicity induced by chemical compounds is hampered by their low cytochrome P450 (CYP) activities. To overcome this limitation, we established HepG2 cell lines expressing major CYP enzymes involved in drug metabolism (CYP2C9, CYP2C19, CYP2D6, and CYP3A4) and CYP oxidoreductase (POR) using the mammalian-derived artificial chromosome vector. Transchromosomic HepG2 (TC-HepG2) cells expressing four CYPs and POR were used to determine time-and concentration- dependent inhibition and toxicity of several compounds by luminescence detection of CYP-specific substrates and cell viability assays. Gene expression levels of all four CYPs and POR, as well as the CYP activities, were higher in TC-HepG2 clones than in parental HepG2 cells. Additionally, the activity levels of all CYPs were reduced in a concentration- dependent manner by specific CYP inhibitors. Furthermore, preincubation of TCHepG2 cells with CYP inhibitors known as time-dependent inhibitors (TDI) prior to the addition of CYP-specific substrates determined that CYP inhibition was enhanced in the TDI group than in the non-TDI group. Finally, the IC50 of bioactivable compound aflatoxin B1 was lower in TC-HepG2 cells than in HepG2 cells. In conclusion, the TC-HepG2 cells characterized in the current study are a highly versatile model to evaluate drug-drug interactions and hepatotoxicity in initial screening of candidate drug compounds, which require a high degree of processing capacity and reliability.	[Satoh, Daisuke; Abe, Satoshi; Kazuki, Kanako; Oshimura, Mitsuo; Kazuki, Yasuhiro] Tottori Univ, Chromosome Engn Res Ctr, Tottori, Japan; [Iwado, Satoru; Kazuki, Yasuhiro] Tottori Univ, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Dept Biomed Sci, Tottori, Japan; [Wakuri, Shinobu] Food & Drug Safety Ctr, Tokyo, Japan	Tottori University; Tottori University	Kazuki, Y (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Tottori, Japan.; Kazuki, Y (corresponding author), Tottori Univ, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Dept Biomed Sci, Tottori, Japan.	kazuki@grape.med.tottori-u.ac.jp		Kazuki, Yasuhiro/0000-0003-4818-4710; Leggas, Markos/0000-0003-4314-4533	Japan Society for the Promotion of Science [26893153, 16K18942]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [16K18942] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-Aid from the Japan Society for the Promotion of Science (26893153 to DS, 16K18942 to DS) and the Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.K. and M.O.). There was no additional external funding received for this study.; We thank Dr. H. Kugoh, Dr. M. Hiratsuka, and Dr. Y. Nakajima at Tottori University for critical discussions. This work was supported, in part, by Grants-in-Aid from the Japan Society for the Promotion of Science (26893153 to DS, 16K18942 to DS) and the Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.K. and M.O.). There was no additional external funding received for this study. This research was partly performed at Tottori Bio Frontier managed by Tottori prefecture.	Bachmann KA, 2005, ANN PHARMACOTHER, V39, P1064, DOI 10.1345/aph.1E508; Bale SS, 2014, EXP BIOL MED, V239, P1180, DOI 10.1177/1535370214531872; Bertelsen KM, 2003, DRUG METAB DISPOS, V31, P289, DOI 10.1124/dmd.31.3.289; DESAGER JP, 1995, CLIN PHARMACOKINET, V28, P419, DOI 10.2165/00003088-199528050-00006; Dohnal V, 2014, ARCH TOXICOL, V88, P1635, DOI 10.1007/s00204-014-1312-9; Donato MT, 2003, CLIN PHARMACOKINET, V42, P153, DOI 10.2165/00003088-200342020-00004; Gao W, 2015, TOXICOL IN VITRO, V29, P1, DOI 10.1016/j.tiv.2014.08.007; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; Gomez-Lechon MJ, 2003, CURR DRUG METAB, V4, P292, DOI 10.2174/1389200033489424; Gunawan B, 2004, DRUG METAB REV, V36, P301, DOI 10.1081/DMR-120034148; Gunawan Basuki K, 2007, Clin Liver Dis, V11, P459, DOI 10.1016/j.cld.2007.06.001; Ha-Duong NT, 2001, BIOCHEMISTRY-US, V40, P12112, DOI 10.1021/bi010254c; He K, 1999, J PHARMACOL EXP THER, V288, P791; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; HONIG PK, 1993, JAMA-J AM MED ASSOC, V269, P1513, DOI 10.1001/jama.269.12.1513; Hosomi H, 2011, DRUG METAB DISPOS, V39, P1388, DOI 10.1124/dmd.110.037077; Huang LZ, 2016, TOXICOL IN VITRO, V32, P132, DOI 10.1016/j.tiv.2015.12.008; Iwamura A, 2011, DRUG METAB DISPOS, V39, P838, DOI 10.1124/dmd.110.037259; Jean P, 1996, EUR J BIOCHEM, V241, P797, DOI 10.1111/j.1432-1033.1996.00797.x; Gomez-Lechon MJ, 2017, EXPERT OPIN DRUG MET, V13, P137, DOI 10.1080/17425255.2017.1238459; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; Katoh M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-37; Kawai H, 2009, J TOXICOL SCI, V34, P27, DOI 10.2131/jts.34.27; Kazuki Y, 2011, GENE THER, V18, P384, DOI 10.1038/gt.2010.147; Kazuki Y, 2011, MOL THER, V19, P1591, DOI 10.1038/mt.2011.136; Knasmuller S, 2004, TOXICOLOGY, V198, P315, DOI 10.1016/j.tox.2004.02.008; Krayenbuhl JC, 1999, EUR J CLIN PHARMACOL, V55, P559, DOI 10.1007/s002280050673; LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Mao JL, 2011, DRUG METAB DISPOS, V39, P591, DOI 10.1124/dmd.110.036400; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; Nassar AEF, 2004, CURR OPIN DRUG DISC, V7, P126; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Oshimura M, 2015, CHROMOSOME RES, V23, P111, DOI 10.1007/s10577-014-9459-z; Robertson SM, 2015, J CLIN PHARMACOL, V55, P56, DOI 10.1002/jcph.377; Saito J, 2016, TOXICOL IN VITRO, V33, P63, DOI 10.1016/j.tiv.2016.02.019; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Sica Domenic A, 2002, Am J Geriatr Cardiol, V11, P48, DOI 10.1111/j.1076-7460.2002.01422.x; SoRelle R, 1998, CIRCULATION, V98, P831, DOI 10.1161/01.CIR.98.9.831; Suzuki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110404; Taesotikul T, 2011, DRUG METAB PHARMACOK, V26, P154, DOI 10.2133/dmpk.DMPK-10-RG-107; Takiguchi M, 2014, ACS SYNTH BIOL, V3, P903, DOI 10.1021/sb3000723; Vignati L, 2005, TOXICOLOGY, V216, P154, DOI 10.1016/j.tox.2005.08.003; White RE, 2000, ANNU REV PHARMACOL, V40, P133, DOI 10.1146/annurev.pharmtox.40.1.133; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Wolfgang GHI, 2002, TOXICOLOGY, V173, P67, DOI 10.1016/S0300-483X(02)00022-7; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416; Xu JJ, 2004, CHEM-BIOL INTERACT, V150, P115, DOI 10.1016/j.cbi.2004.09.011; Xuan JK, 2016, CHEM-BIOL INTERACT, V255, P63, DOI 10.1016/j.cbi.2015.10.009; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yamamoto Y, 2002, DRUG METAB DISPOS, V30, P155, DOI 10.1124/dmd.30.2.155; Yoshitomi S, 2001, TOXICOL IN VITRO, V15, P245, DOI 10.1016/S0887-2333(01)00011-X; Zahno A, 2011, BIOCHEM PHARMACOL, V81, P432, DOI 10.1016/j.bcp.2010.11.002; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664	58	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0187072	10.1371/journal.pone.0187072	http://dx.doi.org/10.1371/journal.pone.0187072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065189	Green Submitted, gold, Green Published			2022-12-26	WOS:000413568900067
J	Abitbol, K; Debiesse, S; Molino, F; Mesirca, P; Bidaud, I; Minami, Y; Mangoni, ME; Yagita, K; Mollard, P; Bonnefont, X				Abitbol, Karine; Debiesse, Segolene; Molino, Francois; Mesirca, Pietro; Bidaud, Isabelle; Minami, Yoichi; Mangoni, Matteo E.; Yagita, Kazuhiro; Mollard, Patrice; Bonnefont, Xavier			Clock-dependent and system-driven oscillators interact in the suprachiasmatic nuclei to pace mammalian circadian rhythms	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; BODY-TEMPERATURE; JET-LAG; REPRODUCTIVE-PERFORMANCE; PERIPHERAL-TISSUES; LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; MUTANT MICE; MOUSE; CYCLE	Circadian clocks drive biological rhythms with a period of approximately 24 hours and keep in time with the outside world through daily resetting by environmental cues. While this external entrainment has been extensively investigated in the suprachiasmatic nuclei (SCN), the role of internal systemic rhythms, including daily fluctuations in core temperature or circulating hormones remains debated. Here, we show that lactating mice, which exhibit dampened systemic rhythms, possess normal molecular clockwork but impaired rhythms in both heat shock response gene expression and electrophysiological output in their SCN. This suggests that body rhythms regulate SCN activity downstream of the clock. Mathematical modeling predicts that systemic feedback upon the SCN functions as an internal oscillator that accounts for in vivo and ex vivo observations. Thus we are able to propose a new bottom-up hierarchical organization of circadian timekeeping in mammals, based on the interaction in the SCN between clock-dependent and system-driven oscillators.	[Abitbol, Karine; Debiesse, Segolene; Molino, Francois; Mesirca, Pietro; Bidaud, Isabelle; Mangoni, Matteo E.; Mollard, Patrice; Bonnefont, Xavier] CNRS, INSERM, Inst Genom Fonct, Montpellier, France; [Molino, Francois] Univ Montpellier, Lab Charles Coulomb, CNRS UMR 5221, Montpellier, France; [Minami, Yoichi; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Physiol & Syst Biosci, Kyoto, Japan	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; Kyoto Prefectural University of Medicine	Bonnefont, X (corresponding author), CNRS, INSERM, Inst Genom Fonct, Montpellier, France.	Xavier.Bonnefont@igf.cnrs.fr	BONNEFONT, Xavier/AAH-3882-2019; Mesirca, Pietro/X-4999-2019; Mangoni, Matteo E/E-6025-2015	BONNEFONT, Xavier/0000-0003-4778-4060; Mangoni, Matteo E/0000-0002-8892-3373; BIDAUD, Isabelle/0000-0002-1812-1447; Mesirca, Pietro/0000-0002-9538-3096	Agence Nationale de Securite Sanitaire de l'alimentation, de l'environnement et du travail [ANSES EST-10-21]; Agence Nationale de la Recherche [ANR-2011-JCJC-052 Lacto-Clock]; Agence Nationale de la Recherche (Fondation pour la Recherche Medicale "FRM Team") [ANR-12-BSV1-0032 Peri-pulse]; Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation	Agence Nationale de Securite Sanitaire de l'alimentation, de l'environnement et du travail(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Agence Nationale de la Recherche (Fondation pour la Recherche Medicale "FRM Team")(French National Research Agency (ANR)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants from Agence Nationale de Securite Sanitaire de l'alimentation, de l'environnement et du travail (ANSES EST-10-21, to XB) and Agence Nationale de la Recherche (ANR-2011-JCJC-052 Lacto-Clock, to XB; Fondation pour la Recherche Medicale "FRM Team" and ANR-12-BSV1-0032 Peri-pulse, to PM). Research in KY lab was supported by the Japan Society for the Promotion of Science (JSPS) and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Best JD, 1999, J NEUROSCI, V19, P828; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Casey TM, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116137; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; De Bundel D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00152; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Fukuyama T, 2008, BIOMED RES-TOKYO, V29, P93, DOI 10.2220/biomedres.29.93; Gamo Y, 2013, J EXP BIOL, V216, P3751, DOI 10.1242/jeb.090308; Guillou A, 2015, ENDOCRINOLOGY, V156, P1924, DOI 10.1210/en.2014-1571; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; Hoshino K, 2006, ENDOCRINOLOGY, V147, P1916, DOI 10.1210/en.2005-1343; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hung HC, 2009, J BIOL RHYTHM, V24, P183, DOI 10.1177/0748730409333171; Ingenwerth M, 2016, NEUROENDOCRINOLOGY, V103, P605, DOI 10.1159/000441947; Kennaway DJ, 2004, REPROD FERT DEVELOP, V16, P801, DOI 10.1071/RD04023; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Koizumi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066021; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kudo T, 2015, ASN NEURO, V7, DOI 10.1177/1759091415610761; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Malek ZS, 2007, ENDOCRINOLOGY, V148, P5165, DOI 10.1210/en.2007-0526; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; Mieda M, 2016, CURR BIOL, V26, P2535, DOI 10.1016/j.cub.2016.07.022; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mohawk JA, 2005, AM J PHYSIOL-REG I, V288, pR221, DOI 10.1152/ajpregu.00272.2004; Moore RY, 1996, BEHAV BRAIN RES, V73, P125; MROSOVSKY N, 1987, NATURE, V330, P372, DOI 10.1038/330372a0; Mrosovsky N, 2001, CHRONOBIOL INT, V18, P613, DOI 10.1081/CBI-100106076; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Ono D, 2017, P NATL ACAD SCI USA, V114, pE3699, DOI 10.1073/pnas.1613374114; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Poirel VJ, 2003, NEUROSCIENCE, V120, P745, DOI 10.1016/S0306-4522(03)00344-0; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Ruby NF, 1999, J NEUROSCI, V19, P8630; Ruby NF, 2011, J BIOL RHYTHM, V26, P368, DOI 10.1177/0748730411411678; Sage D, 2004, J BIOL RHYTHM, V19, P144, DOI 10.1177/0748730403261894; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; TAKAMURE M, 1991, PHYSIOL BEHAV, V50, P443, DOI 10.1016/0031-9384(91)90092-3; Tsuchiya Y, 2015, GENES CELLS, V20, P992, DOI 10.1111/gtc.12305; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Windle RJ, 2013, ENDOCRINOLOGY, V154, P749, DOI 10.1210/en.2012-1779; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	60	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0187001	10.1371/journal.pone.0187001	http://dx.doi.org/10.1371/journal.pone.0187001			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059248	Green Published, Green Submitted, gold			2022-12-26	WOS:000413403000056
J	Alfaleh, MA; Howard, CB; Sedliarou, I; Jones, ML; Gudhka, R; Vanegas, N; Weiss, J; Suurbach, JH; de Bakker, CJ; Milne, MR; Rumballe, BA; MacDiarmid, JA; Brahmbhatt, H; Mahler, SM				Alfaleh, Mohamed A.; Howard, Christopher B.; Sedliarou, Ilya; Jones, Martina L.; Gudhka, Reema; Vanegas, Natasha; Weiss, Jocelyn; Suurbach, Julia H.; de Bakker, Christopher J.; Milne, Michael R.; Rumballe, Bree A.; MacDiarmid, Jennifer A.; Brahmbhatt, Himanshu; Mahler, Stephen M.			Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models	PLOS ONE			English	Article							MALIGNANT-PLEURAL-MESOTHELIOMA; PROGNOSTIC-SIGNIFICANCE; PHAGE DISPLAY; PHASE-III; CANCER; EXPRESSION; SURVIVAL; OVARIAN; IMMUNOHISTOCHEMISTRY; OVEREXPRESSION	Human malignant mesothelioma is a chemoresistant tumour that develops from mesothelial cells, commonly associated with asbestos exposure. Malignant mesothelioma incidence rates in European countries are still rising and Australia has one of the highest burdens of malignant mesothelioma on a population basis in the world. Therapy using systemic delivery of free cytotoxic agents is associated with many undesirable side effects due to non-selectivity, and is thus dose-limited which limits its therapeutic potential. Therefore, increasing the selectivity of anti-cancer agents has the potential to dramatically enhance drug efficacy and reduce toxicity. EnGeneIC Dream Vectors (EDV) are antibody-targeted nanocells which can be loaded with cytotoxic drugs and delivered to specific cancer cells via bispecific antibodies (BsAbs) which target the EDV and a cancer cell-specific receptor, simultaneously. BsAbs were designed to target doxorubicin-loaded EDVs to cancer cells via cell surface mesothelin (MSLN). Flow cytometry was used to investigate cell binding and induction of apoptosis, and confocal microscopy to visualize internalization. Mouse xenograft models were used to assess anti-tumour effects in vivo, followed by immunohistochemistry for ex vivo evaluation of proliferation and necrosis. BsAb-targeted, doxorubicin-loaded EDVs were able to bind to and internalize within mesothelioma cells in vitro via MSLN receptors and induce apoptosis. In mice xenografts, the BsAb-targeted, doxorubicin-loaded EDVs suppressed the tumour growth and also decreased cell proliferation. Thus, the use of MSLNspecific antibodies to deliver encapsulated doxorubicin can provide a novel and alternative modality for treatment of mesothelioma.	[Alfaleh, Mohamed A.; Howard, Christopher B.; Jones, Martina L.; de Bakker, Christopher J.; Mahler, Stephen M.] Univ Queensland, AIBN, Brisbane, Qld, Australia; [Alfaleh, Mohamed A.] King Abdulaziz Univ, Fac Phar, Jeddah, Saudi Arabia; [Howard, Christopher B.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Howard, Christopher B.; Jones, Martina L.; Mahler, Stephen M.] Univ Queensland, Australian Res Council, Training Ctr Biopharmaceut Innovat, Brisbane, Qld, Australia; [Gudhka, Reema; Vanegas, Natasha; Weiss, Jocelyn; Suurbach, Julia H.; MacDiarmid, Jennifer A.; Brahmbhatt, Himanshu] EnGeneIC Ltd, Canc Therapeut, Sydney, NSW, Australia; [Milne, Michael R.; Rumballe, Bree A.] Univ Queensland, QBI, Brisbane, Qld, Australia	University of Queensland; King Abdulaziz University; University of Queensland; University of Queensland; University of Queensland	Howard, CB (corresponding author), Univ Queensland, AIBN, Brisbane, Qld, Australia.; Howard, CB (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.; Howard, CB (corresponding author), Univ Queensland, Australian Res Council, Training Ctr Biopharmaceut Innovat, Brisbane, Qld, Australia.	c.howard2@uq.edu.au	Brahmbhatt, Himanshu/AAY-9997-2020; Howard, Christopher/D-3859-2017	Howard, Christopher/0000-0001-9797-8686; Alfaleh, Mohamed/0000-0003-3716-0019; Jones, Martina/0000-0002-5154-6017; mahler, stephen/0000-0003-2403-1437; de Bakker, Christopher/0000-0002-3232-6246	Australian Research Council through the ARC Linkage Project Scheme [LP110200126]; EnGeneIC; government of Saudi Arabia	Australian Research Council through the ARC Linkage Project Scheme; EnGeneIC; government of Saudi Arabia	This work was supported by the Australian Research Council through the ARC Linkage Project Scheme [Grant number: LP110200126], with EnGeneIC as the affiliated commercial partner. M.A.F. is academically sponsored by the government of Saudi Arabia to pursue PhD studies in the field of biotechnology. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Jamileh Nabizadeh, Dr. Helga Manthey, Dr. Barbara Rolfe (AIBN, University of Queensland) for their valuable recommendations and assistance with immunohistochemical staining, and Mr. Geoffrey Osborne (QBI, University of Queensland) for his advice regarding Annexin V assay. M.A.F. is academically sponsored by the government of Saudi Arabia to pursue PhD studies in the field of biotechnology. This work was performed in part at the Queensland nodes of the Australian National Fabrication Facility (ANFF), and the National Biologics Facility (NBF), facilities established under the National Collaborative Research Infrastructure Strategy to provide biologics, nano- and micro-fabrication facilities for Australian researchers. This project also utilised EnGeneIC Ltd facilities for binding assays and xenografts studies.	ANTMAN KH, 1993, CHEST, V103, pS373, DOI 10.1378/chest.103.4_Supplement.373S; BARRETT JC, 1994, ENVIRON HEALTH PERSP, V102, P19, DOI 10.2307/3432053; Bernards R, 2003, NATURE, V425, P247, DOI 10.1038/425247a; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Bharadwaj U, 2011, CARCINOGENESIS, V32, P1013, DOI 10.1093/carcin/bgr075; Carbone M, 2006, SEMIN DIAGN PATHOL, V23, P56, DOI 10.1053/j.semdp.2006.08.002; Chang MC, 2009, BIOCHEM J, V424, P449, DOI 10.1042/BJ20082196; Cheng WF, 2009, BRIT J CANCER, V100, P1144, DOI 10.1038/sj.bjc.6604964; Chowdhury PS, 1999, J IMMUNOL METHODS, V231, P83, DOI 10.1016/S0022-1759(99)00142-8; Chowdhury PS, 1998, P NATL ACAD SCI USA, V95, P669, DOI 10.1073/pnas.95.2.669; de Graaf-Strukowska L, 1999, INT J RADIAT ONCOL, V43, P511, DOI 10.1016/S0360-3016(98)00409-X; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Enever C, 2009, CURR OPIN BIOTECH, V20, P405, DOI 10.1016/j.copbio.2009.07.002; Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9; Ghanim B, 2015, BRIT J CANCER, V112, P783, DOI 10.1038/bjc.2015.9; Glover AR, 2015, ONCOTARGET, V6, P36675, DOI 10.18632/oncotarget.5383; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hassan Raffit, 2007, Cancer Immun, V7, P20; Hassan R, 2007, CLIN CANCER RES, V13, P7166, DOI 10.1158/1078-0432.CCR-07-1592; Hassan R, 2014, CLIN CANCER RES, V20, P5927, DOI 10.1158/1078-0432.CCR-14-0804; Hasteh F, 2010, CANCER CYTOPATHOL, V118, P90, DOI 10.1002/cncy.20071; Hazarika M, 2004, ONCOLOGIST, V9, P482, DOI 10.1634/theoncologist.9-5-482; Heintz NH, 2010, AM J RESP CELL MOL, V42, P133, DOI 10.1165/rcmb.2009-0206TR; Ho M, 2011, INT J CANCER, V128, P2020, DOI 10.1002/ijc.25557; Husain AN, 2013, ARCH PATHOL LAB MED, V137, P647, DOI 10.5858/arpa.2012-0214-OA; Karagiannis ED, 2009, NAT BIOTECHNOL, V27, P620, DOI 10.1038/nbt0709-620; Kelly RJ, 2011, LUNG CANCER, V73, P256, DOI 10.1016/j.lungcan.2011.04.014; Klabatsa A, 2006, LUNG CANCER-J IASLC, V51, P53, DOI 10.1016/j.lungcan.2005.07.010; Kobayashi M, 2012, EXP THER MED, V3, P952, DOI 10.3892/etm.2012.511; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; MacDiarmid JA, 2007, CELL CYCLE, V6, P2099, DOI 10.4161/cc.6.17.4648; MacDiarmid JA, 2007, CANCER CELL, V11, P431, DOI 10.1016/j.ccr.2007.03.012; MacDiarmid JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151832; MacDiarmid JA, 2009, NAT BIOTECHNOL, V27, P643, DOI 10.1038/nbt.1547; Monnier PP, 2013, ANTIBODIES, V2, P193, DOI 10.3390/antib2020193; Mossman BT, 2013, AM J PATHOL, V182, P1065, DOI 10.1016/j.ajpath.2012.12.028; Muers MF, 2008, LANCET, V371, P1685, DOI 10.1016/S0140-6736(08)60727-8; Park JW, 2002, BREAST CANCER RES, V4, P93; Paton AW, 2012, TRENDS MOL MED, V18, P417, DOI 10.1016/j.molmed.2012.05.006; Pillai K, 2015, AM J CLIN ONCOL-CANC, V38, P388, DOI 10.1097/COC.0b013e3182a0e867; Pillai K, 2013, AM J CANCER RES, V3, P411; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Reid G, 2013, ANN ONCOL, V24, P3128, DOI 10.1093/annonc/mdt412; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Scales SJ, 2014, MOL CANCER THER, V13, P2630, DOI 10.1158/1535-7163.MCT-14-0487-T; Solomon BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144559; STUMPHIUS J, 1968, Annals of Occupational Hygiene, V11, P283; Tada Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/572609; Takahashi K, 2016, J OCCUP HEALTH, V58, P220, DOI 10.1539/joh.16-2002-ST; Tang ZW, 2013, ANTI-CANCER AGENT ME, V13, P276, DOI 10.2174/1871520611313020014; Taylor K, 2015, MABS-AUSTIN, V7, P53, DOI 10.4161/19420862.2014.985952; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; van Zandwijk N, 2013, J THORAC DIS, V5, pE254, DOI 10.3978/j.issn.2072-1439.2013.11.28; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Whittle JR, 2015, J CLIN NEUROSCI, V22, P1889, DOI 10.1016/j.jocn.2015.06.005; Williams M, 2015, ONCOTARGET, V6, P23480, DOI 10.18632/oncotarget.4346	62	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186137	10.1371/journal.pone.0186137	http://dx.doi.org/10.1371/journal.pone.0186137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059207	Green Published, Green Submitted, gold			2022-12-26	WOS:000413403000015
J	Rashno, A; Nazari, B; Koozekanani, DD; Drayna, PM; Sadri, S; Rabbani, H; Parhi, KK				Rashno, Abdolreza; Nazari, Behzad; Koozekanani, Dara D.; Drayna, Paul M.; Sadri, Saeed; Rabbani, Hossein; Parhi, Keshab K.			Fully-automated segmentation of fluid regions in exudative age-related macular degeneration subjects: Kernel graph cut in neutrosophic domain	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; IMAGE SEGMENTATION; OCT IMAGES; LAYER SEGMENTATION; SUBRETINAL FLUID; EDEMA; SET; ALGORITHMS; RETINA	A fully-automated method based on graph shortest path, graph cut and neutrosophic (NS) sets is presented for fluid segmentation in OCT volumes for exudative age related macular degeneration (EAMD) subjects. The proposed method includes three main steps: 1) The inner limiting membrane (ILM) and the retinal pigment epithelium (RPE) layers are segmented using proposed methods based on graph shortest path in NS domain. A flattened RPE boundary is calculated such that all three types of fluid regions, intra-retinal, sub-retinal and sub-RPE, are located above it. 2) Seed points for fluid (object) and tissue (background) are initialized for graph cut by the proposed automated method. 3) A new cost function is proposed in kernel space, and is minimized with max-flow/min-cut algorithms, leading to a binary segmentation. Important properties of the proposed steps are proven and quantitative performance of each step is analyzed separately. The proposed method is evaluated using a publicly available dataset referred as Optima and a local dataset from the UMN clinic. For fluid segmentation in 2D individual slices, the proposed method outperforms the previously proposed methods by 18%, 21% with respect to the dice coefficient and sensitivity, respectively, on the Optima dataset, and by 16%, 11% and 12% with respect to the dice coefficient, sensitivity and precision, respectively, on the local UMN dataset. Finally, for 3D fluid volume segmentation, the proposed method achieves true positive rate (TPR) and false positive rate (FPR) of 90% and 0.74%, respectively, with a correlation of 95% between automated and expert manual segmentations using linear regression analysis.	[Rashno, Abdolreza; Nazari, Behzad; Sadri, Saeed] Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan, Iran; [Rashno, Abdolreza; Parhi, Keshab K.] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN USA; [Koozekanani, Dara D.; Drayna, Paul M.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN USA; [Rabbani, Hossein] Isfahan Univ Med Sci, Dept Biomed Engn, Med Image & Signal Proc Res Ctr, Esfahan, Iran	Isfahan University of Technology; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Isfahan University Medical Science	Parhi, KK (corresponding author), Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN USA.	parhi@umn.edu	Parhi, Keshab K./AAQ-1793-2021; Rabbani, Hossein/H-7515-2014; Rabbani, Hossein/O-4987-2019; Rashno, Abdolreza/ABY-2305-2022	Rabbani, Hossein/0000-0002-0551-3636; Rabbani, Hossein/0000-0002-0551-3636; Rashno, Abdolreza/0000-0003-0014-5050	Minnesota Lions Foundation [UMF14601]; Research to Prevent Blindness	Minnesota Lions Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This research was supported in part by the Minnesota Lions Foundation under grant UMF14601 and by the Research to Prevent Blindness.	Behbehani R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172120; Ben Salah M, 2011, IEEE T IMAGE PROCESS, V20, P545, DOI 10.1109/TIP.2010.2066982; Bogunovic H, 2015, P OPHTHALMIC MED IMA; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Boykov YY, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P105, DOI 10.1109/ICCV.2001.937505; Chen XJ, 2012, IEEE T MED IMAGING, V31, P1521, DOI 10.1109/TMI.2012.2191302; Chiu SJ, 2015, BIOMED OPT EXPRESS, V6, P1172, DOI 10.1364/BOE.6.001172; Chiu SJ, 2012, BIOMED OPT EXPRESS, V3, P1127, DOI 10.1364/BOE.3.001127; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Coscas G, 2010, OPTICAL COHERENCE TOMOGRAPHY IN AGE-RELATED MACULAR DEGENERATION: OCT IN AMD, SECOND EDITION, P1; Doleisi M, 2010, ANAL BIOMEDICAL SIGN; Esmaeili Mahdad, 2016, J Med Signals Sens, V6, P166; Fernandez DC, 2005, IEEE T MED IMAGING, V24, P929, DOI 10.1109/TMI.2005.848655; Gonzalez A, 2013, COMP MED SY, P397, DOI 10.1109/CBMS.2013.6627825; Guo YH, 2015, PATTERN RECOGN, V48, P2710, DOI 10.1016/j.patcog.2015.02.018; Guo YH, 2014, COMPUT ELECTR ENG, V40, P3, DOI 10.1016/j.compeleceng.2014.04.020; Guo YH, 2009, PATTERN RECOGN, V42, P587, DOI 10.1016/j.patcog.2008.10.002; Heshmati A, 2016, IET IMAGE PROCESS, V10, P464, DOI 10.1049/iet-ipr.2015.0738; Huang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082922; Kafieh R, 2013, MED IMAGE ANAL, V17, P907, DOI 10.1016/j.media.2013.05.006; Keane PA, 2012, SURV OPHTHALMOL, V57, P389, DOI 10.1016/j.survophthal.2012.01.006; Kohler J, 2017, INVEST OPHTH VIS SCI, V58; Lang A, 2015, BIOMED OPT EXPRESS, V6, P155, DOI 10.1364/BOE.6.000155; Lin D, 2016, PLOS ONE, V11; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Parhi KK, 2017, INVEST OPHTH VIS SCI, V58; Peng B, 2013, PATTERN RECOGN, V46, P1020, DOI 10.1016/j.patcog.2012.09.015; Pilch M, 2013, INVEST OPHTH VIS SCI, V54, P4385, DOI 10.1167/iovs.12-11396; Quellec G, 2010, IEEE T MED IMAGING, V29, P1321, DOI 10.1109/TMI.2010.2047023; Rashno A, 2017, IEEE T BIOMEDICAL EN; Rashno A, 2017, INVEST OPHTH VIS SCI, V58; Rashno A, 2017, 2017 3RD INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION AND IMAGE ANALYSIS (IPRIA), P50, DOI 10.1109/PRIA.2017.7983063; Roychowdhury S, 2013, IEEE ENG MED BIO, P1426, DOI 10.1109/EMBC.2013.6609778; Sengur A, 2011, COMPUT VIS IMAGE UND, V115, P1134, DOI 10.1016/j.cviu.2011.04.001; Shan J, 2012, MED PHYS, V39, P5669, DOI 10.1118/1.4747271; Sisternes L, 2015, MACHINE LEARNING APR; Smarandache F, 2005, NEUTROSOPHY NEUTROSO; Swingle EK, 2014, SPIE MED IMAGING; Swingle EK, 2015, SPIE MED IMAGING; Terry T, 2016, PLOS ONE, V11; Tian J., 2015, PLOS ONE, V10; Venhuizena FG, 2015, VENDOR INDEPENDENT C; Wang J, 2016, BIOMED OPT EXPRESS, V7, P1577, DOI 10.1364/BOE.7.001577; Wang T, 2016, INFORM SCIENCES, V358, P92, DOI 10.1016/j.ins.2016.04.017; Wieclawek W, 2015, 2015 22ND INTERNATIONAL CONFERENCE MIXED DESIGN OF INTEGRATED CIRCUITS & SYSTEMS (MIXDES), P79, DOI 10.1109/MIXDES.2015.7208485; Wilkins GR, 2012, IEEE T BIO-MED ENG, V59, P1109, DOI 10.1109/TBME.2012.2184759; Xu XY, 2015, IEEE T MED IMAGING, V34, P1616, DOI 10.1109/TMI.2015.2408632; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Zhang L, 2015, I S BIOMED IMAGING, P1494, DOI 10.1109/ISBI.2015.7164160; Zhang M, 2010, SIGNAL PROCESS, V90, P1510, DOI 10.1016/j.sigpro.2009.10.021; Zheng YL, 2013, AM J OPHTHALMOL, V155, P277, DOI 10.1016/j.ajo.2012.07.030	52	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186949	10.1371/journal.pone.0186949	http://dx.doi.org/10.1371/journal.pone.0186949			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059257	Green Published, gold			2022-12-26	WOS:000413403000053
J	Meyers-Wallen, VN; Boyko, AR; Danko, CG; Grenier, JK; Mezey, JG; Hayward, JJ; Shannon, LM; Gao, C; Shafquat, A; Rice, EJ; Pujar, S; Eggers, S; Ohnesorg, T; Sinclair, AH				Meyers-Wallen, Vicki N.; Boyko, Adam R.; Danko, Charles G.; Grenier, Jennifer K.; Mezey, Jason G.; Hayward, Jessica J.; Shannon, Laura M.; Gao, Chuan; Shafquat, Afrah; Rice, Edward J.; Pujar, Shashikant; Eggers, Stefanie; Ohnesorg, Thomas; Sinclair, Andrew H.			XX Disorder of Sex Development is associated with an insertion on chromosome 9 and downregulation of RSPO1 in dogs (Canis lupus familiaris)	PLOS ONE			English	Article							MULLERIAN-INHIBITING SUBSTANCE; PARTURITION DATE PREDICTION; COPY NUMBER VARIATION; COCKER-SPANIEL DOG; DNA METHYLATION; TRUE HERMAPHRODITES; TESTICULAR DISORDER; REGION UPSTREAM; POPULATION-STRUCTURE; OVARIAN DEVELOPMENT	Remarkable progress has been achieved in understanding the mechanisms controlling sex determination, yet the cause for many Disorders of Sex Development (DSD) remains unknown. Of particular interest is a rare XX DSD subtype in which individuals are negative for SRY, the testis determining factor on the Y chromosome, yet develop testes or ovotestes, and both of these phenotypes occur in the same family. This is a naturally occurring disorder in humans (Homo sapiens) and dogs (C. familiaris). Phenotypes in the canine XX DSD model are strikingly similar to those of the human XX DSD subtype. The purposes of this study were to identify 1) a variant associated with XX DSD in the canine model and 2) gene expression alterations in canine embryonic gonads that could be informative to causation. Using a genome wide association study (GWAS) and whole genome sequencing (WGS), we identified a variant on C. familiaris autosome 9 (CFA9) that is associated with XX DSD in the canine model and in affected purebred dogs. This is the first marker identified for inherited canine XX DSD. It lies upstream of SOX9 within the canine ortholog for the human disorder, which resides on 17q24. Inheritance of this variant indicates that XX DSD is a complex trait in which breed genetic background affects penetrance. Furthermore, the homozygous variant genotype is associated with embryonic lethality in at least one breed. Our analysis of gene expression studies (RNA-seq and PRO-seq) in embryonic gonads at risk of XX DSD from the canine model identified significant RSPO1 downregulation in comparison to XX controls, without significant upregulation of SOX9 or other known testis pathway genes. Based on these data, a novel mechanism is proposed in which molecular lesions acting upstream of RSPO1 induce epigenomic gonadal mosaicism.	[Meyers-Wallen, Vicki N.; Danko, Charles G.; Rice, Edward J.; Pujar, Shashikant] Cornell Univ, Baker Inst Anim Hlth, Ithaca, NY 14850 USA; [Meyers-Wallen, Vicki N.; Boyko, Adam R.; Danko, Charles G.; Grenier, Jennifer K.; Hayward, Jessica J.; Shannon, Laura M.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA; [Mezey, Jason G.; Gao, Chuan; Shafquat, Afrah] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Mezey, Jason G.] Weill Cornell Med Coll, Dept Genet Med, New York, NY USA; [Eggers, Stefanie; Ohnesorg, Thomas; Sinclair, Andrew H.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Sinclair, Andrew H.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Shannon, Laura M.] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Gao, Chuan] PAREXEL Int, Durham, NC USA; [Pujar, Shashikant] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA	Cornell University; Cornell University; Cornell University; Cornell University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; Parexel International; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Meyers-Wallen, VN (corresponding author), Cornell Univ, Baker Inst Anim Hlth, Ithaca, NY 14850 USA.; Meyers-Wallen, VN (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	vnm1@cornell.edu	Hayward, Jessica/AGW-0493-2022; Sinclair, Andrew H/A-3598-2010; Fiumefreddo, Andrea/T-2977-2019	Sinclair, Andrew H/0000-0003-2741-7992; Pujar, Shashikant/0000-0001-7132-5513; Danko, Charles/0000-0002-1999-7125; Meyers-Wallen, Vicki/0000-0003-0405-3743; Shafquat, Afrah/0000-0002-2572-5521	National Institutes of Child Health and Human Development [R03HD077119, R01HD19393]; NSF (Cornell University CU-ADVANCE) [HRD-0547373a]; National Institutes of Health General Medicine (G. Acland, Cornell Veterinary BioBank) [5R24 GM082910]; American Kennel Club Canine Health Foundation [73552/A001]; Herndon Canine Disease Research fund; College of Veterinary Medicine; Baker Institute for Animal Health, Cornell University, Ithaca, NY USA; National Institutes of Health [RR02512, GM32592]; NIH [NIH 1S100D010693-01]; National Health and Medical Research Council of Australia	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSF (Cornell University CU-ADVANCE); National Institutes of Health General Medicine (G. Acland, Cornell Veterinary BioBank); American Kennel Club Canine Health Foundation; Herndon Canine Disease Research fund; College of Veterinary Medicine; Baker Institute for Animal Health, Cornell University, Ithaca, NY USA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Institutes of Child Health and Human Development R03HD077119 (M-W) and R01HD19393 (M-W) www.nichd.nih.gov, NSF HRD-0547373a (Cornell University CU-ADVANCE Accel grant, M-W) www.nsf.gov, National Institutes of Health General Medicine 5R24 GM082910 (G. Acland, Cornell Veterinary BioBank, M-W) www.nigms.nih.gov, the American Kennel Club Canine Health Foundation (#73552/A001, M-W, AB) www.akc.org, the Herndon Canine Disease Research fund (M-W), and the Collaborative Research Program, College of Veterinary Medicine (M-W), and the Baker Institute for Animal Health Pursuit of Excellence Fund (M-W), Cornell University, Ithaca, NY USA. Support for establishment of the canine XX DSD model was provided in part by National Institutes of Health Research Resources RR02512 and General Medicine GM32592 (PI: D.F. Patterson, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA). Collection of RNA-seq data at the Cornell University Biotechnology Resource Center (BRC) was enabled by an NIH grant (NIH 1S100D010693-01) for the Illumina HiSeq 2500. Andrew Sinclair was funded by the National Health and Medical Research Council of Australia www.nhmrc.gov.au. Chan Gao was not employed by PAREXEL International during the period in which he contributed to this study. PAREXEL International had no role in funding, study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some funders provided support in the form of salaries for authors [M-W, AHS], but none had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the views of the American Kennel Club Canine Health Foundation.	Abou-Elhamd A, 2015, DEV BIOL, V402, P61, DOI 10.1016/j.ydbio.2015.02.024; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Baetens D, 2017, CLIN GENET, V91, P163, DOI 10.1111/cge.12911; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bashamboo A, 2015, SEMIN CELL DEV BIOL, V45, P77, DOI 10.1016/j.semcdb.2015.10.030; Benko S, 2011, J MED GENET, V48, P825, DOI 10.1136/jmedgenet-2011-100255; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Biason-Lauber A, 2015, SEMIN CELL DEV BIOL, V45, P59, DOI 10.1016/j.semcdb.2015.10.021; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; Castelhano MGP, 2009, JAVMA-J AM VET MED A, V234, P75, DOI 10.2460/javma.234.1.75; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chen H, 2016, AM J HUM GENET, V98, P653, DOI 10.1016/j.ajhg.2016.02.012; CONCANNON PW, 1975, BIOL REPROD, V13, P112, DOI 10.1095/biolreprod13.1.112; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; Danko CG, 2015, NAT METHODS, V12, P433, DOI [10.1038/NMETH.3329, 10.1038/nmeth.3329]; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dixon WJ, 1969, INTRO STATISTICAL AN, P237; Draht MXG, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0211-8; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Eggers S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1105-y; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; Fedele M, 2000, J BIOL CHEM, V275, P7894, DOI 10.1074/jbc.275.11.7894; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Ghosh S, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12228; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361; Hoffman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075707; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hughes IA, 2008, BEST PRACT RES CL EN, V22, P119, DOI 10.1016/j.beem.2007.11.001; Hyon C, 2015, AM J MED GENET A, V167, P1851, DOI 10.1002/ajmg.a.37101; Jarrah N, 2000, EUR J PEDIATR, V159, P912, DOI 10.1007/PL00008369; Joshi RS, 2016, AM J HUM GENET, V99, P555, DOI 10.1016/j.ajhg.2016.06.032; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; KASDAN R, 1973, NEW ENGL J MED, V288, P539, DOI 10.1056/NEJM197303152881102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Y, 2007, THERIOGENOLOGY, V68, P1177, DOI 10.1016/j.theriogenology.2007.08.018; Knarston I, 2016, CLIN SCI, V130, P421, DOI 10.1042/CS20150579; KUHNLE U, 1993, HUM GENET, V92, P571, DOI 10.1007/BF00420941; Kutzler MA, 2003, THERIOGENOLOGY, V60, P1309, DOI 10.1016/S0093-691X(03)00146-8; Kutzler MA, 2003, THERIOGENOLOGY, V60, P1187, DOI 10.1016/S0093-691X(03)00109-2; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lavery R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003170; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lybaek H, 2014, EPIGENETICS-US, V9, P416, DOI 10.4161/epi.27474; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Marcinkowska-Swojak M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14696; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Meyers-Wallen VN, 2012, SEX DEV, V6, P46, DOI 10.1159/000332740; Meyers-Wallen VN, 1999, MOL REPROD DEV, V53, P266, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;266::AID-MRD2&gt;3.0.CO;2-6; Meyers-Wallen VN, 2005, MOL REPROD DEV, V70, P383, DOI 10.1002/mrd.20217; Meyers-Wallen VN, 2003, MOL REPROD DEV, V65, P373, DOI 10.1002/mrd.10317; MEYERSWALLEN VN, 1987, BIOL REPROD, V37, P1015, DOI 10.1095/biolreprod37.4.1015; MEYERSWALLEN VN, 1988, HUM GENET, V80, P23, DOI 10.1007/BF00451450; MEYERSWALLEN VN, 1994, MOL REPROD DEV, V39, P1, DOI 10.1002/mrd.1080390102; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Munger SC, 2012, WIRES SYST BIOL MED, V4, P401, DOI 10.1002/wsbm.1172; Nagashima JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143930; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Ohnesorg T, 2017, CLIN GENET, V92, P347, DOI 10.1111/cge.12976; Ohnesorg T, 2016, SEX DEV, V10, P59, DOI 10.1159/000445398; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Pasterski V, 2010, BEST PRACT RES CL EN, V24, P187, DOI 10.1016/j.beem.2009.11.004; Pujar S, 2007, J HERED, V98, P438, DOI 10.1093/jhered/esm028; Ramos ES, 1996, HUM GENET, V97, P596, DOI 10.1007/BF02281867; Rossi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101244; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seeherunvong T, 2012, J PEDIATR ENDOCR MET, V25, P121, DOI 10.1515/JPEM.2011.370; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SELDEN JR, 1984, HUM GENET, V67, P62, DOI 10.1007/BF00270560; Shi GX, 2016, PROG BIOPHYS MOL BIO, V122, P93, DOI 10.1016/j.pbiomolbio.2016.05.012; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SKORDIS NA, 1987, J PEDIATR-US, V110, P244, DOI 10.1016/S0022-3476(87)80162-2; Slaney SF, 1998, J MED GENET, V35, P17, DOI 10.1136/jmg.35.1.17; Sripathy S, 2011, MOL CELL BIOL, V31, P2920, DOI 10.1128/MCB.05431-11; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Szczerbal I, 2016, SEX DEV, V10, P74, DOI 10.1159/000445464; Temel SG, 2007, SEX DEV, V1, P24, DOI 10.1159/000096236; Tomaselli S, 2008, HUM MUTAT, V29, P220, DOI 10.1002/humu.20665; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vetro A, 2015, EUR J HUM GENET, V23, P1025, DOI 10.1038/ejhg.2014.237; Vetro A, 2011, J MED GENET, V48, P710, DOI 10.1136/jmedgenet-2011-100036; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Wu XF, 2009, J ANDROL, V30, P46, DOI 10.2164/jandrol.108.005736; Zhang Y, 2009, J CELL PHYSIOL, V218, P75, DOI 10.1002/jcp.21569; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	98	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186331	10.1371/journal.pone.0186331	http://dx.doi.org/10.1371/journal.pone.0186331			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053721	gold, Green Published			2022-12-26	WOS:000413315100017
J	Cao, Q; Karthikeyan, A; Dheen, ST; Kaur, C; Ling, EA				Cao, Qiong; Karthikeyan, Aparna; Dheen, S. Thameem; Kaur, Charanjit; Ling, Eng-Ang			Production of proinflammatory mediators in activated microglia is synergistically regulated by Notch-1, glycogen synthase kinase (GSK-3 beta) and NF-kappa B/p65 signalling	PLOS ONE			English	Article							MURINE BV-2 CELLS; CEREBRAL-ISCHEMIA; AMEBOID MICROGLIA; EXPRESSION; BRAIN; INFLAMMATION; RESPONSES; PATHWAYS; RECEPTOR; LITHIUM	Microglia activation and associated inflammatory response are involved in the pathogenesis of different neurodegenerative diseases. We have reported that Notch-1 and NF-kappa B/p65 signalling pathways operate in synergy in regulating the production of proinflammatory mediators in activated microglia. In the latter, there is also evidence by others that glycogen synthase kinase 3 beta (GSK-3 beta) mediates the release of proinflammatory cytokines but the interrelationships between the three signalling pathways have not been fully clarified. This is an important issue as activated microglia are potential therapeutic target for amelioration of microglia mediated neuroinflammation. Here we show that blocking of Notch-1 with N-[(3,5-Difluorophenyl) acetyl]-L-alanyl-2-phenylglycine-1,1-dimethylethyl ester (DAPT) in LPS activated BV-2 microglia not only suppressed Notch intracellular domain (NICD) and Hes-1 protein expression, but also that of GSK-3 beta. Conversely, blocking of the latter with lithium chloride (LiCl) decreased NICD expression in a dose-dependent manner; moreover, Hes-1 immunofluorescence was attenuated. Along with this, the protein expression level of p-GSK-3 beta and p-AKT protein expression was significantly increased. Furthermore, DAPT and LiCl decreased production of IL-1 beta, TNF-alpha, IL-6, iNOS, Cox2 and MCP-1; however, IL-10 expression was increased notably in LiCl treated cells. The effects of DAPT and LiCl on changes of the above-mentioned biomarkers were confirmed by immunofluorescence in both BV-2 and primary microglia. Additionally, NF-kappa B/p65 immunofluorescence was attenuated by DAPT and LiCl; as opposed to this, I.Ba protein expression was increased. Taken together, it is suggested that Notch-1, NF-kappa B/p65 and GSK-3 beta operate in synergy to inhibit microglia activation. This may be effected via increased expression of phospho-GSK-3 beta (p-GSK-3 beta), phospho-protein kinase B (PKB) (p-AKT) and I.Ba. It is concluded that the three signalling pathways are functionally interlinked in regulating microglia activation.	[Cao, Qiong; Karthikeyan, Aparna; Dheen, S. Thameem; Kaur, Charanjit; Ling, Eng-Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore	National University of Singapore	Ling, EA (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore.	antlea@nus.edu.sg	Dheen, S. Thameem/AAU-8627-2020	Dheen, S. Thameem/0000-0001-9600-6789	National University of Singapore [R-181-000-140-592]	National University of Singapore(National University of Singapore)	This study was supported by grant No. R-181-000-140-592 (E-A L) National University of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grant No. R-181-000-140-592 (E-A L) National University of Singapore.	Ajmone-Cat MA, 2016, BRAIN BEHAV IMMUN, V55, P225, DOI 10.1016/j.bbi.2015.11.012; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Cao Q, 2008, GLIA, V56, P1224, DOI 10.1002/glia.20692; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Gentle ME, 2012, J IMMUNOL, V189, P1274, DOI 10.4049/jimmunol.1103102; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Karthikeyan A, 2016, CURR MED CHEM, V23, P3528, DOI 10.2174/0929867323666160814001040; Kaur C, 2017, J NEUROPATH EXP NEUR, V76, P736, DOI 10.1093/jnen/nlx056; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Koistinaho J, 2011, INT J ALZHEIMERS DIS, V2011; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maixner DW, 2014, J PHARM PHARM LOS AN, V1; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Shahal B, 1996, BIOL PSYCHIAT, V40, P1181, DOI 10.1016/S0006-3223(96)00307-1; Stambolic V, 1997, CURR BIOL, V7, pR196; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Yao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078439; Yao LL, 2013, CNS NEUROL DISORD-DR, V12, P807, DOI 10.2174/18715273113126660172; Yuan Y, 2016, NEUROMOL MED, V18, P264, DOI 10.1007/s12017-016-8394-x; Zeng WX, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0351-6; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Ziemka-Nalecz M, 2017, J NEUROPATH EXP NEUR, V76, P644, DOI 10.1093/jnen/nlx046	32	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186764	10.1371/journal.pone.0186764	http://dx.doi.org/10.1371/journal.pone.0186764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049420	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900108
J	Salines, M; Andraud, M; Rose, N				Salines, Morgane; Andraud, Mathieu; Rose, Nicolas			Pig movements in France: Designing network models fitting the transmission route of pathogens	PLOS ONE			English	Article							TRADE PATTERNS; ANIMAL MOVEMENTS; INFECTIOUS-DISEASES; CATTLE; SPREAD; DYNAMICS; SURVEILLANCE; SHIPMENTS; EPIDEMIC; CONTACTS	Pathogen spread between farms results from interaction between the epidemiological characteristics of infectious agents, such as transmission route, and the contact structure between holdings. The objective of our study was to design network models of pig movements matching with epidemiological features of pathogens. Our first model represents the transmission of infectious diseases between farms only through the introduction of animals to holdings (Animal Introduction Model AIM), whereas the second one also accounts for pathogen spread through intermediate transit of trucks through farms even without any animal unloading (i.e. indirect transmission - Transit Model TM). To take the pyramidal organisation of pig production into consideration, these networks were studied at three different scales: the whole network and two subnetworks containing only breeding or production farms. The two models were applied to pig movement data recorded in France from June 2012 to December 2014. For each type of model, we calculated network descriptive statistics, looked for weakly/strongly connected components (WCCs/SCCs) and communities, and analysed temporal patterns. Whatever the model, the network exhibited scale-free and small-world topologies. Differences in centrality values between the two models showed that nucleus, multiplication and post-weaning farms played a key role in the spread of diseases transmitted exclusively by the introduction of infected animals, whereas farrowing and farrow-to-finish herds appeared more vulnerable to the introduction of infectious diseases through indirect contacts. The second network was less fragmented than the first one, a giant SCC being detected. The topology of network communities also varied with modelling assumptions: in the first approach, a huge geographically dispersed community was found, whereas the second model highlighted several small geographically clustered communities. These results underline the relevance of developing network models corresponding to pathogen features (e.g. their transmission route), and the need to target specific types of holdings/areas for surveillance depending on the epidemiological context.	[Salines, Morgane; Andraud, Mathieu; Rose, Nicolas] ANSES Ploufragan Plouzane Lab, Ploufragan, France; [Salines, Morgane; Andraud, Mathieu; Rose, Nicolas] Univ Bretagne Loire, Rennes, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Salines, M (corresponding author), ANSES Ploufragan Plouzane Lab, Ploufragan, France.; Salines, M (corresponding author), Univ Bretagne Loire, Rennes, France.	morgane.salines@anses.fr	Andraud, Mathieu/AAD-5844-2022	Andraud, Mathieu/0000-0003-2891-2901	French Ministry for Agriculture, Food and Forestry; INAPORC; French Ministry for Agriculture (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret); Interprofession Nationale Porcine (INAPORC)	French Ministry for Agriculture, Food and Forestry; INAPORC; French Ministry for Agriculture (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret); Interprofession Nationale Porcine (INAPORC)	The authors are grateful to the French Ministry for Agriculture, Food and Forestry and to INAPORC for their financial support. They thank members of BDporc for making holdings and animal movement data available. They also thank Dr Benoit Durand for his valuable help and advice.; This work was supported by (1) French Ministry for Agriculture (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret), http://agriculture.gouv.fr/, and (2) Interprofession Nationale Porcine (INAPORC), http://www.leporc.com/decouvrir/inaporc.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; Brennan ML, 2008, PREV VET MED, V84, P242, DOI 10.1016/j.prevetmed.2007.12.009; Brioudes A, 2015, TRANSBOUND EMERG DIS; Buttner K, 2015, TRANSBOUND EMERG DIS, V62, P188, DOI 10.1111/tbed.12106; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; Christley RM, 2003, EQUINE VET J, V35, P586, DOI 10.2746/042516403775467298; Ciccolini M, 2012, EPIDEMICS-NETH, V4, P171, DOI 10.1016/j.epidem.2012.09.001; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dorjee S, 2013, PREV VET MED, V112, P118, DOI 10.1016/j.prevetmed.2013.06.008; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Frossling J, 2012, PREV VET MED, V105, P202, DOI 10.1016/j.prevetmed.2011.12.011; Guinat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28429; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lee K, 2017, PREV VET MED, V138, P113, DOI 10.1016/j.prevetmed.2017.02.001; Lichoti JK, 2016, PREV VET MED, V126, P1, DOI 10.1016/j.prevetmed.2016.01.019; Lindstrom T, 2012, J R SOC INTERFACE, V9, P1287, DOI 10.1098/rsif.2011.0625; Lindstrom T, 2010, PREV VET MED, V95, P23, DOI 10.1016/j.prevetmed.2010.03.002; Martinez-Lopez B, 2009, PREV VET MED, V91, P29, DOI 10.1016/j.prevetmed.2009.05.007; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2002, COMPUT PHYS COMMUN, V147, P40, DOI 10.1016/S0010-4655(02)00201-1; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Rautureau S, 2011, TRANSBOUND EMERG DIS, V58, P110, DOI 10.1111/j.1865-1682.2010.01187.x; Relun A, 2015, PREDICTION PIG TRADE; Relun A, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00004; Ribbens S, 2009, PREV VET MED, V88, P57, DOI 10.1016/j.prevetmed.2008.08.002; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Shirley MDF, 2005, EPIDEMIOL INFECT, V133, P1023, DOI 10.1017/S095026880500453X; Thakur KK, 2016, TRANSBOUND EMERG DIS, V63, pE14, DOI 10.1111/tbed.12225; Valdano E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004152; Vernon MC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-31; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; Wasserman S., SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	43	27	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185858	10.1371/journal.pone.0185858	http://dx.doi.org/10.1371/journal.pone.0185858			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049305	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900025
J	Saito, S; Zhuang, Y; Shan, B; Danchuk, S; Luo, FY; Korfei, M; Guenther, A; Lasky, JA				Saito, Shigeki; Zhuang, Yan; Shan, Bin; Danchuk, Svitlana; Luo, Fayong; Korfei, Martina; Guenther, Andreas; Lasky, Joseph A.			Tubastatin ameliorates pulmonary fibrosis by targeting the TGF beta-PI3K-Akt pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE DEACETYLASE INHIBITION; MYOFIBROBLAST DIFFERENTIATION; TUBULIN ACETYLATION; LUNG FIBROSIS; IN-VITRO; TGF-BETA; DISEASE; EXPRESSION; AUTOPHAGY	Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease. Histone deacetylase 6 (HDAC6) alters function and fate of various proteins via deacetylation of lysine residues, and is implicated in TGF-beta 1-induced EMT (epithelial-mesenchymal transition). However, the role of HDAC6 in pulmonary fibrosis is unknown. Methods HDAC6 expression in IPF and control lungs was assessed by quantitative real-time PCR (qRT-PCR) and immunoblots. Lung fibroblasts were treated with TGF-beta 1 +/- HDAC6 inhibitors (Tubacin, Tubastatin, ACY1215, or MC1568), and fibrotic markers such as type I collagen were assessed using qRT-PCR and immunoblots. Mice were treated with bleomycin (oropharyngeal aspiration; single dose) +/- Tubastatin (intraperitoneally injection; daily for 21 days), and lung collagen expression was gauged using immunoblots and trichrome staining. In a separate experiment, HDAC6 wild-type (WT) and knockout (KO) mice were administered bleomycin, and lungs were evaluated in the same manner. Results HDAC6 expression was deregulated in IPF lungs. Among the HDAC6 inhibitors tested, only Tubastatin significantly repressed TGF-beta 1-induced expression of type-1 collagen in lung fibroblasts, and this finding was coupled with decreased Akt phosphorylation and increased Akt-PHLPP (PH domain and Leucine rich repeat Protein Phosphatase) association. Tubastatin repressed TGF-beta 1-induced S6K phosphorylation, HIF-1 alpha expression, and VEGF expression. Tubastatin also repressed TGF-beta 1-induced inhibition of LC3B-II (a marker of autophagosome formation). In bleomycin-treated mouse lungs, HDAC6 expression was increased, and Tubastatin repressed type-1 collagen expression. However, in HDAC6 KO mice, bleomycin-induced type-1 collagen expression was not repressed compared to WT mice. Knockdown of HDAC6, as well as HDAC10, another potential Tubastatin target, did not inhibit TGF-beta 1-induced collagen expression in lung fibroblasts. Conclusions HDAC6 expression is altered during lung fibrogenesis. Tubastatin represses TGF-beta 1induced collagen expression, by diminishing Akt phosphorylation and regulating downstream targets such as HIF-1 alpha-VEGF axis and autophagy. Tubastatin-treated WT mice are protected against bleomycin-induced fibrosis, but HDAC6 KO mice are not. Our data suggest that Tubastatin ameliorates pulmonary fibrosis, by targeting the TGF beta-PI3K-Akt pathway, likely via an HDAC6-independent mechanism.	[Saito, Shigeki; Zhuang, Yan; Lasky, Joseph A.] Tulane Univ, Hlth Sci Ctr, Sect Pulm Dis Crit Care & Environm Med, Dept Med, New Orleans, LA 70118 USA; [Saito, Shigeki] Louisiana Clin & Translat Sci Ctr LACaTS, Roadmap Scholars Program, New Orleans, LA USA; [Shan, Bin] Washington State Univ, Dept Biomed Sci, Spokane Coll Med Sci, Spokane, WA USA; [Danchuk, Svitlana] Univ Missouri, Sch Med, Dept Med, Div Cardiovasc Med, Columbia, MO 65212 USA; [Luo, Fayong] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Korfei, Martina; Guenther, Andreas] Justus Liebig Univ Giessen, UGMLC, Dept Internal Med, Giessen, Germany; [Guenther, Andreas] Agaples Lung Clin Waldhof Elgershausen, Greifenstein, Germany	Tulane University; Washington State University; University of Missouri System; University of Missouri Columbia; University of Texas System; University of Texas Health Science Center Houston; Justus Liebig University Giessen	Lasky, JA (corresponding author), Tulane Univ, Hlth Sci Ctr, Sect Pulm Dis Crit Care & Environm Med, Dept Med, New Orleans, LA 70118 USA.	jlasky@tulane.edu			Wetmore Foundation [553862, 553860G1, 555007, 555007G1]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	Wetmore Foundation; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Wetmore Foundation (Project: 553862, Task: Ml, Award: 553860G1 [to JAL]; Project: 555007, Task: Ml, Award: 555007G1 [to SS]) and by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bacon T, 2015, BIOCHEM J, V472, P367, DOI 10.1042/BJ20150660; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chakraborti S., 2016, CYTOSKELETON HOBOKEN; Conte E, 2013, LAB INVEST, V93, P566, DOI 10.1038/labinvest.2013.6; Conte E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024663; Davies ER, 2012, AM J RESP CELL MOL, V46, P687, DOI 10.1165/rcmb.2011-0040OC; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Gu SC, 2016, J BIOL CHEM, V291, P5396, DOI 10.1074/jbc.M115.713123; Gui YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138625; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hwang I, 2015, BIOCHEM BIOPH RES CO, V467, P973, DOI 10.1016/j.bbrc.2015.10.033; Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721; Korfei M, 2015, THORAX, V70, P1022, DOI 10.1136/thoraxjnl-2014-206411; Kramer OH, 2014, TRENDS PHARMACOL SCI, V35, P501, DOI 10.1016/j.tips.2014.08.001; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117400; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Luo FY, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-51; Mercer PF, 2016, THORAX, V71, P701, DOI 10.1136/thoraxjnl-2015-207429; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Oehme I, 2013, P NATL ACAD SCI USA, V110, pE2592, DOI 10.1073/pnas.1300113110; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Patel AS, 2013, AM J RESP CELL MOL, V48, P1, DOI 10.1165/rcmb.2012-0282TR; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Ricupero DA, 2001, AM J PHYSIOL-CELL PH, V281, pC99, DOI 10.1152/ajpcell.2001.281.1.C99; Sanders YY, 2014, EUR RESPIR J, V43, P1448, DOI 10.1183/09031936.00095113; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sosulski ML, 2015, AGING CELL, V14, P774, DOI 10.1111/acel.12357; Stout-Delgado H.W., 2016, AM J RESP CELL MOL B; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Wang Z, 2009, EUR RESPIR J, V34, P145, DOI 10.1183/09031936.00084808; Warshamana GS, 2001, EXP MOL PATHOL, V71, P13, DOI 10.1006/exmp.2001.2376; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Yue X, 2010, CURR ENZYM INHIB, V6; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zhuang Y, 2010, BIOCHEM BIOPH RES CO, V392, P608, DOI 10.1016/j.bbrc.2010.01.091	44	56	62	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186615	10.1371/journal.pone.0186615	http://dx.doi.org/10.1371/journal.pone.0186615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045477	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100078
J	Araiza-Olivera, D; Feng, Y; Semenova, G; Prudnikova, TY; Rhodes, J; Chernoff, J				Araiza-Olivera, D.; Feng, Y.; Semenova, G.; Prudnikova, T. Y.; Rhodes, J.; Chernoff, J.			Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors	ONCOGENE			English	Article							ZEBRAFISH; MUTATIONS; RAC1; GTPASE; RAS; P21-ACTIVATED-KINASE-1; PROGRESSION	Activating mutations in the RAC1 gene have recently been discovered as driver events in malignant melanoma. Expression of this gene is associated with melanocyte proliferation, and melanoma cells bearing this mutation are insensitive to BRAF inhibitors such as vemurafenib and dabrafenib, and also may evade immune surveillance due to enhanced expression of PD-L1. Activating mutations in RAC1 are of special interest, as small-molecule inhibitors for the RAC effector p21-activated kinase (PAK) are in late-stage clinical development and might impede oncogenic signaling from mutant RAC1. In this work, we explore the effects of PAK inhibition on RAC1(P29S) signaling in zebrafish embryonic development, in the proliferation, survival and motility of RAC1(P29S)-mutant human melanoma cells, and on tumor formation and progression from such cells in mice. We report that RAC1(P29S) evokes a Rasopathy-like phenotype on zebrafish development that can be blocked by inhibitors of PAK or MEK. We also found and that RAC1-mutant human melanoma cells are resistant to clinical inhibitors of BRAF but are uniquely sensitive to PAK inhibitors. These data suggest that suppressing the PAK pathway might be of therapeutic benefit in this type of melanoma.	[Araiza-Olivera, D.; Feng, Y.; Semenova, G.; Prudnikova, T. Y.; Chernoff, J.] Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave W451, Philadelphia, PA 19111 USA; [Semenova, G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Rhodes, J.] Fox Chase Canc Ctr, Blood Cell Dev Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Araiza-Olivera, D.] Univ Nacl Autonoma Mexico, Inst Quim, Mexico City, DF, Mexico	Fox Chase Cancer Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Fox Chase Cancer Center; Universidad Nacional Autonoma de Mexico	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave W451, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	NIH CORE Grant [P30CA006927];  [R01CA227184]; NATIONAL CANCER INSTITUTE [R01CA142928, P30CA006927] Funding Source: NIH RePORTER	NIH CORE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Ruth Halaban and Meenhard Herlyn for providing melanoma cell lines, and Dr Rebecca Burdine for Tg(cmlc2:EGFP) zebrafish, Genentech for providing Frax-1036 and the Fox Chase Cancer Center Animal Facility for assistance with zebrafish experiments. This work was supported by R01CA227184 (JC), NIH CORE Grant P30CA006927, and an appropriation from the state of Pennsylvania to the Fox Chase Cancer Center.	Anastasaki C, 2012, DIS MODEL MECH, V5, P546, DOI 10.1242/dmm.008672; Anastasaki C, 2009, HUM MOL GENET, V18, P2543, DOI 10.1093/hmg/ddp186; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Davis MJ, 2013, P NATL ACAD SCI USA, V110, P912, DOI 10.1073/pnas.1220895110; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Grzmil M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000959; Vu HL, 2015, PIGM CELL MELANOMA R, V28, P590, DOI 10.1111/pcmr.12392; Halaban R, 2016, J INVEST DERMATOL, V136, P1755, DOI 10.1016/j.jid.2016.05.095; Halaban R, 2015, CLIN THER, V37, P682, DOI 10.1016/j.clinthera.2014.10.027; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jindal GA, 2015, DIS MODEL MECH, V8, P769, DOI 10.1242/dmm.020339; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Li A, 2011, DEV CELL, V21, P722, DOI 10.1016/j.devcel.2011.07.008; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Ong CC, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0564-5; Ong CC, 2013, JNCI-J NATL CANCER I, V105, P606, DOI 10.1093/jnci/djt054; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Rhodes J, 2009, MOL CELL BIOL, V29, P5911, DOI 10.1128/MCB.00558-09; Semenova G, 2017, BIOCHEM SOC T, V45, P79, DOI 10.1042/BST20160134; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Watson IR, 2014, CANCER RES, V74, P4845, DOI 10.1158/0008-5472.CAN-14-1232-T	30	37	37	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					944	952		10.1038/onc.2017.400	http://dx.doi.org/10.1038/onc.2017.400			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059171	Green Accepted			2022-12-26	WOS:000425281800011
J	Cuyas, E; Fernandez-Arroyo, S; Verdura, S; Garcia, RAF; Stursa, J; Werner, L; Blanco-Gonzalez, E; Montes-Bayon, M; Joven, J; Viollet, B; Neuzil, J; Menendez, JA				Cuyas, E.; Fernandez-Arroyo, S.; Verdura, S.; Garcia, R. A-F; Stursa, J.; Werner, L.; Blanco-Gonzalez, E.; Montes-Bayon, M.; Joven, J.; Viollet, B.; Neuzil, J.; Menendez, J. A.			Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism	ONCOGENE			English	Article							HUMAN CELL-LINE; MESENCHYMAL TRANSITION; CANCER-CELLS; GENOME-WIDE; BREAST-CANCER; BRCA1 LEADS; AMP-KINASE; BIGUANIDES; SERINE; REVEALS	The anti-diabetic biguanide metformin may exert health-promoting effects via metabolic regulation of the epigenome. Here we show that metformin promotes global DNA methylation in non-cancerous, cancer-prone and metastatic cancer cells by decreasing S-adenosylhomocysteine (SAH), a strong feedback inhibitor of S-adenosylmethionine (SAM)-dependent DNA methyltransferases, while promoting the accumulation of SAM, the universal methyl donor for cellular methylation. Using metformin and a mitochondria/complex I (mCI)-targeted analog of metformin (norMitoMet) in experimental pairs of wild-type and AMP-activated protein kinase (AMPK)-, serine hydroxymethyltransferase 2 (SHMT2)- and mCI-null cells, we provide evidence that metformin increases the SAM: SAH ratio-related methylation capacity by targeting the coupling between serine mitochondrial one-carbon flux and CI activity. By increasing the contribution of one-carbon units to the SAM from folate stores while decreasing SAH in response to AMPK-sensed energetic crisis, metformin can operate as a metabolo-epigenetic regulator capable of reprogramming one of the key conduits linking cellular metabolism to the DNA methylation machinery.	[Cuyas, E.; Verdura, S.; Menendez, J. A.] Catalan Inst Oncol, Metab & Canc Grp, ProCURE Program Canc Therapeut Resistance, Girona, Catalonia, Spain; [Cuyas, E.; Verdura, S.; Menendez, J. A.] Girona Biomed Res Inst IDIBGI, Girona, Catalonia, Spain; [Fernandez-Arroyo, S.; Joven, J.] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Univ St Joan, Unitat Recerca Biomed, Reus, Spain; [Fernandez-Arroyo, S.; Joven, J.] Campus Int Excellence Southern Catalonia, Tarragona, Spain; [Garcia, R. A-F; Blanco-Gonzalez, E.; Montes-Bayon, M.] Univ Oviedo, Fac Chem, Dept Phys & Analyt Chem, Oviedo, Spain; [Stursa, J.; Werner, L.; Neuzil, J.] Inst Chem Technol, Prague, Czech Republic; [Stursa, J.; Werner, L.] Czech Acad Sci, Inst Biotechnol, Prague West, Czech Republic; [Viollet, B.] Inst Cochin, INSERM, U1016, Paris, France; [Viollet, B.] CNRS, UMR 8104, Paris, France; [Viollet, B.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Neuzil, J.] Griffith Univ, Sch Med Sci, Southport, Qld, Australia	Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Oviedo; University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Griffith University	Menendez, JA (corresponding author), Girona Biomed Res Inst IDIBGI, Edifici M2,Parc Hosp Marti & Julia, E-17190 Salt, Girona, Spain.	jmenendez@iconcologia.net	Viollet, Benoit/O-6927-2017; Stursa, Jan/J-4255-2014; WERNER, LUKÁŠ/AAL-7888-2021; Cuyas, Elisabet/G-8582-2018; verdura, Sara/AAC-3696-2022; MENENDEZ, JAVIER A/C-6148-2016; Viollet, Benoit/N-2397-2019; Fernández-Arroyo, Salvador/M-6955-2015	Viollet, Benoit/0000-0002-0121-0224; verdura, Sara/0000-0001-8980-0423; MENENDEZ, JAVIER A/0000-0001-8733-4561; Viollet, Benoit/0000-0002-0121-0224; Fernández-Arroyo, Salvador/0000-0003-0147-1712; Alvarez-Fernandez Garcia, Roberto/0000-0002-9537-2215; Cuyas, Elisabet/0000-0001-5353-440X; Montes-Bayon, Maria/0000-0001-6114-9405; /0000-0002-2844-6739	Ministerio de Ciencia e Innovacion [SAF2016-80639-P]; Plan Nacional de I+D+I, Spain; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2014 SGR229]; Department d'Economia I Coneixement, Catalonia, Spain; Czech Science Foundation [16-12816S]; Czech Health Research Council [16-31704A]; Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria (FIS), Spain [CD15/00033]; Armangue family (Girona, Catalonia)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Nacional de I+D+I, Spain(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Department d'Economia I Coneixement, Catalonia, Spain; Czech Science Foundation(Grant Agency of the Czech Republic); Czech Health Research Council; Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria (FIS), Spain(Instituto de Salud Carlos III); Armangue family (Girona, Catalonia)	This work was supported in part by grants from the Ministerio de Ciencia e Innovacion (Grant SAF2016-80639-P), Plan Nacional de I+D+I, Spain and the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) (Grant 2014 SGR229), Department d'Economia I Coneixement, Catalonia, Spain, to Javier A Menendez and grants from the Czech Science Foundation (16-12816S) to Jan Stursa and Lukas Werner and the Czech Health Research Council (16-31704A) to Jiri Neuzil. Elisabet Cuyas is supported by a Sara Borrell post-doctoral contract CD15/00033 from the Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria (FIS), Spain, The Metabolism and Cancer laboratory is supported by an unrestricted grant from the Armangue family (Girona, Catalonia). This work is in memory of Joan Armangue who passed away after his brave fight against cancer in November 2016.	Banerjee P, 2016, J MOL MED, V94, P1397, DOI 10.1007/s00109-016-1455-7; Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Boukalova S, 2016, MOL CANCER THER, V15, P2875, DOI 10.1158/1535-7163.MCT-15-1021; Bridges HR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0287-9; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Cheng G, 2016, CANCER RES, V76, P3904, DOI 10.1158/0008-5472.CAN-15-2534; Corominas-Faja B, 2012, AGING-US, V4, P480, DOI 10.18632/aging.100472; Cuyas E, 2016, ONCOTARGET, V7, P52974, DOI 10.18632/oncotarget.9732; Cuyas E, 2014, ONCOTARGET, V5, P3970, DOI 10.18632/oncotarget.2147; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Fernandez-Arroyo S., 2016, ONCOSCIENCE, V2, P958, DOI [10.18632/oncoscience.280, DOI 10.18632/ONCOSCIENCE.280]; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gravel SP, 2014, CANCER RES, V74, P7521, DOI 10.1158/0008-5472.CAN-14-2643-T; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Houde VP, 2014, BIOCHEM J, V458, P41, DOI 10.1042/BJ20131324; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Iglesias T, 2015, ANAL BIOANAL CHEM, V407, P2423, DOI 10.1007/s00216-014-8070-7; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kodiha M, 2011, AM J PHYSIOL-CELL PH, V301, pC1307, DOI 10.1152/ajpcell.00309.2011; Konishi H, 2011, P NATL ACAD SCI USA, V108, P17773, DOI 10.1073/pnas.1110969108; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Liu XJ, 2016, CELL METAB, V24, P728, DOI 10.1016/j.cmet.2016.09.005; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; Meiser J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601273; Meiser J, 2016, FEBS J, V283, P3695, DOI 10.1111/febs.13731; Menendez JA, 2016, ONCOTARGET, V7, P11959, DOI 10.18632/oncotarget.7867; Menendez JA, 2016, STEM CELL REP, V6, P273, DOI 10.1016/j.stemcr.2015.12.012; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Miousse IR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/131547; Newman AC, 2017, TRENDS CELL BIOL, V27, P645, DOI 10.1016/j.tcb.2017.05.001; Newman AC, 2017, BRIT J CANCER, V116, P1499, DOI 10.1038/bjc.2017.118; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Ross FA, 2016, BIOCHEM J, V473, P189, DOI 10.1042/BJ20150910; Sedic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8505; Sharma U, 2017, CELL METAB, V25, P544, DOI 10.1016/j.cmet.2017.02.003; Talarico G, 2016, SCI REP-UK, V6, DOI 10.1038/srep18673; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Vazquez-Martin A, 2010, CELL CYCLE, V9, P3807, DOI 10.4161/cc.9.18.13131; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yang QY, 2016, CELL METAB, V24, P542, DOI 10.1016/j.cmet.2016.08.010; Zhong T, 2017, ONCOGENE, V36, P2345, DOI 10.1038/onc.2016.391; Zhou JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10221	56	64	67	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					963	970		10.1038/onc.2017.367	http://dx.doi.org/10.1038/onc.2017.367			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059169				2022-12-26	WOS:000425281800013
J	Dietrich, P; Kuphal, S; Spruss, T; Hellerbrand, C; Bosserhoff, AK				Dietrich, P.; Kuphal, S.; Spruss, T.; Hellerbrand, C.; Bosserhoff, A. K.			Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITION; MEK INHIBITION; METASTATIC MELANOMA; PATHWAY; EXPRESSION; RAF; TUMORIGENESIS; VEMURAFENIB; ACTIVATION; EVOLUTION	Malignant melanoma reveals rapidly increasing incidence and mortality rates worldwide. By now, BRAF inhibition is the standard therapy for advanced melanoma in patients carrying BRAF mutations. However, only approximately 50% of melanoma patients harbor therapeutically attackable BRAF mutations, and overall survival after treatment with BRAF inhibitors is modest. KRAS (Kirsten Rat sarcoma) proteins are acting upstream of BRAF and have a major role in human cancer. Recent approaches awaken the hope to use KRAS inhibition (KRASi) as a clinical tool. In this study, we identified wild-type KRAS as a novel therapeutic target in melanoma. KRASi functions synergistically with BRAF inhibition to reduce melanoma proliferation and to induce apoptosis independently of BRAF mutational status. Moreover, acquired resistance to BRAF inhibitors in melanoma is dependent on dynamic regulation of KRAS expression with subsequent AKT and extracellular-signal regulated kinase activation and can be overcome by KRASi. This suggests KRASi as novel approach in melanoma-alone or in combination with other therapeutic regimes.	[Dietrich, P.; Kuphal, S.; Hellerbrand, C.; Bosserhoff, A. K.] Friedrich Alexander Univ Erlangen Nuremberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Spruss, T.] Univ Regensburg, Inst Pharm, Regensburg, Germany; [Hellerbrand, C.; Bosserhoff, A. K.] Comprehens Canc Ctr CCC Erlangen EMN, Erlangen, Germany	University of Erlangen Nuremberg; University of Regensburg; University of Erlangen Nuremberg	Bosserhoff, AK (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany.	anja.bosserhoff@fau.de	Kuphal, Silke/AAW-2702-2020; Bosserhoff, Anja/GNH-4801-2022	Bosserhoff, Anja/0000-0001-8147-394X	German Research Association (DFG) [RTG 1962/1]; German Cancer Aid (Deutsche Krebshilfe); Bavarian Research Network for Molecular Biosystems (BioSysNet); Interdisciplinary Center for Clinical Research (IZKF) Erlangen [J55, D24]	German Research Association (DFG)(German Research Foundation (DFG)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Bavarian Research Network for Molecular Biosystems (BioSysNet); Interdisciplinary Center for Clinical Research (IZKF) Erlangen	This work was supported by the German Research Association (DFG) (Research Training Group 'RTG 1962/1', University of Erlangen), the German Cancer Aid (Deutsche Krebshilfe), the Bavarian Research Network for Molecular Biosystems (BioSysNet) and the Interdisciplinary Center for Clinical Research (IZKF) Erlangen (J55, to PD and D24, to AB). We thank Meenhard Herlyn (The Wistar Institute, Philadelphia, USA) for providing the resistant cell lines. Furthermore, we thank Rudolf Jung, Annette Serwotka and Darleen Schonwalder for technical assistance.	[Anonymous], 2013, Cancer Discov, V3, pOF20, DOI 10.1158/2159-8290.CD-RW2013-116; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Burotto M, 2014, CANCER-AM CANCER SOC, V120, P3446, DOI 10.1002/cncr.28864; Carlino MS, 2015, J CLIN ONCOL, V33, pE52, DOI 10.1200/JCO.2013.51.5783; Chapuis AG, 2016, J EXP MED, V213, P1133, DOI 10.1084/jem.20152021; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Depasquale I, 2005, HISTOPATHOLOGY, V47, P186, DOI 10.1111/j.1365-2559.2005.02193.x; Dummer R, 2012, ANN ONCOL, V23, P86, DOI 10.1093/annonc/mds229; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Gimotty PA, 2005, J CLIN ONCOL, V23, P8048, DOI 10.1200/JCO.2005.02.0735; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Gross A, 2015, TARGET ONCOL, V10, P77, DOI 10.1007/s11523-014-0318-9; Harries M, 2016, EUR J CANCER, V60, P179, DOI 10.1016/j.ejca.2016.01.011; Herrero A, 2015, CANCER CELL, V28, P170, DOI 10.1016/j.ccell.2015.07.001; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Johnson DB, 2015, JAMA ONCOL, V1, P380, DOI 10.1001/jamaoncol.2015.0565; Karimkhani C, 2014, AM J CLIN DERMATOL, V15, P323, DOI 10.1007/s40257-014-0083-7; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Ledford H, 2015, NATURE, V520, P278, DOI 10.1038/520278a; Leiter Ulrike, 2014, Adv Exp Med Biol, V810, P120; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Loi S, 2016, CLIN CANCER RES, V22, P1499, DOI 10.1158/1078-0432.CCR-15-1125; Luke JJ, 2014, DRUG HEALTHC PATIENT, V6, P77, DOI 10.2147/DHPS.S39568; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; Matin RN, 2013, J EXP MED, V210, P581, DOI 10.1084/jem.20121439; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; Milagre C, 2010, CANCER RES, V70, P5549, DOI 10.1158/0008-5472.CAN-09-4254; Milroy LG, 2014, ACS CHEM BIOL, V9, P2447, DOI 10.1021/cb500555h; Monsma DJ, 2015, AM J CANCER RES, V5, P1507; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Perna D, 2015, P NATL ACAD SCI USA, V112, pE536, DOI 10.1073/pnas.1418163112; Posch C, 2015, J INVEST DERMATOL, V135, P2475, DOI 10.1038/jid.2015.198; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Queirolo P, 2015, CANCER TREAT REV, V41, P519, DOI 10.1016/j.ctrv.2015.04.010; Richman J, 2015, EXPERT OPIN PHARMACO, V16, P1285, DOI 10.1517/14656566.2015.1044971; Ruiz C, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/1/016008; Sale MJ, 2013, BRIT J PHARMACOL, V169, P1708, DOI 10.1111/bph.12220; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Smyth T, 2014, MOL CANCER THER, V13, P2793, DOI 10.1158/1535-7163.MCT-14-0452; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sweetlove M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00135; Villanueva J, 2013, CELL REP, V4, P1090, DOI 10.1016/j.celrep.2013.08.023; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang JH, 2015, J INVEST DERMATOL, V135, P532, DOI 10.1038/jid.2014.418; Whittaker SR, 2015, MOL CANCER THER, V14, P2700, DOI 10.1158/1535-7163.MCT-15-0136-T; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wilson MA, 2016, CLIN CANCER RES, V22, P374, DOI 10.1158/1078-0432.CCR-15-1162; Xue W, 2014, P NATL ACAD SCI USA, V111, pE3553, DOI 10.1073/pnas.1412686111; Yang J, 2015, BIOCHEM BIOPH RES CO, V463, P900, DOI 10.1016/j.bbrc.2015.06.032; Yuan TL, 2014, CANCER DISCOV, V4, P1182, DOI 10.1158/2159-8290.CD-13-0900; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	55	29	30	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					897	911		10.1038/onc.2017.391	http://dx.doi.org/10.1038/onc.2017.391			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059159				2022-12-26	WOS:000425281800007
J	Han, MH; Kim, J; Choi, KS; Kim, CH; Kim, JM; Cheong, JH; Yi, HJ; Lee, SH				Han, Myung-Hoon; Kim, Jinhee; Choi, Kyu-Sun; Kim, Choong Hyun; Kim, Jae Min; Cheong, Jin Hwan; Yi, Hyeong-Joong; Lee, Seon Heui			Monthly variations in aneurysmal subarachnoid hemorrhage incidence and mortality: Correlation with weather and pollution	PLOS ONE			English	Article							DIAGNOSED SPINE METASTASIS; ADULT KOREAN POPULATION; SEASONAL-VARIATION; BLOOD-PRESSURE; METEOROLOGICAL FACTORS; AIR-POLLUTION; BODY-TEMPERATURE; STROKE INCIDENCE; CASE-FATALITY; NATIONWIDE	Background and purpose Although the effect of weather and air pollution on the occurrence of subarachnoid hemorrhage (SAH) has been investigated, results have remained inconsistent. The present study aimed to determine the seasonality of aneurysmal subarachnoid hemorrhage occurrence and mortality. Methods We used the National Inpatient Sample database to evaluate the effect of meteorological factors and air pollutants on patients with subarachnoid hemorrhage in Korea between 2011 and 2014. Monthly variations in SAH occurrence and mortality were analyzed using locally weighted scatter plot smoothing curves. Multivariate Poisson generalized linear regression models were used to evaluate potential independent meteorological and pollutant variables associated with SAH occurrence and mortality. Results In total, 21,407 patients who underwent clip or coil treatment owing to aneurysmal SAH in Korea from January 1, 2011, to December 31, 2014, were included. The crude incidence rate of SAH in Korea was 10.5 per 100,000 people per year. An approximately 0.5% lower risk of SAH was observed per 1 degrees C increase in mean monthly temperature (relative risk, 0.995; 95% confidence interval [CI], 0.992-0.997; p < 0.001), while an approximately 2.3% higher risk of SAH was observed per 1 degrees C increase in mean monthly diurnal temperature. Conclusions We showed distinct patterns of seasonal and monthly variation in the occurrence and mortality of SAH. Our findings suggest that meteorological factors may play an important role in monthly variations in the occurrence of aneurysmal SAH.	[Han, Myung-Hoon; Kim, Choong Hyun; Kim, Jae Min; Cheong, Jin Hwan] Hanyang Univ, Guri Hosp, Dept Neurosurg, Guri, Gyonggi Do, South Korea; [Kim, Jinhee] Chosun Univ, Coll Med, Dept Nursing, Gwangju, South Korea; [Choi, Kyu-Sun; Yi, Hyeong-Joong] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea; [Lee, Seon Heui] Gachon Univ, Coll Nursing, Dept Nursing Sci, Incheon, South Korea	Hanyang University; Chosun University; Hanyang University; Gachon University	Lee, SH (corresponding author), Gachon Univ, Coll Nursing, Dept Nursing Sci, Incheon, South Korea.	sunarea87@gachon.ac.kr	Yi, Hyeong-Joong/AAR-2685-2020		Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C3401]	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC15C3401). URL: https://www.khidi.orkr/board: jsessionid=n3vhZ3dBmrs2TrBkQTPGfGkRJV8pqV DIRtr63n4MysznphH0yvZG!-1652677014? menuld=MENU007768&siteld=null.	Abe T, 2008, J CLIN NEUROSCI, V15, P1005, DOI 10.1016/j.jocn.2007.07.081; Anderson C, 2003, STROKE, V34, P1771, DOI 10.1161/01.STR.0000077015.90334.A7; Backes D, 2016, J NEUROSURG, V125, P737, DOI 10.3171/2015.8.JNS151473; BRENNAN PJ, 1982, BMJ-BRIT MED J, V285, P919, DOI 10.1136/bmj.285.6346.919; BRUCE N, 1991, J HYPERTENS, V9, P851, DOI 10.1097/00004872-199109000-00013; Buxton N, 2001, J NEUROSURG, V95, P391, DOI 10.3171/jns.2001.95.3.0391; Chang Hyuk Won, 2016, Neurointervention, V11, P86, DOI 10.5469/neuroint.2016.11.2.86; CHYATTE D, 1994, J NEUROSURG, V81, P525, DOI 10.3171/jns.1994.81.4.0525; Cowperthwaite MC, 2011, NEUROSURGERY, V68, P132, DOI 10.1227/NEU.0b013e3181fe23a1; de Ridder I, 2013, CEREBROVASC DIS, V35, P60, DOI 10.1159/000345335; Elhadi AM, 2015, J NEUROSURG, V122, P663, DOI 10.3171/2014.10.JNS14175; Fischer T, 2005, NEUROEPIDEMIOLOGY, V24, P32, DOI 10.1159/000081047; GIACONI S, 1989, HYPERTENSION, V14, P22, DOI 10.1161/01.HYP.14.1.22; Gill RS, 2013, WORLD NEUROSURG, V79, P136, DOI 10.1016/j.wneu.2012.06.020; Han MH, 2015, STROKE, V46, P927, DOI 10.1161/STROKEAHA.114.007950; Huang FF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003437; Inagawa T, 2002, J NEUROSURG, V96, P497, DOI 10.3171/jns.2002.96.3.0497; Jakovljevic D, 1996, STROKE, V27, P1774, DOI 10.1161/01.STR.27.10.1774; Johnson JYM, 2010, STROKE, V41, P1319, DOI 10.1161/STROKEAHA.110.580571; Kawai K, 2001, NEUROL MED-CHIR, V41, P229, DOI 10.2176/nmc.41.229; Kim J, 2013, INT J CHRONIC OBSTR, V8, P561, DOI 10.2147/COPD.S48577; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117929; Kozak N, 2007, J NEUROSURG, V106, P234, DOI 10.3171/jns.2007.106.2.234; Kvistad CE, 2014, ACTA NEUROL SCAND, V129, P325, DOI 10.1111/ane.12184; Lautensach H., 2012, KOREA GEOGRAPHY BASE; Law H. Y., 2009, Hong Kong Medical Journal, V15, P85; LEJEUNE JP, 1994, STROKE, V25, P338, DOI 10.1161/01.STR.25.2.338; Lin HL, 2016, INT J HYG ENVIR HEAL, V219, P204, DOI 10.1016/j.ijheh.2015.11.002; McDonald RJ, 2012, AM J NEURORADIOL, V33, P1663, DOI 10.3174/ajnr.A3059; McDonald RJ, 2012, J NEUROSURG, V116, P157, DOI 10.3171/2011.8.JNS11324; Modesti PA, 2006, HYPERTENSION, V47, P155, DOI 10.1161/01.HYP.0000199192.17126.d4; Nyquist PA, 2001, NEUROLOGY, V56, P190, DOI 10.1212/WNL.56.2.190; Ostbye T, 1997, STROKE, V28, P793, DOI 10.1161/01.STR.28.4.793; Park YT, 2012, HEALTHC INFORM RES, V18, P215, DOI 10.4258/hir.2012.18.3.215; Phillips DP, 2010, J GEN INTERN MED, V25, P774, DOI 10.1007/s11606-010-1356-3; Piters WAAD, 2013, J NEUROL, V260, P614, DOI 10.1007/s00415-012-6687-z; Setzer M, 2007, SURG NEUROL, V67, P264, DOI 10.1016/j.surneu.2006.06.060; SHINKAWA A, 1990, STROKE, V21, P1262, DOI 10.1161/01.STR.21.9.1262; Sohn S, 2017, STEREOT FUNCT NEUROS, V95, P189, DOI 10.1159/000475764; Sohn S, 2017, J KOREAN NEUROSURG S, V60, P195, DOI 10.3340/jkns.2016.0505.011; Sohn S, 2016, SPINE J, V16, P937, DOI 10.1016/j.spinee.2016.03.006; Umemura K, 2008, NEUROL MED-CHIR, V48, P101, DOI 10.2176/nmc.48.101; Vlak MHM, 2011, STROKE, V42, P1878, DOI 10.1161/STROKEAHA.110.606558; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Yang HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141724; Yang WS, 2014, INT J CARDIOL, V175, P307, DOI 10.1016/j.ijcard.2014.05.044	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186973	10.1371/journal.pone.0186973	http://dx.doi.org/10.1371/journal.pone.0186973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073210	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400085
J	Johansen, JR; Mares, J; Pietrasiak, N; Bohunicka, M; Zima, J; Stenclova, L; Hauer, T				Johansen, Jeffrey R.; Mares, Jan; Pietrasiak, Nicole; Bohunicka, Marketa; Zima, Jan, Jr.; Stenclova, Lenka; Hauer, Tomas			Highly divergent 16S rRNA sequences in ribosomal operons of Scytonema hyalinum (Cyanobacteria)	PLOS ONE			English	Article							INTRAGENOMIC HETEROGENEITY; DISTINCT TYPES; GENES; DIVERSITY; VERSION; RECOMBINATION; CYANOPHYCEAE; POPULATION; NOSTOCALES; ALGORITHM	A highly divergent 16S rRNA gene was found in one of the five ribosomal operons present in a species complex currently circumscribed as Scytonema hyalinum (Nostocales, Cyanobacteria) using clone libraries. If 16S rRNA sequence macroheterogeneity among ribosomal operons due to insertions, deletions or truncation is excluded, the sequence heterogeneity observed in S. hyalinum was the highest observed in any prokaryotic species thus far (7.3-9.0%). The secondary structure of the 16S rRNA molecules encoded by the two divergent operons was nearly identical, indicating possible functionality. The 23S rRNA gene was examined for a few strains in this complex, and it was also found to be highly divergent from the gene in Type 2 operons (8.7%), and likewise had nearly identical secondary structure between the Type 1 and Type 2 operons. Furthermore, the 16S-23S ITS showed marked differences consistent between operons among numerous strains. Both operons have promoter sequences that satisfy consensus requirements for functional prokaryotic transcription initiation. Horizontal gene transfer from another unknown heterocytous cyanobacterium is considered the most likely explanation for the origin of this molecule, but does not explain the ultimate origin of this sequence, which is very divergent from all 16S rRNA sequences found thus far in cyanobacteria. The divergent sequence is highly conserved among numerous strains of S. hyalinum, suggesting adaptive advantage and selective constraint of the divergent sequence.	[Johansen, Jeffrey R.] John Carroll Univ, Dept Biol, University Hts, OH 44118 USA; [Johansen, Jeffrey R.; Mares, Jan; Stenclova, Lenka; Hauer, Tomas] Univ South Bohemia, Dept Bot, Fac Sci, Ceske Budejovice, Czech Republic; [Mares, Jan; Stenclova, Lenka] CAS, Inst Hydrobiol, Biol Ctr, Vvi, Ceske Budejovice, Czech Republic; [Mares, Jan; Bohunicka, Marketa; Zima, Jan, Jr.; Hauer, Tomas] CAS, Ctr Phycol, Inst Bot, Vvi, Trebon, Czech Republic; [Pietrasiak, Nicole] New Mexico State Univ, Plant & Environm Sci Dept, Las Cruces, NM 88003 USA	John Carroll University; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; New Mexico State University	Johansen, JR (corresponding author), John Carroll Univ, Dept Biol, University Hts, OH 44118 USA.; Johansen, JR (corresponding author), Univ South Bohemia, Dept Bot, Fac Sci, Ceske Budejovice, Czech Republic.	johansen@jcu.edu	Hauer, Tomas/F-5089-2010; Štenclová, Lenka/AAQ-4603-2020; Mareš, Jan/B-2395-2009	Hauer, Tomas/0000-0002-8005-5874; Mareš, Jan/0000-0002-5745-7023; Zima, Jan/0000-0002-8850-0186	Czech Science Foundation [15-11912S]; Institute of Botany, Czech Academy of Sciences [RVO 67985939]; National Science Foundation [DEB-0842702]	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Botany, Czech Academy of Sciences(Czech Academy of Sciences); National Science Foundation(National Science Foundation (NSF))	The research was supported by grant No. 15-11912S from the Czech Science Foundation (JJ JM JZ LS MB TH) and the long term research development project no. RVO 67985939 of the Institute of Botany, Czech Academy of Sciences (JM JZ MB TH). Sequencing was partially supported by National Science Foundation (US) grant DEB-0842702 (JJ NP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Anda M, 2015, P NATL ACAD SCI USA, V112, P14343, DOI 10.1073/pnas.1514326112; [Anonymous], [No title captured]; Berrendero Gomez E, 2016, J PHYCOL, V52, P638, DOI 10.1111/jpy.12425; Bodilis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035647; Bohunicka M, 2015, PHYTOTAXA, V197, P84, DOI 10.11646/phytotaxa.197.2.2; Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Boyer SL, 2002, J PHYCOL, V38, P1222, DOI 10.1046/j.1529-8817.2002.01168.x; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Brown MV, 2005, AQUAT MICROB ECOL, V41, P15, DOI 10.3354/ame041015; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hashimoto JQ, 2003, J BACTERIOL, V185, P966, DOI 10.1128/JB.185.3.966-972.2003; Haugen P, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-159; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kotai J., 1972, PUBLICATION B; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Lopez-Lopez A, 2007, J MOL EVOL, V65, P687, DOI 10.1007/s00239-007-9047-3; Lukesova A, 2009, PHYCOLOGIA, V48, P118, DOI 10.2216/08-56.1; Michon AL, 2010, MICROBIOL-SGM, V156, P2080, DOI 10.1099/mic.0.038224-0; MILLER M, 2012, P 1 C EXTR SCI ENG, V2, P1; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Moreno C, 2002, MICROBIOL-SGM, V148, P1233, DOI 10.1099/00221287-148-4-1233; MYLVAGANAM S, 1992, GENETICS, V130, P399; Osorio-Santos K, 2014, EUR J PHYCOL, V49, P450, DOI 10.1080/09670262.2014.976843; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Pietrasiak N, 2014, PHYCOLOGIA, V53, P529, DOI 10.2216/14-029.1; Rainey FA, 1996, MICROBIOL-UK, V142, P2087, DOI 10.1099/13500872-142-8-2087; Roeselers G, 2007, J MICROBIOL METH, V70, P550, DOI 10.1016/j.mimet.2007.06.011; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rudi K, 1998, J BACTERIOL, V180, P3453, DOI 10.1128/JB.180.13.3453-3461.1998; Seo PS, 2003, J GEN APPL MICROBIOL, V49, P191, DOI 10.2323/jgam.49.191; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Ueda K, 1999, J BACTERIOL, V181, P78, DOI 10.1128/JB.181.1.78-82.1999; Vaccarino MA, 2012, J PHYCOL, V48, P1178, DOI 10.1111/j.1529-8817.2012.01203.x; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Voracova A K, 2017, PLOS ONE, V12; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yeager CM, 2007, FEMS MICROBIOL ECOL, V60, P85, DOI 10.1111/j.1574-6941.2006.00265.x; Yilmaz M, 2009, J PHYCOL, V45, P517, DOI 10.1111/j.1529-8817.2009.00651.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	34	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186393	10.1371/journal.pone.0186393	http://dx.doi.org/10.1371/journal.pone.0186393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073157	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400024
J	Kim, S; Chang, Y; Sung, E; Kim, CH; Yun, KE; Jung, HS; Shin, H; Ryu, S				Kim, Seolhye; Chang, Yoosoo; Sung, Eunju; Kim, Cheol Hwan; Yun, Kyung Eun; Jung, Hyun-Suk; Shin, Hocheol; Ryu, Seungho			Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study	PLOS ONE			English	Article							METABOLIC SYNDROME; KIDNEY-STONES; RISK; ULTRASONOGRAPHY; INFLAMMATION; POPULATION; DIAGNOSIS; GLUCOSE; PLASMA; URINE	Background Non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation or precursor of metabolic syndrome, may increase nephrolithiasis, a renal manifestation of insulin resistance, but the prospective association between NAFLD and incident nephrolithiasis has not been evaluated. We examined the association of NAFLD with the development of nephrolithiasis in a large cohort of Korean men and women. Methods We performed a cohort study of 208,578 Korean adults who underwent a health checkup examination between January 2002 and December 2014 and were followed-up annually or biennially through December 2014. NAFLD was defined as the presence of fatty liver in the absence of excessive alcohol use or other identifiable causes. Fatty liver and nephrolithiasis were determined based on ultrasonographic findings. We used a parametric Cox model to estimate the adjusted hazard ratios (HRs) of nephrolithiasis according to the presence of NAFLD. Results During 1,054,887.6 person-year of follow-up, 16,442 participants developed nephrolithiasis. After adjusting for age, center, year of screening exam, smoking status, alcohol intake, physical activity, education level, body mass index, history of hypertension and diabetes, HOMA-IR, uric acid and C-reactive protein, male participants with NAFLD had a significantly increased risk of nephrolithiasis than those without NAFLD (adjusted HR 1.17, 95% CI 1.06-1.30). However, no association between NAFLD and nephrolithiasis was observed in- women (adjusted HR 0.97, 95% CI 0.811.16). Conclusions In this large cohort study of young and middle-aged Koreans, NAFLD was significantly associated with an increased incidence of nephrolithiasis in men but not in women.	[Kim, Seolhye; Chang, Yoosoo; Sung, Eunju; Kim, Cheol Hwan; Yun, Kyung Eun; Jung, Hyun-Suk; Shin, Hocheol; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Sung, Eunju; Kim, Cheol Hwan; Shin, Hocheol] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Chang, Y; Ryu, S (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea.; Chang, Y; Ryu, S (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea.; Chang, Y; Ryu, S (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea.	yoosoo.chang@gmail.com; sh703.yoo@gmail.com		SUNG, EUNJU/0000-0002-6045-3154; Chang, Yoosoo/0000-0002-6945-9050; Ryu, Seungho/0000-0002-3927-8646				Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; Andrabi Y, 2015, INDIAN J UROL, V31, P185, DOI 10.4103/0970-1591.156924; Ballestri S, 2017, METABOLISM, V72, P57, DOI 10.1016/j.metabol.2017.04.003; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Besiroglu H, 2015, RENAL FAILURE, V37, P1, DOI 10.3109/0886022X.2014.976133; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Chang Y, 2016, ANN INTERN MED, V164, P305, DOI 10.7326/M15-1323; Einollahi B, 2013, Endocr Regul, V47, P27; Gorbachinsky Ilya, 2010, Rev Urol, V12, pe157; Heller HJ, 2002, J UROLOGY, V168, P1923, DOI 10.1016/S0022-5347(05)64264-4; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Kanno T, 2014, UROLOGY, V84, P285, DOI 10.1016/j.urology.2014.04.010; Khan SR, 2014, TRANSL ANDROL UROL, V3, P256, DOI 10.3978/j.issn.2223-4683.2014.06.04; Khan SR, 2002, KIDNEY INT, V62, P2062, DOI 10.1046/j.1523-1755.2002.00676.x; Klisic J, 2002, AM J PHYSIOL-RENAL, V283, pF532, DOI 10.1152/ajprenal.00365.2001; Kramer HJM, 2003, J AM SOC NEPHROL, V14, P1272, DOI 10.1097/01.ASN.0000060682.25472.C3; Lonardo A, 2000, J GASTROEN HEPATOL, V15, P775, DOI 10.1046/j.1440-1746.2000.02226.x; Lonardo A, 2017, DIGEST LIVER DIS, V49, P471, DOI 10.1016/j.dld.2017.01.147; Lonardo A, 2015, DIGEST LIVER DIS, V47, P997, DOI 10.1016/j.dld.2015.08.004; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Rendina D, 2009, NEPHROL DIAL TRANSPL, V24, P900, DOI 10.1093/ndt/gfn548; Romero Victoriano, 2010, Rev Urol, V12, pe86; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ryu S, 2015, J HEPATOL, V62, P1164, DOI 10.1016/j.jhep.2014.11.041; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001; Schepens D, 2000, NEPHROL DIAL TRANSPL, V15, P1080, DOI 10.1093/ndt/15.7.1080; Schwille PO, 2005, CLIN CHEM LAB MED, V43, P590, DOI 10.1515/CCLM.2005.103; Targher G, 2014, AM J KIDNEY DIS, V64, P638, DOI 10.1053/j.ajkd.2014.05.019; Tsao KC, 2007, J CLIN LAB ANAL, V21, P426, DOI 10.1002/jcla.20215; Vryonidou A, 2015, EUR J ENDOCRINOL, V173, pR153, DOI 10.1530/EJE-15-0275; Vupputuri S, 2004, ANN EPIDEMIOL, V14, P222, DOI 10.1016/S1047-2797(03)00126-1; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Xu HS, 2013, EXPERT OPIN PHARMACO, V14, P435, DOI 10.1517/14656566.2013.775250; Yki-Jarvinen H, 2016, DIABETOLOGIA, V59, P1104, DOI 10.1007/s00125-016-3944-1; Yu JS, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/2862173	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0184506	10.1371/journal.pone.0184506	http://dx.doi.org/10.1371/journal.pone.0184506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073130	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400003
J	Kinoshita, T; Nishimura, Y; Nakamura, T; Hashizaki, T; Kojima, D; Kawanishi, M; Uenishi, H; Arakawa, H; Ogawa, T; Kamijo, Y; Kawasaki, T; Tajima, F				Kinoshita, Tokio; Nishimura, Yukihide; Nakamura, Takeshi; Hashizaki, Takamasa; Kojima, Daisuke; Kawanishi, Makoto; Uenishi, Hiroyasu; Arakawa, Hideki; Ogawa, Takahiro; Kamijo, Yoshi-ichiro; Kawasaki, Takashi; Tajima, Fumihiro			Effects of physiatrist and registered therapist operating acute rehabilitation (PROr) in patients with stroke	PLOS ONE			English	Article							FUNCTIONAL INDEPENDENCE MEASURE; RANDOMIZED CONTROLLED-TRIAL; EARLY MOBILIZATION; PHASE-II; AVERT; SCALE; DISABILITY; HANDICAP; OUTCOMES; SAFETY	Objective Clinical evidence suggests that early mobilization of patients with acute stroke improves activity of daily living (ADL). The purpose of this study was to compare the utility of the physiatrist and registered therapist operating acute rehabilitation (PROr) applied early or late after acute stroke. Subjects and methods This study was prospective cohort study, assessment design. Patients with acute stroke (n = 227) admitted between June 2014 and April 2015 were divided into three groups based on the time of start of PROr: within 24 hours (VEM, n = 47), 24-48 hours (EM, n = 77), and more than 48 hours (OM, n = 103) from stroke onset. All groups were assessed for the number of deaths during hospitalization, and changes in the Glasgow Coma Scale (GCS), National Institute of Health Stroke Scale (NIHSS), and Functional Independence Measure (FIM) at hospital discharge. Interventions All patients were assessed by physiatrists, who evaluated the specific needs for rehabilitation, and then referred them to registered physical therapists and occupational therapists to provide early mobilization (longer than one hour per day per patient). Results The number of deaths encountered during the PROr period was 13 (out of 227, 5.7%), including 2 (4.3%) in the VEM group. GCS improved significantly during the hospital stay in all three groups, but the improvement on discharge was significantly better in the VEM group compared with the EM and OM groups. FIM improved significantly in the three groups, and the gains in total FIM and motor subscale were significantly greater in the VEM than the other groups. Conclusions PROr seems safe and beneficial rehabilitation to improve ADL in patients with acute stroke.	[Kinoshita, Tokio; Hashizaki, Takamasa; Kojima, Daisuke; Kawanishi, Makoto; Uenishi, Hiroyasu; Arakawa, Hideki; Ogawa, Takahiro; Kamijo, Yoshi-ichiro; Kawasaki, Takashi; Tajima, Fumihiro] Wakayama Med Univ, Dept Rehabil Med, Wakayama, Japan; [Nishimura, Yukihide] Iwate Med Univ, Dept Rehabil Med, Morioka, Iwate, Japan; [Nakamura, Takeshi] Yokohama City Univ, Sch Med, Dept Rehabil Med, Yokohama, Kanagawa, Japan	Wakayama Medical University; Iwate Medical University; Yokohama City University	Tajima, F (corresponding author), Wakayama Med Univ, Dept Rehabil Med, Wakayama, Japan.	tajibun@gmail.com	Kamijo, Yoshi-ichiro/AAH-2810-2020	Nishimura, Yukihide/0000-0002-5365-1347	JSPS KAKENHI [15K01384]; Japan Society for the Promotion Science (JSPS) [15K01384]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by JSPS KAKENHI Grant Number 15K01384. The URL of Japan Society for the Promotion Science (JSPS) is https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K01384/. The author who received funding is FT.	Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chumney D, 2010, J REHABIL RES DEV, V47, P17, DOI 10.1682/JRRD.2009.08.0140; Cumming TB, 2008, J REHABIL MED, V40, P609, DOI 10.2340/16501977-0226; Cumming TB, 2011, STROKE, V42, P153, DOI 10.1161/STROKEAHA.110.594598; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Greening NJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4315; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Intercollegiat e Stroke Working Party, 2012, NAT CFLIN GUID STROK; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MAHONEY F I, 1965, Md State Med J, V14, P61; Management of Stroke Rehabilitation Working Group, 2010, VA DOD CLIN PRACT GU; Momosaki R, 2016, GERIATR GERONTOL INT, V16, P963, DOI 10.1111/ggi.12582; Moriki T, 2013, OPEN J THER REHABIL, V01, P1; National Stroke Foundation, 2010, CLIN GUID STROK MAN; Roberts L, 1998, STROKE, V29, P986, DOI 10.1161/01.STR.29.5.986; Sorbello D, 2009, CEREBROVASC DIS, V28, P378, DOI 10.1159/000230712; Tay-Teo K, 2008, CEREBROVASC DIS, V26, P475, DOI 10.1159/000155984; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; The Japan Stoke Society, 2015, JAP GUID MAN STROK; Tyedin K, 2010, DISABIL REHABIL, V32, P875, DOI 10.3109/09638280903349552; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	29	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187099	10.1371/journal.pone.0187099	http://dx.doi.org/10.1371/journal.pone.0187099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073250	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400114
J	Percher, AM; Romero, A; Galbany, J; Akoue, GN; Perez-Perez, A; Charpentier, MJE				Percher, Alice M.; Romero, Alejandro; Galbany, Jordi; Akoue, Gontran Nsi; Perez-Perez, Alejandro; Charpentier, Marie J. E.			Buccal dental-microwear and dietary ecology in a free-ranging population of mandrills (Mandrillus sphinx) from southern Gabon	PLOS ONE			English	Article							TOOTH WEAR; FEEDING-BEHAVIOR; JAW MOVEMENT; TEXTURE; VARIABILITY; MASTICATION; HABITS; INVIVO; MIDDLE; INDEX	Analyses of dental micro- and macro-wear offer valuable information about dietary adaptations. The buccal surface of the teeth does not undergo attrition, indicating that dental microwear may directly inform about food properties. Only a few studies have, however, investigated the environmental and individual factors involved in the formation of such microwear in wild animals. Here, we examine variation of buccal microwear patterns of mandibular molars in a large free-ranging population of mandrills (Mandrillus sphinx). We first explore the influence of seasonality and individual's sex, age and tooth macrowear-expressed as the percent of dentine exposure (PDE)-on six microwear variables. Second, we analyze the interplay between individual's diet and PDE. In a last analysis, we revisit our results on mandrills in the light of other primate's microwear studies. We show that the average buccal scratch length and the frequency of vertical buccal scratches are both higher during the long dry season compared to the long rainy season, while we observe the inverse relationship for disto-mesial scratches. In addition, females present more disto-mesial scratches than males and older individuals present higher scratch density, a greater proportion of horizontal scratches but a lower proportion of vertical scratches than young animals. PDE yields similar results than individual's age confirming earlier results in this population on the relationship between age and tooth macrowear. Because seasonality and individual characteristics are both known to impact mandrills' diet in the study population, our results suggest that buccal microwear patterns may inform about individual feeding strategies. Furthermore, PDE increases with the consumption of potentially abrasive monocotyledonous plants, independently of the individuals' age, although it is not affected by food mechanical properties. Finally, buccal scratch densities by orientation appear as relevant proxies for discriminating between different primate taxa.	[Percher, Alice M.; Charpentier, Marie J. E.] Univ Montpellier, ISE M, UMR5554, CNRS,IRD,EPHE, Montpellier, France; [Romero, Alejandro] Univ Alicante, Dept Biotecnol, Alicante, Spain; [Galbany, Jordi] George Washington Univ, Ctr Adv Study Human Paleobiol, Dept Anthropol, Washington, DC USA; [Akoue, Gontran Nsi] Univ Sci & Tech Masuku, Franceville, Gabon; [Perez-Perez, Alejandro] Univ Barcelona, Seccio Zool & Antropol, Dept Biol Evolut Ecol & Ciencies Ambientals, Fac Biol, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universitat d'Alacant; George Washington University; University of Barcelona	Percher, AM (corresponding author), Univ Montpellier, ISE M, UMR5554, CNRS,IRD,EPHE, Montpellier, France.	aipercher@wanadoo.fr	Pérez-Pérez, Alejandro/K-6715-2014; Galbany, Jordi/K-8609-2017; Romero, Alejandro/J-9405-2014	Pérez-Pérez, Alejandro/0000-0002-1442-1397; Galbany, Jordi/0000-0001-6724-3451; Romero, Alejandro/0000-0002-5743-0613; Charpentier, Marie/0000-0001-6530-5874	Deutsche Forschungsgemeinschaft (DFG) [KA 1082-20-1]; "Station d'Etudes en Ecologie Globale" (INEE-CNRS); "Laboratoire International Associe" (CIRMF and INEE-CNRS); Spanish "Ministerio de Ciencia e Innovacion" [CGL2011-22999, CGL2014-52611]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); "Station d'Etudes en Ecologie Globale" (INEE-CNRS); "Laboratoire International Associe" (CIRMF and INEE-CNRS); Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The Deutsche Forschungsgemeinschaft grant (DFG, KA 1082-20-1), the "Station d'Etudes en Ecologie Globale" (INEE-CNRS), the "Laboratoire International Associe" (CIRMF and INEE-CNRS), granted to MJEC, and the Spanish "Ministerio de Ciencia e Innovacion" (grant numbers CGL2011-22999 and CGL2014-52611); We are grateful to past and present field assistants of the Mandrillus Project for data collection, as well as Beatriz Gamarra and Fiacre Itsoma who contributed to the dental molds used in this study. We also thank Laura Carratala Castillo, Sara Mira Sanchez, Veronica Lopez and Andres Amoros for methodological help. Photographs used for tooth macrowear were obtained using a stereoscopic microscope of the Paleontology team at ISE-M (France). The Deutsche Forschungsgemeinschaft grant (DFG, KA 1082-20-1), the "Station d'Etudes en Ecologie Globale" (INEE-CNRS), the "Laboratoire International Associe" (CIRMF and INEE-CNRS), granted to MJEC, and the Spanish "Ministerio de Ciencia e Innovacion" (grant numbers CGL2011-22999 and CGL2014-52611) granted to APP, have all contributed to the achievement of this study. This is a Mandrillus Project publication number 13 and an ISEM 2017-239-SUD.	Agrawal KR, 2000, ARCH ORAL BIOL, V45, P577, DOI 10.1016/S0003-9969(00)00019-4; Aliaga-Martinez A, 2017, AM J PHYS ANTHROPOL, V163, P462, DOI 10.1002/ajpa.23219; Brockmeyer T, 2015, AM J PRIMATOL, V77, P1036, DOI 10.1002/ajp.22439; Charles C, 2007, NATURWISSENSCHAFTEN, V94, P71, DOI 10.1007/s00114-006-0161-7; Daegling DJ, 1999, PRIMATES, V40, P559, DOI 10.1007/BF02574831; Estebaranz F, 2012, J ANTHROPOL SCI, V90, P163, DOI [10.4436/JASS.90006, 10.4436/jass.90006]; FOX CL, 1994, J ARCHAEOL SCI, V21, P29, DOI 10.1006/jasc.1994.1005; Galbany J, 2006, MICROSC RES TECHNIQ, V69, P246, DOI 10.1002/jemt.20296; Galbany J., 2004, ANTHROPOLOGIE, V42, P5; Galbany J., 2004, ANTHROPOLOGIE, V42, P13; Galbany J, 2014, PLOS ONE, P9; Galbany J, 2011, AM J PHYS ANTHROPOL, V144, P51, DOI 10.1002/ajpa.21368; Galbany J, 2009, PRIMATES, V50, P221, DOI 10.1007/s10329-009-0139-0; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; HYLANDER WL, 1979, J MORPHOL, V159, P253, DOI 10.1002/jmor.1051590208; Iriarte-Diaz J, 2011, INTEGR COMP BIOL, V51, P307, DOI 10.1093/icb/icr072; JABLONSKI NG, 1994, INT J PRIMATOL, V15, P29, DOI 10.1007/BF02735233; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; LAHM SA, 1986, AM J PRIMATOL, V11, P9, DOI 10.1002/ajp.1350110103; Lalueza C, 1996, AM J PHYS ANTHROPOL, V100, P367, DOI 10.1002/(SICI)1096-8644(199607)100:3<367::AID-AJPA5>3.0.CO;2-R; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Logan M, 2002, J ZOOL, V256, P63, DOI 10.1017/S0952836902000080; Lucas P.W., 2017, J HUM EVOL, V74, P130, DOI DOI 10.1016/J.JHEV0L.2016.08.004; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; Maas MC, 1994, EVOL ANTHR ISSUES NE, V8, P133; McAfee RK, 2015, ARCH ORAL BIOL, V60, P181, DOI 10.1016/j.archoralbio.2014.09.014; Meldrum DJ, 1997, AM J PHYS ANTHROPOL, V102, P407, DOI 10.1002/(SICI)1096-8644(199703)102:3<407::AID-AJPA8>3.0.CO;2-R; Merceron G, 2010, PLOS ONE, P5; Merceron G, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1032; Merceron G, 2014, FOREST ECOL MANAG, V328, P262, DOI 10.1016/j.foreco.2014.05.041; Martinez LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165447; Nsi Akoue G, 2017, ETHOLOGY; Parker S., 1990, GRIMZIKS ENCY MAMMAL; Peigne S, 2009, P NATL ACAD SCI USA, V106, P15390, DOI 10.1073/pnas.0907373106; Peignot P, 2008, ORYX, V42, P122, DOI 10.1017/S0030605308000136; Percher A, DENT MICROWEAR TEXTU; Perez-Perez A, 2003, J HUM EVOL, V44, P497, DOI 10.1016/S0047-2484(03)00030-7; PEREZPEREZ A, 1994, AM J PHYS ANTHROPOL, V94, P175, DOI 10.1002/ajpa.1330940203; Polet Caroline, 2008, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V20, P165; PUECH PF, 1980, CR ACAD SCI D NAT, V290, P1413; Rabenold D, 2014, J HUM EVOL, V74, P130, DOI 10.1016/j.jhevol.2014.02.001; Rabenold D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028379; Romero A, 2013, SCANNING ELECT MICRO; Romero A, 2012, AM J PHYS ANTHROPOL, V148, P467, DOI 10.1002/ajpa.22054; Romero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072195; Ross CF, 2012, INT J PRIMATOL, V33, P632, DOI 10.1007/s10764-012-9599-y; Scott JR, 2012, MAMMALIA, V76, P157, DOI 10.1515/mammalia-2011-0083; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Shapiro AE, 2015, VARIATION DENT MICRO; Strait SG, 2014, J HUM EVOL, V71, P87, DOI 10.1016/j.jhevol.2014.02.013; TAKADA K, 1994, ARCH ORAL BIOL, V39, P793, DOI 10.1016/0003-9969(94)90009-4; Teaford Mark F., 1994, Evolutionary Anthropology, V3, P17, DOI 10.1002/evan.1360030107; TEAFORD MF, 1991, AM J PHYS ANTHROPOL, V85, P313, DOI 10.1002/ajpa.1330850310; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P391, DOI 10.1002/ajpa.1330800312; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Telfer PT, 2003, MOL ECOL, V12, P2019, DOI 10.1046/j.1365-294X.2003.01877.x; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 1996, AM J PHYS ANTHROPOL, V100, P101; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Venkataraman VV, 2014, AM J PHYS ANTHROPOL, V155, P17, DOI 10.1002/ajpa.22571; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; WALKER PL, 1976, AM J PHYS ANTHROPOL, V45, P299, DOI 10.1002/ajpa.1330450215; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Xia J, 2015, P NATL ACAD SCI USA, V112, P10669, DOI 10.1073/pnas.1509491112	68	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186870	10.1371/journal.pone.0186870	http://dx.doi.org/10.1371/journal.pone.0186870			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073184	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400066
J	Huang, LS; Carey, V; Lindsey, JC; Marzan, F; Gingrich, D; Graham, B; Barlow-Mosha, L; Ssemambo, PK; Kamthunzi, P; Nachman, S; Parikh, S; Aweeka, FT				Huang, Liusheng; Carey, Vincent; Lindsey, Jane C.; Marzan, Florence; Gingrich, David; Graham, Bobbie; Barlow-Mosha, Linda; Ssemambo, Phionah K.; Kamthunzi, Portia; Nachman, Sharon; Parikh, Sunil; Aweeka, Francesca T.		IMPAACT P1079 Protocol Team	Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; INFECTED UGANDAN ADULTS; HUMAN PLASMA; ANTIRETROVIRAL THERAPY; ARTEMISININ RESISTANCE; METABOLITE DIHYDROARTEMISININ; HEALTHY-VOLUNTEERS; DRUG-INTERACTION; ARTEMETHER/LUMEFANTRINE; EFAVIRENZ	Background The antiretroviral drug nevirapine and the antimalarial artemisinin-based combination therapy artemether-lumefantrine are commonly co-administered to treat malaria in the context of HIV. Nevirapine is a known inhibitor of cytochrome P450 3A4, which metabolizes artemether and lumefantrine. To address the concern that the antiretroviral nevirapine impacts the antimalarial artemether-lumefantrine pharmacokinetics, a prospective non-randomized controlled study in children presenting with uncomplicated malaria and HIV in sub-Saharan Africa was carried out. Methods Participants received artemether-lumefantrine (20/120 mg weight-based BID) for 3 days during nevirapine-based antiretroviral therapy (ART) co-administration (158-266 mg/m(2) QD). HIV positive participants who were not yet on ART drugs were also enrolled as the control group. The target enrollment was children aged 3-12 years (n = 24 in each group). Intensive pharmacokinetics after the last artemether-lumefantrine dose was assessed for artemether, its active metabolite dihydroartemisinin, and lumefantrine. Pharmacokinetic parameters (area under the plasma concentration vs. time curve (AUC), maximum concentration and day 7 lumefantrine concentrations) were estimated using non-compartmental methods and compared to controls. Results Nineteen children (16 on nevirapine and three not on ART) enrolled. Fifteen of the 16 (aged 4 to 11 years) on nevirapine-based ART were included in the pharmacokinetic analysis. Due to evolving WHO HIV treatment guidelines, insufficient children were enrolled in the control group (n = 3), so the pharmacokinetic data were compared to a historical control group of 20 HIV-uninfected children 5-12 years of age who also presented with malaria and underwent identical study procedures. Decreases of pharmacokinetic exposure [ as estimated by AUC (AUC(0-8hr))] were marginally significant for artemether (by -46%, p = 0.08) and dihydroartemisinin (-22%, p = 0.06) in the children on nevirapine-based ART, compared to when arte-mether- lumefantrine was administered alone. Similarly, peak concentration was decreased by 50% (p = 0.07) for artemether and 36% (p = 0.01) for dihydroartemisinin. In contrast, exposure to lumefantrine increased significantly in the context of nevirapine [AUC(0120hr): 123% (p< 0.001); C-day7: 116% (p< 0.001), C-max: 95% (p< 0.001)]. Conclusions Nevirapine-based ART increases the exposure to lumefantrine in pre-pubescent children with a trend toward diminished artemether and dihydroartemisinin exposure. These findings contrast with other studies indicating NVP reduces or results in no change in exposure of antimalarial drugs, and may be specific to this age group (4-12 years). Considering the excellent safety profile of artemether-lumefantrine, the increase in lumefantrine is not of concern. However, the reduction in artemisinin exposure may warrant further study, and suggests that dosage adjustment of artemether-lumefantrine with nevirapine-based ART in children is likely warranted.	[Huang, Liusheng; Marzan, Florence; Gingrich, David; Aweeka, Francesca T.] Univ Calif San Francisco, Dept Clin Pharm, Drug Res Unit, San Francisco, CA 94143 USA; [Carey, Vincent; Lindsey, Jane C.] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA; [Graham, Bobbie] Frontier Sci & Technol Res Fdn Inc, Buffalo, NY USA; [Barlow-Mosha, Linda; Ssemambo, Phionah K.] Makerere Univ, MUJHU Res Collaborat, Kampala, Uganda; [Ssemambo, Phionah K.] Kamuzu Cent Hosp, Private Bag A-104, Lilongwe, Malawi; [Nachman, Sharon] SUNY Stony Brook, Sch Med, Stony Brook, NY USA; [Parikh, Sunil] Yale Sch Publ Hlth, New Haven, CT USA	University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; Makerere University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University	Huang, LS; Aweeka, FT (corresponding author), Univ Calif San Francisco, Dept Clin Pharm, Drug Res Unit, San Francisco, CA 94143 USA.	liusheng.huang@ucsf.edu; Fran.Aweeka@ucsf.edu		Hobbs, Charlotte/0000-0003-4829-0791; Barlow-Mosha, Linda/0000-0003-3241-2141; Cressey, Tim R./0000-0002-8106-0974	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1A1068632, UM1A1068616, UM1A1106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD068174]; National Institute of Mental Health (NIMH); UCSF-GIVI Center for AIDS Research (CFAR) [P30 A1027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106716, U01AI068616, UM1AI068616, UM1AI068632] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCSF-GIVI Center for AIDS Research (CFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1A1068632 (IMPAACT LOC), UM1A1068616 (IMPAACT SDMC) and UM1A1106716 (IMPAACT LC) https://www.niaid.nih.govi, with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the award number R01 HD068174, https://wm.nichd.nih.gov/Pages/index.aspx, the National Institute of Mental Health (NIMH), and UCSF-GIVI Center for AIDS Research (CFAR) under award number P30 A1027763, http://cfar.ucsf.edu/.	Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; Anstey NM, 2015, LANCET INFECT DIS, V15, P692, DOI 10.1016/S1473-3099(15)70024-1; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ashley EA, 2007, TROP MED INT HEALTH, V12, P195, DOI [10.1111/j.1365-3165.2006.01784.x, 10.1111/j.1365-3156.2006.01784.x]; Ayele TA, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0567-7; Byakika-Kibwika P, 2012, J ANTIMICROB CHEMOTH, V67, P2213, DOI 10.1093/jac/dks207; Byakika-Kibwika P, 2012, J ANTIMICROB CHEMOTH, V67, P1217, DOI 10.1093/jac/dkr596; Clinical Pharmacology Quality Assurance (CPQA) program, 2012, CPQA GUID CHROM METH; Cooper CL, 2007, HIV MED, V8, P1, DOI 10.1111/j.1468-1293.2007.00426.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Erickson DA, 1999, DRUG METAB DISPOS, V27, P1488; German P, 2009, JAIDS-J ACQ IMM DEF, V51, P424, DOI 10.1097/QAI.0b013e3181acb4ff; Hanpithakpong W, 2009, BIOANALYSIS, V1, P37, DOI 10.4155/BIO.09.6; HIV/ AIDS, DAT STAT; Hoglund RM, 2015, BRIT J CLIN PHARMACO, V79, P636, DOI 10.1111/bcp.12529; Huang LS, 2013, BIOANALYSIS, V5, P1501, DOI [10.4155/BIO.13.91, 10.4155/bio.13.91]; Huang LS, 2012, JAIDS-J ACQ IMM DEF, V61, P310, DOI 10.1097/QAI.0b013e31826ebb5c; Huang LS, 2012, BIOANALYSIS, V4, P157, DOI [10.4155/BIO.11.303, 10.4155/bio.11.303]; Huang LS, 2010, ANAL CHEM INSIGHTS, V5, P15; Huang LS, 2009, J PHARMACEUT BIOMED, V50, P959, DOI 10.1016/j.jpba.2009.06.051; Hyland R, 2008, BRIT J CLIN PHARMACO, V66, P498, DOI 10.1111/j.1365-2125.2008.03198.x; Kajubi Richard, 2016, Open Forum Infect Dis, V3, pofw217, DOI 10.1093/ofid/ofw217; Kekitiinwa A, 2017, PEDIATR INFECT DIS J, V36, P588, DOI 10.1097/INF.0000000000001505; Kredo T, 2011, ANTIMICROB AGENTS CH, V55, P5616, DOI 10.1128/AAC.05265-11; Maganda BA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-205; Makanga M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S5; Mwebaza N, 2017, BASIC CLIN PHARMACOL, V120, P457, DOI 10.1111/bcpt.12714; Mwesigwa J, 2010, ANTIMICROB AGENTS CH, V54, P52, DOI 10.1128/AAC.00679-09; Parikh S, 2016, CLIN INFECT DIS, V63, P414, DOI 10.1093/cid/ciw291; Parikh S, 2015, ANTIMICROB AGENTS CH, V59, P7852, DOI 10.1128/AAC.01153-15; Pozniak AL, 2008, BRIT J CLIN PHARMACO, V65, P54, DOI 10.1111/j.1365-2125.2008.03136.x; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; WHO, 2016, CONS GUID US ANT DRU, p[97, 151]; World Health Organization, 2010, ANT THER HIV INF INF	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186589	10.1371/journal.pone.0186589	http://dx.doi.org/10.1371/journal.pone.0186589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065172	Green Submitted, Green Published, gold			2022-12-26	WOS:000413568900020
J	Cachon, T; Pillard, P; Odent, T; Carozzo, C; Viguier, E				Cachon, Thibaut; Pillard, Paul; Odent, Thierry; Carozzo, Claude; Viguier, Eric			Safe corridor for the implantation of thoracolumbar pedicle screws in growing pigs: A morphometric study	PLOS ONE			English	Article							PORCINE MODEL; ANIMAL-MODELS; SPINAL GROWTH; SCOLIOSIS; PLACEMENT; INSTRUMENTATION; FIXATION	The pig spine is widely used as a large animal model for preclinical research in human medicine to test new spinal implants and surgical procedures. Among them, pedicle screw is one of the most common method of fixation of those implants. However, the pedicle of the porcine vertebra is not as well defined and not as large as the pedicle of the human vertebra. Therefore, the position of the screw should be adapted to the pig and not merely transposed based on the literature on humans. The purpose of this study is to determine the characteristics of the optimum implantation corridors for pedicle screws in the thoracolumbar spine of piglets of different ages using computed tomography (CT) and to determine the size and length of these corridors in pigs of different ages. CT scans from five groups of age: 6, 10, 14, 18, and 26 weeks were reviewed. For each thoracolumbar vertebrae, the pedicle width, pedicle axis length, and the pedicle angle was measured for the left and right pedicle. A total of 326 thoracic vertebrae and 126 lumbar vertebrae were included in the study. Pedicles are statistically larger but not longer for the lumbar vertebrae. An important variation of the pedicle angle is observed along the spine. In all pigs, an abrupt modification of the pedicle angle between T10 and T11 was observed, which corresponds to the level of the anticlinal vertebra which is the vertebra for which the spinous process is nearly perpendicular to the vertebral body. In conclusion, this study provides a quantitative database of pedicle screw implantation corridors in pigs of different ages. When using pedicle screws in experimental studies in pigs, these results should be considered for selecting the most suitable implants for the study but also to ensure a correct and safer screw position. Improving study procedures may limit postoperative complications and pain, thereby limiting the use of live animals.	[Cachon, Thibaut; Pillard, Paul; Carozzo, Claude; Viguier, Eric] Campus Vet LyonVetAgro Sup, Unite ICE USPS 2016 A104, Marcy Letoile, France; [Odent, Thierry] CHU Tours, Hop Enfants Clocheville, Serv Chirurg Orthoped Pediat, Tours, France	CHU Tours	Cachon, T (corresponding author), Campus Vet LyonVetAgro Sup, Unite ICE USPS 2016 A104, Marcy Letoile, France.	thibaut.cachon@vetagro-sup.fr		CACHON, Thibaut/0000-0002-0919-6228				Busscher I, 2010, EUR SPINE J, V19, P1104, DOI 10.1007/s00586-010-1326-9; Cho W, 2010, J BONE JOINT SURG BR, V92B, P1061, DOI 10.1302/0301-620X.92B8.24237; Driscoll M, 2012, EUR SPINE J, V21, P138, DOI 10.1007/s00586-011-1966-4; Dubousset J, 2001, SPINE, V26, P1001, DOI 10.1097/00007632-200105010-00002; Fekete TF, 2011, EUR SPINE J, V20, P1892, DOI 10.1007/s00586-011-1889-0; Hershman SH, 2013, BULL HOSP JT DIS, V71, P49; Janssen MMA, 2011, SPINE J, V11, P347, DOI 10.1016/j.spinee.2011.03.010; KRAG MH, 1988, SPINE, V13, P27, DOI 10.1097/00007632-198801000-00007; Le Cann S, 2014, COMPUT METHOD BIOMEC, V17, P66, DOI 10.1080/10255842.2014.931128; Mageed Mahmoud, 2013, Lab Anim Res, V29, P138, DOI 10.5625/lar.2013.29.3.138; Mahar AT, 2008, SPINE J, V8, P933, DOI 10.1016/j.spinee.2007.10.031; Mattei TA, 2009, NEUROL INDIA, V57, P715, DOI 10.4103/0028-3886.59465; McLain RF, 2002, SPINE, V27, P2467, DOI 10.1097/00007632-200211150-00009; McLain Robert F, 2002, Spine (Phila Pa 1976), V27, pE200; Newton PO, 2008, J BONE JOINT SURG AM, V90A, P2695, DOI 10.2106/JBJS.G.01424; Odent T, 2011, EUR SPINE J, V20, P1869, DOI 10.1007/s00586-011-1830-6; Oetgen M.E., 2012, SEMIN SPINE SURG, V24, P155, DOI [10.1053/j.semss.2012.04.005, DOI 10.1053/J.SEMSS.2012.04.005]; Parent S, 2002, SPINE, V27, P2305, DOI 10.1097/00007632-200211010-00002; Parent S, 2004, SPINE, V29, P239, DOI 10.1097/01.BRS.0000109995.64028.FE; Pillard P, 2014, COMPUT METHOD BIOMEC, V17, P64, DOI 10.1080/10255842.2014.931126; Roth AK, 2013, SPINE J, V13, P675, DOI 10.1016/j.spinee.2013.02.043; Roy-Camille R, 1986, CLIN ORTHOP RELAT R, V7, P17; ROYCAMILLE R, 1986, ORTHOP CLIN N AM, V17, P147; Schwab F, 2009, SPINE, V34, pE397, DOI 10.1097/BRS.0b013e3181a27156; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; Sterba W, 2007, CLIN BIOMECH, V22, P385, DOI 10.1016/j.clinbiomech.2006.11.007; Suk SI, 2012, EUR SPINE J, V21, P13, DOI 10.1007/s00586-011-1986-0; Suk SI, 2011, CLIN ORTHOP SURG, V3, P89, DOI 10.4055/cios.2011.3.2.89; ZINDRICK MR, 1987, SPINE, V12, P160, DOI 10.1097/00007632-198703000-00012	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0184857	10.1371/journal.pone.0184857	http://dx.doi.org/10.1371/journal.pone.0184857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059193	gold, Green Submitted, Green Published			2022-12-26	WOS:000413403000003
J	Harrower, WL; Srivastava, DS; McCallum, C; Fraser, LH; Turkington, R				Harrower, William L.; Srivastava, Diane S.; McCallum, Cindy; Fraser, Lauchlan H.; Turkington, Roy			Temperate grassland songbird species accumulate incrementally along a gradient of primary productivity	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; VESPER SPARROWS; BOTTOM-UP; TOP-DOWN; BIRDS; DIVERSITY; COMMUNITY; NORTH; VEGETATION; DYNAMICS	Global analyses of bird communities along elevation gradients suggest that bird diversity on arid mountains is primarily limited by water availability, not temperature or altitude. However, the mechanism by which water availability, and subsequently primary productivity, increases bird diversity is still unclear. Here we evaluate two possible mechanisms from species-energy theory. The more individuals hypothesis proposes that a higher availability of resources increases the total number of individuals that can be supported, and therefore the greater number of species that will be sampled. By contrast, the more specialization hypothesis proposes that increasing resource availability will permit specialists to exploit otherwise rare resources, thus increasing total diversity. We used 5 years of surveys of grassland songbird communities along an elevational gradient in British Columbia, Canada, to distinguish between these hypotheses. Vegetation changed markedly in composition along the gradient and contrary to the expectations of the more specialization hypothesis, bird community composition was remarkably constant. However, both total abundance and species richness of birds increased with increasing water availability to plants. When we used rarefaction to correct species richness for differences in total abundance, much of the increase in bird diversity was lost, consistent with the expectations of the more individuals hypothesis. Furthermore, high species richness was associated with reductions in territory size of common bird species, rather than the fine-scale spatial partitioning of the landscape. This suggests that bird diversity increases when greater resource availability allows higher densities rather than greater habitat specialization. These results help explain a pervasive global pattern in bird diversity on arid mountains, and suggest that in such landscapes conservation of grassland birds is strongly linked to climate and hydrology.	[Harrower, William L.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada; [Harrower, William L.; Turkington, Roy] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Harrower, William L.; Srivastava, Diane S.; Turkington, Roy] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada; [Srivastava, Diane S.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [McCallum, Cindy] McCallum Environm Consulting Ltd, Kamloops, BC, Canada; [Fraser, Lauchlan H.] Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Harrower, WL (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC, Canada.; Harrower, WL (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.; Harrower, WL (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada.	harrower@biodiversity.ubc.ca			HCTF; Government of British Columbia	HCTF; Government of British Columbia	HCTF provided support in the form of salaries for Cindy McCallum, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Amanda Schmitz, Cameron Carlyle, and Eleanor Basset from the Fraser Lab at Thomson Rivers University for their logistical support on this research. Drs. Gary Bradfield, and Charlie Krebs at the University of British Columbia provided valuable comments on the manuscript. Todd Haughton at British Columbia Parks provided useful advice and provided access to the study area, and Cindy Haddow and the Government of British Columbia helped develop early ideas and provided financial support. The protocol was approved by the Animal Care Committee at the University of British Columbia (Permit Number: BC11-0045).	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Bates D, 2015, J STAT SOFTW, pxx; Bonn A, 2004, P ROY SOC B-BIOL SCI, V271, P1685, DOI 10.1098/rspb.2004.2745; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Canada E, 2015, CANADIAN CLIMATE NOR; Carlyle C, 2014, OECOLOGIA, V174, P1065, DOI 10.1007/s00442-013-2833-2; CODY ML, 1968, AM NAT, V102, P107, DOI 10.1086/282531; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Coristine LE, 2015, ECOL EVOL, V5, P5162, DOI 10.1002/ece3.1683; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Davis SK, 1999, WILSON BULL, V111, P389; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; ESRI, 2013, ARCGIS DESKT REL 10; Evans CW., 2011, A COMPARISON OF THE; Fisher RJ, 2010, J WILDLIFE MANAGE, V74, P265, DOI 10.2193/2009-020; Fiske I, 2010, OVERVIEW UNMARKED PA, P5; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Grant TA, 2006, J WILDLIFE MANAGE, V70, P691, DOI 10.2193/0022-541X(2006)70[691:NSOCAV]2.0.CO;2; Grant TA, 2010, J WILDLIFE MANAGE, V74, P1841, DOI 10.2193/2010-006; Greenville AC, 2014, OECOLOGIA, V175, P1349, DOI 10.1007/s00442-014-2977-8; Harrison ML, 2010, AVIAN CONSERV ECOL, V5; Harrison ML, 2011, J FIELD ORNITHOL, V82, P140, DOI 10.1111/j.1557-9263.2011.00316.x; Hawkins BA, 2003, GLOBAL ECOL BIOGEOGR, V12, P475, DOI 10.1046/j.1466-822X.2003.00060.x; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Jankowski JE, 2007, BIOL CONSERV, V138, P453, DOI 10.1016/j.biocon.2007.05.015; Jankowski JE, 2013, J BIOGEOGR, V40, P950, DOI 10.1111/jbi.12041; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Lee RN, 2014, BOTANY, V92, P837, DOI 10.1139/cjb-2014-0107; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; MAY RM, 1972, P NATL ACAD SCI USA, V69, P1109, DOI 10.1073/pnas.69.5.1109; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McDonald KW, 2012, ECOL EVOL, V2, P3052, DOI 10.1002/ece3.410; McLaren K, 1981, TREASURES LAC BOIS; Meserve PL, 2003, BIOSCIENCE, V53, P633, DOI 10.1641/0006-3568(2003)053[0633:TYOSTA]2.0.CO;2; North American Bird Conservation Initiative, 2016, STAT N AM BIRDS 2016; North American Bird Conservation Initiative Canada, 2012, STAT CAN BIRDS; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Parra JL, 2011, J BIOGEOGR, V38, P2350, DOI 10.1111/j.1365-2699.2011.02558.x; R Core Team, 2016, R FDN STAT COMP; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Richardson AN., 2012, CHANGES GRASSLAND SO; ROTENBERRY JT, 1980, OECOLOGIA, V47, P1, DOI 10.1007/BF00541768; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Schmidt AC, 2012, RANGELAND ECOL MANAG, V65, P292, DOI 10.2111/REM-D-11-00100.1; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Swengel SR, 2001, BIRD CONSERV INT, V11, P113; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849; WIENS JA, 1985, AUK, V102, P500, DOI 10.1093/auk/102.3.500; WIENS JA, 1981, ECOL MONOGR, V51, P21, DOI 10.2307/2937305; WIENS JA, 1987, AM NAT, V129, P920, DOI 10.1086/284684; WIENS JA, 1973, ECOL MONOGR, V43, P237, DOI 10.2307/1942196; Winter M, 2005, J WILDLIFE MANAGE, V69, P185, DOI 10.2193/0022-541X(2005)069&lt;0185:VIVEOD&gt;2.0.CO;2; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	62	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186809	10.1371/journal.pone.0186809	http://dx.doi.org/10.1371/journal.pone.0186809			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059252	gold, Green Submitted, Green Published			2022-12-26	WOS:000413403000044
J	Zabinyakov, N; Bullivant, G; Cao, F; Ojeda, MF; Jia, ZP; Wen, XY; Dowling, JJ; Salomons, GS; Mercimek-Andrews, S				Zabinyakov, Nikita; Bullivant, Garrett; Cao, Feng; Ojeda, Matilde Fernandez; Jia, Zheng Ping; Wen, Xiao-Yan; Dowling, James J.; Salomons, Gajja S.; Mercimek-Andrews, Saadet			Characterization of the first knock-out aldh7a1 zebrafish model for pyridoxine-dependent epilepsy using CRISPR-Cas9 technology	PLOS ONE			English	Article							LYSINE-RESTRICTED DIET; ARGININE SUPPLEMENTATION; PIPECOLIC ACID; MUTATIONS; THERAPY; ANTIQUITIN; SEIZURES	Pyridoxine dependent epilepsy (PDE) is caused by likely pathogenic variants in ALDH7A1 (PDE-ALDH7A1) and inherited autosomal recessively. Neurotoxic alpha-amino adipic semialdehyde (alpha-AASA), piperideine 6-carboxylate and pipecolic acid accumulate in body fluids. Neonatal or infantile onset seizures refractory to anti-epileptic medications are clinical features. Treatment with pyridoxine, arginine and lysine-restricted diet does not normalize neurodevelopmental outcome or accumulation of neurotoxic metabolites. There is no animal model for high throughput drug screening. For this reason, we developed and characterized the first knock-out aldh7a1 zebrafish model using CRISPR-Cas9 technology. Zebrafish aldh7a1 mutants were generated by using a vector free method of CRISPR-Cas9 mutagenesis. Genotype analysis of aldh7a1 knock-out zebrafish was performed by high resolution melt analysis, direct sequencing and QIAxcel system. Electroencephalogram was performed. Alpha-AASA, piperideine 6-carboxylate and pipecolic acid, were measured by liquid chromatography-tandem mass spectrometry. Our knock-out aldh7a1 zebrafish has homozygous 5 base pair (bp) mutation in ALDH7A1. Knock-out aldh7a1 embryos have spontaneous rapid increase in locomotion and a rapid circling swim behavior earliest 8-day post fertilization (dpf). Electroencephalogram revealed large amplitude spike discharges compared to wild type. Knock-out aldh7a1 embryos have elevated alpha-AASA, piperideine 6-carboxylate and pipecolic acid compared to wild type embryos at 3 dpf. Knock-out aldh7a1 embryos showed no aldh7a1 protein by western blot compared to wild type. Our knock-out aldh7a1 zebrafish is a well characterized model for large-scale drug screening using behavioral and biochemical features and accurately recapitulates the human PDE-ALDH7A1 disease.	[Zabinyakov, Nikita; Dowling, James J.; Mercimek-Andrews, Saadet] Hosp Sick Children, Res Inst, Genet & Genome Biol Program, Toronto, ON, Canada; [Bullivant, Garrett; Mercimek-Andrews, Saadet] Univ Toronto, Div Clin & Metab Genet, Dept Pediat, Toronto, ON, Canada; [Cao, Feng; Jia, Zheng Ping] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON, Canada; [Cao, Feng; Jia, Zheng Ping] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ojeda, Matilde Fernandez; Salomons, Gajja S.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Lab,Neurosci Amsterdam, Amsterdam, Netherlands; [Wen, Xiao-Yan] St Michaels Hosp, Zebrafish Ctr Adv Drug Discovery, Toronto, ON, Canada; [Wen, Xiao-Yan] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Dowling, James J.] Univ Toronto, Div Neurol, Dept Pediat, Toronto, ON, Canada; [Dowling, James J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Salomons, Gajja S.] Neurosci Campus, Amsterdam, Netherlands; [Mercimek-Andrews, Saadet] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Mercimek-Andrews, S (corresponding author), Hosp Sick Children, Res Inst, Genet & Genome Biol Program, Toronto, ON, Canada.; Mercimek-Andrews, S (corresponding author), Univ Toronto, Div Clin & Metab Genet, Dept Pediat, Toronto, ON, Canada.; Mercimek-Andrews, S (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	saadet.andrews@sickkids.ca	Jia, zhengping/AAZ-4190-2021	Wen, Xiao-Yan/0000-0001-6728-0025; Andrews, Saadet/0000-0001-8396-6764	Department of Pediatrics, University of Toronto	Department of Pediatrics, University of Toronto	Dr. Saadet Mercimek-Andrews is funded through the Department of Pediatrics, University of Toronto for this study (New Investigator Start-Up Funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As principal author of this study, I, Saadet Mercimek-Andrews, would like to thank Dr. Berge Minassian for his tremendous support by providing laboratory space for the molecular genetic studies and encouragement for the development of my research program and his ongoing and excellent guidance and mentorship. We would like to thank Sarah Hutchinson at the Institutional Zebrafish Genetics and Disease Models Core Facility for generation of aldh7al knockout zebrafish using CRISPR-Cas9 technology. The authors would like to thank Michael Lead ley and Denis Reynaud for LC-MS-MS alpha-AASA, P6C, PA measurements and Analytical Facility for Bioactive Molecules (AFBM) of the Centre for the Study of Complex Childhood Diseases (CSCCD) at The Hospital for Sick Children, Toronto, Ontario. CSCCD was supported by the Canadian Foundation for Innovation (CFI). We would like to thank Dr. Eduard Struys for his help for the development of methods for alpha-AASA, P6C, PA measurements in our Institution. We would like to thank Ann Davidson, Jonathan Volpatti and Ramil Noche for their help with our technical questions regarding zebrafish. We would like to thank CaroLyne DesRoches for breeding and maintaining heterozygous knock-out aldh7al zebrafish. We would like to thank Theodora Bruun and Yannay Khaikin for their help in contributing high resolution melt analysis for genotyping. Dr. Saadet Mercimek-Andrews is funded through the Department of Pediatrics, University of Toronto for this study (New Investigator Start-Up Funding) and we would like to them thank for this funding support. We would like to thank Peter (Peixiang) Wang for his guidance in molecular genetic methods.	Al Teneiji A, 2017, MOL GENET METAB, V120, P235, DOI 10.1016/j.ymgme.2016.12.014; Babcock HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101782; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2013, JOVE-J VIS EXP, DOI 10.3791/50104; Coughlin CR, 2015, MOL GENET METAB, V116, P35, DOI 10.1016/j.ymgme.2015.05.011; Dinday MT, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0068-15.2015; Elango R, 2007, AM J CLIN NUTR, V86, P360, DOI 10.1093/ajcn/86.2.360; Gospe S.M, 1993, PYRIDOXINE DEPENDENT; HUNT AD, 1954, PEDIATRICS, V13, P140; Mahajnah M, 2016, PEDIATR NEUROL, V60, P60, DOI 10.1016/j.pediatrneurol.2016.03.008; Mercimek-Mahmutoglu S, 2014, EUR J PAEDIATR NEURO, V18, P741, DOI 10.1016/j.ejpn.2014.07.001; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Plecko B, 2005, NEUROPEDIATRICS, V36, P200, DOI 10.1055/s-2005-865727; Sadilkova K, 2009, J NEUROSCI METH, V184, P136, DOI 10.1016/j.jneumeth.2009.07.019; Schubert J, 2014, NAT GENET, V46, P1327, DOI 10.1038/ng.3130; Stockler S, 2011, MOL GENET METAB, V104, P48, DOI 10.1016/j.ymgme.2011.05.014; van Karnebeek CDM, 2015, JIMD REP, V15, P47, DOI 10.1007/8904_2014_296; van Karnebeek CDM, 2012, MOL GENET METAB, V107, P335, DOI 10.1016/j.ymgme.2012.09.006; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Winter Matthew J., 2008, Journal of Pharmacological and Toxicological Methods, V57, P176, DOI 10.1016/j.vascn.2008.01.004	20	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186645	10.1371/journal.pone.0186645	http://dx.doi.org/10.1371/journal.pone.0186645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053735	Green Submitted, Green Published, gold			2022-12-26	WOS:000413315100030
J	Garcia-Sanz, V; Paredes-Gallardo, V; Bellot-Arcis, C; Mendoza-Yero, O; Donate-Buendia, C; Montero, J; Albaladejo, A				Garcia-Sanz, Veronica; Paredes-Gallardo, Vanessa; Bellot-Arcis, Carlos; Mendoza-Yero, Omel; Donate-Buendia, Carlos; Montero, Javier; Albaladejo, Alberto			Effects of femtosecond laser and other surface treatments on the bond strength of metallic and ceramic orthodontic brackets to zirconia	PLOS ONE			English	Article							RESIN CEMENT; ADHESIVE; YAG	Femtosecond laser has been proposed as a method for conditioning zirconia surfaces to boost bond strength. However, metallic or ceramic bracket bonding to femtosecond lasertreated zirconia surfaces has not been tested. This study compared the effects of four conditioning techniques, including femtosecond laser irradiation, on shear bond strength (SBS) of metallic and ceramic brackets to zirconia. Three hundred zirconia plates were divided into five groups: 1) control (C); 2) sandblasting (APA); 3) silica coating and silane (SC); 4) femtosecond laser (FS); 5) sandblasting followed by femtosecond laser (APA+SC). A thermal imaging camera measured temperature changes in the zirconia during irradiation. Each group was divided into 2 subgroups (metallic vs ceramic brackets). SBS was evaluated using a universal testing machine. The adhesive remnant index (ARI) was registered and surfaces were observed under SEM. Surface treatment and bracket type significantly affected the bracket-zirconia bond strength. SBS was significantly higher (p<0.001) for ceramic brackets in all groups (APA+FS > APA > FS > SC > control) than metallic brackets (APA+FS > FS > SC > APA > control). For metallic brackets, groups SC (5.99 +/- 1.86 MPa), FS (6.72 +/- 2.30 MPa) and APA+ FS (7.22 +/- 2.73 MPa) reported significantly higher bond strengths than other groups (p < 0.05). For ceramic brackets, the highest bond strength values were obtained in groups APA (25.01 +/- 4.45 MPa), FS (23.18 +/- 6.51 MPa) and APA+ FS (29.22 +/- 8.20 MPa). Femtosecond laser enhances bond strength of ceramic and metallic brackets to zirconia. Ceramic brackets provide significantly stronger adhesion than metallic brackets regardless of the surface treatment method.	[Garcia-Sanz, Veronica; Paredes-Gallardo, Vanessa; Bellot-Arcis, Carlos] Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain; [Mendoza-Yero, Omel; Donate-Buendia, Carlos] Univ Jaume 1, Inst New Imaging Technol, GROC UJI, Castellon de La Plana, Spain; [Montero, Javier; Albaladejo, Alberto] Univ Salamanca, Fac Med, Dept Surg, Orthodont Teaching Unit, Salamanca, Spain	University of Valencia; Universitat Jaume I; University of Salamanca	Paredes-Gallardo, V (corresponding author), Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain.	vanessa.paredes@uv.es	BELLOT-ARCIS, CARLOS/AGP-0731-2022; MONTERO, JAVIER/D-7051-2018; Paredes, Vanessa/AAA-4540-2019; García-Sanz, Verónica/Z-3662-2019; Mendoza-Yero, Omel/F-1310-2016; Buendia, Carlos Doñate/AAD-9522-2019	BELLOT-ARCIS, CARLOS/0000-0003-4363-2713; MONTERO, JAVIER/0000-0003-3936-6539; Paredes, Vanessa/0000-0002-4137-5808; García-Sanz, Verónica/0000-0002-9192-2435; Mendoza-Yero, Omel/0000-0002-3248-1780; Buendia, Carlos Doñate/0000-0002-7022-0960	Generalitat Valenciana [PROMETEU/2016/079]; Ministerio de Economia y Competitividad (MINECO) [FIS2016-75618-R]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Economia y Competitividad (MINECO)(Spanish Government)	This investigation obtained financial support from Generalitat Valenciana through the project PROMETEU/2016/079 and the Ministerio de Economia y Competitividad (MINECO) through the project FIS2016-75618-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the financial support from Generalitat Valenciana through the project PROMETEU/2016/079 and the Ministerio de Economia y Competitividad (MINECO) through the project FIS2016-75618-R. The authors are also very grateful to the 'Serveis Centrals d'Instrumentacio A Cientifica (SCIC) of the University Jaume I for the use of the femtosecond laser and microscopy facilities.	Akin H, 2011, PHOTOMED LASER SURG, V29, P797, DOI 10.1089/pho.2011.3039; Akpinar YZ, 2015, PHOTOMED LASER SURG, V33, P206, DOI 10.1089/pho.2014.3791; Ansari MY, 2016, J CLIN DIAGN RES, V10, pZC64, DOI 10.7860/JCDR/2016/20624.8910; Armengol V, 2000, J ENDODONT, V26, P138, DOI 10.1097/00004770-200003000-00002; ARTUN J, 1984, AM J ORTHOD DENTOFAC, V85, P333, DOI 10.1016/0002-9416(84)90190-8; Cavalcanti AN, 2009, OPER DENT, V34, P280, DOI 10.2341/08-80; Erdur EA, 2015, LASER SURG MED, V47, P512, DOI 10.1002/lsm.22371; Fiedler S, 2013, BIOMED TECH BERL S1, V58; Kaygisiz E, 2016, J ADHES SCI TECHNOL, V30, P45, DOI 10.1080/01694243.2015.1088297; Kim NH, 2017, J ADHES DENT, V19, P21, DOI 10.3290/j.jad.a37724; Gomes AL, 2015, LASER MED SCI, V30, P787, DOI 10.1007/s10103-013-1433-z; Gomes AL, 2013, J DENT, V41, P31, DOI 10.1016/j.jdent.2012.09.013; Malmstrom HS, 2001, J DENT, V29, P521, DOI 10.1016/S0300-5712(01)00028-8; Misch C. E., 2008, CONT IMPLANT DENT; Moradabadi A, 2014, MAT SCI ENG C-MATER, V34, P311, DOI 10.1016/j.msec.2013.09.015; Mosharraf R, 2011, J ADV PROSTHODONT, V3, P221, DOI 10.4047/jap.2011.3.4.221; Mundstock KS, 1999, AM J ORTHOD DENTOFAC, V116, P635, DOI 10.1016/S0889-5406(99)70198-8; Paranhos MPG, 2011, QUINTESSENCE INT, V42, P79; SMITH GA, 1988, AM J ORTHOD DENTOFAC, V94, P245, DOI 10.1016/0889-5406(88)90034-0; Spohr AM, 2008, PHOTOMED LASER SURG, V26, P203, DOI 10.1089/pho.2007.2130; Uehara K, 2002, J MATER PROCESS TECH, V127, P178, DOI 10.1016/S0924-0136(02)00122-X; Usumez A, 2013, LASER MED SCI, V28, P259, DOI 10.1007/s10103-012-1136-x; Varel H, 1997, APPL PHYS A-MATER, V65, P367, DOI 10.1007/s003390050593; Verstrynge A, 2004, Orthod Craniofac Res, V7, P15, DOI 10.1111/j.1601-6343.2004.0276n.x; Vicente M, 2016, LASER SURG MED, V48, P36, DOI 10.1002/lsm.22442; Prieto MV, 2016, J LASERS MED SCI, V7, P214, DOI 10.15171/jlms.2016.38; Zachrisson Bjorn U, 2005, World J Orthod, V6 Suppl, P3	27	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186796	10.1371/journal.pone.0186796	http://dx.doi.org/10.1371/journal.pone.0186796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049418	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900112
J	Liu, P; Sharrock, RA				Liu, Peng; Sharrock, Robert A.			Biological activity and dimerization state of modified phytochrome A proteins	PLOS ONE			English	Article							N-TERMINAL FRAGMENTS; ARABIDOPSIS PHYTOCHROMES; NUCLEAR IMPORT; SIGNALING MECHANISMS; TRANSCRIPTION FACTOR; PLANT PHYTOCHROMES; II PHYTOCHROMES; MAJOR ROLE; RED LIGHT; RESPONSES	To assess potential physical interactions of type I phyA with the type II phyB-phyE phytochromes in vivo, transgenes expressing fusion gene forms of phyA were introduced into the Arabidopsis phyA mutant background. When a single c-Myc (myc) epitope is added to either the N- or C-terminus of phyA, the constructs completely complement phyA mutant phenotypes. However, addition of larger tags, such as six consecutive myc epitopes or the yellow fluorescent protein sequence, result in fusion proteins that show reduced activity. All the tagged phyA proteins migrate as dimers on native gels and co-immunoprecipitation reveals no binding interaction of phyA to any of the type II phys in the dark or under continuous farred light. Dimers of the phyA 1-615 amino acid N-terminal photosensory domain (NphyA), generated in vivo with a yeast GAL4 dimerization domain and attached to a constitutive nuclear localization sequence, are expressed at a low level and, although they cause a cop phenotype in darkness and mediate a very low fluence response to pulses of FR, have no activity under continuous FR. It is concluded that type I phyA in its Pr form is present in plants predominantly or exclusively as a homodimer and does not stably interact with type II phys in a dimer-to-dimer manner. In addition, its activity in mediating response to continuous FR is sensitive to modification of its N- or C-terminus.	[Liu, Peng; Sharrock, Robert A.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Sharrock, RA (corresponding author), Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA.	sharrock@montana.edu		Sharrock, Robert/0000-0002-0194-0534	National Science Foundation [IOS-0920766]	National Science Foundation(National Science Foundation (NSF))	RAS and PL were supported by a grant from the National Science Foundation (IOS-0920766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2013, NEW PHYTOL, V200, P86, DOI 10.1111/nph.12364; Burgie ES, 2014, PLANT CELL, V26, P4568, DOI 10.1105/tpc.114.131623; Casal JJ, 2014, J EXP BOT, V65, P2835, DOI 10.1093/jxb/ert379; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P481, DOI 10.1562/0031-8655(2000)071&lt;0481:TPPOPA&gt;2.0.CO;2; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Chen A, 2014, P NATL ACAD SCI USA, V111, P10037, DOI 10.1073/pnas.1409795111; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Franklin KA, 2014, J EXP BOT, V65, P2859, DOI 10.1093/jxb/eru059; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Fraser DP, 2016, CURR OPIN PLANT BIOL, V33, P1, DOI 10.1016/j.pbi.2016.03.008; Hirschfeld M, 1998, GENETICS, V149, P523; Hu W, 2013, P NATL ACAD SCI USA, V110, P1542, DOI 10.1073/pnas.1221738110; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kim L, 2000, PLANT J, V22, P125, DOI 10.1046/j.1365-313x.2000.00729.x; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kircher S, 2011, PLANT SIGNAL BEHAV, V6, P1714, DOI 10.4161/psb.6.11.17509; Klose C, 2015, NEW PHYTOL, V206, P965, DOI 10.1111/nph.13207; Klose C, 2012, PLANT PHYSIOL, V160, P289, DOI 10.1104/pp.112.197319; Kudla J, 2016, PLANT CELL, V28, P1002, DOI 10.1105/tpc.16.00043; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Li FW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8852; Li Jigang, 2011, Arabidopsis Book, V9, pe0148, DOI 10.1199/tab.0148; Liu P, 2013, PLANT J, V75, P915, DOI 10.1111/tpj.12255; Magliano TMA, 2005, PLANT PHYSIOL, V138, P1126, DOI 10.1104/pp.104.059071; Mancinelli Alberto L., 1994, P211; Martinez-Garcia JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109275; Mateos JL, 2006, J BIOL CHEM, V281, P34421, DOI 10.1074/jbc.M603538200; Mathews S, 2010, PLANT CELL, V22, P4, DOI 10.1105/tpc.109.072280; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Rausenberger J, 2011, CELL, V146, P813, DOI 10.1016/j.cell.2011.07.023; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2017, CURR OPIN PLANT BIOL, V37, P87, DOI 10.1016/j.pbi.2017.04.003; Rockwell NC, 2014, P NATL ACAD SCI USA, V111, P3871, DOI 10.1073/pnas.1401871111; Sanchez-Lamas M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006413; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Sharrock RA, 2004, P NATL ACAD SCI USA, V101, P11500, DOI 10.1073/pnas.0404286101; Sharrock RA, 2003, PLANT J, V34, P317, DOI 10.1046/j.1365-313X.2003.01722.x; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Sheerin D. J., 2017, PLANT CELL ENV; Viczian A, 2017, PLANT CELL ENV; Viczian A, 2012, MOL PLANT, V5, P629, DOI 10.1093/mp/sss035; Vierstra RD, 2011, TRENDS PLANT SCI, V16, P417, DOI 10.1016/j.tplants.2011.05.011; Wolf I, 2011, PLANT CELL PHYSIOL, V52, P361, DOI 10.1093/pcp/pcq194; Xu XS, 2015, TRENDS PLANT SCI, V20, P641, DOI 10.1016/j.tplants.2015.06.010	48	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186468	10.1371/journal.pone.0186468	http://dx.doi.org/10.1371/journal.pone.0186468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049346	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900070
J	Tabatabaeifar, M; Wlodkowski, T; Simic, I; Denc, H; Mollet, G; Weber, S; Moyers, JJ; Bruhl, B; Randles, MJ; Lennon, R; Antignac, C; Schaefer, F				Tabatabaeifar, Mansoureh; Wlodkowski, Tanja; Simic, Ivana; Denc, Helga; Mollet, Geraldine; Weber, Stefanie; Moyers, John Julius; Bruehl, Barbara; Randles, Michael Joseph; Lennon, Rachel; Antignac, Corinne; Schaefer, Franz			An inducible mouse model of podocinmutation-related nephrotic syndrome	PLOS ONE			English	Article							SEVERE RENAL-DISEASE; SEGMENTAL GLOMERULOSCLEROSIS; DIABETIC-NEPHROPATHY; ELECTRON-MICROSCOPY; PIERSON-SYNDROME; NPHS2 MUTATIONS; ALPORT-SYNDROME; LAMININ BETA-2; MUTANT PODOCIN; UP-REGULATION	Mutations in the NPHS2 gene, encoding podocin, cause hereditary nephrotic syndrome. The most common podocin mutation, R138Q, is associated with early disease onset and rapid progression to end-stage renal disease. Knock-in mice carrying a R140Q mutation, the mouse analogue of human R138Q, show developmental arrest of podocytes and lethal renal failure at neonatal age. Here we created a conditional podocin knock-in model named NPHS2(R140Q/)-, using a tamoxifen-inducible Cre recombinase, which permits to study the effects of the mutation in postnatal life. Within the first week of R140Q hemizygosity induction the animals developed proteinuria, which peaked after 4-5 weeks. Subsequently the animals developed progressive renal failure, with a median survival time of 12 (95% CI: 11 - 13) weeks. Foot process fusion was observed within one week, progressing to severe and global effacement in the course of the disease. The number of podocytes per glomerulus gradually diminished to 18% compared to healthy controls 12-16 weeks after induction. The fraction of segmentally sclerosed glomeruli was 25%, 85% and 97% at 2, 4 and 8 weeks, respectively. Severe tubulointerstitial fibrosis was present at later disease stage and was correlated quantitatively with the level of proteinuria at early disease stages. While R140Q podocin mRNA expression was elevated, protein abundance was reduced by more than 50% within one week following induction. Whereas miRNA21 expression persistently increased during the first 4 weeks, miRNA-193a expression peaked 2 weeks after induction. In conclusion, the inducible R140Q-podocin mouse model is an auspicious model of the most common genetic cause of human nephrotic syndrome, with a spontaneous disease course strongly reminiscent of the human disorder. This model constitutes a valuable tool to test the efficacy of novel pharmacological interventions aimed to improve podocyte function and viability and attenuate proteinuria, glomerulosclerosis and progressive renal failure.	[Tabatabaeifar, Mansoureh; Wlodkowski, Tanja; Simic, Ivana; Denc, Helga; Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Div Pediat Nephrol, Heidelberg, Germany; [Mollet, Geraldine; Antignac, Corinne] INSERM, U1163, Imagine Inst, Lab Hereditary Kidney Dis, Paris, France; [Mollet, Geraldine; Antignac, Corinne] Paris Descartes Sorbonne Paris Cite Univ, Paris, France; [Weber, Stefanie] Philipps Univ Marburg, Ctr Pediat & Adolescent Med, Pediat Nephrol, Marburg, Germany; [Moyers, John Julius] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Bruehl, Barbara] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Randles, Michael Joseph; Lennon, Rachel] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Randles, Michael Joseph; Lennon, Rachel] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France	Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Philipps University Marburg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Manchester; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Schaefer, F (corresponding author), Heidelberg Univ, Ctr Pediat & Adolescent Med, Div Pediat Nephrol, Heidelberg, Germany.	franz.schaefer@med.uni-heidelberg.de	ANTIGNAC, Corinne/H-8945-2017; Lennon, Rachel/AAJ-2134-2020; Mollet, Geraldine/E-8049-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Lennon, Rachel/0000-0001-6400-0227; Mollet, Geraldine/0000-0003-4685-5736	EU 7th Framework Programme (EURenOmics) [2012-305608]; Agence Nationale de la Recherche under "Investissements d'avenir" program [ANR-10-IAHU-01]	EU 7th Framework Programme (EURenOmics); Agence Nationale de la Recherche under "Investissements d'avenir" program(French National Research Agency (ANR))	This work has been made possible by support received from the EU 7th Framework Programme (EURenOmics, grant 2012-305608) and State funding from the Agence Nationale de la Recherche under "Investissements d'avenir" program (ANR-10-IAHU-01).	Abrahamson DR, 2003, KIDNEY INT, V63, P826, DOI 10.1046/j.1523-1755.2003.00800.x; Bouchireb K, 2014, HUM MUTAT, V35, P178, DOI 10.1002/humu.22485; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bugeon L, 2003, J AM SOC NEPHROL, V14, P786, DOI 10.1097/01.ASN.0000050222.86847.EA; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175; Fan QF, 2009, GENES CELLS, V14, P1079, DOI 10.1111/j.1365-2443.2009.01336.x; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Hinkes B, 2008, J AM SOC NEPHROL, V19, P365, DOI 10.1681/ASN.2007040452; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; Hoyer PF., 2008, COMPREHENSIVE PEDIAT, P257, DOI [DOI 10.1016/B978-0-323-04883-5.50022-2, 10.1016/B978-0-323-04883-5.50022-2]; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Kalluri R, 2006, J AM SOC NEPHROL, V17, P2383, DOI 10.1681/ASN.2006060628; Kashtan CE, 2001, J AM SOC NEPHROL, V12, P252, DOI 10.1681/ASN.V122252; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Kriz W, 2001, J AM SOC NEPHROL, V12, P496, DOI 10.1681/ASN.V123496; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Mollet G, 2009, J AM SOC NEPHROL, V20, P2181, DOI 10.1681/ASN.2009040379; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Ohashi T, 2003, HISTOCHEM CELL BIOL, V119, P257, DOI 10.1007/s00418-003-0511-x; Okamoto K, 2011, NAT GENET, V43, P459, DOI 10.1038/ng.792; Philippe A, 2008, KIDNEY INT, V73, P1038, DOI 10.1038/ki.2008.27; Puelles VG, 2016, HUMAN PODOCYTE DEPLE, V310, pF656; Randles MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35068; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Roselli S, 2004, TRAFFIC, V5, P37, DOI 10.1046/j.1600-0854.2003.00148.x; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Serrano-Perez M, 2015, J AM SOC NEPHROL, V26, p432A; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Starborg T, 2013, NAT PROTOC, V8, P1433, DOI 10.1038/nprot.2013.086; Suh JH, 2011, P NATL ACAD SCI USA, V108, P15348, DOI 10.1073/pnas.1108269108; Tharaux PL, 2012, SEMIN NEPHROL, V32, P394, DOI 10.1016/j.semnephrol.2012.06.011; Weber S, 2004, KIDNEY INT, V66, P571, DOI 10.1111/j.1523-1755.2004.00776.x; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241; Zhang GQ, 2007, J AM SOC NEPHROL, V18, P846, DOI 10.1681/ASN.2006080886; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Zoja C, 2015, NEPHROL DIAL TRANSPL, V30, P706, DOI 10.1093/ndt/gfu261	51	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186574	10.1371/journal.pone.0186574	http://dx.doi.org/10.1371/journal.pone.0186574			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049388	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900082
J	Lenehan, CE; Tobe, SS; Smith, RJ; Popelka-Filcoff, RS				Lenehan, Claire E.; Tobe, Shanan S.; Smith, Renee J.; Popelka-Filcoff, Rachel S.			Microbial composition analyses by 16S rRNA sequencing: A proof of concept approach to provenance determination of archaeological ochre	PLOS ONE			English	Article							OXIDE PIGMENTS; SPECTROSCOPY; INDICATORS; SAMPLES	Many archaeological science studies use the concept of | provenance , where the origins of cultural material can be determined through physical or chemical properties that relate back to the origins of the material. Recent studies using DNA profiling of bacteria have been used for the forensic determination of soils, towards determination of geographic origin. This manuscript presents a novel approach to the provenance of archaeological minerals and related materials through the use of 16S rRNA sequencing analysis of microbial DNA. Through the microbial DNA characterization from ochre and multivariate statistics, we have demonstrated the clear discrimination between four distinct Australian cultural ochre sites.	[Lenehan, Claire E.; Tobe, Shanan S.; Smith, Renee J.; Popelka-Filcoff, Rachel S.] Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia; [Tobe, Shanan S.] Arcadia Univ, Chem & Phys, Glenside, PA USA; [Smith, Renee J.] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia	Flinders University South Australia; Flinders University South Australia	Popelka-Filcoff, RS (corresponding author), Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia.	rachel.popelkafilcoff@flinders.edu.au	Tobe, Shanan/U-1859-2019; Tobe, Shanan/AAL-9771-2021; Lenehan, Claire/B-2282-2012	Tobe, Shanan/0000-0002-4854-6278; Popelka-Filcoff, Rachel/0000-0001-6826-6401; Lenehan, Claire/0000-0003-3936-8569	Australian Institute of Nuclear Science and Engineering (AINSE)	Australian Institute of Nuclear Science and Engineering (AINSE)	This work was supported by the Australian Institute of Nuclear Science and Engineering (AINSE) Fellowship (R.P.) www.ainse.edu.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chau JF, 2011, ENVIRON FORENSICS, V12, P333, DOI 10.1080/15275922.2011.622348; Clarke J., 1976, STUD CONSERV, V21, P134, DOI DOI 10.2307/1505696; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Concheri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020222; Cornell R.M., 2003, IRON OXIDES, Vsecond; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elias M, 2006, MAT SCI ENG B-SOLID, V127, P70, DOI 10.1016/j.mseb.2005.09.061; Genestar C, 2005, ANAL BIOANAL CHEM, V382, P269, DOI 10.1007/s00216-005-3085-8; Grund BS, 2014, J ARCHAEOL SCI, V46, P217, DOI 10.1016/j.jas.2014.02.010; Horswell J, 2002, J FORENSIC SCI, V47, P350; Hradil D, 2003, APPL CLAY SCI, V22, P223, DOI 10.1016/S0169-1317(03)00076-0; Jeffries TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025173; Jercher M, 1998, ARCHAEOMETRY, V40, P383, DOI 10.1111/j.1475-4754.1998.tb00845.x; Khodakova AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104996; Meyers MS, 2008, J FORENSIC SCI, V53, P652, DOI 10.1111/j.1556-4029.2008.00728.x; Mitusov AV, 2009, HOLOCENE, V19, P1153, DOI 10.1177/0959683609345076; Montagner C, 2013, SPECTROCHIM ACTA A, V103, P409, DOI 10.1016/j.saa.2012.10.064; Mortimore JL, 2004, SPECTROCHIM ACTA A, V60, P1179, DOI 10.1016/j.saa.2003.08.002; Nobbs MF, 1995, ABORIGINAL PAINTERS; Peterson N., 1985, RECORDS AUSTR MUSEUM, V37, P1; Popelka-Filcoff RS, 2007, J RADIOANAL NUCL CH, V272, P17, DOI 10.1007/s10967-006-6836-x; Popelka-Filcoff RS, 2015, ANAL METHODS-UK, V7, P7363, DOI 10.1039/c5ay01547b; Popelka-Filcoff R.S., 2012, J ANTHR SOC S AUSTR, V35, P81; Popelka-Filcoff RS, 2008, J ARCHAEOL SCI, V35, P752, DOI 10.1016/j.jas.2007.05.018; Popelka-Filcoff RS, 2012, J RADIOANAL NUCL CH, V291, P19, DOI 10.1007/s10967-011-1236-2; Popelka-Filcoff RS, 2008, ACS S SERIES; Scadding R, 2015, J ARCHAEOL SCI, V54, P300, DOI 10.1016/j.jas.2014.11.017; Smith M, 2009, GEOCHEMISTRY IDENTIF; Smith M A, 1996, ARCHAEOLOGICAL PERSP; Smith MA, 1997, J ARCHAEOL SCI, V24, P773, DOI 10.1006/jasc.1996.0159; Smith RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081910; Smith RJ, 2013, DETERMINING METABOLI; WEIGAND PC, 1977, TURQUOISE SOURCES SO; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185252	10.1371/journal.pone.0185252	http://dx.doi.org/10.1371/journal.pone.0185252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045459	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100013
J	Zhang, CF; Tong, C; Tian, F; Zhao, K				Zhang, Cunfang; Tong, Chao; Tian, Fei; Zhao, Kai			Integrated mRNA and microRNA transcriptome analyses reveal regulation of thermal acclimation in Gymnocypris przewalskii: A case study in Tibetan Schizothoracine fish	PLOS ONE			English	Article							SALMON SALMO-SALAR; HEAT-STRESS; ENVIRONMENTAL-CHANGE; CLIMATE-CHANGE; TEMPERATURE; EXPRESSION; PHYSIOLOGY; RESPONSES; PLATEAU; FAMILY	Environmental acclimation is important episode in wildlife occupation of the high-altitude Tibetan Plateau (TP). Transcriptome-wide studies on thermal acclimation mechanism in fish species are rarely revealed in Tibetan Plateau fish at high altitude. Thus, we used mRNA and miRNA transcriptome sequencing to investigate regulation of thermal acclimation in larval Tibetan naked carp, Gymnocypris przewalskii. We first remodeled the regulation network of mRNA and miRNA in thermal acclimation, and then identified differential expression of miRNAs and target mRNAs enriched in metabolic and digestive pathways. Interestingly, we identified two candidate genes contributed to normal skeletal development. The altered expression of these gene groups could potentially be associated with the developmental issues of deformity and induced larval death. Our results have three important implications: first, these findings provide strong evidences to support our hypothesis that G. przewalskii possess ability to build heat-tolerance against the controversial issue. Second, this study shows that transcriptional and post-transcriptional regulations are extensively involved in thermal acclimation. Third, the integrated mRNA and microRNA transcriptome analyses provide a large number of valuable genetic resources for future studies on environmental stress response in G. przewalskii and as a case study in Tibetan Schizothoracine fish.	[Zhang, Cunfang; Tong, Chao; Tian, Fei; Zhao, Kai] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Anim Ecol Genom,Key Lab Adaptat &, Lab Plateau Fish Evolutionary & Funct Genom, Xining, Peoples R China; [Tong, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhao, K (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Anim Ecol Genom,Key Lab Adaptat &, Lab Plateau Fish Evolutionary & Funct Genom, Xining, Peoples R China.	zhaokai@nwipb.cas.cn	Tian, Fei/HDL-8149-2022; Tong, Chao/AAT-4685-2020	Tong, Chao/0000-0001-5202-5507	National Natural Science Foundation of China [31572258, 31500306]; West Light Foundation of Key Innovation Plan [KSCX2-EW-N-004]; Natural Science Foundation of Qinghai Province, China [2016-ZJ-939Q]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of Key Innovation Plan; Natural Science Foundation of Qinghai Province, China	This study was funded by the National Natural Science Foundation of China (grant 31572258 to KZ; grant 31500306 to CZ), the West Light Foundation of Key Innovation Plan (grant KSCX2-EW-N-004 to CZ) and the Natural Science Foundation of Qinghai Province, China (grant 2016-ZJ-939Q to CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2015, MOL ECOL, V24, P710, DOI 10.1111/mec.13055; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; ANDERS S, 2010, GENOME BIOL, V11; Anders S., 2010, MOL BIOL+, V43, P1, DOI DOI 10.1186/GB-2010-11-10-R106; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Beitinger TL, 2000, ENVIRON BIOL FISH, V58, P277, DOI 10.1023/A:1007618927527; BRETT JR, 1971, AM ZOOL, V11, P99; Cao W., 1981, ORIGIN AND EVOLUTION; Chen D., 2011, THE PROTECTION RESEA; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Georgakopoulou E, 2010, AQUACULTURE, V308, P13, DOI 10.1016/j.aquaculture.2010.08.006; Glanvillc R. W., 2012, TYPE 4 COLLAGEN STRU, P43; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; Guan LH, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0192-1; Hao Y, 2016, ANIM GENET, V47, P365, DOI 10.1111/age.12419; Haoran L, 2011, FISH PHYSIOLOGY GUAN; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Hu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108582; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapila Rajeev, 2002, Indian Journal of Fisheries, V49, P187; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; KENNEDY AD, 1995, ANNU REV ECOL SYST, V26, P683, DOI 10.1146/annurev.es.26.110195.003343; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Logan C. A., 1979, EFFECTS OF THERMAL A; Logan C. A., 2010, AJP REGULATORY INTEG, P299; LONG Y, 2012, PLOS ONE, V7; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sohn P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-29; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sydeman WJ, 2015, SCIENCE, V350, P772, DOI 10.1126/science.aac9874; Takle H, 2005, AQUACULTURE, V249, P515, DOI 10.1016/j.aquaculture.2005.04.043; Tomanek L, 2011, ANNU REV MAR SCI, V3, P373, DOI 10.1146/annurev-marine-120709-142729; Tong C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174534; Tong C, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0925-z; Tong C, 2016, FISH SHELLFISH IMMUN, V50, P34, DOI 10.1016/j.fsi.2016.01.012; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P366, DOI 10.1016/j.fsi.2015.06.025; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P334, DOI 10.1016/j.fsi.2015.06.023; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Wang YXS, 2003, COMP BIOCHEM PHYS A, V134, P409, DOI 10.1016/S1095-6433(02)00317-3; Wargelius A, 2005, DEV GENES EVOL, V215, P350, DOI 10.1007/s00427-005-0482-0; Windisch HS, 2011, AM J PHYSIOL-REG I, V301, pR1453, DOI 10.1152/ajpregu.00158.2011; Wootton R. J., 1991, FISH ECOLOGY; Wu Y., 1992, THE FISHES OF THE QI; Xu XY, 2014, FISH SHELLFISH IMMUN, V36, P374, DOI 10.1016/j.fsi.2013.12.007; Yu J, 2011, FUNCT INTEGR GENOMIC, V11, P203, DOI 10.1007/s10142-010-0198-8; Zhang M, 1997, AN INTRODUCTION TO S; Zhang RY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09780; [赵兰英 Zhao Lanying], 2012, [中国实验动物学报, Acta Laboratorium Animalis Scientia Sinica], V20, P31; Zhao MR, 2016, FISH SHELLFISH IMMUN, V59, P469, DOI 10.1016/j.fsi.2016.11.012	67	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186433	10.1371/journal.pone.0186433	http://dx.doi.org/10.1371/journal.pone.0186433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045433	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100061
J	Nagao, R; Ueoka-Nakanishi, H; Noguchi, T				Nagao, Ryo; Ueoka-Nakanishi, Hanayo; Noguchi, Takumi			D1-Asn-298 in photosystem II is involved in a hydrogen-bond network near the redox-active tyrosine Y-Z for proton exit during water oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; Fourier transform IR (FTIR); photosynthesis; photosystem II; site-directed mutagenesis; D1-Asn298; YZ; proton trasfer; thermoluminescence; water oxidation	OXYGEN-EVOLVING COMPLEX; S-STATE CYCLE; FTIR DIFFERENCE SPECTROSCOPY; TRANSFORM INFRARED DETECTION; AMINO-ACID SUBSTITUTION; MN4CAO5 CLUSTER; D1 PROTEIN; MOLECULAR-DYNAMICS; STRUCTURAL-CHANGES; OXIDIZING COMPLEX	In photosynthetic water oxidation, two water molecules are converted into one oxygen molecule and four protons at the Mn4CaO5 cluster in photosystem II (PSII) via the S-state cycle. Efficient proton exit from the catalytic site to the lumen is essential for this process. However, the exit pathways of individual protons through the PSII proteins remain to be identified. In this study, we examined the involvement of a hydrogen-bond network near the redox-active tyrosine Y-Z in proton transfer during the S-state cycle. We focused on spectroscopic analyses of a site-directed variant of D1-Asn-298, a residue involved in a hydrogen-bond network near Y-Z. We found that the D1-N298A mutant of Synechocystis sp. PCC 6803 exhibits an O-2 evolution activity of approximate to 10% of the wild-type. D1-N298A and the wild-type D1 had very similar features of thermoluminescence glow curves and of an FTIR difference spectrum upon Y-Z oxidation, suggesting that the hydrogen-bonded structure of Y-Z and electron transfer from the Mn4CaO5 cluster to Y-Z were little affected by substitution. In the D1-N298A mutant, however, the flash-number dependence of delayed luminescence showed a monotonic increase without oscillation, and FTIR difference spectra of the S-state cycle indicated partial and significant inhibition of the S-2 S-3 and S-3 S-0 transitions, respectively. These results suggest that the D1-N298A substitution inhibits the proton transfer processes in the S-2 S-3 and S-3 S-0 transitions. This in turn indicates that the hydrogen-bond network near Y-Z can be functional as a proton transfer pathway during photosynthetic water oxidation.	[Nagao, Ryo; Ueoka-Nakanishi, Hanayo; Noguchi, Takumi] Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Nagoya University	Noguchi, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.; Nagao, R (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	nagaoryo@okayama-u.ac.jp; tnoguchi@bio.phys.nagoya-u.ac.jp	Noguchi, Takumi/I-7105-2014; NAGAO, Ryo/D-4117-2012	NAGAO, Ryo/0000-0001-8212-3001; zhong xi, hua dai/0000-0001-8619-9513	Japan Society for the Promotion of Science [26840091, 17K07442, 17H03662, 17H06435]; Grants-in-Aid for Scientific Research [17K07442] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science 26840091 and 17K07442 (to R.N.) and 17H03662 and 17H06435 (to T.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Amin M, 2015, J PHYS CHEM B, V119, P7366, DOI 10.1021/jp510948e; [Anonymous], 2002, PHOTOSYNTHETICA; Bao H, 2015, P NATL ACAD SCI USA, V112, pE6139, DOI 10.1073/pnas.1512008112; Berthomieu C, 1998, BIOCHEMISTRY-US, V37, P10547, DOI 10.1021/bi980788m; Capone M, 2016, J PHYS CHEM LETT, V7, P592, DOI 10.1021/acs.jpclett.5b02851; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5839, DOI 10.1021/bi00017a016; Chu HA, 2001, BBA-BIOENERGETICS, V1503, P69, DOI 10.1016/S0005-2728(00)00216-4; Chu HA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00146; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Cox N, 2013, BBA-BIOENERGETICS, V1827, P1020, DOI 10.1016/j.bbabio.2013.01.013; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Debus RJ, 2015, BBA-BIOENERGETICS, V1847, P19, DOI 10.1016/j.bbabio.2014.07.007; Debus RJ, 2014, BIOCHEMISTRY-US, V53, P2941, DOI 10.1021/bi500309f; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; Dilbeck PL, 2012, BIOCHEMISTRY-US, V51, P1079, DOI 10.1021/bi201659f; Diner BA, 2005, ADV PHOTO RESPIRAT, V22, P207; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORSTER V, 1985, PHOTOCHEM PHOTOBIOL, V41, P183, DOI 10.1111/j.1751-1097.1985.tb03469.x; Gabdulkhakov A, 2009, STRUCTURE, V17, P1223, DOI 10.1016/j.str.2009.07.010; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Hillier W, 2001, BIOCHEMISTRY-US, V40, P1503, DOI 10.1021/bi002436x; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Hundelt M, 1998, BIOCHEMISTRY-US, V37, P14450, DOI 10.1021/bi981164j; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Ishikita H, 2006, BIOCHEMISTRY-US, V45, P2063, DOI 10.1021/bi051615h; Isobe H, 2015, J PHYS CHEM B, V119, P13922, DOI 10.1021/acs.jpcb.5b05740; JOLIOT P, 1969, PHOTOCHEM PHOTOBIOL, V10, P309, DOI 10.1111/j.1751-1097.1969.tb05696.x; Kim CJ, 2017, BIOCHEMISTRY-US, V56, P2558, DOI 10.1021/acs.biochem.6b01278; Kimura Y, 2005, BIOCHEMISTRY-US, V44, P16072, DOI 10.1021/bi051306r; Kimura Y, 2003, BIOCHEMISTRY-US, V42, P13170, DOI 10.1021/bi035420q; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kuroda H, 2014, PLANT CELL PHYSIOL, V55, P1266, DOI 10.1093/pcp/pcu073; Li ZL, 2002, PHOTOSYNTH RES, V72, P191, DOI 10.1023/A:1016192919500; Linke K, 2014, BBA-BIOENERGETICS, V1837, P14, DOI 10.1016/j.bbabio.2013.08.003; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 2011, RSC ENERGY ENVIRON S, P163; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Nagao R, 2017, J BIOL CHEM, V292, P7474, DOI 10.1074/jbc.M117.781062; Nakamura S, 2017, J AM CHEM SOC, V139, P9364, DOI 10.1021/jacs.7b04924; Nakamura S, 2016, P NATL ACAD SCI USA, V113, P12727, DOI 10.1073/pnas.1607897113; Nakamura S, 2016, BIOCHEMISTRY-US, V55, P597, DOI 10.1021/acs.biochem.5b01120; Nakamura S, 2014, BIOCHEMISTRY-US, V53, P3131, DOI 10.1021/bi500237y; Noguchi T, 2000, BIOCHEMISTRY-US, V39, P10943, DOI 10.1021/bi001040i; Noguchi T, 2005, ADV PHOTO RESPIRAT, V22, P367; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P6035, DOI 10.1021/bi0341612; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P15706, DOI 10.1021/bi020603i; Noguchi T, 2002, SPECTROSC-INT J, V16, P89, DOI 10.1155/2002/960232; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P2322, DOI 10.1021/bi011954k; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; NOGUCHI T, 1995, BBA-BIOENERGETICS, V1228, P189, DOI 10.1016/0005-2728(94)00171-Z; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Noguchi T, 2007, PHOTOSYNTH RES, V91, P59, DOI 10.1007/s11120-007-9137-5; Noguchi T, 2015, BBA-BIOENERGETICS, V1847, P35, DOI 10.1016/j.bbabio.2014.06.009; Noguchi T, 2013, BIOMED SPECTROSC IMA, V2, P115, DOI 10.3233/BSI-130040; Noguchi T, 2012, BIOCHEMISTRY-US, V51, P3205, DOI 10.1021/bi300294n; Ogata K, 2013, J AM CHEM SOC, V135, P15670, DOI 10.1021/ja404317d; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Pokhrel R, 2015, BIOCHEMISTRY-US, V54, P1663, DOI 10.1021/bi501468h; Pokhrel R, 2013, BIOCHEMISTRY-US, V52, P4758, DOI 10.1021/bi301700u; Qian M, 1999, BIOCHEMISTRY-US, V38, P6070, DOI 10.1021/bi982331i; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Renger G, 2012, BBA-BIOENERGETICS, V1817, P1164, DOI 10.1016/j.bbabio.2012.02.005; Rivalta I, 2011, BIOCHEMISTRY-US, V50, P6312, DOI 10.1021/bi200685w; Saito K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9488; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Sakamoto H, 2017, J AM CHEM SOC, V139, P2022, DOI 10.1021/jacs.6b11989; Sakashita N, 2017, BIOCHEMISTRY-US, V56, P3049, DOI 10.1021/acs.biochem.7b00220; Schlodder E, 1999, J BIOL CHEM, V274, P30387, DOI 10.1074/jbc.274.43.30387; Service RJ, 2014, BIOCHEMISTRY-US, V53, P1001, DOI 10.1021/bi401450y; Service RJ, 2011, BIOCHEMISTRY-US, V50, P63, DOI 10.1021/bi1015937; Service RJ, 2010, BIOCHEMISTRY-US, V49, P6655, DOI 10.1021/bi100730d; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; Shimada Y, 2009, BIOCHEMISTRY-US, V48, P6095, DOI 10.1021/bi900317a; Siegbahn PEM, 2012, PHYS CHEM CHEM PHYS, V14, P4849, DOI 10.1039/c2cp00034b; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Styring S, 2012, BBA-BIOENERGETICS, V1817, P76, DOI 10.1016/j.bbabio.2011.03.016; Su XD, 2017, SCIENCE, V357, P816, DOI 10.1126/science.aan0327; Suga M, 2017, NATURE, V543, P131, DOI 10.1038/nature21400; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Suzuki H, 2008, BIOCHEMISTRY-US, V47, P11024, DOI 10.1021/bi801580e; Suzuki H, 2013, BIOCHEMISTRY-US, V52, P4748, DOI 10.1021/bi301699h; Suzuki H, 2009, J AM CHEM SOC, V131, P7849, DOI 10.1021/ja901696m; Tanaka A, 2017, J AM CHEM SOC, V139, P1718, DOI 10.1021/jacs.6b09666; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; Vassiliev S, 2012, BBA-BIOENERGETICS, V1817, P1671, DOI 10.1016/j.bbabio.2012.05.016; Vassiliev S, 2010, BIOCHEMISTRY-US, V49, P1873, DOI 10.1021/bi901900s; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Yamasato A, 2002, PLANT CELL PHYSIOL, V43, P540, DOI 10.1093/pcp/pcf066; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; Young ID, 2016, NATURE, V540, P453, DOI 10.1038/nature20161	99	34	34	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20046	20057		10.1074/jbc.M117.815183	http://dx.doi.org/10.1074/jbc.M117.815183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29046348	hybrid, Green Published			2022-12-26	WOS:000417696400012
J	Chun, BY; Rhiu, S				Chun, Bo Young; Rhiu, Soolienah			Cryopreserved rabbit amniotic membrane alleviated inflammatory response and fibrosis following experimental strabismus surgery in rabbits	PLOS ONE			English	Article							LIMIT POSTOPERATIVE ADHESIONS; EXTRAOCULAR-MUSCLE SURGERY; REDUCING ADHESIONS; MITOMYCIN-C; TRANSPLANTATION; RECONSTRUCTION; SURFACE; SLEEVE; CELLS	We evaluate the ability of cryopreserved rabbit amniotic membrane (AM) transplantation to reduce postoperative inflammation and the extent of fibrosis following experimental strabismus surgery. Ten white rabbits underwent bilateral superior rectus (SR) muscle resection. In the left eye, the resected SR muscle was wrapped with cryopreserved rabbit AM. The right eye underwent SR resection only and served as a control. The eyes were enucleated 4 weeks after strabismus surgery. The degree of postoperative inflammatory infiltration, the extent of fibrosis, and profile of the relative expression of inflammatory mediators in the SR muscle were evaluated and compared between the two groups by histological analysis and real-time polymerase chain reaction (PCR). There were statistically meaningful differences in the degree of postoperative inflammatory infiltration and extent of fibrosis between the eyes treated with cryopreserved rabbit AM after SR resection and those underwent SR resection only. A significant decrease in the expression of inflammatory cytokines [interleukin (IL)-12a, IL-12b, IL-17f, and tumor necrosis factor-alpha (TNF-alpha)], and a markedly increased expression of anti-inflammatory cytokines (transforming growth factor-beta-1 (TGF beta-1) and IL-10) were observed in the eyes treated with cryopreserved rabbit AM. In this study, we demonstrate that cryopreserved rabbit AM is effective in reducing postoperative inflammation and extent of fibrosis in a rabbit model of strabismus surgery. Our results imply that cryopreserved AM allograft has anti-inflammatory and anti-scarring properties that can prevent postoperative adhesions following strabismus surgery.	[Chun, Bo Young] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Ophthalmol, Daegu, South Korea; [Chun, Bo Young] Kyungpook Natl Univ, Brain Sci & Engn Inst, Sch Med, Daegu, South Korea; [Rhiu, Soolienah] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Ophthalmol, Hwaswong, South Korea	Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Hallym University	Chun, BY (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Ophthalmol, Daegu, South Korea.; Chun, BY (corresponding author), Kyungpook Natl Univ, Brain Sci & Engn Inst, Sch Med, Daegu, South Korea.	byjun424@hotmail.com		Chun, Bo Young/0000-0003-2717-7079	Biomedical Research Institute, Kyungpook National University Hospital (BYC)	Biomedical Research Institute, Kyungpook National University Hospital (BYC)	This work was supported by a grant 2013 from the Biomedical Research Institute, Kyungpook National University Hospital (BYC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K, 2001, INVEST OPHTH VIS SCI, V42, P1762; Chun BY, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/369126; Cruz OA, 1996, J PEDIATR OPHTHALMOL, V33, P89; Carvalho Luis Eduardo Morato Rebouças de, 2007, Arq. Bras. Oftalmol., V70, P209; ELSAS FJ, 1992, J PEDIATR OPHTHALMOL, V29, P284; Esme Arif, 2004, Strabismus, V12, P141; Fujishima H, 1998, OPHTHALMIC SURG LAS, V29, P428; Fulga V, 1996, OPHTHALMIC SURG LAS, V27, P228; Kassem RR, 2013, ACTA OPHTHALMOL, V91, pe140, DOI 10.1111/j.1755-3768.2012.02563.x; Kassem RR, 2011, CURR EYE RES, V36, P1020, DOI 10.3109/02713683.2011.601842; Kassem RR, 2010, J AAPOS, V14, P548, DOI 10.1016/j.jaapos.2010.09.017; Kersey JP, 2008, STRABISMUS, V16, P116, DOI 10.1080/09273970802405493; Liu JB, 2010, EXPERT REV OPHTHALMO, V5, P645, DOI 10.1586/EOP.10.63; Ma DHK, 2000, BRIT J OPHTHALMOL, V84, P973, DOI 10.1136/bjo.84.9.973; Mehendale RA, 2011, J AAPOS, V15, P404, DOI 10.1016/j.jaapos.2011.05.001; Minguini N, 2000, INVEST OPHTH VIS SCI, V41, P3399; Mora J S, 1997, J AAPOS, V1, P92, DOI 10.1016/S1091-8531(97)90005-7; Ozkan SB, 2004, J AAPOS, V8, P46, DOI 10.1016/j.jaapos.2003.09.012; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Paolin A, 2016, CELL TISSUE BANK, V17, P399, DOI 10.1007/s10561-016-9553-x; Park CY, 2009, OPHTHALMIC RES, V41, P112, DOI 10.1159/000187629; Sheha H, 2009, J AAPOS, V13, P99, DOI 10.1016/j.jaapos.2008.08.009; Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444; Solomon A, 2003, OPHTHALMOLOGY, V110, P93, DOI 10.1016/S0161-6420(02)01441-0; Solomon A, 2001, OPHTHALMOLOGY, V108, P449, DOI 10.1016/S0161-6420(00)00567-4; SONDHI N, 1987, OPHTHALMIC SURG LAS, V18, P441; Thomasen H, 2009, GRAEF ARCH CLIN EXP, V247, P1691, DOI 10.1007/s00417-009-1162-y; Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9; Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431; Tseng Scheffer C G, 2004, Ocul Surf, V2, P177; Tseng SCG, 2016, INVEST OPHTH VIS SCI, V57, DOI 10.1167/iovs.15-17637; Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2; Von Hertwig R, 1999, ARQ BRAS OFTALMOL, V62, P717; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	34	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0187058	10.1371/journal.pone.0187058	http://dx.doi.org/10.1371/journal.pone.0187058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065159	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900065
J	Orlowska-Baranowska, E; Betka, LGV; Gora, J; Baranowski, R; Pedzich-Placha, E; Zakrzewski, D; Dlugosz, A; Kossowska, H; Zebrowska, A; Zakoscielna, E; Janiszewska, A; Hryniewiecki, T; Gaciong, Z; Placha, G				Orlowska-Baranowska, Ewa; Betka, Lucja Gadomska Vel; Gora, Jaroslaw; Baranowski, Rafal; Pedzich-Placha, Ewa; Zakrzewski, Dariusz; Dlugosz, Angelika; Kossowska, Helena; Zebrowska, Agnieszka; Zakoscielna, Ewelina; Janiszewska, Anna; Hryniewiecki, Tomasz; Gaciong, Zbigniew; Placha, Grzegorz			Functional polymorphism of the renalase gene is associated with cardiac hypertrophy in female patients with aortic stenosis	PLOS ONE			English	Article							SAMPLE-SIZE REQUIREMENTS; GENOME-WIDE ASSOCIATION; HYPERTENSION; SYSTEM; METAANALYSIS; EXPRESSION; OXIDATION; DATABASE; OXIDASE; KINASE	Renalase decreases circulating catecholamines concentration and is important in maintaining primary cellular metabolism. Renalase acts through the plasma membrane calcium ATPase 4b in the heart, which affects pressure overload but not exercise induced heart hypertrophy. The aim of this study was to test the association between a functional polymorphism Glu37Asp (rs2296545) of the renalase gene and left ventricular hypertrophy in a large cohort of patients with aortic stenosis. The study group consisted of 657 patients with aortic stenosis referred for aortic valve replacement. Preoperative echocardiographic assessment was performed to obtain cardiac phenotypes. Generalized-linear models were implemented to analyze data using crude or full model adjusted for selected clinical factors. In females, the Asp37 variant of the Glu37Asp polymorphism was associated with higher left ventricular mass (p = 0.0021 and p = 0.055 crude and full model respectively), intraventricular septal thickness (p = 0.0003 and p = 0.0143) and posterior wall thickness (p = 0.0005 and p = 0.0219) all indexed to body surface area, as well as relative wall thickness (p = 0.001 and p = 0.0097). No significant associations were found among the male patients. In conclusion, we have found the association of the renalase Glu37Asp polymorphism with left ventricle hypertrophy in large group of females with aortic stenosis. The Glu37Asp polymorphism causes not only amino-acid substitution in FAD binding domain but may also change binding affinity of the hypoxia-and hypertrophy-related transcription factors and influence renalase gene expression. Our data suggest that renalase might play a role in hypertrophic response to pressure overload, but the exact mechanism requires further investigation.	[Orlowska-Baranowska, Ewa; Zakrzewski, Dariusz; Zebrowska, Agnieszka; Hryniewiecki, Tomasz] Inst Cardiol, Dept Acquired Cardiac Defects, Warsaw, Poland; [Betka, Lucja Gadomska Vel; Gora, Jaroslaw; Pedzich-Placha, Ewa; Dlugosz, Angelika; Kossowska, Helena; Zakoscielna, Ewelina; Janiszewska, Anna; Gaciong, Zbigniew; Placha, Grzegorz] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland; [Baranowski, Rafal] Inst Cardiol, Dept Arrhythmia, Warsaw, Poland	Institute of Cardiology - Poland; Medical University of Warsaw; Institute of Cardiology - Poland	Placha, G (corresponding author), Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland.	Grzegorz.Placha@wum.edu.pl	Krogulec, Ewelina/O-7443-2018	Krogulec, Ewelina/0000-0001-5360-5212; Baranowski, Rafal/0000-0002-3837-8194; Pedzich, Ewa/0000-0001-8965-0736; Kossowska, Helena/0000-0002-0997-0527	Polpharma Scientific Foundation [12/VIII/2009]; Ministry of Science and Higher Education [4354/B/P01/2007/33]; Foundation for Polish Science, Program TEAM [TEAM/2012-9/2]; European Union European Regional Development Fund	Polpharma Scientific Foundation; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science, Program TEAM; European Union European Regional Development Fund(European Commission)	This work was supported by an unrestricted grant from the Polpharma Scientific Foundation [12/VIII/2009] http://www.polpharma.pl/en/scientific-foundation/; a governmental grant from the Ministry of Science and Higher Education [4354/B/P01/2007/33] http://www.nauka.gov.pl/en/ and an unrestricted grant from the Foundation for Polish Science, Program TEAM [TEAM/2012-9/2] http://www.fnp.org.pl/en/, co-financed by the European Union European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers WS, 2000, AM J PHYSIOL-HEART C, V279, pH2797, DOI 10.1152/ajpheart.2000.279.6.H2797; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beaupre BA, 2015, ARCH BIOCHEM BIOPHYS, V579, P62, DOI 10.1016/j.abb.2015.05.016; Beaupre BA, 2015, BIOCHEMISTRY-US, V54, P795, DOI 10.1021/bi5013436; Buraczynska M, 2011, NEUROMOL MED, V13, P321, DOI 10.1007/s12017-011-8158-6; Desir GV, 2014, NEPHROL DIAL TRANSPL, V29, P22, DOI 10.1093/ndt/gft083; Du M, 2015, CARDIOVASC RES, V105, P182, DOI 10.1093/cvr/cvu255; Duncan AI, 2008, ANN THORAC SURG, V85, P2030, DOI 10.1016/j.athoracsur.2008.02.075; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Ghosh SS, 2009, PEDIATR NEPHROL, V24, P367, DOI 10.1007/s00467-008-0978-8; GRIFFITH MJ, 1991, CLIN CARDIOL, V14, P227, DOI 10.1002/clc.4960140310; Jiang DS, 2013, HYPERTENSION, V61, P1193, DOI 10.1161/HYPERTENSIONAHA.111.00614; Kararigas G, 2014, EUR J HEART FAIL, V16, P1160, DOI 10.1002/ejhf.171; Kosiorek M, 2011, BIOCHEM BIOPH RES CO, V411, P235, DOI 10.1016/j.bbrc.2011.06.098; Lim JY, 2005, J MOL CELL CARDIOL, V39, P627, DOI 10.1016/j.yjmcc.2005.06.016; Lv YB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158880; Malyszko J, 2015, ADV MED SCI-POLAND, V60, P41, DOI 10.1016/j.advms.2014.10.001; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Meyers KJ, 2007, HYPERTENSION, V49, P992, DOI 10.1161/HYPERTENSIONAHA.106.081265; Mohamed TMA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11074; Moran GR, 2016, BBA-PROTEINS PROTEOM, V1864, P177, DOI 10.1016/j.bbapap.2015.04.010; MORGAN HE, 1991, CIRCULATION, V83, P13, DOI 10.1161/01.CIR.83.1.13; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Orlowska-Baranowska E, 2004, J HEART VALVE DIS, V13, P574; Orlowska-Baranowska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096306; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; Rader F, 2015, AM J MED, V128, P344, DOI 10.1016/j.amjmed.2014.10.054; Riva A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S7; Riva A, 2012, NUCLEIC ACIDS RES, V40, pD155, DOI 10.1093/nar/gkr1080; Saeedi Ramesh, 2006, BMC Cardiovasc Disord, V6, P8, DOI 10.1186/1471-2261-6-8; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Sankaralingam S, 2015, PULM CIRC, V5, P15, DOI 10.1086/679608; Schneider J, 2011, BASIC RES CARDIOL, V106, P591, DOI 10.1007/s00395-011-0166-z; SMITH SH, 1990, CIRC RES, V67, P1334, DOI 10.1161/01.RES.67.6.1334; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; TAEGTMEYER H, 1988, HYPERTENSION, V11, P416, DOI 10.1161/01.HYP.11.5.416; Tota B, 2010, J EXP BIOL, V213, P3081, DOI 10.1242/jeb.027391; Tran QK, 2016, J BIOL CHEM, V291, P10805, DOI 10.1074/jbc.M115.697334; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122932; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4	56	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186729	10.1371/journal.pone.0186729	http://dx.doi.org/10.1371/journal.pone.0186729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065134	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900030
J	Jakubaviciute, E; Bergstrom, U; Eklof, JS; Haenel, Q; Bourlat, SJ				Jakubaviciute, Egle; Bergstrom, Ulf; Eklof, Johan S.; Haenel, Quiterie; Bourlat, Sarah J.			DNA metabarcoding reveals diverse diet of the three-spined stickleback in a coastal ecosystem	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS L.; BALTIC SEA; THREESPINE STICKLEBACK; FISH; RECRUITMENT; POPULATIONS; PHENOTYPE; PREDATION; GULF; SIZE	The three-spined stickleback (Gasterosteus aculeatus L., hereafter 'stickleback') is a common mesopredatory fish in marine, coastal and freshwater areas. In large parts of the Baltic Sea, stickleback densities have increased > 10-fold during the last decades, and it is now one of the dominating fish species both in terms of biomass and effects on lower trophic levels. Still, relatively little is known about its diet-knowledge which is essential to understand the increasing role sticklebacks play in the ecosystem. Fish diet analyses typically rely on visual identification of stomach contents, a labour-intensive method that is made difficult by prey digestion and requires expert taxonomic knowledge. However, advances in DNA-based metabarcoding methods promise a simultaneous identification of most prey items, even from semi-digested tissue. Here, we studied the diet of stickleback from the western Baltic Sea coast using both DNA metabarcoding and visual analysis of stomach contents. Using the cytochrome oxidase (CO1) marker we identified 120 prey taxa in the diet, belonging to 15 phyla, 83 genera and 84 species. Compared to previous studies, this is an unusually high prey diversity. Chironomids, cladocerans and harpacticoids were dominating prey items. Large sticklebacks were found to feed more on benthic prey, such as amphipods, gastropods and isopods. DNA metabarcoding gave much higher taxonomic resolution (median rank genus) than visual analysis (median rank order), and many taxa identified using barcoding could not have been identified visually. However, a few taxa identified by visual inspection were not revealed by barcoding. In summary, our results suggest that the three-spined stickleback feeds on a wide variety of both pelagic and benthic organisms, indicating that the strong increase in stickleback populations may affect many parts of the Baltic Sea coastal ecosystem.	[Jakubaviciute, Egle] Nat Res Ctr, Vilnius, Lithuania; [Bergstrom, Ulf] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Coastal Res, Oregrund, Sweden; [Eklof, Johan S.] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Haenel, Quiterie] Univ Basel, Zool Inst, Basel, Switzerland; [Bourlat, Sarah J.] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden	Nature Research Center - Lithuania; Swedish University of Agricultural Sciences; Stockholm University; University of Basel; University of Gothenburg	Jakubaviciute, E (corresponding author), Nat Res Ctr, Vilnius, Lithuania.	ejakubaviciute@ekoi.it	Eklöf, Johan S/C-7722-2017; Bourlat, Sarah/AAR-2251-2020	Eklöf, Johan S/0000-0001-6936-0926; Bergstrom, Ulf/0000-0002-5478-0634	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [2013-1074]; HM Carl XVI Gustaf's Foundation for Science and Education [2014-0002]; Baltic Sea Centre (Asko grants); Groningen University (The Netherlands); Swedish research council [2012-3446]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); HM Carl XVI Gustaf's Foundation for Science and Education; Baltic Sea Centre (Asko grants); Groningen University (The Netherlands)(Netherlands Government); Swedish research council(Swedish Research CouncilEuropean Commission)	This study was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas, www.formas.se, grant 2013-1074), HM Carl XVI Gustaf's Foundation for Science and Education (2014-0002), the Baltic Sea Centre (Asko grants) and in-kind support from Groningen University (The Netherlands). This study was supported by Swedish research council grant 2012-3446 'Biodiversity genomics: Species identification pipelines for analysing marine invertebrate larval stages, community structure, and trophic interactions' (http:/vrproj.vr.se/detail.asp? arendeid=92750) awarded to SJB. This study is a product of project Plant-Fish (www.plantfish.se).	[Anonymous], 2013, PROC ASS BIOL LAB ED; Armitage P. D., 2012, CHIRONOMIDAE BIOL EC; Baker R, 2014, FISH FISH, V15, P170, DOI 10.1111/faf.12026; Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Bergstrom U, 2015, ESTUAR COAST SHELF S, V163, P134, DOI 10.1016/j.ecss.2015.06.017; Berry O, 2015, MAR ECOL PROG SER, V540, P167, DOI 10.3354/meps11524; Bolnick DI, 2014, ECOL LETT, V17, P979, DOI 10.1111/ele.12301; Bowser AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083152; Bystrom P, 2015, AMBIO, V44, pS462, DOI 10.1007/s13280-015-0665-5; CAMPBELL CE, 1991, FRESHWATER BIOL, V25, P155, DOI 10.1111/j.1365-2427.1991.tb00481.x; Candolin U, 2016, ESTUAR COAST, V39, P248, DOI 10.1007/s12237-015-9984-9; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; Des Roches S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059644; Donadi S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0045; Dukowska M, 2009, OCEANOL HYDROBIOL ST, V38, P39, DOI 10.2478/v10009-009-0020-x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eriksson BK, 2011, AMBIO, V40, P786, DOI 10.1007/s13280-011-0158-0; Frande C, 1993, AQUA FENN, P85; Hansen JP, 2008, ESTUAR COAST SHELF S, V77, P535, DOI 10.1016/j.ecss.2007.10.013; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; HART PJB, 1991, J FISH BIOL, V38, P359, DOI 10.1111/j.1095-8649.1991.tb03126.x; Hendry AP, 2013, EVOL ECOL RES, V15, P111; HUNTER JR, 1980, FISH B-NOAA, V78, P811; Huntingford FA, 2009, J FISH BIOL, V75, P1943, DOI 10.1111/j.1095-8649.2009.02420.x; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; IBRAHIM AA, 1988, J FISH BIOL, V33, P823, DOI 10.1111/j.1095-8649.1988.tb05528.x; Jakobsen TS, 2003, MAR ECOL PROG SER, V262, P277, DOI 10.3354/meps262277; Jakubaviciute E, 2017, ICES J MAR SCI, V74, P750, DOI 10.1093/icesjms/fsw224; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kotta J, 2010, J SEA RES, V64, P369, DOI 10.1016/j.seares.2010.05.006; Lankov A, 2010, J FISH BIOL, V77, P2268, DOI 10.1111/j.1095-8649.2010.02805.x; LAVIN PA, 1986, CAN J FISH AQUAT SCI, V43, P2455, DOI 10.1139/f86-305; Lefebure R, 2014, J EXP MAR BIOL ECOL, V451, P82, DOI 10.1016/j.jembe.2013.11.008; Leinikki Jouni, 1995, Aqua Fennica, V25, P71; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Leray M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058076; Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109; Meier HEM, 2006, CLIM DYNAM, V27, P39, DOI 10.1007/s003S2-006-0124-x; Nilsson J, 2006, HYDROBIOLOGIA, V553, P161, DOI 10.1007/s10750-005-1949-8; Oehm J, 2016, IBIS, V158, P51, DOI 10.1111/ibi.12337; Ostman O, 2016, J APPL ECOL, V53, P1138, DOI 10.1111/1365-2664.12654; Peltonen H, 2004, ICES J MAR SCI, V61, P966, DOI 10.1016/j.icesjms.2004.06.008; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Rudman SM, 2015, P ROY SOC B-BIOL SCI, V282, P125, DOI 10.1098/rspb.2015.1234; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Sieben K, 2011, MAR BIOL, V158, P391, DOI 10.1007/s00227-010-1567-5; Sieben K, 2011, J EXP MAR BIOL ECOL, V397, P79, DOI 10.1016/j.jembe.2010.11.020; Snickars M, 2009, ESTUAR COAST SHELF S, V81, P247, DOI 10.1016/j.ecss.2008.10.021; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12	57	44	46	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186929	10.1371/journal.pone.0186929	http://dx.doi.org/10.1371/journal.pone.0186929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059215	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000052
J	Takenaka, T; Nakamura, T; Yanaka, S; Yagi-Utsumi, M; Chandak, MS; Takahashi, K; Paul, S; Makabe, K; Arai, M; Kato, K; Kuwajima, K				Takenaka, Toshio; Nakamura, Takashi; Yanaka, Saeko; Yagi-Utsumi, Maho; Chandak, Mahesh S.; Takahashi, Kazunobu; Paul, Subhankar; Makabe, Koki; Arai, Munehito; Kato, Koichi; Kuwajima, Kunihiro			Formation of the chaperonin complex studied by 2D NMR spectroscopy	PLOS ONE			English	Article							GROEL-GROES COMPLEX; CRYSTAL-STRUCTURE; CO-CHAPERONIN; SUBSTRATE PROTEIN; ALPHA-LACTALBUMIN; SINGLE-RING; BINDING; POLYPEPTIDE; ATP; MINICHAPERONE	We studied the interaction between GroES and a single-ring mutant (SR1) of GroEL by the NMR titration of N-15-labeled GroES with SR1 at three different temperatures (20, 25 and 30 degrees C) in the presence of 3 mM ADP in 100 mM KCl and 10 mM MgCl2 at pH 7.5. We used SR1 instead of wild-type double-ring GroEL to precisely control the stoichiometry of the GroES binding to be 1:1 ([SR1]:[GroES]). Native heptameric GroES was very flexible, showing well resolved cross peaks of the residues in a mobile loop segment (residue 17-34) and at the top of a roof hairpin (Asn51) in the heteronuclear single quantum coherence spectra. The binding of SR1 to GroES caused the cross peaks to disappear simultaneously, and hence it occurred in a single-step cooperative manner with significant immobilization of the whole GroES structure. The binding was thus entropic with a positive entropy change (219 J/mol/K) and a positive enthalpy change (35 kJ/mol), and the binding constant was estimated at 1.9x10(5) M-1 at 25 degrees C. The NMR titration in 3 mM ATP also indicated that the binding constant between GroES and SR1 increased more than tenfold as compared with the binding constant in 3 mM ADP. These results will be discussed in relation to the structure and mechanisms of the chaperonin GroEL/GroES complex.	[Takenaka, Toshio; Nakamura, Takashi; Yanaka, Saeko; Yagi-Utsumi, Maho; Paul, Subhankar; Makabe, Koki; Kato, Koichi; Kuwajima, Kunihiro] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan; [Takenaka, Toshio; Nakamura, Takashi; Yanaka, Saeko; Yagi-Utsumi, Maho; Paul, Subhankar; Makabe, Koki; Kato, Koichi; Kuwajima, Kunihiro] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi, Japan; [Yagi-Utsumi, Maho; Chandak, Mahesh S.; Makabe, Koki; Kato, Koichi; Kuwajima, Kunihiro] Grad Univ Adv Studies Sokendai, Sch Phys Sci, Dept Funct Mol Sci, Okazaki, Aichi, Japan; [Takahashi, Kazunobu; Kuwajima, Kunihiro] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo, Japan; [Makabe, Koki] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan; [Arai, Munehito] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Kuwajima, Kunihiro] KIAS, Sch Computat Sci, Seoul, South Korea; [Nakamura, Takashi] Fuji Pharma Co Ltd, Tokyo, Japan; [Paul, Subhankar] Natl Inst Technol Rourkela, Dept Biotechnol & Med Engn, Rourkela, India	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; University of Tokyo; Yamagata University; University of Tokyo; Korea Institute for Advanced Study (KIAS); National Institute of Technology (NIT System); National Institute of Technology Rourkela	Kuwajima, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan.; Kuwajima, K (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi, Japan.; Kuwajima, K (corresponding author), Grad Univ Adv Studies Sokendai, Sch Phys Sci, Dept Funct Mol Sci, Okazaki, Aichi, Japan.; Kuwajima, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo, Japan.; Kuwajima, K (corresponding author), KIAS, Sch Computat Sci, Seoul, South Korea.	kuwajima@kk.alumni.u-tokyo.ac.jp	Yanaka, Saeko/AAW-5301-2020; Arai, Munehito/A-1258-2012; Yanaka, Saeko/AAU-4487-2020; chandak, mahesh/AAH-2154-2019	Yanaka, Saeko/0000-0002-3513-5701; Arai, Munehito/0000-0002-1223-2242; chandak, mahesh/0000-0001-5657-3877; Yagi-Utsumi, Maho/0000-0001-8144-740X; Kato, Koichi/0000-0001-7187-9612; Kuwajima, Kunihiro/0000-0003-3514-4672	MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan) KAKENHI [JP20107009, JP25102001, JP25102008]; MEXT; JSPS (Japan Society for the Promotion of Science) KAKENHI [JP25440075, JP16K07314]; Research Center of Integrative Molecular Systems of the Institute for Molecular Science; Okazaki ORION of the Okazaki Institute for Integrative Bioscience; Grants-in-Aid for Scientific Research [16H02217, 25102008] Funding Source: KAKEN	MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan) KAKENHI; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Center of Integrative Molecular Systems of the Institute for Molecular Science; Okazaki ORION of the Okazaki Institute for Integrative Bioscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan) KAKENHI Grant Numbers JP20107009, JP25102001 and JP25102008, by the Nanotechnology Platform Program (Molecule and Material Synthesis) of MEXT, by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Numbers JP25440075 and JP16K07314, by Research Center of Integrative Molecular Systems of the Institute for Molecular Science, and by the Okazaki ORION project of the Okazaki Institute for Integrative Bioscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 1997, J BIOL CHEM, V272, P32158, DOI 10.1074/jbc.272.51.32158; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; Chandak MS, 2013, J MOL BIOL, V425, P2541, DOI 10.1016/j.jmb.2013.04.008; Chandak MS, 2013, THESIS; Chatellier J, 2000, J MOL BIOL, V304, P897, DOI 10.1006/jmbi.2000.4278; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Creighton TE., 2010, AQUEOUS SOLUTIONS PH, P42; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Haldar S, 2015, J MOL BIOL, V427, P2244, DOI 10.1016/j.jmb.2015.04.009; Higurashi T, 2003, J MOL BIOL, V333, P605, DOI 10.1016/j.jmb.2003.08.056; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Inbar E, 1997, BIOCHEMISTRY-US, V36, P12276, DOI 10.1021/bi9714870; Inobe T, 2001, BBA-PROTEIN STRUCT M, V1545, P160, DOI 10.1016/S0167-4838(00)00274-0; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kobayashi N, 1999, J MOL BIOL, V292, P181, DOI 10.1006/jmbi.1999.3042; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Li YL, 2010, J PEPT SCI, V16, P693, DOI 10.1002/psc.1288; Li YL, 2009, J BIOL CHEM, V284, P4324, DOI 10.1074/jbc.M804818200; LIN ZL, 1995, J BIOL CHEM, V270, P1011, DOI 10.1074/jbc.270.3.1011; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Liu H, 2009, FEBS LETT, V583, P2365, DOI 10.1016/j.febslet.2009.06.027; Makio T, 1999, J MOL BIOL, V293, P125, DOI 10.1006/jmbi.1999.3142; Makio T, 2001, J MOL BIOL, V312, P555, DOI 10.1006/jmbi.2001.4959; Nishida N, 2006, J BIOCHEM, V140, P591, DOI 10.1093/jb/mvj188; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sameshima T, 2010, J BIOL CHEM, V285, P23157, DOI 10.1074/jbc.M110.122101; Southall NT, 2002, J PHYS CHEM B, V106, P521, DOI 10.1021/jp015514e; Sun Z, 2003, J MOL BIOL, V332, P715, DOI 10.1016/S0022-2836(03)00830-1; Taguchi H, 2005, J BIOCHEM, V137, P543, DOI 10.1093/jb/mvi069; Taguchi H, 2015, J MOL BIOL, V427, P2912, DOI 10.1016/j.jmb.2015.04.007; Tanaka N, 1999, J MOL BIOL, V292, P173, DOI 10.1006/jmbi.1999.3041; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	43	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0187022	10.1371/journal.pone.0187022	http://dx.doi.org/10.1371/journal.pone.0187022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059240	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000059
J	Mohn, ES; Erdman, JW; Kuchan, MJ; Neuringer, M; Johnson, EJ				Mohn, Emily S.; Erdman, John W., Jr.; Kuchan, Matthew J.; Neuringer, Martha; Johnson, Elizabeth J.			Lutein accumulates in subcellular membranes of brain regions in adult rhesus macaques: Relationship to DHA oxidation products	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; NUTRITIONAL MANIPULATION; PRIMATE RETINAS; MACULAR PIGMENT; IN-VIVO; ZEAXANTHIN; CAROTENOIDS; NEUROPROSTANES; STRESS; PLASMA	Objectives Lutein, a carotenoid with anti-oxidant functions, preferentially accumulates in primate brain and is positively related to cognition in humans. Docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid (PUFA), is also beneficial for cognition, but is susceptible to oxidation. The present study characterized the membrane distribution of lutein in brain regions important for different domains of cognitive function and determined whether membrane lutein was associated with brain PUFA oxidation. Methods Adult rhesus monkeys were fed a stock diet (similar to 2 mg/day lutein or similar to 0.5 mu mol/kg body weight/day) (n = 9) or the stock diet plus a daily supplement of lutein (similar to 4.5 mg/day or similar to 1 mu mol/kg body weight/day) and zeaxanthin (similar to 0.5 mg/day or 0.1 mu mol/kg body weight/day) for 6-12 months (n = 4). Nuclear, myelin, mitochondrial, and neuronal plasma membranes were isolated using a Ficoll density gradient from prefrontal cortex (PFC), cerebellum (CER), striatum (ST), and hippocampus (HC). Carotenoids, PUFAs, and PUFA oxidation products were measured using HPLC, GC, and LC-GC/MS, respectively. Results All-trans-lutein (ng/mg protein) was detected in all regions and membranes and was highly variable among monkeys. Lutein/zeaxanthin supplementation significantly increased total concentrations of lutein in serum, PFC and CER, as well as lutein in mitochondrial membranes and total DHA concentrations in PFC only (P < 0.05). In PFC and ST, mitochondrial lutein was inversely related to DHA oxidation products, but not those from arachidonic acid (P < 0.05). Discussion This study provides novel data on subcellular lutein accumulation and its relationship to DHA oxidation in primate brain. These findings support the hypothesis that lutein may be associated with antioxidant functions in the brain.	[Mohn, Emily S.; Johnson, Elizabeth J.] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Boston, MA 02111 USA; [Erdman, John W., Jr.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Kuchan, Matthew J.] Abbott Nutr, Discovery Res, Columbus, OH USA; [Neuringer, Martha] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Tufts University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; Oregon Health & Science University; Oregon National Primate Research Center	Mohn, ES (corresponding author), Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Boston, MA 02111 USA.	Emily.Mohn@tufts.edu			Abbott Nutrition through the Center for Nutrition, Learning, and Memory at the University of Illinois; USDA [1950-51000-073-01S]	Abbott Nutrition through the Center for Nutrition, Learning, and Memory at the University of Illinois; USDA(United States Department of Agriculture (USDA))	This work was supported by a grant from Abbott Nutrition through the Center for Nutrition, Learning, and Memory at the University of Illinois and USDA under grant 1950-51000-073-01S. MJK has a role in the preparation of the manuscript and the decision to publish.	Abdel-Aal EM, 2013, NUTRIENTS, V5, P1169, DOI 10.3390/nu5041169; [Anonymous], 1998, IARC WORK GROUP EV C; Arneson KO, 2007, METHOD ENZYMOL, V433, P127, DOI 10.1016/S0076-6879(07)33007-3; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Balsters JH, 2013, CEREB CORTEX, V23, P1433, DOI 10.1093/cercor/bhs127; Borel P, 2011, ANN MED, V43, P47, DOI 10.3109/07853890.2010.531757; Bovier ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108178; Connor WE, 2007, INVEST OPHTH VIS SCI, V48, P4226, DOI 10.1167/iovs.06-1275; Craft N E, 2004, J Nutr Health Aging, V8, P156; de Pablos RM, 2006, J NEUROSCI, V26, P5709, DOI 10.1523/JNEUROSCI.0802-06.2006; Dreher ML, 2013, CRIT REV FOOD SCI, V53, P738, DOI 10.1080/10408398.2011.556759; Edwards JA, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/3690140; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gemma C, 2007, BRAIN AGING MODELS M; Gonzalez S, 2010, INT J FOOD SCI NUTR, V61, P217, DOI 10.3109/09637480903348098; Gruszecki WI, 1999, Z NATURFORSCH C, V54, P517; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Jeon S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010051; Johnson EJ, 2005, INVEST OPHTH VIS SCI, V46, P692, DOI 10.1167/iovs.02-1192; Johnson EJ, 2008, NUTR NEUROSCI, V11, P75, DOI 10.1179/147683008X301450; Johnson Elizabeth J, 2013, J Aging Res, V2013, P951786, DOI 10.1155/2013/951786; Kelly D, 2015, J ALZHEIMERS DIS, V48, P261, DOI 10.3233/JAD-150199; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; LEMARCHAND L, 1995, INT J CANCER, V63, P18, DOI 10.1002/ijc.2910630105; Lichtenstein AH, 2006, AM J CLIN NUTR, V84, P497, DOI 10.1093/ajcn/84.3.497; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Meyers KJ, 2013, INVEST OPHTH VIS SCI, V54, P2333, DOI [10.1167/iovs.12-10867, 10.1167/iovs.13-13216]; Miller E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/572491; Mohn E, 2013, EXP BIOL C APR BOST; Montine TJ, 2003, BIOCHEM PHARMACOL, V65, P611, DOI 10.1016/S0006-2952(02)01607-6; Mukaka MM, 2012, MALAWI MED J, V24, P69; Musiek ES, 2004, J CHROMATOGR B, V799, P95, DOI 10.1016/j.jchromb.2003.10.036; Muzhingi T, 2008, INT J VITAM NUTR RES, V78, P112, DOI 10.1024/0300-9831.78.3.112; Naberhuis JK, 2015, MED HYPOTHESES, V85, P680, DOI 10.1016/j.mehy.2015.08.005; Neuringer M, 2004, INVEST OPHTH VIS SCI, V45, P3234, DOI 10.1167/iovs.02-1243; O'Callaghan C, 2014, J NEUROL NEUROSUR PS, V85, P371, DOI 10.1136/jnnp-2012-304558; Park JH, 2001, KOREAN MED J INFORM, V34, P754; Perretta G, 2009, SCAND J LAB ANIM SCI, V36, P77; Peters A., 1999, CEREBRAL CORTEX NEUR; Rapp LM, 2000, INVEST OPHTH VIS SCI, V41, P1200; Renzi LM, 2008, FASEB J, V22; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Scott TM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090919; SOLOMONS NW, 2001, PRESENT KNOWLEDGE NU, P127; Song JH, 2000, J NUTR, V130, P3028, DOI 10.1093/jn/130.12.3028; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; SUN GY, 1973, J LIPID RES, V14, P656; Sun GY, 1972, BIOCHIM BIOPHYS ACTA, P280; Tanaka K, 2012, BIOMOL THER, V20, P152, DOI 10.4062/biomolther.2012.20.2.152; Tanprasertsuk J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155488; Vishwanathan R, 2015, NUTR NEUROSCI; Vishwanathan R, 2014, AGE AGEING; Vishwanathan R, 2014, J PEDIATR GASTR NUTR, V59, P659, DOI 10.1097/MPG.0000000000000389; Vishwanathan R, 2013, NUTR NEUROSCI, V16, P21, DOI 10.1179/1476830512Y.0000000024; Walter MF, 2000, ANAL BIOCHEM, V280, P73, DOI 10.1006/abio.1999.4476; Wang W, 2007, AM J CLIN NUTR, V85, P762, DOI 10.1093/ajcn/85.3.762; Weiser MJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020099; Yamini S, 2001, EUR J CLIN NUTR, V55, P252, DOI 10.1038/sj.ejcn.1601152; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013	62	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186767	10.1371/journal.pone.0186767	http://dx.doi.org/10.1371/journal.pone.0186767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049383	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900109
J	Wright, PW; Brier, LM; Bauer, AQ; Baxter, GA; Kraft, AW; Reisman, MD; Bice, AR; Snyder, AZ; Lee, JM; Culver, JP				Wright, Patrick W.; Brier, Lindsey M.; Bauer, Adam Q.; Baxter, Grant A.; Kraft, Andrew W.; Reisman, Matthew D.; Bice, Annie R.; Snyder, Abraham Z.; Lee, Jin-Moo; Culver, Joseph P.			Functional connectivity structure of cortical calcium dynamics in anesthetized and awake mice	PLOS ONE			English	Article							RAT SOMATOSENSORY CORTEX; IMAGING NEURAL ACTIVITY; IN-VIVO; FLAVOPROTEIN AUTOFLUORESCENCE; NEOCORTICAL NEURONS; SLOW OSCILLATION; TRANSGENIC MICE; MOUSE-BRAIN; SLEEP; SIGNAL	The interplay between hemodynamic-based markers of cortical activity (e.g. fMRI and optical intrinsic signal imaging), which are an indirect and relatively slow report of neural activity, and underlying synaptic electrical and metabolic activity through neurovascular coupling is a topic of ongoing research and debate. As application of resting state functional connectivity measures is extended further into topics such as brain development, aging and disease, the importance of understanding the fundamental physiological basis for functional connectivity will grow. Here we extend functional connectivity analysis from hemodynamic-to calcium- based imaging. Transgenic mice (n = 7) expressing a fluorescent calcium indicator (GCaMP6) driven by the Thy1 promoter in glutamatergic neurons were imaged transcranially in both anesthetized (using ketamine/xylazine) and awake states. Sequential LED illumination (lambda = 454, 523, 595, 640nm) enabled concurrent imaging of both GCaMP6 fluorescence emission (corrected for hemoglobin absorption) and hemodynamics. Functional connectivity network maps were constructed for infraslow (0.009-0.08Hz), intermediate (0.08-0.4Hz), and high (0.4-4.0Hz) frequency bands. At infraslow and intermediate frequencies, commonly used in BOLD fMRI and fcOIS studies of functional connectivity and implicated in neurovascular coupling mechanisms, GCaMP6 and HbO(2) functional connectivity structures were in high agreement, both qualitatively and also quantitatively through a measure of spatial similarity. The spontaneous dynamics of both contrasts had the highest correlation when the GCaMP6 signal was delayed with a similar to 0.6-1.5s temporal offset. Within the higher-frequency delta band, sensitive to slow wave sleep oscillations in non-REM sleep and anesthesia, we evaluate the speed with which the connectivity analysis stabilized and found that the functional connectivity maps captured putative network structure within time window lengths as short as 30 seconds. Homotopic GCaMP6 functional connectivity maps at 0.4-4.0Hz in the anesthetized states show a striking correlated and anti-correlated structure along the anterior to posterior axis. This structure is potentially explained in part by Dobserved propagation of delta-band activity from frontal somatomotor regions to visuoparietal areas. During awake imaging, this spatio-temporal quality is altered, and a more complex and detailed functional connectivity structure is observed. The combined calcium/hemoglobin imaging technique described here will enable the dissociation of changes in ionic and hemodynamic functional structure and neurovascular coupling and provide a framework for subsequent studies of neurological disease such as stroke.	[Wright, Patrick W.; Lee, Jin-Moo; Culver, Joseph P.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Wright, Patrick W.; Bauer, Adam Q.; Baxter, Grant A.; Reisman, Matthew D.; Bice, Annie R.; Snyder, Abraham Z.; Lee, Jin-Moo; Culver, Joseph P.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Brier, Lindsey M.; Kraft, Andrew W.; Culver, Joseph P.] Washington Univ, Dept Neurosci, St Louis, MO 63130 USA; [Reisman, Matthew D.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Lee, Jin-Moo] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Culver, JP (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Culver, JP (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.; Culver, JP (corresponding author), Washington Univ, Dept Neurosci, St Louis, MO 63130 USA.	culverj@wustl.edu	Lee, Jin-Moo/K-2024-2015	Lee, Jin-Moo/0000-0002-3979-0906	National Institute of Neurological Disorders and Stroke [R01NS078223, R01NS084028, K25NS083754, P01NS080675]; National Institute of Biomedical Imaging and Bioengineering [T32EB014855]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD087011]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099429, R01NS078223, K25NS083754] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke: R01NS078223 [JPC], R01NS084028-[JML], K25NS083754 [AQB], P01NS080675 [JPC, AZS]; National Institute of Biomedical Imaging and Bioengineering, T32EB014855 [PWW]; and Eunice Kennedy Shriver National Institute of Child Health and Human Development, U54HD087011 [JPC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; Baker WB, 2013, J CEREBR BLOOD F MET, V33, P97, DOI 10.1038/jcbfm.2012.137; Bauer AQ, 2014, NEUROIMAGE, V99, P388, DOI 10.1016/j.neuroimage.2014.05.051; Bentley WJ, 2016, CEREB CORTEX, V26, P346, DOI 10.1093/cercor/bhu260; Bergonzi KM, 2015, J CEREBR BLOOD F MET, V35, P367, DOI 10.1038/jcbfm.2014.211; Bero AW, 2012, J NEUROSCI, V32, P4334, DOI 10.1523/JNEUROSCI.5845-11.2012; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Bumstead JR, 2017, J CEREBR BLOOD F MET, V37, P471, DOI 10.1177/0271678X16629977; Busche MA, 2015, NAT NEUROSCI, V18, P1623, DOI 10.1038/nn.4137; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Choi JH, 2010, J NEUROPHYSIOL, V104, P1825, DOI 10.1152/jn.00188.2010; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Du CW, 2014, P NATL ACAD SCI USA, V111, pE4677, DOI 10.1073/pnas.1410800111; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franklin KBJ, 2008, THE MOUSE BRAIN IN S; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Griffiths MR, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/151097; Heider B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013829; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Hull EL, 2004, OPT EXPRESS, V12, P4496, DOI 10.1364/OPEX.12.004496; Kozberg MG, 2016, J NEUROSCI, V36, P6704, DOI 10.1523/JNEUROSCI.2363-15.2016; Kubota Y, 2008, NEUROSCI RES, V60, P422, DOI 10.1016/j.neures.2007.12.013; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Laumann Timothy O, 2016, CEREBRAL CORTEX; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; Liao F, 2014, J NEUROSCI, V34, P7281, DOI 10.1523/JNEUROSCI.0646-14.2014; Liu X, 2015, CEREB CORTEX, V25, P2929, DOI 10.1093/cercor/bhu089; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Ma Y, 2016, P NATL ACAD SCI USA, V113, pE8463, DOI 10.1073/pnas.1525369113; Ma Y, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0360; Marinkovic Petar, 2015, Cold Spring Harb Protoc, V2015, P875, DOI 10.1101/pdb.top087668; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Matsui T, 2016, P NATL ACAD SCI USA, V113, P6556, DOI 10.1073/pnas.1521299113; Mitra A, 2015, P NATL ACAD SCI USA, V112, pE2235, DOI 10.1073/pnas.1503960112; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Scott BB, 2013, NEURON, V80, P371, DOI 10.1016/j.neuron.2013.08.002; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Silasi G, 2016, J NEUROSCI METH, V267, P141, DOI 10.1016/j.jneumeth.2016.04.012; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Vanni MP, 2014, J NEUROSCI, V34, P15931, DOI 10.1523/JNEUROSCI.1818-14.2014; Vazquez AL, 2014, BRAIN CONNECT, V4, P727, DOI 10.1089/brain.2014.0276; Walter WG, 1936, LANCET, V2, P305; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wright PW, 2017, EXP NEUROL, V295, P18, DOI 10.1016/j.expneurol.2017.05.004; Xie YC, 2016, J NEUROSCI, V36, P1261, DOI 10.1523/JNEUROSCI.2744-15.2016; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	65	51	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185759	10.1371/journal.pone.0185759	http://dx.doi.org/10.1371/journal.pone.0185759			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049297	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900017
J	Chakrabarti, B; Haffey, A; Canzano, L; Taylor, CP; McSorley, E				Chakrabarti, Bhismadev; Haffey, Anthony; Canzano, Loredana; Taylor, Christopher P.; McSorley, Eugene			Individual differences in responsivity to social rewards: Insights from two eye-tracking tasks	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; CIRCUMSCRIBED ATTENTION; CNR1 GENE; CHILDREN; INFANTS; SALIENCE; MOVEMENTS; GAZE; INFORMATION; PREDICTION	Humans generally prefer social over nonsocial stimuli from an early age. Reduced preference for social rewards has been observed in individuals with autism spectrum conditions (ASC). This preference has typically been noted in separate tasks that measure orienting toward and engaging with social stimuli. In this experiment, we used two eye-tracking tasks to index both of these aspects of social preference in in 77 typical adults. We used two measures, global effect and preferential looking time. The global effect task measures saccadic deviation toward a social stimulus (related to 'orienting'), while the preferential looking task records gaze duration bias toward social stimuli (relating to 'engaging'). Social rewards were found to elicit greater saccadic deviation and greater gaze duration bias, suggesting that they have both greater salience and higher value compared to nonsocial rewards. Trait empathy was positively correlated with the measure of relative value of social rewards, but not with their salience. This study thus elucidates the relationship of empathy with social reward processing.	[Chakrabarti, Bhismadev; Haffey, Anthony; Canzano, Loredana; Taylor, Christopher P.; McSorley, Eugene] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Sch Psychol & Clin Language Sci, Whiteknights Campus, Reading, Berks, England; [Canzano, Loredana] Sapienza Univ Rome, Psychol Dept, Rome, Italy; [Canzano, Loredana] IRCCS Santa Lucia Fdn, Rome, Italy; [Taylor, Christopher P.] New England Coll Optometry, Dept Biomed Sci & Dis, Boston, MA USA	University of Reading; Sapienza University Rome; IRCCS Santa Lucia	Chakrabarti, B (corresponding author), Univ Reading, Ctr Integrat Neurosci & Neurodynam, Sch Psychol & Clin Language Sci, Whiteknights Campus, Reading, Berks, England.	b.chakrabarti@reading.ac.uk	Taylor, Christopher/W-1808-2019	Taylor, Christopher/0000-0002-6592-6328; Haffey, Anthony/0000-0002-4445-3584	Leverhulme Trust [PLP-2015-329]; MRC [G1100359/1]; University of Reading Research Endowment Trust Fund; ESRC-Medical Research Council; Sapienza University of Rome; MRC [MR/P023894/1, G1100359] Funding Source: UKRI; Medical Research Council [MR/P023894/1, G1100359] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Reading Research Endowment Trust Fund; ESRC-Medical Research Council; Sapienza University of Rome; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	BC was supported by the Philip Leverhulme Prize (PLP-2015-329) from the Leverhulme Trust and the MRC New Investigator grant (G1100359/1), CPT was supported by the University of Reading Research Endowment Trust Fund, ATH was supported by an ESRC-Medical Research Council interdisciplinary doctoral studentship, LC was supported by Sapienza University of Rome studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Batki A, 2000, INFANT BEHAV DEV, V23, P223, DOI 10.1016/S0163-6383(01)00037-6; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; Bukach C. M., 2009, PERCEPTUAL EXPERTISE, P11; Chakrabarti B, 2006, EUR J NEUROSCI, V23, P1944, DOI 10.1111/j.1460-9568.2006.04697.x; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Chakrabarti B, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-10; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Coutrot A, 2014, J VISION, V14, DOI 10.1167/14.8.5; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Dawson G, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-11; Domschke K, 2008, EUR NEUROPSYCHOPHARM, V18, P751, DOI 10.1016/j.euroneuro.2008.05.003; Eggert T, 2002, VISION RES, V42, P2969, DOI 10.1016/S0042-6989(02)00392-9; Elsabbagh M, 2013, BEHAV BRAIN RES, V251, P147, DOI 10.1016/j.bbr.2012.07.030; Fantz RL, 1958, PSYCHOL REC; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Gossen A, 2014, SOC COGN AFFECT NEUR, V9, P661, DOI 10.1093/scan/nst033; HE PY, 1989, VISION RES, V29, P1165, DOI 10.1016/0042-6989(89)90063-1; Janowski V, 2013, SOC COGN AFFECT NEUR, V8, P201, DOI 10.1093/scan/nsr086; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Lang P. J., 1999, INT AFFECTIVE PICTUR; Leathers ML, 2012, SCIENCE, V338, P132, DOI 10.1126/science.1226405; Legerstee M, 1997, SOC DEV, V6, P307; McSorley E, 2013, EMOTION, V13, P769, DOI 10.1037/a0032185; Mosconi MW, 2009, J AUTISM DEV DISORD, V39, P242, DOI 10.1007/s10803-008-0620-4; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Sasson NJ, 2014, J AUTISM DEV DISORD, V44, P584, DOI 10.1007/s10803-013-1910-z; Sasson NJ, 2011, J AUTISM DEV DISORD, V41, P242, DOI 10.1007/s10803-010-1038-3; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; Schutz AC, 2012, P NATL ACAD SCI USA, V109, P7547, DOI 10.1073/pnas.1115638109; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Talmi D, 2013, J NEUROSCI, V33, P8264, DOI 10.1523/JNEUROSCI.5695-12.2013; Taylor C, 2013, PSYCHON B REV, V20, P916, DOI 10.3758/s13423-013-0411-6; Team RC, 2012, R LANG ENV STAT COMP; Walther D, 2006, NEURAL NETWORKS, P19; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu R, 2011, DEV PSYCHOL, V47, P1220, DOI 10.1037/a0024023; Zalla T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00894	45	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e10185146	10.1371/journal.pone.0185146	http://dx.doi.org/10.1371/journal.pone.0185146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045458	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000413168100011
J	Cohen, EJ; Bravi, R; Minciacchi, D				Cohen, Erez James; Bravi, Riccardo; Minciacchi, Diego			3D reconstruction of human movement in a single projection by dynamic marker scaling	PLOS ONE			English	Article							HUMAN MOTION; CAMERA	The three dimensional (3D) reconstruction of movement from videos is widely utilized as a method for spatial analysis of movement. Several approaches exist for a 3D reconstruction of movement using 2D video projection, most of them require the use of at least two cameras as well as the application of relatively complex algorithms. While a few approaches also exist for 3D reconstruction of movement with a single camera, they are not widely implemented due to tedious and complicated methods of calibration. Here we propose a simple method that allows for a 3D reconstruction of movement by using a single projection and three calibration markers. Such approach is made possible by tracking the change in diameter of a moving spherical marker within a 2D projection. In order to test our model, we compared kinematic results obtained with this model to those with the commonly used approach of two cameras and Direct Linear Transformation (DLT). Our results show that such approach appears to be in line with the DLT method for 3D reconstruction and kinematic analysis. The simplicity of this method may render it approachable for both clinical use as well as in uncontrolled environments.	[Cohen, Erez James; Bravi, Riccardo; Minciacchi, Diego] Univ Florence, Physiol Sci Sect, Dept Expt & Clin Med, Florence, Italy	University of Florence	Minciacchi, D (corresponding author), Univ Florence, Physiol Sci Sect, Dept Expt & Clin Med, Florence, Italy.	diego@unifi.it		MINCIACCHI, Diego/0000-0002-3842-7611; Cohen, Erez James/0000-0001-7798-3947; BRAVI, RICCARDO/0000-0002-7716-974X				Abdel-Aziz Y.I., 1971, P S CLOS RANG PHOT, P18; Ambrosio J, 2001, HUM MOVEMENT SCI, V20, P829, DOI 10.1016/S0167-9457(01)00056-2; Baskwill Amanda J, 2017, Int J Ther Massage Bodywork, V10, P3; Bernardina GRD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160490; Boissin C, 2015, TELEMED E-HEALTH, V21, P887, DOI 10.1089/tmj.2014.0221; Bowden R, 1998, BMVC, V904, P913; Cancela J, 2017, REJUVENATION RES; Castelli A, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/186780; Ceseracciu E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087640; Cheze L, 2014, KINEMATIC ANAL HUMAN; Claesson IM, 2017, PHYSIOTHER THEORY PR, V8, P1; Ferrarello F, 2013, PHYS THER, V93, P1673, DOI 10.2522/ptj.20120344; Hewett TE, 2017, AM J SPORTS MED, V1; Howe NR, 2000, ADV NEUR IN, V12, P820; Krishnan C, 2015, J BIOMECH, V48, P544, DOI 10.1016/j.jbiomech.2014.11.048; Lussiana T, 2017, EUR J SPORT SCI, V17, P847, DOI 10.1080/17461391.2017.1325072; Magalhaes FA, 2013, J SPORT SCI MED, V12, P660; Mustapa A, 2017, REHABIL RES PRACT, V2017, DOI 10.1155/2017/5280146; Nussbaumer S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-194; Remondino F., 2006, INT ARCH PHOTOGRAMM, V36, P266, DOI DOI 10.3929/ETHZ-B-000158067; Riberto M, 2013, INT J PHYS MED REHAB, V1, P131, DOI [10.4172/2329-9096.000131, DOI 10.4172/2329-9096.000131]; ROGERS JL, 1993, PSYCHOL BULL, V113, P553, DOI 10.1037/0033-2909.113.3.553; Sibley KM, 2011, PHYS THER, V91, P1583, DOI 10.2522/ptj.20110063; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Wei XL, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2366145.2366207; Yang C, 2016, J SENSORS, V2016, DOI 10.1155/2016/5036857; Yang F, 2005, ANN BIOMED ENG, V33, P674, DOI 10.1007/s10439-005-1976-7	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186443	10.1371/journal.pone.0186443	http://dx.doi.org/10.1371/journal.pone.0186443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045439	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100063
J	Pena-Soler, E; Aranda, J; Lopez-Estepa, M; Gomez, S; Garces, F; Coll, M; Fernandez, FJ; Tunon, I; Vega, MC				Pena-Soler, Esther; Aranda, Juan; Lopez-Estepa, Miguel; Gomez, Sara; Garces, Fernando; Coll, Miquel; Fernandez, Francisco J.; Tunon, Inaki; Cristina Vega, M.			Insights into the inhibited form of the redox-sensitive SufE-like sulfur acceptor CsdE	PLOS ONE			English	Article							S CLUSTER BIOGENESIS; CYSTEINE DESULFURASE; ESCHERICHIA-COLI; MACROMOLECULAR CRYSTALLOGRAPHY; PROTEIN; PATHWAYS; ENZYMOLOGY; COMPLEXES; BEAMLINE; STRESS	Sulfur trafficking in living organisms relies on transpersulfuration reactions consisting in the enzyme-catalyzed transfer of S atoms via activated persulfidic S across protein-protein interfaces. The recent elucidation of the mechanistic basis for transpersulfuration in the CsdA-CsdE model system has paved the way for a better understanding of its role under oxidative stress. Herein we present the crystal structure of the oxidized, inactivated CsdE dimer at 2.4 angstrom resolution. The structure sheds light into the activation of the Cys61 nucleophile on its way from a solvent-secluded position in free CsdE to a fully extended conformation in the persulfurated CsdA-CsdE complex. Molecular dynamics simulations of available CsdE structures allow to delineate the sequence of conformational changes underwent by CsdE and to pinpoint the key role played by the deprotonation of the Cys61 thiol. The low-energy subunit orientation in the disulfide-bridged CsdE dimer demonstrates the likely physiologic relevance of this oxidative dead-end form of CsdE, suggesting that CsdE could act as a redox sensor in vivo.	[Pena-Soler, Esther; Lopez-Estepa, Miguel; Gomez, Sara; Fernandez, Francisco J.; Cristina Vega, M.] CSIC, CIB, Ctr Biol Res, Chem & Phys Biol Dept, Madrid, Spain; [Pena-Soler, Esther; Coll, Miquel] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Pena-Soler, Esther; Coll, Miquel] Inst Biomed Res IRB Barcelona, Barcelona, Spain; [Aranda, Juan; Tunon, Inaki] Univ Valencia, Dept Quim Fis, Burjassot, Spain; [Garces, Fernando] Scripps Res Inst, La Jolla, CA 92037 USA; [Fernandez, Francisco J.] Abvance Biotech Srl, Madrid, Spain; [Garces, Fernando] Amgen Inc, Thousand Oaks, CA 91320 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Valencia; Scripps Research Institute; Amgen	Vega, MC (corresponding author), CSIC, CIB, Ctr Biol Res, Chem & Phys Biol Dept, Madrid, Spain.; Tunon, I (corresponding author), Univ Valencia, Dept Quim Fis, Burjassot, Spain.	ignacio.tunon@uv.es; cvega@cib.csic.es	Moratalla, Juan Aranda/A-6888-2016; Tunon, Inaki/F-7973-2012; Peña, Esther/AAB-8217-2019; Moratalla, Juan Aranda/G-3376-2017; Vega, M. Cristina/C-3640-2011	Moratalla, Juan Aranda/0000-0001-9385-4651; Tunon, Inaki/0000-0002-6995-1838; Moratalla, Juan Aranda/0000-0001-9385-4651; Vega, M. Cristina/0000-0003-0628-8378; Pena, Esther/0000-0003-2750-0614	Spanish Institute de Salud Carlos III [PI12/01667]; Spanish Ministerio de Economia y Competitividad [PET2008_0101, BIO2009-11184, BFU2010-22260-CO2-02, CTQ2015-66206-C2-2-R, CTQ2015-66223-C2-2-P]; Regional Government of Madrid [S2010/BD-2316]; European Commission [279039]; Universitat Autonoma de Barcelona (UAB); Universidad Complutense de Madrid (UCM)	Spanish Institute de Salud Carlos III(Instituto de Salud Carlos III); Spanish Ministerio de Economia y Competitividad(Spanish Government); Regional Government of Madrid; European Commission(European CommissionEuropean Commission Joint Research Centre); Universitat Autonoma de Barcelona (UAB); Universidad Complutense de Madrid (UCM)	This work was supported by Spanish Institute de Salud Carlos III (http://www.isciii.es) (PI12/01667 to MCV), Spanish Ministerio de Economia y Competitividad (http://www.mineco. gob.es/portal/site/mineco/) (PET2008_0101, BIO2009-11184, BFU2010-22260-CO2-02, and CTQ2015-66206-C2-2-R to MCV, and CTQ2015-66223-C2-2-P to IT), the Regional Government of Madrid (http://www.madrid.org/) (S2010/BD-2316 to MCV), and the European Commission (Framework Programme 7 (FP7)) (https://ec. europe.eu/research/fp7/index_en.cfm) project Complexl NC (Contract No. 279039) to MCV. F.J. Fernandez (FJF) is currently employed by Abvance Biotech srl and contributed to the work presented here when affiliated to CSIC and, as an employee of Abvance, to writing and reviewing the article. Abvance Biotech srl provided support in the form of salary for author FJF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We gratefully acknowledge access to the ALBA Synchrotron Light Source, Barcelona, Spain, for provision of synchrotron radiation facilities at BL13-XALOC, and the European Synchrotron Radiation Facility, Grenoble, France, at the ID23-1 beamline; and the staff for excellent support at the two synchrotrons. EPS and MLE acknowledge the support of the PhD program in Structure and Function of Proteins of the Universitat Autonoma de Barcelona (UAB) and the PhD program in Biochemistry, Molecular Biology and Biomedicine of the Universidad Complutense de Madrid (UCM), respectively. MCV is member of the CIB Intramural Program "Molecular Machines for Better Life" (MACBET).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Begley TP, 1999, CURR OPIN CHEM BIOL, V3, P623, DOI 10.1016/S1367-5931(99)00018-6; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolstad HM, 2010, J PROTEOME RES, V9, P5358, DOI 10.1021/pr1006087; Case DA, 2014, AMBER 14; Case DA, 2015, THE AMBER MOLECULAR; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dai YY, 2012, FEBS LETT, V586, P4016, DOI 10.1016/j.febslet.2012.10.001; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fernandez FJ, 2016, ACS CATAL, V6, P3975, DOI 10.1021/acscatal.6b00360; Goldsmith-Fischman S, 2004, J MOL BIOL, V344, P549, DOI 10.1016/j.jmb.2004.08.074; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenne AN, 2016, INT J BIOL MACROMOL, V87, P317, DOI 10.1016/j.ijbiomac.2016.02.071; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Krivobokova T, 2012, BIOPHYS J, V103, P786, DOI 10.1016/j.bpj.2012.07.022; Liu GH, 2005, PROTEIN SCI, V14, P1597, DOI 10.1110/ps.041322705; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Lopez-Estepa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118606; Marquet A, 2001, CURR OPIN CHEM BIOL, V5, P541, DOI 10.1016/S1367-5931(00)00249-0; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muralidharan S, 2013, J LEUKOCYTE BIOL, V94, P1167, DOI 10.1189/jlb.0313153; Muthuswamy S, 2015, NEUROLOGIST, V20, P51, DOI 10.1097/NRL.0000000000000054; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Roret T, 2014, J BIOL CHEM, V289, P24588, DOI 10.1074/jbc.M114.572701	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186286	10.1371/journal.pone.0186286	http://dx.doi.org/10.1371/journal.pone.0186286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045454	gold, Green Submitted, Green Published			2022-12-26	WOS:000413168100050
J	Surana, P; Gowda, CM; Tripathi, V; Broday, L; Das, R				Surana, Parag; Gowda, Chandrakala M.; Tripathi, Vasvi; Broday, Limor; Das, Ranabir			Structural and functional analysis of SMO-1, the SUMO homolog in Caenorhabditis elegans	PLOS ONE			English	Article							MODIFIER SUMO; NMR-SPECTROSCOPY; P53 ACTIVITY; C-JUN; SUMOYLATION; UBIQUITIN; PROTEIN; SYSTEM; BINDING; GENE	SUMO proteins are important post-translational modifiers involved in multiple cellular pathways in eukaryotes, especially during the different developmental stages in multicellular organisms. The nematode C. elegans is a well known model system for studying metazoan development and has a single SUMO homolog, SMO-1. Interestingly, SMO-1 modification is linked to embryogenesis and development in the nematode. However, high-resolution information about SMO-1 and the mechanism of its conjugation is lacking. In this work, we report the high-resolution three dimensional structure of SMO-1 solved by NMR spectroscopy. SMO-1 has flexible N-terminal and C-terminal tails on either side of a rigid beta-grasp folded core. While the sequence of SMO-1 is more similar to SUMO1, the electrostatic surface features of SMO-1 resemble more with SUMO2/3. SMO-1 can bind to typical SUMO Interacting Motifs (SIMs). SMO-1 can also conjugate to a typical SUMOylation consensus site as well as to its natural substrate HMR-1. Poly-SMO-1 chains were observed in-vitro even though SMO-1 lacks any consensus SUMOylation site. Typical deSUMOylation enzymes like Senp2 can cleave the poly-SMO-1 chains. Despite being a single gene, the SMO-1 structure allows it to function in a large repertoire of signaling pathways involving SUMO in C. elegans. Structural and functional features of SMO-1 studies described here will be useful to understand its role in development.	[Surana, Parag; Gowda, Chandrakala M.; Tripathi, Vasvi; Das, Ranabir] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru, India; [Broday, Limor] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel; [Gowda, Chandrakala M.] TIFR Ctr Interdisciplinary Sci, Hyderabad, Andhra Pradesh, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Tel Aviv University; Sackler Faculty of Medicine; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad	Das, R (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru, India.	rana@ncbs.res.in		Tripathi, Vasvi/0000-0002-9438-5049	Tata Institute of Fundamental Research, Government of India; DBT-Ramalingaswamy fellowship [BT/HRD/23/02/2006]; Research Associate Fellowship from the Department of Biotechnology (DBT), India	Tata Institute of Fundamental Research, Government of India(Tata Institute of Fundamental Research (TIFR)); DBT-Ramalingaswamy fellowship; Research Associate Fellowship from the Department of Biotechnology (DBT), India	This work was funded by the Tata Institute of Fundamental Research, Government of India. Ranabir Das acknowledges the DBT-Ramalingaswamy fellowship (BT/HRD/23/02/2006). Parag Surana is supported by Research Associate Fellowship from the Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre KO, 2011, J BIOL CHEM, V286, P36142, DOI 10.1074/jbc.M111.268847; Anamika, 2016, J BIOL CHEM, V291, P4417, DOI 10.1074/jbc.M115.705061; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Broadbent ID, 2002, CURR BIOL, V12, P59, DOI 10.1016/S0960-9822(01)00624-8; Broday L, 2004, GENE DEV, V18, P2380, DOI 10.1101/gad.1227104; Broday L, 2017, INT J DEV BIOL, V61, P159, DOI 10.1387/ijdb.160388LB; Cai QL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003750; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhury BK, 1997, BIOCHEM BIOPH RES CO, V234, P788, DOI 10.1006/bbrc.1997.6709; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grana-Montes R, 2014, BIOMACROMOLECULES, V15, P1194, DOI 10.1021/bm401776z; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; HAWKES GE, 1975, NATURE, V257, P767, DOI 10.1038/257767a0; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kolli N, 2010, BIOCHEM J, V430, P335, DOI 10.1042/BJ20100504; Lee W, 2016, J BIOMOL NMR, V64, P307, DOI 10.1007/s10858-016-0029-x; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Pelisch F, 2017, MOL CELL, V65, P66, DOI 10.1016/j.molcel.2016.11.001; Pelisch F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6485; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pilla E, 2012, J BIOL CHEM, V287, P44320, DOI 10.1074/jbc.M112.397224; Rytinki MM, 2011, CELL MOL LIFE SCI, V68, P3219, DOI 10.1007/s00018-011-0627-4; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith M, 2012, BIOMOLECULES, V2, P331, DOI 10.3390/biom2030331; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tsur A, 2015, DEV CELL, V35, P63, DOI 10.1016/j.devcel.2015.08.019; Vuister GW, 2014, J BIOMOL NMR, V58, P259, DOI 10.1007/s10858-013-9750-x; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Yuan H, 2010, CELL RES, V20, P185, DOI 10.1038/cr.2009.101; Zhang YQ, 2008, J CELL BIOL, V182, P35, DOI 10.1083/jcb.200712124; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	56	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186622	10.1371/journal.pone.0186622	http://dx.doi.org/10.1371/journal.pone.0186622			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045470	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100080
J	Ye, TJ; Cao, P; Qi, J; Zhou, Q; Rao, DS; Qiu, SJ				Ye, Tingjun; Cao, Peng; Qi, Jin; Zhou, Qi; Rao, D. Sudhaker; Qiu, Shijing			Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats	PLOS ONE			English	Article							BISPHOSPHONATES; OSTEOCLASTS; OSTEOBLAST; RESORPTION; ALENDRONATE; MECHANISMS; FRACTURE; LACUNAE; WOMEN	Osteocyte apoptosis is the first reaction to estrogen depletion, thereby stimulating osteoclastic bone resorption resulting in bone loss. We investigated the effects of two different risedronate (RIS) doses (high and low) on osteocyte apoptosis, osteoclast activity and bone loss in ovariectomized rats. Forty rats with ovariectomy (OVX) and sham ovariectomy (SHAM) were divided into 4 groups: 1) SHAM rats treated with saline (SHAM); 2) OVX rats treated with saline (OVX); 3) OVX rats treated with low-dose RIS (OVX-LR, 0.08 mu g/kg/day); 4) OVX rats treated with high-dose RIS (OVX-HR, 0.8 mu g/kg/day). All animals were sacrificed 90 days after surgery for the examinations of osteocyte apoptosis by caspase-3 staining, osteoclast activity by TRAP staining and bone volume by micro-CT scanning in lumbar vertebral cancellous bone. Both low and high dose RIS significantly reduced caspase-3 positive osteocytes, empty lacunae and TRAP positive osteoclasts in OVX rats. Although the difference in caspase-3 positive osteocytes was not significant between the OVX-LR and OVX-HR groups, numerically these cells were significantly more prevalent in OVX-HR (not OVX-LR) group than in SHAM group. TRAP positive osteoclasts were significantly higher in OVX-LR group than in SHAM or OVX-HR group. There was no significant difference in bone volume among the OVX-LR, OVX-HR and SHAM groups, but lower in OVX group alone. However, significant increase in trabecular thickness only occurred in OVX-LR group. We conclude that both low and high dose RIS significantly inhibit osteocyte apoptosis and osteoclast activity in OVX rats, but the low-dose RIS has weaker effect on osteoclast activity. However, low-dose RIS preserves cancellous bone mass and microarchitecture as well as high-dose RIS after estrogen depletion.	[Ye, Tingjun; Cao, Peng; Qi, Jin; Zhou, Qi; Qiu, Shijing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Prevent & Treatment Bone & Joint, Shanghai Inst Traumatol & Orthoped,Ruijin Hosp, Shanghai, Peoples R China; [Ye, Tingjun; Cao, Peng; Qiu, Shijing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Orthoped, Shanghai, Peoples R China; [Rao, D. Sudhaker; Qiu, Shijing] Henry Ford Hosp, Bone & Mineral Res Lab, Detroit, MI 48202 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Henry Ford Health System; Henry Ford Hospital	Cao, P; Qiu, SJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Prevent & Treatment Bone & Joint, Shanghai Inst Traumatol & Orthoped,Ruijin Hosp, Shanghai, Peoples R China.; Qiu, SJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Orthoped, Shanghai, Peoples R China.; Qiu, SJ (corresponding author), Henry Ford Hosp, Bone & Mineral Res Lab, Detroit, MI 48202 USA.	dr_caopeng8@163.com; sqiu1@hfhs.org	Ye, Tingjun/AAL-5581-2020; Rao, Sudhaker/ABG-8204-2021	Qiu, Shijing/0000-0001-7652-276X	Science and Technology Commission of Shanghai Municipality [11JC1141700, 15DZ1942604]; Shanghai Municipal Commission of Health and Family Planning [20154Y0127]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Commission of Health and Family Planning	This work was supported by the Science and Technology Commission of Shanghai Municipality (No. 11JC1141700 and No. 15DZ1942604), and Shanghai Municipal Commission of Health and Family Planning (No. 20154Y0127). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Science and Technology Commission of Shanghai Municipality (No.11JC1141700 and NO.15DZ1942604), and Shanghai Municipal Commission of Health and Family Planning (No.20154Y0127). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. Frank H. Ebetino, Department of Oncology and Metabolism, Medical School, University of Sheffield, UK, for providing risedronate and discussion about drug dosage used in this study. We also thank Dr. Zhiffeng Yu, associate professor in Orthopedic Department of Shanghai Ninth People's Hospitial, for sharing his expertise of micro CT analysis.	Ballanti P, 1997, OSTEOPOROSIS INT, V7, P39, DOI 10.1007/BF01623458; Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; Bilezikian JP, 2009, AM J MED, V122, P14, DOI 10.1016/j.amjmed.2008.12.003; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Busse B, 2010, AGING CELL, V9, P1065, DOI 10.1111/j.1474-9726.2010.00633.x; Carpentier VT, 2012, BONE, V50, P688, DOI 10.1016/j.bone.2011.11.021; Dominguez LJ, 2011, BIOGERONTOLOGY, V12, P397, DOI 10.1007/s10522-011-9344-5; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Ezra A, 2000, ADV DRUG DELIVER REV, V42, P175, DOI 10.1016/S0169-409X(00)00061-2; Follet H, 2007, BONE, V40, P1172, DOI 10.1016/j.bone.2006.12.052; FROST HM, 1960, J BONE JOINT SURG AM, V42, P144, DOI 10.2106/00004623-196042010-00012; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Jilka RL, 2013, BONE, V54, P264, DOI 10.1016/j.bone.2012.11.038; Jobke B, 2014, BONE, V59, P37, DOI 10.1016/j.bone.2013.10.024; Kennedy OD, 2014, BONE, V64, P132, DOI 10.1016/j.bone.2014.03.049; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Komori T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122045; Komori T, 2013, CELL TISSUE RES, V352, P191, DOI 10.1007/s00441-012-1546-x; Maruotti N, 2012, EUR J CLIN PHARMACOL, V68, P1013, DOI 10.1007/s00228-012-1216-7; Mathavan N, 2015, CALCIFIED TISSUE INT, V97, P134, DOI 10.1007/s00223-015-9991-7; Odvina CV, 2010, CLIN ENDOCRINOL, V72, P161, DOI 10.1111/j.1365-2265.2009.03581.x; PARFITT AM, 1982, METAB BONE DIS RELAT, V4, P1, DOI 10.1016/0221-8747(82)90002-9; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI [10.1359/jbmr.080617, 10.1359/JBMR.080617]; Plotkin LI, 2006, BONE, V39, P443, DOI 10.1016/j.bone.2006.02.060; Qiu S, 2010, DECREASE RATE OSTEOC; Qiu SJ, 2017, CALCIFIED TISSUE INT, V100, P235, DOI 10.1007/s00223-016-0223-6; Qiu SJ, 2005, BONE, V37, P10, DOI 10.1016/j.bone.2005.01.023; Repp Felix, 2017, Bone Rep, V6, P101, DOI 10.1016/j.bonr.2017.03.001; Roelofs AJ, 2012, J BONE MINER RES, V27, P835, DOI 10.1002/jbmr.1543; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Russell RGG, 2015, CURR OPIN PHARMACOL, V22, P115, DOI 10.1016/j.coph.2015.05.005; Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998	36	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186012	10.1371/journal.pone.0186012	http://dx.doi.org/10.1371/journal.pone.0186012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045447	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100034
J	Shi, F; Shang, L; Yang, LY; Jiang, YY; Wang, XM; Hao, JJ; Zhang, Y; Huang, DK; Cai, Y; Xu, X; Zhan, QM; Jia, XM; Cao, Y; Wang, MR				Shi, F.; Shang, L.; Yang, L-Y; Jiang, Y-Y; Wang, X-M; Hao, J-J; Zhang, Y.; Huang, D-K; Cai, Y.; Xu, X.; Zhan, Q-M; Jia, X-M; Cao, Y.; Wang, M-R			Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation	ONCOGENE			English	Article							NF-KAPPA-B; GROWTH-FACTOR; CLINICOPATHOLOGICAL FEATURES; HEPATOCELLULAR-CARCINOMA; INCREASED EXPRESSION; PANCREATIC-CANCER; SEMAPHORIN 3A; E-CADHERIN; RECEPTOR; ACTIVATION	Neuropilin-1 (NRP1) is a non-kinase receptor recently implicated in tumor progression. Here we revealed that over-expression of NRP1 correlates with poor prognosis in esophageal squamous cell carcinoma (ESCC). NRP1-knockdown suppressed ESCC cell proliferation and xenograft tumor growth. Reduced NRP1 expression downregulated P65 mRNA and protein expression, and ectopic expression of P65-restored cell proliferation in NRP1-silenced cells. NRP1 regulates P65 transcription by activating cAMP responsive element binding protein (CREB). NRP1 interacted with and activated epidermal growth factor receptor (EGFR), and b1/b2 domain of NRP1 is responsible for the activation of EGFR. We also found that EGFR regulated CREB transcriptional activity via AKT. These data suggest that NRP1 is an upstream regulator in the P65-dependent proliferation signaling pathway and a candidate therapeutic target for ESCC.	[Shi, F.; Shang, L.; Yang, L-Y; Jiang, Y-Y; Wang, X-M; Hao, J-J; Zhang, Y.; Cai, Y.; Xu, X.; Zhan, Q-M; Wang, M-R] Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Shi, F.; Shang, L.; Yang, L-Y; Jiang, Y-Y; Wang, X-M; Hao, J-J; Zhang, Y.; Cai, Y.; Xu, X.; Zhan, Q-M; Wang, M-R] Chinese Acad Med Sci, Beijing 100021, Peoples R China; [Shi, F.; Shang, L.; Cao, Y.] Cent S Univ, Xiangya Hosp, Sch Basic Med Sci,Canc Res Inst, Key Lab Carcinogenesis & Invas,Chinese Minist Ed, Changsha 410078, Hunan, Peoples R China; [Jia, X-M] Anhui Med Univ, Dept Histol & Embryol, Hefei 230032, Anhui, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Central South University; Anhui Medical University	Wang, MR (corresponding author), Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.; Wang, MR (corresponding author), Chinese Acad Med Sci, Beijing 100021, Peoples R China.; Cao, Y (corresponding author), Cent S Univ, Xiangya Hosp, Sch Basic Med Sci,Canc Res Inst, Key Lab Carcinogenesis & Invas,Chinese Minist Ed, Changsha 410078, Hunan, Peoples R China.; Jia, XM (corresponding author), Anhui Med Univ, Dept Histol & Embryol, Hefei 230032, Anhui, Peoples R China.	jiaxueme@126.com; ycao98@vip.sina.com; wangmr2015@126.com	Zhang, Yu/G-2453-2011	Zhang, Yu/0000-0003-1375-1594	National Natural Science Foundation of China [31471327, 81330052, 81520108023]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS)	This study was supported by National Natural Science Foundation of China (31471327, 81330052, 81520108023) and CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-1-001).	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Berge M, 2011, J HEPATOL, V55, P866, DOI 10.1016/j.jhep.2011.01.033; Brand TM, 2011, DISCOV MED, V12, P419; Chaudhary B, 2014, CANCER IMMUNOL IMMUN, V63, P81, DOI 10.1007/s00262-013-1500-0; Chu WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101931; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Dong JC, 2015, J CELL MOL MED, V19, P2286, DOI 10.1111/jcmm.12623; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Ghosh S, 2008, HUM PATHOL, V39, P1835, DOI 10.1016/j.humpath.2008.06.004; Glinka Y, 2012, BIOCHEM BIOPH RES CO, V425, P775, DOI 10.1016/j.bbrc.2012.07.151; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; Han ZX, 2015, MOL MED REP, V12, P513, DOI 10.3892/mmr.2015.3405; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Hu CX, 2016, TARGET ONCOL, V11, P501, DOI 10.1007/s11523-016-0422-0; Izzo JG, 2007, CANCER EPIDEM BIOMAR, V16, P1200, DOI 10.1158/1055-9965.EPI-06-1083; Jia H, 2010, BRIT J CANCER, V102, P541, DOI 10.1038/sj.bjc.6605539; Jiang HY, 2015, MOL MED REP, V12, P2114, DOI 10.3892/mmr.2015.3580; Lee E, 2013, NEOPLASIA, V15, P112, DOI 10.1593/neo.121638; Li LH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0291-5; Li X, 2016, ONCOTARGET, V7, P86225, DOI 10.18632/oncotarget.13368; Li ZW, 2008, CURR OPIN HEMATOL, V15, P391, DOI 10.1097/MOH.0b013e328302c7f4; Lin DC, 2011, CLIN CANCER RES, V17, P4285, DOI 10.1158/1078-0432.CCR-10-3236; Lu J, 2015, MOL MED REP, V12, P2668, DOI 10.3892/mmr.2015.3752; Matkar PN, 2016, ONCOTARGET, V7, P69489, DOI 10.18632/oncotarget.11060; Muhl L, 2017, J CELL SCI, V130, P1365, DOI 10.1242/jcs.200493; Naik A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03280-0; Nakamura F, 2002, ADV EXP MED BIOL, V515, P55; Ohsaka A, 2015, BIOCHEM BIOPH RES CO, V459, P443, DOI 10.1016/j.bbrc.2015.02.124; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qiao L, 2006, HUM GENE THER, V17, P280, DOI 10.1089/hum.2006.17.280; Rizzolio S, 2011, CURR MED CHEM, V18, P3563, DOI 10.2174/092986711796642544; Rizzolio S, 2012, CANCER RES, V72, P5801, DOI 10.1158/0008-5472.CAN-12-0995; Sakamoto KM, 2015, MOL GENET METAB, V114, P397, DOI 10.1016/j.ymgme.2014.11.017; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Scartozzi M, 2007, J CLIN ONCOL, V25, P3930, DOI 10.1200/JCO.2007.11.5022; Shahrabi-Farahani S, 2016, AM J PATHOL, V186, P1055, DOI 10.1016/j.ajpath.2015.11.021; Shang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111045; Shang L, 2013, FRONT MED-PRC, V7, P401, DOI 10.1007/s11684-013-0286-y; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi F, 2014, CLIN CANCER RES, V20, P6153, DOI 10.1158/1078-0432.CCR-14-0583; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; Song X, 2012, MED ORAL PATOL ORAL, V17, pE962, DOI 10.4317/medoral.18168; Wang XM, 2013, MOL CANCER RES, V11, P986, DOI 10.1158/1541-7786.MCR-12-0704; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Weichert W, 2007, BRIT J CANCER, V97, P523, DOI 10.1038/sj.bjc.6603878; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Wild JRL, 2012, INT J EXP PATHOL, V93, P81, DOI 10.1111/j.1365-2613.2012.00810.x; Xin Y, 2012, CLIN CANCER RES, V18, P6040, DOI 10.1158/1078-0432.CCR-12-1652; Xu Y, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-155; Zhang YF, 2016, PATHOL ONCOL RES, V22, P367, DOI 10.1007/s12253-015-0003-z	53	10	10	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					935	943		10.1038/onc.2017.399	http://dx.doi.org/10.1038/onc.2017.399			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059172				2022-12-26	WOS:000425281800010
J	Kolobova, E; Roland, JT; Lapierre, LA; Williams, JA; Mason, TA; Goldenring, JR				Kolobova, Elena; Roland, Joseph T.; Lapierre, Lynne A.; Williams, Janice A.; Mason, Twila A.; Goldenring, James R.			The C-terminal region of A-kinase anchor protein 350 (AKAP350A) enables formation of microtubule-nucleation centers and interacts with pericentriolar proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase anchoring protein (AKAP); centrosome; microscopy; microtubule; protein kinase A (PKA); AKAP450; AKAP9; Cdk5RAP2; Cep170; Cep68	TUBULIN RING COMPLEX; GOLGI-APPARATUS; CENTROSOME COHESION; TARGETING MOTIF; CENTRIOLE CYCLE; CELL-CYCLE; CDK5RAP2; AKAP450; CEP68; LOCALIZATION	Microtubules in animal cells assemble (nucleate) from both the centrosome and the cis-Golgi cisternae. A-kinase anchor protein 350 kDa (AKAP350A, also called AKAP450/CG-NAP/AKAP9) is a large scaffolding protein located at both the centrosome and Golgi apparatus. Previous findings have suggested that AKAP350 is important for microtubule dynamics at both locations, but how this scaffolding protein assembles microtubule nucleation machinery is unclear. Here, we found that overexpression of the C-terminal third of AKAP350A, enhanced GFP-AKAP350A(2691-3907), induces the formation of multiple microtubule-nucleation centers (MTNCs). Nevertheless, these induced MTNCs lacked true centriole proteins, such as Cep135. Mapping analysis with AKAP350A truncations demonstrated that AKAP350A contains discrete regions responsible for promoting or inhibiting the formation of multiple MTNCs. Moreover, GFP-AKAP350A(2691-3907) recruited several pericentriolar proteins to MTNCs, including -tubulin, pericentrin, Cep68, Cep170, and Cdk5RAP2. Proteomic analysis indicated that Cdk5RAP2 and Cep170 both interact with the microtubule nucleation-promoting region of AKAP350A, whereas Cep68 interacts with the distal C-terminal AKAP350A region. Yeast two-hybrid assays established a direct interaction of Cep170 with AKAP350A. Super-resolution and deconvolution microscopy analyses were performed to define the association of AKAP350A with centrosomes, and these studies disclosed that AKAP350A spans the bridge between centrioles, co-localizing with rootletin and Cep68 in the linker region. siRNA-mediated depletion of AKAP350A caused displacement of both Cep68 and Cep170 from the centrosome. These results suggest that AKAP350A acts as a scaffold for factors involved in microtubule nucleation at the centrosome and coordinates the assembly of protein complexes associating with the intercentriolar bridge.	[Kolobova, Elena; Roland, Joseph T.; Lapierre, Lynne A.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37232 USA; [Mason, Twila A.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Kolobova, Elena; Roland, Joseph T.; Lapierre, Lynne A.; Mason, Twila A.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, MRB 4,Rm 10435-G,2213 Garland Ave, Nashville, TN 37232 USA; [Goldenring, James R.] Nashville Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA; [Williams, Janice A.] Vanderbilt Cell Imaging Shared Resource, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Goldenring, JR (corresponding author), Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, MRB 4,Rm 10435-G,2213 Garland Ave, Nashville, TN 37232 USA.	jim.goldenring@vanderbilt.edu			National Institutes of Health [S10 OD012324, CA68485, DK20593, DK58404, HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, P60DK020593, P30DK020593, R01DK043405] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Fluorescence microscopy was performed through the use of the Vanderbilt University Cell Imaging Shared Resource, and MudPIT Proteomics was performed in the Vanderbilt Protein Mass Spectrometry Shared Resource supported by National Institutes of Health Grants S10 OD012324, CA68485, DK20593, DK58404, and HD15052. Deconvolution microscopy was performed in the Vanderbilt Digital Histology Shared Resource.	ALVEY PL, 1985, J CELL SCI, V78, P147; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Baetz NW, 2013, MOL BIOL CELL, V24, P643, DOI 10.1091/mbc.E12-09-0659; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Fang GL, 2014, J CELL SCI, V127, P1631, DOI 10.1242/jcs.139451; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fry AM, 2015, NAT CELL BIOL, V17, P3, DOI 10.1038/ncb3087; Gillingham AK, 2000, EMBO REP, V1, P524; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Hanafusa H, 2015, NAT CELL BIOL, V17, P1024, DOI 10.1038/ncb3204; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jana SC, 2014, CURR OPIN CELL BIOL, V26, P96, DOI 10.1016/j.ceb.2013.12.001; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068523; Keryer G, 2003, MOL BIOL CELL, V14, P2436, DOI 10.1091/mbc.E02-09-0614; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087016; Kolobova E, 2009, EXP CELL RES, V315, P542, DOI 10.1016/j.yexcr.2008.11.011; Kraemer N, 2011, CELL MOL LIFE SCI, V68, P1719, DOI 10.1007/s00018-011-0635-4; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Larocca MC, 2006, EUR J CELL BIOL, V85, P611, DOI 10.1016/j.ejcb.2005.10.008; Larocca MC, 2004, MOL BIOL CELL, V15, P2771, DOI 10.1091/mbc.E03-10-0757; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Man XH, 2015, EUR J CELL BIOL, V94, P162, DOI 10.1016/j.ejcb.2015.01.004; Mason TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027699; Mattaloni S. M., 2013, CELL LOGIST, V3, DOI DOI 10.4161/CL.26331; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Pagan JK, 2015, NAT CELL BIOL, V17, P31, DOI 10.1038/ncb3076; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schmidt PH, 1999, J BIOL CHEM, V274, P3055, DOI 10.1074/jbc.274.5.3055; Shanks RA, 2002, J BIOL CHEM, V277, P40967, DOI 10.1074/jbc.M203307200; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Steadman BT, 2002, J BIOL CHEM, V277, P30165, DOI 10.1074/jbc.M201914200; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Tonucci FM, 2015, J CELL SCI, V128, P3277, DOI 10.1242/jcs.170878; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Wu JC, 2016, DEV CELL, V39, P44, DOI 10.1016/j.devcel.2016.08.009; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	50	8	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20394	20409		10.1074/jbc.M117.806018	http://dx.doi.org/10.1074/jbc.M117.806018			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29054927	Green Published, hybrid			2022-12-26	WOS:000418267000004
J	Smith, KR; Rajgor, D; Hanley, JG				Smith, Katharine R.; Rajgor, Dipen; Hanley, Jonathan G.			Differential regulation of the Rac1 GTPase-activating protein (GAP) BCR during oxygen/glucose deprivation in hippocampal and cortical neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase-activating protein (GAP); guanine nucleotide exchange factor (GEF); hippocampus; ischemia; NMDA receptor (NMDAR); BCR; cortex; OGD; Tiam1	CELL-DEATH; DENDRITIC SPINES; ISCHEMIC-STROKE; BRAIN ISCHEMIA; NMDA RECEPTOR; KINASES; PTPRT; FYN	Brain ischemia causes oxygen and glucose deprivation (OGD) in neurons, triggering a cascade of events leading to synaptic accumulation of glutamate. Excessive activation of glutamate receptors causes excitotoxicity and delayed cell death in vulnerable neurons. Following global cerebral ischemia, hippocampal CA1 pyramidal neurons are more vulnerable to injury than their cortical counterparts, but the mechanisms that underlie this difference are unclear. Signaling via Rho-family small GTPases, their upstream guanine nucleotide exchange factors, and GTPase-activating proteins (GAPs) is differentially dysregulated in response to OGD/ischemia in hippocampal and cortical neurons. Increased Rac1 activity caused by OGD/ischemia contributes to neuronal death in hippocampal neurons via diverse effects on NADPH oxidase activity and dendritic spine morphology. The Rac1 guanine nucleotide exchange factor Tiam1 mediates an OGD-induced increase in Rac1 activity in hippocampal neurons; however, the identity of an antagonistic GAP remains elusive. Here we show that the Rac1 GAP breakpoint cluster region (BCR) associates with NMDA receptors (NMDARs) along with Tiam1 and that this protein complex is more abundant in hippocampal compared with cortical neurons. Although total BCR is similar in the two neuronal types, BCR is more active in hippocampal compared with cortical neurons. OGD causes an NMDAR- and Ca2+-permeable AMPAR-dependent deactivation of BCR in hippocampal but not cortical neurons. BCR knockdown occludes OGD-induced Rac1 activation in hippocampal neurons. Furthermore, disrupting the Tiam1-NMDAR interaction with a fragment of Tiam1 blocks OGD-induced Tiam1 activation but has no effect on the deactivation of BCR. This work identifies BCR as a critical player in Rac1 regulation during OGD in hippocampal neurons.	[Smith, Katharine R.; Rajgor, Dipen; Hanley, Jonathan G.] Univ Bristol, Ctr Synapt Plast, Biomedical Sci Bldg, Bristol BS8 1TD, Avon, England; [Smith, Katharine R.; Rajgor, Dipen; Hanley, Jonathan G.] Univ Bristol, Sch Biochem, Biomedical Sci Bldg, Bristol BS8 1TD, Avon, England; [Smith, Katharine R.] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Bristol; University of Bristol; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, KR (corresponding author), Univ Bristol, Ctr Synapt Plast, Biomedical Sci Bldg, Bristol BS8 1TD, Avon, England.; Smith, KR (corresponding author), Univ Bristol, Sch Biochem, Biomedical Sci Bldg, Bristol BS8 1TD, Avon, England.; Smith, KR (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	katharine.r.smith@ucdenver.edu		Hanley, Jonathan/0000-0003-1704-4707	Marie Curie Outgoing Postdoctoral Fellowship [302281]; Wellcome Trust Institutional Strategic Support Fund Elizabeth Blackwell Institute Early Career Fellowship (University of Bristol); Biotechnology and Biological Sciences Research Council (BBSRC); MRC [MR/L011131/1] Funding Source: UKRI; Medical Research Council [MR/L011131/1] Funding Source: researchfish	Marie Curie Outgoing Postdoctoral Fellowship; Wellcome Trust Institutional Strategic Support Fund Elizabeth Blackwell Institute Early Career Fellowship (University of Bristol); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Marie Curie Outgoing Postdoctoral Fellowship (302281) and a Wellcome Trust Institutional Strategic Support Fund Elizabeth Blackwell Institute Early Career Fellowship (University of Bristol), both awarded to K. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Biotechnology and Biological Sciences Research Council (BBSRC).	Blanco-Suarez E, 2014, J CEREBR BLOOD F MET, V34, P1898, DOI 10.1038/jcbfm.2014.158; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2008, NEUROSCIENTIST, V14, P139, DOI 10.1177/1073858407309854; Dixon RM, 2009, J BIOL CHEM, V284, P14230, DOI 10.1074/jbc.M901203200; Du CP, 2012, CNS NEUROSCI THER, V18, P754, DOI 10.1111/j.1755-5949.2012.00357.x; Hou XY, 2007, NEUROSCI LETT, V420, P235, DOI 10.1016/j.neulet.2007.03.048; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Lee JR, 2015, BMB REP, V48, P249, DOI 10.5483/BMBRep.2015.48.5.037; Lim SH, 2009, EMBO J, V28, P3564, DOI 10.1038/emboj.2009.289; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Park AR, 2012, J CELL SCI, V125, P4518, DOI 10.1242/jcs.105502; Penzes P, 2008, TRENDS CELL BIOL, V18, P405, DOI 10.1016/j.tcb.2008.07.002; Penzes P, 2012, CYTOSKELETON, V69, P426, DOI 10.1002/cm.21015; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Rajgor D, 2017, J BIOL CHEM, V292, P9774, DOI 10.1074/jbc.M117.776302; Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Um K, 2014, DEV CELL, V29, P701, DOI 10.1016/j.devcel.2014.05.011; Zhang QG, 2009, BRAIN RES, V1265, P138, DOI 10.1016/j.brainres.2009.01.033; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhu H, 2012, J NEUROCHEM, V120, P574, DOI 10.1111/j.1471-4159.2011.07550.x	25	11	11	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20173	20183		10.1074/jbc.M117.796292	http://dx.doi.org/10.1074/jbc.M117.796292			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29046349	Green Published, hybrid			2022-12-26	WOS:000417696400022
J	Baer, A; Colon-Moran, W; Xiang, JH; Stapleton, JT; Bhattarai, N				Baer, Alan; Colon-Moran, Winston; Xiang, Jinhua; Stapleton, Jack T.; Bhattarai, Nirjal			Src-family kinases negatively regulate NFAT signaling in resting human T cells	PLOS ONE			English	Article							LIPID RAFTS; ACTIVATION; LCK; RECEPTOR; FYN; HOMEOSTASIS; INHIBITION; TOLERANCE; INSIGHTS; STIMULATION	T cell signaling is required for activation of both natural and therapeutic T cells including chimeric antigen receptor (CAR) T cells. Identification of novel factors and pathways regulating T cell signaling may aid in development of effective T cell therapies. In resting human T cells, the majority of Src-family of tyrosine kinases (SFKs) are inactive due to phosphorylation of a conserved carboxy-terminal tyrosine residue. Recently, a pool of enzymatically active SFKs has been identified in resting T cells; however, the significance of these is incompletely understood. Here, we characterized the role of active SFKs in resting human T cells. Pharmacologic inhibition of active SFKs enhanced distal TCR signaling as measured by IL-2 release and CD25 surface expression following TCR-independent activation. Mechanistically, inhibition of the active pool of SFKs induced nuclear translocation of NFAT1, and enhanced NFAT1-dependent signaling in resting T cells. The negative regulation of NFAT1 signaling was in part mediated by the Src-kinase Lck as human T cells lacking Lck had increased levels of nuclear NFAT1 and demonstrated enhanced NFAT1-dependent gene expression. Inhibition of active SFKs in resting primary human T cells also increased nuclear NFAT1 and enhanced NFAT1-dependent signaling. Finally, the calcineurin inhibitor FK506 and Cyclosporin A reversed the effect of SFKs inhibition on NFAT1. Together, these data identified a novel role of SFKs in preventing aberrant NFAT1 activation in resting T cells, and suggest that maintaining this pool of active SFKs in therapeutic T cells may increase the efficacy of T cell therapies.	[Baer, Alan; Colon-Moran, Winston; Bhattarai, Nirjal] US FDA, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Xiang, Jinhua; Stapleton, Jack T.] Iowa City Vet Affairs Med Ctr, Res Serv, Iowa City, IA USA; [Xiang, Jinhua; Stapleton, Jack T.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	US Food & Drug Administration (FDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Bhattarai, N (corresponding author), US FDA, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	nirjal.bhattarai@fda.hhs.gov		Stapleton, Jack/0000-0002-2302-9055; Bhattarai, Nirjal/0000-0003-1798-8863	Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration; Research Participation Program at CBER; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000207] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration; Research Participation Program at CBER; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration. This project was supported in part by Dr. Alan Baer's appointment to the Research Participation Program at CBER administered by the Oak Ridge Institute for Science and Education through US Department of Education and U.S. Food and Drug Administration.	Arakaki R, 2014, CRIT REV IMMUNOL, V34, P301, DOI 10.1615/CritRevImmunol.2014009988; Austin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036327; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Ballek O, 2015, IMMUNOL CELL BIOL, V93, P384, DOI 10.1038/icb.2014.100; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Bhattarai N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005183; Bhattarai N, 2013, J IMMUNOL, V190, P6351, DOI 10.4049/jimmunol.1300589; Brandvold KR, 2012, ACS CHEM BIOL, V7, P1393, DOI 10.1021/cb300172e; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Cencioni MT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.164; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Criado G, 2004, J IMMUNOL, V172, P222, DOI 10.4049/jimmunol.172.1.222; Davis SJ, 2011, TRENDS IMMUNOL, V32, P1, DOI 10.1016/j.it.2010.11.003; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Dong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015114; Dutta D, 2017, NAT IMMUNOL, V18, P196, DOI 10.1038/ni.3640; Filipp D, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00155; GAJEWSKI TF, 1995, EUR J IMMUNOL, V25, P1836, DOI 10.1002/eji.1830250707; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Jang IK, 2003, CURR OPIN IMMUNOL, V15, P315, DOI 10.1016/S0952-7915(03)00048-7; KATAGIRI T, 1989, P NATL ACAD SCI USA, V86, P10064, DOI 10.1073/pnas.86.24.10064; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Methi T, 2005, J IMMUNOL, V175, P7398, DOI 10.4049/jimmunol.175.11.7398; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nabbi Arash, 2015, Cold Spring Harb Protoc, V2015, P769, DOI 10.1101/pdb.prot083733; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Papatriantafyllou M, 2013, NAT REV IMMUNOL, V13, P222, DOI 10.1038/nri3429; Posevitz V, 2008, J IMMUNOL, V180, P1634, DOI 10.4049/jimmunol.180.3.1634; ROSSY J, 2012, FRONT IMMUNOL, V3; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Sabat M, 2006, BIOORG MED CHEM LETT, V16, P5973, DOI 10.1016/j.bmcl.2006.08.132; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stanford SM, 2012, IMMUNOLOGY, V137, P1, DOI 10.1111/j.1365-2567.2012.03591.x; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wittmann M, 2006, J LEUKOCYTE BIOL, V80, P75, DOI 10.1189/jlb.0605328; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813	55	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187123	10.1371/journal.pone.0187123	http://dx.doi.org/10.1371/journal.pone.0187123			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073235	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400116
J	del Rio, VC; Mostaza, J; Lahoz, C; Sanchez-Arroyo, V; Sabin, C; Lopez, S; Patron, P; Fernandez-Garcia, P; Fernandez-Puntero, B; Vicent, D; Montesano-Sanchez, L; Garcia-Iglesias, F; Gonzalez-Alegre, T; Estirado, E; Laguna, F; de Burgos-Lunar, C; Gomez-Campelo, P; Abanades-Herranz, JC; de Miguel-Yanes, JM; Salinero-Fort, MA				Cornejo del Rio, V.; Mostaza, J.; Lahoz, C.; Sanchez-Arroyo, V.; Sabin, C.; Lopez, S.; Patron, P.; Fernandez-Garcia, P.; Fernandez-Puntero, B.; Vicent, D.; Montesano-Sanchez, L.; Garcia-Iglesias, F.; Gonzalez-Alegre, T.; Estirado, E.; Laguna, F.; de Burgos-Lunar, C.; Gomez-Campelo, P.; Abanades-Herranz, J. C.; de Miguel-Yanes, J. M.; Salinero-Fort, M. A.		SPREDIA-2 Grp	Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; SERUM URIC-ACID; RESTING HEART-RATE; PULSE PRESSURE; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; LOWER-EXTREMITY; RISK-FACTORS; MORTALITY; ATHEROSCLEROSIS	Aim To describe the prevalence of Peripheral Artery Disease (PAD) in a random population sample and to evaluate its relationship with Mediterranean diet and with other potential cardiovascular risk factors such as serum uric acid and pulse pressure in individuals ranged 45 to 74 years. Methods Cross-sectional analysis of 1568 subjects (mean age 6.5 years, 43% males), randomly selected from the population. A fasting blood sample was obtained to determine glucose, lipids, and HbA1C levels. An oral glucose tolerance test was performed in non-diabetic subjects. PAD was evaluated by ankle-brachial index and/or having a prior diagnosis. Results PAD prevalence was 3.81% (95% CI, 2.97-4.87) for all participants. In men, PAD prevalence was significantly higher than in women [5.17% (95% CI, 3.74-7.11) vs. 2.78% (95% CI, 1.89-4.07); p = 0.014]. Serum uric acid in the upper quartile was associated with the highest odds ratio (OR) of PAD (for uric acid > 6.1 mg/dl, OR = 4.31; 95% CI, 1.49-12.44). The remaining variables more strongly associated with PAD were: Heart rate > 90 bpm (OR = 4.16; 95% CI, 1.62-10.65), pulse pressure in the upper quartile (>= 54 mmHg) (OR = 3.82; 95% CI, 1.50-9.71), adherence to Mediterranean diet (OR = 2.73; 95% CI, 1.48-5.04), and former smoker status (OR = 2.04; 95% CI, 1.00-4.16). Conclusions Our results show the existence of a low prevalence of peripheral artery disease in a population aged 45-74 years. Serum uric acid, pulse pressure and heart rate > 90 bpm were strongly associated with peripheral artery disease. The direct association between Mediterranean diet and peripheral artery disease that we have found should be evaluated through a follow-up study under clinical practice conditions.	[Cornejo del Rio, V.; Mostaza, J.; Lahoz, C.; Sanchez-Arroyo, V.; Sabin, C.; Lopez, S.; Patron, P.; Fernandez-Garcia, P.; Fernandez-Puntero, B.; Vicent, D.; Garcia-Iglesias, F.; Gonzalez-Alegre, T.; Estirado, E.; Laguna, F.] Hosp Carlos III, Madrid, Spain; [Cornejo del Rio, V.] Hosp La Paz, Grp Invest Cuidados IdIPAZ, Madrid, Spain; [Vicent, D.; Gomez-Campelo, P.] Hosp Univ La Paz IdiPAZ, Inst Invest Sanitaria, Madrid, Spain; [Montesano-Sanchez, L.] Hosp Fuenlabrada, Madrid, Spain; [de Burgos-Lunar, C.] Consejeria Sanidad, Direcc Gen Salud Publ, Subdirecc Promoc Prevenc & Educ Salud, Madrid, Spain; [de Burgos-Lunar, C.; Salinero-Fort, M. A.] Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain; [Gomez-Campelo, P.] IdiPAZ, Plataforma Apoyo Investigador Novel, Madrid, Spain; [Abanades-Herranz, J. C.] Ctr Salud Monovar, Madrid, Spain; [de Miguel-Yanes, J. M.] Hosp Gregorio Maranon, Madrid, Spain; [Salinero-Fort, M. A.] Consejeria Sanidad, Subdirecc Gen Invest Sanitaria, Madrid, Spain	Hospital Carlos III; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario Fuenlabrada; General University Gregorio Maranon Hospital	Salinero-Fort, MA (corresponding author), Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain.; Salinero-Fort, MA (corresponding author), Consejeria Sanidad, Subdirecc Gen Invest Sanitaria, Madrid, Spain.	miguel.salinero@salud.madrid.org	SALINERO-FORT, MIGUEL A./GOP-2536-2022	SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; de Miguel-Yanes, Jose M./0000-0003-2802-033X; Lahoz, Carlos/0000-0001-5690-7558	Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) [RS_AP10/6]; FIS (Fondo de Investigaciones Sanitarias, Instituto de la Salud Carlos III) [12/01806, 15/00259]; European Union through the Fondo Europeo de Desarrollo Regional (FEDER, Una manera de hacer Europa)	Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid); FIS (Fondo de Investigaciones Sanitarias, Instituto de la Salud Carlos III); European Union through the Fondo Europeo de Desarrollo Regional (FEDER, Una manera de hacer Europa)	This work was funded by the Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) Grant RS_AP10/6 and by FIS (Fondo de Investigaciones Sanitarias, Instituto de la Salud Carlos III) grants no. 12/01806 and 15/00259 and co-financied by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, Una manera de hacer Europa). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman JA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110680; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Aboyans V, 2011, ATHEROSCLEROSIS, V214, P169, DOI 10.1016/j.atherosclerosis.2010.10.011; Alderman M H, 2001, Curr Hypertens Rep, V3, P184, DOI 10.1007/s11906-001-0036-4; Martinez-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043134; Salinero-Fort MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007195; Benetos A, 1998, HYPERTENSION, V32, P560, DOI 10.1161/01.HYP.32.3.560; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; Blanes JI, 2009, INT ANGIOL, V28, P20; Bonaccio M, 2014, NUTR METAB CARDIOVAS, V24, P853, DOI 10.1016/j.numecd.2014.02.014; Bundo M, 1998, Aten Primaria, V22, P5; Cambou JP, 2010, EUR J VASC ENDOVASC, V39, P577, DOI 10.1016/j.ejvs.2010.02.009; Carbayo JA, 2007, NUTR METAB CARDIOVAS, V17, P41, DOI 10.1016/j.numecd.2005.08.009; Chen J, 2012, AM J CARDIOL, V110, P136, DOI 10.1016/j.amjcard.2012.02.061; Chrysohoou C, 2015, ANGIOLOGY, V66, P708, DOI 10.1177/0003319714556651; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Doobay AV, 2005, ARTERIOSCL THROM VAS, V25, P1463, DOI 10.1161/01.ATV.0000168911.78624.b7; Downer MK, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0394-6; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fan Li-Chi, 2013, Biomed J, V36, P282, DOI 10.4103/2319-4170.113371; Feig DI, 2009, CURR OPIN NEPHROL HY, V18, P526, DOI 10.1097/MNH.0b013e328330d9d0; Felix-Redondo FJ, 2012, REV ESP CARDIOL, V65, P726, DOI [10.1016/j.rec.2012.03.007, 10.1016/j.recesp.2012.03.008]; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; Greenland P, 2000, CIRCULATION, V101, P723; HALE WE, 1988, AGE AGEING, V17, P57, DOI 10.1093/ageing/17.1.57; Hiramoto JS, 2014, VASCULAR, V22, P142, DOI 10.1177/1708538113476023; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Ho WJ, 2010, RHEUMATOLOGY, V49, P1929, DOI 10.1093/rheumatology/keq184; Korhonen P, 2014, J HUM HYPERTENS, V28, P242, DOI 10.1038/jhh.2013.99; Kristal-Boneh E, 2000, EUR HEART J, V21, P116, DOI 10.1053/euhj.1999.1741; Kullo IJ, 2003, VASC MED, V8, P237, DOI 10.1191/1358863x03vm511oa; MADHAVAN S, 1994, HYPERTENSION, V23, P395, DOI 10.1161/01.HYP.23.3.395; Manzano L, 2007, MED CLIN-BARCELONA, V128, P241, DOI 10.1157/13099239; Mosca L, 1997, CIRCULATION, V96, P2468; Murabito JM, 2002, AM HEART J, V143, P961, DOI 10.1067/mhj.2002.122871; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Planas A, 2002, J VASC SURG, V35, P506, DOI 10.1067/mva.2002.120030; Ramos R, 2009, EUR J VASC ENDOVASC, V38, P305, DOI 10.1016/j.ejvs.2009.04.013; Ramos R, 2011, ATHEROSCLEROSIS, V214, P474, DOI 10.1016/j.atherosclerosis.2010.11.015; Ramsay SE, 2015, HEART, V101, P616, DOI 10.1136/heartjnl-2014-306472; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Ruiz-Canela M, 2014, JAMA-J AM MED ASSOC, V311, P415, DOI 10.1001/jama.2013.280618; Sanchez-Lozada LG, 2006, CURR OPIN NEPHROL HY, V15, P30, DOI 10.1097/01.mnh.0000199010.33929.7f; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Selvaraj S, 2016, J AM COLL CARDIOL, V67, P392, DOI 10.1016/j.jacc.2015.10.084; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shankar A, 2008, ATHEROSCLEROSIS, V196, P749, DOI 10.1016/j.atherosclerosis.2006.12.029; Sigvant B, 2007, J VASC SURG, V45, P1185, DOI 10.1016/j.jvs.2007.02.004; Soriguer F, 2013, MED HYPOTHESES, V80, P150, DOI 10.1016/j.mehy.2012.11.015; Tangri N, 2010, AM J KIDNEY DIS, V56, P247, DOI 10.1053/j.ajkd.2010.06.004; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38; Tseng CH, 2004, DIABETIC MED, V21, P724, DOI 10.1111/j.1464-5491.2004.01239.x; VOGT MT, 1993, AM J EPIDEMIOL, V137, P559, DOI 10.1093/oxfordjournals.aje.a116709; Wilkins JT, 2012, AM J HYPERTENS, V25, P535, DOI 10.1038/ajh.2012.13; Xu DC, 2013, CAN J CARDIOL, V29, P492, DOI 10.1016/j.cjca.2012.06.014; Zhan YQ, 2016, VASA, V45, P31, DOI 10.1024/0301-1526/a000492; Zhan YQ, 2015, ANGIOLOGY, V66, P687, DOI 10.1177/0003319714566228; Zhan YQ, 2012, J EPIDEMIOL, V22, P454, DOI 10.2188/jea.JE20110140; ZHANG Y, 2016, MEDICINE, V0095; Zheng ZJ, 2005, AM J PREV MED, V29, P42, DOI 10.1016/j.amepre.2005.07.019	64	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186220	10.1371/journal.pone.0186220	http://dx.doi.org/10.1371/journal.pone.0186220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073236	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400016
J	Huang, SW; Wu, LQ; Huang, J; Panitchob, N; Hu, N; Ranjan, R; Dosdall, DJ				Huang, Shangwei; Wu, Liqun; Huang, Jian; Panitchob, Nuttanont; Hu, Nan; Ranjan, Ravi; Dosdall, Derek J.			Restitution characteristics of His bundle and working myocardium in isolated rabbit hearts	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; VENTRICULAR-FIBRILLATION; CARDIAC TISSUE; CANINE HEART; ALTERNANS; PURKINJE; CELLS; BLEBBISTATIN; ENDOCARDIUM; MECHANISMS	The Purkinje system (PS) and the His bundle have been recently implicated as an important driver of the rapid activation rate after 1-2 minutes of ventricular fibrillation (VF). It is unknown whether activations during VF propagate through the His-Purkinje system to other portions of the the working myocardium (WM). Little is known about restitution characteristic differences between the His bundle and working myocardium at short cycle lengths. In this study, rabbit hearts (n = 9) were isolated, Langendorff-perfused, and electromechanically uncoupled with blebbistatin (10 mu M). Pacing pulses were delivered directly to the His bundle. By using standard glass microelectrodes, action potentials duration (APD) from the His bundle and WM were obtained simultaneously over a wide range of stimulation cycle lengths (CL). The global F-test indicated that the two restitution curves of the His bundle and the WM are statistically significantly different (P<0.05). Also, the APD of the His bundle was significantly shorter than that of WM throughout the whole pacing course (P<0.001). The CL at which alternans developed in the His bundle vs. the WM were shorter for the His bundle (134.2 +/- 13.1ms vs. 148.3 +/- 13.3ms, P<0.01) and 2: 1 block developed at a shorter CL in the His bundle than in WM (130.0 +/- 10.0 vs. 145.6 +/- 14.2ms, P<0.01). The His bundle APD was significantly shorter than that of WM under both slow and rapid pacing rates, which suggest that there may be an excitable gap during VF and that the His bundle may conduct wavefronts from one bundle branch to the other at short cycle lengths and during VF.	[Huang, Shangwei; Wu, Liqun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Dept Cardiol, Shanghai, Peoples R China; [Huang, Shangwei; Ranjan, Ravi; Dosdall, Derek J.] Univ Utah, Div Cardiol, Dept Internal Med, Salt Lake City, UT 84112 USA; [Huang, Jian] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Panitchob, Nuttanont; Ranjan, Ravi; Dosdall, Derek J.] Univ Utah, Nora A Eccles Cardiovasc Res & Training Inst, Salt Lake City, UT 84112 USA; [Hu, Nan] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA; [Dosdall, Derek J.] Univ Utah, Dept Surg, Div Cardiothorac Surg, Salt Lake City, UT 84112 USA	Shanghai Jiao Tong University; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Dosdall, DJ (corresponding author), Univ Utah, Div Cardiol, Dept Internal Med, Salt Lake City, UT 84112 USA.; Dosdall, DJ (corresponding author), Univ Utah, Nora A Eccles Cardiovasc Res & Training Inst, Salt Lake City, UT 84112 USA.; Dosdall, DJ (corresponding author), Univ Utah, Dept Surg, Div Cardiothorac Surg, Salt Lake City, UT 84112 USA.	Derek.Dosdall@utah.edu		Dosdall, Derek/0000-0001-5059-6824	government of the United States of American; National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL128752]; NHLBI [K23HL115084]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128752, K23HL115084] Funding Source: NIH RePORTER	government of the United States of American; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the government of the United States of American, National Heart, Lung, and Blood Institute (https//www.nhlbi.nih.govi) of the National Institutes of Health to DJD under award number R01HL128752. RR is partially supported a NHLBI grant K23HL115084. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101666; Anyukhovsky EP, 1996, CIRCULATION, V94, P1981, DOI 10.1161/01.CIR.94.8.1981; Brack KE, 2013, EXP PHYSIOL, V98, P1009, DOI 10.1113/expphysiol.2012.069369; Dosdall DJ, 2008, AM J PHYSIOL-HEART C, V295, pH883, DOI 10.1152/ajpheart.00466.2008; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; Hammer KP, 2015, J MOL CELL CARDIOL, V84, P1, DOI 10.1016/j.yjmcc.2015.03.012; Hua F, 2004, CIRC RES, V94, P810, DOI 10.1161/01.RES.0000121102.24277.89; Huang J, 2004, CIRCULATION, V110, P3161, DOI 10.1161/01.CIR.0000147618.93579.56; Huang J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000495; Jia ZH, 2012, BIOPHYS J, V102, P1294, DOI 10.1016/j.bpj.2012.02.034; JOYNER RW, 1991, BIOPHYS J, V60, P1038, DOI 10.1016/S0006-3495(91)82141-5; KENKNIGHT BH, 1995, CIRC RES, V77, P849, DOI 10.1161/01.RES.77.4.849; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; Li L, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1192, DOI 10.1161/CIRCEP.113.000459; Myles RC, 2010, AM J PHYSIOL-HEART C, V299, pH1812, DOI 10.1152/ajpheart.00518.2010; National Academies Press (US), 2011, NATL ACAD COLLECTION; Plotnikov AN, 2007, CIRCULATION, V116, P706, DOI 10.1161/CIRCULATIONAHA.107.703231; ROBINSON RB, 1987, AM J PHYSIOL, V253, pH1018, DOI 10.1152/ajpheart.1987.253.5.H1018; Rohr S, 1997, SCIENCE, V275, P841, DOI 10.1126/science.275.5301.841; SAITOH H, 1989, CIRCULATION, V80, P1421, DOI 10.1161/01.CIR.80.5.1421; Sato D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085365; Shaw RM, 1997, CIRC RES, V81, P727; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Tabereaux PB, 2007, CIRCULATION, V116, P1113, DOI 10.1161/CIRCULATIONAHA.107.699264; Zhang YH, 2016, J INTERV CARD ELECTR, V45, P19, DOI 10.1007/s10840-015-0079-0; Zhang YH, 2011, J CARDIOVASC ELECTR, V22, P1256, DOI 10.1111/j.1540-8167.2011.02068.x	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186880	10.1371/journal.pone.0186880	http://dx.doi.org/10.1371/journal.pone.0186880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073179	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400068
J	Pan, LM; Sheng, MT; Huang, ZR; Zhu, ZL; Xu, CL; Teng, L; He, L; Gu, C; Yi, C; Li, JM				Pan, Liming; Sheng, Mengting; Huang, Zirui; Zhu, Zhilin; Xu, Chunli; Teng, Lin; He, Ling; Gu, Chen; Yi, Cai; Li, Junming			Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; PRESSURE-OVERLOAD; ANGIOTENSIN-II; HEART-FAILURE; AP-1; EXPRESSION; PATHWAYS; GENE; CARDIOMYOCYTES; PHENYLEPHRINE	Background This study aimed to investigated the effect and mechanism of zinc-finger protein 418 (ZNF418) on cardiac hypertrophy caused by aortic banding (AB), phenylephrine (PE) or angiotensin II (Ang II) in vivo and in vitro. Methods The expression of ZNF418 in hearts of patients with dilated cardiomyopathy (DCM) or hypertrophic cardiomyopathy (HCM) and AB-induced cardiac hypertrophy mice, as well as in Ang II- or PE-induced hypertrophic primary cardiomyocytes was detected by western blotting. Then, the expression of ZNF418 was up-regulated or down-regulated in AB-induced cardiac hypertrophy mice and Ang II -induced hypertrophic primary cardiomyocytes. The hypertrophic responses and fibrosis were evaluated by echocardiography and histological analysis. The mRNA levels of hypertrophy markers and fibrotic markers were detected by RT-qPCR. Furthermore, the phosphorylation and total levels of c-Jun were measured by western blotting. Results ZNF418 was markedly down-regulated in hearts of cardiac hypertrophy and hypertrophic primary cardiomyocytes. Down-regulated ZNF418 exacerbated the myocyte size and fibrosis, moreover increased the mRNA levels of ANP, BNP, beta-MHC, MCIP1.4, collagen 1a, collagen III, MMP-2 and fibronection in hearts of AB-treated ZNF418 knockout mice or Ang IItreated cardiomyocytes with AdshZNF418. Conversely, these hypertrophic responses were reduced in the ZNF418 transgenic (TG) mice treated by AB and the AdZNF418-transfected primary cardiomyocytes treated by Ang II. Additionally, the deficiency of ZNF418 enhanced the phosphorylation level of c-jun, and overexpression of ZNF418 suppressed the phosphorylation level of c-jun in vivo and in vitro. Conclusion ZNF418 maybe attenuate hypertrophic responses by inhibiting the activity of c-jun/AP-1.	[Pan, Liming; Huang, Zirui; Zhu, Zhilin; Li, Junming] Three Gorges Univ, Peoples Hosp Yichang 1, Peoples Hosp, Dept Cardiol, Yichang, Peoples R China; [Sheng, Mengting] Three Gorges Univ, Peoples Hosp Yichang 1, Peoples Hosp, Dept Intens Care Unit ICU, Yichang, Peoples R China; [Xu, Chunli] Three Gorges Univ, Peoples Hosp Yichang 1, Peoples Hosp, Dept Inspect Off, Yichang, Peoples R China; [Teng, Lin] Three Gorges Univ, Cent Peoples Hosp Yichang, Coll Clin Med Sci 1, Dept Cardiol, Yichang, Peoples R China; [He, Ling] Three Gorges Univ, Peoples Hosp, Dept Geriatr, Peoples Hosp Yichang 1, Yichang, Peoples R China; [Gu, Chen] Three Gorges Univ, Dept Ultrasound Room B, Peoples Hosp, Peoples Hosp Yichang 1, Yichang, Peoples R China; [Yi, Cai] China Three Gorges Univ, Inst Cardiovasc Dis, Yichang, Peoples R China	China Three Gorges University; China Three Gorges University; China Three Gorges University; China Three Gorges University; China Three Gorges University; China Three Gorges University; China Three Gorges University	Li, JM (corresponding author), Three Gorges Univ, Peoples Hosp Yichang 1, Peoples Hosp, Dept Cardiol, Yichang, Peoples R China.	lijunming@medmail.com.cn			National Natural Science Foundation of China [81270280]; Natural Science Foundation of Hubei Province [2016CFB445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This study was supported by National Natural Science Foundation of China (81270280) and Natural Science Foundation of Hubei Province (2016CFB445).	Benbernou N, 2013, CELL SIGNAL, V25, P1486, DOI 10.1016/j.cellsig.2013.02.019; Bisserier M, 2014, CIRCULATION CIRCULAT, V114; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Finckenberg P, 2010, J HYPERTENS, V28, pS33, DOI 10.1097/01.hjh.0000388492.73954.0b; Freire G, 2007, J MOL CELL CARDIOL, V43, P465, DOI 10.1016/j.yjmcc.2007.07.046; Fujiu K, 2014, J MOL CELL CARDIOL, V70, P64, DOI 10.1016/j.yjmcc.2014.01.013; Glennon PE, 1996, CIRC RES, V78, P954, DOI 10.1161/01.RES.78.6.954; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; Hill C, 2013, CARDIOVASCULAR RES; Irukayama-Tomobe Y, 2004, CIRCULATION, V109, P904, DOI 10.1161/01.CIR.0000112596.06954.00; Ji YX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11267; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Li YQ, 2008, MOL CELL BIOCHEM, V310, P141, DOI 10.1007/s11010-007-9674-4; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Luo KM, 2002, BIOCHEM BIOPH RES CO, V299, P606, DOI 10.1016/S0006-291X(02)02700-6; Lupo A, 2013, CURR GENOMICS, V14, P268, DOI 10.2174/13892029113149990002; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Mohamed BA, 2012, J MOL CELL CARDIOL, V53, P459, DOI 10.1016/j.yjmcc.2012.07.014; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; Oishi Y, 2010, FASEB J, V24, P1780, DOI 10.1096/fj.09-146589; Omura T, 2002, HYPERTENSION, V39, P81, DOI 10.1161/hy0102.100783; Schlieper A, 2007, PFLUG ARCH EUR J PHY, V454, P53, DOI 10.1007/s00424-006-0180-4; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shimizu I, 2016, J MOL CELLULAR CARDI; Song X, 2015, BBA-MOL CELL RES, V1853, P513, DOI 10.1016/j.bbamcr.2014.12.001; Taimor G, 2004, AM J PHYSIOL-HEART C, V286, pH2369, DOI 10.1152/ajpheart.00741.2003; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Tripathi S, 2012, MOL CELL BIOCHEM, V368, P47, DOI 10.1007/s11010-012-1341-8; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Valente AJ, 2012, AM J PHYSIOL-HEART C, V303, pH282, DOI 10.1152/ajpheart.00231.2012; Vikstrom KL, 1998, CIRC RES, V82, P773, DOI 10.1161/01.RES.82.7.773; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; Windak R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073294; Xiao TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023747; Yi ZF, 2004, BIOCHEM BIOPH RES CO, V320, P409, DOI 10.1016/j.bbrc.2004.05.182; Yu CJ, 2017, HYPERTENSION, V69, P615, DOI 10.1161/HYPERTENSIONAHA.116.08500; Yuan Y, 2014, J CARDIOL, V63, P73, DOI 10.1016/j.jjcc.2013.06.008	41	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186635	10.1371/journal.pone.0186635	http://dx.doi.org/10.1371/journal.pone.0186635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065170	gold, Green Published, Green Submitted			2022-12-26	WOS:000413568900022
J	Xu, Q; Tong, JL; Zhang, CP; Xiao, Q; Lin, XL; Xiao, XY				Xu, Qi; Tong, Jin-Lu; Zhang, Chen-Peng; Xiao, Qian; Lin, Xiao-Lin; Xiao, Xiu-Ying			miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DOWN-REGULATION; LYSYL OXIDASE; UP-REGULATION; ANGIOGENESIS; EXPRESSION; MIR-126; VEGF; MICRORNA-27A; BIOLOGY	Aim Metastasis of tumor cells occurs through lymphatic vessels, blood vessels and transcoelomic spreading. Growing evidence from in vivo and in vitro studies has indicated that tumor lymphangiogenesis facilitates metastasis. However, the regulation of lymphangiogenesis in colon cancer remains unclear. The aims of this study were to identify key miRNAs in colon cancer lymphangiogenesis and to investigate its target and mechanism. Methods miRNA microarray analysis was conducted to identify miRNAs in human lymphatic endothelial cells (HLECs) that were regulated by co-cultured human colon cancer cells. Gain-and loss-of-function studies were performed to determine the function of miR-27a, a top hint, on lymphangiogenesis and migration in HLECs. Furthermore, bioinformatics prediction and experimental validation were performed to identify miR-27a target genes in lymphangiogenesis. Results We found that expression of miR-27a in HLECs was induced by co-culturing with colon cancer cells. Over-expression of miR-27a in HLECs enhanced lymphatic tube formation and migration, whereas inhibition of miR-27a reduced lymphatic tube formation and migration. Luciferase reporter assays showed that miR-27a directly targeted SMAD4, a pivotal component of the TGF-beta pathway. In addition, gain-of-function and loss-of-function experiments showed that SMAD4 negatively regulated the length of lymphatic vessels formed by HLECs and migration. Conclusions Our data indicated that colon cancer cell induced the expression of miR-27a in HLECs, which promoted lymphangiogenesis by targeting SMAD4. Our finding implicated miR-27a as a potential target for new anticancer therapies in colon cancer.	[Xu, Qi; Lin, Xiao-Lin; Xiao, Xiu-Ying] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Oncol, Shanghai, Peoples R China; [Tong, Jin-Lu] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai, Peoples R China; [Zhang, Chen-Peng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nucl Med, Shanghai, Peoples R China; [Xiao, Qian] Yale Sch Med, Dept Pharmacol, New Haven, CT USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Yale University	Xiao, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Oncol, Shanghai, Peoples R China.	xiaoxiuying2002@163.com	Xiao, Qian/ABC-6551-2021	Xiao, Qian/0000-0002-2103-4854; xiao, xiuying/0000-0002-9873-0380	National Natural Science Foundation of China [81000929, 81401437]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81000929 to JLT, 81401437 to CPZ; https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (No. 81000929, 81401437).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brognara E, 2016, INT J ONCOL, V48, P1029, DOI 10.3892/ijo.2015.3308; Cao J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw660; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gale M, 2016, ONCOTARGET, V7, P39931, DOI 10.18632/oncotarget.9539; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Glover AR, 2015, ONCOTARGET, V6, P36675, DOI 10.18632/oncotarget.5383; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hiwatashi K, 2009, ANN SURG ONCOL, V16, P3176, DOI 10.1245/s10434-009-0614-2; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Jones D, 2012, ARTERIOSCL THROM VAS, V32, P633, DOI 10.1161/ATVBAHA.111.243576; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Li XM, 2011, J GASTROINTEST SURG, V15, P2001, DOI 10.1007/s11605-011-1627-2; Liang P, 2005, ANTICANCER RES, V25, P2705; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Madison BB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005408; Miyaki M, 2003, BIOCHEM BIOPH RES CO, V306, P799, DOI 10.1016/S0006-291X(03)01066-0; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Park KJ, 2017, GASTRIC CANCER, V20, P104, DOI 10.1007/s10120-015-0592-y; Qiu XF, 2010, ONCOL LETT, V1, P579, DOI 10.3892/ol_00000102; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Tang W, 2014, ONCOGENE, V33, P2629, DOI 10.1038/onc.2013.214; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Tong JL, 2011, FEBS LETT, V585, P3560, DOI 10.1016/j.febslet.2011.10.021; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Venkatesh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054643; Wan XC, 2016, INT J BIOCHEM CELL B, V79, P249, DOI 10.1016/j.biocel.2016.08.043; Wang Q, 2011, ONCOGENE, V30, P3875, DOI 10.1038/onc.2011.103; Xiao Q, 2012, CANCER MICROENVIRON, V5, P261, DOI 10.1007/s12307-012-0105-z; Xu LL, 2013, ANTI-CANCER AGENT ME, V13, P1126, DOI 10.2174/18715206113139990006; Xu Y, 2014, BBA-MOL BASIS DIS, V1842, P712, DOI 10.1016/j.bbadis.2014.01.007; Yang J, 2017, INT J ONCOL, V50, P1693, DOI 10.3892/ijo.2017.3957; Yu YJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0372-7; Zhao XH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-55	49	29	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186718	10.1371/journal.pone.0186718	http://dx.doi.org/10.1371/journal.pone.0186718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065177	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900027
J	Wu, YD; Lin, CH; Chao, WC; Liao, TL; Chen, DY; Chen, HH				Wu, Yi-Da; Lin, Ching-Heng; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Der-Yuan; Chen, Hsin-Hua			Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: A nationwide, population-based, case-control study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ANTIBODIES; SMOKING; PREVALENCE; DISEASE; CELLS	Objective To examine the association between a history of periodontitis (PD) and incident systemic lupus erythematosus (SLE) Methods We used 2003-2012 claims data from the Taiwanese National Health Insurance Database to identify 7,204 incident SLE patients during 2007-2012 as the study group, along with randomly selecting 72,040 non-SLE patients matched (1: 10) for age, gender, and first diagnosis date (index date) as the control group. The correlation between PD and SLE risk was estimated using conditional logistic regression analysis, after making adjustments for confounders (including a history of diabetes and number of non-PD related dental visits before the index date). To evaluate the effects of PD severity and the lag time which occurred since the last PD visit on SLE development, odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for subgroups of patients with PD according to their number of visits, cumulative cost and also the time gaps between their last PD-related visit and the index date. Results A statistically significant association between a history of PD and newly diagnosed SLE was observed (OR, 1.21; 95% CI, 1.14-1.28; p-value, < 0.001). The association was both dose and time-dependent and was found to be strongest when the interval between the last PD-related visit and the index date was less than three months (OR, 1.83; 95% CI, 1.61-2.09; p-value, <0.001). The association between PD exposure and SLE risk was consistently significant among subgroups stratified based on age, gender, or DM status. Conclusions The results of this nationwide, population-based, case-control study suggest that there is a significant association between a history of PD and incident SLE in Taiwan. This weak association is limited to lack of information on individual smoking status in the database.	[Wu, Yi-Da; Chen, Der-Yuan; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taichung, Taiwan; [Lin, Ching-Heng; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Ching-Heng] Natl Taipei Univ Nursing & Hlth Sci, Dept Healthcare Management, Taipei, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan; [Chao, Wen-Cheng] Natl Changhua Univ Educ, Dept Business Adm, Taichung, Taiwan; [Liao, Tsai-Ling; Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Liao, Tsai-Ling; Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Taichung Veterans General Hospital; National Changhua University of Education; National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, HH (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taichung, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, HH (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.	shc5555@hotmail.com						ALJANADI M, 1993, J RHEUMATOL, V20, P1885; Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; Boutsi EA, 2000, J CLIN PERIODONTOL, V27, P231, DOI 10.1034/j.1600-051x.2000.027004231.x; Cairo F, 2001, Minerva Stomatol, V50, P321; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chai L, 2012, J PERIODONTAL RES, V47, P273, DOI 10.1111/j.1600-0765.2011.01437.x; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Cooper GS, 2008, ENVIRON HEALTH PERSP, V116, P695, DOI 10.1289/ehp.11092; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Fabbri C, 2014, CLIN RHEUMATOL, V33, P505, DOI 10.1007/s10067-013-2473-2; Fairweather D, 2004, EMERG INFECT DIS, V10, P2005, DOI 10.3201/eid1011.040367; HABER J, 1993, J PERIODONTOL, V64, P16, DOI 10.1902/jop.1993.64.1.16; Hardy CJ, 1998, ANN RHEUM DIS, V57, P451, DOI 10.1136/ard.57.8.451; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jiang F, 2015, CLIN RHEUMATOL, V34, P1885, DOI 10.1007/s10067-015-3008-9; Kobayashi T, 2003, J PERIODONTOL, V74, P378, DOI 10.1902/jop.2003.74.3.378; Kobayashi T, 2007, J PERIODONTOL, V78, P467, DOI 10.1902/jop.2007.060194; Li XA, 2011, J CLIN PERIODONTOL, V38, P148, DOI 10.1111/j.1600-051X.2010.01651.x; Lin YC, 2012, RHEUMATOL INT, V32, P1669, DOI 10.1007/s00296-011-1847-5; MACKLER BF, 1977, J PERIODONTAL RES, V12, P37, DOI 10.1111/j.1600-0765.1977.tb00107.x; Marques CPC, 2016, CLIN EXP IMMUNOL, V183, P187, DOI 10.1111/cei.12708; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Mercado FB, 2001, J PERIODONTOL, V72, P779, DOI 10.1902/jop.2001.72.6.779; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Najera MP, 1997, ORAL SURG ORAL MED O, V83, P453, DOI 10.1016/S1079-2104(97)90144-X; Nesse W, 2010, J PERIODONTOL, V81, P1622, DOI 10.1902/jop.2010.100058; Novo E, 1999, J PERIODONTOL, V70, P185, DOI 10.1902/jop.1999.70.2.185; OLIVER RC, 1994, J PERIODONTOL, V65, P530, DOI 10.1902/jop.1994.65.5s.530; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Schenkein HA, 2003, J DENT RES, V82, P919, DOI 10.1177/154405910308201114; Sebastiani GD, 2009, LUPUS, V18, P1169, DOI 10.1177/0961203309345737; Steinberg AD, 1995, J AUTOIMMUN, V8, P771, DOI 10.1016/S0896-8411(95)80017-4; TEW J, 1989, J PERIODONTAL RES, V24, P225, DOI 10.1111/j.1600-0765.1989.tb01787.x; Uramoto KM, 1999, ARTHRITIS RHEUM, V42, P46, DOI 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2; Wang CY, 2015, J PERIODONTOL, V86, P995, DOI 10.1902/jop.2015.140664	36	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0187075	10.1371/journal.pone.0187075	http://dx.doi.org/10.1371/journal.pone.0187075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059229	Green Published, Green Submitted, gold			2022-12-26	WOS:000413403000060
J	Ouyang, EM; Lu, Y; Ouyang, JT; Wang, LL; Wang, XH				Ouyang, Erming; Lu, Yao; Ouyang, Jiating; Wang, Lele; Wang, Xiaohui			Bacterial community analysis of anoxic/aeration (A/O) system in a combined process for gibberellin wastewater treatment	PLOS ONE			English	Article							MICROBIAL COMMUNITY; FRESH-WATER; ANAEROBIC BIODEGRADATION; SEDIMENT BACTERIAL; DIVERSITY; SOIL; REACTOR; BIOREMEDIATION; REMOVAL; SULFATE	Gibberellin wastewater cannot be directly discharged without treatment due to its high concentrations of sulfate and organic compounds and strong acidity. Therefore, multi-stage anaerobic bioreactor + micro-aerobic + anoxic/aeration (A/O) + biological contact oxidation combined processes are used to treat gibberellin wastewater. However, knowledge of the treatment effects of the A/O process and bacterial community structure in the aeration tank reactors of such systems is sparse. Therefore, this study was conducted to investigate the treatment effects and operation of the A/O process on gibberellin wastewater, as well as changes in the bacterial community structure of activated sludge in the aeration tank during treatment. Moreover, removal was examined based on evaluation of effluent after A/O treatment. Although influent chemical oxygen demand (COD), NH3-N and total phosphorus (TP) fluctuated, effluent COD, NH3-N and TP remained stable. Moreover, average COD, NH3-N and TP removal efficiency were 68.41%, 93.67% and 45.82%, respectively, during the A/O process. At the phylum level, Proteobacteria was the dominant phylum in all samples, followed by Chloroflexi, Bacteroidetes and Actinobacteria. Proteobacteria played an important role in the removal of organic matter. Chloroflexi was found to be responsible for the degradation of carbohydrates and Bacteroidetes also had been found to be responsible for the degradation of complex organic matters. Actinobacteria are able to degrade a variety of environmental chemicals. Additionally, Anaerolineaceae_uncultured was the major genus in samples collected on May 25, 2015, while Novosphingobium and Nitrospira were dominant in most samples. Nitrosomonas are regarded as the dominant ammonia-oxidizing bacteria, while Nitrospira are the main nitrite-oxidizing bacteria. Bacterial community structure varied considerably with time, and a partial Mantel test showed a highly significant positive correlation between bacterial community structure and DO. The bacterial community structure was also positively correlated with temperature and SO42-.	[Ouyang, Erming; Lu, Yao; Ouyang, Jiating; Wang, Lele] Nanchang Univ, Sch Civil Engn & Architecture, Nanchang, Jiangxi, Peoples R China; [Wang, Xiaohui] Beijing Univ Chem Technol, Coll Chem Engn, Beijing, Peoples R China	Nanchang University; Beijing University of Chemical Technology	Wang, XH (corresponding author), Beijing Univ Chem Technol, Coll Chem Engn, Beijing, Peoples R China.	379979971@qq.com			Implement Project of Science and Technology of Colleges and Universities in Jiangxi Province [KJLD13007]	Implement Project of Science and Technology of Colleges and Universities in Jiangxi Province	This work was supported by Implement Project of Science and Technology of Colleges and Universities in Jiangxi Province, grant number KJLD13007 to Erming Ouyang (website: http://www.jxedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Chen YH, 2016, J ENVIRON SCI, V43, P61, DOI 10.1016/j.jes.2015.08.012; Collado N, 2013, CHEMOSPHERE, V93, P99, DOI 10.1016/j.chemosphere.2013.04.094; Dayan J, 2012, PLANT CELL, V24, P66, DOI 10.1105/tpc.111.093096; Farabegoli G, 2009, J HAZARD MATER, V171, P1126, DOI 10.1016/j.jhazmat.2009.06.128; Foesel BU, 2013, SYST APPL MICROBIOL, V36, P82, DOI 10.1016/j.syapm.2012.11.002; Forss J, 2013, BIORESOURCE TECHNOL, V130, P681, DOI 10.1016/j.biortech.2012.12.097; Fuentes S, 2014, APPL MICROBIOL BIOT, V98, P4781, DOI 10.1007/s00253-014-5684-9; Gao DW, 2014, CHEMOSPHERE, V97, P130, DOI 10.1016/j.chemosphere.2013.10.083; Huang XQ, 2015, MICROBIOL RES, V181, P33, DOI 10.1016/j.micres.2015.08.004; Kwon S, 2010, J MICROBIOL BIOTECHN, V20, P1717, DOI 10.4014/jmb.1007.07012; Li B, 2013, WATER RES, V47, P4207, DOI 10.1016/j.watres.2013.04.021; Li WC, 2015, CHEM ENG J, V260, P55, DOI 10.1016/j.cej.2014.08.085; Li YF, 2014, INT BIODETER BIODEGR, V96, P41, DOI 10.1016/j.ibiod.2014.08.012; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; Pereira S, 2011, MICROBIOL-SGM, V157, P451, DOI 10.1099/mic.0.041038-0; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Polti MA, 2014, INT BIODETER BIODEGR, V88, P48, DOI 10.1016/j.ibiod.2013.12.004; Qiu TL, 2016, BIODEGRADATION, V27, P165, DOI 10.1007/s10532-016-9764-7; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Swain SM, 2005, TRENDS PLANT SCI, V10, P123, DOI 10.1016/j.tplants.2005.01.007; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wang Z, 2015, J HAZARD MATER, V286, P306, DOI 10.1016/j.jhazmat.2014.12.057; Weber SD, 2007, APPL ENVIRON MICROB, V73, P6233, DOI 10.1128/AEM.01002-07; Weijma J, 2002, WATER RES, V36, P1825, DOI 10.1016/S0043-1354(01)00390-6; Wong K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00500; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Xie ZF, 2014, BIORESOURCE TECHNOL, V161, P29, DOI 10.1016/j.biortech.2014.03.014; Yang Q, 2015, BIORESOURCE TECHNOL, V196, P169, DOI 10.1016/j.biortech.2015.07.087; Yang YY, 2015, MICROB ECOL, V70, P97, DOI 10.1007/s00248-014-0551-x; Yangin-Gomec C, 2017, BIORESOURCE TECHNOL, V241, P332, DOI 10.1016/j.biortech.2017.05.070; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Ying YL, 2008, J ENVIRON SCI, V20, P1118, DOI 10.1016/S1001-0742(08)62158-0; Zhang J, 2015, MICROBIOL RES, V177, P43, DOI 10.1016/j.micres.2015.05.006; Zhang JX, 2015, APPL MICROBIOL BIOT, V99, P3291, DOI 10.1007/s00253-014-6262-x; Zhang Y, 2015, APPL MICROBIOL BIOT, V99, P1977, DOI 10.1007/s00253-014-6096-6; Zhou XD, 2013, ENVIRON SCI POLLUT R, V20, P2484, DOI 10.1007/s11356-012-1168-6	38	10	11	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186743	10.1371/journal.pone.0186743	http://dx.doi.org/10.1371/journal.pone.0186743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053751	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100036
J	Khosrawipour, T; Khosrawipour, V; Giger-Pabst, U				Khosrawipour, Tanja; Khosrawipour, Veria; Giger-Pabst, Urs			Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma	PLOS ONE			English	Article							SURVIVAL; CANCER; GEMCITABINE; PACLITAXEL; PIPAC	Background Patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma were treated with Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC), initial clinical findings are presented. Methods Single institution, tertiary referral center certified for therapy of peritoneal disease. Prospective data collection of PIPAC therapy with doxorubicin 1.5 mg/m(2) and cisplatin 7.5 mg/m(2) of body surface delivered at intervals of six weeks. The outcome criteria were microscopic pathological response, survival and adverse events (v4.0 CTCAE). Results A total of 20 patients (m/f = 3:1) with a mean age of 64.9 (range: 45.0 to 87.0) years underwent 41 PIPAC procedures without intraoperative complications. The mean number of PIPAC cycles was 2.1 (range: one to four). Ten patients with >= 2 PIPAC applications were eligible for histological analysis to assess carcinoma regression. Complete or high grade tumor regression was found in two (10%) and five (25%) patients, respectively. An overall median survival of 36.6 weeks after the first PIPAC application was observed. One patient died postoperatively due to small bowel obstruction. No CTCAE level 3 and 4 complications occurred. Conclusion In about one third of patients, repeated PIPAC therapy did induce histological regression of systemic chemo-resistant PC of pancreatic adenocarcinoma. Prospective randomized trials are needed to further clarify any clinical impact of such observations.	[Khosrawipour, Tanja; Khosrawipour, Veria; Giger-Pabst, Urs] Ruhr Univ Bochum, St Marys Hosp Herne, Dept Gen Surg, Bochum, Germany; [Khosrawipour, Tanja; Khosrawipour, Veria; Giger-Pabst, Urs] Ruhr Univ Bochum, St Marys Hosp Herne, Therapy Ctr Peritoneal Carcinomatosis, Bochum, Germany; [Khosrawipour, Tanja; Khosrawipour, Veria; Giger-Pabst, Urs] Ruhr Univ Bochum, St Marys Hosp Herne, Dept Surg, Basic Res Labs, Bochum, Germany; [Khosrawipour, Veria] Orthoklin Dortmund, Dept Orthoped & Trauma Surg, Dortmund, Germany	Ruhr University Bochum; St. Marien Hospital; Ruhr University Bochum; St. Marien Hospital; Ruhr University Bochum; St. Marien Hospital	Giger-Pabst, U (corresponding author), Ruhr Univ Bochum, St Marys Hosp Herne, Dept Gen Surg, Bochum, Germany.; Giger-Pabst, U (corresponding author), Ruhr Univ Bochum, St Marys Hosp Herne, Therapy Ctr Peritoneal Carcinomatosis, Bochum, Germany.; Giger-Pabst, U (corresponding author), Ruhr Univ Bochum, St Marys Hosp Herne, Dept Surg, Basic Res Labs, Bochum, Germany.	urs.pabst@elisabethgruppe.de	Giger-Pabst, Urs/AAJ-5008-2021; Khosrawipour, Veria/ABH-8841-2020; Khosrawipour, Tanja/AAI-2372-2019	Khosrawipour, Tanja/0000-0003-0233-551X				Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Dedrick RL, 1997, JNCI-J NATL CANCER I, V89, P480, DOI 10.1093/jnci/89.7.480; Demtroder C, 2016, COLORECTAL DIS, V18, P364, DOI 10.1111/codi.13130; Gohler D, 2017, SURG ENDOSC, V31, P1778, DOI 10.1007/s00464-016-5174-5; Grass F, 2017, BRIT J SURG, V104, P669, DOI 10.1002/bjs.10521; Graversen M, 2017, CLIN EXP METASTAS, V34, P309, DOI 10.1007/s10585-017-9849-7; Khosrawipour V, 2016, ANTICANCER RES, V36, P4595, DOI 10.21873/anticanres.11008; Le Scodan R, 2008, AM J CLIN ONCOL-CANC, V31, P545, DOI 10.1097/COC.0b013e318172d5c5; Lu Z, 2010, FUTURE ONCOL, V6, P1625, DOI 10.2217/FON.10.100; Munch M, 2013, Z GASTROENTEROL, p51 ; Nadiradze G, 2016, J GASTROINTEST SURG, V20, P367, DOI 10.1007/s11605-015-2995-9; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; Robella M, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0892-7; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smeenk HG, 2005, LANGENBECK ARCH SURG, V390, P94, DOI 10.1007/s00423-004-0476-9; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Solass W, 2016, PLEURA PERITONEUM, V1, P99, DOI [10.1515/pap-2016-0011, 10.1515/pp-2016-0011]; Solass W, 2014, ANN SURG ONCOL, V21, P553, DOI 10.1245/s10434-013-3213-1; Solass W, 2013, ANN SURG ONCOL, V20, P3504, DOI 10.1245/s10434-013-3039-x; Solass W, 2012, SURG ENDOSC, V26, P1849, DOI 10.1007/s00464-012-2148-0; Tabernero J, 2015, ONCOLOGIST, V20, P143, DOI 10.1634/theoncologist.2014-0394; Takahara N, 2016, INVEST NEW DRUG, V34, P636, DOI 10.1007/s10637-016-0369-0; Thomassen I, 2013, PANCREAS, V42, P72, DOI 10.1097/MPA.0b013e31825abf8c; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yamamoto T, 2015, WORLD J GASTROENTERO, V21, P262, DOI 10.3748/wjg.v21.i1.262	26	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186709	10.1371/journal.pone.0186709	http://dx.doi.org/10.1371/journal.pone.0186709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049340	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900100
J	Lu, YX; Ho, CS; Liu, X; Chua, AN; Wang, W; McIntyre, RS; Ho, RC				Lu, Yanxia; Ho, Cyrus S.; Liu, Xin; Chua, Anna N.; Wang, Wei; McIntyre, Roger S.; Ho, Roger C.			Chronic administration of fluoxetine and pro-inflammatory cytokine change in a rat model of depression	PLOS ONE			English	Article							CHRONIC MILD STRESS; MAJOR DEPRESSION; SUCROSE CONSUMPTION; ANTIDEPRESSANTS; MICE; ACTIVATION; ANHEDONIA; VALIDITY; DISEASE; UTILITY	This study evaluated the chronic effects of fluoxetine, a commonly prescribed SSRI antide-pressant, on the peripheral and central levels of inflammatory cytokines including IL-1 beta, IL6, TNF-alpha and IL-17 over a 4-interval in a rat model of chronic mild stress (CMS) which resembles the human experience of depression. Twenty-four Sprague-Dawley rats were randomly assigned to CMS+vehicle (n = 9), CMS+fluoxetine (n = 9) and the control (n = 6) groups. Sucrose preference and forced swim tests were performed to assess behavioral change. Blood samples were collected on day 0, 60, 90 and 120 for measurement of cytokine levels in plasma. On day 120, the brain was harvested and central level of cytokines was tested using Luminex. Four months of fluoxetine treatment resulted in changes in the sucrose preference and immobility time measurements, commensurate with antidepressant effects. The CMS+vehicle group exhibited elevated plasma levels of IL-1 beta, IL-17, and TNF-alpha on day 60 or 120. Rats treated with fluoxetine demonstrated lower IL-1 beta in plasma and brain after 90 and 120-day treatment respectively (p<0.05). There was a trend of reduction of IL-6 and TNF-alpha concentration. This study revealed the potential therapeutic effects of fluoxetine by reducing central and peripheral levels of IL-1 beta in the alleviation of depressive symptoms.	[Lu, Yanxia; Wang, Wei] Zhejiang Univ, Coll Med, Sch Publ Hlth, Dept Clin Psychol & Psychiat, Hangzhou, Zhejiang, Peoples R China; [Ho, Cyrus S.; Chua, Anna N.; Ho, Roger C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Ho, Cyrus S.; Ho, Roger C.] Natl Univ Hlth Syst, Dept Psychol Med, Singapore, Singapore; [Liu, Xin] Taishan Med Univ, Shandong Prov Key Lab Cerebral Microcirculat, Tai An, Shandong, Peoples R China; [Liu, Xin] Taishan Med Univ, Sch Basic Med Sci, Dept Med Psychol, Tai An, Shandong, Peoples R China; [McIntyre, Roger S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Toronto, Dept Toxicol & Pharmacol, Toronto, ON, Canada	Zhejiang University; National University of Singapore; National University of Singapore; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Lu, YX; Wang, W (corresponding author), Zhejiang Univ, Coll Med, Sch Publ Hlth, Dept Clin Psychol & Psychiat, Hangzhou, Zhejiang, Peoples R China.	A0068932@u.nus.edu; drwangwei@zju.edu.cn	McIntyre, Roger/AAU-1000-2020; Ho, Cyrus SH/AAN-9344-2020; Wang, Wei/B-8303-2008; Ho, Roger C./ABD-9061-2021; Ho, Roger/ABD-8859-2021; wang, chu/GYJ-2191-2022; Lu, Yanxia/K-7383-2013	McIntyre, Roger/0000-0003-4733-2523; Ho, Cyrus SH/0000-0002-7092-9566; Wang, Wei/0000-0002-6822-8162; Ho, Roger C./0000-0001-9629-4493; Lu, Yanxia/0000-0003-0878-7525	National Science Funds for Young Scientist by the National Natural Science Foundation of China (NSFC) [81600018]; Joint Research Fund for International Cooperation by the National University of Singapore [519600-X11601]	National Science Funds for Young Scientist by the National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Joint Research Fund for International Cooperation by the National University of Singapore(National University of Singapore)	This project was supported by National Science Funds for Young Scientist (81600018 to YL) provided by the National Natural Science Foundation of China (NSFC) and Joint Research Fund for International Cooperation (519600-X11601 to YL) provided by the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FLUOX HYDR; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; Berk M, 1997, J PSYCHOSOM RES, V43, P529, DOI 10.1016/S0022-3999(97)00139-6; Dang HX, 2009, PROG NEURO-PSYCHOPH, V33, P1417, DOI 10.1016/j.pnpbp.2009.07.020; Del Parigi A, 2002, NEUROREPORT, V13, P1141; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dunn AJ, 2007, CYTOKINES STRESS IMM, P193; El-Hage W, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00146; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Forbes NF, 1996, PHYSIOL BEHAV, V60, P1481, DOI 10.1016/S0031-9384(96)00305-8; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Grippo AJ, 2006, BIOL PSYCHIAT, V59, P309, DOI 10.1016/j.biopsych.2005.07.010; Grippo AJ, 2011, SOC PERSONAL PSYCHOL, V5, P164, DOI 10.1111/j.1751-9004.2011.00342.x; Habib M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120559; Hecht D, 2010, NEUROSCI RES, V68, P77, DOI 10.1016/j.neures.2010.06.013; Hill MN, 2012, NEUROSCI BIOBEHAV R, V36, P2085, DOI 10.1016/j.neubiorev.2012.07.001; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lu J, 2015, BEHAV BRAIN RES, V284, P231, DOI 10.1016/j.bbr.2015.02.009; MAES M, 1993, AM J PSYCHIAT, V150, P1189; Maes M, 2012, EXPERT OPIN THER TAR, V16, P1097, DOI 10.1517/14728222.2012.718331; MATTHEWS K, 1995, PHYSIOL BEHAV, V57, P241, DOI 10.1016/0031-9384(94)00286-E; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Myers R.L, 2008, 100 MOST IMPORTANT C; Myint AM, 2003, MED HYPOTHESES, V61, P519, DOI 10.1016/S0306-9877(03)00207-X; O'Neil A, 2016, J AFFECT DISORDERS, V196, P117, DOI 10.1016/j.jad.2016.02.029; Pandey GN, 2007, CYTOKINES STRESS IMM, P51; Papp M, 1996, EUR J PHARMACOL, V296, P129, DOI 10.1016/0014-2999(95)00697-4; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; Costa APR, 2013, PROG NEURO-PSYCHOPH, V45, P150, DOI 10.1016/j.pnpbp.2013.05.002; Roumestan C, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-35; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sillaber I, 2011, NEUROBIOLOGY MENTAL, P378; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Sluzewska A, 1996, PSYCHIAT RES, V64, P161, DOI 10.1016/S0165-1781(96)02783-7; Song C, 2009, PHARMACOPSYCHIATRY, V42, P182, DOI 10.1055/s-0029-1202263; Thomas AJ, 2005, AM J PSYCHIAT, V162, P175, DOI 10.1176/appi.ajp.162.1.175; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Wang C, 2014, PHARMACOL BIOCHEM BE, V116, P116, DOI 10.1016/j.pbb.2013.11.028; Warner-Schmidt JL, 2011, P NATL ACAD SCI USA, V108, P9262, DOI 10.1073/pnas.1104836108; Westenberg HGM, 2006, INT J CLIN PRACT, V60, P482, DOI 10.1111/j.1368-5031.2006.00865.x; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Willner P, 2017, NEUROBIOL STRESS, V6, P78, DOI 10.1016/j.ynstr.2016.08.002; Zhao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08890	48	87	88	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186700	10.1371/journal.pone.0186700	http://dx.doi.org/10.1371/journal.pone.0186700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0UN	29049348	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900096
J	Schneefeld, M; Busche, T; Geffers, R; Kalinowski, J; Bange, FC				Schneefeld, Marie; Busche, Tobias; Geffers, Robert; Kalinowski, Joern; Bange, Franz-Christoph			The transcriptional regulator LysG (Rv1985c) of Mycobacterium tuberculosis activates lysE (Rv1986) in a lysine-dependent manner	PLOS ONE			English	Article							IN-VITRO INTERACTIONS; SALMONELLA-TYPHIMURIUM; POSITIVE REGULATOR; CYSB PROTEIN; FAMILY; EXPRESSION; STRESS; GENES; PERSISTENCE; RESISTANCE	The Mycobacterium tuberculosis protein encoded by the Rv1986 gene is a target for memory T cells in patients with tuberculosis, and shows strong similarities to a lysine exporter LysE of Corynebacterium glutamicum. During infection, the pathogen Mycobacterium tuberculosis adapts its metabolism to environmental changes. In this study, we found that the expression of Rv1986 is controlled by Rv1985c. Rv1985c is located directly upstream of Rv1986 with an overlapping promoter region between both genes. Semiquantitative reverse transcription PCR using an isogenic mutant of Mycobacterium tuberculosis lacking Rv1985c showed that in the presence of lysine, Rv1985c protein positively upregulated the expression of Rv1986. RNA sequencing revealed the transcription start points for both transcripts and overlapping promoters. An inverted repeat in the center of the intergenic region was identified, and binding of Rv1985c protein to the intergenic region was confirmed by electrophoretic mobility shift assays. Whole transcriptome expression analysis and RNAsequencing showed downregulated transcription of ppsBCD in the Rv1985c-mutant compared to the wild type strain. Taken together, our findings characterize the regulatory network of Rv1985c in Mycobacterium tuberculosis. Due to their similarity of an orthologous gene pair in Corynebacterium glutamicum, we suggest to rename Rv1985c to lysG((Mt)), and Rv1986 to lysE((Mt)).	[Schneefeld, Marie; Bange, Franz-Christoph] Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, Hannover, Germany; [Busche, Tobias; Kalinowski, Joern] Bielefeld Univ, Ctr Biotechnol, Microbial Genom & Biotechnol, Bielefeld, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, Braunschweig, Germany	Hannover Medical School; University of Bielefeld; Helmholtz Association; Helmholtz-Center for Infection Research	Bange, FC (corresponding author), Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, Hannover, Germany.; Kalinowski, J (corresponding author), Bielefeld Univ, Ctr Biotechnol, Microbial Genom & Biotechnol, Bielefeld, Germany.	joern@CeBiTec.Uni-Bielefeld.de; bange.franz@mh-hannover.de			Niedersachsischer Verein zur Bekampfung der Tuberkulose, Lungen- und Bronchialerkrankungen; FCB	Niedersachsischer Verein zur Bekampfung der Tuberkulose, Lungen- und Bronchialerkrankungen; FCB	This work was supported by Niedersachsischer Verein zur Bekampfung der Tuberkulose, Lungen- und Bronchialerkrankungen; FCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank S. Suerbaum for his support. We thank D. Gotz (IMP, Vienna) for helpful discussions about protein expression and purification. Transcriptome sequencing was done with excellent technical support from A. Winkler (CeBiTec, Bielefeld University). This work was supported by the Niedersachsischer Verein zur Bekampfung der Tuberkulose, Lungen- und Bronchialerkrankungen.	Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Bange F.-C., 1999, Tubercle and Lung Disease, V79, P171, DOI 10.1054/tuld.1998.0201; Bellmann A, 2001, MICROBIOL-SGM, V147, P1765, DOI 10.1099/00221287-147-7-1765; Bold TD, 2009, CELL, V136, P17, DOI 10.1016/j.cell.2008.12.032; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; DAFFE M, 1988, J GEN MICROBIOL, V134, P2049; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Gomez RL, 2016, FEBS J, V283, P3056, DOI 10.1111/febs.13791; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Healy C, 2016, TUBERCULOSIS, V97, P154, DOI 10.1016/j.tube.2015.10.003; Hilker R, 2016, BIOINFORMATICS, V32, P3702, DOI 10.1093/bioinformatics/btw541; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kumar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004139; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laishram RS, 2007, GENE DEV, V21, P1258, DOI 10.1101/gad.1520507; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; MONROE RS, 1990, J BACTERIOL, V172, P6919, DOI 10.1128/jb.172.12.6919-6929.1990; Nandineni MR, 2004, J BACTERIOL, V186, P3539, DOI 10.1128/JB.186.11.3539-3546.2004; OSTROWSKI J, 1991, J BACTERIOL, V173, P2212, DOI 10.1128/JB.173.7.2212-2218.1991; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Pfaffl MW, 2004, A Z QUANTITATIVE PCR; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Seymour RL, 1996, MOL MICROBIOL, V20, P497, DOI 10.1046/j.1365-2958.1996.5451068.x; Sheehan BJ, 1998, MOL MICROBIOL, V30, P91, DOI 10.1046/j.1365-2958.1998.01041.x; Song NN, 2016, DNA CELL BIOL, V35, P167, DOI 10.1089/dna.2015.3040; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vrljic M, 1996, MOL MICROBIOL, V22, P815, DOI 10.1046/j.1365-2958.1996.01527.x; WHO, 2016, GLOB REP DIAB, P20; Zhou XH, 2010, J MOL BIOL, V396, P1012, DOI 10.1016/j.jmb.2009.12.033	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186505	10.1371/journal.pone.0186505	http://dx.doi.org/10.1371/journal.pone.0186505			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049397	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900075
J	Shen, XJ; Yi, L; Jiang, XP; He, TT; Yang, JC; Xie, W; Hu, P; Hu, XH				Shen, Xianjun; Yi, Li; Jiang, Xingpeng; He, Tingting; Yang, Jincai; Xie, Wei; Hu, Po; Hu, Xiaohua			Identifying protein complex by integrating characteristic of core-attachment into dynamic PPI network	PLOS ONE			English	Article							GENE-EXPRESSION; CONSTRUCTION; ORGANIZATION; PREDICTION; MODULES	How to identify protein complex is an important and challenging task in proteomics. It would make great contribution to our knowledge of molecular mechanism in cell life activities. However, the inherent organization and dynamic characteristic of cell system have rarely been incorporated into the existing algorithms for detecting protein complexes because of the limitation of protein-protein interaction (PPI) data produced by high throughput techniques. The availability of time course gene expression profile enables us to uncover the dynamics of molecular networks and improve the detection of protein complexes. In order to achieve this goal, this paper proposes a novel algorithm DCA (Dynamic Core-Attachment). It detects protein-complex core comprising of continually expressed and highly connected proteins in dynamic PPI network, and then the protein complex is formed by including the attachments with high adhesion into the core. The integration of core-attachment feature into the dynamic PPI network is responsible for the superiority of our algorithm. DCA has been applied on two different yeast dynamic PPI networks and the experimental results show that it performs significantly better than the state-of-the-art techniques in terms of prediction accuracy, hF-measure and statistical significance in biology. In addition, the identified complexes with strong biological significance provide potential candidate complexes for biologists to validate.	[Shen, Xianjun; Yi, Li; Jiang, Xingpeng; He, Tingting; Yang, Jincai; Xie, Wei; Hu, Po; Hu, Xiaohua] Cent China Normal Univ, Sch Comp, Wuhan, Hubei, Peoples R China; [Yi, Li] Letv Cloud Comp Co Ltd, Beijing, Peoples R China; [Hu, Xiaohua] Drexel Univ, Coll Comp & Informat, Philadelphia, PA 19104 USA	Central China Normal University; Drexel University	Shen, XJ (corresponding author), Cent China Normal Univ, Sch Comp, Wuhan, Hubei, Peoples R China.	xjshen@mail.ccnu.edu.cn			National Natural Science Foundation of China [61532008]; Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE [CCNU14A02008, CCNU17TS0003, CCNU16JYKX018]; International Cooperation Project of Hubei Province [2014BHE0017]; National Key Research and Development Program of China [SQ2017YFSF090207]; AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY [R01TS000003] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE; International Cooperation Project of Hubei Province; National Key Research and Development Program of China; AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research is supported by the National Natural Science Foundation of China (No. 61532008), the Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE (No. CCNU14A02008, CCNU17TS0003, CCNU16JYKX018), the International Cooperation Project of Hubei Province (No. 2014BHE0017), and the National Key Research and Development Program of China (SQ2017YFSF090207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the National Natural Science Foundation of China (No. 61532008), the Self-determined Research Funds of CCNU from the Colleges' Basic Research and Operation of MOE (No. CCNU14A02008, CCNU17TS0003, CCNU16JYKX018), the International Cooperation Project of Hubei Province (No. 2014BHE0017), and the National Key Research and Development Program of China (SQ2017YFSF090207).	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chen BL, 2014, BRIEF BIOINFORM, V15, P177, DOI 10.1093/bib/bbt039; Chen BL, 2013, IEEE T NANOBIOSCI, V12, P165, DOI 10.1109/TNB.2013.2264097; Chen BL, 2013, PROTEOMICS, V13, P269, DOI 10.1002/pmic.201200336; Dezso Z, 2003, GENOME RES, V13, P2450, DOI 10.1101/gr.1073603; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jiang P, 2010, BIOINFORMATICS, V26, P1105, DOI 10.1093/bioinformatics/btq078; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lakizadeh A, 2015, J THEOR BIOL, V378, P31, DOI 10.1016/j.jtbi.2015.04.020; Le OY, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1164-9; Leung HCM, 2009, J COMPUT BIOL, V16, P133, DOI 10.1089/cmb.2008.01TT; LI M, 2012, BMC BIOINFORMATICS, V13; Li Min, 2014, Biomed Res Int, V2014, P375262, DOI 10.1155/2014/375262; Li M, 2013, PROTEOMICS, V13, P291, DOI 10.1002/pmic.201200436; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Ou-Yang L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-335; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Srihari S, 2015, FEBS LETT, V589, P2590, DOI 10.1016/j.febslet.2015.04.026; Tang XW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-339; Tingting H, 2014, 2014 IEEE INTERNATIO; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wang JX, 2014, PROTEOMICS, V14, P338, DOI 10.1002/pmic.201300257; Wang JX, 2013, PROTEOMICS, V13, P301, DOI 10.1002/pmic.201200277; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yong CH, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015710018; YU H, 2013, BMC SYST BIOL S5, V7; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P740, DOI 10.1109/TCBB.2011.148; Zhang YJ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1101-y; Zhang YJ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1054-1	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186134	10.1371/journal.pone.0186134	http://dx.doi.org/10.1371/journal.pone.0186134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045465	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100038
J	Garcia-Mariscal, A; Li, H; Pedersen, E; Peyrollier, K; Ryan, KM; Stanley, A; Quondamatteo, F; Brakebusch, C				Garcia-Mariscal, A.; Li, H.; Pedersen, E.; Peyrollier, K.; Ryan, K. M.; Stanley, A.; Quondamatteo, F.; Brakebusch, C.			Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB	ONCOGENE			English	Article							T-CELL LYMPHOMA; MEMBRANE PROTRUSIONS; CANCER GENOMICS; DISTINCT ROLES; STEM-CELLS; IN-VIVO; GTPASE; MUTATIONS; MIGRATION; ADHESION	Cellular movement is controlled by small GTPases, such as RhoA. Although migration is crucial for cancer cell invasion, the specific role of RhoA in tumor formation is unclear. Inducing skin tumors in mice with a keratinocyte-restricted loss of RhoA, we observed increased tumor frequency, growth and invasion. In vitro invasion assays revealed that in the absence of RhoA cell invasiveness is increased in a Rho-associated protein kinase (ROCK) activation and cell contraction-dependent manner. Surprisingly, loss of RhoA causes increased Rho signaling via overcompensation by RhoB because of reduced lysosomal degradation of RhoB in Gamma-aminobutyric acid receptor-associated protein (GABARAP)+autophagosomes and endosomes. In the absence of RhoA, RhoB relocalized to the plasma membrane and functionally replaced RhoA with respect to invasion, clonogenic growth and survival. Our data demonstrate for the first time that RhoA is a tumor suppressor in 7,12-dimethylbenz[a] anthracene/12-O-tetradecanoylphorbol 13-acetate skin carcinogenesis and identify Rho signaling dependent on RhoA and RhoB as a potent driver of tumor progression.	[Garcia-Mariscal, A.; Li, H.; Pedersen, E.; Peyrollier, K.; Brakebusch, C.] Univ Copenhagen, BRIC, Ole Maaloes Vej 5, Copenhagen, Denmark; [Ryan, K. M.] Beatson Inst, Glasgow, Lanark, Scotland; [Stanley, A.; Quondamatteo, F.] NUI, Skin & Extracellular Matrix Res Grp, Anat, Galway, Ireland	University of Copenhagen; Beatson Institute; Ollscoil na Gaillimhe-University of Galway	Brakebusch, C (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, Copenhagen, Denmark.	cord.brakebusch@bric.ku.dk		Stanley, Alanna/0000-0002-0901-8798; Brakebusch, Cord/0000-0002-9342-1634	Cancer Research UK [15816, 22903] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Alfano D, 2012, J CELL SCI, V125, P2369, DOI 10.1242/jcs.091579; Arshad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115447; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman S, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt449; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Filler Renata B, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4837; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Howe GA, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-1; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Jennings RT, 2014, BLOOD, V123, P3635, DOI 10.1182/blood-2014-02-557843; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee Stacey, 2016, F1000Res, V5, DOI 10.12688/f1000research.8800.1; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Meyer N, 2014, J INVEST DERMATOL, V134, P203, DOI 10.1038/jid.2013.278; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Nagata Y, 2016, BLOOD, V127, P596, DOI 10.1182/blood-2015-06-644948; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pedersen E, 2012, EXP CELL RES, V318, P1779, DOI 10.1016/j.yexcr.2012.05.004; Pedersen E, 2012, METHODS MOL BIOL, V827, P157, DOI 10.1007/978-1-61779-442-1_11; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Ridley A, 2013, NAT CELL BIOL, V15, P337, DOI 10.1038/ncb2716; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rodrigues P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6458; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Valero RA, 2010, TRAFFIC, V11, P1221, DOI 10.1111/j.1600-0854.2010.01091.x; Vallois D, 2016, BLOOD, V128, P1490, DOI 10.1182/blood-2016-02-698977; Vega Francisco M, 2018, Small GTPases, V9, P384, DOI 10.1080/21541248.2016.1253528; Vega FM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120076; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916	49	24	24	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					847	860		10.1038/onc.2017.333	http://dx.doi.org/10.1038/onc.2017.333			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059167				2022-12-26	WOS:000425281800003
J	Xue, J; Zhu, W; Song, J; Jiao, Y; Luo, J; Yu, C; Zhou, J; Wu, J; Chen, M; Ding, WQ; Cao, J; Zhang, S				Xue, J.; Zhu, W.; Song, J.; Jiao, Y.; Luo, J.; Yu, C.; Zhou, J.; Wu, J.; Chen, M.; Ding, W-Q; Cao, J.; Zhang, S.			Activation of PPAR alpha by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/beta-catenin pathway	ONCOGENE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; DOWN-REGULATION; WNT PATHWAY; EXPRESSION; FENOFIBRATE; CARCINOMA; GROWTH; RADIOSENSITIVITY; ADENOCARCINOMA; PROLIFERATION	Radiotherapy is emerging as an important modality for the local control of pancreatic cancer, but pancreatic cancer cell radioresistance remains a serious concern. Peroxisome proliferator-activated receptor a (PPAR alpha) is a member of the PPAR nuclear hormone receptor superfamily, which can be activated by fibrate ligands. The clinical relevance of PPAR alpha and its biological function in pancreatic cancer radiosensitivity have not been previously described. In this study, we examined PPAR alpha expression in tissue samples of pancreatic cancer patients. We found significantly higher expression of PPAR alpha in pancreatic cancer tissues than in tumor-adjacent tissues and that the PPAR alpha expression level is inversely associated with higher overall patient survival rate. We further observed that PPAR alpha activation by its agonist clofibrate sensitizes pancreatic cancer cells to radiation by modulating cell cycle progression and apoptosis in several pancreatic cancer cell lines. Small interfering RNA-mediated PPAR alpha silencing and PPAR alpha blockade by the antagonist GW6471 abolish the effect of clofibrate on radiosensitization. An in vivo study showed that PANC1 xenografts treated with clofibrate are more sensitive to radiation than untreated xenografts. mRNA profiling by microarray analysis revealed that the expression of PTPRZ1 and Wnt8a, two core components of the beta-catenin pathway, is downregulated by clofibrate. Chromatin immunoprecipitation analysis confirmed that clofibrate abrogates the binding of nuclear factor-kappa B to the PTPRZ1 and Wnt8a promoters, ultimately decreasing Wnt/beta-catenin signaling activity, which is associated with radiosensitivity. Overall, we demonstrate that PPARa is overexpressed in pancreatic cancer tissues and clofibrate-mediated PPARa activation sensitizes pancreatic cancer cells to radiation through the Wnt/beta-catenin pathway.	[Xue, J.; Zhu, W.; Song, J.; Jiao, Y.; Yu, C.; Cao, J.; Zhang, S.] Soochow Univ, Med Coll, Sch Radiat Med & Protect, 199 Renai Rd, Suzhou 215123, Peoples R China; [Xue, J.; Zhu, W.; Song, J.; Jiao, Y.; Yu, C.; Cao, J.; Zhang, S.] Soochow Univ, Jiangsu Higher Educ Inst, Collaborat Innovat Ctr Radiat Med, Suzhou, Peoples R China; [Xue, J.; Zhu, W.; Song, J.; Jiao, Y.; Yu, C.; Cao, J.; Zhang, S.] Soochow Univ, Jiangsu Prov Key Lab Radiat Med & Protect, Suzhou, Peoples R China; [Luo, J.] Nanjing Med Univ, Affiliated Hosp, Dept Oncol, Changzhou Peoples Hosp 2, Changzhou, Peoples R China; [Zhou, J.; Wu, J.] Nanjing Med Univ, Affiliated Suzhou Hosp, Core Lab, Suzhou Canc Ctr, Suzhou, Peoples R China; [Chen, M.; Zhang, S.] Zhejiang Canc Hosp, Zhejiang Key Lab Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [Ding, W-Q] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA	Soochow University - China; Soochow University - China; Soochow University - China; Nanjing Medical University; Nanjing Medical University; Zhejiang Cancer Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center	Cao, J; Zhang, S (corresponding author), Soochow Univ, Med Coll, Sch Radiat Med & Protect, 199 Renai Rd, Suzhou 215123, Peoples R China.	jpcao@suda.edu.cn; zhang.shuyu@hotmail.com	Chen, Ming/GYE-1379-2022	Chen, Ming/0000-0001-5041-9342	National Natural Science Foundation of China [81522039, 81573080, 81673100, 31670857]; Key Scientific Development Program of China [2016YFC0904700, 2016YFC0904702]; Suzhou Key Medical Center [SZZX201506]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific Development Program of China; Suzhou Key Medical Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (81522039, 81573080, 81673100 and 31670857), the Key Scientific Development Program of China (2016YFC0904700 and 2016YFC0904702), the Suzhou Key Medical Center (SZZX201506) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Afifi MM, 2014, BIOCONJUGATE CHEM, V25, P207, DOI 10.1021/bc400271x; [Anonymous], 2010, J MOL BIOL, V404, P172; [Anonymous], 2010, J MOL BIOL, V388, P225; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chandran K, 2016, ONCOTARGET, V7, P15577, DOI 10.18632/oncotarget.6402; Changela K, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/4189358; Chen H, 2014, WORLD J GASTROENTERO, V20, P8681, DOI 10.3748/wjg.v20.i26.8681; Chen J, 2014, J NEUROSCI RES, V92, P1252, DOI 10.1002/jnr.23415; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng R, 2016, DIABETES, V65, P3730, DOI 10.2337/db16-0426; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Cunningham TJ, 2015, DEV DYNAM, V244, P797, DOI 10.1002/dvdy.24275; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Gao JM, 2015, EUR J PHARMACOL, V765, P560, DOI 10.1016/j.ejphar.2015.09.027; Ge YY, 2014, TUMOR BIOL, V35, P10765, DOI 10.1007/s13277-014-2149-9; Goodman KA, 2016, CANCER J, V22, P290, DOI 10.1097/PPO.0000000000000206; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hajj C, 2015, REP PRACT ONCOL RADI, V20, P377, DOI 10.1016/j.rpor.2015.05.008; Han DF, 2015, ONCOTARGET, V6, P26119, DOI 10.18632/oncotarget.4444; Hoffe S, 2014, SEMIN RADIAT ONCOL, V24, P113, DOI 10.1016/j.semradonc.2013.11.002; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kostapanos MS, 2013, WORLD J HEPATOL, V5, P470, DOI 10.4254/wjh.v5.i9.470; Li XQ, 2015, TUMORI, V101, P123, DOI 10.5301/tj.5000228; Lin H, 2010, AM J PATHOL, V177, P1697, DOI 10.2353/ajpath.2010.090789; Liu YT, 2007, AM J PATHOL, V171, P1978, DOI 10.2353/ajpath.2007.070741; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Luo JD, 2013, CANCER SCI, V104, P1544, DOI 10.1111/cas.12248; Maggiora M, 2010, CELL BIOCHEM FUNCT, V28, P571, DOI 10.1002/cbf.1691; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Midha S, 2016, CANCER LETT, V381, P269, DOI 10.1016/j.canlet.2016.07.022; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Misra P, 2014, BIOCHIMIE, V98, P63, DOI 10.1016/j.biochi.2013.11.011; Pisters PWT, 2002, J CLIN ONCOL, V20, P2537, DOI 10.1200/JCO.2002.11.064; Polireddy K, 2016, J CANCER, V7, P1497, DOI 10.7150/jca.14922; Saitoh T, 2002, INT J ONCOL, V20, P999; Segawa Y, 2002, PROSTATE, V51, P108, DOI 10.1002/pros.10058; Shang DH, 2013, WORLD J UROL, V31, P1547, DOI 10.1007/s00345-013-1077-4; Skrypnyk N, 2014, CANCER RES, V74, P621, DOI 10.1158/0008-5472.CAN-13-1928; Tang YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09476; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; WYSOWSKI DK, 1990, JAMA-J AM MED ASSOC, V263, P2185, DOI 10.1001/jama.263.16.2185; Yamazaki K, 2007, GUT, V56, P1557, DOI 10.1136/gut.2007.129858; Yang W, 2016, ONCOTARGET, V7, P41505, DOI 10.18632/oncotarget.9214; Yin WH, 2013, ACTA CARDIOL SIN, V29, P251; Yokoyama Y, 2007, MOL CANCER THER, V6, P1379, DOI 10.1158/1535-7163.MCT-06-0722; Zhang QH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152407; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105; Zhao WL, 2007, RADIAT RES, V167, P581, DOI 10.1667/RR0814.1; Zhou JD, 2012, J BIOL CHEM, V287, P35161, DOI 10.1074/jbc.M112.367367	51	32	35	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					953	962		10.1038/onc.2017.401	http://dx.doi.org/10.1038/onc.2017.401			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059162				2022-12-26	WOS:000425281800012
J	Barba-Vidal, E; Roll, VFB; Manzanilla, EG; Torrente, C; Munoz, JAM; Perez, JF; Martin-Orue, SM				Barba-Vidal, Emili; Buttow Roll, Victor Fernando; Manzanilla, Edgar Garcia; Torrente, Carlos; Moreno Munoz, Jose Antonio; Francisco Perez, Jose; Maria Martin-Orue, Susana			Blood parameters as biomarkers in a Salmonella spp. disease model of weaning piglets	PLOS ONE			English	Article							ACID-BASE-DISORDERS; WEANED PIGLETS; ZINC-OXIDE; GROWTH; PATHOGENESIS; PERFORMANCE; HEMOGLOBIN; HEMATOCRIT; METABOLISM; DIAGNOSIS	Background The weaning pig is used as an experimental model to assess the impact of diet on intestinal health. Blood parameters (BP) are considered a useful tool in humans, but there is very scarce information of such indicators in the weaning pig. The objective of the present study is to evaluate the use of different BP as indicators in an experimental model of salmonellosis. Methodology Seventy-two 28-day-old piglets were divided into four groups in a 2x2 factorial arrangement, with animals receiving or not a probiotic combination based on B. infantis IM1 (R) and B. lactis BPL6 (10(9) colony forming units (cfu)/d) and orally challenged or not a week later with Salmonella Typhimurium (5x10(8) cfu). Blood samples of one animal per pen (N = 24) were taken four days post-inoculation for the evaluation of different BP using an I-stat (R) System and of plasmatic concentrations of zinc, iron and copper. Principal findings Results reported marginal deficiencies of zinc in piglets at weaning. Moreover, plasmatic zinc, copper and iron presented good correlations with weight gain (r 0.57, r -0.67, r 0.54 respectively; P < 0.01). Blood electrolytes (Na+, Cl- and K+) decreased (P < 0.01) only when the performance of the animals was seriously compromised and clinical symptoms were more apparent. Acid-base balance parameters such as HCO3-, TCO2 and BEecf significantly correlated with weight gain, but only in the challenged animals (r -0.54, r -0.55, and r -0.51, respectively; P < 0.05), suggesting metabolic acidosis depending on Salmonella infection. Glucose was affected by the challenge (P = 0.040), while Htc and Hgb increased with the challenge and decreased with the probiotic (P < 0.05). Furthermore, correlations of Glu, Htc and Hgb with weight gain were observed (P < 0.05). Overall, BP could be regarded as simple, useful indexes to assess performance and health of weaning piglets.	[Barba-Vidal, Emili; Francisco Perez, Jose; Maria Martin-Orue, Susana] Univ Autonoma Barcelona, Dept Ciencia Anim & Dels Aliments, Anim Nutr & Welf Serv, Bellaterra, Spain; [Buttow Roll, Victor Fernando] Univ Fed Pelotas, Fac Agron Eliseu Maciel, Dept Anim Sci, Pelotas, RS, Brazil; [Manzanilla, Edgar Garcia] TEAGASC, Irish Food & Agr Author, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland; [Torrente, Carlos] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Emergency & Crit Care Serv FHCV UAB, Bellaterra, Spain; [Moreno Munoz, Jose Antonio] Labs Ordesa SL, Barcelona, Spain	Autonomous University of Barcelona; Universidade Federal de Pelotas; Teagasc; Autonomous University of Barcelona	Barba-Vidal, E (corresponding author), Univ Autonoma Barcelona, Dept Ciencia Anim & Dels Aliments, Anim Nutr & Welf Serv, Bellaterra, Spain.	emili.barba.vidal@gmail.com	Martín-Orúe, Susana María/AAB-9235-2019; Perez, Jose F/G-4373-2014; Moreno-Munoz, J.A./AAG-2230-2020; Manzanilla, Edgar Garcia/B-2974-2012	Martín-Orúe, Susana María/0000-0001-5266-0906; Perez, Jose F/0000-0001-8853-8945; Moreno-Munoz, J.A./0000-0003-2172-7412; Manzanilla, Edgar Garcia/0000-0002-2301-2560; Roll, Victor/0000-0002-4928-0299; Torrente Artero, Carlos/0000-0001-8052-1655	Spanish Ministry of Education and Science [AGL 2012-31924]; Laboratorios Ordesa S.L.	Spanish Ministry of Education and Science(Spanish Government); Laboratorios Ordesa S.L.	This work was funded by a public research project of the Spanish Ministry of Education and Science (Project AGL 2012-31924) and also by Laboratorios Ordesa S.L. The funder Laboratorios Ordesa S.L. provided support in the form of commercial products and resources, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Victor F.B. Roll was a grant holder from CNPQ Brazil.	Ahmad T, 2006, BRIT POULTRY SCI, V47, P249, DOI 10.1080/00071660600753342; Ahmad T, 2006, WORLD POULTRY SCI J, V62, P638, DOI 10.1017/S0043933906001188; Balaji R, 2000, J ANIM SCI, V78, P1885; Ball J A.S., 2001, Eur J Intern Med, V12, P334, DOI 10.1016/S0953-6205(01)00126-1; BALSBAUGH RK, 1986, J ANIM SCI, V62, P307, DOI 10.2527/jas1986.622307x; BARBAVIDAL E, 2017, FRONT MICR FRONT, V8; Barbosa M, 2010, REV BRAS TER INTENSI, P18; Bernardeau M, 2006, FEMS MICROBIOL REV, V30, P487, DOI 10.1111/j.1574-6976.2006.00020.x; Bhattarai S, 2015, J SWINE HEAL PROD; BREMNER I, 1995, P NUTR SOC, V54, P489, DOI 10.1079/PNS19950017; Burdick Sanchez Nicole C, 2017, Transl Anim Sci, V1, P69, DOI 10.2527/tas2016.0008; Buzzard BL, 2013, J SWINE HEALTH PROD, V21, P148; Carlson D, 2007, J ANIM PHYSIOL AN N, V91, P19, DOI 10.1111/j.1439-0396.2006.00637.x; Case CL, 2002, J ANIM SCI, V80, P1917; CERSOSIMO E, 1987, AM J PHYSIOL, V252, pE313, DOI 10.1152/ajpendo.1987.252.3.E313; Chai WD, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-75; Cherayil BJ, 2011, IMMUNOL RES, V50, P1, DOI 10.1007/s12026-010-8199-1; Constable Peter D., 2000, Veterinary Clinical Pathology, V29, P115, DOI 10.1111/j.1939-165X.2000.tb00241.x; Correa-Matos NJ, 2003, J NUTR, V133, P1845, DOI 10.1093/jn/133.6.1845; Davin R, 2013, J ANIM PHYSIOL AN N, V97, P6, DOI 10.1111/jpn.12046; DiBartola S.P., 2011, FLUID ELECTROLYTE AC; DORUP I, 1991, BRIT J NUTR, V66, P493, DOI 10.1079/BJN19910050; Fencl V, 2000, AM J RESP CRIT CARE, V162, P2246, DOI 10.1164/ajrccm.162.6.9904099; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; GIUGLIANO R, 1984, BRIT J NUTR, V52, P545, DOI 10.1079/BJN19840122; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; Hill GM, 2001, J ANIM SCI, V79, P934; Hopfer SM, 2004, ANN CLIN LAB SCI, V34, P75; Hopper K, 2014, J VET EMERG CRIT CAR, V24, P493, DOI 10.1111/vec.12215; Hopper K, 2014, J VET EMERG CRIT CAR, V24, P502, DOI 10.1111/vec.12214; Ishii K, 2001, J BIOCHEM, V129, P253, DOI 10.1093/oxfordjournals.jbchem.a002852; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1; Kim Ho-Jung, 1994, Journal of Korean Medical Science, V9, P388; King JC, 2011, AM J CLIN NUTR, V94, p679S, DOI 10.3945/ajcn.110.005744; KING JC, 1990, J NUTR, V120, P1474, DOI 10.1093/jn/120.suppl_11.1474; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Kutter APN, 2012, LAB ANIM-UK, V46, P65, DOI 10.1258/la.2011.011086; Lalles JP, 2007, LIVEST SCI, V108, P82, DOI 10.1016/j.livsci.2007.01.091; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Munoz JAM, 2011, APPL ENVIRON MICROB, V77, P8775, DOI 10.1128/AEM.05548-11; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; NCCLS, 2001, C46A NCCLS; Ninh NX, 1996, AM J CLIN NUTR, V63, P514, DOI 10.1093/ajcn/63.4.514; Pluske JR, 2002, NUTR RES REV, V15, P333, DOI 10.1079/NRR200242; Puls R., 1994, Mineral levels in animal health: diagnostic data.; SAKAGUCHI O, 1979, MICROBIOL IMMUNOL, V23, P605, DOI 10.1111/j.1348-0421.1979.tb00501.x; Schott U, 2014, SHOCK, V41, P26, DOI 10.1097/SHK.0000000000000108; Starzynski RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064022; Thorn C., 2000, SCHALMS VET HEMATOL; Torrente C, 2014, J VET EMERG CRIT CAR, V24, P509, DOI 10.1111/vec.12218; VANBEERSSCHREURS HMG, 1992, VET QUART, V14, P29, DOI 10.1080/01652176.1992.9694322; Ventrella D, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0946-2; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025; WEISSMAN C, 1990, ANESTHESIOLOGY, V73, P308, DOI 10.1097/00000542-199008000-00020; WILCOCK BP, 1977, VET PATHOL, V14, P43, DOI 10.1177/030098587701400106	56	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186781	10.1371/journal.pone.0186781	http://dx.doi.org/10.1371/journal.pone.0186781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073182	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400054
J	Berezowska-Cnota, T; Luque-Marquez, I; Elguero-Claramunt, I; Bojarska, K; Okarma, H; Selva, N				Berezowska-Cnota, Teresa; Luque-Marquez, Ignacio; Elguero-Claramunt, Isabel; Bojarska, Katarzyna; Okarma, Henryk; Selva, Nuria			Effectiveness of different types of hair traps for brown bear research and monitoring	PLOS ONE			English	Article							GRIZZLY BEARS; URSUS-ARCTOS; POPULATION-SIZE; PASVIK VALLEY; DNA; SNARES; BLACK; FRAGMENTATION; CONSERVATION; SELECTIVITY	Non-invasive sampling by hair-trapping is increasingly used worldwide in wildlife research. Despite this rise and the potential of hair samples for ecology and conservation studies, the relative performance of hair collection devices has been rarely tested. Here, we compare the effectiveness of five types of hair traps for brown bears Ursus arctos in the Carpathian Mountains (SE Poland) and test the effects of trap type, season, number of days elapsed since trap installation and trap features on the trapping success in order to provide recommendations for optimal sampling in future studies. The trap types were corral, path-trap, "smola" (beechwood tar) tree-trap, turpentine tree-trap and natural rub. In 2010, we collected 858 hair samples during 2330 inspections of 175 hair traps and found that the most effective traps were smola tree-traps (mean percentage of successful inspections +/- SD: 30.2% +/- 26.0) and natural rubs (50.8% +/- 16.7). Based on this finding, over the following 2 years we focused on 24 smola tree-traps and eight natural rubs. During this long-term survey (2010-2012, 969 inspections, 1322 samples collected) the trapping success increased with time and smola tree-traps achieved similar effectiveness to natural rubs (45.5% +/- 29.7 and 45.9 +/- 23.4, respectively). We show that when baiting smola tree-traps ten weeks prior to research or monitoring, sampling effectiveness can reach up to 30%. Taking into account the logistical and methodological constraints associated with detecting and using natural rubs for a proper survey design, we recommend using smola tree-traps baited in advance for hair sampling in wildlife studies.	[Berezowska-Cnota, Teresa; Luque-Marquez, Ignacio; Elguero-Claramunt, Isabel; Bojarska, Katarzyna; Selva, Nuria] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Okarma, Henryk] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Polish Academy of Sciences; Jagiellonian University	Berezowska-Cnota, T; Selva, N (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	berezowska@iop.krakow.pl; nuriselva@gmail.com	Selva, Nuria/J-6970-2013; Okarma, Henryk/W-2050-2019	Selva, Nuria/0000-0003-3389-201X; Bojarska, Katarzyna/0000-0001-7141-3118; Berezowska-Cnota, Teresa/0000-0002-2566-6672; Okarma, Henryk/0000-0002-8912-3546	Polish Ministry of Science and Higher Education [NN304294037]; National Science Center in Poland [2013/08/M/NZ9/00469]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Center in Poland(National Science Centre, Poland)	This study was funded by the Polish Ministry of Science and Higher Education (project NN304294037) and the National Science Center in Poland (project 2013/08/M/NZ9/00469), URL http://ncn.gov.pl/?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh M, 2015, VET ARHIV, V85, P201; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Bautista C, 2017, J APPL ECOL, V54, P282, DOI 10.1111/1365-2664.12708; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Clapham M, 2013, ANIM BEHAV, V85, P1351, DOI 10.1016/j.anbehav.2013.03.026; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; De Barba M, 2010, J APPL ECOL, V47, P172, DOI 10.1111/j.1365-2664.2009.01752.x; Dumond M, 2015, WILDLIFE SOC B, V9999, P1; Frosch C, 2014, MAMM BIOL, V79, P268, DOI 10.1016/j.mambio.2014.04.001; Frosch C, 2011, FORENSIC SCI INT-GEN, V5, P342, DOI 10.1016/j.fsigen.2011.01.009; Garcia-Alaniz N, 2010, TROP CONSERV SCI, V3, P403, DOI 10.1177/194008291000300405; Gervasi V, 2008, URSUS, V19, P105, DOI 10.2192/07GR022.1; Gosling L.M., 1990, Chemoecology, V1, P92, DOI 10.1007/BF01241649; Green GI, 2003, WILDLIFE BIOL, V9, P1; Haroldson MA, 2005, URSUS, V16, P167, DOI 10.2192/1537-6176(2005)016[0167:CNOSCT]2.0.CO;2; Jones ES, 2006, WILDLIFE SOC B, V34, P1320, DOI 10.2193/0091-7648(2006)34[1320:TVISCA]2.0.CO;2; Karamanlidis AA, 2010, EUR J WILDLIFE RES, V56, P693, DOI 10.1007/s10344-010-0363-3; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kendall KC, 2008, NONINVASIVE SURVEY M, P135; Kondracki J., 2002, GEOGRAFIA REGIONALNA; Kopatz A, 2013, ANN ZOOL FENN, V50, P327, DOI 10.5735/086.050.0605; Lamb CT, 2016, URSUS, V27, P31, DOI 10.2192/URSUS-D-15-00025.1; Latham E, 2012, URSUS, V23, P145, DOI 10.2192/URSUS-D-11-00022R2.1; McDaniel GW, 2000, WILDLIFE SOC B, V28, P119; Monterroso P, 2014, EUR J WILDLIFE RES, V60, P279, DOI 10.1007/s10344-013-0780-1; Monterroso P, 2011, WILDLIFE RES, V38, P446, DOI 10.1071/WR11060; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Mumma MA, 2015, MOL ECOL RESOUR, V15, P1133, DOI 10.1111/1755-0998.12390; Persson IL, 2001, WILDLIFE BIOL, V7, P27, DOI 10.2981/wlb.2001.006; Piggott MP, 2003, WILDLIFE RES, V30, P1, DOI 10.1071/WR02077; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Proctor MF, 2002, URSUS, V13, P153; Puchkovskiy SV, 2009, CONTEMP PROBL ECOL+, V2, P260, DOI 10.1134/S1995425509030163; R Development Core Team, 2014, R LANG ENV STAT COMP; Ravaszova P, 2012, PARASITOL RES, V110, P469, DOI 10.1007/s00436-011-2523-0; Romain-Bondi KA, 2004, BIOL CONSERV, V117, P417, DOI 10.1016/j.biocon.2003.07.005; Sato Y, 2014, ACTA THERIOL, V59, P129, DOI 10.1007/s13364-013-0143-z; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Selva N, 2011, MANAGEMENT PLAN BROW; Selva N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090740; Stetz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055967; Stetz JB, 2015, J FISH WILDL MANAG, V6, P191, DOI 10.3996/122013-JFWM-085; Stetz JB, 2010, J WILDLIFE MANAGE, V74, P860, DOI 10.2193/2008-435; UNEP, 2007, CARP ENV OUTL; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Weaver JL, 2005, WILDLIFE SOC B, V33, P1384, DOI 10.2193/0091-7648(2005)33[1384:UOSHST]2.0.CO;2; Winnicki T., 2009, NATURE BIESZCZADY NA; Woods JG, 1999, WILDLIFE SOC B, V27, P616	54	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186605	10.1371/journal.pone.0186605	http://dx.doi.org/10.1371/journal.pone.0186605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073161	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400033
J	Hortobagyi, T; Mieras, A; Rothwell, J; del Olmo, MF				Hortobagyi, Tibor; Mieras, Adinda; Rothwell, John; Fernandez del Olmo, Miguel			Dissociation between behavior and motor cortical excitability before and during ballistic wrist flexion and extension in young and old adults	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SIMPLE REACTION-TIME; CORTICOSPINAL EXCITABILITY; INHIBITORY CONTROL; MOVEMENT; HUMANS; METAANALYSIS; PERFORMANCE; MECHANISMS; CORTEX	Purpose Aging is associated with slow reactive movement generation and poor termination. Objective We examined the hypothesis that the build-up of excitability in the primary motor cortex in the agonist muscle to generate ballistic wrist flexion and extension and in the antagonist to stop the movement, is lower and slower in old compared with young adults. Methods We measured the size of the motor potentials evoked (MEP) produced by transcranial magnetic stimulation (TMS), background integrated EMG (iEMG), and the MEP: iEMG ratio in healthy young (23 y, n = 14) and old adults' (73 y, n = 14) wrist flexors and extensors as they rapidly flexed or extended the wrist in response to an auditory cue. TMS was delivered at 80% of resting motor threshold randomly in 20 ms increments between 130 and 430 ms after the tone. Results Even though old compared to young adults executed the two wrist movements with similar to 23% longer movement duration and similar to 15% longer reaction time (both p < 0.05), the rise in MEP: iEMG ratio before the main similar in the two age groups. Conclusion These data suggest that an adjustment of current models might be needed to better understand how and if age affects the build-up excitability accompanying movement generation and termination.	[Hortobagyi, Tibor; Mieras, Adinda] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Rothwell, John] UCL, Inst Neurol, London, England; [Fernandez del Olmo, Miguel] Univ A Coruna, Learning & Human Movement Control Grp, La Coruna, Spain	University of Groningen; University of London; University College London; Universidade da Coruna	Hortobagyi, T (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	t.hortobagyi@umcg.nl		Fernandez del Olmo, Miguel/0000-0001-5325-503X	University Medical Center Groningen [653013]	University Medical Center Groningen	Supported in part by start-up funds from the University Medical Center Groningen, grant number 653013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; Berghuis KMM, 2017, NEUROBIOL AGING, V55, P61, DOI 10.1016/j.neurobiolaging.2017.03.024; Bhandari A, 2016, CLIN NEUROPHYSIOL, V127, P2834, DOI 10.1016/j.clinph.2016.05.363; Brown RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006683; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Coxon JP, 2016, CEREB CORTEX, V26, P12, DOI 10.1093/cercor/bhu165; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Cuypers K, 2013, AGE, V35, P1705, DOI 10.1007/s11357-012-9471-1; Davey N J, 1998, Motor Control, V2, P241; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029; Duque J, 2017, TRENDS NEUROSCI, V40, P219, DOI 10.1016/j.tins.2017.02.006; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; Falkenstein M, 2006, INT J PSYCHOPHYSIOL, V59, P22, DOI 10.1016/j.ijpsycho.2005.08.004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraser SA, 2009, EXP BRAIN RES, V195, P419, DOI 10.1007/s00221-009-1806-5; Greve C, 2017, EUR J APPL PHYSIOL, V117, P955, DOI 10.1007/s00421-017-3584-2; Haith AM, 2016, J NEUROSCI, V36, P3007, DOI 10.1523/JNEUROSCI.3245-15.2016; Hasbroucq T, 1999, ACTA PSYCHOL, V101, P243, DOI 10.1016/S0001-6918(99)00007-4; Hortobagyi T, 2006, J BIOMECHANICS; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Kosse NM, 2016, GAIT POSTURE, V46, P112, DOI 10.1016/j.gaitpost.2016.02.022; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; LEMON RN, 1995, J NEUROSCI, V15, P6145; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Levin MF, 1997, BRAIN RES, V757, P43, DOI 10.1016/S0006-8993(97)00204-7; Levin O, 2011, NEUROSCI LETT, V487, P53, DOI 10.1016/j.neulet.2010.09.072; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; Mary A, 2015, NEUROIMAGE, V104, P59, DOI 10.1016/j.neuroimage.2014.10.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1992, BRAIN, V115, P109, DOI 10.1093/brain/115.1.109; PASCUALLEONE A, 1994, NEUROLOGY, V44, P884, DOI 10.1212/WNL.44.5.884; Rogasch NC, 1985, J APPL PHYSIOL, V2009, P1874; ROSSINI PM, 1988, BRAIN RES, V458, P20, DOI 10.1016/0006-8993(88)90491-X; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; STARR A, 1988, ELECTROEN CLIN NEURO, V70, P26, DOI 10.1016/0013-4694(88)90191-5; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186585	10.1371/journal.pone.0186585	http://dx.doi.org/10.1371/journal.pone.0186585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073175	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400032
J	Ramirez-Briones, E; Rodriguez-Macias, R; Salcedo-Perez, E; Martinez-Gallardo, N; Tiessen, A; Molina-Torres, J; Delano-Frier, JP; Zanudo-Hernandez, J				Ramirez-Briones, Ernesto; Rodriguez-Macias, Ramon; Salcedo-Perez, Eduardo; Martinez-Gallardo, Norma; Tiessen, Axel; Molina-Torres, Jorge; Delano-Frier, John P.; Zanudo-Hernandez, Julia			Seasonal variation in non-structural carbohydrates, sucrolytic activity and secondary metabolites in deciduous and perennial Diospyros species sampled in Western Mexico	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; TEMPERATE FOREST; STARCH SYNTHESIS; LEAF-AREA; PHOTOSYNTHESIS; LEAVES; TREES; L.; STORAGE; PLANTS	This study was performed to test the working hypothesis that the primary determinants influencing seasonal driven modifications in carbon mobilization and other key biochemical parameters in leaves of poorly known Diospyros digyna (Ddg; semi-domesticated; perennial) and D. rekoi (Dre; undomesticated; deciduous) trees are determined by environmental growing conditions, agronomic management and physiological plasticity. Thus, biochemical changes in leaves of both trees were recorded seasonally during two successive fruiting years. Trees were randomly sampled in Western Mexico habitats with differing soil quality, climatic conditions, luminosity, and cultivation practices. Leaves of Ddg had consistently higher total chlorophyll contents (C-T) that, unexpectedly, peaked in the winter of 2015. In Dre, the highest leaf C-T values recorded in the summer of 2015 inversely correlated with low average luminosity and high Chl a/Chlb ratios. The seasonal C-T variations in Dre were congruent with varying luminosity, whereas those in Ddg were probably affected by other factors, such as fluctuating leaf protein contents and the funneling of light energy to foliar nonstructural carbohydrates (NSCs) accumulation, which were consistently higher than those detected in Dre leaves. Seasonal foliar NSC fluctuations in both species were in agreement with the carbon (C) demands of flowering, fruiting and/or leaf regrowth. Seasonal changes in foliar hexose to sucrose (Hex/Suc) ratios coincided with cell wall invertase activity in both species. In Dre, high Hex/Suc ratios in spring leaves possibly allowed an accumulation of phenolic acids, not observed in Ddg. The above results supported the hypothesis proposed by showing that leaf responses to changing environmental conditions differ in perennial and deciduous Diospyros trees, including a dynamic adjustment of NSCs to supply the C demands imposed by reproduction, leaf regrowth and, possibly, stress.	[Ramirez-Briones, Ernesto; Rodriguez-Macias, Ramon; Zanudo-Hernandez, Julia] Ctr Univ Ciencias Biol & Agr, Camino Ing La Venta Astillero, Zapopan, Jalisco, Mexico; [Salcedo-Perez, Eduardo] Ctr Univ Ciencias Exactas & Ingn, Camino Ing La Venta Astillero, Zapopan, Jalisco, Mexico; [Martinez-Gallardo, Norma; Tiessen, Axel; Molina-Torres, Jorge; Delano-Frier, John P.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Irapuato, Libramiento Norte Carretera Irapuato Leon Kilomet, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Zanudo-Hernandez, J (corresponding author), Ctr Univ Ciencias Biol & Agr, Camino Ing La Venta Astillero, Zapopan, Jalisco, Mexico.; Delano-Frier, JP (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Irapuato, Libramiento Norte Carretera Irapuato Leon Kilomet, Guanajuato, Mexico.	jdelano@ira.cinvestav.mx; zhj27487@cucba.udg.mx	Délano-Frier, John/B-5768-2015; Hernández, Julia Zañudo/ABB-8655-2021; Tiessen, Axel/AAF-2113-2020; Torres, Jorge Molina/B-9325-2019; Rodríguez, Ramón/W-9275-2019; Tiessen, Axel/D-5959-2011	Tiessen, Axel/0000-0001-5572-4274; Tiessen, Axel/0000-0001-5572-4274; Molina Torres, Jorge/0000-0003-2371-0307; Ramirez-Briones, Ernesto/0000-0002-1428-2542	National Council for Science and Technology (Conacyt, Mexico) [212253]	National Council for Science and Technology (Conacyt, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Council for Science and Technology (Conacyt, Mexico) granted a postgraduate scholarship to ERB (code No. 212253). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Acknowledgment is due to The National Council for Science and Technology (Conacyt, Mexico) for the postgraduate scholarship granted to ERB (code No. 212253).	AKAO S, 1981, J JPN SOC HORTIC SCI, V50, P1, DOI 10.2503/jjshs.50.1; [Anonymous], [No title captured]; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bazot S, 2013, TREES-STRUCT FUNCT, V27, P1023, DOI 10.1007/s00468-013-0853-5; BLACK CC, 1987, PHYSIOL PLANTARUM, V69, P387, DOI 10.1111/j.1399-3054.1987.tb04305.x; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUINSMA J, 1961, BIOCHIM BIOPHYS ACTA, V52, P576, DOI 10.1016/0006-3002(61)90418-8; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Cabrera HM, 2002, REV CHIL HIST NAT, V75, P625; Cao KF, 2000, CAN J BOT, V78, P1245, DOI 10.1139/cjb-78-10-1245; Carvalho S, 2014, PHYTOCHEMISTRY, V99, P86, DOI 10.1016/j.phytochem.2013.12.004; Chang XM, 2008, ENVIRON EXP BOT, V63, P216, DOI 10.1016/j.envexpbot.2007.10.017; Chen T, 2012, ACTA PHYSIOL PLANT, V34, P173, DOI 10.1007/s11738-011-0815-8; Da Silva D, 2014, ANN BOT-LONDON, V114, P643, DOI 10.1093/aob/mcu033; Danyagri G, 2014, ENVIRON EXP BOT, V107, P64, DOI 10.1016/j.envexpbot.2014.05.010; DUGGER W. M. JR., 1969, Proceedings 1st int. Citrus Symp., Univ. California, Riverside 1968., V1, P339; Fajardo A, 2013, ANN BOT-LONDON, V112, P623, DOI 10.1093/aob/mct127; Feng YL, 2008, PHYSIOL PLANTARUM, V133, P318, DOI 10.1111/j.1399-3054.2008.01072.x; García Díaz Roger, 2015, Rev. Mex. Cienc. Agríc, V6, P187; GarciaPlazaola JI, 1997, J EXP BOT, V48, P1667, DOI 10.1093/jexbot/48.314.1667; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; Ghasemzadeh A, 2010, INT J MOL SCI, V11, P3885, DOI 10.3390/ijms11103885; Goldschmidt EE, 1977, CITRUS FLOWERING FRU, P63; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gond V, 1999, TREE PHYSIOL, V19, P673; Gough CM, 2010, FORESTS, V1, P65, DOI 10.3390/f1010065; Grant RH, 1997, INT J BIOMETEOROL, V40, P26, DOI 10.1007/s004840050014; Hallik L, 2012, PLANT BIOLOGY, V14, P88, DOI 10.1111/j.1438-8677.2011.00472.x; Hartmann T, 2000, J EXP BOT, V51, P1077, DOI 10.1093/jexbot/51.347.1077; Hauch S, 1998, PLANTA, V207, P266, DOI 10.1007/s004250050482; Hoch G, 2003, PLANT CELL ENVIRON, V26, P1067, DOI 10.1046/j.0016-8025.2003.01032.x; Ibrahim MH, 2012, INT J MOL SCI, V13, P15321, DOI 10.3390/ijms131115321; Jackson J. E., 1980, Horticultural Reviews, V2, P208; Kalberer SR, 2006, PLANT SCI, V171, P3, DOI 10.1016/j.plantsci.2006.02.013; Kerner R, 2014, J PROTEOMICS, V109, P417, DOI 10.1016/j.jprot.2014.05.021; Kitajima K, 2003, PLANT CELL ENVIRON, V26, P857, DOI 10.1046/j.1365-3040.2003.01017.x; Komatsu A, 2002, J EXP BOT, V53, P61, DOI 10.1093/jexbot/53.366.61; Kong DX, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2147-1; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kull O, 1998, FUNCT ECOL, V12, P472, DOI 10.1046/j.1365-2435.1998.00214.x; Li N, 2016, ECOL INDIC, V62, P22, DOI 10.1016/j.ecolind.2015.11.017; LOESCHER WH, 1990, HORTSCIENCE, V25, P274, DOI 10.21273/HORTSCI.25.3.274; Ma ZQ, 2010, HORTSCIENCE, V45, P863, DOI 10.21273/HORTSCI.45.6.863; Marra FP, 2009, TREE PHYSIOL, V29, P1095, DOI 10.1093/treephys/tpp053; Palacio S, 2007, ENVIRON EXP BOT, V59, P34, DOI 10.1016/j.envexpbot.2005.10.003; Percival D, 2012, CAN J PLANT SCI, V92, P1135, DOI [10.4141/CJPS2011-205, 10.4141/cjps2011-205]; Pimienta-Barrios E, 2005, ANN BOT-LONDON, V95, P363, DOI 10.1093/aob/mci034; Proietti P., 1990, Acta Horticulturae, P215; Reig C, 2015, J PLANT PHYSIOL, V177, P51, DOI 10.1016/j.jplph.2014.12.016; Reig C, 2013, J PLANT GROWTH REGUL, V32, P281, DOI 10.1007/s00344-012-9296-2; RYUGO KAY, 1959, PROC AMER SOC HORT SCI, V74, P130; Rzedowski J, 1991, ACTA BOT MEX, V14, P3, DOI [DOI 10.21829/ABM14.1991.611, 10.21829/abm14.1991.611]; SCHOLES JD, 1994, NEW PHYTOL, V126, P213, DOI 10.1111/j.1469-8137.1994.tb03939.x; Schrader S, 2002, J PLANT PHYSIOL, V159, P833, DOI 10.1078/0176-1617-00730; SEMARNAT, 2002, NOM021SEMARNAT200; SHIMIZU T, 1978, J JPN SOC HORTIC SCI, V46, P465, DOI 10.2503/jjshs.46.465; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Teo G, 2006, P NATL ACAD SCI USA, V103, P18842, DOI 10.1073/pnas.0605873103; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Vemmos SN, 2013, SCI HORTIC-AMSTERDAM, V160, P198, DOI 10.1016/j.scienta.2013.05.036; Wallnofer B., 2007, ANN NATHIST MUS B, V108, P207; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Wright DP, 1998, PLANT CELL ENVIRON, V21, P209, DOI 10.1046/j.1365-3040.1998.00280.x; Wyka TP, 2016, TREE PHYSIOL, V36, P536, DOI 10.1093/treephys/tpv108; Xiao XH, 2014, FEBS J, V281, P291, DOI 10.1111/febs.12595; Zhang HY, 2014, TREES-STRUCT FUNCT, V28, P77, DOI 10.1007/s00468-013-0931-8; Zhang S, 2015, J PROTEOMICS, V126, P263, DOI 10.1016/j.jprot.2015.06.019; Zhou R, 2003, J AM SOC HORTIC SCI, V128, P113, DOI 10.21273/JASHS.128.1.0113	70	9	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e018723	10.1371/journal.pone.0187235	http://dx.doi.org/10.1371/journal.pone.0187235			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073239	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400135
J	Reese, DE; Henderson, MC; Silver, M; Mulpuri, R; Letsios, E; Tran, Q; Wolf, JK				Reese, David E.; Henderson, Meredith C.; Silver, Michael; Mulpuri, Rao; Letsios, Elias; Quynh Tran; Wolf, Judith K.			Breast density does not impact the ability of Videssa (R) Breast to detect breast cancer in women under age 50	PLOS ONE			English	Article							SCREENING MAMMOGRAPHY; POSTMENOPAUSAL WOMEN; SUBSEQUENT RISK; LEGISLATION	Breast density is associated with reduced imaging resolution in the detection of breast cancer. A biochemical approach that is not affected by density would provide an important tool to healthcare professionals who are managing women with dense breasts and suspicious imaging findings. Videssa (R) Breast is a combinatorial proteomic biomarker assay (CPBA), comprised of Serum Protein Biomarkers (SPB) and Tumor Associated Autoantibodies (TAAb) integrated with patient-specific clinical data to produce a diagnostic score that reliably detects breast cancer (BC) as an adjunctive tool to imaging. The performance of Videssa (R) Breast was evaluated in the dense (a and b) and non-dense (c and d) groups in a population of n = 545 women under age 50. The sensitivity and specificity in the dense breast group were calculated to be 88.9% and 81.2%, respectively, and 92.3% and 86.6%, respectively, for the non-dense group. No significant differences were observed in the sensitivity (p = 1.0) or specificity (p = 0.18) between these groups. The NPV was 99.3% and 99.1% in non-dense and dense groups, respectively. Unlike imaging, Videssa (R) Breast does not appear to be impacted by breast density; it can effectively detect breast cancer in women with dense and non-dense breasts alike. Thus, Videssa (R) Breast provides a powerful tool for healthcare providers when women with dense breasts present with challenging imaging findings. In addition, Videssa (R) Breast provides assurance to women with dense breasts that they do not have breast cancer, reducing further anxiety in this higher risk patient population.	[Reese, David E.; Henderson, Meredith C.; Silver, Michael; Mulpuri, Rao; Letsios, Elias; Quynh Tran; Wolf, Judith K.] Provista Diagnost, New York, NY 10004 USA		Wolf, JK (corresponding author), Provista Diagnost, New York, NY 10004 USA.	wolfj@provistadx.com			Provista Diagnostics	Provista Diagnostics	Provista Diagnostics provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2017, NOT REQ STAT; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Green VL, 2016, CLIN OBSTET GYNECOL, V59, P419, DOI 10.1097/GRF.0000000000000192; Horne HN, 2016, BREAST CANCER RES, P18; Kressin NR, 2016, JAMA-J AM MED ASSOC, V315, P1786, DOI 10.1001/jama.2016.1712; Lourenco A. P., 2017, CLIN BREAST CANC; Mazor RD, 2016, EUR J RADIOL, V85, P957, DOI 10.1016/j.ejrad.2016.02.023; McCarthy AM, 2016, JNCI-J NATL CANCER I, P108; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Rafferty EA, 2016, JAMA-J AM MED ASSOC, V315, P1784, DOI 10.1001/jama.2016.1708; Sickles E, ACR BIRADS ATLAS BR; Sickles EA, 2013, ACR BI RADS ATLAS BR; Slanetz PJ, 2015, NEW ENGL J MED, V372, P593, DOI 10.1056/NEJMp1413728; Smallenburg VV, 2012, EUR J CANCER, V48, P2097, DOI 10.1016/j.ejca.2012.03.011; Tamimi RM, 2007, JNCI-J NATL CANCER I, V99, P1178, DOI 10.1093/jnci/djm062; White J, 2000, J NATL CANCER I, V92, P443, DOI 10.1093/jnci/92.6.443; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yaghjyan L, 2011, J NATL CANCER I, V103, P1179, DOI 10.1093/jnci/djr225	20	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0186198	10.1371/journal.pone.0186198	http://dx.doi.org/10.1371/journal.pone.0186198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069101	Green Submitted, gold, Green Published			2022-12-26	WOS:000413663600016
J	Gustafsson, P; Crenshaw, AG; Edmundsson, D; Toolanen, G; Crnalic, S				Gustafsson, Patrik; Crenshaw, Albert G.; Edmundsson, David; Toolanen, Goran; Crnalic, Sead			Muscle oxygenation in Type 1 diabetic and non-diabetic patients with and without chronic compartment syndrome	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; VASCULAR-DISEASE; SKELETAL-MUSCLE; LOWER LEG; DIAGNOSIS; EXERCISE; MELLITUS; PAIN	Background Type 1 diabetic patients and non-diabetic patients were referred for evaluation for chronic exertional compartment syndrome (CECS) based on clinical examination and complaints of activity-related leg pain in the region of the tibialis anterior muscle. Previous studies using near-infrared spectroscopy (NIRS) showed greater deoxygenation during exercise for CECS patients versus healthy controls; however, this comparison has not been done for diabetic CECS patients. Methods We used NIRS to test for differences in oxygenation kinetics for Type 1 diabetic patients diagnosed with (CECS-diabetics, n = 9) versus diabetic patients without (CON-diabetics, n = 10) leg anterior chronic exertional compartment syndrome. Comparisons were also made between non-diabetic CECS patients (n = 11) and healthy controls (CON, n = 10). The experimental protocol consisted of thigh arterial cuff occlusion (AO, 1-minute duration), and treadmill running to reproduce symptoms. NIRS variables generated were resting StO(2)%, and oxygen recovery following AO. Also, during and following treadmill running the magnitude of deoxygenation and oxygen recovery, respectively, were determined. Results There was no difference in resting StO2% between CECS-diabetics (78.2 +/- 12.6%) vs. CON-diabetics (69.1 +/- 20.8%), or between CECS (69.3 +/- 16.2) vs. CON (75.9 +/- 11.2%). However, oxygen recovery following AO was significantly slower for CECS (1.8 +/- 0.8%/sec) vs. CON (3.8 +/- 1.7%/sec) (P = 0.002); these data were not different between the diabetic groups. StO2% during exercise was lower (greater deoxygenation) for CECS-diabetics (6.3 +/- 8.6%) vs. CON-diabetics (40.4 +/- 22.0%), and for CECS (11.3 +/- 16.8%) vs. CON (34.1 +/- 21.2%) (P<0.05 for both). The rate of oxygen recovery post exercise was faster for CECS-diabetics (3.5 +/- 2.6%/sec) vs. CON-diabetics (1.4 +/- 0.8%/sec) (P = 0.04), and there was a tendency of difference for CECS (3.1 +/- 1.4%/sec) vs. CON (1.9 +/- 1.3%/sec) (P = 0.05). Conclusion The greater deoxygenation during treadmill running for the CECS-diabetics group (vs. CON-diabetics) is in line with previous studies (and with the present study) that compared non-diabetic CECS patients with healthy controls. Our findings could suggest that NIRS may be useful as a diagnostic tool for assessing Type 1 diabetic patients suspected of CECS.	[Gustafsson, Patrik; Edmundsson, David; Toolanen, Goran; Crnalic, Sead] Umea Univ, Dept Surg & Perioperat Sci Orthopaed, Umea, Sweden; [Crenshaw, Albert G.] Univ Gavle, Fac Hlth & Occupat Studies, Dept Occupat & Publ Hlth Sci, Ctr Musculoskeletal Res, Gavle, Sweden	Umea University; University of Gavle	Gustafsson, P (corresponding author), Umea Univ, Dept Surg & Perioperat Sci Orthopaed, Umea, Sweden.	Patrik.Gustafsson@vil.se	Crnalic, Sead/AAF-3475-2021		County Council of Vasterbotten	County Council of Vasterbotten	The study was supported by grants from the County Council of Vasterbotten. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Carina Pokosta for valuable assistance during data collection, and the patients for their willingness to participate. We also extend thanks to Monica Hell-strom of the Clinical Physiology department for assistance with intramuscular pressure measurements. The study was supported by grants from the County Council of Vasterbotten.	Boezeman RPE, 2016, MICROVASC RES, V104, P11, DOI 10.1016/j.mvr.2015.11.004; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Crenshaw AG, 2012, EUR J APPL PHYSIOL, V112, P2703, DOI 10.1007/s00421-011-2244-1; Crenshaw AG, 2010, J SPORT SCI, V28, P1057, DOI 10.1080/02640414.2010.489195; CUI WJ, 1991, P SOC PHOTO-OPT INS, V1431, P180, DOI 10.1117/12.44189; Edmundsson D, 2011, DIABETIC MED, V28, P81, DOI 10.1111/j.1464-5491.2010.03158.x; Edmundsson D, 2008, ACTA ORTHOP, V79, P534, DOI 10.1080/17453670710015544; Edmundsson D, 2007, ACTA ORTHOP, V78, P136, DOI 10.1080/17453670610013547; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Gregg EW, 2004, DIABETES CARE, V27, P1591, DOI 10.2337/diacare.27.7.1591; Myers DE, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1925250; Otsuki A, 2016, CLIN PHYSIOL FUNCT I, V36, P421, DOI 10.1111/cpf.12232; PEDOWITZ RA, 1990, AM J SPORT MED, V18, P35, DOI 10.1177/036354659001800106; Randall L, 1997, J BONE JOINT SURG AM, V79A, P844, DOI 10.2106/00004623-199706000-00007; Staudt JM, 2008, J BONE JOINT SURG BR, V90B, P215, DOI 10.1302/0301-620X.90B2.19678; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; van den Brand JGH, 2005, AM J SPORT MED, V33, P699, DOI 10.1177/0363546504270565; van den Brand JGH, 2004, AM J SPORT MED, V32, P452, DOI 10.1177/0363546503261733; Zhang Q, 2012, SCAND J MED SCI SPOR, V22, P690, DOI 10.1111/j.1600-0838.2011.01392.x	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186790	10.1371/journal.pone.0186790	http://dx.doi.org/10.1371/journal.pone.0186790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059243	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000042
J	Kazadi, EK; Tshilenge, GM; Mbao, V; Njoumemi, Z; Masumu, J				Kazadi, Eric Kawaya; Tshilenge, Georges Mbuyi; Mbao, Victor; Njoumemi, Zakariaou; Masumu, Justin			Determinants of dog owner-charged rabies vaccination in Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							AFRICA	Rabies is a preventable fatal disease that causes about 61,000 human deaths annually around the world, mostly in developing countries. In Africa, several studies have shown that vaccination of pets is effective in controlling the disease. An annual vaccination coverage of 70% is recommended by the World Health Organization as a control threshold. The effective control of rabies requires vaccination coverage of owned dogs. Identification of the factors determining dog owners' choice to vaccinate is necessary for evidence-based policy-making. However, for the Democratic Republic of Congo (DRC), the limited data on rabies vaccination coverage makes it difficult for its control and formulation of appropriate policies. A cross-sectional study was conducted in Kinshasa (Lemba commune) with dog-owning households and owned dogs as study populations. The association between dog vaccination and independent factors (household socio-demographics characteristics, dog characteristics, knowledge of rabies and location of veterinary offices/clinics) was performed with Epi-info 7. The Odds Ratio (OR) and p-value < 0.05 were used to determine levels of significance. A total of 166 households owning dogs and 218 owned dogs were investigated. 47% of the dogs had been vaccinated within one year preceding the survey which is higher than the critical coverage (25 to 40%) necessary to interrupt rabies transmission but below the 70% threshold recommended by WHO for control. The determinants of vaccination included socio-economic level of the household (OR = 2.9, p < 0.05), formal education level of the dog owner (OR = 4, p < 0.05), type of residence (OR = 4.6, p < 0.05), knowledge of rabies disease (OR = 8.0, p < 0.05), knowledge of location of veterinary offices/clinics (OR = 3.4, p < 0.05), dog gender (OR = 1.6, p < 0.05) and dog breed (OR = 2.1, p < 0.05). This study shows that the vaccination coverage in this area can easily reach the WHO threshold if supplemented by mass vaccination campaigns.	[Kazadi, Eric Kawaya; Tshilenge, Georges Mbuyi] Univ Kinshasa, Vet Fac, Kinshasa, DEM REP CONGO; [Tshilenge, Georges Mbuyi; Masumu, Justin] Vet Lab Kinshasa, Kinshasa, DEM REP CONGO; [Mbao, Victor] Int Dev Res Ctr, Nairobi, Kenya; [Njoumemi, Zakariaou] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Masumu, Justin] Natl Pedag Univ, Vet Fac, Kinshasa, DEM REP CONGO; [Masumu, Justin] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO	Universite de Kinshasa; University of Yaounde I; Institute Nacional de Recherche Biomedical	Kazadi, EK (corresponding author), Univ Kinshasa, Vet Fac, Kinshasa, DEM REP CONGO.	heric.kazadi@unikin.ac.cd	Mbao, Victor/GNP-1821-2022		CDC Foundation; Bill and Melinda Gates Foundation	CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill and Melinda Gates Foundation and the CDC Foundation funded study design, and data collection and analysis.; The authors acknowledge and thank the Bill and Melinda Gates Foundation and the CDC Foundation for funding this study. We express our gratitude to the following people for their cooperation and involvement in the realization of this survey: Dr. Els Mathieu (CDC), Dr. Kebela Ilunga (DLM), study participants and field interviewers from the veterinary faculty of University of Kinshasa.	Abraham Ali, 2010, Ethiopian Veterinary Journal, V14, P91; Ancelle T., 2011, STATISTIQUE EPIDEMIO; [Anonymous], 2014, ENQ DEM SANT REP DEM; Birhane MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004486; Cleaveland S, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.731; Coleman PG, 1996, VACCINE, V14, P185, DOI 10.1016/0264-410X(95)00197-9; Durr S, 2009, EPIDEMIOL INFECT, P1; Frey J, 2013, TROP MED INT HEALTH, V18, P1555, DOI 10.1111/tmi.12202; Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104; Jibat T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003447; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Makumbu D.S, 1977, THESIS ECOLE INTERET; Morters MK, 2013, J ANIM ECOL, V82, P6, DOI 10.1111/j.1365-2656.2012.02033.x; Nottidge HO, 2005, RABIES ANCIENT SCOUR, P39; Office de Vaccination et de Controle Rabique (OVCR), 2003 OVCR; SEGANTI L, 1990, ACTA VIROL, V34, P155; Steele J. H., 1975, The natural history of rabies,, P1; Twabela AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150403; WHO, 2013, WHO TECH REP SER, V982, P1; WHO, 1989, PRINC REG ED COOP PU	20	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186677	10.1371/journal.pone.0186677	http://dx.doi.org/10.1371/journal.pone.0186677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059205	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000033
J	Dzananovic, E; Astha; Chojnowski, G; Deo, S; Booy, EP; Padilla-Meier, P; McEleney, K; Bujnicki, JM; Patel, TR; McKenna, SA				Dzananovic, Edis; Astha; Chojnowski, Grzegorz; Deo, Soumya; Booy, Evan P.; Padilla-Meier, Pauline; McEleney, Kevin; Bujnicki, Janusz M.; Patel, Trushar R.; McKenna, Sean A.			Impact of the structural integrity of the three-way junction of adenovirus VA(I) RNA on PKR inhibition	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SMALL-ANGLE SCATTERING; VAI RNA; CENTRAL DOMAIN; ANTIVIRAL ACTION; BINDING DOMAIN; INTERFERON; SECONDARY; MECHANISM; REVEALS	Highly structured RNA derived from viral genomes is a key cellular indicator of viral infection. In response, cells produce the interferon inducible RNA-dependent protein kinase (PKR) that, when bound to viral dsRNA, phosphorylates eukaryotic initiation factor 2 alpha and attenuates viral protein translation. Adenovirus can evade this line of defence through transcription of a non-coding RNA, VA(I), an inhibitor of PKR. VA(I) consists of three base-paired regions that meet at a three-way junction; an apical stem responsible for the interaction with PKR, a central stem required for inhibition, and a terminal stem. Recent studies have highlighted the potential importance of the tertiary structure of the three-way junction to PKR inhibition by enabling interaction between regions of the central and terminal stems. To further investigate the role of the three-way junction, we characterized the binding affinity and inhibitory potential of central stem mutants designed to introduce subtle alterations. These results were then correlated with small-angle X-ray scattering solution studies and computational tertiary structural models. Our results demonstrate that while mutations to the central stem have no observable effect on binding affinity to PKR, mutations that appear to disrupt the structure of the three-way junction prevent inhibition of PKR. Therefore, we propose that instead of simply sequestering PKR, a specific structural conformation of the PKR-VA(I) complex may be required for inhibition.	[Dzananovic, Edis; Deo, Soumya; Booy, Evan P.; Padilla-Meier, Pauline; McEleney, Kevin; McKenna, Sean A.] Univ Manitoba, Dept Chem, Winnipeg, MB, Canada; [Astha; Chojnowski, Grzegorz; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol Warsaw, Lab Bioinformat & Prot Engn, Ul KS Trojdena 4, Warsaw, Poland; [McEleney, Kevin; McKenna, Sean A.] Univ Manitoba, Manitoba Inst Mat, Winnipeg, MB, Canada; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Lab Bioinformat & Prot Engn, Inst Mol Biol & Biotechnol, Fac Biol, Ul Umultowska 89, Poznan, Poland; [Patel, Trushar R.] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada; [Patel, Trushar R.] Univ Alberta, Fac Med & Dent, DiscoveryLab, Edmonton, AB, Canada; [Patel, Trushar R.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Cumming Sch Med, Univ Dr NW, Calgary, AB, Canada; [McKenna, Sean A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Chojnowski, Grzegorz] DESY, European Mol Biol Lab, Notkestr 85, Hamburg, Germany	University of Manitoba; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Manitoba; Adam Mickiewicz University; University of Lethbridge; University of Alberta; University of Calgary; University of Manitoba; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	McKenna, SA (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB, Canada.; McKenna, SA (corresponding author), Univ Manitoba, Manitoba Inst Mat, Winnipeg, MB, Canada.; Patel, TR (corresponding author), Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada.; Patel, TR (corresponding author), Univ Alberta, Fac Med & Dent, DiscoveryLab, Edmonton, AB, Canada.; Patel, TR (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Cumming Sch Med, Univ Dr NW, Calgary, AB, Canada.; McKenna, SA (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	Trushar.Patel@uleth.ca; sean.mckenna@umanitoba.ca	Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011; Joshi, Astha/U-9014-2019	Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; Joshi, Astha/0000-0003-4914-8228	Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-06142, RGPIN-2017-04003]; Research Manitoba Graduate Fellowship; University of Manitoba; Polish National Science Center [2012/04/A/NZ2/00455]; Foundation for Polish Science [TEAM/2009-4/2]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research Manitoba Graduate Fellowship; University of Manitoba; Polish National Science Center; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	The work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-06142). E.Dz. was supported by a Research Manitoba Graduate Fellowship. S.D. was supported by a University of Manitoba Graduate Fellowship. J.M.B. and A. were supported by the Polish National Science Center (grant 2012/04/A/NZ2/00455). J.M. B. and G.Ch. were supported by the Foundation for Polish Science (grant TEAM/2009-4/2). Publication charges were covered by Natural Sciences and Engineering Research Council of Canada grant to S.A.M. (RGPIN-2015-06142) and TRP (RGPIN-2017-04003).	Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; BHAT RA, 1985, MOL CELL BIOL, V5, P187, DOI 10.1128/MCB.5.1.187; Boniecki MJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1479; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510; Chojnowski G, 2014, NUCLEIC ACIDS RES, V42, pD123, DOI 10.1093/nar/gkt1084; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dey M, 2014, J BIOL CHEM, V289, P5747, DOI 10.1074/jbc.M113.527796; Dzananovic E, 2014, J STRUCT BIOL, V185, P48, DOI 10.1016/j.jsb.2013.11.007; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Francois C, 2000, J VIROL, V74, P5587, DOI 10.1128/JVI.74.12.5587-5596.2000; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FURTADO MR, 1989, J VIROL, V63, P3423, DOI 10.1128/JVI.63.8.3423-3434.1989; Gabel F, 2006, J MOL BIOL, V359, P610, DOI 10.1016/j.jmb.2006.03.049; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Husain B, 2012, BIOCHEMISTRY-US, V51, P8764, DOI 10.1021/bi301226h; KATZE MG, 1987, EMBO J, V6, P689, DOI 10.1002/j.1460-2075.1987.tb04809.x; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Launer-Felty K, 2015, BIOPHYS J, V108, P748, DOI 10.1016/j.bpj.2014.12.014; Launer-Felty K, 2010, J MOL BIOL, V402, P638, DOI 10.1016/j.jmb.2010.08.015; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Lemaire PA, 2006, BIOCHEMISTRY-US, V45, P9074, DOI 10.1021/bi060567d; Ma YL, 1996, RNA, V2, P937; McKenna SA, 2007, METHOD ENZYMOL, V430, P373, DOI 10.1016/S0076-6879(07)30014-1; McKenna SA, 2007, J MOL BIOL, V372, P103, DOI 10.1016/j.jmb.2007.06.028; McKenna SA, 2007, J BIOL CHEM, V282, P11474, DOI 10.1074/jbc.M700301200; McKenna SA, 2006, J MOL BIOL, V358, P1270, DOI 10.1016/j.jmb.2006.03.003; MELLITS KH, 1988, EMBO J, V7, P2849, DOI 10.1002/j.1460-2075.1988.tb03141.x; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Miao ZC, 2015, RNA, V21, P1066, DOI 10.1261/rna.049502.114; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Patel TR, 2012, MATRIX BIOL, V31, P135, DOI 10.1016/j.matbio.2011.11.004; Patel TR, 2011, PROTEIN SCI, V20, P931, DOI 10.1002/pro.628; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; PEERY T, 1993, J VIROL, V67, P3534, DOI 10.1128/JVI.67.6.3534-3543.1993; Puton T, 2013, NUCLEIC ACIDS RES, V41, P4307, DOI 10.1093/nar/gkt101; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993; Vachon VK, 2016, VIRUS RES, V212, P39, DOI 10.1016/j.virusres.2015.06.018; VanOudenhove J, 2009, J MOL BIOL, V387, P910, DOI 10.1016/j.jmb.2009.02.019; Volkov VV, 2003, J APPL CRYSTALLOGR, V36; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072; Wahid AM, 2008, J BIOL CHEM, V283, P17485, DOI 10.1074/jbc.M802300200; Wahid AM, 2009, NUCLEIC ACIDS RES, V37, P5830, DOI 10.1093/nar/gkp595; Wilson JL, 2014, J BIOL CHEM, V289, P23233, DOI 10.1074/jbc.M114.550046	56	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186849	10.1371/journal.pone.0186849	http://dx.doi.org/10.1371/journal.pone.0186849			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053745	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100041
J	Wen, YF; Wong, HM; McGrath, CP				Wen, Yi Feng; Wong, Hai Ming; McGrath, Colman Patrick			A longitudinal study of facial growth of Southern Chinese in Hong Kong: Comprehensive photogrammetric analyses	PLOS ONE			English	Article							SOFT-TISSUE PROFILE; NATURAL HEAD POSTURE; ANTHROPOMETRIC GROWTH; FRONTAL PHOTOGRAPHS; RELIABILITY; DIMENSIONS; PATTERNS; AGE; REPRODUCIBILITY; ADULTHOOD	Introduction Existing studies on facial growth were mostly cross-sectional in nature and only a limited number of facial measurements were investigated. The purposes of this study were to longitudinally investigate facial growth of Chinese in Hong Kong from 12 through 15 to 18 years of age and to compare the magnitude of growth changes between genders. Methods and findings Standardized frontal and lateral facial photographs were taken from 266 (149 females and 117 males) and 265 (145 females and 120 males) participants, respectively, at all three age levels. Linear and angular measurements, profile inclinations, and proportion indices were recorded. Statistical analyses were performed to investigate growth changes of facial features. Comparisons were made between genders in terms of the magnitude of growth changes from ages 12 to 15, 15 to 18, and 12 to 18 years. For the overall face, all linear measurements increased significantly (p < 0.05) except for height of the lower profile in females (p = 0.069) and width of the face in males (p = 0.648). In both genders, the increase in height of eye fissure was around 10% (p < 0.001). There was significant decrease in nasofrontal angle (p < 0.001) and increase in nasofacial angle (p < 0.001) in both genders and these changes were larger in males. Vermilion-total upper lip height index remained stable in females (p = 0.770) but increased in males (p = 0.020). Nasofrontal angle (effect size: 0.55) and lower vermilion contour index (effect size: 0.59) demonstrated large magnitude of gender difference in the amount of growth changes from 12 to 18 years. Conclusions Growth changes of facial features and gender differences in the magnitude of facial growth were determined. The findings may benefit different clinical specialties and other nonclinical fields where facial growth are of interest.	[Wen, Yi Feng; Wong, Hai Ming] Univ Hong Kong, Fac Dent, Paediat Dent & Orthodont, Hong Kong, Hong Kong, Peoples R China; [McGrath, Colman Patrick] Univ Hong Kong, Fac Dent, Periodontol & Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, HM (corresponding author), Univ Hong Kong, Fac Dent, Paediat Dent & Orthodont, Hong Kong, Hong Kong, Peoples R China.	wonghmg@hku.hk	Wen, Yi Feng/ABT-7086-2022	Wen, Yi Feng/0000-0002-5950-9456; Wong, Hai Ming/0000-0003-3411-6442	Research Grants Council of the Hong Kong Special Administrative Region, China [17126115]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was fully supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. 17126115), URL: http://www.ugc.edulik/eng/rgc/. The funding recipient was HMW.	Anic-Milosevic S, 2008, EUR J ORTHODONT, V30, P135, DOI 10.1093/ejo/cjm116; ARNETT GW, 1993, AM J ORTHOD DENTOFAC, V103, P299, DOI 10.1016/0889-5406(93)70010-L; Bergman RT, 2014, ANGLE ORTHOD, V84, P48, DOI 10.2319/041513-291.1; BISHARA SE, 1995, AM J ORTHOD DENTOFAC, V108, P489, DOI 10.1016/S0889-5406(95)70049-8; Bishara SE, 1997, ANGLE ORTHOD, V67, P55; BISHARA SE, 1995, AM J ORTHOD DENTOFAC, V108, P389, DOI 10.1016/S0889-5406(95)70036-6; BISHARA SE, 1984, AM J ORTHOD DENTOFAC, V85, P238, DOI 10.1016/0002-9416(84)90063-0; CHACONAS SJ, 1969, AMER J ORTHODONTICS, V56, P403, DOI 10.1016/S0002-9416(69)80007-2; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COOKE MS, 1990, AM J ORTHOD DENTOFAC, V97, P489, DOI 10.1016/S0889-5406(05)80029-0; Dahlberg G, 1948, STAT METHODS MED BIO; Djordjevic J, 2013, EUR J ORTHODONT, V35, P143, DOI 10.1093/ejo/cjr006; Farkas L G, 1987, ANTHROPOMETRIC FACIA; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P308, DOI 10.1597/1545-1569(1992)029<0308:GPOTFA>2.3.CO;2; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P301, DOI 10.1597/1545-1569(1992)029<0301:GADORU>2.3.CO;2; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P303, DOI 10.1597/1545-1569(1992)029<0303:AGSOTH>2.3.CO;2; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P315, DOI 10.1597/1545-1569(1992)029<0315:GPITOR>2.3.CO;2; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P324, DOI 10.1597/1545-1569(1992)029<0324:AGSOTE>2.3.CO;2; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P318, DOI 10.1597/1545-1569(1992)029<0318:GPOTNR>2.3.CO;2; Fernandez-Riveiro P, 2003, EUR J ORTHODONT, V25, P393, DOI 10.1093/ejo/25.4.393; Ferrario VF, 1999, AM J ORTHOD DENTOFAC, V116, P215, DOI 10.1016/S0889-5406(99)70220-9; Ferrario VF, 1999, PLAST RECONSTR SURG, V103, P768, DOI 10.1097/00006534-199903000-00002; Field A., 2012, DISCOVERING STAT USI; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; GENECOV JS, 1990, ANGLE ORTHOD, V60, P191; JAMISON JE, 1982, AM J ORTHOD DENTOFAC, V82, P217, DOI 10.1016/0002-9416(82)90142-7; Jayaratne YSN, 2014, SURG INNOV, V21, P59, DOI 10.1177/1553350613475883; Keppel G., 2004, DESIGN ANAL RES HDB; Koudelova J, 2015, FORENSIC SCI INT, V248, P33, DOI 10.1016/j.forsciint.2014.12.005; MAMANDRAS AH, 1988, AM J ORTHOD DENTOFAC, V94, P405, DOI 10.1016/0889-5406(88)90129-1; MAUCHAMP O, 1973, AM J ORTHOD DENTOFAC, V64, P83, DOI 10.1016/0002-9416(73)90282-0; Milosevic SA, 2008, J CRANIOFAC SURG, V19, P251, DOI 10.1097/scs.0b013e31815c9446; Naini FB, 2011, FACIAL AESTHETICS CO; NANDA RS, 1990, ANGLE ORTHOD, V60, P177; Peng L, 1999, AM J ORTHOD DENTOFAC, V116, P82, DOI 10.1016/S0889-5406(99)70306-9; POSEN JM, 1967, AMER J ORTHODONTICS, V53, P746, DOI 10.1016/0002-9416(67)90119-4; Powell N., 1984, PROPORTIONS AESTHETI; Powell S J, 1976, Br J Orthod, V3, P207; R Development Core Team, R LANG ENV STAT COMP; Ricketts RM, 1957, ANGLE ORTHOD, V27, P14; Rohlf F., TPSDIG2 DEP ECOLOGY; Rosenthal R, 1991, METAANALYTIC PROCEDU; Rosnow RL, 1996, PSYCHOL METHODS, V1, P331, DOI 10.1037/1082-989X.1.4.331; SARNAS K-V, 1980, European Journal of Orthodontics, V2, P1; SFORZA C, 2010, FORENSIC SCI INT, V182, pE1, DOI DOI 10.1016/J.F0RSCIINT.2010.04.050; Sforza C, 2016, BRIT J ORAL MAX SURG, V54, P192, DOI 10.1016/j.bjoms.2015.11.015; Sforza C, 2014, J CRANIO MAXILL SURG, V42, pE318, DOI 10.1016/j.jcms.2013.10.013; Sforza C, 2009, FORENSIC SCI INT, V187, DOI 10.1016/j.forsciint.2009.02.019; Sforza C, 2009, FORENSIC SCI INT, V185, DOI 10.1016/j.forsciint.2008.12.010; Sforza C, 2011, FORENSIC SCI INT, V204, DOI 10.1016/j.forsciint.2010.07.027; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SIERSBAEKNIELSEN S, 1982, AM J ORTHOD DENTOFAC, V82, P50, DOI 10.1016/0002-9416(82)90546-2; Springate SD, 2012, EUR J ORTHODONT, V34, P158, DOI 10.1093/ejo/cjr010; Subtelny JD, 1959, AM J ORTHOD DENTOFAC, V45, P481, DOI [10.1016/0002-9416(59)90014-4, DOI 10.1016/0002-9416(59)90014-4]; TANNER J. M., 1951, HUMAN BIOL, V23, P93; TANNER JM, 1975, ARCH DIS CHILD, V50, P14, DOI 10.1136/adc.50.1.14; Tanner JM, 1962, GROWTH AT ADOLESCENC, V2nd; Tomczak M., 2014, TRENDS SPORT SCI, V1, P19, DOI DOI 10.7326/0003-4819-159-3-201308060-00005; URSI WJS, 1993, ANGLE ORTHOD, V63, P47; Vahdettin L, 2012, J OROFAC ORTHOP, V73, P440, DOI 10.1007/s00056-012-0099-7; Wen YF, 2015, J CRANIOFAC SURG, V26, P1830, DOI 10.1097/SCS.0000000000001909; Wen YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134525; Zhang XZ, 2007, AM J ORTHOD DENTOFAC, V131, P67, DOI 10.1016/j.ajodo.2005.02.033; ZYLINSKI CG, 1992, AM J ORTHOD DENTOFAC, V101, P514, DOI 10.1016/0889-5406(92)70125-T	66	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186598	10.1371/journal.pone.0186598	http://dx.doi.org/10.1371/journal.pone.0186598			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK2MA	29053713	gold, Green Published, Green Submitted			2022-12-26	WOS:000413315100024
J	Boo, MV; Hiong, KC; Choo, CYL; Cao-Pham, AH; Wong, WP; Chew, SF; Ip, YK				Boo, Mel V.; Hiong, Kum C.; Choo, Celine Y. L.; Cao-Pham, Anh H.; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			The inner mantle of the giant clam, Tridacna squamosa, expresses a basolateral Na+/K+-ATPase alpha-subunit, which displays lightdependent gene and protein expression along the shell-facing epithelium	PLOS ONE			English	Article							ACTIVE AMMONIA EXCRETION; NA-K-ATPASE; KINASE-A; GIGAS L; NA,K-ATPASE; LOCALIZATION; PUMP; NA+,K+-ATPASE; NUTRITION; NITROGEN	Na+/K+-ATPase (NKA) is essential for maintaining the Na+ and K+ gradients, and supporting the secondary active transport of certain ions/molecules, across the plasma membrane of animal cells. This study aimed to clone the NKA alpha-subunit (NKA alpha) from the inner mantle adjacent to the extrapallial fluid of Tridacna squamosa, to determine its subcellular localization, and to examine the effects of light exposure on its transcript level and protein abundance. The cDNA coding sequence of NKA alpha from T. squamosa comprised 3105 bp, encoding 1034 amino acids with an estimated molecular mass of 114 kDa. NKAa had a basolateral localization along the shell-facing epithelium of the inner mantle. Exposure to 12 h of light led to a significantly stronger basolateral NKA alpha-immunofluorescence at the shell-facing epithelium, indicating that NKA might play a role in light-enhanced calcification in T. squamosa. After 3 h of light exposure, the transcript level of NKA alpha decreased transiently in the inner mantle, but returned to the control level thereafter. In comparison, the protein abundance of NKA alpha remained unchanged at hour 3, but became significantly higher than the control after 12 h of light exposure. Hence, the expression of NKA alpha in the inner mantle of T. squamosa was light-dependent. It is probable that a higher expression level of NKA was needed in the shell-facing epithelial cells of the inner mantle to cope with a rise in Na+ influx, possibly caused by increases in activities of some Na+-dependent ion transporters/channels involved in light-enhanced calcification.	[Boo, Mel V.; Hiong, Kum C.; Choo, Celine Y. L.; Cao-Pham, Anh H.; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore, Singapore; [Ip, Yuen K.] Natl Univ Singapore, Trop Marine Sci Inst, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; National University of Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.; Ip, YK (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, Singapore, Singapore.	dbsipyk@nus.edu.sg	Chew, Shit Fun/I-2248-2012	Chew, Shit Fun/0000-0003-4599-5817; Choo, Celine Yen Ling/0000-0001-9099-6988	Singapore Millennium Foundation [R-347-000-212-592]; Ministry of Education [R-154-000-A37-114]	Singapore Millennium Foundation; Ministry of Education	This study was funded in part by the Singapore Millennium Foundation (R-347-000-212-592) and the Ministry of Education (R-154-000-A37-114) to Yuen K. Ip. The URLs for both the Singapore Millennium Foundation and the Ministry of Education can be found here, respectively: http://www.singaporemillenniumfoundation.com.sg/; https://www.moe.gov.sg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; Barott KL, 2015, AM J PHYSIOL-REG I, V309, pR235, DOI 10.1152/ajpregu.00052.2015; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bystriansky JS, 2007, J BIOENERG BIOMEMBR, V39, P373, DOI 10.1007/s10863-007-9100-3; Ching BY, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00135; Cohen I, 2016, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00122; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; Dostanic-Larson I, 2006, AM J PHYSIOL-REG I, V290, pR524, DOI 10.1152/ajpregu.00838.2005; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; FANKBONER PV, 1981, VELIGER, V23, P245; FESCHENKO MS, 1994, J BIOL CHEM, V269, P30436; FISHER CR, 1985, BIOL BULL, V169, P230, DOI 10.2307/1541400; FITT WK, 1993, MAR BIOL, V117, P381; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; GRIFFITHS DJ, 1992, AUST J ZOOL, V40, P319, DOI 10.1071/ZO9920319; GUNDERSEN D, 1991, J CELL BIOL, V112, P863, DOI 10.1083/jcb.112.5.863; HAWKINS AJS, 1995, J EXP MAR BIOL ECOL, V190, P263, DOI 10.1016/0022-0981(95)00044-R; Hiong KC, 2017, PHYSL REP; Hiong KC, 2017, CORAL REEFS, V36, P311, DOI 10.1007/s00338-016-1502-4; Holt AL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0678; HORISBERGER JD, 1991, P NATL ACAD SCI USA, V88, P8397, DOI 10.1073/pnas.88.19.8397; Ip YK, 2006, PHYSIOL BIOCHEM ZOOL, V79, P656, DOI 10.1086/501061; Ip YK, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00781; Ip YK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00068; Ip YK, 2012, AM J PHYSIOL-REG I, V303, pR112, DOI 10.1152/ajpregu.00618.2011; IWANO T, 1990, J HISTOCHEM CYTOCHEM, V38, P225, DOI 10.1177/38.2.2153727; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JUST F, 1994, HISTOCHEMISTRY, V102, P271, DOI 10.1007/BF00269163; KLUMPP DW, 1994, MAR ECOL PROG SER, V115, P103, DOI 10.3354/meps115103; KLUMPP DW, 1992, J EXP MAR BIOL ECOL, V155, P105, DOI 10.1016/0022-0981(92)90030-E; Lavelin I, 2001, AM J PHYSIOL-REG I, V281, pR1169, DOI 10.1152/ajpregu.2001.281.4.R1169; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; LUCAS JS, 1989, AQUACULTURE, V80, P45, DOI 10.1016/0044-8486(89)90272-X; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; Marshall AT, 1996, SCIENCE, V271, P637, DOI 10.1126/science.271.5249.637; Masui DC, 2002, COMP BIOCHEM PHYS C, V132, P471, DOI 10.1016/S1532-0456(02)00110-2; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; Muscatine L, 1983, CARBON BUDGETS SYMBI, P649; NAKAZAWA K, 1995, J HISTOCHEM CYTOCHEM, V43, P981, DOI 10.1177/43.10.7560888; NORTON JH, 1992, BIOL BULL, V183, P503, DOI 10.2307/1542028; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rosewater J., 1965, FAMILY TRIDACNIDAE I; SACHS JR, 1981, J PHYSIOL-LONDON, V319, P515, DOI 10.1113/jphysiol.1981.sp013923; Sano Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1763; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; STREAMER M, 1988, SYMBIOSIS, V6, P237; SUN DY, 1991, J HISTOCHEM CYTOCHEM, V39, P1455, DOI 10.1177/39.11.1655875; SWEADNER KJ, 1992, CAN J PHYSIOL PHARM, V70, pS255, DOI 10.1139/y92-269; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; WARBURG MR, 1989, J CRUSTACEAN BIOL, V9, P525, DOI 10.2307/1548584; Watanabe T, 1999, J GEOPHYS RES-OCEANS, V104, P20667, DOI 10.1029/1999JC900097; Weihrauch D, 2002, J EXP BIOL, V205, P2765; Weihrauch D, 2009, J EXP BIOL, V212, P1716, DOI 10.1242/jeb.024851; WILKERSON FP, 1986, MAR BIOL, V93, P237, DOI 10.1007/BF00508261; Witters H, 1996, CELL TISSUE RES, V283, P461, DOI 10.1007/s004410050557; Yamashita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006303; YODA A, 1988, J BIOL CHEM, V263, P10320; Ziegler A, 1997, TISSUE CELL, V29, P63, DOI 10.1016/S0040-8166(97)80073-0; Zimmermann B., 1992, CELL TISSUE RES; Zoccola D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09983	69	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186865	10.1371/journal.pone.0186865	http://dx.doi.org/10.1371/journal.pone.0186865			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049367	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900120
J	Kawaguchi, I; Kobayashi, A; Higashide, T; Takeji, Y; Sakurai, K; Kawaguchi, C; Sugiyama, K				Kawaguchi, Ichiro; Kobayashi, Akira; Higashide, Tomomi; Takeji, Yasuhiro; Sakurai, Kazushi; Kawaguchi, Chiaki; Sugiyama, Kazuhisa			Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits	PLOS ONE			English	Article							BENZALKONIUM CHLORIDE; SODIUM HYALURONATE; GOBLET CELLS; INCREASES; CORNEAL; CONJUNCTIVA; EXPRESSION; OPC-12759; DRUG	Purpose This study aimed to determine if rebamipide eyedrops can improve ocular surface damage caused by the use of glaucoma eyedrops. Methods Female Kbl:Dutch rabbits were used to evaluate glaucoma eyedrop-induced ocular surface damage; one eye of each rabbit was untreated and the other was administered glaucoma eyedrops for 30 days. To evaluate the effects of rebamipide on ocular surface damage, one eye of each rabbit was administered vehicle-treated glaucoma eyedrops and the other was administered rebamipide-treated glaucoma eyedrops for 30 days. Corneal and conjunctival epithelial damage was evaluated using fluorescein and rose bengal staining, respectively. Conjunctival inflammation was observed by light microscopy with hematoxylin-eosin staining. Dark cells (in which the corneal microvilli were damaged) were analyzed by scanning electron microscopy. Results There were no significant differences in fluorescein staining between the untreated and glaucoma eyedrop-treated groups; however, rose bengal staining and the number of inflammatory cells in the conjunctiva significantly increased after glaucoma eyedrop treatment. There was a four-fold increase in the number of dark cells in the glaucoma eyedrop-treated group compared to untreated. In contrast, in the conjunctiva of the rebamipide-treated glaucoma eyedrop group, rose bengal staining scores, the number of inflammatory cells, and the number of dark cells were decreased compared to the vehicle-treated glaucoma eyedrop group. Conclusions Results from our in vivo rabbit study demonstrated that short-term use of glaucoma eyedrops induces corneal epithelium disorders at the cellular level, but that simultaneous use of rebamipide has the potential to protect and repair the ocular surface.	[Kawaguchi, Ichiro; Kobayashi, Akira; Higashide, Tomomi; Kawaguchi, Chiaki; Sugiyama, Kazuhisa] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan; [Takeji, Yasuhiro; Sakurai, Kazushi] Otsuka Pharmaceut Co Ltd, Ako Res Inst, Ako, Hyogo, Japan	Kanazawa University; Otsuka Pharmaceutical	Kobayashi, A (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan.	eyekoba@gmail.com			Otsuka pharmaceutical Co. Ltd.	Otsuka pharmaceutical Co. Ltd.(Otsuka Pharmaceutical)	The funder (Otsuka pharmaceutical Co. Ltd.) provided support in the form of salaries for authors [YT, KS]. Authors [IK, AK, TH, CK, KS] received no specific funding for this work.	Baudouin C, 2004, OPHTHALMOLOGY, V111, P2186, DOI 10.1016/j.ophtha.2004.06.023; Baudouin C, 2012, EUR J OPHTHALMOL; Baudouin C, 2008, ACTA OPHTHALMOL, V86, P716, DOI 10.1111/j.1755-3768.2008.01250.x; Baudouin C, 2007, INVEST OPHTH VIS SCI, V48, P4123, DOI 10.1167/iovs.07-0266; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P2525; Dogan AL, 2004, CLIN EXP OPHTHALMOL, V32, P62, DOI 10.1046/j.1442-9071.2003.00760.x; Fukuchi T, 2010, CLIN OPHTHALMOL, V4, P203; Gipson IK, 2016, PROG RETIN EYE RES, V54, P49, DOI 10.1016/j.preteyeres.2016.04.005; Govindarajan B, 2010, EXP EYE RES, V90, P655, DOI 10.1016/j.exer.2010.02.014; HERRERAS JM, 1992, OPHTHALMOLOGY, V99, P1082; Iijima K, 2009, DIGEST DIS SCI, V54, P1500, DOI 10.1007/s10620-008-0507-4; Kahook MY, 2008, ADV THER, V25, P743, DOI 10.1007/s12325-008-0078-y; KERN TJ, 1988, VET PATHOL, V25, P468, DOI 10.1177/030098588802500610; Kinoshita S, 2013, OPHTHALMOLOGY, V120, P1158, DOI 10.1016/j.ophtha.2012.12.022; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Naito Y, 2010, EXPERT REV GASTROENT, V4, P261, DOI [10.1586/egh.10.25, 10.1586/EGH.10.25]; Noecker RJ, 2004, CORNEA, V23, P490, DOI 10.1097/01.ico.0000116526.57227.82; Ohguchi T, 2013, INVEST OPHTH VIS SCI, V54, P7793, DOI 10.1167/iovs.13-13128; Tanaka H, 2013, BRIT J OPHTHALMOL, V97, P912, DOI 10.1136/bjophthalmol-2012-302868; Terai N, 2011, CLIN OPHTHALMOL, V5, P517, DOI 10.2147/OPTH.S18849; TODA I, 1993, CORNEA, V12, P366, DOI 10.1097/00003226-199307000-00015; Tokuda N, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/689076; TSENG SCG, 1994, INT OPHTHALMOL CLIN, V34, P57, DOI 10.1097/00004397-199403410-00007; Urashima H, 2004, CORNEA, V23, P613, DOI 10.1097/01.ico.0000126436.25751.fb; Urashima H, 2012, J OCUL PHARMACOL TH, V28, P264, DOI 10.1089/jop.2011.0147; YAMASAKI K, 1987, EUR J PHARMACOL, V142, P23; Yu FF, 2013, INVEST OPHTH VIS SCI, V54, P3385, DOI 10.1167/iovs.12-11181	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186714	10.1371/journal.pone.0186714	http://dx.doi.org/10.1371/journal.pone.0186714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049370	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900102
J	Lotto, M; Aguirre, PEA; Rios, D; Machado, MAAM; Cruvinel, AFP; Cruvinel, T				Lotto, Matheus; Ayala Aguirre, Patricia Estefania; Rios, Daniela; Andrade Moreira Machado, Maria Aparecida; Pereira Cruvinel, Agnes Fatima; Cruvinel, Thiago			Analysis of the interests of Google users on toothache information	PLOS ONE			English	Article							DENTAL PAIN; BEHAVIORAL MEDICINE; OROFACIAL PAIN; GLOBAL BURDEN; ORAL-HEALTH; IMPACT; ADOLESCENTS; PREVALENCE; CHILDREN; TRENDS	Background The knowledge on health interests of a given population of Internet users might contribute to the increase of evidence on community's dental needs, and consequently, to the improvement of public health planning. The frequency of searches for specific issues on Google can be analyzed by the application of Google Trends. Aim In this study, we aimed to characterize the interests on toothache information of Google users from the United States, United Kingdom, Australia and Brazil. Methods The monthly variation of relative search volume (RSV) and the lists of main toothache-related queries were determined from January 2004 through April 2016 using Google Trends. Autoregressive Integrated Moving Average (ARIMA) forecasting models were developed to determine predictive RSV values for toothache for additional 12 months. Autocorrelation plots and general additive model (GAM) were applied to determine trends and seasonality in RSV curves. Through linear regression models, we assessed the association between the variation of annual means of RSV values and national statistics for toothache in the U.S. and U.K. Subsequently, the distribution of main queries according to the identification of endodontic pain, type of searching information, and the interest in self-management of toothache was evaluated for the four countries. Results The autocorrelation plots showed patterns of non-stationary time series. The monthly variation influenced the data of the U.S. and U.K., with the higher RSV values found respectively in January/July and December. Also, the interest on toothache in the U.K. increases in the second semester and in the fourth quarter, especially in December. Additionally, an annual variation affected significantly all time series, with the increment of RSV means over the years, varying from 265% in the U.S. to 745% in Brazil. In parallel, the increments in RSV values were also observed in all predictive curves. The annual variation of observed and fitted RSV values was directly associated with the increase of toothache visits in the U.S. and urgent dental treatments in the U.K. Moreover, the queries typed on Google were markedly linked to searches on endodontic pain information, especially in Brazil, where the residents usually searched for relief and/or self-management of pain. Conclusions Therefore, these findings indicate an increasing interest of Google users on toothache-related topics, regardless of country and season. The Internet activity can be used by policy makers as a complementary source of data for the development and implementation of strategies to control and prevent toothache complications.	[Lotto, Matheus; Ayala Aguirre, Patricia Estefania; Rios, Daniela; Andrade Moreira Machado, Maria Aparecida; Cruvinel, Thiago] Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil; [Pereira Cruvinel, Agnes Fatima] Fed Univ Fronteira Sul, Sch Med, Dept Publ Hlth, Chapeco, SC, Brazil	Universidade de Sao Paulo; Universidade Federal da Fronteira Sul	Cruvinel, T (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil.	thiagocruvinel@fob.usp.br	Lotto, Matheus/X-6400-2019; Cruvinel, Thiago/K-2707-2012; Aguirre, Patricia Estefania Ayala/AAG-7482-2020; Rios, Daniela/GMW-9768-2022; Machado, Maria Aparecida Andrade Moreira/D-8224-2012; Lotto, Matheus/V-4759-2018; Rios, Daniela/G-5738-2012; Rios, Daniela/AFL-1675-2022	Cruvinel, Thiago/0000-0001-7095-908X; Rios, Daniela/0000-0002-9162-3654; Machado, Maria Aparecida Andrade Moreira/0000-0003-3778-7444; Lotto, Matheus/0000-0002-0121-4006; Rios, Daniela/0000-0002-9162-3654; Rios, Daniela/0000-0002-9162-3654	Sao Paulo Research Foundation [2014/21292-2]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation, grant #2014/21292-2, ML and TC URL:http://www.bv.fapesp.br/pt/bolsas/157849/tendencias-do-volume-de-buscas-e-qualidade-da-informacao-na-internet-sobre-dor-de-dente/.	Ahlwardt K, 2014, J AM DENT ASSOC, V145, P737, DOI 10.14219/jada.2014.30; AIHW, 2014, OR HLTH DENT CAR AUS, P34; Althouse BM, 2014, AM J PREV MED, V46, P166, DOI 10.1016/j.amepre.2013.10.008; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Bragazzi NL, 2016, EPILEPSY BEHAV, V55, P120, DOI 10.1016/j.yebeh.2015.12.017; Brasil, 2005, PROJ SB BRAS 2003 CO, P68; Brasil, 2012, SB BRAS 2010 PESQ NA, P118; Centers for Disease Control and Prevention, 2017, NATIONAL HOSPITAL AM; Cho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081422; Cohen LA, 2009, SPEC CARE DENT, V29, P85, DOI 10.1111/j.1754-4505.2008.00068.x; Constante HM, 2016, EUR J ORAL SCI, V124, P62, DOI 10.1111/eos.12242; Fox S, 2013, PEW INTERNET AM LIFE; Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713; Goes PSA, 2008, ACTA ODONTOL SCAND, V66, P7, DOI 10.1080/00016350701810633; Hairon Nerys, 2008, Nurs Times, V104, P33; Heaivilin N, 2011, J DENT RES, V90, P1047, DOI 10.1177/0022034511415273; Health and Social Care Information Centre, 2017, NHS DENT STAT ENGL 2; Hobdell M, 2003, INT DENT J, V53, P285, DOI 10.1111/j.1875-595X.2003.tb00761.x; Honkala E, 2001, J DENT RES, V80, P1823, DOI 10.1177/00220345010800091001; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kikuchi H, 2006, CEPHALALGIA, V26, P1335, DOI 10.1111/j.1468-2982.2006.01221.x; Lewis CW, 2015, J AM DENT ASSOC, V146, P295, DOI 10.1016/j.adaj.2015.01.013; LOCKER D, 1987, J DENT RES, V66, P1414, DOI 10.1177/00220345870660090101; Macfarlane TV, 2002, COMMUNITY DENT ORAL, V30, P52, DOI 10.1034/j.1600-0528.2002.300108.x; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Mejia G, 2014, AUST DENT J, V59, P226, DOI 10.1111/adj.12173; MILLER NE, 1983, ANNU REV PSYCHOL, V34, P1, DOI 10.1146/annurev.ps.34.020183.000245; NetMarketShare, 2017, DESKT SEARCH ENG MAR; Office for National Statistics, 2017, MID EST SINGL YEAR A; Pau A, 2007, BRIT DENT J, V202, DOI 10.1038/bdj.2007.171; Phelan Nigel, 2014, Eur J Orthop Surg Traumatol, V24, P1203, DOI 10.1007/s00590-013-1399-3; Riley JL, 2003, J PUBLIC HEALTH DENT, V63, P166, DOI 10.1111/j.1752-7325.2003.tb03495.x; Santiago BM, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-2; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Shepherd MA, 1999, BRIT DENT J, V187, P38, DOI 10.1038/sj.bdj.4800197a; Stone AA, 2007, PAIN MED, V8, P85, DOI 10.1111/j.1526-4637.2007.00372.x; The World Bank States and Markets, 2017, WORLD DEVELOPMENT IN; U.S. Census Bureau Population Division, 2016, MONTHL POP EST US AP; Vujicic M, 2014, HEALTH SERV RES, V49, P460, DOI 10.1111/1475-6773.12130	39	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186059	10.1371/journal.pone.0186059	http://dx.doi.org/10.1371/journal.pone.0186059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049315	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900038
J	Repas, TS; Gillis, DM; Boubakir, Z; Bao, XH; Samuels, GJ; Kaminskyj, SGW				Repas, Timothy S.; Gillis, D. Michael; Boubakir, Zakia; Bao, Xiaohui; Samuels, Gary J.; Kaminskyj, Susan G. W.			Growing plants on oily, nutrient-poor soil using a native symbiotic fungus	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; WHITE-ROT FUNGI; BIODEGRADATION; BIOREMEDIATION; PHENANTHRENE; TOLERANCE; STRAINS; GROWTH	The roots of land plants associate with microbes, including fungal symbionts that can confer abiotic stress tolerance. Bitumen extraction following oil-sand surface mining in the Athabasca region of Alberta, Canada removes plant nutrients but leaves a petrochemical residue, making the coarse tailings (CT) hostile to both plants and microbes. We isolated an endophyte strain of the Ascomycete Trichoderma harzianum we call TSTh20-1 (hereafter, TSTh) from a dandelion that was naturally growing on CT. TSTh colonization allowed tomato, wheat, and remediation seed mixtures to germinate and their seedlings to flourish on CT without the use of fertilizer. Compared to control plants, TSTh increased germination speed, percent germination, and biomass accumulation. TSTh also improved plant water use efficiency and drought recovery. TSTh-colonized plants secreted twice the level of peroxidase into CT as did plants alone. Over two months, plants colonized with TSTh doubled the petrochemical mobilization from CT over plants alone, suggesting a peroxide-mediated mechanism for petrochemical degradation. TSTh grew on autoclaved CT, bitumen, and other petrochemicals as sole carbon sources. Further, TSTh is a micro-aerobe that could metabolize C-13-phenanthrene to (CO2)-C-13 in 0.5% oxygen. TSTh has excellent potential for contributing to revegetating and remediating petrochemical contamination.	[Repas, Timothy S.; Gillis, D. Michael; Boubakir, Zakia; Bao, Xiaohui; Kaminskyj, Susan G. W.] Univ Saskatchewan, Biol Dept, Sci Pl, Saskatoon, SK, Canada; [Repas, Timothy S.] Roy Northern Environm, Ft St John, BC, Canada; [Samuels, Gary J.] USDA ARS, Systemat Mycol & Microbiol Lab, Beltsville, MD USA	University of Saskatchewan; United States Department of Agriculture (USDA)	Kaminskyj, SGW (corresponding author), Univ Saskatchewan, Biol Dept, Sci Pl, Saskatoon, SK, Canada.	susan.kaminskyj@usask.ca		Kaminskyj, Susan/0000-0001-9743-6967	Natural Sciences and Engineering Research Council (Canada) [NSERC DG 203696-13]; 'Research Tools and Instruments'; Dept Biology (UofS) Biology Graduate Scholarship, NovoZymes BioAg, NSERC IPS; NSERC DG; Kaminskyj Research Ltd	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); 'Research Tools and Instruments'; Dept Biology (UofS) Biology Graduate Scholarship, NovoZymes BioAg, NSERC IPS; NSERC DG(Natural Sciences and Engineering Research Council of Canada (NSERC)); Kaminskyj Research Ltd	We thank the following for support: Natural Sciences and Engineering Research Council (Canada, NSERC DG 203696-13 to SGWK); 'Research Tools and Instruments' (SGWK et al.) for the Axiolmager.Z1; Dept Biology (UofS) Biology Graduate Scholarship, NovoZymes BioAg, NSERC IPS (to TSR); NSERC DG and Kaminskyj Research Ltd (to ZB). We thank Marlynn Mireau for the DAB photograph. We thank Roy Northern Environmental for petrochemical-impacted soils and analysis. We greatly thank colleagues who provided plants and samples from CT sites. TSR was an employee of Roy Northern Environmental during the editing of this manuscript. RNE did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following for support: Natural Sciences and Engineering Research Council (Canada, NSERC Discovery Grant 203696-13 to SGWK); NSERC Research Tools and Instruments (SGWK et al.) for the Axiolmager.Z1; Dept Biology (UofS) Biology Graduate Scholarship, NovoZymes BioAg, NSERC-IPS (to TSR). We thank Marlynn Mireau for the DAB photograph. We thank Roy Northern Environmental for petrochemical-impacted soils and analysis. We greatly thank colleagues who provided plants and samples from CT sites.	Alberta Parks and Environment, 2016, ALB TIER 1 SOIL GROU; Argumedo-Delira R, 2012, J ENVIRON MANAGE, V95, pS291, DOI 10.1016/j.jenvman.2010.08.011; Asgher M, 2008, BIODEGRADATION, V19, P771, DOI 10.1007/s10532-008-9185-3; Azad K, 2016, SYMBIOSIS, V68, P73, DOI 10.1007/s13199-015-0370-y; Azav S, 2012, MOL CELL PROTEOMICS, V11, P11; Bao X., 2009, ENDOPHYTIC FUNGI ASS; BARTHA R, 1969, Soil Biology and Biochemistry, V1, P139, DOI 10.1016/0038-0717(69)90004-2; BGC Engineering Inc, 2010, OIL SANDS RES INF NE; Chaineau CH, 1999, SCI TOTAL ENVIRON, V227, P237, DOI 10.1016/S0048-9697(99)00033-9; Chaudhuri U.R., 2011, FUNDAMENTALS PETROLE; Chaverri P, 2015, MYCOLOGIA, V107, P558, DOI 10.3852/14-147; Clark KA, 1932, IND ENG CHEM, V24, P1410, DOI 10.1021/ie50276a016; Das N., 2011, BIOTECHNOLOGY RES IN; Dashtban Mehdi, 2010, Int J Biochem Mol Biol, V1, P36; Devenny D A., SCREENING STUDY OIL; Environment CCME, 2008, CAN WID STAND PETR H; Fernandez-Fueyo E, 2014, FUNGAL GENET BIOL, V72, P150, DOI 10.1016/j.fgb.2014.02.003; Hadibarata Tony, 2007, Pak J Biol Sci, V10, P2535, DOI 10.3923/pjbs.2007.2535.2543; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Kaminskyj SGW., 2001, FUNGAL GENET REP, V48, P25, DOI [10.4148/1941-4765.1175, DOI 10.4148/1941-4765.1175]; Kannan Neethu, 2012, Advances in Bioscience and Biotechnology, V3, P1160, DOI 10.4236/abb.2012.38142; Llado S, 2013, J HAZARD MATER, V248, P407, DOI 10.1016/j.jhazmat.2013.01.020; Magan Naresh, 2010, Mycobiology, V38, P238, DOI 10.4489/MYCO.2010.38.4.238; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Repas T., 2014, CHARACTERIZATION MET; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Samuels GJ, 2015, TRICHODERMA IDENTIFI; Woodward C, 2012, HORTSCIENCE, V47, P699, DOI 10.21273/HORTSCI.47.6.699; Zafra G, 2015, ENVIRON SCI POLLUT R, V22, P19426, DOI 10.1007/s11356-015-5602-4	33	8	9	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186704	10.1371/journal.pone.0186704	http://dx.doi.org/10.1371/journal.pone.0186704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049338	gold, Green Submitted, Green Published			2022-12-26	WOS:000413195900098
J	Elamin, AA; Steinicke, S; Oehlmann, W; Braun, Y; Wanas, H; Shuralev, EA; Huck, C; Maringer, M; Rohde, M; Singh, M				Elamin, Ayssar A.; Steinicke, Susanne; Oehlmann, Wulf; Braun, Yvonne; Wanas, Hanaa; Shuralev, Eduard A.; Huck, Carmen; Maringer, Marko; Rohde, Manfred; Singh, Mahavir			Novel drug targets in cell wall biosynthesis exploited by gene disruption in Pseudomonas aeruginosa	PLOS ONE			English	Article							ACETYLGLUCOSAMINE ENOLPYRUVYL TRANSFERASE; BACTERIAL BIOFILM FORMATION; UDP-N-ACETYLGLUCOSAMINE; ESCHERICHIA-COLI; VIRULENCE FACTORS; LIPOPOLYSACCHARIDE BIOSYNTHESIS; OPPORTUNISTIC PATHOGEN; CRYSTAL-STRUCTURE; ENDOTOXINS; ANTIBIOTICS	For clinicians, Pseudomonas aeruginosa is a nightmare pathogen that is one of the top three causes of opportunistic human infections. Therapy of P. aeruginosa infections is complicated due to its natural high intrinsic resistance to antibiotics. Active efflux and decreased uptake of drugs due to cell wall/ membrane permeability appear to be important issues in the acquired antibiotic tolerance mechanisms. Bacterial cell wall biosynthesis enzymes have been shown to be essential for pathogenicity of Gram-negative bacteria. However, the role of these targets in virulence has not been identified in P. aeruginosa. Here, we report knockout (k. o) mutants of six cell wall biosynthesis targets (murA, PA4450; murD, PA4414; murF, PA4416; ppiB, PA1793; rmlA, PA5163; waaA, PA4988) in P. aeruginosa PAO1, and characterized these in order to find out whether these genes and their products contribute to pathogenicity and virulence of P. aeruginosa. Except waaA k. o, deletion of cell wall biosynthesis targets significantly reduced growth rate in minimal medium compared to the parent strain. The k. o mutants showed exciting changes in cell morphology and colonial architectures. Remarkably, Delta murF cells became grossly enlarged. Moreover, the mutants were also attenuated in vivo in a mouse infection model except Delta murF and Delta waaA and proved to be more sensitive to macrophage-mediated killing than the wild-type strain. Interestingly, the deletion of the murA gene resulted in loss of virulence activity in mice, and the virulence was restored in a plant model by unknown mechanism. This study demonstrates that cell wall targets contribute significantly to intracellular survival, in vivo growth, and pathogenesis of P. aeruginosa. In conclusion, these findings establish a link between cell wall targets and virulence of P. aeruginosa and thus may lead to development of novel drugs for the treatment of P. aeruginosa infection.	[Elamin, Ayssar A.; Steinicke, Susanne; Oehlmann, Wulf; Braun, Yvonne; Wanas, Hanaa; Singh, Mahavir] LIONEX Diagnost & Therapeut GmbH, Braunschweig, Germany; [Shuralev, Eduard A.] Kazan Fed Univ, Inst Environm Sci, Kazan, Tatarstan, Russia; [Shuralev, Eduard A.] Kazan State Med Acad, Cent Res Lab, FSBEI FPE RMACPE MOH Russia, Branch Campus, Kazan, Tatarstan, Russia; [Huck, Carmen; Maringer, Marko] Mfd Diagnost GmbH, Wendelsheim, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Cent Facil Microscopy, Braunschweig, Germany; [Wanas, Hanaa] Cairo Univ, Pharmacol Dept, Fac Med, Cairo, Egypt	Lionex Diagnostics & Therapeutics GmbH; Kazan Federal University; Kazan State Medical Academy; Helmholtz Association; Helmholtz-Center for Infection Research; Egyptian Knowledge Bank (EKB); Cairo University	Singh, M (corresponding author), LIONEX Diagnost & Therapeut GmbH, Braunschweig, Germany.	info@lionex.de	Shuralev, Eduard/M-1147-2013; Wanas, H. A. Abdel-Gawad/AAC-1882-2020	Shuralev, Eduard/0000-0003-0650-3090; A. Elamin, Ayssar/0000-0003-4123-2441; wanas, hanaa/0000-0002-7109-939X; Singh Dr, Mahavir/0000-0003-0273-8394	Seventh Framework Program of the European Commission [223461]; Deutscher Akademischer Austauschdienst (DAAD)	Seventh Framework Program of the European Commission; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work received funding from the Seventh Framework Program of the European Commission under grant agreement No. 223461(Aeropath). The funder provided support in the form of salaries for authors [AAE, SS, WO, YB, CH, MM and MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AAE, SS, WO and MS are employed by LIONEX Diagnostics and Therapeutics GmbH. YB was employed during Aeropath project by LIONEX Diagnostics and Therapeutics GmbH. HW was supported by a doctoral scholarship from Deutscher Akademischer Austauschdienst (DAAD). CH and MM are employed by mfd Diagnostics GmbH. The specific roles of these authors are articulated in the 'author contributions' section.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Amini S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002298; BELUNIS CJ, 1995, J BIOL CHEM, V270, P27646, DOI 10.1074/jbc.270.46.27646; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; BODEY GP, 1983, REV INFECT DIS, V5, P279; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; CHRISTENSEN BG, 1969, SCIENCE, V166, P123, DOI 10.1126/science.166.3901.123; COMPTON LA, 1992, EUR J BIOCHEM, V206, P927, DOI 10.1111/j.1432-1033.1992.tb17002.x; Edwards KJ, 1997, J MOL BIOL, V271, P258, DOI 10.1006/jmbi.1997.1151; Eschenburg S, 2005, J BIOL CHEM, V280, P3757, DOI 10.1074/jbc.M411325200; Giamarellou H, 2002, J ANTIMICROB CHEMOTH, V49, P229, DOI 10.1093/jac/49.2.229; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goldova J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-437; Heijenoort J.V, 1994, NEW COMPR BIOCH, V27, P39, DOI 10.1016/S0167-7306(08)60406-8; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Krasowski A, 2011, J CHEM INF MODEL, V51, P2829, DOI 10.1021/ci200266d; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Moynie L, 2013, J MOL BIOL, V425, P365, DOI 10.1016/j.jmb.2012.11.017; Moynie L, 2013, ACTA CRYSTALLOGR F, V69, P25, DOI 10.1107/S1744309112044739; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; Rogers H.J., 1980, MICROBIAL CELL WALLS, P239; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017; Steinberger RE, 2002, MICROBIAL ECOL, V43, P416, DOI 10.1007/s00248-001-1063-z; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yoon HJ, 2008, PROTEINS, V71, P1032, DOI 10.1002/prot.21959; Yu H, 1996, INFECT IMMUN, V64, P2774, DOI 10.1128/IAI.64.7.2774-2781.1996	45	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186801	10.1371/journal.pone.0186801	http://dx.doi.org/10.1371/journal.pone.0186801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045498	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100091
J	Li, S; Liang, X; Ma, L; Shen, L; Li, T; Zheng, L; Sun, A; Shang, W; Chen, C; Zhao, W; Jia, J				Li, S.; Liang, X.; Ma, L.; Shen, L.; Li, T.; Zheng, L.; Sun, A.; Shang, W.; Chen, C.; Zhao, W.; Jia, J.			MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis	ONCOGENE			English	Article							HELICOBACTER-PYLORI; CANCER DEVELOPMENT; SUPPRESSOR-CELLS; INFLAMMASOME; PROGRESSION; ACTIVATION; MELANOMA; RECEPTOR; DIFFERENTIATION; SUSCEPTIBILITY	Chronic inflammation is the primary cause of gastric cancer (GC). NLRP3, as an important inflammasome component, has crucial roles in initiating inflammation. However, the potential roles of NLRP3 in GC is unknown. Here, we show that NLRP3 expression is markedly upregulated in GC, which promotes NLRP3 inflammasome activation and interleukin-1 beta (IL-1 beta) secretion in macrophages. In addition, NLRP3 binds to cyclin-D1 (CCND1) promoter and promotes its transcription in gastric epithelial cells. Consequently, NLRP3 enhances epithelial cells proliferation and GC tumorigenesis. Furthermore, we identify miR-22, which is constitutively expressed in gastric mucosa, as a suppressor of NLRP3. MiR-22 directly targets NLRP3 and attenuates its oncogenic effects in vitro and in vivo. However, Helicobacter pylori (H. pylori) infection suppresses miR-22 expression, while enhances NLRP3 expression, and that triggers uncontrolled proliferation of epithelial cells and the emergence of GC. Thus, our research describes a mechanism by which miR-22 suppresses NLRP3 and maintains homeostasis of gastric microenvironments and suggests miR-22 as a potential target for the intervention of GC.	[Li, S.; Liang, X.; Ma, L.; Shen, L.; Li, T.; Zheng, L.; Sun, A.; Shang, W.; Jia, J.] Shandong Univ, Sch Basic Med Sci, Dept Microbiol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Li, S.; Liang, X.; Ma, L.; Shen, L.; Li, T.; Zheng, L.; Sun, A.; Shang, W.; Zhao, W.; Jia, J.] Shandong Univ, Sch Basic Med Sci, Key Lab Infect & Immun Shandong Prov, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Chen, C.] Shandong Univ, Qilu Hosp, Canc Ctr, Jinan, Shandong, Peoples R China; [Zhao, W.] Shandong Univ, Sch Basic Med Sci, Dept Immunol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Jia, J (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Microbiol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Zhao, W; Jia, J (corresponding author), Shandong Univ, Sch Basic Med Sci, Key Lab Infect & Immun Shandong Prov, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Zhao, W (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Immunol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	wzhao@sdu.edu.cn; jiajihui@sdu.edu.cn	Li, Shuyan/AAE-5060-2020	zheng, lixin/0000-0003-0760-4176; Zhao, Wei/0000-0001-8440-2274	National Natural Science Foundation of China [81772151, 81571960, 81371781, 81670146, 81470318, 81372680, 81471991, 81501720]; Science Foundation of Shandong Province [2017GSF18194, 2017GSF18109, 2014GSF118114, ZR2014HQ070]; Independent Innovation Foundation of Shandong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University	This work was supported by the National Natural Science Foundation of China (Nos. 81772151, 81571960, 81371781, 81670146, 81470318, 81372680, 81471991 and 81501720), the Science Foundation of Shandong Province (2017GSF18194, 2017GSF18109, 2014GSF118114 and ZR2014HQ070), and the Independent Innovation Foundation of Shandong University.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Allison CC, 2013, J IMMUNOL, V190, P3706, DOI 10.4049/jimmunol.1200591; Amieva M, 2016, GASTROENTEROLOGY, V150, P64, DOI 10.1053/j.gastro.2015.09.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Bruchard M, 2015, NAT IMMUNOL, V16, P859, DOI 10.1038/ni.3202; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Castano-Rodriguez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098899; Chochi K, 2008, CLIN CANCER RES, V14, P2909, DOI 10.1158/1078-0432.CCR-07-4467; Chow MT, 2012, CANCER RES, V72, P5721, DOI 10.1158/0008-5472.CAN-12-0509; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Huai WW, 2016, P NATL ACAD SCI USA, V113, P11925, DOI 10.1073/pnas.1601556113; Huai WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5738; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karki R, 2016, NATURE; Lamb A, 2013, J CELL BIOCHEM, V114, P491, DOI 10.1002/jcb.24389; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Nam KT, 2004, CLIN CANCER RES, V10, P8105, DOI 10.1158/1078-0432.CCR-04-0896; Pasqualini L, 2015, MOL ENDOCRINOL, V29, P1037, DOI 10.1210/me.2014-1358; Petrilli V, 2017, CURR OPIN ONCOL, V29, P35, DOI 10.1097/CCO.0000000000000346; Ping PH, 2016, ARCH BIOCHEM BIOPHYS, V604, P20, DOI 10.1016/j.abb.2016.06.001; Qin Y, 2015, PIGM CELL MELANOMA R, V28, P236, DOI 10.1111/pcmr.12348; Semper RP, 2014, J IMMUNOL, V193, P3566, DOI 10.4049/jimmunol.1400362; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Song JH, 2012, GASTROENTEROLOGY, V143, P35, DOI 10.1053/j.gastro.2012.05.003; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Suarez G, 2015, CANCER RES, V75, P1749, DOI 10.1158/0008-5472.CAN-14-2291; Tatsuta T, 2012, J CLIN PATHOL, V65, P839, DOI 10.1136/jclinpath-2011-200590; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; Verma D, 2012, PIGM CELL MELANOMA R, V25, P506, DOI 10.1111/j.1755-148X.2012.01008.x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wan WN, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0178-8; Wang X, 2014, BIOCHEM BIOPH RES CO, V445, P175, DOI 10.1016/j.bbrc.2014.01.160; Wei Q, 2014, LAB INVEST, V94, P52, DOI 10.1038/labinvest.2013.126; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang F, 2015, J BIOL CHEM, V290, P6507, DOI 10.1074/jbc.M114.620369; Yoshihama S, 2016, P NATL ACAD SCI USA, V113, P5999, DOI 10.1073/pnas.1602069113; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.297	53	77	85	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 15	2018	37	7					884	896		10.1038/onc.2017.381	http://dx.doi.org/10.1038/onc.2017.381			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FW4KH	29059152				2022-12-26	WOS:000425281800006
J	Shao, C; Chien, SJ; Farah, E; Li, Z; Ahmad, N; Liu, X				Shao, C.; Chien, S-J; Farah, E.; Li, Z.; Ahmad, N.; Liu, X.			Plk1 phosphorylation of Numb leads to impaired DNA damage response	ONCOGENE			English	Article							MAMMALIAN NUMB; SELF-RENEWAL; P53; PROTEIN; DEGRADATION; BINDING; CELLS; MDM2; UBIQUITINATION; IDENTIFICATION	Although Numb is well-recognized as a cell-fate determinant in stem/progenitor cells, accumulating evidence supports that Numb also has a critical role in adult tissues and cancers, in particular, in the context of regulation of tumor suppressor p53. Herein, we identified Numb as a novel substrate of Polo-like kinase 1 (Plk1). Of significance, we showed that Plk1-mediated phosphorylation of Numb leads to its enhanced proteasomal degradation and impaired Numb/p53 pathway, thus providing another mechanism how Plk1 antagonizes p53 during DNA damage response. In addition, the novel phosphorylation event identified by us further supports the notion that post-translational modifications of Numb uncouple Numb from p53 and lead to p53 destabilization. Finally, our data generated from both human cancer cell lines and mouse xenograft model showed that cancer cells carrying the unphosphorylated form of Numb by Plk1 are more sensitive to doxorubicin, a classical chemotherapeutic drug. Therefore, our work may provide future strategies for improving the efficacy of chemotherapy by targeting Numb phosphorylation by Plk1.	[Shao, C.; Farah, E.; Li, Z.; Liu, X.] Purdue Univ, Dept Biochem, 175S Univ St, W Lafayette, IN 47907 USA; [Chien, S-J] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Ahmad, N.] Univ Wisconsin, Dept Dermatol, Madison, WI USA; [Liu, X.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liu, X (corresponding author), Purdue Univ, Dept Biochem, 175S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887	NIH [R01 CA157429, R01 CA192894, R01 CA196835, R01 CA196634, R01 AR059130, R01 CA176748]; Purdue University Center for Cancer Research [P30 CA023168]; NATIONAL CANCER INSTITUTE [R01CA157429, R01CA176748, R01CA196835, R01CA196634, R01CA192894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059130] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants R01 CA157429 (X Liu), R01 CA192894 (X Liu), R01 CA196835 (X Liu), R01 CA196634 (X Liu), R01 AR059130 (N Ahmad) and R01 CA176748 (N Ahmad). The work was also partially supported by Purdue University Center for Cancer Research (P30 CA023168).	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dhami GK, 2013, MOL CELL, V50, P565, DOI 10.1016/j.molcel.2013.04.028; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; George RM, 2013, P NATL ACAD SCI USA, V110, P18549, DOI 10.1073/pnas.1311628110; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Liu D, 2016, HEPATOLOGY, V64, P390, DOI 10.1002/hep.28594; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sakurai Y, 2014, MOL PHARMACEUT, V11, P2713, DOI 10.1021/mp500245z; Schmit TL, 2012, CANCER RES, V72, P3864, DOI 10.1158/0008-5472.CAN-12-0714; Sczaniecka M, 2012, J BIOL CHEM, V287, P14052, DOI 10.1074/jbc.M111.303875; Shao T, 2015, CELL CYCLE, V14, P755, DOI 10.1080/15384101.2014.998050; Siddique HR, 2015, HEPATOLOGY, V62, P1466, DOI 10.1002/hep.27987; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Yogosawa S, 2003, BIOCHEM BIOPH RES CO, V302, P869, DOI 10.1016/S0006-291X(03)00282-1; Zhang H, 2015, CANCER RES, V75, P2363, DOI 10.1158/0008-5472.CAN-14-2928; Zhu K, 2016, STRUCTURE, V24, P1110, DOI 10.1016/j.str.2016.04.012	31	10	12	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					810	820		10.1038/onc.2017.379	http://dx.doi.org/10.1038/onc.2017.379			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059161	Green Accepted			2022-12-26	WOS:000424628100012
J	Sanghez, V; Luzzi, A; Clarke, D; Kee, D; Beuder, S; Rux, D; Osawa, M; Madrenas, J; Chou, TF; Kyba, M; Iacovino, M				Sanghez, Valentina; Luzzi, Anna; Clarke, Don; Kee, Dustin; Beuder, Steven; Rux, Danielle; Osawa, Mitsujiro; Madrenas, Joaquin; Chou, Tsui-Fen; Kyba, Michael; Iacovino, Michelins			Notch activation is required for downregulation of HoxA3-dependent endothelial cell phenotype during blood formation	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; HAEMOGENIC ENDOTHELIUM; VASCULAR DEVELOPMENT; EMBRYONIC LETHALITY; RUNX1 EXPRESSION; SIGNAL STRENGTH; LIGAND JAGGED1; CIS-INHIBITION; AGM REGION; ARTERIAL	Hemogenic endothelium (HE) undergoes endothelial-to-hematopoietic transition (EHT) to generate blood, a process that requires progressive down-regulation of endothelial genes and induction of hematopoietic ones. Previously, we have shown that the transcription factor HoxA3 prevents blood formation by inhibiting Runx1 expression, maintaining endothelial gene expression and thus blocking EHT. In the present study, we show that HoxA3 also prevents blood formation by inhibiting Notch pathway. HoxA3 induced upregulation of Jag1 ligand in endothelial cells, which led to cis-inhibition of the Notch pathway, rendering the HE nonresponsive to Notch signals. While Notch activation alone was insufficient to promote blood formation in the presence of HoxA3, activation of Notch or downregulation of Jag1 resulted in a loss of the endothelial phenotype which is a prerequisite for EHT. Taken together, these results demonstrate that Notch pathway activation is necessary to downregulate endothelial markers during EHT.	[Sanghez, Valentina; Luzzi, Anna; Clarke, Don; Kee, Dustin; Beuder, Steven; Chou, Tsui-Fen; Iacovino, Michelins] Harbor UCLA Med Ctr, Dept Pediat, Div Med Genet, Torrance, CA 90509 USA; [Sanghez, Valentina; Luzzi, Anna; Clarke, Don; Kee, Dustin; Beuder, Steven; Madrenas, Joaquin; Chou, Tsui-Fen; Iacovino, Michelins] Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Rux, Danielle; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Osawa, Mitsujiro] Kyoto Univ, Ctr iPS Cell Res & Applicat, CiRA, Kyoto, Japan; [Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Minnesota System; University of Minnesota Twin Cities; Kyoto University; McGill University	Iacovino, M (corresponding author), Harbor UCLA Med Ctr, Dept Pediat, Div Med Genet, Torrance, CA 90509 USA.; Iacovino, M (corresponding author), Los Angeles Biomed Res Inst, Torrance, CA 90502 USA.	iacovino@UCLA.edu	Madrenas, Quim/P-5008-2019	Kyba, Michael/0000-0002-5579-7534; Kee, Dustin/0000-0001-6806-4957; Rux, Danielle/0000-0002-9952-4474; Sanghez, Valentina/0000-0002-4131-7480; iacovino, michelina/0000-0002-1076-3146	NIH [U01 HL100407, 1R01 HL081186]; American Heart Association grant [12SDG9260007]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association)	This research was supported by NIH grants U01 HL100407 and 1R01 HL081186 and by the American Heart Association grant 12SDG9260007. J.M. holds a Tier I Canada Research Chair ih Human Immunology.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bee T, 2009, BLOOD, V113, P5121, DOI 10.1182/blood-2008-12-193003; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Durand C, 2007, P NATL ACAD SCI USA, V104, P20838, DOI 10.1073/pnas.0706923105; Fitch SR, 2012, CELL STEM CELL, V11, P554, DOI 10.1016/j.stem.2012.07.002; Fleming RJ, 2013, DEVELOPMENT, V140, P2039, DOI 10.1242/dev.087916; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gama-Norton L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9510; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Guiu J, 2013, J EXP MED, V210, P71, DOI 10.1084/jem.20120993; Iacovino M, 2011, NAT CELL BIOL, V13, P72, DOI 10.1038/ncb2137; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Krebs LT, 2000, GENE DEV, V14, P1343; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; Lizama CO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8739; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Richard C, 2013, DEV CELL, V24, P600, DOI 10.1016/j.devcel.2013.02.011; Robert-Moreno A, 2005, DEVELOPMENT, V132, P1117, DOI 10.1242/dev.01660; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Souilhol C, 2016, BLOOD, V128, P1567, DOI 10.1182/blood-2016-03-708164; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Van de Walle I, 2013, J EXP MED, V210, P683, DOI 10.1084/jem.20121798; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	37	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186818	10.1371/journal.pone.0186818	http://dx.doi.org/10.1371/journal.pone.0186818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073173	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000413845400056
J	Theeuwes, HP; van der Ende, B; Potters, JW; Kerver, AJ; Bessems, JHJM; Kleinrensink, GJ				Theeuwes, H. P.; van der Ende, B.; Potters, J. W.; Kerver, A. J.; Bessems, J. H. J. M.; Kleinrensink, G-J.			The course of the radial nerve in the distal humerus: A novel, anatomy based, radiographic assessment	PLOS ONE			English	Article							SURGICAL ANATOMY; SHAFT FRACTURE; PALSY; MANAGEMENT; INJURY	Iatrogenic nerve injury during fracture surgery of the upper arm is a well-known complication. Prevention of this type of injuries would be of great value. The literature describes several methods to reduce this type of injury, but no perfect solution is at hand. In this study we introduce a new radiographic evaluation of the course and variation of the radial nerve in the distal part of the humerus in relation to bony landmarks as observed on a plain (trauma) radiographs. Aim of this new approach is to reduce the chance of iatrogenic nerve injury by defining of a danger zone in the distal upper arm regarding the radial nerve and hence give an advise for future implant fabrication. Methods and findings Measurements were done on both arms of ten specially embalmed specimens. Arms were dissected and radiopaque wires attached to the radial nerve in the distal part of the upper arm. Digital radiographs were obtained to determine the course of the radial nerve in the distal 20 cm of the humerus in relation to bony landmarks; medial epicondyle and capitellum-trochlea projection (CCT). Analysis was done with ImageJ and Microsoft Excel software. We also compared humeral nail specifications from different companies with the course of the radial nerve to predict possible radial nerve damage. Results The distance from the medial epicondyle to point where the radial nerve bends from posterior to lateral was 142 mm on AP radiographs and 152 mm measured on the lateral radiographs. The average distance from the medial epicondyle to point where the radial nerve bends from lateral to anterior on AP radiographs was 66 mm. On the lateral radiographs where the nerve moves away from the anterior cortex 83 mm to the center of capitellum and trochlea (CCT). The distance from the bifurcation of the radial nerve into the posterior interosseous nerve (PIN) and superficial radial nerve was 21 mm on AP radiographs and 42 mm on the lateral radiographs (CCT). Conclusions The course of the radial nerve in the distal part of the upper arm has great variety. Lateral fixation is relatively safe in a zone between the center of capitellum-trochlea and 48 mm proximal to this point. The danger zone in lateral fixation is in-between 48-122 mm proximal from CCT. In anteroposterior direction; distal fixation is dangerous between 21-101 mm measured from the medial epicondyle. The more distal, the more medial the nerve courses making it more valuable to iatrogenic damage. The IMN we compared with our data all show potential risk in case of (blind) distal locking, especially from lateral to medial direction.	[Theeuwes, H. P.; van der Ende, B.; Potters, J. W.; Kleinrensink, G-J.] Erasmus MC, Univ Med Ctr, Dept Neurosci Anat, Rotterdam, Netherlands; [Theeuwes, H. P.; van der Ende, B.; Potters, J. W.; Kleinrensink, G-J.] Erasmus MC, Univ Med Ctr, Erasmus MC Anat Res Project EARP, Rotterdam, Netherlands; [Theeuwes, H. P.] VieCuri Med Ctr, Dept Surg, Tegelseweg Bl Venlo, Netherlands; [van der Ende, B.] Reinier de Graafweg AD Delft, Dept Orthoped Surg, Reinier de Graaf Gasthuis, Delft, Netherlands; [Potters, J. W.] Erasmus MC, Dept Anesthesiol, Univ Med Ctr, Rotterdam, Netherlands; [Kerver, A. J.] Franciscus Gasthuis & Vlietland, Dept Surg, Rotterdam, Netherlands; [Bessems, J. H. J. M.] Erasmus MC, Univ Med Ctr, Dept Orthoped Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; VieCuri Medical Center; Reinier de Graaf Hospital; Erasmus University Rotterdam; Erasmus MC; Franciscus Gasthuis; Erasmus University Rotterdam; Erasmus MC	Theeuwes, HP (corresponding author), Erasmus MC, Univ Med Ctr, Dept Neurosci Anat, Rotterdam, Netherlands.; Theeuwes, HP (corresponding author), Erasmus MC, Univ Med Ctr, Erasmus MC Anat Res Project EARP, Rotterdam, Netherlands.; Theeuwes, HP (corresponding author), VieCuri Med Ctr, Dept Surg, Tegelseweg Bl Venlo, Netherlands.	hilcotheeuwes@gmail.com		Theeuwes, Hilco/0000-0003-4900-3539				Apergis E, 1998, J TRAUMA, V45, P825, DOI 10.1097/00005373-199810000-00040; Arora S, 2011, CLIN ORTHOP RELAT R, V469, P2638, DOI 10.1007/s11999-011-1791-4; Bishop J, 2009, J HAND SURG-AM, V34A, P991, DOI 10.1016/j.jhsa.2008.12.029; Bono CM, 2000, CLIN ORTHOP RELAT R, P259; Chaudhry T, 2010, CLIN ANAT, V23, P222, DOI 10.1002/ca.20903; Chou PH, 2008, CLIN ORTHOP RELAT R, V466, P135, DOI 10.1007/s11999-007-0019-0; Cox CL, 2010, CLIN ANAT, V23, P420, DOI 10.1002/ca.20951; Fleming P, 2004, CLIN ANAT, V17, P26, DOI 10.1002/ca.10181; GUSE TR, 1995, CLIN ORTHOP RELAT R, P149; Hems TEJ, 2012, J BONE JOINT SURG BR, V94B, P799, DOI 10.1302/0301-620X.94B6.28286; Kim SH, 2008, ARTHRIT CARE RES, V64, P407, DOI DOI 10.1002/ACR.21563; Klitsie PJ, 2017, SURG ENDOSC, V31, P1754, DOI 10.1007/s00464-016-5168-3; Kurup H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005959.pub2; Noger M, 2007, INJURY, V38, P954, DOI 10.1016/j.injury.2007.04.014; Putti Amit B, 2009, J Orthop Surg (Hong Kong), V17, P139; Schemitsch EH, 1997, ANN PLAS SURG, V38, P623, DOI 10.1097/00000637-199706000-00010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slieker JC, 2012, SURG ENDOSC, V26, P2189, DOI 10.1007/s00464-012-2158-y; Stahl S, 1998, J ORTHOP TRAUMA, V12, P363, DOI 10.1097/00005131-199806000-00013; Theeuwes H., 2018, ANAT PHYSL BIOCH INT, V3, DOI [10.19080/apbij.2017.03.555604, DOI 10.19080/APBIJ.2017.03.555604]; Venouziou AI, 2011, INJURY, V42, P1289, DOI 10.1016/j.injury.2011.01.020; Wang Xun, 2014, Eur J Orthop Surg Traumatol, V24, P331, DOI 10.1007/s00590-013-1197-y	22	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186890	10.1371/journal.pone.0186890	http://dx.doi.org/10.1371/journal.pone.0186890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073240	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400069
J	Stilhano, RS; Samoto, VY; Silva, LM; Pereira, GJ; Erustes, AG; Smaili, SS; Han, SW				Stilhano, Roberta Sessa; Samoto, Vivian Yochiko; Silva, Leonardo Martins; Pereira, Gustavo Jose; Erustes, Adolfo Garcia; Smaili, Soraya Soubhi; Han, Sang Won			Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; HEPATIC STELLATE CELLS; TYPE-1 RECEPTOR; TGF-BETA; MYOCARDIAL FIBROSIS; CARDIAC FIBROSIS; AT(2) RECEPTOR; INJURIES; REGENERATION; EXPRESSION	Regeneration of injured skeletal muscles is affected by fibrosis, which can be improved by the administration of angiotensin II (AngII) receptor (ATR) blockers in normotensive animals. However, the role of ATR in skeletal muscle fibrosis in hypertensive organisms has not been investigated yet. The tibialis anterior (TA) muscle of spontaneously hypertensive (SHR) and Wistar rats (WR) were lacerated and a lentivector encoding a microRNA targeting AngII receptor type 1 (At1) (Lv-mirAT1a) or control (Lv-mirCTL) was injected. The TA muscles were collected after 30 days to evaluate fibrosis by histology and gene expression by real-time quantitative PCR (RT-qPCR) and Western blot. SHR's myoblasts were analyzed by RT-qPCR, 48 h after transduction. In the SHR's TA, AT1 protein expression was 23.5-fold higher than in WR without injury, but no difference was observed in the angiotensin II receptor type 2 (AT2) protein expression. TA laceration followed by suture (LS) produced fibrosis in the SHR (23.3 +/- 8.5%) and WR (7.9 +/- 1.5%). Lv-mirAT1 treatment decreased At1 gene expression in 50% and reduced fibrosis to 7% 30 days after. RT-qPCR showed that reduction in At1 expression is due to downregulation of the At1a but not of the At1b. RT-qPCR of myoblasts from SHR transduced with Lv-mirAT1a showed downregulation of the Tgf-b1, Tgf-b2, Smad3, Col1a1, and Col3a1 genes by mirAT1a. In vivo and in vitro studies indicate that hypertension overproduces skeletal muscle fibrosis, and AngII-AT1a signaling is the main pathway of fibrosis in SHR. Moreover, muscle fibrosis can be treated specifically by in loco injection of Lv-mirAT1a without affecting other organs.	[Stilhano, Roberta Sessa; Samoto, Vivian Yochiko; Silva, Leonardo Martins; Han, Sang Won] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Biophys, Sao Paulo, Brazil; [Pereira, Gustavo Jose; Erustes, Adolfo Garcia; Smaili, Soraya Soubhi] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Pharmacol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Han, SW (corresponding author), Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Biophys, Sao Paulo, Brazil.	sang.han@unifesp.br	Pereira, Gustavo José Silva/ABH-1344-2020; Martins, Leonardo/N-9454-2013; STILHANO, roberta/F-6923-2015; Adolfo, Erustes/AAT-9246-2021; Han, Sang W/D-4541-2012; Smaili, Soraya/AAH-2129-2019	Pereira, Gustavo José Silva/0000-0002-6765-1276; Martins, Leonardo/0000-0003-3524-4876; STILHANO, roberta/0000-0002-0653-5968; Smaili, Soraya/0000-0001-5844-1368; Erustes, Adolfo/0000-0002-1903-4150	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/20206-8, 2012/00753-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307044/2015-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2015/20206-8) (www.fapesp.br) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (307044/2015-7) (www.cnpg.br) to SWH, and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2012/00753-6) to RSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Halawani Moh'd Z, 2014, J Family Med Prim Care, V3, P272, DOI 10.4103/2249-4863.141635; ALMEKINDERS LC, 1993, SPORTS MED, V15, P139, DOI 10.2165/00007256-199315030-00001; Bedair HS, 2008, AM J SPORT MED, V36, P1548, DOI 10.1177/0363546508315470; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Chen XM, 1997, AM J PHYSIOL-RENAL, V272, pF299, DOI 10.1152/ajprenal.1997.272.3.F299; Cisternas F, 2015, CLIN SCI, V128, P307, DOI 10.1042/CS20140215; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cosentino F, 2005, AM J HYPERTENS, V18, P493, DOI 10.1016/j.amjhyper.2004.11.007; D'Amore A, 2005, HYPERTENSION, V46, P1347, DOI 10.1161/01.HYP.0000193504.51489.cf; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Dinh DT, 2001, CLIN SCI, V100, P481, DOI 10.1042/CS20000263; Dooley S, 2000, HEPATOLOGY, V31, P1094, DOI 10.1053/he.2000.6126; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Fan ZD, 2012, GENE THER, V19, P810, DOI 10.1038/gt.2011.145; Ferreira AJ, 2011, EXP PHYSIOL, V96, P287, DOI 10.1113/expphysiol.2010.055277; Fukuda N, 1998, HYPERTENSION, V31, P672, DOI 10.1161/01.HYP.31.2.672; Morales MG, 2012, INT J BIOCHEM CELL B, V44, P1993, DOI 10.1016/j.biocel.2012.07.028; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gorman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085537; Grefte S, 2010, MED SCI SPORT EXER, V42, P813, DOI 10.1249/MSS.0b013e3181beeb52; Gressner OA, 2008, J CELL MOL MED, V12, P2717, DOI 10.1111/j.1582-4934.2008.00260.x; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; JARVINEN MJ, 1993, SPORTS MED, V15, P78; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Kawano H, 2000, CIRCULATION, V101, P1130, DOI 10.1161/01.CIR.101.10.1130; Kiernan MS, 2012, EUR J HEART FAIL, V14, P1401, DOI 10.1093/eurjhf/hfs145; Kobayashi M, 2016, AM J SPORT MED, V44, P3252, DOI 10.1177/0363546516656823; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Levy BI, 2005, AM J HYPERTENS, V18, p134S, DOI 10.1016/j.amjhyper.2005.05.005; Li A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08334-x; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Matavelli LC, 2015, J CARDIOVASC PHARM, V65, P226, DOI 10.1097/FJC.0000000000000208; Meng GL, 2009, J CARDIOVASC PHARM, V54, P16, DOI 10.1097/FJC.0b013e3181a98b31; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Oemar BS, 1997, ARTERIOSCL THROM VAS, V17, P1483, DOI 10.1161/01.ATV.17.8.1483; Okamoto K, 1966, Jpn Circ J, V30, P703; Orchard J, 2002, CLIN J SPORT MED, V12, P3, DOI 10.1097/00042752-200201000-00004; Pei ZH, 2010, TOXICOL LETT, V199, P173, DOI 10.1016/j.toxlet.2010.08.021; PIACIBELLO W, 1991, HAEMATOLOGICA, V76, P460; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Prisk V, 2003, HISTOL HISTOPATHOL, V18, P1243, DOI 10.14670/HH-18.1243; Pu Q, 2008, J HYPERTENS, V26, P322, DOI 10.1097/HJH.0b013e3282f16aaf; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Santiago B, 2005, J INVEST DERMATOL, V125, P450, DOI 10.1111/j.0022-202X.2005.23859.x; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; SECHI LA, 1992, CIRC RES, V71, P1482, DOI 10.1161/01.RES.71.6.1482; Stilhano RS, 2016, J CONTROL RELEASE, V237, P42, DOI 10.1016/j.jconrel.2016.06.047; Su JZ, 2002, HYPERTENSION, V40, P853, DOI 10.1161/01.HYP.0000042096.17141.B1; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Wang ZQ, 1998, HYPERTENSION, V32, P78, DOI 10.1161/01.HYP.32.1.78; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yabumoto C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14453; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531	66	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186719	10.1371/journal.pone.0186719	http://dx.doi.org/10.1371/journal.pone.0186719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059221	gold, Green Published, Green Submitted			2022-12-26	WOS:000413403000037
J	Ahmed, SS; Liu, DG; Simon, JC				Ahmed, Syed Suhail; Liu, Deguang; Simon, Jean-Christophe			Impact of water-deficit stress on tritrophic interactions in a wheat-aphid-parasitoid system	PLOS ONE			English	Article							CLIMATE-CHANGE; HOST PLANTS; DIFFERENTIAL PERFORMANCE; MYZUS-PERSICAE; FITNESS TRAITS; RESPONSES; NITROGEN; DROUGHT; TEMPERATURE; GIFUENSIS	Increasing temperature and CO2 concentrations can alter tritrophic interactions in ecosystems, but the impact of increasingly severe drought on such interactions is not well understood. We examined the response of a wheat-aphid-parasitoid system to variation in water-deficit stress levels. Our results showed that arid area clones of the aphid, Sitobion avenae ( Fabricius), tended to have longer developmental times compared to semiarid and moist area clones, and the development of S. avenae clones tended to be slower with increasing levels of water-deficit. Body sizes of S. avenae clones from all areas decreased with increasing water-deficit levels, indicating their declining adaptation potential under drought. Compared to arid area clones, moist area clones of S. avenae had a higher frequency of backing under severe water stress only, but a higher frequency of kicking under well watered conditions only, suggesting a water-deficit level dependent pattern of resistance against the parasitoid, Aphidius gifuensis (Ashmead). The number of S. avenae individuals attacked by the parasitoid in 10 min showed a tendency to decrease with increasing water-deficit levels. Clones of S. avenae tended to have lower parasitism rates under treatments with higher water-deficit levels. The development of the parasitoid tended to be slower under higher levels of water-deficit stress. Thus, the bottom-up effects of water-deficit stressed plants were negative on S. avenae. However, the top-down effects via parasitoids were compromised by water-deficit, which could favor the growth of aphid populations. Overall, the first trophic level under water-deficit stress was shown to have an indirect and negative impact on the third trophic level parasitoid, suggesting that parasitoids could be increasingly vulnerable in future warming scenarios.	[Ahmed, Syed Suhail; Liu, Deguang] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Ahmed, Syed Suhail; Liu, Deguang] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Simon, Jean-Christophe] INRA, UMR 1349, IGEPP, Domaine De La Motte, Le Rheu, France	Northwest A&F University - China; Northwest A&F University - China; INRAE	Liu, DG (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Liu, DG (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	dgliu@nwsuaf.edu.cn			National Natural Science Foundation of China [31572002]; Northwest AF University [QN2011059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest AF University	This work was supported by the National Natural Science Foundation of China (No. 31572002), received by D.L. (https://isisn.nsfc.gov.cn), also supported by a grant from Northwest A&F University (No. QN2011059), received by D.L. (http//www.nwsuafedu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank P. Dai (Northwest A&F University, China) for laboratory and field assistance. This research was supported by the National Natural Science Foundation of China (No. 31572002), and a grant from Northwest A&F University (No. QN2011059).	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; [Anonymous], 2008, INFORM OFFICE STATE; ARCHER TL, 1995, CROP PROT, V14, P165, DOI 10.1016/0261-2194(95)92872-K; Becker C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/342982; Bezemer TM, 1998, OECOLOGIA, V116, P128, DOI 10.1007/s004420050571; Burgess AJ, 1996, ACTA HORTIC, P499, DOI 10.17660/ActaHortic.1996.407.63; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Cao Y.-Z., 2006, CHINA PLANT PROT, V26, P11; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Dai P, 2017, BMC ECOL IN PRESS; Dai P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29974; Dai P, 2015, J ECON ENTOMOL, V108, P2250, DOI 10.1093/jee/tov210; Dai XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106179; [邓振镛 Deng Zhenyong], 2010, [生态学报, Acta Ecologica Sinica], V30, P6278; DORSCHNER KW, 1986, ENVIRON ENTOMOL, V15, P118, DOI 10.1093/ee/15.1.118; Gao SX, 2014, INSECT SCI, V21, P352, DOI 10.1111/1744-7917.12085; Gao SX, 2013, J ECON ENTOMOL, V106, P1294, DOI 10.1603/EC13017; Garg BK, 2001, BIOL PLANTARUM, V44, P289, DOI 10.1023/A:1010215812791; Godfray HCJ., 1994, PARASITOIDS BEHAV EV, P473, DOI [10.1515/9780691207025, DOI 10.1515/9780691207025]; Guo H, 2015, J EXP BOT, V32, P365; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Han P, 2016, J CHEM ECOL, V42, P1293, DOI 10.1007/s10886-016-0795-7; Han P, 2015, ECOL EVOL, V5, P5468, DOI 10.1002/ece3.1788; Han P, 2015, J PEST SCI, V88, P685, DOI 10.1007/s10340-015-0662-2; Han P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04455; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Huang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122343; Huang XL, 2013, ENVIRON ENTOMOL, V42, P1174, DOI 10.1603/EN13132; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Johnson SN, 2011, J ECOL, V99, P57, DOI 10.1111/j.1365-2745.2010.01748.x; Leng GY, 2015, GLOBAL PLANET CHANGE, V126, P23, DOI 10.1016/j.gloplacha.2015.01.003; Li H, 2008, ENVIRON EXP BOT, V63, P305, DOI 10.1016/j.envexpbot.2007.11.014; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Mody K, 2009, ECOL ENTOMOL, V34, P133, DOI 10.1111/j.1365-2311.2008.01053.x; Munir S, 2016, J APPL ENTOMOL, V140, P364, DOI 10.1111/jen.12257; Murray TJ, 2013, GLOBAL CHANGE BIOL, V19, P1407, DOI 10.1111/gcb.12142; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Olson DM, 2009, BIOL CONTROL, V49, P239, DOI 10.1016/j.biocontrol.2009.02.011; Pan MZ, 2014, BIOL CONTROL, V69, P90, DOI 10.1016/j.biocontrol.2013.11.007; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pompon J, 2011, J INSECT PHYSIOL, V57, P1317, DOI 10.1016/j.jinsphys.2011.06.007; Romo CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058136; SAS, 2008, SAS SYST VERS 9 1 3; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Van Nouhuys S, 2004, J ANIM ECOL, V73, P526, DOI 10.1111/j.0021-8790.2004.00827.x; Vickers L, 2011, THESIS; Vinson S.B., 1984, P205; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23177; WICKREMASINGHE MGV, 1992, PHYSIOL ENTOMOL, V17, P297, DOI 10.1111/j.1365-3032.1992.tb01025.x; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; Yang S, 2011, J ENTOMOL RES SOC, V13, P87; Yang S, 2009, INSECT SCI, V16, P503, DOI 10.1111/j.1744-7917.2009.01282.x	55	16	17	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186599	10.1371/journal.pone.0186599	http://dx.doi.org/10.1371/journal.pone.0186599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053722	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100025
J	Golebiewska, J; Olechowski, A; Wysocka-Mincewicz, M; Odrobina, D; Baszynska-Wilk, M; Groszek, A; Szalecki, M; Hautz, W				Golebiewska, Joanna; Olechowski, Andrzej; Wysocka-Mincewicz, Marta; Odrobina, Dominik; Baszynska-Wilk, Marta; Groszek, Artur; Szalecki, Mieczyslaw; Hautz, Wojciech			Optical coherence tomography angiography vessel density in children with type 1 diabetes	PLOS ONE			English	Article							FOVEAL AVASCULAR ZONE; RETINOPATHY; DURATION; COMPLICATIONS; ADOLESCENTS; PREVALENCE	Purpose To assess the optical coherence tomography angiography (OCTA) retinal vessel density and foveal avascular zone (FAZ) in children with type 1 diabetes (T1D) and compare potential pathologic early changes in this population to healthy age-matched controls. Methods This study included 130 pubescent children: 94 with T1D (188 eyes) and 36 of their age-matched control group (60 eyes). OCTA was performed using AngioVue (Avanti, Optivue). FAZ area (mm 2) in superficial plexus, whole superficial capillary vessel density (wsVD), fovea superficial vessel density (fsVD), parafovea superficial vessel density (psVD), whole deep vessel density (wdVD), fovea deep vessel density (fdVD), parafovea deep vessel density (pdVD), foveal thickness (FT) (mu m) and parafoveal thickness (PFT) (mu m) were taken into analysis. Among the studied patients with T1D there were assessed codependences regarding the investigated foveal and parafoveal parameters and selected potential predictors, i.e. patient's age (years), diabetes duration time (years), age of onset of the disease (years), mean level of glycated hemoglobin (HbA1C) (%), and concentration of serum creatinine (mg/dL). Results None of the abovementioned OCT and OCTA parameters was statistically significantly different between the groups. The patient's age statistically significantly did not influent any of the OCT and OCTA parameters. Yet an elevated level of HbA1C tended to reduce the parafovea superficial vessel density (p = 0.039), and parafoveal thickness (p = 0.003) and an increased serum creatinine level correlated with the decreased whole deep vessel density (p < 0.001). The parafovea deep vessel density in the diabetic patients decreased when the serum creatinine level (p = 0.008), age of onset of the disease (p = 0.028), and diabetes duration time (p = 0.014) rose. Conclusions Vessel density, both in superficial and deep plexuses, and FAZ area are normal in pubescent children with T1D comparing to healthy subjects. An elevated level of HbA1C correlated with reduced psVD and PFT. Longitudinal observation of these young patients is needed to determine if any of these OCTA measurements are predictive of future DR severity.	[Golebiewska, Joanna; Olechowski, Andrzej; Hautz, Wojciech] Childrens Mem Hlth Inst, Dept Ophthalmol, Aleja Dzieci Polskich 20, Warsaw, Poland; [Wysocka-Mincewicz, Marta; Baszynska-Wilk, Marta; Groszek, Artur; Szalecki, Mieczyslaw] Childrens Mem Hlth Inst, Dept Diabetol & Endocrinol, Aleja Dzieci Polskich 20, Warsaw, Poland; [Odrobina, Dominik; Szalecki, Mieczyslaw] Jan Kochanowski Mem Univ Kielce, Dept Med & Hlth Sci, Kielce, Poland; [Odrobina, Dominik] St John Boni Fratres Lodziensis, Ophthalmol Clin, Lodz, Poland	Children's Memorial Health Institute; Children's Memorial Health Institute	Golebiewska, J (corresponding author), Childrens Mem Hlth Inst, Dept Ophthalmol, Aleja Dzieci Polskich 20, Warsaw, Poland.	joanna.golebiewska@wp.pl	Gołębiewska, Joanna/GMW-5071-2022; Szalecki, Mieczyslaw/AAI-3112-2021; Gołębiewska, Joanna/ABF-6966-2021	Gołębiewska, Joanna/0000-0002-3013-4363; Szalecki, Mieczyslaw/0000-0002-2950-761X; Olechowski, Andrzej/0000-0003-2089-4518; Wysocka-Mincewicz, Marta/0000-0001-8213-9759; Hautz, Wojciech/0000-0003-2065-8646; Groszek, Artur/0000-0003-1047-4579				Agemy SA, 2015, RETINA-J RET VIT DIS, V35, P2353, DOI 10.1097/IAE.0000000000000862; [Anonymous], 1991, OPHTHALMOLOGY, V98, P807; [Anonymous], 1991, OPHTHALMOLOGY, V98, P834; AREND O, 1991, BRIT J OPHTHALMOL, V75, P514, DOI 10.1136/bjo.75.9.514; Chakrabarti R, 2012, EXPERT REV OPHTHALMO, V7, P417, DOI 10.1586/EOP.12.52; Cho YH, 2014, PEDIATR DIABETES, V15, P18, DOI 10.1111/pedi.12112; Choi W, 2017, RETINA-J RET VIT DIS, V37, P11, DOI 10.1097/IAE.0000000000001250; Couturier A, 2015, RETINA-J RET VIT DIS, V35, P2384, DOI 10.1097/IAE.0000000000000859; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Dimitrova G, 2017, INVEST OPHTH VIS SCI, V58, P190, DOI 10.1167/iovs.16-20531; Donaghue KC, 1997, DIABETES CARE, V20, P77, DOI 10.2337/diacare.20.1.77; Downie E, 2011, DIABETES CARE, V34, P2368, DOI 10.2337/dc11-0102; Forlenza GP, 2013, PEDIATR ENDOCR REV P, V10, P217; Geloneck MM, 2015, OPHTHALMOLOGY, V122, P2457, DOI 10.1016/j.ophtha.2015.07.010; Hautz W, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/7849243; Holl RW, 1998, J PEDIATR-US, V132, P790, DOI 10.1016/S0022-3476(98)70305-1; Hwang TS, 2015, RETINA-J RET VIT DIS, V35, P2371, DOI 10.1097/IAE.0000000000000716; Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Lichtenstein SJ, 2005, PEDIATRICS, V116, P270, DOI 10.1542/peds.2005-0875; MANSOUR AM, 1993, RETINA-J RET VIT DIS, V13, P125, DOI 10.1097/00006982-199313020-00006; Matsunaga DR, 2015, OSLI RETINA, V46, P796, DOI 10.3928/23258160-20150909-03; Olsen BS, 2004, J DIABETES COMPLICAT, V18, P160, DOI 10.1016/S1056-8727(03)00073-4; Palejwala NV, 2015, RETINA-J RET VIT DIS, V35, P2204, DOI 10.1097/IAE.0000000000000867; Samara WA, 2017, OPHTHALMOLOGY, V124, P235, DOI 10.1016/j.ophtha.2016.10.008; Samara WA, 2015, RETINA-J RET VIT DIS, V35, P2188, DOI 10.1097/IAE.0000000000000847; Stanga PE, 2016, DEV OPHTHALMOL, V56, P166, DOI 10.1159/000442809; Sultan MB, 2012, BRIT J OPHTHALMOL, V96, P312, DOI 10.1136/bjophthalmol-2011-300169; Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849; Tam J, 2012, OPTOMETRY VISION SCI, V89, pE692, DOI 10.1097/OPX.0b013e3182548b07; Ting DSW, 2017, JAMA OPHTHALMOL, V135, P306, DOI 10.1001/jamaophthalmol.2016.5877; YAMANA Y, 1988, BRIT J OPHTHALMOL, V72, P660, DOI 10.1136/bjo.72.9.660; Yarmohammadi A, 2016, OPHTHALMOLOGY, V123, P2498, DOI 10.1016/j.ophtha.2016.08.041	34	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186479	10.1371/journal.pone.0186479	http://dx.doi.org/10.1371/journal.pone.0186479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053718	gold, Green Published, Green Submitted			2022-12-26	WOS:000413315100021
J	Khan, AA; Qureshi, IZ				Khan, Abdul Aziz; Qureshi, Irfan Zia			Vocalizations of adult male Asian koels (Eudynamys scolopacea) in the breeding season	PLOS ONE			English	Article							SMOOTH-BILLED ANIS; VOCAL BEHAVIOR; BIRD CALLS; REPERTOIRE; COMMUNICATION; CONTEXT; JITTER; SONGS	Defining the vocal repertoire provides a basis for understanding the role of acoustic signals in sexual and social interactions of an animal. The Asian koel (Eudynamys scolopacea) is a migratory bird which spends its summer breeding season in the plains of Pakistan. The bird is typically wary and secretive but produces loud and distinct calls, making it easily detected when unseen. Like the other birds in the wild, presumably Asian koels use their calls for social cohesion and coordination of different behaviors. To date, the description of vocal repertoire of the male Asian koel has been lacking. Presently we analyzed and described for the first time the vocalizations of the adult male Asian koel, recorded in two consecutive breeding seasons. Using 10 call parameters, we categorized the vocalization type into six different categories on the basis of spectrogram and statistical analyses, namely the; "type 1 cooee call", "type 2 cooee call", "type 1 coegh call", "type 2 coegh call", "wurroo call" and "coe call". These names were assigned not on the basis of functional analysis and were therefore onomatopoeic. Stepwise cross validated discriminant function analysis classified the vocalization correctly (100%) into the predicted vocal categories that we initially classified on the basis of spectrographic examination. Our findings enrich the biological knowledge about vocalizations of the adult male Asian koel and provide a foundation for future acoustic monitoring of the species, as well as for comparative studies with vocalizations of other bird species of the cuckoo family. Further studies on the vocalizations of the Asian koel are required to unravel their functions in sexual selection and individual recognition.	[Khan, Abdul Aziz; Qureshi, Irfan Zia] Quaid I Azam Univ, Fac Biol Sci, Dept Anim Sci, Islamabad, Pakistan	Quaid I Azam University	Qureshi, IZ (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Anim Sci, Islamabad, Pakistan.	irfanzia@qau.edu.pk		Khan, Abdul Aziz/0000-0002-6695-0127	Quaid-i-Azam University [QAU-307]; Quaid-i-Azam University, Islamabad	Quaid-i-Azam University; Quaid-i-Azam University, Islamabad	Quaid-i-Azam University funded the research, Grant number: QAU-307, https://qau.edu.pk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to Quaid-i-Azam University, Islamabad for support and funding the present research.	Ali Habib, 2007, Pakistan Journal of Agricultural Sciences, V44, P627; [Anonymous], 1987, COMPACT HDB BIRDS IN; Baldo S, 2011, J FIELD ORNITHOL, V82, P249, DOI 10.1111/j.1557-9263.2011.00328.x; Benedict L, 2013, IBIS, V155, P225, DOI 10.1111/ibi.12049; Bretagnolle V, 1998, BEHAVIOUR, V135, P1161, DOI 10.1163/156853998792913555; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DAVIS WJ, 1988, BEHAVIOUR, V106, P1, DOI 10.1163/156853988X00061; Dorph A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179337; Evans CS, 2007, BIOL LETTERS, V3, P8, DOI 10.1098/rsbl.2006.0561; Farrus M., 2007, P 8 ANN C INT SPEECH, P778; Favaro L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103460; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Friedmann H, 1948, PARASITIC CUCKOOS AF; Garcia-Calero E, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00046; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; Grieves LA, 2014, ANIM BEHAV, V89, P215, DOI 10.1016/j.anbehav.2014.01.008; Grieves LA, 2015, J FIELD ORNITHOL, V86, P130, DOI 10.1111/jofo.12096; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; HOLM S, 1979, SCAND J STAT, V6, P65; Jancovic P, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/982936; Jiang JJ, 2003, J ACOUST SOC AM, V114, P2198, DOI 10.1121/1.1610462; Jung WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111982; Kilner Rebecca M., 2005, Ornithological Science, V4, P55, DOI 10.2326/osj.4.55; Lefevre K, 2001, CONDOR, V103, P134, DOI 10.1650/0010-5422(2001)103[0134:RSAIDO]2.0.CO;2; Li X, 2007, INT CONF ACOUST SPEE, P1081, DOI 10.1109/ICMLC.2007.4370304; Li Y, 2017, AVIAN RES, V8, DOI 10.1186/s40657-017-0079-0; Liu WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3082; Low LSA, 2010, INT CONF ACOUST SPEE, P5154, DOI 10.1109/ICASSP.2010.5495018; Maller CJ, 2001, EMU, V101, P105, DOI 10.1071/MU00025; Marler P, 2004, ANN NY ACAD SCI, V1016, P31, DOI 10.1196/annals.1298.034; Marler P., 2004, NATURES MUSIC SCI BI, P135; Mirza ZB, 2012, FIELD GUIDE BIRDS PA; Moller AP, 2016, ECOL INDIC, V66, P592, DOI 10.1016/j.ecolind.2016.02.037; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Passilongo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063841; Payne RB, 2005, THE CUCKOOS; Potamitis I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096936; Potamitis I, 2014, APPL ACOUST, V80, P1, DOI 10.1016/j.apacoust.2014.01.001; Radford AN, 2004, ETHOLOGY, V110, P11, DOI 10.1046/j.1439-0310.2003.00943.x; Radford AN, 2003, ANIM BEHAV, V66, P1035, DOI 10.1006/anbe.2003.2292; Rothschild M, 1957, FLEAS FLUKES CUCKOOS; Ryall Colin, 2003, Journal of the Bombay Natural History Society, V100, P136; Schodde R, 1997, AVES COLUMBIDAE COR, V2; Seddon N, 2002, BEHAVIOUR, V139, P1331, DOI 10.1163/156853902321104190; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Smotherman M, 2016, J COMP PHYSIOL A, V202, P535, DOI 10.1007/s00359-016-1105-0; Snijders L, 2017, ADV STUD BEHAV, V49, P297, DOI 10.1016/bs.asb.2017.02.004; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; TITZE IR, 1987, J SPEECH HEAR RES, V30, P252, DOI 10.1044/jshr.3002.252; Vieira MN, 2002, J ACOUST SOC AM, V111, P1045, DOI 10.1121/1.1430686; Zdenek CN, 2015, BIOACOUSTICS, V24, P253, DOI 10.1080/09524622.2015.1070281; Zsebok S, 2017, J ORNITHOL, V158, P213, DOI 10.1007/s10336-016-1376-9	53	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186604	10.1371/journal.pone.0186604	http://dx.doi.org/10.1371/journal.pone.0186604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053720	Green Submitted, Green Published, gold			2022-12-26	WOS:000413315100027
J	Lim, YK; Shin, DW; Kim, HS; Yun, JM; Shin, JH; Lee, H; Koo, HY; Kim, MJ; Yoon, JY; Cho, MH				Lim, Yoo Kyoung; Shin, Dong Wook; Kim, Hyeon Suk; Yun, Jae Moon; Shin, Jung-Hyun; Lee, Hyejin; Koo, Hye Yeon; Kim, Min Jung; Yoon, Jeong Yeon; Cho, Mi Hee			Persistent smoking after a cardiovascular event: A nationwide retrospective study in Korea	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; FOLLOW-UP; MAJOR DEPRESSION; 1ST-EVER STROKE; ISCHEMIC-STROKE; MORTALITY RISK; CESSATION; METAANALYSIS; BEHAVIOR	Smoking is a major risk factor of cardiovascular disease (CVD) such as stroke and ischemic heart disease. Prior studies have observed people continued smoking even after being diagnosed with CVD. However, population-level data regarding smoking behavior changes among people who are diagnosed with CVD are still lacking. From the National Health Insurance sample cohort database, we identified 1,700 patients diagnosed as having CVD between 2003 and 2012, and underwent the national health screening examination in the year before and after the CVD event. We found that 486 (28.6%) were smokers before the CVD event. Among them, 240 (49.4%) continued to smoke despite the diagnosis. We observed that a higher smoking amount and longer smoking duration before the diagnosis were associated with persistent smoking. Our finding that approximately 50% of smokers continue smoking even after CVD events supports the need for an assessment of patients' smoking statuses during follow-up after a CVD event and for health-care providers to offer the appropriate smoking cessation interventions to those who continue smoking.	[Lim, Yoo Kyoung; Yun, Jae Moon; Shin, Jung-Hyun; Lee, Hyejin; Koo, Hye Yeon; Kim, Min Jung; Yoon, Jeong Yeon; Cho, Mi Hee] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Lim, Yoo Kyoung; Yun, Jae Moon; Shin, Jung-Hyun; Lee, Hyejin; Koo, Hye Yeon; Kim, Min Jung; Yoon, Jeong Yeon; Cho, Mi Hee] Seoul Natl Univ Hosp, Hlth Promot Ctr, Seoul, South Korea; [Shin, Dong Wook] Samsung Med Ctr, Dept Family Med, Seoul, South Korea; [Shin, Dong Wook] Samsung Med Ctr, Support Care Ctr, Seoul, South Korea; [Kim, Hyeon Suk] Shinhan Univ, Sch Nursing, Uijongbu, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Shin, DW (corresponding author), Samsung Med Ctr, Dept Family Med, Seoul, South Korea.; Shin, DW (corresponding author), Samsung Med Ctr, Support Care Ctr, Seoul, South Korea.; Kim, HS (corresponding author), Shinhan Univ, Sch Nursing, Uijongbu, South Korea.	dwshin.md@gmail.com; september7777@hanmail.net	Shin, Dong Wook/J-6721-2016	Shin, Dong Wook/0000-0001-8128-8920				Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bak S, 2002, STROKE, V33, P2263, DOI 10.1161/01.STR.0000027210.50936.D0; Benowitz NL, 2013, J AM COLL CARDIOL, V61, P533, DOI 10.1016/j.jacc.2012.11.017; Blum MR, 2013, J CARDIOPULM REHABIL, V33, P84, DOI 10.1097/HCR.0b013e3182779b88; Broms U, 2004, NICOTINE TOB RES, V6, P447, DOI 10.1080/14622200410001696637; Caraballo RS, 2014, ADDICT BEHAV, V39, P101, DOI 10.1016/j.addbeh.2013.08.030; Colivicchi F, 2011, AM J CARDIOL, V108, P804, DOI 10.1016/j.amjcard.2011.04.033; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Giallauria Francesco, 2010, Monaldi Arch Chest Dis, V74, P44; Glassman AH, 2001, LANCET, V357, P1929, DOI 10.1016/S0140-6736(00)05064-9; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; He Y, 2014, AM J EPIDEMIOL, V179, P1060, DOI 10.1093/aje/kwu011; Hill MD, 2000, STROKE, V31, P123, DOI 10.1161/01.STR.31.1.123; Hitsman B, 2013, ADDICTION, V108, P294, DOI 10.1111/add.12009; Honjo K, 2010, NICOTINE TOB RES, V12, P1050, DOI 10.1093/ntr/ntq143; Ives SP, 2008, EUR J CARDIOV PREV R, V15, P329, DOI 10.1097/HJR.0b013e3282f37a58; Jung-Choi KH, 2012, TOB CONTROL, V21, P536, DOI 10.1136/tobaccocontrol-2011-050012; Kaplan RC, 2005, NEUROLOGY, V65, P835, DOI 10.1212/01.wnl.0000176058.09848.bb; Karimi-Moonaghi H, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.18162; Kenney BA, 2009, ADDICT BEHAV, V34, P548, DOI 10.1016/j.addbeh.2009.03.020; Kim HE, 2013, KOREAN J FAM MED, V34, P160, DOI 10.4082/kjfm.2013.34.3.160; Kim JS, 2014, J STROKE, V16, P55, DOI 10.5853/jos.2014.16.2.55; Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16; Kwon JA, 2015, YONSEI MED J, V56, P1143, DOI 10.3349/ymj.2015.56.4.1143; Lancaster T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001292.pub3; Lee H, 2015, PREV MED, V70, P19, DOI 10.1016/j.ypmed.2014.11.007; Lee JE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3583-y; Lee KS, 2014, J PUBLIC HEALTH-UK, V36, P225, DOI 10.1093/pubmed/fdt056; Lee SW, 2015, KOREAN CIRC J, V45, P202, DOI 10.4070/kcj.2015.45.3.202; MacCallum H, 2016, NEUROLOGY S, V86; Mathers C, 2012, WHO GLOBAL REPORT MO, P396; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Myung- SK, 2007, J KOREAN MED SCI, V22, P1065, DOI 10.3346/jkms.2007.22.6.1065; Newson JT, 2012, HEALTH REP, V23, P49; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Rahman MA, 2015, NICOTINE TOB RES; Rallidis LS, 2005, INT J CARDIOL, V100, P241, DOI 10.1016/j.ijcard.2004.08.040; Rigotti NA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub2; Shah AM, 2010, AM J CARDIOL, V106, P911, DOI 10.1016/j.amjcard.2010.05.021; Shin DW, 2016, JAMA INTERN MED, V176, P138, DOI 10.1001/jamainternmed.2015.7110; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Twardella D, 2006, J CLIN EPIDEMIOL, V59, P82, DOI 10.1016/j.jclinepi.2005.05.003; Van Spall HGC, 2007, AM HEART J, V154, P213, DOI 10.1016/j.ahj.2007.04.012; Weinberger AH, 2012, ADDICTION, V107, P1847, DOI 10.1111/j.1360-0443.2012.03889.x; Wilchesky M, J CLIN EPIDEMIOLOGY, V57, P131; Wilson K, 2000, ARCH INTERN MED, V160, P939, DOI 10.1001/archinte.160.7.939; Yang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143303; Yun WJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-724	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186872	10.1371/journal.pone.0186872	http://dx.doi.org/10.1371/journal.pone.0186872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0UN	29049380	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900121
J	Murray, JM; Zaunders, J; Emery, S; Cooper, DA; Hey-Nguyen, WJ; Koelsch, KK; Kelleher, AD				Murray, John M.; Zaunders, John; Emery, Sean; Cooper, David A.; Hey-Nguyen, William J.; Koelsch, Kersten K.; Kelleher, Anthony D.			HIV dynamics linked to memory CD4+T cell homeostasis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; LOW-LEVEL VIREMIA; ANTIRETROVIRAL THERAPY; IN-VIVO; RALTEGRAVIR INTENSIFICATION; COMBINATION THERAPY; DECAY KINETICS; INFECTED-CELLS; VIRAL LOAD	The dynamics of latent HIV is linked to infection and clearance of resting memory CD4+ T cells. Infection also resides within activated, non-dividing memory cells and can be impacted by antigen-driven and homeostatic proliferation despite suppressive antiretroviral therapy (ART). We investigated whether plasma viral level (pVL) and HIV DNA dynamics could be explained by HIV's impact on memory CD4+ T cell homeostasis. Median total, 2-LTR and integrated HIV DNA levels per mu L of peripheral blood, for 8 primary (PHI) and 8 chronic HIV infected (CHI) individuals enrolled on a raltegravir (RAL) based regimen, exhibited greatest changes over the 1st year of ART. Dynamics slowed over the following 2 years so that total HIV DNA levels were equivalent to reported values for individuals after 10 years of ART. The mathematical model reproduced the multiphasic dynamics of pVL, and levels of total, 2-LTR and integrated HIV DNA in both PHI and CHI over 3 years of ART. Under these simulations, residual viremia originated from reactivated latently infected cells where most of these cells arose from clonal expansion within the resting phenotype. Since virion production from clonally expanded cells will not be affected by antiretroviral drugs, simulations of ART intensification had little impact on pVL. HIV DNA decay over the first year of ART followed the loss of activated memory cells (120 day half-life) while the 5.9 year half-life of total HIV DNA after this point mirrored the slower decay of resting memory cells. Simulations had difficulty reproducing the fast early HIV DNA dynamics, including 2-LTR levels peaking at week 12, and the later slow loss of total and 2-LTR HIV DNA, suggesting some ongoing infection. In summary, our modelling indicates that much of the dynamical behavior of HIV can be explained by its impact on memory CD4+ T cell homeostasis.	[Murray, John M.] UNSW Australia, Sch Math & Stat, Sydney, NSW, Australia; [Zaunders, John] St Vincents Hosp, Ctr Appl Med Res, Darlinghurst, NSW, Australia; [Emery, Sean; Cooper, David A.; Hey-Nguyen, William J.; Koelsch, Kersten K.; Kelleher, Anthony D.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Kirby Institute	Murray, JM (corresponding author), UNSW Australia, Sch Math & Stat, Sydney, NSW, Australia.	J.Murray@unsw.edu.au	Zaunders, John/J-6553-2012; Emery, Sean/O-9122-2019; Murray, John/B-5481-2009	Zaunders, John/0000-0002-5912-5989; Emery, Sean/0000-0001-6072-8309; Murray, John/0000-0001-9314-2283; Kelleher, Anthony/0000-0002-0009-3337	Investigator-Initiated Studies Program of Merck; Kirby Institute; National Health and Medical Research Council (NHMRC) [510448]; NHMRC project grant [510325]; Practitioner Fellowship (ADK); Australian Government Department of Health & Ageing and is affiliated with the Faculty of Medicine; University of New South Wales	Investigator-Initiated Studies Program of Merck; Kirby Institute; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); Practitioner Fellowship (ADK); Australian Government Department of Health & Ageing and is affiliated with the Faculty of Medicine; University of New South Wales	The PINT study was supported in part by a research grant from the Investigator-Initiated Studies Program of Merck and the Kirby Institute, National Health and Medical Research Council (NHMRC) program grant number 510448, NHMRC project grant (JZ, JMM) number 510325 and a Practitioner Fellowship (ADK). The Kirby Institute is funded by the Australian Government Department of Health & Ageing and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003871; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bacchus C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064219; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Blankson JN, 2000, J INFECT DIS, V182, P1636, DOI 10.1086/317615; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Buzon MJ, 2014, J VIROL, V88, P10056, DOI 10.1128/JVI.01046-14; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Funk GA, 2001, J ACQ IMMUN DEF SYND, V26, P397, DOI 10.1097/00126334-200104150-00001; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hey-Cunningham WJ, 2015, AIDS, V29, P911, DOI 10.1097/QAD.0000000000000625; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Koelsch KK, 2011, AIDS, V25, P2069, DOI 10.1097/QAD.0b013e32834b9658; Kwon YJ, 2003, J VIROL, V77, P5712, DOI 10.1128/JVI.77.10.5712-5720.2003; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Murray JM, 2012, AIDS, V26, P543, DOI 10.1097/QAD.0b013e328350fb3c; Orendi JM, 1998, J INFECT DIS, V178, P1279, DOI 10.1086/314451; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Vallejo A, 2012, AIDS, V26, P1885, DOI 10.1097/QAD.0b013e3283584521; von Stockenstrom S, 2015, J INFECT DIS, V212, P596, DOI 10.1093/infdis/jiv092; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; ZACK JA, 1995, ADV EXP MED BIOL, V374, P27	49	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186101	10.1371/journal.pone.0186101	http://dx.doi.org/10.1371/journal.pone.0186101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049331	Green Submitted, Green Published, gold			2022-12-26	WOS:000413195900042
J	VanDenBerg, KR; Freeborn, RA; Liu, S; Kennedy, RC; Zagorski, JW; Rockwell, CE				VanDenBerg, Kelly R.; Freeborn, Robert A.; Liu, Sheng; Kennedy, Rebekah C.; Zagorski, Joseph W.; Rockwell, Cheryl E.			Inhibition of early T cell cytokine production by arsenic trioxide occurs independently of Nrf2	PLOS ONE			English	Article							ACTIVATION ANTIGEN CD69; ALPHA MESSENGER-RNA; NF-KAPPA-B; SODIUM ARSENITE; RECEPTOR ACTIVATION; GENE-EXPRESSION; TNF-ALPHA; TRANSCRIPTION; ANTIOXIDANT; MICE	Nuclear factor erythroid 2-related factor 2 (Nrf2) is a stress-activated transcription factor that induces a variety of cytoprotective genes. Nrf2 also mediates immunosuppressive effects in multiple inflammatory models. Upon activation, Nrf2 dissociates from its repressor protein, Keap1, and translocates to the nucleus where it induces Nrf2 target genes. The Nrf2-Keap1 interaction is disrupted by the environmental toxicant and chemotherapeutic agent arsenic trioxide (ATO). The purpose of the present study was to determine the effects of ATO on early events of T cell activation and the role of Nrf2 in those effects. The Nrf2 target genes Hmox-1, Nqo-1, and Gclc were all upregulated by ATO (1-2 mu M) in splenocytes derived from wild-type, but not Nrf2-null, mice, suggesting that Nrf2 is activated by ATO in splenocytes. ATO also inhibited IFN., IL-2, and GM-CSF mRNA and protein production in wildtype splenocytes activated with the T cell activator, anti-CD3/anti-CD28. However, ATO also decreased production of these cytokines in activated splenocytes from Nrf2-null mice, suggesting the inhibition is independent of Nrf2. Interestingly, ATO inhibited TNF alpha protein secretion, but not mRNA expression, in activated splenocytes suggesting the inhibition is due to post-transcriptional modification. In addition, c-Fos DNA binding was significantly diminished by ATO in wild-type and Nrf2-null splenocytes activated with anti-CD3/antiCD28, consistent with the observed inhibition of cytokine production by ATO. Collectively, this study suggests that although ATO activates Nrf2 in splenocytes, inhibition of early T cell cytokine production by ATO occurs independently of Nrf2 and may instead be due to impaired AP-1 DNA binding.	[VanDenBerg, Kelly R.; Freeborn, Robert A.; Liu, Sheng; Kennedy, Rebekah C.; Rockwell, Cheryl E.] Michigan State Univ, Dept Pharmacol Toxicol, E Lansing, MI 48824 USA; [VanDenBerg, Kelly R.; Zagorski, Joseph W.; Rockwell, Cheryl E.] Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA; [Zagorski, Joseph W.; Rockwell, Cheryl E.] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Rockwell, CE (corresponding author), Michigan State Univ, Dept Pharmacol Toxicol, E Lansing, MI 48824 USA.; Rockwell, CE (corresponding author), Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA.; Rockwell, CE (corresponding author), Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA.	rockwelc@msu.edu		Rockwell, Cheryl/0000-0002-0987-3460; Freeborn, Robert/0000-0003-0599-9442	National Institutes of Health [ES018885, ES024966, GM092715]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [Grant numbers: ES018885 (CER), ES024966 (CER), and GM092715 (RAF)], https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy C.O., 2001, UN SYNTHESIS REPORT, P68; Abernathy CO, 2003, J NUTR, V133, p1536S, DOI 10.1093/jn/133.5.1536S; ALGARTE M, 1995, EMBO J, V14, P5060, DOI 10.1002/j.1460-2075.1995.tb00188.x; Andrew AS, 2008, ENVIRON HEALTH PERSP, V116, P524, DOI 10.1289/ehp.10861; Aono J, 2003, BIOCHEM BIOPH RES CO, V305, P271, DOI 10.1016/S0006-291X(03)00728-9; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Biswas R, 2008, HUM EXP TOXICOL, V27, P381, DOI 10.1177/0960327108094607; Camperio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048303; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen CJ, 2007, TOXICOL APPL PHARM, V222, P298, DOI 10.1016/j.taap.2006.12.032; Conde P, 2007, ARCH TOXICOL, V81, P251, DOI 10.1007/s00204-006-0152-7; Dangleben NL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-73; Das S, 2011, MOL BIOL REP, V38, P171, DOI 10.1007/s11033-010-0091-5; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JAIN J, 1992, J IMMUNOL, V148, P1240; Johnson DA, 2010, TOXICOL SCI, V114, P237, DOI 10.1093/toxsci/kfp274; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim HJ, 2005, J IMMUNOL, V175, P2948, DOI 10.4049/jimmunol.175.5.2948; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lau A, 2013, J BIOCHEM MOL TOXIC, V27, P99, DOI 10.1002/jbt.21463; Li J, 2004, PHYSIOL GENOMICS, V18, P261, DOI 10.1152/physiolgenomics.00209.2003; Maiti S, 2012, ENVIRON TOXICOL, V27, P342, DOI 10.1002/tox.20647; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Millet P, 2016, J IMMUNOL, V196, P2541, DOI 10.4049/jimmunol.1501345; Morzadec C, 2014, FREE RADICAL BIO MED, V71, P133, DOI 10.1016/j.freeradbiomed.2014.03.006; Osburn WO, 2008, TOXICOL SCI, V104, P218, DOI 10.1093/toxsci/kfn079; OSTROSKYWEGMAN P, 1991, MUTAT RES, V250, P477, DOI 10.1016/0027-5107(91)90204-2; Pi JB, 2003, EXP CELL RES, V290, P234, DOI 10.1016/S0014-4827(03)00341-0; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; RHOADES KL, 1992, J BIOL CHEM, V267, P22102; Rockwell CE, 2012, J IMMUNOL, V188, P1630, DOI 10.4049/jimmunol.1101712; Schuhmacher-Wolz U, 2009, CRIT REV TOXICOL, V39, P271, DOI 10.1080/10408440802291505; Soto-Pena GA, 2006, FASEB J; Soto-Pena GA, 2008, TOXICOL APPL PHARM, V230, P216, DOI 10.1016/j.taap.2008.02.029; Tenorio EP, 2005, INT IMMUNOPHARMACOL, V5, P1853, DOI 10.1016/j.intimp.2005.06.006; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; Turley AE, 2015, CYTOKINE, V71, P289, DOI 10.1016/j.cyto.2014.11.006; Vazquez BN, 2009, J IMMUNOL, V183, P6513, DOI 10.4049/jimmunol.0900839; Vega L, 1999, IMMUNOPHARM IMMUNOT, V21, P203, DOI 10.3109/08923979909052758; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Yedjou CG, 2009, MOL CELL BIOCHEM, V331, P207, DOI 10.1007/s11010-009-0160-z; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Yoshida T, 2015, AM J TRANSPLANT, V15, P2565, DOI 10.1111/ajt.13338; Zagorski JW, 2013, TOXICOL SCI, V136, P63, DOI 10.1093/toxsci/kft172	58	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185579	10.1371/journal.pone.0185579	http://dx.doi.org/10.1371/journal.pone.0185579			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049341	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900012
J	Xia, L; Huang, R; Li, YT; Song, SX				Xia, Ling; Huang, Rong; Li, Yinta; Song, Shaoxian			The effect of growth phase on the surface properties of three oleaginous microalgae (Botryococcus sp FACGB-762, Chlorella sp XJ-445 and Desmodesmus bijugatus XJ-231)	PLOS ONE			English	Article							CELL; FLOCCULATION; ACCUMULATION; SUBSTRATUM; FLOTATION; TENSION; ENERGY; IMPACT	The effects of growth phase on the lipid content and surface properties of oleaginous microalgae Botryococcus sp. FACGB-762, Chlorella sp. XJ-445 and Desmodesmus bijugatus XJ-231 were investigated in this study. The results showed that throughout the growth phases, the lipid content of microalgae increased. The surface properties like particle size, the degree of hydrophobicity, and the total concentration of functional groups increased while net surface zeta potential decreased. The results suggested that the growth stage had significant influence not only on the lipid content but also on the surface characteristics. Moreover, the lipid content was significantly positively related to the concentration of hydroxyl functional groups in spite of algal strains or growth phases. These results provided a basis for further studies on the refinery process using oleaginous microalgae for biofuel production.	[Xia, Ling; Li, Yinta; Song, Shaoxian] Hubei Key Lab Mineral Resources Proc & Environm, Wuhan, Hubei, Peoples R China; [Xia, Ling; Huang, Rong] Wuhan Univ Technol, Sch Resources & Environm Engn, Wuhan, Hubei, Peoples R China; [Li, Yinta; Song, Shaoxian] Univ Autonoma San Luis Potosi, Doctorado Inst Ingn & Ciencia Mat, San Luis Potosi, Mexico	Wuhan University of Technology; Universidad Autonoma de San Luis Potosi	Song, SX (corresponding author), Hubei Key Lab Mineral Resources Proc & Environm, Wuhan, Hubei, Peoples R China.; Song, SX (corresponding author), Univ Autonoma San Luis Potosi, Doctorado Inst Ingn & Ciencia Mat, San Luis Potosi, Mexico.	shaoxian@uaslp.mx	Song, Shaoxian/AGX-4949-2022; , 宋少先/AAM-4178-2020		National Natural Science Foundation of China [51604207]; Independent Innovation Foundation of Wuhan University of Technology [173208001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Wuhan University of Technology	This work was supported by the National Natural Science Foundation of China (Grant No. 51604207 to LX), and the Independent Innovation Foundation of Wuhan University of Technology (Grant No. 173208001 to LX).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980, DOI 10.1128/AEM.48.5.980-983.1984; Danquah MK, 2009, CHEM ENG J, V151, P73, DOI 10.1016/j.cej.2009.01.047; De Philippis R, 2007, BIODEGRADATION, V18, P181, DOI 10.1007/s10532-006-9053-y; Garg S, 2012, BIORESOURCE TECHNOL, V121, P471, DOI 10.1016/j.biortech.2012.06.111; Goncalves AL, 2015, BIORESOURCES AND BIO, V2; Hadjoudja S, 2010, J COLLOID INTERF SCI, V342, P293, DOI 10.1016/j.jcis.2009.10.078; Henderson R, 2008, WATER RES, V42, P1827, DOI 10.1016/j.watres.2007.11.039; Henderson RK, 2010, WATER RES, V44, P3617, DOI 10.1016/j.watres.2010.04.016; Hiemenz P. C., 1997, PRINCIPLES COLLOID S, V3rd; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Irving TE, 2011, APPL MICROBIOL BIOT, V92, P283, DOI 10.1007/s00253-011-3341-0; Ista LK, 2004, APPL ENVIRON MICROB, V70, P4151, DOI 10.1128/AEM.70.7.4151-4157.2004; Kalacheva GS, 2002, MICROBIOLOGY+, V71, P286, DOI 10.1023/A:1015898426573; Lee SJ, 1998, LETT APPL MICROBIOL, V27, P14; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Ong SC, 2010, BIORESOURCE TECHNOL, V101, P2880, DOI 10.1016/j.biortech.2009.10.007; Ozkan A, 2013, COLLOID SURFACE B, V112, P287, DOI 10.1016/j.colsurfb.2013.08.001; Ozkan A, 2013, COLLOID SURFACE B, V112, P302, DOI 10.1016/j.colsurfb.2013.08.007; Pan YY, 2011, BIORESOURCE TECHNOL, V102, P10510, DOI 10.1016/j.biortech.2011.08.091; Pivokonsky M, 2006, WATER RES, V40, P3045, DOI 10.1016/j.watres.2006.06.028; Ruangsomboon S, 2012, BIORESOURCE TECHNOL, V109, P261, DOI 10.1016/j.biortech.2011.07.025; Schlesinger A, 2012, BIOTECHNOL ADV, V30, P1023, DOI 10.1016/j.biotechadv.2012.01.011; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Van Oss C, 2008, PROPERTIES WATER THE; VANOSS CJ, 1989, J COLLOID INTERF SCI, V128, P313, DOI 10.1016/0021-9797(89)90345-7; VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018; VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8; Xia L, 2015, J APPL PHYCOL, P1; Xia L, 2014, BIORESOURCE TECHNOL, V161, P402, DOI 10.1016/j.biortech.2014.03.063; Zhang XZ, 2012, BIORESOURCE TECHNOL, V116, P477, DOI 10.1016/j.biortech.2012.04.002	31	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186434	10.1371/journal.pone.0186434	http://dx.doi.org/10.1371/journal.pone.0186434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045481	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100062
J	Otani, Y; Ichikawa, T; Kurozumi, K; Inoue, S; Ishida, J; Oka, T; Shimizu, T; Tomita, Y; Hattori, Y; Uneda, A; Matsumoto, Y; Michiue, H; Date, I				Otani, Y.; Ichikawa, T.; Kurozumi, K.; Inoue, S.; Ishida, J.; Oka, T.; Shimizu, T.; Tomita, Y.; Hattori, Y.; Uneda, A.; Matsumoto, Y.; Michiue, H.; Date, I.			Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion	ONCOGENE			English	Article							INCREASED EXPRESSION; GLIOBLASTOMA; PHENOTYPES; CANCER; TEMOZOLOMIDE; TRANSITION; RESISTANT; THERAPY; TARGETS; MODELS	Glioblastoma has the poorest prognosis, and is characterized by excessive invasion and angiogenesis. To determine the invasive mechanisms, we previously used two glioma cell lines (J3T-1 and J3T-2) with different invasive phenotypes. The J3T-1 showed abundant angiogenesis and tumor cell invasion around neovasculature, while J3T-2 showed diffuse cell infiltration into surrounding healthy parenchyma. Microarray analyses were used to identify invasion-related genes in J3T-2 cells, and the expressed genes and their intracellular and intratumoral distribution patterns were evaluated in J3T-2 cell lines, human glioma cell lines, human glioblastoma stem cells and human glioblastoma specimens. To determine the role of the invasion-related genes, invasive activities were evaluated in vitro and in vivo. Fibroblast growth factor 13 (FGF13) was overexpressed in J3T-2 cells compared to J3T-1 cells, and in human glioma cell lines, human glioblastoma stem cells and human glioblastoma specimens, when compared to that of normal human astrocytes. Immunohistochemical staining and the RNA-seq (sequencing) data from the IVY Glioblastoma Atlas Project showed FGF13 expression in glioma cells in the invasive edges of tumor specimens. Also, the intracellular distribution was mainly in the cytoplasm of tumor cells and colocalized with tubulin. Overexpression of FGF13 stabilized tubulin dynamics in vitro and knockdown of FGF13 decreased glioma invasion both in vitro and in vivo and prolonged overall survival of several xenograft models. FGF13 was negatively regulated by hypoxic condition. Silencing of FGF13 also decreased in vivo bevacizumab-induced glioma invasion. In conclusion, FGF13 regulated glioma cell invasion and bevacizumab-induced glioma invasion, and could be a novel target for glioma treatment.	[Otani, Y.; Ichikawa, T.; Kurozumi, K.; Ishida, J.; Oka, T.; Shimizu, T.; Tomita, Y.; Hattori, Y.; Uneda, A.; Matsumoto, Y.; Date, I.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Okayama, Japan; [Inoue, S.] Okayama City Hosp, Dept Neurosurg, Okayama, Japan; [Michiue, H.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Physiol, Okayama, Japan	Okayama University; Okayama University	Ichikawa, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, 2-5-1 Shikata, Okayama 7008558, Japan.	tomoichi@cc.okayama-u.ac.jp	Otani, Yoshihiro/AEG-1263-2022; Kurozumi, Kazuhiko/AGT-1723-2022; MICHIUE, Hiroyuki/B-2320-2011; Uneda, Atsuhito/ABB-2477-2021	Otani, Yoshihiro/0000-0002-1615-5125; Kurozumi, Kazuhiko/0000-0002-6942-9919; Matsumoto, Yuji/0000-0001-8798-381X; Uneda, Atsuhito/0000-0001-9709-6034	Japanese Ministry of Education, Culture, Sports, Science, and Technology [22591611, 25462261, 23592125, 26462182]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to TI (No. 22591611 and No. 25462261) and KK (No. 23592125 and No. 26462182). We thank Dr H Wakimoto at Massachusetts General Hospital for providing the human glioblastoma-derived cancer stem cell line.<SUP>18,42</SUP> We thank M Arao and U Ukai in the Department of Neurological Surgery and A Ueda in the Department of Physiology for their technical assistance. The following medical students also contributed to our experiments: K Yamamoto and Y Inoue. The accession number for the gene expression data reported in this paper is GSE88740.	Barker CA, 2013, INT J RADIAT ONCOL, V86, P504, DOI 10.1016/j.ijrobp.2013.02.012; BERENS ME, 1993, IN VITRO CELL DEV-AN, V29A, P310, DOI 10.1007/BF02633959; Berezovsky AD, 2014, NEOPLASIA, V16, pe19; Berges R, 2012, MOL THER, V20, P1367, DOI 10.1038/mt.2012.45; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Delay M, 2012, CLIN CANCER RES, V18, P2930, DOI 10.1158/1078-0432.CCR-11-2390; Draberova E, 2011, J NEUROPATH EXP NEUR, V70, P811, DOI 10.1097/NEN.0b013e31822c256d; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Fife CM, 2014, BRIT J PHARMACOL, V171, P5507, DOI 10.1111/bph.12704; Fujimura A, 2013, NEOPLASIA, V15, P1272, DOI 10.1593/neo.131440; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hampl JA, 2003, HUM GENE THER, V14, P611, DOI 10.1089/104303403321618137; Hayashi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep23372; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichikawa T, 2002, NEOPLASIA, V4, P523, DOI 10.1038/sj.neo.7900266; Ichikawa T, 2016, NEUROL MED-CHIR, V56, P387, DOI 10.2176/nmc.ra.2016-0077; Inoue S, 2012, WORLD NEUROSURG, V78, P670, DOI 10.1016/j.wneu.2011.09.005; Ishida J, 2014, TRANSL ONCOL, V7, P292, DOI 10.1016/j.tranon.2014.02.016; Katsetos CD, 2015, SEMIN PEDIATR NEUROL, V22, P49, DOI 10.1016/j.spen.2015.03.009; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Maruo T, 2013, NEUROPATHOLOGY, V33, P264, DOI 10.1111/j.1440-1789.2012.01361.x; Nagai Shoichi, 2011, Genes Cancer, V2, P859, DOI 10.1177/1947601911431839; Nishimoto S, 2007, J BIOL CHEM, V282, P24255, DOI 10.1074/jbc.M704277200; Oehler C, 2012, ONCOLOGY-BASEL, V83, P1, DOI 10.1159/000339152; Oka T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33319; Okada T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02899; Onishi M, 2015, BRAIN TUMOR PATHOL, V32, P184, DOI 10.1007/s10014-015-0216-6; Onishi M, 2013, NEUROPATHOLOGY, V33, P162, DOI 10.1111/j.1440-1789.2012.01344.x; Onishi M, 2011, BRAIN TUMOR PATHOL, V28, P13, DOI 10.1007/s10014-010-0007-z; Piao Y, 2016, NEURO-ONCOLOGY, V18, P1230, DOI 10.1093/neuonc/now030; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; Saito N, 2014, STEM CELLS, V32, P301, DOI 10.1002/stem.1528; Scherer HJ, 1940, J NEUROL PSYCHIATRY, V3, P147, DOI 10.1136/jnnp.3.2.147; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Song YW, 2014, ACTA BIOCH BIOPH SIN, V46, P1034, DOI 10.1093/abbs/gmu099; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wang F, 2015, ONCOTARGET, V6, P21468, DOI 10.18632/oncotarget.4097; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wu QF, 2012, CELL, V149, P1549, DOI 10.1016/j.cell.2012.04.046; Yu L, 2016, INT J CANCER, V139, P140, DOI 10.1002/ijc.30048	44	22	24	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					777	786		10.1038/onc.2017.373	http://dx.doi.org/10.1038/onc.2017.373			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059154	Green Submitted			2022-12-26	WOS:000424628100009
J	Wang, Y; Wang, MD; Xia, YP; Gao, Y; Zhu, YY; Chen, SC; Mao, L; He, QW; Yue, ZY; Hu, B				Wang, Yong; Wang, Meng-Die; Xia, Yuan-Peng; Gao, Yuan; Zhu, Yi-Yi; Chen, Sheng-Cai; Mao, Ling; He, Quan-Wei; Yue, Zhen-Yu; Hu, Bo			MicroRNA-130a regulates cerebral ischemia-induced blood-brain barrier permeability by targeting Homeobox A5	FASEB JOURNAL			English	Article						ischemic stroke; rats; BMECs; occludin	ARTERY OCCLUSION; ANGIOGENESIS; STROKE; MIR-130A; CANCER; RATS; CELLS	Blood-brain barrier (BBB) disruption plays a critical role in brain injury induced by cerebral ischemia, and preserving BBB integrity during ischemia could alleviate cerebral injury. We examined the role of miR-130a in ischemic BBB disruption by using models of rat middle cerebral artery occlusion and cell oxygen-glucose deprivation. We found that ischemia significantly increased microRNA-130a (miR-130a) level and that miR-130a was predominantly from brain microvascular endothelial cells. Antagomir-130a, an antagonist of miR-130a, could attenuate brain edema, lower BBB permeability, reduce infarct volume, and improve neurologic function. MiR-130a overexpression induced by miR-130a mimic increased monolayer permeability, and intercellular inhibition of miR-130a by a miR-130a inhibitor suppressed oxygen-glucose deprivation-induced increase in monolayer permeability. Moreover, dual luciferase reporter system showed that Homeobox A5 was the direct target of miR-130a. MiR-130a, by inhibiting Homeobox A5 expression, could down-regulate occludin, thereby increasing BBB permeability. Our results suggested that miR-130a might be implicated in ischemia-induced BBB dysfunction and serve as a target for the treatment of ischemic stroke.	[Wang, Yong; Wang, Meng-Die; Xia, Yuan-Peng; Gao, Yuan; Zhu, Yi-Yi; Chen, Sheng-Cai; Mao, Ling; He, Quan-Wei; Hu, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan, Hubei, Peoples R China; [Gao, Yuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nucl Med, Wuhan, Hubei, Peoples R China; [Yue, Zhen-Yu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurol, New York, NY 10029 USA; [Yue, Zhen-Yu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurosci, New York, NY 10029 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Hu, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, 1277 Jiefang Dadao Ave, Hankou Wuhan 430022, Hubei, Peoples R China.	hubo@mail.hust.edu.cn	xia, yuanpeng/S-7988-2019		National Natural Science Foundation of China [81301001, 81571119, 81371311, 81571139, 81671147, 81301002, 81400969, 81400970, 81601027]; National Key Research and Development Program of China [2016YFC1300600]; National Research Foundation for the Doctoral Program of Higher Education of China [20120142110068]; New Century Excellent Talents in University [NCET-10-0406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (Grants 81301001 to M.-D.W., 81571119 and 81371311 to B.H., 81571139 to L.M., 81671147 to J.H.J., 81301002 to Y.-P.X., 81400969 to Q.-W.H., 81400970 to M.L., and 81601027 to Y.N.L.), the National Key Research and Development Program of China (Grant 2016YFC1300600), the National Research Foundation for the Doctoral Program of Higher Education of China (Grant 20120142110068 to B.H.), and the New Century Excellent Talents in University (Grant NCET-10-0406 to B.H.). The authors declare no conflicts of interest.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Feng YQ, 2016, ARCH BIOCHEM BIOPHYS, V598, P57, DOI 10.1016/j.abb.2016.03.019; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Lee SH, 2015, ONCOTARGET, V6, P33269, DOI 10.18632/oncotarget.5037; Li Q, 2016, FEBS J, V283, P1720, DOI 10.1111/febs.13697; Li Q, 2016, AM J TRANSL RES, V8, P955; Li YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13316; Lin L, 2015, ONCOL REP, V34, P3088, DOI 10.3892/or.2015.4301; Lu C, 2015, J MOL CELL CARDIOL, V89, P87, DOI 10.1016/j.yjmcc.2015.10.011; Pan R, 2017, SCI REP-UK, V7, DOI 10.1038/srep40331; Petrovic-Djergovic D, 2016, CIRC RES, V119, P142, DOI 10.1161/CIRCRESAHA.116.308022; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Rhoads Kim, 2005, Lymphatic Research and Biology, V3, P240, DOI 10.1089/lrb.2005.3.240; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sepramaniam S, 2012, J BIOL CHEM, V287, P12006, DOI 10.1074/jbc.M111.280701; Song CL, 2016, ONCOTARGET, V7, P71922, DOI 10.18632/oncotarget.12431; Tan JR, 2011, CURR MOL MED, V11, P76; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Wang MD, 2016, MOL NEUROBIOL, V53, P1310, DOI 10.1007/s12035-015-9099-0; Ye M, 2015, CELL PHYSIOL BIOCHEM, V36, P712, DOI 10.1159/000430132	27	42	44	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					935	944		10.1096/fj.201700139RRR	http://dx.doi.org/10.1096/fj.201700139RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29070584	Bronze			2022-12-26	WOS:000425146900034
J	Jakka, P; Namani, S; Murugan, S; Rai, N; Radhakrishnan, G				Jakka, Padmaja; Namani, Swapna; Murugan, Subathra; Rai, Nivedita; Radhakrishnan, Girish			The Brucella effector protein TcpB induces degradation of inflammatory caspases and thereby subverts non-canonical inflammasome activation in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; cytokine; inflammasome; lipopolysaccharide (LPS); ubiquitylation (ubiquitination); Brucella; caspase-1; caspase-4; pyroptosis	DOMAIN-CONTAINING PROTEIN; INNATE IMMUNE RECEPTORS; BACTERIAL PATHOGENS; CELL-DEATH; ABORTUS INFECTION; INTRACELLULAR LPS; MELITENSIS; RESPONSES; NEOTOMAE; PROMOTES	The inflammasome contains intracellular receptors that recognize various pathogen-associated molecular patterns and play crucial roles in innate immune responses to invading pathogens. Non-canonical inflammasome activation is mediated by caspase-4/11, which recognizes intracellular LPS and promotes pyroptosis and secretion of proinflammatory cytokines. Brucella species are infectious intracellular pathogens that replicate in professional and non-professional phagocytic cells and subvert immune responses for chronic persistence in the host. The Brucella effector protein TcpB suppresses Toll-like receptor 2 (TLR2)- and TLR4-mediated innate immune responses by targeted degradation of the Toll/interleukin-1 receptor (TIR) domain-containing adaptor protein. TcpB is a cell-permeable protein with multiple functions, and its intracellular targets other than TIR domain-containing adaptor protein remain unclear. Here, we report that TcpB induces ubiquitination and degradation of the inflammatory caspases 1, 4, and 11. Furthermore, in both mouse and human macrophages, TcpB attenuated LPS-induced non-canonical inflammasome activation and suppressed pyroptosis and secretion of IL-1 and IL-1 induced by intracellular LPS delivery. The intact TIR domain was essential for TcpB to subvert the non-canonical inflammasome activation as a TcpB(G158A) mutant failed to suppress pyroptotic cell death and inflammatory responses. Brucella-infected macrophages exhibited minimal pyroptosis but secreted IL-1, which was suppressed by TcpB. We also demonstrated that TcpB protein can efficiently attenuate Salmonella enterica serovar Typhimurium-induced pyroptosis and proinflammatory cytokine secretion in macrophages. Because TcpB suppresses both TLR4- and caspase-4/11-mediated inflammation, TcpB might be a candidate target for developing drugs against LPS-induced septicemia.	[Jakka, Padmaja; Namani, Swapna; Murugan, Subathra; Rai, Nivedita; Radhakrishnan, Girish] Natl Inst Anim Biotechnol, Lab Immunol & Microbial Pathogenesis, Hyderabad 500049, Telangana, India; [Jakka, Padmaja] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Manipal Academy of Higher Education (MAHE)	Radhakrishnan, G (corresponding author), Natl Inst Anim Biotechnol, Lab Immunol & Microbial Pathogenesis, Hyderabad 500049, Telangana, India.	girish@niab.org.in		Radhakrishnan, Girish/0000-0001-9088-0029	Department of Biotechnology, Ministry of Science and Technology, Government of India, through the National Institute of Animal Biotechnology, Hyderabad, India	Department of Biotechnology, Ministry of Science and Technology, Government of India, through the National Institute of Animal Biotechnology, Hyderabad, India	This work was supported in part by funding from the Department of Biotechnology, Ministry of Science and Technology, Government of India, through the National Institute of Animal Biotechnology, Hyderabad, India. The authors declare that they have no conflicts of interest with the contents of this article.	Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Aziz M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.488; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Byndloss MX, 2016, ANNU REV ANIM BIOSCI, V4, P111, DOI 10.1146/annurev-animal-021815-111326; Cardoso PCG, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-13; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Covert J, 2009, EXP BIOL MED, V234, P1450, DOI 10.3181/0904-RM-124; Durward M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034925; GOLDSTEIN J, 1992, INFECT IMMUN, V60, P1385, DOI 10.1128/IAI.60.4.1385-1389.1992; Gomes MTR, 2013, J IMMUNOL, V190, P3629, DOI 10.4049/jimmunol.1202817; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kobayashi T, 2013, CELL HOST MICROBE, V13, P570, DOI 10.1016/j.chom.2013.04.012; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martirosyan A, 2013, FUTURE MICROBIOL, V8, P147, DOI [10.2217/FMB.12.140, 10.2217/fmb.12.140]; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Oliveira SC, 2012, VET IMMUNOL IMMUNOP, V148, P129, DOI 10.1016/j.vetimm.2011.05.036; Pallett MA, 2017, MUCOSAL IMMUNOL, V10, P602, DOI 10.1038/mi.2016.77; Radhakrishnan GK, 2011, BIOCHEM J, V439, P79, DOI 10.1042/BJ20110577; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rosadini CV, 2015, CURR OPIN IMMUNOL, V32, P61, DOI 10.1016/j.coi.2014.12.011; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Smith JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003785; STOENNER HG, 1963, AM J VET RES, V24, P376; STOENNER HG, 1957, AM J VET RES, V18, P947; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	44	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20613	20627		10.1074/jbc.M117.815878	http://dx.doi.org/10.1074/jbc.M117.815878			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29061850	Green Published, hybrid			2022-12-26	WOS:000418267000022
J	Fuse, T; Katsumata, K; Morohoshi, K; Mukai, Y; Ichikawa, Y; Kurumizaka, H; Yanagida, A; Urano, T; Kato, H; Shimizu, M				Fuse, Tomohiro; Katsumata, Koji; Morohoshi, Koya; Mukai, Yukio; Ichikawa, Yuichi; Kurumizaka, Hitoshi; Yanagida, Akio; Urano, Takeshi; Kato, Hiroaki; Shimizu, Mitsuhiro			Parallel mapping with site-directed hydroxyl radicals and micrococcal nuclease reveals structural features of positioned nucleosomes in vivo	PLOS ONE			English	Article							BASE-PAIR RESOLUTION; MNASE-SENSITIVE COMPLEXES; SACCHAROMYCES-CEREVISIAE; NONHISTONE BARRIERS; CHROMATIN-STRUCTURE; YEAST NUCLEOSOMES; DNA; GENOME; CORE; TRANSCRIPTION	Micrococcal nuclease (MNase) has been widely used for analyses of nucleosome locations in many organisms. However, due to its sequence preference, the interpretations of the positions and occupancies of nucleosomes using MNase have remained controversial. Next-generation sequencing (NGS) has also been utilized for analyses of MNase-digests, but some technical biases are commonly present in the NGS experiments. Here, we established a gel-based method to map nucleosome positions in Saccharomyces cerevisiae, using isolated nuclei as the substrate for the histone H4 S47C-site-directed chemical cleavage in parallel with MNase digestion. The parallel mapping allowed us to compare the chemically and enzymatically cleaved sites by indirect end-labeling and primer extension mapping, and thus we could determine the nucleosome positions and the sizes of the nucleosome- free regions (or nucleosome-depleted regions) more accurately, as compared to nucleosome mapping by MNase alone. The analysis also revealed that the structural features of the nucleosomes flanked by the nucleosome-free region were different from those within regularly arrayed nucleosomes, showing that the structures and dynamics of individual nucleosomes strongly depend on their locations. Moreover, we demonstrated that the parallel mapping results were generally consistent with the previous genome-wide chemical mapping and MNase-Seq results. Thus, the gel-based parallel mapping will be useful for the analysis of a specific locus under various conditions.	[Fuse, Tomohiro; Katsumata, Koji; Morohoshi, Koya; Shimizu, Mitsuhiro] Meisei Univ, Sch Sci & Engn, Grad Sch Sci & Engn, Program Chem & Life Sci,Dept Chem, Hino, Tokyo, Japan; [Mukai, Yukio] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, Nagahama, Shiga, Japan; [Ichikawa, Yuichi; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, RISE, IMSB,Shinjuku Ku, Tokyo, Japan; [Yanagida, Akio] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo, Japan; [Urano, Takeshi; Kato, Hiroaki] Shimane Univ, Dept Biochem, Sch Med, Izumo, Shimane, Japan	Meisei University; Waseda University; Tokyo University of Pharmacy & Life Sciences; Shimane University	Shimizu, M (corresponding author), Meisei Univ, Sch Sci & Engn, Grad Sch Sci & Engn, Program Chem & Life Sci,Dept Chem, Hino, Tokyo, Japan.	shimizum@chem.meisei-u.ac.jp	Kato, Hiroaki/T-1674-2017	Kato, Hiroaki/0000-0001-9591-1875; Ichikawa, Yuichi/0000-0002-6773-2455; Kurumizaka, Hitoshi/0000-0001-7412-3722	JSPS KAKENHI [JP26430186, JP25116002, JP25250023, JP17H01408, JP26116513]; Science Research Promotion Fund from Promotion and Mutual Aid Corporation for Private Schools of Japan; Waseda Research Institute for Science and Engineering; Priority Research Funding from Meisei University; Grants-in-Aid for Scientific Research [17K08983] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science Research Promotion Fund from Promotion and Mutual Aid Corporation for Private Schools of Japan; Waseda Research Institute for Science and Engineering; Priority Research Funding from Meisei University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers JP26430186 (to M.S.), JP25116002 (to H.Ku.), JP25250023 (to H.Ku. and M.S.), JP17H01408 (to H.Ku. and M.S.) and JP26116513 (to H.Ka.), by the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (to M.S.), by the Waseda Research Institute for Science and Engineering (to H.Ku.), and by the Priority Research Funding from Meisei University (to M.S.).	Ahuja N, 2016, ANNU REV MED, V67, P73, DOI 10.1146/annurev-med-111314-035900; Allan J, 2012, J MOL BIOL, V417, P152, DOI 10.1016/j.jmb.2012.01.043; Arimura Y, 2012, BIOCHEMISTRY-US, V51, P3302, DOI 10.1021/bi300129b; Azegami N, 2013, BIOCHEMISTRY-US, V52, P5155, DOI 10.1021/bi4005655; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brogaard KR, 2012, METHOD ENZYMOL, V513, P315, DOI 10.1016/B978-0-12-391938-0.00014-8; Chen X, 2016, SCI CHINA LIFE SCI, V59, P909, DOI 10.1007/s11427-016-5102-x; Chen YJ, 2017, P NATL ACAD SCI USA, V114, P334, DOI 10.1073/pnas.1611118114; Chereji RV, 2017, MOL CELL, V65, P565, DOI 10.1016/j.molcel.2016.12.009; Chereji RV, 2016, NUCLEIC ACIDS RES, V44, P1036, DOI 10.1093/nar/gkv978; Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754; Clark DJ, 2010, J BIOMOL STRUCT DYN, V27, P781, DOI 10.1080/073911010010524945; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Cole HA, 2016, NUCLEIC ACIDS RES, V44, P573, DOI 10.1093/nar/gkv943; Cole HA, 2012, BBA-GENE REGUL MECH, V1819, P639, DOI 10.1016/j.bbagrm.2012.01.008; Cole HA, 2011, NUCLEIC ACIDS RES, V39, P9521, DOI 10.1093/nar/gkr643; CONS BMG, 1989, NUCLEIC ACIDS RES, V17, P5447, DOI 10.1093/nar/17.14.5447; Cutter AR, 2015, FEBS LETT, V589, P2914, DOI 10.1016/j.febslet.2015.05.016; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Fei J, 2015, GENE DEV, V29, P2563, DOI 10.1101/gad.272633.115; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; Furuyama T, 2013, NUCLEIC ACIDS RES, V41, P5769, DOI 10.1093/nar/gkt314; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hayes JJ, 1996, BIOCHEMISTRY-US, V35, P11931, DOI 10.1021/bi961590+; Henikoff S, 2014, ELIFE, V3, DOI 10.7554/eLife.01861; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; HU GX, 1993, DNA CELL BIOL, V12, P763, DOI 10.1089/dna.1993.12.763; Ichikawa Y, 2016, BIOCHEM BIOPH RES CO, V476, P57, DOI 10.1016/j.bbrc.2016.05.063; Ichikawa Y, 2014, NUCLEIC ACIDS RES, V42, P1541, DOI 10.1093/nar/gkt1006; Ishii H, 2015, P NATL ACAD SCI USA, V112, pE3457, DOI 10.1073/pnas.1424804112; Jansen A, 2011, MICROBIOL MOL BIOL R, V75, P301, DOI 10.1128/MMBR.00046-10; Kaiser C., 1994, METHODS YEAST GENETI; Kato D, 2017, SCIENCE, V356, P205, DOI 10.1126/science.aak9867; Kubik S, 2017, MOL CELL, V65, P578, DOI 10.1016/j.molcel.2017.01.010; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Levendosky RF, 2016, ELIFE, V5, DOI 10.7554/eLife.21356; LOHR D, 1977, BIOCHEMISTRY-US, V16, P463, DOI 10.1021/bi00622a020; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Meyer CA, 2014, NAT REV GENET, V15, P709, DOI 10.1038/nrg3788; Mieczkowski J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11485; MIOZZARI G, 1978, J BACTERIOL, V134, P48, DOI 10.1128/JB.134.1.48-59.1978; Morohashi N, 2006, EUKARYOT CELL, V5, P1925, DOI 10.1128/EC.00105-06; Moyle-Heyrman G, 2013, P NATL ACAD SCI USA, V110, P20158, DOI 10.1073/pnas.1315809110; Nikitina T, 2013, J MOL BIOL, V425, P1946, DOI 10.1016/j.jmb.2013.02.026; Ocampo J, 2016, NUCLEUS-PHILA, V7, P382, DOI 10.1080/19491034.2016.1220466; Ramachandran S, 2015, GENOME RES, V25, P381, DOI 10.1101/gr.182618.114; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Rhee HS, 2014, CELL, V159, P1377, DOI 10.1016/j.cell.2014.10.054; ROTH SY, 1990, MOL CELL BIOL, V10, P2247, DOI 10.1128/MCB.10.5.2247; Shen CH, 2001, MOL CELL BIOL, V21, P534, DOI 10.1128/MCB.21.2.534-547.2001; SHIMIZU M, 1991, EMBO J, V10, P3033, DOI 10.1002/j.1460-2075.1991.tb07854.x; Shimizu M, 2000, EMBO J, V19, P3358, DOI 10.1093/emboj/19.13.3358; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; SULKOWSKI E, 1962, J BIOL CHEM, V237, P2620; SZENTGYORGYI C, 1983, NUCLEIC ACIDS RES, V11, P3717, DOI 10.1093/nar/11.11.3717; SZENTGYORGYI C, 1987, J MOL BIOL, V193, P71, DOI 10.1016/0022-2836(87)90628-0; Tanase JI, 2010, BIOCHEMISTRY-US, V49, P2351, DOI 10.1021/bi901950w; THOMA F, 1985, NATURE, V315, P250, DOI 10.1038/315250a0; THOMA F, 1984, J MOL BIOL, V177, P715, DOI 10.1016/0022-2836(84)90046-9; Tsankov A, 2011, GENOME RES, V21, P1851, DOI 10.1101/gr.122267.111; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; Ulyanova NP, 2005, MOL CELL BIOL, V25, P11156, DOI 10.1128/MCB.25.24.11156-11170.2005; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Voong LN, 2016, CELL, V167, P1555, DOI 10.1016/j.cell.2016.10.049; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024	71	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186974	10.1371/journal.pone.0186974	http://dx.doi.org/10.1371/journal.pone.0186974			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073207	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400086
J	Jia, HJ; Zhan, LL; Wang, XX; He, XB; Chen, GH; Zhang, Y; Feng, Y; Wei, YX; Zhang, Y; Jing, ZZ				Jia, Huaijie; Zhan, Leilei; Wang, Xiaoxia; He, Xiaobing; Chen, Guohua; Zhang, Yu; Feng, Yuan; Wei, Yaxun; Zhang, Yi; Jing, Zhizhong			Transcriptome analysis of sheep oral mucosa response to Orf virus infection	PLOS ONE			English	Article							NF-KAPPA-B; CELL; APOPTOSIS; POXVIRUS; INHIBITOR; PROTEIN; IDENTIFICATION; RECRUITMENT; MIGRATION; PATIENT	Contagious ecthyma is a highly contagious disease with worldwide distribution, which is caused by the Orf virus (ORFV) belonging to the Parapoxvirus. To study the alteration of host gene expression in response to ORFV infection at the transcriptional level, several young small-tailed Han sheep were inoculated with ORFV, and their oral mucosa tissue samples (T0, T3, T7 and T15) were collected on day 0, 3, 7 and 15 after ORFV infection respectively. RNA-seq transcriptome comparisons were performed, showing that 1928, 3219 and 2646 differentially expressed genes (DEGs) were identified among T3 vs. T0, T7 vs. T0, and T15 vs. T0 respectively. Gene Ontology (GO) analyses of the DEGs from these comparisons, revealed that ORFV might provoke vigorous immune response of the host cells during the early stage of infection. Moreover, GO and network analysis showed that positive and negative regulative mechanisms of apoptosis were integrated in the host cells through up or down-regulating the expression level of DEGs involved in apoptotic pathways, in order to reach a homeostasis of oral mucosa tissues during the exposure to ORFV infection. In conclusion, our study for the first time describes the direct effects of ORFV on the global host gene expression of its host using high-throughput RNA sequencing, which provides a resource for future characterizing the interaction mechanism between the mammalian host and ORFV.	[Jia, Huaijie; He, Xiaobing; Chen, Guohua; Feng, Yuan; Jing, Zhizhong] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Publ Hlth,Minist Agr, Lanzhou, Gansu, Peoples R China; [Zhan, Leilei; Zhang, Yu; Wei, Yaxun; Zhang, Yi] ABLife Inc, Ctr Genome Anal, Wuhan, Hubei, Peoples R China; [Wang, Xiaoxia] Lanzhou Univ, Sch Publ Hlth, Fac Med, Lanzhou, Gansu, Peoples R China; [Zhang, Yi] ABLife Inc, Lab Genome Regulat & Human Hlth, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Lanzhou University	Jing, ZZ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Publ Hlth,Minist Agr, Lanzhou, Gansu, Peoples R China.	zhizhongj@163.com	Zhan, Leilei/R-2935-2019	Zhang, Yu/0000-0003-0982-7584; Wang, Xiaoxia/0000-0002-6101-417X	National Key Basic Research Program [2016YF0500907]; National Natural Science Foundation of China [31402199]; ABLife Inc.	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ABLife Inc.	This study was supported by National Key Basic Research Program (No: 2016YF0500907) and National Natural Science Foundation of China (No:31402199). ABLife Inc. provided support in the form of salary for authors Leilei Zhan, Yu Zhang, Yaxun Wei, and Yi Zhang, as well as financial support in the form of research materials. The specific roles of these authors are articulated in the author contributions section. ABLife Inc. did not play any additional role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed CM, 2009, J VIROL, V83, P1402, DOI 10.1128/JVI.01138-08; Al-Qattan MM, 2011, J HAND SURG AM, V36; Bennett JR, 2016, VIRUS RES, V213, P230, DOI 10.1016/j.virusres.2015.12.015; Bergqvist C, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1932; Caravaglio JV, 2017, J DRUGS DERMATOL, V16, P684; Chen S.Y., 2016, INT J MOL SCI, V17; Cuff S, 1996, IMMUNOL CELL BIOL, V74, P527, DOI 10.1038/icb.1996.86; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Demiraslan H, 2017, OVERVIEW ORF VIRUS I; Devadas K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147421; Diel DG, 2011, J VIROL, V85, P2037, DOI 10.1128/JVI.02236-10; Diel DG, 2011, J VIROL, V85, P264, DOI 10.1128/JVI.01149-10; Diel DG, 2010, J VIROL, V84, P3962, DOI 10.1128/JVI.02291-09; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Everett H, 2002, CURR OPIN MICROBIOL, V5, P395, DOI 10.1016/S1369-5274(02)00340-5; Fleming SB, 2007, J GEN VIROL, V88, P1922, DOI 10.1099/vir.0.82833-0; Fleming SB, 2015, VIRUSES-BASEL, V7, P1505, DOI 10.3390/v7031505; Galani V, 2010, PATHOL RES PRACT, V206, P145, DOI 10.1016/j.prp.2009.12.002; Gozzelino R, 2008, CELL RES, V18, P1020, DOI 10.1038/cr.2008.76; Haig DM, 2006, CURR OPIN INFECT DIS, V19, P127, DOI 10.1097/01.qco.0000216622.75326.ef; Haig DM, 2002, VIRUS RES, V88, P3, DOI 10.1016/S0168-1702(02)00117-X; Haig DM, 1998, IMMUNOLOGY, V93, P335, DOI 10.1046/j.1365-2567.1998.00438.x; Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Inoshima Y, 2002, MICROBIOL IMMUNOL, V46, P583, DOI 10.1111/j.1348-0421.2002.tb02738.x; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kilic SS, 2015, J CLIN IMMUNOL, V35, P80, DOI 10.1007/s10875-014-0111-7; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Kumar N, 2014, VIRUS GENES, V48, P312, DOI 10.1007/s11262-013-1025-9; Lateef Z, 2010, CELL MICROBIOL, V12, P665, DOI 10.1111/j.1462-5822.2009.01425.x; Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329; Lederman ER, 2007, CLIN INFECT DIS, V44, pE100, DOI 10.1086/517509; MAYR A, 1981, ZBL VET MED B, V28, P535; Nettleton PF, 1996, VET REC, V138, P184, DOI 10.1136/vr.138.8.184; PYE D, 1990, AUST VET J, V67, P182, DOI 10.1111/j.1751-0813.1990.tb07751.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spyrou V, 2015, VET MICROBIOL, V181, P178, DOI 10.1016/j.vetmic.2015.08.010; Stanford MM, 2007, IMMUNOL CELL BIOL, V85, P93, DOI 10.1038/sj.icb.7100033; Tian H, 2016, RES VET SCI, V108, P93, DOI 10.1016/j.rvsc.2016.08.005; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Westphal D, 2007, J VIROL, V81, P7178, DOI 10.1128/JVI.00404-07; Westphal D, 2009, APOPTOSIS, V14, P1317, DOI 10.1007/s10495-009-0403-1; Wonderlich ER, 2017, J IMMUNOL, V198, P1616, DOI 10.4049/jimmunol.1601770; Zaharia D, 2010, TRANSPL INT, V23, pe62, DOI 10.1111/j.1432-2277.2010.01147.x; Zhao K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-562	49	10	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186681	10.1371/journal.pone.0186681	http://dx.doi.org/10.1371/journal.pone.0186681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073164	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400039
J	Kuo, PJ; Lee, CL; Wang, JH; Hsieh, SY; Huang, SC; Lam, CF				Kuo, Pei-Jen; Lee, Chia-Ling; Wang, Jen-Huang; Hsieh, Shiu-Ying; Huang, Shian-Che; Lam, Chen-Fuh			Inhalation of volatile anesthetics via a laryngeal mask is associated with lower incidence of intraoperative awareness in non-critically ill patients	PLOS ONE			English	Article							AUDIT PROJECT NAP5; GENERAL-ANESTHESIA; ACCIDENTAL AWARENESS; RISK-FACTORS; NATIONAL-SURVEY; BASE-LINE; RECALL; UK; SURGERY; SEQUELAE	Background Increased incidence of intraoperative awareness was reported in critically ill patients during major operations, particularly under total intravenous (N-TIVA) or endotracheal general anesthesia (N-ETGA). However, the incidence and effect of anesthesia techniques on awareness in generally healthy, non-critically ill patients during operations have yet to receive significant attention. Methods and results This retrospective matched case-control study was conducted between January 2009 to December 2014. Surgical patients (N-ASA physical status I-III) whom reported intraoperative awareness during this study period were interviewed and their medical records were reviewed. The potential risk factors for awareness were compared with the non-case matched controls, who were randomly selected from the database. A total of 61436 patients were included and 16 definite cases of intraoperative awareness were identified. Patients who received ETGA and TIVA had significantly higher incidence of developing awareness compared to those who were anesthetized using laryngeal masks (N-LMA) (N-P = 0.03). Compared with the matched controls (N-n = 80), longer anesthesia time was associated with increased incidence of awareness (N-odds ratio 2.04; 95% CI 1.30-3.20, per hour increase). Perioperative use of muscle relaxant was also associated with increased incidence of awareness, while significantly lower incidence of awareness was found in patients who were anesthetized with volatile anesthetics. Conclusions The overall incidence of awareness was 0.023% in the ASA <= III surgical patients who received general anesthesia. Anesthesia with a laryngeal mask under spontaneous ventilation and supplemented with volatile anesthetics may be the preferred anesthesia technique in generally healthy patients in order to provide a lower risk of intraoperative awareness.	[Kuo, Pei-Jen; Lee, Chia-Ling; Hsieh, Shiu-Ying; Huang, Shian-Che; Lam, Chen-Fuh] Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan; [Wang, Jen-Huang] Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Lam, Chen-Fuh] I Shou Univ, Dept Anesthesiol, E Da Hosp, E Da Canc Hosp, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; E-Da Hospital; I Shou University	Lam, CF (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan.; Lam, CF (corresponding author), I Shou Univ, Dept Anesthesiol, E Da Hosp, E Da Canc Hosp, Kaohsiung, Taiwan.	ed110208@edah.org.tw			Ministry of Science and Technology of Taiwan [MOST 105-2314-B-303-007-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The authors claimed that this study was funded by the Ministry of Science and Technology of Taiwan (grant number MOST 105-2314-B-303-007-MY2 to CFL) and there was no additional external funding received for this study.	Al-Hakim L, 2012, INT J HEALTH CARE Q, V25, P322, DOI 10.1108/09526861211221509; Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361; Avidan MS, 2013, BRIT J ANAESTH, V110, P494, DOI 10.1093/bja/aet012; BOGETZ MS, 1984, ANESTHESIOLOGY, V61, P6, DOI 10.1097/00000542-198461010-00003; BRICE DD, 1970, BRIT J ANAESTH, V42, P535, DOI 10.1093/bja/42.6.535; Buchanan FF, 2006, ANESTH ANALG, V102, P291, DOI 10.1213/01.ane.0000181321.55422.C6; Cascella M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002757; Domino KB, 1999, ANESTHESIOLOGY, V90, P1053, DOI 10.1097/00000542-199904000-00019; Drake-Brockman TFE, 2017, LANCET, V389, P701, DOI 10.1016/S0140-6736(16)31719-6; Errando CL, 2008, BRIT J ANAESTH, V101, P178, DOI 10.1093/bja/aen144; Escallier KE, 2014, ANAESTHESIA, V69, P899, DOI 10.1111/anae.12711; Gaszynski T, 2016, ANAESTH INTENSIVE TH, V48, P239, DOI 10.5603/AIT.2016.0044; Ghoneim MM, 2000, ANESTHESIOLOGY, V92, P597, DOI 10.1097/00000542-200002000-00043; Ghoneim MM, 2007, BEST PRACT RES-CLIN, V21, P327, DOI 10.1016/j.bpa.2007.05.002; Ghoneim MM, 2009, ANESTH ANALG, V108, P527, DOI 10.1213/ane.0b013e318193c634; Hopkins TJ, 2016, PERIOPER MED, V5, DOI 10.1186/s13741-016-0054-z; Leslie K, 2005, ANAESTHESIA, V60, P239, DOI 10.1111/j.1365-2044.2004.04087.x; Leslie K, 2007, BEST PRACT RES-CLIN, V21, P403, DOI 10.1016/j.bpa.2007.05.003; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1218, DOI 10.1097/ALN.0b013e31820fc9b6; Osterman JE, 2001, GEN HOSP PSYCHIAT, V23, P198, DOI 10.1016/S0163-8343(01)00142-6; Pandit JJ, 2014, BRIT J ANAESTH, V113, P549, DOI 10.1093/bja/aeu313; Pandit JJ, 2014, BRIT J ANAESTH, V113, P540, DOI 10.1093/bja/aeu312; Pandit JJ, 2013, BRIT J ANAESTH, V110, P501, DOI 10.1093/bja/aet016; Pandit JJ, 2013, ANAESTHESIA, V68, P343, DOI 10.1111/anae.12190; PAYNE JP, 1994, BRIT J ANAESTH, V73, P38, DOI 10.1093/bja/73.1.38; PHILLIPS AA, 1993, CAN J ANAESTH, V40, P922, DOI 10.1007/BF03010093; Pollard RJ, 2007, ANESTHESIOLOGY, V106, P269, DOI 10.1097/00000542-200702000-00014; Ranta SOV, 1998, ANESTH ANALG, V86, P1084, DOI 10.1097/00000539-199805000-00035; Rule E, 2014, BRIT J HOSP MED, V75, P573, DOI 10.12968/hmed.2014.75.10.573; Sandin RH, 2000, LANCET, V355, P707, DOI 10.1016/S0140-6736(99)11010-9; Sebel PS, 2004, ANESTH ANALG, V99, P833, DOI 10.1213/01.ANE.0000130261.90896.6C; Sury MRJ, 2014, BRIT J ANAESTH, V113, P575, DOI 10.1093/bja/aeu292; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Whitlock EL, 2015, ANESTH ANALG, V120, P87, DOI 10.1213/ANE.0000000000000498; Xu L, 2009, ACTA ANAESTH SCAND, V53, P873, DOI 10.1111/j.1399-6576.2009.02016.x; Xu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158137	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186337	10.1371/journal.pone.0186337	http://dx.doi.org/10.1371/journal.pone.0186337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073151	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400023
J	Scaldaferri, F; D'Ambrosio, D; Holleran, G; Poscia, A; Petito, V; Lopetuso, L; Graziani, C; Laterza, L; Pistone, MT; Pecere, S; Curro, D; Gaetani, E; Armuzzi, A; Papa, A; Cammarota, G; Gasbarrini, A				Scaldaferri, Franco; D'Ambrosio, Daria; Holleran, Grainne; Poscia, Andrea; Petito, Valentina; Lopetuso, Loris; Graziani, Cristina; Laterza, Lucrezia; Pistone, Maria Teresa; Pecere, Silvia; Curro, Diego; Gaetani, Eleonora; Armuzzi, Alessandro; Papa, Alfredo; Cammarota, Giovanni; Gasbarrini, Antonio			Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab	PLOS ONE			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; TREATMENT OUTCOMES; ADIPOSE-TISSUE; OBESE-PATIENTS; WEIGHT; TIME; PATHOGENESIS; ADALIMUMAB; ANTIBODIES	Introduction Infliximab is an effective treatment for inflammatory bowel disease (IBD). Studies differ regarding the influence of body mass index (BMI) on the response to infliximab, with the majority of studies indicating that increased BMI may be associated with a poorer response to Infliximab. However, the pharmacokinetic mechanisms causing this have not yet been reported. Aims Examine the correlation between BMI/immunosuppressant use with clinical response, trough and post-infusion levels of infliximab, tumour necrosis factor-alpha(TNF-alpha) and anti-drug antibodies(ATI), and determine if these factors can predict future response. Methods We collected serum from 24 patients receiving Infliximab before and 30 minutes following infusion. Clinical parameters were collected retrospectively and prospectively. ELISA measurements of infliximab, TNF-alpha and ATI were performed. Results We confirmed that patients with higher infliximab trough levels have a better response rate and that patients with an elevated BMI display a higher rate of loss of response (20%). Patients with a higher BMI had elevated post-infusion levels of infliximab. Additionally, the ratio of IFX/TNF-alpha trough levels correlated with clinical response to the following infusion. Conclusion This study confirms that an elevated BMI is associated with a poorer response to infliximab. For the first time, we describe that a higher BMI correlates with higher post-infusion levels, however this does not correlate with a higher rate of response to the drug, suggesting that circulating drug levels do not correlate with tissue levels. Furthermore, in our small cohort of patients, we identified a possible predictive marker of future response to treatment which may be used to guide dose escalation and predict non-response to infliximab.	[Scaldaferri, Franco; D'Ambrosio, Daria; Holleran, Grainne; Poscia, Andrea; Petito, Valentina; Lopetuso, Loris; Graziani, Cristina; Laterza, Lucrezia; Pistone, Maria Teresa; Pecere, Silvia; Curro, Diego; Gaetani, Eleonora; Armuzzi, Alessandro; Papa, Alfredo; Cammarota, Giovanni; Gasbarrini, Antonio] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Holleran, G (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Rome, Italy.	grainneholleran@gmail.com	Cammarota, Giovanni/AAD-1732-2022; Lopetuso, Loris Riccardo/AAC-9065-2019; graziani, cristina/A-8915-2019; Armuzzi, Alessandro/AIC-5188-2022; PETITO, VALENTINA/K-3499-2016; Gasbarrini, Antonio/AAB-8487-2019; scaldaferri, franco/AAC-4056-2020; Papa, Alfredo/AAC-1108-2019; Curro', Diego/F-1430-2016; Laterza, Lucrezia/AAC-5932-2019; PETITO, VALENTINA O=/B-1239-2019; pecere, silvia/M-2541-2018	Cammarota, Giovanni/0000-0002-3626-6148; PETITO, VALENTINA/0000-0003-4396-1613; Papa, Alfredo/0000-0002-4186-7298; Curro', Diego/0000-0001-6726-6872; Laterza, Lucrezia/0000-0001-5515-1197; pecere, silvia/0000-0002-4401-7344; Gaetani, Eleonora/0000-0002-7808-1491; Gasbarrini, Antonio/0000-0003-4863-6924; GRAZIANI, CRISTINA/0000-0003-3578-7571				Al-Mutairi N, 2014, EXPERT OPIN BIOL TH, V14, P749, DOI 10.1517/14712598.2014.900541; Bhalme M, 2013, EUR J GASTROEN HEPAT, V25, P543, DOI 10.1097/MEG.0b013e32835d1f15; Bond A, 2016, EUR J GASTROEN HEPAT, V28, P271, DOI 10.1097/MEG.0000000000000544; Brown P, 2016, J CROHNS COLITIS, V10, P1144, DOI 10.1093/ecco-jcc/jjw079; Cinkajzlova A, 2017, PROTOPLASMA, V254, P1219, DOI 10.1007/s00709-017-1082-3; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Dong J, 2015, PLOS ONE, V10; Dotan I, 2014, INFLAMM BOWEL DIS, V20, P2247, DOI 10.1097/MIB.0000000000000212; Fink C, 2012, INFLAMM BOWEL DIS, V18, P1550, DOI 10.1002/ibd.22893; Franco Scaldaferri, 2016, BIOCHEM PHARMACOL, V5, P2; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Harper JW, 2013, INFLAMM BOWEL DIS, V19, P2118, DOI 10.1097/MIB.0b013e31829cf401; Loring B., 2014, OBESITY INEQUITIES G; Moran GW, 2013, INFLAMM BOWEL DIS, V19, P2949, DOI 10.1097/MIB.0b013e31829936a4; Ottaviani S, 2015, CLIN EXP RHEUMATOL, V33, P478; Pallagi-Kunstar E, 2014, WORLD J GASTROENTERO, V20, P5031, DOI 10.3748/wjg.v20.i17.5031; Parsi MA, 2002, GASTROENTEROLOGY, V123, P707, DOI 10.1053/gast.2002.35390; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Singh S, 2017, NAT REV GASTRO HEPAT, V14, P110, DOI 10.1038/nrgastro.2016.181; Van den Brande JMH, 2007, GUT, V56, P509, DOI 10.1136/gut.2006.105379; Yanai H, 2015, CLIN GASTROENTEROL H, V13, P522, DOI 10.1016/j.cgh.2014.07.029; Zitomersky NL, 2015, INFLAMM BOWEL DIS, V21, P307, DOI 10.1097/MIB.0000000000000284	24	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186575	10.1371/journal.pone.0186575	http://dx.doi.org/10.1371/journal.pone.0186575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073159	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400031
J	Rupprecht, N; Vural, DC				Rupprecht, Nathaniel; Vural, Dervis Can			Collective motion of predictive swarms	PLOS ONE			English	Article							UNDECIDABILITY	Theoretical models of populations and swarms typically start with the assumption that the motion of agents is governed by the local stimuli. However, an intelligent agent, with some understanding of the laws that govern its habitat, can anticipate the future, and make predictions to gather resources more efficiently. Here we study a specific model of this kind, where agents aim to maximize their consumption of a diffusing resource, by attempting to predict the future of a resource field and the actions of other agents. Once the agents make a prediction, they are attracted to move towards regions that have, and will have, denser resources. We find that the further the agents attempt to see into the future, the more their attempts at prediction fail, and the less resources they consume. We also study the case where predictive agents compete against non-predictive agents and find the predictors perform better than the non-predictors only when their relative numbers are very small. We conclude that predictivity pays off either when the predictors do not see too far into the future or the number of predictors is small.	[Rupprecht, Nathaniel; Vural, Dervis Can] Univ Notre Dame, Dept Phys, South Bend, IN 46556 USA	University of Notre Dame	Vural, DC (corresponding author), Univ Notre Dame, Dept Phys, South Bend, IN 46556 USA.	dvural@nd.edu						Basar T., 1999, DYNAMIC NONCOOPERATI, V23; Bennett C.H, 1995, UNIVERSAL TURING MAC, P207; Cubitt TS, 2015, NATURE, V528, P207, DOI 10.1038/nature16059; Fostel A, 2012, J ECON THEORY, V147, P501, DOI 10.1016/j.jet.2011.07.001; Godel K., 1992, FORMALLY UNDECIDABLE; Joshi MS, 2003, CONCEPTS PRACTICE MA, V1; Karamouzas I, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.238701; LLOYD S, 1993, PHYS REV LETT, V71, P943, DOI 10.1103/PhysRevLett.71.943; Lloyd S, 2013, ARXIV13124456; Lloyd S., 2016, ARXIV160205924; MacKenzie D., 2008, ENGINE NOT CAMERA FI; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Maslowska A, 2012, DOES SURPRISE REALLY; MOORE C, 1990, PHYS REV LETT, V64, P2354, DOI 10.1103/PhysRevLett.64.2354; Pathria R., 1986, INT SERIES NATURAL P; Ramachandran KM, 2012, THEORY APPL, V2; Ray D, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.013019; Rupprecht N., SIMULATION CODE; SCHUSTER H. G., 2013, NONEQUILIBRIUM STAT; Tiribocchi A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.188302; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Vural DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020721; Wissner-Gross AD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168702; Yeung D. W. K., 2006, SPRING S OPERAT RES; Zwanzig R., 2001, NONEQUILIBRIUM STAT	25	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186785	10.1371/journal.pone.0186785	http://dx.doi.org/10.1371/journal.pone.0186785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065136	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900038
J	Brown, AG; Tulina, NM; Barila, GO; Hester, MS; Elovitz, MA				Brown, Amy G.; Tulina, Natalia M.; Barila, Guillermo O.; Hester, Michael S.; Elovitz, Michal A.			Exposure to intrauterine inflammation alters metabolomic profiles in the amniotic fluid, fetal and neonatal brain in the mouse	PLOS ONE			English	Article							NEURODEVELOPMENTAL DISORDERS; MATERNAL INFECTION; GLUTARIC ACIDURIA; SEX-DIFFERENCES; PRETERM BIRTH; INJURY; SCHIZOPHRENIA; BEHAVIOR; LEADS; NEUROINFLAMMATION	Introduction Exposure to prenatal inflammation is associated with diverse adverse neurobehavioral outcomes in exposed offspring. The mechanism by which inflammation negatively impacts the developing brain is poorly understood. Metabolomic profiling provides an opportunity to identify specific metabolites, and novel pathways, which may reveal mechanisms by which exposure to intrauterine inflammation promotes fetal and neonatal brain injury. Therefore, we investigated whether exposure to intrauterine inflammation altered the metabolome of the amniotic fluid, fetal and neonatal brain. Additionally, we explored whether changes in the metabolomic profile from exposure to prenatal inflammation occurs in a sex-specific manner in the neonatal brain. Methods CD-1, timed pregnant mice received an intrauterine injection of lipopolysaccharide (50 mu g/dam) or saline on embryonic day 15. Six and 48 hours later mice were sacrificed and amniotic fluid, and fetal brains were collected (n = 8/group). Postnatal brains were collected on day of life 1 (n = 6/group/sex). Global biochemical profiles were determined using ultra performance liquid chromatography/tandem mass spectrometry (Metabolon Inc.). Statistical analyses were performed by comparing samples from lipopolysaccharide and saline treated animals at each time point. For the P1 brains, analyses were stratified by sex. Results/Conclusions Exposure to intrauterine inflammation induced unique, temporally regulated changes in the metabolic profiles of amniotic fluid, fetal brain and postnatal brain. Six hours after exposure to intrauterine inflammation, the amniotic fluid and the fetal brain metabolomes were dramatically altered with significant enhancements of amino acid and purine metabolites. The amniotic fluid had enhanced levels of several members of the (hypo) xanthine pathway and this compound was validated as a potential biomarker. By 48 hours, the number of altered biochemicals in both the fetal brain and the amniotic fluid had declined, yet unique profiles existed. Neonatal pups exposed to intrauterine inflammation have significant alterations in their lipid metabolites, in particular, fatty acids. These sex-specific metabolic changes within the newborn brain offer an explanation regarding the sexual dimorphism of certain psychiatric and neurobehavioral disorders associated with exposure to prenatal inflammation.	[Brown, Amy G.; Tulina, Natalia M.; Barila, Guillermo O.; Hester, Michael S.; Elovitz, Michal A.] Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Maternal Child Hlth Res Ctr, Philadelphia, PA 19104 USA; [Hester, Michael S.] Carl Zeiss Microscopy LLC, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine	Brown, AG (corresponding author), Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Maternal Child Hlth Res Ctr, Philadelphia, PA 19104 USA.	aegreen@mail.med.upenn.edu		Elovitz, Michal/0000-0001-7554-7180	National Institute of Child Health and Human Development [R01 HD076032]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076032] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant R01 HD076032 (MAE) from the National Institute of Child Health and Human Development. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of this manuscript.	Andrikopoulou M, 2014, INT J DEV NEUROSCI, V36, P25, DOI 10.1016/j.ijdevneu.2014.04.002; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Bergeron JDL, 2013, DEV NEUROSCI-BASEL, V35, P504, DOI 10.1159/000355656; Blaise BJ, 2017, DEV NEUROSCI; Boccazzi M, 2014, GLIA, V62, P428, DOI 10.1002/glia.22614; Brown AS, 2009, AM J PSYCHIAT, V166, P683, DOI 10.1176/appi.ajp.2008.08010089; Burd I, 2010, AM J OBSTET GYNECOL, V202, pe291, DOI DOI 10.1016/J.AJ0G.2010.01.022; Burd I, 2009, AM J OBSTET GYNECOL, V201, pe271, DOI DOI 10.1016/J.AJ0G.2009.06.013; Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Burrage LC, 2014, HUM MOL GENET, V23, pR1, DOI 10.1093/hmg/ddu123; Chun PT, 2015, DEV NEUROSCI-BASEL, V37, P161, DOI 10.1159/000370147; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Dada T, 2014, BRAIN BEHAV IMMUN, V38, P142, DOI 10.1016/j.bbi.2014.01.014; de Azevedo MI, 2016, MICROB PATHOGENESIS, V99, P36, DOI 10.1016/j.micpath.2016.07.015; El-Ansary A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0189-0; Ellman LM, 2009, BIOL PSYCHIAT, V65, P1040, DOI 10.1016/j.biopsych.2008.12.015; Elovitz MA, 2006, PEDIATR RES, V59, P50, DOI 10.1203/01.pdr.0000191141.21932.b6; Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Fatemi SH, 2009, EUR NEUROPSYCHOPHARM, V19, P648, DOI 10.1016/j.euroneuro.2009.03.004; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; Fatemi SH, 2016, J NEUROSCIENCE RES; Fernandis AZ, 2007, CURR OPIN LIPIDOL, V18, P121, DOI 10.1097/MOL.0b013e328082e4d5; Funk CBR, 2005, BRAIN, V128, P711, DOI 10.1093/brain/awh401; Graham EM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00196; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jaeger C, 2015, AM J PATHOL, V185, P1699, DOI 10.1016/j.ajpath.2015.02.016; Jansen M, 2013, FASEB J, V27, P865, DOI 10.1096/fj.12-211235; Keller M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029503; Larsson MK, 2016, NEUROCHEM RES, V41, P2243, DOI 10.1007/s11064-016-1939-4; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; McCarthy MM, 2016, DIALOGUES CLIN NEURO, V18, P361; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Ophelders DRMG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0492-z; Pershing ML, 2016, PSYCHOPHARMACOLOGY, V233, P3725, DOI 10.1007/s00213-016-4404-9; Pershing ML, 2015, NEUROPHARMACOLOGY, V90, P33, DOI 10.1016/j.neuropharm.2014.10.017; Petrov AM, 2016, ACTA NATURAE, V8, P58, DOI 10.32607/20758251-2016-8-1-58-73; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Rantakallio P, 1997, INT J EPIDEMIOL, V26, P837, DOI 10.1093/ije/26.4.837; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Sevin DC, 2015, CURR OPIN BIOTECH, V34, P1, DOI 10.1016/j.copbio.2014.10.001; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Yudkoff M, 2017, NEUROCHEM RES, V42, P10, DOI 10.1007/s11064-016-2057-z; Zuckerman L, 2005, J PSYCHIATR RES, V39, P311, DOI 10.1016/j.jpsychires.2004.08.008	51	26	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186656	10.1371/journal.pone.0186656	http://dx.doi.org/10.1371/journal.pone.0186656			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049352	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900092
J	Danko, MJ; Burger, O; Kozlowski, J				Danko, Maciej Jan; Burger, Oskar; Kozlowski, Jan			Density-dependence interacts with extrinsic mortality in shaping life histories	PLOS ONE			English	Article							EVOLUTION; SENESCENCE; REPRODUCTION; GROWTH; AGE; POPULATIONS; COMPETITION; ALLOCATION; FITNESS; SIZE	The role of extrinsic mortality in shaping life histories is poorly understood. However, substantial evidence suggests that extrinsic mortality interacts with density-dependence in crucial ways. We develop a model combining Evolutionarily Stable Strategies with a projection matrix that allows resource allocation to growth, tissue repairs, and reproduction. Our model examines three cases, with density-dependence acting on: (i) mortality, (ii) fecundity, and (iii) production rate. We demonstrate that density-independent extrinsic mortality influences the rate of aging, age at maturity, growth rate, and adult size provided that density-dependence acts on fertility or juvenile mortality. However, density-independent extrinsic mortality has no effect on these life history traits when density-dependence acts on survival. We show that extrinsic mortality interacts with density-dependence via a compensation mechanism: the higher the extrinsic mortality the lower the strength of density-dependence. However, this compensation fully offsets the effect of extrinsic mortality only if density-dependence acts on survival independently of age. Both the age-pattern and the type of density-dependence are crucial for shaping life history traits.	[Danko, Maciej Jan; Burger, Oskar] Max Planck Inst Demog Res, Rostock, Germany; [Kozlowski, Jan] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Max Planck Society; Jagiellonian University	Danko, MJ (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	danko@demogr.mpg.de	Kozlowski, Jan/K-5549-2012; Dańko, Maciej J./W-3099-2019	Kozlowski, Jan/0000-0002-7084-2030; Dańko, Maciej J./0000-0002-7924-9022; Burger, Oskar/0000-0002-7552-5851	Max Planck Institute for Demographic Research, Rostock, Germany; Jagiellonian University, Poland [DS/WBiNoZ/INoS 757/16]	Max Planck Institute for Demographic Research, Rostock, Germany; Jagiellonian University, Poland	The project was founded by the Max Planck Institute for Demographic Research, Rostock, Germany to MJD and OB. JK was funded by Jagiellonian University, Poland (DS/WBiNoZ/INoS 757/16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2004, NATURE, V431, P1048, DOI 10.1038/4311048a; ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; AUSTAD SN, 1991, J GERONTOL, V46, pB47, DOI 10.1093/geronj/46.2.B47; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Caswell H, 2007, ENERGETICS ECOSYSTEM; Caswell H, 2008, MATRIX POPULATION MO; Caswell H, 2007, TRENDS ECOL EVOL, V22, P173, DOI 10.1016/j.tree.2007.01.006; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; CHARNOV EL, 1991, P NATL ACAD SCI USA, V88, P1134, DOI 10.1073/pnas.88.4.1134; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Charnov Eric L., 1993, P1; Cushing J., 1998, J SOC IND APPL MATH; CUSHING JM, 1992, B MATH BIOL, V54, P503, DOI 10.1007/BF02459632; Danko MJ, 2015, J THEOR BIOL, V382, P137, DOI 10.1016/j.jtbi.2015.06.043; Danko MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048302; Danko MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034146; Danko MJ, 2017, EXP GERONTOL; Dawidowicz P, 2010, HYDROBIOLOGIA, V643, P27, DOI 10.1007/s10750-010-0132-z; DeLong JP, 2014, J ANIM ECOL, V83, P51, DOI 10.1111/1365-2656.12065; DeLong JP, 2009, ISME J, V3, P1396, DOI 10.1038/ismej.2009.81; Dudycha JL, 2013, J PLANKTON RES, V35, P253, DOI 10.1093/plankt/fbt008; Dudycha JL, 1999, EVOLUTION, V53, P1744, DOI 10.1111/j.1558-5646.1999.tb04559.x; Evolution M., 1997, P R SOC B, V264, P1383; FERRIERE R, 1995, THEOR POPUL BIOL, V48, P126, DOI 10.1006/tpbi.1995.1024; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; Goldstein JR, 2012, POP STUD-J DEMOG, V66, P29, DOI 10.1080/00324728.2011.635215; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Haldane J.B.S., 1941, NEW PATHS GENETICS; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HANSKI I, 1990, PHILOS T R SOC B, V330, P141, DOI 10.1098/rstb.1990.0188; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Heino M, 2013, ICES J MAR SCI, V70, P707, DOI 10.1093/icesjms/fst077; Heino Mikko, 2008, P308; Kalbfleisch JD, 2002, FAILURE TIME MODELS, P31; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Kozlowski J, 1996, AM NAT, V147, P101, DOI 10.1086/285842; KOZLOWSKI J, 1993, TRENDS ECOL EVOL, V8, P84, DOI 10.1016/0169-5347(93)90056-U; Kozlowski J, 1999, EVOL ECOL RES, V1, P423; Kozlowski J, 2006, POL J ECOL, V54, P585; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Makeham W.M., 1867, J I ACTUARIES 1866 1, V13, P325, DOI [DOI 10.1017/S2046166600003238, 10.1017/s2046166600003238]; Maklakov AA, 2015, BIOESSAYS, V37, P802, DOI 10.1002/bies.201500025; Medawar P., 1952, UNSOLVED PROBLEM BIO; Medawar P. B., 1946, MODERN Q, V2, P30, DOI DOI 10.1111/J.1540-4781.1946.TB04867.X; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Moorad JA, 2008, GENETICS, V179, P2061, DOI 10.1534/genetics.108.088526; Moorad JA, 2010, CURR BIOL, V20, pR406, DOI 10.1016/j.cub.2010.03.016; Partridge L., 1989, LIFETIME REPROD BIRD; Pietrzak B, 2015, EXP GERONTOL, V69, P1, DOI 10.1016/j.exger.2015.05.008; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; RAND DA, 1994, PHILOS T R SOC B, V343, P261, DOI 10.1098/rstb.1994.0025; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Ricklefs RE, 2002, J GERONTOL A-BIOL, V57, pB69, DOI 10.1093/gerona/57.2.B69; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P10314, DOI 10.1073/pnas.1005862107; Robert KA, 2010, AM NAT, V175, P147, DOI 10.1086/649595; Seymour R, 2005, PLOS COMPUT BIOL; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i03; Stearns S.C., 1992, pi; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Takada T, 1998, J MATH BIOL, V36, P497, DOI 10.1007/s002850050111; TAKADA T, 1992, MATH BIOSCI, V112, P155, DOI 10.1016/0025-5564(92)90091-A; TAYLOR HM, 1974, THEOR POPUL BIOL, V5, P104, DOI 10.1016/0040-5809(74)90053-7; Tozzini ET, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-77; Walsh MR, 2014, J ANIM ECOL, V83, P1279, DOI 10.1111/1365-2656.12247; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008; Williams PD, 2003, EVOLUTION, V57, P1478	74	12	12	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186661	10.1371/journal.pone.0186661	http://dx.doi.org/10.1371/journal.pone.0186661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049399	Green Submitted, gold, Green Published			2022-12-26	WOS:000413195900093
J	Kim, JK; Kwon, YE; Lee, SG; Kim, CY; Kim, JG; Huh, M; Lee, E; Kim, YJ				Kim, Jung-Kyun; Kwon, Yong-Eun; Lee, Sang-Gil; Kim, Chang-Yeon; Kim, Jin-Gyu; Huh, Min; Lee, Eunji; Kim, Youn-Joong			Correlative microscopy of the constituents of a dinosaur rib fossil and hosting mudstone: Implications on diagenesis and fossil preservation	PLOS ONE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; SOUTH-KOREA; HYDROTHERMAL SYSTEM; BEARING DEPOSITS; BONE; ILLITE; HYDROXYAPATITE; PHOSPHATE; APATITE; PALEOENVIRONMENTS	We have applied correlative microscopy to identify the key constituents of a dorsal rib fossil from Koreanosaurus boseongensis and its hosting mudstone discovered at the rich fossil site in Boseong, South Korea, to investigate the factors that likely contributed to diagenesis and the preservation of fossil bone. Calcite and illite were the commonly occurring phases in the rib bone, hosting mudstone, and the boundary region in-between. The boundary region may have contributed to bone preservation once it fully formed by acting as a protective shell. Fluorapatite crystals in the rib bone matrix signified diagenetic alteration of the original bioapatite crystals. While calcite predominantly occupied vascular channels and cracks, platy illite crystals widely occupied miniscule pores throughout the bone matrix. Thorough transmission electron microscopy (TEM) study of illite within the bone matrix indicated the solid-state transformation of 1M to 2M without composition change, which was more evident from the lateral variation of 1M to 2M within the same layer. The high level of lattice disordering of 2M illite suggested an early stage of 1M to 2M transformation. Thus, the diagenetic alteration of both apatite and illite crystals within the bone matrix may have increased its overall density, as the preferred orientation of apatite crystals from moderate to strong degrees was evident despite the poor preservation of osteohistological features. The combined effects of rapid burial, formation of a boundary region, and diagenesis of illite and apatite within the bone matrix may have contributed to the rib bone preservation.	[Kim, Jung-Kyun; Kwon, Yong-Eun; Lee, Eunji; Kim, Youn-Joong] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon, South Korea; [Lee, Sang-Gil; Kim, Chang-Yeon; Kim, Jin-Gyu; Kim, Youn-Joong] Korea Basic Sci Inst, Electron Microscopy Res Ctr, Daejeon, South Korea; [Huh, Min] Chonnam Natl Univ, Korea Dinosaur Res Ctr, Gwangju, South Korea; [Huh, Min] Chonnam Natl Univ, Dept Earth Syst & Environm Sci, Gwangju, South Korea	Chungnam National University; Korea Basic Science Institute (KBSI); Chonnam National University; Chonnam National University	Kim, YJ (corresponding author), Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon, South Korea.; Kim, YJ (corresponding author), Korea Basic Sci Inst, Electron Microscopy Res Ctr, Daejeon, South Korea.	y-jkim@kbsi.re.kr	Lee, Eunji/H-1301-2011	Lee, Eunji/0000-0001-7494-1776	National Research Foundation of Korea Grant - Korean Government (MSIP) (R&D Equipment Engineer Education Program) [2014R1A6A9064166]; Korea Basic Science Institute [D37612]	National Research Foundation of Korea Grant - Korean Government (MSIP) (R&D Equipment Engineer Education Program); Korea Basic Science Institute	This study was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MSIP) (2017, R&D Equipment Engineer Education Program, 2014R1A6A9064166) to Jung-Kyun Kim and by the Korea Basic Science Institute (institutional program: D37612) to Jung-Kyun Kim.	Allison P.A., 1991, TAPHONOMY RELEASING; Bauluz B, 2014, LETHAIA, V47, P556, DOI 10.1111/let.12081; Bergmann U, 2010, P NATL ACAD SCI USA, V107, P9060, DOI 10.1073/pnas.1001569107; Boatman E. M., 2013, MICROS TODAY, V21, P34; Chen T, 2013, AM MINERAL, V98, P879, DOI 10.2138/am.2013.4220; Chough S.K., 2013, GEOLOGY SEDIMENTARY, DOI [DOI 10.1016/C2012-0-02847-5, 10.1016/C2012-0-02847-5]; Chough SK, 2000, EARTH-SCI REV, V52, P175, DOI 10.1016/S0012-8252(00)00029-5; Drits VA, 2010, AM MINERAL, V95, P348, DOI 10.2138/am.2010.3300; Dumont M, 2011, PALAEOGEOGR PALAEOCL, V310, P108, DOI 10.1016/j.palaeo.2011.06.021; Dumont M, 2009, POWDER DIFFR, V24, P130, DOI 10.1154/1.3131803; Dumont M, 2014, BIOL J LINN SOC, V112, P782, DOI 10.1111/bij.12335; Elorza J, 1999, CRETACEOUS RES, V20, P169, DOI 10.1006/cres.1999.0144; Flugel E., 2010, MICROFACIES CARBONAT, DOI DOI 10.1007/978-3-642-03796-2; Glimcher MJ, 2006, REV MINERAL GEOCHEM, V64, P223, DOI 10.2138/rmg.2006.64.8; Goodwin MB, 2007, PALAEOGEOGR PALAEOCL, V253, P458, DOI 10.1016/j.palaeo.2007.06.017; GRUBB SMB, 1991, CLAY CLAY MINER, V39, P540; Gualtieri AF, 2000, J APPL CRYSTALLOGR, V33, P267, DOI 10.1107/S002188989901643X; Hubert JF, 1996, J SEDIMENT RES, V66, P531; HUGHES JM, 1989, AM MINERAL, V74, P870; Huh M, 2002, J VERTEBR PALEONTOL, V22, P716, DOI 10.1671/0272-4634(2002)022[0716:RDNSFT]2.0.CO;2; Huh M, 2010, NEUES JAHRB GEOL P-A, V259, P1, DOI 10.1127/0077-7749/2010/0102; INOUE A, 1994, AM MINERAL, V79, P700; Jantou V, 2009, MICRON, V40, P495, DOI 10.1016/j.micron.2008.12.002; Keenan SW, 2017, GEOCHIM COSMOCHIM AC, V196, P209, DOI 10.1016/j.gca.2016.09.033; Kim CB, 2008, J KOR EARTH SCI SOC, V29, P386, DOI 10.5467/JKESS.2008.29.5.386; Kim CB, 2009, CRETACEOUS RES, V30, P93, DOI 10.1016/j.cretres.2008.05.003; Kim JK, 2017, SCI REP-UK, V7, DOI 10.1038/srep45562; Kim JK, 2011, GEOSCI J, V15, P225, DOI 10.1007/s12303-001-0026-1; Lee JM, 2013, B KOREAN CHEM SOC, V34, P788, DOI 10.5012/bkcs.2013.34.3.788; LONKER SW, 1990, AM MINERAL, V75, P1282; Meunier A., 2010, CLAYS; Meunier A., 2010, ILLITE; Monchau F, 2013, MAT SCI ENG C-MATER, V33, P490, DOI 10.1016/j.msec.2012.09.019; Moore D., 1997, XRAY DIFFRACTION IDE, VXVIII, P378; Muller-Reichert T, 2012, METHOD CELL BIOL, V111, pXVII, DOI 10.1016/B978-0-12-416026-2.03001-6; Mugnaioli E, 2009, AM MINERAL, V94, P793, DOI 10.2138/am.2009.2994; Paik IS, 2004, PALAEOGEOGR PALAEOCL, V205, P155, DOI 10.1016/j.palaeo.2003.12.007; Paik IS, 2001, CRETACEOUS RES, V22, P627, DOI 10.1006/cres.2001.0282; Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422; Park JY, 2015, CRETACEOUS RES, V55, P292, DOI 10.1016/j.cretres.2015.03.001; Peacor DR, 2002, CLAY CLAY MINER, V50, P757, DOI 10.1346/000986002762090281; Potter PE, 2005, MUD MUDSTONES; Schweitzer MH, 2008, CR PALEVOL, V7, P159, DOI 10.1016/j.crpv.2008.02.005; Trueman CN, 2002, REV MINERAL GEOCHEM, V48, P489, DOI 10.2138/rmg.2002.48.13; VEBLEN DR, 1990, CLAY CLAY MINER, V38, P1, DOI 10.1346/CCMN.1990.0380101; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; WHITNEY G, 1993, CLAY CLAY MINER, V41, P209, DOI 10.1346/CCMN.1993.0410209; Wilson MJ, 2013, SHEET SILICATES RO C, V3; Wings O, 2004, PALAEOGEOGR PALAEOCL, V204, P15, DOI 10.1016/S0031-0182(03)00709-0; ZOCCO TG, 1994, PALAEONTOLOGY, V37, P493	50	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186600	10.1371/journal.pone.0186600	http://dx.doi.org/10.1371/journal.pone.0186600			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049347	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900086
J	Minguillon, J; Lopez-Gordo, MA; Renedo-Criado, DA; Sanchez-Carrion, MJ; Pelayo, F				Minguillon, Jesus; Angel Lopez-Gordo, Miguel; Renedo-Criado, Diego A.; Jose Sanchez-Carrion, Maria; Pelayo, Francisco			Blue lighting accelerates post-stress relaxation: Results of a preliminary study	PLOS ONE			English	Article							HEART-RATE; DIFFERENT COLORS; MENTAL STRESS; HUMAN BRAIN; EEG; WAVELENGTH; STIMULATION; SENSITIVITY; ADAPTATION; MELATONIN	Several authors have studied the influence of light on both human physiology and emotions. Blue light has been proved to reduce sleepiness by suppression of melatonin secretion and it is also present in many emotion-related studies. Most of these have a common lack of objective methodology since results and conclusions are based on subjective perception of emotions. The aim of this work was the objective assessment of the effect of blue lighting in post-stress relaxation, in comparison with white lighting, by means of bio-signals and standardized procedures. We conducted a study in which twelve healthy volunteers were stressed and then performed a relaxation session within a chromotherapy room with blue (test group) or white (control group) lighting. We conclude that the blue lighting accelerates the relaxation process after stress in comparison with conventional white lighting. The relaxation time decreased by approximately three-fold (1.1 vs. 3.5 minutes). We also observed a convergence time (3.5-5 minutes) after which the advantage of blue lighting disappeared. This supports the relationship between color of light and stress, and the observations reported in previous works. These findings could be useful in clinical and educational environments, as well as in daily-life context and emerging technologies such as neuromarketing. However, our study must be extended to draw reliable conclusions and solid scientific evidence.	[Minguillon, Jesus; Pelayo, Francisco] Univ Granada, Dept Comp Architecture & Technol, Granada, Spain; [Minguillon, Jesus; Pelayo, Francisco] Univ Granada, Res Ctr Informat & Commun Technol CITIC, Granada, Spain; [Angel Lopez-Gordo, Miguel; Renedo-Criado, Diego A.] Univ Granada, Dept Signal Theory Telemat & Commun, Granada, Spain; [Angel Lopez-Gordo, Miguel] Nicolo Assoc, Churriana De La Vega, Spain; [Jose Sanchez-Carrion, Maria] Sch Special Educ San Rafael, Granada, Spain	University of Granada; University of Granada; University of Granada	Minguillon, J (corresponding author), Univ Granada, Dept Comp Architecture & Technol, Granada, Spain.; Minguillon, J (corresponding author), Univ Granada, Res Ctr Informat & Commun Technol CITIC, Granada, Spain.	minguillon@ugr.es	Minguillon, Jesus/C-9013-2015; LOPEZ, MIGUEL A/A-6629-2013	Minguillon, Jesus/0000-0003-4682-6898; LOPEZ, MIGUEL A/0000-0002-5470-1764	Nicolo Association for the R+D in Neurotechnologies for disability; Ministry of Economy and Competitiveness [DPI2015-69098-REDT]; Junta of Andalucia (Spain) [P11-TIC-7983]; Spanish National Grant [TIN2015-67020]; European Regional Development Fund (ERDF); School for Special Education San Rafael of Granada	Nicolo Association for the R+D in Neurotechnologies for disability; Ministry of Economy and Competitiveness; Junta of Andalucia (Spain)(Junta de Andalucia); Spanish National Grant(Spanish Government); European Regional Development Fund (ERDF)(European Commission); School for Special Education San Rafael of Granada	This work was supported by Nicolo Association for the R+D in Neurotechnologies for disability, the Ministry of Economy and Competitiveness DPI2015-69098-REDT, the research project P11-TIC-7983 of Junta of Andalucia (Spain) and the Spanish National Grant TIN2015-67020, co-financed by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all the people who participated in the study, including participants and students that collaborated. The authors would also like to thank the School for Special Education San Rafael of Granada for their support and the provided facilities.	Al-Ayash A, 2015, COLOR RES APPL; ALI MR, 1972, ELECTROEN CLIN NEURO, V33, P332, DOI 10.1016/0013-4694(72)90162-9; Azeemi STY, 2005, EVID-BASED COMPL ALT, V2, P481, DOI 10.1093/ecam/neh137; Bali A, 2015, REV NEUROSCIENCE, V26, P555, DOI 10.1515/revneuro-2015-0004; Bellia L, 2016, COLOUR COLORIMETRY B, VXII, P129; Besenecker U, 2016, COLOUR COLORIMETRY B, VXII, P109; Brouwer A.-M, 2011, J CYBERTHER REHABIL, V4, P21; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Casciani D, 2016, COLOUR COLORIMETRY B, VXII, P81; Chandiramani S, 2007, PACE, V30, P976, DOI 10.1111/j.1540-8159.2007.00795.x; Dagher A, 2009, BRAIN RES, V1293, P40, DOI 10.1016/j.brainres.2009.07.048; Dedovic K, 2005, J PSYCHIATR NEUROSCI, V30, P319; Dedovic K, 2009, BRAIN RES, V1293, P49, DOI 10.1016/j.brainres.2009.06.044; Deguchi Takatsugu, 1992, Annals of Physiological Anthropology, V11, P37; Dimitriev D A, 2015, Ross Fiziol Zh Im I M Sechenova, V101, P98; Ebbesen F, 2003, ARCH DIS CHILD-FETAL, V88, pF430, DOI 10.1136/fn.88.5.F430; Figueiro MG, 2007, ACTA NEUROBIOL EXP, V67, P171; Hi LS, 2009, J HUMAN ENV SYST, V12, P27; Jenke R, 2014, IEEE T AFFECT COMPUT, V5, P327, DOI 10.1109/TAFFC.2014.2339834; Kuijsters A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132732; Kuller R., 1993, Lighting Research and Technology, V25, P71; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Minguillon J, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00101; Moridis CN, 2010, P IEEE EMBS REG 8 IN, P3; Munch M, 2014, NEUROIMAGE, V101, P547, DOI 10.1016/j.neuroimage.2014.06.071; Munch M, 2006, AM J PHYSIOL-REG I, V290, pR1421, DOI 10.1152/ajpregu.00478.2005; Nagano-Saito A, 2013, SYNAPSE, V67, P821, DOI 10.1002/syn.21700; Nardelli M, 2015, IEEE T AFFECT COMPUT, V6, P385, DOI 10.1109/TAFFC.2015.2432810; Papousek I, 2014, BIOL PSYCHOL, V103, P184, DOI 10.1016/j.biopsycho.2014.09.001; Picard RW, 2010, IEEE T AFFECT COMPUT, V1, P11, DOI 10.1109/T-AFFC.2010.10; Rahman SA, 2014, SLEEP, V37, P271, DOI 10.5665/sleep.3396; Regula M, 2014, PROCEEDINGS OF THE 2014 16TH INTERNATIONAL CONFERENCE ON MECHATRONICS (MECHATRONIKA 2014), P639, DOI 10.1109/MECHATRONIKA.2014.7018334; Reinhardt T, 2012, PSYCHIAT RES, V198, P106, DOI 10.1016/j.psychres.2011.12.009; Remor E, 2006, SPAN J PSYCHOL, V9, P86, DOI 10.1017/S1138741600006004; Sanchez-Carrion MJ, 2013, PARTICIP ED REV CONS, V2, P105; SCHAUSS AG, 1979, J ORTHOMOL MED, V8, P218; Semmlow JL, 2014, BIOSIGNAL AND MEDICA; Sroykham W, 2015, BMEICON 2014 7 BIOM; Ssang-Hee Seo, 2010, Convergence and Hybrid Information Technologies, P413; Steinhubl SR, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00145; Tanida M, 2007, BRAIN RES, V1184, P210, DOI 10.1016/j.brainres.2007.09.058; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wright HR, 2001, CHRONOBIOL INT, V18, P801, DOI 10.1081/CBI-100107515; Yoto Ai, 2007, Journal of Physiological Anthropology, V26, P373, DOI 10.2114/jpa2.26.373; Zschucke E, 2015, PSYCHONEUROENDOCRINO, V51, P414, DOI 10.1016/j.psyneuen.2014.10.019	47	18	18	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186399	10.1371/journal.pone.0186399	http://dx.doi.org/10.1371/journal.pone.0186399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0UN	29049332	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900062
J	Cheah, BH; Jadhao, S; Vasudevan, M; Wickneswari, R; Nadarajah, K				Cheah, Boon Huat; Jadhao, Sudhir; Vasudevan, Madavan; Wickneswari, Ratnam; Nadarajah, Kalaivani			Identification of functionally important microRNAs from rice inflorescence at heading stage of a qDTY4.1-QTL bearing Near Isogenic Line under drought conditions	PLOS ONE			English	Article							INITIATION-FACTOR 3; FLOWERING TIME; SMALL RNAS; EXPRESSION ANALYSIS; REGULATORY ROLES; MALE-STERILITY; ARABIDOPSIS; GENE; PROTEIN; TOLERANCE	A cross between IR64 (high-yielding but drought-susceptible) and Aday Sel (drought-tolerant) rice cultivars yielded a stable line with enhanced grain yield under drought screening field trials at International Rice Research Institute. The major effect qDTY4.1 drought tolerance and yield QTL was detected in the IR77298-14-1-2-10 Backcrossed Inbred Line (BIL) and its IR87705-7-15-B Near Isogenic Line (NIL) with 93.9% genetic similarity to IR64. Although rice yield is extremely susceptible to water stress at reproductive stage, currently, there is only one report on the detection of drought-responsive microRNAs in inflorescence tissue of a Japonica rice line. In this study, more drought-responsive microRNAs were identified in the inflorescence tissues of IR64, IR77298-14-1-2-10 and IR87705-7-15-B via next-generation sequencing. Among the 32 families of inflorescence-specific non-conserved microRNAs that were identified, 22 families were up-regulated in IR87705-7-15-B. Overall 9 conserved and 34 non-conserved microRNA families were found as drought-responsive in rice inflorescence with 5 conserved and 30 non-conserved families induced in the IR877057-15-B. The observation of more drought-responsive non-conserved microRNAs may imply their prominence over conserved microRNAs in drought response mechanisms of rice inflorescence. Gene Ontology annotation analysis on the target genes of drought-responsive microRNAs identified in IR87705-7-15-B revealed over-representation of biological processes including development, signalling and response to stimulus. Particularly, four inflorescence-specific microRNAs viz. osa-miR5485, osa-miR5487, osa-miR5492 and osamiR5517, and two non-inflorescence specific microRNAs viz. osa-miR169d and osamiR169f. 2 target genes that are involved in flower or embryonic development. Among them, osa-miR169d, osa-miR5492 and osa-miR5517 are related to flowering time control. It is also worth mentioning that osa-miR2118 and osa-miR2275, which are implicated in the biosynthesis of rice inflorescence-specific small interfering RNAs, were induced in IR87705-715-B but repressed in IR77298-14-1-2-10. Further, gene search within qDTY4.1 QTL region had identified multiple copies of NBS-LRR resistance genes (potential target of osa-miR2118), subtilisins and genes implicated in stomatal movement, ABA metabolism and cuticular wax biosynthesis.	[Cheah, Boon Huat] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biotechnol & Biosci, Bangi, Selangor, Malaysia; [Jadhao, Sudhir; Vasudevan, Madavan] Bionivid Technol Private Ltd, Bangalore, Karnataka, India; [Wickneswari, Ratnam; Nadarajah, Kalaivani] Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Fac Sci & Technol, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Nadarajah, K (corresponding author), Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Fac Sci & Technol, Bangi, Selangor, Malaysia.	vani@ukm.edu.my	Cheah, Boon Huat/E-6975-2016; Ratnam, Wickneswari/V-7863-2017; Ratnam, Wickneswari/AAR-5100-2020	Ratnam, Wickneswari/0000-0002-2085-6434; Nadarajah, Kalaivani/0000-0002-9854-3219	MyBrain 15 (MyPhD) scholarship; Research University Grants from Universiti Kebangsaan Malaysia [UKM-GUP-2011-215, UKM-GUP-2012-075]	MyBrain 15 (MyPhD) scholarship; Research University Grants from Universiti Kebangsaan Malaysia	BHC is sponsored by MyBrain 15 (MyPhD) scholarship. The funder provided support in the form of salaries and study allowances for BHC. KN received Research University Grants UKM-GUP-2011-215 and UKM-GUP-2012-075 (http://www.ukm.my/seri/research-university-grant-gup/) from Universiti Kebangsaan Malaysia, which funded this research. Both funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors from Bionivid Technology Private Limited are our service providers cum collaborators who are entasked with the role of bioinformatics analyses. They do not provide any financial support in this research. The specific roles of these authors are articulated in the 'author contributions' section.	Akdogan G, 2016, FUNCT INTEGR GENOMIC, V16, P221, DOI 10.1007/s10142-015-0452-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Barker R, 1999, P 19 SESSION INT RIC, P96; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Bassett CL, 2005, TREE PHYSIOL, V25, P403, DOI 10.1093/treephys/25.4.403; Bian HW, 2012, NEW PHYTOL, V196, P149, DOI 10.1111/j.1469-8137.2012.04248.x; Bouman B., 2007, WATER FOOD WATER LIF, P515; Cheah BH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1851-3; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Debernardi JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002419; Demirci Y., 2017, J CELL PHYSL; Ding JH, 2012, MOL PLANT, V5, P1210, DOI 10.1093/mp/sss095; Dixit S, 2014, INT J AGRON, V2014, DOI 10.1155/2014/863683; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ferdous J, 2015, PLANT BIOTECHNOL J, V13, P293, DOI 10.1111/pbi.12318; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gleick P., 2002, PRIVATIZATION WATER; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gruszka D, 2013, INT J MOL SCI, V14, P8740, DOI 10.3390/ijms14058740; Guan QM, 2013, MOL PLANT, V6, P386, DOI 10.1093/mp/sss119; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hajyzadeh M, 2015, GENE, V555, P186, DOI 10.1016/j.gene.2014.11.002; Henry A, 2015, J EXP BOT, V66, P1787, DOI 10.1093/jxb/eru506; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Karakulah G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167698; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kumar A, 2014, J EXP BOT, V65, P6265, DOI 10.1093/jxb/eru363; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lebaudy A, 2010, J BIOL CHEM, V285, P6265, DOI 10.1074/jbc.M109.068445; Li BZ, 2009, RICE SCI, V16, P314, DOI 10.1016/S1672-6308(08)60096-7; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Swamy BPM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-319; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Oh E, 2012, NAT CELL BIOL, V14, P802, DOI 10.1038/ncb2545; Oh M, 2015, J PROTEOMICS, V114, P161, DOI 10.1016/j.jprot.2014.11.008; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Qin ZR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00586; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saini S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00950; Sands RD, 2003, CLIMATIC CHANGE, V56, P185, DOI 10.1023/A:1021344614845; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Singh B, 2013, GENE, V532, P177, DOI 10.1016/j.gene.2013.09.078; Smith BD, 1995, AGR SYST, P496; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Stein JC, 1996, PLANT CELL, V8, P429, DOI 10.1105/tpc.8.3.429; Subudhi Prasanta K., 2006, V1, P1; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; SUNKAR R, 2008, BMC PLANT BIOL, V8; Swamy BPM, 2011, IRRIGATION SYSTEMS P, P149; Swamy BPM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062795; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Vaseva I., 2011, DROUGHTS NEW RES, P1; Vega-Sanchez ME, 2008, PLANT CELL, V20, P1456, DOI 10.1105/tpc.108.058610; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang X, 2016, BIOL PLANTARUM, V60, P269, DOI 10.1007/s10535-016-0586-6; Williams ME, 2005, PLANT PHYSIOL, V138, P686, DOI 10.1104/pp.105.061317; Wu BF, 2015, GENE, V574, P34, DOI 10.1016/j.gene.2015.07.072; Wu RH, 2009, PROG NAT SCI-MATER, V19, P347, DOI 10.1016/j.pnsc.2008.07.010; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Xu MY, 2014, J EXP BOT, V65, P89, DOI 10.1093/jxb/ert353; Ye NH, 2012, RICE, V5, DOI 10.1186/1939-8433-5-1; Yu A, 2015, BIOMED RES INT, V16; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhou H, 2012, CELL RES, V22, P649, DOI 10.1038/cr.2012.28; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou LC, 2013, J APPL MATH, DOI 10.1155/2013/565841; Zhou YY, 2015, CELL REP, V10, P1819, DOI 10.1016/j.celrep.2015.02.047; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	98	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186382	10.1371/journal.pone.0186382	http://dx.doi.org/10.1371/journal.pone.0186382			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045473	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100057
J	Razazan, A; Behravan, J; Arab, A; Barati, N; Arabi, L; Gholizadeh, Z; Hatamipour, M; Nikpoor, AR; Momtazi-Borojeni, AA; Mosaffa, F; Ghahremani, MH; Jaafari, MR				Razazan, Atefeh; Behravan, Javad; Arab, Atefeh; Barati, Nastaran; Arabi, Leila; Gholizadeh, Zahra; Hatamipour, Mahdi; Nikpoor, Amin Reza; Momtazi-Borojeni, Amir Abbas; Mosaffa, Fatemeh; Ghahremani, Mohamad Hosein; Jaafari, Mahmoud Reza			Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; MONOPHOSPHORYL-LIPID-A; PH-SENSITIVE LIPOSOMES; DENDRITIC CELLS; ADJUVANT SYSTEM; IN-VIVO; ANTIGEN; INDUCTION; DELIVERY; ACTIVATION	One of the challenging issues in vaccine development is peptide and adjuvant delivery into target cells. In this study, we developed a vaccine and therapeutic delivery system to increase cytotoxic T lymphocyte (CTL) response against a breast cancer model overexpressing HER2/neu. Gp2, a HER2/neu-derived peptide, was conjugated to Maleimide-mPEG2000-DSPE micelles and post inserted into liposomes composed of DMPC, DMPG phospholipids, and fusogenic lipid dioleoylphosphatidylethanolamine (DOPE) containing monophosphoryl lipid A (MPL) adjuvant (DMPC-DMPG-DOPE-MPL-Gp2). BALB/c mice were immunized with different formulations and the immune response was evaluated in vitro and in vivo. ELISpot and intracellular cytokine analysis by flow cytometry showed that the mice vaccinated with Lip-DOPE-MPL-GP2 incited the highest number of IFN-.+ in CD8+ cells and CTL response. The immunization led to lower tumor sizes and longer survival time compared to the other groups of mice immunized and treated with the Lip-DOPE-MPL-GP2 formulation in both prophylactic and therapeutic experiments. These results showed that co-formulation of DOPE and MPL conjugated with GP2 peptide not only induces high antitumor immunity but also enhances therapeutic efficacy in TUBO mice model. Lip-DOPE-MPL-GP2 formulation could be a promising vaccine and a therapeutic delivery system against HER2 positive cancers and merits further investigation.	[Razazan, Atefeh; Ghahremani, Mohamad Hosein] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Mol Med, Tehran, Iran; [Razazan, Atefeh; Arab, Atefeh; Barati, Nastaran; Arabi, Leila; Hatamipour, Mahdi; Momtazi-Borojeni, Amir Abbas; Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Nanotechnol Res Ctr, Mashhad, Iran; [Razazan, Atefeh; Behravan, Javad; Arab, Atefeh; Barati, Nastaran; Arabi, Leila; Mosaffa, Fatemeh; Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran; [Behravan, Javad; Arab, Atefeh; Barati, Nastaran; Arabi, Leila; Hatamipour, Mahdi; Mosaffa, Fatemeh; Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran; [Gholizadeh, Zahra; Nikpoor, Amin Reza] Mashhad Univ Med Sci, Sch Med, Dept Immunol, Mashhad, Iran; [Momtazi-Borojeni, Amir Abbas] Mashhad Univ Med Sci, Fac Med, Dept Med Biotechnol, Student Res Comm, Mashhad, Iran	Tehran University of Medical Sciences; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science	Ghahremani, MH (corresponding author), Univ Tehran Med Sci, Sch Adv Technol Med, Dept Mol Med, Tehran, Iran.; Jaafari, MR (corresponding author), Mashhad Univ Med Sci, Nanotechnol Res Ctr, Mashhad, Iran.; Jaafari, MR (corresponding author), Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran.; Jaafari, MR (corresponding author), Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran.	mhghahremani@sina.tums.ac.ir; JafariMR@mums.ac.ir	Ghahremani, Mohammad H/F-1615-2013; Mosaffa, Fatemeh/A-5367-2011; Barati, Nastaran/GQQ-5548-2022; Arabi, Leila/H-2312-2018; Behravan, Javad/AAR-9538-2020; Behravan, Javad/AAY-1219-2020; Nikpoor, Amin Reza/I-2907-2018; Momtazi-Borojeni, Amir Abaas/AAC-6972-2019; barati, nastaran/W-1903-2019	Ghahremani, Mohammad H/0000-0001-5051-6214; Mosaffa, Fatemeh/0000-0001-7469-2773; Arabi, Leila/0000-0003-1623-3346; Nikpoor, Amin Reza/0000-0001-5619-8771; Momtazi-Borojeni, Amir Abaas/0000-0002-4376-1083; 	Mashhad University of Medical Sciences [930078]; Tehran University of Medical Sciences [92-03-87-23034]	Mashhad University of Medical Sciences; Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This work was financially supported by the Mashhad University of Medical Sciences (grant number: 930078) and Tehran University of Medical Sciences (grant number: 92-03-87-23034).	Allison A.C., 1974, LIPOSOMES IMMUNOLOGI; Alving CR, 2012, EXPERT REV VACCINES, V11, P733, DOI [10.1586/ERV.12.35, 10.1586/erv.12.35]; Alving CR., 1992, LIPOSOME DERMATICS, P226; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Baxevanis CN, 2006, CANCER IMMUNOL IMMUN, V55, P85, DOI 10.1007/s00262-005-0692-3; Berzofsky JA, 2005, CANC TREAT, V123, P115; Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; Carmichael MG, 2010, CANCER-AM CANCER SOC, V116, P292, DOI 10.1002/cncr.24756; Carstens MG, 2011, VACCINE, V29, P4761, DOI 10.1016/j.vaccine.2011.04.081; Chen WH, 2008, MOL PHARMACEUT, V5, P464, DOI 10.1021/mp700126c; Chen WC, 2005, ADV GENET, V54, P315, DOI 10.1016/S0065-2660(05)54013-6; Chikh G, 2002, BIOSCIENCE REP, V22, P339, DOI 10.1023/A:1020151025412; Chikh GG, 2001, J IMMUNOL, V167, P6462, DOI 10.4049/jimmunol.167.11.6462; Clive KS, 2012, J SURG ONCOL, V105, P452, DOI 10.1002/jso.21723; Cluff CW, 2009, ADV EXP MED BIOL, V667, P111, DOI 10.1007/978-1-4419-1603-7_10; CONNOR J, 1984, P NATL ACAD SCI-BIOL, V81, P1715, DOI 10.1073/pnas.81.6.1715; Correa I, 2001, BREAST CANCER RES, V3, P1; Dees EC, 2004, CANCER IMMUNOL IMMUN, V53, P777, DOI 10.1007/s00262-004-0520-1; Dermime S, 2002, BRIT MED BULL, V62, P149, DOI 10.1093/bmb/62.1.149; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; GALDIERO F, 1995, FEMS IMMUNOL MED MIC, V10, P235, DOI 10.1111/j.1574-695X.1995.tb00038.x; Guan HH, 1998, BIOCONJUGATE CHEM, V9, P451, DOI 10.1021/bc970183n; GUSTAFSON GL, 1992, RES IMMUNOL, V143, P483, DOI 10.1016/0923-2494(92)80058-S; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; Gutschalk CM, 2013, CANCER MED-US, V2, P117, DOI 10.1002/cam4.20; Harmon P, 1997, ANAL BIOCHEM, V250, P139, DOI 10.1006/abio.1997.2216; Huang ZH, 2009, ANGEW CHEM INT EDIT, V48, P4146, DOI 10.1002/anie.200900111; Jeong JM, 2002, J BIOTECHNOL, V94, P255, DOI 10.1016/S0168-1656(01)00430-8; Kamath AT, 2012, J IMMUNOL, V188, P4828, DOI 10.4049/jimmunol.1103183; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; Krishnamachari Y, 2011, PHARM RES-DORDR, V28, P215, DOI 10.1007/s11095-010-0241-4; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Lee RJ, 1998, BIOSCIENCE REP, V18, P69, DOI 10.1023/A:1020132226113; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; LITZINGER DC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P201, DOI 10.1016/0304-4157(92)90039-D; Lollini PL, 2006, NAT REV CANCER, V6, P204, DOI 10.1038/nrc1815; Ludewig B, 2000, VACCINE, V19, P23, DOI 10.1016/S0264-410X(00)00163-8; Matyas GR, 2013, VACCINE, V31, P2804, DOI 10.1016/j.vaccine.2013.04.027; Mitri Z, 2012, CHEMOTHERAPY RES PRA, V2012; Mittendorf EA, 2006, ANN SURG ONCOL, V13, P1085, DOI 10.1245/ASO.2006.03.069; Mittendorf EA, 2006, CANCER-AM CANCER SOC, V106, P2309, DOI 10.1002/cncr.21849; Moser Christian, 2003, Expert Rev Vaccines, V2, P189, DOI 10.1586/14760584.2.2.189; Nakamura T, 2013, J CONTROL RELEASE, V171, P216, DOI 10.1016/j.jconrel.2013.07.004; Neidhart J, 2004, VACCINE, V22, P773, DOI 10.1016/j.vaccine.2003.08.021; Oussoren C, 1997, BBA-BIOMEMBRANES, V1328, P261, DOI 10.1016/S0005-2736(97)00122-3; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; Powell M.F., 1995, VACCINE DESIGN SUBUN, P495; Rigo A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-273; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Roth A, 2005, BRIT J CANCER, V92, P1421, DOI 10.1038/sj.bjc.6602526; Saupe A, 2006, EXPERT OPIN DRUG DEL, V3, P345, DOI 10.1517/17425247.3.3.345; Schneble EJ, 2014, ASCO ANN M P; SHAHUM E, 1995, INT J IMMUNOPHARMACO, V17, P9, DOI 10.1016/0192-0561(94)00082-Y; Shariat S, 2014, CANCER LETT, V355, P54, DOI 10.1016/j.canlet.2014.09.016; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; STOLLERY JG, 1977, BIOCHIM BIOPHYS ACTA, V471, P372, DOI 10.1016/0005-2736(77)90043-8; SUBBARAO NK, 1987, BIOCHEMISTRY-US, V26, P2964, DOI 10.1021/bi00385a002; Sue R, 2015, JNCI-J NATL CANCER I, V107; Tanaka Y, 2001, INT J CANCER, V94, P540, DOI 10.1002/ijc.1508; Torchilin VP, 1993, J LIPOSOME RES, V3, P201, DOI DOI 10.3109/08982109309148213]; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P499, DOI 10.1111/j.1440-1681.2007.04601.x; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396; Zhong ZH, 2010, INT J PHARMACEUT, V399, P156, DOI 10.1016/j.ijpharm.2010.07.053; ZHOU F, 1991, J IMMUNOL METHODS, V145, P143, DOI 10.1016/0022-1759(91)90320-F; Zollinger WD, 2012, VACCINE, V30, P712, DOI 10.1016/j.vaccine.2011.11.084	68	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185099	10.1371/journal.pone.0185099	http://dx.doi.org/10.1371/journal.pone.0185099			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045460	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100010
J	Valdivielso, JM; Betriu, A; Martinez-Alonso, M; Arroyo, D; Bermudez-Lopez, M; Fernandez, E				Valdivielso, Jose M.; Betriu, Angels; Martinez-Alonso, Montserrat; Arroyo, David; Bermudez-Lopez, Marcelino; Fernandez, Elvira		NEFRONA investigators	Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; RISK-FACTORS; HEMODIALYSIS-PATIENTS; CAROTID PLAQUE; MORTALITY RISK; DIALYSIS PATIENTS; SERUM PHOSPHORUS; VITAMIN-D; ASSOCIATION	Patients with chronic kidney disease (CKD) have an increased incidence of cardiovascular events (CVE). The contribution of subclinical atheromatosis extent, including femoral arteries, to CVE in CKD patients has not been investigated. In this paper, we examine the prognostic value of subclinical atheromatosis extent, assessed as the number of arterial territories with plaque, in predicting the incidence of major and minor CVE. The NEFRONA is a multicenter, prospective cohorts study that recruited 2445 CKD subjects and 559 controls, free from previous cardiovascular disease, in 81 medical centers across Spain. The presence of atheroma plaque was assessed by arterial ultrasound in ten arterial territories (carotid and femoral). The predictive power of the presence or absence of atheroma plaque in any territory was compared with the quantification of atheroma extent as the number of territories with plaque. During the median follow up of 48 months, 216 CVE were reported. Factors predicting the incidence of CVE in the whole cohort were being male, CKD patient, lower levels of 25(OH) vitamin D, higher levels of cholesterol and the extent of subclinical atheromatosis, yielding a higher concordance (C) index than the presence or absence of plaque. In stratified analysis including specific factors of CKD patients not on dialysis, the variables predicting CVE were the same as in the whole cohort, plus higher levels of potassium. Again, the inclusion of the information about atheromatosis as number of territories with plaque, presented a higher C index than the presence or absence of plaque. In the dialysis population, significant variables were older age, diabetes, dialysis vintage and higher levels of cholesterol and phosphate. In this case the higher C index was obtained with the information about plaque presence. Subclinical atheromatosis extent, including femoral arteries, influences CVE in CKD and its detection could improve the prediction of cardiovascular events.	[Valdivielso, Jose M.; Betriu, Angels; Arroyo, David; Bermudez-Lopez, Marcelino; Fernandez, Elvira] IRBLleida, REDinREN ISCIII, UDETMA, Vasc & Renal Translat Res Grp, Lleida, Spain; [Martinez-Alonso, Montserrat] Univ Lleida, Stat Dept, Lleida, Spain	Universitat de Lleida	Valdivielso, JM; Fernandez, E (corresponding author), IRBLleida, REDinREN ISCIII, UDETMA, Vasc & Renal Translat Res Grp, Lleida, Spain.	valdivielso@medicina.udl.es; efernandez@irblleida.cat	Arroyo, David/H-2896-2019; Valdivielso, Jose M/B-5673-2009; Bermúdez-López, Marcelino/C-3787-2011	Arroyo, David/0000-0003-4652-0311; Valdivielso, Jose M/0000-0003-1343-0184; Bermúdez-López, Marcelino/0000-0002-3188-4158	AbbVie; Spanish government RETIC [RD16/0009/0011]; FIS [PI16/01354]; FEDER	AbbVie(AbbVie); Spanish government RETIC; FIS(Instituto de Salud Carlos III); FEDER(European Commission)	The NEFRONA study is funded by a research grant from AbbVie and the Spanish government RETIC (RD16/0009/0011), FIS PI16/01354 and FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the NEFRONA team (Eva Castro, Virtudes Maria, Teresa Moli, Teresa Vidal, Meritxell Soria) and the Biobank of RedlnRen for their invaluable support. The NEFRONA study is funded by a research grant from AbbVie and the Spanish government RETIC (RD16/0009/0011), FIS PI16/01354 and FEDER funds. The NEFRONA study investigator group is composed by the following: Aladren Regidor, M<SUP>a</SUP> Jose. Hospital Comarcal Ernest Lluch (Calatayud); Almirall, Jaume; Ponz, Esther. Corporacio Parc Tauli (Barcelona); Arteaga Coloma, Jesus. Hospital de Navarra (Pamplona); Bajo Rubio, M<SUP>a</SUP> Auxiliadora; Diaz, Raquel Raquel Hospital La Paz (Madrid); Belart Rodriguez, Montserrat. Sistemes Renals (Lleida); GascOn, Antonio, Hospital Obispo Polanco (Teruel); Bover Sanjuan, Jordi. Fundacio Puigvert. IIB Sant Pau (Barcelona); Bronsoms Artero, Josep. Clinica Girona (Girona); Cabezuelo Romero, Juan B; Muray Cases, Salome. Hospital Reina Sofia (Murcia); Calvino Varela, Jesus. Hospital Universitario Lugus Augusti (Lugo); Caro Acevedo, Pilar. Clinica Ruber (Madrid); Carreras Bassa, Jordi. Diaverum Baix Llobregat (Barcelona); Cases Amenos, Aleix; Masso Jimenez, Elisabet. Hospital Clinic (Barcelona); Moreno Lopez, Rosario. Hospital de la Defensa (Zaragoza); Cigarran Guldris, Secundino; Lopez Prieto, Saray. Hospital Da Costa (Lugo); Comas Mongay, Lourdes. Hospital General de Vic (Barcelona); Comerma, Isabel. Hospital General de Manresa (Barcelona); Compte Jove, Ma Teresa, Hospital Santa Creu Jesus (Tarragona); Cuberes Izquierdo, Marta. Hospital Reina Sofia (Navarra); de Alvaro, Fernando; Hevia Ojanguren, Covadonga. Hospital Infanta Sofia (Madrid); de Arriba de la Fuente, Gabriel. Hospital Universitario Guadalajara (Guadalajara); del Pino y Pino, M<SUP>a</SUP> Dolores. Complejo Hospitalario Universitario Torrecardenas (Almeria); Diaz-Tejeiro Izquierdo, Rafael; Ahijado Hormigos, Francisco Hospital Virgen de la Salud (Toledo); Dotori, Marta. USP Marbella (Malaga); Duarte, Veronica. Hospital de Terrassa (Barcelona); Estupirian Torres, Sara. Hospital Universitario Canarias (Santa Cruz de Tenerife); Fernandez Reyes, Ma Jose. Hospital de Segovia (Segovia); Fernandez Rodriguez, M<SUP>a</SUP> Loreto. Hospital Principe de Asturias (Madrid); Fernandez, Guillermina. Clinica Santa Isabel (Sevilla); Galan Serrano, Antonio. Hospital General Universitario de Valencia (Valencia); Garcia Canton, Cesar. Hospital Universitario Insular de Gran Canaria (Las Palmas); Garcia Herrera, Antonio L. Hospital Universitario Puerto Real (Cadiz); Garcia Mena, Mercedes. Hospital San Juan de Dios (Zaragoza); Gil Sacaluga, Luis; Aguilar, Maria. Hospital Virgen del Rocio (Sevilla); Gorriz, Jose Luis. Hospital Universitario Doctor Peset (Valencia); Huarte Loza, Emma. Hospital San Pedro (Logrono); Lerma, Jose Luis. Hospital Universitario Salamanca (Salamanca); Liebana Canada, Antonio. Hospital de Jaen (Jaen); Marin Alvarez, Jesus Pedro. Hospital San Pedro de Alcantara (Caceres); Martin Alemany, Nadia. Hospital Jose p Trueta (Girona); Martin Garcia, Jesus. Hospital Nuestra Senora de Sonsoles (Avila); Martinez Castelao, Alberto. Hospital Universitari de Bellvitge (Barcelona); Martinez Villaescusa, Maria. Complejo Hospitalario Universitario de Albacete (Albacete); Martinez, Isabel. Hospital Galdakao (Bilbao); Moina Eguren, Iriigo. Hospital Basurto (Bilbao); Moreno Los Huertos, Silvia. Hospital Santa Barbara (Soria); Mouzo Mirco, Ricardo. Hospital El Bierzo, Ponferrada (Leon); Munar Vila, Antonia.; Hospital Universitari Son Espases (Palma de Mallorca); Munoz Diaz, Ana Beatriz. Hospital Virgen del Consuelo (Valencia); Navarro Gonzalez, Juan F. Hospital Universitario Nuestra Senora de Candelaria (Santa Cruz de Tenerife); Nieto, Javier; Carrerio, Agustin. Hospital General Universitario de Ciudad Real (Ciudad Real); Novoa Fernandez, Enrique. Complexo Hospitalario de Ourense (Ourense); Ortiz, Alberto; Fernandez, Beatriz. IIS-Fundacion Jimenez Diaz (Madrid); Paraiso, Vicente. Hospital Universitario del Henares (Madrid); Perez Fontan, Miguel. Complejo Hospitalario Universitario A Coruna (A Coruna); Penis Domingo, Ana. Hospital Francesc de Borja (Valencia); Piriera Haces, Celestino. Hospital Universitario Marques de Valdecilla (Santander); Prados Garrido, Ma Dolores. Hospital Universitario San Cecilio (Granada); Prieto Velasco, Mario. Hospital de Leon (Leon); Puig Mari, Carmina. Hospital d'Igualada (Barcelona); Rivera Gorrin, Maite. Hospital Universitario Ramon y Cajal (Madrid); Rubio, Esther. Hospital Puerta del Hierro (Madrid); Ruiz, Pilar. Hospital Sant Joan Despi Moises Broggi (Barcelona); Salgueira Lazo, Mercedes; Martinez Puerto, Ana Isabel. Hospital Virgen Macarena (Sevilla); Sanchez Tomero, Jose Antonio. Hospital Universitario de la Princesa (Madrid); Sanchez, Jose Emilio. Hospital Universitario Central de Asturias (Oviedo); Sans Lorman, Ramon. Hospital de Figueres (Girona); Saracho, Ramon. Hospital de Santiago (Vitoria); Sarrias, Maria; SerOn, Daniel. Hospital Universitari Vall d'Hebron (Barcelona); Soler, Maria Jose; Barrios, Clara. Hospital del Mar (Barcelona); Sousa, Fernando. Hospital Rio Carrion (Palencia); Toran, Daniel. Hospital General de Jerez (Cadiz); Tornero Molina, Fernando. Hospital de Sureste (Arganda del Rey); Uson Carrasco, Jose Javier. Hospital Virgen de la Luz (Cuenca); Valera Cortes, Ildefonso. Hospital Virgen de la Victoria (Malaga); Vilaprinyo del Perugia, M<SUP>a</SUP> Merce. Institut Catala d'Urologia i Nefrologia (Barcelona); Virto Ruiz, Rafael C. Hospital San Jorge (Huesca); Vicente Pallares Carratala Clinica MEDEFIS (Vila-real. Castellon), Carlos Santos Altozano CS Azuqueca de Henares (Guadalajara); Miguel Artigao Rodenas CS Zona III (Albacete); Ines Gil Gil Area Basica Sanitaria de Aran. CAP Viella (Lleida); Francisco Adan Gil CS Alfaro (La Rioja); Emilio Garcia Criado Centro de Salud del Carpio (Cordoba.); Rafael Dura Belinchon CS Godella (Valencia); Jose Ma Fernandez Toro CS Zona Centro (Caceres); Juan Antonio Divison Garrote Centro de Salud de Casas Ibanez. Consultorio de Fuentealbilla (Albacete).	An JN, 2012, CRIT CARE, V16, DOI 10.1186/cc11872; Arroyo D, 2017, NEPHROL DIAL TRANSPL, V32, P513, DOI 10.1093/ndt/gfw039; Arroyo D, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-168; Barrios C, 2015, ATHEROSCLEROSIS, V242, P37, DOI 10.1016/j.atherosclerosis.2015.06.048; Betriu A, 2014, NEPHROL DIAL TRANSPL, V29, P1415, DOI 10.1093/ndt/gfu038; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Bozic M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136863; Chang A, 2011, NEPHRON CLIN PRACT, V119, pC171, DOI 10.1159/000325669; Coll B, 2010, KIDNEY INT; Coll B, 2011, CLIN J AM SOC NEPHRO, V6, P303, DOI 10.2215/CJN.04290510; Coll B, 2010, NEPHROL DIAL TRANSPL, V25, P3017, DOI 10.1093/ndt/gfq109; Collado S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127344; Cournot M, 2009, AM HEART J, V158, P845, DOI 10.1016/j.ahj.2009.08.017; de La Piedra C, 2008, NEFROLOGIA, V28, P123; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Fernandez-Laso V, 2016, CLIN J AM SOC NEPHRO, V11, P413, DOI 10.2215/CJN.07900715; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gracia M, 2016, CLIN J AM SOC NEPHRO, V11, P287, DOI 10.2215/CJN.01240215; Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044; Junyent M, 2010, NEFROLOGIA, V30, P119, DOI 10.3265/Nefrologia.pre2010.Jan.10216; Junyent M, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-14; Kendrick J, 2011, AM J KIDNEY DIS, V58, P826, DOI 10.1053/j.ajkd.2011.07.020; Kovesdy CP, 2007, J AM SOC NEPHROL, V18, P304, DOI 10.1681/ASN.2006060674; Laclaustra M, 2016, J AM COLL CARDIOL, V67, P1263, DOI 10.1016/j.jacc.2015.12.056; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Luo JC, 2016, CLIN J AM SOC NEPHRO, V11, P90, DOI 10.2215/CJN.01730215; Martin M, 2015, ATHEROSCLEROSIS, V241, P264, DOI 10.1016/j.atherosclerosis.2015.02.048; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Pasterkamp G, 1998, ATHEROSCLEROSIS, V137, P205, DOI 10.1016/S0021-9150(97)00255-4; Perez HA, 2016, ARCH MED SCI, V12, P513, DOI 10.5114/aoms.2016.59924; Polak JF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000087; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Schwaiger JP, 2006, AM J KIDNEY DIS, V47, P888, DOI 10.1053/j.ajkd.2006.01.011; Shamseddin MK, 2011, NAT REV NEPHROL, V7, P145, DOI 10.1038/nrneph.2010.191; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Spence JD, 2002, STROKE, V33, P2916, DOI 10.1161/01.STR.0000042207.16156.B9; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Stork S, 2004, CIRCULATION, V110, P344, DOI 10.1161/01.CIR.0000134966.10793.C9; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Tripepi G, 2010, NEPHROL DIAL TRANSPL, V25, P1399, DOI 10.1093/ndt/gfq018; Valdivielso JM, 2009, EXPERT OPIN THER TAR, V13, P29, DOI [10.1517/14728220802564390, 10.1517/14728220802564390 ]; Valdivielso JM, 2008, KIDNEY INT, V74, pS44, DOI 10.1038/ki.2008.545; Wyman RA, 2006, VASC MED, V11, P123, DOI 10.1191/1358863x06vm666ra	51	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186665	10.1371/journal.pone.0186665	http://dx.doi.org/10.1371/journal.pone.0186665			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045466	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100086
J	Abbaci, A; Talbot, H; Saada, S; Gachard, N; Abraham, J; Jaccard, A; Bordessoule, D; Fauchais, AL; Naves, T; Jauberteau, MO				Abbaci, A.; Talbot, H.; Saada, S.; Gachard, N.; Abraham, J.; Jaccard, A.; Bordessoule, D.; Fauchais, A. L.; Naves, T.; Jauberteau, M. O.			Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis	ONCOGENE			English	Article							NERVE GROWTH-FACTOR; CHEMOKINE RECEPTOR; SIGNALING PATHWAY; COUPLED RECEPTORS; IN-VITRO; EXPRESSION; ACTIVATION; SURVIVAL; BCL-2; OVEREXPRESSION	B-cell chronic lymphocytic leukemia (B-CLL) cells are resistant to apoptosis, and consequently accumulate to the detriment of normal B cells and patient immunity. Because current therapies fail to eradicate these apoptosis-resistant cells, it is essential to identify alternative survival pathways as novel targets for anticancer therapies. Overexpression of cell-surface G protein-coupled receptors drives cell transformation, and thus plays a critical role in malignancies. In this study, we identified neurotensin receptor 2 (NTSR2) as an essential driver of apoptosis resistance in B-CLL. NTSR2 was highly expressed in B-CLL cells, whereas expression of its natural ligand, neurotensin (NTS), was minimal in both B-CLL cells and patient plasma. Surprisingly, NTSR2 remained in a constitutively active phosphorylated state, caused not by a mutation-induced gain-of-function but rather by an interaction with the oncogenic tyrosine kinase receptor TrkB. Functional and biochemical characterization revealed that the NTSR2-TrkB interaction acts as a conditional oncogenic driver requiring the TrkB ligand brain-derived neurotrophic factor (BDNF), which unlike NTS is highly expressed in B-CLL cells. Together, NTSR2, TrkB and BDNF induce autocrine and/or paracrine survival pathways that are independent of mutation status and indolent or progressive disease course. The NTSR2-TrkB interaction activates survival signaling pathways, including the Src and AKT kinase pathways, as well as expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL. When NTSR2 was downregulated, TrkB failed to protect B-CLL cells from a drastic decrease in viability via typical apoptotic cell death, reflected by DNA fragmentation and Annexin V presentation. Together, our findings demonstrate that the NTSR2-TrkB interaction plays a crucial role in B-CLL cell survival, suggesting that inhibition of NTSR2 represents a promising targeted strategy for treating B-CLL malignancy.	[Abbaci, A.; Talbot, H.; Saada, S.; Fauchais, A. L.; Naves, T.; Jauberteau, M. O.] Limoges Univ, Equipe Accueil Cellular Homeostasis & Dis 3842, Fac Med, Limoges, France; [Gachard, N.] Dupuytren Hosp Univ Ctr Limoges, Hematol Lab, Limoges, France; [Gachard, N.; Jaccard, A.; Bordessoule, D.] Limoges Univ, CNRS, UMR 7276, Limoges, France; [Abraham, J.; Jaccard, A.; Bordessoule, D.] Dupuytren Hosp Univ Ctr Limoges, Dept Hematol, Limoges, France; [Fauchais, A. L.] Dupuytren Hosp Univ Ctr Limoges, Dept Internal Med, Limoges, France; [Jauberteau, M. O.] Dupuytren Hosp Univ Ctr Limoges, Dept Immunol, Limoges, France	CHU Limoges; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Limoges; CHU Limoges; CHU Limoges	Jauberteau, MO (corresponding author), Fac Med Limoges, Lab Homeostasie Cellulaire & Pathol, EA3842, 2 Rue Docteur Marcland, F-87025 Limoges, France.	m-o.jauberteau-marchan@unilim.fr	Naves, Thomas/AAB-5874-2020	Naves, Thomas/0000-0002-5291-5689; Jauberteau, Marie-Odile/0000-0002-8811-8948; SAADA, Sofiane/0000-0003-2057-3159; Talbot, Hugo/0000-0001-9774-8573	Limousin regional council from Limoges; La Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne) from Limoges; CORC (Comite d'Orientation de la Recherche en Cancerologie) from Limoges	Limousin regional council from Limoges; La Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne) from Limoges; CORC (Comite d'Orientation de la Recherche en Cancerologie) from Limoges	This work was supported and funded by grants from the Limousin regional council, La Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne) and CORC (Comite d'Orientation de la Recherche en Cancerologie) from Limoges.	Ai LS, 2013, INT J CANCER, V133, P1074, DOI 10.1002/ijc.28116; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barragan M, 2002, BLOOD, V99, P2969, DOI 10.1182/blood.V99.8.2969; Bellanger C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027213; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Burkle A, 2007, BLOOD, V110, P3316, DOI 10.1182/blood-2007-05-089409; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Cattaneo F, 2014, INT J MOL SCI, V15, P19700, DOI 10.3390/ijms151119700; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chiorazzi N., 2005, NEW ENGL J MED, V352, P804, DOI [10.1056/NEJMra041720, DOI 10.1056/NEJMRA041720, 10.1002/9781444300857.ch36]; Choi SY, 1999, BRIT J PHARMACOL, V126, P1050, DOI 10.1038/sj.bjp.0702378; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; Dalwadi H, 2003, J IMMUNOL, V170, P1707, DOI 10.4049/jimmunol.170.4.1707; De la Cruz-Morcillo MA, 2016, ONCOTARGET, V7, P34480, DOI 10.18632/oncotarget.8911; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Dielschneider RF, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.391; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drost AC, 2012, LEUKEMIA LYMPHOMA, V53, P665, DOI 10.3109/10428194.2011.625578; Dupouy S, 2014, ONCOTARGET, V5, P8235, DOI 10.18632/oncotarget.1632; Dupouy S, 2011, BIOCHIMIE, V93, P1369, DOI 10.1016/j.biochi.2011.04.024; El-Shewy HM, 2006, J BIOL CHEM, V281, P31399, DOI 10.1074/jbc.M605339200; Fauchais AL, 2008, J IMMUNOL, V181, P3027, DOI 10.4049/jimmunol.181.5.3027; Frade JM, 1996, NATURE, V383, P166; Ghosh AK, 2013, ADV EXP MED BIOL, V792, P215, DOI 10.1007/978-1-4614-8051-8_10; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kehrl JH, 2016, BIOCHEM PHARMACOL, V114, P40, DOI 10.1016/j.bcp.2016.04.005; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Kitada S, 2002, ONCOGENE, V21, P3459, DOI 10.1038/sj.onc.1205327; Liu Y, 2016, CANCER LETT, V376, P226, DOI 10.1016/j.canlet.2016.03.031; Longo PG, 2007, LEUKEMIA, V21, P110, DOI 10.1038/sj.leu.2404417; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Magazin M, 2004, J INVEST DERMATOL, V122, P111, DOI 10.1046/j.0022-202X.2003.22131.x; Martin S, 2002, J CELL SCI, V115, P165; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Mira E, 2001, EMBO REP, V2, P151, DOI 10.1093/embo-reports/kve027; Mohle R, 1999, LEUKEMIA, V13, P1954, DOI 10.1038/sj.leu.2401602; Moughal NA, 2004, CELL SIGNAL, V16, P127, DOI 10.1016/j.cellsig.2003.08.004; Moughal NA, 2006, J NEUROCHEM, V98, P1920, DOI 10.1111/j.1471-4159.2006.04009.x; Ohman L, 2002, GUT, V51, P392, DOI 10.1136/gut.51.3.392; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Raijmakers R, 2010, ANAL CHEM, V82, P824, DOI 10.1021/ac901764g; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; Rossi D, 2013, BLOOD, V121, P1403, DOI 10.1182/blood-2012-09-458265; Saada S, 2012, J IMMUNOL, V189, P5293, DOI 10.4049/jimmunol.1102937; Saiya-Cork K, 2011, CLIN CANCER RES, V17, P2679, DOI 10.1158/1078-0432.CCR-10-2058; Schrottner P, 2010, ANN HEMATOL, V89, P437, DOI 10.1007/s00277-009-0876-6; Somai S, 2002, BIOCHEM BIOPH RES CO, V295, P482, DOI 10.1016/S0006-291X(02)00703-9; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Sun CY, 2012, INT J CANCER, V130, P827, DOI 10.1002/ijc.26059; Swift SL, 2010, CANCER RES, V70, P347, DOI 10.1158/0008-5472.CAN-09-1252; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Ticchioni M, 2007, ONCOGENE, V26, P7081, DOI 10.1038/sj.onc.1210519; Tomasi ML, 2015, ONCOTARGET, V6, P37706, DOI 10.18632/oncotarget.5342; Vita N, 1998, EUR J PHARMACOL, V360, P265, DOI 10.1016/S0014-2999(98)00678-5; Wilson CM, 2014, CNS NEUROL DISORD-DR, V13, P1354, DOI 10.2174/1871527313666141023151642; Wilson CM, 2014, J CELL SCI, V127, P3983, DOI 10.1242/jcs.149336; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Wu ZR, 2017, CANCER LETT, V388, P73, DOI 10.1016/j.canlet.2016.11.032; Yaktapour N, 2013, BLOOD, V122, P1621, DOI 10.1182/blood-2013-02-484386; Younes M, 2014, ONCOTARGET, V5, P8252, DOI 10.18632/oncotarget.1633	62	15	15	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					756	767		10.1038/onc.2017.365	http://dx.doi.org/10.1038/onc.2017.365			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059151	Green Published, hybrid			2022-12-26	WOS:000424628100007
J	Mitamura, T; Pradeep, S; McGuire, M; Wu, SY; Ma, S; Hatakeyama, H; Lyons, YA; Hisamatsu, T; Noh, K; Villar-Prados, A; Chen, X; Ivan, C; Rodriguez-Aguayo, C; Hu, W; Lopez-Berestein, G; Coleman, RL; Sood, AK				Mitamura, T.; Pradeep, S.; McGuire, M.; Wu, S. Y.; Ma, S.; Hatakeyama, H.; Lyons, Y. A.; Hisamatsu, T.; Noh, K.; Villar-Prados, A.; Chen, X.; Ivan, C.; Rodriguez-Aguayo, C.; Hu, W.; Lopez-Berestein, G.; Coleman, R. L.; Sood, A. K.			Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)	ONCOGENE			English	Article							OVARIAN-CANCER; BEVACIZUMAB; ANGIOGENESIS; CARCINOMA; PROTEIN; PANOBINOSTAT; UPDATE; GENES; TRIAL; CTCF	Anti-vascular endothelial growth factor (VEGF) therapy has demonstrated efficacy in treating human metastatic cancers, but therapeutic resistance is a practical limitation and most tumors eventually become unresponsive. To identify microenvironmental factors underlying the resistance of cancer to antiangiogenesis therapy, we conducted genomic analyses of intraperitoneal ovarian tumors in which adaptive resistance to anti-VEGF therapy (B20 antibody) developed. We found that expression of the microseminoprotein, prostate-associated (MSMP) gene was substantially upregulated in resistant compared with control tumors. MSMP secretion from cancer cells was induced by hypoxia, triggering MAPK signaling in endothelial cells to promote tube formation in vitro. Recruitment of the transcriptional repressor CCCTC-binding factor (CTCF) to the MSMP enhancer region was decreased by histone acetylation under hypoxic conditions in cancer cells. MSMP siRNA, delivered in vivo using the DOPC nanoliposomes, restored tumor sensitivity to anti-VEGF therapy. In ovarian cancer patients treated with bevacizumab, serum MSMP concentration increased significantly only in non-responders. These findings imply that MSMP inhibition combined with the use of antiangiogenesis drugs may be a new strategy to overcome resistance to antiangiogenesis therapy.	[Mitamura, T.; Pradeep, S.; McGuire, M.; Wu, S. Y.; Ma, S.; Hatakeyama, H.; Lyons, Y. A.; Hisamatsu, T.; Noh, K.; Villar-Prados, A.; Chen, X.; Hu, W.; Coleman, R. L.; Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Mitamura, T.] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Pradeep, S.] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Noh, K.] Korea Res Inst Bioscience & Biotechnol, Gene Therapy Res Unit, Daejeon, South Korea; [Ivan, C.; Rodriguez-Aguayo, C.; Lopez-Berestein, G.; Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Ivan, C.; Rodriguez-Aguayo, C.; Lopez-Berestein, G.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Hokkaido University; Medical College of Wisconsin; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Unit 1362, 1515 Holcombe Blvd, Houston, TX 77030 USA.	asood@mdanderson.org	Sood, Anoop Kumar/A-7344-2013; Hatakeyama, Hiroto/V-9987-2017; Coleman, Robert/E-4346-2019; Chen, Xiuhui/CAE-9641-2022	Sood, Anoop Kumar/0000-0001-5702-4108; Hatakeyama, Hiroto/0000-0003-3899-0508; Chen, Xiuhui/0000-0002-7184-9568; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Ivan, Cristina/0000-0002-4848-0168	Foundation for Women's Cancer grant; Ovarian Cancer Research Fund Alliance; Foundation for Women's Cancer; Texas Center for Cancer Nanomedicine; Cancer Prevention and Research Institute of Texas training grants [RP101502, RP101489]; Ovarian Cancer Research Fund Alliance [292015]; KRIBB Research Initiative Program; Uehara Memorial Foundation Research Fellowships for Research Abroad; National Institutes of Health [CA016672, CA109298, P50 CA083639, P50 CA098258, UH3 TR000943]; Ovarian Cancer Research Fund, Inc. (Program Project Development Grant); American Cancer Society Research Professor Award; Blanton-Davis Ovarian Cancer Research Program; RGK Foundation; Frank McGraw Memorial Chair in Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA083639, R01CA109298] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000943] Funding Source: NIH RePORTER	Foundation for Women's Cancer grant; Ovarian Cancer Research Fund Alliance; Foundation for Women's Cancer; Texas Center for Cancer Nanomedicine; Cancer Prevention and Research Institute of Texas training grants; Ovarian Cancer Research Fund Alliance; KRIBB Research Initiative Program; Uehara Memorial Foundation Research Fellowships for Research Abroad; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund, Inc. (Program Project Development Grant); American Cancer Society Research Professor Award(American Cancer Society); Blanton-Davis Ovarian Cancer Research Program; RGK Foundation; Frank McGraw Memorial Chair in Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	SP is supported by a Foundation for Women's Cancer grant and Ovarian Cancer Research Fund Alliance. SW is supported by Ovarian Cancer Research Fund Alliance, Foundation for Women's Cancer, Texas Center for Cancer Nanomedicine, and Cancer Prevention and Research Institute of Texas training grants (RP101502 and RP101489, respectively). KN is supported by the Ovarian Cancer Research Fund Alliance (grant 292015) and KRIBB Research Initiative Program. TH is supported by Uehara Memorial Foundation Research Fellowships for Research Abroad. Portions of this work were supported by the National Institutes of Health grants (CA016672, CA109298, P50 CA083639, P50 CA098258 and UH3 TR000943), Ovarian Cancer Research Fund, Inc. (Program Project Development Grant), American Cancer Society Research Professor Award, Blanton-Davis Ovarian Cancer Research Program, RGK Foundation and the Frank McGraw Memorial Chair in Cancer Research.	BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; BUICK RN, 1985, CANCER RES, V45, P3668; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Drappatz J, 2012, J NEURO-ONCOL, V107, P133, DOI 10.1007/s11060-011-0717-z; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Landen CN, 2008, NEOPLASIA, V10, P1259, DOI 10.1593/neo.08740; LAU DHM, 1991, CANCER RES, V51, P5181; Lee EQ, 2015, NEURO-ONCOLOGY, V17, P862, DOI 10.1093/neuonc/nou350; Pei XL, 2014, J IMMUNOL, V192, P1878, DOI 10.4049/jimmunol.1300758; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Strickler JH, 2012, CANCER CHEMOTH PHARM, V70, P251, DOI 10.1007/s00280-012-1911-1; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Valtonen-Andre C, 2007, BIOL CHEM, V388, P289, DOI 10.1515/BC.2007.032; Weth O, 2014, NUCLEIC ACIDS RES, V42, P11941, DOI 10.1093/nar/gku937; Yoneda J, 1998, JNCI-J NATL CANCER I, V90, P447, DOI 10.1093/jnci/90.6.447	25	24	24	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					722	731		10.1038/onc.2017.348	http://dx.doi.org/10.1038/onc.2017.348			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059175	Green Accepted, Green Submitted			2022-12-26	WOS:000424628100004
J	Soto, AS; Fenoy, IM; Sanchez, VR; March, F; Sibilia, MDP; Aldirico, MD; Picchio, MS; Arcon, N; Acosta, PL; Polack, FP; Martin, V; Goldman, A				Soto, Ariadna S.; Fenoy, Ignacio M.; Sanchez, Vanesa R.; March, Florencia; Perrone Sibilia, Matias D.; de los Angeles Aldirico, Maria; Picchio, Mariano S.; Arcon, Nadia; Acosta, Patricio L.; Polack, Fernando P.; Martin, Valentina; Goldman, Alejandra			Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapy	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IMMUNOTHERAPY; PROTEINASE-INHIBITOR; AIRWAY INFLAMMATION; ACTIVATED RECEPTOR-2; ALLOGRAFT TRANSPLANTATION; NAFAMOSTAT MESILATE; MURINE MODEL; RESPONSES; ALPHA-1-ANTITRYPSIN; MICE	Serine-proteases are important players in the pathogenesis of asthma, promoting inflammation and tissue remodeling. It's also known that many serine protease inhibitors display immunomodulatory properties. TgPI-1 is a Toxoplasma gondii protein that exhibits broad spectrum inhibitory activity against serine proteases. In view of the increased prevalence of atopic disorders and the need to develop new treatment strategies we sought to investigate the potential of TgPI-1 for treating respiratory allergies. For this purpose, we developed a therapeutic experimental model. BALB/c mice were rendered allergic by intraperitoneal ovalbumin-alum sensitization and airway-challenged. Once the asthmatic phenotype was achieved, mice were intranasally treated with rTgPI-1 alone or with a mixture of rTgPI-1 and ovalbumin (OVA). A week later mice were given a secondary aerosol challenge. Treatment with rTgPI-1 alone or co-administered with OVA diminished bronchoalveolar eosinophilia, mucus production and peribronchial lung infiltration. This effect was accompanied by a lung resistance reduction of 26.3% and 50.3% respectively. Both treatments resulted in the production of lower levels of IL-4, IL-5, IFN-gamma and regulatory IL-10 by thoracic lymph node cells stimulated with OVA. Interestingly, significant decreases in OVA specific IgE and T cell proliferation, and increases in FoxP3(+) T cells at local and systemic levels were only detected when the inhibitor was administered along with OVA. These results show that both rTgPI-1 treatments reduced asthma hallmarks. However, co-administration of the inhibitor with the allergen was more effective. Hence, rTgPI-1 emerges as a novel adjuvant candidate for asthma treatment.	[Soto, Ariadna S.; Fenoy, Ignacio M.; Sanchez, Vanesa R.; March, Florencia; Perrone Sibilia, Matias D.; de los Angeles Aldirico, Maria; Picchio, Mariano S.; Arcon, Nadia; Martin, Valentina; Goldman, Alejandra] Univ Nacl San Martin, Escuela Ciencia & Tecnol, CESyMA, Lab Inmunol Vacunas & Alergia, Buenos Aires, DF, Argentina; [Soto, Ariadna S.; Fenoy, Ignacio M.; Sanchez, Vanesa R.; Picchio, Mariano S.; Arcon, Nadia; Acosta, Patricio L.; Martin, Valentina; Goldman, Alejandra] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Acosta, Patricio L.; Polack, Fernando P.] Fdn Infant, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Goldman, A (corresponding author), Univ Nacl San Martin, Escuela Ciencia & Tecnol, CESyMA, Lab Inmunol Vacunas & Alergia, Buenos Aires, DF, Argentina.; Goldman, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	agoldman@unsa.edu.ar	Picchio, Mariano/AAE-1114-2019	Goldman, Alejandra/0000-0002-0340-0726; Acosta, Patricio/0000-0002-4164-7674; Soto, Ariadna/0000-0002-7265-0956	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina) [PICT2014-1377]; Consejo Nacional de Investigaciones Cientificas y Tecnicas I (CONICET, Argentina) [PIP 0168]; Universidad Nacional de San Martin [Puente 17/013]; Comision de Investigaciones Cientificas Buenos Aires, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas I (CONICET, Argentina); Universidad Nacional de San Martin; Comision de Investigaciones Cientificas Buenos Aires, Argentina	This study was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT2014-1377, ANPCyT, Argentina), (http://www.agencia.mincyt.gob.ar/), Consejo Nacional de Investigaciones Cientificas y Tecnicas I (PIP 0168, CONICET, Argentina), (http://www.conicet.gov.ar), Universidad Nacional de San Martin (Puente 17/013), (http://www.unsam.edu.ar/) and the Comision de Investigaciones Cientificas Buenos Aires, Argentina, (http://cic.gba.gov.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; Akdis CA, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0063-2; Chen CL, 2006, J ALLERGY CLIN IMMUN, V118, P105, DOI 10.1016/j.jaci.2006.02.047; Cocks TM, 2001, PULM PHARMACOL THER, V14, P183, DOI 10.1006/pupt.2001.0285; DELPRETE G, 1993, J IMMUNOL, V150, P353; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Fenoy I, 2009, CLIN EXP IMMUNOL, V155, P275, DOI 10.1111/j.1365-2249.2008.03813.x; Fenoy IM, 2015, IMMUNOBIOLOGY, V220, P641, DOI 10.1016/j.imbio.2014.11.016; Fenoy IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043420; Cuppari AF, 2008, VACCINE, V26, P5040, DOI 10.1016/j.vaccine.2008.07.031; FUJIMOTO K, 1995, RESP PHYSIOL, V100, P91, DOI 10.1016/0034-5687(94)00123-H; Guay C, 2006, CURR TOP MED CHEM, V6, P393, DOI 10.2174/156802606776287054; Guerrieri D, 2011, IMMUNOLOGY, V133, P434, DOI 10.1111/j.1365-2567.2011.03451.x; Ishizaki M, 2008, J PHARMACOL SCI, V108, P355, DOI 10.1254/jphs.08162FP; Jin FY, 1998, INFECT IMMUN, V66, P2447, DOI 10.1128/IAI.66.6.2447-2452.1998; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Jutel M, 2016, ALLERGY ASTHMA IMMUN, V8, P191, DOI 10.4168/aair.2016.8.3.191; Jutel M, 2013, ALLERGOL INT, V62, P425, DOI 10.2332/allergolint.13-RAI-0608; Kim BY, 2014, ALLERGY ASTHMA IMMUN, V6, P558, DOI 10.4168/aair.2014.6.6.558; Koga H, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-8; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Maggi E, 2010, CLIN EXP IMMUNOL, V161, P10, DOI 10.1111/j.1365-2249.2010.04148.x; Miike S, 2001, J IMMUNOL, V167, P6615, DOI 10.4049/jimmunol.167.11.6615; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Mizrahi M, 2013, IMMUNOLOGY, V140, P362, DOI 10.1111/imm.12149; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Morris MT, 2002, J BIOL CHEM, V277, P45259, DOI 10.1074/jbc.M205517200; Oh SW, 2002, J IMMUNOL, V168, P1992, DOI 10.4049/jimmunol.168.4.1992; Ozeri E, 2012, J IMMUNOL, V189, P146, DOI 10.4049/jimmunol.1101340; Pariani S, 2016, BIOCHIMIE, V123, P85, DOI 10.1016/j.biochi.2016.02.002; Pszenny V, 2000, MOL BIOCHEM PARASIT, V107, P241, DOI 10.1016/S0166-6851(00)00202-4; Pszenny V, 2002, MOL BIOCHEM PARASIT, V121, P283, DOI 10.1016/S0166-6851(02)00045-2; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Sanchez VR, 2015, ACTA TROP, V150, P159, DOI 10.1016/j.actatropica.2015.07.013; Sano C, 2000, CLIN EXP IMMUNOL, V121, P77, DOI 10.1046/j.1365-2249.2000.01269.x; Saw S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041107; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHWARTZ LB, 1990, J ALLERGY CLIN IMMUN, V86, P594, DOI 10.1016/S0091-6749(05)80222-2; Shahaf G, 2011, MOL MED, V17, P1000, DOI 10.2119/molmed.2011.00145; Simons FER, 2004, J ALLERGY CLIN IMMUN, V113, P1144, DOI 10.1016/j.jaci.2004.03.003; Simpson JL, 2005, AM J RESP CRIT CARE, V172, P559, DOI 10.1164/rccm.200503-369OC; Subramanian S, 2011, METAB BRAIN DIS, V26, P107, DOI 10.1007/s11011-011-9239-9; von Baehr V, 2005, J INVEST ALLERG CLIN, V15, P234; von Mutius E, 2007, IMMUNOBIOLOGY, V212, P433, DOI 10.1016/j.imbio.2007.03.002; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wright CD, 1999, J PHARMACOL EXP THER, V289, P1007; Zhou J, 2013, MOL CELL BIOCHEM, V377, P75, DOI 10.1007/s11010-013-1572-3	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187002	10.1371/journal.pone.0187002	http://dx.doi.org/10.1371/journal.pone.0187002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073215	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400094
J	Sun, XQ; Chandar, AK; Canto, MI; Thota, PN; Brock, M; Shaheen, NJ; Beer, DG; Wane, JS; Palle, GW; Lyer, PG; Abrams, JA; Venkat-Ramani, M; Veigl, M; Miron, A; Willis, J; Pati, DT; Nalbantoglu, I; Guda, K; Markowitz, SD; Zhu, XF; Elston, R; Chak, A				Sun, Xiangqing; Chandar, Apoorva K.; Canto, Marcia I.; Thota, Prashanthi N.; Brock, Malcom; Shaheen, Nicholas J.; Beer, David G.; Wane, Jean S.; Palle, Gary W.; Lyer, Prasad G.; Abrams, Julian A.; Venkat-Ramani, Medha; Veigl, Martina; Miron, Alexander; Willis, Joseph; Pati, Deepa T.; Nalbantoglu, Ilke; Guda, Kishore; Markowitz, Sanford D.; Zhu, Xiaofeng; Elston, Robert; Chak, Amitabh			Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; TUMOR SUPPRESSOR GENE; CANCER RISK LOCUS; WILMS-TUMOR; CHROMOSOME 8Q24; UNITED-STATES; C-MYC; PROSTATE; WT1; EPIDEMIOLOGY	Background Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) are far more prevalent in European Americans than in African Americans. Hypothesizing that this racial disparity in prevalence might represent a genetic susceptibility, we used an admixture mapping approach to interrogate disease association with genomic differences between European and African ancestry. Methods Formalin fixed paraffin embedded samples were identified from 54 African Americans with BE or EAC through review of surgical pathology databases at participating Barrett's Esophagus Translational Research Network (BETRNet) institutions. DNA was extracted from normal tissue, and genotyped on the Illumina OmniQuad SNP chip. Case-only admixture mapping analysis was performed on the data from both all 54 cases and also on a subset of 28 cases with high genotyping quality. Haplotype phases were inferred with Beagle 3.3.2, and local African and European ancestries were inferred with SABER plus. Disease association was tested by estimating and testing excess European ancestry and contrasting it to excess African ancestry. Results Both datasets, the 54 cases and the 28 cases, identified two admixture regions. An association of excess European ancestry on chromosome 11p reached a 5% genome-wide significance threshold, corresponding to -log(10)( P) = 4.28. A second peak on chromosome 8q reached -log(10)( P) = 2.73. The converse analysis examining excess African ancestry found no genetic regions with significant excess African ancestry associated with BE and EAC. On average, the regions on chromosomes 8q and 11p showed excess European ancestry of 15% and 20%, respectively. Conclusions Chromosomal regions on 11p15 and 8q22-24 are associated with excess European ancestry in African Americans with BE and EAC. Because GWAS have not reported any variants in these two regions, low frequency and/or rare disease associated variants that confer susceptibility to developing BE and EAC may be driving the observed European ancestry association evidence.	[Sun, Xiangqing; Zhu, Xiaofeng; Elston, Robert] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Chandar, Apoorva K.; Venkat-Ramani, Medha; Chak, Amitabh] Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland Med Ctr, Div Gastroenterol & Hepatol, Cleveland, OH 44106 USA; [Canto, Marcia I.] Johns Hopkins Med Inst, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Thota, Prashanthi N.] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA; [Brock, Malcom] Johns Hopkins Med Inst, Dept Cardiol & Thorac Surg, Baltimore, MD 21205 USA; [Shaheen, Nicholas J.] Univ North Carolina Chapel Hill, Sch Med, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC USA; [Beer, David G.] Univ Michigan, Dept Surg, Thorac Surg, Ann Arbor, MI 48109 USA; [Wane, Jean S.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Palle, Gary W.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lyer, Prasad G.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Abrams, Julian A.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Veigl, Martina; Guda, Kishore; Chak, Amitabh] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Miron, Alexander] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Willis, Joseph] Case Western Reserve Univ, Sch Med, Dept Pathol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Pati, Deepa T.] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA; [Nalbantoglu, Ilke] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Sch Med, Div Oncol, Cleveland, OH USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Johns Hopkins University; Johns Hopkins Medicine; Cleveland Clinic Foundation; Johns Hopkins University; Johns Hopkins Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Michigan System; University of Michigan; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Columbia University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation; Washington University (WUSTL); Case Western Reserve University; Case Western Reserve University	Chak, A (corresponding author), Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland Med Ctr, Div Gastroenterol & Hepatol, Cleveland, OH 44106 USA.; Chak, A (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA.	axc22@cwru.edu	Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	National Cancer Institute (NCI) [U54 CA163060, CA150964, DK097948]; NATIONAL CANCER INSTITUTE [T32CA094186, P50CA150964, U54CA163060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, P30DK097948] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work received support from grants U54 CA163060, CA150964, and DK097948 from the National Cancer Institute (NCI). AC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; ALTORKI NK, 1990, SEMIN SURG ONCOL, V6, P274, DOI 10.1002/ssu.2980060509; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; American Cancer Society, 2017, CANC FACTS FIG 2017; An Ruopeng, 2014, ISRN Obes, V2014, P185132, DOI 10.1155/2014/185132; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Baquet Claudia R, 2005, J Natl Med Assoc, V97, P1471; Brisbin AG, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-156; BRISCOE D, 1994, J HERED, V85, P59; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; Chak A, 2006, CANCER EPIDEM BIOMAR, V15, P1668, DOI 10.1158/1055-9965.EPI-06-0293; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; DeVault KR, 2000, DIGEST DIS, V18, P195, DOI 10.1159/000051399; Eads CA, 2001, CANCER RES, V61, P3410; Edelstein ZR, 2009, AM J GASTROENTEROL, V104, P834, DOI 10.1038/ajg.2009.137; Elbein SC, 2009, DIABETES, V58, P268, DOI 10.2337/db08-0931; Falk GW, 2009, SURG ONCOL CLIN N AM, V18, P469, DOI 10.1016/j.soc.2009.03.005; Falk GW, 2002, GASTROENTEROLOGY, V122, P1569, DOI 10.1053/gast.2002.33427; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Galwey NW, 2009, GENET EPIDEMIOL, V33, P559, DOI 10.1002/gepi.20408; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; GOODYER P, 1995, ONCOGENE, V10, P1125; Han Y, 2016, JNCI-J NATL CANCER I, P108; HEWITT SM, 1995, CANCER RES, V55, P5386; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lepage C, 2013, DIGEST LIVER DIS, V45, P625, DOI 10.1016/j.dld.2012.12.020; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Ogden C.L., 2011, NCHS DATA BRIEF, V2013, P1; Oji Y, 2004, ANTICANCER RES, V24, P3103; Penney KL, 2009, CLIN CANCER RES, V15, P3223, DOI 10.1158/1078-0432.CCR-08-2733; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Sharma P, 2008, AM J GASTROENTEROL, V103, P2669, DOI 10.1111/j.1572-0241.2008.02089.x; Shetty PB, 2015, CIRC-CARDIOVASC GENE, V8, P106, DOI 10.1161/CIRCGENETICS.114.000481; Shetty PB, 2012, J HYPERTENS, V30, P1970, DOI 10.1097/HJH.0b013e3283578c80; Shi X, 2015, INT J CLIN EXP MED, V8, P4795; Shriner Daniel, 2013, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0123s76; Shriner D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-223; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Sun XQ, 2016, MOL GENET GENOM MED, V4, P407, DOI 10.1002/mgg3.211; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2008, ADV GENET, V60, P547, DOI 10.1016/S0065-2660(07)00419-1	59	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0184962	10.1371/journal.pone.0184962	http://dx.doi.org/10.1371/journal.pone.0184962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073141	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400004
J	Ribeiro, SB; de Araujo, AA; de Araujo, RF; Brito, GAD; Leitao, RC; Barbosa, MM; Garcia, VB; Medeiros, AC; de Medeiros, CACX				Ribeiro, Susana Barbosa; de Araujo, Aurigena Antunes; de Araujo Junior, Raimundo Fernandes; de Castro Brito, Gerly Anne; Leitao, Renata Carvalho; Barbosa, Maisie Mitchele; Garcia, Vinicius Barreto; Medeiros, Aldo Cunha; Carvalho Xavier de Medeiros, Caroline Addison			Protective effect of dexamethasone on 5-FU-induced oral mucositis in hamsters	PLOS ONE			English	Article							NF-KAPPA-B; TGF-BETA; GLUCOCORTICOIDS; INFLAMMATION; REGULATOR; COX-2	Oral mucositis (OM) is an important side effect of cancer treatment, characterized by ulcerative lesions in the mucosa of patients undergoing radiotherapy or chemotherapy, which has marked effects on patient quality of life and cancer therapy continuity. Considering that few protocols have demonstrated efficacy in preventing this side effect, the aim of this study was to examine the effect of dexamethasone (DEX) on OM induced by 5-fluorouracil (5-FU) in hamsters by studying signaling pathways. OM was induced in hamsters by 5-FU followed by mechanical trauma (MT) on day 4. On day 10, the animals were euthanized. The experimental groups included saline, MT, 5-FU, and DEX (0.25, 0.5, or 1 mg/kg). Macroscopic, histopathological, and immunohistochemical analyses as well as immunofluorescence experiments were performed on the oral mucosa of the animals. The oral mucosal samples were analyzed by enzyme-linked immunosorbent assays, and quantitative real-time polymerase chain reaction (qPCR). DEX (0.5 or 1 mg/kg) reduced inflammation and ulceration of the oral mucosa of hamsters. In addition, DEX (1 mg/kg) reduced the cytokine levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and macrophage migration inhibitory factor (MIF). DEX (1 mg/kg) also reduced the immunoexpression of cyclooxygenase (COX)-2, matrix metalloproteinase (MMP)-2, transforming growth factor (TGF)-beta, MIF, Smad 2/3, Smad 2/3 phosphorylated and NF kappa B p65 in the jugal mucosa. Finally, DEX (1 mg/kg) increased interleukin-1 receptor-associated kinase 3 (IRAK-M), glucocorticoid-induced leucine zipper (GILZ), and mitogen-activated protein kinase (MKP1) gene expression and reduced NF kappa B p65 and serine threonine kinase (AKt) gene expression, relative to the 5-FU group. Thus, DEX improved OM induced by 5-FU in hamsters.	[Ribeiro, Susana Barbosa] Univ Fed Rio Grande do Norte, Post Grad Program Biotechnol RENORBIO, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Post Grad Program Publ Hlth, Post Grad Program Pharmaceut Sci, Dept Biophys & Pharmacol, Natal, RN, Brazil; [de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Post Grad Program Funct & Struct Biol, Post Grad Program Hlth Sci, Dept Morphol, Natal, RN, Brazil; [de Castro Brito, Gerly Anne; Leitao, Renata Carvalho] Univ Fed Ceara, Post Grad Program Morphol Sci, Dept Morphol, Fortaleza, Ceara, Brazil; [Barbosa, Maisie Mitchele] Univ Fed Rio Grande do Norte, Post Grad Program Biol Sci, Natal, RN, Brazil; [Garcia, Vinicius Barreto] Univ Fed Rio Grande do Norte, Post Grad Program Hlth Sci, Natal, RN, Brazil; [Medeiros, Aldo Cunha] Univ Fed Rio Grande do Norte, Dept Surg, Post Grad Program Hlth Sci, Natal, RN, Brazil; [Carvalho Xavier de Medeiros, Caroline Addison] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Post Grad Program Biotechnol RENORBIO, Post Grad Program Biol Sci, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Medeiros, CACX (corresponding author), Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Post Grad Program Biotechnol RENORBIO, Post Grad Program Biol Sci, Natal, RN, Brazil.	caralineacidisonfarma@yahoo.com.br	Leitão, Renata FC/GQI-3555-2022; Leitao, Renata/ABG-7682-2020; Leitao, Renata/ABF-9158-2020; de Araujo, Aurigena/ABI-8455-2020; Brito, Gerly/AHB-3965-2022; de Castro Brito, Gerly Anne/C-8597-2013	Leitão, Renata FC/0000-0003-0202-771X; Brito, Gerly/0000-0002-8214-4379; de Castro Brito, Gerly Anne/0000-0002-8214-4379; Araujo, Aurigena/0000-0001-9264-4695	National Counsel of Technological and Scientific Development (CNPq) [443840/2014-8]	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the National Counsel of Technological and Scientific Development (CNPq) universal edict process number 443840/2014-8. CACXM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AA, 2013, N-S ARCH PHARMACOL, V386, P875, DOI 10.1007/s00210-013-0886-8; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Guerra GCB, 2016, BIOL PHARM BULL, V39, P1793, DOI 10.1248/bpb.b16-00296; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bian L, 2015, PROTEIN CELL, V6, P160, DOI 10.1007/s13238-014-0130-4; Blijlevens N, 2007, ANN ONCOL, V18, P817, DOI 10.1093/annonc/mdl332; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; de Araujo WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115606; Joha S, 2012, ONCOGENE, V31, P1419, DOI 10.1038/onc.2011.328; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Lalla Rajesh V, 2008, Dent Clin North Am, V52, P61, DOI 10.1016/j.cden.2007.10.002; Lang TL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00577; Logan RM, 2008, CANCER BIOL THER, V7, P1139; Logan RM, 2007, ORAL ONCOL, V43, P395, DOI 10.1016/j.oraloncology.2006.04.011; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medeiros CACX, 2011, CANCER CHEMOTH PHARM, V67, P1085, DOI 10.1007/s00280-010-1409-7; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Prats PM, 2017, J ORAL PATHOL MED, V46, P142, DOI 10.1111/jop.12473; Nicolatou-Galitis O, 2013, SUPPORT CARE CANCER, V21, P3179, DOI 10.1007/s00520-013-1847-y; Park MH HJ, 2016, CELLS, P10; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Shaikh S., 2012, ISRN ANESTHESIOLOGY, V2012, P1, DOI 10.5402/2012/985495; Shrivastava R., 2013, J CANC RES TREATMENT, V1, P4, DOI [10.12691/jcrt-1-1-2, DOI 10.12691/JCRT-1-1-2]; Silverman Sol Jr, 2007, J Support Oncol, V5, P13; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Sonis ST, 2010, ORAL DIS, V16, P597, DOI 10.1111/j.1601-0825.2010.01681.x; SONIS ST, 1990, ORAL SURG ORAL MED O, V69, P437, DOI 10.1016/0030-4220(90)90376-4; Sonis Stephen T, 2007, J Support Oncol, V5, P3; Sun NB, 2017, ONCOL LETT, V13, P356, DOI 10.3892/ol.2016.5422; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Wen FQ, 2002, INFLAMMATION, V26, P279, DOI 10.1023/A:1021412601538; Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2	36	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186511	10.1371/journal.pone.0186511	http://dx.doi.org/10.1371/journal.pone.0186511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059216	Green Published, Green Submitted, gold			2022-12-26	WOS:000413403000027
J	Zhang, PY; Zhao, X; Zhang, WJ; He, AL; Lei, B; Zhang, WG; Chen, YX				Zhang, Pengyu; Zhao, Xuan; Zhang, Wenjuan; He, Aili; Lei, Bo; Zhang, Wanggang; Chen, Yinxia			Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/beta-catenin signaling pathway	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; CANCER; EXPRESSION; IDENTIFICATION; ONCOGENE	Our laboratory previously used the SEREX method in U937 cells and identified a novel leukemia-associated gene MLAA-34, a novel splice variant of CAB39L associated with acute monocytic leukemia, that exhibited anti-apoptotic activities in U937 cells. Whether MLAA-34 has an anti-apoptotic role in other tumor cells has not yet been reported. We explored whether MLAA-34 exhibited anti-apoptotic effects in HeLa cervical cancer cells and the possible mechanism of action. We generated a HeLa cell line stably expressing MLAA-34 and found that MLAA-34 overexpression had no effect on the growth, apoptosis and cell cycle of HeLa cells. However, upon treatment with arsenic trioxide (ATO) to induce apoptosis, the cell viability and colony formation ability of ATO-treated MLAA-34 stable HeLa cells were significantly higher than that of ATO-treated controls, and the apoptosis rate and proportion of G(2)/M cells also decreased. We found that ATO treatment of HeLa cells resulted in significant decreases in the expression of beta-catenin mRNA and protein and the downstream target factors c-Myc, cyclin B1, and cyclin D1 in the Wnt signaling pathway. Notably, ATO-treated MLAA-34 stable HeLa cells showed a significant reduction in the ATO-mediated downregulation of these factors. In addition, MLAA-34 overexpression significantly increased the expression of nuclear beta-catenin protein in ATO-treated cells compared with HeLa cells treated only with ATO. Thus, here we have found that the Wnt/beta-catenin signaling pathway is involved in ATO-induced apoptosis in HeLa cells. MLAA-34 reduces ATO-induced apoptosis and G(2)/M arrest, and the anti-apoptotic effect may be achieved by activating the Wnt/beta-catenin signaling pathway in HeLa cells.	[Zhang, Pengyu; He, Aili; Lei, Bo; Zhang, Wanggang; Chen, Yinxia] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Hematol, Xian, Shaanxi, Peoples R China; [Zhao, Xuan] Xian Med Coll, Dept Histol & Embryol, Xian, Shaanxi, Peoples R China; [Zhang, Wenjuan] Shaanxi Blood Ctr, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University	Zhang, PY; Chen, YX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Hematol, Xian, Shaanxi, Peoples R China.	zhangpengyu2004@126.com; chenyx204@163.com			National Natural Sciences Foundation of China [81000219]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China [grant number: 81000219].	Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101; Chen G, 2005, LEUKEMIA RES, V29, P503, DOI 10.1016/j.leukres.2004.09.013; Deng YP, 1999, SCI CHINA SER C, V42, P635, DOI 10.1007/BF02881582; Geng Xiao-Xing, 2011, Zhonghua Zhong Liu Za Zhi, V33, P8; Han YH, 2010, INT J MOL MED, V25, P121, DOI 10.3892/ijmm_00000321; Lo WY, 2012, J PROTEOMICS, V77, P154, DOI 10.1016/j.jprot.2012.07.039; Lu Xiu-ning, 2005, Zhonghua Zhongliu Zazhi, V27, P265; Parmar S, 2004, LEUKEMIA RES, V28, P909, DOI 10.1016/j.leukres.2003.12.012; Qian L, 2015, AM J TRANSL RES, V7, P2270; Rahmioglu N, 2015, HUM MOL GENET, V24, P1185, DOI 10.1093/hmg/ddu516; Shen LL, 2011, APOPTOSIS, V16, P1177, DOI 10.1007/s10495-011-0637-6; Ting HC, 2010, ENVIRON TOXICOL PHAR, V29, P117, DOI 10.1016/j.etap.2009.11.009; Um SJ, 2002, CANCER LETT, V181, P11, DOI 10.1016/S0304-3835(02)00039-3; Wang HT, 2014, BIOCHEM BIOPH RES CO, V451, P556, DOI 10.1016/j.bbrc.2014.08.014; Wang XY, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1307-y; Wen XS, 2012, ANTI-CANCER DRUG, V23, P280, DOI 10.1097/CAD.0b013e32834f1fd3; Woo SH, 2002, INT J ONCOL, V21, P57; Yu J, 2007, GYNECOL ONCOL, V106, P400, DOI 10.1016/j.ygyno.2007.04.016; Zhang PY, 2009, CANCER IMMUNOL IMMUN, V58, P281, DOI 10.1007/s00262-008-0552-z; Zhang WJ, 2013, ONCOL REP, V29, P491, DOI 10.3892/or.2012.2129; Zhang Y, 2017, ONCOTARGET, V8, P39077, DOI 10.18632/oncotarget.16590; Zhao JQ, 2011, CANCER IMMUNOL IMMUN, V60, P587, DOI 10.1007/s00262-011-0969-7	22	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186868	10.1371/journal.pone.0186868	http://dx.doi.org/10.1371/journal.pone.0186868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059232	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000048
J	Mullin, KD; McDonald, T; Wells, RS; Balmer, BC; Speakman, T; Sinclair, C; Zolman, ES; Hornsby, F; McBride, SM; Wilkinson, KA; Schwacke, LH				Mullin, Keith D.; McDonald, Trent; Wells, Randall S.; Balmer, Brian C.; Speakman, Todd; Sinclair, Carrie; Zolman, Eric S.; Hornsby, Fawn; McBride, Shauna M.; Wilkinson, Krystan A.; Schwacke, Lori H.			Density, abundance, survival, and ranging patterns of common bottlenose dolphins (Tursiops truncatus) in Mississippi Sound following the Deepwater Horizon oil spill	PLOS ONE			English	Article							GULF-OF-MEXICO; CAPTURE-RECAPTURE DATA; BARATARIA BAY; AERIAL SURVEYS; TEMPORARY EMIGRATION; SEASONAL ABUNDANCE; CETACEANS; SALINITY; HABITAT; PROBABILITY	After the Deepwater Horizon (DWH) oil spill began in April 2010, studies were initiated on northern Gulf of Mexico common bottlenose dolphins (Tursiops truncatus) in Mississippi Sound (MSS) to determine density, abundance, and survival, during and after the oil spill, and to compare these results to previous research in this region. Seasonal boat-based photo-identification surveys (2010-2012) were conducted in a section of MSS to estimate dolphin density and survival, and satellite-linked telemetry (2013) was used to determine ranging patterns. Telemetry suggested two different ranging patterns in MSS: (1) inshore waters with seasonal movements into mid-MSS, and (2) around the barrier islands exclusively. Based upon these data, dolphin density was estimated in two strata (Inshore and Island) using a spatially-explicit robust-design capture-recapture model. Inshore and Island density varied between 0.77-1.61 dolphins km(-2) ((x) over bar = 1.42, 95% CI: 1.28-1.53) and 3.32-5.74 dolphins km(-2) ((x) over bar = 4.43, 95% CI: 2.70-5.63), respectively. The estimated annual survival rate for dolphins with distinctive fins was very low in the year following the spill, 0.73 (95% CI: 0.67-0.78), and consistent with the occurrence of a large scale cetacean unusual mortality event that was in part attributed to the DWH oil spill. Fluctuations in density were not as large or seasonally consistent as previously reported. Total abundance for MSS extrapolated from density results ranged from 4,610 in July 2011 to 3,046 in January 2012 ((x) over bar = 3,469, 95% CI: 3,113-3,725).	[Mullin, Keith D.; Sinclair, Carrie] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pascagoula, MS 39567 USA; [McDonald, Trent; Hornsby, Fawn] Western Ecosyst Technol Inc, Cheyenne, WY USA; [Wells, Randall S.; McBride, Shauna M.; Wilkinson, Krystan A.] Chicago Zool Soc, Mote Marine Lab, Sarasota Dolphin Res Program, Sarasota, FL USA; [Balmer, Brian C.; Speakman, Todd; Zolman, Eric S.; Schwacke, Lori H.] NOAA, Hollings Marine Lab, Natl Ctr Coastal Ocean Sci, Natl Ocean Serv, Charleston, SC USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Mote Marine Laboratory & Aquarium; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS)	Mullin, KD (corresponding author), NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pascagoula, MS 39567 USA.	Keith.D.Mullin@noaa.gov		Balmer, Brian/0000-0001-9734-4042; Wilkinson, Krystan A./0000-0002-2921-6011	BP	BP	This work was part of the Deepwater Horizon Natural Resource Damage Assessment, conducted cooperatively by NOM, other Federal and State Trustees and BP. Funding was provided by BP, as the Responsible Party. The funder provided salary support for NOM contractors TM, RSW, BCB, TS, ESZ, FH, SMM, and KAW, and/or research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Authors TM and FH are employed by Western Ecosystems Technology, Inc., a commercial company.	Adams Jeffrey D., 2006, Aquatic Mammals, V32, P374, DOI 10.1578/AM.32.3.2006.374; [Anonymous], [No title captured]; Balmer B. C., 2013, Marine Mammal Science, V29, pE114, DOI 10.1111/j.1748-7692.2012.00598.x; Balmer B. C., 2008, Journal of Cetacean Research and Management, V10, P157; Balmer BC, 2015, SCI TOTAL ENVIRON, V527, P306, DOI 10.1016/j.scitotenv.2015.05.016; Balmer BC, 2014, MAR MAMMAL SCI, V30, P656, DOI 10.1111/mms.12072; Beyer J, 2016, MAR POLLUT BULL, V110, P28, DOI 10.1016/j.marpolbul.2016.06.027; Christmas J.Y., 1973, COOPERATIVE GULF MEX, P1; Conn PB, 2011, J WILDLIFE MANAGE, V75, P569, DOI 10.1002/jwmg.94; Corkeron P, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P183; CORMACK RM, 1972, BIOMETRICS, V28, P337, DOI 10.2307/2556151; De Guise S, 2017, ENDANGER SPECIES RES, V33, P290, DOI 10.3354/esr00814; Dias LA, 2017, ENDANGER SPECIES RES, V33, P119, DOI 10.3354/esr00770; Eleuterius C.K, 1976, MISSISSIPPI SOUND SA; ELEUTERIUS CK, 1977, GULF RES REP, V6, P17; ELEUTERIUS CK, 1978, GULF RES REP, V6, P185; ELEUTERIUS CK, 1978, GULF RES REP, V6, P179; Ergon T, 2014, METHODS ECOL EVOL, V5, P1327, DOI 10.1111/2041-210X.12133; ESRI, 2016, HOT SPOT AN GET ORD; Fauquier DA, 2017, ENDANGER SPECIES RES, V33, P211, DOI 10.3354/esr00772; Friday N, 2000, MAR MAMMAL SCI, V16, P355, DOI 10.1111/j.1748-7692.2000.tb00930.x; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; HOHN AA, 1989, MAR MAMMAL SCI, V5, P315, DOI 10.1111/j.1748-7692.1989.tb00346.x; Hornsby FE, 2017, ENDANGER SPECIES RES, V33, P181, DOI 10.3354/esr00807; Hubard Carrie W., 2004, Aquatic Mammals, V30, P299, DOI 10.1578/AM.30.2.2004.299; Ingram SN, 2002, MAR ECOL PROG SER, V244, P247, DOI 10.3354/meps244247; IRVINE AB, 1981, FISH B-NOAA, V79, P671; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Karczmarski L, 1999, MAR MAMMAL SCI, V15, P1115, DOI 10.1111/j.1748-7692.1999.tb00880.x; Kellar NM, 2017, ENDANGER SPECIES RES, V33, P143, DOI 10.3354/esr00775; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Kie J.G., 2013, ANIM BIOTELEM, V1, P13, DOI [10.1186/2050-3385-1-13, DOI 10.1186/2050-3385-1-13]; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kjerfve B., 1986, ESTUARINE VARIABILIT, P63, DOI DOI 10.1016/B978-0-12-761890-6.50009-5; Laake JL, 1997, J WILDLIFE MANAGE, V61, P63, DOI 10.2307/3802415; LEATHERWOOD S, 1978, J WILDLIFE MANAGE, V42, P239, DOI 10.2307/3800261; LEATHERWOOD S, 1975, MAR FISH REV, V37, P10; Leatherwood S, 1983, ABUNDANCE BOTTLENOSE; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lynn Spencer K., 2002, Gulf of Mexico Science, V20, P25; Mackey AD, 2010, THESIS; MacLeod CD, 2014, INTRO USING GIS MARI; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; McBride SM, 2013, THESIS; McDonald TL, 2017, ENDANGER SPECIES RES, V33, P193, DOI 10.3354/esr00806; McFee WE, 2010, MAR MAMMAL SCI, V26, P67, DOI 10.1111/j.1748-7692.2009.00306.x; Melancon RAS, NMFSSEFSC627 NOAA; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Miller LJ, 2013, AQUAT CONSERV, V23, P145, DOI 10.1002/aqc.2278; Moncreiff CA., 2007, 20065287 US GEOL SUR; MULLIN K D, 1990, Northeast Gulf Science, V11, P113; Mullin KD, 1992, 1 NAT MAR FISH SERV; Mullin KD, 1992, 2 NAT MAR FISH SERV; Mullin Keith D., 1999, P269; Nixon Z, 2016, MAR POLLUT BULL, V107, P170, DOI 10.1016/j.marpolbul.2016.04.003; NMFS, 2005, REV GUID ASS MAR MAM; Park K, 2014, MAR ENVIRON RES, V94, P48, DOI 10.1016/j.marenvres.2013.12.003; Penland S, 2013, 02206 USGS; Pitchford JL, 2016, SOUTHEAST NAT, V15, P188, DOI 10.1656/058.015.0201; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Powell RA, 2000, METH C CONS, P65; Read AJ, 2003, MAR MAMMAL SCI, V19, P59, DOI 10.1111/j.1748-7692.2003.tb01092.x; Reeves RR, 1984, REP INT WHAL COMMN, V34, P497; Rodgers A, HRT HOME RANGE TOOLS; Rosel P.E., 2011, NOAA TECHNICAL MEMOR; Schaefer J, 2016, T AM FISH SOC, V145, P108, DOI 10.1080/00028487.2015.1111253; Schaub M, 2014, METHODS ECOL EVOL, V5, P1316, DOI 10.1111/2041-210X.12134; Schwacke LH, 2017, ENDANGER SPECIES RES, V33, P265, DOI 10.3354/esr00777; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Shane SH, 1977, ARANSAS PASS AREA TE; Sinclair C, 2016, THESIS; Slooten E, 2004, MAR MAMMAL SCI, V20, P477, DOI 10.1111/j.1748-7692.2004.tb01173.x; Smith CE, 2013, MAR ECOL PROG SER, V487, P231, DOI 10.3354/meps10372; Smith CR, 2017, ENDANGER SPECIES RES, V33, P127, DOI 10.3354/esr00778; Solangi MS, 1983, NA82GAC00023 NMFS; Speakman Todd R., 2010, Journal of Cetacean Research and Management, V11, P153; Takeshita R, 2017, ENDANGER SPECIES RES, V33, P95, DOI 10.3354/esr00808; Torres LG, 2009, MAR MAMMAL SCI, V25, P797, DOI 10.1111/j.1748-7692.2009.00297.x; Tyson RB, 2011, MAR ECOL PROG SER, V438, P253, DOI 10.3354/meps09292; Urian K.W., 2014, J N CAROLINA ACAD SC, V129, P165, DOI [10.7572/2167-5880-129.4.165, DOI 10.7572/2167-5880-129.4.165]; Urian KW, 2009, MAR MAMMAL SCI, V25, P619, DOI 10.1111/j.1748-7692.2009.00284.x; Van Dolah FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130934; Venn-Watson SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132117; Wand M.P., 1995, MONOGRAPHS STAT APPL; Waring GT, NMFSNE231 NOAA; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells R. S., 2013, FRONTIERS ENDOCRINOL, V4, P1; Wells RS, 2017, ENDANGER SPECIES RES, V33, P159, DOI 10.3354/esr00732; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755	94	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186265	10.1371/journal.pone.0186265	http://dx.doi.org/10.1371/journal.pone.0186265			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053728	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100014
J	Trinkaus, E; Villotte, S				Trinkaus, Erik; Villotte, Sebastien			External auditory exostoses and hearing loss in the Shanidar 1 Neandertal	PLOS ONE			English	Article							PLEISTOCENE HUMAN CRANIUM; CHAPELLE-AUX-SAINTS; QUALITY-OF-LIFE; COLD-WATER; PREHISTORIC POPULATION; AURICULAR EXOSTOSES; CONSPECIFIC CARE; CANAL EXOSTOSES; MODERN HUMANS; CAVE	The Late Pleistocene Shanidar 1 older adult male Neandertal is known for the crushing fracture of his left orbit with a probable reduction in vision, the loss of his right forearm and hand, and evidence of an abnormal gait, as well as probable diffuse idiopathic skeletal hyperostosis. He also exhibits advanced external auditory exostoses in his left auditory meatus and larger ones with complete bridging across the porus in the right meatus (both Grade 3). These growths indicate at least unilateral conductive hearing (CHL) loss, a serious sensory deprivation for a Pleistocene hunter-gatherer. This condition joins the meatal atresia of the Middle Pleistocene Atapuerca-SH Cr.4 in providing evidence of survival with conductive hearing loss (and hence serious sensory deprivation) among these Pleistocene humans. The presence of CHL in these fossils thereby reinforces the paleobiological and archeological evidence for supporting social matrices among these Pleistocene foraging peoples.	[Trinkaus, Erik] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Villotte, Sebastien] Univ Bordeaux, CNRS, PACEA UMR5199, Batiment B8,Allee Geoffroy St Hilaire, Pessac, France	Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux	Trinkaus, E (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	trinkaus@wustl.edu		Trinkaus, Erik/0000-0002-5175-1651	National Science Foundation (US) [NSF BNS76-14344, NSF BNS80-04578]	National Science Foundation (US)(National Science Foundation (NSF))	This work was supported by National Science Foundation (US) grant NSF BNS76-14344 (Biological Anthropology Program) (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5407) to Erik Trinkaus; National Science Foundation (US) grant NSF BNS80-04578 (Biological Anthropology Program) (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5407) to Erik Trinkaus. The funder had no role in study design, data collection	Abdel-Aziz M, 2013, J CRANIOFAC SURG, V24, pE418, DOI 10.1097/SCS.0b013e3182942d11; Altuna Mariezkurrena X, 2004, Acta Otorrinolaringol Esp, V55, P364; Apicella CL, 2014, EVOL HUM BEHAV, V35, P508, DOI 10.1016/j.evolhumbehav.2014.07.001; Arnay-de-la-Rosa M, 2001, ANN OTO RHINOL LARYN, V110, P1080, DOI 10.1177/000348940111001117; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; BARYOSEF O, 1992, CURR ANTHROPOL, V33, P497, DOI 10.1086/204112; BINFORD LR, 1971, AM ANTIQUITY, V36, P6, DOI 10.1017/S0081130000002525; Boe LJ, 2007, J PHONETICS, V35, P564, DOI 10.1016/j.wocn.2007.06.006; Boule M, 1911, ANN PALEONTOL, V6, P1; Boule M., 1911, ANTHROPOLOGIE, V22, P1; Boule M, 1911, ANN PALEONTOL, V6, P111; Boule M., 1911, ANN PALEONTOL, V7, P21; Byrne RW, 2002, INT J PRIMATOL, V23, P539, DOI 10.1023/A:1014917600198; Carciumaru M., 2009, ANN U VALAHIA TARGOV, VXI, P7; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Cibot M, 2016, INT J PRIMATOL, V37, P479, DOI 10.1007/s10764-016-9914-0; Ciorba A, 2012, CLIN INTERV AGING, V7, P159, DOI 10.2147/CIA.S26059; Condemi S, 2001, NEANDERTALIENS CHAIS; Cooper A, 2010, BRIT J SPORT MED, V44, P144, DOI 10.1136/bjsm.2008.048157; Crowe F, 2010, AM J PHYS ANTHROPOL, V142, P355, DOI 10.1002/ajpa.21229; CRUBEZY E, 1992, AM J PHYS ANTHROPOL, V89, P411, DOI 10.1002/ajpa.1330890402; Cuozzo FP, 2004, J HUM EVOL, V46, P623, DOI 10.1016/j.jhevol.2004.02.004; d'Errico F, 2002, J HUM EVOL, V42, pA13; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; De La Cruz A, 2001, OTOLOGIC SURG, P54; DeGusta D, 2002, J ARCHAEOL SCI, V29, P1435, DOI 10.1006/jasc.2001.0808; Deleyiannis FWB, 1996, AM J OTOLARYNG, V17, P303, DOI 10.1016/S0196-0709(96)90015-0; DIBARTOLOMEO J R, 1979, Annals of Otology Rhinology and Laryngology, V88, P1; Estalrrich A, 2015, J HUM EVOL, V80, P51, DOI 10.1016/j.jhevol.2014.07.007; Evins M.A., 1982, PALEORIENT, V8, P37; FILIPO R, 1982, J SPORT MED PHYS FIT, V22, P329; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; GEPP (Grupo para Estudo do Paleolitico Porlugues), 1983, ARQUEOLOGO PORTUGUES, V1, P15; Gracia A, 2009, P NATL ACAD SCI USA, V106, P6573, DOI 10.1073/pnas.0900965106; GRAHAM MD, 1979, ANN OTO RHINOL LARYN, V88, P566, DOI 10.1177/000348947908800422; Guest JF, 2004, QJM-INT J MED, V97, P477, DOI 10.1093/qjmed/hch082; HARRISON D F, 1962, Ann R Coll Surg Engl, V31, P187; Hauser G., 1989, EPIGENETIC VARIANTS; Hublin J. J., 1991, THESIS; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P6429, DOI 10.1073/pnas.0902614106; Jackson G., 1909, BMJ-BRIT MED J, V2, P1137; Jaubert J, 2016, NATURE, V534, P111, DOI 10.1038/nature18291; KAREGEANNES JC, 1995, UNDERSEA HYPERBAR M, V22, P301; Katayama K, 1998, ANTHROPOL SCI, V106, P285, DOI 10.1537/ase.106.285; KENNEDY GE, 1986, AM J PHYS ANTHROPOL, V71, P401, DOI 10.1002/ajpa.1330710403; Kesser BW, 2015, CLINICAL OTOLOGY, 4TH EDITION, P192; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Kroon DF, 2002, OTOLARYNG HEAD NECK, V126, P499, DOI 10.1067/mhn.2002.124474; Kuzminsky SC, 2016, INT J OSTEOARCHAEOL, V26, P1014, DOI 10.1002/oa.2512; Lacy SA, 2014, THESIS; Lebel S, 2002, J HUM EVOL, V43, P659, DOI 10.1006/jhev.2002.0598; Leonetti JP, 2015, CLINICAL OTOLOGY, 4TH EDITION, P181; Li ZY, 2017, SCIENCE, V355, P969, DOI 10.1126/science.aal2482; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Lovell NC, 1990, PATTERNS INJURY ILLN; Martinez I, 2013, QUATERN INT, V295, P94, DOI 10.1016/j.quaint.2012.07.001; Marttin-Frances L, 2015, THESIS; Mashkour M, 2009, INT J OSTEOARCHAEOL, V19, P678, DOI 10.1002/oa.997; Matsumoto T, 2016, PRIMATES, V57, P3, DOI 10.1007/s10329-015-0499-6; Mazza B, 2016, INT J OSTEOARCHAEOL, V26, P420, DOI 10.1002/oa.2432; Meignen L., 1993, LABRI DES CANALETTES, P161; Okumura MMM, 2007, AM J PHYS ANTHROPOL, V132, P558, DOI 10.1002/ajpa.20544; PATTE E, 1957, ENFANT NEANDERTHALIE; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Perez PJ, 1997, J HUM EVOL, V33, P409, DOI 10.1006/jhev.1997.0139; Ponce P, 2008, BAR INT SERIES, V1743, P101; Putt SS, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0102; Rabach LA, 2015, CLINICAL OTOLOGY, 4TH EDITION, P139; Rendu W, 2014, P NATL ACAD SCI USA, V111, P81, DOI 10.1073/pnas.1316780110; REYNOLDS V, 1965, AM ANTHROPOL, V67, P691, DOI 10.1525/aa.1965.67.3.02a00050; Roebroeks W, 2016, P NATL ACAD SCI USA, V113, P6372, DOI 10.1073/pnas.1521269113; Roland P S, 1997, J Am Acad Audiol, V8, P367; Rosell Jordi, 2012, Journal of Taphonomy, V10, P125; Sergi S., 1974, CRANIO NEANDERTALIAN; Sparacello VS, 2016, C R PALEVOL; Spoor F, 1998, AM J PHYS ANTHROPOL, V107, P41, DOI 10.1002/(SICI)1096-8644(199809)107:1<41::AID-AJPA4>3.0.CO;2-G; Standen VG, 1997, AM J PHYS ANTHROPOL, V103, P119, DOI 10.1002/(SICI)1096-8644(199705)103:1<119::AID-AJPA8>3.0.CO;2-R; STEWART TD, 1977, P AM PHILOS SOC, V121, P121; Stewart TD, 1958, SUMER, V14, P90; Suzuki H, 1982, B U MUSEUM, V19, P7; Tainter J.A., 1978, ADV ARCHAEOLOGICAL M, V1, P105, DOI DOI 10.1016/B978-0-12-003101-6.50010-X; Trinkaus, 2014, SHANIDAR NEANDERTALS; TRINKAUS E, 1987, AM J PHYS ANTHROPOL, V72, P123, DOI 10.1002/ajpa.1330720115; TRINKAUS E, 1985, AM J PHYS ANTHROPOL, V67, P19, DOI 10.1002/ajpa.1330670105; TRINKAUS E, 2016, KRAPINA HUMAN POSTCR; Trinkaus E., 1994, PHYS ANTHR, V93, P1, DOI DOI 10.1002/AJPA.1330930102; Trinkaus E., 2014, PEOPLE SUNGHIR; Trinkaus E, 2007, CURR BIOL, V17, pR917, DOI 10.1016/j.cub.2007.09.055; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Trinkaus E, 2013, ORIGINS OF MODERN HUMANS: BIOLOGY RECONSIDERED, 2ND EDITION, P393; Turner SE, 2014, J HUM EVOL, V68, P47, DOI 10.1016/j.jhevol.2014.01.002; Velasco-Vazquez J, 2000, AM J PHYS ANTHROPOL, V112, P49, DOI 10.1002/(SICI)1096-8644(200005)112:1<49::AID-AJPA6>3.0.CO;2-U; Verna C., 2006, THESIS; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Villotte S, 2016, J ARCHAEOL SCI-REP, V6, P633, DOI 10.1016/j.jasrep.2015.05.013; Villotte S, 2017, CR PALEVOL, V16, P462, DOI 10.1016/j.crpv.2016.09.004; Villotte S, 2014, ANTHROPOL-INT J HUM, V52, P73; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Whitaker SR, 1998, LARYNGOSCOPE, V108, P195, DOI 10.1097/00005537-199802000-00007; White RD, 2012, CLIN RADIOL, V67, P172, DOI 10.1016/j.crad.2011.08.019; Wu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059587; Wu XJ, 2011, P NATL ACAD SCI USA, V108, P19558, DOI 10.1073/pnas.1117113108; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	103	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186684	10.1371/journal.pone.0186684	http://dx.doi.org/10.1371/journal.pone.0186684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK2MA	29053746	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100034
J	Vogel, KR; Ainslie, GR; Jansen, EE; Salomons, GS; Roullet, JB; Gibson, KM				Vogel, Kara R.; Ainslie, Garrett R.; Jansen, Erwin E.; Salomons, Gajja S.; Roullet, Jean-Baptiste; Gibson, K. Michael			In vitro modeling of experimental succinic semialdehyde dehydrogenase deficiency (SSADHD) using brain-derived neural stem cells	PLOS ONE			English	Article							GABA-METABOLISM; TAURINE TRIAL; MICE; ACTIVATION; BIOMARKERS; DISORDER; TRANSCRIPTION; MECHANISMS; AUTOPHAGY; ACIDURIA	We explored the utility of neural stem cells (NSCs) as an in vitro model for evaluating preclinical therapeutics in succinic semialdehyde dehydrogenase-deficient (SSADHD) mice. NSCs were obtained from aldh5a1(+/+) and aldh5a1(-/-) mice (aldh5a1 = aldehyde dehydrogenase 5a1 = SSADH). Multiple parameters were evaluated including: (1) production of GHB (.hydroxybutyrate), the biochemical hallmark of SSADHD; (2) rescue from cell death with the dual mTOR (mechanistic target of rapamycin) inhibitor, XL-765, an agent previously shown to rescue aldh5a1(-/-) mice from premature lethality; (3) mitochondrial number, total reactive oxygen species, and mitochondrial superoxide production, all previously documented as abnormal in aldh5a1(-/-) mice; (4) total ATP levels and ATP consumption; and (5) selected gene expression profiles associated with epilepsy, a prominent feature in both experimental and human SSADHD. Patterns of dysfunction were observed in all of these parameters and mirrored earlier findings in aldh5a1(-/-) mice. Patterns of dysregulated gene expression between hypothalamus and NSCs centered on ion channels, GABAergic receptors, and inflammation, suggesting novel pathomechanisms as well as a developmental ontogeny for gene expression potentially associated with the murine epileptic phenotype. The NSC model of SSADHD will be valuable in providing a first-tier screen for centrally-acting therapeutics and prioritizing therapeutic concepts of preclinical animal studies applicable to SSADHD.	[Vogel, Kara R.; Ainslie, Garrett R.] Washington State Univ, Expt & Syst Pharmacol & Pharmacotherapy, Coll Pharm, Spokane, WA USA; [Jansen, Erwin E.; Salomons, Gajja S.; Roullet, Jean-Baptiste; Gibson, K. Michael] Vrije Univ Amsterdam, Med Ctr, Metab Unit, Dept Clin Chem, Neurosci Campus, Amsterdam, Netherlands; [Vogel, Kara R.] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Ainslie, Garrett R.] Theravance Biopharma US Inc, San Francisco, CA USA	Washington State University; Vrije Universiteit Amsterdam; University of Wisconsin System; University of Wisconsin Madison; Theravance	Gibson, KM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Metab Unit, Dept Clin Chem, Neurosci Campus, Amsterdam, Netherlands.	mike.gibson@wsu.edu	Ainslie, Garrett/Z-5321-2019		National Institutes of Health [R21 NS85369, R41 NS98856, R01 EY27476]; SSADH Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SSADH Association	Supported in part by R21 NS85369, R41 NS98856, and R01 EY27476 from the National Institutes of Health, and a grant from the SSADH Association (www.ssadh.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported in part by R21 NS85369, R41 NS98856, and R01 EY27476 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie GR, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.265; Attri SV, 2016, JIMD REP; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chamma I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00005; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; GIBSON KM, 1990, BIOMED ENVIRON MASS, V19, P89, DOI 10.1002/bms.1200190207; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Goodman T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00387; Gupta M, 2002, J PHARMACOL EXP THER, V302, P180, DOI 10.1124/jpet.302.1.180; He Z, 2014, ONCOL REP, V32, P1873, DOI 10.3892/or.2014.3421; Ivanov DP, 2016, TOXICOL IN VITRO, V37, P88, DOI 10.1016/j.tiv.2016.09.007; Ivanov VN, 2015, APOPTOSIS, V20, P996, DOI 10.1007/s10495-015-1131-3; Jansen EE, 2016, J INHERIT METAB DIS, V39, P795, DOI 10.1007/s10545-016-9980-7; Kilb W, 2012, NEUROSCIENTIST, V18, P613, DOI 10.1177/1073858411422114; Lakhani R, 2014, EMBO MOL MED, V6, P551, DOI 10.1002/emmm.201303356; Maitre M, 2016, MED RES REV, V36, P363, DOI 10.1002/med.21382; Malaspina P, 2016, NEUROCHEM INT, V99, P72, DOI 10.1016/j.neuint.2016.06.009; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Pearl PL, 2009, J INHERIT METAB DIS, V32, P343, DOI 10.1007/s10545-009-1034-y; Pearl PL, 2014, NEUROLOGY, V82, P940, DOI 10.1212/WNL.0000000000000210; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Schneider E, 2016, GENE, V592, P110, DOI 10.1016/j.gene.2016.07.058; Schreiber JM, 2016, JIMD REP, V30, P81, DOI 10.1007/8904_2015_524; Vangan N, 2016, MICROB PATHOGENESIS, V99, P111, DOI 10.1016/j.micpath.2016.08.011; Vernardis SI, 2013, METAB ENG, V19, P1, DOI 10.1016/j.ymben.2013.04.005; Vogel KR, 2017, PEDIATR NEUROL, V66, P44, DOI 10.1016/j.pediatrneurol.2016.09.016; Vogel KR, 2016, J INHERIT METAB DIS, V39, P877, DOI 10.1007/s10545-016-9959-4; Vogel KR, 2015, ANN CLIN TRANSL NEUR, V2, P699, DOI 10.1002/acn3.200; Vogel KR, 2016, BIOCHIM BIOPHYS ACTA, V1863, P33; Wang KW, 2015, CELL CYCLE, V14, P1631, DOI 10.1080/15384101.2015.1038685; WATANABE M, 2015, FRONT CELL NEUROSCI, V0009	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186919	10.1371/journal.pone.0186919	http://dx.doi.org/10.1371/journal.pone.0186919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053743	Green Submitted, gold, Green Published			2022-12-26	WOS:000413315100050
J	Kim, D; Kim, W; Kwak, MS; Chung, GE; Yim, JY; Ahmed, A				Kim, Donghee; Kim, Won; Kwak, Min-Sun; Chung, Goh Eun; Yim, Jeong Yoon; Ahmed, Aijaz			Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States	PLOS ONE			English	Article							SERUM ALANINE AMINOTRANSFERASE; NUTRITION EXAMINATION SURVEY; INSULIN-RESISTANCE; CANNABIS SMOKING; NATIONAL-HEALTH; BODY-WEIGHT; MICE; RECEPTOR; POPULATION; MORTALITY	Background & aims The impact of marijuana on nonalcoholic fatty liver disease (NAFLD) is largely unknown. We studied the association between marijuana and NAFLD utilizing cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) from 2005-2014 and NHANES III (1988-1994). Methods Suspected NAFLD was diagnosed if serum alanine aminotransferase (ALT) was > 30 IU/L for men and > 19 IU/L for women in the absence of other liver diseases (NHANES 2005-2014). In NHANES III cohort, NAFLD was defined based on ultrasonography. Results Of the 14,080 (NHANES 2005-2014) and 8,286 (NHANES III) participants, prevalence of suspected NAFLD and ultrasonographically-diagnosed NAFLD were inversely associated with marijuana use (p < 0.001). Compared to marijuana-naive participants, marijuana users were less likely to have suspected NAFLD (odds ratio [OR]: 0.90, 95% confidence interval [CI]: 0.82-0.99 for past user; OR: 0.68, 95% CI: 0.58-0.80 for current user) and ultrasonographically-diagnosed NAFLD (OR: 0.75, 95% CI: 0.57-0.98 for current user) in the age, gender, ethnicity-adjusted model. On multivariate analysis, the ORs for suspected NAFLD comparing current light or heavy users to non-users were 0.76 (95% CI 0.58-0.98) and 0.70 (95% CI 0.56-0.89), respectively (P for trend = 0.001) with similar trends in ultrasonographically-diagnosed NAFLD (OR: 0.77, 95% CI: 0.59-1.00 for current user; OR: 0.71, 95% CI: 0.51-0.97 for current light user). In insulin resistance-adjusted model, marijuana use remained an independent predictor of lower risk of suspected NAFLD. Conclusions In this nationally representative sample, active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors. The pathophysiology is unclear and warrants further investigation.	[Kim, Donghee; Ahmed, Aijaz] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA USA; [Kim, Won] Seoul Natl Univ, Coll Med, Seoul Metropolitan Govt Boramae Med Ctr, Div Gastroenterol & Hepatol,Dept Internal Med, Seoul, South Korea; [Kwak, Min-Sun; Chung, Goh Eun; Yim, Jeong Yoon] Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Healthcare Res Inst, Dept Internal Med, Seoul, South Korea	Stanford University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Ahmed, A (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA USA.	aijazahmed@stanford.edu	Kim, Won/H-6940-2019; Kim, Donghee/C-4288-2013	Kim, Won/0000-0002-2926-1007; Kim, Donghee/0000-0003-1919-6800				Administration S. A. a. M. H. S, 2016, KEY SUBST US MENT HL; Alshaarawy O, 2015, EPIDEMIOLOGY, V26, P597, DOI 10.1097/EDE.0000000000000314; Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x; Esposito G, 2013, PHYTOTHER RES, V27, P633, DOI 10.1002/ptr.4781; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Hirvonen J, 2012, MOL PSYCHIATR, V17, P642, DOI 10.1038/mp.2011.82; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Le Strat Y, 2011, AM J EPIDEMIOL, V174, P929, DOI 10.1093/aje/kwr200; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mecha M, 2013, NEUROBIOL DIS, V59, P141, DOI 10.1016/j.nbd.2013.06.016; Migrenne S, 2009, AM J PHYSIOL-REG I, V296, pR929, DOI 10.1152/ajpregu.90824.2008; Muniyappa R, 2013, DIABETES CARE, V36, P2415, DOI 10.2337/dc12-2303; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Patrignani P, 2005, BRAIN RES REV, V48, P352, DOI 10.1016/j.brainresrev.2004.12.024; Penner EA, 2013, AM J MED, V126, P583, DOI 10.1016/j.amjmed.2013.03.002; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Plan and operation of the Third National Health and Nutrition Examination Survey, 1994, VITAL HLTH STAT, P1; Rajavashisth TB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000494; Ribeiro A, 2012, EUR J PHARMACOL, V678, P78, DOI 10.1016/j.ejphar.2011.12.043; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Small-Howard AL, 2005, BIOCHEM J, V388, P465, DOI 10.1042/BJ20041682; Smit E, 2001, PUBLIC HEALTH NUTR, V4, P781, DOI 10.1079/PHN2000114; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Tam J, 2014, AM J PHYSIOL-ENDOC M, V306, pE457, DOI 10.1152/ajpendo.00489.2013; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Vidot DC, 2016, AM J MED, V129, P173, DOI 10.1016/j.amjmed.2015.10.019; Weiss L, 2006, AUTOIMMUNITY, V39, P143, DOI 10.1080/08916930500356674; Weiss L, 2008, NEUROPHARMACOLOGY, V54, P244, DOI 10.1016/j.neuropharm.2007.06.029	31	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186702	10.1371/journal.pone.0186702	http://dx.doi.org/10.1371/journal.pone.0186702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049354	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900097
J	Oh, S; Yap, GC; Hong, PY; Huang, CH; Aw, MM; Shek, LPC; Liu, WT; Lee, BW				Oh, Seungdae; Yap, Gaik Chin; Hong, Pei-Ying; Huang, Chiung-Hui; Aw, Marion M.; Shek, Lynette Pei-Chi; Liu, Wen-Tso; Lee, Bee Wah			Immune-modulatory genomic properties differentiate gut microbiota of infants with and without eczema	PLOS ONE			English	Article							ATOPIC ECZEMA; BIFIDOBACTERIUM-LONGUM; INTESTINAL MICROBIOTA; FECAL MICROFLORA; DENDRITIC CELLS; ASIAN INFANTS; BACTERIAL-DNA; CPG MOTIFS; RISK; SENSITIZATION	Gut microbiota play an important role in human immunological processes, potentially affecting allergic diseases such as eczema. The diversity and structure of gut microbiota in infants with eczema have been previously documented. This study aims to evaluate by comparative metagenomics differences in genetic content in gut microbiota of infants with eczema and their matched controls. Stools were collected at the age of one month old from twelve infants from an at risk birth cohort in a case control manner. Clinical follow up for atopic outcomes were carried out at the age of 12 and 24 months. Microbial genomic DNA were extracted from stool samples and used for shotgun sequencing. Comparative metagenomic analysis showed that immune-regulatory TCAAGCTTGA motifs were significantly enriched in the six healthy controls (C) communities compared to the six eczema subjects (E), with many encoded by Bifidobacterium (38% of the total motifs in the C communities). Draft genomes of five Bifidobacterium species populations (B. longum, B. bifidum, B. breve, B. dentium, and B. pseudocatenulatum) were recovered from metagenomic datasets. The B. longum BFN-1212 genome encoded more TCAAGCTTGA motifs (4.2 copies per one million genome sequence) than other Bifidobacterium genomes. Additionally, the communities in the stool of controls (C) were also significantly enriched in functions associated with tetrapyrrole biosynthesis compared to those of eczema (E). Our results show distinct immune-modulatory genomic properties of gut microbiota in infants associated with eczema and provide new insights into potential role of gut microbiota in affecting human immune homeostasis.	[Oh, Seungdae] Kyung Hee Univ, Dept Civil Engn, Yongin, Gyeonggi Do, South Korea; [Oh, Seungdae; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Yap, Gaik Chin; Huang, Chiung-Hui; Aw, Marion M.; Shek, Lynette Pei-Chi; Lee, Bee Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Hong, Pei-Ying] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Hong, Pei-Ying] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Water Desalinat & Reuse Ctr, Thuwal, Saudi Arabia; [Aw, Marion M.; Shek, Lynette Pei-Chi; Lee, Bee Wah] Natl Univ Hlth Syst, Khoo Teck Puat Natl Univ Childrens Med Inst, Dept Paediat, Singapore, Singapore	Kyung Hee University; University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; National University of Singapore	Liu, WT (corresponding author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.; Lee, BW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore.; Lee, BW (corresponding author), Natl Univ Hlth Syst, Khoo Teck Puat Natl Univ Childrens Med Inst, Dept Paediat, Singapore, Singapore.	wtliu@illinois.edu; paeleebw@nus.edu.sg	Oh, Seungdae/E-7293-2016; Liu, Wen-Tso/C-8788-2011; Hong, Peiying/A-4813-2009	Oh, Seungdae/0000-0002-3171-3631; Liu, Wen-Tso/0000-0002-8700-9803; Shek, Lynette/0000-0001-9064-8983; Hong, Peiying/0000-0002-4474-6600	MOH's National Medical Research Council [NMRC/EDG/1057/2011, NMRC/CIRG/1414/2014]; University of Illinois at Urbana-Champaign; Nanyang Technological University	MOH's National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); University of Illinois at Urbana-Champaign; Nanyang Technological University(Nanyang Technological University)	This study was supported by MOH's National Medical Research Council (NMRC/EDG/1057/2011 and NMRC/CIRG/1414/2014). Seungdae Oh was supported by the start-up grant from the University of Illinois at Urbana-Champaign (to WTL) and Nanyang Technological University (to SO), respectively.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bouladoux N, 2012, MUCOSAL IMMUNOL, V5, P623, DOI 10.1038/mi.2012.36; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007; Di Gioia D, 2014, APPL MICROBIOL BIOT, V98, P563, DOI 10.1007/s00253-013-5405-9; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Flohr C, 2014, ALLERGY, V69, P3, DOI 10.1111/all.12270; Forno Erick, 2008, Clin Mol Allergy, V6, P11, DOI 10.1186/1476-7961-6-11; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Ghadimi D, 2008, IMMUNOBIOLOGY, V213, P677, DOI 10.1016/j.imbio.2008.02.001; Gore C, 2008, J ALLERGY CLIN IMMUN, V121, P135, DOI 10.1016/j.jaci.2007.07.061; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Ismail IH, 2012, PEDIAT ALLERG IMM-UK, V23, P674, DOI 10.1111/j.1399-3038.2012.01328.x; Iwabuchi N, 2009, FEMS IMMUNOL MED MIC, V55, P324, DOI 10.1111/j.1574-695X.2008.00510.x; Jelic D, 2012, EUR J PHARMACOL, V691, P251, DOI 10.1016/j.ejphar.2012.05.049; Alonso-Castro AJ, 2015, BIOORGAN MED CHEM, V23, P2529, DOI 10.1016/j.bmc.2015.03.043; Kendler M, 2006, PEDIAT ALLERG IMM-UK, V17, P141, DOI 10.1111/j.1399-3038.2005.00371.x; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mah KW, 2006, INT ARCH ALLERGY IMM, V140, P157, DOI 10.1159/000092555; Mah KW, 2007, PEDIATR RES, V62, P674, DOI 10.1203/PDR.0b013e31815991d5; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Nylund L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-12; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Paulson JN, 2011, GENOME BIOL, V12, P12, DOI 10.1186/1465-6906-12-S1-P17; Penders J, 2006, CLIN EXP ALLERGY, V36, P1602, DOI 10.1111/j.1365-2222.2006.02599.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schaller M, 2005, BRIT J DERMATOL, V153, P66, DOI 10.1111/j.1365-2133.2005.06530.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarzer M, 2013, VACCINE, V31, P5405, DOI 10.1016/j.vaccine.2013.09.014; Soh SE, 2009, CLIN EXP ALLERGY, V39, P571, DOI 10.1111/j.1365-2222.2008.03133.x; Song H, 2016, J ALLERGY CLIN IMMUN, V137, P852, DOI 10.1016/j.jaci.2015.08.021; Takahashi N, 2006, FEMS IMMUNOL MED MIC, V46, P461, DOI 10.1111/j.1574-695X.2006.00064.x; Tang MF, 2015, THE BRITISH JOURNAL; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Valles Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004406; Watanabe S, 2003, J ALLERGY CLIN IMMUN, V111, P587, DOI 10.1067/mai.2003.105; West CE, 2015, CLIN EXP ALLERGY, V45, P1419, DOI 10.1111/cea.12566; Wu YW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-26; Yap Gaik Chin, 2014, BMC Res Notes, V7, P166, DOI 10.1186/1756-0500-7-166; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zeuner RA, 2002, ARTHRITIS RHEUM, V46, P2219, DOI 10.1002/art.10423; Zheng HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166026; Zhong Y, 2012, FEMS IMMUNOL MED MIC, V66, P71, DOI 10.1111/j.1574-695X.2012.00991.x; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	60	8	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0184955	10.1371/journal.pone.0184955	http://dx.doi.org/10.1371/journal.pone.0184955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049378	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900005
J	Petrick, JL; Yang, BY; Altekruse, SF; Van Dyke, AL; Koshiol, J; Graubard, BI; McGlynn, KA				Petrick, Jessica L.; Yang, Baiyu; Altekruse, Sean F.; Van Dyke, Alison L.; Koshiol, Jill; Graubard, Barry I.; McGlynn, Katherine A.			Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; CHRONIC HEPATITIS-C; VIRUS-INFECTION; INDUCED HYPERTHYROIDISM; METAANALYSIS; DISEASE; OBESITY; CHOLECYSTECTOMY; INFLAMMATION; GALLSTONES	Objectives Intrahepatic (ICC) and extrahepatic (ECC) cholangiocarcinomas are rare tumors that arise from the epithelial cells of the bile ducts, and the etiology of both cancer types is poorly understood. Thus, we utilized the Surveillance, Epidemiology, and End Results (SEER)Medicare resource to examine risk factors and novel preexisting medical conditions that may be associated with these cancer types. Methods Between 2000 and 2011, 2,092 ICC and 2,981 ECC cases and 323,615 controls were identified using the SEER-Medicare database. Logistic regression was used to calculate adjusted odds ratios (OR) and 95% confidence intervals (CI). &&Results Non-alcoholic fatty liver disease was associated with approximately 3-fold increased risks of ICC (OR = 3.52, 95% CI: 2.87-4.32) and ECC (OR = 2.93, 95% CI: 2.42-3.55). Other metabolic conditions, including obesity and type 2 diabetes, were also associated with increased risks of both cancer types. Smoking was associated with a 46% and 77% increased ICC and ECC risk, respectively. Several autoimmune/inflammatory conditions, including type 1 diabetes and gout, were associated with increased risks of ICC/ECC. As anticipated, viral hepatitis, alcohol-related disorders, and bile duct conditions were associated with both cancer types. However, thyrotoxicosis and hemochromatosis were associated with an increased risk of ICC but not ECC, but did not remain significantly associated after Bonferroni correction. Conclusions In this study, risk factors for ICC and ECC were similar, with the exceptions of thyrotoxicosis and hemochromatosis. Notably, metabolic conditions were associated with both cancer types. As metabolic conditions are increasing in prevalence, these could be increasingly important risk factors for both types of cholangiocarcinoma.	[Petrick, Jessica L.; Yang, Baiyu; Van Dyke, Alison L.; Koshiol, Jill; Graubard, Barry I.; McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Yang, Baiyu] Stanford Univ, Stanford Canc Inst, Palo Alto, CA 94304 USA; [Altekruse, Sean F.] NHLBI, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford Cancer Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Petrick, JL (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	jessica.petrick@nih.gov	koshiol, Jill/L-8686-2014; Petrick, Jessica/AAA-9079-2020; Petrick, Jessica/P-1678-2017	koshiol, Jill/0000-0002-3832-6204; Petrick, Jessica/0000-0001-6580-450X	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010158] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute to KAM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla E K, 1999, HPB Surg, V11, P271, DOI 10.1155/1999/70985; Alazmi WM, 2007, CAN J GASTROENTEROL, V21, P81, DOI 10.1155/2007/502931; Altekruse Sean F, 2011, J Registry Manag, V38, P201; Alzahrani B, 2014, CANCER LETT, V345, P223, DOI 10.1016/j.canlet.2013.08.036; Ansaloni L, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0082-5; Carey EJ, 2015, LANCET, V386, P1565, DOI 10.1016/S0140-6736(15)00154-3; Castro FA, 2013, INT J CANCER, V133, P1664, DOI 10.1002/ijc.28161; Chapman RW, 1999, ANN ONCOL, V10, P308, DOI 10.1023/A:1008313809752; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Efird LM, 2013, J GEN INTERN MED, V28, P1333, DOI 10.1007/s11606-013-2453-x; Erichsen R, 2009, EUR J EPIDEMIOL, V24, P513, DOI 10.1007/s10654-009-9365-4; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Fritz A, 2000, INT CLASSIFICATION D; Fukuma H, 1996, J GASTROENTEROL, V31, P538, DOI 10.1007/BF02355054; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Holzheimer RG., 2001, SURG TREATMENT EVIDE, P722; Jing W, 2012, EUR J CANCER PREV, V21, P24, DOI 10.1097/CEJ.0b013e3283481d89; Kaewpitoon Soraya J, 2016, Asian Pac J Cancer Prev, V17, P37; KAJI K, 1994, MODERN PATHOL, V7, P937; Kanwal F, 2016, CLIN GASTROENTEROL H, V14, P301, DOI 10.1016/j.cgh.2015.08.010; Kobayashi M, 2000, CANCER, V88, P2471, DOI 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T; Li H, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0583-9; Li JS, 2014, TUMOR BIOL, V35, P6831, DOI 10.1007/s13277-014-1939-4; Li M, 2012, J GASTROEN HEPATOL, V27, P1561, DOI 10.1111/j.1440-1746.2012.07207.x; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; National Cancer Institute Division of Cancer Control and Population Sciences, SEER MED SEER MED DA; Nogueira L, 2014, AM J EPIDEMIOL, V179, P731, DOI 10.1093/aje/kwt322; Nordenstedt H, 2012, BRIT J CANCER, V106, P1011, DOI 10.1038/bjc.2011.607; Palmer WC, 2012, J HEPATOL, V57, P69, DOI 10.1016/j.jhep.2012.02.022; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Perumal V, 2006, HUM PATHOL, V37, P1211, DOI 10.1016/j.humpath.2006.04.012; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Saha SK, 2016, ONCOLOGIST, V21, P594, DOI 10.1634/theoncologist.2015-0446; Sarkar S, 2016, CLIN LIVER DIS, V20, P67, DOI 10.1016/j.cld.2015.08.005; Selva DM, 2009, J MOL ENDOCRINOL, V43, P19, DOI 10.1677/JME-09-0025; Shaib YH, 2007, AM J GASTROENTEROL, V102, P1016, DOI 10.1111/j.1572-0241.2007.01104.x; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; STROHMEYER G, 1988, ANN NY ACAD SCI, V526, P245, DOI 10.1111/j.1749-6632.1988.tb55510.x; Strongin A, 2013, ENDOSC ULTRASOUND, V2, P71, DOI [10.7178/eus.05.003, 10.4103/2303-9027.117690]; The National Cancer Institute, SEER MED MED ENR CLA; TOMIMATSU M, 1993, CANCER, V72, P683, DOI 10.1002/1097-0142(19930801)72:3<683::AID-CNCR2820720310>3.0.CO;2-C; Venditti P, 2006, J EXP BIOL, V209, P817, DOI 10.1242/jeb.02045; Venditti P, 2006, ARCH BIOCHEM BIOPHYS, V447, P11, DOI 10.1016/j.abb.2006.01.008; Warren JL, 2002, MED CARE, V40, P3; Welzel TM, 2006, J NATL CANCER I, V98, P873, DOI 10.1093/jnci/djj234; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Welzel TM, 2007, CLIN GASTROENTEROL H, V5, P1221, DOI 10.1016/j.cgh.2007.05.020; Wiley LK, 2013, J AM MED INFORM ASSN, V20, P652, DOI 10.1136/amiajnl-2012-001557; Ye XH, 2013, WORLD J GASTROENTERO, V19, P8780, DOI 10.3748/wjg.v19.i46.8780; Yin FZ, 1998, CHINESE MED J-PEKING, V111, P1068	53	90	93	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186643	10.1371/journal.pone.0186643	http://dx.doi.org/10.1371/journal.pone.0186643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049401	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900091
J	Kim, JH; Kim, HJ; Yu, DH; Kweon, HS; Huh, YH; Kim, HR				Kim, Ju Hwan; Kim, Hyo-Jeong; Yu, Da-Hyeon; Kweon, Hee-Seok; Huh, Yang Hoon; Kim, Hak Rim			Changes in numbers and size of synaptic vesicles of cortical neurons induced by exposure to 835 MHz radiofrequency-electromagnetic field	PLOS ONE			English	Article							SYNAPSIN-I; BRAIN; IMPAIRMENT; DAMAGE	We studied the effects of radiofrequency electromagnetic fields (RF-EMFs) exposure on neuronal functions of mice. Particularly, we focused on RF-EMF effects on synaptic vesicles (SVs), which store neurotransmitters at axon terminals or synaptic boutons. C57 BL/6 mice were exposed to 835 MHz RF-EMF (4.0 W/kg SAR, for 5 h daily) and alterations in SVs at presynaptic terminals in the cerebral cortex were determined. Ultrastructure of randomly selected cortical neurons was observed using typical electron microscopy and bio-high voltage electron microscopy (Bio-HVEM) methods, which enable the estimation of the numbers and size of SVs. The density of the SVs (number / 10 mu m(2) or 40 mu m(3)) was significantly decreased in the presynaptic boutons of cortical neurons after RF-EMF exposure. Furthermore, qPCR and immunoblotting analyses revealed that the expression of synapsins I/II (Syns I/II) genes and proteins were significantly decreased in the cortical neurons of RF-EMF exposed mice. The present study suggested that alteration of SVs and Syn levels may result in alterations of neurotransmitters in the cerebral cortex following RF-EMF exposure.	[Kim, Ju Hwan; Kim, Hyo-Jeong; Yu, Da-Hyeon; Kim, Hak Rim] Dankook Univ, Coll Med, Dept Pharmacol, Cheonan, Chungnam, South Korea; [Kim, Hyo-Jeong; Kweon, Hee-Seok; Huh, Yang Hoon] Korea Basic Sci Inst, Ctr Electron Microscopy Res, Ochang, Chungbuk, South Korea	Dankook University; Korea Basic Science Institute (KBSI)	Kim, HR (corresponding author), Dankook Univ, Coll Med, Dept Pharmacol, Cheonan, Chungnam, South Korea.; Huh, YH (corresponding author), Korea Basic Sci Inst, Ctr Electron Microscopy Res, Ochang, Chungbuk, South Korea.	hyh1127@kbsi.re.kr; hrkim@dankook.ac.kr		Kim, Hak Rim/0000-0003-3102-2272	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2014R1A2A2A04003616]; Korea Basic Science Institute [T37416, C37964]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Korea Basic Science Institute	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2014R1A2A2A04003616 to HRK) and Korea Basic Science Institute (T37416, C37964 to YHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rassoul G, 2007, NEUROTOXICOLOGY, V28, P434, DOI 10.1016/j.neuro.2006.07.012; Aldad TS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00312; Awizio AK, 2007, BIOPHYS J, V93, P1051, DOI 10.1529/biophysj.107.104406; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Ballmaier M, 2004, NEUROIMAGE, V23, P325, DOI 10.1016/j.neuroimage.2004.04.026; Bogen IL, 2009, NEUROCHEM INT, V55, P13, DOI 10.1016/j.neuint.2009.02.006; De Luca C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/924184; Faridi K, 2013, CURR NEUROBIOL, V4; Fernandez V, 2016, EMBO J, V35, P1021, DOI 10.15252/embj.201593701; Frederikse PH, 2004, MOL VIS, V10, P794; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Kim JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41129; Kim JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153308; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Liu Y, 2012, J CHENGDU MED COLL, V7, P3, DOI DOI 10.1371/J0URNAL.P0NE.0042332; Maskey D, 2010, BRAIN RES, V1313, P232, DOI 10.1016/j.brainres.2009.11.079; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Ortolano S, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-7; Perlini LE, 2016, ONCOTARGET, V7, P15288, DOI 10.18632/oncotarget.8106; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Salford LG, 2003, ENVIRON HEALTH PERSP, V111, P881, DOI 10.1289/ehp.6039; Schrottner J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-310; Shipp S, 2007, CURR BIOL, V17, pR443, DOI 10.1016/j.cub.2007.03.044; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Swenson R. S., REV CLIN FUNCTIONAL; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; Tang J, 2015, BRAIN RES, V1601, P92, DOI 10.1016/j.brainres.2015.01.019	27	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186416	10.1371/journal.pone.0186416	http://dx.doi.org/10.1371/journal.pone.0186416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045446	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100060
J	Mitsuya, K; Parker, AN; Liu, L; Ruan, JH; Vissers, MCM; Myatt, L				Mitsuya, Kohzoh; Parker, Ashley N.; Liu, Lu; Ruan, Jianhua; Vissers, Margreet C. M.; Myatt, Leslie			Alterations in the placental methylome with maternal obesity and evidence for metabolic regulation	PLOS ONE			English	Article							DNA METHYLATION; ONCOMETABOLITE 2-HYDROXYGLUTARATE; 5-METHYLCYTOSINE OXIDATION; WEIGHT-LOSS; VITAMIN-C; ES CELLS; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; WIDE; DEMETHYLATION	The inflammatory and metabolic derangements of obesity in pregnant women generate an adverse intrauterine environment, increase pregnancy complications and adverse fetal outcomes and program the fetus for obesity and metabolic syndrome in later life. We hypothesized that epigenetic modifications in placenta including altered DNA methylation/hydroxymethylation may mediate these effects. Term placental villous tissue was collected following cesarean section from lean (prepregnancy BMI< 25) or obese (BMI> 30) women. Genomic DNA was isolated, methylated and hydroxymethylated DNA immunoprecipitated and hybridized to the NimbleGen 2.1M human DNA methylation array. Intermediate metabolites in placental tissues were measured by HPLC-ESI-MS, ascorbate levels by reverse phase HPLC and gene expression by RT-PCR. Differentially methylated and hydroxymethylated regions occurred across the genome, with a 21% increase in methylated but a 31% decrease in hydroxymethylated regions in obese vs lean groups. Whereas increased methylation and decreased methylation was evident around transcription start sites of multiple genes in the GH/CSH and PSG gene clusters on chromosomes 17 and 19 in other areas there was no relationship. Increased methylation was associated with decreased expression only for some genes in these clusters. Biological pathway analysis revealed the 262 genes which showed reciprocal differential methylation/hydroxymethylation were enriched for pregnancy, immune response and cell adhesion-linked processes. We found a negative relationship for maternal BMI but a positive relationship for ascorbate with a-ketoglutarate a metabolite that regulates ten eleven translocase (TET) which mediates DNA methylation. We provide evidence for the obese maternal metabolic milieu being linked to an altered DNA methylome that may affect placental gene expression in relation to adverse outcomes.	[Mitsuya, Kohzoh; Parker, Ashley N.; Myatt, Leslie] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA; [Liu, Lu; Ruan, Jianhua] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA; [Vissers, Margreet C. M.] Univ Otago, Dept Pathol, Ctr Free Radical Res, Christchurch, New Zealand; [Myatt, Leslie] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Otago; Oregon Health & Science University	Myatt, L (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA.; Myatt, L (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	myattl@ohsu.edu	Vissers, Margreet C M/T-4159-2017	Mitsuya, Kohzoh/0000-0002-0950-5406; Ruan, Jianhua/0000-0002-5622-3137	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD076266]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD076266] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA113001] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant HD076266 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bouret S, 2015, PHYSIOL REV, V95, P47, DOI 10.1152/physrev.00007.2014; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Charitou P, 2015, EMBO REP, V16, P456, DOI 10.15252/embr.201439096; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Chu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107318; Du YY, 2011, PRENATAL DIAG, V31, P207, DOI 10.1002/pd.2684; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Finer S, 2015, HUM MOL GENET, V24, P3021, DOI 10.1093/hmg/ddv013; Fisher R., 1970, STAT METHODS RES WOR; Friedrich N, 2012, J ENDOCRINOL, V215, P29, DOI 10.1530/JOE-12-0120; Hankey GJ, 2012, LANCET NEUROL, V11, P66, DOI 10.1016/S1474-4422(11)70265-4; Hillman SL, 2015, EPIGENETICS-US, V10, P50, DOI 10.4161/15592294.2014.989741; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Johnston CS, 2007, J NUTR, V137, P1757, DOI 10.1093/jn/137.7.1757; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Kuiper C, 2010, CANCER RES, V70, P5749, DOI 10.1158/0008-5472.CAN-10-0263; Lien LF, 2009, OMICS, V13, P21, DOI 10.1089/omi.2008.0035; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Sardina JL, 2015, MOL CELL, V57, P573, DOI 10.1016/j.molcel.2015.02.005; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Martin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141294; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Mitsuya K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113209; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nikolova YS, 2014, NAT NEUROSCI, V17, P1153, DOI 10.1038/nn.3778; Novakovic B, 2012, PLACENTA, V33, P959, DOI 10.1016/j.placenta.2012.10.003; Panchenko PE, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0188-3; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rampal R, 2014, CELL REP, V9, P1841, DOI 10.1016/j.celrep.2014.11.004; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Ruchat SM, 2013, EPIGENETICS-US, V8, P935, DOI 10.4161/epi.25578; Sun ZY, 2015, MOL CELL, V57, P750, DOI 10.1016/j.molcel.2014.12.035; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang H, 2014, CELL RES, V24, P1017, DOI 10.1038/cr.2014.81; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137	49	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186115	10.1371/journal.pone.0186115	http://dx.doi.org/10.1371/journal.pone.0186115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045485	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100037
J	Heydt, Q; Larrue, C; Saland, E; Bertoli, S; Sarry, JE; Besson, A; Manenti, S; Joffre, C; Mas, VMD				Heydt, Q.; Larrue, C.; Saland, E.; Bertoli, S.; Sarry, J-E; Besson, A.; Manenti, S.; Joffre, C.; Mas, V. Mansat-De			Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia	ONCOGENE			English	Article							INTEGRATED STRESS-RESPONSE; CELL-DEATH; AML CELLS; INHIBITOR; DEGRADATION; CANCER; PROLIFERATION; SURVIVAL; THERAPY; PATHWAY	In acute myeloid leukemia (AML), internal tandem duplication mutations in the FLT3 tyrosine kinase receptor (FLT3-ITD) account for up to 25% of cases and are associated with a poor outcome. In order to better target this AML subtype, a comprehensive view of how FLT3-ITD impacts AML cell biology is required. Here, we found that FLT3-ITD expression increased basal autophagy in AML cells, and that both pharmacological and genetic inhibition of the receptor reduced autophagy in primary AML samples and cell lines. Conditional expression of shRNAs against key autophagy proteins demonstrated that autophagy is required for AML cell proliferation in vitro and for leukemic cells survival in a mouse model of xenograft. Importantly, autophagy inhibition also overcame FLT3 inhibitor resistance both in vitro and in vivo. The transcription factor ATF4 was identified as an essential actor of FLT3-ITD-induced autophagy. Cellular levels of ATF4 were highly dependent on FLT3-ITD activity, and downregulation of ATF4 inhibited autophagy-dependent AML cell proliferation and improved overall mouse survival similarly to autophagy inhibition. These results suggest that targeting autophagy or ATF4 in patients expressing FLT3 mutations may represent a novel promising and innovative therapeutic strategy for AML.	[Heydt, Q.; Larrue, C.; Saland, E.; Sarry, J-E; Besson, A.; Manenti, S.; Joffre, C.; Mas, V. Mansat-De] Univ Toulouse, CNRS, INSERM, U1037,ERL5294,CRCT, Toulouse, France; [Heydt, Q.; Manenti, S.; Joffre, C.; Mas, V. Mansat-De] La Ligue Canc, Equipe Labellisee, Toulouse, France; [Bertoli, S.] IUCT O, Serv Hematol, Toulouse, France; [Mas, V. Mansat-De] Inst Univ Canc Toulouse Oncopole, Lab Hematol, 1 Ave Irene Joliot Curie, F-31059 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Mas, VMD (corresponding author), Inst Univ Canc Toulouse Oncopole, Lab Hematol, 1 Ave Irene Joliot Curie, F-31059 Toulouse 9, France.; Joffre, C (corresponding author), CRCT, 2 Ave Hubert Curien, F-31037 Toulouse 1, France.	carine.joffre@inserm.fr; demas.veronique@iuct-oncopole.fr	De Mas, Véronique/P-2414-2014; SALAND, Estelle/W-7996-2019; JOFFRE, Carine/P-1551-2014; Sarry, Jean-Emmanuel/P-1633-2014; manenti, stephane/P-1518-2014; Sarry, Jean-Emmanuel/AAC-3664-2020; Bertoli, Sarah/GMZ-5043-2022; Besson, Arnaud/J-6254-2014	JOFFRE, Carine/0000-0002-7551-356X; Sarry, Jean-Emmanuel/0000-0002-6704-2032; manenti, stephane/0000-0002-4793-3196; Sarry, Jean-Emmanuel/0000-0002-6704-2032; Bertoli, Sarah/0000-0003-1084-2781; Besson, Arnaud/0000-0002-9599-3943; Larrue, Clement/0000-0001-5827-8433	ANR LABEX TOUCAN; Canceropole GSO; la Ligue regionale contre le Cancer; la Ligue nationale contre le Cancer; Ligue Nationale contre le Cancer	ANR LABEX TOUCAN(French National Research Agency (ANR)); Canceropole GSO; la Ligue regionale contre le Cancer; la Ligue nationale contre le Cancer(Ligue nationale contre le cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	We are very grateful to Jerome Tamburini (Institut Cochin, Paris, France), Paulo De Sepulveda (CRCM, Marseille, France) and Pierre Brousset (CRCT, Toulouse, France) for providing us with specific leukemic cell lines (MOLM-14-TKD and MV4-11 shFLT3, TF-1-FLT3-ITD, and OCI-AML3 respectively). We thank Florence Capilla for performing and managing histochemistry experiments, and we acknowledge excellent technical assistance of Mathilde Gotanegre. We are grateful to Manon Farce and Laetitia Ligat for assistance with flow cytometry and microscopy, respectively. We thank HIMIP collection for patients' samples. This work was supported by the ANR LABEX TOUCAN, the Canceropole GSO, la Ligue regionale contre le Cancer and la Ligue nationale contre le Cancer. Quentin Heydt is a recipient of the Ligue Nationale contre le Cancer.	Alvarado Y, 2014, CANCER-AM CANCER SOC, V120, P2142, DOI 10.1002/cncr.28705; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bosnjak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094374; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Colecchia D, 2015, AUTOPHAGY, V11, P1790, DOI 10.1080/15548627.2015.1084454; Corazzari M, 2015, CELL DEATH DIFFER, V22, P946, DOI 10.1038/cdd.2014.183; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Domenech E, 2015, NAT CELL BIOL, V17, P1304, DOI 10.1038/ncb3231; Gallogly MM, 2016, J BLOOD MED, V7, P73, DOI 10.2147/JBM.S100283; Gammoh N, 2012, P NATL ACAD SCI USA, V109, P6561, DOI 10.1073/pnas.1204429109; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Isakson P, 2010, BLOOD, V116, P2324, DOI 10.1182/blood-2010-01-261040; Ishizawa J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac4380; Jia W, 2015, AUTOPHAGY, V11, P2335, DOI 10.1080/15548627.2015.1110666; Kayser S, 2009, BLOOD, V114, P2386, DOI 10.1182/blood-2009-03-209999; Kiyoi H, 2015, NAGOYA J MED SCI, V77, P7; Larrue C, 2016, BLOOD, V127, P882, DOI 10.1182/blood-2015-05-646497; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Lefort S, 2014, AUTOPHAGY, V10, P2122, DOI 10.4161/15548627.2014.981788; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Mitou G, 2015, ONCOTARGET, V6, P30149, DOI 10.18632/oncotarget.4999; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pasquier B, 2015, J MED CHEM, V58, P376, DOI 10.1021/jm5013352; Piya S, 2016, BLOOD, V128, P1260, DOI 10.1182/blood-2016-01-692244; Rebecca VW, 2016, ONCOGENE, V35, P1, DOI 10.1038/onc.2015.99; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063; Torgersen ML, 2013, BLOOD, V122, P2467, DOI 10.1182/blood-2013-05-500629; Visconte V, 2017, LEUKEMIA, V31, P505, DOI 10.1038/leu.2016.295; Watson AS, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.8; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhou C, 2017, LEUKEMIA, V31, P1196, DOI 10.1038/leu.2016.329	37	63	66	3	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					787	797		10.1038/onc.2017.376	http://dx.doi.org/10.1038/onc.2017.376			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059168	Green Published, hybrid			2022-12-26	WOS:000424628100010
J	Hao, SX; Ma, YY; Zhao, S; Ji, QL; Zhang, KZ; Yang, MF; Yao, YC				Hao, Suxiao; Ma, Yiyi; Zhao, Shuang; Ji, Qianlong; Zhang, Kezhong; Yang, Mingfeng; Yao, Yuncong			McWRI1, a transcription factor of the AP2/SHEN family, regulates the biosynthesis of the cuticular waxes on the apple fruit surface under low temperature	PLOS ONE			English	Article							DNA-BINDING DOMAIN; EPICUTICULAR WAX; PLANT-SURFACES; CHEMICAL-COMPOSITION; CUTICLE DEVELOPMENT; ARABIDOPSIS-THALIANA; AP2 DOMAIN; WRINKLED1; LEAVES; ACCUMULATION	Cuticular waxes of plant and organ surfaces play an important role in protecting plants from biotic and abiotic stress and extending the freshness, storage time and shelf life in the post-harvest agricultural products. WRI1, a transcription factor of AP2/SHEN families, had been found to trigger the related genes taking part in the biosynthesis of seed oil in many plants. But whether WRI1 is involved in the biosynthesis of the cuticular waxes on the Malus fruits surface has been unclear. We investigated the changes of wax composition and structure, the related genes and WRI1 expression on Malus asiatica Nakai and sieversii fruits with the low temperature treatments, found that low temperature induced the up-regulated expression of McWRI1, which promoted gene expression of McKCS, McLACs and McWAX in very-long-chain fatty acid biosynthesis pathway, resulting in the accumulation of alkanes component and alteration of wax structure on the fruit surface. Corresponding results were verified in McWRI1 silenced by VIGS, and WRI1 silenced down-regulated the related genes on two kinds of fruits, it caused the diversity alteration in content of some alkanes, fatty acid and ester component in two kinds of fruits. We further conducted Y1H assay to find that McWRI1 transcription factor activated the promoter of McKCS, McLAC and McWAX to regulate their expression. These results demonstrated that McWRI1 is involved in regulating the genes related synthesis of very long chain fatty acid on surface of apple fruits in storage process, providing a highlight for improvement of the modified atmosphere storage of apple fruits.	[Hao, Suxiao; Ma, Yiyi; Zhao, Shuang; Yao, Yuncong] Beijing Univ Agr, Plant Sci & Technol Coll, Beijing Key Lab New Technol Agr Applicat, Beijing, Peoples R China; [Ji, Qianlong; Yang, Mingfeng] Beijing Univ Agr, Coll Biol Sci & Engn, Beijing, Peoples R China; [Zhang, Kezhong] Beijing Univ Agr, Coll Landscape Architecture, Beijing, Peoples R China; [Yao, Yuncong] Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Beijing University of Agriculture	Yao, YC (corresponding author), Beijing Univ Agr, Plant Sci & Technol Coll, Beijing Key Lab New Technol Agr Applicat, Beijing, Peoples R China.; Yang, MF (corresponding author), Beijing Univ Agr, Coll Biol Sci & Engn, Beijing, Peoples R China.; Yao, YC (corresponding author), Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China.	mfyang@bua.edu.cn; yaoyc_20@126.com			National Science and Technology Support Program [2013BAD02B01-4]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality [IDHT20150503]; Beijing Municipal Commission of Education Science and Technology Promotion Plan [PXM2014-014207-000081]; Beijing Collaborative Innovation Center for Eco-environmental Improvement with Forestry and Fruit Trees [CEFF-PXM2017-014207-000043]	National Science and Technology Support Program; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality; Beijing Municipal Commission of Education Science and Technology Promotion Plan; Beijing Collaborative Innovation Center for Eco-environmental Improvement with Forestry and Fruit Trees	Financial support was provided to Suxiao Hao by the National Science and Technology Support Program (2013BAD02B01-4), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality (IDHT20150503), the Beijing Municipal Commission of Education Science and Technology Promotion Plan (PXM2014-014207-000081), and the Beijing Collaborative Innovation Center for Eco-environmental Improvement with Forestry and Fruit Trees (No. CEFF-PXM2017-014207-000043) and Ji Qianlong provide experiment material, Zhang Kezhong analysis experiment data, Yang Mingfeng and Yao Yuncong design experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Fruit Tree Key Laboratory at the Beijing University of Agriculture (BUA), we are grateful to all the technicians at the BUA Crabapple Germplasm Resource Garden. Financial support was provided by the National Science and Technology Support Program (2013BAD02B01-4), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality (IDHT20150503), Beijing Municipal Commission of Education Science and Technology Promotion Plan (PXM2014-014207-000081), Beijing Collaborative Innovation Center for Eco-environmental Improvement with Forestry and Fruit Trees (No. CEFF-PXM2017-014207-000043).	Adamski NM, 2013, PLANT J, V74, P989, DOI 10.1111/tpj.12185; An D, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00034; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Belding RD, 1998, J AM SOC HORTIC SCI, V123, P348, DOI 10.21273/JASHS.123.3.348; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; Brennan EB, 2001, AUST J ENTOMOL, V40, P270, DOI 10.1046/j.1440-6055.2001.00229.x; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; Budke JM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00832; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chassot C, 2008, PLANT SIGNAL BEHAV, V3, P142, DOI 10.4161/psb.3.2.5071; Curry EA, 2005, J HORTIC SCI BIOTECH, V80, P668, DOI 10.1080/14620316.2005.11511996; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Fukuda S, 2008, J PLANT RES, V121, P179, DOI 10.1007/s10265-007-0143-7; Grimberg A, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0579-1; Guo J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01809; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; Ivarson E, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02032; JENKS MA, 1994, PLANT PHYSIOL, V105, P1239, DOI 10.1104/pp.105.4.1239; Jenks MA, 2001, PHYSIOL PLANTARUM, V112, P62, DOI 10.1034/j.1399-3054.2001.1120109.x; Jetter R, 2008, PLANT J, V54, P670, DOI 10.1111/j.1365-313X.2008.03467.x; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kleinkauf Horst, 2000, Biofactors, V11, P91; Koch K, 2006, ENVIRON EXP BOT, V56, P1, DOI 10.1016/j.envexpbot.2004.09.013; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; KORNBERG A, 1953, J BIOL CHEM, V204, P329; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kunst L, 2009, CURR OPIN PLANT BIOL, V12, P721, DOI 10.1016/j.pbi.2009.09.009; Lee SB, 2015, PLANT CELL REP, V34, P557, DOI 10.1007/s00299-015-1772-2; Liu CX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3517-9; Lu P, 2015, THEOR APPL GENET, V128, P1595, DOI 10.1007/s00122-015-2534-9; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Meldrum FC, 2007, MACROMOL BIOSCI, V7, P152, DOI 10.1002/mabi.200600191; Meyer JR, 1944, GENETICS, V29, P199; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; [倪郁 Ni Yu], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P252; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Oshima Y, 2013, PLANT CELL, V25, P1609, DOI 10.1105/tpc.113.110783; Patel AR, 2015, J AGR FOOD CHEM, V63, P4862, DOI 10.1021/acs.jafc.5b01548; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Riedel M, 2007, PLANTA, V225, P1517, DOI 10.1007/s00425-006-0437-3; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Schuster AC, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw027; Serrano M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00274; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Tessmer MA, 2012, BRAZ ARCH BIOL TECHN, V55, P709, DOI 10.1590/S1516-89132012000500010; Tian J, 2014, J EXP BOT, V65, P311, DOI 10.1093/jxb/ert381; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; Tucker DJ, 2010, J CHEM ECOL, V36, P727, DOI 10.1007/s10886-010-9803-5; TULLOCH AP, 1974, PHYTOCHEMISTRY, V13, P2535, DOI 10.1016/S0031-9422(00)86932-0; Vanhercke T, 2013, FEBS LETT, V587, P364, DOI 10.1016/j.febslet.2012.12.018; Wang J, 2014, THEOR APPL GENET, V127, P831, DOI 10.1007/s00122-014-2260-8; Wang XD, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0475-8; Wen M, 2006, PHYTOCHEMISTRY, V67, P1808, DOI 10.1016/j.phytochem.2006.01.018; Wessler SR, 2005, TRENDS PLANT SCI, V10, P54, DOI 10.1016/j.tplants.2004.12.007; Wijeratnam RSW, 2005, POSTHARVEST BIOL TEC, V36, P323, DOI 10.1016/j.postharvbio.2005.01.003; Zhai ZY, 2017, PLANT CELL, V29, P871, DOI 10.1105/tpc.17.00019; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zhang ZZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140524; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]	66	20	24	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186996	10.1371/journal.pone.0186996	http://dx.doi.org/10.1371/journal.pone.0186996			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073205	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400092
J	Hung, YY; Chan, HY; Pan, YJ				Hung, Yu-Yuan; Chan, Hung-Yu; Pan, Yi-Ju			Risk factors for readmission in schizophrenia patients following involuntary admission	PLOS ONE			English	Article							INFLUENCING COMPULSORY ADMISSION; PSYCHIATRIC-PATIENTS; HOSPITAL ADMISSION; MENTALLY-ILL; EUROPEAN-UNION; PATIENTS VIEWS; 1ST ADMISSION; LEGAL STATUS; ETHNICITY; OUTCOMES	Background Individuals with schizophrenia who are involuntarily admitted may have poorer prognosis, including higher readmission rates, than those voluntarily admitted. However, little is known about the risk factors for readmission in those schizophrenia patients who are involuntarily admitted. Aims We aim to explore the risk factors for readmission in this population. Method We enrolled 138 schizophrenia patients with involuntary admission from July 2008 to June 2013 and followed those patients for readmission outcomes at 3 months and at 1 year. Results The one-year and 3-months readmission rates were 33.3% and 15.2%, respectively. Unmarried status (adjusted odds ratio (aOR) = 6.28, 95% CI: 1.48-26.62), previous history of involuntary admission (aOR = 4.08, 95% CI: 1.19-14.02), longer involuntary admission days (aOR = 1.04, 95% CI: 1.01-1.07) and shorter total admission days (aOR = 1.03, 95% CI: 1.01-1.05) were associated with increased risk for 1-year readmission. Younger age (aOR = 1.10, 95% CI 1.02-1.18) was associated with increased risk for 3-months readmission. Conclusions Unmarried status, prior history of involuntary admission, longer involuntary admission days and shorter total admission days were associated with increased risk for 1-year readmission. Healthcare providers may need to focus on patients with these risk factors to reduce subsequent readmissions.	[Hung, Yu-Yuan; Chan, Hung-Yu] Minist Hlth & Welf, Taoyuan Psychiat Ctr, Taoyuan, Taiwan; [Chan, Hung-Yu] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chan, Hung-Yu] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Pan, Yi-Ju] Far Eastern Mem Hosp, Dept Psychiat, New Taipei, Taiwan; [Pan, Yi-Ju] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University	Pan, YJ (corresponding author), Far Eastern Mem Hosp, Dept Psychiat, New Taipei, Taiwan.; Pan, YJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	panyiju0211@gmail.com			Taoyuan Psychiatric Center, Ministry of Health and Welfare of Taiwan [TYPC-2015-01]	Taoyuan Psychiatric Center, Ministry of Health and Welfare of Taiwan	This study was supported by a grant from the Taoyuan Psychiatric Center, Ministry of Health and Welfare of Taiwan (TYPC-2015-01) to Dr. YY Hung, (http://www.typc.mohw.gov.tw/englsh/). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VS, 2002, J FORENSIC SCI, V47, P1365; APPLEBY L, 1993, AM J PSYCHIAT, V150, P72; BEBBINGTON PE, 1994, BRIT J PSYCHIAT, V165, P743, DOI 10.1192/bjp.165.6.743; Bola JR, 2011, COMMUNITY MENT HLT J, V47, P603, DOI 10.1007/s10597-011-9396-7; Chang HC, 2009, J CLIN PSYCHIAT, V70, P141, DOI 10.4088/JCP.08l04447; Cougnard A, 2004, SOC PSYCH PSYCH EPID, V39, P804, DOI 10.1007/s00127-004-0826-5; CUFFEL BJ, 1992, COMMUNITY MENT HLT J, V28, P471, DOI 10.1007/BF00754192; Donoghue BO, 2011, J MENT HEALTH, V20, P249, DOI 10.3109/09638237.2011.562263; Dressing H, 2004, SOC PSYCH PSYCH EPID, V39, P797, DOI 10.1007/s00127-004-0814-9; Feigon S, 2003, PSYCHOL REP, V93, P816, DOI 10.2466/PR0.93.7.816-818; Fennig S, 1999, PSYCHIAT SERV, V50, P1049, DOI 10.1176/ps.50.8.1049; Haddad PM, 2009, BRIT J PSYCHIAT, V195, pS20, DOI 10.1192/bjp.195.52.s20; HAFNER H, 1989, BRIT J PSYCHIAT, V155, P12, DOI 10.1192/bjp.155.1.12; Hansson L, 1999, SOC PSYCH PSYCH EPID, V34, P99, DOI 10.1007/s001270050118; Houston KG, 2001, PSYCHOL REP, V88, P1012, DOI 10.2466/PR0.88.3.1012-1014; Kallert TW, 2008, EUR ARCH PSY CLIN N, V258, P195, DOI 10.1007/s00406-007-0777-4; Katsakou C, 2006, ACTA PSYCHIAT SCAND, V114, P232, DOI 10.1111/j.1600-0447.2006.00823.x; Krivoy A, 2012, COMPR PSYCHIAT, V53, P995, DOI 10.1016/j.comppsych.2012.03.006; Lin CH, 2010, CLINICS, V65, P481, DOI 10.1590/S1807-59322010000500005; Lin HC, 2006, SCHIZOPHR RES, V83, P211, DOI 10.1016/j.schres.2006.01.012; MCEVOY JP, 1989, COMPR PSYCHIAT, V30, P13, DOI 10.1016/0010-440X(89)90113-2; Myklebust LH, 2012, NORD J PSYCHIAT, V66, P178, DOI 10.3109/08039488.2011.611252; Preti A, 2009, PSYCHOL MED, V39, P485, DOI 10.1017/S0033291708003607; Priebe S, 2010, BRIT J PSYCHIAT, V196, P179, DOI 10.1192/bjp.bp.109.068916; Priebe S, 2009, BRIT J PSYCHIAT, V194, P49, DOI 10.1192/bjp.bp.108.052266; RIECHER A, 1991, PSYCHOL MED, V21, P197, DOI 10.1017/S0033291700014781; Salize HJ, 2004, BRIT J PSYCHIAT, V184, P163, DOI 10.1192/bjp.184.2.163; Silva NC, 2009, PSYCHIAT SERV, V60, P786, DOI 10.1176/ps.2009.60.6.786; Singh SP, 1998, SOC PSYCH PSYCH EPID, V33, P39; Thieda P, 2003, PSYCHIAT SERV, V54, P508, DOI 10.1176/appi.ps.54.4.508; Valevski A, 2007, SOC PSYCH PSYCH EPID, V42, P916, DOI 10.1007/s00127-007-0243-7; van der Post L, 2012, INT J SOC PSYCHIATR, V58, P374, DOI 10.1177/0020764011399970; van der Post LFM, 2014, SOC PSYCH PSYCH EPID, V49, P283, DOI 10.1007/s00127-013-0742-7; Wang JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129204; Woo BKP, 2006, J GERIATR PSYCH NEUR, V19, P226, DOI 10.1177/0891988706292754; Zinkler M, 2002, ACTA PSYCHIAT SCAND, V106, P3, DOI 10.1034/j.1600-0447.2002.02268.x	36	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186768	10.1371/journal.pone.0186768	http://dx.doi.org/10.1371/journal.pone.0186768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073180	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400051
J	Dahl, C; Stanislawski, M; Iszatt, N; Mandal, S; Lozupone, C; Clemente, JC; Knight, R; Stigum, H; Eggesbo, M				Dahl, Cecilie; Stanislawski, Maggie; Iszatt, Nina; Mandal, Siddhartha; Lozupone, Catherine; Clemente, Jose C.; Knight, Rob; Stigum, Hein; Eggesbo, Merete			Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus	PLOS ONE			English	Article							PRETERM BIRTH; INFECTION; OUTCOMES; INFANTS; DISEASE; WOMEN; RISK	Objective Preterm birth is the main reason for neonatal deaths worldwide. We investigate whether maternal gut microbiota may play a previously overlooked role. Methods The Norwegian Microbiota Study (NoMIC) is a case control study on preterm birth (< 259 days of gestation, calculated primarily based on the last menstrual period), including two consecutively born term infants per infant born prematurely. Eligible mothers were fluent in Norwegian and recruited from the maternity ward at a county hospital in Eastern Norway in the period 2002-2005. Fecal samples were collected at day 4 postpartum, and analyzed using 16S ribosomal RNA gene sequencing. We used samples from 121 mothers giving birth vaginally. Measures of alpha diversity (Shannon, Phylogenetic Diversity and Observed Operational Taxonomic Units) and microbiome composition were combined with information from the Medical Birth Registry, pregnancy journals, and questionnaires. Results The association between maternal gut diversity and preterm delivery was examined using logistic regression. One IQR increase in Shannon diversity was significantly associated with 38% lower odds of spontaneous preterm birth, (95% confident interval (CI): 1%, 61%), and the association was stronger when adjusting for maternal age, marital status, ethnicity, parity, BMI, education, antibiotic use, pets in the household, income and smoking (48% lower odds, 95% CI: 4.2%, 72%). Mothers delivering prematurely also had lower abundance of OTUs belonging to Bifidobacterium and Streptococcus, and of the Clostridiales order. Conclusion Analysis of maternal gut microbiota using next-generation sequencing shows that low gut diversity, with a distinct microbial composition, is associated with spontaneous preterm delivery.	[Dahl, Cecilie; Iszatt, Nina; Eggesbo, Merete] Norwegian Inst Publ Hlth, Dept Environm Exposure & Epidemiol, Oslo, Norway; [Stanislawski, Maggie; Lozupone, Catherine] Univ Colorado, Sch Med, Boulder, CO 80309 USA; [Mandal, Siddhartha] Publ Hlth Fdn India, Gurgaon, India; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Div Clin Immunol, Dept Med, New York, NY 10029 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA; [Knight, Rob] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Stigum, Hein] Norwegian Inst Publ Hlth, Dept Noncommunicable Dis, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; Public Health Foundation of India; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; University of California System; University of California San Diego; Norwegian Institute of Public Health (NIPH)	Eggesbo, M (corresponding author), Norwegian Inst Publ Hlth, Dept Environm Exposure & Epidemiol, Oslo, Norway.	merete.eggesbo@fhi.no	Iszatt, Nina/F-8422-2017; Lozupone, Catherine/AAD-9317-2020; Mandal, Siddhartha/J-3844-2017	Iszatt, Nina/0000-0002-8977-156X; Knight, Rob/0000-0002-0975-9019; Mandal, Siddhartha/0000-0002-2329-9733; Stanislawski, Maggie/0000-0001-7768-8868	Norwegian Research Council [214324/f 20]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded by the Norwegian Research Council grant agreement "Human Infant Gut Microbiota" No 214324/f 20 http://www.forskningsradet.no/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; [Anonymous], 2015, FOLLOW YOUR GUT ENOR; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barbour A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100541; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Blondel A, 2002, BJOG-INT J OBSTET GY, V109, P718; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2015, BREIMAN CUTLERS RAND; Broms G, 2014, INFLAMM BOWEL DIS, V20, P1091, DOI 10.1097/MIB.0000000000000060; Cammarota G, 2015, PHARMACOL THERAPEUT, V149, P191, DOI 10.1016/j.pharmthera.2014.12.006; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Eggesbo M, 2011, APMIS, V119, P17, DOI 10.1111/j.1600-0463.2010.02688.x; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Freeman K, 2005, BJOG-INT J OBSTET GY, V112, P31, DOI 10.1111/j.1471-0528.2004.00299.x; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Jost T, 2014, CURR MICROBIOL, V68, P419, DOI 10.1007/s00284-013-0491-6; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kuczynski J, 2012, CURR PROTOC CHEM BIO, V1, P1, DOI DOI 10.1002/9780471729259.MC01E05S27.USING; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Myhre R, 2011, AM J CLIN NUTR, V93, P151, DOI 10.3945/ajcn.110.004085; Nakazawa F, 2000, INT J SYST EVOL MICR, V50, P679, DOI 10.1099/00207713-50-2-679; Nepomnyaschy L, 2012, MATERN CHILD HLTH J, V16, P1612, DOI 10.1007/s10995-011-0853-2; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Rrgc Diaz-Uriarte, 2014, VARIABLE SELECTION U; Shiozaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111374	34	27	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0184336	10.1371/journal.pone.0184336	http://dx.doi.org/10.1371/journal.pone.0184336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069100	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000413663600001
J	Sciscio, L; Bordy, EM; Abrahams, M; Knoll, F; McPhee, BW				Sciscio, L.; Bordy, E. M.; Abrahams, M.; Knoll, F.; McPhee, B. W.			The first megatheropod tracks from the Lower Jurassic upper Elliot Formation, Karoo Basin, Lesotho	PLOS ONE			English	Article							SOUTHERN AFRICA; TETRAPOD FAUNA; DINOSAUR; SUPERGROUP; EVOLUTION; SEDIMENTOLOGY; FOOTPRINTS; RADIATION; TAPHONOMY	A palaeosurface with one megatheropod trackway and several theropod tracks and track-ways from the Lower Jurassic upper Elliot Formation (Stormberg Group, Karoo Supergroup) in western Lesotho is described. The majority of the theropod tracks are referable to either Eubrontes or Kayentapus based on their morphological characteristics. The larger megatheropod tracks are 57 cm long and have no Southern Hemisphere equivalent. Morphologically, they are more similar to the Early Jurassic Kayentapus, as well as the much younger Upper Cretaceous ichnogenus Irenesauripus, than to other contemporaneous ichnogenera in southern Africa. Herein they have been placed within the ichnogenus Kayentapus and described as a new ichnospecies (Kayentapus ambrokholohali). The tracks are preserved on ripple marked, very fine-grained sandstone of the Lower Jurassic upper Elliot Formation, and thus were made after the end-Triassic mass extinction event (ETE). This new megatheropod trackway site marks the first occurrence of very large carnivorous dinosaurs (estimated body length >8-9 meters) in the Early Jurassic of southern Gondwana, an evolutionary strategy that was repeatedly pursued and amplified in the following similar to 135 million years, until the next major biotic crisis at the end-Cretaceous.	[Sciscio, L.; Bordy, E. M.; Abrahams, M.] Univ Cape Town, Dept Geol Sci, Cape Town, South Africa; [Knoll, F.] Fdn Conjunto Paleontol Teruel Dinopolis, Teruel, Spain; [McPhee, B. W.] Univ Sao Paulo, FFCLRP, Dept Biol, Sao Paulo, Brazil	University of Cape Town; Universidade de Sao Paulo	Sciscio, L (corresponding author), Univ Cape Town, Dept Geol Sci, Cape Town, South Africa.	lara.sciscio@uct.ac.za	Bordy, Emese Maria M/J-1361-2016; Knoll, Fabien/D-3812-2014	Bordy, Emese Maria M/0000-0003-4699-0823; Knoll, Fabien/0000-0001-7822-8740	National Research Foundation of South Africa Competitive Programme [NRF] [93544]; DST-NRF Centre of Excellence in Palaeosciences (CoE in Palaeosciences); FAPESP (Sao Paulo Research Foundation); ARAID	National Research Foundation of South Africa Competitive Programme [NRF]; DST-NRF Centre of Excellence in Palaeosciences (CoE in Palaeosciences); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ARAID	This work was supported by the National Research Foundation of South Africa Competitive Programme for Rated Researches [NRF Grant number 93544 Bordy]. LS and MA are recipients of postdoctoral and postgraduate funding, respectively, from the DST-NRF Centre of Excellence in Palaeosciences (CoE in Palaeosciences). BWM is a recipient of postdoctoral funding from FAPESP (Sao Paulo Research Foundation). FK is an ARAID researcher (Aragon Agency for Research and Development, Zaragoza, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions expressed and conclusions arrived at are those of the authors and are not necessarily to be attributed to the CoE in Palaeosciences or NRF CPRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Although we discovered the megatheropod tracks in February 2016, David Ambrose, Emeritus Professor of the National University of Lesotho, brought to our attention the dinosaur track heritage of the Roma Valley over 15 years ago. We hereby acknowledge not only the generous hospitality we received from him and his wife, Dr Sumitra Talukdar, during our repeated visits but also their meticulous bibliographic work on the palaeontology of southern African and other countless regional topics. We are also very grateful to the reviewers T. L. Adams and D. Rubilar-Rogers for their insightful comments and suggestions that helped improve this manuscript. The work of FK was made possible through the support of the ARAID (https//www.araid.es/).	Abrahams M, 2017, HIST BIOL, V29, P958, DOI 10.1080/08912963.2016.1267164; Adams T.L., 2010, PALAEONTOL ELECTRON, V13, P1; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Ambrose D., 2003, NOTE FOSSIL TRACKWAY, P14; Belvedere M., 2016, DINOSAUR TRACKS NEXT, P92; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; Bordy E. M., 2004, Palaeontologia Africana, V40, P43; Bordy EM, 2017, PALAEOGEOGR PALAEOCL, V468, P362, DOI 10.1016/j.palaeo.2016.12.024; Bordy EM, 2015, S AFR J GEOL, V118, P311, DOI 10.2113/gssajg.118.3.311; Bordy EM, 2004, J AFR EARTH SCI, V38, P383, DOI 10.1016/j.jafrearsci.2004.02.004; Botha BJ., 1967, PALAEONTOLOGIA AFRIC, V25, p[763, 87]; Bristowe Anthea, 2004, Palaeontologia Africana, V40, P31; Brusatte SL, 2008, BIOL LETTERS, V4, P733, DOI 10.1098/rsbl.2008.0441; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Charig A.J., 1984, Symposia of the Zoological Society of London, P597; Cobos A, 2014, PALAEOGEOGR PALAEOCL, V399, P31, DOI 10.1016/j.palaeo.2014.02.008; Duncan RA, 1997, J GEOPHYS RES-SOL EA, V102, P18127, DOI 10.1029/97JB00972; Ellenberger P., 1970, IUGS 2 S GONDW STRAT, P343; Ellenberger P., 1974, CONTRIBUTION CLASSIF, P170; Ellenberger P., 1972, PALEOVERTEBRATA MEMO, P152; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; GIERLINSKI G, 2005, C TRACK DIN OR TRIAS, P3; Gierlinski G, 2001, ACTA PALAEONTOLOGICA, V46; Gierlinski Gerard, 2004, Ichnos, V11, P195, DOI 10.1080/10420940490444861; Gierlinski Gerard, 1999, Kwartalnik Geologiczny, V43, P329; Hendrickx Christophe, 2015, PalArch's Journal of Vertebrate Palaeontology, V12, P1; KITCHING J W, 1984, Palaeontologia Africana, V25, P111; Knoll F, 2005, B SOC GEOL FR, V176, P81, DOI 10.2113/176.1.81; Knoll F, 2004, B SOC GEOL FR, V175, P73, DOI 10.2113/175.1.73; Lallensack JN, 2016, PEERJ, V4, DOI 10.7717/peerj.2059; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; Lockley M. G., 2010, GEOL Q, V53, P415; Lockley M.G., 2011, NEW MEXICO MUSEUM NA, V53, P321; Lockley Martin G., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P287; Lockley Martin G., 2000, Gaia (Lisboa), V15, P313; Lockley Martin G., 2011, Bulletin of the New Mexico Museum of Natural History and Science, V53, P330; Lockley Martin G., 1997, New Mexico Geological Society Field Conference Guidebook, V48, P133; Lockley Martin G., 1996, Museum of Northern Arizona Bulletin, V60, P113; Lockley MG, 2014, NEW MEXICO MUSEUM NA, V62, P279; Lucas SG, 2007, EARTH-SCI REV, V84, P1, DOI 10.1016/j.earscirev.2007.05.002; Lucas S.G., 2001, ALBERTIANA, V25, P5; Lucas Spencer G., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P86; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; Marsicano CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103255; Mateus O., 2006, N MEX MUS NAT HIST S, V36, P223; McCrea R. T., 2000, THESIS; McCrea RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103613; McPhee BW, 2017, ACTA PALAEONTOL POL, V62, P441, DOI 10.4202/app.00377.2017; Milner ARC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004591; MORATALLA JJ, 1988, GEOBIOS-LYON, V21, P395, DOI 10.1016/S0016-6995(88)80042-1; Munyikwa Darlington, 1999, Palaeontologia Africana, V35, P55; Nesbitt SJ, 2013, GEOL SOC SPEC PUBL, V379, P241, DOI 10.1144/SP379.1; Niedzwiedzki Grzegorz, 2006, Przeglad Geologiczny, V54, P615; Niedzwiedzki Grzegorz, 2008, Przeglad Geologiczny, V56, P823; OLSEN P E, 1984, Palaeontologia Africana, V25, P87; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586, DOI 10.1080/02724634.1998.10011086; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Pacyna Grzegorz, 2013, Acta Palaeobotanica, V53, P141, DOI 10.2478/acpa-2013-0015; Piubelli D, 2005, BOLL SOC GEOL ITAL, V124, P259; Porchetti Simone D'Orazi, 2007, Ichnos, V14, P219, DOI 10.1080/10420940601049990; RAATH M A, 1990, Palaeontologia Africana, V27, P89; Raath M. A., 1977, THESIS, P1; Raath MA, 1990, MORPHOLOGICAL VARIAT; Raath Michael A., 2005, Palaeontologia Africana, V41, P101; Rainforth E. C., 2005, THESIS; Rauhut OWM, 2011, SPEC PAP PALAEONTOL, P195, DOI 10.1111/j.1475-4983.2011.01084.x; Ray S, 2002, J BIOSCIENCES, V27, P295, DOI 10.1007/BF02704918; Razzolini NL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31494; SCHWARTZ HL, 1994, J PALEONTOL, V68, P1118, DOI 10.1017/S0022336000026718; Sciscio L, 2016, PEERJ, V4, DOI 10.7717/peerj.2285; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Smith R, 1997, PALAEOGEOGR PALAEOCL, V131, P29, DOI 10.1016/S0031-0182(96)00143-5; Smith RMH, 2009, PALAIOS, V24, P672, DOI 10.2110/palo.2008.p08-115r; STERNBERG C. M., 1932, ANN REPT NATION MUS CANADA 1930, P59; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; THULBORN RA, 1984, ALCHERINGA, V8, P243, DOI 10.1080/03115518408618947; Thulborn T., 1990, DINOSAUR TRACKS, P410, DOI DOI 10.1007/978-94-009-0409-5; Turner S, 2009, GFF, V131, P49, DOI 10.1080/11035890902924877; Wagensommer A, 2016, ICHNOS, V23, P312, DOI 10.1080/10420940.2016.1168739; Wagensommer A, 2016, NEUES JAHRB GEOL P-A, V281, P155, DOI 10.1127/njgpa/2016/0593; Wagensommer A, 2012, PALAEONTOLOGY, V55, P109, DOI 10.1111/j.1475-4983.2011.01121.x; Wcislo-Luraniec E., 1991, PALACOVEGETATIONAL D, P331; Weems R. E, 1992, REEVALUATION TAXONOM; Weems Robert E., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P369; Wilson JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007331; Xing LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122715; Yates Adam M., 2005, Palaeontologia Africana, V41, P105	90	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0185941	10.1371/journal.pone.0185941	http://dx.doi.org/10.1371/journal.pone.0185941			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069093	gold, Green Published, Green Submitted			2022-12-26	WOS:000413663600010
J	Semple, SJ; Pitpitan, EV; Goodman-Meza, D; Strathdee, SA; Chavarin, CV; Rangel, G; Torres, K; Patterson, TL				Semple, Shirley J.; Pitpitan, Eileen V.; Goodman-Meza, David; Strathdee, Steffanie A.; Chavarin, Claudia V.; Rangel, Gudelia; Torres, Karla; Patterson, Thomas L.			Correlates of condomless anal sex among men who have sex with men (MSM) in Tijuana, Mexico: The role of public sex venues	PLOS ONE			English	Article							PSYCHOSOCIAL HEALTH-PROBLEMS; HIV TRANSMISSION RISK; INTERNALIZED HOMONEGATIVITY; DEPRESSIVE SYMPTOMS; SYNDEMIC CONDITIONS; PROBABILITY SAMPLE; SELF-EFFICACY; SUBSTANCE USE; TOWNSHIP MEN; NEGATIVE MEN	Condomless anal sex between male partners is the primary risk factor for HIV transmission among men who have sex with men (MSM). Correlates of condomless anal sex have been well-studied in developed countries, but they have received less attention in lower-to-middle income countries (LMIC), where MSM are often subject to stigma, discrimination, intolerance, and even the criminalization of same sex behavior. In Mexico, a LMIC where traditional views on homosexuality are common, HIV prevalence among MSM is high (16.9%), yet little research has been conducted on the correlates of condomless anal sex in this highrisk population. The present study examined correlates of condomless anal sex among 201 MSM recruited in Tijuana, Mexico, with a focus on the role of public sex venues in relation to sexual risk behavior. Eligibility requirements were: biologically male, 18 years of age or older, resident of Tijuana, and self-reported anal or oral sex with a male partner in the past year. Participants completed an interviewer-administered, demographic and psychosocial survey, and were tested for HIV and syphilis. A hierarchical multiple linear regression model was tested to identify correlates of condomless anal sex. Thirty-eight percent of participants (N = 76) reported condomless anal sex with a male partner in the past 2 months. Higher levels of condomless anal sex were associated with higher levels of depressive symptoms, greater sexual compulsivity, and more frequent seeking out of sex partners in a public venue in the past 2 months. In view of these findings, we recommend the development of multi-level, "combination" interventions, which in the Mexican context should include enhanced condom promotion and distribution, improved availability and access to mental health treatment and counseling services, and expanded HIV/STI testing in public venues.	[Semple, Shirley J.; Chavarin, Claudia V.; Patterson, Thomas L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Pitpitan, Eileen V.; Strathdee, Steffanie A.] Univ Calif San Diego, Div Global Publ Hlth, Dept Med, La Jolla, CA 92093 USA; [Goodman-Meza, David] Univ Calif Los Angeles, Div Infect Dis, Los Angeles, CA USA; [Rangel, Gudelia] US Mexico Border Hlth Commiss, Tijuana, Mexico; [Torres, Karla] Agencia Familiar Binac AC, Tijuana, Mexico	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Patterson, TL (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	tpatterson@ucsd.edu	Strathdee, Steffanie A/B-9042-2009; Goodman-Meza, David/V-6994-2019	Goodman, David/0000-0001-9382-3564; Strathdee, Steffanie/0000-0002-7724-691X; Patterson, Thomas/0000-0003-2311-6164	AIDS International Training in Research Program (AITRP) seed grant [D43 TW008633]; National Institute on Drug Abuse training grant [T32 DA023356]	AIDS International Training in Research Program (AITRP) seed grant; National Institute on Drug Abuse training grant	This study was funded by an AIDS International Training in Research Program (AITRP) seed grant to DGM (D43 TW008633). This study was also funded by a National Institute on Drug Abuse training grant (T32 DA023356) to SAS and TLP. url: https://proiectreporter.nih.gov/ project info_description.cfm?aid-90967378&icde-346248508&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC&pball=.	Adebajo Sylvia B, 2012, Afr J Reprod Health, V16, P21; Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; Alvy LM, 2011, AIDS BEHAV, V15, P1171, DOI 10.1007/s10461-010-9678-z; Ayala G, 2012, AM J PUBLIC HEALTH, V102, pS242, DOI 10.2105/AJPH.2011.300641; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral SD, 2012, PUBLIC HEALTH REP, V127, P572, DOI 10.1177/003335491212700607; Barron-Limon S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-433; Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616; BECK A T, 1976, P356; Beck A.T., 1967, DEPRESSION CLIN EXPT; Beck A.T., 1987, BECK DEPRESSION INVE; Binson D, 2001, AM J PUBLIC HEALTH, V91, P1482, DOI 10.2105/AJPH.91.9.1482; Bousman CA, 2009, J AFFECT DISORDERS, V119, P84, DOI 10.1016/j.jad.2009.04.006; Clatts MC, 2005, J URBAN HLTH S1, V82, P9; Coleman E, 2010, ARCH SEX BEHAV, V39, P1045, DOI 10.1007/s10508-009-9507-5; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1046/j.1360-0443.1995.901013496.x; Cottler LB, 2005, J NERV MENT DIS, V193, P431, DOI 10.1097/01.nmd.0000168245.56563.90; Cuadra-Hernandez SM, 2012, SALUD COLECT, V8, P191, DOI 10.1590/S1851-82652012000200007; De Santis JP, 2008, AM J MENS HEALTH, V2, P314, DOI 10.1177/1557988307312883; Diaz Rafael M, 2004, Cultur Divers Ethnic Minor Psychol, V10, P255, DOI 10.1037/1099-9809.10.3.255; Diaz RM, 1996, AIDS EDUC PREV, V8, P415; do Amaral MLS, 2015, J SEX MED, V12, P557, DOI 10.1111/jsm.12761; Dyer TP, 2012, J URBAN HEALTH, V89, P697, DOI 10.1007/s11524-012-9674-x; Fendrich M, 2013, ADDICT BEHAV, V38, P1715, DOI 10.1016/j.addbeh.2012.09.005; Fendrich M, 2010, J URBAN HEALTH, V87, P452, DOI 10.1007/s11524-009-9432-x; Gama A, 2017, ARCH SEX BEHAV, V46, P1061, DOI 10.1007/s10508-016-0707-5; Goldenberg SM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2491-x; Grov C, 2014, JAIDS-J ACQ IMM DEF, V67, P564, DOI 10.1097/QAI.0000000000000343; Grov C, 2012, AIDS EDUC PREV, V24, P102, DOI 10.1521/aeap.2012.24.2.102; Grov C, 2010, ARCH SEX BEHAV, V39, P940, DOI 10.1007/s10508-009-9483-9; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herek GM., 1998, J GAY LESBIAN MED AS, V2, P17, DOI DOI 10.1016/0145-2134(92)90011-F; Jerome RC, 2016, AIDS BEHAV, V20, P273, DOI 10.1007/s10461-015-1083-1; KALICHMAN SC, 1995, J PERS ASSESS, V65, P586, DOI 10.1207/s15327752jpa6503_16; Kendall T, 2007, CULT HEALTH SEX, V9, P459, DOI 10.1080/13691050601183629; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; Lautz TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040816; Lewnard JA, 2014, SEX TRANSM INFECT, V90, P290, DOI 10.1136/sextrans-2013-051332; Logie CH, 2016, AIDS PATIENT CARE ST, V30, P92, DOI 10.1089/apc.2015.0197; Mackesy-Amiti ME, 2010, DRUG ALCOHOL DEPEN, V110, P38, DOI 10.1016/j.drugalcdep.2010.01.016; Martin JL, 1988, SUMMARY MEASURES MEN; Maternowska MC, 2014, CULT HEALTH SEX, V16, P989, DOI 10.1080/13691058.2014.920529; Mayer KH, 2013, JAIDS-J ACQ IMM DEF, V63, pS161, DOI 10.1097/QAI.0b013e318298700e; McKirnan DJ, 1996, AIDS CARE, V8, P655, DOI 10.1080/09540129650125371; Meyer IH., 1998, STIGMA SEXUAL ORIENT, P160, DOI [10.4135/9781452243818.n8, DOI 10.4135/9781452243818.N8]; Mimiaga MJ, 2011, INT J STD AIDS, V22, P121, DOI 10.1258/ijsa.2009.009059; Mimiaga MJ, 2015, ARCH SEX BEHAV, V44, P1869, DOI 10.1007/s10508-015-0488-2; Mimiaga MJ, 2013, AIDS CARE, V25, P1109, DOI 10.1080/09540121.2012.749340; Mustanski B, 2008, AIDS BEHAV, V12, P118, DOI 10.1007/s10461-007-9335-3; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; Nelson LE, 2015, RES NURS HEALTH, V38, P194, DOI 10.1002/nur.21650; Newcomb ME, 2010, CLIN PSYCHOL REV, V30, P1019, DOI 10.1016/j.cpr.2010.07.003; Orozco-Nunez E, 2015, SALUD PUBLICA MEXICO, V57, pS190; Ortiz-Hernandez Luis, 2015, Rev Med Inst Mex Seguro Soc, V53, P336; Parsons JT, 2007, J ADDICT DIS, V26, P5, DOI 10.1300/J069v26n03_02; Parsons JT, 2012, AM J PUBLIC HEALTH, V102, P156, DOI 10.2105/AJPH.2011.300284; Parsons JT, 2002, AIDS CARE, V14, P815, DOI 10.1080/0954012021000031886; Peitzmeier SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139320; Pitpitan EV, 2016, AIDS BEHAV, V20, P431, DOI 10.1007/s10461-015-1172-1; Pitpitan EV, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19304; Poppen PJ, 2004, AIDS BEHAV, V8, P379, DOI 10.1007/s10461-004-7322-5; Qu L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3809-z; Ramakrishnan L, 2015, AIDS BEHAV, V19, P2255, DOI 10.1007/s10461-015-1058-2; Ratti R, 2000, AIDS CARE, V12, P193, DOI 10.1080/09540120050001878; Ross MW, 2013, INT J STD AIDS, V24, P409, DOI 10.1177/0956462412472793; Ross Michael W, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-001928; Ross MW, 2010, ARCH SEX BEHAV, V39, P1207, DOI 10.1007/s10508-010-9634-z; Ross MW, 2008, AIDS EDUC PREV, V20, P547, DOI 10.1521/aeap.2008.20.6.547; Ross MW, 1996, J CLIN PSYCHOL, V52, P15, DOI 10.1002/(SICI)1097-4679(199601)52:1<15::AID-JCLP2>3.3.CO;2-D; Rosser BRS, 2014, SEX ADDICT COMPULS, V21, P276, DOI 10.1080/10720162.2014.959145; Safren SA, 2010, HEALTH PSYCHOL, V29, P215, DOI 10.1037/a0017859; Safren SA, 2009, PSYCHOL HEALTH MED, V14, P705, DOI 10.1080/13548500903334754; Sandfort TGM, 2015, AIDS BEHAV, V19, P2270, DOI 10.1007/s10461-015-1067-1; Satinsky S, 2008, AIDS PATIENT CARE ST, V22, P553, DOI 10.1089/apc.2007.0255; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Secretaria de Salud Centro Nacional para la Prevencion y el Control del VIH y el SIDA (CENSIDA), 2015, INF NAC AV RESP VIH; Semple SJ, 2006, AIDS BEHAV, V10, P587, DOI 10.1007/s10461-006-9127-1; Semple SJ, 2006, J ADDICT DIS, V25, P105, DOI 10.1300/J069v25n04_10; Semple SJ, 2017, ARCH SEX BEHAV, V46, P1011, DOI 10.1007/s10508-016-0747-x; Semple SJ, 2015, ARCH SEX BEHAV, V44, P1025, DOI 10.1007/s10508-015-0514-4; Semple SJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-178; Semple SJ, 2000, J CONSULT CLIN PSYCH, V68, P934, DOI 10.1037/0022-006X.68.5.934; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Smolenski DJ, 2009, AIDS CARE, V21, P42, DOI 10.1080/09540120802068803; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Steffens MC, 2015, J SEX RES, V52, P898, DOI 10.1080/00224499.2014.966047; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Thomas B, 2009, AIDS EDUC PREV, V21, P372, DOI 10.1521/aeap.2009.21.4.372; Tucker A, 2014, AIDS CARE, V26, P882, DOI 10.1080/09540121.2013.859652; Tucker A, 2013, AIDS CARE, V25, P1227, DOI 10.1080/09540121.2013.764383; UNAIDS, 2012, REP GLOB AIDS EP; Verduzco IL, 2014, AM J MENS HLTH, P1; Wang HY, 2015, BIOMED RES INT; Wei CY, 2016, JAIDS-J ACQ IMM DEF, V71, P87, DOI 10.1097/QAI.0000000000000815; Williams John K, 2004, Cultur Divers Ethnic Minor Psychol, V10, P268; Wim VB, 2014, AIDS BEHAV, V18, P50, DOI 10.1007/s10461-013-0516-y; Yi S, 2015, PLOS ONE, V10; Young SD, 2016, AIDS CARE, V28, P112, DOI 10.1080/09540121.2015.1069789; Zellner JA, 2009, AM J PUBLIC HEALTH, V99, P125, DOI 10.2105/AJPH.2007.129809; Zhang H, 2015, ARCH SEX BEHAV, V44, P375, DOI 10.1007/s10508-014-0396-x	100	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186814	10.1371/journal.pone.0186814	http://dx.doi.org/10.1371/journal.pone.0186814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK5VD	29065132	gold, Green Published			2022-12-26	WOS:000413568900044
J	Tokarz, D; Cisek, R; Wein, MN; Turcotte, R; Haase, C; Yeh, SCA; Bharadwaj, S; Raphael, AP; Paudel, H; Alt, C; Liu, TM; Kronenberg, HM; Lin, CP				Tokarz, Danielle; Cisek, Richard; Wein, Marc N.; Turcotte, Raphael; Haase, Christa; Yeh, Shu-Chi A.; Bharadwaj, Srinidhi; Raphael, Anthony P.; Paudel, Hari; Alt, Clemens; Liu, Tzu-Ming; Kronenberg, Henry M.; Lin, Charles P.			Intravital imaging of osteocytes in mouse calvaria using third harmonic generation microscopy	PLOS ONE			English	Article							3RD-HARMONIC GENERATION; IN-VIVO; LACUNOCANALICULAR SYSTEM; BONE; TRANSPORT; EXPRESSION; CELL	Osteocytes are the most abundant cell in the bone, and have multiple functions including mechanosensing and regulation of bone remodeling activities. Since osteocytes are embedded in the bone matrix, their inaccessibility makes in vivo studies problematic. Therefore, a non-invasive technique with high spatial resolution is desired. The purpose of this study is to investigate the use of third harmonic generation (THG) microscopy as a noninvasive technique for high-resolution imaging of the lacunar-canalicular network (LCN) in live mice. By performing THG imaging in combination with two-and three-photon fluorescence microscopy, we show that THG signal is produced from the bone-interstitial fluid boundary of the lacuna, while the interstitial fluid-osteocyte cell boundary shows a weaker THG signal. Canaliculi are also readily visualized by THG imaging, with canaliculi oriented at small angles relative to the optical axis exhibiting stronger signal intensity compared to those oriented perpendicular to the optical axis (parallel to the image plane). By measuring forward-versus epi-detected THG signals in thinned versus thick bone samples ex vivo, we found that the epi-collected THG from the LCN of intact bone contains a superposition of backward-directed and backscattered forward-THG. As an example of a biological application, THG was used as a label-free imaging technique to study structural variations in the LCN of live mice deficient in both histone deacetylase 4 and 5 (HDAC4, HDAC5). Three-dimensional analyses were performed and revealed statistically significant differences between the HDAC4/5 double knockout and wild type mice in the number of osteocytes per volume and the number of canaliculi per lacunar surface area. These changes in osteocyte density and dendritic projections occurred without differences in lacunar size. This study demonstrates that THG microscopy imaging of the LCN in live mice enables quantitative analysis of osteocytes in animal models without the use of dyes or physical sectioning.	[Tokarz, Danielle; Turcotte, Raphael; Haase, Christa; Yeh, Shu-Chi A.; Bharadwaj, Srinidhi; Raphael, Anthony P.; Paudel, Hari; Alt, Clemens; Lin, Charles P.] Harvard Med Sch, Massachusetts Gen Hosp, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02115 USA; [Tokarz, Danielle; Turcotte, Raphael; Haase, Christa; Yeh, Shu-Chi A.; Bharadwaj, Srinidhi; Raphael, Anthony P.; Paudel, Hari; Alt, Clemens; Lin, Charles P.] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02115 USA; [Cisek, Richard] Univ Toronto, Dept Phys & Chem Sci, Mississauga, ON, Canada; [Wein, Marc N.; Kronenberg, Henry M.] Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Raphael, Anthony P.] Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Translat Res Inst, Brisbane, Qld, Australia; [Liu, Tzu-Ming] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Liu, Tzu-Ming] Natl Taiwan Univ, Mol Imaging Ctr, Taipei, Taiwan; [Liu, Tzu-Ming] Univ Macau, Fac Hlth Sci, Macau, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Toronto; University Toronto Mississauga; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Queensland; National Taiwan University; National Taiwan University; University of Macau	Tokarz, D; Lin, CP (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02115 USA.; Tokarz, D; Lin, CP (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02115 USA.	danielle.tokarz@smu.ca; lin@helix.mgh.harvard.edu	Liu, Tzu-Ming/M-9331-2016	Turcotte, Raphael/0000-0002-2257-4190; Bharadwaj, Srinidhi/0000-0002-1200-0070; Tokarz, Danielle/0000-0001-8893-0293	National Institutes of Health (NIH) [EB017274, AR067285, DK011794, AR066261]; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR067285] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (NIH) grants EB017274 (CPL), AR067285 (M NW), DK011794 (HMK), and AR066261 (HMK). DT kindly acknowledges a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Barzda Virginijus, 2008, V26, P35; Bashkatov AN, 2006, P SOC PHOTO-OPT INS, V6163; Boyd R, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Carriles R, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3184828; Chang CF, 2010, OPT EXPRESS, V18, P7397, DOI 10.1364/OE.18.007397; Cheng JX, 2002, J OPT SOC AM B, V19, P1604, DOI 10.1364/JOSAB.19.001604; Cisek R., 2009, BIOCH APPL NONLINEAR, P71; Cisek R, 2011, IEEE J SEL TOP QUANT, V17, P915, DOI 10.1109/JSTQE.2010.2065796; Clay GO, 2006, J OPT SOC AM B, V23, P932, DOI 10.1364/JOSAB.23.000932; Dallas SL, 2012, METHODS MOL BIOL, V816, P425, DOI 10.1007/978-1-61779-415-5_26; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; GROENHUIS RAJ, 1983, APPL OPTICS, V22, P2456, DOI 10.1364/AO.22.002456; Kagayama M, 1997, ANAT EMBRYOL, V195, P491, DOI 10.1007/s004290050068; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kalajzic I, 2013, BONE, V54, P296, DOI 10.1016/j.bone.2012.09.040; Kamel-ElSayed SA, 2015, BONE, V76, P129, DOI 10.1016/j.bone.2015.02.011; Kamioka H, 2015, J ORAL BIOSCI, V57, P61, DOI 10.1016/j.job.2015.02.002; Kamioka H, 2012, INTEGR BIOL-UK, V4, P1198, DOI 10.1039/c2ib20092a; Lafage-Proust MH, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.29; Lai XH, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.9; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Mortensen LJ, 2015, BIOMED OPT EXPRESS, V6, P32, DOI 10.1364/BOE.6.000032; Muller M, 1998, J MICROSC-OXFORD, V191, P266, DOI 10.1046/j.1365-2818.1998.00399.x; Olivier N, 2008, OPT EXPRESS, V16, P14703, DOI 10.1364/OE.16.014703; Petzold U, 2013, J OPT SOC AM B, V30, P1725, DOI 10.1364/JOSAB.30.001725; ROTH S, 1979, J CHEM PHYS, V70, P1637, DOI 10.1063/1.437677; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Saeta PN, 2001, APPL PHYS LETT, V79, P2704, DOI 10.1063/1.1412434; Sandkuijl D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094458; Sano H, 2015, BONE, V74, P134, DOI 10.1016/j.bone.2015.01.013; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Tate MLK, 1998, BONE, V22, P107; Thompson WR, 2011, J BONE MINER RES, V26, P618, DOI 10.1002/jbmr.236; TSANG TYF, 1995, PHYS REV A, V52, P4116, DOI 10.1103/PhysRevA.52.4116; Turcotte R, 2014, BIOMED OPT EXPRESS, V5, P3578, DOI 10.1364/BOE.5.003578; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wang LY, 2005, P NATL ACAD SCI USA, V102, P11911, DOI 10.1073/pnas.0505193102; Webster DJ, 2013, BONE, V54, P285, DOI 10.1016/j.bone.2013.01.004; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Wu JW, 2014, METHODS MOL BIOL, V1185, P247, DOI 10.1007/978-1-4939-1133-2_17; You LD, 2004, ANAT REC PART A, V278A, P505, DOI 10.1002/ar.a.20050	49	27	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186846	10.1371/journal.pone.0186846	http://dx.doi.org/10.1371/journal.pone.0186846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065178	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900049
J	Beseler, C; Vollmer, T; Graner, M; Yu, XL				Beseler, Cheryl; Vollmer, Timothy; Graner, Michael; Yu, Xiaoli			The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution	PLOS ONE			English	Article							IGG; BRAIN; REPERTOIRE; MARKERS; CELLS	Introduction Intrathecal immunoglobulin G (IgG) and oligoclonal bands (OCBs) are the most consistent and characteristic features of Multiple Sclerosis (MS). OCBs in MS are considered products of clonally expanded B cells in the cerebrospinal fluid (CSF), representing the sum of contributions from B cells in the brain. However, large amounts of IgG can be eluted from MS plaques in which lymphocytes are absent, and there is no correlation between levels of plaque-associated IgG and the presence of lymphocytes. It is calculated that it would take 3.2 billion lymphocytes to generate such large amounts of intrathecal IgG (30 mg in 500 ml CSF) in MS patients. Therefore, circulating lymphocytes in CSF could only account for <0.1% of the extra IgG in MS. Methods We analyzed clinical laboratory parameters from sera and CSF of 115 patients including 91 patients with MS and 24 patients with other inflammatory central nervous system (CNS) disorders (IC). We investigated the relationship between oligoclonal bands, IgG antibodies, CSF cells, IgG Index, albumin, and total protein. Results MS patients have significantly elevated serum concentrations of IgG antibodies, albumin, and total protein, lower levels of lymphocytes, albumin, and total protein in the cerebrospinal fluid, but no difference in CSF IgG concentration compared to those with other inflammatory neurological disorders. Furthermore, in MS there was no linear relationship between the numbers of OCBs, CSF lymphocytes, CSF IgG, and IgG Index, and between serum IgG and serum albumin, but significant correlation between IgG in CSF and serum, and between CSF IgG and CSF albumin. Conclusion There are unique differences between MS and patients with other inflammatory neurological disorders. Our data suggest that in MS patient (a) B cells and their products in the CSF may not be the sole source of intrathecal IgG; (b) oligoclonal bands may not be the products of single B cell clones in the CSF; and (c) there is a strong connection between serum components in the peripheral circulation and the central nervous system.	[Beseler, Cheryl; Graner, Michael; Yu, Xiaoli] Univ Colorado Denver, Sch Med, Dept Neurosurg, Aurora, CO 80045 USA; [Vollmer, Timothy] Univ Colorado Denver, Dept Neurol, Sch Med, Aurora, CO USA; [Yu, Xiaoli] YuScience LLC, BioSci Pk Ctr, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Yu, XL (corresponding author), Univ Colorado Denver, Sch Med, Dept Neurosurg, Aurora, CO 80045 USA.; Yu, XL (corresponding author), YuScience LLC, BioSci Pk Ctr, Aurora, CO 80045 USA.	Xiaoli@yuScience.com			yuScience, LLC; Department of Neurosurgery, University of Colorado Denver School of Medicine	yuScience, LLC; Department of Neurosurgery, University of Colorado Denver School of Medicine	This study was supported by yuScience, LLC and the Department of Neurosurgery, University of Colorado Denver School of Medicine. The funders provided support in the form of salaries for authors [XY], [MG], and [CB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Bakshi R, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000200; Bankoti J, 2014, ANN NEUROL, V75, P266, DOI 10.1002/ana.24088; Calabrese M, 2012, BRAIN, V135, P2952, DOI 10.1093/brain/aws246; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Delmotte P., 2013, HUMORAL IMMUNITY NEU, P221; ESIRI MM, 1980, NEUROPATH APPL NEURO, V6, P9, DOI 10.1111/j.1365-2990.1980.tb00199.x; Ferreira D, 2014, J NEUROIMMUNOL, V274, P149, DOI 10.1016/j.jneuroim.2014.06.010; GANROT K, 1974, CLIN CHEM, V20, P571; GLYNN P, 1982, CLIN EXP IMMUNOL, V48, P102; Han S, 2014, J IMMUNOL, V192, P2551, DOI 10.4049/jimmunol.1302884; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Heigl F, 2013, ATHEROSCLEROSIS SUPP, V14, P167, DOI 10.1016/j.atherosclerosissup.2012.10.025; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; KASCHKA WP, 1979, INFECT IMMUN, V26, P933, DOI 10.1128/IAI.26.3.933-941.1979; Komori M, 2015, ANN NEUROL, V78, P3, DOI 10.1002/ana.24408; Lefranc D, 2004, J IMMUNOL, V172, P669, DOI 10.4049/jimmunol.172.1.669; LINK H, 1967, ACTA NEUROL SCAND, VS 43, P180; Long YM, 2013, NEUROL RES, V35, P922, DOI 10.1179/1743132813Y.0000000229; LOSY J, 1990, ACTA NEUROL SCAND, V82, P4; LUMSDEN CE, 1971, BRAIN RES, V28, P365, DOI 10.1016/0006-8993(71)90052-7; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mares J, 2008, BIOMED PAP, V152, P247, DOI 10.5507/bp.2008.038; MATTSON DH, 1980, NATURE, V287, P335, DOI 10.1038/287335a0; MATTSON DH, 1982, J NEUROIMMUNOL, V3, P63, DOI 10.1016/0165-5728(82)90018-2; Mouzaki A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135434; OLSSON JE, 1979, NEUROLOGY, V29, P1383, DOI 10.1212/WNL.29.10.1383; SALIER JP, 1983, CLIN EXP IMMUNOL, V54, P634; Shimizu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092872; TAVOLATO BF, 1975, J NEUROL SCI, V24, P1, DOI 10.1016/0022-510X(75)90002-7; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; TOURTELLOTTE WW, 1980, NEUROLOGY, V30, P240, DOI 10.1212/WNL.30.3.240; Villar LM, 2012, ARCH NEUROL-CHICAGO, V69, P191, DOI 10.1001/archneurol.2011.971; Williamson RT, 1908, LANCET, V1, P1272; Zeman AZJ, 1996, QJM-INT J MED, V89, P187; Zephir H, 2009, MULT SCLER J, V15, P593, DOI 10.1177/1352458508101951	35	16	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186842	10.1371/journal.pone.0186842	http://dx.doi.org/10.1371/journal.pone.0186842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059249	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000046
J	Le Pennec, G; Butlin, RK; Jonsson, PR; Larsson, AI; Lindborg, J; Bergstrom, E; Westram, AM; Johannesson, K				Le Pennec, Guenole; Butlin, Roger K.; Jonsson, Per R.; Larsson, Ann I.; Lindborg, Jessica; Bergstrom, Erik; Westram, Anja M.; Johannesson, Kerstin			Adaptation to dislodgement risk on wave-swept rocky shores in the snail Littorina saxatilis	PLOS ONE			English	Article							INTERTIDAL SNAIL; PHENOTYPIC PLASTICITY; REPRODUCTIVE ISOLATION; PARALLEL EVOLUTION; FUCUS-GARDNERI; GENE EXCHANGE; SHELL-SHAPE; SELECTION; SIZE; DIFFERENTIATION	The periwinkle Littorina saxatilis has repeatedly evolved both a small, fragile and globose "wave ecotype" confined to wave-swept shores and a large, robust and elongated "crab ecotype" found in nearby crab-rich but less-exposed shores. This phenotypic divergence is assumed to reflect, in some part, local adaptation to wave exposure, but this hypothesis has received incomplete experimental testing. Here, we report a test of the prediction that the wave ecotype has a higher capacity to resist water flow than the crab ecotype. We sampled snails along a crab-wave transect and measured their resistance to dislodgement in a highspeed water flume with water speeds that match those of breaking waves in a range of relevant field conditions. Snails from the wave environment were consistently more resistant to water flow than snails from the crab environment and high resistance was positively correlated with the surface area of the foot and the area of the outer aperture contour both relative to shell size, and to the extent of lateral shell compression. In a separate experiment, we found that snails raised in still water in a common garden showed higher resistance to water flow if originating from a wave environment than from a crab environment, and this was true both at juvenile (2 weeks) and adult (10 months) developmental stages. This result suggests genetic control of a distinct "wave adapted" phenotype, likely to be maintained under strong divergent selection between the two adjacent habitats.	[Le Pennec, Guenole; Butlin, Roger K.; Jonsson, Per R.; Larsson, Ann I.; Lindborg, Jessica; Bergstrom, Erik; Johannesson, Kerstin] Tjamo Univ Gothenburg, Dept Marine Sci, Stromstad, Sweden; [Butlin, Roger K.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England; [Le Pennec, Guenole] Carl von Ossietzky Univ Oldenburg, Dept Ecol Genom, Oldenburg, Germany	University of Sheffield; Carl von Ossietzky Universitat Oldenburg	Le Pennec, G (corresponding author), Tjamo Univ Gothenburg, Dept Marine Sci, Stromstad, Sweden.; Le Pennec, G (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Ecol Genom, Oldenburg, Germany.	lepennec.guenole@gmail.com	Butlin, Roger K/F-7709-2013; Johannesson, Kerstin/X-7994-2019	Butlin, Roger K/0000-0003-4736-0954; Johannesson, Kerstin/0000-0003-0176-7986; Westram, Anja Marie/0000-0003-1050-4969	Swedish Research Councils VR; Formas [217-2008-1719, 215-2012-1134]; NERC [NE/P001610/1, NE/K014021/1] Funding Source: UKRI; Natural Environment Research Council [NE/K014021/1, NE/P001610/1] Funding Source: researchfish	Swedish Research Councils VR(Swedish Research Council); Formas(Swedish Research Council Formas); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was performed within the Linnaeus Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se/) supported by a Linnaeus-grant from the Swedish Research Councils VR (https://www.vr.se/) and Formas (http://www.formas.se/) grant number 217-2008-1719 to KJ. Additional support came from Formas through contract 215-2012-1134 to AIL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ATKINSON WD, 1984, J ANIM ECOL, V53, P93, DOI 10.2307/4344; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchette CA, 1997, ECOLOGY, V78, P1563; Bolker B., 2020, BBMLE TOOLS GEN MAXI; BOULDING EG, 1993, EVOLUTION, V47, P576, DOI 10.1111/j.1558-5646.1993.tb02114.x; Butlin RK, 2014, EVOLUTION, V68, P935, DOI 10.1111/evo.12329; Conde-Padin P, 2009, EVOLUTION, V63, P1356, DOI 10.1111/j.1558-5646.2009.00636.x; De Wolf H, 1999, J MAR BIOL ASSOC UK, V79, P1129, DOI 10.1017/S0025315499001411; DENNY M, 1995, ECOL MONOGR, V65, P371, DOI 10.2307/2963496; Denny M, 1999, J EXP BIOL, V202, P3463; Denny MW, 2000, J EXP BIOL, V203, P2623; Derryberry EP, 2014, MOL ECOL RESOUR, V14, P652, DOI 10.1111/1755-0998.12209; Edwards AWF, 1990, TIME SERIES STAT; Erlandsson J, 1998, EVOL ECOL, V12, P913, DOI 10.1023/A:1006559904596; ETTER RJ, 1988, EVOLUTION, V42, P322, DOI 10.1111/j.1558-5646.1988.tb04136.x; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; GRAHAME J, 1986, J ZOOL, V208, P229; Grahame JW, 2006, EVOLUTION, V60, P268; Hohenlohe PA, 2003, VELIGER, V46, P162; Hollander J, 2006, J EVOLUTION BIOL, V19, P1861, DOI 10.1111/j.1420-9101.2006.01171.x; JANSON K, 1983, OECOLOGIA, V59, P58, DOI 10.1007/BF00388072; Johannesson B, 1996, J ZOOL, V240, P475, DOI 10.1111/j.1469-7998.1996.tb05299.x; JOHANNESSON B, 1986, J EXP MAR BIOL ECOL, V102, P183, DOI 10.1016/0022-0981(86)90175-9; Johannesson K, 1997, BIOL J LINN SOC, V61, P267; JOHANNESSON K, 1993, EVOLUTION, V47, P1770, DOI 10.1111/j.1558-5646.1993.tb01268.x; Johannesson K, 2003, J SEA RES, V49, P107, DOI 10.1016/S1385-1101(02)00218-6; Johannesson K, 2016, EVOL APPL, V9, P153, DOI 10.1111/eva.12277; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; KITCHING JA, 1966, J ANIM ECOL, V35, P113, DOI 10.2307/2693; Panova M, 2006, MOL ECOL, V15, P4021, DOI 10.1111/j.1365-294X.2006.03067.x; Panova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017511; RAUP DM, 1961, P NATL ACAD SCI USA, V47, P602, DOI 10.1073/pnas.47.4.602; Ravinet M, 2016, MOL ECOL, V25, P287, DOI 10.1111/mec.13332; Reid D. G., 1996, SYSTEMATICS EVOLUTIO; Rolan-Alvarez E, 1997, EVOLUTION, V51, P1838, DOI 10.1111/j.1558-5646.1997.tb05107.x; Rolan-Alvarez E, 2015, OCEANOGR MAR BIOL, V53, P157; Ruuskanen AT, 2005, ANN BOT FENN, V42, P27; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; TRUSSELL GC, 1993, MAR ECOL PROG SER, V100, P135, DOI 10.3354/meps100135; Trussell GC, 1997, MAR ECOL PROG SER, V151, P73, DOI 10.3354/meps151073; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; Urdy S, 2010, J EXP ZOOL PART B, V314B, P280, DOI 10.1002/jez.b.21337; Westram AM, 2016, MOL ECOL, V25, P3169, DOI 10.1111/mec.13640; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x; Yamada SB, 1996, J EXP MAR BIOL ECOL, V204, P59, DOI 10.1016/0022-0981(96)02579-8	46	24	24	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186901	10.1371/journal.pone.0186901	http://dx.doi.org/10.1371/journal.pone.0186901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059225	gold, Green Published, Green Accepted			2022-12-26	WOS:000413403000051
J	Paez-Rosas, D; Villegas-Amtmann, S; Costa, D				Paez-Rosas, Diego; Villegas-Amtmann, Stella; Costa, Daniel			Intraspecific variation in feeding strategies of Galapagos sea lions: A case of trophic specialization	PLOS ONE			English	Article							INDIVIDUAL DIET SPECIALIZATION; FORAGING BEHAVIOR; STABLE-ISOTOPE; MARINE PREDATOR; NORTH PACIFIC; NEW-ZEALAND; FUR SEALS; ECOLOGY; PREY; VARIABILITY	The trophic behavior of marine predators varies according to the level of competition to which they are exposed. In general, populations that inhabit lower productivity systems face a strong intraspecific competition, which contributes to the development of different foraging strategies to maximize nutritional efficiency. Given the high trophic flexibility of Zalophus wollebaeki, this species is considered appropriate for the analysis of such behavior. Furthermore, this trophic flexibility has allowed them to persist in a seemingly marginal ecosystem. In this study, we used a comparative analysis of variables (diet and dive behavior) related to Z. wollebaeki trophic niche plasticity to better understand their foraging ecology, using techniques such scat analysis, satellite telemetry and complementarily an isotopic analysis. Scat analysis revealed intra-population variation in their diet, represented by prey from different environments (epipelagic and benthic). These results are supported by the animals' locations at sea and diving profiles. Global Positioning System (GPS) and time-depth recorder (TDR) records showed the existence of two groups, with differing feeding areas and diving behavior. Also the delta N-15 values showed differences in the trophic level at which the species fed. These results constitute a relevant finding in the evolutionary behavior of the species, showing that Z. wollebaeki has developed a high degree of foraging flexibility, thus increasing its survival rate in an ecosystem that is highly demanding in terms of resource availability.	[Paez-Rosas, Diego] Univ San Francisco Quito, Galapagos, Ecuador; [Paez-Rosas, Diego] Galapagos Sci Ctr, Galapagos, Ecuador; [Paez-Rosas, Diego] Direcc Parque Nacl Galapagos, Unidad Tecn Operat San Cristobal, Galapagos, Ecuador; [Villegas-Amtmann, Stella; Costa, Daniel] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Paez-Rosas, D (corresponding author), Univ San Francisco Quito, Galapagos, Ecuador.; Paez-Rosas, D (corresponding author), Galapagos Sci Ctr, Galapagos, Ecuador.; Paez-Rosas, D (corresponding author), Direcc Parque Nacl Galapagos, Unidad Tecn Operat San Cristobal, Galapagos, Ecuador.	dpaez@usfq.edu.ec	Páez-Rosas, Diego/X-3047-2019; Costa, Daniel/E-2616-2013	Páez-Rosas, Diego/0000-0002-2446-9888; Costa, Daniel/0000-0002-0233-5782	Office of Naval Research; IAGOP [JIP 2207-23]; Concejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico; Universidad San Francisco de Quito (USFQ) through Galapagos Science Center; CONACYT-Mexico; Universidad San Francisco de Quito; Galapagos Science Center	Office of Naval Research(Office of Naval Research); IAGOP; Concejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico; Universidad San Francisco de Quito (USFQ) through Galapagos Science Center; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad San Francisco de Quito; Galapagos Science Center	Part of this work were funded and supported by Office of Naval Research, the E&P Sound and Marine Life Joint Industry Project of the IAGOP (#JIP 2207-23), and the Concejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico through the scholarship provided to DPR. Also to the grants from the Universidad San Francisco de Quito (USFQ) through the Galapagos Science Center awarded DPR, for research stays during the writing phase of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Galapagos National Park (DPNG) for the logistics and the permits granted for animal sampling and tagging. Additionally, we thank the Office of Naval Research, the E&P Sound and Marine Life Joint Industry Project of the IAGOP (# JIP 2207-23), also the CONACYT-Mexico for funding and logistic support of the Project. We are grateful to: DPNG rangers for help in collecting data, Daniela Alarcon-Ruales for assistance in the geographical analysis and David Aurioles-Gamboa for his collaboration and constructive comments during this study and earlier versions of the manuscript. Finally, we thank Universidad San Francisco de Quito and Galapagos Science Center for their support during the writing phase of this work.	Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Baylis AMM, 2015, OECOLOGIA, V179, P1053, DOI 10.1007/s00442-015-3421-4; Blanchet MA, 2013, MAR ECOL PROG SER, V477, P285, DOI 10.3354/meps10110; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Canales M, 2003, GALAPAGOS ESTACION C; Chilvers BL, 2011, POLAR BIOL, V34, P565, DOI 10.1007/s00300-010-0915-8; Costa DP, 2012, ANNU REV ECOL EVOL S, V43, P73, DOI 10.1146/annurev-ecolsys-102710-145045; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Costa DP, 2004, INT CONGR SER, V1275, P359, DOI 10.1016/j.ics.2004.08.058; Dellinger T, 1999, CAN J ZOOL, V77, P1204, DOI 10.1139/cjz-77-8-1204; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Elorriaga-Verplancken F, 2013, MAR BIOL, V160, P641, DOI 10.1007/s00227-012-2119-y; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Garcia-Rodriguez F.J., 2011, Journal of Fisheries and Aquatic Science, V6, P186; Grove J.S., 1997, FISHES GALAPAGOS ISL; Herman DP, 2005, MAR ECOL PROG SER, V302, P275, DOI 10.3354/meps302275; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hoskins AJ, 2015, MAR ECOL PROG SER, V526, P227, DOI 10.3354/meps11200; Huckstadt LA, 2016, J EXP BIOL, V219, P2320, DOI 10.1242/jeb.138677; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jaeger A, 2009, MAR BIOL, V156, P1233, DOI 10.1007/s00227-009-1165-6; Jeglinski JWE, 2015, OECOLOGIA, V179, P1041, DOI 10.1007/s00442-015-3424-1; Jeglinski JWE, 2013, J ANIM ECOL, V82, P694, DOI 10.1111/1365-2656.12019; Kernaleguen L, 2015, J ANIM ECOL, V84, P1081, DOI 10.1111/1365-2656.12347; Kokubun N, 2010, MAR BIOL, V157, P811, DOI 10.1007/s00227-009-1364-1; Layman CA, 2015, OECOLOGIA, V178, P1, DOI 10.1007/s00442-014-3209-y; LINTON LR, 1981, J ANIM ECOL, V50, P283, DOI 10.2307/4045; Lluch-Cota DB, 1997, FAO FISHERIES CIRCUL, V934; Lowther AD, 2012, ANIM BEHAV, V83, P691, DOI 10.1016/j.anbehav.2011.12.015; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; McHuron EA, 2016, OECOLOGIA, V182, P995, DOI 10.1007/s00442-016-3732-0; Meynier L, 2009, MAR MAMMAL SCI, V25, P302, DOI 10.1111/j.1748-7692.2008.00252.x; Newsome SD, 2015, OECOLOGIA, V178, P45, DOI 10.1007/s00442-015-3223-8; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Nims BD, 2008, CONSERV GENET, V9, P1413, DOI 10.1007/s10592-007-9465-1; Okey TA, 2004, ECOL MODEL, V172, P383, DOI 10.1016/j.ecolmodel.2003.09.019; Orr AJ, 2011, CAN J ZOOL, V89, P109, DOI 10.1139/Z10-101; Paez-Rosas D., 2017, TROPICAL PINNIPEDS B, P159; Paez-Rosas D, 2014, J MAR BIOL ASSOC UK, V94, P1099, DOI 10.1017/S002531541300163X; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Paez-Rosas D, 2010, MAR BIOL, V157, P2769, DOI 10.1007/s00227-010-1535-0; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Riet-Sapriza FG, 2013, DEEP-SEA RES PT II, V88-89, P106, DOI 10.1016/j.dsr2.2012.09.005; Riofrio-Lazo M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168829; Salazar S.M.G., 2005, THESIS; Schaeffer BA, 2008, REMOTE SENS ENVIRON, V112, P3044, DOI 10.1016/j.rse.2008.03.005; Smith EAE, 2015, OECOLOGIA, V178, P17, DOI 10.1007/s00442-014-3206-1; Svanback R, 2005, EVOL ECOL RES, V7, P993; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Tollit DJ, 2003, MAR MAMMAL SCI, V19, P724, DOI 10.1111/j.1748-7692.2003.tb01127.x; Tremblay Y, 2000, MAR ECOL PROG SER, V204, P257, DOI 10.3354/meps204257; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Trillmich F., 1991, PINNIPEDS NINO, P247; Trillmich F, 2008, BEHAV ECOL SOCIOBIOL, V62, P363, DOI 10.1007/s00265-007-0423-1; Villegas-Amtmann S, 2016, DEEP SEA RES 2; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Villegas-Amtmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070748; Villegas-Amtmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023166; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1	64	16	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0185165	10.1371/journal.pone.0185165	http://dx.doi.org/10.1371/journal.pone.0185165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059188	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000006
J	Setien-Olarra, A; Marichalar-Mendia, X; Bediaga, NG; Aguirre-Echebarria, P; Aguirre-Urizar, JM; Mosqueda-Taylor, A				Setien-Olarra, A.; Marichalar-Mendia, X.; Bediaga, N. G.; Aguirre-Echebarria, P.; Aguirre-Urizar, J. M.; Mosqueda-Taylor, A.			MicroRNAs expression profile in solid and unicystic ameloblastomas	PLOS ONE			English	Article							CANCER CELL-PROLIFERATION; HUMAN COLORECTAL-CANCER; OSTEOGENIC DIFFERENTIATION; POOR-PROGNOSIS; LUNG; MIR-489; MIR-592; MIR-31; PROGRESSION; MUTATIONS	Objectives Odontogenic tumors (OT) represent a specific pathological category that includes some lesions with unpredictable biological behavior. Although most of these lesions are benign, some, such as the ameloblastoma, exhibit local aggressiveness and high recurrence rates. The most common types of ameloblastoma are the solid/multicystic (SA) and the unicystic ameloblastoma (UA); the latter considered a much less aggressive entity as compared to the SA. The microRNA system regulates the expression of many human genes while its deregulation has been associated with neoplastic development. The aim of the current study was to determine the expression profiles of microRNAs present in the two most common types of ameloblastomas. Material & methods MicroRNA expression profiles were assessed using TaqMan (R) Low Density Arrays (TLDAs) in 24 samples (8 SA, 8 UA and 8 control samples). The findings were validated using quantitative RTqPCR in an independent cohort of 19 SA, 8 UA and 19 dentigerous cysts as controls. Results We identified 40 microRNAs differentially regulated in ameloblastomas, which are related to neoplastic development and differentiation, and with the osteogenic process. Further validation of the top ranked microRNAs revealed significant differences in the expression of 6 of them in relation to UA, 7 in relation to SA and 1 (miR-489) that was related to both types. Conclusion We identified a new microRNA signature for the ameloblastoma and for its main types, which may be useful to better understand the etiopathogenesis of this neoplasm. In addition, we identified a microRNA (miR-489) that is suggestive of differentiating among solid from unicystic ameloblastoma.	[Setien-Olarra, A.; Marichalar-Mendia, X.; Aguirre-Urizar, J. M.] Univ Basque Country, UPV EHU, Dept Stomatol 2, Oral Med & Pathol, Leioa, Spain; [Bediaga, N. G.] Univ Basque Country, UPV EHU, Lascaray Res Ctr, BIOMICs Res Grp, Miguel De Unamuno, Vitoria Gazteiz, Spain; [Aguirre-Echebarria, P.] Univ Basque Country, EHU, Univ Hosp Donostia, Head & Neck Sect,Serv Pathol, San Sebastian, Spain; [Mosqueda-Taylor, A.] Univ Autonoma Metropolitana Xochimilco, Hlth Care Dept, Ciudad De Mexico, Mexico	University of Basque Country; University of Basque Country; University Hospital Donostia; University of Basque Country; Universidad Autonoma Metropolitana - Mexico	Marichalar-Mendia, X (corresponding author), Univ Basque Country, UPV EHU, Dept Stomatol 2, Oral Med & Pathol, Leioa, Spain.	xabier.marichalar@gmail.com	Marichalar-Mendia, Xabier/I-2621-2015; Bediaga, Naiara/AAD-6062-2020; Marichalar-Mendia, Xabier/Z-2255-2019; Mosqueda-Taylor, Adalberto/AAS-1112-2020	Marichalar-Mendia, Xabier/0000-0001-5948-9443; Marichalar-Mendia, Xabier/0000-0001-5948-9443; Mosqueda-Taylor, Adalberto/0000-0001-8956-6016; G. Bediaga, Naiara/0000-0002-7363-0068; Aguirre Urizar, Jose Manuel/0000-0001-7822-0968	Basque Goverment [IT809-13]	Basque Goverment	This research was supported by a Grant from Basque Goverment (IT809-13). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank Dr. Maria Luisa Gainza Cirauqui for revising the language and style of the manuscript. This research was supported by a Grant from Basque Goverment (IT809-13). Technical and human support provided by SGIker (UPV/EHU, MINECO, GV/EJ, ERDF, and ESF) is gratefully acknowledged.	Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bediaga NG, 2013, BRIT J CANCER, V109, P2404, DOI 10.1038/bjc.2013.623; Brown NA, 2014, CLIN CANCER RES, V20, P5517, DOI 10.1158/1078-0432.CCR-14-1069; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Chai P, 2016, BIOCHEM BIOPH RES CO, V471, P123, DOI 10.1016/j.bbrc.2016.01.168; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; CHOI YW, 2016, MEDICINE BALTIMORE, V95; Davanian H, 2017, ONCOTARGET, V8, P4530, DOI 10.18632/oncotarget.13889; DeVilliers P, 2011, J DENT RES, V90, P463, DOI 10.1177/0022034510391791; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Edmonds MD, 2016, J CLIN INVEST, V126, P349, DOI 10.1172/JCI82720; Filizzola AI, 2014, MED ORAL PATOL ORAL, V19, pE556, DOI 10.4317/medoral.19802; Fu Q, 2016, EXPERT OPIN THER TAR, V20, P771, DOI 10.1080/14728222.2016.1181753; Gardner DG, 2005, WHO CLASSIFICATION T, V3rd, P296; Hao M, 2016, ONCOTARGET, V7, P19589, DOI 10.18632/oncotarget.7319; He HF, 2016, TUMOR BIOL, V37, P1599, DOI 10.1007/s13277-015-3844-x; Heikinheimo K, 2015, J DENT RES, V94, P237, DOI 10.1177/0022034514560373; Jhamb T, 2014, EXP MOL PATHOL, V97, P345, DOI 10.1016/j.yexmp.2014.09.001; Jin H, 2017, MOL THER-NUCL ACIDS, V8, P111, DOI 10.1016/j.omtn.2017.06.008; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Kim J, 2014, ANTICANCER RES, V34, P2297; Kim KH, 2015, NUCLEIC ACIDS RES, V43, P7462, DOI 10.1093/nar/gkv735; Kitkumthorn N, 2010, ORAL DIS, V16, P286, DOI 10.1111/j.1601-0825.2009.01640.x; Kurppa KJ, 2014, J PATHOL, V232, P492, DOI 10.1002/path.4317; Liu ML, 2015, BIOMED PHARMACOTHER, V69, P214, DOI 10.1016/j.biopha.2014.12.001; Lu WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108049; Marabita F, 2016, BRIEF BIOINFORM, V17, P204, DOI 10.1093/bib/bbv056; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nagi Ravleen, 2016, J Oral Maxillofac Pathol, V20, P497; Nezu Y, 2016, ONCOGENE, V35, P6177, DOI 10.1038/onc.2016.157; Nodit L, 2004, MODERN PATHOL, V17, P1062, DOI 10.1038/modpathol.3800147; Patel Y, 2016, ONCOTARGET, V7, P18295, DOI 10.18632/oncotarget.7577; REICHART PA, 1995, ORAL ONCOL, V31B, P86; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Setien-Olarra A, 2016, ORAL DIS, V22, P754, DOI 10.1111/odi.12536; Siow MY, 2014, ORAL DIS, V20, P345, DOI 10.1111/odi.12118; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weilner S, 2016, AGING CELL, V15, P744, DOI 10.1111/acel.12484; Xie H, 2015, INT J CANCER, V136, pE230, DOI 10.1002/ijc.29160; Xie Q, 2014, BIOCHEM BIOPH RES CO, V446, P98, DOI 10.1016/j.bbrc.2014.02.058; Xie ZT, 2015, TUMOR BIOL, V36, P6497, DOI 10.1007/s13277-015-3340-3; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186841	10.1371/journal.pone.0186841	http://dx.doi.org/10.1371/journal.pone.0186841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053755	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100040
J	Kumagai, H; Nakanishi, T; Matsuura, T; Kato, Y; Watanabe, H				Kumagai, Hitoshi; Nakanishi, Takashi; Matsuura, Tomoaki; Kato, Yasuhiko; Watanabe, Hajime			CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna	PLOS ONE			English	Article							TARGETED INTEGRATION; HETERODIMERIC TALENS; HUMAN-CELLS; GENOME; RNA; CAS9; DNA; DROSOPHILA; ZEBRAFISH; NUCLEASE	The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system (Cas) is widely used for mediating the knock-in of foreign DNA into the genomes of various organisms. Here, we report a process of CRISPR/Cas-mediated knockin via non-homologous end joining by the direct injection of Cas9/gRNA ribonucleoproteins (RNPs) in the crustacean Daphnia magna, which is a model organism for studies on toxicology, ecology, and evolution. First, we confirmed the cleavage activity of Cas9 RNPs comprising purified Cas9 proteins and gRNAs in D. magna. We used a gRNA that targets exon 10 of the eyeless gene. Cas9 proteins were incubated with the gRNAs and the resulting Cas9 RNPs were injected into D. magna eggs, which led to a typical phenotype of the eyeless mutant, i. e., eye deformity. The somatic and heritable mutagenesis efficiencies were up to 96% and 40%, respectively. Second, we tested the CRISPR/Cas-mediated knock-in of a plasmid by the injection of Cas9 RNPs. The donor DNA plasmid harboring the fluorescent reporter gene was designed to contain the gRNA recognition site. The co-injection of Cas9 RNPs together with the donor DNAs resulted in generation of one founder animal that produced fluorescent progenies. This transgenic Daphnia had donor DNA at the targeted genomic site, which suggested the concurrent cleavage of the injected plasmid DNA and genomic DNA. Owing to its simplicity and ease of experimental design, we suggest that the CRISPR/Cas-mediated knock-in method represents a promising tool for studying functional genomics in D. magna.	[Kumagai, Hitoshi; Nakanishi, Takashi; Matsuura, Tomoaki; Kato, Yasuhiko; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka, Japan; [Kato, Yasuhiko] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, 2-1 Yamadaoka, Suita, Osaka, Japan	Osaka University; Osaka University	Watanabe, H (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka, Japan.	watanabe@bio.eng.osaka-u.ac.jp	Kato, Yasuhiko/AES-3929-2022; Matsuura, Tomoaki/W-6086-2019; WATANABE, Hajime/AAJ-8904-2021; Watanabe, Hajime/S-8957-2019; matsuura, tomoaki/O-7368-2018	Kato, Yasuhiko/0000-0002-1041-1044; Matsuura, Tomoaki/0000-0003-1015-6781; matsuura, tomoaki/0000-0003-1015-6781; Watanabe, Hajime/0000-0001-9657-6554	JSPS KAKENHI Grant [15H01472, 26281027]; Frontier Research Base for Global Young Researchers, Osaka University;  [15J005870];  [14J04949]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Frontier Research Base for Global Young Researchers, Osaka University; ; 	This work was supported by JSPS KAKENHI Grant Number (15H01472, 26281027) to Y.K. and H.W. This work was also supported by Grant-in-Aid for JSPS Fellows (15J005870, 14J04949) to T.N. and H.K.	Alfred J, 2015, ELIFE, V4, DOI 10.7554/eLife.06956; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Eads B. D., 2007, BMC GENOMICS, P8; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Goldstein B, 2016, TRENDS CELL BIOL, V26, P818, DOI 10.1016/j.tcb.2016.08.005; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; Honda Y, 2017, J CELL SCI, V130, P1652, DOI 10.1242/jcs.200923; Huang YP, 2016, J GENET GENOMICS, V43, P263, DOI 10.1016/j.jgg.2016.04.007; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kato Y, 2008, GENOMICS, V91, P94, DOI 10.1016/j.ygeno.2007.09.002; Kato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045318; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Lampert W, 2011, DAPHNIA DEV MODEL OR; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Miner BE, 2012, P ROY SOC B-BIOL SCI, V279, P1873, DOI 10.1098/rspb.2011.2404; Naitou A, 2015, BIOL OPEN, V4, P364, DOI 10.1242/bio.20149738; Nakanishi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36252; Nakanishi T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18312; Nakanishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098363; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Orsini L, 2011, BIOL LETTERS, V7, P2, DOI 10.1098/rsbl.2010.0629; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Pan YZ, 2013, MOL BIOTECHNOL, V55, P54, DOI 10.1007/s12033-012-9613-9; Rahdar M, 2015, P NATL ACAD SCI USA, V112, pE7110, DOI 10.1073/pnas.1520883112; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; STROSS RG, 1965, SCIENCE, V150, P1462, DOI 10.1126/science.150.3702.1462; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Torner K, 2014, MOL GENET GENOMICS, V289, P707, DOI 10.1007/s00438-014-0830-8; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Watanabe H, 2007, ENVIRON TOXICOL CHEM, V26, P669, DOI 10.1897/06-075R.1	42	29	30	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186112	10.1371/journal.pone.0186112	http://dx.doi.org/10.1371/journal.pone.0186112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045453	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100036
J	Momeni, M; Ena, LN; Van Dyck, M; Matta, A; Kahn, D; Thiry, D; Gregoire, A; Watremez, C				Momeni, Mona; Ena, Lompoli Nkoy; Van Dyck, Michel; Matta, Amine; Kahn, David; Thiry, Dominique; Gregoire, Andre; Watremez, Christine			The dose of hydroxyethyl starch 6% 130/0.4 for fluid therapy and the incidence of acute kidney injury after cardiac surgery: A retrospective matched study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; RESUSCITATION; SEPSIS; RISK	The safety of hydroxyethyl starches (HES) is still under debate. No studies have compared different dosing regimens of HES in cardiac surgery. We analyzed whether the incidence of Acute Kidney Injury (AKI) differed taking into account a weight-adjusted cumulative dose of HES 6% 130/0.4 for perioperative fluid therapy. This retrospective cohort study included all adult patients undergoing elective or emergency cardiac surgery with or without cardiopulmonary bypass. Exclusion criteria were patients on renal replacement therapy (RRT), cardiac trauma surgery, heart transplantation, patients with ventricular assist devices, subjects who required a surgical revision for bleeding and those whose medical records were incomplete. Primary endpoint was AKI following the creatinine based RIFLE classification. Secondary endpoints were 30-day mortality and RRT. Patients were divided into 2 groups whether they had received a cumulative HES dose of < 30 mL/kg (Low HES) or >= 30 mL/kg (High HES) during the intra-and postoperative period. A total of 1501 patients were analyzed with 983 patients in the Low HES and 518 subjects in the High HES group. 185 (18.8%) patients in the Low HES and 119 (23.0%) patients in the High HES group developed AKI (P = 0.06). In multivariable regression analysis the dose of HES administered per weight was not associated with AKI. After case-control matching 217 patients were analyzed in each group. AKI occurred in 39 (18.0%) patients in the Low HES and 50 (23.0%) patients in the High HES group (P = 0.19). In conditional regression analysis performed on the matched groups a lower weight-adjusted dose of HES was significantly associated with a reduced incidence of AKI [(Odds Ratio (95% CI) = 0.825 (0.727-0.936); P = 0.003]. In the absence of any safety study the cumulative dose of modern HES in cardiac surgery should be kept less than 30 mL/kg.	[Momeni, Mona; Ena, Lompoli Nkoy; Van Dyck, Michel; Matta, Amine; Kahn, David; Watremez, Christine] Catholic Univ Louvain, Dept Anesthesiol, Clin Univ St Luc, Brussels, Belgium; [Thiry, Dominique; Gregoire, Andre] Catholic Univ Louvain, Dept Perfus Serv, Clin Univ St Luc, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Momeni, M (corresponding author), Catholic Univ Louvain, Dept Anesthesiol, Clin Univ St Luc, Brussels, Belgium.	mona.momeni@uclouvain.be	Momeni, Mona/M-4353-2019; Momeni, Mona/ABH-7592-2020	Momeni, Mona/0000-0003-1965-2335				Bayer O, 2013, CRIT CARE MED, V41, P2532, DOI 10.1097/CCM.0b013e3182978fb6; Bellomo R, 2007, INTENS CARE MED, V33, P409, DOI 10.1007/s00134-006-0478-x; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Cruz DN, 2007, CLIN J AM SOC NEPHRO, V2, P418, DOI 10.2215/CJN.03361006; De Robertis E, 2016, EUR J ANAESTH, V33, P483, DOI 10.1097/EJA.0000000000000441; Dickenmann M, 2008, AM J KIDNEY DIS, V51, P491, DOI 10.1053/j.ajkd.2007.10.044; Garwood S, 2010, J CARDIOTHOR VASC AN, V24, P990, DOI 10.1053/j.jvca.2010.05.010; Heringlake M, 2006, MINERVA ANESTESIOL, V72, P645; Jacob M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0656-0; Jacob M, 2013, CURR OPIN CRIT CARE, V19, P282, DOI 10.1097/MCC.0b013e3283632d5e; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Kuitunen A, 2006, ANN THORAC SURG, V81, P542, DOI 10.1016/j.athoracsur.2005.07.047; Lagny MG, 2016, J CARDIOTHOR VASC AN, V30, P869, DOI 10.1053/j.jvca.2015.10.010; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Magder S, 2010, CRIT CARE MED, V38, P2117, DOI 10.1097/CCM.0b013e3181f3e08c; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mutter TC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub3; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Raghunathan K, 2013, CURR OPIN CRIT CARE, V19, P290, DOI 10.1097/MCC.0b013e3283632d77; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Vandijck DM, 2007, ACTA CLIN BELG, V62, P332, DOI 10.1179/acb.2007.075; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484	24	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186403	10.1371/journal.pone.0186403	http://dx.doi.org/10.1371/journal.pone.0186403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045467	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100058
J	Nakamura, S; Kunikata, T; Matsumoto, Y; Hanaya, T; Harashima, A; Nishimoto, T; Ushio, S				Nakamura, Shuji; Kunikata, Toshio; Matsumoto, Yohsuke; Hanaya, Toshiharu; Harashima, Akira; Nishimoto, Tomoyuki; Ushio, Shimpei			Effects of a non-cyclodextrin cyclic carbohydrate on mouse melanoma cells: Characterization of a new type of hypopigmenting sugar	PLOS ONE			English	Article							BACILLUS-GLOBISPORUS C-11; MELANOGENESIS; INHIBITION; TETRASACCHARIDE; PURIFICATION; TYROSINASE; TREHALOSE; PIGMENTATION; MACROPHAGES; MELANOCYTES	Cyclic nigerosyl nigerose (CNN) is a cyclic tetrasaccharide that exhibits properties distinct from other conventional cyclodextrins. Herein, we demonstrate that treatment of B16 mela-noma with CNN results in a dose-dependent decrease in melanin synthesis, even under conditions that stimulate melanin synthesis, without significant cytotoxity. The effects of CNN were prolonged for more than 27 days, and were gradually reversed following removal of CNN. Undigested CNN was found to accumulate within B16 cells at relatively high levels. Further, CNN showed a weak but significant direct inhibitory effect on the enzymatic activity of tyrosinase, suggesting one possible mechanism of hypopigmentation. While a slight reduction in tyrosinase expression was observed, tyrosinase expression was maintained at significant levels, processed into a mature form, and transported to late-stage melanosomes. Immunocytochemical analysis demonstrated that CNN treatment induced drastic morphological changes of Pmel17-positive and LAMP-1-positive organelles within B16 cells, suggesting that CNN is a potent organelle modulator. Colocalization of both tyrosinase- positive and LAMP-1-positive regions in CNN-treated cells indicated possible degradation of tyrosinase in LAMP-1-positive organelles; however, that possibility was ruled out by subsequent inhibition experiments. Taken together, this study opens a new paradigm of functional oligosaccharides, and offers CNN as a novel hypopigmenting molecule and organelle modulator.	[Nakamura, Shuji; Kunikata, Toshio; Matsumoto, Yohsuke; Hanaya, Toshiharu; Harashima, Akira; Nishimoto, Tomoyuki; Ushio, Shimpei] Hayashibara Co Ltd, R&D Ctr, Okayama, Japan		Nakamura, S (corresponding author), Hayashibara Co Ltd, R&D Ctr, Okayama, Japan.	shuji.nakamura@hb.nagase.co.jp		Nakamura, Shuji/0000-0001-6286-884X				Aga H, 2003, J BIOSCI BIOENG, V95, P215, DOI 10.1263/jbb.95.215; Aga H, 2002, J BIOSCI BIOENG, V94, P336, DOI 10.1263/jbb.94.336; Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Arora A, 2004, FEBS LETT, V564, P121, DOI 10.1016/S0014-5793(04)00326-6; BIELY P, 1994, EUR J BIOCHEM, V226, P633, DOI 10.1111/j.1432-1033.1994.tb20090.x; Bissig C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091438; Bradbrook GM, 2000, CARBOHYD RES, V329, P655, DOI 10.1016/S0008-6215(00)00212-3; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Busca R, 1996, J BIOL CHEM, V271, P31824, DOI 10.1074/jbc.271.50.31824; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; COTE GL, 1994, EUR J BIOCHEM, V226, P641, DOI 10.1111/j.1432-1033.1994.tb20091.x; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Fenyvesi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084856; Fujita H, 2009, J INVEST DERMATOL, V129, P1489, DOI 10.1038/jid.2008.376; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; Hashimoto T., 2006, Journal of Applied Glycoscience, V53, P233; IMOKAWA G, 1982, CANCER RES, V42, P1994; KNAPP PE, 1990, J CELL SCI, V95, P433; KOBAYASHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P1861, DOI 10.1271/bbb.59.1861; KUSHIBE S, 1995, BIOSCI BIOTECH BIOCH, V59, P31, DOI 10.1271/bbb.59.31; Land EJ, 2004, METHOD ENZYMOL, V378, P88; Lazova R, 2009, EXP DERMATOL, V18, P934, DOI 10.1111/j.1600-0625.2009.00933.x; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Lu Y, 2002, PIGM CELL RES, V15, P454, DOI 10.1034/j.1600-0749.2002.02065.x; Mayer AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38586; Miyake M, 2010, BIOSCI BIOTECH BIOCH, V74, P753, DOI 10.1271/bbb.90795; Ni-Komatsu L, 2008, J INVEST DERMATOL, V128, P1236, DOI 10.1038/sj.jid.5701163; Nishimoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P1806, DOI 10.1271/bbb.66.1806; Otani T, 2005, EXP HEMATOL, V33, P632, DOI 10.1016/j.exphem.2005.03.006; Raposo GA, 2002, CELL STRUCT FUNCT, V27, P443, DOI 10.1247/csf.27.443; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski RM, 2015, EXP DERMATOL, V24, P258, DOI 10.1111/exd.12618; SWANSON J, 1987, P NATL ACAD SCI USA, V84, P1921, DOI 10.1073/pnas.84.7.1921; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Watanabe K., 2004, J APPL GLYCOSCI, V51, P345; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016841	44	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186640	10.1371/journal.pone.0186640	http://dx.doi.org/10.1371/journal.pone.0186640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045474	gold, Green Submitted, Green Published			2022-12-26	WOS:000413168100083
J	Sood, C; Francis, AC; Desai, TM; Melikyan, GB				Sood, Chetan; Francis, Ashwanth C.; Desai, Tanay M.; Melikyan, Gregory B.			An improved labeling strategy enables automated detection of single-virus fusion and assessment of HIV-1 protease activity in single virions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						confocal microscopy; FRET; retrovirus; single particle analysis; virus entry; HIV maturation; live-cell imaging; fusion pore	MEMBRANE-FUSION; PARTICLE FUSION; PORE FORMATION; LIVING CELLS; HEMIFUSION; MATURATION; VISUALIZATION; GLYCOPROTEIN; ENDOCYTOSIS; ENDOSOMES	Enveloped viruses transfer their genomes into host cells by fusing their membrane to that of the cell. To visualize single-virus fusion in living cells, researchers take advantage of the proteolytic maturation of HIV, type 1 (HIV-1), which can generate free fluorescent proteins within the viral particle. Co-labeling viruses with a content marker and a fluorescently tagged Vpr (a viral core protein) enables detection of single-virus fusions, but a major limitation of this approach is that not all viral particles incorporate both markers. Here we designed a labeling strategy based on the bifunctional mCherry-2xCL-YFP-Vpr construct, in which 2xCL denotes a tandem cleavage site for the viral protease. This bifunctional marker was efficiently cleaved during virus maturation, producing free mCherry and the core-associated YFP-Vpr. A nearly perfect colocalization of these two markers in virions and their fixed 1:1 ratio enabled automated detection of single-particle fusion in both fixed and live cells based on loss of the mCherry signal. Furthermore, a drop in FRET efficiency between YFP and mCherry because of cleavage of the bifunctional marker, which manifested as a marked shift in the normalized YFP/mCherry fluorescence ratio, reliably predicted viral protease activity in single virions. This feature could discriminate between the particles containing free mCherry, and therefore likely representing mature viruses, and immature particles whose fusion cannot be detected. In summary, our new labeling strategy offers several advantages compared with previous approaches, including increased reliability and throughput of detection of viral fusion. We anticipate that our method will have significant utility for studying viral fusion and maturation.	[Sood, Chetan; Francis, Ashwanth C.; Desai, Tanay M.; Melikyan, Gregory B.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Desai, Tanay M.] Carl Zeiss Microscopy, Thornwood, NY 10594 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Carl Zeiss AG	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.; Melikyan, GB (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Francis, Ashwanth Christopher/N-5730-2018	Francis, Ashwanth Christopher/0000-0002-8663-2038	National Institutes of Health [R01 GM054787, R01 AI053668]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM054787 and R01 AI053668 (to G. B. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akrap N, 2010, ANAL BIOCHEM, V402, P105, DOI 10.1016/j.ab.2010.03.026; Banerjee I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068450; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Desai TM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0215-z; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Francis AC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005709; Francis AC, 2014, AIDS RES HUM RETROV, V30, P717, DOI [10.1089/aid.2013.0277, 10.1089/AID.2013.0277]; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Jiang JY, 2006, VIROLOGY, V346, P460, DOI 10.1016/j.virol.2005.11.008; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Jones DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13449; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Mamede JI, 2017, P NATL ACAD SCI USA, V114, pE7169, DOI 10.1073/pnas.1706245114; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Matos PM, 2013, J BIOL CHEM, V288, P12416, DOI 10.1074/jbc.M113.462028; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Oum YH, 2016, J VIROL METHODS, V233, P62, DOI 10.1016/j.jviromet.2016.02.016; Padilla-Parra S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-47; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Padilla-Parra S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002694; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Santos CD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005897; Simmons JA, 2016, J VIROL, V90, P605, DOI 10.1128/JVI.01828-15; Sood C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148944; Spence JS, 2016, MBIO, V7, DOI 10.1128/mBio.01857-15; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	44	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20196	20207		10.1074/jbc.M117.818088	http://dx.doi.org/10.1074/jbc.M117.818088			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29046351	hybrid, Green Published			2022-12-26	WOS:000417696400024
J	Chng, YR; Ong, JLY; Ching, B; Chen, XL; Hiong, KC; Wong, WP; Chew, SF; Lam, SH; Ip, YK				Chng, You R.; Ong, Jasmine L. Y.; Ching, Biyun; Chen, Xiu L.; Hiong, Kum C.; Wong, Wai P.; Chew, Shit F.; Lam, Siew H.; Ip, Yuen K.			Molecular characterization of three Rhesus glycoproteins from the gills of the African lungfish, Protopterus annectens, and effects of aestivation on their mRNA expression levels and protein abundance	PLOS ONE			English	Article							PHOSPHATE SYNTHETASE-III; INCREASED UREA SYNTHESIS; AMMONIA EXCRETION; RH GLYCOPROTEINS; NITROGEN-METABOLISM; ESCHERICHIA-COLI; SKELETAL-MUSCLE; MUCUS COCOON; FISH GILLS; DOLLOI	African lungfishes are ammonotelic in water. They can aestivate for long periods on land during drought. During aestivation, the gills are covered with dried mucus and ammonia excretion ceases. In fishes, ammonia excretion through the gills involves Rhesus glycoproteins (RhGP/Rhgp). This study aimed to obtain the complete cDNA coding sequences of rhgp from the gills of Protopterus annectens, and to determine their branchial mRNA and protein expression levels during the induction, maintenance and arousal phases of aestivation. Three isoforms of rhgp (rhag, rhbg and rhcg) were obtained in the gills of P. annectens. Their complete cDNA coding sequences ranged between 1311 and 1398 bp, coding for 436 to 465 amino acids with estimated molecular masses between 46.8 and 50.9 kDa. Dendrogramic analyses indicated that Rhag was grouped closer to fishes, while Rhbg and Rhcg were grouped closer to tetrapods. During the induction phase, the protein abundance of Rhag, but not its transcript level, was down-regulated in the gills, suggesting that there could be a decrease in the release of ammonia from the erythrocytes to the plasma. Furthermore, the branchial transcript levels of rhbg and rhcg decreased significantly, in preparation for the subsequent shutdown of gill functions. During the maintenance phase, the branchial expression levels of rhag/Rhag, rhbg/Rhbg and rhcg/Rhcg decreased significantly, indicating that their transcription and translation were down-regulated. This could be part of an overall mechanism to shut down branchial functions and save metabolic energy used for transcription and translation. It could also be regarded as an adaptive response to stop ammonia excretion. During the arousal phase, it is essential for the lungfish to regain the ability to excrete ammonia. Indeed, the protein abundance of Rhag, Rhbg and Rhcg recovered to the corresponding control levels after 1 day or 3 days of recovery from 6 months of aestivation.	[Chng, You R.; Ong, Jasmine L. Y.; Ching, Biyun; Chen, Xiu L.; Hiong, Kum C.; Wong, Wai P.; Lam, Siew H.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore, Singapore; [Lam, Siew H.] Natl Univ Singapore, NUS Environm Res Inst, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; National University of Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	dbsipyk@nus.edu.sg	Chew, Shit Fun/I-2248-2012; Ip, Yuen Kwong/H-8041-2012	Chew, Shit Fun/0000-0003-4599-5817; Ip, Yuen Kwong/0000-0001-9124-7911	Singapore National Research Foundation [1301-IRIS-23]; Singapore Ministry of Education [R154-000-429-112]	Singapore National Research Foundation(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore)	This study was supported in part by the Singapore National Research Foundation administered by the PUB through a grant (1301-IRIS-23) to S. H. Lam and Y. K. Ip, and by the Singapore Ministry of Education through a grant (R154-000-429-112) to Y. K. Ip. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WIRES COMPUT STAT, DOI DOI 10.1002/WMTS.105; Baday S, 2015, STRUCTURE, V23, P1550, DOI 10.1016/j.str.2015.06.010; Bakouh N, 2006, TRANSFUS CLIN BIOL, V13, P139, DOI 10.1016/j.tracli.2006.02.008; Braun MH, 2009, J EXP BIOL, V212, P3846, DOI 10.1242/jeb.034157; Chew S.F., 2015, PHYLOGENY ANATOMY PH, P81; Chew SF, 2003, J EXP BIOL, V206, P3615, DOI 10.1242/jeb.00619; Chew SF, 2004, J EXP BIOL, V207, P777, DOI 10.1242/jeb.00813; Ching BY, 2014, FASEB J, V28, P3506, DOI 10.1096/fj.14-249508; Chng YR, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00071; Chng YR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00532; Chng YR, 2014, J COMP PHYSIOL B, V184, P835, DOI 10.1007/s00360-014-0842-z; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Frick N. T., 2010, BIOL LUNGFISHES, P301; Frick NT, 2008, COMP BIOCHEM PHYS A, V151, P85, DOI 10.1016/j.cbpa.2008.06.003; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hiong KC, 2015, J EXP BIOL, V218, P3717, DOI 10.1242/jeb.125260; Hiong KC, 2014, J COMP PHYSIOL B, V184, P571, DOI 10.1007/s00360-014-0809-0; Huang C. H., 2008, HAEMATOLOGICA, V2, P149; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Huang CH, 2010, CELL MOL LIFE SCI, V67, P1203, DOI 10.1007/s00018-009-0217-x; Icardo JM, 2008, J ANAT, V213, P106, DOI 10.1111/j.1469-7580.2008.00901.x; Icardo JM, 2012, ANAT REC, V295, P60, DOI 10.1002/ar.21476; Ip YK, 2010, PROG MOL SUBCELL BIO, V49, P63, DOI 10.1007/978-3-642-02421-4_4; Ip YK, 2005, J EXP ZOOL PART A, V303A, P1054, DOI 10.1002/jez.a.237; Ip YK, 2005, J EXP ZOOL PART A, V303A, P272, DOI 10.1002/jez.a.165; Jacobson MP, 2014, TRENDS BIOCHEM SCI, V39, P363, DOI 10.1016/j.tibs.2014.05.006; JANSSENS PA, 1968, COMP BIOCHEM PHYSIOL, V24, P887, DOI 10.1016/0010-406X(68)90800-1; JANSSENS PA, 1968, COMP BIOCHEM PHYSIOL, V24, P879, DOI 10.1016/0010-406X(68)90799-8; JANSSENS PA, 1966, SCIENCE, V152, P358, DOI 10.1126/science.152.3720.358; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; Loong AM, 2008, J COMP PHYSIOL B, V178, P351, DOI 10.1007/s00360-007-0228-6; Loong AM, 2005, J EXP ZOOL PART A, V303A, P354, DOI 10.1002/jez.a.147; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; Nakada T, 2007, FASEB J, V21, P1067, DOI 10.1096/fj.06-6834com; Ojeda JL, 2008, ANAT REC, V291, P1156, DOI 10.1002/ar.20729; Ong JLY, 2017, J COMP PHYSIOL B, V187, P575, DOI 10.1007/s00360-017-1057-x; Ong JLY, 2015, COMP BIOCHEM PHYS B, V183, P30, DOI 10.1016/j.cbpb.2014.12.007; Perry SF, 2010, J EXP BIOL, V213, P3656, DOI 10.1242/jeb.045955; Storey KB, 2010, PROG MOL SUBCELL BIO, V49, P25, DOI 10.1007/978-3-642-02421-4_2; Sturla M, 2001, CELL TISSUE RES, V303, P351, DOI 10.1007/s004410000341; Weihrauch D, 2009, J EXP BIOL, V212, P1716, DOI 10.1242/jeb.024851; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; Wilkie MP, 1997, COMP BIOCHEM PHYS A, V118, P39, DOI 10.1016/S0300-9629(96)00407-0; Wilkie MP, 2002, J EXP ZOOL, V293, P284, DOI 10.1002/jez.10123; Wright PA, 2012, RESP PHYSIOL NEUROBI, V184, P231, DOI 10.1016/j.resp.2012.07.003; Wright PA, 2009, J EXP BIOL, V212, P2303, DOI 10.1242/jeb.023085; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	55	4	4	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0185814	10.1371/journal.pone.0185814	http://dx.doi.org/10.1371/journal.pone.0185814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073147	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400007
J	Fischer, C; Lingsma, H; Klazinga, N; Hardwick, R; Cromwell, D; Steyerberg, E; Groene, O				Fischer, Claudia; Lingsma, Hester; Klazinga, Niek; Hardwick, Richard; Cromwell, David; Steyerberg, Ewout; Groene, Oliver			Volume-outcome revisited: The effect of hospital and surgeon volumes on multiple outcome measures in oesophago-gastric cancer surgery	PLOS ONE			English	Article							ADJUSTED SURGICAL OUTCOMES; OPERATIVE MORTALITY; ANASTOMOTIC LEAKAGE; BREAST-CANCER; QUALITY; RISK; ESOPHAGECTOMY; NETHERLANDS; IMPROVEMENT; 30-DAY	Background Most studies showing a volume outcome effect in resection surgery for oesophago-gastric cancer were conducted before the centralisation of clinical services. This study evaluated the relation between hospital-and surgeon volume and different risk-adjusted outcomes after oesophago-gastric (OG) cancer surgery in England between 2011 and 2013. Methods In data from the National Oesophago-Gastric Cancer Audit from the UK, multivariable random-effects logistic regression models were used to quantify the effect of surgeon and hospital volume on three outcomes: 30-day and 90-day mortality and anastomotic leakage. The models included patient risk factors to adjust for differences in case-mix among hospitals and surgeons. The between-cluster heterogeneity was estimated with the median odds ratio (MOR). Results The study included patients treated at 42 hospitals and 329 surgeons. The median (interquartile range) of the annual hospital and surgeon volumes were 110 patients (82 to 137) and 13 patients (8 to 19), respectively. The overall rates for 30-day and 90-day mortality were 2.3% and 4.4% respectively, and the anastomotic leakage was 6.3%. Higher hospital volume was associated with lower 30-day mortality (OR: 0.94; 95% CI: 0.91-0.98) and lower anastomotic leakage rates (OR: 0.96; 95% CI: 0.93-0.98) but not 90-day mortality. Higher surgeon volume was only associated with lower anastomotic leakage rates (OR: 0.81; 95% CI: 0.72-0.92). Hospital volume explained a part of the between-hospital variation in 30-day mortality whereas surgeon volume explained part of the between-hospital variation in anastomotic leakage. Conclusions In the setting of centralized O-G cancer surgery in England, we could still observe an effect of volume on short-term outcomes. However, the effect is inconsistent, depending on the type of outcome measure under consideration, and much smaller than in previous studies. Efforts to centralise O-G cancer services further should carefully address the effects of both hospital and surgeon volume on the range of outcome measures that are relevant to patients.	[Fischer, Claudia; Lingsma, Hester; Steyerberg, Ewout] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Klazinga, Niek] Amsterdam Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Hardwick, Richard] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Oesophagogastr Ctr, Cambridge, England; [Cromwell, David; Groene, Oliver] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Groene, Oliver] OptiMedis AG, Hamburg, Germany; [Fischer, Claudia] Inst Adv Studies Hlth Econ & Hlth Policy, Vienna, Austria	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Groene, O (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England.; Groene, O (corresponding author), OptiMedis AG, Hamburg, Germany.	oliver.groene@lshtm.ac.uk	Cromwell, David/AAD-6519-2019; Hardwick, Richard Henry/H-8859-2019	Fischer, Claudia/0000-0001-7574-8097	NHS England; Welsh Government; Health Department of the Scottish Government; DHSSPS Northern Ireland; Channel Islands	NHS England; Welsh Government; Health Department of the Scottish Government; DHSSPS Northern Ireland; Channel Islands	The National Oesophago-Gastric Cancer Audit is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit Programme (NCA). HQIP is led by a consortium of the Academy of Medical Royal Colleges, the Royal College of Nursing and National Voices. Its aim is to promote quality improvement, and in particular to increase the impact that clinical audit has on healthcare quality in England and Wales. HQIP holds the contract to manage and develop the NCA Programme, comprising more than 30 clinical audits that cover care provided to people with a wide range of medical, surgical and mental health conditions. The programme is funded by NHS England, the Welsh Government and, with some individual audits, also funded by the Health Department of the Scottish Government, DHSSPS Northern Ireland and the Channel Islands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken LH, 2003, JAMA-J AM MED ASSOC, V290, P1617, DOI 10.1001/jama.290.12.1617; Almoudaris AM, 2013, GUT, V62, P423, DOI 10.1136/gutjnl-2011-301489; [Anonymous], [No title captured]; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, 2010, GUID MIN SURG VOL; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Brusselaers N, 2014, GUT, V63, P1393, DOI 10.1136/gutjnl-2013-306074; Daley J, 2001, ANNU REV MED, V52, P275, DOI 10.1146/annurev.med.52.1.275; Daley J, 1997, J AM COLL SURGEONS, V185, P341, DOI 10.1016/S1072-7515(97)00091-4; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Dudley RA, 2001, SURGERY, V130, P425, DOI 10.1067/msy.2001.117136; Epstein AM, 2002, NEW ENGL J MED, V346, P1161, DOI 10.1056/NEJM200204113461512; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Finlayson EVA, 2003, ARCH SURG-CHICAGO, V138, P721, DOI 10.1001/archsurg.138.7.721; Fischer C, 2015, EUR J SURG ONCOL; Fischer C LH, 2015, DEV CASE MIX CORRECT; Gooiker GA, 2011, ANN SURG ONCOL, V18, P1821, DOI 10.1245/s10434-010-1511-4; Gort M, 2007, BREAST CANCER RES TR, V102, P219, DOI 10.1007/s10549-006-9327-4; Hannan EL, 2002, SURGERY, V131, P6, DOI 10.1067/msy.2002.120238; Hardwick G GO, 2013, NATL OESOPHAGOGASTRI; Junemann-Ramirez M, 2005, EUR J CARDIO-THORAC, V27, P3, DOI 10.1016/j.ejcts.2004.09.018; Khuri SF, 2001, SURGERY, V130, P429, DOI 10.1067/msy.2001.117138; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lee HS, 2012, NUTR RES PRACT, V6, P294, DOI 10.4162/nrp.2012.6.4.294; Lingsma HF, 2010, QJM-INT J MED, V103, P99, DOI 10.1093/qjmed/hcp169; Low DE, 2015, ANN SURG, V262, P286, DOI 10.1097/SLA.0000000000001098; McMillan RR, 2014, ANN THORAC SURG, V98, P1769, DOI 10.1016/j.athoracsur.2014.06.024; Modrall JG, 2011, J VASC SURG, V54, P1599, DOI 10.1016/j.jvs.2011.05.103; Natioanl Oesophago-Gastric Cancer Audit. Natioanal Oesophago-Gastric Cancer Audit, 2012, 3 NAT OES GASTR CANC; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Rutegard M, 2015, ANN SURG ONCOL; Snijders HS, 2013, BMJ QUAL SAF, V22, P759, DOI 10.1136/bmjqs-2012-001644; Talsma AK, 2014, ANN SURG, V260, P267, DOI 10.1097/SLA.0000000000000482	33	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0183955	10.1371/journal.pone.0183955	http://dx.doi.org/10.1371/journal.pone.0183955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073140	Green Published, Green Accepted, gold			2022-12-26	WOS:000413845400002
J	Flamme, I; Ellinghaus, P; Urrego, D; Kruger, T				Flamme, Ingo; Ellinghaus, Peter; Urrego, Diana; Krueger, Thilo			FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; GROWTH-FACTOR 23; CHRONIC KIDNEY-DISEASE; IRON-DEFICIENCY; MICE; ANEMIA; BONE	Plasma levels of FGF23 are increased in patients with chronic kidney disease. Beside its role in phosphate homeostasis, iron deficiency and anemia are associated with increased FGF23 plasma levels. Recently, FGF23 plasma levels were shown to be increased in mice after treatment with hypoxia inducible factor-proline hydroxylase (HIF-PH) inhibitors which are strong inducers of erythropoietin and erythropoiesis and are known to modulate iron uptake and availability. Therefore we investigated a potential context between expression of FGF23 and stimulation of erythropoiesis using a HIF-PH inhibitor and erythropoietin in rats. FGF23 plasma levels are induced at peak levels 2 h after intravenous injection of recombinant human Erythropoietin (rhEPO). Likewise induction of endogenous EPO using a HIF-PH inhibitor (BAY 85-3934) is followed by an increase of FGF23 plasma levels. In contrast to rhEPO the HIF-PH inhibitor induces lower peak levels of FGF23 applying equivalent hematopoietic doses. Bone and bone marrow were identified as sources of EPO-induced FGF23. Immediate induction of FGF23 mRNA was also detected in EPO receptor positive murine hematopoietic BAF3 cells after treatment with rhEPO but not after treatment with the HIF-PH inhibitor. Pretreatment of mice with a neutralizing anti-EPO antibody abrogated FGF23 induction by the HIF-PH inhibitor. Thus, direct impact on FGF23 expression by HIF-PH inhibition in vivo via hypoxia mimicking and modulation of iron metabolism appears unlikely. Collectively, the findings point to an EPO dependent regulation pathway of FGF23 gene expression which might be important in the context of erythropoiesis stimulating therapies in patients with renal anemia.	[Flamme, Ingo; Urrego, Diana] Bayer AG, Drug Discovery, Pharmaceut, Therapeut Res Grp,Cardiol, Wuppertal, Germany; [Ellinghaus, Peter] Bayer AG, Drug Discovery, Biomarker Res, Pharmaceut,Therapeut Res Grp, Wuppertal, Germany; [Krueger, Thilo] Bayer AG, Dev, CD Cardiovasc, Drug Dev,Pharmaceut, Wuppertal, Germany	Bayer AG; Bayer AG; Bayer AG	Flamme, I (corresponding author), Bayer AG, Drug Discovery, Pharmaceut, Therapeut Res Grp,Cardiol, Wuppertal, Germany.	ingo.flamme@bayer.com			Bayer AG	Bayer AG(Bayer AG)	This study was funded by Bayer AG. All the authors are employees of Bayer AG. Bayer AG provided support in the form of salaries for all authors, and played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Bansal S, 2017, NEPHROL DIAL TRANSPL, V32, P960, DOI [10.1093/ndt/gfw376, 10.1093/ndt/gfx003]; Blau JE, 2015, REV ENDOCR METAB DIS, V16, P165, DOI 10.1007/s11154-015-9318-z; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; Ellinghaus P, 2005, J THORAC CARDIOV SUR, V129, P1383, DOI 10.1016/j.jtcvs.2004.08.031; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Flamme I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111838; Grabner A, 2017, CONTRIB NEPHROL, V190, P83, DOI 10.1159/000468952; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Hanudel M, 2016, J AM SOC NEPHROL, V27, p49A; Hiram-Bab S, 2017, CYTOKINE, V89, P155, DOI 10.1016/j.cyto.2016.01.008; Honda H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176984; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Kanbay M, 2017, CALCIFIED TISSUE INT, V100, P217, DOI 10.1007/s00223-016-0206-7; Leifheit-Nestler M, 2016, NEPHROL DIAL TRANSPL, V31, P1088, DOI 10.1093/ndt/gfv421; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Macdougall IC, 2016, NEPHROL DIAL TRANSPL, V31, P16; Mastrogiannaki M, 2012, HAEMATOL-HEMATOL J, V97, P827, DOI 10.3324/haematol.2011.056119; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; Nakashima Y, 2016, GROWTH FACTORS, V34, P196, DOI 10.1080/08977194.2016.1273222; Rauner M, 2016, J BONE MINER RES, V31, P1877, DOI 10.1002/jbmr.2857; Rinaudo D, 2000, BIOTECHNIQUES, V29, P218, DOI 10.2144/00292bm03; Saji F, 2009, NEPHRON PHYSIOL, V111, P59, DOI 10.1159/000210389; Thede K., 2008, Patent Application, Patent No. [2008067871, WO, 2008067871 A1]; Wolf M, 2014, CURR OPIN NEPHROL HY, V23, P411, DOI 10.1097/01.mnh.0000447020.74593.6f; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Wyatt CM, 2016, KIDNEY INT, V90, P923, DOI 10.1016/j.kint.2016.08.016; Yousaf F, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0629-6; Zhang Q, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.11	28	44	46	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186979	10.1371/journal.pone.0186979	http://dx.doi.org/10.1371/journal.pone.0186979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073196	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400089
J	Kumar, P; Ram, U				Kumar, Prakash; Ram, Usha			Patterns, factors associated and morbidity burden of asthma in India	PLOS ONE			English	Article							SELF-REPORTED ASTHMA; QUALITY-OF-LIFE; RISK-FACTORS; CHILDHOOD ASTHMA; PREVALENCE; ADULT; POPULATION; COMMUNITY; SYMPTOMS; CHILDREN	Background Asthma is a non-curable but preventable disease, responsible for higher morbidity worldwide. According to recent WHO report, nearly 235 million people are suffering from asthma leading to 383000 deaths in 2015. The burden of asthma morbidity is higher in developed countries and is increasing in developing countries. Objective The present study was aimed at studying the change in prevalence rate of asthma, associated risk factors and estimation of morbidity burden and avoidable cases of asthma in India. Methods The second round of Indian Human Development Survey (IHDS-II), 2011-12, was used for the study. For the present study, asthma was defines as ever diagnosed with asthma or having cough with short breath. Multiple-logistic regression was used to identify the possible risk factors associated with prevalence of reporting asthma. Population attributable fractions (PAFs) were computed to estimate the overall and risk factors specific burden of morbidity due to asthma using the extrapolated population of year 2015 using 2011 census. Results Overall prevalence rate of asthma increased from 41.9 (per 1000 population) in 2004-05 to 54.9 (per 1000 population) in 2011-12. The prevalence rate of reporting asthma was higher in poorer states compared to richer states, and also varied by sub-geographies, with higher prevalence rate in northern states of the country and lower rates in north-eastern states of the country. The odds of reporting asthma was higher for younger and older ages, individual with fewer years of schooling (OR: 1.41; 95% CI: 1.21-1.64) for individual with zero years of schooling compared to those with 11 or more years of schooling, individual from lower economic status, individual living in household using unclean fuels (OR: 1.21; 95% CI: 1.08-1.34) and smokers (OR: 1.34; 95% CI: 1.17-1.55) compared to their counterparts. In the year 2015, the overall morbidity burden of asthma was estimated at nearly 65 million and more than 82 thousand deaths were attributed due to asthma. The burden was highest among individuals living in households using solid fuels (firewood similar to 80%, Kerosene similar to 78%). One-third of the cases could be eliminated by minimising the use of any solid fuels. Around 17% of all the asthma cases in population could be attributed to underweight. Conclusion Eliminating the modifiable risk factors could help reduce in huge amount of asthma cases for example by providing education, cessation in smoking, and schemes like Pradhan Mantri Ujjwala Yojana (PMUY), by providing clean fuel (LPG) to poor and vulnerable households.	[Kumar, Prakash] Int Inst Populat Sci, Bombay, Maharashtra, India; [Ram, Usha] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Kumar, P (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	prakashkumar@iips.net	Kumar, Prakash/L-5419-2019; Ram, Usha/AAS-4140-2020	Ram, Usha/0000-0001-6722-7347				Aggarwal A N, 2006, Indian J Chest Dis Allied Sci, V48, P13; Agnihotram R., 2005, INTERNET J EPIDEMIOL, V2; Agrawal S, 2013, INT J TUBERC LUNG D, V17, P275, DOI 10.5588/ijtld.12.0438; Bates D. V, 1995, OBSERVATIONS ASTHMA, P243; Bhowmik S.K., 1979, EC POLIT WKLY, V14, P481; Brashier B, 2012, OPEN J RESP DIS, V02, P73, DOI DOI 10.4236/OJRD.2012.23011; Chowgule RV, 1998, AM J RESP CRIT CARE, V158, P547, DOI 10.1164/ajrccm.158.2.9708064; Davoodi P, 2013, INDIAN J MED RES, V138, P497; Douwes J, 2007, ALLERGY, V62, P1158, DOI 10.1111/j.1398-9995.2007.01490.x; Ford ES, 2003, CHEST, V123, P119, DOI 10.1378/chest.123.1.119; G. A. Network, 2014, GLOB ASTHM REP 2014; GIBSON PG, 1995, ARCH DIS CHILD, V73, P321, DOI 10.1136/adc.73.4.321; Haby MM, 2001, THORAX, V56, P589, DOI 10.1136/thorax.56.8.589; HAMMAN RF, 1975, BRIT J PREV SOC MED, V29, P228; Hoskins G, 2000, THORAX, V55, P19, DOI 10.1136/thorax.55.1.19; Huovinen E, 2003, RESP MED, V97, P273, DOI 10.1053/rmed.2003.1419; IHME, 2013, GLOB BURD DIS STUD 2; Jindal S. K., 2010, INDIAN STUDY EPIDEMI, P335; Kankaria Ankita, 2014, Indian J Community Med, V39, P203, DOI 10.4103/0970-0218.143019; Kaur B, 1998, BRIT MED J, V316, P118; Kotwani A, 2012, INDIAN J MED RES, V135, P184; Kumar Ganesh S, 2014, J Nat Sci Biol Med, V5, P59, DOI 10.4103/0976-9668.127289; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pal Ranabir, 2009, Indian J Community Med, V34, P310, DOI 10.4103/0970-0218.58389; Patra J, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2015-000121; Rowe AK, 2004, AM J PREV MED, V26, P243, DOI 10.1016/j.amepre.2003.12.007; SEIDMAN DS, 1991, ARCH DIS CHILD, V66, P584, DOI 10.1136/adc.66.5.584; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P569, DOI 10.1093/ije/dym007; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Vollmer RT, 1996, AM J CLIN PATHOL, V105, P115; von Kries R, 2001, ALLERGY, V56, P318, DOI 10.1034/j.1398-9995.2001.00727.x; WHO, 2011, ADDR 61 WORLD HLTH A	33	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0185938	10.1371/journal.pone.0185938	http://dx.doi.org/10.1371/journal.pone.0185938			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073132	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400008
J	Sastry, M; Zhang, BS; Chen, M; Joyce, MG; Kong, WP; Chuang, GY; Ko, K; Kumar, A; Silacci, C; Thom, M; Salazar, AM; Corti, D; Lanzavecchia, A; Taylor, G; Mascola, JR; Graham, BS; Kwong, PD				Sastry, Mallika; Zhang, Baoshan; Chen, Man; Joyce, M. Gordon; Kong, Wing-Pui; Chuang, Gwo-Yu; Ko, Kiyoon; Kumar, Azad; Silacci, Chiara; Thom, Michelle; Salazar, Andres M.; Corti, Davide; Lanzavecchia, Antonio; Taylor, Geraldine; Mascola, John R.; Graham, Barney S.; Kwong, Peter D.			Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; PARTICLE VACCINE; REVERSE GENETICS; YOUNG-WOMEN; COTTON RATS; INFECTION; IMMUNIZATION; CHALLENGE; INFLUENZA; EFFICACY	Appropriate adjuvant selection may be essential to optimize the potency and to tailor the immune response of subunit vaccines. To induce protective responses against respiratory syncytial virus (RSV)-a highly prevalent childhood pathogen without a licensed vaccine-we previously engineered a pre-fusion-stabilized trimeric RSV F (pre-F) "DS-Cav1" immunogen, which induced high titer RSV-neutralizing antibodies, in mice and non-human primates, when formulated with adjuvants Poly (I:C) and Poly (IC:LC), respectively. To assess the impact of different adjuvants, here we formulated RSV F DS-Cav1 with multiple adjuvants and assessed immune responses. Very high RSV-neutralizing antibody responses (19,006 EC50) were observed in naive mice immunized with 2 doses of DS-Cav1 adjuvanted with Sigma adjuvant system (SAS), an oil-in-water adjuvant, plus Carbopol; high responses (3658-7108) were observed with DS-Cav1 adjuvanted with Alum, SAS alone, Adjuplex, Poly (I: C) and Poly (IC: LC); and moderate responses (1251-2129) were observed with DS-Cav1 adjuvanted with the TLR4 agonist MPLA, Alum plus MPLA or AddaVax. In contrast, DS-Cav1 without adjuvant induced low-level responses (6). A balanced IgG1 and IgG2a (Th2/Th1) immune response was elicited in most of the high to very high response groups (all but Alum and Adjuplex). We also tested the immune response induced by DS-Cav1 in elderly mice with pre-existing DS-Cav1 immunity; we observed that DS-Cav1 adjuvanted with SAS plus Carbopol boosted the response 2-3-fold, whereas DS-Cav1 adjuvanted with alum boosted the response 5-fold. Finally, we tested whether a mixture of ISA 71 VG and Carbopol would enhanced the antibody response in DS-Cav1 immunized calves. While pre-F-stabilized bovine RSV F induced very high titers in mice when adjuvanted with SAS plus Carbopol, the addition of Carbopol to ISA 71 VG did not enhance immune responses in calves. The vaccine response to pre-F-stabilized RSV F is augmented by adjuvant, but the degree of adjuvant-induced enhancement appears to be both context-dependent and species-specific.	[Sastry, Mallika; Zhang, Baoshan; Chen, Man; Joyce, M. Gordon; Kong, Wing-Pui; Chuang, Gwo-Yu; Ko, Kiyoon; Kumar, Azad; Mascola, John R.; Graham, Barney S.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Silacci, Chiara; Corti, Davide; Lanzavecchia, Antonio] Inst Res Biomed, Bellinzona, Switzerland; [Thom, Michelle; Taylor, Geraldine] Pirbright Inst, Ash Rd, Woking GU24 0NF, Surrey, England; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA; [Corti, Davide] Humabs BioMed SA, Bellinzona, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universita della Svizzera Italiana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Mascola, John/AAI-7193-2021; Kumar, Azad/AAD-2093-2020; Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853; Thom, Michelle/0000-0002-5678-8760	Division of Intramural Research, National Institute of Allergy and Infectious Diseases-ZIA [AI005024-16]; Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Helmut Horten Foundation; BBSRC Institute Strategic Program on Livestock Viral Diseases at The Pirbright Institute; BBSRC [BBS/E/I/00001709] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001709] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005111, ZIAAI005024] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases-ZIA; Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Helmut Horten Foundation; BBSRC Institute Strategic Program on Livestock Viral Diseases at The Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Division of Intramural Research, National Institute of Allergy and Infectious Diseases-ZIA AI005024-16-Dr. Peter D. Kwong This work was supported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Helmut Horten Foundation; and the BBSRC Institute Strategic Program on Livestock Viral Diseases at The Pirbright Institute, where GT is a Jenner Investigator. D.C. is an employee of Humabs Biomed SA, a subsidiary of Vir Biotechnology, Inc. Humabs BioMed SA did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. A.S. is the founder of Oncovir, Inc. Oncovir did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank members of the Structural Biology Section and the Structural Bioinformatics Core at the Vaccine Research Center for helpful discussions and comments. We thank Jonathan Stuckey for assistance with figures and tables, and the Animal service staff at Animal and Plant Health Agency, Addlestone, Surrey, UK for their care of the experimental calves. This work was supported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Helmut Horten Foundation and the BBSRC Institute Strategic Program on Livestock Viral Diseases at The Pirbright Institute, where GT is a Jenner Investigator.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Boyington JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159709; Carter D, 2010, CURR OPIN HIV AIDS, V5, P409, DOI 10.1097/COH.0b013e32833d2cdb; Cherukuri A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-21; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Collins PL, 2013, CURR TOP MICROBIOL, V372, P3, DOI 10.1007/978-3-642-38919-1_1; De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Dowling JK, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.22; Drachenberg KJ, 2001, ALLERGY, V56, P498, DOI 10.1034/j.1398-9995.2001.056006498.x; Elliot AJ, 2008, EXPERT REV VACCINES, V7, P249, DOI 10.1586/14760584.7.2.249; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; GOLDING B, 1991, AIDS RES HUM RETROV, V7, P435, DOI 10.1089/aid.1991.7.435; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Green CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5745; GUALANDI GL, 1988, MICROBIOLOGICA, V11, P363; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Hertz T, 2017, J IMMUNOL, V198, P4025, DOI 10.4049/jimmunol.1700029; Hoogland MJ, 2006, J SWINE HEALTH PROD, V14, P133; Hotard AL, 2012, VIROLOGY, V434, P129, DOI 10.1016/j.virol.2012.09.022; Jeener E., 1798, 3 ORIGINAL PUBLICATI; Kim KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139916; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Lai RPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035083; Liang B, 2017, J VIROL, V91, DOI 10.1128/JVI.00189-17; Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Mehrotra S, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0459-2; Mumford JA, 2009, EPIDEMIOLOGY INFECT, V112, P421; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; MURPHY BR, 1989, VACCINE, V7, P533, DOI 10.1016/0264-410X(89)90278-8; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Polack FP, 2007, PEDIATR RES, V62, P111, DOI 10.1203/PDR.0b013e3180686ce0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Schneider-Ohrum K, 2017, J VIROL, V91, DOI 10.1128/JVI.02180-16; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Stegmann T, 2010, VACCINE, V28, P5543, DOI 10.1016/j.vaccine.2010.06.041; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Stewart-Jones GBE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128779; Thoelen S, 2001, VACCINE, V19, P2400, DOI 10.1016/S0264-410X(00)00462-X; Tollersrud T, 2002, VET RES COMMUN, V26, P587, DOI 10.1023/A:1020960402112; Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712; Wang YF, 2012, J BIOL CHEM, V287, P17152, DOI 10.1074/jbc.M112.347179; Wegmann F, 2015, CLIN VACCINE IMMUNOL, V22, P1004, DOI 10.1128/CVI.00736-14; Zhang BS, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0005-9	51	31	31	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186854	10.1371/journal.pone.0186854	http://dx.doi.org/10.1371/journal.pone.0186854			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073183	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400061
J	Vatter, T; Maurer, A; Kopahnke, D; Perovic, D; Ordon, F; Pillen, K				Vatter, Thomas; Maurer, Andreas; Kopahnke, Doris; Perovic, Dragan; Ordon, Frank; Pillen, Klaus			A nested association mapping population identifies multiple small effect QTL conferring resistance against net blotch (Pyrenophora teres f. teres) in wild barley	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; ADULT-PLANT RESISTANCE; NORTHERN LEAF-BLIGHT; GENETIC ARCHITECTURE; TRIGGERED SUSCEPTIBILITY; SEEDLING RESISTANCE; DISEASE RESISTANCE; NAM POPULATION; MAJOR GENES	The net form of net blotch caused by the necrotrophic fungus Pyrenophora teres f. teres is a major disease of barley, causing high yield losses and reduced malting and feed quality. Exploiting the allelic richness of wild barley proved to be a valuable tool to broaden the genetic base of resistance of modern elite cultivars. In this study, a SNP-based nested association mapping (NAM) study was conducted to map QTL for P. teres resistance in the barley population HEB-25 comprising 1,420 lines derived from BC1S3 generation. By scoring the percentage of infected leaf area followed by calculation of the average ordinate (AO) and scoring of the reaction type (RT) in two-year field trials a large variability of net blotch resistance across and within families of HEB-25 was observed. Genotype response to net blotch infection showed a range of 48.2% for AO (0.9-49.1%) and 6.4 for RT (2.2-8.6). NAM based on 5,715 informative SNPs resulted in the identification of 24 QTL for resistance against net blotch. Out of these, six QTL are considered novel showing no correspondence to previously reported QTL for net blotch resistance. Overall, variation of net blotch resistance in HEB-25 turned out to be controlled by small effect QTL. Results indicate the presence of alleles in HEB-25 differing in their effect on net blotch resistance. Results provide valuable information regarding the genetic architecture of the complex barley-P. teres f. teres interaction as well as for the improvement of net blotch resistance of elite barley cultivars.	[Vatter, Thomas; Kopahnke, Doris; Perovic, Dragan; Ordon, Frank] Fed Res Ctr Cultivated Plants, Julius Kuehn Inst, Inst Resistance Res & Stress Tolerance, Quedlinburg, Germany; [Maurer, Andreas; Pillen, Klaus] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany	Julius Kuhn-Institut; Martin Luther University Halle Wittenberg	Pillen, K (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany.	klaus.pillen@landw.uni-halle.de	Perovic, Dragan G/C-1149-2008; Pillen, Klaus/I-6511-2012	Perovic, Dragan G/0000-0002-0292-1693; Pillen, Klaus/0000-0003-4646-6351; Maurer, Andreas/0000-0002-2916-7475	German Research Foundation (DFG) through the European ERA-NET Coordinating Action in Plant Sciences (ERA-CAPS) [OR72/10-1 (BARLEY-NAM_ERACAPS13.098)]; German Research Foundation (DFG) through the priority program 1530 "Flowering time control: from natural variation to crop improvement" grant [P1339/7-1, P1339/7-2]; German Research Foundation (DFG) [P1339/7-1, P1339/7-2, OR72/10-1, P1339/8-1]	German Research Foundation (DFG) through the European ERA-NET Coordinating Action in Plant Sciences (ERA-CAPS)(German Research Foundation (DFG)); German Research Foundation (DFG) through the priority program 1530 "Flowering time control: from natural variation to crop improvement" grant(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	TV was funded by the German Research Foundation (DFG) through the European ERA-NET Coordinating Action in Plant Sciences (ERA-CAPS) grants OR72/10-1 (BARLEY-NAM_ERACAPS13.098). AM was funded by the German Research Foundation (DFG) through the priority program 1530 "Flowering time control: from natural variation to crop improvement" grants P1339/7-1 and P1339/7-2. We thank the German Research Foundation (DFG) for financial support (grants OR72/10-1; P1339/7-1, P1339/7-2 and P1339/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Qamar M, 2008, THEOR APPL GENET, V117, P1261, DOI 10.1007/s00122-008-0860-x; Afanasenko O, 2007, EUR J PLANT PATHOL, V117, P267, DOI 10.1007/s10658-006-9093-5; [Anonymous], 2016, BSA BUNDESSORTENAMT; Bajgain P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155760; Balint-Kurti PJ, 2010, CROP SCI, V50, P458, DOI 10.2135/cropsci2009.02.0066; BOCKELMAN HE, 1977, CAN J BOT, V55, P2142, DOI 10.1139/b77-242; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cakir M, 2003, AUST J AGR RES, V54, P1369, DOI 10.1071/AR02229; CANTALAPIEDRA CP, 2015, MOL BREEDING, V35; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Douiyssi A, 1998, PLANT DIS, V82, P316, DOI 10.1094/PDIS.1998.82.3.316; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Friesen TL, 2006, GENOME, V49, P855, DOI 10.1139/G06-024; Graner A, 1996, EUPHYTICA, V91, P229; Grewal TS, 2008, THEOR APPL GENET, V116, P529, DOI 10.1007/s00122-007-0688-9; Grewal TS, 2012, MOL BREEDING, V30, P267, DOI 10.1007/s11032-011-9616-4; Gupta S, 2010, PLANT BREEDING, V129, P362, DOI 10.1111/j.1439-0523.2009.01716.x; Gupta S, 2011, PLANT BREEDING, V130, P423, DOI 10.1111/j.1439-0523.2011.01854.x; Haffner E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-235; Ho KM, 1996, CAN J PLANT SCI, V76, P715, DOI 10.4141/cjps96-123; Islamovic E, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0621-0; Jordan DR, 2011, CROP SCI, V51, P1444, DOI 10.2135/cropsci2010.06.0326; Konig J, 2013, MOL BREEDING, V32, P641, DOI 10.1007/s11032-013-9897-x; Konig J, 2014, PLANT BREEDING, V133, P356, DOI 10.1111/pbr.12147; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lehmensiek A, 2007, AUST J AGR RES, V58, P1191, DOI 10.1071/AR07141; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li HH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01674; Liu W, 2011, THEOR APPL GENET, V123, P545, DOI 10.1007/s00122-011-1606-8; Liu ZH, 2015, MOL PLANT PATHOL, V16, P188, DOI 10.1111/mpp.12172; Liu ZH, 2011, MOL PLANT PATHOL, V12, P1, DOI 10.1111/j.1364-3703.2010.00649.x; Liu ZH, 2010, PLANT GENOME-US, V3, P41, DOI 10.3835/plantgenome2010.02.0002; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127699; Ma ZQ, 2004, EUPHYTICA, V137, P291, DOI 10.1023/B:EUPH.0000040441.36990.58; Manninen O, 2000, MOL GEN GENET, V264, P325, DOI 10.1007/s004380000326; Manninen OM, 2006, GENOME, V49, P1564, DOI 10.1139/G06-119; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mathre D. E., 1997, COMPENDIUM BARLEY DI; Maurer A, 2017, HEREDITY, V118, P477, DOI 10.1038/hdy.2016.121; Maurer A, 2016, J EXP BOT, V67, P2507, DOI 10.1093/jxb/erw070; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Moll E, 2010, BERICHTE J KUHN I, V154; Murray GM, 2010, AUSTRALAS PLANT PATH, V39, P85, DOI 10.1071/AP09064; Nice LM, 2016, GENETICS, V203, P1453, DOI 10.1534/genetics.116.190736; O'Boyle PD, 2014, CROP SCI, V54, P2596, DOI 10.2135/cropsci2013.08.0514; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Peiffer JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067066; Pierre SS, 2010, PHYTOPATHOLOGY, V100, P80, DOI 10.1094/PHYTO-100-1-0080; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Richards JK, 2017, THEOR APPL GENET, P1; Richards J, 2016, G3-GENES GENOM GENET, V6, P1809, DOI 10.1534/g3.116.028902; Richter K, 1998, THEOR APPL GENET, V97, P1225, DOI 10.1007/s001220051014; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Saade S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32586; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schweizer P, 2011, MOL PLANT MICROBE IN, V24, P1492, DOI 10.1094/MPMI-05-11-0107; Serfling A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01668; STEFFENSON BJ, 1992, PHYTOPATHOLOGY, V82, P407, DOI 10.1094/Phyto-82-407; STEFFENSON BJ, 1992, PHYTOPATHOLOGY, V82, P170, DOI 10.1094/Phyto-82-170; Steffenson BJ, 1996, THEOR APPL GENET, V92, P552, DOI 10.1007/BF00224557; Tamang P, 2015, PHYTOPATHOLOGY, V105, P500, DOI 10.1094/PHYTO-04-14-0106-R; TEKAUZ A, 1985, CAN J PLANT PATHOL, V7, P181, DOI 10.1080/07060668509501499; TEKAUZ A, 1990, CAN J PLANT PATHOL, V12, P141, DOI 10.1080/07060669009501017; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Utz HF, 2000, GENETICS, V154, P1839; Veronese P, 2003, PLANT J, V35, P574, DOI 10.1046/j.1365-313X.2003.01830.x; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Yaniv E, 2014, ANN C COST SUST ZAKO, V2; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245	77	31	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186803	10.1371/journal.pone.0186803	http://dx.doi.org/10.1371/journal.pone.0186803			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073176	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400055
J	Auguet, T; Aragones, G; Berlanga, A; Martinez, S; Sabench, F; Binetti, J; Aguilar, C; Porras, JA; Molina, A; Del Castillo, D; Richart, C				Auguet, Teresa; Aragones, Gemma; Berlanga, Alba; Martinez, Salome; Sabench, Fatima; Binetti, Jessica; Aguilar, Carmen; Porras, Jose Antonio; Molina, Alicia; Del Castillo, Daniel; Richart, Cristobal			Hepcidin in morbidly obese women with nonalcoholic fatty liver disease	PLOS ONE			English	Article							SERUM HEPCIDIN; IRON OVERLOAD; HEPATIC IRON; INSULIN-RESISTANCE; GENE-EXPRESSION; STEATOHEPATITIS; METABOLISM; CHILDREN; INFLAMMATION; ASSOCIATION	Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries. Both iron and lipid metabolism seem to be involved in its pathogenesis. We aimed to assess the relationship between levels of hepcidin, the master ironregulatory protein, in plasma and the presence of NAFLD in morbidly obese (MO) patients, and to investigate the association between the hepatic expression of the main iron and lipid metabolism - related genes. Materials and methods Enzyme-linked immunosorbent assay was used to measure plasma hepcidin levels in 49 normal-weight control women, 23 MO women with normal liver (NL) histology and 46 MO women with NAFLD. The mRNA expression of hepcidin, the main iron metabolism-related genes, and the main lipid-metabolism genes was quantified by qRT-PCR in liver biopsies from members of the MO group undergoing bariatric surgery. Results Circulating hepcidin levels were significantly greater in MO than in normal-weight control women. However, there were no significant differences between MO women with NL and those with NAFLD. PCR analysis showed increased expression of hepcidin, FPN1, TfR1 and TfR2 in the liver of MO NAFLD women compared to those with NL. Moreover, a positive association of hepatic hepcidin mRNA expression and the iron metabolism-related genes was found with some key genes involved in the lipid metabolism. Conclusion These findings suggest that circulating hepcidin levels are associated with obesity but not with the presence of NAFLD. However, the hepatic expression of hepcidin and the iron metabolism-related genes seem to play a role in regulating lipid metabolism pathways in liver, which has implications for NAFLD pathogenesis.	[Auguet, Teresa; Aragones, Gemma; Berlanga, Alba; Aguilar, Carmen; Richart, Cristobal] URV, IISPV, Grp Recerca GEMMAIR AGAUR Med Aplicada, Dept Med & Cirurg, Tarragona, Spain; [Auguet, Teresa; Binetti, Jessica; Porras, Jose Antonio; Richart, Cristobal] Hosp Univ Joan XXIII, Serv Med Interna, Tarragona, Spain; [Martinez, Salome] Hosp Univ Joan XXIII, Serv Anat Patol, Tarragona, Spain; [Sabench, Fatima; Molina, Alicia; Del Castillo, Daniel] URV, Hosp Univ Sant Joan, IISPV, Dept Med & Cirurg,Serv Cirurg, Reus, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Auguet, T; Richart, C (corresponding author), URV, IISPV, Grp Recerca GEMMAIR AGAUR Med Aplicada, Dept Med & Cirurg, Tarragona, Spain.; Auguet, T; Richart, C (corresponding author), Hosp Univ Joan XXIII, Serv Med Interna, Tarragona, Spain.	tauguet.hj23.ics@gencat.cat; crichart.hj23.ics@gencat.cat	Auguet, Teresa/AAC-5838-2020; Binetti, Jessica/AAC-5815-2020; Porras, José Antonio/ABU-0274-2022; Carmen, Aguilar Crespillo/AAC-6209-2020; RICHART, CRISTOBAL C/S-9158-2017; Aragones, Gemma/A-9693-2013	Auguet, Teresa/0000-0003-0396-6428; Binetti, Jessica/0000-0001-9660-7752; Carmen, Aguilar Crespillo/0000-0002-4440-562X; RICHART, CRISTOBAL C/0000-0003-0852-6739; Aragones, Gemma/0000-0002-1924-9231; Sabench, Fatima/0000-0002-9262-8756; MOLINA, ALICIA/0000-0003-4227-0706; Porras Ledantes, Jose Antonio/0000-0001-6418-1822	Fondo de Investigacion Sanitaria (FEDER) [PI116/00498]; Agenda de Gestio d'Ajuts Universitaris de Recerca [AGAUR 2009 SGR 959]; Grup de Recerca en Medicina Aplicada URV [2016 PFR-URV-B2-72]; Fundacion Biociencia	Fondo de Investigacion Sanitaria (FEDER); Agenda de Gestio d'Ajuts Universitaris de Recerca; Grup de Recerca en Medicina Aplicada URV; Fundacion Biociencia	This study was supported by the Fondo de Investigacion Sanitaria (FEDER, Grant Number PI116/00498 to Teresa Auguet), the Agenda de Gestio d'Ajuts Universitaris de Recerca (AGAUR 2009 SGR 959 to Cristobal Richart), the Grup de Recerca en Medicina Aplicada URV (2016 PFR-URV-B2-72 to Cristobal Richart) and the Fundacion Biociencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146; Ahmed U, 2012, WORLD J GASTROENTERO, V18, P4651, DOI 10.3748/wjg.v18.i34.4651; Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Aigner E, 2015, WORLD J HEPATOL, V7, P177, DOI 10.4254/wjh.v7.i2.177; Aigner E, 2014, NUTRIENTS, V6, P3587, DOI 10.3390/nu6093587; Amato A, 2010, INT J OBESITY, V34, P1772, DOI 10.1038/ijo.2010.204; Andrews M, 2015, NUTRITION, V31, P51, DOI 10.1016/j.nut.2014.04.019; Auguet T, 2016, INT J MOL SCI, V17, P1; Auguet T, 2014, INT J MOL SCI, V15, P22173, DOI 10.3390/ijms151222173; Barisani D, 2008, J HEPATOL, V49, P123, DOI 10.1016/j.jhep.2008.03.011; Beaton MD, 2013, ALIMENT PHARM THER, V37, P720, DOI 10.1111/apt.12255; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; Boga S, 2015, J GASTROINTEST LIVER, V24, P293, DOI 10.15403/jgld.2014.1121.243.hak; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Buzzetti E, 2016, METABOLISM, P1; Cheng HL, 2012, OBES REV, V13, P150, DOI 10.1111/j.1467-789X.2011.00938.x; De Minicis S, 2013, CURR PHARM DESIGN, V19, P5239; del Giudice EM, 2009, J CLIN ENDOCR METAB, V94, P5102, DOI 10.1210/jc.2009-1361; Demircioglu F, 2014, EUR J PEDIATR, V173, P947, DOI 10.1007/s00431-014-2268-8; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fargion S, 2001, AM J GASTROENTEROL, V96, P2448, DOI 10.1111/j.1572-0241.2001.04052.x; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; Graham RM, 2010, HEPATOLOGY, V52, P462, DOI 10.1002/hep.23712; Handa P, 2017, ANN HEPATOL, V16, P77, DOI 10.5604/16652681.1226818; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kirsch R, 2006, LIVER INT, V26, P1258, DOI 10.1111/j.1478-3231.2006.01329.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee Sang Hyub, 2010, Korean J Hepatol, V16, P288, DOI 10.3350/kjhep.2010.16.3.288; Lu SZ, 2015, J BIOL CHEM, V290, P24178, DOI 10.1074/jbc.M115.648212; Lui J, 2016, MEDICINE BLATIMORE, V95, P1; Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048250; Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x; Moreno-navarrete M, 2016, CLIN NUTR, P31262; Nai A, 2011, BLOOD, V118, P4459, DOI 10.1182/blood-2011-06-364034; Nemeth Elizabeta, 2010, Expert Rev Hematol, V3, P153, DOI 10.1586/ehm.10.1; Noureddin M, 2015, EXP BIOL MED, V240, P809, DOI 10.1177/1535370215579161; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Senates E, 2011, METAB SYNDR RELAT D, V9, P287, DOI 10.1089/met.2010.0121; Terra X, 2013, OBESITY, V21, P170, DOI 10.1002/oby.20233; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tsuchiya H, 2010, HEPATOL RES, V40, P1227, DOI 10.1111/j.1872-034X.2010.00719.x; Tussing-Humphreys LM, 2010, OBESITY, V18, P2010, DOI 10.1038/oby.2009.490; Tussing-Humphreys LM, 2010, OBESITY, V18, P1449, DOI 10.1038/oby.2009.319; Uysal S, 2011, CLIN BIOCHEM, V44, P1375, DOI 10.1016/j.clinbiochem.2011.09.017; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Vuppalanchi R, 2014, OBESITY, V22, P836, DOI 10.1002/oby.20403; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zimmermann A, 2011, EUR J INTERN MED, V22, P305, DOI 10.1016/j.ejim.2011.01.011	52	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0187065	10.1371/journal.pone.0187065	http://dx.doi.org/10.1371/journal.pone.0187065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065180	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900066
J	Vaghefi, N; Kikkert, JR; Bolton, MD; Hanson, LE; Secor, GA; Nelson, SC; Pethybridge, SJ				Vaghefi, Niloofar; Kikkert, Julie R.; Bolton, Melvin D.; Hanson, Linda E.; Secor, Gary A.; Nelson, Scot C.; Pethybridge, Sarah J.			Global genotype flow in Cercospora beticola populations confirmed through genotyping-by-sequencing	PLOS ONE			English	Article							SUGAR-BEET; LEAF-SPOT; SEXUAL REPRODUCTION; GENETIC DIVERSITY; MICROSATELLITES; CONSERVATION; MARKERS; DIFFERENTIATION; DISPERSAL; GENOMICS	Genotyping-by-sequencing (GBS) was conducted on 333 Cercospora isolates collected from Beta vulgaris (sugar beet, table beet and swiss chard) in the USA and Europe. Cercospora beticola was confirmed as the species predominantly isolated from leaves with Cercospora leaf spot (CLS) symptoms. However, C. cf. flagellaris also was detected at a frequency of 3% in two table beet fields in New York. Resolution of the spatial structure and identification of clonal lineages in C. beticola populations using genome-wide single nucleotide polymorphisms (SNPs) obtained from GBS was compared to genotyping using microsatellites. Varying distance thresholds (bitwise distance = 0, 1.854599 x 10(-4), and 1.298 x 10(-3)) were used for delineation of clonal lineages in C. beticola populations. Results supported previous reports of long distance dispersal of C. beticola through genotype flow. The GBS-SNP data set provided higher resolution in discriminating clonal lineages; however, genotype identification was impacted by filtering parameters and the distance threshold at which the multilocus genotypes (MLGs) were contracted to multi-locus lineages. The type of marker or different filtering strategies did not impact estimates of population differentiation and structure. Results emphasize the importance of robust filtering strategies and designation of distance thresholds for delineating clonal lineages in population genomics analyses that depend on individual assignment and identification of clonal lineages. Detection of recurrent clonal lineages shared between the USA and Europe, even in the relaxed-filtered SNP data set and with a conservative distance threshold for contraction of MLGs, provided strong evidence for global genotype flow in C. beticola populations. The implications of intercontinental migration in C. beticola populations for CLS management are discussed.	[Vaghefi, Niloofar; Pethybridge, Sarah J.] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14850 USA; [Kikkert, Julie R.] Cornell Cooperat Extens, Canandaigua, NY USA; [Bolton, Melvin D.] USDA ARS, Red River Valley Agr Res Ctr, Fargo, ND USA; [Bolton, Melvin D.; Secor, Gary A.] North Dakota State Univ, Dept Plant Pathol, Fargo, ND USA; [Hanson, Linda E.] Michigan State Univ, USDA ARS, Sugar Beet & Bean Res Unit, E Lansing, MI 48824 USA; [Nelson, Scot C.] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA	Cornell University; Cornell University; United States Department of Agriculture (USDA); North Dakota State University Fargo; Michigan State University; United States Department of Agriculture (USDA); University of Hawaii System; University of Hawaii Manoa	Pethybridge, SJ (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14850 USA.	sjp277@cornell.ed.au	Vaghefi, Niloofar/GLS-1601-2022; Vaghefi, Niloofar/B-2349-2019	Vaghefi, Niloofar/0000-0003-0430-4856; Hanson, Linda/0000-0002-0375-2940	United States Department of Agriculture, National Institute of Food and Agriculture Hatch project [NYG-625424]; Federal Capacity Funds Initiative [2015-16-118]; NYSAES Directors Controlled Endowment Fund	United States Department of Agriculture, National Institute of Food and Agriculture Hatch project; Federal Capacity Funds Initiative; NYSAES Directors Controlled Endowment Fund	This research was supported by the United States Department of Agriculture, National Institute of Food and Agriculture Hatch project NYG-625424, and the Federal Capacity Funds Initiative (2015-16-118) managed by the New York State Agricultural Experiment Station (NYSAES), Cornell University, Geneva, New York, USA, and the NYSAES Directors Controlled Endowment Fund.	Agarwal P., 2006, PLANT HLTH PROG; Andrews KR, 2016, NATURE REV GENETICS, V17, P92, DOI DOI 10.1038/NRG.2015.28; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Biasi A, 2016, PHYTOPATHOLOGY, V106, P1006, DOI 10.1094/PHYTO-11-15-0299-R; Bolton MD, 2012, FUNGAL BIOL-UK, V116, P511, DOI 10.1016/j.funbio.2012.01.011; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; BYFORD WJ, 1985, T BRIT MYCOL SOC, V84, P21, DOI 10.1016/S0007-1536(85)80215-1; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DeFaveri J, 2013, MOL ECOL RESOUR, V13, P377, DOI 10.1111/1755-0998.12071; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; du Toit L. J., 2007, CROP PROFILE TABLE B; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fischer MC, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3459-7; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Granevitze Z, 2014, ANIM GENET, V45, P87, DOI 10.1111/age.12088; Groenewald JZ, 2013, STUD MYCOL, P115, DOI 10.3114/sim0012; Groenewald M, 2008, PLANT PATHOL, V57, P25, DOI 10.1111/j.1365-3059.2007.01697.x; Groenewald M, 2005, PHYTOPATHOLOGY, V95, P951, DOI 10.1094/PHYTO-95-0951; Groenewald M, 2007, MOL ECOL NOTES, V7, P890, DOI 10.1111/j.1471-8286.2007.01739.x; Groenewald M, 2006, FUNGAL GENET BIOL, V43, P813, DOI 10.1016/j.fgb.2006.05.008; Grunwald NJ, 2006, PHYTOPATHOLOGY, V96, P1134, DOI 10.1094/PHYTO-96-1134; Grunwald NJ, 2016, ANNU REV PHYTOPATHOL, V54, P323, DOI 10.1146/annurev-phyto-080614-115913; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hansen ZR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165690; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Jeffries DL, 2016, MOL ECOL, V25, P2997, DOI 10.1111/mec.13613; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Khan J, 2008, PLANT DIS, V92, P741, DOI 10.1094/PDIS-92-5-0741; Knaus B. J., 2016, BIORXIV, V041277, DOI 10.1101/041277; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Landegren U, 1998, GENOME RES, V8, P769, DOI 10.1101/gr.8.8.769; LAWRENCE JS, 1970, PHYTOPATHOLOGY, V60, P1076, DOI 10.1094/Phyto-60-1076; Lehner MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173915; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MANTEL N, 1967, CANCER RES, V27, P209; Mascheretti S, 2008, MOL ECOL, V17, P2755, DOI 10.1111/j.1365-294X.2008.03773.x; McDonald BA, 2015, PLANT PATHOL, V64, P1005, DOI 10.1111/ppa.12415; McKay MB, 1918, PHYTOPATHOLOGY, V8, P119; MEREDITH DS, 1967, PHYTOPATHOLOGY, V57, P889; Mesak F, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00074; Milgroom MG, 2003, PLANT DIS, V87, P608, DOI 10.1094/PDIS.2003.87.6.608; Milgroom MG., 2015, POPULATION BIOL PLAN; Milgroom MG, 2016, PHYTOPATHOLOGY, V106, P1038, DOI 10.1094/PHYTO-11-15-0300-R; Milgroom MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106740; Moretti M, 2006, ANN MICROBIOL, V56, P215, DOI 10.1007/BF03175008; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Nagel CM, 1938, PHYTOPATHOLOGY, V28, P342; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; NEI M, 1978, GENETICS, V89, P583; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; Ozerov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082434; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 2000, GENETICS, V155, P945; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; Ryynanen HJ, 2007, J HERED, V98, P692, DOI 10.1093/jhered/esm093; Schilling MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095292; Schoebel CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085368; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SOLEL Z, 1970, T BRIT MYCOL SOC, V54, P504, DOI 10.1016/S0007-1536(70)80173-5; Sornmerhalder RJ, 2010, PHYTOPATHOLOGY, V100, P855, DOI 10.1094/PHYTO-100-9-0855; Summers CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143665; Summers CF, 2015, CAN J PLANT PATHOL, V37, P315, DOI 10.1080/07060661.2015.1053989; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Turgay EB, 2010, PLANT PATHOLOGY J, V26, P306, DOI 10.5423/PPJ.2010.26.4.306; Vaghefi N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01929-4; Vaghefi N, 2017, FUNGAL ECOL, V26, P125, DOI 10.1016/j.funeco.2017.01.006; Vaghefi N, 2016, PLANT DIS, V100, P1466, DOI 10.1094/PDIS-09-15-1014-RE; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Vercauteren A, 2010, MOL ECOL, V19, P92, DOI 10.1111/j.1365-294X.2009.04443.x; Vereijssen J, 2007, PHYTOPATHOLOGY, V97, P1550, DOI 10.1094/PHYTO-97-12-1550; Vereijssen J, 2006, EUR J PLANT PATHOL, V116, P187, DOI 10.1007/s10658-006-9046-z; Vestal EF, 1933, RES B, P168; Weiland J., 2001, PHYTOPATHOLOGY, V91, P94; Winter DJ, 2012, MOL ECOL RESOUR, V12, P1158, DOI 10.1111/j.1755-0998.2012.03174.x	91	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186488	10.1371/journal.pone.0186488	http://dx.doi.org/10.1371/journal.pone.0186488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065114	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000413568900015
J	Piralla, A; Lunghi, G; Ruggiero, L; Girello, A; Bianchini, S; Rovida, F; Caimmi, S; Marseglia, GL; Principi, N; Baldanti, F; Esposito, S				Piralla, Antonio; Lunghi, Giovanna; Ruggiero, Luca; Girello, Alessia; Bianchini, Sonia; Rovida, Francesca; Caimmi, Silvia; Marseglia, Gian Luigi; Principi, Nicola; Baldanti, Fausto; Esposito, Susanna			Molecular epidemiology of influenza B virus among hospitalized pediatric patients in Northern Italy during the 2015-16 season	PLOS ONE			English	Article							HEMAGGLUTININ	Background The influenza B viruses belong to two lineages distinguished by their genetic and antigenic characteristics, which are referred to as the Yamagata and Victoria lineages, designated after their original isolates, B/Yamagata/16/88 and B/Victoria/2/87. The primary aim of this study was to evaluate the molecular characteristics of influenza B viruses circulating in a region of Northern Italy, Lombardia, during the influenza season of 2015-2016. Methods Influenza B virus was detected using a respiratory virus panel of assays and an influenza B-specific real-time polymerase chain reaction. The complete influenza B hemagglutinin (HA) gene was amplified and sequenced directly from clinical specimens. Phylogenetic analysis was performed using nucleotide sequences. Results A total of 71 hospitalized pediatric patients were influenza B positive. Phylogenetic analysis showed that the great majority of influenza B strains (66/71, 93.0%) belonged to the Victoria- lineage and were antigenically like vaccine strain (B/Brisbane/60/2008) included only in the quadrivalent vaccine. In the detected influenza B strains, a series of amino acid changes were observed in the antigenic regions: I117V, V124A, N129D, V146I, N197D, T199A, and A202T. However, only 2 amino acid changes were observed in the HA regions involved in receptor binding or in antibody recognition. Conclusions All the influenza B strains identified in this study belonged to the influenza B Victoria lineage not included in the trivalent vaccine commonly used by the general population during the 2015-2016 influenza season in Italy. This indicates that protection against influenza B infection in the vaccinated population was in general very poor during the 2015-2016 influenza season.	[Piralla, Antonio; Girello, Alessia; Rovida, Francesca; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Microbiol & Virol Dept, Pavia, Italy; [Lunghi, Giovanna] Politecn Milan, UOS Virol, IRCCS Fdn Ca Granda Osped Maggiore, Milan, Italy; [Ruggiero, Luca; Bianchini, Sonia; Principi, Nicola; Esposito, Susanna] Politecn Milan, Pediat Highly Intens Care Unit, IRCCS Fdn Ca Granda Osped Maggiore, Milan, Italy; [Ruggiero, Luca; Bianchini, Sonia; Principi, Nicola; Esposito, Susanna] Univ Milan, Milan, Italy; [Caimmi, Silvia; Marseglia, Gian Luigi] Univ Pavia, Pediat Clin, Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Baldanti, Fausto] Univ Pavia, Clin Surg Diagnost & Pediat Sci, Pavia, Italy; [Esposito, Susanna] Univ Perugia, Pediat Clin, Perugia, Italy	IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; Polytechnic University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Polytechnic University of Milan; University of Milan; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Perugia	Esposito, S (corresponding author), Politecn Milan, Pediat Highly Intens Care Unit, IRCCS Fdn Ca Granda Osped Maggiore, Milan, Italy.; Esposito, S (corresponding author), Univ Milan, Milan, Italy.; Esposito, S (corresponding author), Univ Perugia, Pediat Clin, Perugia, Italy.	susanna.esposito@unimi.it	Caimmi, Silvia/AHH-2804-2022; Girello, Alessia/J-5350-2018; Lunghi, Giovanna/AAL-5384-2020; Esposito, Susanna/AAA-8275-2022; MARSEGLIA, GIAN LUIGI/AAL-2254-2020; Rovida, Francesca/K-7984-2016; Baldanti, Fausto/J-4924-2018; Piralla, Antonio/K-4756-2018; Esposito, Susanna/K-3475-2016	Caimmi, Silvia/0000-0003-0515-524X; Girello, Alessia/0000-0002-9498-157X; MARSEGLIA, GIAN LUIGI/0000-0003-3662-0159; Rovida, Francesca/0000-0003-2345-2790; Baldanti, Fausto/0000-0002-3358-8969; Piralla, Antonio/0000-0002-6062-2579; Esposito, Susanna/0000-0003-4103-2837	Italian Ministry of Health (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) [2016 850/01]; Italian Ministry of Health (Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente) [80622]	Italian Ministry of Health (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico); Italian Ministry of Health (Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente)	This study was financially supported by Italian Ministry of Health (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Ricerca Corrente Grant 2016 850/01 and Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente, Grant 80622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr IG, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.4.30118; Centers for Disease Control and Prevention, QUADR INFL VACC; Centers for Disease Control and Prevention, SEAS INFL VACC EFF 2; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; European Centre for Disease Prevention and Control (ECDC), 2016, SURVEILLANCE REPORT; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; Piralla A, 2014, DIAGN MICR INFEC DIS, V79, P183, DOI 10.1016/j.diagmicrobio.2014.02.010; Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Principi N, 2015, HUM VACC IMMUNOTHER, V11, P2350, DOI 10.1080/21645515.2015.1055428; Saito T, 2004, J MED VIROL, V74, P336, DOI 10.1002/jmv.20178; Tewawong N, 2017, INFECT GENET EVOL, V47, P35, DOI 10.1016/j.meegid.2016.11.010; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Wang QH, 2007, P NATL ACAD SCI USA, V104, P16874, DOI 10.1073/pnas.0708363104; World Health Organization, WHO REC COMP INFL VI	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185893	10.1371/journal.pone.0185893	http://dx.doi.org/10.1371/journal.pone.0185893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049310	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900028
J	Scott, AJ; Rowse, G; Webb, TL				Scott, Alexander J.; Rowse, Georgina; Webb, Thomas L.			A structural equation model of the relationship between insomnia, negative affect, and paranoid thinking	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; ANXIETY STRESS SCALES; PSYCHIATRIC-DISORDERS; PERSECUTORY DELUSIONS; EMOTION REGULATION; SLEEP DISTURBANCE; PSYCHOSIS CONTINUUM; SAMPLE-SIZE; DEPRESSION; METAANALYSIS	Background A growing body of evidence points to relationships between insomnia, negative affect, and paranoid thinking. However, studies are needed to examine (i) whether negative affect mediates the relation between insomnia and paranoid thinking, (ii) whether different types of insomnia exert different effects on paranoia, and (iii) to compare the impact of objective and self-reported sleeping difficulties. Method Structural equation modelling was therefore used to test competing models of the relationships between self-reported insomnia, negative affect, and paranoia. n = 348 participants completed measures of insomnia, negative affect and paranoia. A subset of these participants (n = 91) went on to monitor their sleep objectively (using a portable sleep monitor made by Zeo) for seven consecutive nights. Associations between objectively recorded sleep, negative affect, and paranoia were explored using linear regression. Results The findings supported a fully mediated model where self-reported delayed sleep onset, but not self-reported problems with sleep maintenance or objective measures of sleep, was directly associated with negative affect that, in turn, was associated with paranoia. There was no evidence of a direct association between delayed sleep onset or sleep maintenance problems and paranoia. Conclusions Taken together, the findings point to an association between perceived (but not objective) difficulties initially falling asleep (but not maintaining sleep) and paranoid thinking; a relationship that is fully mediated by negative affect. Future research should seek to disentangle the causal relationships between sleep, negative affect, and paranoia (e.g., by examining the effect of an intervention using prospective designs that incorporate experience sampling). Indeed, interventions might profitably target (i) perceived sleep quality, (ii) sleep onset, and/or (iii) emotion regulation as a route to reducing negative affect and, thus, paranoid thinking.	[Scott, Alexander J.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Rowse, Georgina] Univ Sheffield, Clin Psychol Unit, Sheffield, S Yorkshire, England; [Webb, Thomas L.] Univ Sheffield, Dept Psychol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Scott, AJ (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England.	alex.scott@sheffield.ac.uk	Webb, Thomas/E-8946-2010; Scott, Alexander/B-1947-2016	Webb, Thomas/0000-0001-9320-0068; Scott, Alexander/0000-0001-7426-7099				Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; [Anonymous], 2012, STAT METHODS VALIDAT; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arbuckle J.L., 2013, AMOS VERSION 22 0; Argyropoulos SV, 2003, PSYCHIAT RES, V120, P179, DOI 10.1016/S0165-1781(03)00187-2; Asarnow LD, 2013, CURR OPIN PSYCHIATR, V26, P566, DOI 10.1097/YCO.0b013e328365a2fa; Baglioni C, 2016, SLEEP MENTAL DISORDE; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Baker FC, 1999, J PSYCHOSOM RES, V47, P335, DOI 10.1016/S0022-3999(99)00017-3; Bandalos DL, 2002, STRUCT EQU MODELING, V9, P78, DOI 10.1207/S15328007SEM0901_5; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Basto M, 2012, J STAT SOFTW, V46, P1; Bebbington P, 2007, ADULT PSYCHIAT MORBI; Bebbington PE, 2013, BRIT J PSYCHIAT, V202, P419, DOI 10.1192/bjp.bp.112.119032; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; BRABBINS CJ, 1993, INT J GERIATR PSYCH, V8, P473, DOI 10.1002/gps.930080604; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chan MS, 2017, SLEEP MED REV, V32, P69, DOI 10.1016/j.smrv.2016.03.001; Clarke G, 2015, BEHAV RES THER, V69, P111, DOI 10.1016/j.brat.2015.04.009; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Dudley R, 2016, SCHIZOPHRENIA BULL, V42, P652, DOI 10.1093/schbul/sbv150; Field A.P., 2020, DISCOVERING STAT USI, V4th; Finney SJ, NONNORMAL CATEGORICA; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Fowler D, 2012, SCHIZOPHRENIA BULL, V38, P1063, DOI 10.1093/schbul/sbr019; Freeman D, 2002, BRIT J CLIN PSYCHOL, V41, P331, DOI 10.1348/014466502760387461; Freeman D, 2005, BRIT J PSYCHIAT, V186, P427, DOI 10.1192/bjp.186.5.427; Freeman D, 2000, BRIT J CLIN PSYCHOL, V39, P407, DOI 10.1348/014466500163400; Freeman D, 2017, LANCET PSYCHIAT; Freeman D, 2016, LANCET PSYCHIAT, V3, P685, DOI 10.1016/S2215-0366(16)00066-3; Freeman D, 2015, LANCET PSYCHIAT, V2, P975, DOI 10.1016/S2215-0366(15)00314-4; Freeman D, 2012, SOC PSYCH PSYCH EPID, V47, P1195, DOI 10.1007/s00127-011-0433-1; Freeman D, 2010, J PSYCHIATR RES, V44, P1021, DOI 10.1016/j.jpsychires.2010.03.018; Freeman D, 2009, SCHIZOPHR RES, V108, P280, DOI 10.1016/j.schres.2008.12.001; Green CEL, 2008, PSYCHOL MED, V38, P101, DOI 10.1017/S0033291707001638; Grezellschak S, 2016, J BEHAV THE IN PRESS; Grezellschak S, 2017, J BEHAV THER EXP PSY, V56, P27, DOI 10.1016/j.jbtep.2016.08.001; Guastella AJ, 2007, PERS INDIV DIFFER, V42, P1151, DOI 10.1016/j.paid.2006.04.028; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Harvey AG, 2015, J CONSULT CLIN PSYCH, V83, P564, DOI 10.1037/a0038655; Harvey AG, 2012, PSYCHOL BULL, V138, P77, DOI 10.1037/a0025730; Hau KT, 2004, BRIT J MATH STAT PSY, V57, P327, DOI 10.1111/j.2044-8317.2004.tb00142.x; Hektner J. M., 2007, EXPERIENCE SAMPLING, DOI [10.4135/9781412984201, DOI 10.4135/9781412984201]; Hennig T, 2017, CHILD PSYCHIAT HUMAN, P1; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; IBM Corp, IBM SPSS STAT WIND V; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kendler KS, 2009, PSYCHOL MED, V39, P881, DOI 10.1017/S0033291708004467; Kim K, 2000, SLEEP, V23, P41; Kramer I, 2014, SCHIZOPHRENIA BULL, V40, P278, DOI 10.1093/schbul/sbs194; Lancee J, 2012, BEHAV RES THER, V50, P22, DOI 10.1016/j.brat.2011.09.012; Lincoln TM, 2009, PSYCHOL MED, V39, P1129, DOI 10.1017/S0033291708004613; Lincoln TM, 2010, SCHIZOPHRENIA BULL, V36, P1140, DOI 10.1093/schbul/sbp029; Linscott RJ, 2010, ANNU REV CLIN PSYCHO, V6, P391, DOI 10.1146/annurev.clinpsy.032408.153506; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Manber R, 2011, J CLIN SLEEP MED, V7, P645, DOI 10.5664/jcsm.1472; Marsh HW, 1998, MULTIVAR BEHAV RES, V33, P181, DOI 10.1207/s15327906mbr3302_1; Michels F., 2014, INT J DREAM RES, V7, P9, DOI DOI 10.11588/IJODR.2014.1.11819; Monti JM, 2013, PROG NEURO-PSYCHOPH, V43, P209, DOI 10.1016/j.pnpbp.2012.12.021; Morphy H, 2007, SLEEP, V30, P274; Mulligan LD, 2016, J ABNORM PSYCHOL, V125, P788, DOI 10.1037/abn0000180; Myers E, 2011, J BEHAV THER EXP PSY, V42, P330, DOI 10.1016/j.jbtep.2011.02.004; Nevitt J, 2001, STRUCT EQU MODELING, V8, P353, DOI 10.1207/S15328007SEM0803_2; Newman AB, 1997, J AM GERIATR SOC, V45, P1; NICASSIO PM, 1985, BEHAV RES THER, V23, P263, DOI 10.1016/0005-7967(85)90004-X; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Pai ALH, 2007, J PEDIATR PSYCHOL, V32, P288, DOI 10.1093/jpepsy/jsl021; Pillai V, 2015, SLEEP AND AFFECT ASS; Pillai V, 2014, J PSYCHOSOM RES, V77, P70, DOI 10.1016/j.jpsychores.2014.05.004; QUERASALVA MA, 1991, SLEEP, V14, P386, DOI 10.1093/sleep/14.5.386; Raiche G., 2006, INT ANN M PSYCH SOC; Reeve S, 2017, SCHIZOPHRENIA B; Reeve S, 2015, CLIN PSYCHOL REV, V42, P96, DOI 10.1016/j.cpr.2015.09.001; Riedel BW, 2000, SLEEP MED REV, V4, P277, DOI 10.1053/smrv.1999.0074; Ross RM, 2015, SCHIZOPHRENIA BULL, V41, P1183, DOI 10.1093/schbul/sbu187; Rotenberg VS, 2000, INT J PSYCHOPHYSIOL, V37, P291, DOI 10.1016/S0167-8760(00)00110-0; Roth T, 2007, J CLIN SLEEP MED, V3, pS7, DOI [10.5664/jcsm.26929, DOI 10.5664/JCSM.26929]; Ruscio J, 2012, PSYCHOL ASSESSMENT, V24, P282, DOI 10.1037/a0025697; Shambroom JR, 2012, J SLEEP RES, V21, P221, DOI 10.1111/j.1365-2869.2011.00944.x; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Sheaves B, 2016, SLEEP, V39, P173, DOI 10.5665/sleep.5342; Sheaves B, 2015, CAN J PSYCHIAT, V60, P354, DOI 10.1177/070674371506000804; SPIEGELHALDER K, 2013, CURR PSYCHIAT REP, V15; Spoormaker Victor I, 2005, Behav Sleep Med, V3, P227, DOI 10.1207/s15402010bsm0304_4; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Thewissen V, 2011, BRIT J CLIN PSYCHOL, V50, P178, DOI 10.1348/014466510X508677; Thomsen DK, 2003, PERS INDIV DIFFER, V34, P1293, DOI 10.1016/S0191-8869(02)00120-4; Thomsen DK, 2006, COGNITION EMOTION, V20, P1216, DOI 10.1080/02699930500473533; Tonetti L, 2013, BIOL RHYTHM RES, V44, P333, DOI 10.1080/09291016.2012.692252; van Os J, 2000, SCHIZOPHR RES, V45, P11, DOI 10.1016/S0920-9964(99)00224-8; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Prooijen JW, 2001, EDUC PSYCHOL MEAS, V61, P777, DOI 10.1177/00131640121971518; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Vitiello MV, 2004, J PSYCHOSOM RES, V56, P503, DOI 10.1016/S0022-3999(04)00023-6; Vorontsova N, 2013, J ABNORM PSYCHOL, V122, P1121, DOI 10.1037/a0034952; Wagley JN, 2013, J CLIN PSYCHOL, V69, P1043, DOI 10.1002/jclp.21927; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Watanabe N, 2011, J CLIN PSYCHIAT, V72, P1651, DOI 10.4088/JCP.10m06130gry; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; WEST LJ, 1962, ANN NY ACAD SCI, V96, P66, DOI 10.1111/j.1749-6632.1962.tb50101.x; West S. G., 1995, STRUCTURAL EQUATION, P56; Westermann S, 2014, PSYCHOL PSYCHOTHER-T, V87, P1, DOI 10.1111/papt.12000; Westermann S, 2013, COGNITIVE THER RES, V37, P881, DOI 10.1007/s10608-013-9523-6; Westermann S, 2012, BEHAV THER, V43, P329, DOI 10.1016/j.beth.2011.07.005; Westermann S, 2011, PSYCHOL PSYCHOTHER-T, V84, P273, DOI 10.1348/147608310X523019; Westland JC, 2010, ELECTRON COMMER R A, V9, P476, DOI 10.1016/j.elerap.2010.07.003; Winkelman JW, 2001, J CLIN PSYCHIAT, V62, P8, DOI 10.4088/JCP.v62n0103; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; Wulff K, 2012, BRIT J PSYCHIAT, V200, P308, DOI 10.1192/bjp.bp.111.096321; Zoccola PM, 2009, PSYCHOSOM MED, V71, P771, DOI 10.1097/PSY.0b013e3181ae58e8; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	120	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186233	10.1371/journal.pone.0186233	http://dx.doi.org/10.1371/journal.pone.0186233			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0UN	29049381	gold, Green Accepted, Green Published			2022-12-26	WOS:000413195900051
J	Vystavna, Y; Hejzlar, J; Kopacek, J				Vystavna, Yuliya; Hejzlar, Josef; Kopacek, Jiri			Long-term trends of phosphorus concentrations in an artificial lake: Socio-economic and climate drivers	PLOS ONE			English	Article							CENTRAL-EUROPEAN CATCHMENT; WATER-QUALITY; RE-OLIGOTROPHICATION; NUTRIENT MANAGEMENT; THERMAL STRUCTURE; ECOLOGICAL STATE; FOREST SOURCES; LAND-USE; RIVER; PHYTOPLANKTON	European freshwater ecosystems have undergone significant human-induced and environmentally-driven variations in nutrient export from catchments throughout the past five decades, mainly in connection with changes in land-use, agricultural practice, waste water production and treatment, and climatic conditions. We analysed the relations among concentration of total phosphorus (TP) in the Slapy Reservoir (a middle reservoir of the Vltava River Cascade, Czechia), and socio-economic and climatic factors from 1963 to 2015. The study was based on a time series analysis, using conventional statistical tools, and the identification of breaking points, using a segmented regression. Results indicated clear longterm trends and seasonal patterns of TP, with annual average TP increasing up until 1991 and decreasing from 1992 to 2015. Trends in annual, winter and spring average TP concentrations reflected a shift in development of sewerage and sanitary infrastructure, agricultural application of fertilizers, and livestock production in the early 1990s that was associated with changes from the planned to the market economy. No trends were observed for average TP in autumn. The summer average TP has fluctuated with increased amplitude since 1991 in connection with recent climate warming, changes in thermal stratification stability, increased water flow irregularities, and short-circuiting of TP-rich inflow during high flow events. The climate-change-induced processes confound the generally declining trend in lake-water TP concentration and can result in eutrophication despite decreased phosphorus loads from the catchment. Our findings indicate the need of further reduction of phosphorus sources to meet ecological quality standards of the EU Water Framework Directive because the climate change may lead to a greater susceptibility of the aquatic ecosystem to the supply of nutrients.	[Vystavna, Yuliya; Hejzlar, Josef; Kopacek, Jiri] Biol Ctr CAS, Inst Hydrobiol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Hejzlar, J (corresponding author), Biol Ctr CAS, Inst Hydrobiol, Ceske Budejovice, Czech Republic.	hejzlar@hbu.cas.cz	Hejzlar, Josef/AAE-3963-2020; Hejzlar, Josef/F-8526-2014; Kopacek, Jiri/A-7373-2014; Vystavna, Yuliya/I-9474-2016	Kopacek, Jiri/0000-0002-4409-4032; Vystavna, Yuliya/0000-0002-1366-0767; Hejzlar, Josef/0000-0002-7186-4776	Grant Agency of the Czech Republic [P504/15/04034S]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This study was supported by the Grant Agency of the Czech Republic (https://gacr.cz/), project No. P504/15/04034S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HE, 2006, SCI TOTAL ENVIRON, V365, P223, DOI 10.1016/j.scitotenv.2006.02.036; [Anonymous], [No title captured]; Bai ZH, 2016, NUTR CYCL AGROECOSYS, V104, P361, DOI 10.1007/s10705-015-9737-y; Bouraoui F, 2011, SCI TOTAL ENVIRON, V409, P4899, DOI 10.1016/j.scitotenv.2011.08.015; Bouwman AF, 2017, SCI REP-UK, V7, DOI 10.1038/srep40366; Bowes MJ, 2009, SCI TOTAL ENVIRON, V407, P1954, DOI 10.1016/j.scitotenv.2008.11.026; Brazdil R, 2009, INT J CLIMATOL, V29, P223, DOI 10.1002/joc.1718; Brzakova M, 2003, HYDROBIOLOGIA, V504, P39, DOI 10.1023/B:HYDR.0000008506.29287.11; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Correll DL, 1999, J ENVIRON QUAL, V28, P144, DOI 10.2134/jeq1999.00472425002800010017x; ENDERLEIN RE, 1995, WATER SCI TECHNOL, V31, P1, DOI 10.1016/0273-1223(95)00350-V; Flaim G, 2016, FRESHWATER BIOL, V61, P1802, DOI 10.1111/fwb.12819; Foley B, 2012, FRESHWATER BIOL, V57, P278, DOI 10.1111/j.1365-2427.2011.02662.x; Gebre S, 2014, J HYDROL, V510, P208, DOI 10.1016/j.jhydrol.2013.12.023; Hayes NM, 2015, ECOLOGY, V96, P392, DOI 10.1890/13-1840.1; Hejzlar J, 2003, SCI TOTAL ENVIRON, V310, P143, DOI 10.1016/S0048-9697(02)00634-4; Hejzlar J., 2016, WASTE FORUM, V4, P225; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Horn H, 2015, INT REV HYDROBIOL, V100, P43, DOI 10.1002/iroh.201401743; Hrbacek J, 2003, HYDROBIOLOGIA, V504, P203, DOI 10.1023/B:HYDR.0000008520.83751.e2; Hukari S, 2016, SCI TOTAL ENVIRON, V542, P1127, DOI 10.1016/j.scitotenv.2015.09.064; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; Istvanovics V, 2012, HYDROBIOLOGIA, V686, P55, DOI 10.1007/s10750-012-0999-y; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jeppesen E, 2011, HYDROBIOLOGIA, V663, P1, DOI 10.1007/s10750-010-0547-6; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Jochimsen MC, 2013, ECOL LETT, V16, P81, DOI 10.1111/ele.12018; Johnson LL, 2002, AQUAT CONSERV, V12, P517, DOI 10.1002/aqc.522; Kohler J, 2005, FRESHWATER BIOL, V50, P1639, DOI 10.1111/j.1365-2427.2005.01430.x; KOPACEK J, 1993, INT J ENVIRON AN CH, V53, P173, DOI 10.1080/03067319308045987; Kopacek J, 2014, SCI TOTAL ENVIRON, V470, P543, DOI 10.1016/j.scitotenv.2013.10.013; Kopacek J, 2013, BIOGEOCHEMISTRY, V115, P149, DOI 10.1007/s10533-013-9825-5; Kopacek J, 2013, ENVIRON SCI TECHNOL, V47, P6400, DOI 10.1021/es400181m; Kowalkowski T, 2012, J MARINE SYST, V89, P48, DOI 10.1016/j.jmarsys.2011.07.011; Krasa J., 2015, Innovative strategies and policies for soil conservation, P21; Kredba M., 1969, VLTAVA RIVER CASCADE; Lennartz ST, 2014, BIOGEOSCIENCES, V11, P6323, DOI 10.5194/bg-11-6323-2014; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Ma WX, 2015, ENVIRON SCI POLLUT R, V22, P18372, DOI 10.1007/s11356-015-4764-4; Manca M, 2007, FRESHWATER BIOL, V52, P2256, DOI 10.1111/j.1365-2427.2007.01827.x; Marada P, 2012, AGR ECON-CZECH, V58, P201, DOI 10.17221/38/2012-AGRICECON; Mariani MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17964; Matias NG, 2012, WATER RESOUR MANAG, V26, P1041, DOI 10.1007/s11269-011-9946-3; Muller B, 2014, ENVIRON SCI TECHNOL, V48, P6671, DOI 10.1021/es4040304; Munawar M, 2009, INT VER THEOR ANGEW, V30, P1013; Murdoch PS, 2006, WATER RESOUR RES, V42, DOI 10.1029/2004WR003892; Naselli-Flores L, 2003, HYDROBIOLOGIA, V506, P13, DOI 10.1023/B:HYDR.0000008550.34409.06; Noges P, 2011, HYDROBIOLOGIA, V667, P255, DOI 10.1007/s10750-011-0649-9; North RP, 2013, INLAND WATERS, V3, P341, DOI 10.5268/IW-3.3.560; Ott C, 2012, RESOUR CONSERV RECY, V60, P159, DOI 10.1016/j.resconrec.2011.12.007; Pokorny D, 2015, REPORT WATER MANAGEM; POPOVSKY J, 1970, Internationale Revue der Gesamten Hydrobiologie, V55, P435, DOI 10.1002/iroh.19700550314; Recanatesi F, 2013, ENVIRON MANAGE, V52, P503, DOI 10.1007/s00267-013-0060-6; Schindler DW, 2016, ENVIRON SCI TECHNOL, V50, P8923, DOI 10.1021/acs.est.6b02204; Schindler DW, 1996, LIMNOL OCEANOGR, V41, P1004, DOI 10.4319/lo.1996.41.5.1004; Simic SB, 2017, FUND APPL LIMNOL, V190, P1, DOI 10.1127/fal/2017/0975; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Straskraba M, 1973, HYDROBIOLOGICAL STUD, V2, P7; Strickland J. D. H., 1960, Fisheries Research Board of Canada Bulletin, V125, P185; Temnerud J, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003023; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Trolle D, 2015, CLIM RES, V64, P55, DOI 10.3354/cr01278; van de Waal DB, 2010, FRONT ECOL ENVIRON, V8, P145, DOI 10.1890/080178; van Vliet MTH, 2013, GLOBAL ENVIRON CHANG, V23, P450, DOI 10.1016/j.gloenvcha.2012.11.002; Vanacker M, 2015, ECOL INDIC, V52, P184, DOI 10.1016/j.ecolind.2014.12.011; Vetter M, 2012, FUND APPL LIMNOL, V180, P41, DOI 10.1127/1863-9135/2012/0123; Vystavna Y, 2013, ENVIRON MONIT ASSESS, V185, P3581, DOI 10.1007/s10661-012-2811-x; Wagner I, 2016, ECOL ENG, V94, P275, DOI 10.1016/j.ecoleng.2016.05.073; Waters S, 2016, J HYDRO-ENVIRON RES, V10, P32, DOI 10.1016/j.jher.2015.11.002; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Yakovlev V, 2015, APPL GEOCHEM, V53, P71, DOI 10.1016/j.apgeochem.2014.12.009	72	17	20	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186917	10.1371/journal.pone.0186917	http://dx.doi.org/10.1371/journal.pone.0186917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049408	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900123
J	Atici, L; Birch, SEP; Erdogu, B				Atici, Levent; Birch, Suzanne E. Pilaar; Erdogu, Burcin			Spread of domestic animals across Neolithic western Anatolia: New zooarchaeological evidence from Ugurlu Hoyuk, the island of Gokceada, Turkey	PLOS ONE			English	Article							ANCIENT DNA; WILD BOAR; EUROPE; PLEISTOCENE; POPULATIONS; HUSBANDRY; PATTERNS; RECORD; CATTLE; GREECE	The zooarchaeological research presented here investigates Neolithic and Chalcolithic (ca. 6500-5000 cal. BC) animal exploitation strategies at Ugurlu Hoyuk on the Turkish island of Gokceada in the northeastern Aegean Sea. Toward this end, we first discuss the results of our analysis of the zooarchaeological assemblages from Ugurlu Hoyuk and then consider the data within a wider regional explanatory framework using a diachronic approach, comparing them with those from western and northwestern Anatolian sites. The first settlers of Gokceada were farmers who introduced domestic sheep, goats, cattle and pigs to the island as early as 6500 years BC. Our results align well with recently published zooarchaeological data on the westward spread of domestic animals across Turkey and the Neolithization of southeast Europe. Using an island site as a case study, we independently confirm that the dispersal of early farming was a polynucleated and multidirectional phenomenon that did not sweep across the land, replace everything on its way, and deliver the same "Neolithic package" everywhere. Instead, this complex process generated a diversity of human-animal interactions. Thus, studying the dispersal of early farmers from southwest Asia into southeast Europe via Anatolia requires a rigorous methodological approach to develop a fine-resolution picture of the variability seen in human adaptations and dispersals within complex and rapidly changing environmental and cultural settings. For this, the whole spectrum of human-animal interactions must be fully documented for each sub-region of southwest Asia and the circum-Mediterranean.	[Atici, Levent] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Birch, Suzanne E. Pilaar] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Birch, Suzanne E. Pilaar] Univ Georgia, Dept Geog, Athens, GA 30602 USA; [Erdogu, Burcin] Univ Thrace, Dept Archaeol, Edirne, Turkey	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Atici, L (corresponding author), Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA.	Levent.Atici@unlv.edu		Pilaar Birch, Suzanne/0000-0003-1544-5881; Atici, Levent/0000-0002-4929-173X	National Geographic Society [9674-15]; University of Nevada, Las Vegas; University of Georgia; Turkish Ministry of Culture and Tourism; University of Thrace (BAP)	National Geographic Society(National Geographic Society); University of Nevada, Las Vegas; University of Georgia; Turkish Ministry of Culture and Tourism; University of Thrace (BAP)	This research was made possible by grants to Levent Atici (PI) and Suzanne E. Pilaar Birch from National Geographic Society (Grant# 9674-15) (http://www.nationalgeographic.com/), to Levent Atici from the University of Nevada, Las Vegas (http://www.unlv.edu), to Suzanne E. Pilaar Birch from the University of Georgia (http://www.uga.edu), to Burcin Erdogu from the Turkish Ministry of Culture and Tourism (http://www.kultur.gov.tri? dil=2) and the University of Thrace (BAP 2014-25) (http://www-en.trakya.edu.tr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarella U., 2006, ARCHAEOZOOLOGICAL ST, P285; Albarella U, 2009, ENVIRON ARCHAEOL, V14, P103, DOI 10.1179/146141009X12481709928283; Ammerman A.J., 1973, EXPLANATION CULTURE, P343; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; Arbuckle BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099845; Arbuckle BS, 2013, LEVANT, V45, P219, DOI 10.1179/0075891413Z.00000000026; Arbuckle BS, 2013, J ARCHAEOL SCI, V40, P1805, DOI 10.1016/j.jas.2012.12.008; Atici L, 2011, BRIT ARCHAEOLOGICAL, V2251; Atici L., 2009, FARMING, V3, P136; Atici Levent, 2009, Anthropozoologica, V44, P13, DOI 10.5252/az2009n1a1; Atici Levent, 2014, COMMINGLED DISARTICU, P213, DOI DOI 10.1007/978-1-4614-7560-6_12; Bellwood P, 2009, CURR ANTHROPOL, V50, P621, DOI 10.1086/605112; Birch S Pilaar, 2017, J ISLAND COASTAL ARC; Birch S Pilaar, ARCHAEOLOGICAL UNPUB; Boric D, 2013, P NATL ACAD SCI USA, V110, P3298, DOI 10.1073/pnas.1211474110; Buitenhuis Hijke, ILIPINAR ZOOARCHAEOL; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; Cakirlar C, 2012, ANTHROPOZOOLOGICA; Cakirlar C, 2017, OXFORD HDB ZOOARCHAE, P266; Cakirlar C, 2012, ANATOL STUD, V62, P1, DOI 10.1017/S0066154612000014; Cakrlar C, 2013, ENV ARCHAEOLOGY SUBS, P59; Cannon M.D., 2012, J ARCHAEOL METHOD TH, P1; Chalkioti A., 2016, GEOARCHEOLOGIE ILES, P109; Cunliffe B., 2008, EUROPE OCEANS 9000 B; DeCupere B, 2008, P 8 INT S ARCH SW AS, P367; Deguilloux MF, 2012, EVOL ANTHROPOL, V21, P24, DOI 10.1002/evan.20341; Erdogu B, 2013, NEOLITHIC TURKEY NEW, P5; Erdogu B, 2011, ANATOLICA, VXXXVII, P45; Erdogu B., 2016, G OARCH OLOGIE LES I, P89; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Galik Alfred, CUKURICI HOYUK ZOOAR; Galik Alfred, BARCIN HOYUK ZOOARCH; Gkiasta M, 2003, ANTIQUITY, V77, P45, DOI 10.1017/S0003598X00061330; Gourichon Lionel, FAUNAL DATA NEOLITHI; Gurova M, 2008, DOC PRAEHIST, V35, P111, DOI 10.4312/dp.35.8; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Hongo Hitomi, 2000, ARCHAEOZOOLOGY NEAR, P121; Lichter, 2005, DID FARMING REACH EU, P13; Lichter C, 2011, FORSCHUNG CLUSTER, V1, P33; Lyman R.L., 2008, QUANTITAIVE PALEOZOO; LYMAN RL, 1994, AM ANTIQUITY, V59, P36, DOI 10.2307/3085500; Meadow RH., 1999, HISTORICI ANIMALIUM, P285; MORLAN RE, 1994, J ARCHAEOL SCI, V21, P797, DOI 10.1006/jasc.1994.1077; Munro ND, 2015, CURR ANTHROPOL, V56, P596, DOI 10.1086/682326; Orton David, 2016, Open Quaternary, V2, P6, DOI 10.5334/oq.28; Ottoni C, 2013, MOL BIOL EVOL, V30, P824, DOI 10.1093/molbev/mss261; Ozbek O, 2012, QUATERNARY INT; Ozdogan M., 2007, BLACK SEA FLOOD QUES, P651; Ozdogan M, 2011, CURR ANTHROPOL, V52; Ozdogan M., 2012, NEOLITHIC TURKEY NEW; Ozdogan M, 2013, GOING W SPREAD FARMI, P167; Payne S., 1982, BAR BRIT SERIES, V109, P155; Perissoratis C, 2003, MAR GEOL, V196, P145, DOI 10.1016/S0025-3227(03)00047-1; Perles C., DOCUMENTA PRAEHISTOR, V30, P99; Perles C, 2014, NEOLITHIC TURKEY 105, V6, P403; Perles C, 2013, ANTIQUITY, V87, P1001, DOI 10.1017/S0003598X00049826; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Price T.D., 2000, EUROPES 1 FARMERS, P1, DOI [10.1017/CBO9780511607851.002, DOI 10.1017/CBO9780511607851.002]; Price TD, 2000, EUROPES 1 FARMERS; Reingruber A, 2011, DOC PRAEHIST, V38, P291, DOI 10.4312/dp.38.23; Robb J., 2007, GOING MESOLITHIC NEO, P99; Rowley-Conwy P, 2014, WORLD ARCHAEOL, V46, P835, DOI 10.1080/00438243.2014.953712; Shipman P., 1981, LIFE HIST FOSSIL INT; Simmons AH, 2007, NEOLITHIC REVOLUTION; Sondaar P.Y., 1977, MAJOR PATTERNS VERTE, P671, DOI DOI 10.1007/978-1-4684-8851-7; Souvatzi Stella, 2013, TRACKING NEOLITHIC H, P45, DOI [10.1007/978-1-4614-5289-8_3, DOI 10.1007/978-1-4614-5289-8_3]; STINER MC, 1990, J ANTHROPOL ARCHAEOL, V9, P305, DOI 10.1016/0278-4165(90)90010-B; Uerpmann M., 1994, QALAAT AL BAHRAIN TH, V30(1), P417; uzdogan M., 2013, NEOLITHIC TURKEY NEW; VANANDEL TH, 1983, INT J NAUT ARCHAEOL, V12, P303, DOI 10.1111/j.1095-9270.1983.tb01165.x; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109; Von Den Driesch A., 1976, GUIDE MEASUREMENT AN; Zeder Melinda A., 2006, P87; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeder MA, 2015, P NATL ACAD SCI USA, V112, P3191, DOI 10.1073/pnas.1501711112	75	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186519	10.1371/journal.pone.0186519	http://dx.doi.org/10.1371/journal.pone.0186519			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045476	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100066
J	Sitras, V; Benth, JS; Eberhard-Gran, M				Sitras, Vasilis; Benth, Jurate Saltyte; Eberhard-Gran, Malin			Obstetric and psychological characteristics of women choosing epidural analgesia during labour: A cohort study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; CHILDBIRTH; FEAR; VALIDATION; PREGNANCY; BELIEFS; RISK	Objectives To investigate the obstetric and psychological characteristics of women who opt to use epidural analgesia (EDA) during labour and the impact of participating in labour preparation courses on women's decisions to use EDA. Design Longitudinal cohort study. Setting Akershus University Hospital, Norway. Population 2596 women with singleton pregnancies and intended vaginal delivery. Methods Data were collected using two self-completed questionnaires at pregnancy weeks 17 and 32. Fear of childbirth was assessed by the Wijma Delivery Expectancy Questionnaire (WDEQ). Symptoms of anxiety were measured by the Hopkins Symptom Check List (SCL-25) and depression by the Edinburgh Postnatal Depression Scale (EPDS). Obstetric and socio-demographic information was retrieved from birth records at the maternity ward. Main outcome measure Preference for EDA was indicated by the questionnaire item "I would prefer an epidural regardless" on a 4-point scale (1 = highly agree, 4 = highly disagree) at pregnancy week 32. Results Twenty-one percent of the women (540/2596) answered that they would choose EDA as the only alternative method of analgesia during labour. Counselling for fear of childbirth [OR 3.23 (95% CI 2.12; 4.92)] and W-DEQ sum score >= 85 [OR 2.95 (95% CI 2.06; 4.23)] were significantly (p<0.001) associated with choice of EDA. Participation in labour preparation courses was significantly (p = 0.008) associated with a reduction of intended use of EDA during labour [OR 0.67 (95% CI 0.49; 0.90)]. Conclusion Fear of childbirth is significantly associated with women's choice of EDA during labour. On the other hand, women that participate in labour preparation courses would rather consider other methods of analgesia during labour.	[Sitras, Vasilis] Akershus Univ Hosp, Dept Obstet & Gynaecol, Oslo, Norway; [Sitras, Vasilis] Oslo Univ Hosp, Dept Fetal Med, Oslo, Norway; [Sitras, Vasilis; Benth, Jurate Saltyte; Eberhard-Gran, Malin] Univ Oslo, Inst Clin Med, Oslo, Norway; [Benth, Jurate Saltyte; Eberhard-Gran, Malin] Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway; [Eberhard-Gran, Malin] Norwegian Inst Publ Hlth, Dept Child Hlth, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Sitras, V (corresponding author), Akershus Univ Hosp, Dept Obstet & Gynaecol, Oslo, Norway.; Sitras, V (corresponding author), Oslo Univ Hosp, Dept Fetal Med, Oslo, Norway.; Sitras, V (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	vsit@ous-hf.no	Sitras, Vasilis/R-1287-2018; Dangal, Ganesh/O-1989-2017	Sitras, Vasilis/0000-0003-3264-3302; Dangal, Ganesh/0000-0002-5834-5525	Norwegian Research Council [191098]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The present study was supported by grants from the Norwegian Research Council (project number: 191098).	Ahearn EP, 1997, J PSYCHIATR RES, V31, P569, DOI 10.1016/S0022-3956(97)00029-0; [Anonymous], 2014, THESIS; Bonouvrie K, 2016, EUR J OBSTET GYN R B, V207, P23, DOI 10.1016/j.ejogrb.2016.07.488; Chang KY, 2008, CLIN J PAIN, V24, P265, DOI 10.1097/AJP.0b013e31816111a5; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Fabian HM, 2005, ACTA OBSTET GYN SCAN, V84, P436, DOI 10.1111/j.0001-6349.2005.00732.x; GLAZE R, 1991, J AFFECT DISORDERS, V22, P73, DOI 10.1016/0165-0327(91)90086-8; Harkins J, 2010, ANESTHESIOL RES PRAC, V2010, DOI 10.1155/2010/356789; Hawkins JL, 2010, NEW ENGL J MED, V362, P1503, DOI 10.1056/NEJMct0909254; Heinze SD, 2003, J REPROD INFANT PSYC, V21, P323, DOI 10.1080/02646830310001622132; HUESTON WJ, 1994, OBSTET GYNECOL, V84, P579; Johnson R, 2002, BJOG-INT J OBSTET GY, V109, P1213, DOI 10.1046/j.1471-0528.2002.01351.x; Jones L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009234.pub2; Le Ray C, 2008, BIRTH-ISS PERINAT C, V35, P171, DOI 10.1111/j.1523-536X.2008.00237.x; NETTELBLADT P, 1993, J OCCUP ENVIRON MED, V35, P53; Ryding EL, 1998, ACTA OBSTET GYN SCAN, V77, P542; Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064; Storksen HT, 2013, ACTA OBSTET GYN SCAN, V92, P318, DOI 10.1111/aogs.12072; Storksen HT, 2012, ACTA OBSTET GYN SCAN, V91, P237, DOI 10.1111/j.1600-0412.2011.01323.x; Van den Bussche E, 2007, EUR J PAIN, V11, P275, DOI 10.1016/j.ejpain.2006.03.002; Wijma K, 1998, J PSYCHOSOM OBST GYN, V19, P84, DOI 10.3109/01674829809048501; Williams ACD, 2016, PAIN, V157, P2420, DOI 10.1097/j.pain.0000000000000613; WINOKUR A, 1984, AM J PSYCHIAT, V141, P1427	24	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186564	10.1371/journal.pone.0186564	http://dx.doi.org/10.1371/journal.pone.0186564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045499	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000413168100074
J	Castelhano, J; Duarte, IC; Abuhaiba, SI; Rito, M; Sales, F; Castelo-Branco, M				Castelhano, Joao; Duarte, Isabel C.; Abuhaiba, Sulaiman I.; Rito, Manuel; Sales, Francisco; Castelo-Branco, Miguel			Cortical functional topography of high-frequency gamma activity relates to perceptual decision: an Intracranial study	PLOS ONE			English	Article							BAND ACTIVITY; OSCILLATIONS; SYNCHRONY; TASK; EEG; LOCALIZATION; RESPONSES; DYNAMICS; STIMULI; MODEL	High-frequency activity (HFA) is believed to subserve a functional role in cognition, but these patterns are often not accessible to scalp EEG recordings. Intracranial studies provide a unique opportunity to link the all-encompassing range of high-frequency patterns with holistic perception. We tested whether the functional topography of HFAs (up to 250Hz) is related to perceptual decision-making. Human intracortical data were recorded (6 subjects; > 250channels) during an ambiguous object-recognition task. We found a spatial topography of HFAs reflecting processing anterior dorsal and ventral streams, linked to decision independently of the type of processed object/stimulus category. Three distinct regional fingerprints could be identified, with lower gamma frequency patterns (< 45Hz) dominating in the anterior semantic ventral object processing and dorsoventral integrating networks and evolving later, during perceptual decision phases, than early sensory posterior patterns (60-250Hz). This suggests that accurate object recognition/ perceptual decision-making is related to distinct spatiotemporal signatures in the low gamma frequency range.	[Castelhano, Joao; Duarte, Isabel C.; Abuhaiba, Sulaiman I.; Castelo-Branco, Miguel] Univ Coimbra, CIBIT, ICNAS, Coimbra, Portugal; [Castelhano, Joao; Duarte, Isabel C.; Abuhaiba, Sulaiman I.; Castelo-Branco, Miguel] Univ Coimbra, IBILI, Fac Med, Coimbra, Portugal; [Rito, Manuel; Sales, Francisco] CHUC, Epilepsy Unit, Coimbra, Portugal; [Castelo-Branco, Miguel] ICNAS, Hlth Sci, CIBIT, Polo 3, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Castelo-Branco, M (corresponding author), Univ Coimbra, CIBIT, ICNAS, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), Univ Coimbra, IBILI, Fac Med, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), ICNAS, Hlth Sci, CIBIT, Polo 3, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Duarte, Isabel Catarina/GQA-4258-2022; Castelhano, Joao/I-5090-2019; Duarte, Isabel Catarina/AAY-1534-2020	Castelo-Branco, Miguel/0000-0003-4364-6373; Duarte, Isabel Catarina/0000-0002-5620-2424; Castelhano, Joao/0000-0002-8996-1515; Duarte, Isabel Catarina/0000-0002-5620-2424; Inacio, Francisco/0000-0003-0834-066X; Abuhaiba, Sulaiman I S/0000-0003-0140-2549	Centro FEDER; PAC-MEDPERSYST [POCI-01- 0145-FEDER-016428]; BIGDATIMAGE [CENTRO-01-0145-FEDER-000016];  [FP7-HEALTH-2013-INNOVATION-1-602186-BRAINTRAIN];  [UID/NEU/04539/2013 COMPETE POCI-01-0145-FEDER-007440];  [CENTRO-07-ST24-FEDER-00205]	Centro FEDER; PAC-MEDPERSYST; BIGDATIMAGE; ; ; 	Funded by FP7-HEALTH-2013-INNOVATION-1-602186-BRAINTRAIN, UID/NEU/04539/2013 COMPETE POCI-01-0145-FEDER-007440, CENTRO-07-ST24-FEDER-00205, BIGDATIMAGE, CENTRO-01-0145-FEDER-000016, Centro 2020 FEDER, COMPETE, PAC-MEDPERSYST, POCI-01- 0145-FEDER-016428. Bial 373/14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano E, 2009, NEUROIMAGE, V45, P477, DOI 10.1016/j.neuroimage.2008.12.003; Basar E, 2013, INT J PSYCHOPHYSIOL, V90, P99, DOI 10.1016/j.ijpsycho.2013.07.005; Bernardino I, 2013, NEUROPSYCHOLOGIA, V51, P1287, DOI 10.1016/j.neuropsychologia.2013.03.020; Castelhano J, 2015, J COGNITIVE NEUROSCI, V27, P2416, DOI 10.1162/jocn_a_00863; Castelhano J, 2014, HUM BRAIN MAPP, V35, P5219, DOI 10.1002/hbm.22545; Castelhano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066363; Cho-Hisamoto Y, 2015, CLIN NEUROPHYSIOL, V126, P17, DOI 10.1016/j.clinph.2014.03.034; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 2011, INT J PSYCHOPHYSIOL, V79, P9, DOI 10.1016/j.ijpsycho.2010.10.013; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Crone NE, 2001, NEUROLOGY, V57, P2045, DOI 10.1212/WNL.57.11.2045; Dalal SS, 2007, P ANN INT IEEE EMBS, P4941, DOI 10.1109/IEMBS.2007.4353449; Davis JJ, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BRAIN COMPUTER INTERFACES (CIBCI), P16, DOI 10.1109/CIBCI.2014.7007787; de Pesters A, 2016, NEUROIMAGE, V134, P122, DOI 10.1016/j.neuroimage.2016.03.074; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duarte IC, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.507; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Engell AD, 2011, CEREB CORTEX, V21, P1213, DOI 10.1093/cercor/bhq206; Farivar R, 2009, BRAIN RES REV, V61, P144, DOI 10.1016/j.brainresrev.2009.05.006; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gaona CM, 2011, J NEUROSCI, V31, P2091, DOI 10.1523/JNEUROSCI.4722-10.2011; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gruber T, 2008, BRAIN RES, V1196, P74, DOI 10.1016/j.brainres.2007.12.037; Guntekin B, 2014, NEUROPSYCHOLOGIA, V58, P33, DOI 10.1016/j.neuropsychologia.2014.03.014; Harvey BM, 2013, NEUROIMAGE, V65, P424, DOI 10.1016/j.neuroimage.2012.10.020; Hermes D, 2015, CEREB CORTEX, V25, P2951, DOI 10.1093/cercor/bhu091; Hermes D, 2014, TRENDS COGN SCI; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Jacobs J, 2012, PROG NEUROBIOL, V98, P302, DOI 10.1016/j.pneurobio.2012.03.001; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Kucewicz MT, 2014, BRAIN, V137, P2231, DOI 10.1093/brain/awu149; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee B, 2007, NEUROSCI LETT, V413, P210, DOI 10.1016/j.neulet.2006.11.066; Lee HW, 2013, NEUROIMAGE, V83, P616, DOI 10.1016/j.neuroimage.2013.07.010; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Matsuzaki N, 2015, NEUROIMAGE, V109, P249, DOI 10.1016/j.neuroimage.2015.01.015; Michalareas G, 2016, NEURON, V89, P384, DOI 10.1016/j.neuron.2015.12.018; MISHKIN M, 1983, TRENDS NEUROSCI; MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P219, DOI 10.1037/h0083717; Nagasawa T, 2012, HUM BRAIN MAPP, V33, P569, DOI 10.1002/hbm.21233; Nagasawa T, 2011, NEUROIMAGE, V58, P1101, DOI 10.1016/j.neuroimage.2011.07.043; Navarrete M, 2017, J PHYSL PARIS; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sedley W, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00595; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sun LM, 2012, J NEUROSCI, V32, P9563, DOI 10.1523/JNEUROSCI.1073-12.2012; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Tallon-Baudry C, 2009, FRONT BIOSCI-LANDMRK, V14, P321, DOI 10.2741/3246; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Vansteensel MJ, 2014, HUM BRAIN MAPP, V35, P5903, DOI 10.1002/hbm.22593; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; WYLER AR, 1984, J NEUROSURG, V60, P1195, DOI 10.3171/jns.1984.60.6.1195	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186428	10.1371/journal.pone.0186428	http://dx.doi.org/10.1371/journal.pone.0186428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073154	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400025
J	Grenier, JK; Foureman, PA; Sloma, EA; Miller, AD				Grenier, Jennifer K.; Foureman, Polly A.; Sloma, Erica A.; Miller, Andrew D.			RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; GENE-EXPRESSION; INTRACRANIAL-MENINGIOMAS; DIFFERENTIAL EXPRESSION; QUANTITATIVE PCR; BRAIN-TUMORS; PROGRESSION; CELL; NEOPLASIA; GROWTH	Meningiomas are the most commonly reported primary intracranial tumor in dogs and humans and between the two species there are similarities in histology and biologic behavior. Due to these similarities, dogs have been proposed as models for meningioma pathobiology. However, little is known about specific pathways and individual genes that are involved in the development and progression of canine meningioma. In addition, studies are lacking that utilize RNAseq to characterize gene expression in clinical cases of canine meningioma. The primary objective of this study was to develop a technique for which high quality RNA can be extracted from formalin-fixed, paraffin embedded tissue and then used for transcriptome analysis to determine patterns of gene expression. RNA was extracted from thirteen canine meningiomas-eleven from formalin fixed and two flash-frozen. These represented six grade I and seven grade II meningiomas based on the World Health Organization classification system for human meningioma. RNA was also extracted from fresh frozen leptomeninges from three control dogs for comparison. RNAseq libraries made from formalin fixed tissue were of sufficient quality to successfully identify 125 significantly differentially expressed genes, the majority of which were related to oncogenic processes. Twelve genes (AQP1, BMPER, FBLN2, FRZB, MEDAG, MYC, PAMR1, PDGFRL, PDPN, PECAM1, PERP, ZC2HC1C) were validated using qPCR. Among the differentially expressed genes were oncogenes, tumor suppressors, transcription factors, VEGF-related genes, and members of the WNT pathway. Our work demonstrates that RNA of sufficient quality can be extracted from FFPE canine meningioma samples to provide biologically relevant transcriptome analyses using a next-generation sequencing technique, such as RNAseq.	[Grenier, Jennifer K.; Foureman, Polly A.; Sloma, Erica A.; Miller, Andrew D.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Foureman, Polly A.] Chandler Gilbert Community Coll, Div Biol Sci, Chandler, AZ USA	Cornell University	Miller, AD (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	adm10@cornell.edu		Foureman, Polly/0000-0003-4802-969X				Aarhus M, 2011, ACTA NEUROCHIR, V153, P447, DOI 10.1007/s00701-010-0906-0; Antonescu CR, 2014, GENE CHROMOSOME CANC, V53, P951, DOI 10.1002/gcc.22206; Barrett CSX, 2016, PROSTATE, V77, P2016; Bo HJ, 2016, MOL MED REP, V13, P1163, DOI 10.3892/mmr.2015.4642; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Callari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086511; de Vicente JC, 2015, VIRCHOWS ARCH, V466, P549, DOI 10.1007/s00428-015-1746-3; Chang X, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.10.FOCUS13326; Clarke VE, 2016, NAT GENET, V48, P1253, DOI 10.1038/ng.3651; Courtay-Cahen C, 2008, VET COMP ONCOL, V6, P182, DOI 10.1111/j.1476-5829.2008.00159.x; Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902; Dai K, 2016, ONCOTARGET, V7, P4770, DOI 10.18632/oncotarget.6613; DETTA A, 1993, NEUROSURGERY, V33, P1065; Dickinson PJ, 2009, VET PATHOL, V46, P884, DOI 10.1354/vp.08-VP-0251-D-FL; Domingues P, 2015, ONCOTARGET, V6, P10671, DOI 10.18632/oncotarget.3870; Eikrem O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149743; Esser JS, 2015, ARTERIOSCL THROM VAS, V35, P358, DOI 10.1161/ATVBAHA.114.304345; Fevre-Montange M, 2009, INT J ONCOL, V35, P1395, DOI 10.3892/ijo_00000457; Florkowska M, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-8; Guo FJ, 2010, WORLD J GASTROENTERO, V16, P1465, DOI 10.3748/wjg.v16.i12.1465; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Heinke J, 2012, ONCOGENE, V31, P2919, DOI 10.1038/onc.2011.473; Hicks J, 2017, VET COMP ONCOL, V15, P252, DOI 10.1111/vco.12152; Hofman I, 2014, APPL IMMUNOHISTO M M, V22, P46; Howng SL, 2002, CANCER LETT, V183, P95, DOI 10.1016/S0304-3835(02)00085-X; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jeanne A, 2015, FRONT PHARMACOL, V6, DOI [10.3389/tphar2115.00257, 10.3389/fphar.2015.00252]; Kalamarides M, 2011, ONCOGENE, V30, P2333, DOI 10.1038/onc.2010.609; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YJ, 2006, VIRCHOWS ARCH, V449, P529, DOI 10.1007/s00428-006-0285-3; Koestner A, 1999, HIST CLASSIFICATION; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeBlanc AK, 2016, NEURO-ONCOLOGY, V18, P1209, DOI 10.1093/neuonc/now051; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Millman R.E., 2014, J INTERPROF CARE, P1; Muller P, 1999, CLIN CANCER RES, V5, P3569; Murovic JA, 2014, WORLD NEUROSURG, V81, P714, DOI [10.1016/J.WNEU.2013.08.048, 10.1016/j.wneu.2013.08.048]; Niedermayer I, 1997, J NEUROPATH EXP NEUR, V56, P879, DOI 10.1097/00005072-199708000-00006; Ongaratti BR, 2016, BRAZ J MED BIOL RES, V49, P4; Ortiz A, 2015, FASEB J, V29, P1080, DOI 10.1096/fj.14-261594; PATNAIK AK, 1986, VET PATHOL, V23, P369, DOI 10.1177/030098588602300404; Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rigau V, 2011, BRAIN PATHOL, V21, P633, DOI 10.1111/j.1750-3639.2011.00491.x; Saraf S, 2011, ONCOLOGIST, V16, P1604, DOI 10.1634/theoncologist.2011-0193; Schiffman JD, 2015, PHILOS T R SOC LON B, V370, P1065; Schulten HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153681; Shintaku M, 2010, BRAIN TUMOR PATHOL, V27, P23, DOI 10.1007/s10014-009-0262-z; Snyder JM, 2006, J VET INTERN MED, V20, P669, DOI 10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2; Song RB, 2013, J VET INTERN MED, V27, P1143, DOI 10.1111/jvim.12136; Stassen Quirine E M, 2015, BMC Res Notes, V8, P761, DOI 10.1186/s13104-015-1628-4; Sturges BK, 2008, J VET INTERN MED, V22, P586, DOI 10.1111/j.1939-1676.2008.00042.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas R, 2009, J NEURO-ONCOL, V94, P333, DOI 10.1007/s11060-009-9877-5; Thomson SAM, 2005, VET PATHOL, V42, P550, DOI 10.1354/vp.42-5-550; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Troxel MT, 2003, J VET INTERN MED, V17, P850, DOI 10.1892/0891-6640(2003)017&lt;0850:FINRRO&gt;2.3.CO;2; Ucar T, 2003, BRIT J NEUROSURG, V17, P525, DOI 10.1080/02688690310001627759; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Yang M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-219; Zengin T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132757; Zhang Y, 2016, ONCOL REP, V36, P3619, DOI 10.3892/or.2016.5194; Zhao PL, 2015, INT J CLIN EXP MED, V8, P3291; Zheng B, 2016, MOL CARCINOGEN, V55, P1560, DOI 10.1002/mc.22409; Zouaoui S, 2012, NEUROCHIRURGIE, V58, P4, DOI 10.1016/j.neuchi.2012.01.004	70	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187150	10.1371/journal.pone.0187150	http://dx.doi.org/10.1371/journal.pone.0187150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073243	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400123
J	Menendez, I; Cano, ARG; Yelo, BAG; Domingo, L; Domingo, MS; Cantalapiedra, JL; Blanco, F; Fernandez, MH				Menendez, Iris; Gomez Cano, Ana R.; Garcia Yelo, Blanca A.; Domingo, Laura; Soledad Domingo, M.; Cantalapiedra, Juan L.; Blanco, Fernando; Hernandez Fernandez, Manuel			Body-size structure of Central Iberian mammal fauna reveals semidesertic conditions during the middle Miocene Global Cooling Event	PLOS ONE			English	Article							PLIOPLEISTOCENE CLIMATIC-CHANGE; ESTIMATING PAST TEMPERATURES; TIBETAN PLATEAU UPLIFT; COMMUNITY STRUCTURE; MADRID BASIN; BIOMIC SPECIALIZATION; VEGETATION PATTERNS; MULTIPLE-REGRESSION; MASS DISTRIBUTIONS; FOREST MAMMALS	We developed new quantitative palaeoclimatic inference models based on the body-size structure of mammal faunas from the Old World tropics and applied them to the Somosaguas fossil site (middle Miocene, central Iberian Peninsula). Twenty-six mammal species have been described at this site, including proboscideans, ungulates, carnivores, insectivores, lagomorphs and rodents. Our analyses were based on multivariate and bivariate regression models correlating climatic data and body-size structure of 63 modern mammal assemblages from Sub-Saharan Africa and the Indian subcontinent. The results showed an average temperature of the coldest month higher than 26 degrees C for the Somosaguas fossil site, a mean annual thermal amplitude around 10 degrees C, a drought length of 10 months, and an annual total precipitation greater than 200 mm per year, which are climate conditions typical of an ecotonal zone between the savanna and desert biomes. These results are congruent with the aridity peaks described over the middle Aragonian of Spain and particularly in the local biozone E, which includes Somosaguas. The aridity increase detected in this biozone is associated with the Middle Miocene Global Cooling Event. The environment of Somosaguas around 14 Ma was similar to the current environment in the Sahel region of North Africa, the Horn of Africa, the boundary area between the Kalahari and the Namib in Southern Africa, south-central Arabia, or eastern Pakistan and northwestern India. The distribution of modern vegetation in these regions follows a complex mosaic of plant communities, dominated by scattered xerophilous shrublands, semidesert grasslands, and vegetation linked to seasonal watercourses and ponds.	[Menendez, Iris; Domingo, Laura; Soledad Domingo, M.; Blanco, Fernando; Hernandez Fernandez, Manuel] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Menendez, Iris; Domingo, Laura; Hernandez Fernandez, Manuel] UCM, CSIC, Inst Geociencias, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain; [Gomez Cano, Ana R.] Transmitting Sci, Barcelona, Spain; [Gomez Cano, Ana R.] Univ Autonoma Barcelona, Inst Catala Paleontol Miguel Crusafont, Cerdanyola Del Valles, Spain; [Garcia Yelo, Blanca A.] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain; [Domingo, Laura] Univ Calif Santa Cruz, Earth & Planetary Sci Dept, Santa Cruz, CA 95064 USA; [Soledad Domingo, M.] Estn Biol Donana CSIC, Dept Ecol Evolut, Seville, Spain; [Cantalapiedra, Juan L.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany	Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of California System; University of California Santa Cruz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Leibniz Institut fur Evolutions und Biodiversitatsforschung	Menendez, I (corresponding author), Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain.; Menendez, I (corresponding author), UCM, CSIC, Inst Geociencias, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain.	irismene@ucm.es	Cantalapiedra, Juan L/L-2135-2014; Fernández, Manuel Hernández/I-5012-2013; Domingo, M. Soledad/I-1614-2014; Menéndez, Iris/AAX-8813-2020; Blanco, Fernando/F-5823-2018	Cantalapiedra, Juan L/0000-0003-0913-7735; Fernández, Manuel Hernández/0000-0001-5640-9647; Menéndez, Iris/0000-0003-1866-8351; Domingo, M. Soledad/0000-0002-4755-8867; Blanco, Fernando/0000-0001-6339-3460	Complutense University of Madrid; Spanish Ministry of Economy, Industry and Competitiveness; Spanish Ministry of Economy, Industry and Competitiveness ('MINECO Formacion Postdoctoral' program); Humboldt Fellowship; Spanish Ministry of Economy, Industry and Competitiveness [CGL2015-68333-P]; Generalitat de Catalunya (CERCA program)	Complutense University of Madrid; Spanish Ministry of Economy, Industry and Competitiveness; Spanish Ministry of Economy, Industry and Competitiveness ('MINECO Formacion Postdoctoral' program); Humboldt Fellowship(Alexander von Humboldt Foundation); Spanish Ministry of Economy, Industry and Competitiveness; Generalitat de Catalunya (CERCA program)	I.M. was funded by a predoctoral grant from the Complutense University of Madrid (www.ucm.es). L.D. acknowledges a Juan de la Cierva fellowship from the Spanish Ministry of Economy, Industry and Competitiveness (www.idi.mineco.gob.es). M.S.D. was supported by a postdoctoral fellowship from the Spanish Ministry of Economy, Industry and Competitiveness ('MINECO Formacion Postdoctoral 2013' program, www.idi.mineco.gob.es). J.L.C. was funded by a Humboldt Fellowship (www.humboldt-foundation.de). This work was partially supported by the Spanish Ministry of Economy, Industry and Competitiveness (project CGL2015-68333-P, www.idi.mineco.gob.es) and the Generalitat de Catalunya (CERCA program, web.gencat.cat).	Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Alba DM, 2011, GEOBIOS-LYON, V44, P135, DOI 10.1016/j.geobios.2010.10.003; ALBERDI MT, 1995, BIOL J LINN SOC, V54, P349, DOI 10.1111/j.1095-8312.1995.tb01042.x; Alcala L., 1994, MACROMAMIFEROS NEOGE; Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Alonso-Zarza A.M., 2004, GEOLOGIA ESPANA, P556; AMEZUA L, 2000, PATRIMONIO PALEONTOL, P155; ANDREWS P, 1979, BIOL J LINN SOC, V11, P177, DOI 10.1111/j.1095-8312.1979.tb00034.x; Andrews P, 2006, PALAEOGEOGR PALAEOCL, V241, P572, DOI 10.1016/j.palaeo.2006.04.012; Barron Eduardo, 1999, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V95, P67; Barron E, 2010, REV PALAEOBOT PALYNO, V162, P382, DOI 10.1016/j.revpalbo.2009.11.007; Blanco F, 2016, ESTUD GEOL-MADRID, V72, DOI 10.3989/egeol.42255.386; BLONDEL J, 1991, TRENDS ECOL EVOL, V6, P271, DOI 10.1016/0169-5347(91)90001-E; Blondel J., 1979, BIOGEOGRAPHIE ECOLOG; Bohme M, 2006, GEOLOGY, V34, P425, DOI 10.1130/G22460.1; Bojar AV, 2004, PALAEOGEOGR PALAEOCL, V203, P95, DOI 10.1016/S0031-0182(03)00662-X; Bourliere F., 1983, ECOSYSTEMS WORLD; Bruch AA, 2007, PALAEOGEOGR PALAEOCL, V253, P1, DOI 10.1016/j.palaeo.2007.03.030; Bustillo MA, 1990, B I GEOL MIN ESP, V101, P932; Campani M, 2012, EARTH PLANET SC LETT, V337, P174, DOI 10.1016/j.epsl.2012.05.017; Cano Gomez, 2006, ESTUD GEOL-MADRID, V62, P135, DOI DOI 10.3989/EGE0L.0662113; Cantalapiedra JL, 2014, ECOGRAPHY, V37, P1, DOI 10.1111/j.1600-0587.2013.00236.x; Carr CJ, 1998, PLANT ECOL, V135, P135, DOI 10.1023/A:1009704427916; Carrasco A., 2008, PALEONTOLOGICA NOVA, V8, P135; Climate Research Group, 2016, GLOB CLIM MON TOOL H; CODY ML, 1978, ANNU REV ECOL SYST, V9, P265, DOI 10.1146/annurev.es.09.110178.001405; COLE MM, 1982, ECOL STUD, V42, P145; Cole MM, 1963, S AFR GEOGR J, V45, P3; Corbet GB, 1992, MAMMALS INDO MALAYAN; Costeur L, 2008, PALAIOS, V23, P280, DOI 10.2110/palo.2006.p06-092r; Costeur L, 2007, GEOBIOS-LYON, V40, P775, DOI 10.1016/j.geobios.2007.07.001; Cowlishaw G, 1997, J ARID ENVIRON, V36, P271, DOI 10.1006/jare.1996.0203; CREIGHTON GK, 1980, J ZOOL, V191, P435; Croft Darin A., 2001, Diversity and Distributions, V7, P271, DOI 10.1046/j.1366-9516.2001.00117.x; CROWDER LB, 1980, ECOLOGY, V61, P194; Daams R., 1984, Paleobiologie Continentale, V14, P241; de Bonis L., 1993, Paleontologia i Evolucio, V24-25, P93; de Siria Catalan AS, 1985, DATOS CONOCIMIENTO F, P167; Deblauwe V, 2008, GLOBAL ECOL BIOGEOGR, V17, P715, DOI 10.1111/j.1466-8238.2008.00413.x; DeMiguel D, 2011, PALAEOGEOGR PALAEOCL, V302, P452, DOI 10.1016/j.palaeo.2011.02.005; Diez-Canseco Davinia, 2012, Spanish Journal of Palaeontology, V27, P93; Domingo L, 2012, PALAEOGEOGR PALAEOCL, V339, P98, DOI 10.1016/j.palaeo.2012.04.026; Domingo L, 2009, PALAEOGEOGR PALAEOCL, V272, P53, DOI 10.1016/j.palaeo.2008.11.006; EMMONS LH, 1983, J ZOOL, V199, P209; Evenari M, 1986, ECOSYSTEMS WORLD B; Fern andez Marr on M.T., 2004, REV ESPAN PALEONTOL, V19, P199; Fernandez Marron M., 2005, REV PALEOBIOLOGIE, V24, P647; Fernandez Marron M.T., 2002, GEOGACETA, V31, P177; Fernandez MH, 2005, J BIOGEOGR, V32, P1243, DOI 10.1111/j.1365-2699.2005.01270.x; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Fernandez MH, 2005, J BIOGEOGR, V32, P903, DOI 10.1111/j.1365-2699.2004.01188.x; Fernandez MH, 2005, GLOBAL ECOL BIOGEOGR, V14, P39, DOI 10.1111/j.1466-822X.2004.00125.x; Fernandez MH, 2003, GLOBAL ECOL BIOGEOGR, V12, P507, DOI 10.1046/j.1466-822X.2003.00057.x; Fernandez MH, 2001, GLOBAL ECOL BIOGEOGR, V10, P189, DOI 10.1046/j.1466-822x.2001.00218.x; Fernandez-Jalvo Y, 1998, J HUM EVOL, V34, P137, DOI 10.1006/jhev.1997.0188; Fesharaki O, 2015, J IBER GEOL, V41, P205, DOI 10.5209/rev_JIGE.2015.v41.n2.44802; Figueirido B, 2012, P NATL ACAD SCI USA, V109, P722, DOI 10.1073/pnas.1110246108; FLEMING TH, 1973, ECOLOGY, V54, P555, DOI 10.2307/1935340; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Fortelius M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0232; Fox Barry J., 1994, V108, P363; Franzese RJ., 2009, MODELING INTERPRETIN; Futuyma DJ, 1986, EVOL BIOL; Yelo BAG, 2014, J IBER GEOL, V40, P129, DOI 10.5209/rev_JIGE.2014.v40.n1.44092; Giess W., 1971, Dinteria, pmap; Cano ARG, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-94; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GREGOR HJ, 1990, REV PALAEOBOT PALYNO, V62, P309, DOI 10.1016/0034-6667(90)90093-X; GROVE AT, 1977, PHILOS T ROY SOC B, V278, P457, DOI 10.1098/rstb.1977.0055; Guerin G., 1984, PALEOBIOLOGIE CONTIN, V14, P287; Hair J.F., 2006, MULTIVARIATE DATA AN, V6th; Fernandez MH, 2006, J ARID ENVIRON, V66, P585, DOI 10.1016/j.jaridenv.2006.01.013; HERNANDEZ FERNANDEZ M., 2006, ESTUD GEOL-MADRID, V62, P263, DOI [10.3989/egeol.0662126, DOI 10.3989/EGEOL.0662126]; Hernandez Fernandez M, 2003, COLOQ PALEONTOL, P253; Fernandez MH, 2006, J HUM EVOL, V50, P595, DOI 10.1016/j.jhevol.2005.11.004; Fernandez MH, 2015, PALAEOBIO PALAEOENV, V95, P387, DOI 10.1007/s12549-015-0196-x; Hernandez-Ballarin V., 2017, HIST BIOL; Hoorn C, 2012, PALAEOGEOGR PALAEOCL, V344, P16, DOI 10.1016/j.palaeo.2012.05.011; HUNTLEY BJ, 1982, ECOL STUD, V42, P101; I.B.M. Corp, 2013, IBM SPSS STAT WIND V; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Joubert DF, 2008, J ARID ENVIRON, V72, P2201, DOI 10.1016/j.jaridenv.2008.07.004; JOUBERT E, 1971, Madoqua, V1, P5; Kay RF, 1997, J HUM EVOL, V32, P161, DOI 10.1006/jhev.1996.0104; Keith T.Z., 2014, MULTIPLE REGRESSION; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Krapp M, 2011, CLIM PAST, V7, P1169, DOI 10.5194/cp-7-1169-2011; Kroh A, 2007, PALAEOGEOGR PALAEOCL, V253, P169, DOI 10.1016/j.palaeo.2007.03.039; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; Kurschner H., 1998, VEGETATION ARABIAN P, P63, DOI [10.1007/978-94-017-3637-4_4, DOI 10.1007/978-94-017-3637-4_4]; Lambert W, 2006, ECOSYSTEMS, V9, P97, DOI 10.1007/s10021-005-0076-8; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre S., 1986, Palaeovertebrata (Montpellier), V16, P191; Legendre S, 2005, EARTH PLANET SC LETT, V235, P408, DOI 10.1016/j.epsl.2005.04.018; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Lehmann CER, 2014, SCIENCE, V343, P548, DOI 10.1126/science.1247355; LEISTNER O A, 1973, Vegetatio, V28, P353, DOI 10.1007/BF02386499; Lewis ME, 1997, J HUM EVOL, V32, P257, DOI 10.1006/jhev.1996.0103; LOMOSCHITZ A, 1985, Estudios Geologicos (Madrid), V41, P343; Lopez-Martinez N, 2000, C PALEONTOL, V51, P71; Luis A, 2000, COLOQ PALEONTOL, P87; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Lopez-Garcia JM, 2010, QUATERNAIRE, V21, P249; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; Megias AG, 1982, QUINT C LAT AM GEOL; Meloro C, 2011, CURR ZOOL, V57, P269, DOI 10.1093/czoolo/57.3.269; Mendoza M, 2004, J THEOR BIOL, V230, P203, DOI 10.1016/j.jtbi.2004.05.002; Menendez I, 2017, ESTUDIOS GEOLOGICOS; Menendez I, 2016, NEW PERSPECTIVES EVO; Menendez I, 2015, CURRENT TRENDS PALEO; *MET OFF, 1983, TABL TEMP REL HUM 4; Meteorological Office, 1965, TABL TEMP REL HUM PR; Meulen F. van der, 1983, Bothalia, V14, P675; Minguez Gandu D., 2000, COLOQUIOS PALEONTOLO, V51, P183; Monson R.K., 1999, C4 PLANT BIOL, P339; Montuire S, 1997, PALAEOGEOGR PALAEOCL, V128, P187, DOI 10.1016/S0031-0182(96)00038-7; Morales J., 2000, PATRIMONIO PALEONTOL; Okitsu S., 2005, FACTORS CONTROLLING; OLSVIGWHITTAKER L, 1983, VEGETATIO, V54, P153, DOI 10.1007/BF00047104; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Perales R, 2009, PALEOLUSITANA, V1, P318; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Perez-Garcia Adan, 2013, Spanish Journal of Palaeontology, V28, P55; PICKFORD M, 1994, PALAEOGEOGR PALAEOCL, V112, P297, DOI 10.1016/0031-0182(94)90078-7; Pickford M, 2014, ESTUD GEOL-MADRID, V70, DOI 10.3989/egeol.41261.262; Polonio I, 2000, COLOQ PALEONTOL, V51, P1132; Mijarra JMP, 2009, J BIOGEOGR, V36, P2025, DOI 10.1111/j.1365-2699.2009.02142.x; Prista GA, 2015, OPEN GEOSCI, V7, P65, DOI 10.1515/geo-2015-0007; Rivas-Martinez S., 2016, WORLDWIDE BIOCLIMATI; Rodriguez J, 2004, GLOBAL ECOL BIOGEOGR, V13, P163, DOI 10.1111/j.1466-882X.2004.00085.x; Rodriguez J, 2001, ANTHROPOLOGIE, V105, P131; Rodriguez J, 1999, LETHAIA, V32, P331, DOI 10.1111/j.1502-3931.1999.tb00551.x; ROWELL DP, 1995, Q J ROY METEOR SOC, V121, P669, DOI 10.1256/smsqj.52310; Samuels JX, 2009, J VERTEBR PALEONTOL, V29, P254, DOI 10.1080/02724634.2009.10010376; Sanchez I.M., 2006, Estudios Geologicos (Madrid), V62, P533; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Shmida S., 1985, ECOSYSTEMS WORLD A, V12a, P23; SKARPE C, 1986, VEGETATIO, V68, P3; Smith B, 2002, FOLIA GEOBOT, V37, P171, DOI 10.1007/BF02804230; Domingo MS, 2017, PALAEOGEOGR PALAEOCL, V465, P103, DOI 10.1016/j.palaeo.2016.10.023; STRAHLER AN, 1987, MODERN PHYS GEOGRAPH; THOMPSON ML, 1978, INT STAT REV, V46, P1, DOI 10.2307/1402505; Torroba Juan, 2010, Cidaris, V30, P325; Urban MA, 2016, PALAEOGEOGR PALAEOCL, V443, P10, DOI 10.1016/j.palaeo.2015.11.012; VALVERDE J. A, 1967, ESTRUCTURA COMUNIDAD; Valverde JA, 1964, REMARQUES STRUCTURE; van Couvering J.A.H., 1980, P272; van Dam JA, 2006, PALAEOGEOGR PALAEOCL, V238, P190, DOI 10.1016/j.palaeo.2006.03.025; van der Meulen AJ, 2011, GEOBIOS-LYON, V44, P309, DOI 10.1016/j.geobios.2010.11.004; VANDERMEULEN AJ, 1992, PALAEOGEOGR PALAEOCL, V93, P227, DOI 10.1016/0031-0182(92)90099-Q; VESEYFITZGERALD DF, 1963, J ECOL, V51, P243, DOI 10.2307/2257683; Villalobos F, 2017, J BIOGEOGR, V44, P136, DOI 10.1111/jbi.12826; Vrba E.S., 1995, PAL EVOL EMPH HUM OR, P242; Vrba Elizabeth S., 1995, PALEOCLIMATE EVOLUTI; WALTER H, 1986, ECOSYSTEMS WORLD B, V12, P245; Walter H., 1985, VEGETATION EARTH REL; Walter H., 1988, ECOLOGICAL SYSTEMS G; White F., 1983, NAT RESOUR RES, V20, P1, DOI DOI 10.2307/2260340; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Xiao GQ, 2012, EARTH PLANET SC LETT, V317, P185, DOI 10.1016/j.epsl.2011.11.008; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhou YB, 2011, J BIOGEOGR, V38, P137, DOI 10.1111/j.1365-2699.2010.02396.x	164	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186762	10.1371/journal.pone.0186762	http://dx.doi.org/10.1371/journal.pone.0186762			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073193	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000413845400049
J	Abbott, JH; Usiskin, IM; Wilson, R; Hansen, P; Losina, E				Abbott, J. Haxby; Usiskin, Ilana M.; Wilson, Ross; Hansen, Paul; Losina, Elena			The quality-of-life burden of knee osteoarthritis in New Zealand adults: A model-based evaluation	PLOS ONE			English	Article							COST-EFFECTIVENESS; GLOBAL BURDEN; UNITED-STATES; HEALTH-STATUS; PREVALENCE; IMPACT; POPULATION; ARTHRITIS; HIP; PROJECTIONS	Background Knee osteoarthritis is a leading global cause of health-related quality of life loss. The aim of this project was to quantify health losses arising from knee osteoarthritis in New Zealand (NZ) in terms of quality-adjusted life years (QALYs) lost. Methods The Osteoarthritis Policy Model (OAPol), a validated Monte Carlo computer simulation model, was used to estimate QALYs lost due to knee osteoarthritis in the NZ adult population aged 40-84 over their lifetimes from the base year of 2006 until death. Data were from the NZ Health Survey, NZ Burden of Diseases, NZ Census, and relevant literature. QALYs were derived from NZ EQ-5D value set 2. Sensitivity to health state valuation, disease and pain prevalence were assessed in secondary analyses. Results Based on NZ EQ-5D health state valuations, mean health losses due to knee osteoarthritis over people's lifetimes in NZ are 3.44 QALYs per person, corresponding to 467,240 QALYs across the adult population. Average estimated per person QALY losses are higher for non-Maori females (3.55) than Maori females (3.38), and higher for non-Maori males (3.34) than Maori males (2.60). The proportion of QALYs lost out of the total quality-adjusted life expectancy for those without knee osteoarthritis is similar across all subgroups, ranging from 20 to 23 percent. Conclusions At both the individual and population levels, knee osteoarthritis is responsible for large lifetime QALY losses. QALY losses are higher for females than males due to greater prevalence of knee osteoarthritis and higher life expectancy, and lower for Maori than non-Maori due to lower life expectancy. Large health gains are potentially realisable from public health and policy measures aimed at decreasing incidence, progression, pain, and disability of osteoarthritis.	[Abbott, J. Haxby; Wilson, Ross] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Ctr Musculoskeletal Outcomes Res, Dunedin, New Zealand; [Usiskin, Ilana M.; Losina, Elena] Brigham & Womens Hosp, Dept Orthopaed Surg, Orthopaed & Arthrit Ctr Outcomes Res, 75 Francis St, Boston, MA 02115 USA; [Hansen, Paul] Univ Otago, Dept Econ, Dunedin, New Zealand	University of Otago; Harvard University; Brigham & Women's Hospital; University of Otago	Abbott, JH (corresponding author), Univ Otago, Dunedin Sch Med, Dept Surg Sci, Ctr Musculoskeletal Outcomes Res, Dunedin, New Zealand.	haxby.abbott@otago.ac.nz	Wilson, Ross/AAH-3161-2019; ABBOTT, J. Haxby/AAH-3262-2019; Abbott, J. Haxby/AAK-4346-2020	Wilson, Ross/0000-0001-8505-8081; Abbott, J. Haxby/0000-0001-6468-7284; Losina, ELENA/0000-0002-3424-0892	Health Research Council of New Zealand; University of Otago Division of Health Sciences Research Technology; Dunedin School of Medicine; Health Research Council of New Zealand; University of Otago Division of Health Sciences Research Technology; Dunedin School of Medicine	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago Division of Health Sciences Research Technology; Dunedin School of Medicine; Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago Division of Health Sciences Research Technology; Dunedin School of Medicine	JHA was supported by a Sir Charles Hercus Health Research Fellowship from the Health Research Council of New Zealand. This study was supported, in part, by a University of Otago Division of Health Sciences Research Technology Voucher award and a Dunedin School of Medicine Dean's Bequest Fund grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NZ BURD DIS STAT ANN; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Devlin N, 2000, NEW ZEAL MED J, V113, P517; Devlin NJ, 2003, HEALTH ECON, V12, P529, DOI 10.1002/hec.741; Devlin NJ, 2000, 180 CHE; Hooper G, 2014, NEW ZEAL MED J, V127, P82; Hunter DJ, 2014, NAT REV RHEUMATOL, V10, P437, DOI 10.1038/nrrheum.2014.44; Katz JN, 2016, OSTEOARTHR CARTILAGE, V24, P409, DOI 10.1016/j.joca.2015.10.006; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Losina E, 2016, OSTEOARTHR CARTILAGE, V24, P776, DOI 10.1016/j.joca.2015.12.011; Losina E, 2014, OSTEOARTHRITIS CARTI; Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412; Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898; Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001; March LM, 1998, OSTEOARTHR CARTILAGE, V6, P87, DOI 10.1053/joca.1997.0098; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; New Zealand Ministry of Health, 2008, PORTR HLTH ONL DAT T; New Zealand Ministry of Health, 2013, NZ BURD DIS INJ RISK; Oiestad BE, 2016, ARTHRIT CARE RES, V68, P325, DOI 10.1002/acr.22674; Pereira D, 2011, OSTEOARTHR CARTILAGE, V19, P1270, DOI 10.1016/j.joca.2011.08.009; Perruccio AV, 2006, J RHEUMATOL, V33, P1856; PHARMAC, 2012, PRESCR PHARM AN METH; Richardson J., 2014, ENCY HLTH EC, P341; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sassi F, 2006, HEALTH POLICY PLANN, V21, P402, DOI 10.1093/heapol/czl018; Statistics New Zealand, 2008, NZ CENS POP DWELL 20; Statistics New Zealand, 2009, NZ LIF TABL 2005 07; Statistics New Zealand, 2014, NAT POP PROJ 2014 BA; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Thomas E, 2014, RHEUMATOLOGY, V53, P338, DOI 10.1093/rheumatology/ket346; Torrance GW, 2001, MED DECIS MAKING, V21, P329, DOI 10.1177/02729890122062622; United States National Health Interview Survey, US NATL HLTH INTERVI; Wesseling J, 2009, ANN RHEUM DIS, V68, P1413, DOI 10.1136/ard.2008.096164; World Health Organization Country Office Fiji, 2013, PAC HLTH WORKF SERV	36	39	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0185676	10.1371/journal.pone.0185676	http://dx.doi.org/10.1371/journal.pone.0185676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK5VD	29065119	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900005
J	Ju, SM; Wang, LP; Zhang, CY; Yin, TC; Shao, SL				Ju, Shuming; Wang, Liping; Zhang, Cuiying; Yin, Tingchao; Shao, Siliang			Alleviatory effects of silicon on the foliar micromorphology and anatomy of rice (Oryza sativa L.) seedlings under simulated acid rain	PLOS ONE			English	Article							STOMATAL CHARACTERISTICS; DROUGHT STRESS; UV-B; GROWTH; WHEAT; PHOTOSYNTHESIS; MITOCHONDRIA; CONDUCTANCE; RESPONSES; CHLORIDE	Silicon (Si) is a macroelement in plants. The biological effects and mitigation mechanisms of silicon under environmental stress have become hot topics. The main objectives of this study were to elucidate the roles of Si in alleviating the effects on the phenotype, micromorphology and anatomy of the leaves of rice seedlings under acid rain stress. The results indicated that the combined or single effects of Si and simulated acid rain (SAR) stress on rice roots depended on the concentration of Si and the intensity of the SAR stress. The combined or single effects of the moderate concentration of Si (2.0 mM) and light SAR (pH 4.0) enhanced the growth of the rice leaves and the development of the mesophyll cells, and the combined effects were stronger than those of the single treatments. The high concentration of Si (4.0 mM) and severe SAR (pH 3.0 or 2.0) exerted deleterious effects. The incorporation of Si (2.0 or 4.0 mM) into SAR at pH values of 3.0 or 2.0 promoted rice leaf growth, decreased necrosis spots, maintained the structure and function of the mesophyll cells, increased the epicuticular wax content and wart-like protuberance (WP) density, and improved the stomatal characteristics of the leaves of rice seedlings more than the SAR only treatments. The alleviatory effects observed with a moderate concentration of Si (2.0 mM) were better than the effects obtained with the high concentration of Si (4.0 mM). The alleviatory effects were due to the enhancement of the mechanical barriers in the leaf epidermis.	[Ju, Shuming; Wang, Liping; Zhang, Cuiying] China Univ Min & Technol, Sch Environm & Spatial Informat, Xuzhou, Jiangsu, Peoples R China; [Ju, Shuming; Zhang, Cuiying; Yin, Tingchao; Shao, Siliang] Xuzhou Inst Technol, Sch Environm, Xuzhou, Jiangsu, Peoples R China; [Ju, Shuming] Jiangsu Lab Pollut Control & Resource Reuse, Xuzhou, Jiangsu, Peoples R China	China University of Mining & Technology; Xuzhou University of Technology	Wang, LP (corresponding author), China Univ Min & Technol, Sch Environm & Spatial Informat, Xuzhou, Jiangsu, Peoples R China.	qusm2010@163.com			national spark plan project [S2013C100537]; program of Environmental Science and Technology of Jiangsu Province [2007024]	national spark plan project; program of Environmental Science and Technology of Jiangsu Province	This work was supported by the national spark plan project (S2013C100537) and The program of Environmental Science and Technology of Jiangsu Province (2007024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Spark Plan Project (No. S2013C100537) and the Programme of Environmental Science and Technology of Jiangsu Province (No. 2007024).	Ahmed M, 2016, ARCH AGRON SOIL SCI, V62, P299, DOI 10.1080/03650340.2015.1048235; Al-Mayahi A. M. W., 2016, American Journal of Plant Sciences, V7, P1711, DOI 10.4236/ajps.2016.713161; Balasubramanian G, 2007, J TROP FOR SCI, V19, P198; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Pascual MB, 2016, PLANT PHYSIOL BIOCH, V108, P132, DOI 10.1016/j.plaphy.2016.07.008; Bogdan K, 2008, ENVIRON SCI TECHNOL, V42, P7885, DOI 10.1021/es801194q; Bybordi A, 2014, J INTEGR AGR, V13, P1889, DOI 10.1016/S2095-3119(13)60639-5; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102532; Chen Y, 2002, ACTA BOT BOREALI-OCC, V23, P304; COPELAND E, 1966, SCIENCE, V151, P470, DOI 10.1126/science.151.3709.470; COPELAND E, 1964, J CELL BIOL, V23, P253, DOI 10.1083/jcb.23.2.253; Crooks R, 2017, SILICON-NETH, V9, P301, DOI 10.1007/s12633-015-9379-3; Currie HA, 2007, ANN BOT-LONDON, V100, P1383, DOI 10.1093/aob/mcm247; Dorneles KR, 2017, PHYSIOL MOL PLANT P, V97, P69, DOI 10.1016/j.pmpp.2017.01.001; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Farshidi M, 2012, ACTA PHYSIOL PLANT, V34, P1779, DOI 10.1007/s11738-012-0975-1; Gabara B, 2003, PLANT SCI, V164, P507, DOI 10.1016/S0168-9452(02)00447-8; Gao P, 2011, AFR J BIOTECHNOL, V10, P6904; Gao XP, 2006, J PLANT NUTR, V29, P1637, DOI 10.1080/01904160600851494; Guntzer F., 2012, AGRONOMY SUSTAINABLE, V32, P201, DOI DOI 10.1007/S13593-011-0039-8; HARDY JP, 1995, AM J BOT, V82, P1, DOI 10.2307/2445779; HARTE J, 1983, ATMOS ENVIRON, V17, P403, DOI 10.1016/0004-6981(83)90058-6; Helaly MN, 2017, PLANT PHYSIOL BIOCH, V118, P31, DOI 10.1016/j.plaphy.2017.05.021; James SA, 2000, TREE PHYSIOL, V20, P1007; [金鑫 Jin Xin], 2015, [环境监测管理与技术, The Administration and Technique of Environmental Monitoring], V27, P65; Ju SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173378; Ju SM, 2017, PROTOPLASMA; Jumrani K, 2017, PHOTOSYNTH RES, V131, P333, DOI 10.1007/s11120-016-0326-y; Khan WUD, 2017, ARCH AGRON SOIL SCI, V63, P599, DOI 10.1080/03650340.2016.1233322; Khazaei H, 2010, GENET RESOUR CROP EV, V57, P307, DOI 10.1007/s10722-009-9471-x; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Lee Y, 2006, PLANT PHYSIOL BIOCH, V44, P38, DOI 10.1016/j.plaphy.2006.01.003; Li WD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044230, 10.1371/journal.pone.0044099]; Liang J, 2008, THESIS; Liang YC, 2006, NEW PHYTOL, V172, P63, DOI 10.1111/j.1469-8137.2006.01797.x; Lim MY, 2012, KOREAN J HORTIC SCI, V30, P579, DOI 10.7235/hort.2012.12062; Lin HM, 2017, PLANT GROWTH REGUL, V81, P91, DOI 10.1007/s10725-016-0191-x; Liu TW, 2011, TREE PHYSIOL, V31, P402, DOI 10.1093/treephys/tpr019; [罗璇 Luo Xuan], 2013, [地球与环境, Earth and Environment], V41, P566; Lux A, 2003, PLANT SOIL, V255, P85, DOI 10.1023/A:1026157424794; Ma J.F., 2002, SOIL FERTILIZER PLAN; Ma JF, 2014, SOIL SCI, V50, p[1, 11]; Macaulay BM, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4844-4; Mariani C, 2000, Plant Cell, V12, P1795; Morikawa CK, 2004, PLANT SOIL, V258, P1, DOI 10.1023/B:PLSO.0000016489.69114.55; Mostowfizadeh-Ghalamfarsa R, 2017, AUSTRALAS PLANT PATH, V46, P323, DOI 10.1007/s13313-017-0496-x; Pambou E, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0396; Paoletti E, 1998, CHEMOSPHERE, V36, P835, DOI 10.1016/S0045-6535(97)10134-5; PERCY KE, 1987, NEW PHYTOL, V107, P577, DOI 10.1111/j.1469-8137.1987.tb02928.x; Putra E. T. S., 2015, Journal of Agronomy, V14, P49, DOI 10.3923/ja.2015.49.61; Qiang WY, 2003, TREES-STRUCT FUNCT, V17, P258, DOI 10.1007/s00468-002-0235-x; RINALLO C, 1989, EUR J FOREST PATHOL, V19, P151; ROBERTS BR, 1989, CAN J FOREST RES, V19, P1200, DOI 10.1139/x89-180; Sahebi M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/396010; Sant'Anna-Santos BF, 2006, ENVIRON EXP BOT, V58, P158, DOI 10.1016/j.envexpbot.2005.07.005; Shetty R, 2012, PLANT PATHOL, V61, P120, DOI 10.1111/j.1365-3059.2011.02493.x; SIEW D, 1968, J CELL BIOL, V37, P590, DOI 10.1083/jcb.37.2.590; Sivanesan I, 2014, SCI WORLD J, DOI 10.1155/2014/521703; State Environmental Protection Administration of China, 2005, ENV PROT, V6, P11; Stoyanova D, 1998, BIOL PLANTARUM, V40, P581, DOI 10.1023/A:1001709405012; Stoyanova D, 1998, BIOL PLANTARUM, V40, P589, DOI 10.1023/A:1001761421851; Stupnikova I, 2006, PLANT PHYSIOL, V140, P326, DOI 10.1104/pp.105.073015; Sun ZG, 2012, ECOTOX ENVIRON SAFE, V79, P62, DOI 10.1016/j.ecoenv.2011.12.004; Tripathi DK, 2017, PLANT PHYSIOL BIOCH, V110, P70, DOI 10.1016/j.plaphy.2016.06.026; Wailes EJ, 2010, ARKANSAS GLOBAL RICE, P1; Wang CY, 2010, SCI TOTAL ENVIRON, V408, P2706, DOI 10.1016/j.scitotenv.2010.03.023; Wang LH, 2014, CHEMOSPHERE, V112, P355, DOI 10.1016/j.chemosphere.2014.04.069; Wyrwicka A, 2006, ENVIRON EXP BOT, V56, P198, DOI 10.1016/j.envexpbot.2005.02.003; Yang SK, 1991, KOREAN J CROP SCI, V36, P70; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang WJ, 2017, J PLANT RES, V130, P611, DOI 10.1007/s10265-017-0927-3; Zhang ZB, 2007, COLLOID SURFACE B, V55, P1, DOI 10.1016/j.colsurfb.2006.10.036	73	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0187021	10.1371/journal.pone.0187021	http://dx.doi.org/10.1371/journal.pone.0187021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065171	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900063
J	Mowlaboccus, S; Mullally, CA; Richmond, PC; Howden, BP; Stevens, K; Speers, DJ; Keil, AD; Bjornstad, ON; Perkins, TT; Kahler, CM				Mowlaboccus, Shakeel; Mullally, Christopher A.; Richmond, Peter C.; Howden, Benjamin P.; Stevens, Kerrie; Speers, David J.; Keil, Anthony D.; Bjornstad, Ottar N.; Perkins, Timothy T.; Kahler, Charlene M.			Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia	PLOS ONE			English	Article							INVASIVE MENINGOCOCCAL DISEASE; NEW-SOUTH-WALES; SEROGROUP W; B DISEASE; INCREASE; VACCINE; EMERGENCE; SYDNEY; EPIDEMIOLOGY; IMMUNIZATION	Neisseria meningitidis is the causative agent of invasive meningococcal disease (IMD). A recombinant vaccine called Bexsero (R) incorporates four subcapsular antigens (fHbp, NHBA, NadA and PorA) which are used to assign a Bexsero (R) antigen sequence type (BAST) to each meningococcal strain. The vaccine elicits an immune response against combinations of variants of these antigens which have been grouped into specific BAST profiles that have been shown to have different distributions within geographical locations thus potentially affecting the efficacy of the vaccine. In this study, invasive meningococcal disease isolates from the western seaboard of Australia (Western Australia; WA) were compared to those from the south-eastern seaboard (Victoria; VIC) from 2008 to 2012. Whole-genome sequencing (WGS) of 131 meningococci from VIC and 70 meningococci from WA were analysed for MLST, FetA and BAST profiling. Serogroup B predominated in both jurisdictions and a total of 10 MLST clonal complexes (cc) were shared by both states. Isolates belonging to cc22, cc103 and cc1157 were unique to VIC whilst isolates from cc60 and cc212 were unique to WA. Clonal complex 41/44 represented one-third of the meningococcal population in each state but the predominant ST was locally different: ST-6058 in VIC and ST-146 in WA. Of the 108 BAST profiles identified in this collection, only 9 BASTs were simultaneously observed in both states. A significantly larger proportion of isolates in VIC harboured alleles for the NHBA-2 peptide and fHbp-1, antigenic variants predicted to be covered by the Bexsero (R) vaccine. The estimate for vaccine coverage in WA (47.1% [95% CI: 41.1-53.1%]) was significantly lower than that in VIC (66.4% [95% CI: 62.3-70.5%]). In conclusion, the antigenic structure of meningococci causing invasive disease in two geographically distinct states of Australia differed significantly during the study period which may affect vaccine effectiveness and highlights the need for representative surveillance when predicting potential impact of meningococcal B vaccines.	[Mowlaboccus, Shakeel; Mullally, Christopher A.; Kahler, Charlene M.] Univ Western Australia, Sch Biomed Sci, Marshall Ctr Infect Dis Res & Training, Perth, WA, Australia; [Richmond, Peter C.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Richmond, Peter C.; Kahler, Charlene M.] Telethon Kids Inst, Perth, WA, Australia; [Howden, Benjamin P.; Stevens, Kerrie] Univ Melbourne, Microbiol Diagnost Unit, Publ Hlth Lab, Dept Microbiol & Immunol,Doherty Inst Infect & Im, Melbourne, Vic, Australia; [Howden, Benjamin P.] Austin Hlth, Dept Infect Dis, Heidelberg, Vic, Australia; [Speers, David J.] PathWest Lab Med WA, QEII Med Ctr, Dept Microbiol, Nedlands, WA, Australia; [Speers, David J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Keil, Anthony D.] PathWest Lab Med WA, Princess Margaret Hosp Children, Dept Microbiol, Perth, WA, Australia; [Bjornstad, Ottar N.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Western Australia; University of Western Australia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kahler, CM (corresponding author), Univ Western Australia, Sch Biomed Sci, Marshall Ctr Infect Dis Res & Training, Perth, WA, Australia.; Kahler, CM (corresponding author), Telethon Kids Inst, Perth, WA, Australia.	Charlene.Kahler@uwa.edu.au	Kahler, Charlene M/H-5159-2014; Richmond, Peter C/G-3379-2012	Kahler, Charlene M/0000-0003-4322-3055; Richmond, Peter C/0000-0001-7562-7228; Howden, Benjamin/0000-0003-0237-1473; Mowlaboccus, Shakeel/0000-0001-9408-6068	University of Western Australia	University of Western Australia	S.M. is supported by an International Postgraduate Research Scholarship award from The University of Western Australia. Collection of meningococcal isolates is facilitated by the National Neisseria Network.; S.M. is supported by an International Postgraduate Research Scholarship award from The University of Western Australia. Collection of meningococcal isolates is facilitated by the National Neisseria Network.	Abad R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150721; Bambini S, 2014, CLIN VACCINE IMMUNOL, V21, P966, DOI 10.1128/CVI.00825-13; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Boan P, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0686-x; Bond KA, 2016, MED J AUSTRALIA, V204, P265, DOI 10.5694/mja15.01222; Brehony C, 2016, VACCINE, V34, P4690, DOI 10.1016/j.vaccine.2016.08.015; Carville KS, 2016, EMERG INFECT DIS, V22, P1785, DOI 10.3201/eid2210.151935; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; CLEMENTS DA, 1989, LANCET, V2, P1464; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; Gibson A, 2015, EPIDEMIOL INFECT, V143, P2570, DOI 10.1017/S0950268814003355; Gunaratnam P, 2013, WEST PAC SURVEILL RE, V4, P4, DOI [10.5365/WPSAR.2013.4.4.001, 10.5365/wpsar.2013.4.4.001]; HANSMAN D, 1983, J HYG-CAMBRIDGE, V90, P49, DOI 10.1017/S0022172400063828; Hansman D, 1994, PATHOLOGY, P26; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jardine A, 2009, COMMUN DIS INTELL, V33, P221; Jelfs J, 2001, J Paediatr Child Health, V37, pS3, DOI 10.1046/j.1440-1754.2001.00680.x; Jelfs J, 1998, EPIDEMIOL INFECT, V120, P263, DOI 10.1017/S0950268898008681; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Ladhani SN, 2016, EMERG INFECT DIS, V22, P309, DOI 10.3201/eid2202.150369; Ladhani SN, 2015, CLIN INFECT DIS, V60, P578, DOI 10.1093/cid/ciu881; Lahra MM, 2016, COMMUN DIS INTELL, V40, pE503; Lawrence GL, 2016, EPIDEMIOL INFECT, V144, P2382, DOI 10.1017/S0950268816000704; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Mowlaboccus S, 2017, EMERG INFECT DIS, V23, P1364, DOI 10.3201/eid2308.170259; Mowlaboccus S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158315; Munro R, 1996, AUST NZ J MED, V26, P526, DOI 10.1111/j.1445-5994.1996.tb00599.x; Mustapha MM, 2016, VACCINE, V34, P1515, DOI 10.1016/j.vaccine.2016.02.014; Nissen M TS, 2012, 18 INT PATH NEISS C; Olesch CA, 1999, J PAEDIATR CHILD H, V35, P42, DOI 10.1046/j.1440-1754.1999.t01-1-00337.x; Patel M, 1997, Commun Dis Intell, V21, P233; PELTOLA H, 1983, REV INFECT DIS, V5, P71; Pereira LJ, 2006, ACTA ODONTOL SCAND, V64, P193, DOI 10.1080/00016350600703459; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Shirley M, 2015, BIODRUGS, V29, P353, DOI 10.1007/s40259-015-0139-0; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Tribe DE, 2002, EPIDEMIOL INFECT, V128, P7, DOI 10.1017/S0950268801006343; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Veitch MGK, 2016, COMMUN DIS INTELL, V40, pE451; Watkins ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045349; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186839	10.1371/journal.pone.0186839	http://dx.doi.org/10.1371/journal.pone.0186839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065137	gold, Green Published, Green Submitted			2022-12-26	WOS:000413568900048
J	Paech, GM; Crowley, SJ; Fogg, LF; Eastman, CI				Paech, Gemma M.; Crowley, Stephanie J.; Fogg, Louis F.; Eastman, Charmane I.			Advancing the sleep/wake schedule impacts the sleep of African-Americans more than European-Americans	PLOS ONE			English	Article							RUNNING CIRCADIAN PERIOD; FORCED DESYNCHRONY; GENETIC ANCESTRY; NEUROBEHAVIORAL FUNCTION; BODY-TEMPERATURE; OLDER SUBJECTS; DOSE-RESPONSE; SHIFT WORK; NIGHT WORK; JET-LAG	There are differences in sleep duration between Blacks/African-Americans and Whites/European-Americans. Recently, we found differences between these ancestry groups in the circadian system, such as circadian period and the magnitude of phase shifts. Here we document the role of ancestry on sleep and cognitive performance before and after a 9-h advance in the sleep/wake schedule similar to flying east or having a large advance in sleep times due to shiftwork, both of which produce extreme circadian misalignment. Non-Hispanic African and European-Americans (N = 20 and 17 respectively, aged 21-43 years) were scheduled to four baseline days each with 8 h time in bed based on their habitual sleep schedule. This sleep/wake schedule was then advanced 9 h earlier for three days. Sleep was monitored using actigraphy. During the last two baseline/aligned days and the first two advanced/misaligned days, beginning 2 h after waking, cognitive performance was measured every 3 h using the Automated Neuropsychological Assessment Metrics (ANAM) test battery. Mixed model ANOVAs assessed the effects of ancestry (African-American or European-American) and condition (baseline/aligned or advanced/misaligned) on sleep and cognitive performance. There was decreased sleep and impaired performance in both ancestry groups during the advanced/misaligned days compared to the baseline/aligned days. In addition, African-Americans obtained less sleep than European-Americans, especially on the first two days of circadian misalignment. Cognitive performance did not differ between African-Americans and European-Americans during baseline days. During the two advanced/misaligned days, however, African-Americans tended to perform slightly worse compared to European-Americans, particularly at times corresponding to the end of the baseline sleep episodes. Advancing the sleep/wake schedule, creating extreme circadian misalignment, had a greater impact on the sleep of African-Americans than European-Americans. Ancestry differences in sleep appear to be exacerbated when the sleep/wake schedule is advanced, which may have implications for individuals undertaking shiftwork and transmeridian travel.	[Paech, Gemma M.; Crowley, Stephanie J.; Fogg, Louis F.; Eastman, Charmane I.] Rush Univ, Dept Behav Sci, Biol Rhythms Res Lab, Med Ctr, Chicago, IL 60612 USA	Rush University	Eastman, CI (corresponding author), Rush Univ, Dept Behav Sci, Biol Rhythms Res Lab, Med Ctr, Chicago, IL 60612 USA.	ceastman@rush.edu		Crowley, Stephanie/0000-0003-2057-9876; Paech, Gemma/0000-0002-1969-5215; Eastman, Charmane/0000-0002-4057-1233	National Institutes of Health (NIH) from National Institute of Nursing Research (NINR) [R01NR007677]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR007677] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from National Institute of Nursing Research (NINR); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Research was supported by National Institutes of Health (NIH) grant R01NR007677 from the National Institute of Nursing Research (NINR) to CIE.	Adenekan B, 2013, SLEEP MED REV, V17, P255, DOI 10.1016/j.smrv.2012.07.002; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benloucif S, 2005, J BIOL RHYTHM, V20, P178, DOI 10.1177/0748730404273983; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Butcher JN, 1989, MINNESOTA MULTIPHASI; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carnethon MR, 2016, SLEEP MED, V18, P50, DOI 10.1016/j.sleep.2015.07.005; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chen X, 2015, SLEEP; Chinoy ED, 2016, OCCUP ENV MED; Cohen DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000458; CZEISLER CA, 1980, SCIENCE, V210, P1264, DOI 10.1126/science.7434029; Darwent D, 2010, CHRONOBIOL INT, V27, P898, DOI 10.3109/07420528.2010.488621; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Eastman CI, 2017, J SLEEP RES, V26, P547, DOI 10.1111/jsr.12521; Eastman CI, 2016, SCI REP-UK, V6, DOI 10.1038/srep36716; Eastman CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep08381; Eastman CI, 2012, CHRONOBIOL INT, V29, P1072, DOI 10.3109/07420528.2012.700670; Eastman CI, 2000, CHRONOBIOL INT, V17, P807, DOI 10.1081/CBI-100102116; Egan KJ, 2016, SLEEP MED REV; Ferguson SA, 2012, ACCIDENT ANAL PREV, V45, P50, DOI 10.1016/j.aap.2011.09.026; Ferguson SA, 2011, APPL ERGON, V42, P210, DOI 10.1016/j.apergo.2010.06.010; Ferguson SA, 2011, APPL ERGON, V42, P699, DOI 10.1016/j.apergo.2010.11.004; Gamaldo AA, 2013, J GERONTOL B; Goel N, 2015, SLEEP, V38, P1151, DOI 10.5665/sleep.4876; Goel N, 2013, PROG MOL BIOL TRANSL, V119, P155, DOI 10.1016/B978-0-12-396971-2.00007-5; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Halder I, 2015, SLEEP, V38, P1185, DOI 10.5665/sleep.4888; Hale L, 2007, SLEEP, V30, P1096, DOI 10.1093/sleep/30.9.1096; Hall MH, 2009, SLEEP, V32, P73; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Jackson ML, 2013, SLEEP MED REV, V17, P215, DOI 10.1016/j.smrv.2012.06.007; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lamond N, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.11.e13; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; LAVIE P, 1986, ELECTROEN CLIN NEURO, V63, P414, DOI 10.1016/0013-4694(86)90123-9; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Malone SK, 2015, CHRONOBIOL INT, P1; McMenamin TM, 2007, MON LABOR REV, V130, P3; McNair D.M., 1971, MANUAL PROFILES MOOD; Mezick EJ, 2008, PSYCHOSOM MED, V70, P410, DOI 10.1097/PSY.0b013e31816fdf21; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; National Sleep Foundation, 2010, SLEEP AM POLL SUMMAR; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nunes J, 2008, J NATL MED ASSOC, V100, P317, DOI 10.1016/S0027-9684(15)31244-X; Paech GM, 2016, PHARMACOL BIOCHEM BE, V145, P27, DOI 10.1016/j.pbb.2016.03.011; Paech GM, 2012, SLEEP, V35, P941, DOI 10.5665/sleep.1956; Paech GM, 2010, ERGONOMIA IJE HF, V32, P125; Profant J, 2002, AM J HUM BIOL, V14, P321, DOI 10.1002/ajhb.10032; Rao U, 1999, J PSYCHIATR RES, V33, P419, DOI 10.1016/S0022-3956(99)00019-9; Reid K, 1999, SLEEP, V22, P378, DOI 10.1093/sleep/22.3.378; Reid K, 2001, OCCUP ENVIRON MED, V58, P58, DOI 10.1136/oem.58.1.58; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Ruiter ME, 2011, SLEEP MED, V12, P209, DOI 10.1016/j.sleep.2010.12.010; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sallinen M, 1998, J SLEEP RES, V7, P240, DOI 10.1046/j.1365-2869.1998.00121.x; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Smith MR, 2012, NAT SCI SLEEP, V4, P111, DOI 10.2147/NSS.S10372; Smith MR, 2009, SLEEP, V32, P1481, DOI 10.1093/sleep/32.11.1481; Smith MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006014; Song YS, 2012, BEHAV SLEEP MED, V10, P54, DOI 10.1080/15402002.2012.636276; Spitzer RL, 1999, AM J PSYCHIAT, V156, P1392; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stepnowsky CJ, 2003, SLEEP, V26, P329, DOI 10.1093/sleep/26.3.329; STONE BM, 1984, BRIT J CLIN PHARMACO, V18, pS15, DOI 10.1111/j.1365-2125.1984.tb02578.x; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; Suarez E, 2015, SLEEP HLTH; Van Dongen HPA, 2011, SLEEP, V34, P917, DOI 10.5665/SLEEP.1128; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Whinnery J, 2014, SLEEP, V37, P601, DOI 10.5665/sleep.3508; Whitney Paul, 2015, Sleep, V38, P745, DOI 10.5665/sleep.4668; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Zhou X, 2012, J SLEEP RES, V21, P40, DOI 10.1111/j.1365-2869.2011.00924.x; Zhou X, 2011, SLEEP, V34, P931, DOI 10.5665/SLEEP.1130; Zhou XA, 2011, SLEEP, V34, P57, DOI 10.1093/sleep/34.1.57; ZULLEY J, 1981, PFLUG ARCH EUR J PHY, V391, P314, DOI 10.1007/BF00581514	84	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186887	10.1371/journal.pone.0186887	http://dx.doi.org/10.1371/journal.pone.0186887			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK3RE	29059251	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000050
J	Zhang, SJ; Wu, Y; Xuan, ZA; Chen, XM; Zhang, JJ; Ge, DY; Wang, XD				Zhang, Shujing; Wu, Ying; Xuan, Zinan; Chen, Xiaoming; Zhang, Junjie; Ge, Dongyu; Wang, Xudan			Screening differential miRNAs responsible for permeability increase in HUVECs infected with influenza A virus	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ACTIVATION; KINASE; H1N1; HYPERPERMEABILITY; PATHOGENESIS	Severe influenza infections are featured by acute lung injury, a syndrome of increased pulmonary microvascular permeability. A growing number of evidences have shown that influenza A virus induces cytoskeletal rearrangement and permeability increase in endothelial cells. Although miRNA's involvement in the regulation of influenza virus infection and endothelial cell (EC) function has been well documented, little is known about the miRNA profiles in influenza-infected endothelial cells. Using human umbilical vein endothelial cells (HUVECs) as cell models, the present study aims to explore the differential miRNAs in influenza virus-infected ECs and analyze their target genes involved in EC permeability regulation. As the results showed, permeability increased and F-actin cytoskeleton reorganized after HUVECs infected with influenza A virus (CA07 or PR8) at 30 MOI. MicroRNA microarray revealed a multitude of miRNAs differentially expressed in HUVECs after influenza virus infection. Through target gene prediction, we found that a series of miRNAs were involved in PKC, Rho/ROCK, HRas/Raf/MEK/ERK, and Ca-2+/CaM pathways associated with permeability regulation, and most of these miRNAs were down-regulated after flu infection. It has been reported that PKC, Rho/ROCK, HRas/Raf/MEK/ERK, and Ca-2+/CaM pathways are activated by flu infection and play important roles in permeability regulation. Therefore, the cumulative effects of these down-regulated miRNAs which synergistically enhanced activation of PKC, Rho/ROCK, Ras/Raf/MEK/ERK, and Ca-2+/CaM pathways, can eventually lead to actin rearrangement and hyperpermeability in flu-infected HUVECs.	[Zhang, Shujing; Ge, Dongyu] Beijing Univ Chinese Med, Sci Res Ctr, Beijing, Peoples R China; [Wu, Ying; Xuan, Zinan; Chen, Xiaoming; Zhang, Junjie; Wang, Xudan] Beijing Univ Chinese Med, Sch Life Sci, Dept Microbiol & Immunol, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Wu, Y (corresponding author), Beijing Univ Chinese Med, Sch Life Sci, Dept Microbiol & Immunol, Beijing, Peoples R China.	aqiwuying@hotmail.com	chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022		National Natural Science Foundation of China [81473520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81473520) to YW.; This work was supported by grants from the National Natural Science Foundation of China (No. 81473520). We thank Chenyue Zhang, PhD, at the Department of Integrative Oncology in Fudan University Shanghai Cancer Center, for language proofreading.	Alexy T, 2014, PHYSIOL GENOMICS, V46, P833, DOI 10.1152/physiolgenomics.00079.2014; Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779; Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Bogatcheva NV, 2011, J CELL PHYSIOL, V226, P3132, DOI 10.1002/jcp.22669; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Chan LY, 2011, J ETHNOPHARMACOL, V137, P1542, DOI 10.1016/j.jep.2011.08.022; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Haidari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021444; Haidari M, 2009, PHYTOMEDICINE, V16, P1127, DOI 10.1016/j.phymed.2009.06.002; HARTSHORN KL, 1990, BLOOD, V75, P218; HARTSHORN KL, 1992, BLOOD, V79, P1049; Hwang HW, 2006, BR J CANC S, V96, pR40; Kalani M, 2016, PROBIOTICS ANTIMICRO, V8, P61, DOI 10.1007/s12602-016-9214-1; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Ma YJ, 2012, J CELL MOL MED, V16, P2539, DOI 10.1111/j.1582-4934.2012.01572.x; NUGENT KM, 1984, ARCH VIROL, V81, P163, DOI 10.1007/BF01309305; OCHIAI H, 1991, ANTIVIR RES, V15, P149, DOI 10.1016/0166-3542(91)90032-M; Pepini T, 2010, J VIROL, V84, P11929, DOI 10.1128/JVI.01658-10; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Root CN, 2000, J GEN VIROL, V81, P2697, DOI 10.1099/0022-1317-81-11-2697; Ruan W, 2012, CARDIOVASC RES, V93, P623, DOI 10.1093/cvr/cvr290; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tambyah PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076811; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Zeng J, 2013, EXP CLIN ENDOCR DIAB, V121, P425, DOI 10.1055/s-0033-1345169; Zhang CY, 2014, VIRUS RES, V192, P6, DOI 10.1016/j.virusres.2014.07.027	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186477	10.1371/journal.pone.0186477	http://dx.doi.org/10.1371/journal.pone.0186477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059211	gold, Green Published, Green Submitted			2022-12-26	WOS:000413403000026
J	Turturice, BA; McGee, HS; Oliver, B; Baraket, M; Nguyen, BT; Ascoli, C; Ranjan, R; Rani, A; Perkins, DL; Finn, PW				Turturice, Benjamin A.; McGee, Halvor S.; Oliver, Brian; Baraket, Melissa; Nguyen, Brian T.; Ascoli, Christian; Ranjan, Ravi; Rani, Asha; Perkins, David L.; Finn, Patricia W.			Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction	PLOS ONE			English	Article							CLUSTER-ANALYSIS; DISEASE; SEVERITY; DYNAMICS; ALLERGEN; IL-10	Background Differences in asthma severity may be related to inflammation in the airways. The lower airway microbiota has been associated with clinical features such as airway obstruction, symptom control, and response to corticosteroids. Objective To assess the relationship between local airway inflammation, severity of disease, and the lower airway microbiota in atopic asthmatics. Methods A cohort of young adult, atopic asthmatics with intermittent or mild/moderate persistent symptoms (n = 13) were assessed via bronchoscopy, lavage, and spirometry. These individuals were compared to age matched non-asthmatic controls (n = 6) and to themselves after six weeks of treatment with fluticasone propionate (FP). Inflammation of the airways was assessed via a cytokine and chemokine panel. Lower airway microbiota composition was determined by metagenomic shotgun sequencing. Results Unsupervised clustering of cytokines and chemokines prior to treatment with FP identified two asthmatic phenotypes (AP), termed AP1 and AP2, with distinct bronchoalveolar lavage inflammatory profiles. AP2 was associated with more obstruction, compared to AP1. After treatment with FP reduced MIP-1 beta and TNF-alpha and increased IL-2 was observed. A module of highly correlated cytokines that include MIP-1 beta and TNF-alpha was identified that negatively correlated with pulmonary function. Independently, IL-2 was positively correlated with pulmonary function. The airway microbiome composition correlated with asthmatic phenotypes. AP2, prior to FP treatment, was enriched with Streptococcus pneumoniae. Unique associations between IL-2 or the cytokine module and the microbiota composition of the airways were observed in asthmatics subjects prior to treatment but not after or in controls. Conclusion The underlying inflammation in atopic asthma is related to the composition of microbiota and is associated with severity of airway obstruction. Treatment with inhaled corticosteroids was associated with changes in the airway inflammatory response to microbiota.	[Turturice, Benjamin A.; McGee, Halvor S.; Nguyen, Brian T.; Ascoli, Christian; Ranjan, Ravi; Rani, Asha; Finn, Patricia W.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA; [Turturice, Benjamin A.; Finn, Patricia W.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Oliver, Brian] Woolcock Inst Med Res, Resp Cellular & Mol Biol, Sydney, NSW, Australia; [Oliver, Brian] Univ Technol Sydney, Sch Life Sci, Mol Biosci, Sydney, NSW, Australia; [Baraket, Melissa] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia; [Baraket, Melissa] Liverpool Hosp, Dept Resp Med & Sleep Med, Liverpool, NSW, Australia; [Baraket, Melissa] Liverpool Hosp, Ingham Inst Appl Med Res, Liverpool, NSW, Australia; [Perkins, David L.] Univ Illinois, Dept Med, Div Nephrol, Chicago, IL USA; [Perkins, David L.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Perkins, David L.] Univ Illinois, Dept Bioengn, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Sydney; Woolcock Institute of Medical Research; University of Technology Sydney; University of New South Wales Sydney; Liverpool Hospital; Ingham Institute for Applied Medical Research; Liverpool Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Finn, PW (corresponding author), Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.; Finn, PW (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA.	pwfinn@uic.edu	Oliver, Brian/E-7939-2010; Turturice, Benjamin/AAF-6819-2019	Oliver, Brian/0000-0002-7122-9262; Turturice, Benjamin/0000-0001-9382-4612; Finn, Patricia/0000-0001-6936-103X; Rani, Asha/0000-0002-8556-4715	National Institutes of Health; National Institute of Allergy and Infectious Diseases [5R01AI053878]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health and the National Institute of Allergy and Infectious Diseases, 5R01AI053878	Albacker LA, 2013, NAT MED, V19, P1297, DOI 10.1038/nm.3321; Baraket M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-11; Bennett WD, 2011, CLIN EXP ALLERGY, V41, P1719, DOI 10.1111/j.1365-2222.2011.03814.x; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bohm L, 2015, J IMMUNOL, V194, P887, DOI 10.4049/jimmunol.1401612; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Denner DR, 2015, J ALLERGY CLIN IMMUN; Durack J, 2015, J ALLERGY CLIN IMMUN, V135, P25; Einarsson GG, 2016, THORAX, V71, P795, DOI 10.1136/thoraxjnl-2015-207235; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Green BJ, 2014, PLOS ONE, V9; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Kloepfer KM, 2014, J ALLERGY CLIN IMMUN, V133, P1301, DOI 10.1016/j.jaci.2014.02.030; Lai TW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22835; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mcgee HS, 2009, AM J RESP CRIT CARE, V180, P211, DOI 10.1164/rccm.200809-1505OC; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083; Schaub B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-40; Segal LN, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.31, 10.1038/NMICROBIOL.2016.31]; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Singh A, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-32; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sverrild A, 2016, J ALLERGY CLIN IMMUN; Taylor SL, 2017, J ALLERGY CLIN IMMUN, P1097; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Wang Z, 2016, EUR RESPIR J, V47, P1082, DOI 10.1183/13993003.01406-2015; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Williams AE, 2015, AM J PHYSIOL-LUNG C, V308, pL539, DOI 10.1152/ajplung.00141.2014; Wu KF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31562	39	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e018456	10.1371/journal.pone.0184566	http://dx.doi.org/10.1371/journal.pone.0184566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053714	Green Submitted, gold, Green Published			2022-12-26	WOS:000413315100001
J	Fu, SH; Liu, JY; Huang, CC; Lin, FL; Yang, RS; Hou, CH				Fu, Shau-Huai; Liu, Jyh-You; Huang, Chuan-Ching; Lin, Feng-ling; Yang, Rong-Sen; Hou, Chun-han			Quality control processes in allografting: A twenty-year retrospective review of a hospital-based bone bank in Taiwan	PLOS ONE			English	Article							ANTIGEN CARRIER MOTHERS; HEPATITIS-B VACCINATION; INFECTION; EXPERIENCE; VIRUS; TRANSMISSION; PROCUREMENT; INFANTS; PROGRAM; BLOOD	Musculoskeletal allografts are now commonly used. To decrease the potential risks of transmission of pathogenic bacteria, fungi, or viruses to the transplant recipients, certain issues regarding the management of patients who receive contaminated allografts need to be addressed. We aimed to clarify the incidence and extent of disease transmission from allografts by analyzing the allografting procedures performed in the bone bank of our hospital over the past 20 years. We retrospectively reviewed the data from our allograft registry center on 3979 allografts that were implanted in 3193 recipients throughout a period of two decades, from July 1991 to June 2011. The source of the allografts, results of all screening tests, dates of harvesting and implantation, and recipients of all allografts were checked. With the help of the Center for Infection Control of our hospital, a strict prospective, hospitalwide, on-site surveillance was conducted, and every patient with healthcare-associated infection was identified. Fisher's exact test was used to compare the infection rate between recipients with sterile allografts and those with contaminated allografts. The overall discard and infection rates were, respectively, 23% and 1.3% in the first decade(1991-2001); and 18.4% and 1.25% in the second decade(2001-2011). The infection rate of contaminated allograft recipients was significantly higher than that of sterile allograft recipients(10% vs. 1.15%, P < 0.01) in the second decade. Both infection and discard rates of our bone bank are comparable with those of international bone banks. Strict allograft processing and adequate prophylactic use of antibiotics are critical to prevent infection and disease transmission in such cases.	[Fu, Shau-Huai; Huang, Chuan-Ching] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Orthoped, Huwei Township, Yunlin, Taiwan; [Liu, Jyh-You] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lin, Feng-ling] Cathay Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Yang, Rong-Sen; Hou, Chun-han] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Cathay General Hospital; National Taiwan University; National Taiwan University Hospital	Hou, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan.	chhou@ntu.edu.tw		Huang, Chuan-Ching/0000-0002-8184-9860; Yang, Rong-Sen/0000-0002-0553-4779; Hou, Chun-han/0000-0002-3850-0997; Fu, Shau-Huai/0000-0001-9853-872X	Center for Infection Control of the National Taiwan University Hospital	Center for Infection Control of the National Taiwan University Hospital	We are grateful for the support received from the Center for Infection Control of the National Taiwan University Hospital, and from Mrs. Shu-Ru Tsai, the full-time employee of the bone bank.	Aho AJ, 1998, ACTA ORTHOP SCAND, V69, P559, DOI 10.3109/17453679808999255; ANGERMANN P, 1991, J HOSP INFECT, V17, P159, DOI 10.1016/0195-6701(91)90227-Y; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; BUCK BE, 1989, CLIN ORTHOP RELAT R, P129; BUCK BE, 1990, CLIN ORTHOP RELAT R, P249; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Chuang YC, 2010, J HOSP INFECT, V76, P143, DOI 10.1016/j.jhin.2010.05.001; Deijkers RLM, 1997, J BONE JOINT SURG BR, V79B, P161, DOI 10.1302/0301-620X.79B1.7137; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Hou CH, 2005, J HOSP INFECT, V59, P41, DOI 10.1016/j.jhin.2004.03.017; HSU HM, 1988, JAMA-J AM MED ASSOC, V260, P2231, DOI 10.1001/jama.260.15.2231; IVORY JP, 1993, J BONE JOINT SURG BR, V75, P355, DOI 10.1302/0301-620X.75B3.8496199; Joyce MJ, 2004, 71 ANN M AM AC ORTH; Judas F, 2005, TRANSPLANT P, V37, P2799, DOI 10.1016/j.transproceed.2005.05.004; Lawing CR, 2015, J BONE JOINT SURG AM, V97A, P1844, DOI 10.2106/JBJS.O.00072; Liu JW, 2002, J HOSP INFECT, V50, P293, DOI 10.1053/jhin.2002.1192; Sutherland AG, 1997, J HOSP INFECT, V35, P215, DOI 10.1016/S0195-6701(97)90209-7; TOMFORD WW, 1981, J BONE JOINT SURG AM, V63, P244, DOI 10.2106/00004623-198163020-00010; VEEN MR, 1994, CLIN ORTHOP RELAT R, P259; Vehmeyer SBW, 2001, J HOSP INFECT, V47, P193, DOI 10.1053/jhin.2000.0836; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yap PL, 1999, J HOSP INFECT, V43, pS137, DOI 10.1016/S0195-6701(99)90076-2	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0184809	10.1371/journal.pone.0184809	http://dx.doi.org/10.1371/journal.pone.0184809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049290	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900004
J	Hwang, SH; Lee, W; Park, SH; Lee, HJ; Park, SH; Lee, DC; Lim, MH; Back, SA; Yun, BG; Jeun, JH; Lim, JY; Kang, JM; Kim, SW				Hwang, Se Hwan; Lee, WeonSun; Park, Sang Hi; Lee, Hee Jin; Park, Sun Hwa; Lee, Dong Chang; Lim, Mi Hyun; Back, Sang A.; Yun, Byeong Gon; Jeun, Jung Ho; Lim, Jung Yeon; Kang, Jun Myung; Kim, Sung Won			Evaluation of characteristic of human turbinate derived mesenchymal stem cells cultured in the serum free media	PLOS ONE			English	Article							STROMAL CELLS; CHROMOSOMAL-ABERRATIONS; ACQUISITION	We evaluated the effect of serum-free and xeno-cultivation (SFXFM) on the characterization, proliferation, and differentiation properties of human nasal stem cells (airway tissue; hTMSCs). hTMSCs were isolated from 10 patients, after which patient samples were separated into two groups, an SFXFM group and a control group. The control group was treated with bovine serum-containing medium. FACS analysis revealed that SFXFM-cultured hTMSCs maintained a characteristic mesenchymal stem cell phenotype. hTMSC proliferation was not influenced by SFXFM. In addition, upregulation of IL-8 and GM-CSF and down-regulation of RANTES expression were shown in response to SFXFM. Moreover, two-lineage differentiation properties (osteocyte and adipocyte) of hTMSCs were enhanced under SFXFM. Finally, the genetic stability of SFXFM-cultured hTMSCs was demonstrated by normal karyotype results. SFXFM enables good expansion, multipotentiality, and normal genotype maintenance of MSCs. Moreover, this approach serves as a substitute to conventional media for the cultivation of capable MSCs for upcoming medical applications.	[Hwang, Se Hwan; Lee, Dong Chang; Kang, Jun Myung; Kim, Sung Won] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Lee, WeonSun; Park, Sang Hi; Lee, Hee Jin] Catholic Univ Korea, Coll Med, Inst Clin Med Res, Seoul, South Korea; [Park, Sun Hwa; Lim, Mi Hyun; Back, Sang A.; Yun, Byeong Gon; Jeun, Jung Ho; Lim, Jung Yeon] Catholic Univ Korea, Coll Med, Dept Biomed Sci, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kang, JM; Kim, SW (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	entkjm@catholic.ac.kr; kswent@catholic.ac.kr	, GETEE/AAL-4946-2020; Moreda-Piñeiro, Antonio/S-3464-2016; Moreda-Pineiro, Jorge/Q-7008-2016; Bermejo-Barrera, Pilar/G-9646-2017	Moreda-Piñeiro, Antonio/0000-0002-3512-6434; Moreda-Pineiro, Jorge/0000-0001-6101-1879; Bermejo-Barrera, Pilar/0000-0001-5864-6144; Hwang, Se Hwan/0000-0002-2838-7820	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1A02936924]; National Research Foundation of Korea grant - Ministry of Science, ICT and Future Planning [2014R1A2A2A01004325]; Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund; E.N.T. Fund of the Catholic University of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [H114C3228, HI15C1199, H116C0133]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Research Foundation of Korea grant - Ministry of Science, ICT and Future Planning; Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund; E.N.T. Fund of the Catholic University of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1A02936924), by the National Research Foundation of Korea grant funded by the Ministry of Science, ICT and Future Planning (no. 2014R1A2A2A01004325), and the Institute of Clinical Medicine Research of Bucheon St. Mary's Hospital, Research Fund, 2016 and 2017. This research was also supported by a grant of the E.N.T. Fund of the Catholic University of Korea made in the program year of 2016 and 2017. Additionally, This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: H114C3228, HI15C1199, and H116C0133).	Agata H, 2009, BIOCHEM BIOPH RES CO, V382, P353, DOI 10.1016/j.bbrc.2009.03.023; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Chase LG, 2012, STEM CELL TRANSL MED, V1, P750, DOI 10.5966/sctm.2012-0072; Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8; Diaferia GR, 2011, STEM CELLS DEV, V20, P1411, DOI 10.1089/scd.2010.0359; Estrada JC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.211; Gottipamula S, 2013, CELL PROLIFERAT, V46, P608, DOI 10.1111/cpr.12063; Gottipamula S, 2014, CELL TISSUE RES, V356, P123, DOI 10.1007/s00441-013-1783-7; Hwang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138041; Hwang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101558; Hwang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100219; Hwang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074330; Hwang SH, 2012, OTOLARYNG HEAD NECK, V147, P568, DOI 10.1177/0194599812447172; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P536; Kang HS, 2005, EXP HEMATOL, V33, P796, DOI 10.1016/j.exphem.2005.03.012; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Mohammadi Saeed, 2016, Int J Hematol Oncol Stem Cell Res, V10, P161; Oikonomopoulos A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16570; Patrikoski M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt175; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Rakian R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0235-6; Rebuzzini P, 2015, CYTOGENET GENOME RES, V147, P1, DOI 10.1159/000441645; Safwani WKZW, 2016, CYTOTECHNOLOGY, V68, P1859, DOI 10.1007/s10616-015-9939-9; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Swamynathan P, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt477; Tarle SA, 2011, J CELL PHYSIOL, V226, P66, DOI 10.1002/jcp.22304; Wu M, 2014, CELL PHYSIOL BIOCHEM, V33, P569, DOI 10.1159/000358635	30	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186249	10.1371/journal.pone.0186249	http://dx.doi.org/10.1371/journal.pone.0186249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049314	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900053
J	Batista, EPA; Ngowo, HS; Opiyo, M; Shubis, GK; Meza, FC; Okumu, FO; Eiras, AE				Batista, Elis P. A.; Ngowo, Halfan S.; Opiyo, Mercy; Shubis, Gasper K.; Meza, Felician C.; Okumu, Fredros O.; Eiras, Alvaro E.			Semi-field assessment of the BG-Malaria trap for monitoring the African malaria vector, Anopheles arabiensis	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITOS; HUMAN-LANDING CATCHES; CARBON-DIOXIDE; GAMBIAE-S.S.; ATTRACTANTS; RESISTANCE; CULICIDAE; DIPTERA; BLEND	Odour-baited technologies are increasingly considered for effective monitoring of mosquito populations and for the evaluation of vector control interventions. The BG-Malaria trap (BGM), which is an upside-down variant of the widely used BG-Sentinel trap (BGS), has been demonstrated to be effective to sample the Brazilian malaria vector, Anopheles darlingi. We evaluated the BGM as an improved method for sampling the African malaria vectors, Anopheles arabiensis. Experiments were conducted inside a large semi-field cage to compare trapping efficiencies of BGM and BGS traps, both baited with the synthetic attractant, Ifakara blend, supplemented with CO2. We then compared BGMs baited with either of four synthetic mosquito lures, Ifakara blend, Mbita blend, BG-lure or CO2, and an unbaited BGM. Lastly, we compared BGMs baited with the Ifakara blend dispensed via either nylon strips, BG cartridges (attractant-infused microcapsules encased in cylindrical plastic cartridge) or BG sachets (attractant-infused microcapsules encased in plastic sachets). All tests were conducted between 6P.M. and 7A.M., with 200-600 laboratory-reared An. arabiensis released nightly in the test chamber. The median number of An. arabiensis caught by the BGM per night was 83, IQR:(73.5-97.75), demonstrating clear superiority over BGS (median catch = 32.5 (25.25-37.5)). Compared to unbaited controls, BGMs baited with Mbita blend caught most mosquitoes (45 (29.5-70.25)), followed by BGMs baited with CO2 (42.5 (27.5-64)), Ifakara blend (31 (9.25-41.25)) and BG lure (16 (4-22)). BGM caught 51 (29.5-72.25) mosquitoes/night, when the attractants were dispensed using BG-Cartridges, compared to BG-Sachet (29.5 (24.75-40.5)), and nylon strips (27 (19.25-38.25)), in all cases being significantly superior to unbaited controls (p < 000.1). The findings demonstrate potential of the BGM as a sampling tool for African malaria vectors over the standard BGS trap. Its efficacy can be optimized by selecting appropriate odour baits and odour-dispensing systems.	[Batista, Elis P. A.; Eiras, Alvaro E.] Univ Fed Minas Gerais, Lab Ecol Quim Insetos Vetores, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Batista, Elis P. A.; Ngowo, Halfan S.; Opiyo, Mercy; Shubis, Gasper K.; Meza, Felician C.; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania; [Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Parktown, South Africa; [Okumu, Fredros O.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Universidade Federal de Minas Gerais; Ifakara Health Institute; University of Witwatersrand; University of Glasgow	Batista, EPA (corresponding author), Univ Fed Minas Gerais, Lab Ecol Quim Insetos Vetores, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.; Batista, EPA (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania.	ebatista@ihi.or.tz	Ngowo, Halfan/AFS-8039-2022; Batista, Elis P A/O-7790-2018; Eiras, Alvaro/Z-6023-2019	Ngowo, Halfan/0000-0003-2789-0261; Batista, Elis P A/0000-0002-5545-6633; Eiras, Alvaro/0000-0002-3045-0673	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES) [88881.133584/2016-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e lnovagao (CNPq/MCTI); Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [PPM-00502-15]; CNPq/MCTI [42070/2013-2]; Wellcome Trust [WT102350/Z/13/Z]	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e lnovagao (CNPq/MCTI); Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq/MCTI; Wellcome Trust(Wellcome TrustEuropean Commission)	EPAB was funded by the Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES) (Grant 88881.133584/2016-01) and AEE funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e lnovagao (CNPq/MCTI) (Grant 310205/2014-0) and Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (Grant PPM-00502-15).FOO was funded by a Visiting Researcher Fellowship from CNPq/MCTI, (Grant 42070/2013-2) and a Wellcome Trust Intermediate Research Fellowship (Grant WT102350/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr. Joseph Mgando, who helped to take care of the laboratory-reared mosquitoes during the entire study period. We thank all our Ifakara Health Institute colleagues for their support during the work. EPAB was funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Grant 88881.133584/2016-01) and AEE funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Ministerio da Ciencia, Tecnologia e Inovacao (CNPq/MCTI) (Grant 310205/2014-0) and Fundacao de Amparo Pesquisa do Estado de Minas Gerais (FAPEMIG) (Grant PPM-00502-15). FOO was funded by a Wellcome Trust Intermediate Research Fellowship (Grant WT102350/Z/13/Z) and a Visiting Researcher Fellowship from CNPq/MCTI, (Grant 42070/2013-2).	[Anonymous], OPEN TROP MED J; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bates D, 2014, ARXIV14065823; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Busula AO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0635-1; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Costantini C., 1993, Parassitologia (Rome), V35, P5; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dia I, 2005, J MED ENTOMOL, V42, P104, DOI 10.1603/0022-2585(2005)042[0104:COHCAO]2.0.CO;2; Dunn CE, 2011, SOC SCI MED, V72, P408, DOI 10.1016/j.socscimed.2010.11.009; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Ferguson HM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-158; Gama RA, 2013, MEM I OSWALDO CRUZ, V108, P763, DOI 10.1590/0074-0276108062013013; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Hoel DF, 2014, J MED ENTOMOL, V51, P1268, DOI 10.1603/ME14065; Jawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019676; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kline DL, 1999, J AM MOSQUITO CONTR, V15, P276; Kline DL, 2002, J VECTOR ECOL, V27, P1; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Matowo NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145653; Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Monroe A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0543-4; Mukabana WR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-202; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mwangangi JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-114; Mweresa CK, 2016, J CHEM ECOL, V42, P508, DOI 10.1007/s10886-016-0711-1; Mweresa CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121533; Mweresa CK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-376; Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160; Okumu F, 2010, J MED ENTOMOL, V47, P274, DOI 10.1603/ME09114; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Rodrigues MS, 2014, J AM MOSQUITO CONTR, V30, P184, DOI 10.2987/14-6423R.1; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Silver J, 2007, MOSQUITO ECOLOGY FIE, Vthird; Smallegange RC, 2010, ECOL CONT VECTOR-BOR, V2, P143; Torr SJ, 1997, B ENTOMOL RES, V87, P299, DOI 10.1017/S0007485300037251; Verhulst NO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-28	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186696	10.1371/journal.pone.0186696	http://dx.doi.org/10.1371/journal.pone.0186696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045484	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000413168100089
J	Harris-Birtill, D; Singh, M; Zhou, Y; Shah, A; Ruenraroengsak, P; Gallina, ME; Hanna, GB; Cass, AEG; Porter, AE; Bamber, J; Elson, DS				Harris-Birtill, David; Singh, Mohan; Zhou, Yu; Shah, Anant; Ruenraroengsak, Pakatip; Gallina, Maria Elena; Hanna, George B.; Cass, Anthony E. G.; Porter, Alexandra E.; Bamber, Jeffrey; Elson, Daniel S.			Gold nanorod reshaping in vitro and in vivo using a continuous wave laser	PLOS ONE			English	Article							CANCER-THERAPY; NANOPARTICLES; FEMTOSECOND; AGGREGATION; CELLS; TOMOGRAPHY; DELIVERY; ENERGY; LONG	Gold nanorods (GNRs) are increasingly being investigated for cancer theranostics as they possess features which lend themselves in equal measures as contrast agents and catalysts for photothermal therapy. Their optical absorption spectral peak wavelength is determined by their size and shape. Photothermal therapy using GNRs is typically established using near infrared light as this allows sufficient penetration into the tumour matrix. Continuous wave (CW) lasers are the most commonly applied source of near infrared irradiation on GNRs for tumour photothermal therapy. It is perceived that large tumours may require fractionated or prolonged irradiation. However the true efficacy of repeated or protracted CW irradiation on tumour sites using the original sample of GNRs remains unclear. In this study spectroscopy and transmission electron microscopy are used to demonstrate that GNRs reshape both in vitro and in vivo after CW irradiation, which reduces their absorption efficiency. These changes were sustained throughout and beyond the initial period of irradiation, resulting from a spectral blue-shift and a considerable diminution in the absorption peak of GNRs. Solid subcutaneous tumours in immunodeficient BALB/c mice were subjected to GNRs and analysed with electron microscopy pre- and post-CW laser irradiation. This phenomenon of thermally induced GNR reshaping can occur at relatively low bulk temperatures, well below the bulk melting point of gold. Photoacoustic monitoring of GNR reshaping is also evaluated as a potential clinical aid to determine GNR absorption and reshaping during photothermal therapy. Aggregation of particles was coincidentally observed following CW irradiation, which would further diminish the subsequent optical absorption capacity of irradiated GNRs. It is thus established that sequential or prolonged applications of CW laser will not confer any additional photothermal effect on tumours due to significant attenuations in the peak optical absorption properties of GNRs following primary laser irradiation.	[Harris-Birtill, David; Singh, Mohan; Ruenraroengsak, Pakatip; Gallina, Maria Elena; Elson, Daniel S.] Imperial Coll London, Hamlyn Ctr Robot Surg, London, England; [Harris-Birtill, David; Singh, Mohan; Gallina, Maria Elena; Hanna, George B.; Elson, Daniel S.] Imperial Coll London, Dept Surg & Canc, London, England; [Zhou, Yu; Cass, Anthony E. G.] Imperial Coll London, Dept Chem, London, England; [Shah, Anant; Bamber, Jeffrey] Inst Canc Res, Joint Dept Phys & CRUK Canc Imaging Ctr, London, England; [Shah, Anant; Bamber, Jeffrey] Royal Marsden NHS Fdn Trust, London, England; [Ruenraroengsak, Pakatip; Porter, Alexandra E.] Imperial Coll London, Dept Mat, London, England; [Ruenraroengsak, Pakatip; Porter, Alexandra E.] Imperial Coll London, London Ctr Nanotechnol, London, England	Imperial College London; Imperial College London; Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Imperial College London; Imperial College London; University of London; University College London	Elson, DS (corresponding author), Imperial Coll London, Hamlyn Ctr Robot Surg, London, England.; Elson, DS (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.	ds.elson@imperial.ac.uk	Bamber, Jeffrey C/B-8839-2014; Elson, Daniel/B-4921-2008	Bamber, Jeffrey C/0000-0001-9436-1832; Shah, Anant/0000-0002-9470-0520; Harris-Birtill, David/0000-0002-0740-3668; Elson, Daniel/0000-0002-5578-3941; Singh, Mohan/0000-0002-8431-5629	ERC grant [242991]; Cancer Research UK via the CRUK Cancer Imaging Centre at the Institute of Cancer Research (ICR); ERC starting grant [257182]; BRC [P46143]; NHS; Cancer Research UK Imperial Centre; Cancer Research UK [16464] Funding Source: researchfish	ERC grant; Cancer Research UK via the CRUK Cancer Imaging Centre at the Institute of Cancer Research (ICR); ERC starting grant; BRC; NHS; Cancer Research UK Imperial Centre; Cancer Research UK(Cancer Research UK)	Funding for this project was provided by ERC grant 242991 (D. Elson), and by Cancer Research UK via the CRUK Cancer Imaging Centre at the Institute of Cancer Research (ICR) to J. Bamber. We acknowledge an ERC starting grant (project number 257182) to A. Porter, and BRC funding (project number P46143) to A. Porter, D. Elson and P. Ruenraroengsak. We acknowledge NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden (J. Bamber) and at Imperial College London, as well as support provided by the Cancer Research UK Imperial Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank: E. Alles from the Institute of Cancer Research (ICR) for his advice and assistance on the laboratory setup; C. Bunton from the ICR mechanical workshop for assistance in making the transducer holder, water bath, and sample holder for the photoacoustic measurements; R. Campbell for the function shadedErrorBar used to produce Fig 303). Funding for this project is gratefully acknowledged from ERC grant 242991 (D. Elson), and from Cancer Research UK via the CRUK Cancer Imaging Centre at the Institute of Cancer Research (ICR) to J. Bamber. We acknowledge an ERC starting grant (project number 257182) to A. Porter, and a BRC funding (project number P46143) to A. Porter, D. Elson and P. Ruenraroengsak. We acknowledge NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden (J. Bamber) and at Imperial College London, as well as support provided by the Cancer Research UK Imperial Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777127; Alkilany AM, 2012, ADV DRUG DELIVER REV, V64, P190, DOI 10.1016/j.addr.2011.03.005; Barriere C, 2012, PROC SPIE, V8234, DOI 10.1117/12.908253; Chang SS, 1999, LANGMUIR, V15, P701, DOI 10.1021/la980929l; Chen HJ, 2013, CHEM SOC REV, V42, P2679, DOI 10.1039/c2cs35367a; Chen YS, 2010, OPT EXPRESS, V18, P8867, DOI 10.1364/OE.18.008867; Choi WI, 2011, ACS NANO, V5, P1995, DOI 10.1021/nn103047r; Chou CH, 2005, J PHYS CHEM B, V109, P11135, DOI 10.1021/jp0444520; Comenge J, 2016, ACS NANO, V10, P7106, DOI 10.1021/acsnano.6b03246; Gomez-Grana S, 2015, CHEM MATER, V27, P8310, DOI 10.1021/acs.chemmater.5b03620; Goodrich GP, 2010, J BIOMEDICAL OPTICS, V15; Gordel M, 2014, PHYS CHEM CHEM PHYS, V16, P71, DOI 10.1039/c3cp53457j; Ha SH, 2011, BIOMED OPT EXPRESS, V2, P645, DOI 10.1364/BOE.2.000645; Hamner KL, 2013, LANGMUIR, V29, P15217, DOI 10.1021/la4037887; Heo K, 2013, NANO LETT, V13, P5297, DOI 10.1021/nl402813q; Horiguchi Y, 2008, LANGMUIR, V24, P12026, DOI 10.1021/la800811j; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huff TB, 2007, NANOMEDICINE-UK, V2, P125, DOI 10.2217/17435889.2.1.125; Kim KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2748312; Kirui DK, 2013, NANOMED-NANOTECHNOL, V9, P702, DOI 10.1016/j.nano.2012.11.009; Kirui DK, 2011, MACROMOL BIOSCI, V11, P779, DOI 10.1002/mabi.201100050; Li CH, 2009, PHYS MED BIOL, V54, pR59, DOI 10.1088/0031-9155/54/19/R01; Li PC, 2008, OPT EXPRESS, V16, P18605, DOI 10.1364/OE.16.018605; Link S, 1999, CHEM PHYS LETT, V315, P12, DOI 10.1016/S0009-2614(99)01214-2; Link S, 2000, J PHYS CHEM B, V104, P6152, DOI 10.1021/jp000679t; Link S, 1999, J PHYS CHEM B, V103, P8410, DOI 10.1021/jp9917648; Link S, 1999, J PHYS CHEM A, V103, P1165, DOI 10.1021/jp983141k; Link S, 2001, J CHEM PHYS, V114, P2362, DOI 10.1063/1.1336140; Mohamed MB, 1998, J PHYS CHEM B, V102, P9370, DOI 10.1021/jp9831482; Nam J, 2009, J AM CHEM SOC, V131, P13639, DOI 10.1021/ja902062j; Ng KC, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/10/105602; Shah AJ, 2014, SPIE PHOTONICS W, V6, P1; Shah J, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940362; Singh M, 2015, NANOMED-NANOTECHNOL, V11, P2083, DOI 10.1016/j.nano.2015.05.010; Taruttis A, 2010, OPT EXPRESS, V18, P19592, DOI 10.1364/OE.18.019592; Taylor AB, 2014, ACS NANO, V8, P12071, DOI 10.1021/nn5055283; Ungureanu C, 2011, NANO LETT, V11, P1887, DOI 10.1021/nl103884b; von Maltzahn G, 2009, CANCER RES, V69, P3892, DOI 10.1158/0008-5472.CAN-08-4242; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Yang JA, 2012, J CLUST SCI, V23, P799, DOI 10.1007/s10876-012-0474-y; Zijlstra P, 2009, PHYS CHEM CHEM PHYS, V11, P5915, DOI 10.1039/b905203h	41	18	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185990	10.1371/journal.pone.0185990	http://dx.doi.org/10.1371/journal.pone.0185990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045438	Green Published, gold			2022-12-26	WOS:000413168100032
J	Haj, M; Wijeweera, A; Rudnizky, S; Taunton, J; Pnueli, L; Melamed, P				Haj, Majd; Wijeweera, Andrea; Rudnizky, Sergei; Taunton, Jack; Pnueli, Lilach; Melamed, Philippa			Mitogen- and stress-activated protein kinase 1 is required for gonadotropin-releasing hormone-mediated activation of gonadotropin -subunit expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone modification; mitogen-activated protein kinase (MAPK); phosphorylation; pituitary gland	HISTONE H3 PHOSPHORYLATION; IMMEDIATE-EARLY GENES; RNA-POLYMERASE-II; LUTEINIZING-HORMONE; TRANSCRIPTIONAL ACTIVATION; CHROMATIN MODIFICATION; DISTINCT MECHANISMS; MSK1; ACETYLATION; PROMOTER	Pituitary gonadotropin hormones are regulated by gonadotropin-releasing hormone (GnRH) via MAPK signaling pathways that stimulate gene transcription of the common -subunit (Cga) and the hormone-specific -subunits of gonadotropin. We have reported previously that GnRH-induced activities at these genes include various histone modifications, but we did not examine histone phosphorylation. This modification adds a negative charge to residues of the histone tails that interact with the negatively charged DNA, is associated with closed chromatin during mitosis, but is increased at certain genes for transcriptional activation. Thus, the functions of this modification are unclear. We initially hypothesized that GnRH might induce phosphorylation of Ser-10 in histone 3 (H3S10p) as part of its regulation of gonadotropin gene expression, possibly involving cross-talk with H3K9 acetylation. We found that GnRH increases the levels of both modifications around the Cga gene transcriptional start site and that JNK inhibition dramatically reduces H3S10p levels. However, this modification had only a minor effect on Cga expression and no effect on H3K9ac. GnRH also increased H3S28p and H3K27ac levels and also those of activated mitogen- and stress-activated protein kinase 1 (MSK1). MSK1 inhibition dramatically reduced H3S28p levels in untreated and GnRH-treated cells and also affected H3K27ac levels. Although not affecting basal Cga expression, MSK1/2 inhibition repressed GnRH activation of Cga expression. Moreover, ChIP analysis revealed that GnRH-activated MSK1 targets the first nucleosome just downstream from the TSS. Given that the elongating RNA polymerase II (RNAPII) stalls at this well positioned nucleosome, GnRH-induced H3S28p, possibly in association with H3K27ac, would facilitate the progression of RNAPII.	[Haj, Majd; Wijeweera, Andrea; Rudnizky, Sergei; Pnueli, Lilach; Melamed, Philippa] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Technion Israel Institute of Technology; University of California System; University of California San Francisco	Melamed, P (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	philippa@tx.technion.ac.il		el haj, mohamad/0000-0001-7635-7557; Rudnizky, Sergei/0000-0002-0520-0752	Israel Science Foundation [840/12]; European Framework program Marie Curie Actions	Israel Science Foundation(Israel Science Foundation); European Framework program Marie Curie Actions	This work was supported by Israel Science Foundation Grant 840/12 (to P. M.) and the European Framework program Marie Curie Actions. The authors declare that they have no conflicts of interest with the contents of this article.	Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Banerjee T, 2011, MOL CELL BIOL, V31, P4858, DOI 10.1128/MCB.05631-11; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Feng J, 2008, BIOL REPROD, V79, P546, DOI 10.1095/biolreprod.108.068106; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Josefowicz SZ, 2016, MOL CELL, V64, P347, DOI 10.1016/j.molcel.2016.09.026; Karam CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000975; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Klein AM, 2013, CURR OPIN CELL BIOL, V25, P272, DOI 10.1016/j.ceb.2013.01.002; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Melamed P, 2006, MOL CELL ENDOCRINOL, V252, P167, DOI 10.1016/j.mce.2006.03.024; Melamed P, 2008, TRENDS ENDOCRIN MET, V19, P25, DOI 10.1016/j.tem.2007.10.008; Miller RS, 2012, MOL CELL BIOL, V32, P2349, DOI 10.1128/MCB.00394-12; Mouillet JF, 2004, J BIOL CHEM, V279, P7832, DOI 10.1074/jbc.M312574200; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Petesch SJ, 2012, TRENDS GENET, V28, P285, DOI 10.1016/j.tig.2012.02.005; Pnueli L, 2015, P NATL ACAD SCI USA, V112, P4369, DOI 10.1073/pnas.1414841112; Pnueli L, 2011, MOL CELL BIOL, V31, P5023, DOI 10.1128/MCB.06083-11; Reyskens KMSE, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00056; Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975; Rudnizky S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12958; Sawicka A, 2014, GENOME RES, V24, P1808, DOI 10.1101/gr.176255.114; Sawicka A, 2014, BBA-GENE REGUL MECH, V1839, P711, DOI 10.1016/j.bbagrm.2014.04.013; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Simboeck E, 2010, J BIOL CHEM, V285, P41062, DOI 10.1074/jbc.M110.184481; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wiersma M, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0103-3; Wijeweera A, 2015, BBA-GENE REGUL MECH, V1849, P328, DOI 10.1016/j.bbagrm.2015.01.001; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Xie JJ, 2005, MOL ENDOCRINOL, V19, P2624, DOI 10.1210/me.2005-0056; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yosefzon Y, 2017, P NATL ACAD SCI USA, V114, P10131, DOI 10.1073/pnas.1704393114; Zhong SP, 2001, J BIOL CHEM, V276, P33213, DOI 10.1074/jbc.M103973200; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	48	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20720	20731		10.1074/jbc.M117.797845	http://dx.doi.org/10.1074/jbc.M117.797845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29054929	Green Published, hybrid			2022-12-26	WOS:000418267000032
J	Chiu, YT; Bain, A; Deng, SL; Ho, YC; Chen, WH; Tzeng, HY				Chiu, Yu-Ting; Bain, Anthony; Deng, Shu-Lin; Ho, Yi-Chiao; Chen, Wen-Hsuan; Tzeng, Hsy-Yu			Effects of climate change on a mutualistic coastal species: Recovery from typhoon damages and risks of population erosion	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; FIG-WASP; FICUS; PHENOLOGY; CYCLONES; TAIWAN; TEMPERATURE; VARIABILITY; DISTURBANCE; STABILITY	Presently, climate change has increased the frequency of extreme meteorological events such as tropical cyclones. In the western Pacific basin, these cyclones are called typhoons, and in this area, around Taiwan Island, their frequency has almost doubled since 2000. When approaching landmasses, typhoons have devastating effects on coastal vegetation. The increased frequency of these events has challenged the survival of coastal plant species and their posttyphoon recovery. In this study, a population of coastal gynodioecious Ficus pedunculosa var. mearnsii (Mearns fig) was surveyed for two years to investigate its recovery after Typhoon Morakot, which occurred in August 2009. Similar to all the Ficus species, the Mearns fig has an obligate mutualistic association with pollinating fig wasp species, which requires syconia (the closed Ficus inflorescence) to complete its life cycle. Moreover, male gynodioecious fig species produces both pollen and pollen vectors, whereas the female counterpart produces only seeds. The recovery of the Mearns fig was observed to be rapid, with the production of both leaves and syconia. The syconium: leaf ratio was greater for male trees than for female trees, indicating the importance of syconium production for the wasp survival. Pollinating wasps live for approximately 1 day; therefore, receptive syconia are crucial. Every typhoon season, few typhoons pass by the coasts where the Mearns fig grows, destroying all the leaves and syconia. In this paper, we highlight the potential diminution of the fig population that can lead to the extinction of the mutualistic pair of species. The effects of climate change on coastal species warrant wider surveys.	[Chiu, Yu-Ting; Bain, Anthony; Ho, Yi-Chiao; Chen, Wen-Hsuan; Tzeng, Hsy-Yu] Natl Chung Hsing Univ, Dept Forestry, Taichung, Taiwan; [Bain, Anthony] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Coll Life Sci, Taipei, Taiwan; [Deng, Shu-Lin] Chungpu Res Ctr, Forestry Res Inst, Chiayi, Taiwan	National Chung Hsing University; National Taiwan University	Tzeng, HY (corresponding author), Natl Chung Hsing Univ, Dept Forestry, Taichung, Taiwan.	erecta@nchu.edu.tw	Bain, Anthony/H-4244-2019	Bain, Anthony/0000-0002-6142-8137	Ministry of Science and Technology [NSC 98-2313-B-002-005-MY3, NSC 99-2923-B-002-001-MY3]; agence national de la Recherche, France [ANR-09-BLAN-0392-CSD 7]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); agence national de la Recherche, France(French National Research Agency (ANR))	This study was supported by the National Science Council of the Republic of China, Taiwan, (now called Ministry of Science and Technology, https://www.most.gov.tw/en/public) with the grant number NSC 98-2313-B-002-005-MY3. This grant was used for data collection and analysis. The study was also supported by the International cooperation grant between National Science Council of the Republic of China, Taiwan, (now called Ministry of Science and Technology, https://www.most.gov.tw/en/public) with the grant number NSC 99-2923-B-002-001-MY3 and the agence national de la Recherche, France (http://www.agence-nationale-recherche.fr/en/) for the grant number ANR-09-BLAN-0392-CSD 7. This cooperation grant was used for data collection and analysis.	Bain A, 2016, EVOL ECOL, V30, P663, DOI 10.1007/s10682-016-9836-5; Bain A, 2015, BOT STUD, V56, DOI 10.1186/s40529-015-0090-x; Bain A, 2014, ACTA OECOL, V57, P124, DOI 10.1016/j.actao.2013.10.004; BELLINGHAM PJ, 1995, ECOLOGY, V76, P2562, DOI 10.2307/2265828; Berg CC, 2005, FLORA MALESIANA 1, V17; Chang H.M., 2012, FLORA TAIWAN SELAGIN; Chen Chao-Hsing, 1997, Journal of Taiwan Museum, V50, P113; Chen H, 2015, SCI REP, P5; Chen JM, 2011, J CLIMATE, V24, P5786, DOI 10.1175/2011JCLI4043.1; Chen ST, 2009, HYDROLOG SCI J, V54, P430, DOI 10.1623/hysj.54.3.430; Choi BH, 2013, CHINA OCEAN ENG, V27, P141, DOI 10.1007/s13344-013-0013-0; Conchou L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103581; Conner W.H., 1989, Wetlands Ecology and Management, V1, P45; Corner EJH, 1965, GARDENS B, P21; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Crimmins TM, 2011, NEW PHYTOL, V191, P468, DOI 10.1111/j.1469-8137.2011.03705.x; Ding F, 2011, 33 HYDR WAT RES S 10; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Franklin J, 2004, J TROP ECOL, V20, P409, DOI 10.1017/S0266467404001543; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; Goulding W, 2016, BIOL CONSERV, V193, P143, DOI 10.1016/j.biocon.2015.11.022; Hansen J, 2016, EARTH SYST DYN DISCU, V2016, P1, DOI DOI 10.5194/ESD-2016-42; Harrison RD, 2000, ECOL RES, V15, P47, DOI 10.1046/j.1440-1703.2000.00319.x; Harrison RD, 2001, POPUL ECOL, V43, P63, DOI 10.1007/PL00012017; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Ho Y.-C., 2011, Q J FOR RES, V33, P21; HOPKINS MS, 1987, AUST J ECOL, V12, P25, DOI 10.1111/j.1442-9993.1987.tb00924.x; Hudson I.L., 2010, PHENOLOGICAL RES; Kauffman JB, 2010, WETLANDS, V30, P1077, DOI 10.1007/s13157-010-0114-y; Kharin VV, 2013, CLIMATIC CHANGE, V119, P345, DOI 10.1007/s10584-013-0705-8; KJELLBERG F, 1987, EVOLUTION, V41, P693, DOI 10.1111/j.1558-5646.1987.tb05846.x; Kjellberg Finn, 2005, P539; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kuaraksa C, 2012, FOREST ECOL MANAG, V265, P82, DOI 10.1016/j.foreco.2011.10.022; LAMBERT FR, 1991, J ECOL, V79, P793, DOI 10.2307/2260668; Lee HS, 2013, DYNAM ATMOS OCEANS, V59, P1, DOI 10.1016/j.dynatmoce.2012.09.002; Li JH, 2007, GLOBAL CHANGE BIOL, V13, P1101, DOI 10.1111/j.1365-2486.2007.01358.x; Liu PC, 2008, ANN GEOPHYS-GERMANY, V26, P1327, DOI 10.5194/angeo-26-1327-2008; Lo TT, 2008, CLIM DYNAM, V31, P449, DOI 10.1007/s00382-007-0311-4; Lu ShiangYue, 2016, Taiwan Journal of Forest Science, V31, P49; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mendelsohn R, 2012, NAT CLIM CHANGE, V2, P205, DOI 10.1038/NCLIMATE1357; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Monoy CC, 2016, ECOSYSTEMS, P1; Moore NJ, 2008, AUSTRAL ECOL, V33, P417, DOI 10.1111/j.1442-9993.2008.01897.x; Morellato L.P.C., 2013, PHENOLOGY INTEGRATIV, P91, DOI [DOI 10.1007/978-94-007-6925-0_6, 10.1007/978-94-007-6925-0_6]; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Ou SH, 2002, OCEAN ENG, V29, P947, DOI 10.1016/S0029-8018(01)00049-X; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pavelka MSM, 2003, INT J PRIMATOL, V24, P1037, DOI 10.1023/A:1026276228635; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; Primack RB, 2011, NEW PHYTOL, V191, P307, DOI 10.1111/j.1469-8137.2011.03773.x; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Spencer H, 1996, J BIOGEOGR, V23, P467, DOI 10.1111/j.1365-2699.1996.tb00008.x; Thornton B, 2000, GRASSLAND ECOPHYSIOL; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Tsai HC, 2009, J APPL METEOROL CLIM, V48, P997, DOI 10.1175/2008JAMC1963.1; Tu JY, 2009, J CLIMATE, V22, P3617, DOI 10.1175/2009JCLI2411.1; Tzeng HY, 2006, BOT STUD, V47, P307; Tzeng HY, 2004, THESIS; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; WALKER LR, 1991, BIOTROPICA, V23, P379, DOI 10.2307/2388255; Wang XuMing, 2016, Acta Ecologica Sinica - International Journal, V36, P23, DOI 10.1016/j.chnaes.2015.12.006; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Weiblen GD, 2010, BIOTROPICA, V42, P656, DOI 10.1111/j.1744-7429.2010.00633.x	70	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186763	10.1371/journal.pone.0186763	http://dx.doi.org/10.1371/journal.pone.0186763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073190	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400050
J	Fernandez-Novoa, D; Gomez-Gesteira, M; Mendes, R; deCastro, M; Vaz, N; Dias, JM				Fernandez-Novoa, D.; Gomez-Gesteira, M.; Mendes, R.; deCastro, M.; Vaz, N.; Dias, J. M.			Influence of main forcing affecting the Tagus turbid plume under high river discharges using MODIS imagery	PLOS ONE			English	Article							TOTAL SUSPENDED MATTER; OCEAN COLOR; SURFACE-TEMPERATURE; CENTRAL PORTUGAL; COASTAL WATERS; 250-M IMAGERY; FRESH-WATER; ESTUARY; WIND; TRANSPORT	The role of river discharge, wind and tide on the extension and variability of the Tagus River plume was analyzed from 2003 to 2015. This study was performed combining daily images obtained from the Moderate Resolution Imaging Spectroradiometer (MODIS) sensor located onboard the Aqua and Terra satellites. Composites were generated by averaging pixels with the same forcing conditions. River discharge shows a strong relation with the extension of the Tagus plume. The plume grows with the increasing river discharge and express a two day lag caused by the long residence time of water within the estuary. The Tagus turbid plume was found to be smaller under northerly and easterly winds, than under southerly and westerly winds. It is suggested that upwelling favoring winds provoke the offshore movement of the plume material with a rapidly decrease in turbidity values whereas downwelling favoring winds retain plume material in the north coast close to the Tagus mouth. Eastern cross-shore (oceanward) winds spread the plume seaward and to the north following the coast geometry, whereas western cross-shore (landward) winds keep the plume material in both alongshore directions occupying a large part of the area enclosed by the bay. Low tides produce larger and more turbid plumes than high tides. In terms of fortnightly periodicity, the maximum plume extension corresponding to the highest turbidity is observed during and after spring tides. Minimum plume extension associated with the lowest turbidity occurs during and after neap tides.	[Fernandez-Novoa, D.; Gomez-Gesteira, M.; deCastro, M.] Univ Vigo, Fac Ciencias, Environm Phys Lab, EPHYSLAB, Orense, Spain; [Mendes, R.; Vaz, N.; Dias, J. M.] Univ Aveiro, Phys Dept, CESAM, Aveiro, Portugal	Universidade de Vigo; Universidade de Aveiro	Fernandez-Novoa, D (corresponding author), Univ Vigo, Fac Ciencias, Environm Phys Lab, EPHYSLAB, Orense, Spain.	diefernandez@uvigo.es	Mendes, Renato/D-5952-2015; Gesteira, Moncho Gomez/R-9431-2019; Vaz, Nuno AF/F-5552-2010; Vaz, Nuno/GXH-8216-2022; deCastro, Maite/R-6739-2019; Dias, João Miguel/F-3292-2010; Mendes, Renato/AAW-8775-2021	Mendes, Renato/0000-0002-2964-9757; Gesteira, Moncho Gomez/0000-0002-0661-9731; Vaz, Nuno AF/0000-0002-8484-6948; deCastro, Maite/0000-0001-6443-3620; Dias, João Miguel/0000-0002-7613-6241; Mendes, Renato/0000-0002-2964-9757; Fernandez-Novoa, Diego/0000-0002-7508-6502	Xunta de Galicia under project "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referenda Competitiva)" - European Regional Development Fund (FEDER) [GRC2013-001]; Xunta de Galicia [GRC2013-001, EM2013/003]; Xunta de Galicia through the Plan galego de investigation, innovacion e crecemento (Plan I2C); International Campus do Mar [PRE/2013/395]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/79555/2011]; CESAM [UID/AMB/50017];  [SFRH/BPD/110615/201]	Xunta de Galicia under project "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referenda Competitiva)" - European Regional Development Fund (FEDER); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Xunta de Galicia through the Plan galego de investigation, innovacion e crecemento (Plan I2C); International Campus do Mar; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); CESAM; 	This work was partially supported by Xunta de Galicia (GRC2013-001) under projects "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referenda Competitiva)" co-founded by European Regional Development Fund (FEDER) and EM2013/003. D. Fernandez-Novoa has been supported by the Xunta de Galicia through the Plan galego de investigation, innovacion e crecemento 2011-2015 (Plan I2C) in collaboration with the International Campus do Mar (PRE/2013/395). R. Mendes has been supported by the Fundacao para a Ciencia e Tecnologia (FCT) through a doctoral grant (SFRH/BD/79555/2011). N. Vaz is supported by a post-doctoral grant (SFRH/BPD/110615/201) and partially supported by CESAM (UID/AMB/50017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2014, DEEP-SEA RES PT II, V106, P38, DOI 10.1016/j.dsr2.2013.09.028; Aurin D, 2013, REMOTE SENS ENVIRON, V137, P212, DOI 10.1016/j.rse.2013.06.018; Baith K., 2001, EOS T AM GEOPHYS UN, V82, P202, DOI [10.1029/01eo00109, DOI 10.1029/01E000109, DOI 10.1029/01EO00109]; Braunschweig F, 2003, OCEAN DYNAM, V53, P137, DOI 10.1007/s10236-003-0040-0; Chen ZQ, 2007, REMOTE SENS ENVIRON, V109, P207, DOI 10.1016/j.rse.2006.12.019; Choi BJ, 2007, J PHYS OCEANOGR, V37, P1878, DOI 10.1175/JPO3081.1; Costoya X, 2016, J GEOPHYS RES-OCEANS, V121, P966, DOI 10.1002/2015JC011157; Dagg M, 2004, CONT SHELF RES, V24, P833, DOI 10.1016/j.csr.2004.02.003; Fernandez-Novoa D, 2015, J MARINE SYST, V142, P40, DOI 10.1016/j.jmarsys.2014.09.009; Fong DA, 2002, J PHYS OCEANOGR, V32, P957, DOI 10.1175/1520-0485(2002)032<0957:TATOFI>2.0.CO;2; Fong DA, 2001, J GEOPHYS RES-OCEANS, V106, P1067, DOI 10.1029/2000JC900134; Fortunato AB, 1997, CONT SHELF RES, V17, P1689, DOI 10.1016/S0278-4343(97)00047-2; Gameiro C, 2007, ESTUAR COAST SHELF S, V75, P21, DOI 10.1016/j.ecss.2007.05.014; Garvine R.W., 1995, SHELF RES, V15, P1585, DOI DOI 10.1016/0278-4343(94)00065-U); GARVINE RW, 1982, TELLUS, V34, P293, DOI 10.1111/j.2153-3490.1982.tb01818.x; Hetland RD, 2005, J PHYS OCEANOGR, V35, P1667, DOI 10.1175/JPO2774.1; Horner-Devine AR, 2015, ANNU REV FLUID MECH, V47, P569, DOI 10.1146/annurev-fluid-010313-141408; Jouanneau JM, 1998, PROG OCEANOGR, V42, P233, DOI 10.1016/S0079-6611(98)00036-6; Jurisa JT, 2012, OCEAN DYNAM, V62, P771, DOI 10.1007/s10236-012-0527-7; Lorenzo MN, 2008, INT J CLIMATOL, V28, P1493, DOI 10.1002/joc.1646; Mendes R, 2014, REMOTE SENS ENVIRON, V154, P127, DOI 10.1016/j.rse.2014.08.003; Mestres M, 2003, SCI MAR, V67, P379, DOI 10.3989/scimar.2003.67n4379; Miller RL, 2004, REMOTE SENS ENVIRON, V93, P259, DOI 10.1016/j.rse.2004.07.012; Moita MT, 2003, ACTA OECOL, V24, pS125, DOI 10.1016/S1146-609X(03)00011-0; Neves F., 2010, THESIS U LISBOA PORT; Nezlin NP, 2005, REMOTE SENS ENVIRON, V98, P494, DOI 10.1016/j.rse.2005.08.008; Oliveira PB, 2009, CONT SHELF RES, V29, P759, DOI 10.1016/j.csr.2008.08.004; Otero P, 2008, J MARINE SYST, V72, P238, DOI 10.1016/j.jmarsys.2007.05.016; Petus C, 2010, CONT SHELF RES, V30, P379, DOI 10.1016/j.csr.2009.12.007; Pond S, 1998, INTRO DYNAMICAL OCEA, P329; Rusu L, 2011, OCEAN ENG, V38, P1174, DOI 10.1016/j.oceaneng.2011.05.016; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Saldias GS, 2012, REMOTE SENS ENVIRON, V123, P220, DOI 10.1016/j.rse.2012.03.010; Shi W, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029724; Valente AS, 2009, J MARINE SYST, V75, P131, DOI 10.1016/j.jmarsys.2008.08.008; Vaz N, 2015, J MARINE SYST, V147, P123, DOI 10.1016/j.jmarsys.2014.05.022; Vaz N, 2011, J COASTAL RES, P1619; Vaz N, 2009, J COASTAL RES, P1090; Vaz N, 2014, J COASTAL RES, P610, DOI 10.2112/SI70-103.1; Wang MH, 2007, OPT EXPRESS, V15, P15722, DOI 10.1364/OE.15.015722; Yankovsky AE, 1997, J PHYS OCEANOGR, V27, P1386, DOI 10.1175/1520-0485(1997)027<1386:ASTFTF>2.0.CO;2; Zhang YL, 2016, REMOTE SENS ENVIRON, V173, P109, DOI 10.1016/j.rse.2015.11.020	42	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187036	10.1371/journal.pone.0187036	http://dx.doi.org/10.1371/journal.pone.0187036			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073209	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400100
J	Frydlova, J; Rychtarcikova, Z; Gurieva, I; Vokurka, M; Truksa, J; Krijt, J				Frydlova, Jana; Rychtarcikova, Zuzana; Gurieva, Iuliia; Vokurka, Martin; Truksa, Jaroslav; Krijt, Jan			Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice	PLOS ONE			English	Article							SERINE-PROTEASE MATRIPTASE-2; TRANSFERRIN RECEPTOR 2; ANTIMICROBIAL PEPTIDE HEPCIDIN; REPULSIVE GUIDANCE MOLECULE; BONE MORPHOGENETIC PROTEIN; DEFICIENCY ANEMIA; GENE-EXPRESSION; MOUSE-LIVER; JUVENILE HEMOCHROMATOSIS; TMPRSS6 GENE	Tmprss6-mutated mask mice display iron deficiency anemia and high expression of hepcidin. The aim of the study was to determine the effect of erythropoietin administration on proteins participating in the control of iron homeostasis in the liver and spleen in C57BL/6 and mask mice. Administration of erythropoietin for four days at 50 IU/mouse/day increased hemoglobin and hematocrit in C57BL/6 mice, no such increase was seen in mask mice. Erythropoietin administration decreased hepcidin expression in C57BL/6 mice, but not in mask mice. Erythropoietin treatment significantly increased the spleen size in both C57BL/6 and mask mice. Furthermore, erythropoietin administration increased splenic Fam132b, Fam132a and Tfr2 mRNA content. At the protein level, erythropoietin increased the amount of splenic erythroferrone and transferrin receptor 2 both in C57BL/6 and mask mice. Splenic ferroportin content was decreased in erythropoietin-treated mask mice in comparison with erythropoietin-treated C57BL/6 mice. In mask mice, the amount of liver hemojuvelin was decreased in comparison with C57BL/6 mice. The pattern of hemojuvelin cleavage was different between C57BL/6 and mask mice: In both groups, a main hemojuvelin band was detected at approximately 52 kDa; in C57BL/6 mice, a minor cleaved band was seen at 47 kDa. In mask mice, the 47 kDa band was absent, but additional minor bands were detected at approximately 45 kDa and 48 kDa. The results provide support for the interaction between TMPRSS6 and hemojuvelin in vivo; they also suggest that hemojuvelin could be cleaved by another as yet unknown protease in the absence of functional TMPRSS6. The lack of effect of erythropoietin on hepcidin expression in mask mice can not be explained by changes in erythroferrone synthesis, as splenic erythroferrone content increased after erythropoietin administration in both C57BL/6 and mask mice.	[Frydlova, Jana; Gurieva, Iuliia; Vokurka, Martin; Krijt, Jan] Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague, Czech Republic; [Rychtarcikova, Zuzana; Truksa, Jaroslav] Czech Acad Sci, BIOCEV Res Ctr, Inst Biotechnol, Lab Tumour Resistance, Vestec, Czech Republic; [Rychtarcikova, Zuzana] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague	Krijt, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague, Czech Republic.; Truksa, J (corresponding author), Czech Acad Sci, BIOCEV Res Ctr, Inst Biotechnol, Lab Tumour Resistance, Vestec, Czech Republic.	truksaj@ibt.cas.cz; jkri@LF1.cuni.cz	Krijt, Jan/B-2359-2009; Truksa, Jaroslav/G-9454-2014; Truksa, Jaroslav/AAB-5089-2020; Frydlova, Jana/H-8878-2017; Vokurka, Martin/F-7533-2017	Truksa, Jaroslav/0000-0002-8967-7354; Truksa, Jaroslav/0000-0002-8967-7354; Frydlova, Jana/0000-0001-9725-9526; Vokurka, Martin/0000-0001-5943-5939	Czech Science Foundation (GACR) [15-16803S, 13-28830S]; MEYS of CR within the National Sustainability Program II (Project BIOCEV-FAR) [LQ1604]; project "BIOCEV" [CZ.1.05/1.1.00/02.0109];  [PROGRES Q26];  [SW 260371/2017]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); MEYS of CR within the National Sustainability Program II (Project BIOCEV-FAR); project "BIOCEV"; ; 	Supported by Czech Science Foundation (GACR, http://gacr.cz/), grant 15-16803S to JK and grant 13-28830S to JT; by the MEYS of CR within the LQ1604 National Sustainability Program II (Project BIOCEV-FAR); by the project "BIOCEV" (CZ.1.05/1.1.00/02.0109) and by institutional grants PROGRES Q26 and SW 260371/2017.	Aschemeyer S, 2017, AM J HEMATOL, V92, pE61, DOI 10.1002/ajh.24672; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Forejtnikova H, 2010, BLOOD, V116, P5357, DOI 10.1182/blood-2010-04-281360; Frazer DM, 2016, BRIT J HAEMATOL, V175, P308, DOI 10.1111/bjh.14206; Frydlova J, 2013, PHYSIOL RES, V62, P405, DOI 10.33549/physiolres.932455; Frydlova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148540; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Gurieva I, 2017, BLOOD CELL MOL DIS, V64, P1, DOI 10.1016/j.bcmd.2017.02.007; Healey EG, 2015, NAT STRUCT MOL BIOL, V22, P458, DOI 10.1038/nsmb.3016; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kim A, 2015, CURR OPIN HEMATOL, V22, P199, DOI 10.1097/MOH.0000000000000132; Kim TS, 2015, J CLIN INVEST, V125, P3965, DOI 10.1172/JCI81919; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Lee P, 2012, BRIT J HAEMATOL, V156, P415, DOI 10.1111/j.1365-2141.2011.09006.x; Lehmberg K, 2013, ANN HEMATOL, V92, P387, DOI 10.1007/s00277-012-1618-8; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Nai A, 2015, BLOOD, V125, P1170, DOI 10.1182/blood-2014-08-596254; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Nicolas G, 2011, BRIT J HAEMATOL, V152, P498, DOI 10.1111/j.1365-2141.2010.08473.x; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Nili M, 2010, J BIOL CHEM, V285, P24783, DOI 10.1074/jbc.M110.130286; Pagani A, 2015, HAEMATOLOGICA, V100, P461, DOI 10.3324/haematol.2014.118521; Pasricha SR, 2016, HEMATOL ONCOL CLIN N, V30, P309, DOI 10.1016/j.hoc.2015.11.003; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Peng H, 2010, BRIT J HAEMATOL, V151, P106, DOI 10.1111/j.1365-2141.2010.08306.x; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Rausa M, 2015, J CELL MOL MED, V19, P879, DOI 10.1111/jcmm.12462; Rishi G, 2016, AM J HEMATOL, V91, P812, DOI 10.1002/ajh.24417; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Stirnberg M, 2015, BIOL CHEM, V396, P81, DOI 10.1515/hsz-2014-0120; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Wahedi M, 2017, J BIOL CHEM; Wallace DF, 2015, BRIT J HAEMATOL, V168, P891, DOI 10.1111/bjh.13225; Willemetz A, 2014, BLOOD, V124, P441, DOI 10.1182/blood-2014-01-551150	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186844	10.1371/journal.pone.0186844	http://dx.doi.org/10.1371/journal.pone.0186844			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073189	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400060
J	Peng, Y; Wang, ZQ; Dong, B; Cao, SF; Hu, J; Adegbija, O				Peng, Yang; Wang, Zhiqiang; Dong, Bin; Cao, Sifan; Hu, Jie; Adegbija, Odewumi			Life's Simple 7 and ischemic heart disease in the general Australian population	PLOS ONE			English	Article							IDEAL CARDIOVASCULAR HEALTH; GLOBAL BURDEN; ALL-CAUSE; MORTALITY; STROKE; ASSOCIATIONS; EVENTS; RISK; PREVALENCE; METRICS	Background The American Heart Association released 7 modifiable factors, Life's Simple 7, that are expected to improve cardiovascular health (CVH), but their contributions to ischemic heart disease (IHD) in the general Australians are not well clarified. Methods We performed a cross-sectional study based on 7499 adults (>= 18 years) who have tested for total cholesterol and fasting plasma glucose as part of 2011-12 Australian Health Survey. Poisson regression analyses were used to estimate the incidence rate ratios and population attributable fractions of those factors to IHD prevalence. Participants were classified into three CVH groups based on the number of ideal metrics: inadequate (0-2), average (3-4), and optimal (5-7). Logistic regression analyses were performed to elucidate the relationship between overall CVH and IHD prevalence. Results 357 participants were self-reported having IHD condition, with a weighted prevalence of 3.3%. Physical inactivity, elevated body mass index (BMI) and total cholesterol (TC) were independently associated with IHD. Compared to the inadequate category, participants in the optimal and average categories have a 78% [adjusted odds ratio (OR), 0.22; 95% confidence interval (CI), 0.03-1.96] and a 45% (adjusted OR, 0.55; 95% CI, 0.39-0.77) lower IHD risk. One more optimal metric was associated with an 18% lower IHD risk (adjusted OR, 0.82; 95% CI, 0.71-0.93). Conclusions Our findings indicate that physical inactivity, raised BMI and elevated TC were independent modifiable risk factors of IHD in the general Australian population. The improvement of overall CVH may also reduce IHD risk among the general Australian adults.	[Peng, Yang; Wang, Zhiqiang; Dong, Bin; Hu, Jie; Adegbija, Odewumi] Univ Queensland, Ctr Chron Dis, Ctr Clin Res, Herston, Qld, Australia; [Dong, Bin] Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Cao, Sifan] Univ Queensland, Sch Publ Hlth, Ctr Longitudinal & Life Course Res, Herston, Qld, Australia	University of Queensland; Peking University; University of Queensland	Peng, Y (corresponding author), Univ Queensland, Ctr Chron Dis, Ctr Clin Res, Herston, Qld, Australia.	y.peng@uq.edu.au	Cao, Sifan/AAX-3278-2021; Adegbija, Odewumi/N-1434-2019; Wang, Zhiqiang/A-5835-2010; Peng, Yang/J-8980-2016	Cao, Sifan/0000-0001-5704-0394; Wang, Zhiqiang/0000-0002-5839-743X; Peng, Yang/0000-0002-9119-5506; Adegbija, Odewumi/0000-0001-6517-3795; Hu, Jie/0000-0003-2940-6525	University of Queensland International Scholarship [44078179]; National Health and Medical Research Council of Australia [APP1042343]	University of Queensland International Scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a University of Queensland International Scholarship (no. 44078179; URLs: http://www.uq.edu.au/) to YP and the National Health and Medical Research Council of Australia (no. APP1042343; URLs: https://www.nhmrc.gov.au/) to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatola H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000532; Artero EG, 2012, MAYO CLIN PROC, V87, P944, DOI 10.1016/j.mayocp.2012.07.015; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV US G; Australian Bureau of Statistics, 2014, MICR AUSTR HLTH SURV; Caleyachetty R, 2015, INT J CARDIOL, V191, P296, DOI 10.1016/j.ijcard.2015.05.007; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Gaye B, 2017, J AM COLL CARDIOL, V69, P3015, DOI 10.1016/j.jacc.2017.05.011; Gong WW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165647; Hildebrandt Mandy, 2006, BMC Med Res Methodol, V6, P32, DOI 10.1186/1471-2288-6-32; Jankovic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141731; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; Kim Ji Young, 2013, J Prev Med Public Health, V46, P319, DOI 10.3961/jpmph.2013.46.6.319; Korda RJ, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0471-0; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Health and Medical Research Council, 2013, AUSTRALIAN DIETARY G; Olson NC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001494; Peters SAE, 2016, ATHEROSCLEROSIS, V248, P123, DOI 10.1016/j.atherosclerosis.2016.03.016; Saleem Y, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001851; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839	29	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187020	10.1371/journal.pone.0187020	http://dx.doi.org/10.1371/journal.pone.0187020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073220	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400096
J	Rivadeneira, MM; Nielsen, SN				Rivadeneira, Marcelo M.; Nielsen, Sven N.			Diversification dynamics, species sorting, and changes in the functional diversity of marine benthic gastropods during the Pliocene-Quaternary at temperate western South America	PLOS ONE			English	Article							SEA-LEVEL CHANGES; MOLLUSCAN ASSEMBLAGES; MASS EXTINCTION; MURICIDAE; SELECTIVITY; END; PLIOPLEISTOCENE; BIODIVERSITY; TURNOVER; ECOLOGY	Functional diversity based on species traits is a powerful tool to investigate how changes in species richness and composition affect ecosystem functioning. However, studies aimed at understanding changes in functional diversity over large temporal and spatial scales are still scant. Here we evaluate the combined effect of diversification and species sorting on functional diversity of fossil marine gastropods during the Pliocene-Quaternary transition in the Pacific coast of South America. We analyzed a total of 172 species in 29 Pliocene and 97 Quaternary sites. Each species was characterized according to six functional traits: body size, feeding type, mobility, attachment, life-habit, and larval mode. Functional diversity was estimated according to four indexes (functional richness, evenness, divergence and dispersion) based on functional traits measured. Extrapolated species richness showed a slight yet not significant decrease from the Pliocene to the Quaternary despite the fact that a large faunal turnover took place; furthermore, a large extinction of Pliocene species (61-76%) was followed by a high pulse of appearances (49-56%) during the Quaternary. Three out of four indices of functional diversity (evenness, divergence and dispersion) increased significantly towards the Quaternary which is more than expected under a random turnover of species. The increase in functional diversity is associated with a loss of large-sized carnivore forms, which tended to be replaced by small-sized grazers. Hence, this trait-selective species turnover, even in the absence of significant changes in species richness, likely had a large effect and has shaped the functional diversity of present-day assemblages.	[Rivadeneira, Marcelo M.] CEAZA, Lab Paleobiol, Av Bernardo Ossandon, Coquimbo, Chile; [Rivadeneira, Marcelo M.] Univ Catolica Norte, Dept Biol Marina, Larrondo, Coquimbo, Chile; [Nielsen, Sven N.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Tierra, Isla Teja S-N, Valdivia, Chile	Universidad Catolica del Norte; Universidad Austral de Chile	Rivadeneira, MM (corresponding author), CEAZA, Lab Paleobiol, Av Bernardo Ossandon, Coquimbo, Chile.; Rivadeneira, MM (corresponding author), Univ Catolica Norte, Dept Biol Marina, Larrondo, Coquimbo, Chile.	marcelo.rivadeneira@ceaza.cl	Nielsen, Sven N/A-2187-2009	Nielsen, Sven N/0000-0003-2064-8050; Rivadeneira, Marcelo/0000-0002-1681-416X	FONDECYT [1140841, 1150664, INACH G_05-11]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by FONDECYT projects 1140841,1150664 and INACH G_05-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Paleolab CEAZA, Alex Alballay, Jaime Villafana, and Pablo Oyanadel, for their help collecting the information used. Geraat Vermeij and Nicole Webster provided very constructive comments that improved the manuscript. This work was funded by FONDECYT projects 1140841, 1150664 and INACH G_05-11.	Aberhan M, 2015, P NATL ACAD SCI USA, V112, P7207, DOI 10.1073/pnas.1422248112; Allmon W.D., 1989, Historical Biology, V3, P141; Berke SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101494; Boyer AG, 2014, GLOBAL ECOL BIOGEOGR, V23, P679, DOI 10.1111/geb.12147; Bush AM, 2011, ANNU REV EARTH PL SC, V39, P241, DOI 10.1146/annurev-earth-040809-152556; Cardenas J, 2009, ANDEAN GEOL, V36, P81, DOI 10.4067/S0718-71062009000100007; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; DeVries TJ, 2008, VELIGER, V50, P129; DeVries TJ, 2007, NAUTILUS, V121, P163; DeVries TJ, 2007, J PALEONTOL, V81, P331, DOI 10.1666/0022-3360(2007)81[331:CTGFSP]2.0.CO;2; DeVries TJ, 2007, VELIGER, V48, P247; DeVries TJ, 2006, NAUTILUS, V120, P139; DeVries TJ, 2005, NAUTILUS, V119, P164; DeVries TJ, 2005, VELIGER, V47, P277; DeVries TJ, 2005, VELIGER, V47, P259; DeVries TJ, 2004, VELIGER, V47, P6; DeVries TJ, 2003, VELIGER, V46, P332; DEVRIES TJ, 1995, VELIGER, V38, P284; DeVries TJ, 1997, J PALEONTOL, V71, P610, DOI 10.1017/S0022336000040099; DeVriesi TJ, 2008, VELIGER, V50, P274; Dineen AA, 2015, GLOBAL PLANET CHANGE, V133, P79, DOI 10.1016/j.gloplacha.2015.08.001; Dineen AA, 2014, EARTH-SCI REV, V136, P339, DOI 10.1016/j.earscirev.2014.06.002; Dowsett HJ, 2009, CLIM PAST, V5, P769, DOI 10.5194/cp-5-769-2009; Dowsett HJ, 2009, PHILOS T R SOC A, V367, P109, DOI 10.1098/rsta.2008.0206; Foster WJ, 2014, NAT GEOSCI, V7, P233, DOI [10.1038/ngeo2079, 10.1038/NGEO2079]; Garreaud RD, 2010, EARTH PLANET SC LETT, V292, P39, DOI 10.1016/j.epsl.2010.01.017; Gonzalez-Wevar CA, 2010, MOL PHYLOGEN EVOL, V56; Guzman N, 2000, C GEOL GIC CHIL; Herm D., 1969, Zitteliana, V2, P1; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hopkins MJ, 2014, ECOL LETT, V17, P314, DOI 10.1111/ele.12232; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; JOHNSON KG, 1995, PALEOBIOLOGY, V21, P52, DOI 10.1017/S0094837300013075; Johnson KG, 2001, PALAEOGEOGR PALAEOCL, V172, P39, DOI 10.1016/S0031-0182(01)00267-X; Keller G, 2009, PALAEOGEOGR PALAEOCL, V284, P47, DOI 10.1016/j.palaeo.2009.08.029; Kiel S, 2010, GEOLOGY, V38, P955, DOI 10.1130/G31282.1; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Le Roux JP, 2006, SEDIMENT GEOL, V184, P133, DOI 10.1016/j.sedgeo.2005.09.023; Le Roux JP, 2005, J S AM EARTH SCI, V19, P83, DOI 10.1016/j.jsames.2003.11.003; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MORICKE W, 1896, BEILAGE BAND, V10, P548; Mouillot D, 2014, P NATL ACAD SCI USA, V111, P13757, DOI 10.1073/pnas.1317625111; Nielsen SN, 2009, PALAEOGEOGR PALAEOCL, V280, P480, DOI 10.1016/j.palaeo.2009.06.035; Nielsen SN, 2008, NAUTILUS, V122, P201; Ortlieb L, 1996, QUATERNARY SCI REV, V15, P857, DOI 10.1016/S0277-3791(96)00062-5; Ortlieb L, 1995, AN M INT GEOL CORR P; Ortlieb L., 1994, ESTUDIOS OCEANOL GIC, V13, P57; Ortlieb Luc, 1990, Boletin de la Sociedad Geologica del Peru, V81, P127; Paskoff R, 1995, AN M INT GEOL CORR P; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Philippi RA, 1887, FO SILES TERCIARIOS; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; R Core Team, R LANG ENV STAT COMP; Rivadeneira MM, 2008, REV GEOL CHILE, V35, P163; Rivadeneira MM, 2007, PALEOBIOLOGY, V33, P455, DOI 10.1666/06042.1; Schmera D, 2009, AQUAT ECOL, V43, P157, DOI 10.1007/s10452-007-9152-9; Smith AB, 1998, NATURE, V392, P69, DOI 10.1038/32155; Smith JT, 2006, PALEOBIOLOGY, V32, P408, DOI 10.1666/05078.1; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; STANLEY SM, 1981, NATURE, V293, P457, DOI 10.1038/293457a0; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Todd JA, 2002, P ROY SOC B-BIOL SCI, V269, P571, DOI 10.1098/rspb.2001.1923; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Valentine JW, 2002, MAR ECOL PROG SER, V228, P153, DOI 10.3354/meps228153; Valenzuela-Toro AM, 2013, J VERTEBR PALEONTOL, V33, P216, DOI 10.1080/02724634.2012.710282; Vermeij GJ, 2012, BIOL J LINN SOC, V106, P776, DOI 10.1111/j.1095-8312.2012.01897.x; Villafana JA, 2014, PALEOBIOLOGY, V40, P659, DOI 10.1666/13069; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2011, ECOL LETT, V14, P561, DOI 10.1111/j.1461-0248.2011.01618.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	83	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187140	10.1371/journal.pone.0187140	http://dx.doi.org/10.1371/journal.pone.0187140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073224	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400121
J	Valkovic, L; Dragonu, I; Almujayyaz, S; Batzakis, A; Young, LAJ; Purvis, LAB; Clarke, WT; Wichmann, T; Lanz, T; Neubauer, S; Robson, MD; Klomp, DWJ; Rodgers, CT				Valkovic, Ladislav; Dragonu, Iulius; Almujayyaz, Salam; Batzakis, Alex; Young, Liam A. J.; Purvis, Lucian A. B.; Clarke, William T.; Wichmann, Tobias; Lanz, Titus; Neubauer, Stefan; Robson, Matthew D.; Klomp, Dennis W. J.; Rodgers, Christopher T.			Using a whole-body P-31 birdcage transmit coil and 16-element receive array for human cardiac metabolic imaging at 7T	PLOS ONE			English	Article							SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; SPECTROSCOPY; SUPPRESSION	Purpose Cardiac phosphorus magnetic resonance spectroscopy (P-31-MRS) provides unique insight into the mechanisms of heart failure. Yet, clinical applications have been hindered by the restricted sensitivity of the surface radiofrequency-coils normally used. These permit the analysis of spectra only from the interventricular septum, or large volumes of myocardium, which may not be meaningful in focal disease. Loring et al. recently presented a prototype whole-body (52 cm diameter) transmit/receive birdcage coil for P-31 at 7T. We now present a new, easily-removable, whole-body P-31 transmit radiofrequency-coil built into a patient-bed extension combined with a 16-element receive array for cardiac P-31-MRS. Materials and methods A fully-removable (55 cm diameter) birdcage transmit coil was combined with a 16-element receive array on a Magnetom 7T scanner (Siemens, Germany). Electro-magnetic field simulations and phantom tests of the setup were performed. In vivo maps of B1(+), metabolite signals, and saturation-band efficiency were acquired across the torsos of eight volunteers. Results The combined (volume-transmit, local receive array) setup increased signal-to-noise ratio 2.6-fold 10 cm below the array (depth of the interventricular septum) compared to using the birdcage coil in transceiver mode. The simulated coefficient of variation for B1(+) of the whole-body coil across the heart was 46.7% (surface coil 129.0%); and the in vivo measured value was 38.4%. Metabolite images of 2,3-diphosphoglycerate clearly resolved the ventricular blood pools, and muscle tissue was visible in phosphocreatine (PCr) maps. Amplitude-modulated saturation bands achieved 71 +/- 4% suppression of phosphocreatine PCr in chest-wall muscles. Subjects reported they were comfortable. Conclusion This easy-to-assemble, volume-transmit, local receive array coil combination significantly improves the homogeneity and field-of-view for metabolic imaging of the human heart at 7T.	[Valkovic, Ladislav; Young, Liam A. J.; Purvis, Lucian A. B.; Clarke, William T.; Neubauer, Stefan; Robson, Matthew D.; Rodgers, Christopher T.] Univ Oxford, Oxford Ctr Clin Magnet Resonance Res OCMR, BHF Ctr Res Excellence, Oxford, England; [Valkovic, Ladislav] Slovak Acad Sci, Inst Measurement Sci, Dept Imaging Methods, Bratislava, Slovakia; [Dragonu, Iulius] Siemens Healthcare Ltd, Frimley, Surrey, England; [Almujayyaz, Salam; Batzakis, Alex; Klomp, Dennis W. J.] MR Coils BV, Zaltbommel, Netherlands; [Wichmann, Tobias; Lanz, Titus] Rapid Biomed GmbH, Rimpar, Germany; [Klomp, Dennis W. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	University of Oxford; Slovak Academy of Sciences; Institute of Measurement Science, SAS; Siemens AG; Utrecht University; Utrecht University Medical Center	Valkovic, L (corresponding author), Univ Oxford, Oxford Ctr Clin Magnet Resonance Res OCMR, BHF Ctr Res Excellence, Oxford, England.; Valkovic, L (corresponding author), Slovak Acad Sci, Inst Measurement Sci, Dept Imaging Methods, Bratislava, Slovakia.	ladislav.valkovic@cardiov.ox.ac.uk	Rodgers, Christopher T./AAD-3344-2019; Valkovič, Ladislav/J-5731-2019	Rodgers, Christopher T./0000-0003-1275-1197; Valkovič, Ladislav/0000-0003-2567-3642; Neubauer, Stefan/0000-0001-9017-5645; Young, Liam/0000-0003-0720-421X	Wellcome Trust; Royal Society [098436/Z/12/Z]; Wellcome Trust Science Enhancement [098436/Z/12/A]; EPA Cephalosporin Fund [CF 284]; BHF Centre of Research Excellence, Oxford [RE/13/1/30181]; Austrian National Bank Annual Fund [15455]; Grant Agency of the Slovak Ministry of Education, Science, Research and Sport and Slovak Academy of Sciences VEGA [2/0001/17]; Slovak Research and Development Agency [15-0029]; MRC [G0900883, 1966877] Funding Source: UKRI; Medical Research Council [G0900883, 1515231] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Wellcome Trust Science Enhancement(Wellcome Trust); EPA Cephalosporin Fund; BHF Centre of Research Excellence, Oxford; Austrian National Bank Annual Fund; Grant Agency of the Slovak Ministry of Education, Science, Research and Sport and Slovak Academy of Sciences VEGA(Slovak Academy of Sciences); Slovak Research and Development Agency(Slovak Research and Development Agency); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by: Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society (Grant No. 098436/Z/12/Z, https://wellcome.ac.uk/) to C.T.R.; Wellcome Trust Science Enhancement (Grant No. 098436/Z/12/A, https:/wellcome.ac.uk./) to C.T.R.; EPA Cephalosporin Fund (Grant No. CF 284, http//opencharities.org/charities/309698) to S.N.; BHF Centre of Research Excellence, Oxford (Grant No. RE/13/1/30181, https://www.bhf.org.uk/) to C.T.R.; Austrian National Bank Annual Fund (Grant No. 15455, https.//www.oenb.at/) to L.V.; Grant Agency of the Slovak Ministry of Education, Science, Research and Sport and Slovak Academy of Sciences VEGA (Grant No. 2/0001/17, https://www.minedu.skivedecka-grantova-agentura-rnsvvas-sr-a-sav-vega/); and Slovak Research and Development Agency (Grant No. 15-0029, ham://www.apvv.sk/?lang=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTTOMLEY PA, 1988, MAGN RESON MED, V7, P319, DOI 10.1002/mrm.1910070309; Bottomley PA, 2009, ENCY MAGNETIC RESONA; Chmelik M, 2014, J MAGN RESON IMAGING, V40, P391, DOI 10.1002/jmri.24401; Levelt E, 2016, EUR HEART J, V37, P3461, DOI 10.1093/eurheartj/ehv442; Loring J, 2016, NMR BIOMED, V29, P709, DOI 10.1002/nbm.3517; Luo Y, 2001, MAGNET RESON MED, V45, P1095, DOI 10.1002/mrm.1144; Neubauer S, 1997, CIRCULATION, V96, P2190; Purvis LAB, 2017, MAGNETIC RESONANCE M; Purvis LAB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185356; Rider OJ, 2012, CIRCULATION, V125, P1511, DOI 10.1161/CIRCULATIONAHA.111.069518; Robson MD, 2005, MAGNET RESON MED, V53, P267, DOI 10.1002/mrm.20344; Rodgers CT, 2016, MAGN RESON MED, V75, P473, DOI 10.1002/mrm.25618; Rodgers CT, 2014, MAGN RESON MED, V72, P304, DOI 10.1002/mrm.24922; Rodgers CT, 2014, 22 JOINT ANN M ISMRM; Schaller B, 2016, MAGN RESON MED, V75, P962, DOI 10.1002/mrm.25755; Sedivy P, 2015, MED PHYS, V42, P1678, DOI 10.1118/1.4914448; Stoll VM, 2016, RADIOLOGY, V281, P409, DOI 10.1148/radiol.2016152629; Valkovic L, 2016, MAGNETIC RESONANCE M; Valkovic L, 2017, ANAL BIOCHEM, V529, P193, DOI 10.1016/j.ab.2017.01.018; Valkovic L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20087; van der Kemp WJM, 2013, NMR BIOMED, V26, P1299, DOI 10.1002/nbm.2952	21	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187153	10.1371/journal.pone.0187153	http://dx.doi.org/10.1371/journal.pone.0187153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073228	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400124
J	Averianov, A; Sues, HD				Averianov, Alexander; Sues, Hans-Dieter			The oldest record of Alvarezsauridae (Dinosauria: Theropoda) in the Northern Hemisphere	PLOS ONE			English	Article							PATAGONYKUS-PUERTAI THEROPODA; RIO NEGRO; ARGENTINA; CHINA	Procoelous caudal vertebrae, a carpometacarpus with a hypertrophied metacarpal II, and robust proximal and ungual phalanges of manual digit II of a small theropod dinosaur from the Upper Cretaceous (Turonian) Bissekty Formation at Dzharakuduk, Uzbekistan, show unequivocal synapomorphies of the clade Alvarezsauridae and thus are referred to it. The caudal vertebrae have a unique longitudinal canal within the neural arch. The carpometacarpus, with metacarpal III occupying about one third of the width of the carpometacarpus, shows the most plesiomorphic stage of the evolution of the forelimb among known alvarezsaurids. The proximal phalanx of manual digit II differs from the corresponding bone in Parvicursorinae in having a less asymmetrical proximal articular surface without a dorsal process and short ventral ridges. The ungual phalanx of manual digit II has laterally open ventral foramina. The Bissekty alvarezsaurid possibly represents a basal parvicursorine and is the stratigraphically oldest known alvarezsaurid in Asia known to date.	[Averianov, Alexander] Russian Acad Sci, Zool Inst, Univ Skaya Nab 1, St Petersburg, Russia; [Averianov, Alexander] Kazan Fed Univ, Inst Geol & Petr Technol, Kazan, Russia; [Sues, Hans-Dieter] Natl Museum Nat Hist, Dept Paleobiol, Smithsonian Inst, Washington, DC 20560 USA	Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Kazan Federal University; Smithsonian Institution; Smithsonian National Museum of Natural History	Sues, HD (corresponding author), Natl Museum Nat Hist, Dept Paleobiol, Smithsonian Inst, Washington, DC 20560 USA.	suesh@si.edu		Sues, Hans-Dieter/0000-0002-9911-7254	National Science Foundation [EAR-9804771, EAR-0207004]; National Geographic Society [5901-97, 6281-98]; Navoi Mining and Metallurgy Combinat; Russian Scientific Fund [14-14-00015]; Russian Science Foundation [17-14-00026] Funding Source: Russian Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Navoi Mining and Metallurgy Combinat; Russian Scientific Fund(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The field work in 1997-2006 was funded by the National Science Foundation (EAR-9804771 and EAR-0207004 to J.D. Archibald and H.-D. Sues), the National Geographic Society (5901-97 and 6281-98 to J.D. Archibald and H.-D. Sues), and the Navoi Mining and Metallurgy Combinat. The laboratory research by AA received support from the Russian Scientific Fund (14-14-00015).	Agnolin FL, 2012, CRETACEOUS RES, V35, P33, DOI 10.1016/j.cretres.2011.11.014; Alifanov VR., 2009, PALEONTOLOGICAL JOUR, V43, P86; ALTANGEREL P, 1993, NATURE, V362, P623, DOI 10.1038/362623a0; Archibald J.D., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P21; Averianov A., 2012, Journal of Stratigraphy, V36, P462; Bonaparte JF., 1991, REV MUSEO ARGENTINO, V4, P17; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Chiappe LM, 2003, AMEGHINIANA, V40, P119; Chiappe Luis M., 2002, P87; Choiniere JN, 2014, AM MUS NOVIT, V3816, P1, DOI [10.1206/3816.1, DOI 10.1206/3816.1]; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hone DWE, 2013, ACTA PALAEONTOL POL, V58, P453, DOI 10.4202/app.2011.0127; Hutchinson JR, 1998, J VERTEBR PALEONTOL, V18, P447, DOI 10.1080/02724634.1998.10011073; Karhu AA., 1996, PALEONTOL J, V30, P583; Longrich NR, 2009, CRETACEOUS RES, V30, P239, DOI 10.1016/j.cretres.2008.07.005; Makovicky Peter J., 2012, Fieldiana-Life and Earth Sciences, V5, P90; Marsh O. C., 1892, American Journal of Science, V(3), P449; Marsh O.C., 1881, AM J SCI 3, V23, P81, DOI DOI 10.2475/AJS.S3-23.133.81; Martinelli AG, 2007, ZOOTAXA, P1; Naish D, 2004, NEUES JAHRB GEOL P-M, P385; Nesbitt SJ, 2011, J VERTEBR PALEONTOL, V31, P144, DOI 10.1080/02724634.2011.540053; Nessov Lev A., 1998, Bulletin of Carnegie Museum of Natural History, V34, P40; Novas FE, 1997, J VERTEBR PALEONTOL, V17, P137, DOI 10.1080/02724634.1997.10010959; Novas Fernando E., 1996, Memoirs of the Queensland Museum, V39, P675; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Pittman M, 2015, PEERJ, V3, DOI 10.7717/peerj.986; Redman CM, 2009, PALAIOS, V24, P18, DOI 10.2110/palo.2007.p07-072r; Salgado L, 2009, ANDEAN GEOL, V36, P67, DOI 10.4067/S0718-71062009000100006; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Suzuki S, 2002, CONTRIBUTIONS SCI NA, V494, P1; Turner AH, 2009, AM MUS NOVIT, P1; Xu X, 2010, ZOOTAXA, P1; Xu X, 2013, ACTA PALAEONTOL POL, V58, P25, DOI 10.4202/app.2011.0083; Xu X, 2011, P NATL ACAD SCI USA, V108, P2338, DOI 10.1073/pnas.1011052108; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124	38	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0186254	10.1371/journal.pone.0186254	http://dx.doi.org/10.1371/journal.pone.0186254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7DC	29069094	Green Published, gold, Green Submitted			2022-12-26	WOS:000413663600017
J	Taverna, L; Tremolada, M; Bonichini, S; Tosetto, B; Basso, G; Messina, C; Pillon, M				Taverna, Livia; Tremolada, Marta; Bonichini, Sabrina; Tosetto, Barbara; Basso, Giuseppe; Messina, Chiara; Pillon, Marta			Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic stem cell transplantation therapy as an important risk factor	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HANDWRITING SKILLS; ADAPTIVE BEHAVIORS; CHILDHOOD-CANCER; ADULT SURVIVORS; YOUNG-CHILDREN; KINDERGARTEN; BALANCE; ADOLESCENTS; INTEGRATION	CNS-directed therapies for the treatment of leukemia can adversely affect the acquisition of new skills, such as reading/writing and math. Two years after the end of treatments, children show gross and fine motor skill delays that may persist even when patients are considered healed. The goal of the present study was to assess motor skills difficulties in pre-school children with leukemia one year after treatment. Particular attention has been paid to those patients who had undergone Hematopoietic Stem Cell Transplantation (HSCT) and to the relationship between motor delays and age bands. Participants were 60 children (median age of 5; inter quartile range: 3.07-5.76), including 31 females and 29 males, 91.7% of them were affected by acute lymphoblastic leukemia (ALL), and 8.3% by acute myeloid leukemia (AML). Five children had undergone HCST. Parents were interviewed by Vineland Adaptive Behavior Scales (VABS) on children's motor skills and filled in the Italian Temperament Questionnaire (QUIT). VABS's total scores were converted into equivalent mental age scores (EMA). A score difference of at least three months between current age and equivalent mental age was considered a developmental delay. Non-parametric analyses were run to understand if HSCT treatment and a specific age band influence children's motor skills. Significant delays were found in global motor skills (56.7%) as well as in fine and gross motor domains. Mann Whitney U tests showed that children with HSCT were reported to have lower gross motor mean ranks (U = 62; p = 0.004; Mean rank = 15.40) than peers without HSCT (Mean rank = 31.87) and lower mean rank values on motor temperament scale (U = 9; p = 0.003; HSCT Mean rank = 4.75 versus no HSCT Mean rank = 27.81). Kruskal Wallis' tests identified the high risk treatment showing that HSCT experience negatively impacted the motor skills and temperamental motor activity of pre-school children one year after the diagnosis of leukemia.	[Taverna, Livia] Free Univ Bolzano Bozen, Fac Educ, Brixen, Italy; [Tremolada, Marta; Bonichini, Sabrina] Univ Padua, Fac Psychol, Dept Dev Psychol & Socializat, Padua, Italy; [Tosetto, Barbara] Med Sch Hlth Profess Claudiana, Bolzano, Italy; [Basso, Giuseppe; Messina, Chiara; Pillon, Marta] Univ Hosp Padua, Hematol Oncol Div, Dept Child & Woman Hlth, Padua, Italy	Free University of Bozen-Bolzano; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova	Taverna, L (corresponding author), Free Univ Bolzano Bozen, Fac Educ, Brixen, Italy.	livia.taverna@unibz.it	Taverna, Livia/G-8124-2018; Tremolada, Marta/Q-3508-2018; Pillon, Marta/AAB-9581-2022	Taverna, Livia/0000-0003-3230-5725; Tremolada, Marta/0000-0003-0392-4332; Pillon, Marta/0000-0002-1190-3198; BASSO, GIUSEPPE/0000-0002-2634-9302	RTD position of Ph.D. Livia Taverna - Faculty of Education of the Free University of Bozen; Foundation "Citta della Speranza"	RTD position of Ph.D. Livia Taverna - Faculty of Education of the Free University of Bozen; Foundation "Citta della Speranza"	This study was supported by the RTD position of Ph.D. Livia Taverna, who received funding from the Faculty of Education of the Free University of Bozen.; The authors greatly appreciate support and facilities received by the Faculty of Education at the Free University of Bolzano-Bozen. A special acknowledgment to the Foundation "Citta della Speranza" that sponsored this research.	AIRTUM Associazione Italiana Registro Tumori, CANC SURV CHILDR AD; Armstrong GT, 2013, J CLIN ONCOL, V31, P3673, DOI 10.1200/JCO.2013.49.3205; Axia G., 2002, QUIT QUESTIONARI ITA; Balboni G, 2003, ADATTAMENTO ITALIANO, P1; Barrera M, 2008, J PEDIATR PSYCHOL, V33, P536, DOI 10.1093/jpepsy/jsm080; BERNINGER VW, 1992, J SCHOOL PSYCHOL, V30, P363, DOI 10.1016/0022-4405(92)90004-O; Bornstein MH, 2005, INFANT CHILD DEV, V14, P403, DOI 10.1002/icd.414; Buizer AI, 2005, J INT NEUROPSYCH SOC, V11, P554, DOI 10.1017/S135561770505666; Calvo V, 2002, ETA EVOLUTIVA, V72, P68; Daly CJ, 2003, AM J OCCUP THER, V57, P459, DOI 10.5014/ajot.57.4.459; De Luca CR, 2013, DEV NEUROREHABIL, V16, P180, DOI 10.3109/17518423.2013.771221; Esbenshade AJ, 2014, PEDIATR PHYS THER, V26, P301, DOI 10.1097/PEP.0000000000000053; Flegle JH, 2013, BEST PRACTICES OCCUP, P331; Galea V, 2004, GAIT POSTURE, V19, P1, DOI 10.1016/S0966-6362(03)00014-6; GALLAHUE D. L., 2013, COMPREENDENDO DESENV; Garralda ME, 2004, J CHILD PSYCHOL PSYC, V45, P543; Graham S, 1996, EDUC PSYCHOL REV, V8, P7, DOI 10.1007/BF01761831; Harper FWK, 2014, J PEDIATR PSYCHOL, V39, P459, DOI 10.1093/jpepsy/jst141; Hockenberry M, 2007, J PEDIAT HEMATOL ONC, V29, P535, DOI 10.1097/MPH.0b013e3180f61b92; Kramer JH, 1997, BONE MARROW TRANSPL, V19, P607, DOI 10.1038/sj.bmt.1700699; Marr D, 2003, AM J OCCUP THER, V57, P550, DOI 10.5014/ajot.57.5.550; Masten AS, 1998, AM PSYCHOL, V53, P205, DOI 10.1037/0003-066X.53.2.205; MCHALE K, 1992, AM J OCCUP THER, V46, P898, DOI 10.5014/ajot.46.10.898; Ness KK, 2015, BLOOD, V125, P3411, DOI 10.1182/blood-2015-01-621680; Pinquart M, 2012, J PEDIATR PSYCHOL, V37, P376, DOI 10.1093/jpepsy/jsr106; Reinders-Messelink H, 1999, MED PEDIATR ONCOL, V33, P545, DOI 10.1002/(SICI)1096-911X(199912)33:6<545::AID-MPO4>3.0.CO;2-Y; ReindersMesselink HA, 1996, MED PEDIATR ONCOL, V27, P551, DOI 10.1002/(SICI)1096-911X(199612)27:6<551::AID-MPO8>3.0.CO;2-K; Santangelo T, 2016, EDUC PSYCHOL REV, V28, P225, DOI 10.1007/s10648-015-9335-1; Scheede-Bergdahl C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00049; Shah AJ, 2008, J PEDIAT HEMATOL ONC, V30, P411, DOI 10.1097/MPH.0b013e318168e750; Simms S, 2002, J PEDIAT HEMATOL ONC, V24, P115, DOI 10.1097/00043426-200202000-00011; Sontgerath R, 2015, PEDIATR HEMAT ONCOL, V32, P585, DOI 10.3109/08880018.2015.1079756; Spanaki IE, 2012, COMPREHENSIVE PSYCHO, V3; Sparrow S. S., 2016, VINELAND ADAPTIVE BE, V3rd; Taverna L., 2016, BR J ED SOC BEHAV SC, V18, P1, DOI [10.9734/BJESBS/2016/3032227121178, DOI 10.9734/BJESBS/2016/3032227121178, 10.9734/BJESBS/2016/30322, DOI 10.9734/BJESBS/2016/30322]; Taverna L, 2011, J CROSS CULT PSYCHOL, V42, P445, DOI 10.1177/0022022110362748; Tremolada M, 2017, PSICOLOGIA CLIN SVIL; Tremolada M, 2011, PSICOL CLIN SVILUPP, V15, P625, DOI 10.1449/35890; Tremolada M, 2017, CANCERS, V9, DOI 10.3390/cancers9060055; TSENG MH, 1994, OCCUP THER J RES, V14, P19, DOI 10.1177/153944929401400102; Vago C, 2011, DISABIL REHABIL, V33, P953, DOI 10.3109/09638288.2010.520804; WEIL MJ, 1994, AM J OCCUP THER, V48, P982, DOI 10.5014/ajot.48.11.982; Wright MJ, 1998, MED PEDIATR ONCOL, V31, P86, DOI 10.1002/(SICI)1096-911X(199808)31:2<86::AID-MPO7>3.0.CO;2-V	43	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186787	10.1371/journal.pone.0186787	http://dx.doi.org/10.1371/journal.pone.0186787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK5VD	29065156	gold, Green Published, Green Submitted			2022-12-26	WOS:000413568900039
J	Sun, X; Chen, WJ; He, LL; Sheng, JX; Liu, YJ; Vu, GP; Yang, Z; Li, W; Trang, P; Wang, Y; Hai, R; Zhu, H; Lu, SW; Liu, FY				Sun, Xu; Chen, Weijie; He, Lingling; Sheng, Jingxue; Liu, Yujun; Gia-Phong Vu; Yang, Zhu; Li, Wei; Phong Trang; Wang, Yu; Hai, Rong; Zhu, Hua; Lu, Sangwei; Liu, Fenyong			Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant	PLOS ONE			English	Article							BACTERIAL RIBONUCLEASE-P; EXTERNAL GUIDE SEQUENCES; MESSENGER-RNA; ESCHERICHIA-COLI; CATALYTIC RNA; HUMAN-CELLS; SUBSTRATE-BINDING; IN-VITRO; REPLICATION; SUBUNIT	We have previously engineered new RNase P-based ribozyme variants with improved in vitro catalytic activity. In this study, we employed a novel engineered variant to target a shared mRNA region of human cytomegalovirus (HCMV) immediate early proteins 1 (IE1) and 2 (IE2), which are essential for the expression of viral early and late genes as well as viral growth. Ribozyme F-R228-IE represents a novel variant that possesses three unique base substitution point mutations at the catalytic domain of RNase P catalytic RNA. Compared to F-M1-IE that is the ribozyme derived from the wild type RNase P catalytic RNA sequence, the functional variant F-R228-IE cleaved the target mRNA sequence in vitro at least 100 times more efficiently. In cultured cells, expression of F-R228-IE resulted in IE1/IE2 expression reduction by 98-99% and in HCMV production reduction by 50,000 folds. In contrast, expression of F-M1-IE resulted in IE1/IE2 expression reduction by less than 80% and in viral production reduction by 200 folds. Studies of the ribozyme-mediated antiviral effects in cultured cells suggest that overall viral early and late gene expression and viral growth were inhibited due to the ribozyme-mediated reduction of HCMV IE1 and IE2 expression. Our results provide direct evidence that engineered RNase P ribozymes, such as F-R228-IE, can serve as a novel class of inhibitors for the treatment and prevention of HCMV infection. Moreover, these results suggest that F-R228-IE, with novel and unique mutations at the catalytic domain to enhance ribozyme activity, can be a candidate for the construction of effective agents for anti-HCMV therapy.	[Sun, Xu; Chen, Weijie; He, Lingling; Liu, Yujun; Li, Wei; Phong Trang; Wang, Yu; Hai, Rong; Zhu, Hua; Liu, Fenyong] Jinan Univ, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Sheng, Jingxue; Gia-Phong Vu; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Liu, Yujun] St Georges Univ, Sch Med, True Blue, Grenada; [Liu, Yujun] Shandong Univ Tradit Chinese Med, Sch Pharm, Jinan, Shandong, Peoples R China; [Yang, Zhu; Wang, Yu] Guangzhou Qinheli Biotechnol Inc, Guangzhou, Guangdong, Peoples R China; [Yang, Zhu; Wang, Yu] Jiangsu Affynigen Biotechnol Inc, Taizhou, Jiangsu, Peoples R China; [Yang, Zhu] Taizhou Inst Virol, Taizhou, Jiangsu, Peoples R China	Jinan University; University of California System; University of California Berkeley; Shandong University of Traditional Chinese Medicine	Liu, FY (corresponding author), Jinan Univ, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China.; Lu, SW; Liu, FY (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	sangwei@berkeley.edu; liu_fy@berkeley.edu	Vu, Gia-Phong/HCH-7906-2022		Guangdong Innovative and Entepreneurial Research Team Program [2014ZT05S136]; National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; National Mega Project on Major Infectious Disease Prevention [2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development [2009ZX09103-678, 2012ZX09102301-004, 2012ZX09103301-20, 2013ZX09102-031, 2014ZX09509001-001]; Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province [XTCX2014B01-09]; National Small Business Innovation and Research (SBIR) Program of China; Technology R & D Program of Jiangsu Province, China [BG2007035, BG2008662]; State Key Laboratory of Virology of China [2013001, 2013005, 2015KF011]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE023935, RO1-DE025462]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025462, R01DE023935] Funding Source: NIH RePORTER	Guangdong Innovative and Entepreneurial Research Team Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention; National Mega Project on Major Drug Development; Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province; National Small Business Innovation and Research (SBIR) Program of China; Technology R & D Program of Jiangsu Province, China; State Key Laboratory of Virology of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from Guangdong Innovative and Entepreneurial Research Team Program (No. 2014ZT05S136), National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146), the National Mega Project on Major Infectious Disease Prevention (2012ZX10002006-003 and 2012ZX10004-207), National Mega Project on Major Drug Development (2009ZX09103-678, 2012ZX09102301-004, 2012ZX09103301-20, 2013ZX09102-031, 2014ZX09509001-001), Antiviral Cooperative Innovation Center of Traditional Chinese Medicine at Shandong Province (XTCX2014B01-09), National Small Business Innovation and Research (SBIR) Program of China, the Technology R & D Program of Jiangsu Province, China (BG2007035 and BG2008662), Open Research Fund Program of the State Key Laboratory of Virology of China (2013001, 2013005, and 2015KF011), and NIH (RO1-AI041927, RO1-AI091536, RO1-DE023935, and RO1-DE025462). Z.Y and Y.W, are employed by commercial companies, Jiangsu Affynigen Biotechnologies, Inc., and Guangzhou Qinheli Biotechnologies, Inc. The funders provided support in the form of salaries for authors [Z.Y., Y.W.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Bai Y, 2008, P NATL ACAD SCI USA, V105, P10919, DOI 10.1073/pnas.0804922105; Bai Y, 2010, P NATL ACAD SCI USA, V107, P7269, DOI 10.1073/pnas.0912813107; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; GOPALAN V, 2006, RNA WORLD; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kilani AF, 2000, J BIOL CHEM, V275, P10611, DOI 10.1074/jbc.275.14.10611; Kim JJ, 1997, RNA, V3, P613; Kim K, 2007, BBA-GENE STRUCT EXPR, V1769, P603, DOI 10.1016/j.bbaexp.2007.09.001; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Mocarski E.S., 2007, FIELDS VIROL, P2701; Mondragon A, 2013, ANNU REV BIOPHYS, V42, P537, DOI 10.1146/annurev-biophys-083012-130406; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pei YG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002968; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Roizman B, 2001, FIELDS VIROL, P2381; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; STENBERG RM, 1985, J VIROL, V56, P665, DOI 10.1128/JVI.56.3.665-675.1985; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Trang P, 2003, J MOL BIOL, V328, P1123, DOI 10.1016/S0022-2836(03)00398-X; Trang P, 2002, J MOL BIOL, V315, P573, DOI 10.1006/jmbi.2001.5291; Trang P, 2001, NUCLEIC ACIDS RES, V29, P5071, DOI 10.1093/nar/29.24.5071; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Trang P, 2000, J MOL BIOL, V301, P817, DOI 10.1006/jmbi.2000.4022; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Z, 2014, VIRUSES-BASEL, V6, P2376, DOI 10.3390/v6062376; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; ZAUG AJ, 1995, RNA, V1, P363; Zeng WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051855; Zou H, 2003, J BIOL CHEM, V278, P37265, DOI 10.1074/jbc.M303531200	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186791	10.1371/journal.pone.0186791	http://dx.doi.org/10.1371/journal.pone.0186791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059242	Green Published, gold, Green Submitted			2022-12-26	WOS:000413403000043
J	Semizer-Cuming, D; Kjaer, ED; Finkeldey, R				Semizer-Cuming, Devrim; Kjaer, Erik Dahl; Finkeldey, Reiner			Gene flow of common ash (Fraxinus excelsior L.) in a fragmented landscape	PLOS ONE			English	Article							DISTANCE SEED DISPERSAL; POLLEN DISPERSAL; EXACT IDENTIFICATION; COMPUTER-PROGRAM; CHALARA-FRAXINEA; SMALL POPULATION; MATING PATTERNS; NULL ALLELES; SSR MARKERS; PLANT	Gene flow dynamics of common ash (Fraxinus excelsior L.) is affected by several human activities in Central Europe, including habitat fragmentation, agroforestry expansion, controlled and uncontrolled transfer of reproductive material, and a recently introduced emerging infectious disease, ash dieback, caused by Hymenoscyphus fraxineus. Habitat fragmentation may alter genetic connectivity and effective population size, leading to loss of genetic diversity and increased inbreeding in ash populations. Gene flow from cultivated trees in landscapes close to their native counterparts may also influence the adaptability of future generations. The devastating effects of ash dieback have already been observed in both natural and managed populations in continental Europe. However, potential long-term effects of genetic bottlenecks depend on gene flow across fragmented landscapes. For this reason, we studied the genetic connectivity of ash trees in an isolated forest patch of a fragmented landscape in Rosenbeck, Germany. We applied two approaches to parentage analysis to estimate gene flow patterns at the study site. We specifically investigated the presence of background pollination at the landscape level and the degree of genetic isolation between native and cultivated trees. Local meteorological data was utilized to understand the effect of wind on the pollen and seed dispersal patterns. Gender information of the adult trees was considered for calculating the dispersal distances. We found that the majority of the studied seeds (55-64%) and seedlings (75-98%) in the forest patch were fathered and mothered by the trees within the same patch. However, we determined a considerable amount of pollen flow (260-45%) from outside of the study site, representing background pollination at the landscape level. Limited pollen flow was observed from neighbouring cultivated trees (2%). Both pollen and seeds were dispersed in all directions in accordance with the local wind directions. Whereas there was no positive correlation between pollen dispersal distance and wind speed, the correlation between seed dispersal distance and wind speed was significant (0.71, p < 0.001), indicating that strong wind favours long-distance dispersal of ash seeds. Finally, we discussed the implications of establishing gene conservation stands and the use of enrichment planting in the face of ash dieback.	[Semizer-Cuming, Devrim; Finkeldey, Reiner] Univ Gottingen, Fac Forest Sci & Forest Ecol, Dept Forest Genet & Forest Tree Breeding, Gottingen, Germany; [Semizer-Cuming, Devrim; Kjaer, Erik Dahl] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Finkeldey, Reiner] Univ Kassel, Kassel, Germany	University of Gottingen; University of Copenhagen; Universitat Kassel	Semizer-Cuming, D (corresponding author), Univ Gottingen, Fac Forest Sci & Forest Ecol, Dept Forest Genet & Forest Tree Breeding, Gottingen, Germany.; Semizer-Cuming, D (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark.	dsemize@forst.uni-goettingen.de	Kjaer, Erik D/D-6534-2017; Finkeldey, Reiner/ABD-4392-2021	Kjaer, Erik D/0000-0001-8624-1611; Finkeldey, Reiner/0000-0003-3500-5656	European Commission; German Research Foundation; University of Gottingen	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation(German Research Foundation (DFG)); University of Gottingen	This study is funded by the European Commission under the Forest and Nature for Society (FONASO) Erasmus Mundus Joint Doctorate Program (fonaso.eu). We acknowledge the support by the German Research Foundation and the Open Access Publication Funds of the University of Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W. T., 1992, New Forests, V6, P217, DOI 10.1007/BF00120646; ADAMS WT, 1991, BIOCHEMICAL MARKERS IN THE POPULATION GENETICS OF FOREST TREES, P157; Aggarwal RK, MOLECULAR ECOLOGY RE, V11, P219; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; [Anonymous], 2007, INTERPRETATION MANUA; Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Bai XG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020714; Bakys R, 2011, SCAND J FOREST RES, V26, P128, DOI 10.1080/02827581.2010.536569; Bakys R, 2009, EUR J FOREST RES, V128, P51, DOI 10.1007/s10342-008-0238-2; Baral HO, 2014, IMA FUNGUS, V5, P79, DOI 10.5598/imafungus.2014.05.01.09; Beatty GE, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0919-1; Binggeli P, 1991, MISCELLANEOUS NOTES, P1; Bochenek GM, 2011, INT J PLANT SCI, V172, P60, DOI 10.1086/657298; Budde KB, 2016, CURR FOR REP, V2, P18, DOI 10.1007/s40725-016-0029-9; Burczyk J, 2006, GENETICS, V173, P363, DOI 10.1534/genetics.105.046805; Burczyk J., 2004, Forest Genetics, V11, P179; Burczyk J, 2004, EVOLUTION, V58, P956, DOI 10.1111/j.0014-3820.2004.tb00430.x; Burczyk J, 2002, MOL ECOL, V11, P2379, DOI 10.1046/j.1365-294X.2002.01603.x; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Chybicki IJ, 2010, MOL ECOL RESOUR, V10, P1071, DOI 10.1111/j.1755-0998.2010.02849.x; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; CURTIS JD, 1995, INT J PLANT SCI, V156, P29, DOI 10.1086/297225; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DAMATO G, 1988, CLIN ALLERGY, V18, P541, DOI 10.1111/j.1365-2222.1988.tb02905.x; DiFazio SP, 2012, NEW PHYTOL, V193, P903, DOI 10.1111/j.1469-8137.2011.04012.x; DIGIOVANNI F, 1991, CAN J FOREST RES, V21, P1155, DOI 10.1139/x91-163; Dobrowolska D, 2011, FORESTRY, V84, P133, DOI 10.1093/forestry/cpr001; Douglas G., 2013, FOREST TREE BREEDING, P403, DOI [10.1007/978-94-007-6146-9_9, DOI 10.1007/978-94-007-6146-9_9]; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Ellstrand NC, 2016, EVOL APPL, V9, P833, DOI 10.1111/eva.12402; Enderle R., 2017, Dieback of European Ash (Fraxinus spp.) - consequences and guidelines for sustainable management, P89; Enderle R, 2015, ANN FOREST SCI, V72, P183, DOI 10.1007/s13595-014-0413-1; Ferrazzini D, 2007, ANN FOREST SCI, V64, P159, DOI 10.1051/forest:2006100; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; FRAXIGEN, 2005, ASH SPECIES IN EUROP, P128; Garcia C, 2007, MOL ECOL, V16, P1947, DOI 10.1111/j.1365-294X.2006.03126.x; Gerard PR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-96; Godoy JA, 2001, MOL ECOL, V10, P2275, DOI 10.1046/j.0962-1083.2001.01342.x; Goto S, 2006, MOL ECOL, V15, P2985, DOI 10.1111/j.1365-294X.2006.02976.x; Graudal L, 2014, FOREST ECOL MANAG, V333, P35, DOI 10.1016/j.foreco.2014.05.002; Greene DF, 2005, ECOLOGY, V86, P3105, DOI 10.1890/04-1430; Harper AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19335; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Heydel F, 2015, J VEG SCI, V26, P1090, DOI 10.1111/jvs.12305; Heydel F, 2014, ECOL RES, V29, P641, DOI 10.1007/s11284-014-1142-5; Hintze C, 2013, PERSPECT PLANT ECOL, V15, P180, DOI 10.1016/j.ppees.2013.02.001; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Ingvarsson PK, 2001, TRENDS ECOL EVOL, V16, P62, DOI 10.1016/S0169-5347(00)02065-6; Iwaizumi MG, 2009, J HERED; Jackson ST, 1999, BOT REV, V65, P39, DOI 10.1007/BF02856557; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kjaer ED, 2012, EVOL APPL, V5, P219, DOI 10.1111/j.1752-4571.2011.00222.x; Klein EK, 2003, ECOL MONOGR, V73, P131, DOI 10.1890/0012-9615(2003)073[0131:CPDQMM]2.0.CO;2; Kowalski T, 2006, FOREST PATHOL, V36, P264, DOI 10.1111/j.1439-0329.2006.00453.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Krauss SL, 2009, HEREDITY, V102, P274, DOI 10.1038/hdy.2008.118; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Lefort F, 1999, MOL ECOL, V8, P1088, DOI 10.1046/j.1365-294X.1999.00655_8.x; Li H, 2007, FOREST ECOL MANAG, P242; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McKinney LV, 2014, PLANT PATHOL, P63; Morand ME, 2002, MOL ECOL, V11, P377, DOI 10.1046/j.1365-294X.2002.01461.x; Nathan R, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P187; Noakes AG, 2014, CONSERV GENET RESOUR, V6, P969, DOI 10.1007/s12686-014-0260-2; Orlova-Bienkowskaja MJ, 2014, BIOL INVASIONS, V16, P1345, DOI 10.1007/s10530-013-0579-8; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Payn T, 2015, FOREST ECOL MANAG, V352, P57, DOI 10.1016/j.foreco.2015.06.021; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peeters A. G., 1998, AEROBIOLOGIA, V14, P375; Percival Glynn C., 2006, Urban Forestry & Urban Greening, V5, P17, DOI 10.1016/j.ufug.2006.03.002; Pliura A, 2011, BALT FOR, V17, P17; Przybyl K, 2002, FOREST PATHOL, V32, P387, DOI 10.1046/j.1439-0329.2002.00301.x; QGIS Development Team, 2016, QGIS GEOGRAPHIC INFO; Queloz V, 2011, FOREST PATHOL, V41, P133, DOI 10.1111/j.1439-0329.2010.00645.x; Richards CM, 2000, AM NAT, V155, P383, DOI 10.1086/303324; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; Robledo-Arnuncio JJ, 2007, MOL ECOL, V16, P5098, DOI 10.1111/j.1365-294X.2007.03427.x; Sakai WS, 2000, ACTA HORTIC, P215, DOI 10.1079/9780851995045.0215; Schippers P, 2005, ECOL MODEL, V185, P93, DOI 10.1016/j.ecolmodel.2004.11.018; Schumacher J., 2011, Bulletin OEPP, V41, P7, DOI 10.1111/j.1365-2338.2010.02427.x; Schutt P, 1995, ENZYKLOPADIE HOLZGEW, P49; Slavov GT, 2005, MOL ECOL, V14, P3109, DOI 10.1111/j.1365-294X.2005.02620.x; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Steinitz O, 2012, MOL ECOL, V21, P300, DOI 10.1111/j.1365-294X.2011.05394.x; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Tapper PG., 1992, J VEGETATION SCI, V3; Thomasset M, 2014, HEREDITY, V112, P596, DOI 10.1038/hdy.2013.141; Tollefsrud MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167104; Trakhtenbrot A, 2014, ECOL MODEL, V274, P29, DOI 10.1016/j.ecolmodel.2013.11.029; Valenta V, 2016, J APPL ENTOMOLOGY; Van Oosterhout C, 2004, MOL ECOLOGY NOTES, V4; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wallander E., 2012, BELGISCHE DENDROLOGI, V2012, P39; Wallander E., 2001, THESIS GOTEBORG U SW; Wallander E, 2008, PLANT SYST EVOL, V273, P25, DOI 10.1007/s00606-008-0005-3; WARDLE P, 1961, J ECOL, V49, P739, DOI 10.2307/2257236; WAWRZYNSKI R P, 1989, Journal of Arboriculture, V15, P215; White GM, 2002, P NATL ACAD SCI USA, V99, P2038, DOI 10.1073/pnas.042649999; Whitehead D.R., 1983, POLLINATION BIOL, V97; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	113	14	14	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186757	10.1371/journal.pone.0186757	http://dx.doi.org/10.1371/journal.pone.0186757			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053740	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100037
J	Namestnikova, D; Gubskiy, I; Kholodenko, I; Melnikov, P; Sukhinich, K; Gabashvili, A; Vishnevskiy, D; Soloveva, A; Abakumov, M; Vakhrushev, I; Lupatov, A; Chekhonin, V; Gubsky, L; Yarygin, K				Namestnikova, Daria; Gubskiy, Ilya; Kholodenko, Irina; Melnikov, Pavel; Sukhinich, Kirill; Gabashvili, Anna; Vishnevskiy, Daniil; Soloveva, Anastasia; Abakumov, Maxim; Vakhrushev, Igor; Lupatov, Alexei; Chekhonin, Vladimir; Gubsky, Leonid; Yarygin, Konstantin			Methodological aspects of MRI of transplanted superparamagnetic iron oxide-labeled mesenchymal stem cells in live rat brain	PLOS ONE			English	Article							IN-VIVO TRACKING; MAGNETIC-RESONANCE; CONTRAST AGENTS; SINGLE CELLS; PARTICLES; NANOPARTICLES; VITRO; DIFFERENTIATION; ENGRAFTMENT; PROGENITOR	In vivo tracking of transplanted mesenchymal stem cells (MSCs) migration and homing is vital for understanding the mechanisms of beneficial effects of MSCs transplantation in animal models of diseases and in clinical trials. Transplanted cells can be labeled with superparamagnetic iron oxide (SPIO) particles and visualized in vivo using a number of iron sensitive MRI techniques. However, the applicability of those techniques for SPIO-labeled MSCs tracking in live brain has not been sufficiently investigated. The goal of this study was to estimate the efficiency of various MRI techniques of SPIO-labeled cell tracing in the brain. To achieve that goal, the precision and specificity of T2WI, T2*WI and SWI (Susceptibility-Weighted Imaging) techniques of SPIO-labeled MSCs tracing in vitro and in live rat brain were for the first time compared in the same experiment. We have shown that SWI presents the most sensitive pulse sequence for SPIO-labeled MSCs MR visualization. After intracerebral administration due to limitations caused by local micro-hemorrhages the visualization threshold was 10(2) cells, while after intra-arterial transplantation SWI permitted detection of several cells or even single cells. There is just one publication claiming detection of individual SPIO-labeled MSCs in live brain, while the other state much lower sensitivity, describe detection of different cell types or high resolution tracing of MSCs in other tissues. This study confirms the possibility of single cell tracing in live brain and outlines the necessary conditions. SWI is a method convenient for the detection of single SPIO labeled MSCs and small groups of SPIO labeled MSCs in brain tissue and can be appropriate for monitoring migration and homing of transplanted cells in basic and translational neuroscience.	[Namestnikova, Daria; Gubskiy, Ilya; Melnikov, Pavel; Vishnevskiy, Daniil; Soloveva, Anastasia; Abakumov, Maxim; Chekhonin, Vladimir; Gubsky, Leonid] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Kholodenko, Irina; Gabashvili, Anna; Vakhrushev, Igor; Lupatov, Alexei; Yarygin, Konstantin] Inst Biomed Chem, Moscow, Russia; [Melnikov, Pavel; Chekhonin, Vladimir] Serbsky Fed Med Res Ctr Psychiat & Narcol, Moscow, Russia; [Sukhinich, Kirill] Koltzov Inst Dev Biol, Moscow, Russia; [Abakumov, Maxim] Natl Univ Sci & Technol, Moscow, Russia	Pirogov Russian National Research Medical University; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; National University of Science & Technology (MISIS)	Namestnikova, D (corresponding author), Pirogov Russian Natl Res Med Univ, Moscow, Russia.	dadnam89@gmail.com	Sukhinich, Kirill/U-9587-2019; Namestnikova, Daria/AAO-2518-2020; Kholodenko, Irina V/F-7313-2017; Vakhrushev, Igor/C-6044-2012; Melnikov, Pavel/AAD-9766-2019; Lupatov, Alexey/ABF-7776-2020; Chekhonin, Vladimir VP/T-4511-2018; Gabashvili, Anna/F-1638-2017; Gubskiy, Ilya/V-4376-2017; Vishnevskiy, Daniil/AAG-7909-2020; Yarygin, Konstantin N/C-4047-2009; Abakumov, Maxim A/O-5728-2017	Sukhinich, Kirill/0000-0001-6030-4346; Namestnikova, Daria/0000-0001-6635-511X; Kholodenko, Irina V/0000-0002-4079-5210; Melnikov, Pavel/0000-0002-2544-878X; Gabashvili, Anna/0000-0002-4251-3002; Gubskiy, Ilya/0000-0003-1726-6801; Vishnevskiy, Daniil/0000-0002-5778-215X; Yarygin, Konstantin N/0000-0002-2261-851X; Abakumov, Maxim A/0000-0003-2622-9201; Chekhonin, Vladimir P./0000-0003-4386-7897	Program for Basic Research of the State Academies of Sciences [0518-2014-0005]; Ministry of Education and Science of the Russian Federation [14.621.21.0017, RFMEFI62117X0017]; Russian Foundation for Basic Research [16-29-07116]	Program for Basic Research of the State Academies of Sciences; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Part of the work (labeling of hMSCs, immunocytochemistry, fluorescent, confocal and bright-field microscopy) was carried out within the framework of the Program for Basic Research of the State Academies of Sciences for 2013-2020, theme no. 0518-2014-0005; URL: www.fano.gov.ru. Isolation and characterization of hMSCs were supported with grant of Ministry of Education and Science of the Russian Federation agreement 14.621.21.0017, unique project ID RFMEFI62117X0017. MRI experiments were supported by grant no. 16-29-07116 from the Russian Foundation for Basic Research; URL: vvww.rfbr.ru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2016, STEM CELLS; Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064; Argibay B, 2016, CELL TRANSPLANT, V25, P1787, DOI 10.3727/096368916X691303; Boulland JL, 2012, CELL TRANSPLANT, V21, P1743, DOI 10.3727/096368911X627598; Bulte JWM, 2015, TOMOGRAPHY, V1, P91, DOI 10.18383/j.tom.2015.00172; BULTE JWM, 1993, MAGNET RESON MED, V29, P32, DOI 10.1002/mrm.1910290108; Burunova VV, 2010, B EXP BIOL MED+, V149, P497, DOI 10.1007/s10517-010-0978-0; Byun JS, 2013, J KOREAN NEUROSURG S, V54, P467, DOI 10.3340/jkns.2013.54.6.467; Cheglakov IB, 2008, B EXP BIOL MED+, V145, P504, DOI 10.1007/s10517-008-0129-z; Cheng JL, 2010, CHIN J TRAUMATOL, V13, P173, DOI 10.3760/cma.j.issn.1008-1275.2010.03.008; Cianciaruso C, 2014, NANOMEDICINE-UK, V9, P1457, DOI [10.2217/nnm.14.84, 10.2217/NNM.14.84]; Cohen ME, 2010, J NEUROSCI RES, V88, P936, DOI 10.1002/jnr.22277; Czarzasta J, 2017, INT J DEV NEUROSCI, V57, P46, DOI 10.1016/j.ijdevneu.2017.01.003; de Schellenberger AA, 2016, INT J NANOMED, V11, P1517, DOI 10.2147/IJN.S101141; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Delcroix GJR, 2009, BRAIN RES, V1255, P18, DOI 10.1016/j.brainres.2008.12.013; Dodd SJ, 1999, BIOPHYS J, V76, P103, DOI 10.1016/S0006-3495(99)77182-1; Dulamea AO, 2015, J NEUROL SCI, V352, P1, DOI 10.1016/j.jns.2015.03.014; Ha BC, 2015, ACTA RADIOL, V56, P219, DOI 10.1177/0284185114525605; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Heyn C, 2006, MAGNET RESON MED, V55, P23, DOI 10.1002/mrm.20747; Hinds KA, 2003, BLOOD, V102, P867, DOI 10.1182/blood-2002-12-3669; Hu SL, 2012, J CELL BIOCHEM, V113, P1005, DOI 10.1002/jcb.23432; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Kallur T, 2011, EUR J NEUROSCI, V34, P382, DOI 10.1111/j.1460-9568.2011.07759.x; Konieva AA, 2010, B EXP BIOL MED+, V150, P131, DOI 10.1007/s10517-010-1087-9; Liu L., 2013, SCI WORLD J, V2013, P1, DOI DOI 10.1155/2013/435093; Lobsien D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062644; MA N, 2015, SCI REP UK, V5; Magnitsky S, 2005, NEUROIMAGE, V26, P744, DOI 10.1016/j.neuroimage.2005.02.029; Meamar Rokhsareh, 2016, Adv Biomed Res, V5, P46, DOI 10.4103/2277-9175.178791; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Mori Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06997; Namestnikova D, 2017, J PHYS CONF SER, V886, DOI 10.1088/1742-6596/886/1/012012; Neuwelt A, 2015, AM J ROENTGENOL, V204, pW302, DOI 10.2214/AJR.14.12733; Park S, 2015, IRAN J RADIOL, V12, DOI 10.5812/iranjradiol.20782; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Richards JMJ, 2012, CIRC-CARDIOVASC IMAG, V5, P509, DOI 10.1161/CIRCIMAGING.112.972596; Rodriguez-Ruano A, 2009, PROC 17TH SCI MEET I, P4457; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shapiro EM, 2007, CONTRAST MEDIA MOL I, V2, P147, DOI 10.1002/cmmi.134; Shim J, 2015, KOREAN J RADIOL, V16, P575, DOI 10.3348/kjr.2015.16.3.575; Stroh A, 2005, NEUROIMAGE, V24, P635, DOI 10.1016/j.neuroimage.2004.09.014; Taylor A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100259; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Toyoshima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127302; Umashankar A, 2016, INT J NANOMED, V11, P1731, DOI 10.2147/IJN.S102006; von der Haar K, 2015, APPL MICROBIOL BIOT, V99, P9907, DOI 10.1007/s00253-015-6965-7; Wang YQ, 2013, THERANOSTICS, V3, P544, DOI 10.7150/thno.5634; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; Yin Y, 2015, NEURAL REGEN RES, V10, P909, DOI 10.4103/1673-5374.158355; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304; Zhu WZ, 2007, J HUAZHONG U SCI-MED, V27, P107, DOI 10.1007/s11596-007-0130-1	57	13	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186717	10.1371/journal.pone.0186717	http://dx.doi.org/10.1371/journal.pone.0186717			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049361	Green Submitted, Green Published, gold			2022-12-26	WOS:000413195900103
J	Sun, KS; Tsai, CF; Chen, SCC; Huang, WC				Sun, Kuo-Shao; Tsai, Ching-Fang; Chen, Solomon Chih-Cheng; Huang, Wan-Chun			Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan	PLOS ONE			English	Article							MOLD INFECTIONS; GALACTOMANNAN INDEX; FUNGAL-INFECTIONS; REGISTRY; DISEASE; EPIDEMIOLOGY; MORTALITY; THERAPY	Background Invasive pulmonary aspergillosis (IPA) has high mortality rate but prognostic factors are not well established. The aim of our study was to evaluate the trend in in-hospital mortality over a period of 11 years and identify factors affecting the clinical outcomes of patients with IPA. Method We conducted a nationwide inpatient population study using data from the Taiwan National Health Insurance Research Database. A total of 407 IPA patients from 2002 to 2012 were included in the study. Differences in demographics, comorbidities, and treatment were evaluated between in-hospital death group and survival group. Multivariate analysis was also performed to identify risk factors for mortality. Result Male patients represented 63.14% of the patients (n = 257) and the mean age was 53.15 +/- 20.93 years. Hematological cancer (n = 216, 53.07%) and diabetes mellitus (n = 75, 18.43%) were the most common underlying conditions. The overall case fatality rate was 30.22% with female slightly higher then male (32.67% versus 28.79%). The in-hospital case fatality rate increased since 2002 and peaked in 2006. It then declined over time with an inhospital mortality of 25% in 2012. The in-hospital death group had a higher intubation rate (p<0.0001), a longer ICU stay (p = 0.0062), higher percentages of DM (p = 0.0412) and COPD (p = 0.0178), and a lower percentage of hematological cancer (p = 0.0079) as compared to survivor. The in-hospital death group was more likely to have steroid treatment (p<0.0001), develop acute renal failure (p<0.0001) and other infectious diseases (p = 0.0008) during hospitalization. Multivariate analysis identified female gender, older age (>= 65 years old), intubation, bone marrow transplantation, acute renal failure, other infectious diseases and steroid use as predictive factors for mortality. Conclusion The present study shows the trend in mortality among patients with IPA over an 11-year period. Female gender, older age, intubation, bone marrow transplantation, acute renal failure, other infectious diseases and steroid use were identified as risk factors for mortality.	[Sun, Kuo-Shao; Huang, Wan-Chun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Sun, Kuo-Shao] Chung Jen Jr Coll Nursing Hlth Sci & Management, Chiayi, Taiwan; [Tsai, Ching-Fang; Chen, Solomon Chih-Cheng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Taipei, Taiwan; [Chen, Solomon Chih-Cheng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Pediat, Chiayi, Taiwan	Taipei Medical University	Huang, WC (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Div Pulm & Crit Care Med, Chiayi, Taiwan.	erick720730@gmail.com	Huang, Wan-Chun/L-8846-2019	Huang, Wan-Chun/0000-0002-3781-103X; sun, ken/0000-0002-9091-1179				Lerma FA, 2015, MED INTENSIVA, V39, P149, DOI 10.1016/j.medin.2014.02.004; Baddley JW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-29; Bassetti M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0458-4; Bitar D, 2014, EMERG INFECT DIS, V20, P1149, DOI 10.3201/eid2007.140087; Burghi G, 2011, INTENS CARE MED, V37, P1605, DOI 10.1007/s00134-011-2344-8; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Gallien S, 2008, INFECTION, V36, P533, DOI 10.1007/s15010-008-7375-x; Han SB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1014-9; Hsiue HC, 2012, EUR J CLIN MICROBIOL, V31, P1319, DOI 10.1007/s10096-011-1445-1; Husain S, 2017, MED MYCOL, V55, P269, DOI 10.1093/mmy/myw086; Iqbal N, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000155; Kim A, 2011, MYCOSES, V54, pE301, DOI 10.1111/j.1439-0507.2010.01903.x; Maertens J, 2005, CLIN INFECT DIS, V41, P1242, DOI 10.1086/496927; Miceli MH, 2008, CLIN INFECT DIS, V46, P1412, DOI 10.1086/528714; Montagna MT, 2014, INFECTION, V42, P141, DOI 10.1007/s15010-013-0539-3; Nivoix Yasmine, 2008, Infection Control and Hospital Epidemiology, V29, P1176, DOI 10.1086/592255; Perkhofer S, 2010, INT J ANTIMICROB AG, V36, P531, DOI 10.1016/j.ijantimicag.2010.08.010; Porpon R, 2017, MED MYCOLOGY; Steinbach WJ, 2012, J INFECTION, V65, P453, DOI 10.1016/j.jinf.2012.08.003; Sun KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156566; TACCONE FS, 2015, CRIT CARE, V19; Tan BH, 2011, INT J INFECT DIS, V15, pE350, DOI 10.1016/j.ijid.2011.01.011; Thammahong A, 2015, ADV MICROBIOL, V5, P298, DOI DOI 10.4236/AIM.2015.55029; Ullmann AJ, 2007, NEW ENGL J MED, V356, P335, DOI 10.1056/NEJMoa061098; Vandewoude KH, 2004, J HOSP INFECT, V56, P269, DOI 10.1016/j.jhin.2004.01.006	25	26	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186422	10.1371/journal.pone.0186422	http://dx.doi.org/10.1371/journal.pone.0186422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049319	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900066
J	Thirunavukkarasan, M; Wang, C; Rao, A; Hind, T; Teo, YR; Siddiquee, AAM; Goghari, MAI; Kumar, AP; Herr, DR				Thirunavukkarasan, Madhumathi; Wang, Chao; Rao, Angad; Hind, Tatsuma; Teo, Yuan Ru; Siddiquee, Abrar Al-Mahmood; Goghari, Mohamed Ally Ibrahim; Kumar, Alan Prem; Herr, Deron R.			Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; METASTASIS; MECHANISMS; GPR43; IDENTIFICATION; PROLIFERATION; PROPIONATE; ACTIVATION	Short chain fatty acids (2 to 6 carbons in length) are ubiquitous lipids that are present in human plasma at micromolar concentrations. In addition to serving as metabolic precursors for lipid and carbohydrate synthesis, they also act as cognate ligands for two known G protein-coupled receptors (GPCRs), FFAR2 and FFAR3. While there is evidence that these receptors may inhibit the progression of colorectal cancer, their roles in breast cancer cells are largely unknown. We evaluated the effects of enforced overexpression of these receptors in two phenotypically distinct breast cancer cell lines: MCF7 and MDA-MD-231. Our results demonstrate that both receptors inhibit cell invasiveness, but through different signaling processes. In invasive, mesenchymal-like MDA-MB-231 cells, FFAR2 inhibits the Hippo-Yap pathway and increases expression of adhesion protein E-cadherin, while FFAR3 inhibits MAPK signaling. Both receptors have the net effect of reducing actin polymerization and invasion of cells through a Matrigel matrix. These effects were absent in the less invasive, epithelial-like MCF7 cells. Correspondingly, there is reduced expression of both receptors in invasive breast carcinoma and in aggressive triple-negative breast tumors, relative to normal breast tissue. Cumulatively, our data suggest that the activation of cognate receptors by short chain fatty acids drives breast cancer cells toward a non-invasive phenotype and therefore may inhibit metastasis.	[Thirunavukkarasan, Madhumathi; Wang, Chao; Rao, Angad; Hind, Tatsuma; Teo, Yuan Ru; Siddiquee, Abrar Al-Mahmood; Goghari, Mohamed Ally Ibrahim; Kumar, Alan Prem; Herr, Deron R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore; [Wang, Chao; Kumar, Alan Prem] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Hind, Tatsuma] Univ British Columbia, Dept Pharmacol, Vancouver, BC, Canada; [Kumar, Alan Prem] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Kumar, Alan Prem] Natl Univ Canc Inst, Singapore, Singapore; [Kumar, Alan Prem] Univ North Texas, Dept Biol Sci, Denton, TX USA; [Herr, Deron R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	National University of Singapore; National University of Singapore; University of British Columbia; Curtin University; National University of Singapore; University of North Texas System; University of North Texas Denton; California State University System; San Diego State University	Herr, DR (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore.; Herr, DR (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	phcdrh@nus.edu.sg	Kumar, Alan Prem/ABE-7492-2020; Herr, Deron/AAB-7380-2020	Kumar, Alan Prem/0000-0002-3754-5712; Herr, Deron/0000-0001-5755-0896; Siddiquee, Abrar Al-Mahmood/0000-0002-1496-5853	Ministry of Education, Singapore [T1-2012]; National University of Singapore; Ministry of Education, Singapore	Ministry of Education, Singapore(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported by the Ministry of Education, Singapore (T1-2012 Oct -03), and the National University of Singapore.; The authors would like to thank A/Prof. Gautam Sethi for helpful discussions. This work was supported by the Ministry of Education, Singapore (DRH), and the National University of Singapore (DRH).	Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; Bindels LB, 2013, TRENDS PHARMACOL SCI, V34, P226, DOI 10.1016/j.tips.2013.02.002; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Godfrey J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139012; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harris GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035129; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Herr DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24541; Herr DR, 2013, J BIOL CHEM, V288, P29882, DOI 10.1074/jbc.M113.510099; Herr DR, 2012, INT REV CEL MOL BIO, V297, P45, DOI 10.1016/B978-0-12-394308-8.00002-9; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Jechlinger M, 2002, J MAMMARY GLAND BIOL, V7, P415, DOI 10.1023/A:1024090116451; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim S, 2012, ARCH PHARM RES, V35, P1505, DOI 10.1007/s12272-012-0900-6; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Patmanathan SN, 2017, CELL SIGNAL, V34, P66, DOI 10.1016/j.cellsig.2017.03.002; Pyne NJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030344; Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001; Rao A, 2017, BBA-MOL CELL RES, V1864, P1318, DOI 10.1016/j.bbamcr.2017.05.001; Seljeset S, 2012, J RECEPT SIG TRANSD, V32, P196, DOI 10.3109/10799893.2012.692118; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tang JH, 2013, CLIN SCI, V124, P651, DOI 10.1042/CS20120504; Tang Y, 2011, CELL DEATH DIFFER, V18, P602, DOI 10.1038/cdd.2010.117; Tang Y, 2011, AUTOPHAGY, V7, P235, DOI 10.4161/auto.7.2.14277; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Wu J, 2012, J GENET GENOMICS, V39, P375, DOI 10.1016/j.jgg.2012.05.008; Yonezawa T, 2007, CELL SIGNAL, V19, P185, DOI 10.1016/j.cellsig.2006.06.004; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	56	50	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186334	10.1371/journal.pone.0186334	http://dx.doi.org/10.1371/journal.pone.0186334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049318	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900058
J	Zasada, M; Lenart, M; Rutkowska-Zapala, M; Stec, M; Durlak, W; Grudzien, A; Krzeczkowska, A; Mol, N; Pilch, M; Siedlar, M; Kwinta, P				Zasada, Magdalena; Lenart, Marzena; Rutkowska-Zapala, Magdalena; Stec, Malgorzata; Durlak, Wojciech; Grudzien, Andrzej; Krzeczkowska, Agnieszka; Mol, Nina; Pilch, Marta; Siedlar, Maciej; Kwinta, Przemko			Analysis of PD-1 expression in the monocyte subsets from non-septic and septic preterm neonates	PLOS ONE			English	Article							IMPROVES SURVIVAL; IMMUNE FUNCTION; SEPSIS; LIGANDS; BETAMETHASONE; DEPLETION; CHILDREN; CELLS	Programmed death-1 (PD-1) receptor system represents a part of recently reported immunoregulatory pathway. PD-1 is an immune checkpoint molecule, which plays an important role in downregulating the immune system proinflammatory activity. Until recently, PD-1 expression was not established on immune cells of the preterm infants. The study objectives were to confirm expression of the PD-1 receptors on the monocytes isolated from very low birth weight newborns (VLBW), and to analyze their expression during the first week of life and late-onset sepsis. Peripheral blood mononuclear cells were isolated from 76 VLBW patients without early-onset sepsis on their 5th day of life (DOL). PD-1 expression was determined on the monocyte subsets (classical, intermediate, non-classical) by flow cytometry. In case of late-onset sepsis (LOS), the same analysis was performed. Our results demonstrated that on the 5th DOL, PD-1 receptors were present in all the monocyte subsets. Children, whose mothers had received antenatal steroids, presented higher absolute numbers of non-classical monocytes with PD-1 expression. Infants born extremely preterm who later developed LOS, initially showed a lower percentage of PD-1 receptor-positive intermediate monocytes in comparison to neonates born very preterm. During LOS, we observed a rise in the percentage of classical monocytes with PD-1 expression. In case of septic shock or fatal outcome, there was a higher percentage and absolute count of intermediate monocytes with PD-1 expression in comparison to children without these complications. In conclusion, monocytes from VLBW children express PD-1 receptors. Antenatal steroid administration seems to induce PD-1 receptor expression in the non-classical monocytes. PD-1 might play a role in immunosuppressive phase of sepsis in the prematurely born children with septic shock and fatal outcome.	[Zasada, Magdalena; Durlak, Wojciech; Grudzien, Andrzej; Krzeczkowska, Agnieszka; Mol, Nina; Pilch, Marta; Kwinta, Przemko] Jagiellonian Univ, Med Coll, Fac Med, Dept Paediat,Inst Paediat, Krakow, Poland; [Lenart, Marzena; Rutkowska-Zapala, Magdalena; Stec, Malgorzata; Siedlar, Maciej] Jagiellonian Univ, Med Coll, Fac Med, Dept Clin Immunol,Inst Paediat, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Zasada, M (corresponding author), Jagiellonian Univ, Med Coll, Fac Med, Dept Paediat,Inst Paediat, Krakow, Poland.	magdalena.zasada@uj.edu.pl	Lenart, Marzena/AGW-9505-2022; Stec, Małgorzata/AAP-3814-2020; Kwinta, Przemko/C-6056-2008; Durlak, Wojciech/AAP-6434-2021; Stec, Malgorzata/U-9740-2018; Siedlar, Maciej/U-9190-2018	Lenart, Marzena/0000-0001-6176-2891; Kwinta, Przemko/0000-0002-3017-0348; Durlak, Wojciech/0000-0002-6236-493X; Stec, Malgorzata/0000-0003-2063-9939; Zasada, Magdalena/0000-0003-0459-7046; Siedlar, Maciej/0000-0002-3904-5412	National Science Center, Poland [DEC-2012/07/B/NZ5/01221]	National Science Center, Poland(National Science Centre, Poland)	Study supported by National Science Center, Poland: grant number: DEC-2012/07/B/NZ5/01221.	Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Dayyani F, 2003, J LEUKOCYTE BIOL, V74, P33, DOI 10.1189/jlb.1202612; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; FINGERLE G, 1993, BLOOD, V82, P3170; Fingerle-Rowson G, 1998, CLIN EXP IMMUNOL, V112, P501; Goldstein B, 2006, PEDIATR CRIT CARE ME, V7, P200, DOI 10.1097/01.PCC.0000217470.68764.36; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Heimbeck I, 2010, CYTOM PART A, V77A, P823, DOI 10.1002/cyto.a.20942; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kavelaars A, 1999, PEDIATR RES, V45, P306, DOI 10.1203/00006450-199903000-00003; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kramer BW, 2004, PEDIATR RES, V55, P764, DOI 10.1203/01.PDR.0000120678.72485.19; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; MARRACO SAF, 2015, FRONT IMMUNOL, V6, P1, DOI DOI 10.3389/fimmu.2015.00310; Monneret G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1370-x; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Patera AC, 2016, J LEUKOCYTE BIOL, V100, P1239, DOI 10.1189/jlb.4HI0616-255R; Pickkers P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-016-1583-z; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Roy S, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.12; Shindo Y, 2017, J SURG RES, V208, P33, DOI 10.1016/j.jss.2016.08.099; Siedlar M, 2011, CLIN IMMUNOL, V139, P122, DOI 10.1016/j.clim.2011.01.002; Skrzeczynska J, 2002, SCAND J IMMUNOL, V55, P629, DOI 10.1046/j.1365-3083.2002.01092.x; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Wisgrill L, 2016, J LEUKOCYTE BIOL, V100, P607, DOI 10.1189/jlb.4A0116-001RR; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Xing KL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0103-2; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Young WA, 2017, SURGERY, V161, P1387, DOI 10.1016/j.surg.2016.11.008; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354; Zhao C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.69; Zhou M, 2017, BIOCH BIOPHYS ACTA; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V289, P135, DOI 10.1016/j.cellimm.2014.03.019; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	43	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186819	10.1371/journal.pone.0186819	http://dx.doi.org/10.1371/journal.pone.0186819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049359	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900117
J	Zhou, P; Zhang, X; Zeng, WJ; Zheng, QX; Hao, XQ; Lin, X; Zheng, Y; Wang, LF; Zhang, GH; Li, SJ				Zhou, Pei; Zhang, Xin; Zeng, Weijie; Zheng, Qingxu; Hao, Xiangqi; Lin, Xi; Zheng, Yun; Wang, Lifang; Zhang, Guihong; Li, Shoujun			MicroRNA expression analysis of feline and canine parvovirus infection in vivo (felis)	PLOS ONE			English	Article							VIRUS-ENCODED MICRORNA; PANLEUKOPENIA VIRUS; GENE-EXPRESSION; DOMESTIC CATS; HOST-RANGE; ENTERITIS; DOGS; EVOLUTION; MODULATION; PREDICTION	Feline panleukopenia is a common contagious disease with high morbidity and mortality. At present, feline parvovirus (FPV) and canine parvovirus (CPV) variants are the pathogens of feline panleukopenia. Many studies have shown that miRNAs are involved in virus-host interactions. Nevertheless, miRNA expression profiling of FPV (original virus) or CPV-2b (new virus) in cats has not been reported. To investigate these profiles, three 10-week-old cats were orally inoculated with 10 6 TCID50 of the viruses (FPV and CPV-2b), and the jejunums of one cat in each group were sectioned for miRNA sequencing at 5 days post-inoculation (dpi). This study is the first attempt to use miRNA analysis to understand the molecular basis of FPV and CPV infection in cats. The miRNA expression profiles of the jejunums of cats infected with FPV and CPV were obtained, and a subset of miRNAs was validated by real-time qPCR. The results show that a variety of metabolism-related pathways, cytokine-and pathogen-host interaction-related pathways, and pathology-and cellar structure-related pathways, as well as others, were affected. Specifically, the JAK-STAT signaling pathway, which is critical for cytokines and growth factors, was enriched. This description of the miRNAs involved in regulating FPV and CPV infection in vivo provides further insight into the mechanisms of viral infection and adaptation and might provide an alternative antiviral strategy for disease control and prevention.	[Zhou, Pei; Zhang, Xin; Zeng, Weijie; Zheng, Qingxu; Hao, Xiangqi; Lin, Xi; Zheng, Yun; Wang, Lifang; Zhang, Guihong; Li, Shoujun] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Pei; Zhang, Xin; Zeng, Weijie; Zheng, Qingxu; Hao, Xiangqi; Lin, Xi; Zheng, Yun; Wang, Lifang; Li, Shoujun] Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou, Guangdong, Peoples R China; [Zhou, Pei; Zhang, Xin; Zeng, Weijie; Zheng, Qingxu; Hao, Xiangqi; Lin, Xi; Zheng, Yun; Wang, Lifang; Li, Shoujun] Guangdong Engn & Technol Res Ctr Pets, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhang, GH; Li, SJ (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Guangdong Engn & Technol Res Ctr Pets, Guangzhou, Guangdong, Peoples R China.	guihongzh@scau.edu.cn; shoujunli@scau.edu.cn	Hao, Xiangqi/AET-3260-2022	Hao, Xiangqi/0000-0002-1316-1415	China Scholarship Council (CSC); National Key Research and Development Program of China [2016YFD0501004]; Special Fund for Agro-scientific Research in the Public Interest [201303042]; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases [2013A061401013]	China Scholarship Council (CSC)(China Scholarship Council); National Key Research and Development Program of China; Special Fund for Agro-scientific Research in the Public Interest; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases	Pei Zhou received financial support from the China Scholarship Council (CSC).; This work was supported by the National Key Research and Development Program of China (2016YFD0501004), the Special Fund for Agro-scientific Research in the Public Interest (201303042), the Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases (2013A061401013). Pei Zhou received financial support from the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AB, 2013, J VIROL, V87, P2342, DOI 10.1128/JVI.02428-12; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; APPEL MJG, 1979, VET REC, V105, P156, DOI 10.1136/vr.105.8.156; APPEL MJG, 1979, CORNELL VET, V69, P123; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BINN L N, 1970, Infection and Immunity, V1, P503; BLACK JW, 1979, VET MED SM ANIM CLIN, V74, P47; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; CARMICHAEL LE, 1981, ADV VET SCI COMP MED, V25, P1; Clegg SR, 2012, VET MICROBIOL, V157, P78, DOI 10.1016/j.vetmic.2011.12.024; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gamoh K, 2003, J VET MED SCI, V65, P1027, DOI 10.1292/jvms.65.1027; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ikeda Y, 2000, VIROLOGY, V278, P13, DOI 10.1006/viro.2000.0653; JOHNSON RH, 1979, AUST VET J, V55, P151, DOI 10.1111/j.1751-0813.1979.tb15259.x; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Li YK, 2012, CELL MOL IMMUNOL, V9, P497, DOI 10.1038/cmi.2012.35; Li YK, 2013, PROTEIN CELL, V4, P130, DOI 10.1007/s13238-012-2081-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Nakamura K, 2001, CLIN DIAGN LAB IMMUN, V8, P663, DOI 10.1128/CDLI.8.3.663-668.2001; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; OSTERHAUS ADME, 1980, ZBL VET MED B, V27, P11; Panaro NJ, 2000, CLIN CHEM, V46, P1851; Parrish C R, 1990, Adv Virus Res, V38, P403; PARRISH CR, 1995, BAILLIERE CLIN HAEM, V8, P57, DOI 10.1016/S0950-3536(05)80232-X; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; REED AP, 1988, J VIROL, V62, P266, DOI 10.1128/JVI.62.1.266-276.1988; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Su CH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-354; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; TRUYEN U, 1992, J VIROL, V66, P5399, DOI 10.1128/JVI.66.9.5399-5408.1992; Truyen U, 1996, VIROLOGY, V215, P186, DOI 10.1006/viro.1996.0021; TRUYEN U, 1995, J VIROL, V69, P4702, DOI 10.1128/JVI.69.8.4702-4710.1995; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	47	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0185698	10.1371/journal.pone.0185698	http://dx.doi.org/10.1371/journal.pone.0185698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049413	gold, Green Submitted, Green Published			2022-12-26	WOS:000413195900015
J	Kolowski, JM; Forrester, TD				Kolowski, Joseph M.; Forrester, Tavis D.			Camera trap placement and the potential for bias due to trails and other features	PLOS ONE			English	Article							FOREST MAMMALS; OCCUPANCY; HABITAT; JAGUAR; DENSITIES; ABUNDANCE; LOCATION; MATTER; BRAZIL; SPACE	Camera trapping has become an increasingly widespread tool for wildlife ecologists, with large numbers of studies relying on photo capture rates or presence/absence information. It is increasingly clear that camera placement can directly impact this kind of data, yet these biases are poorly understood. We used a paired camera design to investigate the effect of small-scale habitat features on species richness estimates, and capture rate and detection probability of several mammal species in the Shenandoah Valley of Virginia, USA. Cameras were deployed at either log features or on game trails with a paired camera at a nearby random location. Overall capture rates were significantly higher at trail and log cameras compared to their paired random cameras, and some species showed capture rates as much as 9.7 times greater at feature-based cameras. We recorded more species at both log (17) and trail features (15) than at their paired control cameras (13 and 12 species, respectively), yet richness estimates were indistinguishable after 659 and 385 camera nights of survey effort, respectively. We detected significant increases (ranging from 11-33%) in detection probability for five species resulting from the presence of game trails. For six species detection probability was also influenced by the presence of a log feature. This bias was most pronounced for the three rodents investigated, where in all cases detection probability was substantially higher (24.9-38.2%) at log cameras. Our results indicate that small-scale factors, including the presence of game trails and other features, can have significant impacts on species detection when camera traps are employed. Significant biases may result if the presence and quality of these features are not documented and either incorporated into analytical procedures, or controlled for in study design.	[Kolowski, Joseph M.; Forrester, Tavis D.] Smithsonian Conservat Biol Inst, Natl Zool Pk, Front Royal, VA 22630 USA; [Forrester, Tavis D.] Oregon Dept Fish & Wildlife, La Grande, OR USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Kolowski, JM (corresponding author), Smithsonian Conservat Biol Inst, Natl Zool Pk, Front Royal, VA 22630 USA.	kolowskij@si.edu		Kolowski, Joseph/0000-0002-3721-8332				Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Blake John G, 2014, Mastozool. neotrop., V21, P17; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Di Bitetti Mario S, 2014, Mastozool. neotrop., V21, P37; Gregory T, 2014, METHODS ECOL EVOL, V5, P443, DOI 10.1111/2041-210X.12177; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hines JE., 2006, PRESENCESOFTWARE EST; Hsieh T. C., INEXT ONLINE INTERPO; Karanth KU, 1998, ECOLOGY, V79, P2852; Kays Roland, 2011, International Journal of Research and Reviews in Wireless Sensor Networks, V1, P19; Kays R, 2016, J APPL ECOLOGY; Kelly MJ, 2008, NORTHEAST NAT, V15, P249, DOI 10.1656/1092-6194(2008)15[249:CTOCTS]2.0.CO;2; Kolowski JM, 2010, BIOL CONSERV, V143, P917, DOI 10.1016/j.biocon.2009.12.039; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mann GKH, 2015, BIODIVERS CONSERV, V24, P531, DOI 10.1007/s10531-014-0834-z; McShea WJ, EMAMMAL BROWSE DATA; Meek P., 2014, CAMERA TRAPPING WILD, V2; Meek PD, 2014, BIODIVERS CONSERV, V23, P2321, DOI 10.1007/s10531-014-0712-8; Meek PD, 2015, AUST MAMMAL, V37, P13, DOI 10.1071/AM14023; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; Niedballa J, CAMTRAPR CAMERA TRAP; O'Brien TG, 2010, ANIM CONSERV, V13, P335, DOI 10.1111/j.1469-1795.2010.00357.x; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Pepper MA, BIODIVERSITY CONSERV; Rovero F., 2016, CAMERA TRAPPING WILD; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; Sollmann R, 2012, MAMM BIOL, V77, P41, DOI 10.1016/j.mambio.2011.06.011; Srbek-Araujo AC, 2013, BIOTA NEOTROP, V13, P51, DOI 10.1590/S1676-06032013000200005; Team RC, 2016, R LANG ENV STAT COMP; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tobler MW, 2013, BIOL CONSERV, V159, P375, DOI 10.1016/j.biocon.2012.12.012; Tobler MW, 2009, J TROP ECOL, V25, P261, DOI 10.1017/S0266467409005896; Trolle M, 2005, MAMMALIA, V69, P409, DOI 10.1515/mamm.2005.032; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Weckel M, 2006, J ZOOL, V270, P25, DOI 10.1111/j.1469-7998.2006.00106.x	41	66	68	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186679	10.1371/journal.pone.0186679	http://dx.doi.org/10.1371/journal.pone.0186679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045478	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100087
J	Luan, PP; Zhuang, JH; Zou, J; Li, HL; Shuai, P; Xu, XP; Zhao, YF; Kou, WX; Ji, SY; Peng, A; Xu, YW; Su, Q; Jian, WX; Peng, WH				Luan, Peipei; Zhuang, Jianhui; Zou, Jun; Li, Hailing; Shuai, Ping; Xu, Xiaopeng; Zhao, Yifan; Kou, Wenxin; Ji, Shuya; Peng, Ai; Xu, Yawei; Su, Qing; Jian, Weixia; Peng, Wenhui			NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation	FASEB JOURNAL			English	Article						albuminuria; innate immunity; macrophages; diabetes; kidney injury	NUCLEOTIDE-BINDING DOMAIN; NF-KAPPA-B; IMMUNE-RESPONSES; RECEPTOR NLRC5; RENAL INJURY; MACROPHAGE; PATHWAYS; MHC; FIBROSIS; PROGRESSION	NOD-like receptor family caspase recruitment domain family domain containing 5 (NLRC5) has important roles in inflammation and innate immunity. NLRC5 was highly expressed in kidney from streptozotocin-induced diabetic mice, db/db mice and patients with diabetes. Based on that evidence, the present study was designed to explore the roles of NLRC5 in the progression of diabetic nephropathy (DN). We examined kidney injury, including inflammation and fibrosis in Nlrc5 gene knockout ( Nlrc5(-/-)) and wild-type (WT) diabetic mice. We found that Nlrc5(-/-) mice developed less-severe diabetic kidney injury compared with WT mice, exhibiting lower albuminuria, less fibronectin and collagen IV expression, and reduced macrophage infiltration but greater levels of podocin and nephrin in the diabetic kidney. The underlying mechanisms were further investigated in vitro with peritoneal macrophages and mesangial cells treated with high glucose. Reduced proinflammatory effect was observed in peritoneal macrophages from Nlrc5(-/-) mice, associated with NF-kappa B pathway suppression. Knocking down of NLRC5 in mesangial cells in high-glucose conditions was also associated with reduced NF-kappa B and TGF-beta/Smad signaling. Taken together, NLRC5 promotes inflammation and fibrosis during DN progression partly through the effects on NF-kappa B and TGF-beta/Smad pathways. NLRC5 may, therefore, be a promising therapeutic target for DN treatment.	[Luan, Peipei; Su, Qing; Jian, Weixia] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Endocrinol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Zou, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Nephropathy, Shanghai, Peoples R China; [Zhuang, Jianhui; Li, Hailing; Xu, Xiaopeng; Zhao, Yifan; Kou, Wenxin; Ji, Shuya; Xu, Yawei; Peng, Wenhui] Tongji Univ, Sch Med, Dept Cardiol, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China; [Peng, Ai] Tongji Univ, Sch Med, Dept Nephropathy, Shanghai Peoples Hosp 10, Shanghai, Peoples R China; [Shuai, Ping] Gannan Med Univ, Dept Pathol, Affiliated Hosp 1, Ganzhou, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University; Tongji University; Gannan Medical University	Jian, WX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Endocrinol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.; Peng, WH (corresponding author), Tongji Univ, Sch Med, Dept Cardiol, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	jianweixia@xinhuamed.com.cn; pwenhui@tongji.edu.cn		Zou, Jun/0000-0002-4781-2538	Chinese National Natural Science Foundation [81670746, 81370391, 81670230]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The authors thank the patients who participated in this study. The authors also thank Dr. Wei Wang (Columbia Center for Translational Immunology, Columbia University Medical Center (New York, NY, USA) for her critical discussions and comments on the article. This study was supported by Grants 81670746,81370391 and 81670230 from the Chinese National Natural Science Foundation. The authors declare no conflicts of interest.	Abdel-Rahman EM, 2012, J GEN INTERN MED, V27, P458, DOI 10.1007/s11606-011-1912-5; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Bashir S, 2016, INFLAMM RES, V65, P1, DOI 10.1007/s00011-015-0874-1; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chang AS, 2016, AM J PHYSIOL-RENAL, V310, pF689, DOI 10.1152/ajprenal.00502.2015; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Guiteras R, 2016, CLIN KIDNEY J, V9, P765, DOI 10.1093/ckj/sfw096; Hull RP, 2008, BMJ-BRIT MED J, V336, P1185, DOI 10.1136/bmj.39576.709711.80; Jian WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094763; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Lamkanfi M, 2012, IMMUNOBIOLOGY, V217, P13, DOI 10.1016/j.imbio.2011.08.011; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Picken MM, 2009, KIDNEY INT, V75, P574, DOI 10.1038/ki.2008.651; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Robbins GR, 2012, J BIOL CHEM, V287, P24294, DOI 10.1074/jbc.M112.364604; Saran R, 2017, AM J KIDNEY DIS, V69, DOI 10.1053/j.ajkd.2016.12.004; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; Tian SJ, 2015, AM J PHYSIOL-RENAL, V308, pF69, DOI 10.1152/ajprenal.00484.2014; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Wada J, 2016, NAT REV NEPHROL, V12, P13, DOI 10.1038/nrneph.2015.175; Wolf G, 2004, EUR J CLIN INVEST, V34, P785, DOI 10.1111/j.1365-2362.2004.01429.x; Xu T, 2016, INT J BIOCHEM CELL B, V70, P92, DOI 10.1016/j.biocel.2015.11.010; Yao YK, 2013, PROTEIN CELL, V4, P168, DOI 10.1007/s13238-012-2109-3; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56; Yiu W.H., 2015, KIDNEY INT	39	32	34	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1070	1084		10.1096/fj.201700511RR	http://dx.doi.org/10.1096/fj.201700511RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29070585	Bronze			2022-12-26	WOS:000425146900045
J	Wang, LJ; Iorio, C; Yan, K; Yang, H; Takeshita, S; Kang, SM; Neel, BG; Yang, WT				Wang, Lijun; Iorio, Caterina; Yan, Kevin; Yang, Howard; Takeshita, Sunao; Kang, Sumin; Neel, Benjamin G.; Yang, Wentian			A ERK/RSK-mediated negative feedback loop regulates M-CSF-evoked PI3K/AKT activation in macrophages	FASEB JOURNAL			English	Article						SHP2; MAPK; c-Fms; M-CSFR	TYROSINE-PHOSPHATASE SHP2; SIGNAL-TRANSDUCTION; MAP KINASE; ERK ACTIVATION; RECEPTOR; GROWTH; DIFFERENTIATION; PROLIFERATION; PHOSPHORYLATION; INHIBITORS	Activation of the RAS/ERK and its downstream signaling components is essential for growth factor-induced cell survival, proliferation, and differentiation. The Src homology-2 domain containing protein tyrosine phosphatase 2 (SHP2), encoded by protein tyrosine phosphatase, non-receptor type 11 (Ptpn11), is a positive mediator required for most, if not all, receptor tyrosine kinase-evoked RAS/ERK activation, but differentially regulates the PI3K/AKT signaling cascade in various cellular contexts. The precise mechanisms underlying the differential effects of SHP2 deficiency on the PI3K pathway remain unclear. We found that mice with myelomonocytic cell-specific [Tg(LysM-Cre); Ptpn11(fl/fl) mice] Ptpn11 deficiency exhibit mild osteopetrosis. SHP2-deficient bone marrow macrophages (BMMs) showed decreased proliferation in response to M-CSF and decreased osteoclast generation. M-CSF-evoked ERK1/2 activation was decreased, whereas AKT activation was enhanced in SHP2-deficient BMMs. ERK1/2, via its downstream target RSK2, mediates this negative feedback by negatively regulating phosphorylation of M-CSF receptor at Tyr721 and, consequently, its binding to p85 subunit of PI3K and PI3K activation. Pharmacologic inhibition of RSK or ERK phenotypically mimics the signaling defects observed in SHP2-deficient BMMs. Furthermore, this increase in PI3K/AKT activation enables BMM survival in the setting of SHP2 deficiency.	[Wang, Lijun; Yan, Kevin; Yang, Wentian] Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Alpert Med Sch, Providence, RI 02903 USA; [Iorio, Caterina; Neel, Benjamin G.] Univ Toronto, Campbell Family Canc Res Inst, Univ Hlth Network, Dept Med Biophys,Ontario Canc Inst,Princess Marga, Toronto, ON, Canada; [Yang, Howard] Univ Rhode Isl, Coll Engn, Kingston, RI 02881 USA; [Takeshita, Sunao] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Aichi, Japan; [Kang, Sumin] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA USA; [Neel, Benjamin G.] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Rhode Island; National Center for Geriatrics & Gerontology; Emory University; New York University; NYU Langone Medical Center	Neel, BG (corresponding author), NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.; Yang, WT (corresponding author), Brown Univ, Alpert Med Sch, Dept Orthopaed Surg, Suite 402E,Coro W Bldg,1 Hoppin St, Providence, RI 02903 USA.	Benjamin.Neel@nyumc.org; wyang@lifespan.org			U.S. National Institutes of Health (NIH) National Cancer Institute [R01CA114945, R37 CA49152]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR57156, RO1AR066746]; NIH National Center for Research Resources Grant [P20RR025179]; Arthritis National Research Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC); Grants-in-Aid for Scientific Research [16K08681] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R37CA049152, R01CA114945] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057156, R01AR066746] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Center for Research Resources Grant; Arthritis National Research Foundation(National Research Foundation of Korea); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Changqi Sun (Rhode Island Hospital) for technical assistance in constructing pMX(puro) expression constructs. This work was supported in part by U.S. National Institutes of Health (NIH) National Cancer Institute Grants R01CA114945 and R37 CA49152 (to B.G.N.), NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R21AR57156, RO1AR066746, and NIH National Center for Research Resources Grant P20RR025179 (to W.Y.). This study was also aided by a grant from the Arthritis National Research Foundation (to W.Y.). B.G.N. was a Canada Research Chair, Tier 1, and this research was also funded, in part, by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. The authors declare no conflicts of interest.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; Caescu CI, 2015, BLOOD, V125, pE1, DOI 10.1182/blood-2014-10-608000; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Edouard T, 2010, MOL CELL BIOL, V30, P2498, DOI 10.1128/MCB.00646-09; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feng X, 2002, ENDOCRINOLOGY, V143, P4868, DOI 10.1210/en.2002-220467; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hersey P, 2009, ANN ONCOL, V20, P35, DOI 10.1093/annonc/mdp254; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee AWM, 2006, CELL DEATH DIFFER, V13, P1900, DOI 10.1038/sj.cdd.4401884; Lee AWM, 2000, MOL CELL BIOL, V20, P6779, DOI 10.1128/MCB.20.18.6779-6798.2000; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leung GC, 2009, METHODS MOL BIOL, V570, P187, DOI 10.1007/978-1-60327-394-7_7; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Liu Y, 2001, MOL CELL BIOL, V21, P3047, DOI 10.1128/MCB.21.9.3047-3056.2001; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Neel B. G., 2009, HDB CELL SIGNALING, P771; Novak U, 1998, GROWTH FACTORS, V15, P159, DOI 10.3109/08977199809002114; Novak U, 1996, ONCOGENE, V13, P2607; NOVAK U, 1995, BLOOD, V86, P2948, DOI 10.1182/blood.V86.8.2948.bloodjournal8682948; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ramjaun AR, 2007, CELL CYCLE, V6, P2902, DOI 10.4161/cc.6.23.4996; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sebolt-Leopold JS, 2004, CURR PHARM DESIGN, V10, P1907, DOI 10.2174/1381612043384439; Sefton B. M., 2001, CURR PROTOC PROTEIN; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Suzu S, 2007, J CELL PHYSIOL, V212, P519, DOI 10.1002/jcp.21045; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Warner N, 2008, FEBS J, V275, P2561, DOI 10.1111/j.1742-4658.2008.06405.x; Wilson NJ, 2005, FEBS J, V272, P4141, DOI 10.1111/j.1742-4658.2005.04826.x; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Xiong Y, 2011, J BIOL CHEM, V286, P952, DOI 10.1074/jbc.M110.166702; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu WF, 2012, J BIOL CHEM, V287, P13694, DOI 10.1074/jbc.M112.355610; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002	73	28	28	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					875	887		10.1096/fj.201700672RR	http://dx.doi.org/10.1096/fj.201700672RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29046360	Green Published, Bronze			2022-12-26	WOS:000425146900029
J	Liu, F; Xu, K; Xu, ZJ; de las Rivas, M; Wang, CR; Li, X; Lu, JS; Zhou, YY; Delso, I; Merino, P; Hurtado-Guerrero, R; Zhang, Y; Wu, F				Liu, Feng; Xu, Kai; Xu, Zhijue; de las Rivas, Matilde; Wang, Congrong; Li, Xing; Lu, Jishun; Zhou, Yueyang; Delso, Ignacio; Merino, Pedro; Hurtado-Guerrero, Ramon; Zhang, Yan; Wu, Fang			The small molecule luteolin inhibits N-acetyl--galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein (APP); crystal structure; glycoprotein; glycosylation inhibitor; glycosyltransferase; O-glycosylation; luteolin; ppGalNAc-T	TRANSFERASE GENE FAMILY; GALNAC-TRANSFERASE; GLCNAC TRANSFERASE; UDP-GALNAC; LINKED GLYCOSYLATION; STRUCTURAL INSIGHT; ENDOTHELIAL-CELLS; SERUM-ALBUMIN; SUBSTRATE; BETA	Mucin-type O-glycosylation is the most abundant type of O-glycosylation. It is initiated by the members of the polypeptide N-acetyl--galactosaminyltransferase (ppGalNAc-T) family and closely associated with both physiological and pathological conditions, such as coronary artery disease or Alzheimer's disease. The lack of direct and selective inhibitors of ppGalNAc-Ts has largely impeded research progress in understanding the molecular events in mucin-type O-glycosylation. Here, we report that a small molecule, the plant flavonoid luteolin, selectively inhibits ppGalNAc-Ts in vitro and in cells. We found that luteolin inhibits ppGalNAc-T2 in a peptide/protein-competitive manner but not promiscuously (e.g. via aggregation-based activity). X-ray structural analysis revealed that luteolin binds to the PXP motif-binding site found in most protein substrates, which was further validated by comparing the interactions of luteolin with wild-type enzyme and with mutants using H-1 NMR-based binding experiments. Functional studies disclosed that luteolin at least partially reduced production of -amyloid protein by selectively inhibiting the activity of ppGalNAc-T isoforms. In conclusion, our study provides key structural and functional details on luteolin inhibiting ppGalNAc-T activity, opening up the way for further optimization of more potent and specific ppGalNAc-T inhibitors. Moreover, our findings may inform future investigations into site-specific O-GalNAc glycosylation and into the molecular mechanism of luteolin-mediated ppGalNAc-T inhibition.	[Liu, Feng; Xu, Kai; Xu, Zhijue; Wang, Congrong; Li, Xing; Lu, Jishun; Zhou, Yueyang; Zhang, Yan; Wu, Fang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Liu, Feng; Xu, Kai; Xu, Zhijue; Wang, Congrong; Li, Xing; Lu, Jishun; Zhou, Yueyang; Zhang, Yan; Wu, Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Collaborat Innovat Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [de las Rivas, Matilde; Merino, Pedro; Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, BIFI IQFR CSIC Joint Unit, E-50009 Zaragoza, Spain; [Wang, Congrong] Shanghai Univ Med & Hlth Sci, Sch Basic Med Sci, 279 Zhouzhu Rd, Shanghai 201318, Peoples R China; [Delso, Ignacio] Univ Zaragoza, ISQCH, CSIC, E-50009 Zaragoza, Aragon, Spain; [Hurtado-Guerrero, Ramon] Fdn ARAID, Zaragoza 50018, Spain; [Xu, Kai] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; Shanghai University of Medicine & Health Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC-UZA - Instituto de Sintesis Quimica y Catalisis Homogenea (ISQCH); University of Zaragoza; Shanghai Ocean University	Hurtado-Guerrero, R (corresponding author), Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, BIFI IQFR CSIC Joint Unit, E-50009 Zaragoza, Spain.; Zhang, Y; Wu, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	rhurtado@bifi.es; yanzhang2006@sjtu.edu.cn; fang.wu@sjtu.edu.cn	Wu, Fang/B-1945-2008; Yang, Fang/AAF-3024-2019; Delso, Ignacio/AAW-2250-2021; Merino, Pedro/K-2742-2014; de las Rivas, Matilde/AAE-4248-2021; Delso, Ignacio/F-2952-2016	Wu, Fang/0000-0002-4194-2243; Delso, Ignacio/0000-0001-8355-2289; Merino, Pedro/0000-0002-2202-3460; Delso, Ignacio/0000-0001-8355-2289; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; de las Rivas, Matilde/0000-0002-4563-6593	National Basic Research Program of China [2012CB822103, 2011CB910603]; National High Technology Research and Development Program of China [2012AA020203]; National Natural Science Foundation [31170771, 31370806, 31570796, 31270853, 81102377]; Agencia Aragonesa para la Investigacion y Desarrollo (ARAID), Ministerio de Economia y Competitividad [CTQ2013-44367-C2-2-P, BFU2016-75633-P]; Diputacion General de Aragon (DGA) [B89]; EU under BioStruct-X [283570, BIOSTRUCTX 5186]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020203] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Agencia Aragonesa para la Investigacion y Desarrollo (ARAID), Ministerio de Economia y Competitividad; Diputacion General de Aragon (DGA)(Gobierno de Aragon); EU under BioStruct-X; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Basic Research Program of China Grants 2012CB822103 and 2011CB910603 (to Y. Z.); National High Technology Research and Development Program of China Grant 2012AA020203 (to Y. Z.); National Natural Science Foundation Grants 31170771 (to Y. Z.), 31370806 (to Y. Z.), and 31570796 (to Y. Z.); National Basic Research Program of China Grant 2012CB822103 (to F. W.); National Natural Science Foundation Grants 31270853 and 81102377 (to F. W.); Agencia Aragonesa para la Investigacion y Desarrollo (ARAID), Ministerio de Economia y Competitividad, Grants CTQ2013-44367-C2-2-P and BFU2016-75633-P (to R. H.-G.); Diputacion General de Aragon (DGA) Grant B89 (to R. H.-G.); and the EU Seventh Framework Programme (2007-2013) under BioStruct-X (Grant Agreement 283570 and BIOSTRUCTX 5186) (to R. H.-G.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal K, 2013, J AM CHEM SOC, V135, P14189, DOI 10.1021/ja405189k; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Cai WR, 2014, EUR FOOD RES TECHNOL, V238, P121, DOI 10.1007/s00217-013-2091-x; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; FISCHER JJ, 1965, J AM CHEM SOC, V87, P3237, DOI 10.1021/ja01092a040; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Ghirardello M, 2016, CHEM-EUR J, V22, P7215, DOI 10.1002/chem.201600467; Glenner G G, 1984, Appl Pathol, V2, P357; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; Halim A, 2011, P NATL ACAD SCI USA, V108, P11848, DOI 10.1073/pnas.1102664108; Hang HC, 2004, CHEM BIOL, V11, P337, DOI 10.1016/j.chembiol.2004.02.023; Iakovleva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128222; Kaneko MK, 2007, FEBS LETT, V581, P331, DOI 10.1016/j.febslet.2006.12.044; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li X, 2012, GLYCOBIOLOGY, V22, P602, DOI 10.1093/glycob/cwr179; Lira-Navarrete E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7937; Lira-Navarrete E, 2014, ANGEW CHEM INT EDIT, V53, P8206, DOI 10.1002/anie.201402781; Lolli G, 2012, BIOCHEMISTRY-US, V51, P6097, DOI 10.1021/bi300531c; Mjiqiza SJ, 2013, J ETHNOPHARMACOL, V149, P648, DOI 10.1016/j.jep.2013.07.019; Narwal M, 2013, J MED CHEM, V56, P3507, DOI 10.1021/jm3018783; Pan YF, 2014, BLOOD, V124, P3656, DOI 10.1182/blood-2014-04-572107; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Perdivara I, 2009, J PROTEOME RES, V8, P631, DOI 10.1021/pr800758g; Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; SARRAZIN M, 1979, MOL PHARMACOL, V15, P71; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Singh M, 2014, EUR J MED CHEM, V84, P206, DOI 10.1016/j.ejmech.2014.07.013; Slade PG, 2012, J PROTEOME RES, V11, P6175, DOI 10.1021/pr300810f; Song L, 2017, ELIFE, V6, DOI 10.7554/eLife.24051; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; SUGIURA M, 1982, J BIOL CHEM, V257, P9501; Theoharides TC, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00225; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Wang S., 2000, STRAIT PHARM J, V12, P23; Wang Y, 2017, J MED CHEM, V60, P263, DOI 10.1021/acs.jmedchem.6b01237; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Xu YJ, 2016, J BIOL CHEM, V291, P23477, DOI 10.1074/jbc.M116.743955; Yokoyama T, 2015, J MED CHEM, V58, P7400, DOI 10.1021/acs.jmedchem.5b00893; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200	54	28	29	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21304	21319		10.1074/jbc.M117.814202	http://dx.doi.org/10.1074/jbc.M117.814202			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29061849	Green Published, hybrid			2022-12-26	WOS:000419013000008
J	Sengupta, I; Das, D; Singh, SP; Chakravarty, R; Das, C				Sengupta, Isha; Das, Dipanwita; Singh, Shivaram Prasad; Chakravarty, Runu; Das, Chandrima			Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; hepatitis B virus (HBV; Hep B); signal transducers and activators of transcription 1 (STAT1); small ubiquitin-like modifier (SUMO); viral protein; promyelocytic leukemia nuclear Bodies; Speckled 110 kDa (Sp110); hepatitis B virus protein x (HBx); type I interferon-response pathway	INDUCED HEPATOCELLULAR-CARCINOMA; HEPATOMA-CELL LINES; PULMONARY TUBERCULOSIS; GENE-EXPRESSION; DNA-DAMAGE; REPLICATION; INHIBITION; HBX; IDENTIFICATION; RECEPTOR	Promyelocytic leukemia nuclear bodies (PML-NB) are sub-nuclear organelles that are the hub of numerous proteins. DNA/RNA viruses often hijack the cellular factors resident in PML-NBs to promote their proliferation in host cells. Hepatitis B virus (HBV), belonging to Hepadnaviridae family, remains undetected in early infection as it does not induce the innate immune response and is known to be the cause of several hepatic diseases leading to cirrhosis and hepatocellular carcinoma. The association of PML-NB proteins and HBV is being addressed in a number of recent studies. Here, we report that the PML-NB protein Speckled 110 kDa (Sp110) is SUMO1-modified and undergoes a deSUMOylation-driven release from the PML-NB in the presence of HBV. Intriguingly, Sp110 knockdown significantly reduced viral DNA load in the culture supernatant by activation of the type I interferon-response pathway. Furthermore, we found that Sp110 differentially regulates several direct target genes of hepatitis B virus protein X (HBx), a viral co-factor. Subsequently, we identified Sp110 as a novel interactor of HBx and found this association to be essential for the exit of Sp110 from the PML-NB during HBV infection and HBx recruitment on the promoter of these genes. HBx, in turn, modulates the recruitment of its associated transcription cofactors p300/HDAC1 to these co-regulated genes, thereby altering the host gene expression program in favor of viral persistence. Thus, we report a mechanism by which HBV can evade host immune response by hijacking the PML-NB protein Sp110, and therefore, we propose it to be a novel target for antiviral therapy.	[Sengupta, Isha; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, India; [Das, Dipanwita; Chakravarty, Runu] Infect Dis & Beliaghata Gen Hosp Campus, Indian Council Med Res ICMR Virus Unit, Kolkata 700010, India; [Singh, Shivaram Prasad] Kalinga Gastroenterol Fdn, Beam Diagnost Premises, Cuttack 753001, Orissa, India	Saha Institute of Nuclear Physics	Das, C (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, India.	chandrima.das@saha.ac.in	Das, Chandrima/AAI-7398-2021; Singh, Shivaram Prasad/AAR-1521-2020	Singh, Shivaram Prasad/0000-0002-8197-2674; Sengupta, Isha/0000-0003-0575-3960; Das, Dipanwita/0000-0002-4804-2141; Das, Chandrima/0000-0002-8117-2810	Department of Atomic Energy, Government of India [12-RD-SIN-5.04-0103]	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was supported in part by Research Grants titled Biomolecular Assembly, Recognition, and Dynamics (BARD) Project Grant 12-R&D-SIN-5.04-0103 by the Department of Atomic Energy, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary S, 2016, J BIOL CHEM, V291, P2664, DOI 10.1074/jbc.M115.679985; Arzberger S, 2010, J VIROL, V84, P11994, DOI 10.1128/JVI.00653-10; Bandopadhyay M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0085-6; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Cai Dawei, 2013, Methods Mol Biol, V1030, P151, DOI 10.1007/978-1-62703-484-5_13; Cai L, 2013, HUM GENET, V132, P265, DOI 10.1007/s00439-012-1244-5; Cai L, 2011, MED CHEM, V7, P121, DOI 10.2174/157340611794859343; Chae S, 2013, CARCINOGENESIS, V34, P1680, DOI 10.1093/carcin/bgt105; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Cheng ZK, 2016, J MED VIROL, V88, P653, DOI 10.1002/jmv.24366; Cheng ZK, 2015, VIROL SIN, V30, P261, DOI 10.1007/s12250-015-3584-5; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Choi J, 2003, BIOCHEM BIOPH RES CO, V305, P1049, DOI 10.1016/S0006-291X(03)00881-7; Chung YL, 2013, J PATHOL, V230, P377, DOI 10.1002/path.4195; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Cromlish JA, 1996, TRENDS MICROBIOL, V4, P270, DOI 10.1016/0966-842X(96)10046-9; Datta S, 2006, J MED VIROL, V78, P53, DOI 10.1002/jmv.20503; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Duprez E, 1999, J CELL SCI, V112, P381; Gearhart TL, 2010, VIROLOGY, V407, P14, DOI 10.1016/j.virol.2010.07.042; Genin P, 2003, J VIROL, V77, P7113, DOI 10.1128/JVI.77.12.7113-7119.2003; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Hu LA, 2011, J VIROL, V85, P3214, DOI 10.1128/JVI.01841-10; Hussain Z, 2009, J GEN VIROL, V90, P2272, DOI 10.1099/vir.0.010421-0; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; Kim YH, 2005, FEBS LETT, V579, P6272, DOI 10.1016/j.febslet.2005.10.010; Kock J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037248; Kumar A, 2015, COMPUT STRUCT BIOTEC, V13, P204, DOI 10.1016/j.csbj.2015.03.001; Li N, 2012, HEPATOLOGY, V56, P803, DOI 10.1002/hep.25608; Liang L, 2011, INFECT GENET EVOL, V11, P934, DOI 10.1016/j.meegid.2011.02.017; Liu HY, 2012, J PROTEOME RES, V11, P4803, DOI 10.1021/pr2012297; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23; Mhamdi M, 2007, HEPATOLOGY, V46, P95, DOI 10.1002/hep.21666; Moller A, 2003, ARCH IMMUNOL THER EX, V51, P295; Nakao K, 1999, J BIOL CHEM, V274, P28075, DOI 10.1074/jbc.274.40.28075; Nicewonger J, 2004, J VIROL, V78, P9412, DOI 10.1128/JVI.78.17.9412-9422.2004; Niu CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169648; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V371, P823, DOI 10.1016/j.bbrc.2008.04.179; Olioso D, 2007, EUR J CLIN MICROBIOL, V26, P43, DOI 10.1007/s10096-006-0223-y; Pei RJ, 2014, WORLD J GASTROENTERO, V20, P11618, DOI 10.3748/wjg.v20.i33.11618; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Png E, 2012, INFECT GENET EVOL, V12, P1319, DOI 10.1016/j.meegid.2012.04.006; SELLS MA, 1988, J VIROL, V62, P2836, DOI 10.1128/JVI.62.8.2836-2844.1988; Shamay M, 2002, J BIOL CHEM, V277, P9982, DOI 10.1074/jbc.M111354200; Shona JK, 2009, VIRUS RES, V139, P14, DOI 10.1016/j.virusres.2008.09.006; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sung WK, 2009, J BIOL CHEM, V284, P21941, DOI 10.1074/jbc.M109.014563; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; TRUANT R, 1995, J VIROL, V69, P1851, DOI 10.1128/JVI.69.3.1851-1859.1995; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Wang Q, 2014, INT J BIOL SCI, V10, P1181, DOI 10.7150/ijbs.10275; Wang T, 2012, CLIN IMMUNOL, V145, P102, DOI 10.1016/j.clim.2012.07.016; Wang WH, 2011, HEPATOLOGY, V53, P1137, DOI 10.1002/hep.24163; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Wu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22041; Yuasa K, 2016, GENES CELLS, V21, P25, DOI 10.1111/gtc.12316; Zhang T, 2013, J PROTEOMICS, V84, P92, DOI 10.1016/j.jprot.2013.03.028; Zhang Xiaoyong, 2013, Frontiers in Genetics, V4, P202, DOI 10.3389/fgene.2013.00202	65	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20379	20393		10.1074/jbc.M117.796839	http://dx.doi.org/10.1074/jbc.M117.796839			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29046350	hybrid, Green Published			2022-12-26	WOS:000418267000003
J	Son, S; Hwang, I; Han, SH; Shin, JS; Shin, OS; Yu, JW				Son, Seunghwan; Hwang, Inhwa; Han, Seung Hyeok; Shin, Jeon-Soo; Shin, Ok Sarah; Yu, Je-Wook			Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycation; inflammasome; innate immunity; macrophage; NLRP3	FACTOR-KAPPA-B; ACTIVATED PROTEIN-KINASES; NLRP3-INFLAMMASOME ACTIVATION; INSULIN-RESISTANCE; INFLUENZA-VIRUS; CELL-DEATH; RECEPTOR; DISEASE; EXPRESSION; AGE	Advanced glycation end products (AGEs) are adducts formed on proteins by glycation with reducing sugars, such as glucose, and tend to form and accumulate under hyperglycemic conditions. AGE accumulation alters protein function and has been implicated in the pathogenesis of many degenerative diseases such as diabetic complications. AGEs have also been shown to promote the production of pro-inflammatory cytokines, but the roles of AGEs in inflammasome signaling have not been explored in detail. Here, we present evidence that AGEs attenuate activation of the NLRP3 inflammasome in bone marrow-derived macrophages (BMDMs) as determined by caspase-1 processing and interleukin-1 production. AGEs also dampened the assembly of the NLRP3 inflammasome, but did not affect the NLRC4 or AIM2 inflammasome activation. Moreover, our data indicated that AGE treatment inhibited Toll-like receptor (TLR)-dependent production of pro-inflammatory cytokines in BMDMs. This immunosuppressive effect of AGE was not associated with a receptor for AGEs (RAGE)-mediated signaling. Instead, AGE treatment markedly suppressed lipopolysaccharide-induced M1 polarization of macrophages. Furthermore, AGEs significantly dampened innate immune responses including NLRP3 inflammasome activation and type-I interferon production in macrophages upon influenza virus infection. These observations collectively suggest that AGEs could impair host NLRP3 inflammasome-mediated innate immune defenses against RNA virus infection leading to an increased susceptibility to infection.	[Son, Seunghwan; Hwang, Inhwa; Shin, Jeon-Soo; Yu, Je-Wook] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol,Coll Med, Seoul 03722, South Korea; [Han, Seung Hyeok] Yonsei Univ, Dept Internal Med, Inst Kidney Dis Res, Coll Med, Seoul 03722, South Korea; [Shin, Ok Sarah] Korea Univ, Dept Biomed Sci, Coll Med, Guro Hosp, Seoul 08308, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine)	Yu, JW (corresponding author), Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol,Coll Med, Seoul 03722, South Korea.	jewookyu@yuhs.ac	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Hwang, Inhwa/0000-0001-5235-3519; Yu, Je-Wook/0000-0001-5943-4071; Son, Seunghwan/0000-0003-2408-2613; Shin, Jeon-Soo/0000-0002-8294-3234	National Research Foundation of Korea from the Korean Government [2014R1A4A1008625, 2015M3A9B6073856, 2017R1A2B2007467]; Yonsei University College of Medicine Faculty Research Grant [6-2016-0090]	National Research Foundation of Korea from the Korean Government(National Research Foundation of Korea); Yonsei University College of Medicine Faculty Research Grant	This work was supported by National Research Foundation of Korea Grants 2014R1A4A1008625, 2015M3A9B6073856, and 2017R1A2B2007467 from the Korean Government and Yonsei University College of Medicine Faculty Research Grant 6-2016-0090. The authors declare that they have no conflicts of interest with the contents of this article.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andreea SI, 2008, EXP DIABETES RES, DOI 10.1155/2008/473603; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kilhovd BK, 1999, DIABETES CARE, V22, P1543, DOI 10.2337/diacare.22.9.1543; Kim JA, 2016, IMMUNE NETW, V16, P286, DOI 10.4110/in.2016.16.5.286; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Liu JH, 2009, FEBS J, V276, P4598, DOI 10.1111/j.1742-4658.2009.07165.x; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; MIYATA T, 1994, J CLIN INVEST, V93, P521, DOI 10.1172/JCI117002; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Pertynska-Marczewska M, 2004, CYTOKINE, V28, P35, DOI 10.1016/j.cyto.2004.06.006; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Seno K, 2017, J REPROD DEVELOP, V63, P401, DOI 10.1262/jrd.2017-032; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Song Y, 2017, J CELL MOL MED, V21, P1373, DOI 10.1111/jcmm.13067; Stitt AW, 2001, BRIT J OPHTHALMOL, V85, P746, DOI 10.1136/bjo.85.6.746; Uribarri J, 2015, J CLIN ENDOCR METAB, V100, P1957, DOI 10.1210/jc.2014-3925; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Valencia JV, 2004, DIABETOLOGIA, V47, P844, DOI 10.1007/s00125-004-1392-9; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Vladimer GI, 2013, CURR OPIN MICROBIOL, V16, P23, DOI 10.1016/j.mib.2012.11.008; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Won JH, 2015, J BIOL CHEM, V290, P27425, DOI 10.1074/jbc.M115.667063; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00333; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2016, ARCH PHARM RES, V39, P1503, DOI 10.1007/s12272-016-0827-4; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	49	39	42	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20437	20448		10.1074/jbc.M117.806307	http://dx.doi.org/10.1074/jbc.M117.806307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29051224	hybrid, Green Published			2022-12-26	WOS:000418267000008
J	Pluangnooch, P; Timalsena, S; Wongkajornsilp, A; Soontrapa, K				Pluangnooch, Panwadee; Timalsena, Sunita; Wongkajornsilp, Adisak; Soontrapa, Kitipong			Cytokine-induced killer cells: A novel treatment for allergic airway inflammation	PLOS ONE			English	Article							ADOPTIVE IMMUNOTHERAPY; CIK CELLS; T-CELLS; ASTHMA; INTERLEUKIN-13; THERAPIES; PHENOTYPE; LYMPHOMA; DISEASE; MODEL	The effectiveness of cytokine-induced killer (CIK) cells for treatment of cancers has long been appreciated. Here, we report for the first time that CIK cells can be applied to treat allergic airway inflammation. Adopting from an established protocol with some modifications, we generated CIK cells ex vivo from mouse T cells, and examined their effectiveness in treatment of allergic airway inflammation using the ovalbumin-induced model of allergic airway inflammation. Based upon evaluation of bronchoalveolar lavage cellularity,T helper type2 cytokine levels and lung histology, all of which are important parameters for determining the severity of allergic airway inflammation, diseased mice treated with CIK cells showed significant reductions in all the parameters without any obvious adverse effects. Interestingly, the observed effects were comparable to those treated with dexamethasone. Thus, our study provides a novel application of CIK cells in treatment of allergic airway inflammation.	[Pluangnooch, Panwadee; Timalsena, Sunita; Wongkajornsilp, Adisak; Soontrapa, Kitipong] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Pharmacol, Bangkok, Thailand	Mahidol University	Soontrapa, K (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Pharmacol, Bangkok, Thailand.	kitipong.soo@mahidol.ac.th	Wongkajornsilp, Adisak/AAH-7668-2019	Wongkajornsilp, Adisak/0000-0002-3965-0997; Soontrapa, Kitipong/0000-0002-1704-3301	Thailand Research Fund [MRG-5580129]; Siriraj Foundation [D-003658]	Thailand Research Fund(Thailand Research Fund (TRF)); Siriraj Foundation	This study was supported by Thailand Research Fund (MRG-5580129) and the Siriraj Foundation (D-003658) to KS.; The authors wish to thank Dr. Toru Oga at Kyoto University and Dr. Wanpen Chaicumpa, Dr. Nitat Sookrung and Dr. Kittipong. Maneechotesuwan at Mahidol Univerity and for helpful advice. This work was supported by the Thailand Research Fund (MRG-5580129) and the Siriraj Foundation (D-003658).	Ayars AG, 2016, MED CLIN N AM, V100, P851, DOI 10.1016/j.mcna.2016.03.010; Baker J, 2001, BLOOD, V97, P2923, DOI 10.1182/blood.V97.10.2923; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Fulkerson PC, 2006, AM J PATHOL, V169, P2117, DOI 10.2353/ajpath.2006.060617; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Haworth O, 2011, J IMMUNOL, V186, P6129, DOI 10.4049/jimmunol.1004007; Irifune K, 2005, EUR RESPIR J, V25, P653, DOI 10.1183/09031936.05.00021304; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Jakel CE, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/473245; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Leemhuis T, 2005, BIOL BLOOD MARROW TR, V11, P181, DOI 10.1016/j.bbmt.2004.11.019; Linn YC, 2010, J BIOMED BIOTECHNOL, V2010, P8; Liu YF, 2016, ONCOL LETT, V12, P5205, DOI 10.3892/ol.2016.5337; McDonald VM, 2017, RESPIROLOGY, V22, P53, DOI 10.1111/resp.12957; Mesiano G, 2012, EXPERT OPIN BIOL TH, V12, P673, DOI 10.1517/14712598.2012.675323; Niu Q, 2011, INT IMMUNOPHARMACOL, V11, P449, DOI 10.1016/j.intimp.2010.12.014; Randolph DA, 1999, J IMMUNOL, V162, P2375; Schmeel FC, 2014, INT J MOL SCI, V15, P14632, DOI 10.3390/ijms150814632; Schmidt TL, 2014, IMMUNOL RES, V58, P300, DOI 10.1007/s12026-014-8507-2; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Timalsena S, 2016, ASIAN PAC J ALLERGY; Wang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14124; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	26	3	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186971	10.1371/journal.pone.0186971	http://dx.doi.org/10.1371/journal.pone.0186971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073213	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400083
J	Voigt, J; Carpenter, L; Leuchter, A				Voigt, Jeffrey; Carpenter, Linda; Leuchter, Andrew			Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis	PLOS ONE			English	Article							TREATMENT-RESISTANT; ELECTROCONVULSIVE-THERAPY; CLINICAL-RESPONSE; DOUBLE-BLIND; EFFICACY; SAFETY; METAANALYSIS; MORTALITY; RTMS	Objective Repetitive Transcranial Magnetic Stimulation (rTMS) commonly is used for the treatment of Major Depressive Disorder (MDD) after patients have failed to benefit from trials of multiple antidepressant medications. No analysis to date has examined the cost-effectiveness of rTMS used earlier in the course of treatment and over a patients' lifetime. Methods We used lifetime Markov simulation modeling to compare the direct costs and quality adjusted life years (QALYs) of rTMS and medication therapy in patients with newly diagnosed MDD (ages 20-59) who had failed to benefit from one pharmacotherapy trial. Patients' life expectancies, rates of response and remission, and quality of life outcomes were derived from the literature, and treatment costs were based upon published Medicare reimbursement data. Baseline costs, aggregate per year quality of life assessments (QALYs), Monte Carlo simulation, tornado analysis, assessment of dominance, and one way sensitivity analysis were also performed. The discount rate applied was 3%. Results Lifetime direct treatment costs, and QALYs identified rTMS as the dominant therapy compared to antidepressant medications (i. e., lower costs with better outcomes) in all age ranges, with costs/improved QALYs ranging from $2,952/0.32 (older patients) to $11,140/ 0.43 (younger patients). One-way sensitivity analysis demonstrated that the model was most sensitive to the input variables of cost per rTMS session, monthly prescription drug cost, and the number of rTMS sessions per year. Conclusion rTMS was identified as the dominant therapy compared to antidepressant medication trials over the life of the patient across the lifespan of adults with MDD, given current costs of treatment. These models support the use of rTMS after a single failed antidepressant medication trial versus further attempts at medication treatment in adults with MDD.	[Voigt, Jeffrey] Med Device Consultants Ridgewood LLC, Ridgewood, NJ 07450 USA; [Carpenter, Linda] Brown Univ, Dept Psychiat & Human Behav, Brown Inst Brain Sci, Providence, RI 02912 USA; [Leuchter, Andrew] Univ Calif Los Angeles, Neuromodulat Div, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA	Brown University; University of California System; University of California Los Angeles	Voigt, J (corresponding author), Med Device Consultants Ridgewood LLC, Ridgewood, NJ 07450 USA.	meddevconsultant@aol.com		Voigt, Jeffrey/0000-0002-1755-8612	Magstim; Neuronetics; NeoSync; Jannssen	Magstim; Neuronetics; NeoSync; Jannssen	The funder (Magstim) provided an unrestricted grant to Medical Device Consultants of Ridgewood (commercial company) for the research, analysis, and preparation of the manuscript. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Linda Carpenter, MD, has received consulting income from Magstim, Inc (<$5,000/year). Additionally, Dr. Carpenter has received clinical trial research support from Neuronetics, NeoSync, and Jannssen; and equipment support from NeoSync and Neuronetics.	Berlim MT, 2013, PSYCHOL MED, V43, P2245, DOI 10.1017/S0033291712002802; Brakemeier EL, 2007, J PSYCHIATR RES, V41, P395, DOI 10.1016/j.jpsychires.2006.01.013; Buikema A, 2015, AM J PHARM BENEFIST, V7, P135; Dunner DL, 2014, J CLIN PSYCHIAT, V75, P1394, DOI 10.4088/JCP.13m08977; Gallo JJ, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f2570; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; Gold MR, 1996, COST EFFECTIVENESS H, P285; Greenberg PE, 2015, J CLIN PSYCHIAT, P76; Health Quality Ontario, 2016, Ont Health Technol Assess Ser, V16, P1; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; Janicak PG, 2008, J CLIN PSYCHIAT, V69, P222, DOI 10.4088/JCP.v69n0208; Kedzior KK, 2015, DEPRESS ANXIETY, V32, P193, DOI 10.1002/da.22339; Kozel FA, 2004, CNS SPECTRUMS, V9, P476; Leuchter AF, 2015, BRAIN STIMUL, V8, P787, DOI 10.1016/j.brs.2015.05.005; Levkovitz Y, 2015, WORLD PSYCHIATRY, V14, P64, DOI 10.1002/wps.20199; Liu BS, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0342-4; MedPAC, 2017, HOSP INP OUTP SERV A; Miller LW, 2013, CIRCULATION, V127, P743, DOI 10.1161/CIRCULATIONAHA.112.139824; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Nguyen KH, 2015, VALUE HEALTH, V18, P597, DOI 10.1016/j.jval.2015.04.004; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010; Philip NS, 2016, BRAIN STIMUL, V9, P251, DOI 10.1016/j.brs.2015.11.007; Piatt EE, 2010, PSYCHIAT SERV, V61, P663, DOI 10.1176/ps.2010.61.7.663; PRUDIC J, 1990, PSYCHIAT RES, V31, P287, DOI 10.1016/0165-1781(90)90098-P; Prudic J, 1996, AM J PSYCHIAT, V153, P985; Rasanen P, 1999, J AFFECT DISORDERS, V55, P67, DOI 10.1016/S0165-0327(99)00002-6; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; SACKEIM HA, 1990, J CLIN PSYCHOPHARM, V10, P96, DOI 10.1097/00004714-199004000-00004; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Simpson KN, 2009, ADV THER, V26, P346, DOI 10.1007/s12325-009-0013-x; Sinyor M, 2010, CAN J PSYCHIAT, V55, P126, DOI 10.1177/070674371005500303; Tosteson ANA, 2008, ANN INTERN MED, V149, P845, DOI 10.7326/0003-4819-149-12-200812160-00003; Udupa K, 2007, J AFFECT DISORDERS, V104, P231, DOI 10.1016/j.jad.2007.04.002; Vallejo-Torres L, 2015, PSYCHOL MED, V45, P1459, DOI 10.1017/S0033291714002554; Zivin K, 2012, PSYCHIAT SERV, V63, P823, DOI 10.1176/appi.ps.201100317	40	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186950	10.1371/journal.pone.0186950	http://dx.doi.org/10.1371/journal.pone.0186950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073256	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400079
J	Elliott, KC; McCright, AM; Allen, S; Dietz, T				Elliott, Kevin C.; McCright, Aaron M.; Allen, Summer; Dietz, Thomas			Values in environmental research: Citizens' views of scientists who acknowledge values	PLOS ONE			English	Article							ANTI-REFLEXIVITY; MECHANICAL TURK; INDUCTIVE RISK; CLIMATE-CHANGE; BISPHENOL-A; POPULATION; SCIENCE; TRUST	Scientists who perform environmental research on policy-relevant topics face challenges when communicating about how values may have influenced their research. This study examines how citizens view scientists who publicly acknowledge values. Specifically, we investigate whether it matters: if citizens share or oppose a scientist's values, if a scientist's conclusions seem contrary to or consistent with the scientist's values, and if a scientist is assessing the state of the science or making a policy recommendation. We conducted two 3x2 factorial design online experiments. Experiment 1 featured a hypothetical scientist assessing the state of the science on the public-health effects of exposure to Bisphenol A (BPA), and Experiment 2 featured a scientist making a policy recommendation on use of BPA. We manipulated whether or not the scientist expressed values and whether the scientist's conclusion appeared contrary to or consistent with the scientist's values, and we accounted for whether or not subjects' values aligned with the scientist's values. We analyzed our data with ordinary least squares (OLS) regression techniques. Our results provide at least preliminary evidence that acknowledging values may reduce the perceived credibility of scientists within the general public, but this effect differs depending on whether scientists and citizens share values, whether scientists draw conclusions that run contrary to their values, and whether scientists make policy recommendations.	[Elliott, Kevin C.] Michigan State Univ, Dept Fisheries & Wildlife, Lyman Briggs Coll, Dept Philosophy, E Lansing, MI 48824 USA; [McCright, Aaron M.] Michigan State Univ, Dept Sociol, Lyman Briggs Coll, Environm Sci & Policy Program, E Lansing, MI 48824 USA; [Allen, Summer] Michigan State Univ, Dept Sociol, E Lansing, MI 48824 USA; [Dietz, Thomas] Michigan State Univ, Dept Sociol, Environm Sci & Policy Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Elliott, KC (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Lyman Briggs Coll, Dept Philosophy, E Lansing, MI 48824 USA.	kce@msu.edu	McCright, Aaron M./Z-1967-2019	Dietz, Thomas/0000-0001-9399-0784	MSU AgBioResearch; Michigan State University AgBio Research	MSU AgBioResearch; Michigan State University AgBio Research	This research was funded with support from MSU AgBioResearch to Tom Dietz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study; The research leading to these results was partially supported by Michigan State University AgBio Research. The authors thank Jayden Elliott for assistance creating the figures.	Allen S, 2015, ENERGY RES SOC SCI, V10, P133, DOI 10.1016/j.erss.2015.07.014; [Anonymous], 2004, SCIENCEVALUES OBJECT; Betz G, 2013, EUR J PHILOS SCI, V3, P207, DOI 10.1007/s13194-012-0062-x; Campbell TH, 2014, J PERS SOC PSYCHOL, V107, P809, DOI 10.1037/a0037963; Clements J., 2015, ENVIRON SOCIOL, V1, P27, DOI [10.1080/23251042.2015.1020466, DOI 10.1080/23251042.2015.1020466]; Cole S, 1992, MAKING SCI NATURE SO; de Melo-Martin I, 2016, PHILOS SCI, V83, P500, DOI 10.1086/687259; Dietz T., 2013, STRUCTURAL HUMAN ECO, P31; Dietz T, 2013, P NATL ACAD SCI USA, V110, P14081, DOI 10.1073/pnas.1212740110; Douglas H., 2008, PUBLIC AFFAIRS Q, V22, P1; Douglas HE, 2009, SCI POLICY VALUE FRE, DOI [DOI 10.2307/J.CTT6WRC78, 10.2307/j.ctt6wrc78]; Elliott K., 2011, IS LITTLE POLLUTION; Elliott K.C., 2017, TAPESTRY VALUES INTR; Elliott KC, 2017, EXPLORING INDUCTIVE; Elliott KC, 2017, CURR CONTROV PHILOS, P1; Elliott KC, 2014, ENVIRON HEALTH PERSP, V122, P647, DOI 10.1289/ehp.1408107; Funtowicz S. O., 1990, UNCERTAINTY QUALITY; Giere RN, 2003, PHILOS SCI, V70, P15, DOI 10.1086/367865; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Goodwin RE, 2009, BRIT FOOD J, V111, P408, DOI 10.1108/00070700910957267; Horne Z, 2015, P NATL ACAD SCI USA, V112, P10321, DOI 10.1073/pnas.1504019112; Hudson Robert, 2016, Perspectives on Science, V24, P167, DOI 10.1162/POSC_a_00199; Humphreys, 2016, OXFORD HDB PHILOS SC, P609; Intemann K, 2015, EUR J PHILOS SCI, V5, P217, DOI 10.1007/s13194-014-0105-6; Jasanoff S., 1990, 5 BRANCH SCI ADVISER; John S, 2015, SYNTHESE, V192, P79, DOI 10.1007/s11229-014-0554-7; John S, 2012, STUD HIST PHILOS SCI, V43, P218, DOI 10.1016/j.shpsa.2011.10.007; Lacey H, 1999, IS SCI VALUE FREE; Lacey H, 2015, STUD HIST PHILOS SCI, V53, P89, DOI 10.1016/j.shpsa.2015.05.009; Levay KE, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016636433; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Longino H. E., 1990, SCI SOCIAL KNOWLEDGE, DOI [10.1515/9780691209753, DOI 10.2307/J.CTVX5WBFZ]; McCright AM, 2016, HUM ECOL REV, V22, P77; McCright AM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044029; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; McCright AM, 2010, THEOR CULT SOC, V27, P100, DOI 10.1177/0263276409356001; McKaughan DJ, 2013, ACCOUNT RES, V20, P206, DOI 10.1080/08989621.2013.788384; Mitchell Sandra D., 2004, SCI VALUES OBJECTIVI, P245, DOI DOI 10.2307/J.CTT5VKG7T.16; Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Petty RE, 2001, SOC COGNITION, V19, P418, DOI 10.1521/soco.19.4.418.20758; Resnik DB, 2015, BIOETHICS, V29, P182, DOI 10.1111/bioe.12079; Rosa E., 2014, RISK SOC REVISITED S; Rosenbaum L, 2015, NEW ENGL J MED, V372, P1959, DOI 10.1056/NEJMms1502497; Schnaiberg Allan, 1980, ENV SURPLUS SCARCITY; Schroter S, 2004, BRIT MED J, V328, P742, DOI 10.1136/bmj.38035.705185.F6; Stewart N, 2015, JUDGM DECIS MAK, V10, P479; Vandenburg LN, 2016, ANDROL; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Weinberg JD, 2014, SOCIOL SCI, V1, P292, DOI 10.15195/v1.a19; Wilholt T, 2013, BRIT J PHILOS SCI, V64, P233, DOI 10.1093/bjps/axs007	53	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2017	12	10							e0186049	10.1371/journal.pone.0186049	http://dx.doi.org/10.1371/journal.pone.0186049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FK7DC	29069087	Green Published, Green Submitted, gold			2022-12-26	WOS:000413663600012
J	Moosavi, V; Isacchini, G				Moosavi, Vahid; Isacchini, Giulio			A Markovian model of evolving world inputoutput network	PLOS ONE			English	Article							SENSITIVITY; PERTURBATION; CHAIN	The initial theoretical connections between Leontief input-output models and Markov chains were established back in 1950s. However, considering the wide variety of mathematical properties of Markov chains, so far there has not been a full investigation of evolving world economic networks with Markov chain formalism. In this work, using the recently available world input-output database, we investigated the evolution of the world economic network from 1995 to 2011 through analysis of a time series of finite Markov chains. We assessed different aspects of this evolving system via different known properties of the Markov chains such as mixing time, Kemeny constant, steady state probabilities and perturbation analysis of the transition matrices. First, we showed how the time series of mixing times and Kemeny constants could be used as an aggregate index of globalization. Next, we focused on the steady state probabilities as a measure of structural power of the economies that are comparable to GDP shares of economies as the traditional index of economies welfare. Further, we introduced two measures of systemic risk, called systemic influence and systemic fragility, where the former is the ratio of number of influenced nodes to the total number of nodes, caused by a shock in the activity of a node, and the latter is based on the number of times a specific economic node is affected by a shock in the activity of any of the other nodes. Finally, focusing on Kemeny constant as a global indicator of monetary flow across the network, we showed that there is a paradoxical effect of a change in activity levels of economic nodes on the overall flow of the world economic network. While the economic slowdown of the majority of nodes with high structural power results to a slower average monetary flow over the network, there are some nodes, where their slowdowns improve the overall quality of the network in terms of connectivity and the average flow of the money.	[Moosavi, Vahid] Swiss Fed Inst Technol, Dept Architecture, Chair Comp Aided Architectural Design, Zurich, Switzerland; [Isacchini, Giulio] Swiss Fed Inst Technol, Dept Phys, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Moosavi, V (corresponding author), Swiss Fed Inst Technol, Dept Architecture, Chair Comp Aided Architectural Design, Zurich, Switzerland.	svm@arch.ethz.ch						Acemoglu D, 2015, AM ECON REV, V105, P564, DOI 10.1257/aer.20130456; [Anonymous], PAGERANK CITATION RA; Baldwin R, 2015, WORLD ECON, V38, P1682, DOI 10.1111/twec.12189; Battiston S, 2012, SCI REPORTS, P2; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Braess D, 2005, TRANSPORT SCI, V39, P446, DOI 10.1287/trsc.1050.0127; Cao XR, 1998, IEEE T CONTR SYST T, V6, P482, DOI 10.1109/87.701341; Cerina F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134025; Cho GE, 2000, LINEAR ALGEBRA APPL, V316, P21, DOI 10.1016/S0024-3795(99)00263-3; Crisostomi E, 2011, INT J CONTROL, V84, P633, DOI 10.1080/00207179.2011.568005; Cristelli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117174; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Duchin F, 2010, J IND ECOL, V14, P586, DOI 10.1111/j.1530-9290.2010.00258.x; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Kirkland S, 2010, LINEAR ALGEBRA APPL, V433, P1988, DOI 10.1016/j.laa.2010.07.016; Langville A. N., 2011, GOOGLES PAGERANK; Leontief W.W., 1951, STRUCTURE AM EC 1919; Levene M, 2002, AM MATH MON, V109, P741, DOI 10.2307/3072398; LEVIN D. A., 2009, MARKOV CHAINS MIXING; Markov AA., 1906, IZVESTIYA FIZIKO MAT, V15, P18; Moosavi V, 2013, P 2 ACM SIGKDD INT W, P10; SENETA E, 1993, STAT PROBABIL LETT, V17, P163, DOI 10.1016/0167-7152(93)90011-7; Solow R, 1952, ECONOMETRICA, V20, P29, DOI 10.2307/1907805; Tacchella A, 2012, SCI REPORTS, P2; Timmer MP, 2015, REV INT ECON, V23, P575, DOI 10.1111/roie.12178; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110; Zhu Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126699	27	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186746	10.1371/journal.pone.0186746	http://dx.doi.org/10.1371/journal.pone.0186746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065145	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900032
J	Rumisha, C; Huyghe, F; Rapanoel, D; Mascaux, N; Kochzius, M				Rumisha, Cyrus; Huyghe, Filip; Rapanoel, Diary; Mascaux, Nemo; Kochzius, Marc			Genetic diversity and connectivity in the East African giant mud crab Scylla serrata: Implications for fisheries management	PLOS ONE			English	Article							PRAWN PENAEUS-MONODON; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; TRACE-METALS; SOFTWARE; PORTUNIDAE; DECAPODA; HABITAT; NUCLEAR; DIFFERENTIATION	The giant mud crab Scylla serrata provides an important source of income and food to coastal communities in East Africa. However, increasing demand and exploitation due to the growing coastal population, export trade, and tourism industry are threatening the sustainability of the wild stock of this species. Because effective management requires a clear understanding of the connectivity among populations, this study was conducted to assess the genetic diversity and connectivity in the East African mangrove crab S. serrata. A section of 535 base pairs of the cytochrome oxidase subunit I (COI) gene and eight microsatellite loci were analysed from 230 tissue samples of giant mud crabs collected from Kenya, Tanzania, Mozambique, Madagascar, and South Africa. Microsatellite genetic diversity (H-e) ranged between 0.56 and 0.6. The COI sequences showed 57 different haplotypes associated with low nucleotide diversity (current nucleotide diversity = 0.29%). In addition, the current nucleotide diversity was lower than the historical nucleotide diversity, indicating overexploitation or historical bottlenecks in the recent history of the studied population. Considering that the coastal population is growing rapidly, East African countries should promote sustainable fishing practices and sustainable use of mangrove resources to protect mud crabs and other marine fauna from the increasing pressure of exploitation. While microsatellite loci did not show significant genetic differentiation (p > 0.05), COI sequences revealed significant genetic divergence between sites on the East coast of Madagascar (ECM) and sites on the West coast of Madagascar, mainland East Africa, as well as the Seychelles. Since East African countries agreed to achieve the Convention on Biological Diversity (CBD) target to protect over 10% of their marine areas by 2020, the observed pattern of connectivity and the measured genetic diversity can serve to provide useful information for designing networks of marine protected areas.	[Rumisha, Cyrus] Sokoine Univ Agr, Solomon Mahlangu Coll Sci & Educ, Dept Biosci, Morogoro, Tanzania; [Rumisha, Cyrus; Huyghe, Filip; Rapanoel, Diary; Mascaux, Nemo; Kochzius, Marc] Vrije Univ Brussel, Dept Biol, Marine Biol, Brussels, Belgium	Sokoine University of Agriculture; Vrije Universiteit Brussel	Rumisha, C (corresponding author), Sokoine Univ Agr, Solomon Mahlangu Coll Sci & Educ, Dept Biosci, Morogoro, Tanzania.; Rumisha, C (corresponding author), Vrije Univ Brussel, Dept Biol, Marine Biol, Brussels, Belgium.	cyrus.rumisha@gmail.com	Kochzius, Marc/AAN-3799-2021; Rumisha, Cyrus/V-6019-2019	Rumisha, Cyrus/0000-0002-8240-7087; Kochzius, Marc/0000-0001-8953-4719	Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelingssamenwerking [ICP PhD 2013-009]	Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelingssamenwerking	The study was funded by the Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelingssamenwerking (Project Identification Number: ICP PhD 2013-009) through a scholarship given to the first author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts-Hubatsch H, 2016, HYDROBIOLOGIA, V763, P5, DOI 10.1007/s10750-015-2393-z; Alcazar DSR, 2016, J MAR BIOL ASSOC UK, V96, P707, DOI 10.1017/S0025315415000971; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Alves MJ, 2001, HEREDITY, V87, P463, DOI 10.1046/j.1365-2540.2001.00929.x; [Anonymous], 2010, INT NEWS ANAL MARINE, P1; Avise John C., 2004, P1; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bonine KM, 2008, PAC SCI, V62, P1, DOI 10.2984/1534-6188(2008)62[1:PCOTMC]2.0.CO;2; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Dixon JD, 2007, CONSERV GENET, V8, P455, DOI 10.1007/s10592-006-9184-z; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewel KC, 2009, PAC SCI, V63, P15, DOI 10.2984/1534-6188(2009)63[15:COSSDP]2.0.CO;2; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreri M, 2011, AFR J BIOTECHNOL, V10, P12799; Fondo E. N., 2010, International Journal of Fisheries and Aquaculture, V2, P79; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fratini S, 2002, J EXP MAR BIOL ECOL, V272, P103, DOI 10.1016/S0022-0981(02)00052-7; Fratini S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158582; Fratini S, 2010, ESTUAR COAST SHELF S, V86, P51, DOI 10.1016/j.ecss.2009.10.009; Fu XY, 2007, GENETICS, V147, P915; Fuseya R, 2007, AQUACULTURE, V272, pS257, DOI 10.1016/j.aquaculture.2007.07.063; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Gopurenko D, 1999, MAR BIOL, V134, P227, DOI 10.1007/s002270050541; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; HOLM S, 1979, SCAND J STAT, V6, P65; Holme MH, 2006, AQUA FEEDS FORMULATI, V3, P3; Humphries EM, 2011, MOL ECOL, V20, P573, DOI 10.1111/j.1365-294X.2010.04965.x; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Larsson LC, 2009, CONSERV GENET, V10, P1255, DOI 10.1007/s10592-008-9693-z; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ma HY, 2011, BIOCHEM SYST ECOL, V39, P371, DOI 10.1016/j.bse.2011.05.007; Martien KK, 2014, J HERED, V105, P611, DOI 10.1093/jhered/esu029; Meynecke JO, 2014, ICES J MAR SCI, V71, P484, DOI 10.1093/icesjms/fst181; Mirera DO, 2013, OCEAN COAST MANAGE, V84, P119, DOI 10.1016/j.ocecoaman.2013.08.002; Mirera OD, 2011, OCEAN COAST MANAGE, V54, P844, DOI 10.1016/j.ocecoaman.2011.08.001; Mwaluma James, 2002, Western Indian Ocean Journal of Marine Science, V1, P127; Nehemia A, 2017, J MOLLUS STUD, V83, P1, DOI 10.1093/mollus/eyw040; Olsen KH, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P507, DOI 10.1007/978-0-387-77101-4_26; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Richmond M. D., 2002, FIELD GUIDE SEA SHOR; Rodriguezl SR, 1993, SETTLEMENT BENTHIC M, V97, P193; Roehrdanz R.L., 1993, Insect Molecular Biology, V2, P89, DOI 10.1111/j.1365-2583.1993.tb00129.x; Rumisha C, 2015, AFR J AQUAT SCI, V40, P143, DOI 10.2989/16085914.2015.1051504; Rumisha C, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6248-0; Rumisha C, 2017, MAR POLLUT BULL, V114, P759, DOI 10.1016/j.marpolbul.2016.10.057; Rumisha C, 2016, ECOTOX ENVIRON SAFE, V132, P77, DOI 10.1016/j.ecoenv.2016.05.028; Schouten MW, 2003, DEEP-SEA RES PT II, V50, P1987, DOI 10.1016/S0967-0645(03)00042-0; Silva IC, 2010, MAR BIOL, V157, P1113, DOI 10.1007/s00227-010-1393-9; Silva SE, 2013, BIOL J LINN SOC, V108, P494, DOI 10.1111/j.1095-8312.2012.02041.x; sterlund K, MARINE PLANTS TANZAN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor ML., 2003, UNEP WCMC BIODIVERSI, V13; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wang J, 2015, MOL ECOL, V24, P3546, DOI 10.1111/mec.13204; Welch JM, 1997, MAR ECOL PROG SER, V154, P143, DOI 10.3354/meps154143; Wells S, 2007, OCEAN COAST MANAGE, V50, P67, DOI 10.1016/j.ocecoaman.2006.08.012; Wilkie M. L, 2003, 63 FOR RES DIV; Yao HF, 2012, GENET MOL RES, V11, P1503, DOI 10.4238/2012.May.21.7; Zhao HW., 2013, AFR J BIOTECHNOL, V12, P2088, DOI [10.5897/AJB12.1912, DOI 10.5897/AJB12.1912]	67	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186817	10.1371/journal.pone.0186817	http://dx.doi.org/10.1371/journal.pone.0186817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065166	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900045
J	Sun, Y; Luo, T; Shen, Y; Haapasalo, M; Zou, L; Liu, J				Sun, Yan; Luo, Tao; Shen, Ya; Haapasalo, Markus; Zou, Ling; Liu, Jun			Effect of iRoot Fast Set root repair material on the proliferation, migration and differentiation of human dental pulp stem cells in vitro	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; TRICALCIUM SILICATE; PROGNOSTIC-FACTORS; CALCIUM HYDROXIDE; BIODENTINE; MECHANISM; ADHESION; TISSUE	The present study investigated the effect of iRoot Fast Set root repair material (iRoot FS) on the proliferation, migration and differentiation of human dental pulp stem cells (hDPSCs). The hDPSCs were treated with eluates of iRoot FS at concentrations of 0.2 and 2 mg/mL, referred to as FS0.2 and FS2, respectively, and Biodentine (BD; Septodont, Saint Maur des Fausses, France) eluates at the corresponding concentrations as positive controls. A CCK8 assay was performed to determine cell proliferation. Wound healing and transwell assays were conducted to examine cell migration. Osteogenic differentiation was evaluated based on alkaline phosphatase activity, Alizarin Red S staining and quantitative real-time reverse-transcriptase polymerase chain reaction (qRT-PCR) to analyze the mRNA expression of differentiation gene markers. Cell proliferation was higher in the FS and BD groups than in the blank controls at 3 and 7 days. Moreover, FS0.2 enhanced cell migration and significantly promoted the osteogenic differentiation of hDPSCs. These findings suggested that iRoot FS is a bioactive material that promotes the proliferation, migration and osteogenic differentiation of hDPSCs.	[Sun, Yan; Luo, Tao; Zou, Ling] Sichuan Univ, West China Hosp Stomatol, Dept Endodont, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Shen, Ya; Haapasalo, Markus] Univ British Columbia, Div Endodont, Dept Oral Biol & Med Sci, Fac Dent, Vancouver, BC, Canada; [Liu, Jun] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Dept Orthodont, Chengdu, Sichuan, Peoples R China	Sichuan University; University of British Columbia; Sichuan University	Zou, L (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Endodont, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.; Liu, J (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Dept Orthodont, Chengdu, Sichuan, Peoples R China.	zouling@scu.edu.cn; junliu@scu.edu.cn	Liu, Jun/AAR-7236-2020; Shen, Ya/X-5855-2019; LIU, JUN/AAR-8044-2020	LIU, JUN/0000-0001-5072-3205; Sun, Yan/0000-0002-3974-1645; Zou, Ling/0000-0002-6022-2911; , Ya/0000-0002-0792-4279	National Natural Science Foundation of China (NSFC) [81201379, 81470722]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201365]; Foundation for Outstanding Young Scholars of Sichuan University [2014SCU04A10]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Foundation for Outstanding Young Scholars of Sichuan University	This study was supported by National Natural Science Foundation of China (NSFC) Grant No. 81201379 and 81470722 (JL), the Foundation for the Author of National Excellent Doctoral Dissertation of China Grant No. 201365 (JL), and the Foundation for Outstanding Young Scholars of Sichuan University Grant No. 2014SCU04A10 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported through the National Natural Science Foundation of China (NSFC) Grant No. 81201379 and 81470722 (JL), the Foundation for the Author of National Excellent Doctoral Dissertation of China Grant No. 201365 (JL), and the Foundation for Outstanding Young Scholars of Sichuan University Grant No. 2014SCU04A10 (JL).	Ames JM, 2009, J ENDODONT, V35, P225, DOI 10.1016/j.joen.2008.11.008; BAUME LJ, 1981, INT DENT J, V31, P251; Bidar Maryam, 2014, J Dent Res Dent Clin Dent Prospects, V8, P134, DOI 10.5681/joddd.2014.025; Bosio CC, 2014, INT ENDOD J, V47, P667, DOI 10.1111/iej.12203; Caliskan MK, 2017, CLIN ORAL INVEST, V21, P357, DOI 10.1007/s00784-016-1798-z; Camilleri J, 2014, DENT MATER, V30, P709, DOI 10.1016/j.dental.2014.03.012; Chalisserry EP, 2017, J TISSUE ENG, V8, DOI 10.1177/2041731417702531; Cho SY, 2013, J ENDODONT, V39, P327, DOI 10.1016/j.joen.2012.11.034; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; D'Anto V, 2010, J ENDODONT, V36, P1839, DOI 10.1016/j.joen.2010.08.010; Daltoe MO, 2016, J ENDODONT, V42, P596, DOI 10.1016/j.joen.2015.12.018; De-Deus G, 2012, INT ENDOD J, V45, P508, DOI 10.1111/j.1365-2591.2011.02003.x; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136; GLASS RL, 1949, J DENT RES, V28, P97, DOI 10.1177/00220345490280021101; Graham L, 2006, BIOMATERIALS, V27, P2865, DOI 10.1016/j.biomaterials.2005.12.020; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Guo YJ, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0184-1; Hakki SS, 2009, J ENDODONT, V35, P513, DOI 10.1016/j.joen.2008.12.016; Hilton TJ, 2009, OPER DENT, V34, P615, DOI 10.2341/09-132-0; Jiang Y, 2014, THESCIENTIFICWORLDJO, V2014; Jittapiromsak N, 2010, TISSUE ENG PT A, V16, P1997, DOI [10.1089/ten.tea.2009.0593, 10.1089/ten.TEA.2009.0593]; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Kim Jia, 2016, Restor Dent Endod, V41, P29, DOI 10.5395/rde.2016.41.1.29; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li DM, 2014, J DENT, V42, P1327, DOI 10.1016/j.jdent.2014.07.007; Liu J, 2013, BIOMATERIALS, V34, P7862, DOI 10.1016/j.biomaterials.2013.07.029; Luo ZR, 2014, J ENDODONT, V40, P937, DOI 10.1016/j.joen.2013.11.022; Luo Z, 2014, J DENT, V42, P490, DOI 10.1016/j.jdent.2013.12.011; Malkondu O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160951; Mukhtar-Fayyad D, 2011, ORAL SURG ORAL MED O, V112, pE137, DOI 10.1016/j.tripleo.2011.05.042; Nakashima M, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0506-5; Nowicka A, 2015, J ENDODONT, V41, P1234, DOI 10.1016/j.joen.2015.03.017; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Paino F, 2014, STEM CELLS, V32, P279, DOI 10.1002/stem.1544; Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009; Peng WW, 2011, J ENDODONT, V37, P1240, DOI 10.1016/j.joen.2011.05.035; Qiao D, 2016, Beijing Da Xue Xue Bao Yi Xue Ban, V48, P324; Rathinam E, 2015, J ENDODONT, V41, P1805, DOI 10.1016/j.joen.2015.07.015; Robey PG, 1996, CONNECT TISSUE RES, V35, P131, DOI 10.3109/03008209609029183; Shi S, 2016, INT ENDOD J, V49, P154, DOI 10.1111/iej.12439; Shi Shuang, 2015, Iran Endod J, V10, P99; Shie MY, 2014, J BIOMED MATER RES A, V102, P769, DOI 10.1002/jbm.a.34737; STUART KG, 1991, ORAL SURG ORAL MED O, V72, P101, DOI 10.1016/0030-4220(91)90198-L; Sugawara Y, 2002, JPN J PHARMACOL, V88, P262, DOI 10.1254/jjp.88.262; Tatullo M, 2015, J TISSUE ENG REGEN M, V9, P1205, DOI 10.1002/term.1899; Tirino V, 2011, STEM CELL REV REP, V7, P608, DOI 10.1007/s12015-011-9235-9; Villat Cyril, 2013, Restor Dent Endod, V38, P258, DOI 10.5395/rde.2013.38.4.258; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; ZANDER H. A., 1939, JOUR DENTAL RES, V18, P373, DOI 10.1177/00220345390180040601; Zanini M, 2012, J ENDODONT, V38, P1220, DOI 10.1016/j.joen.2012.04.018; Zhang J, 2015, J DENT RES, V94, P853, DOI 10.1177/0022034515572020; Zhang W, 2010, J ENDODONT, V36, P1978, DOI 10.1016/j.joen.2010.08.038; Zhao X, 2012, MOL BIOL REP, V39, P215, DOI 10.1007/s11033-011-0728-z; Zhou HM, 2013, J ENDODONT, V39, P478, DOI 10.1016/j.joen.2012.11.026; Zhou YH, 2012, ACTA BIOMATER, V8, P2307, DOI 10.1016/j.actbio.2012.03.012; Zhu LX, 2014, ACTA BIOMATER, V10, P5156, DOI 10.1016/j.actbio.2014.08.014	57	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186848	10.1371/journal.pone.0186848	http://dx.doi.org/10.1371/journal.pone.0186848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059236	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000047
J	Egarnes, B; Blanchet, MR; Gosselin, J				Egarnes, Benoit; Blanchet, Marie-Renee; Gosselin, Jean			Treatment with the NR4A1 agonist cytosporone B controls influenza virus infection and improves pulmonary function in infected mice	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTORS; NF-KAPPA-B; INFLAMMATORY RESPONSES; ALVEOLAR MACROPHAGES; MONOCYTES; NUR77; GENE; REPLICATION; CELLS; ATHEROSCLEROSIS	The transcription factor NR4A1 has emerged as a pivotal regulator of the inflammatory response and immune homeostasis. Although contribution of NR4A1 in the innate immune response has been demonstrated, its role in host defense against viral infection remains to be investigated. In the present study, we show that administration of cytosporone B (CsnB), a specific agonist of NR4A1, to mice infected with influenza virus (IAV) reduces lung viral loads and improves pulmonary function. Our results demonstrate that administration of Csn-B to naive mice leads to a modest production of type 1 IFN. However, in IAV-infected mice, such production of IFNs is markedly increased following treatment with Csn-B. Our study also reveals that alveolar macrophages (AMs) appear to have a significant role in Csn-B effects, since selective depletion of AMs with clodronate liposome correlates with a marked reduction of IFN production, viral clearance and morbidity in IAV-infected mice. Furthermore, when reemergence of AMs is observed following clodronate liposome administration, an increased production of IFNs was detected in bronchoalveolar fluids of IAV-infected mice treated with Csn-B, supporting the contribution of AMs in Csn-B effects. While treatment of mice with Csn-B induces phosphorylation of transcriptional factors IRF3 and IRF7, the latter appears to be less indispensable since effects of Csn-B treatment on the synthesis of IFNs were slightly affected in IAV-infected mice lacking functional IRF7. Together, our results highlight the capacity of Csn-B and consequently of NR4A1 transcription factor in controlling IAV infection.	[Egarnes, Benoit; Gosselin, Jean] Univ Laval CHUL, CHU Quebec, Ctr Rech, Lab Innate Immunol, Quebec City, PQ, Canada; [Egarnes, Benoit; Gosselin, Jean] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Blanchet, Marie-Renee] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Gosselin, J (corresponding author), Univ Laval CHUL, CHU Quebec, Ctr Rech, Lab Innate Immunol, Quebec City, PQ, Canada.; Gosselin, J (corresponding author), Univ Laval, Dept Mol Med, Quebec City, PQ, Canada.	jean.gosselin@crchudequebec.ulaval.ca			Canadian Institutes of Health Research [MOP-123440, MOP-142304]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research to JG (MOP-123440 and MOP-142304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; Brunet A, 2016, EUR J IMMUNOL, V46, P2789, DOI 10.1002/eji.201646406; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Coulombe F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036734; Dare RK, 2016, INFECT DIS CLIN N AM, V30, P1053, DOI 10.1016/j.idc.2016.07.004; De Silva S, 2005, ARTHRITIS RHEUM-US, V52, P333, DOI 10.1002/art.20736; Garaigorta U, 2005, J VIROL, V79, P15246, DOI 10.1128/JVI.79.24.15246-15257.2005; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Gaudreault E, 2012, INT IMMUNOL, V24, P693, DOI 10.1093/intimm/dxs074; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Hamers AAJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133598; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hatesuer B, 2017, J INNATE IMMUN, V9, P145, DOI 10.1159/000450705; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hu YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087313; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Killip MJ, 2014, J VIROL, V88, P3942, DOI 10.1128/JVI.03109-13; Kreijtz JHCM, 2009, HUM VACCINES, V5, P126, DOI 10.4161/hv.5.3.6986; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; Liu T, 2002, J VIROL, V76, P13055, DOI 10.1128/JVI.76.24.13055-13061.2002; McEvoy C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00007; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Murphy EP, 2015, BIOMOLECULES, V5, P1302, DOI 10.3390/biom5031302; Ogle ME, 2016, EXP BIOL MED, V241, P1084, DOI 10.1177/1535370216650293; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; Wu H, 2016, J PATHOL, V238, P457, DOI 10.1002/path.4670; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhao Y, 2010, CIRC RES, V107, P501, DOI 10.1161/CIRCRESAHA.110.222083; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	45	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186639	10.1371/journal.pone.0186639	http://dx.doi.org/10.1371/journal.pone.0186639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053748	gold, Green Published, Green Submitted			2022-12-26	WOS:000413315100029
J	Tartas, A; Zarkadas, C; Palaiomylitou, M; Gounalaki, N; Tzamarias, D; Vlassi, M				Tartas, Athanassios; Zarkadas, Christoforos; Palaiomylitou, Maria; Gounalaki, Niki; Tzamarias, Dimitris; Vlassi, Metaxia			Ssn6-Tup1 global transcriptional co-repressor: Role of the N-terminal glutamine-rich region of Ssn6	PLOS ONE			English	Article							III SECRETION TRANSLOCATOR; CIRCULAR-DICHROISM SPECTRA; SACCHAROMYCES-CEREVISIAE; GENERAL REPRESSOR; TPR DOMAIN; MITOCHONDRIAL FISSION; COREPRESSOR COMPLEX; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; PROTEIN COMPLEX	The Ssn6-Tup1 complex is a general transcriptional co-repressor formed by the interaction of Ssn6, a tetratricopeptide repeat (TPR) protein, with the Tup1 repressor. We have previously shown that the N-terminal domain of Ssn6 comprising TPRs 1 to 3 is necessary and sufficient for this interaction and that TPR1 plays critical role. In a subsequent study, we provided evidence that in the absence of Tup1, TPR1 is susceptible to proteolysis and that conformational change(s) accompany the Ssn6-Tup1 complex formation. In this study, we address the question whether the N-terminal non-TPR, glutamine-rich tail of Ssn6 (NTpolyQ), plays any role in the Ssn6/Tup1 association. Our biochemical and yeast-two-hybrid data show that truncation/deletion of the NTpolyQ domain of Ssn6 results in its self association and prevents Tup1 interaction. These results combined with in silico modeling data imply a major role of the NTpolyQ tail of Ssn6 in regulating its interaction with Tup1.	[Tartas, Athanassios; Zarkadas, Christoforos; Palaiomylitou, Maria; Vlassi, Metaxia] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece; [Gounalaki, Niki] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Tzamarias, Dimitris] Univ Crete, Biol Dept, Iraklion, Crete, Greece	National Centre of Scientific Research "Demokritos"; University of Crete	Vlassi, M (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.; Tzamarias, D (corresponding author), Univ Crete, Biol Dept, Iraklion, Crete, Greece.	tzamaria@imbb.forth.gr; meta@bio.demokritos.gr	Vlassi, Metaxia/B-8692-2013	Vlassi, Metaxia/0000-0003-0931-2660				ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Barta ML, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-21; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Carrico PM, 1998, GENETICS, V148, P637; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Conlan RS, 1999, J BIOL CHEM, V274, P205, DOI 10.1074/jbc.274.1.205; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Gibney BR, 1997, BIOCHEMISTRY-US, V36, P2798, DOI 10.1021/bi9618225; Gounalaki N, 2000, FEBS LETT, V473, P37, DOI 10.1016/S0014-5793(00)01480-0; Grbavec D, 1999, BIOCHEM J, V337, P13, DOI 10.1042/0264-6021:3370013; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAMENS J, 1990, MOL CELL BIOL, V10, P2840, DOI 10.1128/MCB.10.6.2840; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Limbach MP, 2000, MOL GEN GENET, V263, P455, DOI 10.1007/s004380051189; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Marold JD, 2015, STRUCTURE, V23, P2055, DOI 10.1016/j.str.2015.07.022; Matsumura H, 2012, J BIOL CHEM, V287, P26528, DOI 10.1074/jbc.M112.369652; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Palaiomylitou M, 2008, PROTEINS, V70, P72, DOI 10.1002/prot.21489; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; Papamichos-Chronakis M, 2002, MOL CELL, V9, P1297, DOI 10.1016/S1097-2765(02)00545-2; Pernigo S, 2013, SCIENCE, V340, P356, DOI 10.1126/science.1234264; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; SMITH RL, 1995, GENE DEV, V9, P2903, DOI 10.1101/gad.9.23.2903; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; Varanasi US, 1996, MOL CELL BIOL, V16, P6707; Vlassi M, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-17; Voukkalis N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154198; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; Zaman Z, 2001, P NATL ACAD SCI USA, V98, P2550, DOI 10.1073/pnas.041611198; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zhu HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033943	52	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186363	10.1371/journal.pone.0186363	http://dx.doi.org/10.1371/journal.pone.0186363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053708	Green Published, Green Submitted, gold			2022-12-26	WOS:000413315100018
J	Ubrich, R; Barthel, P; Haller, B; Hnatkova, K; Huster, KM; Steger, A; Muller, A; Malik, M; Schmidt, G				Ubrich, Romy; Barthel, Petra; Haller, Bernhard; Hnatkova, Katerina; Huster, Katharina Maria; Steger, Alexander; Mueller, Alexander; Malik, Marek; Schmidt, Georg			Sex differences in long-term mortality among acute myocardial infarction patients: Results from the ISAR-RISK and ART studies	PLOS ONE			English	Article							QUALITY-OF-LIFE; PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; GENDER-DIFFERENCES; YOUNG-PATIENTS; HEALTH-STATUS; WOMEN; MEN; PROGNOSIS; OUTCOMES	Background Mortality rates in females who survived acute myocardial infarction (AMI) exceed those in males. Differences between sexes in age, cardiovascular risk factors and revascularization therapy have been proposed as possible reasons. Objective To select sets of female and male patients comparable in respect of relevant risk factors in order to compare the sex-specific risk in a systematic manner. Methods Data of the ISAR-RISK and ART studies were investigated. Patients were enrolled between 1996 and 2005 and suffered from AMI within 4 weeks prior to enrolment. Patients of each sex were selected with 1: 1 equivalent age, previous AMI history, sinus-rhythm presence, hypertension, diabetes mellitus, smoking status, left ventricular ejection fraction (LVEF), and revascularization therapy. Survival times were compared between sex groups in the whole study cohort and in the matched cohort. Results Of 3840 consecutive AMI survivors, 994 (25.9%) were females and 2846 (74.1%) were males. Females were older and suffered more frequently from hypertension and diabetes mellitus. In the whole cohort, females showed an increased mortality with a hazard ratio (HR) of 1.54 compared to males (p < 0.0001). The matched cohort comprised 802 patients of each sex and revealed a trend towards poorer survival in females (HR for female sex 1.14; p = 0.359). However, significant mortality differences with a higher risk in matched females was observed during the first year after AMI (HR = 1.61; p = 0.045) but not during the subsequent years. Conclusion Matched sub-groups of post-AMI patients showed a comparable long-term mortality. However, a female excess mortality remained during first year after AMI and cannot be explained by differences in age, cardiovascular risk factors, and modes of acute treatment. Other causal factors, including clinical as well as psychological and social aspects, need to be considered. Female post-AMI patients should be followed more actively particularly during the first year after AMI.	[Ubrich, Romy; Barthel, Petra; Huster, Katharina Maria; Steger, Alexander; Mueller, Alexander; Schmidt, Georg] Tech Univ Munich, Innere Med 1, Klinikum Rechts Isar, Munich, Germany; [Haller, Bernhard] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany; [Hnatkova, Katerina; Malik, Marek] Imperial Coll, Natl Heart & Lung Inst, London, England; [Schmidt, Georg] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany	Technical University of Munich; Technical University of Munich; Imperial College London; German Centre for Cardiovascular Research; Munich Heart Alliance	Schmidt, G (corresponding author), Tech Univ Munich, Innere Med 1, Klinikum Rechts Isar, Munich, Germany.; Schmidt, G (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany.	gschmidt@tum.de	Haller, Bernhard/I-1943-2019	Haller, Bernhard/0000-0002-9723-393X; Malik, Marek/0000-0002-3792-1407; Mueller, Alexander/0000-0001-9090-3374	British Heart Foundation [NH/16/2/32499] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Alter DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065130; Anderson ML, 2012, CIRCULATION, V126, P2190, DOI 10.1161/CIRCULATIONAHA.112.111369; Barthel P, 2003, CIRCULATION, V108, P1221, DOI 10.1161/01.CIR.0000088783.34082.89; Barthel P, 2013, EUR HEART J, V34, P1644, DOI 10.1093/eurheartj/ehs420; Barthel P, 2012, HEART RHYTHM, V9, P1288, DOI 10.1016/j.hrthm.2012.04.017; Bauer A, 2009, EUR HEART J, V30, P576, DOI 10.1093/eurheartj/ehn540; Beck CA, 2001, AM HEART J, V142, P271, DOI 10.1067/mhj.2001.116758; Birkemeyer R, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-71; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Brink E, 2005, QUAL LIFE RES, V14, P749, DOI 10.1007/s11136-004-0785-z; Bucholz EM, 2014, CIRCULATION, V130, P757, DOI 10.1161/CIRCULATIONAHA.114.009480; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Bugiardini R, 2004, CIRCULATION, V109, P2518, DOI 10.1161/01.CIR.0000128208.22378.E3; Cenko E, 2015, CARDIOVASC DRUG THER, V29, P339, DOI 10.1007/s10557-015-6595-4; CHANDRA V, 1983, AM J EPIDEMIOL, V117, P320, DOI 10.1093/oxfordjournals.aje.a113544; Chaudhry SI, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001197; Chen W, 2005, J PAIN SYMPTOM MANAG, V30, P553, DOI 10.1016/j.jpainsymman.2005.06.004; Choi JS, 2013, CARDIOL J, V20, P526, DOI 10.5603/CJ.2013.0138; Ciambrone G, 2011, CURR PHARM DESIGN, V17, P1079, DOI 10.2174/138161211795656945; Cossette S, 2001, PSYCHOSOM MED, V63, P257, DOI 10.1097/00006842-200103000-00009; D'Onofrio G, 2015, CIRCULATION, V131, P1324, DOI 10.1161/CIRCULATIONAHA.114.012293; Dodson JA, 2012, AM HEART J, V163, P790, DOI 10.1016/j.ahj.2012.02.024; Dreyer RP, 2015, CIRCULATION, V131, P1971, DOI 10.1161/CIRCULATIONAHA.114.014503; Dreyer RP, 2013, HEART LUNG CIRC, V22, P861, DOI 10.1016/j.hlc.2013.03.078; Eitel I, 2012, CIRC-CARDIOVASC IMAG, V5, P119, DOI 10.1161/CIRCIMAGING.111.965467; Emery CF, 2004, PSYCHOSOM MED, V66, P190, DOI 10.1097/01.psy.0000116775.98593.f4; Frasure-Smith N, 1999, PSYCHOSOM MED, V61, P26, DOI 10.1097/00006842-199901000-00006; Gevaert SA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-62; Grunau GL, 2006, CAN J CARDIOL, V22, P473, DOI 10.1016/S0828-282X(06)70263-X; Ho DE., 2011, J STAT SOFTW, V42, P1, DOI DOI 10.18637/JSS.V042.I08; Hudson MP, 2011, CIRC-CARDIOVASC QUAL, V4, P183, DOI 10.1161/CIRCOUTCOMES.110.945311; Hvelplund A, 2012, J INVASIVE CARDIOL, V24, P19; Kilpi F, 2015, SOC SCI MED, V133, P93, DOI 10.1016/j.socscimed.2015.03.054; King G, 2006, POLIT ANAL, V14, P131, DOI 10.1093/pan/mpj004; Lam CSP, 2015, EUR J HEART FAIL, V17, P301, DOI 10.1002/ejhf.238; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Leuzzi C, 2010, FUND CLIN PHARMACOL, V24, P711, DOI 10.1111/j.1472-8206.2010.00873.x; Norris Colleen M, 2007, Eur J Cardiovasc Nurs, V6, P92, DOI 10.1016/j.ejcnurse.2006.05.003; Otten AM, 2013, EUR HEART J-ACUTE CA, V2, P334, DOI 10.1177/2048872612475270; Pepine CJ, 2015, J AM COLL CARDIOL, V66, P1918, DOI 10.1016/j.jacc.2015.08.876; Poon S, 2012, AM HEART J, V163, P66, DOI 10.1016/j.ahj.2011.09.025; Rathore SS, 2009, AM J CARDIOL, V104, P1198, DOI 10.1016/j.amjcard.2009.06.034; Rizas KD, 2014, J CLIN INVEST, V124, P1770, DOI 10.1172/JCI70085; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Shin JY, 2010, HEART LUNG, V39, P283, DOI 10.1016/j.hrtlng.2009.10.010; Sinnecker D, 2016, J AM COLL CARDIOL, V67, P2213, DOI 10.1016/j.jacc.2016.03.484; Sinnecker D, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000857; Skelding KA, 2013, J INTERV CARDIOL, V26, P14, DOI 10.1111/joic.12009; Sulzgruber P, 2016, EUR J CLIN INVEST, V46, P60, DOI 10.1111/eci.12567; Ubrich R, 2016, CURR PHARM DESIGN, V22, P3817, DOI 10.2174/1381612822666160311115605; Wheeler A, 2012, AUST NZ J PSYCHIAT, V46, P669, DOI 10.1177/0004867412449875; Wijnbergen I, 2013, CATHETER CARDIO INTE, V82, P379, DOI 10.1002/ccd.24800; Yinko SSLL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000901; Yu J, 2015, CATHETER CARDIO INTE, V85, P359, DOI 10.1002/ccd.25630	56	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186783	10.1371/journal.pone.0186783	http://dx.doi.org/10.1371/journal.pone.0186783			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK2MA	29053758	gold, Green Published, Green Submitted			2022-12-26	WOS:000413315100038
J	Borgio, JF				Borgio, J. Francis			Impact of annotation error in alpha-globin genes on molecular diagnosis	PLOS ONE			English	Article							VARIANT DESCRIPTIONS; MUTATION; CONVERSION	Background Recent studies on the variants in duplicated human alpha globin genes (HBA2 and HBA1) actively target the a-globin gene as molecular modulators for the treatment of beta-thalassemia major. Identification of the exact position of variant in HBA1, HBA2 or its patchworks is mandatory to support the therapeutic aims in beta-thalassemia major, by identifying specific modulators for the reactivation of fetal hemoglobin production. Hence, accurate identification of the variants in a-globin genes is crucial for the proper diagnosis, treatment and genetic counseling. Method The objective was to reveal the annotation errors produced in a-globin gene sequence analysis while using different analytic tools. An HBA2 gene sequence with the HBA2: c. 95+2_95 +6delTGAGG variant and a recently reported HBA12 gene convert have been taken as examples to prove annotation error in a-globin gene from different analytic tools. Results and discussion Although various bioinformatics tools used to predict variants are usually of high reliability, the current study using the an alpha globin 2 sequence with the HBA2: c. 95+2_95+6del T-GAGG variant and a recently reported HBA12 gene convert, has showcased ambiguous outputs among the three bioinformatics tools used and against the manual analytical method adopted. Conclusions This report emphasizes the necessity for caution in the usage of DNA sequence analysis tools during molecular diagnosis and the importance of the selection of more appropriate tools for analysis. Furthermore, ethnic specific sequences should be considered as reference sequence for the analysis to bypass sequence dissimilarities among diverse populations.	[Borgio, J. Francis] Imam Abdulrahman Bin Faisal Univ, IRMC, Dept Genet Res, Dammam, Saudi Arabia	Imam Abdulrahman Bin Faisal University	Borgio, JF (corresponding author), Imam Abdulrahman Bin Faisal Univ, IRMC, Dept Genet Res, Dammam, Saudi Arabia.	borgiomicro@gmail.com	Borgio, J Francis/P-5586-2014	Borgio, J Francis/0000-0001-7199-1540				Borgio JF, 2015, SAUDI MED J, V36, P1271, DOI 10.15537/smj.2015.11.12704; Borgio JF, 2014, BLOOD CELL MOL DIS, V53, P199, DOI 10.1016/j.bcmd.2014.07.001; Dong CM, 2011, METHODS MOL BIOL, V760, P223, DOI 10.1007/978-1-61779-176-5_14; FELBER BK, 1982, CELL, V29, P895, DOI 10.1016/0092-8674(82)90451-2; Gaspar P, 2014, HUM MUTAT, V35, P202, DOI 10.1002/humu.22474; Giardine B, 2014, NUCLEIC ACIDS RES, V42, pD1063, DOI 10.1093/nar/gkt911; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Law HY, 2006, HAEMATOLOGICA, V91, P297; Mettananda S, 2015, BLOOD, V125, P3694, DOI 10.1182/blood-2015-03-633594; Moradkhani K, 2009, ANN HEMATOL, V88, P535, DOI 10.1007/s00277-008-0624-3; ORKIN SH, 1981, P NATL ACAD SCI-BIOL, V78, P5041, DOI 10.1073/pnas.78.8.5041; Pecriaux A, 2017, INT J LAB HEMATOL, V39, pE55, DOI 10.1111/ijlh.12609; Piel FB, 2014, NEW ENGL J MED, V371, P1908, DOI 10.1056/NEJMra1404415; Vis JK, 2015, BIOINFORMATICS, V31, P3751, DOI 10.1093/bioinformatics/btv443; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654	16	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0185270	10.1371/journal.pone.0185270	http://dx.doi.org/10.1371/journal.pone.0185270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049312	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900008
J	Hao, GX; Zhang, SJ; Stover, E				Hao, Guixia; Zhang, Shujian; Stover, Ed			Transgenic expression of antimicrobial peptide D2A21 confers resistance to diseases incited by Pseudomonas syringae pv. tabaci and Xanthomonas citri, but not Candidatus Liberibacter asiaticus	PLOS ONE			English	Article							IN-VITRO; TRANSFORMATION; MECHANISMS; PATHOGENS; SEQUENCE	Citrus Huanglongbing (HLB) associated with 'Candidatus Liberibacter asiaticus' (Las) and citrus canker disease incited by Xanthomonas citri are the most devastating citrus diseases worldwide. To control citrus HLB and canker disease, we previously screened over forty antimicrobial peptides (AMPs) in vitro for their potential application in genetic engineering. D2A21 was one of the most active AMPs against X. citri, Agrobacterium tumefaciens and Sinorhizobium meliloti with low hemolysis activity. Therefore, we conducted this work to assess transgenic expression of D2A21 peptide to achieve citrus resistant to canker and HLB. We generated a construct expressing D2A21 and initially transformed tobacco as a model plant. Transgenic tobacco expressing D2A21 was obtained by Agrobacterium-mediated transformation. Successful transformation and D2A21 expression was confirmed by molecular analysis. We evaluated disease development incited by Pseudomonas syringae pv. tabaci in transgenic tobacco. Transgenic tobacco plants expressing D2A21 showed remarkable disease resistance compared to control plants. Therefore, we performed citrus transformations with the same construct and obtained transgenic Carrizo citrange. Gene integration and gene expression in transgenic plants were determined by PCR and RT-qPCR. Transgenic Carrizo expressing D2A21 showed significant canker resistance while the control plants showed clear canker symptoms following both leaf infiltration and spray inoculation with X. citri3213. Transgenic Carrizo plants were challenged for HLB evaluation by grafting with Las infected rough lemon buds. Las titer was determined by qPCR in the leaves and roots of transgenic and control plants. However, our results showed that transgenic plants expressing D2A21 did not significantly reduce Las titer compared to control plants. We demonstrated that transgenic expression of D2A21 conferred resistance to diseases incited by P. syringae pv. tabaci and X. citri but not Las. Our results underscore the difficulty in controlling HLB compared to other bacterial diseases.	[Hao, Guixia; Zhang, Shujian; Stover, Ed] USDA ARS, US Hort Res Lab, Ft Pierce, FL 34945 USA; [Hao, Guixia] USDA ARS, Mycotoxin Prevent & Appl Microbiol Res Unit, NCAUR, Peoria, IL 61604 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Hao, GX; Stover, E (corresponding author), USDA ARS, US Hort Res Lab, Ft Pierce, FL 34945 USA.; Hao, GX (corresponding author), USDA ARS, Mycotoxin Prevent & Appl Microbiol Res Unit, NCAUR, Peoria, IL 61604 USA.	guixia.hao@ars.usda.gov; ed.stover@ars.usda.gov			Citrus Research and Development Foundation [15-025]	Citrus Research and Development Foundation	Funding was awarded to Dr. Ed Stover by the Citrus Research and Development Foundation (Grant number:15-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benyon LS, 2013, IN VITRO CELL DEV-PL, V49, P255, DOI 10.1007/s11627-013-9509-9; Brlansky R. H., 2007, PLANT HLTH PROGR, DOI [10.1094/apsnetfeature-2007-1207, DOI 10.1094/APSNETFEATURE-2007-1207]; Callies T, 2017, CITRUS IND; Day CD, 2000, GENE DEV, V14, P2869, DOI 10.1101/gad.849600; de Lucca AJ, 1999, ANTIMICROB AGENTS CH, V43, P1, DOI 10.1093/jac/43.1.1; Dutt M, 2016, PLANT CELL TISS ORG, V126, P229, DOI 10.1007/s11240-016-0993-6; Dutt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137134; Fagen J, 2012, INT J SYST EVOL MICR, V64, P2461; Furman N, 2013, J BIOTECHNOL, V167, P412, DOI 10.1016/j.jbiotec.2013.07.019; Gottwald T. R., 2007, Outlooks on Pest Management, V18, P274, DOI 10.1564/18dec09; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; Hao GX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01078; Hao GX, 2016, MOL PLANT MICROBE IN, V29, P132, DOI 10.1094/MPMI-09-15-0211-R; Haroldsen VM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00039; Hoffman MT, 2013, PHYTOPATHOLOGY, V103, P15, DOI 10.1094/PHYTO-06-12-0138-R; Hu Y, 2014, P NATL ACAD SCI USA, V111, pE521, DOI 10.1073/pnas.1313271111; Huang Y, 1997, PHYTOPATHOLOGY, V87, P494, DOI 10.1094/PHYTO.1997.87.5.494; Jacobi V, 2000, CAN J BOT, V78, P455, DOI 10.1139/cjb-78-4-455; JAYNES J M, 1989, Peptide Research, V2, P157; Jia HG, 2017, PLANT BIOTECHNOL J, V15, P817, DOI 10.1111/pbi.12677; Johnson EG, 2013, PLANT PATHOL; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Leonard MT, 2012, STAND GENOMIC SCI, V7, P271, DOI 10.4056/sigs.3326772; Mendes BMJ, 2010, PLANT PATHOL, V59, P68, DOI 10.1111/j.1365-3059.2009.02148.x; Mirkov TE, U.S. Patent application, Patent No. [14/139,791, 14139791]; Moghaddam MRB, 2016, MOL PLANT PATHOL, V17, P464, DOI 10.1111/mpp.12299; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Nawrocki KL, 2014, ANTIBIOTICS-BASEL, V3, P461, DOI 10.3390/antibiotics3040461; de Oliveira MLP, 2013, MOL PLANT MICROBE IN, V26, P1190, DOI 10.1094/MPMI-04-13-0122-R; Pereira ALA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-157; Rioux D, 2000, CAN J BOT, V78, P462, DOI 10.1139/b00-007; Stansly PA, 2014, PEST MANAG SCI, V70, P415, DOI 10.1002/ps.3577; Stover E, 2013, J AM SOC HORTIC SCI, V138, P142, DOI 10.21273/JASHS.138.2.142; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Tam JP, 2015, PHARMACEUTICALS-BASE, V8, P711, DOI 10.3390/ph8040711; Yang L, 2011, PLANT MOL BIOL, V75, P11, DOI 10.1007/s11103-010-9699-z; Zhang MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111032; Zhang XD, 2010, EUR J PLANT PATHOL, V128, P91, DOI 10.1007/s10658-010-9633-x; Zou X, 2016, PLANT MOL BIOL	40	17	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186810	10.1371/journal.pone.0186810	http://dx.doi.org/10.1371/journal.pone.0186810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049366	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900116
J	Alvarez, E; Del Pino, F; Jara, L; Godoy-Herrera, R				Alvarez, Eduardo; Del Pino, Francisco; Jara, Lilian; Godoy-Herrera, Raul			The genetics and development of mandibles and hypopharyngeal sclerite and cornua in larvae of Drosophila gaucha	PLOS ONE			English	Article							FORAGING BEHAVIOR; WIDESPREAD; HOOKS; SIZE	The genetics and epigenetic processes associated with morphological organization are a principal aim of biology, ranging from cohesion between cells to shape and size of organisms. We investigate the post-embryonic development of Hypopharyngeal sclerite and cornua HPC and mandibles M of Drosophila gaucha larva. Integrated functioning of these Cephalopharyngeal skeleton parts of D. gaucha larva is essential for food acquisition, participating in locomotion and microhabitat selection. We examined two isolates by recording the growth of the HPC and M every 24 h for 8 days in parental, F-1, F-2 and backcross larvae. In F-1 larvae, the HPC and M growth was similar to the parental. In F-2 and backcross larvae, the growth was slower. Epistasis and dominance are the principal sources upon which the growth of HPC and M are based. Pleiotropic genes seem also to be involved in integrating the development of M and HPC. Our data suggest that hybridization of the isolates modified epigenetic processes involved in the development of those morphological structures of D. gaucha larva.	[Alvarez, Eduardo; Del Pino, Francisco; Jara, Lilian; Godoy-Herrera, Raul] Univ Chile, Fac Med, ICBM, Programa Genet Humana, Santiago, Chile	Universidad de Chile	Godoy-Herrera, R (corresponding author), Univ Chile, Fac Med, ICBM, Programa Genet Humana, Santiago, Chile.	raulgodoy.herrera@gmail.com	Corrêa, Marcio N Nunes/D-1034-2019	Corrêa, Marcio N Nunes/0000-0003-0855-2750				Alberts B, 2008, MOL BIOL CELL; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; ALVAREZ E, 2014, DROS INFORM SERV, V97, P76; [Anonymous], 1993, DEV DROSOPHILA MELAN; BRNCIC D, 1987, Revista Chilena de Entomologia, V15, P37; Burdick AB, 1957, DROSOPH INF SER, V28, P170; Carson H L., 1971, ECOLOGY DROSOPHILA B, V2; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Del Pino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136363; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Frias D, 2005, ISRAEL J ENTOMOL, P35; Godoy-Herrera R, 2005, GENETICA, V124, P33, DOI 10.1007/s10709-004-5913-8; Godoy-Herrera R, 2007, BEHAV GENET, V37, P595, DOI 10.1007/s10519-007-9151-6; GODOYHERRERA R, 1986, HEREDITY, V56, P33, DOI 10.1038/hdy.1986.6; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; HEALD R, 2015, SIZE CONTROL BIOL OR; Hughes KA, 2006, GENETICS, V173, P1347, DOI 10.1534/genetics.105.051474; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Kearsey M.J., 1996, GENETIC ANAL QUANTIT, DOI [10.1007/978-1-4899-4441-2, DOI 10.1007/978-1-4899-4441-2]; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; KOREFSA.S, 1961, EVOLUTION, V15, P401, DOI 10.2307/2406308; Lailvaux SP, 2014, Q REV BIOL, V89, P285, DOI 10.1086/678567; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Mather K, 1982, BIOMETRICAL GENETICS; Miller A., 1950, BIOL DROSOPHILA, P420; OKADA T, 1963, EVOLUTION, V17, P84, DOI 10.2307/2406337; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; SEWELL D, 1974, GENET RES, V24, P163, DOI 10.1017/S0016672300015196; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; SOKOLOWSKI MB, 1986, ANIM BEHAV, V34, P403, DOI 10.1016/S0003-3472(86)80109-9; Stern D, 2001, CURR BIOL, V11, pR917, DOI 10.1016/S0960-9822(01)00554-1; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wallace B., 2000, EVOL GENET, P41; ZELDITCH ML, 1993, J EVOLUTION BIOL, V6, P621, DOI 10.1046/j.1420-9101.1993.6050621.x	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185054	10.1371/journal.pone.0185054	http://dx.doi.org/10.1371/journal.pone.0185054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045450	gold, Green Published, Green Submitted			2022-12-26	WOS:000413168100009
J	Felczak, MM; Chodavarapu, S; Kaguni, JM				Felczak, Magdalena M.; Chodavarapu, Sundari; Kaguni, Jon M.			DnaC, the indispensable companion of DnaB helicase, controls the accessibility of DnaB helicase by primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DNAB; SINGLE-STRANDED-DNA; N-TERMINAL DOMAIN; PROTEIN-PROTEIN INTERACTIONS; REPLICATION-FORK; CHROMOSOMAL ORIGIN; HEXAMERIC HELICASE; CRYSTAL-STRUCTURE; PRIMER SYNTHESIS; SALMONELLA-TYPHIMURIUM	Former studies relying on hydrogen/deuterium exchange analysis suggest that DnaC bound to DnaB alters the conformation of the N-terminal domain (NTD) of DnaB to impair the ability of this DNA helicase to interact with primase. Supporting this idea, the work described herein based on biosensor experiments and enzyme-linked immunosorbent assays shows that the DnaB-DnaC complex binds poorly to primase in comparison with DnaB alone. Using a structural model of DnaB complexed with the C-terminal domain of primase, we found that Ile-85 is located at the interface in the NTD of DnaB that contacts primase. An alanine substitution for Ile-85 specifically interfered with this interaction and impeded DnaB function in DNA replication, but not its activity as a DNA helicase or its ability to bind to ssDNA. By comparison, substitutions of Asn for Ile-136 (I136N) and Thr for Ile-142 (I142T) in a subdomain previously named the helical hairpin in the NTD of DnaB altered the conformation of the helical hairpin and/or compromised its pair-wise arrangement with the companion subdomain in each brace of protomers of the DnaB hexamer. In contrast with the I85A mutant, the latter were defective in DNA replication due to impaired binding to both ssDNA and primase. In view of these findings, we propose that DnaC controls the ability of DnaB to interact with primase by modifying the conformation of the NTD of DnaB.	[Felczak, Magdalena M.; Chodavarapu, Sundari; Kaguni, Jon M.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Kaguni, JM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	kaguni@msu.edu	chodavarapu, sundari/Q-3272-2019; chodavarapu, sundari/Q-3279-2019		National Institutes of Health Grant [R01 GM090063]; United States Department of Agriculture National Institute of Food and Agriculture Hatch project [MICL02370]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090063] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture National Institute of Food and Agriculture Hatch project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM090063 and by United States Department of Agriculture National Institute of Food and Agriculture Hatch project MICL02370. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersen PA, 2000, MOL MICROBIOL, V36, P1327, DOI 10.1046/j.1365-2958.2000.01945.x; ARAI K, 1979, P NATL ACAD SCI USA, V76, P4308, DOI 10.1073/pnas.76.9.4308; ARAI K, 1981, J BIOL CHEM, V256, P5253; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Bastia D, 2008, P NATL ACAD SCI USA, V105, P12831, DOI 10.1073/pnas.0805898105; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; Biswas SB, 2006, BIOCHEMISTRY-US, V45, P11505, DOI 10.1021/bi060118d; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; Chang P, 2000, J BIOL CHEM, V275, P26187, DOI 10.1074/jbc.M001800200; Chintakayala K, 2008, MOL MICROBIOL, V68, P360, DOI 10.1111/j.1365-2958.2008.06155.x; Chodavarapu S, 2016, NUCLEIC ACIDS RES, V44, P210, DOI 10.1093/nar/gkv961; Chodavarapu S, 2013, NUCLEIC ACIDS RES, V41, P10254, DOI 10.1093/nar/gkt774; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Fass D, 1999, STRUCTURE, V7, P691, DOI 10.1016/S0969-2126(99)80090-2; Felczak MM, 2016, J BIOL CHEM, V291, P4803, DOI 10.1074/jbc.M115.708586; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Gauci Victoria J, 2011, J Chem Biol, V4, P3, DOI 10.1007/s12154-010-0043-5; Henderson TA, 2001, MOL GENET GENOMICS, V265, P941; HWANG DS, 1988, J BIOL CHEM, V263, P10633; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kashav T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007515; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; Kurth I, 2013, TRENDS BIOCHEM SCI, V38, P195, DOI 10.1016/j.tibs.2012.10.003; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Leipe DD, 2000, GENOME RES, V10, P5; Lewis JS, 2016, ENZYMES, V39, P31, DOI 10.1016/bs.enz.2016.04.001; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MARSZALEK J, 1992, J BIOL CHEM, V267, P19334; MASAI H, 1990, J BIOL CHEM, V265, P15134; MAURER R, 1988, J BACTERIOL, V170, P3682, DOI 10.1128/jb.170.8.3682-3688.1988; McHenry CS, 2011, CURR OPIN CHEM BIOL, V15, P587, DOI 10.1016/j.cbpa.2011.07.018; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Oakley AJ, 2005, J BIOL CHEM, V280, P11495, DOI 10.1074/jbc.M412645200; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Rehman SAA, 2013, J BACTERIOL, V195, P2826, DOI 10.1128/JB.00091-13; San Martin C, 1998, STRUCTURE, V6, P501; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 2005, STRUCTURE, V13, P839, DOI 10.1016/j.str.2005.04.006; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Stordal L, 1996, J BACTERIOL, V178, P4620, DOI 10.1128/jb.178.15.4620-4627.1996; Strycharska MS, 2013, MOL CELL, V52, P844, DOI 10.1016/j.molcel.2013.11.016; Su XC, 2006, FEBS J, V273, P4997, DOI 10.1111/j.1742-4658.2006.05495.x; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Syson K, 2005, STRUCTURE, V13, P609, DOI 10.1016/j.str.2005.01.022; TAL M, 1985, J BIOL CHEM, V260, P9976; Thirlway J, 2004, NUCLEIC ACIDS RES, V32, P2977, DOI 10.1093/nar/gkh628; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; Tougu K, 1996, J BIOL CHEM, V271, P21391, DOI 10.1074/jbc.271.35.21391; TOUGU K, 1994, J BIOL CHEM, V269, P4675; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weigelt J, 1999, STRUCT FOLD DES, V7, P681, DOI 10.1016/S0969-2126(99)80089-6; WOLD MS, 1982, P NATL ACAD SCI-BIOL, V79, P4907, DOI 10.1073/pnas.79.16.4907; WONG A, 1988, J BACTERIOL, V170, P2668, DOI 10.1128/jb.170.6.2668-2675.1988; WU CA, 1992, J BIOL CHEM, V267, P4030; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	80	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20871	20882		10.1074/jbc.M117.807644	http://dx.doi.org/10.1074/jbc.M117.807644			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29070678	Green Published, hybrid			2022-12-26	WOS:000418453400006
J	El Alaoui, C; Chemin, J; Fechtall, T; Lory, P				El Alaoui, Chaymae; Chemin, Jean; Fechtall, Taoufiq; Lory, Philippe			Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts	PLOS ONE			English	Article							GATED CALCIUM-CHANNELS; ROSMARINIC ACID; NEUROPATHIC PAIN; SENSORY NEURONS; ESSENTIAL OIL; THALAMIC NEURONS; RAT MODEL; OFFICINALIS; INHIBITION; BLOCK	Medicinal plants represent a significant reservoir of unexplored substances for early-stage drug discovery. Of interest, two flowering Mediterranean plants have been used for thousands of years for their beneficial effects on nervous disorders, including anxiety and mood. However, the therapeutic potential of these plants regarding their ability to target ion channels and neuronal excitability remains largely unknown. Towards this goal, we have investigated the ability of Lavender and Rosemary to modulate T-type calcium channels (TTCCs). TTCCs play important roles in neuronal excitability, neuroprotection, sensory processes and sleep. These channels are also involved in epilepsy and pain. Using the whole-cell patch-clamp technique, we have characterized how Lavender and Rosemary extracts, as well as their major active compounds Linalool and Rosmarinic acid, modulate the electro-physiological properties of recombinant TTCCs (Ca(V)3.2) expressed in HEK-293T cells. Both the methanolic and essential oil extracts as well as the active compounds of these plants inhibit Ca(v)3.2 current in a concentration-dependent manner. In addition, these products also induce a negative shift of the steady-state inactivation of Ca(V)3.2 current with no change in the activation properties. Taken together, our findings reveal that TTCCs are a molecular target of the Lavender and Rosemary compounds, suggesting that inhibition of TTCCs could contribute to the anxiolytic and the neuroprotective effects of these plants.	[El Alaoui, Chaymae; Chemin, Jean; Lory, Philippe] Univ Montpellier, NSERM, CNRS, Inst Genom Fonct, Montpellier, France; [El Alaoui, Chaymae; Chemin, Jean; Lory, Philippe] LabEx Ion Channel Sci & Therapeut, Montpellier, France; [El Alaoui, Chaymae; Fechtall, Taoufiq] Univ Hassan 2, Lab Neurosci Physiopathol Integrees & Subst Nat, Fac Sci & Tech Mohammedia, Casablanca, Morocco	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Hassan II University of Casablanca	Lory, P (corresponding author), Univ Montpellier, NSERM, CNRS, Inst Genom Fonct, Montpellier, France.; Lory, P (corresponding author), LabEx Ion Channel Sci & Therapeut, Montpellier, France.	phippe.lory@igf.cnrs.fr		LORY, philippe/0000-0002-1638-7604	LabEx 'Ion Channel Science and Therapeutics'; 'Bourse du Ministere de l'Enseignement Superieur et de la Recherche Scientifique' Maroc; Erasmus Mundus Averroes; L'Oreal-UNESCO for Women in Science Programs	LabEx 'Ion Channel Science and Therapeutics'; 'Bourse du Ministere de l'Enseignement Superieur et de la Recherche Scientifique' Maroc; Erasmus Mundus Averroes; L'Oreal-UNESCO for Women in Science Programs	This work was supported by LabEx 'Ion Channel Science and Therapeutics' to PL. CEA was supported by 'Bourse du Ministere de l'Enseignement Superieur et de la Recherche Scientifique' Maroc, Erasmus Mundus Averroes and L'Oreal-UNESCO for Women in Science Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by LabEx 'Ion Channel Science and Therapeutics' to PL. CEA was supported by 'Bourse du Ministere de l'Enseignement Superieur et de la Recherche Scientifique' Maroc, Erasmus Mundus Averroes and L'Oreal-UNESCO for Women in Science Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors are grateful to Dr. Isabelle Bidaud for critical help with cell culture. Special thanks to Dr. R. Bouharroud (INRA, Agadir) for plant extraction protocols.	Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Barbara G, 2009, J NEUROSCI, V29, P13106, DOI 10.1523/JNEUROSCI.2919-09.2009; Berger ND, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-77; Bialer M, 2015, EPILEPSY RES, V111, P85, DOI 10.1016/j.eplepsyres.2015.01.001; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Cain SM, 2013, BBA-BIOMEMBRANES, V1828, P1572, DOI 10.1016/j.bbamem.2012.07.028; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103; Cazade M, 2014, MOL PHARMACOL, V85, P218, DOI 10.1124/mol.113.089581; Chemin J, 2002, J NEUROSCI, V22, P6856; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2001, EMBO J, V20, P7033, DOI 10.1093/emboj/20.24.7033; Chemin J, 2000, FEBS LETT, V478, P166, DOI 10.1016/S0014-5793(00)01832-9; Chioca LR, 2013, J ETHNOPHARMACOL, V147, P412, DOI 10.1016/j.jep.2013.03.028; Chuang RSI, 1998, NAT NEUROSCI, V1, P668, DOI 10.1038/3669; Elisabetsky E, 1999, PHYTOMEDICINE, V6, P107, DOI 10.1016/S0944-7113(99)80044-0; Enyeart JA, 2009, J NAT PROD, V72, P1533, DOI 10.1021/np900227x; Fallarini S, 2009, BRIT J PHARMACOL, V157, P1072, DOI 10.1111/j.1476-5381.2009.00213.x; Gamaro Giovana Duzzo, 2011, ISRN Pharmacol, V2011, P451682, DOI 10.5402/2011/451682; Gilani AH, 2000, J ETHNOPHARMACOL, V71, P161, DOI 10.1016/S0378-8741(99)00198-1; Gomora JC, 2001, MOL PHARMACOL, V60, P1121, DOI 10.1124/mol.60.5.1121; Gonzalez-Rodriguez P, 2015, J PHYSIOL-LONDON, V593, P4729, DOI 10.1113/JP271053; Gonzalez-Trujano ME, 2007, J ETHNOPHARMACOL, V111, P476, DOI 10.1016/j.jep.2006.12.011; Hering S, 1997, P NATL ACAD SCI USA, V94, P13323, DOI 10.1073/pnas.94.24.13323; Herrero M, 2010, J CHROMATOGR A, V1217, P2512, DOI 10.1016/j.chroma.2009.11.032; Hill TDM, 2013, BRIT J PHARMACOL, V170, P679, DOI 10.1111/bph.12321; Hosking RD, 2008, BRIT J ANAESTH, V101, P59, DOI 10.1093/bja/aen119; Huang LP, 2008, J PHARM PHARMACOL, V60, P1515, DOI 10.1211/jpp/60.11.0013; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Jagodic MM, 2008, J NEUROPHYSIOL, V99, P3151, DOI 10.1152/jn.01031.2007; Jarvis MF, 2014, BIOCHEM PHARMACOL, V89, P536, DOI 10.1016/j.bcp.2014.03.015; Jin X, 2013, NEUROCHEM RES, V38, P1828, DOI 10.1007/s11064-013-1088-y; Kawai F, 1996, J GEN PHYSIOL, V108, P525, DOI 10.1085/jgp.108.6.525; Kelm MA, 2000, PHYTOMEDICINE, V7, P7, DOI 10.1016/S0944-7113(00)80015-X; KIMURA Y, 1987, J NAT PROD, V50, P392, DOI 10.1021/np50051a009; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Koulivand PH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/681304; Lee M, 2014, J PERIPHER NERV SYST, V19, pS11, DOI 10.1111/jns.12080_2; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Linck VM, 2010, PHYTOMEDICINE, V17, P679, DOI 10.1016/j.phymed.2009.10.002; Linck VD, 2009, PHYTOMEDICINE, V16, P303, DOI 10.1016/j.phymed.2008.08.001; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lory P, 2007, EXPERT OPIN THER TAR, V11, P717, DOI 10.1517/14728222.11.5.717; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; Narusuye K, 2005, J NEURAL TRANSM, V112, P193, DOI 10.1007/s00702-004-0187-y; Ngo SNT, 2011, CRIT REV FOOD SCI, V51, P946, DOI 10.1080/10408398.2010.490883; Ozarowski M, 2013, FITOTERAPIA, V91, P261, DOI 10.1016/j.fitote.2013.09.012; Park SE, 2010, CELL MOL NEUROBIOL, V30, P759, DOI 10.1007/s10571-010-9502-3; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Petrovska Biljana Bauer, 2012, Pharmacogn Rev, V6, P1, DOI 10.4103/0973-7847.95849; Powell KL, 2014, BRIT J CLIN PHARMACO, V77, P729, DOI 10.1111/bcp.12205; Re L, 2000, PHARMACOL RES, V42, P177, DOI 10.1006/phrs.2000.0671; Rocha J, 2015, BASIC CLIN PHARMACOL, V116, P398, DOI 10.1111/bcpt.12335; Ross HR, 2008, J BIOL CHEM, V283, P16124, DOI 10.1074/jbc.M707104200; Sahu A, 1999, BIOCHEM PHARMACOL, V57, P1439, DOI 10.1016/S0006-2952(99)00044-1; Sakkaki S, 2016, NEUROPHARMACOLOGY, V101, P320, DOI 10.1016/j.neuropharm.2015.09.032; Schuwald AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059998; Sen T, 2015, ADV BIOCHEM ENG BIOT, V147, P59, DOI 10.1007/10_2014_273; Seo H, 2013, J PHARMACOL EXP THER, V347, P310, DOI 10.1124/jpet.113.207936; Serra J, 2015, PAIN, V156, P2175, DOI 10.1097/j.pain.0000000000000249; Shen FY, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0008-3; Sucher NJ, 2015, EPILEPSY BEHAV, V52, P308, DOI 10.1016/j.yebeh.2015.05.012; Takaki I, 2008, J MED FOOD, V11, P741, DOI 10.1089/jmf.2007.0524; Talley EM, 1999, J NEUROSCI, V19, P1895; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Traboulsie A, 2006, MOL PHARMACOL, V69, P1963, DOI 10.1124/mol.105.020842; Tringham E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003120; TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995; Won J, 2003, EUR J IMMUNOL, V33, P870, DOI 10.1002/eji.200323010; Woronuk G, 2011, PLANTA MED, V77, P7, DOI 10.1055/s-0030-1250136; Xiao CN, 2008, J AGR FOOD CHEM, V56, P10142, DOI 10.1021/jf8016833; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Ziegler D, 2015, PAIN, V156, P2013, DOI 10.1097/j.pain.0000000000000263	77	23	23	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186864	10.1371/journal.pone.0186864	http://dx.doi.org/10.1371/journal.pone.0186864			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073181	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400065
J	Lin, CC; Hung, YY; Tsai, MC; Huang, TL				Lin, Chin-Chuen; Hung, Yi-Yung; Tsai, Meng-Chang; Huang, Tiao-Lai			Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia	PLOS ONE			English	Article							NMDA-RECEPTOR; ALCOHOL-WITHDRAWAL; SUBUNIT NR1; 1ST EPISODE; SCHIZOPHRENIA; AUTOANTIBODIES; ENCEPHALITIS; PREVALENCE; LORAZEPAM; DIAGNOSIS	Objective Anti-N-methyl-D-aspartate receptor (NMDAR) antibody was thought to be the cause of anti-NMDAR encephalitis, with manifestations similar to catatonia and schizophrenia. Anti-NMDAR antibody in neuropsychiatric patients who had catatonia before were investigated in a follow-up evaluation. The intensity of antibody immunofluorescence was quantified and compared with healthy controls. Method Nineteen patients (eight males and eleven females) agreed to be followed-up. Thirteen had the diagnosis of schizophrenia, two had the diagnosis of major depressive disorder, two had bipolar disorder, one had postpartum depression, and one had herpes simplex encephalitis. No patient had catatonia during the follow-up. Nineteen sex-matched healthy controls were recruited. Results Using Mann-Whitney U test, patients had greater intensity of anti-NMDAR antibody immunofluorescence than the healthy controls (121,979 +/- 86,526 vs. 47,692 +/- 26,102, p = 0.003). No correlation was found between immunofluorescence intensity and catatonia scales or symptom severity scores. Neuropsychiatric patients with past catatonia showed greater anti-NMDAR antibody response than the healthy controls. Conclusion NMDAR dysfunction might play a role in the mechanism underlying catatonia. Further studies are needed to confirm this finding.	[Huang, Tiao-Lai] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Huang, TL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan.	a540520@adm.cgmh.org.tw			Kaohsiung Chang Gung Memorial Hospital in Taiwan [CMRPG8D0571]	Kaohsiung Chang Gung Memorial Hospital in Taiwan	This work was supported by a clinical research grant, No. CMRPG8D0571, from Kaohsiung Chang Gung Memorial Hospital in Taiwan (www.cgmh.org.tw).; This work was supported by a clinical research grant, No. CMRPG8D0571, from Kaohsiung Chang Gung Memorial Hospital in Taiwan.	Basu A, 2014, J PHARMACOL PHARMACO, V5, P261, DOI 10.4103/0976-500X.142449; Busse S, 2014, EUR ARCH PSY CLIN N, V264, P545, DOI 10.1007/s00406-014-0493-9; Castillo-Gomez E., 2016, MOL PSYCHIAT; Castillo-Gomez E, 2016, ANN NEUROL, V79, P144, DOI 10.1002/ana.24545; Chen CH, 2017, SCHIZOPHR RES; CHONG MY, 1989, PSYCHOL MED, V19, P495, DOI 10.1017/S0033291700012526; Dahm L, 2014, ANN NEUROL, V76, P82, DOI 10.1002/ana.24189; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Dauvilliers Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25230; Ezeoke A, 2013, SCHIZOPHR RES, V150, P245, DOI 10.1016/j.schres.2013.07.029; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Geoffroy PA, 2012, ALCOHOL ALCOHOLISM, V47, P288, DOI 10.1093/alcalc/agr170; Gleichman AJ, 2012, J NEUROSCI, V32, P11082, DOI 10.1523/JNEUROSCI.0064-12.2012; Gresa-Arribas N, 2014, LANCET NEUROL, V13, P167, DOI 10.1016/S1474-4422(13)70282-5; Grover S, 2011, GEN HOSP PSYCHIAT, V33, DOI 10.1016/j.genhosppsych.2010.06.006; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Haussleiter IS, 2012, SCHIZOPHR RES, V140, P258, DOI 10.1016/j.schres.2012.05.006; Hsieh MH, 2011, PSYCHOSOMATICS, V52, P475, DOI 10.1016/j.psym.2011.01.024; Huang TL, 2005, PSYCHIAT CLIN NEUROS, V59, P52, DOI 10.1111/j.1440-1819.2005.01331.x; Huang Yu-Chi, 2013, Biomed J, V36, P35, DOI 10.4103/2319-4170.107162; Hung YY, 2006, CLIN NEUROPHARMACOL, V29, P144, DOI 10.1097/01.WNF.0000221908.56361.C7; Inta D, 2015, SCHIZOPHR RES, V168, P581, DOI 10.1016/j.schres.2015.07.029; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Kiani R, 2015, BJPSYCH BULL, V39, P32, DOI 10.1192/pb.bp.112.041954; Kolli Venkata, 2013, Innov Clin Neurosci, V10, P11; Komori T, 1997, ACTA PSYCHIAT SCAND, V96, P155, DOI 10.1111/j.1600-0447.1997.tb09921.x; Kreye J, 2016, BRAIN, V139, P2641, DOI 10.1093/brain/aww208; Lai JY, 2004, PSYCHIAT CLIN NEUROS, V58, P157, DOI 10.1111/j.1440-1819.2003.01210.x; Lin CC, 2016, COMPR PSYCHIAT, V66, P157, DOI 10.1016/j.comppsych.2016.01.011; Lin CC, 2013, COMPR PSYCHIAT, V54, P1210, DOI 10.1016/j.comppsych.2013.06.003; Masdeu JC, 2012, AM J PSYCHIAT, V169, P1120, DOI 10.1176/appi.ajp.2012.12050646; Masopust J, 2015, NEUROPSYCH DIS TREAT, V11, P619, DOI 10.2147/NDT.S80746; Narayanaswamy JC, 2011, PSYCHOPATHOLOGY, V44, P136, DOI 10.1159/000319849; Parenti A, 2016, PSYCHOSOMATICS, V57, P336, DOI 10.1016/j.psym.2016.01.007; Pearlman DM, 2014, SCHIZOPHR RES, V157, P249, DOI 10.1016/j.schres.2014.05.001; Pollak TA, 2014, PSYCHOL MED, V44, P2475, DOI 10.1017/S003329171300295X; Rhoads J, 2011, SCHIZOPHR RES, V129, P213, DOI 10.1016/j.schres.2010.12.018; Rosebush PI, 2006, CUR CLIN NEUROL, P81; Steiner J, 2015, SCHIZOPHR RES, V162, P291, DOI 10.1016/j.schres.2015.01.009; Steiner J, 2014, JAMA PSYCHIAT, V71, P838, DOI 10.1001/jamapsychiatry.2014.469; Steiner J, 2013, JAMA PSYCHIAT, V70, P271, DOI 10.1001/2013.jamapsychiatry.86; Timucin D, 2016, NEUROPSYCH DIS TREAT, V12, P2327, DOI 10.2147/NDT.S113872; Tsutsui K, 2017, NEUROPSYCH DIS TREAT, V13, P339, DOI 10.2147/NDT.S125800; Tsutsui K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-37; Wilson JE, 2013, PSYCHOSOMATICS; Zandi MS, 2011, J NEUROL, V258, P686, DOI 10.1007/s00415-010-5788-9; Zerche M, 2015, STROKE, V46, P1180, DOI 10.1161/STROKEAHA.114.008323	49	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187156	10.1371/journal.pone.0187156	http://dx.doi.org/10.1371/journal.pone.0187156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073246	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400125
J	Murai, N; Ohtaki, H; Watanabe, J; Xu, ZF; Sasaki, S; Yagura, K; Shioda, S; Nagasaka, S; Honda, K; Izumizaki, M				Murai, Norimitsu; Ohtaki, Hirokazu; Watanabe, Jun; Xu, Zhifang; Sasaki, Shun; Yagura, Kazumichi; Shioda, Seiji; Nagasaka, Shoichiro; Honda, Kazuho; Izumizaki, Masahiko			Intrapancreatic injection of human bone marrow-derived mesenchymal stem/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice	PLOS ONE			English	Article							STEM-CELLS; STROMAL CELLS; STEM/PROGENITOR CELLS; PANCREATIC-ISLETS; CD40; MSCS; TRANSPLANTATION; MICROENVIRONMENT; DIFFERENTIATION; PROLIFERATION	Type 1 diabetes mellitus is a progressive disease caused by the destruction of pancreatic beta-cells, resulting in insulin dependency and hyperglycemia. While transplanted bone marrow-derived mesenchymal stem/stromal cells (BMMSCs) have been explored as an alternative therapeutic approach for diseases, the choice of delivery route may be a critical factor determining their sustainability. This study evaluated the effects of intrapancreatic and intravenous injection of human BMMSCs (hBMMSCs) in streptozotocin (STZ)-induced type 1 diabetic mouse model. C57/BL6 mice were intraperitoneally injected with 115 mg/kg STZ on day 0. hBMMSCs (1 x 10(6) cells) or vehicle were injected into the pancreas or jugular vein on day 7. Intrapancreatic, but not intravenous, hBMMSC injection significantly reduced blood glucose levels on day 28 compared with vehicle injection by the same route. This glucose-lowering effect was not induced by intrapancreatic injection of human fibroblasts as the xenograft control. Intrapancreatically injected fluorescence-labeled hBMMSCs were observed in the intra- and extra-lobular spaces of the pancreas, and intravenously injected cells were in the lung region, although the number of cells mostly decreased within 2 weeks of injection. For hBMMSCs injected twice into the pancreatic region on days 7 and 28, the injected mice had further reduced blood glucose to borderline diabetic levels on day 56. Animals injected with hBMMSCs twice exhibited increases in the plasma insulin level, number and size of islets, insulin-positive proportion of the total pancreas area, and intensity of insulin staining compared with vehicle-injected animals. We found a decrease of Iba1-positive cells in islets and an increase of CD206-positive cells in both the endocrine and exocrine pancreas. The hBMMSC injection also reduced the number of CD40-positive cells merged with glucagon immunoreactions in the islets. These results suggest that intrapancreatic injection may be a better delivery route of hBMMSCs for the treatment of type 1 diabetes mellitus.	[Murai, Norimitsu; Izumizaki, Masahiko] Showa Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Murai, Norimitsu; Ohtaki, Hirokazu; Watanabe, Jun; Xu, Zhifang; Sasaki, Shun; Yagura, Kazumichi; Honda, Kazuho] Showa Univ, Dept Anat, Sch Med, Tokyo, Japan; [Murai, Norimitsu; Nagasaka, Shoichiro] Showa Univ, Div Diabet Metab & Endocrinol, Fujigaoka Hosp, Yokohama, Kanagawa, Japan; [Watanabe, Jun] Showa Univ, Ctr Biotechnol, Tokyo, Japan; [Shioda, Seiji] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Global Res Ctr Innovat Life Sci, Peptide Drug Innovat, Tokyo, Japan	Showa University; Showa University; Showa University; Showa University; Hoshi University	Izumizaki, M (corresponding author), Showa Univ, Sch Med, Dept Physiol, Tokyo, Japan.	masahiko@med.showa-u.ac.ip	Xu, Zhifang/AAF-4798-2019	Xu, Zhifang/0000-0002-0576-163X	KAKENHI [25462236, 60646298]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by KAKENHI grants numbers 25462236 (H.O.) and 60646298 (Z.X.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabraba EB, 2008, HEPATOLOGY, V47, P552, DOI 10.1002/hep.22011; Barbe-Tuana FM, 2006, DIABETES, V55, P2437, DOI 10.2337/db05-1673; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Brissova M, 2014, CELL METAB, V19, P498, DOI 10.1016/j.cmet.2014.02.001; Carlsson PO, 2015, DIABETES, V64, P587, DOI 10.2337/db14-0656; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Dmitrieva RI, 2012, CELL CYCLE, V11, P377, DOI 10.4161/cc.11.2.18858; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Furlani D, 2009, MICROVASC RES, V77, P370, DOI 10.1016/j.mvr.2009.02.001; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Godfrey KJ, 2012, DIABETIC MED, V29, P14, DOI 10.1111/j.1464-5491.2011.03433.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Greene JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144133; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hebert SL, 2010, CLIN NUTR, V29, P13, DOI 10.1016/j.clnu.2009.09.001; Ho JH, 2012, CELL TRANSPLANT, V21, P997, DOI 10.3727/096368911X603611; Jacob AN, 2006, DIABETES OBES METAB, V8, P404, DOI 10.1111/j.1463-1326.2005.00515.x; Ji ATQ, 2015, DIABETES, V64, P926, DOI 10.2337/db14-1042; Jung DY, 2008, EXP MOL MED, V40, P1, DOI 10.3858/emm.2008.40.1.1; Karaca C, 2011, GASTROINTEST ENDOSC, V73, P603, DOI 10.1016/j.gie.2010.11.003; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Klein D, 2008, DIABETOLOGIA, V51, P1853, DOI 10.1007/s00125-008-1092-y; Klein D, 2005, DIABETOLOGIA, V48, P268, DOI 10.1007/s00125-004-1645-7; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Kover KL, 2000, DIABETES, V49, P1666, DOI 10.2337/diabetes.49.10.1666; Laxmanan S, 2005, J AM SOC NEPHROL, V16, P2714, DOI 10.1681/ASN.2005010045; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Leibacher J, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0271-2; Liu SY, 2014, J INVEST DERMATOL, V134, P2648, DOI 10.1038/jid.2014.169; Liu XX, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00165; Lundberg J, 2012, CELL TRANSPLANT, V21, P333, DOI 10.3727/096368911X576036; Milanesi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042177; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Niederhaus SV, 2013, TRANSPL INT, V26, P704, DOI 10.1111/tri.12122; Oh HC, 2008, GASTROINTEST ENDOSC, V67, P636, DOI 10.1016/j.gie.2007.09.038; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Portillo JAC, 2014, INVEST OPHTH VIS SCI, V55, P8590, DOI 10.1167/iovs.14-15340; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Qi M, 2014, ACTA DIABETOL, V51, P833, DOI 10.1007/s00592-014-0627-6; Rickels MR, 2012, CURR DIABETES REP, V12, P587, DOI 10.1007/s11892-012-0294-3; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Senhaji N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00529; Smid JK, 2015, ENDOCRINOLOGY, V156, P824, DOI 10.1210/en.2014-1637; Song DD, 2013, J NEUROIMMUNOL, V263, P55, DOI 10.1016/j.jneuroim.2013.07.018; Sujata L, 2008, CELL MOL IMMUNOL, V5, P107, DOI 10.1038/cmi.2008.13; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067475; Tatsumi K, 2013, BIOCHEM BIOPH RES CO, V431, P203, DOI 10.1016/j.bbrc.2012.12.134; Tessem JS, 2008, DIABETES, V57, P1605, DOI 10.2337/db07-1577; Tondreau T, 2004, CYTOTHERAPY, V6, P372, DOI 10.1080/14653240410004943; Tsumuraya T, 2015, J NEUROINFLAMM, V12, P252; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Uno S, 2007, DIABETOLOGIA, V50, P596, DOI 10.1007/s00125-006-0569-9; Vaitaitis GM, 2014, DIABETOLOGIA, V57, P2366, DOI 10.1007/s00125-014-3342-5; Valles G, 2015, BIOMATERIALS, V37, P124, DOI 10.1016/j.biomaterials.2014.10.028; Vendrame F, 2016, AM J TRANSPLANT, V16, P235, DOI 10.1111/ajt.13426; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Wang M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30696; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Yang DY, 2012, J NEUROSURG, V116, P1357, DOI 10.3171/2012.2.JNS111360; Yellin MJ, 1997, ARTHRITIS RHEUM, V40, P124, DOI 10.1002/art.1780400117; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	71	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186637	10.1371/journal.pone.0186637	http://dx.doi.org/10.1371/journal.pone.0186637			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073149	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400035
J	Lin, CY; Wu, YM; Hsieh, MH; Wang, CW; Wu, CY; Chen, YJ; Fang, YF				Lin, Chun-Yu; Wu, Yen-Mu; Hsieh, Meng-Heng; Wang, Chih-Wei; Wu, Ching-Yang; Chen, Ying-Jen; Fang, Yueh-Fu			Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; INTERNATIONAL ASSOCIATION; COPY NUMBERS; K-RAS; CANCER; KRAS; IMPACT; GEFITINIB; SURVIVAL; RECURRENCE	Introduction The prognostic value of epidermal growth factor receptor (EGFR) mutations and the correlation between EGFR mutations and the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) histological classification remain controversial. The current study aimed to investigate the pure prognostic role of EGFR mutations in treatment-naive patients with resected stage I lung adenocarcinoma. Methods We retrospectively reviewed 373 patients with stage I pulmonary non-small-cell lung cancer who underwent complete surgical resection between January 2010 and May 2014. The tumors were classified according to IASLC/ATS/ERS criteria. EGFR mutation status was determined by established methods. Results A total of 120 patients were included for analysis; 87 had tumors with EGFR mutations and 33 had wild-type tumors. More low-and intermediate-grade tumors had EGFR mutations, and nearly half of the high-grade tumors were wild-type (75.7% versus 46.2%, p = 0.041). Patients with low-grade tumors had significantly greater median disease-free survival (DFS) (76.8 versus 13 months, p < 0.0001) and better overall survival (OS) (median OS not reached, p = 0.0003) than those with intermediate- and high-grade tumors. Tumor recurrence was 41.4% and 30.3% in mutant and wild-type patients. The 5-years survival rate was 54% and 71.2%. Multivariate analysis revealed that the new histological classification and the pathologic stage were independent predictors of both DFS and OS. EGFR mutation status had no prognostic implications. Conclusion Low grade tumors according to IASLC/ATS/ERS histological classification and the pathologic stage IA tumors of resected stage I lung adenocarcinomas independently predict better DFS and OS. EGFR mutations were frequently seen in histologically low- and intermediate-grade tumors but not a prognostic factor.	[Lin, Chun-Yu; Chen, Ying-Jen] Chang Gung Mem Hosp Linkou, Dept Gen Med & Geriatr, Taoyuan, Taiwan; [Lin, Chun-Yu; Hsieh, Meng-Heng; Fang, Yueh-Fu] Chang Gung Mem Hosp Linkou, Dept Thorac Med, Taoyuan, Taiwan; [Lin, Chun-Yu; Hsieh, Meng-Heng; Wang, Chih-Wei; Wu, Ching-Yang; Chen, Ying-Jen; Fang, Yueh-Fu] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Yen-Mu] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Infect Dis, Dept Internal Med, Taoyuan, Taiwan; [Wu, Yen-Mu] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Wang, Chih-Wei] Chang Gung Mem Hosp Linkou, Dept Pathol, Taoyuan, Taiwan; [Wu, Ching-Yang] Chang Gung Mem Hosp, Div Surg, Dept Thorac & Cardiovasc Surg, Linkou, Taiwan; [Fang, Yueh-Fu] St Pauls Hosp, Dept Pulm & Crit Care, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Fang, YF (corresponding author), Chang Gung Mem Hosp Linkou, Dept Thorac Med, Taoyuan, Taiwan.; Fang, YF (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Fang, YF (corresponding author), St Pauls Hosp, Dept Pulm & Crit Care, Taoyuan, Taiwan.	dr.fang.yf@gmail.com		Fang, Yueh-Fu/0000-0003-2211-3076				Azzoli CG, 2015, ANN SURG ONCOL, V22, P3459, DOI 10.1245/s10434-015-4704-z; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; D'Angelo SP, 2012, J THORAC ONCOL, V7, P1815, DOI 10.1097/JTO.0b013e31826bb7b2; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hsieh MH, 2006, LUNG CANCER-J IASLC, V53, P311, DOI 10.1016/j.lungcan.2006.06.005; Isaka T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001784; Izar B, 2014, J THORAC ONCOL, V9, P1363, DOI 10.1097/JTO.0000000000000266; Izar B, 2013, ANN THORAC SURG, V96, P962, DOI 10.1016/j.athoracsur.2013.05.091; Kadota K, 2016, AM J SURG PATHOL, V40, P1579, DOI 10.1097/PAS.0000000000000744; Kim YT, 2013, J THORAC ONCOL, V8, P171, DOI 10.1097/JTO.0b013e318277a3bb; Kobayashi N, 2008, J THORAC ONCOL, V3, P704, DOI 10.1097/JTO.0b013e31817c6080; Kobayashi N, 2007, J THORAC ONCOL, V2, P808, DOI 10.1097/JTO.0b013e31814617c7; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee YJ, 2009, J CANCER RES CLIN, V135, P1647, DOI 10.1007/s00432-009-0611-7; Liu HP, 2010, J THORAC ONCOL, V5, P1175, DOI 10.1097/JTO.0b013e3181e2f4d6; Liu WS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0771-9; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mansuet-Lupo A, 2014, CHEST, V146, P633, DOI 10.1378/chest.13-2499; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nakamura H, 2015, CLIN LUNG CANCER, V16, P209, DOI 10.1016/j.cllc.2014.10.004; Nishii T, 2016, ASIA PAC J CLIN ONCO; Ohba T, 2016, SURG TODAY, V46, P1091, DOI 10.1007/s00595-015-1295-z; Ohba T, 2014, SURG TODAY, V44, P478, DOI 10.1007/s00595-013-0589-2; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sonobe M, 2012, ANN SURG ONCOL, V19, pS347, DOI 10.1245/s10434-011-1799-8; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Zhang Q, 2014, LUNG CANCER, V85, P339, DOI 10.1016/j.lungcan.2014.06.011; Zhang ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106053	38	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186567	10.1371/journal.pone.0186567	http://dx.doi.org/10.1371/journal.pone.0186567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065153	gold, Green Published, Green Submitted			2022-12-26	WOS:000413568900017
J	Shamu, T; Chimbetete, C; Shawarira-Bote, S; Mudzviti, T; Luthy, R				Shamu, Tinei; Chimbetete, Cleophas; Shawarira-Bote, Sandra; Mudzviti, Tinashe; Luthy, Ruedi			Outcomes of an HIV cohort after a decade of comprehensive care at Newlands Clinic in Harare, Zimbabwe: TENART cohort	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; 5-YEAR OUTCOMES; MORTALITY; SURVIVAL; TOXICITY; THERAPY	Background Data on long-term outcomes of patients receiving antiretroviral therapy (ART) in sub-Saharan Africa are few. We describe outcomes of patients commenced on ART at Newlands Clinic between 2004 and 2006 after >= 10 years of comprehensive care including, psychosocial, adherence and food support. Methods In this retrospective cohort study, patient data from an electronic medical record collected during routine care were analysed. We describe baseline characteristics, virological and clinical outcomes, attrition rates, and treatment adverse effects until November 2016. We defined virological suppression as viral load <50 copies/ml and virological failure as >1000 copies/ml after >= 6 months of ART. Results We analysed data for 605 patients (67% female) who commenced ART, and were followed-up for 5819 person-years (median: 10.7 years, IQR: 10.1-11.4). Median age at ART initiation was 34 years (IQR: 17-42). Pre-ART, 129 (21.3%) patients had history of pulmonary tuberculosis (PTB). In care, 66 (11%) developed PTB, and 24 (4%) developed extrapulmonary tuberculosis. 385 (63.6%) patients experienced >= 1 adverse event, the most frequent being stavudine-induced peripheral neuropathy (n = 252, 41.7%). At database closure on 14 November 2016, 474 (78.3%) patients were still in care, 428 (90.3%) being virologically suppressed, and 21 (4.4%) failing. While 483 (79.8%) remained on first line, 122 (20.2%) were switched to second line ART. Fifty-nine patients (9.8%) were transferred to other ART facilities, 45 (7.4%) were lost to follow-up, 25 (4.1%) died, and two stopped ART. Conclusion Comprehensive HIV care can result in low mortality, high retention in care and virologic suppression rates in resource limited settings.	[Shamu, Tinei; Chimbetete, Cleophas; Shawarira-Bote, Sandra; Mudzviti, Tinashe; Luthy, Ruedi] Newlands Clin, Harare, Zimbabwe; [Mudzviti, Tinashe] Univ Zimbabwe, Sch Pharm, Harare, Zimbabwe	University of Zimbabwe	Shamu, T (corresponding author), Newlands Clin, Harare, Zimbabwe.	tineis@newlandsclinic.org.zw	Mudzviti, Tinashe/AAZ-5627-2020; Shamu, Tinei/E-8255-2016	Mudzviti, Tinashe/0000-0002-9817-7108; Shamu, Tinei/0000-0001-8931-4484; Shawarira-Bote, Sandra/0000-0002-5929-7035	Ruedi Luethy Foundation	Ruedi Luethy Foundation	We would like to thank the Newlands Clinic patients whose data were analysed and the staff who attended to the patients as well as the Ruedi Luethy Foundation that financed the work of Newlands Clinic.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Boulle A, 2007, ANTIVIR THER, V12, P753; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Castelnuovo B, 2011, JAIDS-J ACQ IMM DEF, V56, P59, DOI 10.1097/QAI.0b013e3181f5bd03; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Fatti G, 2016, AIDS CARE, V28, P1365, DOI 10.1080/09540121.2016.1191605; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Johannessen A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-108; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; May MT, MORTALITY ACCORDING; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; National Drug and Therapeutics Policy Advisory Committee (NDTPAC) The AIDS and TB Unit Ministry of Health and Child Welfare Zimbabwe, 2010, GUID ANT THER ZIMB; National Medicine and Therapeutics Policy Advisory Committee AIDS and TB Directorate, 2013, GUID ANT THER PREV T; Pierre S, 2016, NEW ENGL J MED, V374, P397, DOI 10.1056/NEJMc1508934; UNAIDS, 2015, GLOB AIDS RRESPONSE; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; ZIMPHIA, 2020, ZIMB POP BAS HIV IMP	19	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186726	10.1371/journal.pone.0186726	http://dx.doi.org/10.1371/journal.pone.0186726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065149	Green Submitted, Green Published, gold			2022-12-26	WOS:000413568900029
J	Callet, T; Medale, F; Larroquet, L; Surget, A; Aguirre, P; Kerneis, T; Labbe, L; Quillet, E; Geurden, I; Skiba-Cassy, S; Dupont-Nivet, M				Callet, Therese; Medale, Francoise; Larroquet, Laurence; Surget, Anne; Aguirre, Pierre; Kerneis, Thierry; Labbe, Laurent; Quillet, Edwige; Geurden, Inge; Skiba-Cassy, Sandrine; Dupont-Nivet, Mathilde			Successful selection of rainbow trout (Oncorhynchus mykiss) on their ability to grow with a diet completely devoid of fishmeal and fish oil, and correlated changes in nutritional traits	PLOS ONE			English	Article							PLANT-BASED DIETS; FATTY-ACID COMPOSITIONS; TOTAL REPLACEMENT; PROTEIN-SOURCES; FINISHING DIET; PERFORMANCE; DIGESTIBILITY; MARINE; GENERATIONS; AQUACULTURE	In the context of limited marine resources, the exponential growth of aquaculture requires the substitution of fish oil and fishmeal, the traditional components of fish feeds by terrestrial plant ingredients. High levels of such substitution are known to negatively impact fish performance such as growth and survival in rainbow trout (Oncorhynchus mykiss) as in other salmonids. In this respect, genetic selection is a key enabler for improving those performances and hence for the further sustainable development of aquaculture. We selected a rainbow trout line over three generations for its ability to survive and grow on a 100% plant-based diet devoid of both fish oil and fishmeal (V diet) from the very first meal. In the present study, we compared the control line and the selected line after 3 generations of selection, both fed either the V diet or a marine resources-based diet (M diet). The objective of the study was to assess the efficiency of selection and the consequences on various correlated nutritional traits: feed intake, feed efficiency, digestibility, composition of whole fish, nutrient retention and fatty acid (FA) profile. We demonstrated that the genetic variability present in our rainbow trout population can be selected to improve survival and growth. The major result of the study is that after only three generations of selection, selected fish fed the V diet grew at the same rate as the control line fed the M diet, whilst the relative reduction of body weight was 36.8% before the selection. This enhanced performance on the V diet seems to be mostly linked to a higher feed intake for the selected fish.	[Callet, Therese; Quillet, Edwige; Dupont-Nivet, Mathilde] Univ Paris Saclay, AgroParisTech, INRA, UMR GABI, Jouy En Josas, France; [Callet, Therese; Medale, Francoise; Larroquet, Laurence; Surget, Anne; Aguirre, Pierre; Geurden, Inge; Skiba-Cassy, Sandrine] INRA, UMR NuMeA, St Pee Sur Niyelle, France; [Kerneis, Thierry; Labbe, Laurent] INRA, PEIMA, Sizun, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Dupont-Nivet, M (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, UMR GABI, Jouy En Josas, France.	mathilde.dupont-nivet@inra.fr	, Dupont-Nivet/J-2850-2019	Medale, Francoise/0000-0002-8083-1298; Callet, Therese/0000-0003-0594-664X; Dupont-Nivet, Mathilde/0000-0002-9299-0560	ANR, the French research agency [ANR-13-ADAP-001]	ANR, the French research agency(French National Research Agency (ANR))	This work was carried out within the framework of the AGREENFISH project (project ANR-13-ADAP-001) funded by ANR, the French research agency.	Bell JG, 2004, LIPIDS, V39, P223, DOI 10.1007/s11745-004-1223-5; Bell JG, 2003, J NUTR, V133, P2793, DOI 10.1093/jn/133.9.2793; BERGOT F, 1983, AQUACULTURE, V34, P203, DOI 10.1016/0044-8486(83)90203-X; Burel C, 1998, AQUACULTURE, V163, P325, DOI 10.1016/S0044-8486(98)00241-5; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; Cashion T, 2017, FISH FISHERIES, V5; Collins SA, 2013, AQUACULTURE, V400, P85, DOI 10.1016/j.aquaculture.2013.03.006; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; de Francesco M, 2004, AQUACULTURE, V236, P413, DOI 10.1016/j.aquaculture.2004.01.006; Drew MD, 2007, AQUACULTURE, V267, P260, DOI 10.1016/j.aquaculture.2007.01.002; Dupont-Nivet M, 2009, AQUACULTURE, V295, P15, DOI 10.1016/j.aquaculture.2009.06.031; Espe M, 2006, AQUACULTURE, V255, P255, DOI 10.1016/j.aquaculture.2005.12.030; Fisheries FAO., 2016, STAT WORLD FISH AQ; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Geurden I, 2005, PHYSIOL BEHAV, V85, P107, DOI 10.1016/j.physbeh.2005.03.010; Gjedrem T., 2012, World Aquaculture, V43, P10; Gjedrem T, 2012, AQUACULTURE, V350, P117, DOI 10.1016/j.aquaculture.2012.04.008; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; GOMES EF, 1995, AQUACULTURE, V130, P177, DOI 10.1016/0044-8486(94)00211-6; Janhunen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038766; Kamalam BS, 2016, AQUACULTURE; Kause A, 2005, AQUACULTURE, V247, P177, DOI 10.1016/j.aquaculture.2005.02.023; Kaushik SJ, 2004, AQUACULTURE, V230, P391, DOI 10.1016/S0044-8486(03)00422-8; KINCAID HL, 1977, T AM FISH SOC, V106, P621, DOI 10.1577/1548-8659(1977)106<621:TGOSFG>2.0.CO;2; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Lazzarotto V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117609; Le Boucher R, 2013, J ANIM SCI, V91, P1522, DOI 10.1093/ansci/91.3.1522; Le Boucher R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044898; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Leaver MJ, 2011, COMP BIOCHEM PHYS D, V6, P62, DOI 10.1016/j.cbd.2010.04.002; Leeds TD, 2016, AQUACULTURE, V465, P341, DOI 10.1016/j.aquaculture.2016.08.036; Medale F, 2013, INRA PROD ANIM, V26, P303; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Overturf K, 2013, AQUAC RES, V44, P604, DOI 10.1111/j.1365-2109.2011.03065.x; Palti Y, 2006, AQUACULTURE, V255, P548, DOI 10.1016/j.aquaculture.2005.11.029; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Pierce LR, 2008, AQUACULTURE, V278, P37, DOI 10.1016/j.aquaculture.2008.03.017; Quinton CD, 2007, GENET SEL EVOL, V39, P431, DOI 10.1051/gse:2007013; R. Core Team, 2015, R A LANGUAGE AND ENV; Refstie S, 1997, AQUACULTURE, V153, P263, DOI 10.1016/S0044-8486(97)00025-2; Sargent John R., 2002, P181; SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9; Tacon AGJ., 2011, DEMAND SUPPLY FEED I; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Thivend P, 1972, METHOD CARBOHYD CHEM, P100, DOI DOI 10.1016/B978-0-12-746206-6.50021-7; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Torstensen BE, 2008, AQUACULTURE, V285, P193, DOI 10.1016/j.aquaculture.2008.08.025; Torstensen BE, 2005, J AGR FOOD CHEM, V53, P10166, DOI 10.1021/jf051308i; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Venold FF, 2012, AQUACULTURE, V364, P281, DOI 10.1016/j.aquaculture.2012.08.035; Yamamoto T, 2016, AQUACULTURE, V465, P380, DOI 10.1016/j.aquaculture.2016.09.030; Yamamoto T, 2015, FISHERIES SCI, V81, P83, DOI 10.1007/s12562-014-0817-8; Yamamoto T, 2014, FISHERIES SCI, V80, P569, DOI 10.1007/s12562-014-0707-0	58	21	21	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186705	10.1371/journal.pone.0186705	http://dx.doi.org/10.1371/journal.pone.0186705			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059226	Green Published, Green Submitted, gold			2022-12-26	WOS:000413403000035
J	Duijvis, NW; Moerland, PD; Kunne, C; Slaman, MMW; van Dooren, FH; Vogels, EW; de Jonge, WJ; Meijer, SL; Fluiter, K; te Velde, AA				Duijvis, Nicolette W.; Moerland, Perry D.; Kunne, Cindy; Slaman, Monique M. W.; van Dooren, Faas H.; Vogels, Esther W.; de Jonge, Wouter J.; Meijer, Sybren L.; Fluiter, Kees; te Velde, Anje A.			Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; EPITHELIAL BARRIER; PROTEIN-SYNTHESIS; MURINE COLITIS; IMMUNE-SYSTEM; MICRORNAS; EXPRESSION; COLON	Background MicroRNAs (miRNAs) are epigenetically involved in regulating gene expression. They may be of importance in the pathogenesis of inflammatory bowel disease (IBD). The aim of this study was to determine the role of miRNAs by their specific blocking in the CD4+CB45RB(hi) T-cell transfer model of chronic experimental colitis. Methods Colitis caused by transfer of WT CD4+CD45RB(hi) T cells in severe combined immunodeficiency (SCID) mice shares many features with human IBD. Colonic miRNA expression levels were measured at three time points in colitic mice, where a time-dependent upregulation of multiple miRNAs was seen. To inhibit these miRNAs, specific locked-nucleic-acid-modified (LNA) oligonucleotides were administered in further experiments at the moment the mice demonstrated the first signs of colitis. As controls, PBS and a scrambled sequence of anti-miRNA were used. Genome-wide expression analyses were also performed in order to detect candidate target genes of miR-142-5p, of which inhibition resulted in most effective amelioration of colitis. Results Anti-miR-142-5p reduced colitis and related wasting disease when administered in the T-cell transfer model, reflected in reduced weight loss and a lower disease activity index (DAI). In further validation experiments we also observed a higher survival rate and less colonic histological inflammation in the antagomir-treated mice. Moreover, by genome-wide expression analyses, we found downstream activation of the anti-inflammatory IL10RA pathway, including three genes also found in the top-20 candidate target genes of miR-142-5p. Conclusion In conclusion, CD4+CD45RB(hi)-transfer colitis induces miR-142-5p. Blocking miR-142-5p reduced colitis and prevented wasting disease, possibly by activation of the IL10RA pathway.	[Duijvis, Nicolette W.; Kunne, Cindy; Slaman, Monique M. W.; van Dooren, Faas H.; Vogels, Esther W.; de Jonge, Wouter J.; te Velde, Anje A.] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Moerland, Perry D.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, Amsterdam, Netherlands; [Meijer, Sybren L.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Fluiter, Kees] Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Duijvis, NW; te Velde, AA (corresponding author), Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.	n.w.duijvis@amc.uva.nl; a.a.tevelde@amc.uva..nl	Moerland, Perry/AAG-1425-2020; Fluiter, Kees/H-2828-2015	Moerland, Perry/0000-0002-2357-3659; Fluiter, Kees/0000-0003-0898-7260; Meijer, Sybren/0000-0002-6953-2406				Aviello G, 2014, AM J PHYSIOL-GASTR L, V306, pG769, DOI 10.1152/ajpgi.00399.2013; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Cao Ke, 2015, Molecular Medicine (Baltimore), V21, DOI 10.2119/molmed.2014.00189; Caspi M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-164; COOPER HS, 1993, LAB INVEST, V69, P238; Corr SC, 2014, MUCOSAL IMMUNOL, V7, P57, DOI 10.1038/mi.2013.24; den Kamp CMO, 2013, AM J CLIN NUTR, V98, P738, DOI 10.3945/ajcn.113.058388; Devoss J, 2014, TOXICOL PATHOL, V42, P99, DOI 10.1177/0192623313509729; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Franchimont N, 2004, CLIN EXP IMMUNOL, V138, P491, DOI 10.1111/j.1365-2249.2004.02643.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; Gantier MP, 2007, IMMUNOL CELL BIOL, V85, P458, DOI 10.1038/sj.icb.7100091; Ghosh S, 2016, GENE, V584, P97, DOI 10.1016/j.gene.2016.03.008; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Huang SC, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004786; Jones-Hall Yava L, 2014, Pathophysiology, V21, P267, DOI 10.1016/j.pathophys.2014.05.002; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; READ S, 2001, CURR PROTOC IMMUNOL; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Schuck RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110162; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Simard B, 2013, CYTOKINE, V61, P104, DOI 10.1016/j.cyto.2012.08.035; Soe MJ, 2011, J HISTOCHEM CYTOCHEM, V59, P661, DOI 10.1369/0022155411409411; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Toiyama Y, 2011, J GASTROENTEROL, V46, P153, DOI 10.1007/s00535-010-0318-1; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yang J, 2014, ACTA PHYSIOL, V210, P590, DOI 10.1111/apha.12176; Zhang DK, 2010, J PATHOL, V222, P213, DOI 10.1002/path.2749; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	47	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0185097	10.1371/journal.pone.0185097	http://dx.doi.org/10.1371/journal.pone.0185097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059189	gold, Green Published, Green Submitted			2022-12-26	WOS:000413403000004
J	Cameron, AC; Anderson, JJ; Page, RB				Cameron, Alexander C.; Anderson, Jeffry J.; Page, Robert B.			Assessment of intra and interregional genetic variation in the Eastern Red-backed Salamander, Plethodon cinereus, via analysis of novel microsatellite markers	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; TERRESTRIAL SALAMANDER; POLYMORPHIC SALAMANDER; BIASED DISPERSAL; F-STATISTICS; SOFTWARE; PROGRAM; LOCI; DIFFERENTIATION; DIVERGENCE	The red-backed salamander (Plethodon cinereus) has long-served as a model system in ecology, evolution, and behavior, and studies surveying molecular variation in this species have become increasingly common over the past decade. However, difficulties are commonly encountered when extending microsatellite markers to populations that are unstudied from a genetic perspective due to high levels of genetic differentiation across this species' range. To ameliorate this issue, we used 454 pyrosequencing to identify hundreds of microsatellite loci. We then screened 40 of our top candidate loci in populations in Virginia, Pennsylvania, and Ohio-including an isolated island population similar to 4.5 km off the shore of Lake Erie (South Bass Island). We identified 25 loci that are polymorphic in a well-studied region of Virginia and 11 of these loci were polymorphic in populations located in the genetically unstudied regions of Ohio and Pennsylvania. Use of these loci to examine patterns of variation within populations revealed that South Bass Island has low diversity in comparison to other sites. However, neither South Bass Island nor isolated populations around Cleveland are inbred. Assessment of variation between populations revealed three well defined genetic clusters corresponding to Virginia, mainland Ohio/Pennsylvania, and South Bass Island. Comparisons of our results to those of others working in various parts of the range are consistent with the idea that differentiation is lower in regions that were once glaciated. However, these comparisons also suggest that well differentiated isolated populations in the formerly glaciated portion of the range are not uncommon. This work provides novel genetic resources that will facilitate population genetic studies in a part of the red-backed salamander's range that has not previously been studied in this manner. Moreover, this work refines our understanding of how neutral variation is distributed in this ecologically important organism.	[Cameron, Alexander C.] John Carroll Univ, Dept Biol, University Hts, OH USA; [Anderson, Jeffry J.] St Johns Univ, Dept Biol, Collegeville, MN 56321 USA; [Page, Robert B.] Texas A&M Univ San Antonio, Dept Sci & Math, San Antonio, TX 78224 USA; [Cameron, Alexander C.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Anderson, Jeffry J.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	John Carroll University; College of Saint Benedict & Saint Johns University; Saint Johns University Collegeville; Texas A&M University System; Texas A&M University San Antonio; University of New Mexico; Medical College of Wisconsin	Page, RB (corresponding author), Texas A&M Univ San Antonio, Dept Sci & Math, San Antonio, TX 78224 USA.	Robert.Page@tamusa.edu						[Anonymous], 2010, SALAMANDERS US CANAD; ANTHONY C. D., 2013, OHIO BIOL SURVEY B, V17, P335; Anthony CD, 2008, J ANIM ECOL, V77, P646, DOI 10.1111/j.1365-2656.2008.01398.x; Bhargava A, 2010, MOL BIOTECHNOL, V44, P250, DOI 10.1007/s12033-009-9230-4; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; BURTON TM, 1975, COPEIA, P541; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Connors LM, 2003, MOL ECOL NOTES, V3, P131, DOI 10.1046/j.1471-8286.2003.00373.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fisher-Reid MC, 2013, MOL ECOL, V22, P4681, DOI 10.1111/mec.12412; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gillette J. R., 2003, THESIS; Gillette JR, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P431; Grant AH, 2017, J HERED, V108, P588, DOI 10.1093/jhered/esx040; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hickerson CAM, 2017, HERPETOLOGICA, V73, P180, DOI 10.1655/HERPETOLOGICA-D-16-00081.1; Hickerson CAM, 2012, AM MIDL NAT, V168, P30, DOI 10.1674/0003-0031-168.1.30; HIGHTON R, 1976, EVOLUTION, V30, P33, DOI 10.1111/j.1558-5646.1976.tb00879.x; HOLM S, 1979, SCAND J STAT, V6, P65; JAEGER RG, 1981, AM NAT, V117, P962, DOI 10.1086/283780; JAEGER RG, 1986, ANIM BEHAV, V34, P860, DOI 10.1016/S0003-3472(86)80071-9; Jaeger RG., 2016, BEHAV ECOLOGY E RED; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T., 2015, TUTORIAL DISCRIMINAN, DOI DOI 10.1007/s10750-017-3486-7; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jordan MA, 2009, CONSERV GENET, V10, P1647, DOI 10.1007/s10592-008-9741-8; Leblois R, 2003, MOL BIOL EVOL, V20, P491, DOI 10.1093/molbev/msg034; Liebgold EB, 2006, MOL ECOL, V15, P4153, DOI 10.1111/j.1365-294X.2006.03076.x; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Marsh DM, 2007, CAN J ZOOL, V85, P319, DOI 10.1139/Z07-008; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Noel S, 2007, CONSERV GENET, V8, P599, DOI 10.1007/s10592-006-9202-1; Noel S, 2010, BIOL CONSERV, V143, P2823, DOI 10.1016/j.biocon.2010.07.033; Paluh DJ, 2015, AM MIDL NAT, V174, P265; Paquette SR., 2012, R PACKAGE, V1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Prosen ED, 2004, ANIM BEHAV, V67, P85, DOI 10.1016/j.anbehav.2003.02.005; Radomski TP, 2016, THESIS; Reiter MK, 2014, COPEIA, P481, DOI 10.1643/CE-13-154; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; TEST FH, 1948, AM MIDL NAT, V39, P362, DOI 10.2307/2421590; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Venesky MD, 2015, J ZOOL, V295, P279, DOI 10.1111/jzo.12208; Walton BM, 2013, HERPETOLOGICA, V69, P127, DOI 10.1655/HERPETOLOGICA-D-12-00029; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wood JP, 2016, AMPHIBIA-REPTILIA, V37, P121, DOI 10.1163/15685381-00003030; Wood JP, 2015, AMPHIBIA-REPTILIA, V36, P444, DOI 10.1163/15685381-00003016; Zhdanova OL, 2008, J HERED, V99, P694, DOI 10.1093/jhered/esn061	67	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186866	10.1371/journal.pone.0186866	http://dx.doi.org/10.1371/journal.pone.0186866			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053730	Green Published, gold, Green Submitted			2022-12-26	WOS:000413315100043
J	de Souza, MR; do Amaral, WN; Guimaraes, RA; Rezza, G; Brunini, SM				de Souza, Marise Ramos; do Amaral, Waldemar Naves; Guimaraes, Rafael Alves; Rezza, Giovanni; Brunini, Sandra Maria			Reproductive desire among women living with HIV/AIDS in Central Brazil: Prevalence and associated factors	PLOS ONE			English	Article							HIV-SEROPOSITIVE WOMEN; FERTILITY INTENTIONS; HEALTH-CARE; DECISION; CHILD; MEN; AGE	Background The purpose of this study was to estimate the prevalence and examine the factors associated with reproductive desire among women living with HIV/AIDS (WLWHA) in Central Brazil. Methods A cross-sectional study involving 274 WLWHA, aged 18 to 49 years, was conducted with the support of treatment services and non-governmental organizations that assist people living with HIV/AIDS. Data regarding sociodemographic characteristics, substance use, sexual behavior, and reproductive variables were collected through interviews. Poisson regression with robust variance was used to analyze the factors associated with reproductive desire. Results The prevalence of reproductive desire was 25.9% (95.0% confidence interval [CI]: 21.1-31.4%). This outcome was associated with age < 30 years (adjusted prevalence ratio [APR]: 2.93; p < 0.001), black skin color or race (APR: 2.28; p = 0.017), partner's reproductive desire (APR: 7.55; p < 0.001), absence of children (APR: 2.13; p = 0.003), history of abortion (APR: 1.65; p = 0.045) and undetectable viral load at the time of data collection (APR: 1.92; p = 0.043). Conclusion The prevalence of reproductive desire among WLWHA was relatively high. It is necessary to include fertility issues as part of assistance and counseling for women in referral services to support them with their feelings, goals, and needs regarding reproductive choices.	[de Souza, Marise Ramos] Univ Fed Goias, Nursing Course, Jatai, Go, Brazil; [de Souza, Marise Ramos; do Amaral, Waldemar Naves] Univ Fed Goias, Med Sch, Goiania, Go, Brazil; [Guimaraes, Rafael Alves] Univ Fed Goias, Trop Dis & Publ Hlth, Goiania, Go, Brazil; [Rezza, Giovanni] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Brunini, Sandra Maria] Univ Fed Goias, Nursing Sch, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Istituto Superiore di Sanita (ISS); Universidade Federal de Goias	Brunini, SM (corresponding author), Univ Fed Goias, Nursing Sch, Goiania, Go, Brazil.	sandrabrunini@hotmail.com	rezza, giovanni/D-4393-2016	rezza, giovanni/0000-0003-0268-6790				Alemayehu B., 2012, J AIDS HIV RES, V4, P128; Asfaw HM, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-36; Badell Martina L, 2012, Infect Dis Obstet Gynecol, V2012, P107878, DOI 10.1155/2012/107878; Berhan Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-409; Cordova FP, 2013, REV BRAS ENFERM, V66, P97, DOI 10.1590/S0034-71672013000100015; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Demissie DB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0382-2; Eka PO, 2016, TROP J OBSTET GYNAEC, V33, P232, DOI DOI 10.4103/0189-5117.192235; Finocchario-Kessler S, 2012, AIDS BEHAV, V16, P99, DOI 10.1007/s10461-011-9906-1; Hernando V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-194; Hyma J, 2016, J CLIN DIAGNOSTIC RE, V10, P19; IBGE, 2011, CAR ETHN RAC POP EST; Jones DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160190; Kakaire O, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-27; Kuete M, 2016, SEX MED-UK, V4, pE97, DOI 10.1016/j.esxm.2016.01.004; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; MacCarthy Sarah, 2012, Reprod Health Matters, V20, P119, DOI 10.1016/S0968-8080(12)39641-9; Matthews LT, 2013, AIDS BEHAV, V17, P461, DOI 10.1007/s10461-011-0068-y; Melaku YA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0137-2; Mmbaga EJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-86; Mohammed F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150566; MS, 2016, B EPIDEMIOLOGICO HIV; Ndlovu V, 2009, SAHARA J-J SOC ASP H, V6, P58, DOI 10.1080/17290376.2009.9724931; Nedjat S, 2015, INT J HEALTH POLICY, V4, P591, DOI 10.15171/ijhpm.2015.68; Nobrega AA, 2007, AIDS PATIENT CARE ST, V21, P261, DOI 10.1089/apc.2006.0116; Nurudeen SK, 2013, J WOMENS HEALTH, V22, P243, DOI 10.1089/jwh.2012.3855; Ogilvie GS, 2007, AIDS, V21, pS83, DOI 10.1097/01.aids.0000255090.51921.60; Okome-Nkoumou Madeleine, 2015, Open AIDS J, V9, P1, DOI 10.2174/1874613601509010001; Paiva V, 2007, AIDS PATIENT CARE ST, V21, P268, DOI 10.1089/apc.2006.0129; Paiva Vera, 2002, Cad. Saúde Pública, V18, P1609, DOI 10.1590/S0102-311X2002000600015; Reis Cláudia Bastos da Silveira, 2015, Texto contexto - enferm., V24, P1053, DOI 10.1590/0104-0707201500003560014; Reis EK, 2013, CIENCIA CUIDADO SAUD, V12, P210; Rhodes CM., 2016, INFECT DIS OBSTET GY, V2016, DOI [10.1155/2016/8048457 27313441, DOI 10.1155/2016/804845727313441]; Sant'Anna Ana Carolina Cunha, 2009, Psicol. Reflex. Crit., V22, P244, DOI 10.1590/S0102-79722009000200011; Santos Naila JS, 2002, Rev. Saúde Pública, V36, P12, DOI 10.1590/S0034-89102002000500004; Ujiji OA, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-13; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2016, AIDS CHANG EV THING; UNAIDS, 2016, GLOB AIDS UPD; van Dijk MG, 2014, J ASSOC NURSE AIDS C, V25, P224, DOI 10.1016/j.jana.2013.04.006; Viso AT, 2015, SAUDE REPRODUTIVA PE	41	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186267	10.1371/journal.pone.0186267	http://dx.doi.org/10.1371/journal.pone.0186267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK2MA	29053712	Green Submitted, Green Published, gold			2022-12-26	WOS:000413315100015
J	Kesselring, T; Viquerat, S; Brehm, R; Siebert, U				Kesselring, Tina; Viquerat, Sacha; Brehm, Ralph; Siebert, Ursula			Coming of age: - Do female harbour porpoises (Phocoena phocoena) from the North Sea and Baltic Sea have sufficient time to reproduce in a human influenced environment?	PLOS ONE			English	Article							LIFE-HISTORY; GERMAN NORTH; STRESS; MATURATION; OVULATION; MATURITY; GROWTH; RAT	The harbour porpoise is the only cetacean species native to German waters. Since human pressures are suggested to shorten their reproductive lifespan, basic knowledge on reproduction is strongly required. One parameter is the onset of sexual maturity in female harbour porpoises. Therefore, we investigated the first signs of sexual maturity for a period of almost two decades (1990-2016). Ovaries from 111 female harbour porpoises from the German North Sea and Baltic Sea were examined for the presence and morphological structure of follicles, corpora lutea and corpora albicantia. Based on the ovarian characteristics we performed the first model-based estimation of age at sexual maturity for harbour porpoises from German waters. Additionally, we produced a demographical age structure based on all female strandings and bycatches from German coasts. Our results showed that corpora lutea and corpora albicantia as signs of former ovulation could be found in individuals at an age of 4.95 (+/- 0.6) years. No significant differences between specimens from the North Sea and Baltic Sea were detected. However, the average age at death differed significantly with 5.70 (+/- 0.27) years for North Sea animals and 3.67 (+/- 0.30) years for those in the Baltic Sea. Growing evidence exists that the shortened lifespan of Baltic Sea harbour porpoises is linked to an anthropogenically influenced environment with rising bycatch mortalities due to local gillnet fisheries. Thus, our findings support the idea of local management plans based on a model-based detection of age at sexual maturity and considering the anthropogenic impacts on the population for effective protection of harbour porpoises and the North Sea and Baltic Sea.	[Kesselring, Tina; Viquerat, Sacha; Siebert, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res ITAW, Busum, Germany; [Brehm, Ralph] Univ Vet Med Hannover, Inst Anat, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Siebert, U (corresponding author), Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res ITAW, Busum, Germany.	ursula.siebert@tiho-hannover.de		Viquerat, Sacha/0000-0002-2519-7319				Addink M. J., 1999, Lutra, V41, P55; ADDISON RF, 1989, CAN J FISH AQUAT SCI, V46, P360, DOI 10.1139/f89-047; Age T., 2001, ICES J MAR SCI, V58, P154; Aguilar Alex, 1995, Reports of the International Whaling Commission Special Issue, V16, P231; Ahmed SR, 2000, TOXICOLOGY, V150, P191; Akaike H., 1974, 2 INT S INF THEOR, P267; BAKER ER, 1985, CLIN OBSTET GYNECOL, V28, P573, DOI 10.1097/00003081-198528030-00013; Bando T, 2014, JARPAII REV M UNPUB, P29; Bandomir B, 1998, P 12 ANN C EUR CET S; Beineke A, 2005, ENVIRON SCI TECHNOL, V39, P3933, DOI 10.1021/es048709j; Benke H, 1998, ARCH FISH MAR RES, V46, P97; Berggren P, 2002, BIOL CONSERV, V103, P313, DOI 10.1016/S0006-3207(01)00142-2; Berggren Per, 1994, Reports of the International Whaling Commission Special Issue, V15, P211; Das K, 2006, ARCH ENVIRON CON TOX, V51, P720, DOI 10.1007/s00244-005-0098-4; Eckert R, 1993, TIERPHYSIOLOGIE, P358; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellis BJ, 2007, CHILD DEV, V78, P1799, DOI 10.1111/j.1467-8624.2007.01092.x; FISHER HD, 1970, J ZOOL, V161, P471; Gaskin D.E., 1984, Reports of the International Whaling Commission Special Issue, P135; Gilles A, 2009, MAR ECOL PROG SER, V383, P295, DOI 10.3354/meps08020; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Halldorsson SD, 2001, NAMMCO SCI PUBLICATI, V5, P121; Hasselmeier I., 2004, Journal of Cetacean Research and Management, V6, P259; HENNESSY DP, 1983, THERIOGENOLOGY, V20, P13, DOI 10.1016/0093-691X(83)90019-5; Hohn A, REPROD BIOL PHYLOGEN; Imazaki PH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/438295; JANSEN HT, 1993, REPROD TOXICOL, V7, P237, DOI 10.1016/0890-6238(93)90230-5; Jauniaux TP, 2010, EMERG INFECT DIS, V16, P1966, DOI 10.3201/eid1612.101008; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Karakosta CV, 1999, J ZOOL, V249, P111, DOI 10.1111/j.1469-7998.1999.tb01064.x; Kasuya T, 1965, AGE DETERMINATION RE; KINZE C C, 1990, Fauna och Flora Naturhistoriska Riksmuseet, V85, P114; Koschinski S, 16 ASCOBANS ADV COMM; lafsdottir D, 2002, NAMMCO SCI PUBLICATI, V5, P121; Learmonth JA, 2014, MAR MAMMAL SCI, V30, P1427, DOI 10.1111/mms.12130; Lind PM, 1999, TOXICOL APPL PHARM, V154, P236, DOI 10.1006/taap.1998.8568; Lockyer C., 2003, NAMMCO Scientific Publications, V5, P71; LOCKYER C, 1972, J CONSEIL, V34, P276; Lockyer Christina, 1995, Reports of the International Whaling Commission Special Issue, V16, P511; March H, 1984, REP INT WHAL COMMN; Mikuni Masato, 1995, Hokkaido Journal of Medical Science, V70, P561; Muller S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-145; Murphy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131085; Nakamura K, 2008, J ASSIST REPROD GEN, V25, P47, DOI 10.1007/s10815-008-9206-5; OHSUMI S, 1986, Scientific Reports of the Whales Research Institute Tokyo, P1; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P1; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P97; READ AJ, 1995, MAR MAMMAL SCI, V11, P423, DOI 10.1111/j.1748-7692.1995.tb00667.x; Reijnders PJH, 1986, NATURE, V324, P556; RIVIER C, 1990, ENDOCRINOLOGY, V127, P849; Romano TA, 2004, CAN J FISH AQUAT SCI, V61, P1124, DOI [10.1139/f04-055, 10.1139/F04-055]; ROOZENDAAL MM, 1995, EUR J ENDOCRINOL, V133, P347, DOI 10.1530/eje.0.1330347; SERGEANT DE, 1973, J FISH RES BOARD CAN, V30, P1009, DOI 10.1139/f73-165; Siebert U, 2009, J APPL MICROBIOL, V106, P329, DOI 10.1111/j.1365-2672.2008.04006.x; Siebert U, 2006, J COMP PATHOL, V134, P134, DOI 10.1016/j.jcpa.2005.09.002; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Slooten E, 1999, CAN J ZOOL, V69, P1689; Smollich A, 1992, MIKROSKOPISCHE ANATO, V2, P283; SORENSEN TB, 1994, OPHELIA, V39, P159, DOI 10.1080/00785326.1994.10429541; Sveegaard S, 2011, MAR MAMMAL SCI, V27, P230, DOI 10.1111/j.1748-7692.2010.00379.x; Takahashi Y, 2006, MAR MAMMAL SCI, V22, P819, DOI 10.1111/j.1748-7692.2006.00050.x; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/ror.0.0050105; Unger B, 2017, MARINE ENV RES; VANUTRECHT WL, 1978, BIJDR DIERKD, V48, P16, DOI 10.1163/26660644-04801002; Yasui W. Y., 1986, PHOCOENA PHOCOENA, V25, P183, DOI DOI 10.1080/00HTTPS://	66	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186951	10.1371/journal.pone.0186951	http://dx.doi.org/10.1371/journal.pone.0186951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK2MA	29053754	Green Submitted, Green Published, gold			2022-12-26	WOS:000413315100052
J	Velazco, SJE; Galvao, F; Villalobos, F; De Marco, P				Elias Velazco, Santiago Jose; Galvao, Franklin; Villalobos, Fabricio; De Marco Junior, Paulo			Using worldwide edaphic data to model plant species niches: An assessment at a continental extent	PLOS ONE			English	Article							CLIMATE-CHANGE; SAMPLING BIAS; DISTRIBUTIONS; CONSERVATION; PREDICTORS; ACCURACY; RANGE; RARE; INFORMATION; UNCERTAINTY	Ecological niche modeling (ENM) is a broadly used tool in different fields of plant ecology. Despite the importance of edaphic conditions in determining the niche of terrestrial plant species, edaphic data have rarely been included in ENMs of plant species perhaps because such data are not available for many regions. Recently, edaphic data has been made available at a global scale allowing its potential inclusion and evaluation on ENM performance for plant species. Here, we take advantage of such data and address the following main questions: What is the influence of distinct predictor variables (e.g. climatic vs edaphic) on different ENM algorithms? and what is the relationship between the performance of different predictors and geographic characteristics of species? We used 125 plant species distributed over the Neotropical region to explore the effect on ENMs of using edaphic data available from the SoilGrids database and its combination with climatic data from the CHELSA database. In addition, we related these different predictor variables to geographic characteristics of the target species and different ENM algorithms. The use of different predictors (climatic, edaphic, and both) significantly affected model performance and spatial complexity of the predictions. We showed that the use of global edaphic plus climatic variables generates ENMs with similar or better accuracy compared to those constructed only with climate variables. Moreover, the performance of models considering these different predictors, separately or jointly, was related to geographic properties of species records, such as number and distribution range. The large geographic extent, the variability of environments and the different species' geographical characteristics considered here allowed us to demonstrate that global edaphic data adds useful information for plant ENMs. This is particularly valuable for studies of species that are distributed in regions where more detailed information on soil properties is poor or does not even exist.	[Elias Velazco, Santiago Jose; Galvao, Franklin] Univ Fed Parana, Dept Ciencias Agrarias, Lab Ecol Florestal, Curitiba, Parana, Brazil; [Villalobos, Fabricio] Inst Ecol AC, Red Biol Evolut, Lab Macroecol Evolut, Xalapa, Veracruz, Mexico; [De Marco Junior, Paulo] Univ Fed Goias, ICB, Dept Ecol, Lab Teoria Metacomunidades & Ecol Paisagens, Goiania, Go, Brazil	Universidade Federal do Parana; Instituto de Ecologia - Mexico; Universidade Federal de Goias	Velazco, SJE (corresponding author), Univ Fed Parana, Dept Ciencias Agrarias, Lab Ecol Florestal, Curitiba, Parana, Brazil.	sjevelazco@gmail.com	velazco, santiago/AAD-3077-2020; Villalobos, Fabricio/J-6246-2012; De Marco, Paulo/B-2209-2009	velazco, santiago/0000-0002-7527-0967; Villalobos, Fabricio/0000-0002-5230-2217; De Marco, Paulo/0000-0002-3628-6405	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Consejo Nacional de Ciencia y Tecnologia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CONACyT	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	SJEV is supported by a doctoral research grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. PDMJ and FG are supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. FV is supported by Consejo Nacional de Ciencia y Tecnologia. The authors received no specific funding for this work.; SJEV was supported by a doctoral research grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). PDMJ and FG thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for productivity grants. FV thanks A. Lira-Noriega, A.T. Peterson, O. Rojas-Soto and J. Soberon for several discussions on ENMs, and CONACyT for financial support.	Aguirre-Gutierrez Jesus, 2013, PLoS One, V8, pe63708, DOI 10.1371/journal.pone.0063708; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; ANDERSON DW, 1988, BIOGEOCHEMISTRY, V5, P71, DOI 10.1007/BF02180318; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Arnold RW., 2008, ENCYCLOPEDIA OF SOIL, P902; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x; AUSTIN MP, 1989, VEGETATIO, V83, P35, DOI 10.1007/BF00031679; Austin MP, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P73; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barbet-Massin M, 2010, ECOGRAPHY, V33, P878, DOI 10.1111/j.1600-0587.2010.06181.x; Barcenas-Arguello ML, 2013, SOIL PROCESSES CURRE; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Beauregard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092642; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Bertrand R, 2012, GLOBAL CHANGE BIOL, V18, P2648, DOI 10.1111/j.1365-2486.2012.02679.x; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Breemen N. van, 2002, Soil formation; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carretero MA, 2016, ACTA OECOL, V77, P207, DOI 10.1016/j.actao.2016.08.014; Ceddia MB, 2009, SCI AGR, V66, P338, DOI 10.1590/S0103-90162009000300009; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Coudun C, 2006, J BIOGEOGR, V33, P1750, DOI 10.1111/j.1365-2699.2005.01443.x; Crawford JA, 2016, LANDSCAPE ECOL, V31, P2231, DOI 10.1007/s10980-016-0394-6; Cruz-Cardenas G, 2014, REV MEX BIODIVERS, V85, P189, DOI 10.7550/rmb.36723; de Souza RA, 2014, ECOL MODEL, V291, P250, DOI 10.1016/j.ecolmodel.2014.07.007; Diekmann M, 2015, BASIC APPL ECOL, V16, P563, DOI 10.1016/j.baae.2015.08.010; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duan H-Y, 2014, PLOS ONE, V9; Dubuis A, 2013, J VEG SCI, V24, P593, DOI 10.1111/jvs.12002; Dubuis A, 2011, DIVERS DISTRIB, V17, P1122, DOI 10.1111/j.1472-4642.2011.00792.x; Dupin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020957; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fernandez M, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00049.1; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Filzmoser Peter, 2014, PCAPP ROBUST PCA PRO; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Fox J., 2018, R COMPANION APPL REG, VThird; Franklin J, 2009, MAPPING SPECIES DIST; Goodwin ZA, 2015, CURR BIOL, V25, pR1066, DOI 10.1016/j.cub.2015.10.002; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Gröger Andreas, 2007, Braz. J. Bot., V30, P599, DOI 10.1590/S0100-84042007000400006; Guillera-Arroita G, 2014, METHODS ECOL EVOL, V5, P1192, DOI 10.1111/2041-210X.12252; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hanberry BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044486; Harris Rebecca M. B., 2013, Ecological Management & Restoration, V14, P230, DOI 10.1111/emr.12055; Hastie T., 1986, STAT SCI, V1986, P297, DOI [DOI 10.1214/SS/1177013604, 10.1214/ss/1177013604]; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hengl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125814; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Heuvelink GBM, 2001, GEODERMA, V100, P269, DOI 10.1016/S0016-7061(01)00025-8; Hijmans RJ, 2015, **DATA OBJECT**, DOI DOI 10.HTTPS://CRAN.R-PROJECT.ORG/WEB/PACKAGES/RASTER/INDEX.HTML; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Hutchinson G.E., 1978, INTRO POPULATION ECO; Jackson-Gilbert MMwanjalolo, 2015, ADV AGR, V2015, P1, DOI DOI 10.1155/2015/752936; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; Jimenez-Valverde A, 2009, COMMUNITY ECOL, V10, P196, DOI 10.1556/ComEc.10.2009.2.9; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kamath C, 2009, PHILADELPHIA SOC IND; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Karatzoglou A., 2006, J STAT SOFTW, V15, P1, DOI [10.18637/jss.v015.i09, DOI 10.18637/JSS.V015.I09]; Karger D. N., 2016, ARXIV160700217; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Lloyd J, 2015, BIOGEOSCIENCES, V12, P6529, DOI 10.5194/bg-12-6529-2015; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lorena AC, 2011, EXPERT SYST APPL, V38, P5268, DOI 10.1016/j.eswa.2010.10.031; Luoto M, 2005, GLOBAL ECOL BIOGEOGR, V14, P575, DOI 10.1111/j.1466-822x.2005.00186.x; Mccarthy KP, 2012, CONSERV BIOL, V26, P68, DOI 10.1111/j.1523-1739.2011.01754.x; McGarigal K., 2012, TECH REP; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Meleckova Z, 2014, ANN BOT FENN, V51, P285, DOI 10.5735/085.051.0504; Meyer C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9221; Mod HK, 2016, J VEG SCI, V27, P1308, DOI 10.1111/jvs.12444; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinheiro J, 2020, R PACKAGE VERSION 31; Pliscoff P, 2014, ECOL MODEL, V288, P166, DOI 10.1016/j.ecolmodel.2014.06.003; Priti H, 2016, ECOL ENG, V89, P14, DOI 10.1016/j.ecoleng.2016.01.006; Qiao HJ, 2015, METHODS ECOL EVOL, V6, P1126, DOI 10.1111/2041-210X.12397; R Core Team, 2021, R LANGUAGE ENV STAT; Rachwal MFG, 2001, BRASIL SCI FOR, V59, P156; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Reef R, 2010, TREE PHYSIOL, V30, P1148, DOI 10.1093/treephys/tpq048; Ridgeway G., 2015, GBM GEN BOOSTED REGR; Ruggiero PGC, 2002, PLANT ECOL, V160, P1, DOI 10.1023/A:1015819219386; Salcedo-Sanz S, 2014, WIRES DATA MIN KNOWL, V4, P234, DOI 10.1002/widm.1125; Sanchez-Fernandez D, 2011, DIVERS DISTRIB, V17, P163, DOI 10.1111/j.1472-4642.2010.00716.x; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sousa-Silva R, 2014, GLOB ECOL CONSERV, V2, P226, DOI 10.1016/j.gecco.2014.09.011; Still SM, 2015, NAT AREA J, V35, P106, DOI 10.3375/043.035.0115; Storlie C., 2014, SDMTOOLS SPECIES DIS; Svenning JC, 2011, QUATERNARY SCI REV, V30, P2930, DOI 10.1016/j.quascirev.2011.06.012; Syphard AD, 2010, J VEG SCI, V21, P177, DOI 10.1111/j.1654-1103.2009.01133.x; Teillier Sebastián, 2003, Gayana Bot., V60, P114; Thuiller W, 2013, J VEG SCI, V24, P591, DOI 10.1111/jvs.12076; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Vale CG, 2014, DIVERS DISTRIB, V20, P20, DOI 10.1111/ddi.12115; Wan JZ, 2016, J FORESTRY RES, V27, P389, DOI 10.1007/s11676-015-0170-5; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x	115	51	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							0186025	10.1371/journal.pone.0186025	http://dx.doi.org/10.1371/journal.pone.0186025			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049298	gold, Green Published, Green Submitted			2022-12-26	WOS:000413195900035
J	Golle, A; Janezic, S; Rupnik, M				Golle, Andrej; Janezic, Sandra; Rupnik, Maja			Low overlap between carbapenem resistant Pseudomonas aeruginosa genotypes isolated from hospitalized patients and wastewater treatment plants	PLOS ONE			English	Article							ANTIMICROBIAL-RESISTANCE; GENETIC DIVERSITY; DRINKING-WATER; SPREAD; DISSEMINATION; ANTIBIOTICS; MECHANISMS; BACTERIA; BRAZIL; SPP.	The variability of carbapenem-resistant Pseudomonas aeruginosa strains (CRPA) isolated from urine and respiratory samples in a large microbiological laboratory, serving several health care settings, and from effluents of two wastewater treatment plants (WWTP) from the same region was assessed by PFGE typing and by resistance to 10 antibiotics. During the 12-month period altogether 213 carbapenem-resistant P. aeruginosa isolates were cultured and distributed into 65 pulsotypes and ten resistance profiles. For representatives of all 65 pulsotypes 49 different MLSTs were determined. Variability of clinical and environmental strains was comparable, 130 carbapenem-resistant P. aeruginosa obtained from 109 patients were distributed into 38 pulsotypes, while 83 isolates from WWTPs were classified into 31 pulsotypes. Only 9 pulsotypes were shared between two or more settings (hospital or WWTP). Ten MLST were determined for those prevalent pulsotypes, two of them (ST111 and ST235) are among most successful CRPA types worldwide. Clinical and environmental carbapenem-resistant P. aeruginosa strains differed in antibiotic resistance. The highest proportion of clinical isolates was resistant to piperacillin/tazobactam (52.3%) and ceftazidime (42.3%). The highest proportion of environmental isolates was resistant to ceftazidime (37.1%) and ciprofloxacin (35.5%). The majority of isolates was resistant only to imipenem and/or meropenem. Strains with additional resistances were distributed into nine different patterns. All of them included clinically relevant strains, while environmental strains showed only four additional different patterns.	[Golle, Andrej; Janezic, Sandra; Rupnik, Maja] Natl Lab Hlth Environm & Food, Maribor, Slovenia; [Janezic, Sandra; Rupnik, Maja] Univ Maribor, Fac Med, Maribor, Slovenia	University of Maribor	Rupnik, M (corresponding author), Natl Lab Hlth Environm & Food, Maribor, Slovenia.; Rupnik, M (corresponding author), Univ Maribor, Fac Med, Maribor, Slovenia.	maja.rupnik@nlzoh.si						Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006; Birosova L, 2014, SCI TOTAL ENVIRON, V490, P440, DOI 10.1016/j.scitotenv.2014.05.030; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Czekalski N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00106; ECDC, 2015, ANN REPORT EUROPEAN; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; Flores Ribeiro Angela, 2014, Sci Total Environ, V490, P370, DOI 10.1016/j.scitotenv.2014.05.012; Fuentefria DB, 2008, REV SOC BRAS MED TRO, V41, P470, DOI 10.1590/S0037-86822008000500007; Garcia-Castillo M, 2011, J CLIN MICROBIOL, V49, P2905, DOI 10.1128/JCM.00753-11; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gomila M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-138; Hong DJ, 2015, INFECT CHEMOTHER, V47, P81, DOI 10.3947/ic.2015.47.2.81; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Kittinger C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00586; Libisch B, 2008, RES MICROBIOL, V159, P162, DOI 10.1016/j.resmic.2007.12.008; Lutz JK, 2011, INT J ENV RES PUB HE, V8, P554, DOI 10.3390/ijerph8020554; Martins VV, 2014, ENVIRON SCI POLLUT R, V21, P5873, DOI 10.1007/s11356-014-2509-4; Martins VV, 2014, APMIS, V122, P92, DOI 10.1111/apm.12112; Meletis G, 2012, HIPPOKRATIA, V16, P303; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Miranda CC, 2015, J APPL MICROBIOL, V118, P1276, DOI 10.1111/jam.12792; Nemec A, 2010, RES MICROBIOL, V161, P234, DOI 10.1016/j.resmic.2010.02.002; Pappa O, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw086; Petit SMC, 2013, RES MICROBIOL, V164, P856, DOI 10.1016/j.resmic.2013.06.007; Picao RC, 2009, ANTIMICROB AGENTS CH, V53, P3908, DOI 10.1128/AAC.00453-09; PIRNAY JP, 2009, PLOS ONE, V4; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; Schwartz T, 2006, FEMS MICROBIOL ECOL, V57, P158, DOI 10.1111/j.1574-6941.2006.00100.x; Schwartz T, 2015, MICROB BIOTECHNOL, V8, P116, DOI 10.1111/1751-7915.12156; Slekovec C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049300; Streeter K, 2016, INFECT EPIDEMIOL MIC, V2, P25, DOI 10.7508/iem.2016.01.008; Vaz-Moreira I, 2012, SCI TOTAL ENVIRON, V426, P366, DOI 10.1016/j.scitotenv.2012.03.046; Wang H, 2012, APPL ENVIRON MICROB, V78, P6285, DOI 10.1128/AEM.01492-12; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zavascki AP, 2010, EXPERT REV ANTI-INFE, V8, P71, DOI 10.1586/ERI.09.108	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186736	10.1371/journal.pone.0186736	http://dx.doi.org/10.1371/journal.pone.0186736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049368	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900104
J	Ogundijo, OE; Wang, XD				Ogundijo, Oyetunji E.; Wang, Xiaodong			A sequential Monte Carlo approach to gene expression deconvolution	PLOS ONE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; LASER CAPTURE MICRODISSECTION; MICROARRAY ANALYSIS; REGULATED GENES; CANCER; BIOINFORMATICS; IDENTIFICATION; PROFILES; TISSUES; CELLS	High-throughput gene expression data are often obtained from pure or complex (heterogeneous) biological samples. In the latter case, data obtained are a mixture of different cell types and the heterogeneity imposes some difficulties in the analysis of such data. In order to make conclusions on gene expresssion data obtained from heterogeneous samples, methods such as microdissection and flow cytometry have been employed to physically separate the constituting cell types. However, these manual approaches are time consuming when measuring the responses of multiple cell types simultaneously. In addition, exposed samples, on many occasions, end up being contaminated with external perturbations and this may result in an altered yield of molecular content. In this paper, we model the heterogeneous gene expression data using a Bayesian framework, treating the cell type proportions and the cell-type specific expressions as the parameters of the model. Specifically, we present a novel sequential Monte Carlo (SMC) sampler for estimating the model parameters by approximating their posterior distributions with a set of weighted samples. The SMC framework is a robust and efficient approach where we construct a sequence of artificial target (posterior) distributions on spaces of increasing dimensions which admit the distributions of interest as marginals. The proposed algorithm is evaluated on simulated datasets and publicly available real datasets, including Affymetrix oligonucleotide arrays and national center for biotechnology information (NCBI) gene expression omnibus (GEO), with varying number of cell types. The results obtained on all datasets show a superior performance with an improved accuracy in the estimation of cell type proportions and the celltype specific expressions, and in addition, more accurate identification of differentially expressed genes when compared to other widely known methods for blind decomposition of heterogeneous gene expression data such as Dsection and the nonnegative matrix factorization (NMF) algorithms. MATLAB implementation of the proposed SMC algorithm is available to download at https://github.com/moyanre/smcgenedeconv.git.	[Ogundijo, Oyetunji E.; Wang, Xiaodong] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	Columbia University	Wang, XD (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.	wangx@ee.columbia.edu						Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Andrew H., 2015, J BIOMETRICS BIOSTAT, V6, P1; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bayar B, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014500012; Bhattacherjee V, 2004, GENESIS, V39, P58, DOI 10.1002/gene.20026; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Carter SL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-107; Chu YJ, 2012, NUCLEIC ACID THER, V22, P271, DOI 10.1089/nat.2012.0367; Clarke J, 2010, BIOINFORMATICS, V26, P1043, DOI 10.1093/bioinformatics/btq097; Cleator SJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1506; Del Moral P, 2006, J R STAT SOC B, V68, P411, DOI 10.1111/j.1467-9868.2006.00553.x; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Doucet A., 2001, SEQUENTIAL MONTE CAR; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Erkkila T, 2010, BIOINFORMATICS, V26, P2571, DOI 10.1093/bioinformatics/btq406; Espina V, 2007, EXPERT REV MOL DIAGN, V7, P647, DOI 10.1586/14737159.7.5.647; Fearnhead P, 2013, BAYESIAN ANAL, V8, P411, DOI 10.1214/13-BA814; Frumkin D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-17; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; Gaujoux R, 2012, INFECT GENET EVOL, V12, P913, DOI 10.1016/j.meegid.2011.08.014; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Gong T, 2011, PLOS ONE, V6; Hanai T, 2006, J BIOSCI BIOENG, V101, P377, DOI 10.1263/jbb.101.377; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobsen M, 2006, METHOD INFORM MED, V45, P557, DOI 10.1055/s-0038-1634118; Kim H, 2008, SIAM J MATRIX ANAL A, V30, P713, DOI 10.1137/07069239X; Kitagawa G, 1998, J AM STAT ASSOC, V93, P1203, DOI 10.2307/2669862; Kitagawa G., 1996, J OF COMPUTATIONAL A, V5, P1, DOI DOI 10.2307/1390750; Lahdesmaki H, 2005, BMC BIOINFORMATICS, V6, P1; Lee DD, 2001, ADV NEUR IN, V13, P556; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Meng T, 2012, OMICS, V16, P301, DOI 10.1089/omi.2011.0066; Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518; Neal RM, 2001, STAT COMPUT, V11, P125, DOI 10.1023/A:1008923215028; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Ogundijo OE, 2015, COMP ADV BIO MED SCI, P1; Ogundijo OE, 2017, EURASIP J BIOINFORM, DOI 10.1186/s13637-016-0055-8; Peters GW, 2012, STAT COMPUT, V22, P1209, DOI 10.1007/s11222-012-9315-y; Peters G. W., 2005, THESIS; Repsilber D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-27; Sarkka S, 2013, BAYESIAN FILTERING S; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Nguyen TLT, 2016, IEEE T SIGNAL PROCES, V64, P1305, DOI 10.1109/TSP.2015.2504342; Venet D, 2001, Bioinformatics, V17 Suppl 1, pS279; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkinson DJ, 2007, BRIEF BIOINFORM, V8, P109, DOI 10.1093/bib/bbm007; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhong Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-89	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186167	10.1371/journal.pone.0186167	http://dx.doi.org/10.1371/journal.pone.0186167			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049343	Green Published, gold, Green Submitted			2022-12-26	WOS:000413195900045
J	Rucker, JL; McDowd, JM; Mahnken, JD; Burns, JM; Sabus, CH; Britton-Carpenter, AJ; Utech, NB; Kluding, PM				Rucker, Jason L.; McDowd, Joan M.; Mahnken, Jonathan D.; Burns, Jeffrey M.; Sabus, Carla H.; Britton-Carpenter, Amanda J.; Utech, Nora B.; Kluding, Patricia M.			Multitasking in older adults with type 2 diabetes: A cross-sectional analysis	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY; GAIT; TASK; DYSFUNCTION; WALKING; DISEASE; IMPACT	Background and purpose Deficits in the ability to multitask contribute to gait abnormalities and falls in many at-risk populations. However, it is unclear whether older adults with type 2 diabetes mellitus (DM) also demonstrate impairments in multitasking. The purpose of this study was to compare multitasking performance in cognitively intact older adults with and without DM and explore its relationship to measures of gait and functional ability. Methods We performed a cross-sectional analysis of 40 individuals aged 60 and older with type 2 DM and a matched group of 40 cognitively intact older adults without DM. Multitasking was examined via the ambulatory Walking and Remembering Test (WART) and seated Pursuit Rotor Test (PRT). Self-selected normal and fast walking speed and stride length variability were quantitatively measured, and self-reported functional ability was assessed via the Late Life Function and Disability Index (LLFDI). Results Participants with DM walked slower and took more steps off path when multitasking during the WART. No between-group differences in multitasking performance were observed on the PRT. Multitasking performance demonstrated little correlation with gait and functional ability in either group. Discussion and conclusions Older adults with DM appear to perform poorly on an ambulatory measure of multitasking. However, we analyzed a relatively small, homogenous sample of older adults with and without type 2 DM and factors such as peripheral neuropathy and the use of multiple comparisons complicate interpretation of the data. Future research should explore the interactions between multitasking and safety, fall risk, and function in this vulnerable population. Clinicians should recognize that an array of factors may contribute to gait and physical dysfunction in older adults with type 2 diabetes, and be prepared to assess and intervene appropriately.	[Rucker, Jason L.; Sabus, Carla H.; Britton-Carpenter, Amanda J.; Utech, Nora B.; Kluding, Patricia M.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA; [McDowd, Joan M.] Rockhurst Univ, Dept Psychol, Kansas City, MO USA; [Mahnken, Jonathan D.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [Burns, Jeffrey M.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Rucker, JL (corresponding author), Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA.	jrucker2@kumc.edu		Burns, Jeffrey/0000-0001-7609-8954	Kansas Training Program in Neurological and Rehabilitation Sciences [5 T32 HD57850]; University of Kansas Medical Center Biomedical Research Training Program; Kansas Partners for Progress; National Center for Advancing Translational Science [UL1TR000001, TL1TR000120]; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	Kansas Training Program in Neurological and Rehabilitation Sciences; University of Kansas Medical Center Biomedical Research Training Program; Kansas Partners for Progress; National Center for Advancing Translational Science; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study received funding from the following sources: 1. Kansas Training Program in Neurological and Rehabilitation Sciences (AJB; 5 T32 HD57850; http://www.kumc.edu/landon-center-on-aging/neurological-and-rehabilitation-sciences-training-program.html); 2. The University of Kansas Medical Center Biomedical Research Training Program (JLR; httpl://www.kurric.edu/brtp.html); 3. The Kansas Partners for Progress (JLR). Additional support for recruitment and testing was provided by: 1. Clinical and Translational Science Award from the National Center for Advancing Translational Science, awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research #UL1TR000001 (formerly #UL1RR033179) and #TL1TR000120; 2. The University of Kansas Alzheimer's Disease Center (NIH P30 AG035982). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCATS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Brach JS, 2008, PHYS THER, V88, P1365, DOI 10.2522/ptj.20080016; Bruce D, 2015, AGE AGEING, V44, P687, DOI 10.1093/ageing/afv024; Centers for Disease Control, 2020, NATL DIABETES STAT R; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Dubuc N, 2004, DISABIL REHABIL, V26, P362, DOI 10.1080/09638280410001658667; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2010, NUTR REV, V68, pS119, DOI 10.1111/j.1753-4887.2010.00353.x; Kemper S, 2009, AGING NEUROPSYCHOL C, V16, P241, DOI 10.1080/13825580802438868; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; MacAulay RK, 2017, J INT NEUROPSYCH SOC, V23, P493, DOI 10.1017/S1355617717000261; Makino K, 2017, GERIATRICS GERONTOLO; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McCulloch KL, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932010-00002; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Montero-Odasso M, 2014, J GERONTOL A-BIOL, V69, P1415, DOI 10.1093/gerona/glu155; Paul L, 2009, DIABETIC MED, V26, P234, DOI 10.1111/j.1464-5491.2008.02655.x; Petrofsky J, 2005, EUR J APPL PHYSIOL, V93, P640, DOI 10.1007/s00421-004-1246-7; Roman de Mettelinge T, 2013, ARCH PHYS MED REHAB, V94, P1074, DOI 10.1016/j.apmr.2013.01.018; Rucker JL, 2014, J NEUROL PHYS THER, V38, P104, DOI 10.1097/NPT.0000000000000032; Schwenk M, 2010, NEUROLOGY, V74, P1961, DOI 10.1212/WNL.0b013e3181e39696; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Silsupadol P, 2009, GAIT POSTURE, V29, P634, DOI 10.1016/j.gaitpost.2009.01.006; Sinnreich M, 2005, NEUROLOGIST, V11, P63, DOI 10.1097/01.nrl.0000156314.24508.ed; Verghese J, 2007, ARCH PHYS MED REHAB, V88, P50, DOI 10.1016/j.apmr.2006.10.007; Yavuzer G, 2006, Eura Medicophys, V42, P127; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x	30	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186583	10.1371/journal.pone.0186583	http://dx.doi.org/10.1371/journal.pone.0186583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045492	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100076
J	Baruah, J; Hitzman, R; Zhang, JE; Chaudhuri, S; Mastej, V; Wary, KK				Baruah, Jugajyoti; Hitzman, Ryan; Zhang, Jane; Chaudhuri, Suhnrita; Mastej, Victoria; Wary, Kishore K.			The allosteric glycogen synthase kinase-3 inhibitor NP12 limits myocardial remodeling and promotes angiogenesis in an acute myocardial infarction model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; angiogenesis; endothelial cell; glycogen synthase kinase 3 (GSK-3); myocardial infarction; Wnt signaling	TIDEGLUSIB; CARDIOPROTECTION; EXPRESSION; INJURY; CELLS; MODULATION; STRATEGIES; PROTECTION; GSK-3-BETA; ISCHEMIA	A key feature of acute myocardial infarction (AMI) is an alteration in cardiac architecture. Signaling events that result in the inhibition of glycogen synthase kinase-3 (GSK-3) represent an adaptive response that might limit the extent of adverse remodeling in the aftermath of AMI. Here, we report that an allosteric inhibitor of GSK-3, 4-benzyl-2-(naphthalene-1-yl)-1,2,4-thiadiazolidine-3,5-dione (NP12), lessens the magnitude of adverse myocardial remodeling and promotes angiogenesis. Male and female mice 8-10 weeks old were grouped (six animals in each group) into sham surgery (sham group), left anterior descending (LAD) ligation of the coronary artery followed by intramyocardial PBS injections (control group), and LAD ligation followed by NP12 administration (NP12 group). After 7 and 14 days, the extents of fibrosis and integrity of blood vessels were determined. Intramyocardial administration of NP12 increased phosphorylation of GSK-3, reduced fibrosis, and restored diastolic function in the mice that had experienced an AMI. Morphometric analyses revealed increased CD31(+) and Ki67(+) vascular structures and decreased apoptosis in these mice. NP12 administration mediated proliferation of reparative cells in the AMI hearts. In a time-course analysis, Wnt3a and NP12 stabilized -catenin and increased expression of both Nanog and VEGFR2. Moreover, NP12 increased the expression of -catenin and Nanog in myocardium from AMI mice. Finally, loss- and gain-of-function experiments indicated that the NP12-mediated benefit is, in part, Nanog-specific. These findings indicate that NP12 reduces fibrosis, reestablishes coronary blood flow, and improves ventricular function following an AMI. We conclude that NP12 might be useful for limiting ventricular remodeling after an AMI.	[Baruah, Jugajyoti; Hitzman, Ryan; Zhang, Jane; Chaudhuri, Suhnrita; Mastej, Victoria; Wary, Kishore K.] Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,Rm E403, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wary, KK (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,Rm E403, Chicago, IL 60612 USA.	kkwary@uic.edu	Baruah, Jugajyoti/AAJ-7545-2020		National Institutes of Health [HL079356]; American Heart Association [GRNT25710129, GRNT33700162]; University of Illinois at Chicago Center for Clinical and Translation Science Award [UL1RR029879]; American Heart Association Pre-doctoral Fellowships (Mid-West affiliate) [15PRE22760004]; CCTS-PECTs [1UL1TR002003]; Fulbright-Nehru Fellowship Program [2038/FNPDR/2015]; CCTS-PECTs Grant [1UL1TR002003]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079356, T32HL007829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Illinois at Chicago Center for Clinical and Translation Science Award; American Heart Association Pre-doctoral Fellowships (Mid-West affiliate); CCTS-PECTs; Fulbright-Nehru Fellowship Program; CCTS-PECTs Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health Grant HL079356, American Heart Association Grants GRNT25710129 and GRNT33700162, and by University of Illinois at Chicago Center for Clinical and Translation Science Award UL1RR029879 (to K. K. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains supplemental Figs. S1-S13.; Supported by American Heart Association Pre-doctoral Fellowships (Mid-West affiliate) 15PRE22760004 and CCTS-PECTs 1UL1TR002003.; Supported by the Fulbright-Nehru Fellowship Program (2038/FNPDR/2015).; Supported by CCTS-PECTs Grant 1UL1TR002003.	Anderson JL, 2017, NEW ENGL J MED, V376, P2053, DOI 10.1056/NEJMra1606915; Bonaventura A, 2016, EUR J CLIN INVEST, V46, P590, DOI 10.1111/eci.12633; Cambier L, 2017, EMBO MOL MED, V9, P337, DOI 10.15252/emmm.201606924; Cieslik KA, 2014, J MOL CELL CARDIOL, V70, P56, DOI 10.1016/j.yjmcc.2013.10.017; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054; del Ser T, 2013, J ALZHEIMERS DIS, V33, P205, DOI 10.3233/JAD-2012-120805; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Fan D, 2015, CIRC-HEART FAIL, V8, P970, DOI 10.1161/CIRCHEARTFAILURE.114.002029; Gaffin RD, 2011, J MOL CELL CARDIOL, V51, P812, DOI 10.1016/j.yjmcc.2011.07.026; Hausenloy DJ, 2017, CARDIOVASC RES, V113, P564, DOI 10.1093/cvr/cvx049; Hoglinger GU, 2014, MOVEMENT DISORD, V29, P479, DOI 10.1002/mds.25815; Humtsoe JO, 2010, MOL CELL BIOL, V30, P1593, DOI 10.1128/MCB.00038-09; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kohler EE, 2014, STEM CELLS, V32, P1538, DOI 10.1002/stem.1658; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Kornowski R, 2000, CIRCULATION, V101, P454, DOI 10.1161/01.CIR.101.4.454; Lal H, 2015, CIRC RES, V116, P138, DOI 10.1161/CIRCRESAHA.116.303613; Lal H, 2012, CIRCULATION, V125, P65, DOI 10.1161/CIRCULATIONAHA.111.050666; Loh KM, 2016, DEV CELL, V38, P643, DOI 10.1016/j.devcel.2016.08.011; Lovestone S, 2015, J ALZHEIMERS DIS, V45, P75, DOI 10.3233/JAD-141959; Dominguez JM, 2012, J BIOL CHEM, V287, P893, DOI 10.1074/jbc.M111.306472; Marijianowski MMH, 1997, J AM COLL CARDIOL, V30, P76, DOI 10.1016/S0735-1097(97)00100-9; Miura T, 2010, CARDIOVASC DRUG THER, V24, P255, DOI 10.1007/s10557-010-6234-z; Pagel PS, 2006, ANESTH ANALG, V102, P1348, DOI 10.1213/01.ane.0000202379.61338.37; Patel P, 2017, CURR TOP DEV BIOL, V123, P277, DOI 10.1016/bs.ctdb.2016.11.011; Preda MB, 2010, COMPARATIVE MED, V60, P443; Scofield SLC, 2016, JOVE-J VIS EXP, DOI 10.3791/54814; Terashima Y, 2010, J MOL CELL CARDIOL, V49, P762, DOI 10.1016/j.yjmcc.2010.08.001; Thygesen K, 2012, NAT REV CARDIOL, V9, P620, DOI 10.1038/nrcardio.2012.122; Tolosa E, 2014, MOVEMENT DISORD, V29, P470, DOI 10.1002/mds.25824; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556; van Berlo JH, 2014, NAT MED, V20, P1386, DOI 10.1038/nm.3764; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Wary KK, 2009, STEM CELLS, V27, P3112, DOI 10.1002/stem.241; Woulfe KC, 2010, CIRC RES, V106, P1635, DOI 10.1161/CIRCRESAHA.109.211482; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhang RL, 2016, J CLIN INVEST, V126, P4654, DOI 10.1172/JCI90425; Zhao JL, 2013, CIRCULATION, V128, pS121, DOI 10.1161/CIRCULATIONAHA.112.000045	40	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20785	20798		10.1074/jbc.M117.814376	http://dx.doi.org/10.1074/jbc.M117.814376			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29070680	hybrid, Green Published			2022-12-26	WOS:000418267000037
J	Chen, FF; Zhang, CX; Wu, HN; Ma, Y; Luo, XM; Gong, XQ; Jiang, F; Gui, YT; Zhang, H; Lu, F				Chen, Fangfang; Zhang, Chunxiao; Wu, Haonan; Ma, Yue; Luo, Xiaomin; Gong, Xinqi; Jiang, Fan; Gui, Yaoting; Zhang, Hui; Lu, Fei			The E3 ubiquitin ligase SCFFBXL14 complex stimulates neuronal differentiation by targeting the Notch signaling factor HES1 for proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; neurodifferentiation; proteolysis; small interfering RNA (siRNA); ubiquitylation (ubiquitination); FBXL14; HES1 oscillation; SCF ubiquitin ligase	F-BOX PROTEINS; SOMITE SEGMENTATION CLOCK; NEGATIVE FEEDBACK LOOP; EMBRYONIC STEM-CELLS; CIRCADIAN CLOCK; GENE HES1; ULTRADIAN OSCILLATIONS; PRESOMITIC MESODERM; NEURAL PROGENITORS; EXPRESSION	Molecular oscillators are important cellular regulators of, for example, circadian clocks, oscillations of immune regulators, and short-period (ultradian) rhythms during embryonic development. The Notch signaling factor HES1 (hairy and enhancer of split 1) is a well-known repressor of proneural genes, and HES1 ultradian oscillation is essential for keeping cells in an efficiently proliferating progenitor state. HES1 oscillation is driven by both transcriptional self-repression and ubiquitin-dependent proteolysis. However, the E3 ubiquitin ligase targeting HES1 for proteolysis remains unclear. Based on siRNA-mediated gene silencing screening, co-immunoprecipitation, and ubiquitination assays, we discovered that the E3 ubiquitin ligase SCFFBXL14 complex regulates HES1 ubiquitination and proteolysis. siRNA-mediated knockdown of the Cullin-RING E3 ubiquitin ligases RBX1 or CUL1 increased HES1 protein levels, prolonged its half-life, and dampened its oscillation. FBXL14, an F-box protein for SCF ubiquitin ligase, associates with HES1. FBXL14 silencing stabilized HES1, whereas FBXL14 overexpression decreased HES1 protein levels. Of note, the SCFFBXL14 complex promoted the ubiquitination of HES1 in vivo, and a conserved WRPW motif in HES1 was essential for HES1 binding to FBXL14 and for ubiquitin-dependent HES1 degradation. HES1 knockdown promoted neuronal differentiation, but FBXL14 silencing inhibited neuronal differentiation induced by HES1 ablation in mES and F9 cells. Our results suggest that SCFFBXL14 promotes neuronal differentiation by targeting HES1 for ubiquitin-dependent proteolysis and that the C-terminal WRPW motif in HES1 is required for this process.	[Chen, Fangfang; Zhang, Chunxiao; Wu, Haonan; Ma, Yue; Jiang, Fan; Lu, Fei] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Guangdong, Peoples R China; [Chen, Fangfang; Luo, Xiaomin; Gui, Yaoting] Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen 518036, Peoples R China; [Zhang, Chunxiao; Zhang, Hui] Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy,SEB 4138, Las Vegas, NV 89154 USA; [Gong, Xinqi] Renmin Univ China, Inst Math Sci, Beijing 100872, Peoples R China	Peking University; University Town of Shenzhen; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Renmin University of China	Gui, YT (corresponding author), Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen 518036, Peoples R China.; Zhang, H (corresponding author), Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy,SEB 4138, Las Vegas, NV 89154 USA.; Lu, F (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Rm 407,Bldg F,2199 Lishui Rd, Shenzhen 518055, Peoples R China.	guiyaoting2007@aliyun.com; hui.zhang@unlv.edu; lufei@pkusz.edu.cn	zhang, chunxiao/AAH-3229-2019; Luo, Xiao-min/A-3359-2011; gui, yaoting/GLT-3684-2022	Luo, Xiao-min/0000-0002-2334-6544; Zhang, Chunxiao/0000-0001-5543-4509; Chen, Fangfang/0000-0001-9097-5036	Natural Science Foundation of Guangdong Province [2014A030313779]; Shenzhen Science, Technology and Innovation Commission [JCYJ20160527100529884]; National Institutes of Health [R15GM116087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM116087] Funding Source: NIH RePORTER	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Science, Technology and Innovation Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Natural Science Foundation of Guangdong Province Grant 2014A030313779), Shenzhen Science, Technology and Innovation Commission Grant JCYJ20160527100529884, and National Institutes of Health Grant R15GM116087. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmoity AT, 2011, EUR J MED GENET, V54, P198, DOI 10.1016/j.ejmg.2010.11.010; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bonev B, 2012, CELL REPORTS, V2, P10, DOI 10.1016/j.celrep.2012.05.017; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Fang XG, 2017, J EXP MED, V214, P245, DOI 10.1084/jem.20151673; Gong XQ, 2010, PROTEINS, V78, P3150, DOI 10.1002/prot.22831; Gong XQ, 2010, SCI CHINA LIFE SCI, V53, P1152, DOI 10.1007/s11427-010-4050-0; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Hiyama A, 2011, ARTHRITIS RHEUM-US, V63, P1355, DOI 10.1002/art.30246; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kang SA, 2005, BIOCHEM BIOPH RES CO, V332, P33, DOI 10.1016/j.bbrc.2005.04.089; Kitagawa K, 2016, CURR CANCER DRUG TAR, V16, P119, DOI 10.2174/1568009616666151112122231; Kobayashi T, 2015, FEBS J, V282, P2475, DOI 10.1111/febs.13290; Kobayashi T, 2011, GENES-BASEL, V2, P219, DOI 10.3390/genes2010219; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Li S., 2016, J FLUORESC, V2016, P1, DOI DOI 10.1109/PERC0M.2016; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shimojo H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00078; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sun Y, 2003, CANCER BIOL THER, V2, P623; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Ventre S, 2015, J MOL BIOL, V427, P1887, DOI 10.1016/j.jmb.2015.03.007; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Zheng HP, 2012, CELL RES, V22, P936, DOI 10.1038/cr.2012.37; Zhou CY, 2015, J PHYS CHEM B, V119, P1035, DOI 10.1021/jp5064676	54	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20100	20112		10.1074/jbc.M117.815001	http://dx.doi.org/10.1074/jbc.M117.815001			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29070679	hybrid, Green Published			2022-12-26	WOS:000417696400017
J	Good, MM; Montoya, TI; Shi, HL; Zhou, J; Huang, YH; Tang, LP; Acevedo, JF; Word, RA				Good, Meadow M.; Montoya, T. Ignacio; Shi, Haolin; Zhou, Jun; Huang, YiHui; Tang, Liping; Acevedo, Jesus F.; Word, R. Ann			Thermosensitive hydrogels deliver bioactive protein to the vaginal wall	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; DRUG-DELIVERY; URINARY-INCONTINENCE; EXTRACELLULAR-MATRIX; IN-VIVO; FIBULIN-5; TISSUE; RELEASE; MICE; NANOPARTICLES	The pathophysiology and natural history of pelvic organ prolapse (POP) are poorly understood. Consequently, our approaches to treatment of POP are limited. Alterations in the extracellular matrix components of pelvic support ligaments and vaginal tissue, including collagen and elastin, have been associated with the development of POP in animals and women. Prior studies have shown the protease MMP-9, a key player of ECM degradation, is upregulated in vaginal tissues from both mice and women with POP. On the other hand, fibulin-5, an elastogenic organizer, has been found to inhibit MMP-9 in the vaginal wall. Hence, we hypothesized that prolonged release of fibulin-5 may delay progression of POP. To test the hypothesis, oligo (ethylene glycol)-based thermosensitive hydrogels were fabricated, characterized and then used to deliver fibulin-5 to the vaginal wall and inhibit MMP-9 activity. The results indicate that hydrogels are cell and tissue compatible. The hydrogels also prolong the 1/2 life of fibulin-5 in cultured vaginal fibroblasts and in the vaginal wall in vivo. Finally, fibulin-5-containing hydrogels resulted in incorporation of fibulin-5 into the vaginal matrix and inhibition of MMP-9 for several weeks after injection. These results support the idea of fibulin-5 releasing hydrogel being developed as a new treatment for POP.	[Good, Meadow M.; Montoya, T. Ignacio; Shi, Haolin; Acevedo, Jesus F.; Word, R. Ann] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Div Female Pelv Med & Reconstruct Surg, Dallas, TX 75390 USA; [Zhou, Jun; Huang, YiHui; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Arlington	Word, RA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Div Female Pelv Med & Reconstruct Surg, Dallas, TX 75390 USA.; Tang, LP (corresponding author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.	ltang@uta.edu; Ruth.word@UTSouthwestern.edu	Huang, Yihui/Q-2909-2019	Huang, Yihui/0000-0001-6994-8180	NIH [AG028048]; NATIONAL INSTITUTE ON AGING [R01AG028048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH AG028048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from NIH (AG028048).	Ankareddi I, 2008, BIRTH DEFECTS RES B, V83, P112, DOI 10.1002/bdrb.20150; Bae YH, 1998, J CONTROL RELEASE, V53, P249, DOI 10.1016/S0168-3659(97)00258-7; Bekerecioglu M, 2008, ARCH GYNECOL OBSTET, V277, P551, DOI 10.1007/s00404-007-0403-8; Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X; Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; Cai T, 2012, NANOMED-NANOTECHNOL, V8, P1301, DOI 10.1016/j.nano.2012.02.002; Choi B., 2015, IN SITU GELLING POLY, P5; Clark AL, 2003, AM J OBSTET GYNECOL, V189, P1261, DOI 10.1067/S0002-9378(03)00829-9; Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Gyhagen M, 2013, BJOG-INT J OBSTET GY, V120, P152, DOI 10.1111/1471-0528.12020; Han CK, 1998, POLYMER, V39, P2809, DOI 10.1016/S0032-3861(97)00612-5; Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Moalli PA, 2005, OBSTET GYNECOL, V106, P953, DOI 10.1097/01.AOG.0000182584.15087.dd; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Northington GM, 2011, J CLIN INVEST, V121, P1688, DOI 10.1172/JCI57438; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Phillips CH, 2006, BJOG-INT J OBSTET GY, V113, P39, DOI 10.1111/j.1471-0528.2005.00773.x; Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153; Shu XZ, 2004, BIOMATERIALS, V25, P1339, DOI 10.1016/j.biomaterials.2003.08.014; Stile RA, 2002, BIOMACROMOLECULES, V3, P591, DOI 10.1021/bm0101466; Tehrani SM, 2016, MACROMOLECULES, V49, P8711, DOI 10.1021/acs.macromol.6b01270; Vihola H, 2005, BIOMATERIALS, V26, P3055, DOI 10.1016/j.biomaterials.2004.09.008; Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106; Word RA, 2009, OBSTET GYN CLIN N AM, V36, P521, DOI 10.1016/j.ogc.2009.09.001; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yang JA, 2014, PROG POLYM SCI, V39, P1973, DOI 10.1016/j.progpolymsci.2014.07.006; Yang J, 2013, CARBOHYD POLYM, V92, P719, DOI 10.1016/j.carbpol.2012.09.036; Zheng Q, 2007, MOL CELL BIOL, V27, P1083, DOI 10.1128/MCB.01330-06; Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064	35	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186268	10.1371/journal.pone.0186268	http://dx.doi.org/10.1371/journal.pone.0186268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073153	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400019
J	Nowak, I; Bylinska, A; Wilczynska, K; Wisniewski, A; Malinowski, A; Wilczynski, JR; Radwan, P; Radwan, M; Barcz, E; Ploski, R; Motak-Pochrzest, H; Banasik, M; Sobczynski, M; Kusnierczyk, P				Nowak, Izabela; Bylinska, Aleksandra; Wilczynska, Karolina; Wisniewski, Andrzej; Malinowski, Andrzej; Wilczynski, Jacek R.; Radwan, Pawel; Radwan, Michel; Barcz, Ewa; Ploski, Rafal; Motak-Pochrzest, Hanna; Banasik, Malgorzata; Sobczynski, Maciej; Kusnierczyk, Piotr			The methylenetetrahydrofolate reductase c.c.677 C > T and c.c.1298 A > C polymorphisms in reproductive failures: Experience from an RSA and RIF study on a Polish population	PLOS ONE			English	Article							MALE-INFERTILITY; GENETIC-POLYMORPHISM; C677T POLYMORPHISM; MTHFR; THROMBOPHILIA; ASSOCIATION; RISK; MISCARRIAGE; DEFINITION; EXPRESSION	Almost 1600 individuals from the Polish population were recruited to this study. Among them 319 were fertile couples, 289 were recurrent spontaneous abortion (RSA) couples, and 131 were in the group of recurrent implantation failure (RIF) following in vitro fertilization. The aim of this study was to evaluate the MTHFR c.c.677 C > T and c.c.1298 A > C polymorphisms' association with RSA and RIF. We used PCR-RFLP with HinfI (677 C > T) and MboII (1298 A > C) digestion. We observed a protective effect of the female AC genotype (OR = 0.64, p = 0.01) and the C allele (AC+CC genotypes; OR = 0.65, p = 0.009) against RSA. Moreover, 1298 AA/677 CT women were more frequent in RSA (31.14%) and RIF (25.20%) groups in comparison to fertile women (22.88%), although this difference was significant only in the case of RSA (p = 0.022, OR = 1.52). Male combined genotype analysis revealed no association with reproductive failure of their partners. Nevertheless, the female/male combination AA/AC of the 1298 polymorphism was more frequent in RSA couples (p = 0.049, OR = 1.49). However, the significant results became insignificant after Bonferroni correction. In addition, analysis of haplotypes showed significantly higher frequency of the C/C haplotype (1298 C/677 C) in the female control group than in the female RSA group (p = 0.03, OR = 0.77). Moreover, the association between elevated homocysteine (Hcy) level in plasma of RSA and RIF women and MTHFR polymorphisms was investigated but did not reveal significant differences. In conclusion, for clinical practice, it is better to check the homocysteine level in plasma and, if the Hcy level is increased, to recommend patients to take folic acid supplements rather than undergo screening of MTHFR for 1298 A > C and 677 C > T polymorphisms.	[Nowak, Izabela; Bylinska, Aleksandra; Wilczynska, Karolina; Wisniewski, Andrzej; Kusnierczyk, Piotr] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Lab Immunogenet & Tissue Immunol, Wroclaw, Poland; [Malinowski, Andrzej] Polish Mothers Mem Hosp, Res Inst, Dept Surg Endoscop & Oncol Gynecol, Lodz, Poland; [Wilczynski, Jacek R.] Polish Mothers Mem Hosp, Res Inst, Dept Gynecol & Gynecol Oncol, Lodz, Poland; [Radwan, Pawel; Radwan, Michel] Gameta Hosp, Dept Reprod Med, Rzgow, Poland; [Radwan, Pawel] Biogenoreg Sci Technol Ctr, Podzamcze, Poland; [Barcz, Ewa] Med Univ Warsaw, Chair 1, Warsaw, Poland; [Barcz, Ewa] Med Univ Warsaw, Clin Obstet & Gynecol, Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Ctr Biostruct Res, Warsaw, Poland; [Motak-Pochrzest, Hanna] Opole Univ Technol, Fac Phys Educ & Physiotherapy, Opole, Poland; [Motak-Pochrzest, Hanna] Dist Hosp Strzelce Opolskie, Obstet Gynecol Dept, Strzelce Opolskie, Poland; [Banasik, Malgorzata] APC Med Anal, Lodz, Poland; [Sobczynski, Maciej] Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Opole University of Technology; University of Wroclaw	Nowak, I (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Lab Immunogenet & Tissue Immunol, Wroclaw, Poland.	izan@iitd.pan.wroc.pl	Kusnierczyk, Piotr/ABB-6734-2020; Barcz, Ewa/AAS-7533-2020; Radwan, Pawel/ABC-4159-2020; Radwan, Paweł/D-1360-2013	Radwan, Pawel/0000-0002-9724-8517; Malinowski, Andrzej/0000-0002-3129-1504; Piekarska, Karolina/0000-0002-4175-965X; Wisniewski, Andrzej/0000-0002-1919-2298; Wilczynski, Jacek R/0000-0002-2072-6533; Kusnierczyk, Piotr/0000-0002-9224-8921; Ploski, Rafal/0000-0001-6286-5526; Sobczynski, Maciej/0000-0003-2428-0927; Nowak, Izabela/0000-0002-9127-1089	National Science Centre, Poland [2014/13/B/NZ5/00273, N N401 588340]; Dr. Izabela Nowak and Wroclaw Centre of Biotechnology; Leading National Research Centre (KNOW)	National Science Centre, Poland(National Science Centre, Poland); Dr. Izabela Nowak and Wroclaw Centre of Biotechnology; Leading National Research Centre (KNOW)	This work was supported by National Science Centre, Poland, 2014/13/B/NZ5/00273 and N N401 588340, Dr. Izabela Nowak and Wroclaw Centre of Biotechnology, the programme The Leading National Research Centre (KNOW) for years 2014-2018 (to I. Nowak, Ph.D.).	Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS60, DOI 10.1016/j.fertnstert.2008.08.065; Ata B, 2016, J ASSIST REPROD GEN, V33, P1305, DOI 10.1007/s10815-016-0771-8; Azem F, 2004, HUM REPROD, V19, P368, DOI 10.1093/humrep/deh069; Burda P, 2017, J INHERIT METAB DIS, V40, P297, DOI 10.1007/s10545-016-9987-0; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Choi Y, 2016, PLOS ONE, V25; Coughlan C, 2014, REPROD BIOMED ONLINE, V28, P14, DOI 10.1016/j.rbmo.2013.08.011; Di Nisio M, 2011, BLOOD, V118, P2670, DOI 10.1182/blood-2011-03-340216; Diejomaoh MFE, 2015, MED PRIN PRACT, V24, P38, DOI 10.1159/000365973; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Heby O, 1995, INT J DEV BIOL, V39, P737; Hekmatdoost A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143569; Karimian M, 2016, REPROD FERT DEVELOP, V28, P785, DOI 10.1071/RD14186; Koot YEM, 2012, BBA-MOL BASIS DIS, V1822, P1943, DOI 10.1016/j.bbadis.2012.05.017; Levin BL, 2016, J GENET COUNS, V25, P901, DOI 10.1007/s10897-016-9956-7; Mfady DS, 2014, GENE, V536, P40, DOI 10.1016/j.gene.2013.12.001; Montjean D, 2011, FERTIL STERIL, V95, P635, DOI 10.1016/j.fertnstert.2010.08.054; Nair RR, 2013, FERTIL STERIL, V99, P1311, DOI 10.1016/j.fertnstert.2012.12.027; Nikzad H, 2015, REPROD BIOMED ONLINE, V31, P668, DOI 10.1016/j.rbmo.2015.07.015; Nowak I, 2015, TISSUE ANTIGENS, V85, P450, DOI 10.1111/tan.12544; Nowak I, 2016, ARCH IMMUNOL THER EX, V64, P505, DOI 10.1007/s00005-016-0389-7; Pereza N, 2017, FERTIL STERIL, V107, P150, DOI 10.1016/j.fertnstert.2016.10.007; Qublan HS, 2006, HUM REPROD, V21, P2694, DOI 10.1093/humrep/del203; Shi X, 2017, CLIN GENET, V91, P265, DOI 10.1111/cge.12910; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simur A, 2009, GYNECOL OBSTET INVES, V67, P109, DOI 10.1159/000165776; Sugiura-Ogasawara M, 2014, J OBSTET GYNAECOL RE, V40, P1174, DOI 10.1111/jog.12388; Tan XF, 2016, J ASSIST REPROD GEN, V33, P1093, DOI 10.1007/s10815-016-0726-0; Tara Somayeh-Sadat, 2015, J Reprod Infertil, V16, P193; Timeva Tanya, 2014, J Reprod Infertil, V15, P173; Unfried G, 2002, OBSTET GYNECOL, V99, P614, DOI 10.1016/S0029-7844(01)01789-6; Vlachadis N, 2014, REPROD BIOMED ONLINE, V29, P144, DOI 10.1016/j.rbmo.2014.03.003; Weiner AS, 2014, FERTIL STERIL, V101, P87, DOI 10.1016/j.fertnstert.2013.09.014; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; Wolski H, GINEKOL POL; Wu W, 2012, INT J ANDROL, V35, P18, DOI 10.1111/j.1365-2605.2011.01147.x	37	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186022	10.1371/journal.pone.0186022	http://dx.doi.org/10.1371/journal.pone.0186022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073227	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400012
J	Brunner, MAT; Jagannathan, V; Waluk, DP; Roosje, P; Linek, M; Panakova, L; Leeb, T; Wiener, DJ; Welle, MM				Brunner, Magdalena A. T.; Jagannathan, Vidhya; Waluk, Dominik P.; Roosje, Petra; Linek, Monika; Panakova, Lucia; Leeb, Tosso; Wiener, Dominique J.; Welle, Monika M.			Novel insights into the pathways regulating the canine hair cycle and their deregulation in alopecia X	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; STEM-CELLS; FOLLICLE DEVELOPMENT; CANDIDATE GENE; MELATONIN; SKIN; EXPRESSION; GROWTH; ARREST; POMERANIANS	Alopecia X is a hair cycle arrest disorder in Pomeranians. Histologically, kenogen and telogen hair follicles predominate, whereas anagen follicles are sparse. The induction of anagen relies on the activation of hair follicle stem cells and their subsequent proliferation and differentiation. Stem cell function depends on finely tuned interactions of signaling molecules and transcription factors, which are not well defined in dogs. We performed transcriptome profiling on skin biopsies to analyze altered molecular pathways in alopecia X. Biopsies from five affected and four non-affected Pomeranians were investigated. Differential gene expression revealed a downregulation of key regulator genes of the Wnt (CTNNB1, LEF1, TCF3, WNT10B) and Shh (SHH, GLI1, SMO, PTCH2) pathways. In mice it has been shown that Wnt and Shh signaling results in stem cell activation and differentiation Thus our findings are in line with the lack of anagen hair follicles in dogs with Alopecia X. We also observed a significant downregulation of the stem cell markers SOX9, LHX2, LGR5, TCF7L1 and GLI1 whereas NFATc1, a quiescence marker, was upregulated in alopecia X. Moreover, genes coding for enzymes directly involved in the sex hormone metabolism (CYP1A1, CYP1B1, HSD17B14) were differentially regulated in alopecia X. These findings are in agreement with the so far proposed but not yet proven deregulation of the sex hormone metabolism in this disease.	[Brunner, Magdalena A. T.; Wiener, Dominique J.; Welle, Monika M.] Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Bern, Switzerland; [Brunner, Magdalena A. T.; Waluk, Dominik P.; Roosje, Petra; Leeb, Tosso; Wiener, Dominique J.; Welle, Monika M.] Univ Bern, DermFocus, Bern, Switzerland; [Jagannathan, Vidhya; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Waluk, Dominik P.] Univ Bern, Dept Clin Res Mol Dermatol & Stem Cell Res, Bern, Switzerland; [Roosje, Petra] Univ Bern, Vetsuisse Fac, Div Clin Dermatol, Bern, Switzerland; [Linek, Monika] AniCura Tierarztliche Spezialisten, Hamburg, Germany; [Panakova, Lucia] Univ Vet Med, Clin Small Anim & Horses, Vienna, Austria	University of Bern; University of Bern; University of Bern; University of Bern; University of Bern; University of Veterinary Medicine Vienna	Welle, MM (corresponding author), Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Bern, Switzerland.; Welle, MM (corresponding author), Univ Bern, DermFocus, Bern, Switzerland.	monika.welle@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Wiener, Dominique Judith/AAN-3313-2021; Welle, Monika Maria/ABF-6113-2021; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Brunner, Magdalena/0000-0002-0449-0989; Welle, Monika/0000-0002-4876-5112	Swiss National Science Foundation [CRSII3_160738/1]; International Society for Veterinary Dermatology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); International Society for Veterinary Dermatology	This study was supported by grants from the Swiss National Science Foundation (CRSII3_160738/1) and the International Society for Veterinary Dermatology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Monika Linek, one of the coauthors, is employed by a private veterinary referral practice (AniCura Tierarztliche Spezialisten). Anicura, provided support in the form of salaries for Monika Linek [ML], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Albanese F, 2014, VET DERMATOL, V25, P519, DOI 10.1111/vde.12148; Alcolea MP, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015206; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ansel L, 2010, J BIOL RHYTHM, V25, P81, DOI 10.1177/0748730410361918; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Ashley P, 1999, J AM VET MED ASSOC, P215; Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; Cerundolo R, 2007, VET REC, V160, P393, DOI 10.1136/vr.160.12.393; Chen CC, 2015, J MOL BIOL; Chen CC, 2012, J DERMATOL SCI, V66, P3, DOI 10.1016/j.jdermsci.2012.02.007; Chottanapund S, 2014, TOXICOL IN VITRO, V28, P1215, DOI 10.1016/j.tiv.2014.05.015; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dlugosz A, 1999, J CLIN INVEST, V104, P851, DOI 10.1172/JCI8416; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ekins S, 2007, METH MOL B, V356, P319; Fischer TW, 2008, J PINEAL RES, V44, P1, DOI 10.1111/j.1600-079X.2007.00512.x; Frank LA, 2006, VET DERMATOL, V17, P252, DOI 10.1111/j.1365-3164.2006.00520.x; Frank LA, 2005, JAVMA-J AM VET MED A, V226, P1494, DOI 10.2460/javma.2005.226.1494; Frank LA, 2004, VET DERMATOL, V15, P278, DOI 10.1111/j.1365-3164.2004.00372.x; Frank LA, 2007, VET DERMATOL, V18, P63, DOI 10.1111/j.1365-3164.2007.00559.x; Frank LA, 2010, VET DERMATOL, V21, P490, DOI 10.1111/j.1365-3164.2010.00896.x; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gerhards NM, 2016, J HISTOCHEM CYTOCHEM, V64, P190, DOI 10.1369/0022155415627679; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Higgins CA, 2009, J INVEST DERMATOL, V129, P2100, DOI 10.1038/jid.2009.66; Hong SH, 2017, TOX RESEARCH, V33, P49, DOI 10.5487/TR.2017.33.1.049; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Hu HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040124; Katoh I, 2016, CELL CYCLE, V15, P699, DOI 10.1080/15384101.2016.1148837; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; Kim BK, 2013, J DERMATOL SCI, V71, P203, DOI 10.1016/j.jdermsci.2013.04.019; Lee J, 2012, SEMIN CELL DEV BIOL, V23, P906, DOI 10.1016/j.semcdb.2012.08.003; Lei MX, 2013, J INVEST DERMATOL, V133, P7, DOI 10.1038/jid.2012.446; Li N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040582; Linek M, 2009, HAIR LOSS DISORDERS, P119; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma XC, 2005, DRUG METAB DISPOS, V33, P489, DOI 10.1124/dmd.104.002410; Maharaj DS, 2007, BIOSCIENCE REP, V27, P299, DOI 10.1007/s10540-007-9052-1; Mausberg EM, 2007, ANIM BIOTECHNOL, V18, P391, DOI 10.1080/10495390701547461; Mausberg EM, 2008, VET REC, P163; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Mediavilla MD, 2010, CURR MED CHEM, V17, P4462, DOI 10.2174/092986710794183015; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Milner Y, 2002, J INVEST DERMATOL, V119, P639, DOI 10.1046/j.1523-1747.2002.01842.x; Muntener T, 2012, VET DERMATOL, V23, P206, DOI 10.1111/j.1365-3164.2012.01049.x; Myung PS, 2013, J INVEST DERMATOL, V133, P31, DOI 10.1038/jid.2012.230; Nikolakis G, 2016, REV ENDOCR METAB DIS, V17, P247, DOI 10.1007/s11154-016-9390-z; Ohnemus U, 2006, ENDOCR REV, V27, P677, DOI 10.1210/er.2006-0020; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Purba TS, 2015, EXP DERMATOL, V24, P462, DOI 10.1111/exd.12700; Purba TS, 2014, BIOESSAYS, V36, P513, DOI 10.1002/bies.201300166; Qin FJ, 2015, REPROD BIOMED ONLINE, V31, P638, DOI 10.1016/j.rbmo.2015.07.009; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Rompolas P, 2014, SEMIN CELL DEV BIOL, V25, P34, DOI 10.1016/j.semcdb.2013.12.005; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; SCHMEITZEL LP, 1990, J AM VET MED ASSOC, V197, P1333; Sivik T, 2012, HORM METAB RES, V44, P949, DOI 10.1055/s-0032-1321815; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Solanas G, 2013, NAT REV MOL CELL BIO, V14, P737, DOI 10.1038/nrm3675; Stratakis CA, 1999, CRIT REV CL LAB SCI, V36, P329, DOI 10.1080/10408369991239222; Takada K, 2002, RES VET SCI, V73, P159, DOI 10.1016/S0034-5288(02)00070-X; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zouboulis CC, 2009, DERM-ENDOCRINOL, V1, P250, DOI 10.4161/derm.1.5.9499	74	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186469	10.1371/journal.pone.0186469	http://dx.doi.org/10.1371/journal.pone.0186469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065140	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900013
J	Jin, Z; Ji, FY; He, Y; Zhao, M; Xu, X; Zheng, XY				Jin, Zhan; Ji, Fangying; He, Yin; Zhao, Min; Xu, Xuan; Zheng, Xiang-yong			Evaluating the efficiency of carbon utilisation via bioenergetics between biological aerobic and denitrifying phosphorus removal systems	PLOS ONE			English	Article							ORGANISMS; NITROGEN	There are two biological systems available for removing phosphorus from waste water, conventional phosphorus removal (CPR) and denitrifying phosphorus removal (DPR) systems, and each is characterized by the type of sludge used in the process. In this study, we compared the characteristics associated with the efficiency of carbon utilization between CPR and DPR sludge using acetate as a carbon source. For DPR sludge, the heat emitted during the phosphorus release and phosphorus uptake processes were 45.79 kJ/mol e(-) and 84.09 kJ/mol e(-), respectively. These values were about 2 fold higher than the corresponding values obtained for CPR sludge, suggesting that much of the energy obtained from the carbon source was emitted as heat. Further study revealed a smaller microbial mass within the DPR sludge compared to CPR sludge, as shown by a lower sludge yield coefficient (0.05 gVSS/g COD versus 0.36 gVSS/g COD), a result that was due to the lower energy capturing efficiency of DPR sludge according to bioenergetic analysis. Although the efficiency of anoxic phosphorus removal was only 39% the efficiency of aerobic phosphorus removal, the consumption of carbon by DPR sludge was reduced by 27.8% compared to CPR sludge through the coupling of denitrification with dephosphatation.	[Jin, Zhan; Zhao, Min; Zheng, Xiang-yong] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Peoples R China; [Jin, Zhan; Ji, Fangying; He, Yin; Xu, Xuan] Minist Educ, Key Lab Three Gorges Reservoir Reg Ecoenvironm, Chongqing, Peoples R China	Wenzhou University	Zhao, M (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Peoples R China.; Ji, FY (corresponding author), Minist Educ, Key Lab Three Gorges Reservoir Reg Ecoenvironm, Chongqing, Peoples R China.	jfytou@sina.cn; 578189107@qq.com		Ji, Fangying/0000-0003-0224-2639; Jin, Zhan/0000-0001-8937-7282	National Critical Patented Projects in the Control and Management of the Polluted Water Bodies [012ZX07320-001]; National Science and Technology Major Project [2013zx0731200101]; Wenzhou Science and Technology Innovation Project in the Control and Management of the Polluted Water Bodies [S20150003]	National Critical Patented Projects in the Control and Management of the Polluted Water Bodies; National Science and Technology Major Project; Wenzhou Science and Technology Innovation Project in the Control and Management of the Polluted Water Bodies	The work was funded by the National Critical Patented Projects in the Control and Management of the Polluted Water Bodies (No. 012ZX07320-001), National Science and Technology Major Project (No. 2013zx0731200101) and Wenzhou Science and Technology Innovation Project in the Control and Management of the Polluted Water Bodies (No. S20150003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassin JP, 2012, WATER RES, V46, P3805, DOI 10.1016/j.watres.2012.04.015; Critter SAM, 2002, THERMOCHIM ACTA, V394, P145, DOI 10.1016/S0040-6031(02)00247-2; Debord J., 2008, ANAL BIOCHEM, V373, P97; Guigon-Lopez C, 2010, THERMOCHIM ACTA, V509, P40, DOI 10.1016/j.tca.2010.05.018; HASCOET MC, 1985, WATER SA, V11, P1; He Y, 2011, THESIS; [吉芳英 Ji Fangying], 2006, [环境污染治理技术与设备, Techniques and equipment for environmental pollution control], V7, P20; Ji M, 2001, INSTRUM SCI TECHNOL, V29, P53, DOI 10.1081/CI-100001408; Kim JM, 2013, APPL ENVIRON MICROB, V79, P1969, DOI 10.1128/AEM.03464-12; Kong WJ, 2011, J HAZARD MATER, V185, P346, DOI 10.1016/j.jhazmat.2010.09.040; Kuba T, 1996, WATER RES, V30, P1702, DOI 10.1016/0043-1354(96)00050-4; Kuba T, 1996, BIOTECHNOL BIOENG, V52, P685, DOI 10.1002/(SICI)1097-0290(19961220)52:6<685::AID-BIT6>3.0.CO;2-K; Kuba T, 1993, WATER SCI TECH, V27, P11; Liu L., 2010, PHARM BIOTECHNOL, V137, P7753; Liu SL, 2015, INT BIODETER BIODEGR, V100, P140, DOI 10.1016/j.ibiod.2015.02.003; LOTTER LH, 1985, WATER SCI TECHNOL, V17, P127; Metcalf & Eddy Inc, 2004, WASTEWATER ENG TREAT; Wang SY, 2008, J APPL ENV BIOL, V14, P4; Zhang M, 2016, BIOCHEM ENG J, V106, P26, DOI 10.1016/j.bej.2015.10.027; ZHENG P., 2004, NEW THEORY BIOTECHNO	20	3	5	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0187007	10.1371/journal.pone.0187007	http://dx.doi.org/10.1371/journal.pone.0187007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065157	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900062
J	Kim, JH; Lee, SI; Kim, BR; Choi, IY; Ryser, P; Kim, NS				Kim, Jong-Hwa; Lee, Sung-Il; Kim, Bo-Ram; Choi, Ik-Young; Ryser, Peter; Kim, Nam-Soo			Chloroplast genomes of Lilium lancifolium, L. amabile, L. callosum, and L. philadelphicum: Molecular characterization and their use in phylogenetic analysis in the genus Lilium and other allied genera in the order Liliales	PLOS ONE			English	Article							PLASTID GENOMES; INVERTED REPEAT; SEQUENCE; DNA; ANGIOSPERMS; TORTOISE; EVOLUTION; REGIONS; UTILITY	Chloroplast (cp) genomes of Lilium amabile, L. callosum, L. lancifolium, and L. philadelphicum were fully sequenced. Using these four novel cp genome sequences and five other previously sequenced cp genomes, features of the cp genomes were characterized in detail among species in the genus Lilium and other related genera in the order Liliales. The lengths and nucleotide composition showed little variation. No structural variation was found among the cp genomes in Liliales. Gene contents were conserved among four newly sequenced cp genome in Lilium species, the only differences being in two pseudogenes. We identified 112 genes in 13 functional categories, 18 of which carried introns that were conserved among the species in Liliales. There were 16-21 SSR loci (> 12 bp, > 3 repeats) in the cp genomes in Lilium and the genomic locations of these loci were highly variable among the species. Average mutations were 15 SNPs per 1kb and 5 indels per 1kb, respectively, in the cp genomes of the newly sequenced four Lilium species. Phylogenetic classifications revealed some discrepancies between trees based on the cp genomes and previous classifications based on the morphology and geographic distributions.	[Kim, Jong-Hwa; Kim, Bo-Ram] Kangwon Natl Univ, Dept Hort, Chunchon, South Korea; [Lee, Sung-Il; Kim, Nam-Soo] Kangwon Natl Univ, Inst Biosci & Biomed Sci, Chunchon, South Korea; [Lee, Sung-Il] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup, Jeonbuk, South Korea; [Choi, Ik-Young] Kangwon Natl Univ, Dept Agr Life Sci, Chunchon, South Korea; [Ryser, Peter] Laurentian Univ, Dept Biol, Sudbury, ON, Canada; [Kim, Nam-Soo] Kangwon Natl Univ, Dept Mol Biosci, Chunchon, South Korea	Kangwon National University; Kangwon National University; Korea Atomic Energy Research Institute (KAERI); Kangwon National University; Laurentian University; Kangwon National University	Kim, NS (corresponding author), Kangwon Natl Univ, Inst Biosci & Biomed Sci, Chunchon, South Korea.; Kim, NS (corresponding author), Kangwon Natl Univ, Dept Mol Biosci, Chunchon, South Korea.	kimnamsu@kangwon.ac.kr	CHOI, Ik-Young/ABI-6938-2020; Ryser, Peter/G-7772-2011	Ryser, Peter/0000-0002-9495-9508	National Research Foundation of Korea [C1013144-01-01]; Golden Seed Project grant from the Rural Development Administration of Korea [213007-05-1-CGM00]	National Research Foundation of Korea(National Research Foundation of Korea); Golden Seed Project grant from the Rural Development Administration of Korea	This work was carried out with a grant from National Research Foundation of Korea (https://www.nrf.re.kr/index) (Project No. C1013144-01-01) to NSK, and a Golden Seed Project grant from the Rural Development Administration of Korea (http://www.rda.go.kr; http://www.rda.go.kr/main/mainPage.do) to JHK (project No. 213007-05-1-CGM00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANO Y, 1986, Journal of the Faculty of Agriculture Hokkaido University, V62, P333; Benschop M., 2010, Horticultural Reviews, V36, P1; Bi Y, 2016, CONSERV GENET RESOUR, V8, P419, DOI 10.1007/s12686-016-0585-0; Brozynska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110387; Clark CM, 2000, AM J BOT, V87, P774, DOI 10.2307/2656885; Comber HF, 1949, LILY YB, V15, P86; Du YP, 2016, CONSERV GENET RESOUR, V8, P375, DOI 10.1007/s12686-016-0562-7; Endlicher S, 1836, GENERA PLANTARUM, P1836; Gao YD, 2013, MOL PHYLOGENET EVOL, V68, P443, DOI 10.1016/j.ympev.2013.04.026; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Hayashi Kazuhiko, 2000, Plant Species Biology, V15, P73, DOI 10.1046/j.1442-1984.2000.00025.x; Huang J., 2015, CHIN RURAL EC, V2015, P10, DOI DOI 10.1016/j.agrformet.2015.10.013; Hwang YJ, 2016, MITOCHONDRIAL DNA A, V27, P4633, DOI 10.3109/19401736.2015.1101591; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kim JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068180; Kim K, 2016, MITOCHONDRIAL DNA A, V27, P3678, DOI 10.3109/19401736.2015.1079852; Kim K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15655; Lanslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI DOI 10.1093/nar/gkh152; Lee SI, 2015, GENETICA, V143, P343, DOI 10.1007/s10709-015-9833-6; Lei WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21669; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Nikiforova SV, 2013, MOL BIOL EVOL, V30, P1751, DOI 10.1093/molbev/mst092; Noda S, 1987, THE LILIES IN JAPAN, P98; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; PALMER JD, 1987, P NATL ACAD SCI USA, V84, P769, DOI 10.1073/pnas.84.3.769; PALMER JD, 1987, CURR GENET, V11, P275, DOI 10.1007/BF00355401; Park YJ, 2009, MOLECULES, V14, P4546, DOI 10.3390/molecules14114546; Pelkonen V.P., 2012, FLORICULTURE ORNAMEN, V6, P1; Peruzzi L, 2016, PLANT BIOSYST, V150, P1341, DOI 10.1080/11263504.2015.1115435; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Song JH, 2016, MITOCHONDRIAL DNA B, V1, P318, DOI 10.1080/23802359.2016.1172043; Song Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00662; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stoebe B, 1999, TRENDS GENET, V15, P344, DOI 10.1016/S0168-9525(99)01815-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Tuyl JM, 2011, ACTA HORTIC, V900, P223; Wheeler GL, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400059; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhang Q, 2016, CONSERV GENET RESOUR, V9, P201	46	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186788	10.1371/journal.pone.0186788	http://dx.doi.org/10.1371/journal.pone.0186788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065181	Green Published, Green Submitted, gold			2022-12-26	WOS:000413568900040
J	More, VR; Lao, JL; McLaren, DG; Cumiskey, AM; Murphy, BA; Chen, Y; Previs, S; Stout, S; Patel, R; Satapati, S; Li, WY; Kowalik, E; Szeto, D; Nawrocki, A; Pocai, A; Wang, LS; Carrington, P				More, Vijay R.; Lao, Julie; McLaren, David G.; Cumiskey, Anne-Marie; Murphy, Beth Ann; Chen, Ying; Previs, Stephen; Stout, Steven; Patel, Rajesh; Satapati, Santhosh; Li, Wenyu; Kowalik, Edward; Szeto, Daphne; Nawrocki, Andrea; Pocai, Alessandro; Wang, Liangsu; Carrington, Paul			Glucagon like receptor 1/ glucagon dual agonist acutely enhanced hepatic lipid clearance and suppressed de novo lipogenesis in mice	PLOS ONE			English	Article							IN-VIVO; METABOLISM; ACTIVATION	Lipid lowering properties of glucagon have been reported. Blocking glucagon signaling leads to rise in plasma LDL levels. Here, we demonstrate the lipid lowering effects of acute dosing with Glp1r/Gcgr dual agonist (DualAG). All the experiments were performed in 25 week-old male diet-induced (60% kCal fat) obese mice. After 2 hrs of fasting, mice were injected subcutaneously with vehicle, liraglutide (25nmol/kg) and DualAG (25nmol/kg). De novo cholesterol and palmitate synthesis was measured by deuterium incorporation method using D2O. C-13(18)-oleate infusion was used for measuring fatty acid esterification. Simultaneous activation of Glp1r and Gcgr resulted in decrease in plasma triglyceride and cholesterol levels. DualAG enhanced hepatic LDLr protein levels, along with causing decrease in content of plasma ApoB48 and ApoB100. VLDL secretion, de novo palmitate synthesis and fatty acid esterification decreased with acute DualAG treatment. On the other hand, ketone levels were elevated with DualAG treatment, indicating increased fatty acid oxidation. Lipid relevant changes were absent in liraglutide treated group. In an acute treatment, DualAG demonstrated significant impact on lipid homeostasis, specifically on hepatic uptake, VLDL secretion and de novo synthesis. These effects collectively reveal that lipid lowering abilities of DualAG are primarily through glucagon signaling and are liver centric.	[More, Vijay R.; Lao, Julie; Chen, Ying; Previs, Stephen; Patel, Rajesh; Satapati, Santhosh; Li, Wenyu; Pocai, Alessandro; Wang, Liangsu; Carrington, Paul] Merck & Co Inc, Cardiometab Dis Biol Discovery, Kenilworth, NJ 07033 USA; [McLaren, David G.; Stout, Steven; Kowalik, Edward] Merck & Co Inc, In Vitro Pharmacol, Kenilworth, NJ USA; [Cumiskey, Anne-Marie; Murphy, Beth Ann; Szeto, Daphne; Nawrocki, Andrea] Merck & Co Inc, In Vivo Pharmacol, Kenilworth, NJ USA	Merck & Company; Merck & Company; Merck & Company	More, VR (corresponding author), Merck & Co Inc, Cardiometab Dis Biol Discovery, Kenilworth, NJ 07033 USA.	vijay.more@merck.com	Murphy, Beth Ann/W-2055-2019	More, Vijay/0000-0002-0605-745X	Merck Co., Inc.; 'Merck Postdoctoral Program'	Merck Co., Inc.(Merck & Company); 'Merck Postdoctoral Program'	The funder (Merck & Co., Inc.) provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Authors thank 'Merck Postdoctoral Program' for supporting this research and publication.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cefalu WT, 2016, DIABETES CARE, V39, P1186, DOI 10.2337/dc16-0873; DAVIDSON IWF, 1957, NATURE, V180, P1124, DOI 10.1038/1801124a0; Day JW, 2012, BIOPOLYMERS, V98, P443, DOI 10.1002/bip.22072; DEMANT T, 1988, KLIN WOCHENSCHR, V66, P703, DOI 10.1007/BF01726412; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Guan HP, 2015, J LIPID RES, V56, P2183, DOI 10.1194/jlr.M060897; Han S, 2013, J LIPID RES, V54, P2615, DOI 10.1194/jlr.M035592; Kosinski JR, 2012, OBESITY, V20, P1566, DOI 10.1038/oby.2012.67; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; Lo CM, 2008, AM J PHYSIOL-GASTR L, V294, pG344, DOI 10.1152/ajpgi.00123.2007; McLaren DG, 2016, J LIPID RES, V57, P398, DOI 10.1194/jlr.M063842; McLaren DG, 2013, ANAL CHEM, V85, P6287, DOI 10.1021/ac400363k; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Owens AP, 2012, J CLIN INVEST, V122, P558, DOI 10.1172/JCI58969; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schofield JD, 2016, DIABETES THER, V7, P203, DOI 10.1007/s13300-016-0167-x; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Vuguin PM, 2011, DIABETES OBES METAB, V13, P144, DOI 10.1111/j.1463-1326.2011.01447.x	23	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186586	10.1371/journal.pone.0186586	http://dx.doi.org/10.1371/journal.pone.0186586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065174	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900018
J	Shibata, A; Kuno, M; Adachi, R; Sato, Y; Hattori, H; Matsuda, A; Okuzono, Y; Igaki, K; Tominari, Y; Takagi, T; Yabuki, M; Okaniwa, M				Shibata, Akira; Kuno, Masako; Adachi, Ryutaro; Sato, Yosuke; Hattori, Harumi; Matsuda, Atsushi; Okuzono, Yuumi; Igaki, Keiko; Tominari, Yusuke; Takagi, Terufumi; Yabuki, Masato; Okaniwa, Masanori			Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; GROWTH-FACTOR-BETA; LOCALIZED SCLERODERMA; SYSTEMIC-SCLEROSIS; HALOFUGINONE; COLLAGEN; FIBROBLASTS; SMAD3; ACTIVATION; EXPRESSION	Scleroderma has clinical characteristics including skin and other tissue fibrosis, but there is an unmet need for anti-fibrotic therapy. Halofuginone (HF) is a well-known anti-fibrosis agent in preclinical and clinical studies which exerts its effect via inhibition of TGF-beta/Smad3 signaling pathway. Recently, prolyl-tRNA synthetase (PRS) was elucidated as a target protein for HF that binds to the proline binding site of the catalytic domain of PRS. Here, we characterized a new class of PRS inhibitor (T-3833261) that is carefully designed in a way that binds to the ATP site of the catalytic domain and does not disrupt binding of proline. The anti-fibrotic activity and the mechanism of action for T-3833261 on TGF-beta-induced fibrotic assay were compared with those of HF in primary human skin fibroblast. We evaluated in vivo effect of topical application of T-3833261 and HF on TGF-beta-induced fibrotic genes expression in mice. We found that T-3833261 suppressed TGF-beta-induced alpha-smooth muscle actin (alpha-SMA) and type I collagen alpha 1 (COL1A1) expression through the Smad3 axis in a similar fashion to HF. In vivo topical application of T-3833261 reduced the increase of fibrotic genes expression such as alpha-Sma, Col1a1 and Col1a2 by TGF-beta intradermal injection to the ear of a mouse. We revealed that T-3833261 is more effective than HF under the conditions of high proline concentration, as reported in fibrotic tissues. These results suggest the potential of ATP competitive PRS inhibitors for the treatment of fibrotic diseases such as scleroderma.	[Shibata, Akira; Kuno, Masako; Sato, Yosuke; Hattori, Harumi; Matsuda, Atsushi; Okuzono, Yuumi; Igaki, Keiko; Tominari, Yusuke; Yabuki, Masato; Okaniwa, Masanori] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Immunol Unit, Fujisawa, Kanagawa, Japan; [Adachi, Ryutaro] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Biomol Res Labs, Fujisawa, Kanagawa, Japan; [Takagi, Terufumi] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Med Chem Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Shibata, A; Okaniwa, M (corresponding author), Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Immunol Unit, Fujisawa, Kanagawa, Japan.	bata.176518@gmail.com; masanori.okaniwa@takeda.com		Okaniwa, Masanori/0000-0002-6982-9947; Sato, Yosuke/0000-0001-7592-3342; Shibata, Akira/0000-0001-9458-813X	Takeda Pharmaceutical Company, Ltd.	Takeda Pharmaceutical Company, Ltd.(Takeda Pharmaceutical Company Ltd)	This research was supported by Takeda Pharmaceutical Company, Ltd. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi R, 2017, BIOCHEM BIOPH RES CO, V488, P393, DOI 10.1016/j.bbrc.2017.05.064; Arita T, 2017, BIOCHEM BIOPH RES CO, V488, P648, DOI 10.1016/j.bbrc.2017.01.045; Badea I, 2009, RHEUMATOLOGY, V48, P213, DOI 10.1093/rheumatology/ken405; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Chujo S, 2005, J CELL PHYSIOL, V203, P447, DOI 10.1002/jcp.20251; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Distler O, 2016, SEMIN IMMUNOPATHOL, V38, P87, DOI 10.1007/s00281-015-0551-z; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Gilbane AJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4230; Halevy O, 1996, BIOCHEM PHARMACOL, V52, P1057, DOI 10.1016/0006-2952(96)00427-3; Herman JD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0511-2; Ishiguro S, 2009, WOUND REPAIR REGEN, V17, P617, DOI 10.1111/j.1524-475X.2009.00511.x; Jacquet H, 2003, J Med Genet, V40, pe7, DOI 10.1136/jmg.40.1.e7; KAHARI VM, 1988, J INVEST DERMATOL, V90, P664, DOI 10.1111/1523-1747.ep12560826; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; KERSHENOBICH D, 1970, J CLIN INVEST, V49, P2246, DOI 10.1172/JCI106443; Kubo E, 2017, J CELL MOL MED, V21, P916, DOI 10.1111/jcmm.13030; Kurzinski K, 2011, CYTOKINE, V55, P157, DOI 10.1016/j.cyto.2011.04.001; McGaha TL, 2002, ARTHRITIS RHEUM, V46, P2748, DOI 10.1002/art.10549; McGaha TL, 2002, J INVEST DERMATOL, V118, P461, DOI 10.1046/j.0022-202x.2001.01690.x; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Nelson EF, 2012, MOL VIS, V18, P479; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 2001, BIOCHEM PHARMACOL, V62, P1221, DOI 10.1016/S0006-2952(01)00753-5; Reddy AT, 2014, FASEB J, V28, P5299, DOI 10.1096/fj.14-256263; Rice LM, 2015, J CLIN INVEST, V125, P2795, DOI 10.1172/JCI77958; Tamaki Z, 2014, J DERMATOL SCI, V74, P251, DOI 10.1016/j.jdermsci.2014.02.002; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Xie Feng, 2014, Cells, V3, P981, DOI 10.3390/cells3040981; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	32	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0186587	10.1371/journal.pone.0186587	http://dx.doi.org/10.1371/journal.pone.0186587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065190	Green Published, gold, Green Submitted			2022-12-26	WOS:000413568900019
J	Williams, VL; Loveridge, AJ; Newton, DJ; Macdonald, DW				Williams, Vivienne L.; Loveridge, Andrew J.; Newton, David J.; Macdonald, David W.			A roaring trade? The legal trade in Panthera leo bones from Africa to East-Southeast Asia	PLOS ONE			English	Article								The African lion is the only big cat listed on CITES Appendix II, and the only one for which international commercial trade is legal under CITES. The trade in lion body parts, and especially the contentious trade in bones from South Africa to Asia, has raised concerns spanning continents and cultures. Debates were amplified at the 2016 CITES Conference of the Parties (CoP17) when a proposal to up-list lions to Appendix I was not supported and a compromise to keep them on Appendix II, with a bone trade quota for South Africa, was reached instead. CoP17 underscored a need for further information on the lion bone trade and the consequences for lions across the continent. Legal international trade in bones to Asia, allegedly to supply the substitute 'tiger bone' market, began in South Africa in February 2008 when the first CITES permits were issued. It was initially unclear the degree to which bones were sourced from captive-origin lions, and whether trade was a threat to wild lion populations. Our original assessment of the legal CITES-permitted lion bone trade from South Africa to East-Southeast Asia was for the period 2008-2011 (published 2015). In this paper, we consolidate new information that has become available for 2012-2016, including CITES reports from other African countries, and data on actual exports for three years to 2016 supplied by a freight forwarding company. Thus, we update the figures on the legal trade in lion bones from Africa to East-Southeast Asia in the period 2008-2016. We also contextualise the basis for global concerns by reviewing the history of the trade and its relation to tigers, poaching and wildlife trafficking. CITES permits issued to export bones escalated from +/- 314y(-1) skeletons from 2008-2011, to +/- 1312y(-1) skeletons from 2013-2015. South Africa was the only legal exporter of bones to Asia until 2013 when Namibia issued permits to export skeletons to Vietnam. While CITES permits to export +/- 5363 skeletons from Africa to Asia from 2008-2015 were issued (99.1% from South Africa; 0.7% from Namibia) (51% for Laos), actual exports were less than stated on the permits. However, information on actual exports from 2014-2016 indicated that >3400 skeletons were exported in that period. In total, >6000 skeletons weighing no less than 70 tonnes have been shipped to East-Southeast Asia since 2008. Since few wild lions are hunted and poached within South African protected areas, skeletons for the legal trade appear to be derived from captive bred lions. However, confirmation of a 116kg shipment from Uganda to Laos, and reports of lion poaching in neighbouring countries, indicate that urgent proactive monitoring and evaluation of the legal and illegal trade is necessary in African lion range states where vulnerable wild lion populations are likely to be adversely affected.	[Williams, Vivienne L.; Newton, David J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Loveridge, Andrew J.; Macdonald, David W.] Univ Oxford, Recananti Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney House, Tubney, Oxon, England; [Newton, David J.] IUCN ESARO, TRAFFIC East Southern Africa, Pretoria, South Africa	University of Witwatersrand; University of Oxford	Williams, VL (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	vivienne.pub1@wildscience.co.za	Williams, Vivienne Linda/M-1453-2019	Williams, Vivienne Linda/0000-0003-0698-6512	Robertson Foundation; Recanati-Kaplan Foundation; National Research Foundation (South Africa); University of the Witwatersrand; Mackenzie Foundation	Robertson Foundation; Recanati-Kaplan Foundation; National Research Foundation (South Africa)(National Research Foundation - South Africa); University of the Witwatersrand; Mackenzie Foundation	DWM and AJL acknowledge funding support from the Robertson Foundation and the Recanati-Kaplan Foundation. VLW acknowledges financial support from the National Research Foundation (South Africa) and the University of the Witwatersrand. DJN acknowledges funding support from the Mackenzie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, LEGALBRIEF TODA 0402; [Anonymous], 2007, LION KILLINGS GIR SE; [Anonymous], 2009, DAILY SUN       0528; [Anonymous], 2007, TIGER POACHERS KILLI; Badhwa A., 2002, INDIAN FOREST; Breitenmoser Urs, 2016, Cat News, P3; Callister D, 1995, TIGER TREATMENTS RHI; CITES, 2016, COP17COM129 CITES; CITES, 2016, DEC C PART CITES EFF; CITES, 2011, GUID PREP SUBM CITES; *CITES, 2007, DEC C PART CITES EFF; CITES, COP17PROP4 CITES; CITES, 2015, NOT PART 2015 013; CITES, 2015, NOT PART 2015 055; Clifton M., 2015, UN ARM CITES RECOMME; D'Cruze N, 2016, NAT CONSERV-BULGARIA, P47, DOI 10.3897/natureconservation.15.10005; Davies N, 2016, REVEALED SENIOR LABS; Davies N, 2016, CRIME FAMILY CTR ASI; Du Plessis C., 2011, THE HERALD; Du Plessis C., 2011, TIMES; Ellis R., 2005, DESTRUCTION WILDLIFE; Environmental Investigation Agency, 2013, SUMM TIG FARM TIM; Environmental Investigation Agency, 2010, COLD BLOOD COMB ORG; FAIR J., 2009, BBC WILDLIFE     MAR, P39; Fuller T., 2013, INT HERALD TRIBUNE; Gratwicke B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002544; Groenewald Y., 2009, MAIL GUARDIAN; Henry L.A., 2004, TALE 2 CITIES COMP S; Hosken G., 2009, IOL             0402; INTERPOL, WANT PERS; Johnsingh AJT, 2009, FRONTLINE; Khoshoo TN, 1997, CURR SCI; Kotecha K., 2007, REQUEST HELP 3 ASIAT; Macleod F., 2011, MAIL GUARDIAN; Miller E., 2009, MAIL ONLINE; Milliken T., 2012, S AFRICA VIET NAM RH; Mills J. A., 1997, RHINOCEROS HORN TIGE; Nowell K., 2007, TAMING TIGER TRADE C; Nowell K., 2000, FAR CURE TIGER TRADE; Nowell K, 2014, CITES SECR 65 M STAN; Nowell K, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P463, DOI 10.1016/B978-0-8155-1570-8.00038-4; Oswell AH., 2010, BIG CAT TRADE MYANMA; Otto H., 2009, PRETORIA NEWS   0512; Otto H., 2009, PRETORIA NEWS   0416; Otto H., 2009, PRETORIA NEWS   0528; Rademeyer J, 2012, MAIL GUARDIAN; Rademeyer J., 2012, KILLING FOR PROFIT; Ramesh R, 2007, GUARDIAN; SA Predator Breeders Association and Others v Minister of Environmental Affairs and Tourism, 2010, 151 ZASCA SA PRED BR, V72, P151; Sinovas P., 2016, SO AFRICAS WILDLIFE; Smillie S, 2011, STAR; Smith C., 2009, NEWS; South African Department of Environmental Affairs, 2011, 18 S AFR DEP ENV AFF; South African Department of Environmental Affairs, 2010, 27 S AFR DEP ENV AFF; South African Department of Environmental Affairs, 2009, DEP ENV AFF WELC DEC; Species Survival Network, 2014, CAG ASS TIG FARM TRA; Srivastava M., 2007, TEHELKA; 't Sas-Rolfes M, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P477, DOI 10.1016/B978-0-8155-1570-8.00039-6; TRAFFIC, 2015, TRAFFIC B, V27, P66; TRAFFIC, 2016, TRAFFIC B, V28, P29; TRAFFIC, 1997, TRAFFIC B; U.S. Department of State, 2013, TRANSN ORG CRIM REW; Williams VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135144; Williams VL, 2015, NATURE, V523, P290, DOI 10.1038/523290a; Williams VL, PLOS ONE IN PRESS; Williams VL., 2015, BONES CONTENTION ASS	66	32	32	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2017	12	10							e0185996	10.1371/journal.pone.0185996	http://dx.doi.org/10.1371/journal.pone.0185996			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK5VD	29065143	gold, Green Published, Green Submitted			2022-12-26	WOS:000413568900010
J	Galitskaya, P; Biktashev, L; Saveliev, A; Grigoryeva, T; Boulygina, E; Selivanovskaya, S				Galitskaya, Polina; Biktashev, Liliya; Saveliev, Anatoly; Grigoryeva, Tatiana; Boulygina, Eugenia; Selivanovskaya, Svetlana			Fungal and bacterial successions in the process of co-composting of organic wastes as revealed by 454 pyrosequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITY; RIBOSOMAL-RNA; GALACTOMYCES-GEOTRICHUM; DYNAMICS; DIVERSITY; SLUDGE; MANURE; IDENTIFICATION; BIODIVERSITY; DEGRADATION	Composting is viewed as one of the primary methods to treat organic wastes. Co-composting may improve the efficiency of this treatment by establishing the most suitable conditions for decomposers than those present in the individual wastes. Given that bacteria and fungi are the driving agents of composting, information about the composition of their communities and dynamics during composting may improve reproducibility, performance and quality of the final compost as well as help to evaluate the potential human health risk and the choice of the most appropriate application procedure. In this study, the co-composting of mixtures containing two similar components (organic fraction of municipal solid waste and sawdust polluted by oil) and one discriminate component (sewage sludges of different origin) were investigated. Bacterial and fungal community successions in the two mixtures were analyzed during the composting process by determining the change in their structural dynamics using qPCR and 454 pyrosequencing methods in a lab experiment for a period of 270 days. During the initial composting stage, the number of 16S bacterial copies was (3.0 +/- 0.2) x 10(6) and (0.4 +/- 0.0) x 10(7) g(-1), and the Rhodospiralles and Lactobacialles orders dominated. Fungal communities had (2.9 +/- 0.0) x 10(5) and (6.1 +/- 0.2) x10(5) ITS copies g(-1), and the Saccharomycetales order dominated. At the end of the thermophilic stage on the 30 th day of composting, bacterial and fungal communities underwent significant changes: dominants changed and their relative abundance decreased. Typical compost residents included Flavobacteriales, Chitinophagaceae and Bacterioidetes for bacteria and Microascaceae, Dothideomycetes, Eurotiomycetes, Sordariomycetes, and Agaricomycetes for fungi. During the later composting stages, the dominating taxa of both bacterial and fungal communities remained, while their relative abundance decreased. In accordance with the change in the dominating OTUs, it was concluded that the dynamics of the bacterial and fungal communities were not similar. Analysis by non-metric multidimensional scaling (NMDS) revealed that the bacterial communities of the two composts became progressively more similar; a similar trend was followed by the fungal community.	[Galitskaya, Polina; Biktashev, Liliya; Selivanovskaya, Svetlana] Kazan Fed Univ, Dept Appl Ecol, Inst Environm Sci, Kazan, Russia; [Saveliev, Anatoly] Kazan Fed Univ, Dept Ecol Syst Modeling, Inst Environm Sci, Kazan, Russia; [Grigoryeva, Tatiana; Boulygina, Eugenia] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia	Kazan Federal University; Kazan Federal University; Kazan Federal University	Biktashev, L (corresponding author), Kazan Fed Univ, Dept Appl Ecol, Inst Environm Sci, Kazan, Russia.	biktasheval@mail.ru	Grigoryeva, Tatiana/H-8611-2014; Saveliev, Anatoly A/M-1804-2016; Galitskaya, Polina/AAR-3186-2021; Selivanovskaya, Svetlana/L-8851-2013; Boulygina, Eugenia/N-9045-2016	Grigoryeva, Tatiana/0000-0001-5314-7012; Saveliev, Anatoly A/0000-0002-6270-7744; Galitskaya, Polina/0000-0002-5070-786X; Boulygina, Eugenia/0000-0003-3458-1176				Anastasi A, 2005, MYCOLOGIA, V97, P33, DOI 10.3852/mycologia.97.1.33; [Anonymous], 1998, 142351998 ISO; [Anonymous], 2012, 1126922012 ISO, P19; [Anonymous], 2012, 14371 ISO, P16; Lopez-Gonzalez JA, 2015, BIORESOURCE TECHNOL, V187, P305, DOI 10.1016/j.biortech.2015.03.124; Anuradha S, 2008, Med J Malaysia, V63, P75; Bacaro G, 2007, J VEG SCI, V18, P793, DOI 10.1111/j.1654-1103.2007.tb02595.x; Beffa T, 1996, APPL ENVIRON MICROB, V62, P1723, DOI 10.1128/AEM.62.5.1723-1727.1996; Bennett LT, 2008, SOIL BIOL BIOCHEM, V40, P1601, DOI 10.1016/j.soilbio.2008.01.008; Bonito G, 2010, BIORESOURCE TECHNOL, V101, P1021, DOI 10.1016/j.biortech.2009.08.109; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-37; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; de Bertoldi M., 1983, WASTE MANAGE RES, V1, P157, DOI DOI 10.1177/0734242X8300100118; De Gannes V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00164; de Gannes V, 2013, BIORESOURCE TECHNOL, V133, P573, DOI 10.1016/j.biortech.2013.01.138; Ortega-Larrocea MD, 2010, ENVIRON POLLUT, V158, P1922, DOI 10.1016/j.envpol.2009.10.034; Eichorst SA, 2013, ENVIRON MICROBIOL, V15, P2573, DOI 10.1111/1462-2920.12159; Epstein E., 1997, SCI COMPOSTING; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Franke-Whittle IH, 2005, J MICROBIOL METH, V62, P37, DOI 10.1016/j.mimet.2005.01.008; Franke-Whittle IH, 2014, WASTE MANAGE, V34, P632, DOI 10.1016/j.wasman.2013.12.009; Galitskaya P. Y., 2014, World Applied Sciences Journal, V30, P1689; Ge HQ, 2015, WATER RES, V69, P173, DOI 10.1016/j.watres.2014.11.026; Gonzalez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029973; Green SJ, 2004, FEMS MICROBIOL LETT, V233, P115, DOI 10.1016/j.femsle.2004.01.049; Gupta A, 2001, J MOL MICROB BIOTECH, V3, P445; Hagn A, 2008, BIOL FERT SOILS, V44, P481, DOI 10.1007/s00374-007-0230-x; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hansgate AM, 2005, FEMS MICROBIOL ECOL, V51, P209, DOI 10.1016/j.femsec.2004.08.009; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hultman J, 2010, J APPL MICROBIOL, V108, P472, DOI 10.1111/j.1365-2672.2009.04439.x; Insam H, 2007, WASTE MANAG SER, V8, P25; Izquierdo JA, 2010, APPL ENVIRON MICROB, V76, P3545, DOI 10.1128/AEM.02689-09; Jadhav SU, 2008, J CHIN INST CHEM ENG, V39, P563, DOI 10.1016/j.jcice.2008.06.003; Jindou S, 2006, FEMS MICROBIOL LETT, V254, P308, DOI 10.1111/j.1574-6968.2005.00040.x; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kovarik J, 2013, PATHOBIOLOGY, V80, P275, DOI 10.1159/000346960; Kuryntseva P, 2016, WASTE MANAGE, V58, P90, DOI 10.1016/j.wasman.2016.09.031; Kutzner H.J., 2000, BOITECHNOLOGY MULTI, V11, P35; Langarica-Fuentes A, 2014, FUNGAL ECOL, V11, P132, DOI 10.1016/j.funeco.2014.05.007; Langarica-Fuentes A, 2014, FEMS MICROBIOL ECOL, V88, P296, DOI 10.1111/1574-6941.12293; Lens PNL, 2004, RESOURE RECOVERY REU; Li Y, 2015, BIOCHEM ENG J, V95, P104, DOI 10.1016/j.bej.2014.12.011; Li ZT, 2013, CHEMOSPHERE, V93, P1247, DOI 10.1016/j.chemosphere.2013.06.064; Makinen AE, 2013, INT J HYDROGEN ENERG, V38, P15606, DOI 10.1016/j.ijhydene.2013.04.137; MENDONCAHAGLER LC, 1993, INT J SYST BACTERIOL, V43, P368, DOI 10.1099/00207713-43-2-368; Mhedbi-Hajri N, 2011, ADV EXP MED BIOL, V715, P71, DOI 10.1007/978-94-007-0940-9_5; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Moore DR, 2011, EAR HEARING, V32, P269, DOI 10.1097/AUD.0b013e318201c468; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; Nitin M., 2014, INT J CURR RES, V6, P4492; Nohit A-M, 2006, BACTERIAL COMMUNITY; Nubel U, 1996, J BACTERIOL, V178, P5636; Partanen P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-94; Pedro MS, 2001, J BIOSCI BIOENG, V91, P159, DOI 10.1263/jbb.91.159; Riddech N, 2002, MICROBIOLOGY OF COMPOSTING, P43; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Sadaie T, 2007, BIOSCI BIOTECH BIOCH, V71, P791, DOI 10.1271/bbb.60632; Sasaki N, 2003, J BIOSCI BIOENG, V96, P47, DOI 10.1263/jbb.96.47; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; Schleheck D, 2011, STAND GENOMIC SCI, V5, P298, DOI 10.4056/sigs.2215005; Shannon C.E., 1963, MATH THEORY COMMUNIC; Shrestha K, 2011, BIORESOURCE TECHNOL, V102, P8027, DOI 10.1016/j.biortech.2011.06.076; Silvestri G, 2007, MEAT SCI, V77, P413, DOI 10.1016/j.meatsci.2007.04.015; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Song CH, 2014, MICROB BIOTECHNOL, V7, P424, DOI 10.1111/1751-7915.12131; Steel H, 2013, EUR J SOIL BIOL, V56, P1, DOI 10.1016/j.ejsobi.2013.01.003; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Ueno Y, 2001, J BIOSCI BIOENG, V92, P397, DOI 10.1263/jbb.92.397; Wang C, 2014, APPL MICROBIOL BIOT, V98, P3327, DOI 10.1007/s00253-013-5424-6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30; Yan JY, 2007, J MOL CATAL B-ENZYM, V49, P28, DOI 10.1016/j.molcatb.2007.07.006; Yu D, 2015, APPL SOIL ECOL, V92, P47, DOI 10.1016/j.apsoil.2015.03.005; Zhang X, 2014, BIORESOURCE TECHNOL, V170, P183, DOI 10.1016/j.biortech.2014.07.093; Zhang YM, 2008, RESOUR CONSERV RECY, V52, P1132, DOI 10.1016/j.resconrec.2008.05.003; Zhao HY, 2013, J INTEGR AGR, V12, P1087, DOI 10.1016/S2095-3119(13)60488-8; Zhou J, 2013, BIORESOURCE TECHNOL, V132, P217, DOI 10.1016/j.biortech.2012.12.179; Zornoza R, 2009, APPL SOIL ECOL, V42, P315, DOI 10.1016/j.apsoil.2009.05.011; ZUCCONI F, 1981, BIOCYCLE, V22, P27	84	43	46	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186051	10.1371/journal.pone.0186051	http://dx.doi.org/10.1371/journal.pone.0186051			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059245	Green Submitted, gold, Green Published			2022-12-26	WOS:000413403000012
J	Green, DR; Green, GM; Colman, AS; Bidlack, FB; Tafforeau, P; Smith, TM				Green, Daniel R.; Green, Gregory M.; Colman, Albert S.; Bidlack, Felicitas B.; Tafforeau, Paul; Smith, Tanya M.			Synchrotron imaging and Markov Chain Monte Carlo reveal tooth mineralization patterns	PLOS ONE			English	Article							ENAMEL MATURATION; ISOTOPE COMPOSITIONS; BIOMINERALIZATION; TEETH; RECONSTRUCTIONS; MICROTOMOGRAPHY; AMELOBLASTS; PROFILES; SILICA; STAGE	The progressive character of tooth formation records aspects of mammalian life history, diet, seasonal behavior and climate. Tooth mineralization occurs in two stages: secretion and maturation, which overlap to some degree. Despite decades of study, the spatial and temporal pattern of elemental incorporation during enamel mineralization remains poorly characterized. Here we use synchrotron X-ray microtomography and Markov Chain Monte Carlo sampling to estimate mineralization patterns from an ontogenetic series of sheep molars (n = 45 M1s, 18 M2s). We adopt a Bayesian approach that posits a general pattern of maturation estimated from individual- and population-level mineral density variation over time. This approach converts static images of mineral density into a dynamic model of mineralization, and demonstrates that enamel secretion and maturation waves advance at nonlinear rates with distinct geometries. While enamel secretion is ordered, maturation geometry varies within a population and appears to be driven by diffusive processes. Our model yields concrete expectations for the integration of physiological and environmental signals, which is of particular significance for paleoseasonality research. This study also provides an avenue for characterizing mineralization patterns in other taxa. Our synchrotron imaging data and model are available for application to multiple disciplines, including health, material science, and paleontological research.	[Green, Daniel R.; Smith, Tanya M.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Green, Daniel R.; Bidlack, Felicitas B.] Forsyth Inst, Cambridge, MA USA; [Green, Gregory M.] Stanford Univ, Dept Phys, Palo Alto, CA 94304 USA; [Green, Gregory M.] Stanford Univ, Kavli Inst Particle Phys & Cosmol, Palo Alto, CA 94304 USA; [Colman, Albert S.] Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA; [Tafforeau, Paul] European Synchrotron Radiat Facil, Grenoble, France; [Smith, Tanya M.] Griffith Univ, Australian Res Ctr Human Evolut, Brisbane, Qld, Australia	Harvard University; Harvard University; Forsyth Institute; Stanford University; Stanford University; University of Chicago; European Synchrotron Radiation Facility (ESRF); Griffith University	Green, DR (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.; Green, DR (corresponding author), Forsyth Inst, Cambridge, MA USA.	drgreen@fas.harvard.edu	Smith, Tanya/T-2683-2017	Smith, Tanya M./0000-0001-8175-8208; Tafforeau, Paul/0000-0002-5962-1683; Green, Gregory/0000-0001-5417-2260; Green, Daniel/0000-0002-9817-541X; Bidlack, Felicitas/0000-0001-8105-223X	National Science Foundation Grants [1247426, 0923831]; Wenner-Gren Foundation; Leakey Foundation; Harvard University; European Synchrotron Radiation Facility award [EC 1018]	National Science Foundation Grants(National Science Foundation (NSF)); Wenner-Gren Foundation; Leakey Foundation; Harvard University; European Synchrotron Radiation Facility award	This work was supported by National Science Foundation Grants 1247426 to DRG and 0923831 to ASC, the Wenner-Gren Foundation, the Leakey Foundation, Harvard University, and the European Synchrotron Radiation Facility award EC 1018 all to DRG.; We are indebted to Michael Thonney and Mary Smith at the Cornell Sheep project for their careful records, and provision of sheep mandible specimens. We are grateful to Daniel Lieberman and David Pilbeam for their helpful comments on this manuscript. This work was supported by National Science Foundation Grants 1247426 and 0923831, the Wenner-Gren Foundation, the Leakey Foundation, Harvard University, and the European Synchrotron Radiation Facility award EC 1018.	Andra SS, 2015, ENVIRON INT, V83, P137, DOI 10.1016/j.envint.2015.05.010; Austin C, 2013, NATURE, V498, P216, DOI 10.1038/nature12169; Aw MS, 2011, NANOMEDICINE-UK, V6, P1159, DOI [10.2217/nnm.11.29, 10.2217/NNM.11.29]; Balasse M, 2012, ARCHAEOMETRY, V54, P349, DOI 10.1111/j.1475-4754.2011.00624.x; Bendrey R, 2015, ARCHAEOMETRY, V57, P1104, DOI 10.1111/arcm.12151; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Blumenthal S, GEOCHIMICA COSMOCHIM; Britton K, 2009, J ARCHAEOL SCI, V36, P1163, DOI 10.1016/j.jas.2009.01.003; Chai H, 2009, P NATL ACAD SCI USA, V106, P7289, DOI 10.1073/pnas.0902466106; Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911; Copeland SR, 2016, QUATERNARY SCI REV, V141, P65, DOI 10.1016/j.quascirev.2016.04.002; Damkier HH, 2014, BONE, V60, P227, DOI 10.1016/j.bone.2013.12.018; De Yoreo JJ, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6760; DeVol RT, 2015, J AM CHEM SOC, V137, P13325, DOI 10.1021/jacs.5b07931; Diekwisch TGH, 1998, CONNECT TISSUE RES, V38, P101, DOI 10.3109/03008209809017026; Driessens F. C. M., 1990, BIOMINERALS, Patent No. 37087491; Eerkens JW, 2016, J ARCHAEOL SCI-REP, V5, P656, DOI 10.1016/j.jasrep.2015.11.003; Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521; Enamel Boyde A., 2009, TEETH, P309; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Fricke HC, 2011, NATURE, P10570; Fukae M, 2007, J DENT RES, V86, P758, DOI 10.1177/154405910708600814; Gat J, 1996, ANN REV EARTH PLANET, V24; Gong YUT, 2012, P NATL ACAD SCI USA, V109, P6088, DOI 10.1073/pnas.1118085109; Green D, 2016, THESIS; Green DW, 2015, TISSUE ENG PART B-RE, V21, P438, DOI [10.1089/ten.teb.2015.0055, 10.1089/ten.TEB.2015.0055]; Guerette PA, 2013, NAT BIOTECHNOL, V31, P908, DOI 10.1038/nbt.2671; Hillson S., 2005, TEETH; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V206, P355, DOI 10.1016/j.palaeo.2004.01.012; Humphrey LT, 2014, ANN HUM BIOL, V41, P348, DOI 10.3109/03014460.2014.923939; Jalevik B, 2010, EUR ARCH PAEDIATR DE, V11, P59; Jordana X, 2011, PALAEOGEOGR PALAEOCL, V300, P59, DOI 10.1016/j.palaeo.2010.12.008; Josephsen K, 2010, AM J PHYSIOL-CELL PH, V299, pC1299, DOI 10.1152/ajpcell.00218.2010; Kallistova A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171424; Kierdorf H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074597; Kirsanow K, 2008, J ARCHAEOL SCI, V35, P3159, DOI 10.1016/j.jas.2008.06.025; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Kucherenko S, 2005, COMPUT OPTIM APPL, V30, P297, DOI 10.1007/s10589-005-4615-1; Lacruz RS, 2017, PHYSIOL REV, V97, P939, DOI 10.1152/physrev.00030.2016; Leeuwenhoeck A., 1677, PHILOS T R SOC LON B, V12, P1002, DOI [10.1098/rstl.1677.0052., DOI 10.1098/RSTL.1677.0052.]; Ludecke T, 2016, PALAEOGEOGR PALAEOCL, V459, P170, DOI 10.1016/j.palaeo.2016.07.010; Nelson SV, 2007, PALAEOGEOGR PALAEOCL, V243, P204, DOI 10.1016/j.palaeo.2006.07.017; Nuzzo S, 2002, MED PHYS, V29, P2672, DOI 10.1118/1.1513161; Passey BH, 2005, GEOCHIM COSMOCHIM AC, V69, P4101, DOI 10.1016/j.gca.2004.12.002; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Powell M. J. D., 1998, Acta Numerica, V7, P287, DOI 10.1017/S0962492900002841; Richards M, 2008, J ARCHAEOL SCI, V35, P1251, DOI 10.1016/j.jas.2007.08.018; Simmer JP, 2012, INT J ORAL SCI, V4, P129, DOI 10.1038/ijos.2012.59; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith TM, 2008, EVOL ANTHROPOL, V17, P213, DOI 10.1002/evan.20176; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Smith TM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601517; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Suga S, 1989, Adv Dent Res, V3, P188; SUGA S, 1982, J DENT RES, V61, P1532; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Trayler RB, 2017, GEOCHIM COSMOCHIM AC, V198, P32, DOI 10.1016/j.gca.2016.10.023; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Wang JG, 2007, J PHYS CHEM C, V111, P16544, DOI 10.1021/jp075667n; Wang QQ, 2013, ADV FUNCT MATER, V23, P2908, DOI 10.1002/adfm.201202894; Weaver JC, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70016-X; Zazzo A, 2005, GEOCHIM COSMOCHIM AC, V69, P3631, DOI 10.1016/j.gca.2005.02.031; Zazzo A, 2010, GEOCHIM COSMOCHIM AC, V74, P3571, DOI 10.1016/j.gca.2010.03.017; Zazzo A, 2012, GEOCHIMICA COSMOCHIM, V84, P113; Zou W, 2011, J DENT RES, V90, P18, DOI 10.1177/0022034510378429; Zou W, 2009, ANALYST, V134, P72, DOI 10.1039/b806884d	67	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186391	10.1371/journal.pone.0186391	http://dx.doi.org/10.1371/journal.pone.0186391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0UN	29049333	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900060
J	Mulligan, JK; Pasquini, WN; Carroll, WW; Williamson, T; Reaves, N; Patel, KJ; Mappus, E; Schlosser, RJ; Atkinson, C				Mulligan, Jennifer K.; Pasquini, Whitney N.; Carroll, William W.; Williamson, Tucker; Reaves, Nicholas; Patel, Kunal J.; Mappus, Elliott; Schlosser, Rodney J.; Atkinson, Carl			Dietary vitamin D3 deficiency exacerbates sinonasal inflammation and alters local 25 (OH) D-3 metabolism	PLOS ONE			English	Article							TARGETED COMPLEMENT INHIBITION; ALLERGIC AIRWAY INFLAMMATION; NUTRITION-EXAMINATION-SURVEY; RESPIRATORY-TRACT INFECTION; 25-HYDROXYVITAMIN D LEVEL; PHASE NASAL BLOCKAGE; CHRONIC RHINOSINUSITIS; ASPERGILLUS-FUMIGATUS; DENDRITIC CELLS; MURINE MODEL	Rationale Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have been shown to be vitamin D3 (VD3) deficient, which is associated with more severe disease and increased polyp size. To gain mechanistic insights into these observational studies, we examined the impact of VD3 deficiency on inflammation and VD3 metabolism in an Aspergillus fumigatus (Af) mouse model of chronic rhinosinusitis (Af-CRS). Methods Balb/c mice were fed control or VD3 deficient diet for 4 weeks. Mice were then sensitized with intraperitoneal Af, and one week later given Af intranasally every three days for four weeks while being maintained on control or VD3 deficient diet. Airway function, sinonasal immune cell infiltrate and sinonasal VD3 metabolism profiles were then examined. Results Mice with VD3 deficiency had increased Penh and sRaw values as compared to controls as well as exacerbated changes in sRaw when coupled with Af-CRS. As compared to controls, VD3 deficient and Af-CRS mice had reduced sinonasal 1 alpha-hydroxylase and the active VD3 metabolite, 1,25(OH) 2D3. Differential analysis of nasal lavage samples showed that VD3 deficiency alone and in combination with Af-CRS profoundly upregulated eosinophil, neutrophil and lymphocyte numbers. VD3 deficiency exacerbated increases in monocyte-derived dendritic cell (DC) associated with Af-CRS. Conversely, T-regulatory cells were decreased in both Af-CRS mice and VD3 deficient mice, though coupling VD3 deficiency with Af-CRS did not exacerbate CD4 or T-regulatory cells numbers. Lastly, VD3 deficiency had a modifying or exacerbating impact on nasal lavage levels of IFN-gamma, IL-6, IL-10 and TNF-alpha, but had no impact on IL-17A. Conclusions VD3 deficiency causes changes in sinonasal immunity, which in many ways mirrors the changes observed in Af-CRS mice, while selectively exacerbating inflammation. Furthermore, both VD3 deficiency and Af-CRS were associated with altered sinonasal VD3 metabolism causing reductions in local levels of the active VD3 metabolite, 1,25(OH) 2D3, even with adequate circulating levels.	[Mulligan, Jennifer K.; Pasquini, Whitney N.; Carroll, William W.; Mappus, Elliott; Schlosser, Rodney J.] Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA; [Mulligan, Jennifer K.; Williamson, Tucker; Reaves, Nicholas] Med Univ South Carolina, Dept Pediat, Charleston, SC 29425 USA; [Patel, Kunal J.; Atkinson, Carl] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Patel, Kunal J.; Atkinson, Carl] Med Univ South Carolina, Dept Surg, Lee Patterson Allen Transplant Immunobiol Lab, Charleston, SC 29425 USA; [Schlosser, Rodney J.] Ralph H Johnson VA Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mulligan, JK (corresponding author), Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA.; Mulligan, JK (corresponding author), Med Univ South Carolina, Dept Pediat, Charleston, SC 29425 USA.	konopa@musc.edu		Mulligan, Jennifer/0000-0001-6880-6092	NIH [R01HL091944]; Flight Attendants Medical Research Institute [092079, 92401]; NIH/NIDCD [T32 DC0014435]; Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award, CSRD [1I01CX000377-01A2]; South Carolina Clinical AMP; Translational Research (SCTR) Institute; Medical University of South Carolina; NIH/NCATS [KL2 TR001452, UL1 TR001450]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001450, KL2TR001452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC014435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award, CSRD; South Carolina Clinical AMP; Translational Research (SCTR) Institute; Medical University of South Carolina; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were funded by grants from the NIH to CA (R01HL091944), the Flight Attendants Medical Research Institute to CA (092079) and JKM (92401). Grant T32 DC0014435 (awarded to J. Dubno) from NIH/NIDCD supported EM and these studies. This material is based upon work in part supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award, CSRD 1I01CX000377-01A2 (RJS). This material is the result of work supported with resources and the use of facilities at the Ralph H. Johnson VA Medical Center, Charleston, SC. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. JKM is supported by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina, NIH/NCATS Grant Numbers KL2 TR001452 & UL1 TR001450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; Adams JS, 2014, J STEROID BIOCHEM, V144, P22, DOI 10.1016/j.jsbmb.2013.12.009; Agrawal T, 2013, CLIN EXP ALLERGY, V43, P672, DOI 10.1111/cea.12102; Agrawal T, 2012, EXP MOL PATHOL, V93, P74, DOI 10.1016/j.yexmp.2012.04.004; Ahn BH, 2009, AURIS NASUS LARYNX, V36, P422, DOI 10.1016/j.anl.2008.08.009; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Assa A., 2014, J INFECT DIS; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; Atkinson C, 2008, J IMMUNOL, V180, P1231, DOI 10.4049/jimmunol.180.2.1231; Barragan M, 2015, NUTRIENTS, V7, P8127, DOI 10.3390/nu7095383; Berraies A, 2014, J ASTHMA ALLERGY, V7, P23, DOI 10.2147/JAA.S46944; Bjerk SM, 2013, INT J CHRONIC OBSTR, V8, P97, DOI 10.2147/COPD.S40885; Brehm JM, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0461-5; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Carroll WW, 2016, INT FORUM ALLERGY RH, V6, P605, DOI 10.1002/alr.21704; Carroll WW, 2016, INT FORUM ALLERGY RH, V6, P162, DOI 10.1002/alr.21636; Castro M, 2014, JAMA-J AM MED ASSOC, V311, P2083, DOI 10.1001/jama.2014.5052; Chary AV, 2015, J STEROID BIOCHEM, V147, P48, DOI 10.1016/j.jsbmb.2014.11.020; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112589; Christensen JM, 2016, INT FORUM ALLERGY RH; Coughlan CA, 2012, AM J RESP CRIT CARE, V186, P999, DOI 10.1164/rccm.201203-0478OC; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; DiFranco KM, 2017, J STEROID BIOCH MOL; Erdag O, 2016, MED SCI MONITOR, V22, P4636, DOI 10.12659/MSM.898410; Flandre TD, 2003, J APPL PHYSIOL, V94, P1129, DOI 10.1152/japplphysiol.00561.2002; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Foong RE, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.276; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gorman S, 2017, PHYSL REPORTS, V5; Gorman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067823; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hamilos DL, 2015, J ALLERGY CLIN IMMUN, V136, P1454, DOI 10.1016/j.jaci.2015.10.011; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Han JL, 2008, J INT MED RES, V36, P830, DOI 10.1177/147323000803600426; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hewison M, 2000, J MOL ENDOCRINOL, V25, P141, DOI 10.1677/jme.0.0250141; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Hollis BW, 2013, J CLIN ENDOCR METAB, V98, P4619, DOI 10.1210/jc.2013-2653; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Jain AV, 2009, INFECT IMMUN, V77, P5389, DOI 10.1128/IAI.00809-09; Jiao J, J ALLERGY CLIN IMMUN, V138; Jolliffe DA, 2013, J STEROID BIOCHEM, V136, P321, DOI 10.1016/j.jsbmb.2012.11.017; Khalid AN, 2008, OTOLARYNG HEAD NECK, V139, P695, DOI 10.1016/j.otohns.2008.07.018; Khalid AN, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001447; Kim JH, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-49; Kim SW, 2007, ANN OTO RHINOL LARYN, V116, P76, DOI 10.1177/000348940711600113; Kokturk N, 2018, CLIN RESPIR J, V12, P382, DOI 10.1111/crj.12588; Korn S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-25; Kreindler JL, 2010, J CLIN INVEST, V120, P3242, DOI 10.1172/JCI42388; Lewis E, 2012, ANN ALLERG ASTHMA IM, V108, P281, DOI 10.1016/j.anai.2012.01.003; Li P, 2015, MEDIAT INFLAMM, V2015; Li P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099805; Lindsay R, 2006, OTOLARYNG HEAD NECK, V134, P724, DOI 10.1016/j.otohns.2005.11.048; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; Mizutani N, 2001, JPN J PHARMACOL, V86, P170, DOI 10.1254/jjp.86.170; Mostafa BE, 2016, INT FORUM ALLERGY RH, V6, P185, DOI 10.1002/alr.21585; Mulligan JK, 2011, CLIN EXP IMMUNOL, V164, P312, DOI 10.1111/j.1365-2249.2011.04325.x; Mulligan J.K., 2014, J ALLERGY CLIN IMMUN; Mulligan JK, 2014, J ALLERGY CLIN IMMUN, V134, P342, DOI 10.1016/j.jaci.2014.01.039; Mulligan JK, 2012, OTOLARYNG HEAD NECK, V147, P773, DOI 10.1177/0194599812448852; Mulligan JK, 2011, INT FORUM ALLERGY RH, V1, P268, DOI 10.1002/alr.20055; MULLINS J, 1978, CLIN ALLERGY, V8, P525, DOI 10.1111/j.1365-2222.1978.tb01506.x; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Nabe T, 1998, INFLAMM RES, V47, P369, DOI 10.1007/s000110050346; Nguyen Nikki Lynn Hue, 2015, Asthma Res Pract, V1; Nguyen NLH, 2013, INFECT IMMUN, V81, P1510, DOI 10.1128/IAI.01345-12; O'Connell BP, 2014, OTOLARYNG HEAD NECK, V150, P312, DOI 10.1177/0194599813516277; Ogita-Nakanishi Hiromi, 2009, Allergology International, V58, P171, DOI 10.2332/allergolint.08-OA-0021; Oyer SL, 2013, LARYNGOSCOPE, V123, pE72, DOI 10.1002/lary.24305; Ozkara S, 2012, EUR ARCH OTO-RHINO-L, V269, P2519, DOI 10.1007/s00405-012-1967-x; Pfeffer Paul E, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS314, DOI 10.1513/AnnalsATS.201405-204AW; Philpott C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006680; Pinto JM, 2008, J ALLERGY CLIN IMMUN, V122, P415, DOI 10.1016/j.jaci.2008.05.038; Promsopa C, 2016, INT FORUM ALLERGY RH, V6, P373, DOI 10.1002/alr.21674; PRYKE AM, 1990, J CELL PHYSIOL, V142, P652, DOI 10.1002/jcp.1041420327; Psaltis AJ, 2013, INT FORUM ALLERGY RH, V3, P621, DOI 10.1002/alr.21173; Roggenbuck M, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0435-3; Sautter NB, 2012, LARYNGOSCOPE, V122, P711, DOI 10.1002/lary.22148; Sautter NB, 2011, INT FORUM ALLERGY RH, V1, P262, DOI 10.1002/alr.20059; Schlosser RJ, 2016, INT FORUM ALLERGY RH, V6, P58, DOI 10.1002/alr.21576; Schlosser RJ, 2014, INT FORUM ALLERGY RH, V4, P196, DOI 10.1002/alr.21274; Science M, 2013, CLIN INFECT DIS, V57, P392, DOI 10.1093/cid/cit289; Selvaraj S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039600; Shahangian A, 2016, ADV OTO-RHINO-LARYNG, V79, P86, DOI 10.1159/000445136; Stokes PJ, 2016, AM J RHINOL ALLERGY, V30, P23, DOI 10.2500/ajra.2016.30.4267; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Tolppanen AM, 2013, EPIDEMIOLOGY, V24, P310, DOI [10.1097/EDE.obo13e318280dd5e, 10.1097/EDE.0b013e318280dd5e]; Tse SM, 2012, J ALLERGY CLIN IMMUN, V130, P53, DOI 10.1016/j.jaci.2012.04.005; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Welsh J, 2012, ARCH BIOCHEM BIOPHYS, V523, P107, DOI 10.1016/j.abb.2011.10.019; Welsh J, 2011, MOL CELL ENDOCRINOL, V347, P55, DOI 10.1016/j.mce.2011.05.020; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yamasaki M, 2001, INFLAMM RES, V50, P466, DOI 10.1007/PL00000272; Yawn J, 2015, J STEROID BIOCHEM, V148, P326, DOI 10.1016/j.jsbmb.2015.01.017; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	99	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186374	10.1371/journal.pone.0186374	http://dx.doi.org/10.1371/journal.pone.0186374			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045457	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100055
J	Gan, L; Meng, J; Xu, M; Liu, M; Qi, Y; Tan, C; Wang, Y; Zhang, P; Weng, W; Sheng, W; Huang, M; Wang, Z				Gan, L.; Meng, J.; Xu, M.; Liu, M.; Qi, Y.; Tan, C.; Wang, Y.; Zhang, P.; Weng, W.; Sheng, W.; Huang, M.; Wang, Z.			Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin beta 4/FAK/SOX2/HIF-1 alpha signaling pathway in gastric cancer	ONCOGENE			English	Article							STEM-CELLS; ECM1; OVEREXPRESSION; ACTIVATION; PHENOTYPE; MECHANISM; MIGRATION	Extracellular matrix protein 1 (ECM1) is related to strong invasiveness and poor prognosis in major malignancies, but the underlying mechanism remains unknown. Here we aimed to elucidate the function of ECM1 on cell metastasis and glucose metabolism in gastric cancer (GC). The level of ECM1 in sera and tissues of patient with GC were positively correlated with tumor invasion and recurrence. Genetic manipulation of ECM1 expression affected cell metastasis and glucose metabolism in GC cell lines. Enhanced ECM1 expression facilitated gene expression levels associated with epithelial-mesenchymal transition (EMT) and glucose metabolism. Interestingly, our results indicated that ECM1 directly interacted with integrin beta 4 (ITGB4) and activated ITGB4/focal adhesion kinase (FAK)/glycogen synthase kinase 3 beta signaling pathway, which further induced the expression of transcription factor SOX2. Aberrant expression of SOX2 altered gene expression of EMT factors and glucose metabolism enzymes. Furthermore, SOX2 enhanced hypoxia-inducible factor alpha (HIF-1 alpha) promoter activity to regulate glucose metabolism. The micro-positron emission tomography/computed tomography imaging of xenograft model showed that ECM1 substantially increased F-18-fluorodeoxyglucose uptake in xenograft tumors. Using in vivo mouse tail vein injection experiments, ECM1 was also found to increase in lung surface metastasis. These findings provide evidence that ECM1 regulates GC cell metastasis and glucose metabolism by inducing ITGB4/FAK/SOX2/HIF-1 alpha signal pathway and have important implications for the development of therapeutic target to prevent tumor metastasis and recurrence.	[Gan, L.; Meng, J.; Liu, M.; Zhang, P.; Wang, Z.] Fudan Univ, Canc Inst, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China; [Gan, L.; Meng, J.; Qi, Y.; Huang, M.] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China; [Gan, L.; Xu, M.; Qi, Y.; Tan, C.; Weng, W.; Sheng, W.; Huang, M.; Wang, Z.] Fudan Univ, Dept Oncol, Shanghai Med Coll, 270 Dongan Rd, Shanghai 200032, Peoples R China; [Gan, L.] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China; [Xu, M.; Tan, C.; Weng, W.; Sheng, W.] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China; [Wang, Y.] Nanchang Univ, Nanchang Med Coll, Nanchang, Jiangxi, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Nanchang University	Wang, Z (corresponding author), Fudan Univ, Canc Inst, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China.; Huang, M; Wang, Z (corresponding author), Fudan Univ, Dept Oncol, Shanghai Med Coll, 270 Dongan Rd, Shanghai 200032, Peoples R China.	mingzhuhuang0718@163.com; huf_zlwang@126.com	xu, midie/AFS-3427-2022; Sheng, Weiqi/GXF-1216-2022	xu, midie/0000-0003-1775-6608; Sheng, Weiqi/0000-0002-8726-277X	National Nature Science Young Foundation of China [81502235, 81302096, 81602078]; Shanghai Natural Science Foundation [17ZR1406500]; Hospital Foundation of Fudan University Shanghai Cancer Center [YJ201504]; project of Shanghai Municipal Health Bureau [20114009]	National Nature Science Young Foundation of China; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Hospital Foundation of Fudan University Shanghai Cancer Center; project of Shanghai Municipal Health Bureau	This work was supported by the National Nature Science Young Foundation of China (81502235, 81302096 and 81602078), Shanghai Natural Science Foundation (17ZR1406500), Hospital Foundation of Fudan University Shanghai Cancer Center (YJ201504) and by the project of Shanghai Municipal Health Bureau (20114009).	Basan M, 2015, NATURE, V528, P99, DOI 10.1038/nature15765; Beger RD, 2013, METABOLITES, V3, P552, DOI 10.3390/metabo3030552; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Bugaj LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7898; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chamoto K, 2013, STEM CELL RES, V10, P267, DOI 10.1016/j.scr.2012.12.006; Chen H, 2011, MED ONCOL, V28, pS318, DOI 10.1007/s12032-010-9763-1; Chen HW, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-016-0524-8; Ci YQ, 2016, MOLECULES, V21, DOI 10.3390/molecules21121634; Desrochers LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11958; Duan J, 2011, INT J BIOCHEM CELL B, V43, P1218, DOI 10.1016/j.biocel.2011.04.015; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Gao F, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0533-9; Gomez-Contreras P, 2016, CLIN EXP METASTASIS; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper KL, 2016, NATURE, V540, P588, DOI 10.1038/nature20609; Huang PH, 2017, ONCOGENE, V36, P2202, DOI 10.1038/onc.2016.378; Ji SR, 2016, CLIN CANCER RES, V22, P3950, DOI 10.1158/1078-0432.CCR-15-2380; Khurana S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13500; Lal G, 2009, ANN SURG ONCOL, V16, P2280, DOI 10.1245/s10434-009-0533-2; Lauwers G, 2010, WHO CLASSIFICATION T, P48; Leask A, 2013, ADV WOUND CARE, V2, P160, DOI 10.1089/wound.2012.0365; Lee KM, 2015, ONCOGENE, V34, P6055, DOI 10.1038/onc.2015.54; Lee K, 2014, IEEE T MULTIMEDIA, V16, P1201, DOI 10.1109/TMM.2014.2311012; Lee KM, 2015, CELL SIGNAL, V27, P228, DOI 10.1016/j.cellsig.2014.11.004; Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629; Massari F, 2016, CANCER TREAT REV, V45, P46, DOI 10.1016/j.ctrv.2016.03.005; MATHIEU E, 1994, J BONE MINER RES, V9, P903; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Nie W, 2015, LAB INVEST, V95, P56, DOI 10.1038/labinvest.2014.124; Qi P, 2015, INT J CANCER, V137, P1269, DOI 10.1002/ijc.29516; ROSZKOWSKI M, 1981, APPL RES MENT RETARD, V2, P359, DOI 10.1016/0270-3092(81)90030-8; Semenza G L, 2001, Novartis Found Symp, V240, P251; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Wang LP, 2003, CANCER LETT, V200, P57, DOI 10.1016/S0304-3835(03)00350-1; Wang ZL, 2015, ONCOTARGET, V6, P6670, DOI 10.18632/oncotarget.3118; Wang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079117; Xiong GP, 2012, NEOPLASMA, V59, P409, DOI 10.4149/neo_2012_053; Xu MD, 2017, CLIN CANCER RES, V23, P2071, DOI 10.1158/1078-0432.CCR-16-0742; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Ye HQ, 2016, BIOMED PHARMACOTHER, V80, P109, DOI 10.1016/j.biopha.2016.02.019; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zhang W, 2016, ONCOTARGET, V7, P5800, DOI 10.18632/oncotarget.6807; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	47	75	77	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 8	2018	37	6					744	755		10.1038/onc.2017.363	http://dx.doi.org/10.1038/onc.2017.363			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FV5ND	29059156				2022-12-26	WOS:000424628100006
J	Lachowski, D; Cortes, E; Robinson, B; Rice, A; Rombouts, K; Hernandez, AED				Lachowski, Dariusz; Cortes, Ernesto; Robinson, Benjamin; Rice, Alistair; Rombouts, Krista; Hernandez, Armando E. Del Rio			FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis	FASEB JOURNAL			English	Article						mechanotransduction; focal adhesions; directed migration	FOCAL ADHESION KINASE; MATRIX STIFFNESS; PATHWAY; YAP/TAZ; CELLS; MECHANOTRANSDUCERS; HOMEOSTASIS; CARCINOMA; RIGIDITY; SIZE	Focal adhesion kinase (FAK) is a key molecule in focal adhesions and regulates fundamental processes in cells such as growth, survival, and migration. FAK is one of the first molecules recruited to focal adhesions in response to external mechanical stimuli and therefore is a pivotal mediator of cell mechanosignaling, and relays these stimuli to other mechanotransducers within the cytoplasm. Yes-associated protein (YAP) has been identified recently as one of these core mechanotransducers. YAP translocates to the nucleus following changes in cell mechanics to promote the expression of genes implicated in motility, apoptosis, proliferation, and organ growth. Here, we show that FAK controls the nuclear translocation and activation of YAP in response to mechanical activation and submit that the YAP-dependent process of durotaxis requires a cell with an asymmetric distribution of active and inactive FAK molecules.	[Lachowski, Dariusz; Cortes, Ernesto; Robinson, Benjamin; Rice, Alistair; Hernandez, Armando E. Del Rio] Imperial Coll London, Dept Bioengn, Cellular & Mol Biomech Lab, London SW7 2AZ, England; [Rombouts, Krista] UCL, Inst Liver & Digest Hlth, Royal Free Hosp, Regenerat Med & Fibrosis Grp, London NW3 2PF, England	Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Hernandez, AED (corresponding author), Imperial Coll London, Dept Bioengn, Cellular & Mol Biomech Lab, London SW7 2AZ, England.; Rombouts, K (corresponding author), UCL, Inst Liver & Digest Hlth, Royal Free Hosp, Regenerat Med & Fibrosis Grp, London NW3 2PF, England.	k.rombouts@ucl.ac.uk; a.del-rio-hernandez@imperial.ac.uk	Cortes Lopez, Ernesto/ABE-5343-2021; Rombouts, Krista/ABB-2602-2020; del rio hernandez, armando e/N-4262-2013; del Río Hernández, Armando E/D-3555-2012; Rombouts, Krista/AAE-8179-2020	Cortes Lopez, Ernesto/0000-0001-6106-1323; del rio hernandez, armando e/0000-0001-5062-8910; del Río Hernández, Armando E/0000-0001-5062-8910; Rombouts, Krista/0000-0001-9440-0571; Lachowski, Dariusz/0000-0003-1194-8019	European Research Council [282051]	European Research Council(European Research Council (ERC)European Commission)	The authors thank the Cellular and Molecular Biomechanics Laboratory members for help and advice throughout this work. This work was supported by the European Research Council (Grant Agreement 282051). The authors declare no conflicts of interest.	Attwood SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34334; Carloni V, 2014, LIVER INT, V34, P834, DOI 10.1111/liv.12465; Chakraborty S, 2017, CELL REP, V18, P2464, DOI 10.1016/j.celrep.2017.02.041; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Handorf AM, 2015, ORGANOGENESIS, V11, P1, DOI 10.1080/15476278.2015.1019687; Harris AR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/34/345102; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Keshet R, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.995006; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Lachowski D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02689-x; Ladoux B, 2016, TRENDS CELL BIOL, V26, P420, DOI 10.1016/j.tcb.2016.02.002; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li YW, 2016, CELL CYCLE, V15, P2497, DOI 10.1080/15384101.2016.1207836; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Mann DA, 2010, J HEPATOL, V52, P949, DOI 10.1016/j.jhep.2010.02.005; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mueller S, 2010, HEPATIC MED-EVID RES, V2, P49; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Rice AJ, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.54; Rinschen MM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf8165; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Sun M, 2016, BIOPHYS J, V110, P2540, DOI 10.1016/j.bpj.2016.04.040; Thomasy SM, 2013, EXP EYE RES, V113, P66, DOI 10.1016/j.exer.2013.05.014; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Yujiri T, 2003, J BIOL CHEM, V278, P3846, DOI 10.1074/jbc.M206087200; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	41	78	78	2	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1099	1107		10.1096/fj.201700721R	http://dx.doi.org/10.1096/fj.201700721R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29070586	Bronze			2022-12-26	WOS:000425146900047
J	Martin-Sanchez, P; Luengo, A; Griera, M; Orea, MJ; Lopez-Olaneta, M; Chiloeches, A; Lara-Pezzi, E; de Frutos, S; Rodriguez-Puyol, M; Calleros, L; Rodriguez-Puyol, D				Martin-Sanchez, Paloma; Luengo, Alicia; Griera, Mercedes; Jesus Orea, Maria; Lopez-Olaneta, Marina; Chiloeches, Antonio; Lara-Pezzi, Enrique; de Frutos, Sergio; Rodriguez-Puyol, Manuel; Calleros, Laura; Rodriguez-Puyol, Diego			H-ras deletion protects against angiotensin II-induced arterial hypertension and cardiac remodeling through protein kinase G-I beta pathway activation	FASEB JOURNAL			English	Article						PKG; CREB; H-ras(-/-); cardiac hypertrophy	TARGETED GENOMIC DISRUPTION; K-RAS; N-RAS; BINDING-PROTEINS; TGF-BETA; MOUSE; HYPERTROPHY; GROWTH; INACTIVATION; EXPRESSION	Ras proteins regulate cell survival, growth, differentiation, blood pressure, and fibrosis in some organs. We have demonstrated that H-ras gene deletion producesmice hypotension via a soluble guanylate cyclase-protein kinase G (PKG)-dependent mechanism. In this study, we analyzed the consequences of H-ras deletion on cardiac remodeling induced by continuous angiotensin II (AngII) infusion and the molecular mechanisms implied. Left ventricular posterior wall thickness and mass and cardiomyocyte cross-sectional area were similar between AngII-treated H-Ras knockout (H-ras(-/-)) and control wild-type (H-ras(+/+)) mice, as were extracellular matrix protein expression. Increased cardiac PKG-I beta protein expression in H-ras(-/-) mice suggests the involvement of this protein in heart protection. Ex vivo experiments on cardiac explants could support this mechanism, as PKG blockade blunted protection against AngII-induced cardiac hypertrophy and fibrosis markers in H-ras(-/-) mice. Genetic modulation studies in cardiomyocytes and cardiac and embryonic fibroblasts revealed that the lack of H-Ras down-regulates the B-RAF/MEK/ERK pathway, which induces the glycogen synthase kinase-3b-dependent activation of the transcription factor, cAMP response element-binding protein, which is responsible for PKG-I beta overexpression in H-ras(-/-) mouse embryonic fibroblasts. This study demonstrates that H-ras deletion protects against AngII-induced cardiac remodeling, possibly via a mechanism in which PKG-I beta overexpression could play a partial role, and points to H-Ras and/ordownstream proteins as potential therapeutic targets in cardiovascular disease.	[Martin-Sanchez, Paloma; Luengo, Alicia; Griera, Mercedes; Jesus Orea, Maria; Chiloeches, Antonio; de Frutos, Sergio; Rodriguez-Puyol, Manuel; Calleros, Laura] Univ Alcala, Dept Syst Biol, Madrid, Spain; [Rodriguez-Puyol, Diego] Univ Alcala, Dept Med, Madrid, Spain; [Martin-Sanchez, Paloma; Luengo, Alicia; Griera, Mercedes; de Frutos, Sergio; Rodriguez-Puyol, Manuel; Calleros, Laura; Rodriguez-Puyol, Diego] IRSIN, Madrid, Spain; [Martin-Sanchez, Paloma; Luengo, Alicia; Griera, Mercedes; de Frutos, Sergio; Rodriguez-Puyol, Manuel; Calleros, Laura; Rodriguez-Puyol, Diego] Inst Salud Carlos III, Red Invest Renal REDinREN, Madrid, Spain; [Lopez-Olaneta, Marina; Lara-Pezzi, Enrique] Ctr Nacl Invest Cardiovasc, Myocardial Pathophysiol Area, Madrid, Spain; [Rodriguez-Puyol, Diego] Hosp Univ Principe Asturias, Res Unit Fdn, Nephrol Sect, Madrid, Spain	Universidad de Alcala; Universidad de Alcala; Instituto de Salud Carlos III; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Prince of Asturias University Hospital	Calleros, L (corresponding author), Univ Alcala, Fac Med, Dept Syst Biol, Physiol Unit, Carretera Madrid Barcelona Km 33-600, Madrid 28871, Spain.	laura.calleros@uah.es	de Frutos, Sergio/AAE-7761-2021; Puyol, Diego Rodriguez/AAG-9752-2020; Chiloeches, Antonio/Z-5993-2019; Lara-Pezzi, Enrique/E-2350-2015; Puyol, Manuel Rodriguez/AAG-7049-2020; Calleros, Laura/L-3122-2015	de Frutos, Sergio/0000-0002-1225-5911; Puyol, Diego Rodriguez/0000-0002-9125-9311; Lara-Pezzi, Enrique/0000-0002-2743-1033; Puyol, Manuel Rodriguez/0000-0002-5230-6664; Calleros, Laura/0000-0001-7739-1319; Antonio, Chiloeches Galvez/0000-0001-7162-330X	Instituto de Salud Carlos III (ISCIII); European Fund for Economic and Regional Development (FEDER) [PI11/01630, PI14/01939, PI14/02075]; FEDER; ISCIII RETIC REDinREN [RD12/0021/0006, RD16/0009/0018]; University of Alcala [CCG2015/BIO-034, CCG2016/BIO-043]; Fundacion Senefro (Senefro); Instituto de Investigaciones Sanitarias Reina Sofia; Fundacion Renal Inigo Alvarez de Toledo	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European Fund for Economic and Regional Development (FEDER); FEDER(European Commission); ISCIII RETIC REDinREN; University of Alcala; Fundacion Senefro (Senefro); Instituto de Investigaciones Sanitarias Reina Sofia; Fundacion Renal Inigo Alvarez de Toledo	The authors thank Santiago Ropero (Universidad de Alcala) for intellectual contribution. This work was supported by the Instituto de Salud Carlos III (ISCIII) and the European Fund for Economic and Regional Development (FEDER) (Grants PI11/01630, PI14/01939, and PI14/02075), FEDER and ISCIII RETIC REDinREN (Grants RD12/0021/0006 and RD16/0009/0018), the University of Alcala (Grants CCG2015/BIO-034 and CCG2016/BIO-043), the Fundacion Senefro (Senefro-2016; to L.C.), the Instituto de Investigaciones Sanitarias Reina Sofia, and Fundacion Renal Inigo Alvarez de Toledo. The authors declare no conflicts of interest.	Alcock RA, 2002, ONCOGENE, V21, P7883, DOI 10.1038/sj.onc.1205948; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Calleros L, 2009, CARCINOGENESIS, V30, P1670, DOI 10.1093/carcin/bgp188; Chamorro-Jorganes A, 2011, AM J PHYSIOL-CELL PH, V300, pC683, DOI 10.1152/ajpcell.00251.2010; Chamorro-Jorganes A, 2010, HYPERTENSION, V56, P484, DOI 10.1161/HYPERTENSIONAHA.110.152587; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Ehrhardt A, 2004, MOL CELL BIOL, V24, P6311, DOI 10.1128/MCB.24.14.6311-6323.2004; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Felkin LE, 2011, CIRCULATION, V123, P2838, DOI 10.1161/CIRCULATIONAHA.110.012211; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Goto D, 1999, Angiogenesis, V3, P137, DOI 10.1023/A:1009050131966; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kataoka C, 2002, HYPERTENSION, V39, P245, DOI 10.1161/hy0202.103271; KIM NN, 1995, AM J PHYSIOL-ENDOC M, V269, pE426, DOI 10.1152/ajpendo.1995.269.3.E426; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; Martin P, 2014, AM J PHYSIOL-RENAL, V307, pF75, DOI 10.1152/ajprenal.00398.2013; Martinez-Salgado C, 2006, EXP CELL RES, V312, P2093, DOI 10.1016/j.yexcr.2006.03.008; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; MIYATA S, 1994, AM J PHYSIOL, V266, pH2443, DOI 10.1152/ajpheart.1994.266.6.H2443; Muthalif MM, 2000, HYPERTENSION, V36, P604, DOI 10.1161/01.HYP.36.4.604; Ohtsu H, 2006, HYPERTENSION, V48, P534, DOI 10.1161/01.HYP.0000237975.90870.eb; Panse KD, 2012, J CARDIOVASC TRANSL, V5, P814, DOI 10.1007/s12265-012-9400-9; Park BJ, 2000, CANCER RES, V60, P3031; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Rodriguez-Pena AB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/124902; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; SATOH S, 1993, FEBS LETT, V324, P211, DOI 10.1016/0014-5793(93)81395-G; Schieffer B, 1996, J BIOL CHEM, V271, P10329, DOI 10.1074/jbc.271.17.10329; Schuhmacher AJ, 2008, J CLIN INVEST, V118, P2169, DOI [10.1172/JCI3438S, 10.1172/JCI34385]; Straubinger J, 2015, J PHARMACOL EXP THER, V354, P406, DOI 10.1124/jpet.115.226092; Sugiura T, 2008, CIRC RES, V103, P53, DOI 10.1161/CIRCRESAHA.108.176321; Susic D, 1996, HYPERTENSION, V28, P265, DOI 10.1161/01.HYP.28.2.265; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Grande MT, 2010, KIDNEY INT, V77, P509, DOI 10.1038/ki.2009.498; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b	52	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					920	934		10.1096/fj.201700134RRRR	http://dx.doi.org/10.1096/fj.201700134RRRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29054855	Bronze			2022-12-26	WOS:000425146900033
J	Park, Y; Han, GS; Carman, GM				Park, Yeonhee; Han, Gil-Soo; Carman, George M.			A conserved tryptophan within the WRDPLVDID domain of yeast Pah1 phosphatidate phosphatase is required for its in vivo function in lipid metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diacylglycerol; glycerophospholipid; phosphatase; phosphatidic acid; triacylglycerol; yeast	SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; MEMBRANE BIOGENESIS; MEDIATED REGULATION; ORTHOLOGUE PAH1P; PROTEIN; PHOSPHORYLATION; GENE; PHO85P-PHO80P; ENZYME	PAH1-encoded phosphatidate phosphatase, which catalyzes the dephosphorylation of phosphatidate to produce diacylglycerol at the endoplasmic reticulum membrane, plays a major role in controlling the utilization of phosphatidate for the synthesis of triacylglycerol or membrane phospholipids. The conserved N-LIP and haloacid dehalogenase-like domains of Pah1 are required for phosphatidate phosphatase activity and the in vivo function of the enzyme. Its non-conserved regions, which are located between the conserved domains and at the C terminus, contain sites for phosphorylation by multiple protein kinases. Truncation analyses of the non-conserved regions showed that they are not essential for the catalytic activity of Pah1 and its physiological functions (e.g. triacylglycerol synthesis). This analysis also revealed that the C-terminal region contains a previously unrecognized WRDPLVDID domain (residues 637-645) that is conserved in yeast, mice, and humans. The deletion of this domain had no effect on the catalytic activity of Pah1 but caused the loss of its in vivo function. Site-specific mutational analyses of the conserved residues within WRDPLVDID indicated that Trp-637 plays a crucial role in Pah1 function. This work also demonstrated that the catalytic activity of Pah1 is required but is not sufficient for its in vivo functions.	Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu			National Institutes of Health from the United States Public Health Service [GM028140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140 from the United States Public Health Service. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fernandez-Murray JP, 2016, J LIPID RES, V57, P1789, DOI 10.1194/jlr.R070920; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lussier M, 1997, GENETICS, V147, P435; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rose MD., 1990, METHODS YEAST GENETI; Ruiz C, 1999, YEAST, V15, P1001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sherr GL, 2017, BIOCHEM BIOPH RES CO, V491, P693, DOI 10.1016/j.bbrc.2017.07.127; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Siniossoglou S, 2009, TRAFFIC, V10, P1181, DOI 10.1111/j.1600-0854.2009.00923.x; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798	67	10	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19580	19589		10.1074/jbc.M117.819375	http://dx.doi.org/10.1074/jbc.M117.819375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29066621	hybrid, Green Published			2022-12-26	WOS:000416911300004
J	Dewolf, AH; Ivanenko, YP; Lacquaniti, F; Willems, PA				Dewolf, Arthur H.; Ivanenko, Yuri P.; Lacquaniti, Francesco; Willems, Patrick A.			Pendular energy transduction within the step during human walking on slopes at different speeds	PLOS ONE			English	Article							CENTER-OF-MASS; MECHANICAL WORK; DIFFERENT GRADIENTS; INVERTED PENDULUM; GAIT MECHANICS; BODY CENTER; COST; LOCOMOTION; TRANSITION; MODEL	When ascending (descending) a slope, positive (negative) work must be performed to overcome changes in gravitational potential energy at the center of body mass (COM). This modifies the pendulum-like behavior of walking. The aim of this study is to analyze how energy exchange and mechanical work done vary within a step across slopes and speeds. Ten subjects walked on an instrumented treadmill at different slopes (from - 9 degrees to 9 degrees), and speeds (between 0.56 and 2.22 m s(-1)). From the ground reaction forces, we evaluated energy of the COM, recovery (i.e. the potential-kinetic energy transduction) and pendular energy savings (i.e. the theoretical reduction in work due to this recovered energy) throughout the step. When walking uphill as compared to level, pendular energy savings increase during the first part of stance (when the COM is lifted) and decreases during the second part. Conversely in downhill walking, pendular energy savings decrease during the first part of stance and increase during the second part (when the COM is lowered). In uphill and downhill walking, the main phase of external work occurs around double support. Uphill, the positive work phase is extended during the beginning of single support to raise the body. Downhill, the negative work phase starts before double support, slowing the downward velocity of the body. Changes of the pendulum-like behavior as a function of slope can be illustrated by tilting the 'classical compass model' backwards (uphill) or forwards (downhill).	[Dewolf, Arthur H.; Willems, Patrick A.] Catholic Univ Louvain, Inst NeuroSci, Lab Biomech & Physiol Locomot, Louvain La Neuve, Belgium; [Ivanenko, Yuri P.; Lacquaniti, Francesco] Santa Lucia Fdn, IRCCS, Lab Neuromotor Physiol, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space BioMed, Rome, Italy	Universite Catholique Louvain; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Willems, PA (corresponding author), Catholic Univ Louvain, Inst NeuroSci, Lab Biomech & Physiol Locomot, Louvain La Neuve, Belgium.	patrick.willems@uclouvain.be	Ivanenko, Yury/L-1599-2018	Ivanenko, Yury/0000-0001-9363-9548; Willlems, patrick/0000-0002-5283-4950; Dewolf, Arthur/0000-0003-1498-3987	Universite catholique de Louvain (Belgium); Fonds de la Recherche Scientifique (Belgium); Italian Space Agency [1/006/06/0, 2013-084-R.0]; Italian Ministry of University and Research (PRIN) [2015HFWRYY_002]; Horizon 2020 Robotics Program [ICT-23-2014, 644727]; Italian Ministry of Health (IRCCS Ricerca corrente)	Universite catholique de Louvain (Belgium); Fonds de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Horizon 2020 Robotics Program; Italian Ministry of Health (IRCCS Ricerca corrente)(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC))	This study was funded by the Universite catholique de Louvain (Belgium), the Fonds de la Recherche Scientifique (Belgium), the Italian Ministry of Health (IRCCS Ricerca corrente), Italian Space Agency (grant n. 1/006/06/0) (COREA grant 2013-084-R.0), Italian Ministry of University and Research (PRIN grant 2015HFWRYY_002) and Horizon 2020 Robotics Program (ICT-23-2014 under Grant Agreement 644727-CoglMon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk PG, 2009, J EXP BIOL, V212, P2668, DOI 10.1242/jeb.027581; ALEXANDER RM, 1980, J ZOOL, V192, P97, DOI 10.1111/j.1469-7998.1980.tb04222.x; ALEXANDER RM, 1995, BEHAV BRAIN SCI, V18, P745, DOI 10.1017/S0140525X00040711; Ardigo LP, 2003, EUR J APPL PHYSIOL, V90, P365, DOI 10.1007/s00421-003-0882-7; Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Bastien GJ, 2003, J EXP BIOL, V206, P2967, DOI 10.1242/jeb.00494; Bertram JEA, 2013, J EXP BIOL, V216, P933, DOI 10.1242/jeb.078543; Biewener AA, 2006, J EXP ZOOL PART A, V305A, P899, DOI 10.1002/jez.a.334; Birn-Jeffery AV, 2014, INTEGR COMP BIOL, V54, P1159, DOI 10.1093/icb/icu015; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVAGNA GA, 1966, J APPL PHYSIOL, V21, P271, DOI 10.1152/jappl.1966.21.1.271; Cavagna GA, 2002, J EXP BIOL, V205, P3413; CAVAGNA GA, 1983, J PHYSIOL-LONDON, V343, P323, DOI 10.1113/jphysiol.1983.sp014895; Detrembleur C, 2003, GAIT POSTURE, V18, P47, DOI 10.1016/S0966-6362(02)00193-5; Detrembleur C, 2000, GAIT POSTURE, V12, P243, DOI 10.1016/S0966-6362(00)00081-3; Dewolf AH, 2016, J EXP BIOL, V219, P2276, DOI 10.1242/jeb.142976; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Fenn WO, 1930, AM J PHYSIOL, V93, P433, DOI 10.1152/ajplegacy.1930.93.2.433; Franz JR, 2012, J BIOMECH, V45, P257, DOI 10.1016/j.jbiomech.2011.10.034; Fu XY, 2015, MED SCI SPORT EXER, V47, P1435, DOI 10.1249/MSS.0000000000000554; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; Gomenuka NA, 2014, SCANDINAVIAN J MED S, V24; Gomenuka NA, 2016, HUM MOVEMENT SCI, V47, P175, DOI 10.1016/j.humov.2016.03.008; Gosseye TP, 2010, EUR J APPL PHYSIOL, V110, P709, DOI 10.1007/s00421-010-1549-9; Gottschall JS, 2006, J EXP BIOL, V209, P4895, DOI 10.1242/jeb.02584; Gottschall JS, 2003, J APPL PHYSIOL, V94, P1766, DOI 10.1152/japplphysiol.00670.2002; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; HEGLUND NC, 1995, NATURE, V375, P52, DOI 10.1038/375052a0; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; Ivanenko YP, 2004, J EXP BIOL, V207, P3797, DOI 10.1242/jeb.01214; Jeffers JR, 2015, J BIOMECH, V48, P2919, DOI 10.1016/j.jbiomech.2015.04.023; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Lay AN, 2007, J BIOMECH, V40, P1276, DOI 10.1016/j.jbiomech.2006.05.023; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Lee DV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1779; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Margaria R, 1968, Int Z Angew Physiol, V25, P339; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; McIntosh AS, 2006, J BIOMECH, V39, P2491, DOI 10.1016/j.jbiomech.2005.07.025; Meurisse GM, 2016, GAIT POSTURE, V43, P245, DOI 10.1016/j.gaitpost.2015.10.005; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; MINETTI AE, 1995, MED SCI SPORT EXER, V27, P1194; MINETTI AE, 1993, J PHYSIOL-LONDON, V472, P725, DOI 10.1113/jphysiol.1993.sp019969; Minetti AE, 2001, PFLUG ARCH EUR J PHY, V442, P542, DOI 10.1007/s004240100570; MOCHON S, 1980, J BIOMECH, V13, P49, DOI 10.1016/0021-9290(80)90007-X; Neptune RR, 2004, J BIOMECH, V37, P817, DOI 10.1016/j.jbiomech.2003.11.001; Oh K, 2014, J MECH SCI TECHNOL, V28, P1393, DOI 10.1007/s12206-014-0126-2; Redfern MS, 1997, GAIT POSTURE, V6, P119; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Schepens B, 2004, J EXP BIOL, V207, P587, DOI 10.1242/jeb.00793; Silverman AK, 2012, J BIOMECH, V45, P965, DOI 10.1016/j.jbiomech.2012.01.012; Usherwood JR, 2008, J EXP BIOL, V211, P3744, DOI 10.1242/jeb.023416; Willems PA, 1995, J EXPT BIOL, V198; Yeom J, 2011, J BIOMECH, V44, P59, DOI 10.1016/j.jbiomech.2010.08.024; Zelik KE, 2016, J EXP BIOL, V219, P3676, DOI 10.1242/jeb.140376; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297	58	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186963	10.1371/journal.pone.0186963	http://dx.doi.org/10.1371/journal.pone.0186963			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073208	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400081
J	Eroshenko, GA; Nosov, NY; Krasnov, YM; Oglodin, YG; Kukleva, LM; Guseva, NP; Kuznetsov, AA; Abdikarimov, ST; Dzhaparova, AK; Kutyrev, VV				Eroshenko, Galina A.; Nosov, Nikita Yu; Krasnov, Yaroslav M.; Oglodin, Yevgeny G.; Kukleva, Lyubov M.; Guseva, Natalia P.; Kuznetsov, Alexander A.; Abdikarimov, Sabyrzhan T.; Dzhaparova, Aigul K.; Kutyrev, Vladimir V.			Yersinia pestis strains of ancient phylogenetic branch 0. ANT are widely spread in the high-mountain plague foci of Kyrgyzstan	PLOS ONE			English	Article								Fifty six Yersinia pestis strains, isolated over the period of more than 50 years in three high-mountain foci of Kyrgyzstan (Tien Shan, Alai, and Talas), have been characterized by means of PCR and single nucleotide polymorphism (SNP) typing methods. Seven of these strains were also characterized by means of whole genome sequencing and genome-wide SNP phylogenetic analysis. It was found that forty two strains belong to 0.ANT2, 0.ANT3 and 0.ANT5 phylogenetic branches. From these, strains of 0.ANT2 and 0.ANT3 branches were earlier detected in China only, whereas 0.ANT5 phylogenetic branch was identified for Y. pestis phylogeny for the first time. According to the results of genome-wide SNP analysis, 0.ANT5 strains are ones of the most closely related to Y. pestis strain responsible for the Justinianic Plague. We have also found out that four of the studied strains belong to the phylogenetic branch 2.MED1, and ten strains from Talas high-mountain focus belong to the phylogenetic branch 0.PE4 (sub-branch 0.PE4t). Established diversity of Y. pestis strains and extensive dissemination of the strains pertaining to the 0.ANT branch confirm the antiquity of the mentioned above plague foci and suggest that strains of the 0.ANT branch, which serve as precursors for all highly virulent Y. pestis strains, had their origin in the Tien Shan mountains.	[Eroshenko, Galina A.; Nosov, Nikita Yu; Krasnov, Yaroslav M.; Oglodin, Yevgeny G.; Kukleva, Lyubov M.; Guseva, Natalia P.; Kuznetsov, Alexander A.; Kutyrev, Vladimir V.] Fed Serv Surveillance Sphere Consumers Rights Pro, Russian Res Antiplague Inst Microbe, Saratov, Russia; [Abdikarimov, Sabyrzhan T.; Dzhaparova, Aigul K.] Minist Hlth Kyrgyz Republ, Dept Dis Prevent, Ctr Quarantine & Particularly Dangerous Infect, Bishkek, Kyrgyzstan	Ministry of Health - Kyrgyzstan	Eroshenko, GA (corresponding author), Fed Serv Surveillance Sphere Consumers Rights Pro, Russian Res Antiplague Inst Microbe, Saratov, Russia.	geroshenko@yandex.ru	Nosov, Nikita/ABH-2045-2021; Eroshenko, Galina/AAL-1818-2020	Krasnov, Aroslav/0000-0002-4909-2394; Eroshenko, Galina/0000-0001-5403-989X				Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Bos KI, 2016, ELIFE, V5, DOI 10.7554/eLife.12994; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Devignat R, 1951, B WORLD HEALTH ORGAN, V4, P241; Eroshenko G. A., 2012, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P25; Eroshenko GA, 2012, ADV EXP MED BIOL, V954, P45, DOI 10.1007/978-1-4614-3561-7_6; Feldman M, 2016, MOL BIOL EVOL, V33, P2911, DOI 10.1093/molbev/msw170; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Motin VL, 2002, J BACTERIOL, V184, P1019, DOI 10.1128/jb.184.4.1019-1027.2002; Nikiforov K. A., 2015, INVENTIONS USEFUL MO, V29; Odinokov GN, 2013, PROBLEMY OSOBO OPASN, V3, P49; Onishchenko GG, 2004, NATURAL PLAGUE FOCI; Onishchenko GG., 2013, PRACTICE GUIDELINES; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Spyrou MA, 2016, CELL HOST MICROBE, V19, P874, DOI 10.1016/j.chom.2016.05.012; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2	16	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187230	10.1371/journal.pone.0187230	http://dx.doi.org/10.1371/journal.pone.0187230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073248	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400134
J	Meyer-Rath, G; van Rensburg, C; Larson, B; Jamieson, L; Rosen, S				Meyer-Rath, Gesine; van Rensburg, Craig; Larson, Bruce; Jamieson, Lise; Rosen, Sydney			Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case	PLOS ONE			English	Article							HEALTH; LIFE; CARE	Background The use of cost-effectiveness thresholds based on a country's income per capita has been criticized for not being relevant to decision making, in particular in middle-income countries such as South Africa. The recent South African HIV Investment Case produced an alternative cost-effectiveness threshold for HIV prevention and treatment interventions based on estimates of life years saved and the country's committed HIV budget. Methods We analysed the optimal mix of HIV interventions over a baseline of the current HIV programme under the committed HIV budget for 2016-2018. We calculated the incremental cost-effectiveness ratio (ICER) as cost per life-year saved (LYS) of 16 HIV prevention and treatment interventions over 20 years (2016-2035). We iteratively evaluated the most cost effective option (defined by an intervention and its coverage) over a rolling baseline to which the more cost effective options had already been added, thereby allowing for diminishing marginal returns to interventions. We constrained the list of interventions to those whose combined cost was affordable under the current HIV budget. Costs are presented from the government perspective, unadjusted for inflation and undiscounted, in 2016 USD. Results The current HIV budget of about $ 1.6 billion per year was sufficient to pay for the expansion of condom availability, medical male circumcision, universal treatment, and infant testing at 6 weeks to maximum coverage levels, while also implementing a social and behavior change mass media campaign with a message geared at increasing testing uptake and reducing the number of sexual partners. The combined ICER of this package of services was $547/LYS. The ICER of the next intervention that was above the affordability threshold was $872/LYS. Conclusions The results of the South African HIV Investment Case point to an HIV cost-effectiveness threshold based on affordability under the current budget of $547-872 per life year saved, a small fraction of the country's GDP per capita of about $6,000.	[Meyer-Rath, Gesine; Larson, Bruce; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Meyer-Rath, Gesine; van Rensburg, Craig; Jamieson, Lise; Rosen, Sydney] Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci,Hlth Econ & Epidemiol Res Off HE2RO, Johannesburg, South Africa	Boston University; University of Witwatersrand	Meyer-Rath, G (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.; Meyer-Rath, G (corresponding author), Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci,Hlth Econ & Epidemiol Res Off HE2RO, Johannesburg, South Africa.	gesine@bu.edu		Rosen, Sydney/0000-0002-6560-2964; Larson, Bruce/0000-0002-9322-2387	United States Agency for International Development (USAID) [AID 674-A-12-00029]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under award number AID 674-A-12-00029. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the US Government. The authors acknowledge the contribution of the HIV Investment Case Steering Committee, Task Team and working groups under the leadership of the National Department of Health and the South African AIDS Council.	Barton GR, 2013, TROP MED INT HEALTH, V18, P769, DOI 10.1111/tmi.12093; Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418; Bertram MY, 2017, 2017 INT HLTH EC ASS; Chiu C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4023-3; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH D; Department of Health, 2016, S AFR S AFR NAT AIDS; Edoka I, 2017, 2017 INT HLTH EC ASS; Freeman A.M., 2014, MEASUREMENT ENV RESO; Hausler HP, 2006, B WORLD HEALTH ORGAN, V84, P528, DOI 10.2471/BLT.04.018606; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Meyer-Rath G, PER PATIENT COSTS HI; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Ochalek J, 2016, 136 CHE U YORK; Revill P, 2015, COST EFECTIVENESS TH; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Smith JA, 2015, LANCET HIV, V2, pE159, DOI 10.1016/S2352-3018(15)00016-8; STATS SA, 2017, GROSS DOM PROD 4 QUA; Vella V, 2011, AIDS CARE, V23, P1146, DOI 10.1080/09540121.2011.554517; VISCUSI WK, 1993, J ECON LIT, V31, P1912; Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017	22	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186496	10.1371/journal.pone.0186496	http://dx.doi.org/10.1371/journal.pone.0186496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073167	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400027
J	Yue, MJ; Liu, HJ; He, MF; Wu, FY; Li, XX; Pang, YX; Yang, XD; Zhou, G; Mae, J; Liu, MT; Gong, P; Li, JH; Zhang, XM				Yue, Mengjia; Liu, Hongjian; He, Minfu; Wu, Fangyuan; Li, Xuanxuan; Pang, Yingxin; Yang, Xiaodi; Zhou, Ge; Mae, Juan; Liu, Meitian; Gong, Ping; Li, Jinghua; Zhang, Xiumin			Gender-specific association of metabolic syndrome and its components with arterial stiffness in the general Chinese population	PLOS ONE			English	Article							ANKLE VASCULAR INDEX; CARDIOVASCULAR RISK-FACTORS; LIPOPROTEIN PARTICLE-SIZE; LOW-DENSITY-LIPOPROTEIN; PULSE-WAVE VELOCITY; ESTERIFICATION RATE; ATHEROGENIC INDEX; LIPID PARAMETERS; CORONARY EVENTS; HDL-CHOLESTEROL	Objectives Metabolic syndrome (MS) is considered to be a cluster of interrelated risk factors for metabolism, which may increase arterial stiffness and cardiovascular morbidity. The cardio-ankle vascular index (CAVI) is a reliable indicator of arterial stiffness and early arteriosclerosis. The main objective of this study is to evaluate the gender-specific relationship between MS and CAVI in the general Chinese population. Methods A total of 1,301 subjects aged 20 to 60 years participated in this study. CAVI was measured noninvasively using a Vasera VS-1000 device. Blood samples and waist circumference were examined to identify metabolic syndrome according to the criteria set forth in the 2009 Joint Scientific Statement. Results The prevalence of MS in the study subjects was 17.4% (30.7% in males and 7.0% in females, P < 0.001). CAVI values were significantly higher in MS subjects than in non-MS subjects and increased linearly as the number of MS components increased in females, but not in males. Using multiple regression analysis, we found that BMI was correlated with CAVI in the overall population and in both genders, and that high-density lipoprotein cholesterol (HDL-C) was associated with CAVI in males, while the number of MS components was related to CAVI in females. CAVI values increased linearly with age in both genders (P-trend < 0.001 for both), and this correlation was stronger in males than in females. Conclusions There are gender-specific differences in the association of MS and CAVI. First, the effects of the number of MS components on CAVI are stronger in females than in males. Second, the effect of each MS component on arterial stiffness may differ in relation to gender. In addition, aging affects arterial stiffness more severely in males, and the increase in arterial stiffness tends to occur at a younger age in males than in females. Larger samples and longitudinal studies are needed to further confirm our results in the future.	[Yue, Mengjia; Liu, Hongjian; Pang, Yingxin; Yang, Xiaodi; Zhou, Ge; Liu, Meitian; Gong, Ping] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China; [He, Minfu; Wu, Fangyuan; Li, Xuanxuan; Mae, Juan; Li, Jinghua; Zhang, Xiumin] Jilin Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Zhang, XM (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changchun, Jilin, Peoples R China.	xiu_min@jlu.edu.cn	Zhang, Xiumin/J-8135-2018; Gong, Ping/J-8072-2018	Zhang, Xiumin/0000-0003-3286-8667; Gong, Ping/0000-0002-3783-2957	Jilin Provincial Science and Technology Grant, China [201105074]	Jilin Provincial Science and Technology Grant, China	This study was supported by Jilin Provincial Science and Technology Grant, China (No. 201105074, http://kjt.jl.gov.cn/). XMZ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0265-5; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Cardiometabolic Risk Working Group: Executive Committee, 2011, Can J Cardiol, V27, pe1, DOI 10.1016/j.cjca.2010.12.054; Chen LY, 2015, ATHEROSCLEROSIS, V240, P345, DOI 10.1016/j.atherosclerosis.2015.03.031; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; El Harchaoui K, 2009, ANN INTERN MED, V150, P84, DOI 10.7326/0003-4819-150-2-200901200-00006; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; Frohlich J, 2003, CLIN CHEM, V49, P1873, DOI 10.1373/clinchem.2003.022558; Frost PH, 1998, AM J CARDIOL, V81, p26B, DOI 10.1016/S0002-9149(98)00034-4; Ghiadoni L, 2008, HYPERTENSION, V51, P440, DOI 10.1161/HYPERTENSIONAHA.107.103093; Gomez-Sanchez L, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0465-7; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gutierrez-Fisac JL, 2004, OBES RES, V12, P710, DOI 10.1038/oby.2004.83; Hallberg V, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-25; He Y N, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P212, DOI 10.3760/cma.j.issn.0254-6450.2017.02.015; HELIOVAARA M, 1978, BRIT MED J, V1, P268, DOI 10.1136/bmj.1.6108.268; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kim HL, 2015, J CARDIOL, V65, P243, DOI 10.1016/j.jjcc.2014.05.009; Lee MH, 2013, DISABIL REHABIL-ASSI, V8, P140, DOI 10.3109/17483107.2012.737142; Li R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2870-y; Liu HJ, 2011, METAB SYNDR RELAT D, V9, P105, DOI 10.1089/met.2010.0019; Sabio JM, 2009, J RHEUMATOL, V36, P2204, DOI 10.3899/jrheum.081253; Miura S, 2003, MATURITAS, V45, P293, DOI 10.1016/S0378-5122(03)00158-0; Mizuguchi Y, 2007, J CARD FAIL, V13, P744, DOI 10.1016/j.cardfail.2007.05.010; NAGAYAMA D, 2017, VASC HEALTH RISK MAN, V13, P1, DOI [DOI 10.2147/VHRM.S119646, 10.2147/VHRM.S119646]; Nam SH, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/328585; Oguejiofor OC, 2012, ANN AFR MED, V11, P197, DOI 10.4103/1596-3519.102846; Olamoyegun MA, 2016, ANN AFR MED, V15, P194, DOI 10.4103/1596-3519.194280; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Rader DJ, 2003, AM J CARDIOL, V91, p20C, DOI 10.1016/S0002-9149(03)00005-5; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Sasaki JIH, 2008, DIABETES RES CLIN PR, V80, P265, DOI 10.1016/j.diabres.2007.12.016; Satoh H, 2009, HYPERTENS RES, V32, P1067, DOI 10.1038/hr.2009.158; Satoh N, 2008, HYPERTENS RES, V31, P1921, DOI 10.1291/hypres.31.1921; Scuteri A, 2014, ATHEROSCLEROSIS, V233, P654, DOI 10.1016/j.atherosclerosis.2014.01.041; Scuteri A, 2010, EUR HEART J, V31, P602, DOI 10.1093/eurheartj/ehp491; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; Wang HY, 2013, J AM SOC HYPERTENS, V7, P426, DOI 10.1016/j.jash.2013.06.003; Yokoyama H, 2007, DIABETES RES CLIN PR, V75, P200, DOI 10.1016/j.diabres.2006.06.015; Zhao WW, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-37	47	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186863	10.1371/journal.pone.0186863	http://dx.doi.org/10.1371/journal.pone.0186863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073198	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400064
J	Cheung, SY; Suzuki, K; Saito, H; Umezawa, Y; Xia, XM; Liu, HB				Cheung, Shunyan; Suzuki, Koji; Saito, Hiroaki; Umezawa, Yu; Xia, Xiaomin; Liu, Hongbin			Highly heterogeneous diazotroph communities in the Kuroshio Current and the Tokara Strait, Japan	PLOS ONE			English	Article							SOUTH CHINA SEA; VAHINE MESOCOSM EXPERIMENT; NITROGEN-FIXATION; N-2 FIXATION; CROCOSPHAERA-WATSONII; UPSTREAM KUROSHIO; GENE-EXPRESSION; UCYN-A; NORTH; DISTRIBUTIONS	In this study, we used 454-pyrosequencing to report the highly diverse diazotroph communities in the Kuroshio and its adjacent waters along a transect across the Tokara Strait, Japan. Terrestrial input from the islands resulted in a highly heterogeneous diazotroph community within a relatively small geographic region, which was presumably caused by the remarkably different responses of UCYN-A2, UCYN-C and Trichodesmium to the steep environmental gradient. On the other hand, most major cyanobacterial OTUs found in this study were also detected in an unpublished dataset from the upstream Kuroshio, which suggests transportation of diazotrophs by the Kuroshio in large geographic scale. A significant amount of UCYN-C was found in the Kuroshio and offshore stations, suggesting the importance of this potentially overlooked group in the western North Pacific Ocean (WNPO). Moreover, a novel sublineage of UCYN-B was defined, which was predominant in an oligo-trophic water sample; and it was also found to be widely distributed in oceanic waters. In addition, the apparent increase in relative abundance of UCYN-A2 from offshore to near-shore water provides evidence for the earlier and under-debating view that UCYN-A2 prefers coastal conditions. Our report provides new knowledge for understanding the phylogeny and ecology of unicellular cyanobacterial diazotrophs in WNPO.	[Cheung, Shunyan; Xia, Xiaomin; Liu, Hongbin] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Suzuki, Koji] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Saito, Hiroaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Tokyo, Japan; [Umezawa, Yu] Nagasaki Univ, Fac Fisheries, Nagasaki, Japan	Hong Kong University of Science & Technology; Hokkaido University; University of Tokyo; Nagasaki University	Liu, HB (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	liuhb@ust.hk	SAITO, HIROAKI/J-6948-2017; Cheung, Shun Yan/AAD-6083-2022; UMEZAWA, Yu/Q-2380-2017; Suzuki, Koji/AAD-2630-2022; Liu, Hongbin/AAV-8862-2020; Suzuki, Koji/GVS-9807-2022; Suzuki, Koji/A-4349-2013	SAITO, HIROAKI/0000-0002-5502-9076; Cheung, Shun Yan/0000-0001-7244-7221; Suzuki, Koji/0000-0001-5354-1044; Suzuki, Koji/0000-0001-5354-1044	Hong Kong Research Grants Council (RGC) General Research Fund (GRF) [661911, 661912, 661813]; National Key Scientific Research Project - Ministry of Science and Technology of the PRC [2015CB954003]	Hong Kong Research Grants Council (RGC) General Research Fund (GRF)(Hong Kong Research Grants Council); National Key Scientific Research Project - Ministry of Science and Technology of the PRC	This study was supported by the Hong Kong Research Grants Council (RGC) General Research Fund (GRF) awards: 661911, 661912, 661813, and a National Key Scientific Research Project (2015CB954003) sponsored by the Ministry of Science and Technology of the PRC.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Bench SR, 2016, ENVIRON MICROBIOL, V18, P514, DOI 10.1111/1462-2920.13180; Bench SR, 2013, J PHYCOL, V49, P786, DOI 10.1111/jpy.12090; Bird C, 2013, FEMS MICROBIOL ECOL, V84, P189, DOI 10.1111/1574-6941.12049; Bombar D, 2014, ISME J, V8, P2530, DOI 10.1038/ismej.2014.167; Cabello AM, 2015, J ISME; CAPONE DG, 1982, SCIENCE, V217, P1140, DOI 10.1126/science.217.4565.1140; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Chase Z, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000987; Chen YLL, 2008, LIMNOL OCEANOGR, V53, P1705, DOI 10.4319/lo.2008.53.5.1705; Chen YLL, 2014, DEEP-SEA RES PT I, V85, P56, DOI 10.1016/j.dsr.2013.11.006; Church MJ, 2008, LIMNOL OCEANOGR, V53, P63, DOI 10.4319/lo.2008.53.1.0063; Emiliani C, 1972, EARTH-SCI REV, V8, P250; Farnelid H, 2016, AQUAT MICROB ECOL, V77, P125, DOI 10.3354/ame01794; Farnelid H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019223; Hagino K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081749; HOERING TC, 1960, J AM CHEM SOC, V82, P376, DOI 10.1021/ja01487a031; Hu JY, 2016, REV GEOPHYS, V54, P653, DOI 10.1002/2015RG000505; Hunt BPV, 2016, BIOGEOSCIENCES, V13, P3131, DOI 10.5194/bg-13-3131-2016; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Kong LL, 2011, AQUAT MICROB ECOL, V65, P15, DOI 10.3354/ame01531; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Martinez-Perez C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.163, 10.1038/nmicrobiol.2016.163]; MARUMO R, 1974, Journal of the Oceanographical Society of Japan, V30, P298, DOI 10.1007/BF02109673; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; MINAGAWA M, 1986, MAR CHEM, V19, P245, DOI 10.1016/0304-4203(86)90026-5; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Moisander PH, 2014, ISME J, V8, P1962, DOI 10.1038/ismej.2014.49; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Qiu B., 2001, ENCY OCEAN SCI, P1413, DOI DOI 10.1006/RWOS.2001.0350; REDFIELD AC, 1958, AM SCI, V46, P205; Robidart JC, 2014, ISME J, V8, P1175, DOI 10.1038/ismej.2013.244; Sachs JP, 2007, ENCYCOPEDIA PALEOCLI; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shiozaki T, 2015, BIOGEOSCIENCES, V12, P6931, DOI 10.5194/bg-12-6931-2015; Shiozaki T, 2014, CONT SHELF RES, V80, P20, DOI 10.1016/j.csr.2014.02.015; Shiozaki T, 2014, GEOPHYS RES LETT, V41, P2907, DOI 10.1002/2014GL059835; Shiozaki T, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003620; Sigman DM, 1999, PALEOCEANOGRAPHY, V14, P118, DOI 10.1029/1998PA900018; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Subramaniam A, 2013, GEOPHYS RES LETT, V40, P1766, DOI 10.1002/grl.50250; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taniuchi Y, 2012, ENVIRON MICROBIOL, V14, P641, DOI 10.1111/j.1462-2920.2011.02606.x; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thompson A, 2014, ENVIRON MICROBIOL, V16, P3238, DOI 10.1111/1462-2920.12490; Thompson AW, 2013, J PHYCOL, V49, P1024, DOI 10.1111/jpy.12117; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Turk KA, 2011, ISME J, V5, P1201, DOI 10.1038/ismej.2010.205; Turk-Kubo KA, 2015, BIOGEOSCIENCES, V12, P7435, DOI 10.5194/bg-12-7435-2015; Turk-Kubo KA, 2016, J PHYCOL; Wang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00592-13; Webb EA, 2009, ENVIRON MICROBIOL, V11, P338, DOI 10.1111/j.1462-2920.2008.01771.x; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Zani S, 2000, APPL ENVIRON MICROB, V66, P3119, DOI 10.1128/AEM.66.7.3119-3124.2000; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169; Zehr JP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.214; Zehr JP, 2001, METHOD MICROBIOL, V30, P271, DOI 10.1016/S0580-9517(01)30049-1; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	64	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2017	12	10							e0186875	10.1371/journal.pone.0186875	http://dx.doi.org/10.1371/journal.pone.0186875			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK3RE	29059241	Green Submitted, Green Published, gold			2022-12-26	WOS:000413403000049
J	Horst, K; Andruszkow, H; Weber, CD; Pishnamaz, M; Herren, C; Zhi, Q; Knobe, M; Lefering, R; Hildebrand, F; Pape, HC				Horst, Klemens; Andruszkow, Hagen; Weber, Christian D.; Pishnamaz, Miguel; Herren, Christian; Zhi, Qiao; Knobe, Matthias; Lefering, Rolf; Hildebrand, Frank; Pape, Hans-Christoph			Thoracic trauma now and then: A 10 year experience from 16,773 severely injured patients	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CHEST COMPUTED-TOMOGRAPHY; MULTIPLE-ORGAN FAILURE; LUNG INJURY; X-RAY; MANAGEMENT; OUTCOMES; MORTALITY; VENTILATION; INTUBATION	Background and purpose Thoracic trauma remains to be a relevant injury to the polytraumatised patient. However, literature regarding how far changes in clinical guidelines for pre- and in-hospital trauma management and diagnostic procedures affect the outcome of multiple injured patients with severe chest injury during a long-term observation period is sparse. Methods Multiple traumatised patients (age >= 16y) documented in the TraumaRegister DGU((R)) (TR-DGU) from January 1st 2005 to December 31st 2014 with severe chest trauma (AIS >= 3) were included in this study. Demographic data, the pattern of injury, injury severity, radiographic emergency procedures, indication for intubation, duration of mechanical ventilation, emergency surgery, occurrence of complications and mortality were evaluated per year and over time. Results A total of 16,773 patients were analysed. The use of whole body computer tomography increased (p<0.001), while the incidence of plain x-rays decreased (p<0.001). Furthermore, incidence of AIS(Thorax) = 3 graded injuries increased (p<0.001) while AIS(Thorax) = 4 decreased (p<0.001). Both, rate of patients being intubated at the time of ICU admission decreased (p<0.001) and the time of mechanical ventilation decreased (p<0.001). Additionally, need for emergency surgery, lung failure, sepsis, and multi organ failure all decreased (p<0.001). However, mortality remained unchanged. Interpretation Severity of severe chest trauma and associated complications decreased while diagnostics and treatment improved over time. However, mortality remained unchanged. Our results are in line with those expected in the context of the incidence of CT diagnostics, which has increased parallel to the clinical outcome Thus, our data demonstrate a positive trend in the treatment of patients with severe chest trauma.	[Horst, Klemens; Andruszkow, Hagen; Weber, Christian D.; Pishnamaz, Miguel; Herren, Christian; Knobe, Matthias; Hildebrand, Frank] Rhein Westfal TH Aachen, Dept Orthopaed Trauma, Aachen, Germany; [Horst, Klemens; Zhi, Qiao] Rhein Westfal TH Aachen, Harald Tscherne Res Lab, Aachen, Germany; [Lefering, Rolf] Witten Herdecke Univ, Dept Med, Fac Hlth, IFOM Inst Res Operat Med, Cologne, Germany; [Pape, Hans-Christoph] Univ Hosp Zurich, Dept Trauma Surg, Zurich, Switzerland	RWTH Aachen University; RWTH Aachen University; University of Zurich; University Zurich Hospital	Horst, K (corresponding author), Rhein Westfal TH Aachen, Dept Orthopaed Trauma, Aachen, Germany.; Horst, K (corresponding author), Rhein Westfal TH Aachen, Harald Tscherne Res Lab, Aachen, Germany.	khorst@ukaachen.de	Knobe, Matthias/Y-3537-2019	Knobe, Matthias/0000-0002-9166-0965; Pape, Hans-Christoph/0000-0002-2059-4980				Aldrian S, 2007, INJURY, V38, P1059, DOI 10.1016/j.injury.2007.04.022; Bakowitz M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-54; Bohmer AB, 2016, LANGENBECKS ARCH SUR; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 2009, CHEST, V136, pe28; BURGESS AR, 1995, J TRAUMA, V38, P509, DOI 10.1097/00005373-199504000-00008; Cai WL, 2012, COMPUT MED IMAG GRAP, V36, P375, DOI 10.1016/j.compmedimag.2012.03.005; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Ciesla DJ, 2006, SURGERY, V140, P640, DOI 10.1016/j.surg.2006.06.015; Corbacioglu SK, 2015, INJURY, V46, P849, DOI 10.1016/j.injury.2014.12.022; Cummins Justin S, 2011, Am J Orthop (Belle Mead NJ), V40, pE26; Silva CSD, 2012, CLINICS, V67, P995, DOI 10.6061/clinics/2012(09)02; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; El-Menyar A, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.31888; Exadaktylos AK, 2001, J TRAUMA, V51, P1173, DOI 10.1097/00005373-200112000-00025; Fu CY, 2012, WORLD J SURG, V36, P819, DOI 10.1007/s00268-012-1457-8; Goligher E, 2009, CURR OPIN CRIT CARE, V15, P44, DOI 10.1097/MCC.0b013e3283220df2; Harris T, 2012, POSTGRAD MED J, V88, P588, DOI 10.1136/postgradmedj-2010-74245; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Hildebrand F, 2013, SHOCK, V40, P247, DOI 10.1097/SHK.0b013e3182a3cd74; Huber S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0052-4; Huber-Wagner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068880; Hussmann B, 2011, CRIT CARE, V15, DOI 10.1186/cc10442; Inaba K, 2011, J TRAUMA, V70, P1366, DOI 10.1097/TA.0b013e3181ebb4d4; Jiang LB, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0054-2; Jores APW, 2016, ROFO-FORTSCHR RONTG, V188, P163, DOI 10.1055/s-0041-107199; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Kallet RH, 2005, CRIT CARE MED, V33, P925, DOI 10.1097/01.CCM.0000162382.59289.9C; Karcz Marcin K, 2015, World J Crit Care Med, V4, P47, DOI 10.5492/wjccm.v4.i1.47; Khalil M, 2015, J TRAUMA ACUTE CARE, V79, P60, DOI 10.1097/TA.0000000000000687; Kilgo PD, 2004, J TRAUMA, V57, P479, DOI 10.1097/01.TA.0000141024.96440.7C; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Kuner EH, 1996, INJURY, V27, P185, DOI 10.1016/0020-1383(95)00211-1; Langdorf MI, 2015, ANN EMERG MED, V66, P589, DOI 10.1016/j.annemergmed.2015.06.003; LEFERING R, 2014, CRIT CARE, V0018; Lefering R, 2015, TRAUMAREGISTER DGU A; Martin M, 2005, J TRAUMA, V59, P1107, DOI 10.1097/01.ta.0000188633.94766.d0; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Michelet P, 2010, J TRAUMA, V68, P395, DOI 10.1097/TA.0b013e3181a601cb; Mokra D, 2015, RESP PHYSIOL NEUROBI, V209, P52, DOI 10.1016/j.resp.2014.10.006; Mommsen P, 2011, CYTOKINE, V53, P60, DOI 10.1016/j.cyto.2010.09.005; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Ragaller Maximillian, 2010, J Emerg Trauma Shock, V3, P43, DOI 10.4103/0974-2700.58663; Richter M, 2005, INJURY, V36, P484, DOI 10.1016/j.injury.2004.10.001; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147; Schoeneberg C, 2016, UNFALLCHIRURG, V119, P314, DOI 10.1007/s00113-015-0116-6; Schouten LRA, 2015, ANESTHESIOLOGY, V123, P389, DOI 10.1097/ALN.0000000000000687; Simon BJ, 2005, J TRAUMA, V59, P1256, DOI 10.1097/01.ta.0000178063.77946.f5; Sise MJ, 2009, J TRAUMA, V66, P32, DOI 10.1097/TA.0b013e318191bb0c; Smith JE, 2010, ANN ROY COLL SURG, V92, P486, DOI 10.1308/003588410X12699663903511; Traub M, 2007, INJURY, V38, P43, DOI 10.1016/j.injury.2006.07.006; TraumaRegister DGU, 2014, INJURY, V45, pS6, DOI 10.1016/j.injury.2014.08.011; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; van Olden GDJ, 2004, AM J EMERG MED, V22, P522, DOI 10.1016/j.ajem.2004.08.013; Veysi VT, 2009, INT ORTHOP, V33, P1425, DOI 10.1007/s00264-009-0746-9; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Waydhas C, 2000, UNFALLCHIRURG, V103, P871, DOI 10.1007/s001130050635; Wolfschmidt F, 2014, ANASTH INTENSIVMED, V49, P43; Wolfschmidt F, 2014, ANASTH INTENSIV NOTF, V49, P536, DOI 10.1055/s-0034-1390057; Wutzler S, 2009, J AM COLL SURGEONS, V209, P75, DOI 10.1016/j.jamcollsurg.2009.03.015; ZIEGLER DW, 1994, J TRAUMA, V37, P975, DOI 10.1097/00005373-199412000-00018	67	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186712	10.1371/journal.pone.0186712	http://dx.doi.org/10.1371/journal.pone.0186712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049422	Green Published, gold, Green Accepted			2022-12-26	WOS:000413195900101
J	Isaksson, S; Jonsson, P; Monsef, N; Brunnstrom, H; Bendahl, PO; Jonsson, M; Staaf, J; Planck, M				Isaksson, Sofi; Jonsson, Per; Monsef, Nastaran; Brunnstrom, Hans; Bendahl, Par-Ola; Jonsson, Mats; Staaf, Johan; Planck, Maria			CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma	PLOS ONE			English	Article							TUMOR-MARKERS CEA; OVARIAN-CANCER; CLINICAL-VALUE; SERUM MARKERS; CA125; NSCLC; METASTASIS; BIOMARKERS; CYFRA21-1; DIAGNOSIS	Objectives Among patients who underwent primary surgery for non-small cell lung cancer (NSCLC), recurrent disease is frequent and cannot be accurately predicted solely from TNM stage and histopathological features. The aim of this study was to examine the association of tumor markers in pre-operative serum with recurrent disease. Material and methods Blood samples were collected prior to lung cancer surgery from 107 patients with stage I-III lung adenocarcinoma surgically treated at Lund University hospital, Lund, Sweden, between 2005 and 2011. The serum tumor markers Carcinoembryonic antigen (CEA), Neuron-specific enolase (NSE), Cancer antigen 125 (CA 125), Human epididymis protein 4 (HE4) and Carbohydrate antigen (CA 19-9) were analyzed retrospectively and clinical follow-up data were collected from patient charts. Forty (37%) patients were diagnosed with recurrent disease. Results Sixty-eight (64%) patients had at least one elevated tumor marker prior to surgery. In analysis of disease-free survival (DFS), CA 125 and/or CA 19-9 were significantly associated with recurrent disease adjusted to stage and adjuvant treatment (hazard ratio 2.8, 95% confidence interval 1.4-5.7, p = 0.006). Conclusion High pre-operative serum CA 19-9 and/or CA 125 might indicate an increased incidence of recurrent disease in resectable lung adenocarcinomas.	[Isaksson, Sofi; Brunnstrom, Hans; Bendahl, Par-Ola; Jonsson, Mats; Staaf, Johan; Planck, Maria] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden; [Jonsson, Per] Lund Univ, Skane Univ Hosp, Dept Thorac Surg, Lund, Sweden; [Monsef, Nastaran] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Lund University; Lund University; Skane University Hospital; Linkoping University	Isaksson, S (corresponding author), Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden.	sofi.isaksson@med.lu.se	Brunnström, Hans/AAZ-6803-2020	Brunnström, Hans/0000-0001-7402-138X	Swedish Cancer Society; Mrs Berta Kamprad Foundation; Gustav V:s Jubilee Foundation; governmental funding (ALF)	Swedish Cancer Society(Swedish Cancer Society); Mrs Berta Kamprad Foundation; Gustav V:s Jubilee Foundation; governmental funding (ALF)	This work was supported by Swedish Cancer Society (Maria Planck), Mrs Berta Kamprad Foundation (Maria Planck), Gustav V:s Jubilee Foundation, and governmental funding (ALF) (Maria Planck).	[Anonymous], 2015, LANDSTINGENS OCH REG; Brunnstrom H, 2013, AM J CLIN PATHOL, V140, P37, DOI 10.1309/AJCP50RDXSCSBTBO; Cedres S, 2011, CLIN LUNG CANCER, V12, P172, DOI 10.1016/j.cllc.2011.03.019; Crosbie PAJ, 2013, TRANSL LUNG CANCER R, V2, P382, DOI 10.3978/j.issn.2218-6751.2013.09.02; Doubeni CA, 2016, AM FAM PHYSICIAN, V93, P937; Figueredo A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-26; Galgano MT, 2006, MODERN PATHOL, V19, P847, DOI 10.1038/modpathol.3800612; Gaspar MJ, 2003, ANTICANCER RES, V23, P3427; Ghosh I, 2013, INDIAN J CLIN BIOCHE, V28, P24, DOI 10.1007/s12291-012-0257-0; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Harmsma M, 2013, BBA-REV CANCER, V1836, P255, DOI 10.1016/j.bbcan.2013.06.002; Inomata M, 2015, MOL CLIN ONCOL, V3, P802, DOI 10.3892/mco.2015.568; Iwahori K, 2012, TUMOR BIOL, V33, P1141, DOI 10.1007/s13277-012-0356-9; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Lamy PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128836; Lindquist KE, 2017, ONCOTARGET, V8, P34796, DOI 10.18632/oncotarget.16276; Ma SH, 2011, CANCER BIOMARK, V10, P155, DOI 10.3233/CBM-2012-0246; Molina R, 2010, CANCER BIOMARK, V6, P163, DOI 10.3233/CBM-2009-0127; Pollan M, 2003, INT J CANCER, V107, P781, DOI 10.1002/ijc.11472; Reinmuth N, 2002, LUNG CANCER, V36, P265, DOI 10.1016/S0169-5002(02)00009-0; Sobin L, 2009, TNM CLASSIFICATION M; Soletormos G, 2016, INT J GYNECOL CANCER, V26, P43, DOI 10.1097/IGC.0000000000000586; Suh KJ, CLIN LUNG CANC; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Travis W, 2004, WHO CLASSIFICATION T; Yu DF, 2013, INT J MOL SCI, V14, P11145, DOI 10.3390/ijms140611145; Zeng Q, 2016, CLIN CHIM ACTA, V455, P102, DOI 10.1016/j.cca.2016.02.002	27	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e186284	10.1371/journal.pone.0186284	http://dx.doi.org/10.1371/journal.pone.0186284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049328	gold, Green Submitted, Green Published			2022-12-26	WOS:000413195900054
J	Perland, E; Hellsten, SV; Schweizer, N; Arapi, V; Rezayee, F; Bushra, M; Fredriksson, R				Perland, Emelie; Hellsten, Sofie Victoria; Schweizer, Nadine; Arapi, Vasiliki; Rezayee, Fatemah; Bushra, Mona; Fredriksson, Robert			Structural prediction of two novel human atypical SLC transporters, MFSD4A and MFSD9, and their neuroanatomical distribution in mice	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; COMBINED TRANSMEMBRANE TOPOLOGY; SIGNAL PEPTIDE PREDICTION; SOLUTE CARRIERS; SWISS-MODEL; PROTEIN; CLASSIFICATION; REVEALS; SYSTEM; IDENTIFICATION	Out of the 430 known solute carriers (SLC) in humans, 30% are still orphan transporters regarding structure, distribution or function. Approximately one third of all SLCs belong to the evolutionary conserved and functionally diverse Major Facilitator Superfamily (MFS). Here, we studied the orphan proteins, MFSD4A and MFSD9, which are atypical SLCs of MFS type. Hidden Markov Models were used to identify orthologues in several vertebrates, and human MFSD4A and MFSD9 share high sequence identity with their identified orthologues. MFSD4A and MFSD9 also shared more than 20% sequence identity with other phylogenetically related SLC and MFSD proteins, allowing new family clustering. Homology models displayed 12 transmembrane segments for both proteins, which were predicted to fold into a transporter-shaped structure. Furthermore, we analysed the location of MFSD4A and MFSD9 in adult mouse brain using immunohistochemistry, showing abundant neuronal protein staining. As MFSD4A and MFSD9 are plausible transporters expressed in food regulatory brain areas, we monitored transcriptional changes in several mouse brain areas after 24 hours food-deprivation and eight weeks of high-fat diet, showing that both genes were affected by altered food intake in vivo. In conclusion, we propose MFSD4A and MFSD9 to be novel transporters, belonging to disparate SLC families. Both proteins were located to neurons in mouse brain, and their mRNA expression levels were affected by the diet.	[Perland, Emelie; Hellsten, Sofie Victoria; Schweizer, Nadine; Arapi, Vasiliki; Fredriksson, Robert] Uppsala Univ, Dept Pharmaceut Biosci, Mol Neuropharmacol, Uppsala, Sweden; [Perland, Emelie; Rezayee, Fatemah; Bushra, Mona] Uppsala Univ, Dept Neurosci, Funct Pharmacol, Uppsala, Sweden	Uppsala University; Uppsala University	Perland, E (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Mol Neuropharmacol, Uppsala, Sweden.; Perland, E (corresponding author), Uppsala Univ, Dept Neurosci, Funct Pharmacol, Uppsala, Sweden.	Emelie.Perland@farmbio.uu.se		Perland, Emelie/0000-0001-6672-2442; Fredriksson, Robert/0000-0002-2810-3226; Schweizer, Nadine/0000-0002-8701-2690	Swedish Research Council; Swedish Brain Foundation; Novo Nordisk Foundation; Gunvor and Josef Aners Foundation; Magnus Bergvalls Foundation; Tore Nilssons Foundation; Ahlens Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Gunvor and Josef Aners Foundation; Magnus Bergvalls Foundation; Tore Nilssons Foundation; Ahlens Foundation	This work was supported by the Swedish Research Council, Swedish Brain Foundation, Novo Nordisk Foundation, Gunvor and Josef Aners Foundation, Magnus Bergvalls Foundation, Tore Nilssons Foundation and Ahlens Foundation. We have received funding from the Novo Nordisk Foundation, but this does not alter our adherence to PLOS ONE policies on sharing data and materials.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Angers M, 2008, BIOCHEM J, V416, P347, DOI 10.1042/BJ20080165; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dahlin A, 2009, J PHARMACOL EXP THER, V329, P558, DOI 10.1124/jpet.108.149831; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ferrario CR, 2016, J NEUROSCI, V36, P11469, DOI 10.1523/JNEUROSCI.2338-16.2016; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gray KA, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0062-6; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hellsten SV, 2017, FEBS OPEN BIO; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Horiba N, 2003, FEBS LETT, V546, P276, DOI 10.1016/S0014-5793(03)00600-8; Horiba N, 2003, J BIOL CHEM, V278, P14669, DOI 10.1074/jbc.M212240200; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kanda M, 2016, ONCOTARGET, V7, P13667, DOI 10.18632/oncotarget.7269; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lee J, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00021; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lekholm E, 2017, FRONTIERS IN MOLECUL, V10; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Matsuo N, 1997, CLONING CDNA ENCODIN; Mikulaskova B, 2016, MOL CELL ENDOCRINOL, V436, P78, DOI [10.1016/j.mce.2016.07.021, 10.10165/j.mce.2016.07.021]; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Perland E, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170142; Perland E, 2017, TRENDS PHARMACOL SCI, V38, P305, DOI 10.1016/j.tips.2016.11.008; Perland E, 2017, J MOL NEUROSCI, V61, P199, DOI 10.1007/s12031-016-0867-8; Perland E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156912; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Rask-Andersen M, 2013, MOL ASPECTS MED, V34, P702, DOI 10.1016/j.mam.2012.07.015; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Routh VH, 2010, SENSORS-BASEL, V10, P9002, DOI 10.3390/s101009002; Schlessinger A, 2010, PROTEIN SCI, V19, P412, DOI 10.1002/pro.320; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Siintola E, 2007, AM J HUM GENET, V81, P136, DOI 10.1086/518902; Sreedharan S, 2011, GENE, V478, P11, DOI 10.1016/j.gene.2010.10.011; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Ushijima H, 2008, BIOCHEM BIOPH RES CO, V374, P325, DOI 10.1016/j.bbrc.2008.07.034; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verberne AJM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00038; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Zhao RB, 2013, MOL ASPECTS MED, V34, P373, DOI 10.1016/j.mam.2012.07.006	65	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186325	10.1371/journal.pone.0186325	http://dx.doi.org/10.1371/journal.pone.0186325			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0UN	29049335	Green Submitted, Green Published, gold			2022-12-26	WOS:000413195900057
J	Sibhatu, KT; Qaim, M				Sibhatu, Kibrom T.; Qaim, Matin			Rural food security, subsistence agriculture, and seasonality	PLOS ONE			English	Article							DIETARY DIVERSITY; HOUSEHOLD DIET; NUTRITIONAL-STATUS; MARKET ACCESS; SYSTEM; IMPACT; INCOME; INTERVENTIONS; BIODIVERSITY; QUALITY	Many of the world's food-insecure and undernourished people are smallholder farmers in developing countries. This is especially true in Africa. There is an urgent need to make smallholder agriculture and food systems more nutrition-sensitive. African farm households are known to consume a sizeable part of what they produce at home. Less is known about how much subsistence agriculture actually contributes to household diets, and how this contribution changes seasonally. We use representative data from rural Ethiopia covering every month of one full year to address this knowledge gap. On average, subsistence production accounts for 58% of rural households' calorie consumption, that is, 42% of the calories consumed are from purchased foods. Some seasonal variation occurs. During the lean season, purchased foods account for more than half of all calories consumed. But even during the main harvest and post-harvest season, purchased foods contribute more than one-third to total calorie consumption. Markets are even more important for dietary quality. During all seasons, purchased foods play a much larger role for dietary diversity than subsistence production. These findings suggest that strengthening rural markets needs to be a key element in strategies to improve food security and dietary quality in the African small-farm sector.	[Sibhatu, Kibrom T.; Qaim, Matin] Univ Gottingen, Dept Agr Econ & Rural Dev, Pl Goettinger Sieben 5, Gottingen, Germany; [Qaim, Matin] Univ Gottingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany	University of Gottingen; University of Gottingen	Qaim, M (corresponding author), Univ Gottingen, Dept Agr Econ & Rural Dev, Pl Goettinger Sieben 5, Gottingen, Germany.; Qaim, M (corresponding author), Univ Gottingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany.	mqaim@uni-goettingen.de	Sibhatu, Kibrom T./AAE-8005-2019; Qaim, Matin/P-4489-2016	Sibhatu, Kibrom T./0000-0002-3063-8369; Qaim, Matin/0000-0003-4143-0763	German Research Foundation [RTG 1666]	German Research Foundation(German Research Foundation (DFG))	Funding was provided by the German Research Foundation (www.dfg.de), grant number RTG 1666 (GlobalFood). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abay K, 2017, J DEV STUD, V53, P1414, DOI 10.1080/00220388.2016.1251586; Babatunde RO, 2010, FOOD POLICY, V35, P303, DOI 10.1016/j.foodpol.2010.01.006; Bachewe F, 2016, 90 INT FOOD POL RES; Barrett C. B., 2010, AFRICAN FOOD SYSTEM, P242; Burlingame B, 2012, SUSTAINABLE DIETS AN; Central Statistical Agency of Ethiopia, 2012, STAT B, V563; Central Statistical Agency of Ethiopia, 2006, STAT B, V365; Central Statistical Agency of Ethiopia Ethiopian Development Research Institute and International Food Policy Research Institute, 2016, ATL ETH RUR EC ADD A; Chiputwa B, 2016, J DEV STUD, V52, P1241, DOI 10.1080/00220388.2016.1156090; Deckelbaum RJ, 2006, FOOD NUTR BULL, V27, P335, DOI 10.1177/156482650602700408; Dorosh P, 2010, 13 ETH STRAT SUPP PR; Duflo E., 2004, INTRAHOUSEHOLD RESOU, DOI [10.3386/W10498, DOI 10.3386/W10498]; Ericksen PJ, 2009, ENVIRON SCI POLICY, V12, P373, DOI 10.1016/j.envsci.2009.04.007; Ethiopian Health and Nutrition Research Institute, 1998, FOOD COMP TABL US 4; FAO, 2011, GUID MEAS HOUS IND D; FAO, 2014, STAT FOOD AGR INN FA; FAO (Food and Agriculture Organization), 2001, HUMAN ENERGY REQUIRE; Fischer E, 2012, FOOD SECUR, V4, P441, DOI 10.1007/s12571-012-0199-7; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agricultural Organization of the United Nations (FAO), 2015, EC LIV SMALLH FARM A; Frelat R, 2016, P NATL ACAD SCI USA, V113, P458, DOI 10.1073/pnas.1518384112; Frison EA, 2006, FOOD NUTR BULL, V27, P167, DOI 10.1177/156482650602700208; Gilbert CL, 2017, FOOD POLICY, V67, P119, DOI 10.1016/j.foodpol.2016.09.016; Global Panel on Agriculture and Food Systems for Nutrition, 2016, FOOD SYSTEMS DIETS F; Hassen IW, 2016, 87 INT FOOD POL RES; Headey D, 2013, FOOD SECUR, V5, P327, DOI 10.1007/s12571-013-0253-0; Hengsdijk H., 2014, SMALL IS BEAUTIFUL F; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; Hirvonen K, 2017, AGR ECON-BLACKWELL, V48, P469, DOI 10.1111/agec.12348; Hirvonen K, 2016, PUBLIC HEALTH NUTR, V19, P1723, DOI 10.1017/S1368980015003237; HODDINOTT J, 1995, OXFORD B ECON STAT, V57, P77, DOI 10.1111/j.1468-0084.1995.tb00028.x; Hoddinott J., 2002, 136 IFPRIFCND; Hoddinott J, 2015, J DEV STUD, V51, P958, DOI 10.1080/00220388.2015.1018903; Hunter D, 2013, ISS AGRIC DIVERS, P1; IFPRI, 2016, GLOB NUTR REP 2016; International Household Survey Network, ETH HOUS CONS EXP SU; Jones AD, 2017, J NUTR, V147, P86, DOI 10.3945/jn.116.235879; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Koppmair S, 2017, PUBLIC HEALTH NUTR, V20, P325, DOI [10.1017/S1368980016002135, 10.1017/s1368980016002135]; Luckett BG, 2015, PUBLIC HEALTH NUTR, V18, P2479, DOI 10.1017/S136898001500169X; Maleta K, 2003, ACTA PAEDIATR, V92, P491, DOI 10.1111/j.1651-2227.2003.tb00584.x; Masset E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8222; Pandey VL, 2016, FOOD POLICY, V62, P28, DOI 10.1016/j.foodpol.2016.05.002; Pingali P, 2015, FOOD SECUR, V7, P583, DOI 10.1007/s12571-015-0461-x; Pinstrup-Andersen P, 2013, LANCET, V382, P375, DOI 10.1016/S0140-6736(13)61053-3; Popkin BM, 2014, FOOD POLICY, V47, P91, DOI 10.1016/j.foodpol.2014.05.001; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Qaim M, 2017, P NUTR SOC, V76, P12, DOI 10.1017/S0029665116000598; Qaim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064879; RAVALLION M, 1994, AM ECON REV, V84, P359; Romeo A, 2016, FOOD SECUR, V8, P1069, DOI 10.1007/s12571-016-0617-3; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; Savy M, 2006, J NUTR, V136, P2625, DOI 10.1093/jn/136.10.2625; Sibhatu K.T., 2016, 80 U GOETT; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Snapp SS, 2015, FOOD SECUR, V7, P83, DOI 10.1007/s12571-014-0410-0; Stephens EC, 2011, J AGR ECON, V62, P1, DOI 10.1111/j.1477-9552.2010.00274.x; Stifel D, 2015, 77 INT FOOD POL RES; Taffesse A.S., 2012, FOOD AGR ETHIOPIA PR, P53, DOI DOI 10.1080/20964129.2020.1819168; Tschirley D, 2015, J INT DEV, V27, P628, DOI 10.1002/jid.3107; Turner R, 2013, FOOD NUTR BULL, V34, P369, DOI 10.1177/156482651303400401; UNICEF & WHO, 2017, STAT FOOD SEC NUTR W; Upton JB, 2016, AGR ECON-BLACKWELL, V47, P135, DOI 10.1111/agec.12305; van Wesenbeeck CFA, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-37; Worku I, 2015, 87 INT FOOD POL RES; *WORLD BANK, 2007, WORLD DEV REP 2008 A	67	107	109	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2017	12	10							e0186406	10.1371/journal.pone.0186406	http://dx.doi.org/10.1371/journal.pone.0186406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0UN	29049329	Green Published, Green Submitted, gold			2022-12-26	WOS:000413195900064
J	Orozco-Beltran, D; Gil-Guillen, VF; Redon, J; Martin-Moreno, JM; Pallares-Carratala, V; Navarro-Perez, J; Valls-Roca, F; Sanchis-Domenech, C; Fernandez-Gimenez, A; Perez-Navarro, A; Bertomeu-Martinez, V; Bertomeu-Gonzalez, V; Cordero, A; de la Torre, MP; Trillo, JL; Carratala-Munuera, C; Pita-Fernandez, S; Uso, R; Durazo-Arvizu, R; Cooper, R; Sanz, G; Castellano, JM; Ascaso, JF; Carmena, R; Tellez-Plaza, M				Orozco-Beltran, Domingo; Gil-Guillen, Vicente F.; Redon, Josep; Martin-Moreno, Jose M.; Pallares-Carratala, Vicente; Navarro-Perez, Jorge; Valls-Roca, Francisco; Sanchis-Domenech, Carlos; Fernandez-Gimenez, Antonio; Perez-Navarro, Ana; Bertomeu-Martinez, Vicente; Bertomeu-Gonzalez, Vicente; Cordero, Alberto; de la Torre, Manuel Pascual; Trillo, Jose L.; Carratala-Munuera, Concepcion; Pita-Fernandez, Salvador; Uso, Ruth; Durazo-Arvizu, Ramon; Cooper, Richard; Sanz, Gines; Castellano, Jose M.; Ascaso, Juan F.; Carmena, Rafael; Tellez-Plaza, Maria		ESCARVAL Study Grp	Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; ELECTRICITY GENERATING AUTHORITY; RANDOMIZED CONTROLLED-TRIALS; PREDICTION MODEL; HDL CHOLESTEROL; OLDER-PEOPLE; SERUM-LIPIDS; EVENTS; HEALTH	Introduction The potential impact of targeting different components of an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association between different components of the standard lipid profile with allcause mortality and hospitalization due to cardiovascular events in a high-risk population. Methods This prospective registry included high risk adults over 30 years old free of cardiovascular disease (2008-2012). Diagnosis of hypertension, dyslipidemia or diabetes mellitus was inclusion criterion. Lipid biomarkers were evaluated. Primary endpoints were all-cause mortality and hospital admission due to coronary heart disease or stroke. We estimated adjusted rate ratios (aRR), absolute risk differences and population attributable risk associated with adverse lipid profiles. Results 51,462 subjects were included with a mean age of 62.6 years (47.6% men). During an average follow-up of 3.2 years, 919 deaths, 1666 hospitalizations for coronary heart disease and 1510 hospitalizations for stroke were recorded. The parameters that showed an increased rate for total mortality, coronary heart disease and stroke hospitalization were, respectively, low HDL-Cholesterol: aRR 1.25, 1.29 and 1.23; high Total/HDL-Cholesterol: aRR 1.22, 1.38 and 1.25; and high Triglycerides/HDL-Cholesterol: aRR 1.21, 1.30, 1.09. The parameters that showed highest population attributable risk (%) were, respectively, low HDL-Cholesterol: 7.70, 11.42, 8.40; high Total/HDL-Cholesterol: 6.55, 12.47, 8.73; and high Triglycerides/HDL-Cholesterol: 8.94, 15.09, 6.92. Conclusions In a population with cardiovascular risk factors, HDL-cholesterol, Total/HDL-cholesterol and triglycerides/HDL-cholesterol ratios were associated with a higher population attributable risk for cardiovascular disease compared to other common biomarkers.	[Orozco-Beltran, Domingo; Gil-Guillen, Vicente F.; Carratala-Munuera, Concepcion] Miguel Hernandez Univ, Catedra Med Familia, Alacant, Spain; [Redon, Josep; Navarro-Perez, Jorge] Hosp Clin Valencia, Dept Internal Med, Valencia, Spain; [Redon, Josep; Navarro-Perez, Jorge] INCLIVA Res Inst, Valencia, Spain; [Redon, Josep] ISCIII, CIBERObn, Madrid, Spain; [Martin-Moreno, Jose M.] Univ Valencia, Med Sch, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Pallares-Carratala, Vicente] Jaume I Univ, Dept Med, Mutual Soc Castellon, Hlth Surveillance Dept, Castellon de La Plana, Spain; [Navarro-Perez, Jorge] Univ Valencia, Dept Med, Valencia, Spain; [Valls-Roca, Francisco] Generalitat Valenciana, Hlth Ctr Beniganim, Valencia, Spain; [Sanchis-Domenech, Carlos] Generalitat Valenciana, Hlth Ctr Algemesi, Valencia, Spain; [Fernandez-Gimenez, Antonio; Perez-Navarro, Ana] ESCARVAL Project, Valencia, Spain; [Bertomeu-Martinez, Vicente; Bertomeu-Gonzalez, Vicente; Cordero, Alberto] Hosp Univ San Juan de Alicante, Dept Cardiol, Alacant, Spain; [Bertomeu-Martinez, Vicente; Bertomeu-Gonzalez, Vicente; Cordero, Alberto] Miguel Hernandez Univ, Dept Clin Med, Alacant, Spain; [de la Torre, Manuel Pascual] Conselleria Sanitat, Elect Hlth Record Off, Biomed Informat, Valencia, Spain; [Trillo, Jose L.] Hosp Clin Valencia, Dept Pharm, Valencia, Spain; [Pita-Fernandez, Salvador] Univ A Coruna, SERGAS, CHUAC, Clin Epidemiol & Biostat Unit, La Coruna, Spain; [Uso, Ruth] Conselleria Sanitat, Pharm Management, Valencia, Spain; [Durazo-Arvizu, Ramon; Cooper, Richard] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL USA; [Sanz, Gines; Castellano, Jose M.] CNIC, Natl Cardiovasc Res Ctr, Madrid, Spain; [Castellano, Jose M.] Hosp Univ HM Monteprincipe, HM Hosp, Madrid, Spain; [Ascaso, Juan F.; Carmena, Rafael] Univ Valencia, Hosp Clin Valencia, Serv Endocrinol & Nutr, Valencia, Spain; [Ascaso, Juan F.; Carmena, Rafael] Carlos III, Ciber Diabet & Enfermedades Metabol CIBERDEM, INCLIVA Res Inst, Valencia, Spain; [Tellez-Plaza, Maria] Hosp Clin Valencia, Inst Biomed Res, Valencia, Spain; [Tellez-Plaza, Maria] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Valencia; Universitat Jaume I; University of Valencia; Universidad Miguel Hernandez de Elche; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Loyola University Chicago; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Orozco-Beltran, D (corresponding author), Miguel Hernandez Univ, Catedra Med Familia, Alacant, Spain.	dorozcobeltran@gmail.com; josep.redon@uv.es; maria.tellez@uv.es	Castellano, José María/L-8097-2014; Bertomeu-Gonzalez, Vicente/AAA-9850-2020; Tellez-Plaza, Maria/AAL-9820-2021; REDON, JOSEP/E-1719-2019; Guillén, Vicente Francisco Gil/AAE-8201-2019; CARRATALA, VICENTE PALLARES/AAH-5511-2019; Carratala-Munuera, Concepcion/ABH-1205-2020; Cordero, Alberto/GNW-2600-2022; Redon, Josep/L-5997-2019	Castellano, José María/0000-0003-3624-1298; Bertomeu-Gonzalez, Vicente/0000-0001-5309-0562; Tellez-Plaza, Maria/0000-0002-3850-1228; CARRATALA, VICENTE PALLARES/0000-0002-2985-6078; Carratala-Munuera, Concepcion/0000-0002-1303-6294; Cordero, Alberto/0000-0003-0000-7109; Redon, Josep/0000-0001-8777-6773; Gil-Guillen, Vicente F/0000-0003-3793-9786; Orozco-Beltran, Domingo/0000-0002-8231-2635				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Andersson C, 2014, AM HEART J, V168, P878, DOI 10.1016/j.ahj.2014.08.007; Arsenault BJ, 2009, J AM COLL CARDIOL, V55, P35, DOI 10.1016/j.jacc.2009.07.057; Assmann G, 1998, EUR HEART J, V19, pA2; Azimi SS, 2015, J RES HEALTH SCI, V15, P22; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; BRINDLE P, 2003, BRIT MED J, V327, P1; Bruckert E, 2007, INT J CLIN PRACT, V61, P1905, DOI 10.1111/j.1742-1241.2007.01509.x; Casey JA, 2016, ANNU REV PUBL HEALTH, V37, P61, DOI 10.1146/annurev-publhealth-032315-021353; Colantonio LD, 2016, CIRCULATION, V133, P256, DOI 10.1161/CIRCULATIONAHA.115.011646; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Elshazly MB, 2015, CIRCULATION, V132, P667, DOI 10.1161/CIRCULATIONAHA.115.016163; ETTINGER WH, 1992, CIRCULATION, V86, P858, DOI 10.1161/01.CIR.86.3.858; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gabriel R, 2014, REV ESP CARDIOL, VS1885-5857, P00244; GBD 2013 Mortality and Causes of Death Collaborators, 2014, GLOB REG NAT AG SEX; Gil-Guillen V, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-717; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; Khalili D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105804; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Kontush A, 2014, CARDIOVASC RES, V103, P341, DOI 10.1093/cvr/cvu147; LAMARCHE B, 1995, AM J CARDIOL, V75, P1189, DOI 10.1016/S0002-9149(99)80760-7; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Marrugat J, 2014, PREV MED, V61, P66, DOI 10.1016/j.ypmed.2013.12.031; Mora S, 2015, CIRCULATION, V132, P2220, DOI 10.1161/CIRCULATIONAHA.115.016857; National Clinical Guideline Centre (UK), 2014, NICE CLINICAL GUIDEL; Pikula A, 2015, NEUROLOGY, V84, P472, DOI 10.1212/WNL.0000000000001202; Pinies JA, 2014, DIABETOLOGIA, V57, P2324, DOI 10.1007/s00125-014-3370-1; Pocock SJ, 2001, BMJ-BRIT MED J, V323, P75, DOI 10.1136/bmj.323.7304.75; Reddy VS, 2015, AM J CARDIOL, V115, P557, DOI 10.1016/j.amjcard.2014.12.006; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Sritara P, 2003, INT J EPIDEMIOL, V32, P461, DOI 10.1093/ije/dyg105; Sritara P, 2007, ANGIOLOGY, V58, P757, DOI 10.1177/0003319707304042; Tikhonoff V, 2005, J AM GERIATR SOC, V53, P2159, DOI 10.1111/j.1532-5415.2005.00492.x; Toth PP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-109	39	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186196	10.1371/journal.pone.0186196	http://dx.doi.org/10.1371/journal.pone.0186196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045483	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100041
J	Wood, S; Krishnamurthy, N; Santini, T; Raval, S; Farhat, N; Holmes, JA; Ibrahim, TS				Wood, Sossena; Krishnamurthy, Narayanan; Santini, Tales; Raval, Shailesh; Farhat, Nadim; Holmes, John Andy; Ibrahim, Tamer S.			Design and fabrication of a realistic anthropomorphic heterogeneous head phantom for MR purposes	PLOS ONE			English	Article							POWER REQUIREMENTS; QUALITY-ASSURANCE; MULTICENTER FMRI; NOISE-RATIO; FIELD; ABSORPTION; ACTIVATION; DEPOSITION; TISSUE; COILS	Objective The purpose of this study is to design an anthropomorphic heterogeneous head phantom that can be used for MRI and other electromagnetic applications. Materials and methods An eight compartment, physical anthropomorphic head phantom was developed from a 3T MRI dataset of a healthy male. The designed phantom was successfully built and preliminarily evaluated through an application that involves electromagnetic-tissue interactions: MRI (due to it being an available resource). The developed phantom was filled with media possessing electromagnetic constitutive parameters that correspond to biological tissues at similar to 297 MHz. A preliminary comparison between an in-vivo human volunteer (based on whom the anthropomorphic head phantom was created) and various phantoms types, one being the anthropomorphic heterogeneous head phantom, were performed using a 7 Tesla human MRI scanner. Results Echo planar imaging was performed and minimal ghosting and fluctuations were observed using the proposed anthropomorphic phantom. The magnetic field distributions (during MRI experiments at 7 Tesla) and the scattering parameter (measured using a network analyzer) were most comparable between the anthropomorphic heterogeneous head phantom and an in-vivo human volunteer. Conclusion The developed anthropomorphic heterogeneous head phantom can be used as a resource to various researchers in applications that involve electromagnetic-biological tissue interactions such as MRI.	[Wood, Sossena; Krishnamurthy, Narayanan; Santini, Tales; Raval, Shailesh; Farhat, Nadim; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Holmes, John Andy] Univ Pittsburgh, Swanson Ctr Product Innovat, Pittsburgh, PA USA; [Ibrahim, Tamer S.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	tibrahim@pitt.edu	Raval, Shailesh/O-5176-2019	Raval, Shailesh/0000-0001-9202-236X; Wood, Susan/0000-0002-8319-612X; Santini, Tales/0000-0003-4533-9190; Fugh-Berman, Adriane/0000-0002-1717-7617	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [1F31EB019872-02, 1R01MH111265-01, 1R01EB009848-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062065] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work reported in this publication is supported by National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under award numbers: 1F31EB019872-02 (https://projectreporter.nih.gov/ project_info_details.cfm?icde=0&aid=8838518), 1R01MH111265-01 (https://projectreporter.nih.gov/proiect_info_details.cfm?aid=9196861&icde= 32699708&daparam=&ddvalue=&ddsub=&cr1&csb=default&cs=ASC&pball=), and 1R01EB009848-01 (https://projectreporter.nih.gov/ project_info_details.cfm?aid=8287175&icde= 32705670). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (https://www.nibib.nih.gov/).	Alon L, 2015, MAGN RESON MED, V74, P1397, DOI 10.1002/mrm.25521; Angelone LM, 2006, MAGN RESON IMAGING, V24, P801, DOI 10.1016/j.mri.2006.01.006; Caon M, 2004, RADIAT ENVIRON BIOPH, V42, P229, DOI 10.1007/s00411-003-0221-8; Chen CC, 2004, J DIGIT IMAGING, V17, P279, DOI 10.1007/s10278-004-1023-5; Chen X, 2013, COMPUTATIONAL ANAL M; CHOU CK, 1984, BIOELECTROMAGNETICS, V5, P435, DOI 10.1002/bem.2250050408; Christ A, 2005, BIOELECTROMAGNETICS, V26, P125, DOI 10.1002/bem.20088; Collins CM, 2011, MAGN RESON MED, V65, P1470, DOI 10.1002/mrm.22845; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Friedman L, 2006, NEUROIMAGE, V33, P471, DOI 10.1016/j.neuroimage.2006.07.012; Fukunaga K, P 11 INT S EL IEEE; Gabriel C, 1998, CHEM SOC REV, V27, P213, DOI 10.1039/a827213z; Gandhi OP, 1996, IEEE T MICROW THEORY, V44, P1884, DOI 10.1109/22.539947; Graedel NN, 2015, MAGN RESON MED, V73, P442, DOI 10.1002/mrm.25123; Hoult DI, 2000, J MAGN RESON IMAGING, V12, P46, DOI 10.1002/1522-2586(200007)12:1<46::AID-JMRI6>3.0.CO;2-D; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; Huber JS, 2009, IEEE T NUCL SCI, V56, P2722, DOI 10.1109/TNS.2009.2028073; Ibrahim TS, 2007, J MAGN RESON IMAGING, V25, P1235, DOI 10.1002/jmri.20919; Ibrahim TS, 2009, NMR BIOMED, V22, P927, DOI 10.1002/nbm.1406; Ibrahim TS, 2004, IEEE T MICROW THEORY, V52, P1999, DOI 10.1109/TMTT.2004.832021; Ibrahim TS, 2005, MAGN RESON MED, V54, P683, DOI 10.1002/mrm.20596; Ikemoto Y, 2011, MED PHYS, V38, P6336, DOI 10.1118/1.3656077; Jurgen K, 2010, HUMAN BRAIN ATLAS HU; Kato H, 2005, MED PHYS, V32, P3199, DOI 10.1118/1.2047807; Kim GB, 2016, KOREAN J RADIOL, V17, P182, DOI 10.3348/kjr.2016.17.2.182; Krishnamurthy N, 2014, J MAGN RESON IMAGING, V39, P475, DOI 10.1002/jmri.24152; Liu YL, 2013, IEEE INT WORKS GENET, P1, DOI 10.1109/GEFS.2013.6601048; Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001; Mobashsher AT, 2014, IEEE ANTENN WIREL PR, V13, DOI 10.1109/LAWP.2014.2340409; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Oh S, 2010, MAGN RESON MED, V63, P218, DOI 10.1002/mrm.22174; Pang Y, 2014, QUANT IMAGING MED SU, V4, P50, DOI 10.3978/j.issn.2223-4292.2014.02.07; Pizarro YAA, 2014, SPECIFIC ABSORPTION; Radiology ACo, 2004, RADIOLOGY, P1; Shmueli K, 2007, J MAGN RESON IMAGING, V26, P202, DOI 10.1002/jmri.20993; Simmons A, 1999, MAGNETIC RESONANCE M; Tang L, 2011, CONCEPT MAGN RESON B, V39B, P11, DOI 10.1002/cmr.b.20185; Tofts PS, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, P55, DOI 10.1002/0470869526.ch3; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; VAUGHAN JT, 1994, MAGNET RESON MED, V32, P206, DOI 10.1002/mrm.1910320209; Weisskoff RM, 1996, MAGN RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wood S, ANATOMICALLY DETAILE; Yang QX, 2004, MAGN RESON MED, V52, P1016, DOI 10.1002/mrm.20245; Zhang XT, 2013, IEEE T MED IMAGING, V32, P1058, DOI 10.1109/TMI.2013.2251653	45	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183168	10.1371/journal.pone.0183168	http://dx.doi.org/10.1371/journal.pone.0183168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806768	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800059
